PMID- 33634751
OWN - NLM
STAT- MEDLINE
DCOM- 20220314
LR  - 20240102
IS  - 1554-8635 (Electronic)
IS  - 1554-8627 (Print)
IS  - 1554-8627 (Linking)
VI  - 17
IP  - 1
DP  - 2021 Jan
TI  - Guidelines for the use and interpretation of assays for monitoring autophagy (4th 
      edition)(1).
PG  - 1-382
LID - 10.1080/15548627.2020.1797280 [doi]
AB  - In 2008, we published the first set of guidelines for standardizing research in 
      autophagy. Since then, this topic has received increasing attention, and many 
      scientists have entered the field. Our knowledge base and relevant new 
      technologies have also been expanding. Thus, it is important to formulate on a 
      regular basis updated guidelines for monitoring autophagy in different organisms. 
      Despite numerous reviews, there continues to be confusion regarding acceptable 
      methods to evaluate autophagy, especially in multicellular eukaryotes. Here, we 
      present a set of guidelines for investigators to select and interpret methods to 
      examine autophagy and related processes, and for reviewers to provide realistic 
      and reasonable critiques of reports that are focused on these processes. These 
      guidelines are not meant to be a dogmatic set of rules, because the 
      appropriateness of any assay largely depends on the question being asked and the 
      system being used. Moreover, no individual assay is perfect for every situation, 
      calling for the use of multiple techniques to properly monitor autophagy in each 
      experimental setting. Finally, several core components of the autophagy machinery 
      have been implicated in distinct autophagic processes (canonical and noncanonical 
      autophagy), implying that genetic approaches to block autophagy should rely on 
      targeting two or more autophagy-related genes that ideally participate in 
      distinct steps of the pathway. Along similar lines, because multiple proteins 
      involved in autophagy also regulate other cellular pathways including apoptosis, 
      not all of them can be used as a specific marker for bona fide autophagic 
      responses. Here, we critically discuss current methods of assessing autophagy and 
      the information they can, or cannot, provide. Our ultimate goal is to encourage 
      intellectual and technical innovation in the field.
FAU - Klionsky, Daniel J
AU  - Klionsky DJ
AD  - Life Sciences Institute and Department of Molecular, Cellular and Developmental 
      Biology, University of Michigan, Ann Arbor, MI, USA.
FAU - Abdel-Aziz, Amal Kamal
AU  - Abdel-Aziz AK
AD  - Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams 
      University, Cairo, Egypt; Department of Experimental Oncology, IEO, European 
      Institute of Oncology IRCCS, Milan, Italy.
FAU - Abdelfatah, Sara
AU  - Abdelfatah S
AD  - Johannes Gutenberg University, Institute of Pharmaceutical and Biomedical 
      Sciences, Department of Pharmaceutical Biology, Mainz, Germany.
FAU - Abdellatif, Mahmoud
AU  - Abdellatif M
AD  - Medical University of Graz, Division of Cardiology, Graz, Austria.
FAU - Abdoli, Asghar
AU  - Abdoli A
AD  - Pasteur institute of Iran, Department of Hepatitis and HIV, Tehran, Iran.
FAU - Abel, Steffen
AU  - Abel S
AD  - Department of Molecular Signal Processing, Leibniz Institute of Plant 
      Biochemistry, Halle (Saale), Germany.
FAU - Abeliovich, Hagai
AU  - Abeliovich H
AD  - Hebrew University of Jerusalem, Department of Biochemistry and Food Science, 
      Rehovot, Israel.
FAU - Abildgaard, Marie H
AU  - Abildgaard MH
AD  - Danish Cancer Society Research Center, RNA and Autophagy Group, Copenhagen, 
      Denmark.
AD  - University of Copenhagen, Biotech Research and Innovation Centre, Copenhagen, 
      Denmark.
FAU - Abudu, Yakubu Princely
AU  - Abudu YP
AD  - University of Tromsø - The Arctic University of Norway, Department of Medical 
      Biology, Tromsø, Norway.
FAU - Acevedo-Arozena, Abraham
AU  - Acevedo-Arozena A
AD  - Hospital Universitario de Canarias, Research Unit; CIBERNED and Universidad de La 
      Laguna, ITB, Santa Cruz de Tenerife, Spain.
FAU - Adamopoulos, Iannis E
AU  - Adamopoulos IE
AD  - University of California, Davis, Division of Rheumatology, Allergy and Clinical 
      Immunology, School of Medicine, Sacramento, CA, USA.
FAU - Adeli, Khosrow
AU  - Adeli K
AD  - University of Toronto, Department of Biochemistry, Toronto, Ontario, Canada.
FAU - Adolph, Timon E
AU  - Adolph TE
AD  - Medical University Innsbruck, Department of Medicine I, Innsbruck, Austria.
FAU - Adornetto, Annagrazia
AU  - Adornetto A
AD  - University of Calabria, Department of Pharmacy, Health and Nutritional Sciences, 
      Arcavacata di Rende (CS), Italy.
FAU - Aflaki, Elma
AU  - Aflaki E
AD  - National Institutes of Health, National Eye institute, Protein Structure and 
      Function Section, Bethesda, MD, USA.
FAU - Agam, Galila
AU  - Agam G
AD  - Ben-Gurion University of the Negev, Faculty of Health Sciences, Department of 
      Clinical Biochemistry and Pharmacology, Beer-Sheva, Israel.
FAU - Agarwal, Anupam
AU  - Agarwal A
AD  - University of Alabama at Birmingham, Division of Nephrology and Birmingham VA 
      Medical Center, Birmingham, AL, USA.
FAU - Aggarwal, Bharat B
AU  - Aggarwal BB
AD  - Inflammation Research Center, San Diego, CA, USA.
FAU - Agnello, Maria
AU  - Agnello M
AD  - University of Palermo, Dipartimento di Scienze e Tecnologie Biologiche, Chimiche 
      e Farmaceutiche (STEBICEF), Palermo, Italy.
FAU - Agostinis, Patrizia
AU  - Agostinis P
AD  - Cell Death Research & Therapy (CDRT) Lab, Department of Cellular & Molecular 
      Medicine, Center for Cancer Biology, VIB-KU Leuven, Leuven, Belgium.
FAU - Agrewala, Javed N
AU  - Agrewala JN
AD  - Indian Institute of Technology, Ropar, India.
FAU - Agrotis, Alexander
AU  - Agrotis A
AD  - University of Dundee, School of Life Sciences, MRC Protein Phosphorylation and 
      Ubiquitylation Unit, Dundee, UK.
FAU - Aguilar, Patricia V
AU  - Aguilar PV
AD  - University of Texas Medical Branch, Department of Pathology, Galveston, TX, USA.
FAU - Ahmad, S Tariq
AU  - Ahmad ST
AD  - Colby College, Department of Biology, Waterville, ME, USA.
FAU - Ahmed, Zubair M
AU  - Ahmed ZM
AD  - University of Maryland School of Medicine, Departments of Otorhinolaryngology 
      Head & Neck Surgery, Ophthalmology and Visual Science, Baltimore, MD, USA.
FAU - Ahumada-Castro, Ulises
AU  - Ahumada-Castro U
AD  - Universidad Mayor, Center for Integrative Biology, and Geroscience Center for 
      Brain Health and Metabolism, Santiago, Chile.
FAU - Aits, Sonja
AU  - Aits S
AD  - Lund University, Department of Experimental Medical Science, Cell Death, 
      Lysosomes and Artificial Intelligence Group, Lund, Sweden.
FAU - Aizawa, Shu
AU  - Aizawa S
AD  - Nihon University, College of Bioresource Sciences, Fujisawa, Kanagawa, Japan.
FAU - Akkoc, Yunus
AU  - Akkoc Y
AD  - Koç University School of Medicine, Department of Molecular Biology and Genetics 
      and KUTTAM Research Center for Translational Medicine, Istanbul, Turkey.
FAU - Akoumianaki, Tonia
AU  - Akoumianaki T
AD  - University of Crete, School of Medicine, Laboratory of Clinical Microbiology and 
      Microbial Pathogenesis, Voutes, Heraklion, Crete, Greece; Foundation for Research 
      and Technology, Institute of Molecular Biology and Biotechnology (IMBB), 
      Heraklion, Crete, Greece.
AD  - University of Crete, School of Medicine, Laboratory of Clinical Microbiology and 
      Microbial Pathogenesis, Voutes, Heraklion, Crete, Greece.
FAU - Akpinar, Hafize Aysin
AU  - Akpinar HA
AD  - The Institute of Cancer Research, Cancer Therapeutics Unit, Sutton, UK.
FAU - Al-Abd, Ahmed M
AU  - Al-Abd AM
AD  - Pharmaceutical Sciences Department, College of Pharmacy, Gulf Medical University, 
      Ajman, United Arab Emirates.
FAU - Al-Akra, Lina
AU  - Al-Akra L
AD  - University of Sydney, Department of Pathology and Bosch Institute, Sydney, NSW, 
      Australia.
FAU - Al-Gharaibeh, Abeer
AU  - Al-Gharaibeh A
AD  - Insight Institute of Neurosurgery & Neuroscience, Department of Research, Flint, 
      MI, USA.
FAU - Alaoui-Jamali, Moulay A
AU  - Alaoui-Jamali MA
AD  - McGill University, Departments of Medicine and Oncology and Segal Cancer Centre, 
      Montreal, Quebec, Canada.
FAU - Alberti, Simon
AU  - Alberti S
AD  - Technical University Dresden, Center for Molecular and Cellular Bioengineering 
      (CMCB), Biotechnology Center (BIOTEC), Department of Cellular Biochemistry, 
      Dresden, Germany.
FAU - Alcocer-Gómez, Elísabet
AU  - Alcocer-Gómez E
AD  - Universidad de Sevilla, Departamento de Psicología Experimental, Facultad de 
      Psicología, Sevilla, Spain.
FAU - Alessandri, Cristiano
AU  - Alessandri C
AD  - Sapienza University of Rome, Department of Clinical, Internal, Anesthesiological 
      and Cardiovascular Sciences, Rome, Italy.
FAU - Ali, Muhammad
AU  - Ali M
AD  - The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, 
      MD, USA.
FAU - Alim Al-Bari, M Abdul
AU  - Alim Al-Bari MA
AD  - University of Rajshahi, Department of Pharmacy, Rajshahi, Bangladesh.
FAU - Aliwaini, Saeb
AU  - Aliwaini S
AD  - Department of Biological Sciences and Biotechnology, Faculty of Sciences, Islamic 
      University of Gaza, Gaza 108, Palestine.
FAU - Alizadeh, Javad
AU  - Alizadeh J
AD  - Department of Human Anatomy and Cell Science, Max Rady College of Medicine, Rady 
      Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
FAU - Almacellas, Eugènia
AU  - Almacellas E
AD  - University of Barcelona, Faculty of Pharmacy, Department of Biochemistry and 
      Physiology, Barcelona, Spain.
AD  - Metabolism and Cancer Laboratory, Molecular Mechanisms and Experimental Therapy 
      in Oncology Program (Oncobell), Institut d'Investigació Biomèdica de Bellvitge - 
      IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
AD  - The Francis Crick Institute, Molecular Cell Biology of Autophagy, London, UK.
FAU - Almasan, Alexandru
AU  - Almasan A
AD  - Cleveland Clinic, Department of Cancer Biology, Cleveland, OH, USA.
FAU - Alonso, Alicia
AU  - Alonso A
AD  - University of the Basque Country, Instituto Biofisika (UPV/EHU, CSIC), and 
      Department of Biochemistry and Molecular Biology, Leioa, Spain.
FAU - Alonso, Guillermo D
AU  - Alonso GD
AD  - Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. 
      Héctor N. Torres", Laboratorio de señalización y mecanismos adaptativos en 
      Tripanosomátidos, Buenos Aires, Argentina; Universidad de Buenos Aires, 
      Departamento de Fisiología, Biología Molecular y Celular, Facultad de Ciencias 
      Exactas y Naturales, Buenos Aires, Argentina.
FAU - Altan-Bonnet, Nihal
AU  - Altan-Bonnet N
AD  - Laboratory of Host-Pathogen Dynamics, National Heart Lung and Blood Institute, 
      National Institutes of Health, Bethesda, MD, USA.
FAU - Altieri, Dario C
AU  - Altieri DC
AD  - The Wistar Institute, Philadelphia, PA, USA.
FAU - Álvarez, Élida M C
AU  - Álvarez ÉMC
AD  - Buenos Aires University, Biochemistry and Pharmacy School, Deparment of 
      Microbiology Immunology Biotechnology and Genetic, IDEHU, CABA, Argentina.
FAU - Alves, Sara
AU  - Alves S
AD  - Universidade do Porto, i3S-Instituto de Investigação e Inovação em Saúde, Porto, 
      Portugal; IPATIMUP - Institute of Molecular Pathology and Immunology of the 
      University of Porto, Cancer Drug Resistance Group, Porto, Portugal; FFUP - 
      Faculty of Pharmacy of the University of Porto, Department of Biological 
      Sciences, Porto, Portugal.
FAU - Alves da Costa, Cristine
AU  - Alves da Costa C
AD  - Université Côte d'Azur, INSERM, CNRS, IPMC, team labeled Laboratory of Excellence 
      (LABEX) Distalz, Valbonne, France.
FAU - Alzaharna, Mazen M
AU  - Alzaharna MM
AD  - Islamic University of Gaza, Department of Medical Laboratory Sciences, Faculty of 
      Health Sciences, Gaza, Palestine.
FAU - Amadio, Marialaura
AU  - Amadio M
AD  - University of Pavia, Department of Drug Sciences, Pharmacology Unit, Pavia, 
      Italy.
FAU - Amantini, Consuelo
AU  - Amantini C
AD  - University of Camerino, School of Biosciences and Veterinary Medicine, Camerino, 
      Italy.
FAU - Amaral, Cristina
AU  - Amaral C
AD  - University of Porto, Faculty of Pharmacy, UCIBIO, REQUIMTE, Porto, Portugal.
FAU - Ambrosio, Susanna
AU  - Ambrosio S
AD  - Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.
FAU - Amer, Amal O
AU  - Amer AO
AD  - Ohio State University, Department of Microbial Infection and Immunity, and the 
      Infectious Disease Research Institute, Columbus, OH, USA.
FAU - Ammanathan, Veena
AU  - Ammanathan V
AD  - Save as Ravi Manjithaya.
FAU - An, Zhenyi
AU  - An Z
AD  - University of California, San Francisco, San Francisco, CA, USA.
FAU - Andersen, Stig U
AU  - Andersen SU
AD  - Aarhus University, Department of Molecular Biology and Genetics, Aarhus C, 
      Denmark.
FAU - Andrabi, Shaida A
AU  - Andrabi SA
AD  - Departments of Pharmacology and Toxicology, and Neurology, The University of 
      Alabama at Birmingham, Birmingham, AL, USA.
FAU - Andrade-Silva, Magaiver
AU  - Andrade-Silva M
AD  - Federal University of São Paulo, Department of Medicine, Nephrology Division, 
      Laboratory of Clinical and Experimental Immunology, São Paulo, SP, Brazil.
AD  - Universidade Nove de Julho (UNINOVE), Faculty of Pharmacy, São Paulo, SP, Brazil.
FAU - Andres, Allen M
AU  - Andres AM
AD  - Cedars-Sinai Medical Center, Smidt Heart Institute, Los Angeles CA, USA.
FAU - Angelini, Sabrina
AU  - Angelini S
AD  - University of Bologna, Department of Pharmacy and Biotechnology, Bologna, Italy.
FAU - Ann, David
AU  - Ann D
AD  - City of Hope Comprehensive Cancer Center, Beckman Research Institute, Department 
      of Diabetes Complications and Metabolism, Duarte, CA, USA.
FAU - Anozie, Uche C
AU  - Anozie UC
AD  - University of Tennessee, Department of Chemical and Biomolecular Engineering, 
      Knoxville, TN, USA.
FAU - Ansari, Mohammad Y
AU  - Ansari MY
AD  - Northeast Ohio Medical university, Department of Anatomy & Neurobiology, 
      Rootstown, OH, USA.
FAU - Antas, Pedro
AU  - Antas P
AD  - iNOVA4Health Chronic Diseases Research Center (CEDOC), Faculdade de Ciências 
      Médicas, Universidade Nova de Lisboa, Lisboa, Portugal.
FAU - Antebi, Adam
AU  - Antebi A
AD  - Max Planck Institute for Biology of Ageing and CECAD, University of Cologne, 
      Germany.
FAU - Antón, Zuriñe
AU  - Antón Z
AD  - School of Biochemistry, Faculty of Life Sciences, University of Bristol, Bristol, 
      UK.
FAU - Anwar, Tahira
AU  - Anwar T
AD  - University of Helsinki, Molecular and Integrative Biosciences Research Programme, 
      Helsinki, Finland.
FAU - Apetoh, Lionel
AU  - Apetoh L
AD  - INSERM, U1231, Dijon, France.
FAU - Apostolova, Nadezda
AU  - Apostolova N
AD  - University of Valencia, Faculty of Medicine, Department of Pharmacology, 
      Valencia, Spain; CIBERehd (Centre for Networked Biomedical Research in Hepatic 
      and Digestive Diseases), Valencia, Spain.
FAU - Araki, Toshiyuki
AU  - Araki T
AD  - National Institute of Neuroscience, National Center of Neurology and Psychiatry, 
      Department of Peripheral Nervous System Research, Kodaira, Tokyo, Japan.
FAU - Araki, Yasuhiro
AU  - Araki Y
AD  - Osaka University, Graduate School of Dentistry, Osaka, Japan.
FAU - Arasaki, Kohei
AU  - Arasaki K
AD  - Tokyo University of Pharmacy and Life Sciences, School of Life Sciences, 
      Hachioji, Horinouchi, Tokyo, Japan.
FAU - Araújo, Wagner L
AU  - Araújo WL
AD  - Universidade Federal de Viçosa, Departamento de Biologia Vegetal, Viçosa, MG, 
      Brazil.
FAU - Araya, Jun
AU  - Araya J
AD  - The Jikei University School of Medicine, Division of Respiratory Disease, 
      Departent of Internal Medicine, Tokyo, Japan.
FAU - Arden, Catherine
AU  - Arden C
AD  - Newcastle University, Biosciences Institute, Newcastle Upon Tyne, UK.
FAU - Arévalo, Maria-Angeles
AU  - Arévalo MA
AD  - Instituto Cajal, Consejo Superior de Investigaciones Científicas (CSIC) and 
      CIBERFES, Madrid, Spain.
FAU - Arguelles, Sandro
AU  - Arguelles S
AD  - University of Seville, Faculty of Pharmacy, Department of Physiology, Seville, 
      Spain.
FAU - Arias, Esperanza
AU  - Arias E
AD  - Albert Einstein College of Medicine, Department of Medicine, Bronx, NY, USA.
FAU - Arikkath, Jyothi
AU  - Arikkath J
AD  - Howard University College of Medicine, Department of Anatomy, Washington D.C., 
      USA.
FAU - Arimoto, Hirokazu
AU  - Arimoto H
AD  - Tohoku University, Graduate School fo Life Sciences, Sendai, Miyagi, Japan.
FAU - Ariosa, Aileen R
AU  - Ariosa AR
AD  - University of Michigan, Life Sciences Institute, Ann Arbor, MI, USA.
FAU - Armstrong-James, Darius
AU  - Armstrong-James D
AD  - Imperial College London, MRC Centre for Molecular Bacteriolgy and Infection, 
      Department of Microbiology, London, UK.
FAU - Arnauné-Pelloquin, Laetitia
AU  - Arnauné-Pelloquin L
AD  - Toulouse University, CNRS, UPS, Center for Integrative Biology (CBI), Research 
      Center on Animal Cognition (CRCA), Toulouse, France.
FAU - Aroca, Angeles
AU  - Aroca A
AD  - Iowa State University, Department of Genetics, Development and Cell Biology, Roy 
      J. Carver Co-Laboratory, Ames, IA, USA.
FAU - Arroyo, Daniela S
AU  - Arroyo DS
AD  - Universidad Nacional de Cordoba, Laboratorio de Oncohematología, Hospital 
      Nacional de Clínicas, CONICET, Córdoba, Argentina.
FAU - Arsov, Ivica
AU  - Arsov I
AD  - York College/The City University of New York, Department of Biology, Jamaica, NY, 
      USA.
FAU - Artero, Rubén
AU  - Artero R
AD  - Translational Genomics Group, Incliva Health Research Institute, Burjasot, 
      Valencia, Spain; Interdisciplinary Research Structure for Biotechnology and 
      Biomedicine (ERI BIOTECMED), University of Valencia, Burjasot, Valencia, Spain.
FAU - Asaro, Dalia Maria Lucia
AU  - Asaro DML
AD  - University of Palermo, Department of Biological, Chemical and and Pharmaceutical 
      Sciences and Technologies, Palermo, Italy.
FAU - Aschner, Michael
AU  - Aschner M
AD  - Albert Einstein College of Medicine, Department of Molecular Pharmacology, Bronx, 
      NY, USA.
FAU - Ashrafizadeh, Milad
AU  - Ashrafizadeh M
AD  - Faculty of Engineering and Natural Sciences, Sabanci University, Orta Mahalle, 
      Üniversite Caddesi No. 27, Orhanlı, Tuzla, 34956 Istanbul, Turkey; Sabanci 
      University Nanotechnology Research and Application Center (SUNUM), Tuzla, 34956, 
      Istanbul, Turkey.
FAU - Ashur-Fabian, Osnat
AU  - Ashur-Fabian O
AD  - Meir Medical Center, Translational Hemato-Oncology Laboratory, Kfar-Saba, Israel; 
      Tel Aviv University, Department of Human Molecular Genetics and Biochemistry, 
      Sackler School of Medicine, Tel Aviv, Israel.
FAU - Atanasov, Atanas G
AU  - Atanasov AG
AD  - The Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, 
      Magdalenka, Poland; Ludwig Boltzmann Institute for Digital Health and Patient 
      Safety, Medical University of Vienna, Vienna, Austria; Institute of Neurobiology, 
      Bulgarian Academy of Sciences, Sofia, Bulgaria; Department of Pharmacognosy, 
      University of Vienna, Vienna, Austria.
FAU - Au, Alicia K
AU  - Au AK
AD  - University of Pittsburgh Medical Center, Department of Critical Care Medicine, 
      Department of Pediatrics, Safar Center for Resuscitation Research and the 
      Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.
FAU - Auberger, Patrick
AU  - Auberger P
AD  - University of Nice, Mediterranean Center for Molecular Medicine, Inserm U1065, 
      Nice, France.
FAU - Auner, Holger W
AU  - Auner HW
AD  - Imperial College London, Faculty of Medicine, London, UK.
FAU - Aurelian, Laure
AU  - Aurelian L
AD  - Departments of Pharmacology and Microbiology, University of Maryland School of 
      Medicine, Baltimore, MD, USA; Stanford University School of Medicine Stanford, 
      CA, USA.
FAU - Autelli, Riccardo
AU  - Autelli R
AD  - University of Turin, Department of Clinical and Biological Sciences, Turin, 
      Italy.
FAU - Avagliano, Laura
AU  - Avagliano L
AD  - University of Milan, Department of Health Sciences, Milano, Italy.
FAU - Ávalos, Yenniffer
AU  - Ávalos Y
AD  - Universidad de Santiago de Chile, Faculty of Chemistry and Biology, Department of 
      Biology, Santiago, Chile.
FAU - Aveic, Sanja
AU  - Aveic S
AD  - Fondazione Istituto di Ricerca Pediatrica Città della Speranza, Neuroblastoma 
      Laboratory, Padua, Italy.
FAU - Aveleira, Célia Alexandra
AU  - Aveleira CA
AD  - CNC - Center for Neuroscience and Cell Biology, Coimbra, IIIUC - Instituto de 
      Investigação Interdisciplinar, University of Coimbra, Coimbra, Portugal.
FAU - Avin-Wittenberg, Tamar
AU  - Avin-Wittenberg T
AD  - The Hebrew University of Jerusalem, Alexander Silberman Institute of Life 
      Sciences, Department of Plant and Environmental Sciences, Edmond Safra Campus, 
      Jerusalem, Israel.
FAU - Aydin, Yucel
AU  - Aydin Y
AD  - Tulane Health Sciences Center, Department of Pathology and Laboratory Sciences, 
      New Orleans, LA, USA.
FAU - Ayton, Scott
AU  - Ayton S
AD  - Melbourne Dementia Research Centre, The Florey Institute of Neuroscience & Mental 
      Health, The University of Melbourne, Parkville, VIC, Australia.
FAU - Ayyadevara, Srinivas
AU  - Ayyadevara S
AD  - University of Arkansas for Medical Sciences, Department of Geriatrics, Little 
      Rock, AR, USA.
FAU - Azzopardi, Maria
AU  - Azzopardi M
AD  - University of Malta, Department of Physiology & Biochemistry, Msida, Malta.
FAU - Baba, Misuzu
AU  - Baba M
AD  - Kogakuin University, Research Institute for Science and Technology, Hachioji, 
      Tokyo, Japan.
FAU - Backer, Jonathan M
AU  - Backer JM
AD  - Albert Einstein College of Medicine, Departments of Molecular Pharmacology and 
      Biochemistry, Bronx, NY, USA.
FAU - Backues, Steven K
AU  - Backues SK
AD  - Eastern Michigan University, Department of Chemistry, Ypsilanti, MI, USA.
FAU - Bae, Dong-Hun
AU  - Bae DH
AD  - University of Sydney, Department of Pathology and Bosch Institute, Sydney, NSW, 
      Australia.
FAU - Bae, Ok-Nam
AU  - Bae ON
AD  - Hanyang University, College of Pharmacy, Ansan, Gyeonggido, Korea.
FAU - Bae, Soo Han
AU  - Bae SH
AD  - Yonsei University College of Medicine, Severance Biomedical Science Institute, 
      Seoul, Korea.
FAU - Baehrecke, Eric H
AU  - Baehrecke EH
AD  - University of Massachusetts Medical School, Department of Molecular, Cell and 
      Cancer Biology, Worcester, MA, USA.
FAU - Baek, Ahruem
AU  - Baek A
AD  - Konkuk University, Department of Bioscience and Biotechnology, Seoul, Korea.
FAU - Baek, Seung-Hoon
AU  - Baek SH
AD  - Ajou University, College of Pharmacy and Research Institute of Pharmaceutical 
      Science and Technology (RIPST), Suwon, Korea.
FAU - Baek, Sung Hee
AU  - Baek SH
AD  - Seoul National University, Department of Biological Sciences, Seoul, South Korea.
FAU - Bagetta, Giacinto
AU  - Bagetta G
AD  - University of Calabria, Department of Pharmacy, Health Science and Nutrition, 
      Section of Preclinical and Translational Pharmacology, Cosenza, Italy.
FAU - Bagniewska-Zadworna, Agnieszka
AU  - Bagniewska-Zadworna A
AD  - Adam Mickiewicz University/Faculty of Biology, Institute of Experimental Biology, 
      Department of General Botany, Poznan, Poland.
FAU - Bai, Hua
AU  - Bai H
AD  - Iowa State University, Department of Genetics, Development, and Cell Biology, 
      Ames, IA, USA.
FAU - Bai, Jie
AU  - Bai J
AD  - Kunming University of Science and Technology, Medical School, Kunming, Yunnan, 
      China.
FAU - Bai, Xiyuan
AU  - Bai X
AD  - National Jewish Health, Department of Academic Affairs, Denver, CO, USA.
FAU - Bai, Yidong
AU  - Bai Y
AD  - University of Texas Health Science Center at San Antonio, Department of Cell 
      Systems and Anatomy, San Antonio, TX, USA.
FAU - Bairagi, Nandadulal
AU  - Bairagi N
AD  - Jadavpur University, Department of Mathematics, Centre for Mathematical Biology 
      and Ecology, Kolkata, India.
FAU - Baksi, Shounak
AU  - Baksi S
AD  - Karolinska Institute, Department of Cell and Molecular Biology, Stockholm, 
      Sweden.
FAU - Balbi, Teresa
AU  - Balbi T
AD  - University of Genoa, Department of Earth, Environment and Life Sciences, Genoa, 
      Italy.
FAU - Baldari, Cosima T
AU  - Baldari CT
AD  - University of Siena, Department of Life Sciences, Siena, Italy.
FAU - Balduini, Walter
AU  - Balduini W
AD  - University of Urbino Carlo Bo, Department of Biomolecular Sciences, Urbino (PU), 
      Italy.
FAU - Ballabio, Andrea
AU  - Ballabio A
AD  - Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy; Baylor 
      College of Medicine, Houston, TX, USA.
AD  - University of Naples Federico II, Department of Translational Medical Sciences, 
      Naples, Italy.
FAU - Ballester, Maria
AU  - Ballester M
AD  - Institute for Research and Technology in Food and Agriculture (IRTA), Animal 
      Breeding and Genetics Programme, Caldes de Montbui, Spain.
FAU - Balazadeh, Salma
AU  - Balazadeh S
AD  - Max Planck Institute of Molecular Plant Physiology, Potsdam-Golm, Germany.
FAU - Balzan, Rena
AU  - Balzan R
AD  - University of Malta, Department of Physiology & Biochemistry, Msida, Malta.
FAU - Bandopadhyay, Rina
AU  - Bandopadhyay R
AD  - UCL Queen Square Institute of Neurology, Reta Lila Weston Institute, London, UK.
FAU - Banerjee, Sreeparna
AU  - Banerjee S
AD  - Middle East Technical University, Department of Biological Sciences, Ankara, 
      Turkey.
FAU - Banerjee, Sulagna
AU  - Banerjee S
AD  - University of Miami, Department of Surgery and Sylvester Comprehensive Cancer 
      Center, Miami, FL, USA.
AD  - University of Miami, Department of Surgery, Miami, FL, USA.
FAU - Bánréti, Ágnes
AU  - Bánréti Á
AD  - Université Côte D'Azur, CNRS, Inserm, Institut de Biologie Valrose, Nice, France.
FAU - Bao, Yan
AU  - Bao Y
AD  - School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai, 
      China.
FAU - Baptista, Mauricio S
AU  - Baptista MS
AD  - Universidade de São Paulo. Department of Biochemistry, Institute of Chemistry, 
      Sao Paulo, Brazil.
FAU - Baracca, Alessandra
AU  - Baracca A
AD  - University of Bologna, Department of Biomedical and Neuromotor Sciences, Bologna, 
      Italy.
FAU - Barbati, Cristiana
AU  - Barbati C
AD  - Sapienza University of Rome, Department of Clinical, Internal, Anesthesiological 
      and Cardiovascular Sciences, Rome, Italy.
FAU - Bargiela, Ariadna
AU  - Bargiela A
AD  - Translational Genomics Group, Incliva Health Research Institute, Burjasot, 
      Valencia, Spain; Interdisciplinary Research Structure for Biotechnology and 
      Biomedicine (ERI BIOTECMED), University of Valencia, Burjasot, Valencia, Spain.
FAU - Barilà, Daniela
AU  - Barilà D
AD  - University of Rome Tor Vergata, Department of Biology, Rome, Italy; Istituto di 
      Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione Santa Lucia, 
      Laboratory of Cell Signaling, Rome, Italy.
FAU - Barlow, Peter G
AU  - Barlow PG
AD  - Edinburgh Napier University, School of Applied Sciences, Edinburgh, UK.
FAU - Barmada, Sami J
AU  - Barmada SJ
AD  - University of Michigan, Department of Neurology, Ann Arbor, MI, USA.
FAU - Barreiro, Esther
AU  - Barreiro E
AD  - Pulmonology Department, Hospital del Mar-IMIM, Pompeu Fabra University, CIBERES, 
      Barcelona, Spain.
FAU - Barreto, George E
AU  - Barreto GE
AD  - University of Limerick, Department of Biological Sciences, Limerick, Ireland; 
      University of Limerick, Health Research Institute, Limerick, Ireland.
FAU - Bartek, Jiri
AU  - Bartek J
AD  - Danish Cancer Society Research Center, Copenhagen, Denmark.
FAU - Bartel, Bonnie
AU  - Bartel B
AD  - Rice University, Department of Biosciences, Houston, TX, USA.
FAU - Bartolome, Alberto
AU  - Bartolome A
AD  - Columbia University, Department of Medicine, New York, NY, USA.
FAU - Barve, Gaurav R
AU  - Barve GR
AD  - Jawaharlal Nehru Centre for Advanced Scientific Research, Molecular Biology and 
      Genetics Unit, and Neuroscience Unit, Autophagy Laboratory, Jakkur, Bangalore, 
      India.
FAU - Basagoudanavar, Suresh H
AU  - Basagoudanavar SH
AD  - ICAR-Indian Veterinary Research Institute, FMD Vaccine Research Laboratory, 
      Bengaluru, India.
FAU - Bassham, Diane C
AU  - Bassham DC
AD  - Iowa State University, Department of Genetics, Development, and Cell Biology, 
      Ames, IA, USA.
FAU - Bast, Robert C Jr
AU  - Bast RC Jr
AD  - The University of Texas M.D. Anderson Cancer Center, Department of Experimental 
      Therapeutics, Houston, TX, USA.
FAU - Basu, Alakananda
AU  - Basu A
AD  - University of North Texas Health Science Center, Department of Microbiology, 
      Immunology & Genetics, Fort Worth, TX, USA.
FAU - Batoko, Henri
AU  - Batoko H
AD  - University of Louvain, Louvain Institute of Biomolecular Science and Technology 
      (LIBST), Louvain-la-Neuve, Belgium.
FAU - Batten, Isabella
AU  - Batten I
AD  - Trinity College Dublin, School of Medicine, Trinity Translational Medicine 
      Institute, Dublin, Ireland.
FAU - Baulieu, Etienne E
AU  - Baulieu EE
AD  - Université Paris-Saclay, INSERM UMR1195, Hôpital Le Kremlin Bicêtre, 80 rue du 
      Général Leclerc, 94276 Kremlin-Bicêtre, France.
FAU - Baumgarner, Bradley L
AU  - Baumgarner BL
AD  - University of South Carolina Upstate, Spartanburg, SC, USA.
FAU - Bayry, Jagadeesh
AU  - Bayry J
AD  - Institut National de la Santé et de la Recherche Médicale (INSERM), Sorbonne 
      Université, Université de Paris, Centre de Recherche des Cordeliers, Paris, 
      France.
FAU - Beale, Rupert
AU  - Beale R
AD  - Francis Crick Institute, London, UK; UCL, Royal Free Hospital, London, UK.
FAU - Beau, Isabelle
AU  - Beau I
AD  - Université Paris-Saclay, Inserm U1185, Le Kremlin-Bicêtre, France.
FAU - Beaumatin, Florian
AU  - Beaumatin F
AD  - Université de Pau et des Pays de l'Adour, E2S UPPA, INRAE, NUMEA, 64310 
      Saint-Pée-sur-Nivelle, France.
FAU - Bechara, Luiz R G
AU  - Bechara LRG
AD  - University of Sao Paulo, Institute of Biomedical Sciences, Sao Paulo, SP, Brazil.
FAU - Beck, George R Jr
AU  - Beck GR Jr
AD  - Emory University School of Medicine, Division of Endocrinology, Metabolism and 
      Lipids, Atlanta, GA, USA.
FAU - Beers, Michael F
AU  - Beers MF
AD  - University of Pennsylvania, Perelman School of Medicine, PENN Center for 
      Pulmonary Biology, Lung Epithelial Biology Laboratories, Philadelphia, PA, USA.
FAU - Begun, Jakob
AU  - Begun J
AD  - Mater Research Institute, University of Queensland, Brisbane Australia.
FAU - Behrends, Christian
AU  - Behrends C
AD  - Ludwig-Maximilians-Universität München, Munich Cluster for Systems Neurology, 
      München, Germany.
FAU - Behrens, Georg M N
AU  - Behrens GMN
AD  - Hannover Medical School, Department for Clinical Immunology and Rheumatology, 
      Hannover, Germany.
FAU - Bei, Roberto
AU  - Bei R
AD  - University of Rome "Tor Vergata", Department of Clinical Sciences and 
      Translational Medicine, Rome, Italy.
FAU - Bejarano, Eloy
AU  - Bejarano E
AD  - Tufts University, USDA Human Nutrition Research Center on Aging, Laboratory for 
      Nutrition and Vision Research, Boston, MA, USA.
AD  - Universidad Cardenal Herrera-CEU, CEU Universities, School of Health Sciences, 
      Department of Biomedical Sciences, Moncada, Spain.
FAU - Bel, Shai
AU  - Bel S
AD  - Bar-Ilan University, Azrieli Faculty of Medicine, Safed, Israel.
FAU - Behl, Christian
AU  - Behl C
AD  - University Medical Center of the Johannes Gutenberg University, Institute of 
      Pathobiochemistry, Mainz, Germany.
FAU - Belaid, Amine
AU  - Belaid A
AD  - Boston University, Metcalf Science Center, Boston, MA, USA.
FAU - Belgareh-Touzé, Naïma
AU  - Belgareh-Touzé N
AD  - Sorbonne Université, CNRS UMR8226, Institut de Biologie Physico-Chimique, 
      Laboratoire de Biologie Moléculaire et Cellulaire des Eucaryotes, Paris, France.
FAU - Bellarosa, Cristina
AU  - Bellarosa C
AD  - Italian Liver Foundation, Trieste, Italy.
FAU - Belleudi, Francesca
AU  - Belleudi F
AD  - University of Rome "Sapienza", Department of Clinical and Molecular Medicine, 
      Laboratory affiliated to Istituto Pasteur Italia Fondazione Cenci Bolognetti, 
      Rome, Italy.
FAU - Belló Pérez, Melissa
AU  - Belló Pérez M
AD  - Centro Nacional de Biotecnología-CNB-CSIC, Madrid, Spain.
FAU - Bello-Morales, Raquel
AU  - Bello-Morales R
AD  - Universidad Autónoma de Madrid, Departamento de Biología Molecular, Madrid, 
      Spain.
FAU - Beltran, Jackeline Soares de Oliveira
AU  - Beltran JSO
AD  - University of São Paulo, Faculty of Pharmaceutical Sciences, Department of 
      Pathophysiology, Sao Paulo, Brazil.
FAU - Beltran, Sebastián
AU  - Beltran S
AD  - Universidad Mayor, Center for Integrative Biology, Santiago, Chile.
FAU - Benbrook, Doris Mangiaracina
AU  - Benbrook DM
AD  - University of Oklahoma Health Sciences Center/Stephenson Cancer Center, 
      Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, 
      Oklahoma City, OK, USA.
FAU - Bendorius, Mykolas
AU  - Bendorius M
AD  - UMR 7242 "Biotechnology and cellular signaling", CNRS, Illkirch, France.
FAU - Benitez, Bruno A
AU  - Benitez BA
AD  - Washington University in Saint Louis, School of Medicine, Department of 
      Psychiatry, Saint Louis MO, USA.
FAU - Benito-Cuesta, Irene
AU  - Benito-Cuesta I
AD  - Universidad Francisco de Vitoria, Madrid, Spain.
FAU - Bensalem, Julien
AU  - Bensalem J
AD  - Hopwood Centre for Neurobiology, Lifelong Health Theme, South Australian Health 
      and Medical Research Institute, Adelaide, Australia.
FAU - Berchtold, Martin W
AU  - Berchtold MW
AD  - University of Copenhagen, Department of Biology, Copenhagen, Denmark.
FAU - Berezowska, Sabina
AU  - Berezowska S
AD  - University of Lausanne Hospital and Lausanne University, Institute of Pathology, 
      Department of Laboratory Medicine and Pathology, Lausanne, Switzerland.
FAU - Bergamaschi, Daniele
AU  - Bergamaschi D
AD  - Queen Mary University of London, Blizard Institute, Centre for Cell Biology and 
      Cutaneous Research, London, UK.
FAU - Bergami, Matteo
AU  - Bergami M
AD  - University of Cologne and University Hospital Cologne, Cologne Excellence Cluster 
      on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, 
      Germany; Center for Molecular Medicine, Cologne, Germany.
FAU - Bergmann, Andreas
AU  - Bergmann A
AD  - University of Massachusetts Medical School, Department of Molecular, Cell and 
      Cancer Biology (MCCB), Worcester, MA, USA.
FAU - Berliocchi, Laura
AU  - Berliocchi L
AD  - Magna Graecia University, Department of Health Sciences, Catanzaro, Italy.
FAU - Berlioz-Torrent, Clarisse
AU  - Berlioz-Torrent C
AD  - Université Paris Descartes, Institut Cochin, INSERM U1016, CNRS UMR8104, Paris, 
      France.
FAU - Bernard, Amélie
AU  - Bernard A
AD  - CNRS, Université de Bordeaux, Laboratoire de Biogenèse Membranaire UMR5200, 33140 
      Villenave d'Ornon, Bordeaux, France; Université de Bordeaux, CNRS, Laboratoire de 
      Biogenèse Membranaire UMR5200, Villenave d'Ornon, Bordeaux, France.
FAU - Berthoux, Lionel
AU  - Berthoux L
AD  - Université du Québec à Trois-Rivières, Département de Biologie Médicale, 
      Trois-Rivières, Québec, Canada.
FAU - Besirli, Cagri G
AU  - Besirli CG
AD  - University of Michigan, Department of Ophthalmology and Visual Sciences, Ann 
      Arbor, MI, USA.
FAU - Besteiro, Sebastien
AU  - Besteiro S
AD  - University of Montpellier, CNRS/UMR5235 LPHI, Montpellier, France.
FAU - Betin, Virginie M
AU  - Betin VM
AD  - Bristol Medical School, University of Bristol, Bristol, UK.
FAU - Beyaert, Rudi
AU  - Beyaert R
AD  - Ghent University, VIB Center for Inflammation Research, Ghent, Belgium.
FAU - Bezbradica, Jelena S
AU  - Bezbradica JS
AD  - University of Oxford, Kennedy Institute of Rheumatology, Oxford, UK.
FAU - Bhaskar, Kiran
AU  - Bhaskar K
AD  - University of New Mexico, Department of Molecular Genetics and Microbiology, 
      Department of Neurology, Albuquerque, NM, USA.
FAU - Bhatia-Kissova, Ingrid
AU  - Bhatia-Kissova I
AD  - Comenius University, Department of Biochemistry, Bratislava, Slovakia.
FAU - Bhattacharya, Resham
AU  - Bhattacharya R
AD  - University of Oklahoma Health Sciences Center, Department of Obstetrics and 
      Gynecology, Oklahoma City, OK, USA.
FAU - Bhattacharya, Sujoy
AU  - Bhattacharya S
AD  - Vanderbilt University Medical Center, Vanderbilt Eye Institute, Nashville, TN, 
      USA.
FAU - Bhattacharyya, Shalmoli
AU  - Bhattacharyya S
AD  - Department of Biophysics, Post Graduate Institute of Medical Education and 
      Research, Chandigarh, India.
FAU - Bhuiyan, Md Shenuarin
AU  - Bhuiyan MS
AD  - Louisiana State University Health Sciences Center-Shreveport, Department of 
      Pathology and Translational Pathobiology, Shreveport, LA, USA.
FAU - Bhutia, Sujit Kumar
AU  - Bhutia SK
AD  - National Institute of Technology Rourkela, Department of Life Science, Cancer and 
      Cell Death Laboratory, Rourkela, Odisha, India.
FAU - Bi, Lanrong
AU  - Bi L
AD  - Michigan Technological University, Department of Chemistry, Houghton, MI, USA.
FAU - Bi, Xiaolin
AU  - Bi X
AD  - Dalian Medical University, College of Basic Medical Sciences, Dalian, China.
FAU - Biden, Trevor J
AU  - Biden TJ
AD  - Garvan Institute of Medical Research, St Vincent's Medical School, Faculty of 
      Medicine, UNSW, Sydney, Australia.
FAU - Bijian, Krikor
AU  - Bijian K
AD  - McGill University, Departments of Medicine and Oncology and Segal Cancer Centre, 
      Montreal, Quebec, Canada.
FAU - Billes, Viktor A
AU  - Billes VA
AD  - Eötvös Loránd University (ELTE), Department of Genetics, Budapest, Hungary.
FAU - Binart, Nadine
AU  - Binart N
AD  - Université Paris-Saclay, Inserm U1185, Le Kremlin-Bicêtre, France.
FAU - Bincoletto, Claudia
AU  - Bincoletto C
AD  - Federal University of São Paulo, Department of Pharmacology, Paulista School of 
      Medicine, São Paulo, Brazil.
FAU - Birgisdottir, Asa B
AU  - Birgisdottir AB
AD  - University Hospital of North Norway, The Heart and Lung Clinic; University of 
      Tromso-The Artic University of Norway, Department of Clinical Medicine, Tromso, 
      Norway.
FAU - Bjorkoy, Geir
AU  - Bjorkoy G
AD  - Norwegian University of Science and Technology, Department of Biomedical 
      Laboratory Science, Trondheim, Norway.
FAU - Blanco, Gonzalo
AU  - Blanco G
AD  - University of York, Department of Biology, Heslington, UK.
FAU - Blas-Garcia, Ana
AU  - Blas-Garcia A
AD  - University of Valencia, Faculty of Medicine, Department of Physiology, Valencia, 
      Spain; CIBERehd, Valencia, Spain.
FAU - Blasiak, Janusz
AU  - Blasiak J
AD  - University of Lodz, Faculty of Biology and Environmental Protection, Lodz, 
      Poland.
FAU - Blomgran, Robert
AU  - Blomgran R
AD  - Linköping University, Department of Biomedical and Clinical Sciences, Faculty of 
      Medicine and Health Sciences, Linköping, Sweden.
FAU - Blomgren, Klas
AU  - Blomgren K
AD  - Karolinska Institutet, Department of Women's and Children's Health, Stockholm, 
      Sweden AND Karolinska University Hospital, Pediatric Oncology, Stockholm, Sweden.
FAU - Blum, Janice S
AU  - Blum JS
AD  - Indiana University School of Medicine, Department of Microbiology and Immunology, 
      Indianapolis, IN, USA.
FAU - Boada-Romero, Emilio
AU  - Boada-Romero E
AD  - St. Jude Children's Research Hospital, Department of Immunology, Memphis, TN, 
      USA.
FAU - Boban, Mirta
AU  - Boban M
AD  - University of Zagreb, School of Medicine, Croatian Institute for Brain Research, 
      Zagreb, Croatia.
FAU - Boesze-Battaglia, Kathleen
AU  - Boesze-Battaglia K
AD  - University of Pennsylvania, Department of Basic and Translational Sciences, 
      Philadelphia, PA, USA.
FAU - Boeuf, Philippe
AU  - Boeuf P
AD  - Burnet Institute, Melbourne, Australia.
FAU - Boland, Barry
AU  - Boland B
AD  - University College Cork, Department of Pharmacology and Therapeutics, County 
      Cork, Ireland.
FAU - Bomont, Pascale
AU  - Bomont P
AD  - INMG, INSERM, CNRS, University of Lyon, Lyon, France.
FAU - Bonaldo, Paolo
AU  - Bonaldo P
AD  - University of Padova, Department of Molecular Medicine, Padova, Italy.
FAU - Bonam, Srinivasa Reddy
AU  - Bonam SR
AD  - Institut National de la Santé et de la Recherche Médicale, Centre de Recherche 
      des Cordeliers, Sorbonne Université, Université de Paris, Paris, France.
FAU - Bonfili, Laura
AU  - Bonfili L
AD  - University of Camerino, School of Biosciences and Veterinary Medicine, Camerino, 
      Italy.
FAU - Bonifacino, Juan S
AU  - Bonifacino JS
AD  - National Institutes of Health, Eunice Kennedy Shriver National Institute of Child 
      Health and Human Development, Neurosciences and Cellular and Structural Biology 
      Division (NCSBD), Bethesda, MD, USA.
FAU - Boone, Brian A
AU  - Boone BA
AD  - West Virginia University, Department of Surgery, Morgantown, WV, USA.
FAU - Bootman, Martin D
AU  - Bootman MD
AD  - The Open University, School of Life, Health and Chemical Sciences, Faculty of 
      Science, Technology, Engineering and Mathematics, Milton Keynes, UK.
FAU - Bordi, Matteo
AU  - Bordi M
AD  - University of Rome Tor Vergata, Department of Biology, Rome, Italy.
AD  - IRCCS Bambino Gesù Children's Hospital, Department of Pediatric Hemato-Oncology 
      and Cell and Gene Therapy, Rome, Italy.
FAU - Borner, Christoph
AU  - Borner C
AD  - Albert Ludwigs University of Freiburg, Faculty of Medicine, Institute of 
      Molecular Medicine and Cell Research, Freiburg, Germany.
FAU - Bornhauser, Beat C
AU  - Bornhauser BC
AD  - University Children's Hospital Zurich, Children's Research Center and Department 
      of Oncology, Zurich, Switzerland.
FAU - Borthakur, Gautam
AU  - Borthakur G
AD  - University of Texas M.D. Anderson Cancer Center, Department of Leukemia, Houston, 
      TX, USA.
FAU - Bosch, Jürgen
AU  - Bosch J
AD  - Case Western Reserve University School of Medicine, Department of Pediatrics, 
      Cleveland, OH, USA; InterRayBio, LLC, Baltimore, MD, USA.
FAU - Bose, Santanu
AU  - Bose S
AD  - Washington State University, Department of Veterinary Microbiology and Pathology, 
      College of Veterinary Medicine, Pullman, WA, USA.
FAU - Botana, Luis M
AU  - Botana LM
AD  - University Santiago de Compostela, Department of Pharmacology, Veterinary 
      Faculty, Lugo, Spain.
FAU - Botas, Juan
AU  - Botas J
AD  - Baylor College of Medicine, Jan and Dan Duncan Neurological Research Institute 
      and Department of Molecular and Human Genetics, Houston, TX, USA.
FAU - Boulanger, Chantal M
AU  - Boulanger CM
AD  - Université de Paris, PARCC, INSERM, Paris, France.
FAU - Boulton, Michael E
AU  - Boulton ME
AD  - University of Alabama at Birmingham, Department of Ophthalmology and Visual 
      Sciences, Birmingham, AL, USA.
FAU - Bourdenx, Mathieu
AU  - Bourdenx M
AD  - Albert Einstein College of Medicine, Department of Developmental and Molecular 
      Biology, Bronx, NY, USA.
FAU - Bourgeois, Benjamin
AU  - Bourgeois B
AD  - Medical University of Graz, Gottfried Schatz Research Center for Cell Signaling, 
      Metabolism and Aging, Molecular Biology and Biochemistry, Graz, Austria.
FAU - Bourke, Nollaig M
AU  - Bourke NM
AD  - Trinity College Dublin, School of Medicine, Trinity Translational Medicine 
      Institute, Dublin, Ireland.
FAU - Bousquet, Guilhem
AU  - Bousquet G
AD  - University Paris 13, UMR_S942 Inserm; University of Paris, Bobigny, France.
FAU - Boya, Patricia
AU  - Boya P
AD  - Centro de Investigaciones Biológicas Margarita Salas, CSIC, Madrid, Spain.
FAU - Bozhkov, Peter V
AU  - Bozhkov PV
AD  - Swedish University of Agricultural Sciences and Linnean Center for Plant Biology, 
      Uppsala BioCenter, Department of Molecular Sciences, Uppsala, Sweden.
FAU - Bozi, Luiz H M
AU  - Bozi LHM
AD  - Stanford University, Department of Chemical & Systems Biology, Stanford, CA, USA.
AD  - University of Sao Paulo, Institute of Biomedical Sciences, Sao Paulo, SP, Brazil.
FAU - Bozkurt, Tolga O
AU  - Bozkurt TO
AD  - Imperial College London, Department of Life Sciences, London, UK.
FAU - Brackney, Doug E
AU  - Brackney DE
AD  - The Connecticut Agricultural Experiment Station, Center for Vector Biology and 
      Zoonotic Diseases, Department of Environmental Sciences, New Haven, CT, USA.
FAU - Brandts, Christian H
AU  - Brandts CH
AD  - Goethe University, University Hospital, University Cancer Center Frankfurt (UCT), 
      Department of Medicine, Hematology/Oncology, Frankfurt, Germany.
FAU - Braun, Ralf J
AU  - Braun RJ
AD  - Danube Private University, Department of Medicine/Dental Medicine, Krems/Donau, 
      Austria.
FAU - Braus, Gerhard H
AU  - Braus GH
AD  - Georg-August-Universität Göttingen, Institute for Microbiology and Genetics, 
      Department of Molecular Microbiology and Genetics, Göttingen, Germany.
FAU - Bravo-Sagua, Roberto
AU  - Bravo-Sagua R
AD  - Universidad de Chile, Instituto de Nutrición y Tecnología de los Alimentos 
      (INTA), Santiago, Chile.
FAU - Bravo-San Pedro, José M
AU  - Bravo-San Pedro JM
AD  - Université de Paris, Sorbonne Université, Centre de Recherche des Cordeliers, 
      INSERM U1138, Paris, France.
FAU - Brest, Patrick
AU  - Brest P
AD  - University Côte d'Azur (UCA), Institute for Research on Cancer and Aging of Nice 
      (IRCAN), Centre National de la Recherche Scientifique (CNRS) UMR7284, Institut 
      National de la Santé et de la Recherche Médicale (INSERM) U1081, Nice, France.
FAU - Bringer, Marie-Agnès
AU  - Bringer MA
AD  - Centre des Sciences du Goût et de l'Alimentation, AgroSup Dijon, CNRS, INRAE, 
      University of Bourgogne Franche-Comté, Eye and Nutrition Research Group, Dijon, 
      France.
FAU - Briones-Herrera, Alfredo
AU  - Briones-Herrera A
AD  - National Autonomous University of Mexico, Faculty of Chemistry, Department of 
      Biology, Mexico city, Mexico.
FAU - Broaddus, V Courtney
AU  - Broaddus VC
AD  - University of California San Francisco, Department of Medicine, Zuckerberg San 
      Francisco General Hospital and TraumaCenter, San Francisco, CA, USA.
FAU - Brodersen, Peter
AU  - Brodersen P
AD  - University of Copenhagen, Department of Biology, Denmark.
FAU - Brodsky, Jeffrey L
AU  - Brodsky JL
AD  - University of Pittsburgh, Department of Biological Sciences, Pittsburgh, PA, USA.
FAU - Brody, Steven L
AU  - Brody SL
AD  - Washington University School of Medicine, Department of Medicine, Saint Louis, 
      MO, USA.
FAU - Bronson, Paola G
AU  - Bronson PG
AD  - Department of Human Genetics, Genentech, Inc., South San Francisco, CA, USA.
FAU - Bronstein, Jeff M
AU  - Bronstein JM
AD  - David Geffen School of Medicine at UCLA, Department of Neurology, Los Angeles, 
      CA, USA.
FAU - Brown, Carolyn N
AU  - Brown CN
AD  - University of Colorado, AMC, Department of Pharmacology, Aurora, CO, USA.
FAU - Brown, Rhoderick E
AU  - Brown RE
AD  - University of Minnesota, Hormel Institute, Austin, MN, USA.
FAU - Brum, Patricia C
AU  - Brum PC
AD  - University of Sao Paulo, School of Physical Education and Sport, Cellular and 
      Molecular Exercise Physiology Laboratory, Sao Paulo, SP, Brazil.
FAU - Brumell, John H
AU  - Brumell JH
AD  - Hospital for Sick Children, Cell Biology Program, Toronto, ON, Canada.
FAU - Brunetti-Pierri, Nicola
AU  - Brunetti-Pierri N
AD  - Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.
AD  - University of Naples Federico II, Department of Translational Medical Sciences, 
      Naples, Italy.
FAU - Bruno, Daniele
AU  - Bruno D
AD  - University of Insubria, Department of Biotechnology and Life Sciences, Varese, 
      Italy.
FAU - Bryson-Richardson, Robert J
AU  - Bryson-Richardson RJ
AD  - Monash University, School of Biological Sciences, Melbourne, Victoria, Australia.
FAU - Bucci, Cecilia
AU  - Bucci C
AD  - University of Salento, Dept of Biological and Environmental Sciences and 
      Technologies, Lecce, Italy.
FAU - Buchrieser, Carmen
AU  - Buchrieser C
AD  - Institut Pasteur, Biologie des Bactéries Intracellulaires and CNRS UMR 3525, 
      Paris, France.
FAU - Bueno, Marta
AU  - Bueno M
AD  - University of Pittsburgh, Aging Institute, Department of Medicine, Pittsburgh, 
      PA, USA.
FAU - Buitrago-Molina, Laura Elisa
AU  - Buitrago-Molina LE
AD  - University Duisburg-Essen, Essen University Hospital, Department of 
      Gastroenterology and Hepatology, Essen, Germany; Department of Gastroenterology, 
      Hepatology & Endocrinology, Hannover Medical School, Hannover, Germany.
FAU - Buraschi, Simone
AU  - Buraschi S
AD  - Thomas Jefferson University, Department of Pathology, Anatomy, and Cell Biology, 
      Philadelphia, PA, USA.
FAU - Buch, Shilpa
AU  - Buch S
AD  - Department of Pharmacology and Experimental Neuroscience, University of Nebraska 
      Medical Center, Omaha, NE, USA.
FAU - Buchan, J Ross
AU  - Buchan JR
AD  - University of Arizona, Department of Molecular and Cellular Biology, Tucson, AZ, 
      USA.
FAU - Buckingham, Erin M
AU  - Buckingham EM
AD  - University of Iowa, Iowa City, IA, USA.
FAU - Budak, Hikmet
AU  - Budak H
AD  - Montana BioAg. Inc. Missoula, MT, USA.
FAU - Budini, Mauricio
AU  - Budini M
AD  - Universidad de Chile, Facultad de Odontología, Autophagy Research Center (ARC), 
      Santiago, Chile.
FAU - Bultynck, Geert
AU  - Bultynck G
AD  - KU Leuven, Department of Cellular & Molecular Medicine, Campus Gasthuisberg, 
      Leuven, Belgium.
FAU - Burada, Florin
AU  - Burada F
AD  - University of Medicine and Pharmacy of Craiova, Department of Medical Genetics, 
      Craiova, Romania.
FAU - Burgoyne, Joseph R
AU  - Burgoyne JR
AD  - King's College London, School of Cardiovascular Medicine & Sciences, The Rayne 
      Institute, St Thomas' Hospital, London, UK.
FAU - Burón, M Isabel
AU  - Burón MI
AD  - University of Cordoba, Department of Cell Biology, Physiology and Immunology, 
      Córdoba, Spain.
FAU - Bustos, Victor
AU  - Bustos V
AD  - The Rockefeller University, Laboratory of Cellular and Molecular Neuroscience, 
      New York, NY, USA.
FAU - Büttner, Sabrina
AU  - Büttner S
AD  - Stockholm University, The Wenner-Gren Institute, Department of Molecular 
      Biosciences, Stockholm, Sweden.
FAU - Butturini, Elena
AU  - Butturini E
AD  - University of Verona, Department of Neurosciences, Biomedicine and Movement 
      Sciences, Biological Chemistry Section, Verona, Italy.
FAU - Byrd, Aaron
AU  - Byrd A
AD  - University of Arizona, Department of Molecular and Cellular Biology, Tucson, AZ, 
      USA.
FAU - Cabas, Isabel
AU  - Cabas I
AD  - Departmento de Biología Celular e Histología, Facultad de Biología, Universidad 
      de Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB)-Arrixaca, 
      Murcia, Spain.
FAU - Cabrera-Benitez, Sandra
AU  - Cabrera-Benitez S
AD  - Universidad Nacional Autónoma de México, Faculty of Sciences, Department of Cell 
      Biology, Fibrosis Lab, Mexico City, Mexico.
FAU - Cadwell, Ken
AU  - Cadwell K
AD  - New York University School of Medicine, Skirball Institute and Department of 
      Microbiology, New York, NY, USA.
FAU - Cai, Jingjing
AU  - Cai J
AD  - Wenzhou Medical University, State Key Laboratory of Ophthalmology, Optometry and 
      Visual Science, School of Optometry and Ophthalmology and the Eye Hospital, 
      Wenzhou, China.
FAU - Cai, Lu
AU  - Cai L
AD  - University of Louisville, Pediatric Research Institute, Department of Pediatrics, 
      Louisville, KY, USA.
FAU - Cai, Qian
AU  - Cai Q
AD  - Rutgers University, The State University of New Jersey, Department of Cell 
      Biology and Neuroscience, Piscataway, NJ, USA.
FAU - Cairó, Montserrat
AU  - Cairó M
AD  - University of Barcelona, Department of Biochemistry and Molecular Biomedicine, 
      and Network Center for Biomedical Research in Pathophysiology of Obesity and 
      Nutrition (CIBEROBN), Barcelona, Spain.
FAU - Calbet, Jose A
AU  - Calbet JA
AD  - University of Las Palmas de Gran Canaria, Department of Physical Education and 
      Research Institute of Biomedical and Health Sciences (IUIBS), Las Palmas de Gran 
      Canaria, Spain; Norwegian School of Sport Sciences, Department of Physical 
      Performance, Oslo, Norway.
FAU - Caldwell, Guy A
AU  - Caldwell GA
AD  - University of Alabama, Department of Biological Sciences, Tuscaloosa, AL, USA.
FAU - Caldwell, Kim A
AU  - Caldwell KA
AD  - University of Alabama, Department of Biological Sciences, Tuscaloosa, AL, USA.
FAU - Call, Jarrod A
AU  - Call JA
AD  - University of Georgia, Department of Kinesiology, Athens, GA, USA.
FAU - Calvani, Riccardo
AU  - Calvani R
AD  - Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, Rome, Italy.
FAU - Calvo, Ana C
AU  - Calvo AC
AD  - University of Zaragoza, Faculty of Veterinary-IIS Aragón, IA2-CITA, CIBERNED, 
      Laboratory of Genetics and Biochemistry (LAGENBIO), Zaragoza, Spain.
FAU - Calvo-Rubio Barrera, Miguel
AU  - Calvo-Rubio Barrera M
AD  - University of Cordoba, Department of Cell Biology, Physiology and Immunology, 
      Córdoba, Spain.
FAU - Camara, Niels Os
AU  - Camara NO
AD  - University of São Paulo, Department of Immunology, Laboratory of Transplantation 
      Immunobiology, São Paulo, SP, Brazil.
FAU - Camonis, Jacques H
AU  - Camonis JH
AD  - CNRS, Institut Curie, Paris, France.
FAU - Camougrand, Nadine
AU  - Camougrand N
AD  - University of Bordeaux, CNRS, IBGC, UMR 5095, Bordeaux, France.
FAU - Campanella, Michelangelo
AU  - Campanella M
AD  - University of London, The Royal Veterinary College, Department of Comparative 
      Biomedical Sciences, UCL Consortium for Mitochondrial Research, London, UK.
FAU - Campbell, Edward M
AU  - Campbell EM
AD  - Loyola University, Stritch School of Medicine, Department of Microbiology and 
      Immunology, Chicago, IL, USA.
FAU - Campbell-Valois, François-Xavier
AU  - Campbell-Valois FX
AD  - University of Ottawa, Department of Chemistry and Biomolecular Sciences and 
      Department of Biochemistry, Microbiology and Immunology, Host-Microbe 
      Interactions Laboratory, Ottawa, ON, Canada.
FAU - Campello, Silvia
AU  - Campello S
AD  - University of Rome "Tor Vergata", Department of Biology, Rome, Italy.
FAU - Campesi, Ilaria
AU  - Campesi I
AD  - Università di Sassari, Dipartimento di Scienze Biomediche, Sassari, Italy.
FAU - Campos, Juliane C
AU  - Campos JC
AD  - University of Sao Paulo, Institute of Biomedical Sciences, Sao Paulo, SP, Brazil.
FAU - Camuzard, Olivier
AU  - Camuzard O
AD  - Université Côte d'Azur, Université Nice Sophia Antipolis, CEA/DRF/BIAM, Faculté 
      de Médecine, UMR E-4320 TIRO-MATOs, Nice, France.
FAU - Cancino, Jorge
AU  - Cancino J
AD  - Universidad San Sebastián, Centro de Biología Celular y Biomedicina (CEBICEM), 
      Facultad de Medicina y Ciencia, Santiago, Chile.
FAU - Candido de Almeida, Danilo
AU  - Candido de Almeida D
AD  - Federal University of São Paulo, Department of Medicine, Nephrology Division, 
      Laboratory of Clinical and Experimental Immunology, São Paulo, SP, Brazil.
FAU - Canesi, Laura
AU  - Canesi L
AD  - University of Genoa, Department of Earth, Environment and Life Sciences, Genoa, 
      Italy.
FAU - Caniggia, Isabella
AU  - Caniggia I
AD  - University of Toronto, Sinai Health System, Lunenfeld-Tanenbaum Research 
      Institute, Toronto, Ontario, Canada.
FAU - Canonico, Barbara
AU  - Canonico B
AD  - University of Urbino Carlo Bo, Department of Biomolecular Sciences, Urbino (PU), 
      Italy.
FAU - Cantí, Carles
AU  - Cantí C
AD  - IRBLleida-University of Lleida,Department of Experimental Medicine, Lleida, 
      Spain.
FAU - Cao, Bin
AU  - Cao B
AD  - Xiamen University School of Medicine, Fujian Provincial Key Laboratory of 
      Reproductive Health Research, Xiang'an, Xiamen, China.
FAU - Caraglia, Michele
AU  - Caraglia M
AD  - University of Campania "L. Vanvitelli", Department of Precision Medicine, Naples, 
      Italy; Institute of Genetic Research, Biogem scarl, Laboratory of Molecular and 
      Precision Oncology, Ariano Irpino (AV), Italy.
FAU - Caramés, Beatriz
AU  - Caramés B
AD  - Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario 
      Universitario de A Coruña (CHUAC), Sergas, Universidade da Coruña (UDC), A 
      Coruña, Spain.
FAU - Carchman, Evie H
AU  - Carchman EH
AD  - University of Wisconsin, Department of Surgery, Madison, WI, USA.
FAU - Cardenal-Muñoz, Elena
AU  - Cardenal-Muñoz E
AD  - University of Geneva, Department of Biochemistry, Faculty of Science, 
      Switzerland.
FAU - Cardenas, Cesar
AU  - Cardenas C
AD  - Universidad Mayor, Center for Integrative Biology, and Geroscience Center for 
      Brain Health and Metabolism, Santiago, Chile.
FAU - Cardenas, Luis
AU  - Cardenas L
AD  - Universidad Nacional Autónoma de México, Institute of Biotechnology, Plant 
      Molecular Biology Department, Cuernavaca, Morelos, México.
FAU - Cardoso, Sandra M
AU  - Cardoso SM
AD  - University of Coimbra, Faculty of Medicine and CNC-Center for Neuroscience and 
      Cell Biology, Coimbra, Portugal.
FAU - Carew, Jennifer S
AU  - Carew JS
AD  - University of Arizona Cancer Center, Tucson, AZ, USA.
FAU - Carle, Georges F
AU  - Carle GF
AD  - Université Côte d'Azur, Université Nice Sophia Antipolis, CEA/DRF/Institut 
      Frédéric Joliot, Faculté de Médecine, UMR E-4320 TIRO-MATOs, Nice, France.
FAU - Carleton, Gillian
AU  - Carleton G
AD  - Trev and Joyce Deeley Research Centre, BC Cancer, Victoria, British Columbia, 
      Canada.
FAU - Carloni, Silvia
AU  - Carloni S
AD  - University of Urbino Carlo Bo, Department of Biomolecular Sciences, Urbino (PU), 
      Italy.
FAU - Carmona-Gutierrez, Didac
AU  - Carmona-Gutierrez D
AD  - University of Graz, Institute of Molecular Biosciences, NAWI Graz, Graz, Austria.
FAU - Carneiro, Leticia A
AU  - Carneiro LA
AD  - Federal University of Rio de Janeiro, Institute of Microbiology, Department of 
      Immunology, Rio de Janeiro, Brazil.
FAU - Carnevali, Oliana
AU  - Carnevali O
AD  - Polytechnic University of Marche, Department of Life and Environmental Sciences, 
      Ancona, Italy.
FAU - Carosi, Julian M
AU  - Carosi JM
AD  - Hopwood Centre for Neurobiology, Lifelong Health Theme, South Australian Health 
      and Medical Research Institute, Adelaide, Australia.
FAU - Carra, Serena
AU  - Carra S
AD  - University of Modena and Reggio Emilia, Department of Biomedical, Metabolic and 
      Neural Sciences, Modena, Italy.
FAU - Carrier, Alice
AU  - Carrier A
AD  - Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS 
      UMR7258, Aix-Marseille Université U105, Institut Paoli-Calmettes, Parc 
      Scientifique et Technologique de Luminy, Marseille, France.
FAU - Carrier, Lucie
AU  - Carrier L
AD  - Functional Genomics of Cardiomyopathies, Institute of Experimental Pharmacology 
      and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, 
      Germany.
FAU - Carroll, Bernadette
AU  - Carroll B
AD  - School of Biochemistry, Faculty of Life Sciences, University of Bristol, Bristol, 
      UK.
FAU - Carter, A Brent
AU  - Carter AB
AD  - University of Alabama at Birmingham, Department of Medicine, Pulmonary, Allergy, 
      and Critical Care Medicine, Birmingham VA Medical Center, Birmingham, AL, USA.
FAU - Carvalho, Andreia Neves
AU  - Carvalho AN
AD  - Universidade de Lisboa, Faculty of Pharmacy, Research Institute for Medicines 
      (iMed.ULisboa), Lisboa, Portugal.
FAU - Casanova, Magali
AU  - Casanova M
AD  - Aix Marseille Univ, CNRS, LISM, Institut de Microbiologie de la Méditerranée, 
      Marseille, France.
FAU - Casas, Caty
AU  - Casas C
AD  - Universitat Autònoma de Barcelona, Institute of Neuroscience, Barcelona, Spain.
FAU - Casas, Josefina
AU  - Casas J
AD  - Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Department of 
      Biological Chemistry; Networking Biomedical Research Centre on Hepatic and 
      Digestive Diseases (CIBER-EHD), Barcelona, Spain.
FAU - Cassioli, Chiara
AU  - Cassioli C
AD  - University of Siena, Department of Life Sciences, Siena, Italy.
FAU - Castillo, Eliseo F
AU  - Castillo EF
AD  - University of New Mexico Health Sciences Center, Division of Gastroenterology and 
      Hepatology, Department of Internal Medicine, Albuquerque, NM, USA.
FAU - Castillo, Karen
AU  - Castillo K
AD  - Universidad de Valparaíso, Centro Interdisciplinario de Neurociencia de 
      Valparaíso, Laboratory of Molecular Sensors, Valparaíso, Chile.
FAU - Castillo-Lluva, Sonia
AU  - Castillo-Lluva S
AD  - Complutense University, Instituto de Investigaciones Sanitarias San Carlos 
      (IdISSC), Department of Biochemistry and Molecular Biology, School of Biology, 
      Madrid, Spain.
FAU - Castoldi, Francesca
AU  - Castoldi F
AD  - Université de Paris, Sorbonne Université, Centre de Recherche des Cordeliers, 
      INSERM U1138, Team "Metabolism, Cancer & Immunity", Paris, France; Gustave Roussy 
      Cancer Campus, Metabolomics and Cell Biology Platforms, Villejuif, France.
FAU - Castori, Marco
AU  - Castori M
AD  - Division of Medical Genetics, Fondazione IRCCS-Casa Sollievo della Sofferenza, 
      San Giovanni Rotondo, Italy.
FAU - Castro, Ariel F
AU  - Castro AF
AD  - Universidad de Concepción, Department of Biochemistry and Molecular Biology, 
      Concepción, Chile.
FAU - Castro-Caldas, Margarida
AU  - Castro-Caldas M
AD  - Universidade de Lisboa, Faculty of Pharmacy, Research Institute for Medicines 
      (iMed.ULisboa), Lisboa, Portugal.
AD  - Universidade NOVA de Lisboa, Faculdade de Ciências e Tecnologia, Departamento 
      Ciências da Vida, UCIBIO, Caparica, Portugal.
FAU - Castro-Hernandez, Javier
AU  - Castro-Hernandez J
AD  - Universidad de La Laguna, Departamento de Ciencias Médicas Básicas, Tenerife, 
      Spain.
FAU - Castro-Obregon, Susana
AU  - Castro-Obregon S
AD  - Universidad Nacional Autónoma de México (UNAM), Instituto de Fisiologia Celular, 
      Ciudad Universitaria, Ciudad de México, México.
FAU - Catz, Sergio D
AU  - Catz SD
AD  - The Scripps Research Institute, Department of Molecular Medicine, La Jolla, CA, 
      USA.
FAU - Cavadas, Claudia
AU  - Cavadas C
AD  - University of Coimbra, Portugal, CNC - Center for Neuroscience and Cell Biology & 
      Faculty of Pharmacy, Coimbra, Portugal.
FAU - Cavaliere, Federica
AU  - Cavaliere F
FAU - Cavallini, Gabriella
AU  - Cavallini G
AD  - University of Pisa, Interdepartmental Research Centre on Biology and Pathology of 
      Aging, Pisa, Italy.
FAU - Cavinato, Maria
AU  - Cavinato M
AD  - University of Innsbruck, Institute for Biomedical Aging Research, Department of 
      Molecular Biology, Innsbruck, Austria.
FAU - Cayuela, Maria L
AU  - Cayuela ML
AD  - Biomedical Research Institute of Murcia, IMIB-Arrixaca, Telomerase, Cancer and 
      Aging Group, Surgical Department, Murcia, Spain.
FAU - Cebollada Rica, Paula
AU  - Cebollada Rica P
AD  - Research Center Borstel, Leibniz Lung Center, Priority Area Infections, Division 
      Cellular Microbiology, Borstel, Germany.
FAU - Cecarini, Valentina
AU  - Cecarini V
AD  - University of Camerino, School of Biosciences and Veterinary Medicine, Camerino, 
      Italy.
FAU - Cecconi, Francesco
AU  - Cecconi F
AD  - Danish Cancer Society Research Center, Center for Autophagy, Recycling and 
      Disease (CARD), Cell Stress and Survival Unit, Copenhagen, Denmark; IRCCS Bambino 
      Gesù Children's Hospital, Department of Pediatric Hemato-Oncology and Cell and 
      Gene therapy, Rome, Italy; University of Rome Tor Vergata, Department of Biology, 
      Rome, Italy.
FAU - Cechowska-Pasko, Marzanna
AU  - Cechowska-Pasko M
AD  - Medical University of Bialystok, Department of Pharmaceutical Biochemistry, 
      Bialystok, Poland.
FAU - Cenci, Simone
AU  - Cenci S
AD  - Ospedale San Raffaele and Vita-Salute San Raffaele University, Division of 
      Genetics and Cell Biology, Milano, Italy.
FAU - Ceperuelo-Mallafré, Victòria
AU  - Ceperuelo-Mallafré V
AD  - Hospital Universitari de Tarragona Joan XXIII, Institut d'Investigació Sanitària 
      Pere Virgili, Madrid, Spain; CIBER de Diabetes y Enfermedades Metabólicas 
      Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
FAU - Cerqueira, João J
AU  - Cerqueira JJ
AD  - University of Minho, School of Medicine, Life and Health Sciences Research 
      Institute (ICVS), Braga, Portugal.
FAU - Cerutti, Janete M
AU  - Cerutti JM
AD  - Universidade Federal de São Paulo, Department of Morphology and Genetics, São 
      Paulo, SP, Brazil.
FAU - Cervia, Davide
AU  - Cervia D
AD  - University of Tuscia, Department for Innovation in Biological, Agro-food, and 
      Forest systems (DIBAF), Viterbo, Italy.
FAU - Cetintas, Vildan Bozok
AU  - Cetintas VB
AD  - Ege University, Faculty of Medicine, Department of Medical Biology, Izmir, 
      Turkey.
FAU - Cetrullo, Silvia
AU  - Cetrullo S
AD  - University of Bologna, Department of Biomedical and Neuromotor Sciences, Bologna, 
      Italy.
FAU - Chae, Han-Jung
AU  - Chae HJ
AD  - School of Pharmacy, Jeonbuk National University, Jeollabuk-do, Republic of Korea.
FAU - Chagin, Andrei S
AU  - Chagin AS
AD  - Karolinska Institutet, Department of Physiology and Pharmacology, Stockholm, 
      Sweden.
FAU - Chai, Chee-Yin
AU  - Chai CY
AD  - Kaohsiung Medical University, Department of Pathology, Kaohsiung City, Taiwan.
FAU - Chakrabarti, Gopal
AU  - Chakrabarti G
AD  - University of Calcutta, Department of Biotechnology and Dr. B.C. Guha Centre for 
      Genetic Engineering and Biotechnology, Kolkata, India.
FAU - Chakrabarti, Oishee
AU  - Chakrabarti O
AD  - Saha Institute of Nuclear Physics, Biophysics & Structural Genomics Division, 
      HBNI, Kolkata, India.
FAU - Chakraborty, Tapas
AU  - Chakraborty T
AD  - Ehime University, Department of Aquatic Life Sciences, Ainan, Ehime, Japan.
FAU - Chakraborty, Trinad
AU  - Chakraborty T
AD  - Justus-Liebig-University Giessen, Institute of Medical Microbiology, Giessen, 
      Germany.
FAU - Chami, Mounia
AU  - Chami M
AD  - Université Côte d'Azur, INSERM, CNRS, IPMC, team labeled Laboratory of Excellence 
      (LABEX) Distalz, Valbonne, France.
FAU - Chamilos, Georgios
AU  - Chamilos G
AD  - University of Crete, School of Medicine, Laboratory of Clinical Microbiology and 
      Microbial Pathogenesis, Voutes, Heraklion, Crete, Greece; Foundation for Research 
      and Technology, Institute of Molecular Biology and Biotechnology (IMBB), 
      Heraklion, Crete, Greece.
FAU - Chan, David W
AU  - Chan DW
AD  - The University of Hong Kong, Li Ka Shing Faculty of Medicine, Department of 
      Obstetrics and Gynecology, Hong Kong, China.
FAU - Chan, Edmond Y W
AU  - Chan EYW
AD  - Queen's University, Department of Biomedical and Molecular Sciences, Kingston, 
      Ontario, Canada.
FAU - Chan, Edward D
AU  - Chan ED
AD  - National Jewish Health, Department of Academic Affairs, Denver, CO, USA.
FAU - Chan, H Y Edwin
AU  - Chan HYE
AD  - The Chinese University of Hong Kong, School of Life Sciences, Shatin N.T., Hong 
      Kong, China.
FAU - Chan, Helen H
AU  - Chan HH
AD  - The Chinese University of Hong Kong, School of Biomedical Sciences, Hong Kong, 
      China.
FAU - Chan, Hung
AU  - Chan H
AD  - The Chinese University of Hong Kong, Department of Anaesthesia and Intensive 
      Care, Hong Kong, China.
FAU - Chan, Matthew T V
AU  - Chan MTV
AD  - The Chinese University of Hong Kong, Department of Anaesthesia and Intensive 
      Care, Hong Kong, China.
FAU - Chan, Yau Sang
AU  - Chan YS
AD  - The University of Hong Kong, Li Ka Shing Faculty of Medicine, Department of 
      Obstetrics and Gynecology, Hong Kong, China.
FAU - Chandra, Partha K
AU  - Chandra PK
AD  - Tulane University School of Medicine, Department of Pharmacology, New Orleans, 
      LA, USA.
FAU - Chang, Chih-Peng
AU  - Chang CP
AD  - National Cheng Kung University, College of Medicine, Department of Microbiology 
      and Immunology, Tainan, Taiwan.
FAU - Chang, Chunmei
AU  - Chang C
AD  - University of California, Berkeley, Department of Molecular Biology and Cell 
      Biology, Berkeley, CA, USA; University of California, Berkeley, California 
      Institute for Quantitative Biosciences, Berkeley, CA, USA.
FAU - Chang, Hao-Chun
AU  - Chang HC
AD  - National University of Singapore, Faculty of Sciences, Department of Pharmacy, 
      Singapore.
FAU - Chang, Kai
AU  - Chang K
AD  - Iowa State University, Department of Genetics, Development, and Cell Biology, 
      Ames, IA, USA.
FAU - Chao, Jie
AU  - Chao J
AD  - Southeast University, School of Medicine, Department of Physiology, Nanjing, 
      Jiangsu, China.
FAU - Chapman, Tracey
AU  - Chapman T
AD  - University of East Anglia, School of Biological Sciences, Norwich Research Park, 
      UK.
FAU - Charlet-Berguerand, Nicolas
AU  - Charlet-Berguerand N
AD  - Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM 
      U964, CNRS UMR7104, University of Strasbourg, Illkirch, France.
FAU - Chatterjee, Samrat
AU  - Chatterjee S
AD  - NCR Biotech Science Cluster, Translational Health Science and Technology 
      Institute, Complex Analysis Group, Faridabad, India.
FAU - Chaube, Shail K
AU  - Chaube SK
AD  - Banaras Hindu University, Institute of Science, Department of Zoology, Lanka, 
      Varanasi, Uttar Pradesh, India.
FAU - Chaudhary, Anu
AU  - Chaudhary A
AD  - University of Washington, Department of Laboratory Medicine, Seattle, WA, USA.
FAU - Chauhan, Santosh
AU  - Chauhan S
AD  - Institute of Life Sciences, Bhubaneswar, Odisha, India.
FAU - Chaum, Edward
AU  - Chaum E
AD  - Vanderbilt University Medical Center, Vanderbilt Eye Institute, Nashville, TN, 
      USA.
FAU - Checler, Frédéric
AU  - Checler F
AD  - Université Côte d'Azur, INSERM, CNRS, IPMC, team labeled Laboratory of Excellence 
      (LABEX) Distalz, Valbonne, France.
FAU - Cheetham, Michael E
AU  - Cheetham ME
AD  - UCL Institute of Ophthalmology, London, UK.
FAU - Chen, Chang-Shi
AU  - Chen CS
AD  - National Cheng Kung University, Department of Biochemistry and Molecular Biology, 
      Tainan, Taiwan.
FAU - Chen, Guang-Chao
AU  - Chen GC
AD  - Academia Sinica, Institute of Biological Chemistry, Taipei, Taiwan.
FAU - Chen, Jian-Fu
AU  - Chen JF
AD  - University of Southern California, Center for Craniofacial Molecular Biology, Los 
      Angeles, CA, USA.
FAU - Chen, Liam L
AU  - Chen LL
AD  - University of Minnesota Medical School, Department of Laboratory Medicine and 
      Pathology, Minneapolis, MN, USA.
FAU - Chen, Leilei
AU  - Chen L
AD  - Qingdao University, Institute of Brain Science and Disease, Qingdao, Shandong, 
      China.
FAU - Chen, Lin
AU  - Chen L
AD  - Army Medical University (Third Military Medical University), Daping Hospital, 
      Center of Bone Metabolism and Repair, State Key Laboratory of Trauma, Burns and 
      Combined Injury, Trauma Center, Research Institute of Surgery, Laboratory for the 
      Prevention and Rehabilitation of Training Related Injuries, Chongqing, China.
FAU - Chen, Mingliang
AU  - Chen M
AD  - Third Military Medical University, Southwest Hospital, Institute of Pathology and 
      Southwest Cancer Centre, Chongqing, China.
FAU - Chen, Mu-Kuan
AU  - Chen MK
AD  - Changhua Christian Hospital, Department of Otorhinolaryngology-Head and Neck 
      Surgery, Changhua, Taiwan.
FAU - Chen, Ning
AU  - Chen N
AD  - Wuhan Sports University, College of Health Science, Tianjiu Research and 
      Development Center for Exercise Nutrition and Foods, Hubei Key Laboratory of 
      Exercise Training and Monitoring, Wuhan, Hubei, China.
FAU - Chen, Quan
AU  - Chen Q
AD  - College of Life Sciences, Nankai University, Tianjin, China.
FAU - Chen, Ruey-Hwa
AU  - Chen RH
AD  - Academia Sinica, Institute of Biological Chemistry, Taipei, Taiwan.
FAU - Chen, Shi
AU  - Chen S
AD  - Wuhan University, School of Pharmaceutical Sciences, Zhongnan Hospital, Wuhan, 
      China.
FAU - Chen, Wei
AU  - Chen W
AD  - Duke University, Department of Medicine, Durham, NC, USA.
FAU - Chen, Weiqiang
AU  - Chen W
AD  - Chinese Academy of Sciences, Institute of Modern Physics, Lanzhou, China.
FAU - Chen, Xin-Ming
AU  - Chen XM
AD  - University of Sydney, Sydney Medical School, Renal Medicine, St Leonards, NSW, 
      Australia.
FAU - Chen, Xiong-Wen
AU  - Chen XW
AD  - Temple University, Lewis Katz School of Medicine, Cardiovascular Research Center 
      and Department of Physiology, Philadelphia, PA, USA.
FAU - Chen, Xu
AU  - Chen X
AD  - Chinese Academy of Medical Sciences and Peking Union Medical College, Institute 
      of Dermatology, Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and 
      STIs, Nanjing, Jiangsu, China.
FAU - Chen, Yan
AU  - Chen Y
AD  - Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, 
      Shanghai, China.
FAU - Chen, Ye-Guang
AU  - Chen YG
AD  - Tsinghua University, School of Life Sciences, Beijing, China.
FAU - Chen, Yingyu
AU  - Chen Y
AD  - Peking University School of Basic Medical Science, Department of Immunology, 
      Beijing, China.
FAU - Chen, Yongqiang
AU  - Chen Y
AD  - Research Institute in Oncology and Hematology, CancerCare Manitoba, Winnipeg, 
      Manitoba, Canada.
FAU - Chen, Yu-Jen
AU  - Chen YJ
AD  - Mackay Memorial Hospital, Department of Radiation Oncology, Taipei, Taiwan.
FAU - Chen, Yue-Qin
AU  - Chen YQ
AD  - Sun Yat-sen University, School of Life Science, Guangzhou, China.
FAU - Chen, Zhefan Stephen
AU  - Chen ZS
AD  - The Chinese University of Hong Kong, School of Life Sciences, Shatin N.T., Hong 
      Kong, China.
FAU - Chen, Zhi
AU  - Chen Z
AD  - Wuhan University, School and Hospital of Stomatology, Key Lab of Oral Biomedicine 
      of Ministry of Education (KLOBME), Wuhan, Hubei, China.
FAU - Chen, Zhi-Hua
AU  - Chen ZH
AD  - 2nd Affiliated Hospital of Zhejiang University School of Medicine, Department of 
      Respiratory and Critical Care Medicine, Hangzhou, China.
FAU - Chen, Zhijian J
AU  - Chen ZJ
AD  - University of Texas Southwestern Medical Center, Department of Molecular Biology, 
      Dallas, Texas, USA.
FAU - Chen, Zhixiang
AU  - Chen Z
AD  - Purdue University, Department of Botany and Plant Pathology, West Lafayette, IN, 
      USA.
FAU - Cheng, Hanhua
AU  - Cheng H
AD  - Wuhan University, Hubei Key laboratory of Cell Homeostasis, College of Life 
      Sciences, Wuhan, China.
FAU - Cheng, Jun
AU  - Cheng J
AD  - Capital Medical University, Beijing Ditan Hospital, Liver Disease Center, 
      Beijing, China.
FAU - Cheng, Shi-Yuan
AU  - Cheng SY
AD  - Northwestern University Feinberg School of Medicine, Department of Neurology & 
      Lou & Jean Malnati Brain Tumor Institute, Chicago, IL, USA.
FAU - Cheng, Wei
AU  - Cheng W
AD  - Albert Einstein College of Medicine, Department of Genetics, Bronx, NY, USA.
FAU - Cheng, Xiaodong
AU  - Cheng X
AD  - The University of Texas Health Science Center at Houston, Department of 
      Integrative Biology and Pharmacology, Houston, TX, USA.
FAU - Cheng, Xiu-Tang
AU  - Cheng XT
AD  - National Institutes of Health, National Institute of Neurological Disorders and 
      Stroke, Bethesda, MD, USA.
FAU - Cheng, Yiyun
AU  - Cheng Y
AD  - East China Normal University, School of Life Sciences, Shanghai, China.
FAU - Cheng, Zhiyong
AU  - Cheng Z
AD  - University of Florida, Food Science and Human Nutrition Department, Gainesville, 
      FL, USA.
FAU - Chen, Zhong
AU  - Chen Z
AD  - Zhejiang University, College of Pharmaceutical Sciences, Institute of 
      Pharmacology and Toxicology, Hangzhou, Zhejiang, China.
FAU - Cheong, Heesun
AU  - Cheong H
AD  - National Cancer Center Korea, Goyang, Gyeonggi, Korea.
FAU - Cheong, Jit Kong
AU  - Cheong JK
AD  - National University of Singapore, Yong Loo Lin School of Medicine, Department of 
      Biochemistry, Singapore.
AD  - National University of Singapore, Yong Loo Lin School of Medicine, Strategic 
      Research Programme in Precision Medicine, Singapore.
FAU - Chernyak, Boris V
AU  - Chernyak BV
AD  - Lomonosov Moscow State University, A.N. Belozersky Institute of Physico-Chemical 
      Biology, Moscow, Russia.
FAU - Cherry, Sara
AU  - Cherry S
AD  - University of Pennsylvania, Department of Pathology and Laboratory Medicine, 
      Philadelphia, PA, USA.
FAU - Cheung, Chi Fai Randy
AU  - Cheung CFR
AD  - The Chinese University of Hong Kong, School of Biomedical Sciences, Hong Kong, 
      China.
FAU - Cheung, Chun Hei Antonio
AU  - Cheung CHA
AD  - National Cheng Kung University, College of Medicine, Department of Pharmacology, 
      Tainan, Taiwan.
FAU - Cheung, King-Ho
AU  - Cheung KH
AD  - Sun Yat-Sen University, School of Pharmaceutical Sciences, Guangzhou, China.
FAU - Chevet, Eric
AU  - Chevet E
AD  - INSERM U1242, University of Rennes, Rennes, France; Centre de Lutte Contre le 
      Cancer Eugène Marquis, Rennes, France.
FAU - Chi, Richard J
AU  - Chi RJ
AD  - University of North Carolina at Charlotte, Department of Biological Sciences, 
      Charlotte, NC, USA.
FAU - Chiang, Alan Kwok Shing
AU  - Chiang AKS
AD  - The University of Hong Kong, Queen Mary Hospital, Department of Paediatrics and 
      Adolescent Medicine, Pokfulam, Hong Kong, China.
FAU - Chiaradonna, Ferdinando
AU  - Chiaradonna F
AD  - University of Milano-Bicocca, Department of Biotechnology and Biosciences, Milan, 
      Italy.
FAU - Chiarelli, Roberto
AU  - Chiarelli R
AD  - University of Palermo, Dipartimento di Scienze e Tecnologie Biologiche, Chimiche 
      e Farmaceutiche (STEBICEF), Palermo, Italy.
FAU - Chiariello, Mario
AU  - Chiariello M
AD  - Istituto di Fisiologia Clinica, Consiglio Nazionale delle Ricerche, Siena, Italy; 
      Core Research Laboratory, Istituto per lo Studio, la Prevenzione e la Rete 
      Oncologica, Siena, Italy.
FAU - Chica, Nathalia
AU  - Chica N
AD  - The Norwegian Radium Hospital, Institute for Cancer Research, Department of 
      Molecular Cell Biology, Montebello, Oslo, Norway; University of Oslo, Faculty of 
      Mathematics and Natural Sciences, The Department of Biosciences, Oslo, Norway.
AD  - The Norwegian Radium Hospital, Institute for Cancer Research, Department of 
      Molecular Cell Biology, Montebello, Oslo, Norway; University of Oslo, Faculty of 
      Medicine, Institute of Clinical Medicine, Centre for Cancer Cell Reprogramming, 
      Oslo, Norway.
FAU - Chiocca, Susanna
AU  - Chiocca S
AD  - IEO, European Institute of Oncology IRCCS, IFOM-IEO Campus, Department of 
      Experimental Oncology, Milan, Italy.
FAU - Chiong, Mario
AU  - Chiong M
AD  - University of Chile, Faculty of Chemical and Pharmaceutical Sciences, Advanced 
      Center for Chronic Diseases (ACCDiS), Santiago, Chile.
FAU - Chiou, Shih-Hwa
AU  - Chiou SH
AD  - Taipei Veterans Generals Hospital, Department of Medical Research, Taipei, 
      Taiwan.
FAU - Chiramel, Abhilash I
AU  - Chiramel AI
AD  - National Institutes of Health (NIH), National Institute of Allergy and Infectious 
      Diseases (NIAID), Rocky Mountain Laboratories (RML), Laboratory of Virology, 
      Innate Immunity and Pathogenesis Section, Hamilton, MT, USA.
FAU - Chiurchiù, Valerio
AU  - Chiurchiù V
AD  - Institute of Translational Pharmacology, National Research Council, Rome, Italy; 
      European Center for Brain Research, Laboratory of Resolution of 
      Neuroinflammation, IRCCS Santa Lucia Foundation, Rome, Italy.
FAU - Cho, Dong-Hyung
AU  - Cho DH
AD  - Kyungpook National University, Department of Life Science, Deagu, Korea.
FAU - Choe, Seong-Kyu
AU  - Choe SK
AD  - Wonkwang University School of Medicine, Department of Microbiology, Iksan, 
      Jeonbuk, Korea.
FAU - Choi, Augustine M K
AU  - Choi AMK
AD  - Weill Cornell Medicine, Department of Medicine, New York, NY, USA.
FAU - Choi, Mary E
AU  - Choi ME
AD  - Weill Cornell Medicine, Division of Nephrology and Hypertension, Joan and Sanford 
      I. Weill Department of Medicine, New York, NY, USA.
FAU - Choudhury, Kamalika Roy
AU  - Choudhury KR
AD  - CSIR-Indian Institute of Chemical Biology, Kolkata, India.
FAU - Chow, Norman S
AU  - Chow NS
AD  - BC Cancer Research Centre, Department of Experimental Therapeutics, Vancouver, 
      BC, Canada.
FAU - Chu, Charleen T
AU  - Chu CT
AD  - University of Pittsburgh School of Medicine, Department of Pathology, Pittsburgh, 
      PA, USA.
FAU - Chua, Jason P
AU  - Chua JP
AD  - University of Michigan, Department of Neurology, Ann Arbor, MI, USA.
FAU - Chua, John Jia En
AU  - Chua JJE
AD  - National University of Singapore, Yong Loo Lin School of Medicine, Department of 
      Physiology; National University of Singapore, LSI Neurobiology Programme; 
      National University of Singapore, Institute for Health Innovation and Technology; 
      National University Hospital Singapore, Centre for Healthy Longevity; Institute 
      of Molecular and Cell Biology, Agency for Science, Technology and Research 
      (A*STAR), Singapore.
FAU - Chung, Hyewon
AU  - Chung H
AD  - Konkuk University School of Medicine, Department of Ophthalmology, Seoul, Korea.
FAU - Chung, Kin Pan
AU  - Chung KP
AD  - Max-Planck-Institut für Molekulare Pflanzenphysiologie, Potsdam, Germany.
FAU - Chung, Seockhoon
AU  - Chung S
AD  - University of Ulsan College of Medicine, Asan Medical Center, Department of 
      Psychiatry, Seoul, Korea.
FAU - Chung, So-Hyang
AU  - Chung SH
AD  - The Catholic University of Korea, Seoul St, Mary's Hospital, Department of 
      Ophthalmology and Visual Science, Seoul, Kor.
FAU - Chung, Yuen-Li
AU  - Chung YL
AD  - Institute of Cancer Research, Cancer Research UK Cancer Imaging Centre, Division 
      of Radiotherapy and Imaging, London, UK.
FAU - Cianfanelli, Valentina
AU  - Cianfanelli V
AD  - IRCCS Bambino Gesù Children's Hospital, Department of Pediatric Hemato-Oncology 
      and Cell and Gene Therapy, Rome, Italy.
FAU - Ciechomska, Iwona A
AU  - Ciechomska IA
AD  - Nencki Institute of Experimental Biology of Polish Academy of Sciences, 
      Neurobiology Center, Laboratory of Molecular Neurobiology, Warsaw, Poland.
FAU - Cifuentes, Mariana
AU  - Cifuentes M
AD  - University of Chile, Institute of Nutrition and Food Technology (INTA), Advanced 
      Center for Chronic Diseases (ACCDiS), Santiago, Chile.
FAU - Cinque, Laura
AU  - Cinque L
AD  - Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.
FAU - Cirak, Sebahattin
AU  - Cirak S
AD  - University of Cologne, Faculty of Medicine and University Hospital Cologne, 
      Department of Pediatrics, Cologne, Germany; University of Cologne, Faculty of 
      Medicine and University Hospital Cologne, Center for Molecular Medicine (CMMC), 
      Cologne, Germany.
FAU - Cirone, Mara
AU  - Cirone M
AD  - University of Rome "La Sapienza", Rome, Italy.
FAU - Clague, Michael J
AU  - Clague MJ
AD  - University of Liverpool, Institute of Translational Research, Cellular and 
      Molecular Physiology, Liverpool, UK.
AD  - Molecular Physiology and Cell Signaling, Institute of Systems, Molecular and 
      Integrative Biology, University of Liverpool, Liverpool, UK.
FAU - Clarke, Robert
AU  - Clarke R
AD  - University of Minnesota, Hormel Institute, Austin, MN, USA.
FAU - Clementi, Emilio
AU  - Clementi E
AD  - Università di Milano, Department of Biomedical and Clinical Sciences L. Sacco, 
      Milan, Italy.
FAU - Coccia, Eliana M
AU  - Coccia EM
AD  - Istituto Superiore di Sanità, Department of Infectious Diseases, Rome, Italy.
FAU - Codogno, Patrice
AU  - Codogno P
AD  - Institut Necker-Enfants Malades (INEM), INSERM U1151/CNRS UMR 8253, Université de 
      Paris, Paris, France.
FAU - Cohen, Ehud
AU  - Cohen E
AD  - The Hebrew University of Jerusalem, The Institute for Medical Research 
      Israel-Canada, Department of Biochemistry and Molecular Biology, Ein Karem, 
      Jerusalem, Israel.
FAU - Cohen, Mickael M
AU  - Cohen MM
AD  - Sorbonne Université, CNRS UMR8226, Institut de Biologie Physico-Chimique, 
      Laboratoire de Biologie Moléculaire et Cellulaire des Eucaryotes, Paris, France.
FAU - Colasanti, Tania
AU  - Colasanti T
AD  - Sapienza University of Rome, Department of Clinical, Internal, Anesthesiological 
      and Cardiovascular Sciences, Rome, Italy.
FAU - Colasuonno, Fiorella
AU  - Colasuonno F
AD  - University Roma Tre, Department of Science, LIME, Rome, Italy.
FAU - Colbert, Robert A
AU  - Colbert RA
AD  - National Institutes of Health, National Institute of Arthritis and 
      Musculoskeletal and Skin Diseases, Pediatric Translational Research Branch, 
      Bethesda, MD, USA.
FAU - Colell, Anna
AU  - Colell A
AD  - Institut d'Investigacions Biomèdiques de Barcelona (CSIC, IDIBAPS), and Centro de 
      Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), 
      Barcelona, Spain.
FAU - Čolić, Miodrag
AU  - Čolić M
AD  - University of Belgrade, Institute for the Application of Nuclear Energy (INEP), 
      Belgrade, Serbia.
FAU - Coll, Nuria S
AU  - Coll NS
AD  - Centre for Research in Agricultural Genomics (CRAG), CSIC-IRTA-UAB-UB, Campus 
      UAB, Bellaterra, Barcelona, Spain.
FAU - Collins, Mark O
AU  - Collins MO
AD  - University of Sheffield, Department of Biomedical Science, Firth Court, Western 
      Bank, Sheffield, UK.
FAU - Colombo, María I
AU  - Colombo MI
AD  - Instituto de Histología y Embriología (IHEM)-Universidad Nacional de 
      Cuyo-CONICET, Facultad de Ciencias Médicas, Mendoza, Argentina.
FAU - Colón-Ramos, Daniel A
AU  - Colón-Ramos DA
AD  - Yale University School of Medicine, Department of Neuroscience and Department of 
      Cell Biology, New Haven, CT, USA.
FAU - Combaret, Lydie
AU  - Combaret L
AD  - Clermont-Auvergne University, INRAE, Human Nutrition Unit, F-63000, 
      Clermont-Ferrand, France.
FAU - Comincini, Sergio
AU  - Comincini S
AD  - University of Pavia, Department of Biology and Biotechnology "L. Spallanzani", 
      Pavia, Italy.
FAU - Cominetti, Márcia R
AU  - Cominetti MR
AD  - Federal University of São Carlos, Department of Gerontology, São Carlos, SP, 
      Brazil.
FAU - Consiglio, Antonella
AU  - Consiglio A
AD  - Department of Pathology and Experimental Therapeutics and Institute of 
      Biomedicine of the University of Barcelona (IBUB), Bellvitge University 
      Hospital-IDIBELL, Hospitalet de Llobregat; University of Brescia, Department of 
      Molecular and Translational Medicine, Brescia BS, Italy.
FAU - Conte, Andrea
AU  - Conte A
AD  - National Institutes of Health, NIAMS, Lymphocyte Nuclear Biology, Bethesda, MD, 
      USA.
FAU - Conti, Fabrizio
AU  - Conti F
AD  - Sapienza University of Rome, Department of Clinical, Internal, Anesthesiological 
      and Cardiovascular Sciences, Rome, Italy.
FAU - Contu, Viorica Raluca
AU  - Contu VR
AD  - Rutgers University, Department of Biological Sciences, Newark, NJ, USA.
FAU - Cookson, Mark R
AU  - Cookson MR
AD  - National Institutes of Health, National Institute on Aging, Laboratory of 
      Neurogenetics, Bethesda, MD, USA.
FAU - Coombs, Kevin M
AU  - Coombs KM
AD  - University of Manitoba, Department of Medical Microbiology & Infectious Diseases, 
      Winnipeg, Manitoba, Canada.
FAU - Coppens, Isabelle
AU  - Coppens I
AD  - Johns Hopkins University, Department of Molecular Microbiology and Immunology, 
      Baltimore, MD, USA.
FAU - Corasaniti, Maria Tiziana
AU  - Corasaniti MT
AD  - University Magna Graecia of Catanzaro, Department of Health Sciences, Catanzaro, 
      Italy.
FAU - Corkery, Dale P
AU  - Corkery DP
AD  - Umeå University, Umeå Centre for Microbial Research (UCMR), Department of 
      Chemistry, Umeå, Sweden.
FAU - Cordes, Nils
AU  - Cordes N
AD  - OncoRay National Center for Radiation Research in Oncology, Faculty of Medicine 
      and University Hospital Carl Gustav Carus, Technische Universität Dresden, 
      Germany; Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiooncology - 
      OncoRay, Dresden, Germany; German Cancer Consortium (DKTK), Partner site Dresden, 
      Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany.
AD  - OncoRay National Center for Radiation Research in Oncology, Faculty of Medicine, 
      Technische Universität Dresden, Dresden, Germany.
FAU - Cortese, Katia
AU  - Cortese K
AD  - University of Genoa, DIMES Department of Experimental Medicine, Human Anatomy, 
      Genoa, Italy.
FAU - Costa, Maria do Carmo
AU  - Costa MDC
AD  - University of Michigan Medical School, Department of Neurology, Ann Arbor, MI, 
      USA.
FAU - Costantino, Sarah
AU  - Costantino S
AD  - University of Zürich, Schlieren Campus, Center for Molecular Cardiology, 
      Schlieren, Switzerland.
FAU - Costelli, Paola
AU  - Costelli P
AD  - University of Turin, Department of Clinical and Biological Sciences, Turin, 
      Italy.
FAU - Coto-Montes, Ana
AU  - Coto-Montes A
AD  - University of Oviedo, Department of Morphology and Cell Biology, Oviedo, Spain.
FAU - Crack, Peter J
AU  - Crack PJ
AD  - University of Melbourne, Department of Pharmacology and Therapeutics, Melbourne, 
      Victoria, Australia.
FAU - Crespo, Jose L
AU  - Crespo JL
AD  - CSIC-Universidad de Sevilla, Instituto de Bioquímica Vegetal y Fotosíntesis, 
      Sevilla, Spain.
FAU - Criollo, Alfredo
AU  - Criollo A
AD  - Universidad de Chile, Facultad de Odontología, Advanced Center for Chronic 
      Diseases, Santiago, Chile.
FAU - Crippa, Valeria
AU  - Crippa V
AD  - Università degli Studi di Milano, Dipartimento di Scienze Farmacologiche e 
      Biomolecolari, Centro di Eccellenza per lo studio delle Malattie 
      Neurodegenerative, Milano, Italy.
FAU - Cristofani, Riccardo
AU  - Cristofani R
AD  - Università degli Studi di Milano, Dipartimento di Scienze Farmacologiche e 
      Biomolecolari, Centro di Eccellenza per lo studio delle Malattie 
      Neurodegenerative, Milano, Italy.
FAU - Csizmadia, Tamas
AU  - Csizmadia T
AD  - Department of Anatomy, Cell and Developmental Biology, Eötvös Loránd University, 
      Budapest, Hungary.
FAU - Cuadrado, Antonio
AU  - Cuadrado A
AD  - Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas 
      (CIBERNED), Instituto de Investigación Sanitaria La Paz (IdiPaz), Instituto de 
      Investigaciones Biomédicas Alberto Sols UAM-CSIC, Madrid, Spain; Universidad 
      Autónoma de Madrid, School of Medicine, Department of Biochemistry, Madrid, 
      Spain.
FAU - Cui, Bing
AU  - Cui B
AD  - Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of 
      Materia Medica, State Key Laboratory of Bioactive Substance and Function of 
      Natural Medicines, Molecular Immunology and Cancer Pharmacology Group, Beijing, 
      China.
FAU - Cui, Jun
AU  - Cui J
AD  - Sun Yat-sen University, School of Life Sciences, MOE Key Laboratory of Gene 
      Function and Regulation, Guangzhou, Guangdong, China.
FAU - Cui, Yixian
AU  - Cui Y
AD  - Medical Research Institute, Wuhan University, Wuhan, China.
FAU - Cui, Yong
AU  - Cui Y
AD  - The Chinese University of Hong Kong, School of Life Sciences, Centre for Cell & 
      Developmental Biology and State Key Laboratory of Agrobiotechnology, Shatin, New 
      Territories, Hong Kong, China.
FAU - Culetto, Emmanuel
AU  - Culetto E
AD  - Université Paris-Saclay, CEA, 1035 CNRS, Institute for Integrative Biology of the 
      Cell (I2BC), INSERM U1280, Gif-sur-Yvette, France.
FAU - Cumino, Andrea C
AU  - Cumino AC
AD  - University of Mar del Plata, Department of Biology and Chemestry, Mar del Plata, 
      BA, Argentina.
FAU - Cybulsky, Andrey V
AU  - Cybulsky AV
AD  - McGill University Health Centre, Montréal, QC, Canada.
FAU - Czaja, Mark J
AU  - Czaja MJ
AD  - Emory University School of Medicine, Department of Medicine, Atlanta, GA, USA.
FAU - Czuczwar, Stanislaw J
AU  - Czuczwar SJ
AD  - Medical University of Lublin, Department of Pathophysiology, Lublin, Poland.
FAU - D'Adamo, Stefania
AU  - D'Adamo S
AD  - University of Bologna, Department of Medical and Surgical Sciences; Rizzoli 
      Orthopaedics Institute, Laboratory of Immunorheumatology and Tissue Regeneration, 
      Bologna, Italy.
FAU - D'Amelio, Marcello
AU  - D'Amelio M
AD  - University Campus Bio-Medico, Department of Medicine, Rome, Italy.
FAU - D'Arcangelo, Daniela
AU  - D'Arcangelo D
AD  - Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.
FAU - D'Lugos, Andrew C
AU  - D'Lugos AC
AD  - University of Florida, Department of Physical Therapy, Gainesville, FL, USA.
FAU - D'Orazi, Gabriella
AU  - D'Orazi G
AD  - University "G. D'Annunzio", Department of Medical Sciences DSMOB, Chieti, Italy; 
      Regina Elena National Cancer Institute, Department of Research, Rome, Italy.
FAU - da Silva, James A
AU  - da Silva JA
AD  - Federal University of Sergipe, Department of Pharmacy, São José, SE, Brazil.
FAU - Dafsari, Hormos Salimi
AU  - Dafsari HS
AD  - Max Planck Institute for Biology of Ageing and CECAD, University of Cologne, 
      Germany.
AD  - University of Cologne, Faculty of Medicine and University Hospital Cologne, 
      Department of Pediatrics, Cologne, Germany.
FAU - Dagda, Ruben K
AU  - Dagda RK
AD  - University of Nevada, Reno School of Medicine, Department of Pharmacology, Reno, 
      NV, USA.
FAU - Dagdas, Yasin
AU  - Dagdas Y
AD  - Gregor Mendel Institute, Vienna Biocenter, Vienna, Austria.
FAU - Daglia, Maria
AU  - Daglia M
AD  - University of Naples Federico II, Department of Pharmacy, Naples, Italy.
FAU - Dai, Xiaoxia
AU  - Dai X
AD  - Xi'an Jiaotong University, Department of Public Health, Xi'an, Shaanxi, China.
FAU - Dai, Yun
AU  - Dai Y
AD  - The First Hospital of Jilin University, Laboratory of Cancer Precision Medicine, 
      Changchun, Jilin, China.
FAU - Dai, Yuyuan
AU  - Dai Y
AD  - Model Animal Research Center of Nanjing University, Nanjing, Jiangsu, China.
FAU - Dal Col, Jessica
AU  - Dal Col J
AD  - University of Salerno, Department of Medicine, Surgery and Dentistry "Scuola 
      Medica Salernitana", Baronissi, SA, Italy.
FAU - Dalhaimer, Paul
AU  - Dalhaimer P
AD  - University of Tennessee, Department of Chemical and Biomolecular Engineering, 
      Knoxville, TN, USA.
FAU - Dalla Valle, Luisa
AU  - Dalla Valle L
AD  - University of Padova, Department of Biology, Padova, Italy.
FAU - Dallenga, Tobias
AU  - Dallenga T
AD  - Research Center Borstel, Cellular Microbiology, Borstel, Germany.
FAU - Dalmasso, Guillaume
AU  - Dalmasso G
AD  - University of Clermont Auvergne, M2iSH (Microbes, Intestine, Inflammation and 
      Susceptibility of the Host), UMR 1071 Inserm, INRA USC 2018, CRNH, 
      Clermont-Ferrand, France.
FAU - Damme, Markus
AU  - Damme M
AD  - Christian-Albrechts-University Kiel, Biochemical Institute, Kiel, Germany.
FAU - Dando, Ilaria
AU  - Dando I
AD  - University of Verona, Department of Neurosciences, Biomedicine and Movement 
      Sciences, Biological Chemistry Section, Verona, Italy.
FAU - Dantuma, Nico P
AU  - Dantuma NP
AD  - Karolinska Institutet, Biomedicum, Department of Cell and Molecular Biology, 
      Stockholm, Sweden.
FAU - Darling, April L
AU  - Darling AL
AD  - University of South Florida, Morsani College of Medicine, Department of Molecular 
      Medicine and USF Health Byrd Alzheimer's Research Institute, Tampa, FL, USA; 
      Institute for Biological Instrumentation of Russian Academy of Sciences, 
      Laboratory of New Methods in Biology, Pushchino, Moscow region, Russia.
AD  - University of South Florida, Morsani College of Medicine, Department of Molecular 
      Medicine, Tampa, FL, USA.
FAU - Das, Hiranmoy
AU  - Das H
AD  - Texas Tech University Health Sciences Center, Department of Pharmaceutical 
      Sciences, Amarillo, TX, USA.
FAU - Dasarathy, Srinivasan
AU  - Dasarathy S
AD  - Cleveland Clinic, Department of Gastroenterology, Hepatology and Nutrition, 
      Cleveland, OH, USA.
FAU - Dasari, Santosh K
AU  - Dasari SK
AD  - MD Anderson Cancer Center, Department of Gynecologic Oncology and Reproductive 
      Medicine, Houston, TX, USA.
FAU - Dash, Srikanta
AU  - Dash S
AD  - Tulane University Health Sciences Center, Department of Pathology and Laboratory 
      Medicine, New Orleans, LA, USA.
FAU - Daumke, Oliver
AU  - Daumke O
AD  - Max-Delbrück-Center for Molecular Medicine, Department of Crystallography, 
      Berlin, Germany.
FAU - Dauphinee, Adrian N
AU  - Dauphinee AN
AD  - Swedish University of Agricultural Sciences and Linnean Center for Plant Biology, 
      Uppsala BioCenter, Department of Molecular Sciences, Uppsala, Sweden.
FAU - Davies, Jeffrey S
AU  - Davies JS
AD  - Institute of Life Sciences, School of Medicine, Swansea University, Swansea, 
      Wales, UK.
FAU - Dávila, Valeria A
AU  - Dávila VA
AD  - University of Mar del Plata, Department of Biology and Chemestry, Mar del Plata, 
      BA, Argentina.
FAU - Davis, Roger J
AU  - Davis RJ
AD  - University of Massachusetts Medical School, Program in Molecular Medicine, 
      Worcester, MA, USA.
FAU - Davis, Tanja
AU  - Davis T
AD  - Stellenbosch University, Department of Physiological Sciences, Stellenbosch, 
      Western Cape, South Africa.
FAU - Dayalan Naidu, Sharadha
AU  - Dayalan Naidu S
AD  - University of Dundee School of Medicine, Division of Cellular Medicine, Dundee, 
      Scotland, UK.
FAU - De Amicis, Francesca
AU  - De Amicis F
AD  - University of Calabria, Department of Farmacy Health and Nutritional Sciences, 
      Rende, Italy.
FAU - De Bosscher, Karolien
AU  - De Bosscher K
AD  - Ghent University, Translational Nuclear Receptor Research, VIB Center for Medical 
      Biotechnology, Department of Biomolecular Medicine, Ghent, Belgium.
FAU - De Felice, Francesca
AU  - De Felice F
AD  - "Sapienza" University of Rome, Department of Radiotherapy, Policlinico Umberto I, 
      Rome, Italy.
FAU - De Franceschi, Lucia
AU  - De Franceschi L
AD  - University of Verona, Azienda Ospedaliera Universitaria Integrata-Verona, 
      Department of Medicine, Verona; Italy.
FAU - De Leonibus, Chiara
AU  - De Leonibus C
AD  - Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.
FAU - de Mattos Barbosa, Mayara G
AU  - de Mattos Barbosa MG
AD  - Oswaldo Cruz Foundation, Oswaldo Cruz Institute, Leprosy Laboratory, Rio de 
      Janeiro, Brazil.
FAU - De Meyer, Guido R Y
AU  - De Meyer GRY
AD  - University of Antwerp, Laboratory of Physiopharmacology, Antwerp, Belgium.
FAU - De Milito, Angelo
AU  - De Milito A
AD  - Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institute, 
      Stockholm, Sweden.
FAU - De Nunzio, Cosimo
AU  - De Nunzio C
AD  - Sapienza University of Rome, Ospedale Sant'Andrea, Rome, Italy.
FAU - De Palma, Clara
AU  - De Palma C
AD  - Università degli Studi di Milano, Department of Medical Biotechnology and 
      Translational Medicine, Milano, Italy.
FAU - De Santi, Mauro
AU  - De Santi M
AD  - University of Urbino Carlo Bo, Department of Biomolecular Sciences, Unit of 
      Pharmacology and Public Health, Urbino, Italy.
FAU - De Virgilio, Claudio
AU  - De Virgilio C
AD  - University of Fribourg, Department of Biology, Fribourg, Switzerland.
FAU - De Zio, Daniela
AU  - De Zio D
AD  - Danish Cancer Society Research Center, Cell Stress and Survival Unit, Center for 
      Autophagy, Recycling and Disease (CARD), Copenhagen, Denmark.
FAU - Debnath, Jayanta
AU  - Debnath J
AD  - University of California, San Francisco, Department of Pathology, San Francisco, 
      CA, USA.
FAU - DeBosch, Brian J
AU  - DeBosch BJ
AD  - Washington University School of Medicine, Departments of Pediatrics and Cell 
      Biology & Physiology, St. Louis, MO, USA.
FAU - Decuypere, Jean-Paul
AU  - Decuypere JP
AD  - KU Leuven, Department of Development and Regenaration, Laboratory of Pediatrics, 
      PKD Research Group, Leuven, Belgium.
FAU - Deehan, Mark A
AU  - Deehan MA
AD  - Boston University, Department of Biology, Boston, MA, USA.
FAU - Deflorian, Gianluca
AU  - Deflorian G
AD  - IFOM, The FIRC Institute of Molecular Oncology, Milan, Italy.
FAU - DeGregori, James
AU  - DeGregori J
AD  - University of Colorado Anschutz Medical Campus, Department of Biochemistry and 
      Molecular Genetics, Aurora, CO, USA.
FAU - Dehay, Benjamin
AU  - Dehay B
AD  - University of Bordeaux, CNRS, IMN, UMR 5293, Bordeaux, France.
FAU - Del Rio, Gabriel
AU  - Del Rio G
AD  - Instituto de Fisiologia Celular, UNAM, Department of Biochemistry and Structural 
      Biology, Mexico City, Mexico.
FAU - Delaney, Joe R
AU  - Delaney JR
AD  - Medical University of South Carolina, Charleston, SC 29425, USA.
FAU - Delbridge, Lea M D
AU  - Delbridge LMD
AD  - University of Melbourne, School of Biomedical Sciences, Melbourne, Victoria, 
      Australia.
FAU - Delorme-Axford, Elizabeth
AU  - Delorme-Axford E
AD  - University of Michigan, Life Sciences Institute, Ann Arbor, MI, USA.
FAU - Delpino, M Victoria
AU  - Delpino MV
AD  - University of Buenos Aires, Faculty of Pharmacy and Biochemistry, Institute of 
      Immunology, Genetics and Metabolism (INIGEM), CONICET. Buenos Aires, Argentina.
FAU - Demarchi, Francesca
AU  - Demarchi F
AD  - L.N.C.I.B. Laboratorio Nazionale Consorzio Interuniversitario Biotecnologie, AREA 
      Science Park, Trieste, Italy.
FAU - Dembitz, Vilma
AU  - Dembitz V
AD  - University of Zagreb School of Medicine, Department of Physiology and Croatian 
      Institute for Brain Research, Zagreb, Croatia.
FAU - Demers, Nicholas D
AU  - Demers ND
AD  - Hospital for Sick Children, Program in Cell Biology Department, Toronto, Canada; 
      University of Toronto, Department of Biochemistry, Toronto, Canada.
FAU - Deng, Hongbin
AU  - Deng H
AD  - Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of 
      Medicinal Biotechnology, Beijing, China.
FAU - Deng, Zhiqiang
AU  - Deng Z
AD  - Wuhan University, School of Pharmaceutical Sciences, Zhongnan Hospital, Wuhan, 
      China.
FAU - Dengjel, Joern
AU  - Dengjel J
AD  - University of Fribourg, Department of Biology, Fribourg, Switzerland.
FAU - Dent, Paul
AU  - Dent P
AD  - Virginia Commonwealth University, Department of Biochemistry and Molecular 
      Biology, Richmond, VA, USA.
FAU - Denton, Donna
AU  - Denton D
AD  - Centre for Cancer Biology, University of South Australia, Adelaide, Australia.
FAU - DePamphilis, Melvin L
AU  - DePamphilis ML
AD  - Division of Developmental Biology, National Institute of Child Health & Human 
      Development, National Institutes of Health, Bethesda, MD, USA.
FAU - Der, Channing J
AU  - Der CJ
AD  - University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer 
      Center, Chapel Hill, NC, USA.
FAU - Deretic, Vojo
AU  - Deretic V
AD  - University of New Mexico Health Sciences Center, Autophagy, Inflamamtion and 
      Metabolism (AIM) Center, Albuquerque, NM, USA.
FAU - Descoteaux, Albert
AU  - Descoteaux A
AD  - Institut National de la Recherche Scientifique, Centre Armand-Frappier Santé 
      Biotechnologie, Laval, QC, Canada.
FAU - Devis, Laura
AU  - Devis L
AD  - Bellvitge Biomedical Research Institute-IDIBELL, Oncobell Program. L'Hospitalet 
      de Llobregat, Barcelona, Spain.
FAU - Devkota, Sushil
AU  - Devkota S
AD  - University of California, San Diego; Section of Cell and Developmental Biology, 
      La Jolla, CA, USA.
FAU - Devuyst, Olivier
AU  - Devuyst O
AD  - University of Zurich, Institute of Physiology, Zurich, Switzerland.
FAU - Dewson, Grant
AU  - Dewson G
AD  - Walter and Eliza Hall Institute of Medical Research, Ubiquitin Signalling 
      Division, Melbourne, Australia; University of Melbourne, Department of Medical 
      Biology, Melbourne, Australia.
FAU - Dharmasivam, Mahendiran
AU  - Dharmasivam M
AD  - University of Sydney, Department of Pathology and Bosch Institute, Sydney, NSW, 
      Australia.
FAU - Dhiman, Rohan
AU  - Dhiman R
AD  - National Institute of Technology Rourkela, Department of Life Science, Cancer and 
      Cell Death Laboratory, Rourkela, Odisha, India.
FAU - di Bernardo, Diego
AU  - di Bernardo D
AD  - Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.
AD  - University of Naples "Federico II", Department of Chemical, Materials and 
      Industrial Production Engineering, Naples, Italy.
FAU - Di Cristina, Manlio
AU  - Di Cristina M
AD  - University of Perugia, Department of Chemistry, Biology and Biotechnology, 
      Perugia, Italy.
FAU - Di Domenico, Fabio
AU  - Di Domenico F
AD  - Sapienza University of Rome, Department of Biochemical Sciences A. Rossi Fanelli, 
      Rome, Italy.
FAU - Di Fazio, Pietro
AU  - Di Fazio P
AD  - Philipps University of Marburg, Department of Visceral, Thoracic and Vascular 
      Surgery, Marburg, Germany.
FAU - Di Fonzo, Alessio
AU  - Di Fonzo A
AD  - IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Dino Ferrari Center, 
      Neuroscience Section, University of Milan, Department of Pathophysiology and 
      Transplantation, Milan, Italy.
FAU - Di Guardo, Giovanni
AU  - Di Guardo G
AD  - University of Teramo, Faculty of Veterinary Medicine, Teramo, Italy.
FAU - Di Guglielmo, Gianni M
AU  - Di Guglielmo GM
AD  - Western University, Department of Physiology and Pharmacology, London, ON, 
      Canada.
FAU - Di Leo, Luca
AU  - Di Leo L
AD  - Danish Cancer Society Research Center, Cell Stress and Survival Unit, Center for 
      Autophagy, Recycling and Disease (CARD), Copenhagen, Denmark.
FAU - Di Malta, Chiara
AU  - Di Malta C
AD  - Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.
FAU - Di Nardo, Alessia
AU  - Di Nardo A
AD  - Harvard Medical School, Boston Children's Hospital, F.M. Kirby Neurobiology 
      Center, Translational Neuroscience Center, Department of Neurology, Boston, MA, 
      USA.
FAU - Di Rienzo, Martina
AU  - Di Rienzo M
AD  - National Institute for Infectious Diseases "L. Spallanzani" IRCCS, Rome, Italy.
FAU - Di Sano, Federica
AU  - Di Sano F
AD  - University of Rome "Tor Vergata", Department of Biology, Rome, Italy.
FAU - Diallinas, George
AU  - Diallinas G
AD  - National and Kapodistrian University of Athens, Department of Biology, 
      Panepistimioupolis, Athens, Greece.
FAU - Diao, Jiajie
AU  - Diao J
AD  - University of Cincinnati College of Medicine, Department of Cancer Biology, 
      Cincinnati, OH, USA.
FAU - Diaz-Araya, Guillermo
AU  - Diaz-Araya G
AD  - University of Chile, Faculty of Chemical and Pharmaceutical Sciences, Department 
      of Chemical Pharmacology and Toxicology, Santiago de Chile, Chile.
FAU - Díaz-Laviada, Inés
AU  - Díaz-Laviada I
AD  - University of Alcalá, Deparment of Systems Biology, Biochemistry and Molecular 
      Biology, Alcalá de Henares, Madrid, Spain.
FAU - Dickinson, Jared M
AU  - Dickinson JM
AD  - Arizona State University, Phoenix, AZ, USA.
FAU - Diederich, Marc
AU  - Diederich M
AD  - Seoul National University, College of Pharmacy, Seoul, Korea.
FAU - Dieudé, Mélanie
AU  - Dieudé M
AD  - University of Montreal, Faculty of Medicine, Microbiology, Infectious diseases 
      and Immunology Department, CRCHUM, Montréal, QC, Canada.
FAU - Dikic, Ivan
AU  - Dikic I
AD  - Goethe University, Institute of Biochemistry II, Faculty of Medicine, Frankfurt 
      am Main, Germany.
FAU - Ding, Shiping
AU  - Ding S
AD  - Zhejiang University, School of Medicine, Department of Cell Biology, Hangzhou, 
      Zhejiang Province, China.
FAU - Ding, Wen-Xing
AU  - Ding WX
AD  - University of Kansas Medical Center, Department of Pharmacology, Toxicology and 
      Therapeutics, Kansas City, KS, USA.
FAU - Dini, Luciana
AU  - Dini L
AD  - University of Rome La Sapienza, Department of Biology and Biotechnology C. 
      Darwin, Rome, Italy.
FAU - Dinić, Jelena
AU  - Dinić J
AD  - University of Belgrade, Institute for Biological Research "Sinisa Stankovic" - 
      National Institute of Republic of Serbia, Department of Neurobiology, Belgrade, 
      Serbia.
FAU - Dinic, Miroslav
AU  - Dinic M
AD  - University of Belgrade, Institute of Molecular Genetics and Genetic Engineering, 
      Belgrade, Serbia.
FAU - Dinkova-Kostova, Albena T
AU  - Dinkova-Kostova AT
AD  - University of Dundee School of Medicine, Division of Cellular Medicine, Dundee, 
      Scotland, UK.
AD  - Johns Hopkins University School of Medicine, Department of Pharmacology and 
      Molecular Sciences and Department of Medicine, Baltimore, MD, USA.
FAU - Dionne, Marc S
AU  - Dionne MS
AD  - Imperial College London, Department of Life Sciences and MRC Centre for Molecular 
      Bacteriology and Infection, London, UK.
FAU - Distler, Jörg H W
AU  - Distler JHW
AD  - Friedrich-Alexander University (FAU) Erlangen-Nürnberg and Universitätsklinikum 
      Erlangen, Department of Internal Medicine 3 - Rheumatology and Immunology, 
      Erlangen, Germany.
FAU - Diwan, Abhinav
AU  - Diwan A
AD  - Washington University School of Medicine and John Cochran VA Medical Center, 
      Department of Medicine, St. Louis, MO, USA.
FAU - Dixon, Ian M C
AU  - Dixon IMC
AD  - University of Manitoba, Institute of Cardiovascular Sciences, Department of 
      Physiology and Pathophysiology, Winnipeg, Manitoba, Canada.
FAU - Djavaheri-Mergny, Mojgan
AU  - Djavaheri-Mergny M
AD  - Centre de Recherche des Cordeliers, INSERM UMRS 1138, Sorbonne Université, 
      Université de Paris, Equipe 11 labellisée par la Ligue contre le Cancer, 75006 
      Paris, France; Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 
      94805 Villejuif, France.
FAU - Dobrinski, Ina
AU  - Dobrinski I
AD  - University of Calgary, Department of Comparative Biology and Experimental 
      Medicine, Calgary, AB, Canada.
FAU - Dobrovinskaya, Oxana
AU  - Dobrovinskaya O
AD  - University of Colima, University Center for Biomedical Research, Colima, Mexico.
FAU - Dobrowolski, Radek
AU  - Dobrowolski R
AD  - Rutgers University, Department of Biological Sciences, Newark, NJ, USA.
FAU - Dobson, Renwick C J
AU  - Dobson RCJ
AD  - University of Canterbury, Biomolecular Interaction Centre, School of Biological 
      Sciences, Christchurch, New Zealand.
FAU - Đokić, Jelena
AU  - Đokić J
AD  - University of Belgrade, Institute of Molecular Genetics and Genetic Engineering, 
      Belgrade, Serbia.
FAU - Dokmeci Emre, Serap
AU  - Dokmeci Emre S
AD  - Hacettepe University, Faculty of Medicine, Department of Medical Biology, Ankara, 
      Turkey.
FAU - Donadelli, Massimo
AU  - Donadelli M
AD  - University of Verona, Department of Neurosciences, Biomedicine and Movement 
      Sciences, Biological Chemistry Section, Verona, Italy.
FAU - Dong, Bo
AU  - Dong B
AD  - University of Kentucky, College of Medicine, Markey Cancer Center, Lexington, KY, 
      USA.
FAU - Dong, Xiaonan
AU  - Dong X
AD  - University of Texas Southwestern Medical Center, Department of Internal Medicine, 
      Center for Autophagy Research, Dallas, TX, USA.
FAU - Dong, Zhiwu
AU  - Dong Z
AD  - Jinshan Branch of Shanghai Sixth People's Hospital, Department of Laboratory 
      Medicine, Shanghai, China.
FAU - Dorn Ii, Gerald W
AU  - Dorn Ii GW
AD  - Washington University in St Louis School of Medicine, Department of Internal 
      Medicine, St. Louis, MO, USA.
FAU - Dotsch, Volker
AU  - Dotsch V
AD  - Goethe University, Institute of Biophysical Chemistry, Frankfurt, Germany.
FAU - Dou, Huan
AU  - Dou H
AD  - Nanjing University, Medical School, Division of Immunology, Nanjing, Jiangsu, 
      China.
FAU - Dou, Juan
AU  - Dou J
AD  - Emory University School of Medicine, Department of Psychiatry and Behavioral 
      Sciences, Atlanta, GA, USA.
FAU - Dowaidar, Moataz
AU  - Dowaidar M
AD  - Umeå University, Department of Chemistry, Umeå, Sweden.
FAU - Dridi, Sami
AU  - Dridi S
AD  - University of Arkansas, Center of Excellence for Poultry Science, Fayetteville, 
      AR, USA.
FAU - Drucker, Liat
AU  - Drucker L
AD  - Oncogenetic Laboratory, Meir Medical Center, Kfar Saba, and Sackler Faculty of 
      Medicine, Tel Aviv University, Tel Aviv, Israel.
FAU - Du, Ailian
AU  - Du A
AD  - Tongren Hospital, Shanghai Jiaotong University School of Medicine, Department of 
      Neurology, Shanghai, China.
FAU - Du, Caigan
AU  - Du C
AD  - University of British Columbia, Department of Urologic Sciences, Vancouver, BC, 
      Canada.
FAU - Du, Guangwei
AU  - Du G
AD  - The University of Texas Health Science Center at Houston, Department of 
      Integrative Biology and Pharmacology, Houston, TX, USA.
FAU - Du, Hai-Ning
AU  - Du HN
AD  - Wuhan University, Hubei Key laboratory of Cell Homeostasis, College of Life 
      Sciences, Wuhan, China.
FAU - Du, Li-Lin
AU  - Du LL
AD  - National Institute of Biological Sciences, Beijing, China.
FAU - du Toit, André
AU  - du Toit A
AD  - Stellenbosch University, Department of Physiological Sciences, Stellenbosch, 
      Western Cape, South Africa.
FAU - Duan, Shao-Bin
AU  - Duan SB
AD  - Central South University, The Second Xiangya Hospital, Department of Nephrology, 
      Changsha , Hunan, China.
FAU - Duan, Xiaoqiong
AU  - Duan X
AD  - Chinese Academy of Medical Sciences and Peking Union Medical College, Institute 
      of Blood Transfusion, Chengdu, China.
FAU - Duarte, Sónia P
AU  - Duarte SP
AD  - University of Coimbra, Faculty of Medicine and CNC-Center for Neuroscience and 
      Cell Biology, Coimbra, Portugal.
AD  - CNC - Center for Neuroscience and Cell Biology, Coimbra, IIIUC - Instituto de 
      Investigação Interdisciplinar, University of Coimbra, Coimbra, Portugal.
FAU - Dubrovska, Anna
AU  - Dubrovska A
AD  - OncoRay National Center for Radiation Research in Oncology, Faculty of Medicine 
      and University Hospital Carl Gustav Carus, Technische Universität Dresden, 
      Germany; Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiooncology - 
      OncoRay, Dresden, Germany; German Cancer Consortium (DKTK), Partner site Dresden, 
      Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany.
FAU - Dunlop, Elaine A
AU  - Dunlop EA
AD  - Cardiff University, Division of Cancer and Genetics, Heath Park, Cardiff, UK.
FAU - Dupont, Nicolas
AU  - Dupont N
AD  - Institut Necker-Enfants Malades (INEM), INSERM U1151/CNRS UMR 8253, Université de 
      Paris, Paris, France.
FAU - Durán, Raúl V
AU  - Durán RV
AD  - Centro Andaluz de Biología Molecular y Medicina Regenerativa CABIMER, Consejo 
      Superior de Investigaciones Científicas, Universidad de Sevilla, Universidad 
      Pablo de Olavide, Seville, Spain.
FAU - Dwarakanath, Bilikere S
AU  - Dwarakanath BS
AD  - Shanghai Proton and Heavy Ion Center, Department of Research & Development, 
      Pudong, Shanghai, China.
FAU - Dyshlovoy, Sergey A
AU  - Dyshlovoy SA
AD  - University Medical Center Hamburg-Eppendorf, Department of Oncology, Hematology 
      and Bone Marrow Transplantation with Section Pneumology, Hamburg, Germany.
AD  - A.V. Zhirmunsky National Scientific Center of Marine Biology, Laboratory of 
      Pharmacology, Far Eastern Branch, Russian Academy of Sciences, Vladivostok, 
      Russian Federation.
AD  - Far Eastern Federal University, School of Natural Sciences, Vladivostok, Russian 
      Federation.
FAU - Ebrahimi-Fakhari, Darius
AU  - Ebrahimi-Fakhari D
AD  - Department of Neurology, Boston Children's Hospital, Boston, MA, USA.
FAU - Eckhart, Leopold
AU  - Eckhart L
AD  - Medical University of Vienna, Department of Dermatology, Division for Biology and 
      Pathobiology of the Skin, Vienna, Austria.
FAU - Edelstein, Charles L
AU  - Edelstein CL
AD  - University of Colorado Anschutz Medical Campus, Division of Renal diseases, 
      Aurora, CO, USA.
FAU - Efferth, Thomas
AU  - Efferth T
AD  - Johannes Gutenberg University, Institute of Pharmaceutical and Biomedical 
      Sciences, Department of Pharmaceutical Biology, Mainz, Germany.
FAU - Eftekharpour, Eftekhar
AU  - Eftekharpour E
AD  - University of Manitoba, Department of Physiology and Pathophysiology, 
      Regenerative Medicine Program, Winnipeg, Manitoba, Canada.
FAU - Eichinger, Ludwig
AU  - Eichinger L
AD  - University of Cologne, Centre for Biochemistry, Institute of Biochemistry I, 
      Medical Faculty, Cologne, Germany.
FAU - Eid, Nabil
AU  - Eid N
AD  - United Arab Emirates University, College of Medicine & Health Sciences, 
      Department of Anatomy, Al Ain, UAE.
FAU - Eisenberg, Tobias
AU  - Eisenberg T
AD  - University of Graz, NAWI Graz, Institute of Molecular Biosciences, Graz, Austria; 
      BioTechMed Graz, Graz, Austria; University of Graz, Field of Excellence 
      BioHealth, Graz, Austria.
FAU - Eissa, N Tony
AU  - Eissa NT
AD  - Long Beach VA and University of California, Irvine, Irvine, CA, USA.
FAU - Eissa, Sanaa
AU  - Eissa S
AD  - Ain Shams University, Faculty of Medicine, Department of Medical Biochemistry and 
      Molecular Biology, Cairo, Egypt.
FAU - Ejarque, Miriam
AU  - Ejarque M
AD  - Hospital Universitari de Tarragona Joan XXIII, Institut d'Investigació Santitària 
      Pere Virgili.
FAU - El Andaloussi, Abdeljabar
AU  - El Andaloussi A
AD  - University of Illinois at Chicago, Department of Pathology, College of Medicine, 
      Chicago, IL, USA.
FAU - El-Hage, Nazira
AU  - El-Hage N
AD  - Florida International University, Department of Immunology and Nano-Medicine, 
      Miami, FL, USA.
FAU - El-Naggar, Shahenda
AU  - El-Naggar S
AD  - Children's Cancer Hospital Egypt 57357, Tumor Biology Research Program, Cairo, 
      Egypt.
FAU - Eleuteri, Anna Maria
AU  - Eleuteri AM
AD  - University of Camerino, Department of Biosciences and Biotechnology, Camerino, 
      Italy.
FAU - El-Shafey, Eman S
AU  - El-Shafey ES
AD  - Damietta University, Faculty of Science, Biochemistry Department, Damietta, 
      Egypt.
FAU - Elgendy, Mohamed
AU  - Elgendy M
AD  - Technische Universität Dresden, Medical Clinic I, University Hospital Carl Gustav 
      Carus, Dresden, Germany; Technische Universität Dresden, Faculty of Medicine, 
      Institute for Clinical Chemistry and Laboratory Medicine, Dresden, Germany; 
      Institute of Molecular Genetics of the ASCR, Department of Cancer Cell Biology, 
      Prague, Czech Republic.
FAU - Eliopoulos, Aristides G
AU  - Eliopoulos AG
AD  - National and Kapodistrian University of Athens, Department of Biology, 
      Panepistimioupolis, Athens, Greece.
FAU - Elizalde, María M
AU  - Elizalde MM
AD  - Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), 
      Universidad de Buenos Aires-CONICET, Argentina.
FAU - Elks, Philip M
AU  - Elks PM
AD  - University of Sheffield, The Bateson Centre, Department of Infection, Immunity 
      and Cardiovascular Disease,Sheffield, South Yorkshire, UK.
FAU - Elsasser, Hans-Peter
AU  - Elsasser HP
AD  - Philipps University of Marburg, Department of Cytobiology and Cytopathology, 
      Marburg, Germany.
FAU - Elsherbiny, Eslam S
AU  - Elsherbiny ES
AD  - Damietta University, Faculty of Science, Biochemistry Department, Damietta, 
      Egypt.
FAU - Emerling, Brooke M
AU  - Emerling BM
AD  - Sanford Burnham Prebys Medical Discovery Research Institute, La Jolla, CA, USA.
FAU - Emre, N C Tolga
AU  - Emre NCT
AD  - Bogazici University, Department of Molecular Biology and Genetics, Bebek, 
      Istanbul, Turkey.
FAU - Eng, Christina H
AU  - Eng CH
AD  - Pfizer, Oncology Research & Development, Pearl River, NY, USA.
FAU - Engedal, Nikolai
AU  - Engedal N
AD  - Oslo University Hospital, Institute for Cancer Research, Department of Tumor 
      Biology, Montebello, Oslo, Norway.
FAU - Engelbrecht, Anna-Mart
AU  - Engelbrecht AM
AD  - Stellenbosch University, Department of Physiological Sciences, Stellenbosch, 
      Western Cape, South Africa.
FAU - Engelsen, Agnete S T
AU  - Engelsen AST
AD  - University of Bergen, Department of Biomedicine/ Centre for Cancer Biomarkers 
      (CCBIO), Bergen, Norway.
FAU - Enserink, Jorrit M
AU  - Enserink JM
AD  - The Norwegian Radium Hospital, Institute for Cancer Research, Department of 
      Molecular Cell Biology, Montebello, Oslo, Norway; University of Oslo, Faculty of 
      Mathematics and Natural Sciences, The Department of Biosciences, Oslo, Norway.
FAU - Escalante, Ricardo
AU  - Escalante R
AD  - Instituto de Investigaciones Biomédicas Alberto Sols, C.S.I.C./U.A.M., Madrid, 
      Spain.
FAU - Esclatine, Audrey
AU  - Esclatine A
AD  - Université Paris-Saclay, CEA, 1035 CNRS, Institute for Integrative Biology of the 
      Cell (I2BC), INSERM U1280, Gif-sur-Yvette, France.
FAU - Escobar-Henriques, Mafalda
AU  - Escobar-Henriques M
AD  - Universität zu Köln, CECAD Forschungszentrum, Institut für Genetik, Köln, 
      Germany.
FAU - Eskelinen, Eeva-Liisa
AU  - Eskelinen EL
AD  - University of Turku, Institute of Biomedicine, Turku, Finland.
FAU - Espert, Lucile
AU  - Espert L
AD  - IRIM, University of Montpellier, CNRS, Montpellier, France.
FAU - Eusebio, Makandjou-Ola
AU  - Eusebio MO
AD  - Medical University of Lodz, Department of Laboratory Diagnostics, Lodz, Poland.
FAU - Fabrias, Gemma
AU  - Fabrias G
AD  - Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Department of 
      Biological Chemistry; Networking Biomedical Research Centre on Hepatic and 
      Digestive Diseases (CIBER-EHD), Barcelona, Spain.
FAU - Fabrizi, Cinzia
AU  - Fabrizi C
AD  - Sapienza University of Rome, DAHFMO-Section of Anatomy, Rome, Italy.
FAU - Facchiano, Antonio
AU  - Facchiano A
AD  - Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.
FAU - Facchiano, Francesco
AU  - Facchiano F
AD  - Istituto Superiore di Sanità, Department of Oncology and Molecular Medicine, 
      Rome, Italy.
FAU - Fadeel, Bengt
AU  - Fadeel B
AD  - Karolinska Institutet, Institute of Environmental Medicine, Stockholm, Sweden.
FAU - Fader, Claudio
AU  - Fader C
AD  - Universidad Nacional de Cuyo, Facultad de Ciencias Médicas, Laboratorio de 
      Biología Celular y Molecular, IHEM-CONICET, Mendoza, Argentina.
FAU - Faesen, Alex C
AU  - Faesen AC
AD  - Max-Planck-Institute of Biophysical Chemistry, Biochemistry of Signal Dynamics, 
      Göttingen, Germany.
FAU - Fairlie, W Douglas
AU  - Fairlie WD
AD  - La Trobe Institute for Molecular Science, La Trobe University, Melbourne, 
      Victoria, Australia; Olivia Newton-John Cancer Research Institute, Heidelberg, 
      Victoria, Australia; School of Cancer Medicine, La Trobe University, Melbourne, 
      Victoria, Australia.
FAU - Falcó, Alberto
AU  - Falcó A
AD  - Universidad Miguel Hernández (UMH), Instituto de Investigación, Desarrollo e 
      Innovación en Biotecnología Sanitaria de Elche (IDiBE), Elche, Spain.
FAU - Falkenburger, Bjorn H
AU  - Falkenburger BH
AD  - Dresden University Medical Center, Department of Neurology, Dresden, Germany.
FAU - Fan, Daping
AU  - Fan D
AD  - University of South Carolina School of Medicine, Department of Cell Biology and 
      Anatomy, Columbia, SC, USA.
FAU - Fan, Jie
AU  - Fan J
AD  - University of Pittsburgh, Department of Surgery, Pittsburgh, PA, USA.
FAU - Fan, Yanbo
AU  - Fan Y
AD  - University of Cincinnati, Department of Cancer Biology, Cincinnati, OH, USA.
FAU - Fang, Evandro F
AU  - Fang EF
AD  - University of Oslo and Akershus University Hospital, Department of Clinical 
      Molecular Biology, Lørenskog, Norway; The Norwegian Centre on Healthy Ageing 
      (NO-Age), Oslo, Norway.
FAU - Fang, Yanshan
AU  - Fang Y
AD  - Shanghai Institute of Organic Chemistry, Chinese Academy of Science, 
      Interdisciplinary Research Center on Biology and Chemistry, Shanghai, China; 
      University of Chinese Academy of Sciences, Beijing, China.
FAU - Fang, Yognqi
AU  - Fang Y
AD  - The First Affiliated Hospital of Guangzhou University of Chinese Medicine, 
      Guangzhou, China.
FAU - Fanto, Manolis
AU  - Fanto M
AD  - King's College London, Department of Basic and Clinical Neuroscience, London, 
      United Kingdom; Institut du Cerveau et de la Moelle épinière (ICM), Paris, 
      France.
FAU - Farfel-Becker, Tamar
AU  - Farfel-Becker T
AD  - National Institutes of Health, National Institute of Neurological Disorders and 
      Stroke, Bethesda, MD, USA.
FAU - Faure, Mathias
AU  - Faure M
AD  - Centre International de Recherche en Infectiologie (CIRI), University Lyon, 
      Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS Lyon, Lyon, 
      France.
FAU - Fazeli, Gholamreza
AU  - Fazeli G
AD  - Rudolf Virchow Center, University of Würzburg, Würzburg, Germany.
FAU - Fedele, Anthony O
AU  - Fedele AO
AD  - South Australian Health and Medical Research Institute, Hopwood Centre for 
      Neurobiology, Lifelong Health Theme, Adelaide, South Australia, Australia.
FAU - Feldman, Arthur M
AU  - Feldman AM
AD  - Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
FAU - Feng, Du
AU  - Feng D
AD  - Guangzhou Medical University, School of Basic Medical Sciences, State Key 
      Laboratory of Respiratory Disease, Guangzhou, China.
FAU - Feng, Jiachun
AU  - Feng J
AD  - The First Hospital of Jilin University, Department of Neurology, Changchun, 
      China.
FAU - Feng, Lifeng
AU  - Feng L
AD  - Medical School of Zhejiang University, Sir Run Run Shaw Hospital, Key lab of 
      Biotherapy in Zhejiang, Laboratory of Cancer Biology, Hangzhou, China.
FAU - Feng, Yibin
AU  - Feng Y
AD  - The University of Hong Kong, School of Chinese Medicine, Li Ka Shing Faculty of 
      Medicine, Hong Kong, China.
FAU - Feng, Yuchen
AU  - Feng Y
AD  - Baylor College of Medicine, Department of Biochemistry and Molecular Biology, 
      Houston TX, USA.
FAU - Feng, Wei
AU  - Feng W
AD  - Chinese Academy of Sciences, Institute of Biophysics, Beijing, China.
FAU - Fenz Araujo, Thais
AU  - Fenz Araujo T
AD  - University of São Paulo (USP), Ribeirão Preto Medical School, Department of 
      Genetics, Ribeirão Preto, SP, Brazil.
FAU - Ferguson, Thomas A
AU  - Ferguson TA
AD  - Washington University in St. Louis, Department of Ophthalmology and Visual 
      Sciences, St. Louis, MO, USA.
FAU - Fernández, Álvaro F
AU  - Fernández ÁF
AD  - University of Texas Southwestern Medical Center, Center for Autophagy Research, 
      Department of Internal Medicine and Howard Hughes Medical Institute, Dallas, TX, 
      USA.
FAU - Fernandez-Checa, Jose C
AU  - Fernandez-Checa JC
AD  - Institute of Biomedical Research of Barcelona (IIBB)-CSIC, Barcelona, Spain; 
      Liver Unit, Hospital Clinic i Provincial de Barcelona, IDIBAPS and CIBEREHD, 
      Barcelona, Spain; Research Center for ALPD, Keck School of Medicine, University 
      of Southern California, Los Angeles, CA, USA.
FAU - Fernández-Veledo, Sonia
AU  - Fernández-Veledo S
AD  - Hospital Universitari de Tarragona Joan XXIII, Institut d'Investigació Sanitària 
      Pere Virgili, Madrid, Spain; CIBER de Diabetes y Enfermedades Metabólicas 
      Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
FAU - Fernie, Alisdair R
AU  - Fernie AR
AD  - Max Planck Institute of Molecular Plant Physiology, Potsdam-Golm, Germany.
FAU - Ferrante, Anthony W Jr
AU  - Ferrante AW Jr
AD  - Columbia University, New York, NY, USA.
FAU - Ferraresi, Alessandra
AU  - Ferraresi A
AD  - Università del Piemonte Orientale, Department of Health Sciences, Laboratory of 
      Molecular Pathology, Novara, Italy.
FAU - Ferrari, Merari F
AU  - Ferrari MF
AD  - University of Sao Paulo, Institute of Biosciences, Sao Paulo, SP, Brazil.
FAU - Ferreira, Julio C B
AU  - Ferreira JCB
AD  - Stanford University, Department of Chemical & Systems Biology, Stanford, CA, USA.
AD  - University of Sao Paulo, Institute of Biomedical Sciences, Sao Paulo, SP, Brazil.
FAU - Ferro-Novick, Susan
AU  - Ferro-Novick S
AD  - University of California, San Diego, Department of Cellular and Molecular 
      Medicine, La Jolla, CA, USA.
FAU - Figueras, Antonio
AU  - Figueras A
AD  - Instituto de Investigaciones Marinas CSIC, Department of Biotechnology and 
      Aquaculture, Immunology and Genomics, Vigo, Spain.
FAU - Filadi, Riccardo
AU  - Filadi R
AD  - University of Padua, Department of Biomedical Sciences, Padua, Italy; Italian 
      National Research Council (CNR), Neuroscience Institute, Padua, Italy.
FAU - Filigheddu, Nicoletta
AU  - Filigheddu N
AD  - University of Piemonte Orientale, Department of Translational Medicine, Novara, 
      Italy.
FAU - Filippi-Chiela, Eduardo
AU  - Filippi-Chiela E
AD  - Universidade Federal do Rio Grande do Sul (UFRGS), Morphological Sciences 
      Department, Porto Alegre, RS, Brazil; Clinicas Hospital of Porto Alegre, Porto 
      Alegre, RS, Brazil.
FAU - Filomeni, Giuseppe
AU  - Filomeni G
AD  - Danish Cancer Society Research Center, Redox Signaling and Oxidative Stress 
      Group, Copenhagen, Denmark.
FAU - Fimia, Gian Maria
AU  - Fimia GM
AD  - National Institute for Infectious Diseases "L. Spallanzani" IRCCS, Rome, Italy.
AD  - Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
FAU - Fineschi, Vittorio
AU  - Fineschi V
AD  - Università degli Studi Sapienza di Roma, SAIMLAL Department, Roma, Italy.
FAU - Finetti, Francesca
AU  - Finetti F
AD  - University of Siena, Department of Life Sciences, Siena, Italy.
FAU - Finkbeiner, Steven
AU  - Finkbeiner S
AD  - Center for Systems and Therapeutics, Gladstone Institutes; Departments of 
      Neurology and Physiology, University of California San Francisco, San Francisco, 
      CA, USA.
FAU - Fisher, Edward A
AU  - Fisher EA
AD  - NYU School of Medicine, Department of Medicine, New York, NY, USA.
FAU - Fisher, Paul B
AU  - Fisher PB
AD  - Virginia Commonwealth University, School of Medicine, Department of Human and 
      Molecular Genetics, Richmond, VA, USA; Virginia Commonwealth University, VCU 
      Institute of Molecular Medicine, Richmond, VA, USA; Columbia University, College 
      of Physicians and Surgeons, Departments of Pathology, Neurosurgery and Urology, 
      New York, NY, USA.
FAU - Flamigni, Flavio
AU  - Flamigni F
AD  - University of Bologna, Department of Biomedical and Neuromotor Sciences, Bologna, 
      Italy.
FAU - Fliesler, Steven J
AU  - Fliesler SJ
AD  - State University of New York, University at Buffalo, Jacobs School of Medicine 
      and Biomedical Sciences, Departments of Ophthalmology/Biochemistry and 
      Neuroscience Program, Buffalo, NY, USA.
FAU - Flo, Trude H
AU  - Flo TH
AD  - Norwegian University of Science and Technology, Department of Clinical and 
      Molecular Medicine, Centre for Molecular Inflammation Research, Trondheim, 
      Norway.
FAU - Florance, Ida
AU  - Florance I
AD  - Central University of Tamil Nadu, Thiruvarur, Tamil Nadu, India.
FAU - Florey, Oliver
AU  - Florey O
AD  - Babraham Institute, Signalling ISP, Cambridge, UK.
FAU - Florio, Tullio
AU  - Florio T
AD  - University of Genova, Department of Internal Medicine and IRCCS Policlinico San 
      Martino, Genova, Italy.
FAU - Fodor, Erika
AU  - Fodor E
AD  - Eötvös Loránd University (ELTE), Department of Genetics, Budapest, Hungary.
FAU - Follo, Carlo
AU  - Follo C
AD  - University of California San Francisco, Department of Medicine, Zuckerberg San 
      Francisco General Hospital and TraumaCenter, San Francisco, CA, USA.
FAU - Fon, Edward A
AU  - Fon EA
AD  - Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill 
      University, Montreal, Quebec, Canada.
FAU - Forlino, Antonella
AU  - Forlino A
AD  - University of Pavia, Department of Molecular Medicine, Biochemistry Unit, Pavia, 
      Italy.
FAU - Fornai, Francesco
AU  - Fornai F
AD  - University of Pisa, Department of Translational Medicine and New Technologies in 
      Medicine and Surgery, Pisa, Italy; I.R.C.C.S. Neuromed Pozzilli, Pozzilli, Italy.
FAU - Fortini, Paola
AU  - Fortini P
AD  - Istituto Superiore di Sanità, Department of Environment and Health, Section of 
      Mechanisms, Biomarkers and Models, Rome, Italy.
FAU - Fracassi, Anna
AU  - Fracassi A
AD  - University of Texas Medical Branch, Mitchell Center for Neurodegenerative 
      Diseases, Department of Neurology, Galveston, TX, USA.
FAU - Fraldi, Alessandro
AU  - Fraldi A
AD  - Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.
AD  - University of Naples Federico II, Department of Translational Medical Sciences, 
      Naples, Italy.
FAU - Franco, Brunella
AU  - Franco B
AD  - Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.
AD  - University of Naples Federico II, Department of Translational Medical Sciences, 
      Naples, Italy.
FAU - Franco, Rodrigo
AU  - Franco R
AD  - University of Nebraska-Lincoln, Redox Biology Center, Lincoln, NE, USA.
FAU - Franconi, Flavia
AU  - Franconi F
AD  - Laboratory of Sex-gender Medicine, National Institute of Biostructures and 
      Biosystems, Sassari, Italy.
FAU - Frankel, Lisa B
AU  - Frankel LB
AD  - Danish Cancer Society Research Center, RNA and Autophagy Group, Copenhagen, 
      Denmark.
AD  - University of Copenhagen, Biotech Research and Innovation Centre, Copenhagen, 
      Denmark.
FAU - Friedman, Scott L
AU  - Friedman SL
AD  - Icahn School of Medicine at Mount Sinai, Department of Medicine, Division of 
      Liver Diseases, New York, NY, USA.
FAU - Fröhlich, Leopold F
AU  - Fröhlich LF
AD  - Institute of Science and Technology Austria (IST), Klosterneuburg, Austria.
FAU - Frühbeck, Gema
AU  - Frühbeck G
AD  - Clínica Universidad de Navarra, Metabolic Research Laboratory, CIBEROBN, IdiSNA, 
      Pamplona, Spain.
FAU - Fuentes, Jose M
AU  - Fuentes JM
AD  - University of Extremadura, Centro de Investigación Biomedica en Red de 
      Enfermedades Neurodegenerativas (CIBERNED), Instituto de Investigación 
      Biosanitaria de Extremadura (INUBE), Department of Biochemistry, Molecular 
      Biology and Genetics, Faculty of Nursing and Occupational Therapy, Cáceres, 
      Spain.
FAU - Fujiki, Yukio
AU  - Fujiki Y
AD  - Kyushu University, Medical Institute of Bioregulation, Fukuoka, Japan.
FAU - Fujita, Naonobu
AU  - Fujita N
AD  - Tokyo Institute of Technology, Institute of Innovative Research, Cell Biology 
      Center, Yokohama, Japan.
FAU - Fujiwara, Yuuki
AU  - Fujiwara Y
AD  - National Institute of Neuroscience, National Center of Neurology and Psychiatry, 
      Department of Degenerative Neurological Diseases, Kodaira, Tokyo, Japan.
FAU - Fukuda, Mitsunori
AU  - Fukuda M
AD  - Tohoku University, Graduate School of Life Sciences, Department of Integrative 
      Life Sciences, Sendai, Miyagi, Japan.
FAU - Fulda, Simone
AU  - Fulda S
AD  - Goethe-University Frankfurt, Institute for Experimental Cancer Research in 
      Pediatrics, Frankfurt, Germany.
FAU - Furic, Luc
AU  - Furic L
AD  - Monash University, Cancer Program, Biomedicine Discovery Institute and Department 
      of Anatomy & Developmental Biology, VIC, Australia; Peter MacCallum Cancer 
      Centre, Prostate Cancer Translational Research Laboratory, Melbourne, Victoria, 
      Australia; University of Melbourne, Sir Peter MacCallum Department of Oncology, 
      Parkville, VIC, Australia.
FAU - Furuya, Norihiko
AU  - Furuya N
AD  - Juntendo University Graduate School of Medicine, Department of Neurology, 
      Bunkyo-ku, Tokyo Japan.
FAU - Fusco, Carmela
AU  - Fusco C
AD  - Division of Medical Genetics, Fondazione IRCCS-Casa Sollievo della Sofferenza, 
      San Giovanni Rotondo, Italy.
FAU - Gack, Michaela U
AU  - Gack MU
AD  - The University of Chicago, Department of Microbiology, Chicago, IL, USA.
FAU - Gaffke, Lidia
AU  - Gaffke L
AD  - University of Gdansk, Department of Molecular Biology, Gdansk, Poland.
FAU - Galadari, Sehamuddin
AU  - Galadari S
AD  - New York University - Abu Dhabi, Saadiyat Island Campus, Division of Science 
      (Biology), Cell Death Signaling Laboratory, Abu Dhabi, UAE.
FAU - Galasso, Alessia
AU  - Galasso A
AD  - University of Oxford, Sir William Dunn School of Pathology, Oxford, UK.
FAU - Galindo, Maria F
AU  - Galindo MF
AD  - Universidad Castilla La Mancha, Facultad de Farmacia, Área Tecnología 
      Farmacéutica, Albacete, Spain.
FAU - Gallolu Kankanamalage, Sachith
AU  - Gallolu Kankanamalage S
AD  - Beckman Research Institute at City of Hope, Department of Systems Biology, 
      Monrovia, CA, USA.
FAU - Galluzzi, Lorenzo
AU  - Galluzzi L
AD  - Weill Cornell Medical College, Department of Radiation Oncology, New York, NY, 
      USA; Sandra and Edward Meyer Cancer Center, New York, NY, USA; Caryl and Israel 
      Englander Institute for Precision Medicine, New York, NY, USA; Yale School of 
      Medicine, Department of Dermatology, New Haven, CT, USA; Université de Paris, 
      Paris, France.
FAU - Galy, Vincent
AU  - Galy V
AD  - Sorbonne Université, Developmental Biology Laboratory, CNRS, Institut de Biologie 
      Paris Seine, IBPS, UMR7622, Paris, France.
FAU - Gammoh, Noor
AU  - Gammoh N
AD  - University of Edinburgh, Cancer Research UK Edinburgh Centre, Institute of 
      Genetics and Molecular Medicine, Edinburgh, UK.
FAU - Gan, Boyi
AU  - Gan B
AD  - University of Texas MD Anderson Cancer Center, Department of Experimental 
      Radiation Oncology, Houston, TX, USA.
FAU - Ganley, Ian G
AU  - Ganley IG
AD  - MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, 
      University of Dundee, UK.
FAU - Gao, Feng
AU  - Gao F
AD  - Fourth Military Medical University, School of Aerospace Medicine, Xi'an, China.
FAU - Gao, Hui
AU  - Gao H
AD  - Chinese Academy of Sciences, Institute of Zoology, State Key Laboratory of Stem 
      cell and Reproductive Biology, Beijing, China.
FAU - Gao, Minghui
AU  - Gao M
AD  - Harbin Institute of Technology, the HIT Center for Life Sciences, School of Life 
      Sciences and Technology, Harbin, China.
FAU - Gao, Ping
AU  - Gao P
AD  - South China University of Technology, School of Medicine and Institute for Life 
      Sciences, GuangZhou, China.
FAU - Gao, Shou-Jiang
AU  - Gao SJ
AD  - University of Pittsburgh School of Medicine, Hillman Cancer Center and Department 
      of Microbiology and Molecular Genetics, Pittsburgh, PA, USA.
FAU - Gao, Wentao
AU  - Gao W
AD  - University of Pittsburgh School of Medicine, Department of Surgery, Pittsburgh, 
      PA, USA.
FAU - Gao, Xiaobo
AU  - Gao X
AD  - Chinese Academy of Sciences Center for Excellence in Molecular and Cellular 
      Sciences, Shanghai Institute of Biochemistry and Cell Biology, Shanghai, China.
FAU - Garcera, Ana
AU  - Garcera A
AD  - Universitat de Lleida, Department of Experimental Medicine, IRBLleida, Lleida, 
      Spain.
FAU - Garcia, Maria Noé
AU  - Garcia MN
AD  - Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de 
      Microbiología, Inmunología y Biotecnología, Cátedra de Inmunología, Buenos Aires, 
      Argentina; Universidad de Buenos Aires, CONICET, Instituto de Estudios de la 
      Inmunidad Humoral (IDEHU), Buenos Aires, Argentina.
FAU - Garcia, Verónica E
AU  - Garcia VE
AD  - Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y 
      Técnicas, Instituto de Química Biológica de la Facultad de Ciencias Exactas y 
      Naturales (IQUIBICEN), Buenos Aires, Argentina.
FAU - García-Del Portillo, Francisco
AU  - García-Del Portillo F
AD  - National Center for Biotechnology (CNB)-CSIC, Laboratory of Intracellular 
      Bacterial Pathogens, Madrid, Spain.
FAU - Garcia-Escudero, Vega
AU  - Garcia-Escudero V
AD  - Universidad Autónoma de Madrid, Facultad de Medicina, Departamento de Anatomía, 
      Histología y Neurociencia, Madrid, Spain.
FAU - Garcia-Garcia, Aracely
AU  - Garcia-Garcia A
AD  - Universidad Autonoma de Nuevo Leon, School of Medicine, Department of Histology, 
      Monterrey, Nuevo Leon, Mexico.
FAU - Garcia-Macia, Marina
AU  - Garcia-Macia M
AD  - Universidad de Salamanca, Institute of Functional Biology and Genomics (IBFG), 
      Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.
FAU - García-Moreno, Diana
AU  - García-Moreno D
AD  - Department of Cell Biology and Histology, Faculty of Biology, University of 
      Murcia, IMIB-Arrixaca, Murcia, Spain.
FAU - Garcia-Ruiz, Carmen
AU  - Garcia-Ruiz C
AD  - Department of Cell Death and Proliferation, Institute of Biomedical Research of 
      Barcelona (IIBB- CSIC); Liver Unit, Hospital Clinic i Provincial de Barcelona, 
      IDIBAPS, CIBEREHD, Barcelona, Spain.
FAU - García-Sanz, Patricia
AU  - García-Sanz P
AD  - Cajal Institute/CSIC and CIBERNED, ISCIII, Madrid, Spain.
FAU - Garg, Abhishek D
AU  - Garg AD
AD  - KU Leuven, Department of Cellular and Molecular Medicine, Leuven, Belgium.
FAU - Gargini, Ricardo
AU  - Gargini R
AD  - Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Madrid, Spain.
FAU - Garofalo, Tina
AU  - Garofalo T
AD  - Sapienza University of Rome, Department of Experimental Medicine, Rome, Italy.
FAU - Garry, Robert F
AU  - Garry RF
AD  - Tulane University, Department of Microbiology and Immunology, New Orleans, LA, 
      USA.
FAU - Gassen, Nils C
AU  - Gassen NC
AD  - University of Bonn, Clinical Centre, Department of Psychiatry, Neurohomeostasis 
      Group, Bonn, Germany.
FAU - Gatica, Damian
AU  - Gatica D
AD  - Life Sciences Institute and Department of Molecular, Cellular and Developmental 
      Biology, University of Michigan, Ann Arbor, MI, USA.
FAU - Ge, Liang
AU  - Ge L
AD  - Tsinghua University, School of Life Sciences, Beijing, China.
FAU - Ge, Wanzhong
AU  - Ge W
AD  - Zhejiang University School of Medicine,Women's Hospital,Hangzhou, Zhejiang, 
      China.
FAU - Geiss-Friedlander, Ruth
AU  - Geiss-Friedlander R
AD  - Albert Ludwigs University of Freiburg, Faculty of Medicine, Institute of 
      Molecular Medicine and Cell Research, Freiburg, Germany.
FAU - Gelfi, Cecilia
AU  - Gelfi C
AD  - University of Milano, Department of Biomedical Sciences for Health, Milan, Italy.
FAU - Genschik, Pascal
AU  - Genschik P
AD  - Institut de Biologie Moléculaire des Plantes, Centre National de la Recherche 
      Scientifique, Unité Propre de Recherche 2357, Conventionné avec l'Université de 
      Strasbourg, Strasbourg, France.
FAU - Gentle, Ian E
AU  - Gentle IE
AD  - University Clinic Freiburg, Institute for Microbiology and Hygiene, University of 
      Freiburg - Faculty of Medicine, Freiburg, Germany.
FAU - Gerbino, Valeria
AU  - Gerbino V
AD  - Mortimer B. Zuckerman Mind Brain and Behavior Institute, Columbia University, New 
      York, NY, USA.
FAU - Gerhardt, Christoph
AU  - Gerhardt C
AD  - Institute for Animal Developmental and Molecular Biology, Heinrich-Heine 
      University Düsseldorf, Düsseldorf, Germany.
FAU - Germain, Kyla
AU  - Germain K
AD  - Hospital for Sick Children, Program in Cell Biology Department, Toronto, Canada; 
      University of Toronto, Department of Biochemistry, Toronto, Canada.
FAU - Germain, Marc
AU  - Germain M
AD  - Université du Québec à Trois-Rivières, Département de Biologie Médicale, 
      Trois-Rivières, Québec, Canada.
FAU - Gewirtz, David A
AU  - Gewirtz DA
AD  - Virginia Commonwealth University, Departments of Pharmacology, Toxicology and 
      Medicine and Massey Cancer Center, Richmond, VA, USA.
FAU - Ghasemipour Afshar, Elham
AU  - Ghasemipour Afshar E
AD  - Kerman University of Medical Sciences, Institute of Neuropharmacology, 
      Neuroscience Research Center, Kerman, Iran.
FAU - Ghavami, Saeid
AU  - Ghavami S
AD  - Department of Human Anatomy and Cell Science, Max Rady College of Medicine, Rady 
      Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
AD  - Autophagy Research Center, Health Policy Research Center, Institute of Health, 
      Shiraz University of Medical Sciences, Shiraz, Iran.
FAU - Ghigo, Alessandra
AU  - Ghigo A
AD  - University of Torino, Department of Molecular Biotechnology and Health Sciences, 
      Torino, Italy.
FAU - Ghosh, Manosij
AU  - Ghosh M
AD  - KU Leuven, Department of Public Health and Primary Care, Centre Environment & 
      Health, Leuven, Belgium.
FAU - Giamas, Georgios
AU  - Giamas G
AD  - University of Sussex, School of Life Sciences, Department of Biochemistry and 
      Biomedicine, Brighton, UK.
FAU - Giampietri, Claudia
AU  - Giampietri C
AD  - Sapienza University of Rome, Department of Anatomy, Histology, Forensic Medicine 
      and Orthopedics, Rome, Italy.
FAU - Giatromanolaki, Alexandra
AU  - Giatromanolaki A
AD  - Democritus University of Thrace, Medical School, Department of Pathology, 
      Alexandroupolis, Greece.
FAU - Gibson, Gary E
AU  - Gibson GE
AD  - Weill Cornell Medicine, Brain and Mind Research Institute, Burke Neurological 
      Institute, White Plains, NY, USA.
FAU - Gibson, Spencer B
AU  - Gibson SB
AD  - University of Manitoba, Departments of Biochemistry and Medical Genetics, 
      Winnipeg, Canada.
FAU - Ginet, Vanessa
AU  - Ginet V
AD  - Department of Fundamental Neurosciences, University of Lausanne, Lausanne, 
      Switzerland.
AD  - Clinic of Neonatology, Department of Women, Mother and Child, University Hospital 
      Center of Vaud (CHUV), Lausanne, Switzerland.
FAU - Giniger, Edward
AU  - Giniger E
AD  - National Institutes of Health, National Institutes of Neurological Disorders and 
      Stroke (NINDS), Bethesda, MD, USA.
FAU - Giorgi, Carlotta
AU  - Giorgi C
AD  - University of Ferrara, Department of Morphology, Surgery and Experimental 
      Medicine, Ferrara, Italy.
FAU - Girao, Henrique
AU  - Girao H
AD  - University of Coimbra, Coimbra Institute for Clinical and Biomedical Research 
      (iCBR), Faculty of Medicine, Coimbra, Portugal; University of Coimbra, Center for 
      Innovative Biomedicine and Biotechnology, Coimbra, Portugal.
FAU - Girardin, Stephen E
AU  - Girardin SE
AD  - University of Toronto, Department of Laboratory Medicine and Pathobiology, 
      Toronto, Ontario, Canada.
FAU - Giridharan, Mridhula
AU  - Giridharan M
AD  - Jawaharlal Nehru Centre for Advanced Scientific Research, Molecular Biology and 
      Genetics Unit, and Neuroscience Unit, Autophagy Laboratory, Jakkur, Bangalore, 
      India.
FAU - Giuliano, Sandy
AU  - Giuliano S
AD  - University Côte d'Azur (UCA), Institute for Research on Cancer and Aging of Nice 
      (IRCAN), Centre National de la Recherche Scientifique (CNRS) UMR7284, Institut 
      National de la Santé et de la Recherche Médicale (INSERM) U1081, Nice, France.
FAU - Giulivi, Cecilia
AU  - Giulivi C
AD  - University of California, Davis and MIND Institute, School of Veterinary 
      Medicine, Dept. Molecular Biosciences, Davis, CA, USA.
FAU - Giuriato, Sylvie
AU  - Giuriato S
AD  - INSERM, UMR1037 CRCT, Toulouse, France; Université Toulouse III-Paul Sabatier, 
      UMR1037 CRCT, Toulouse, France; CNRS, ERL5294 CRCT, Toulouse, France.
FAU - Giustiniani, Julien
AU  - Giustiniani J
AD  - Université Paris-Saclay, INSERM UMR1195, Hôpital Le Kremlin Bicêtre, 80 rue du 
      Général Leclerc, 94276 Kremlin-Bicêtre, France.
FAU - Gluschko, Alexander
AU  - Gluschko A
AD  - University of Cologne, Faculty of Medicine and University Hospital Cologne, 
      Institute for Medical Microbiology, Immunology and Hygiene, Cologne, Germany.
FAU - Goder, Veit
AU  - Goder V
AD  - University of Seville, Department of Genetics, Seville, Spain.
FAU - Goginashvili, Alexander
AU  - Goginashvili A
AD  - Ludwig Institute for Cancer Research; University of California San Diego, 
      Department of Cellular and Molecular Medicine, La Jolla, CA, USA.
FAU - Golab, Jakub
AU  - Golab J
AD  - Medical University of Warsaw, Department of Immunology, Warsaw, Poland.
FAU - Goldstone, David C
AU  - Goldstone DC
AD  - University of Auckland, School of Biological Sciences, Auckland, New Zealand.
FAU - Golebiewska, Anna
AU  - Golebiewska A
AD  - Luxembourg Institute of Health, Department of Oncology, NorLux Neuro-Oncology 
      Laboratory, Luxembourg, Luxembourg.
FAU - Gomes, Luciana R
AU  - Gomes LR
AD  - Center of Toxins, Immune-response and Cell Signaling (CeTICS) and Laboratório 
      Especial de Ciclo Celular (LECC), Instituto Butantan, São Paulo, Brazil.
FAU - Gomez, Rodrigo
AU  - Gomez R
AD  - CNRS, Université de Bordeaux, Laboratoire de Biogenèse Membranaire UMR5200, 33140 
      Villenave d'Ornon, Bordeaux, France; Université de Bordeaux, CNRS, Laboratoire de 
      Biogenèse Membranaire UMR5200, Villenave d'Ornon, Bordeaux, France.
FAU - Gómez-Sánchez, Rubén
AU  - Gómez-Sánchez R
AD  - University of Groningen, University Medical Center of Groningen, Department of 
      Biomedical Sciences of Cells and Systems, Groningen, The Netherlands.
FAU - Gomez-Puerto, Maria Catalina
AU  - Gomez-Puerto MC
AD  - Leiden University Medical Center, Department of Cell and Chemical Biology and 
      Oncode Institute, Leiden, The Netherlands.
FAU - Gomez-Sintes, Raquel
AU  - Gomez-Sintes R
AD  - Albert Einstein College of Medicine, Department of Developmental and Molecular 
      Biology, Bronx, NY, USA.
AD  - Centro de Investigaciones Biológicas Margarita Salas, CSIC, Madrid, Spain.
FAU - Gong, Qingqiu
AU  - Gong Q
AD  - Shanghai Jiao Tong University, School of Life Sciences and Biotechnology, 
      Shanghai, China.
FAU - Goni, Felix M
AU  - Goni FM
AD  - University of the Basque Country, Instituto Biofisika (UPV/EHU, CSIC), and 
      Department of Biochemistry and Molecular Biology, Leioa, Spain.
FAU - González-Gallego, Javier
AU  - González-Gallego J
AD  - University of León, Institute of Biomedicine (IBIOMED) and Centro de 
      Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 
      León, Spain.
FAU - Gonzalez-Hernandez, Tomas
AU  - Gonzalez-Hernandez T
AD  - University of La Laguna, Institute of Biomedical Technologies, Department of 
      Basic Medical Sciences, La Laguna, Tenerife, Spain.
FAU - Gonzalez-Polo, Rosa A
AU  - Gonzalez-Polo RA
AD  - University of Extremadura, Centro de Investigación Biomedica en Red de 
      Enfermedades Neurodegenerativas (CIBERNED), Instituto de Investigación 
      Biosanitaria de Extremadura (INUBE), Department of Biochemistry, Molecular 
      Biology and Genetics, Faculty of Nursing and Occupational Therapy, Cáceres, 
      Spain.
FAU - Gonzalez-Reyes, Jose A
AU  - Gonzalez-Reyes JA
AD  - University of Cordoba, Department of Cell Biology, Physiology and Immunology, 
      Córdoba, Spain.
FAU - González-Rodríguez, Patricia
AU  - González-Rodríguez P
AD  - Karolinska Institutet, Institute of Environmental Medicine, Stockholm, Sweden.
FAU - Goping, Ing Swie
AU  - Goping IS
AD  - University of Alberta, Department of Biochemistry, Edmonton, Alberta, Canada.
FAU - Gorbatyuk, Marina S
AU  - Gorbatyuk MS
AD  - University of Alabama at Birmingham, Department of Optometry and Vision Science, 
      Birmingham, AL, USA.
FAU - Gorbunov, Nikolai V
AU  - Gorbunov NV
AD  - The Henry M. Jackson Foundation, Inc. Bethesda, MD, USA.
FAU - Görgülü, Kıvanç
AU  - Görgülü K
AD  - Technische Universität München, Klinikum rechts der Isar, Comprehensive Cancer 
      Center München, München, Germany.
FAU - Gorojod, Roxana M
AU  - Gorojod RM
AD  - Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y 
      Técnicas (CONICET), Instituto de Química Biológica Ciencias Exactas y Naturales 
      (IQUIBICEN), Facultad de Ciencias Exactas y Naturales, Departamento de Química 
      Biológica, Laboratorio de Disfunción Celular en Enfermedades Neurodegenerativas y 
      Nanomedicina, Buenos Aires, Argentina.
FAU - Gorski, Sharon M
AU  - Gorski SM
AD  - BC Cancer, Michael Smith Genome Sciences Centre, Vancouver, BC, Canada.
FAU - Goruppi, Sandro
AU  - Goruppi S
AD  - Harvard Medical School, Department of Dermatology, Cutaneous Biology Research 
      Center Massachusetts General Hospital, Boston, MA, USA.
FAU - Gotor, Cecilia
AU  - Gotor C
AD  - Consejo Superior de Investigaciones Científicas, Instituto de Bioquímica Vegetal 
      y Fotosíntesis (CSIC-IBVF), Sevilla, Spain.
FAU - Gottlieb, Roberta A
AU  - Gottlieb RA
AD  - Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
FAU - Gozes, Illana
AU  - Gozes I
AD  - Tel Aviv University, Sackler Faculty of Medicine and Sagol School of 
      Neuroscience, Department of Human Molecular Genetics and Biochemistry, Tel Aviv, 
      Israel.
FAU - Gozuacik, Devrim
AU  - Gozuacik D
AD  - Koç University School of Medicine, Department of Molecular Biology and Genetics 
      and KUTTAM Research Center for Translational Medicine, Istanbul, Turkey.
FAU - Graef, Martin
AU  - Graef M
AD  - Max Planck Institute for Biology of Ageing, Cologne, Germany; University of 
      Cologne, Cologne Excellence Cluster on Cellular Stress Responses in 
      Aging-Associated Diseases (CECAD), Cologne, Germany.
FAU - Gräler, Markus H
AU  - Gräler MH
AD  - Jena University Hospital, Department of Anesthesiology and Intensive Care 
      Medicine, Center for Molecular Biomedicine (CMB) and Center for Sepsis Control 
      and Care (CSCC), Jena, Germany.
FAU - Granatiero, Veronica
AU  - Granatiero V
AD  - Weill Cornell Medicine, Feil Family Brain and Mind Research Institute, New York, 
      NY, USA.
FAU - Grasso, Daniel
AU  - Grasso D
AD  - Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de 
      Microbiología, Inmunología y Biotecnología, Cátedra de Inmunología, Buenos Aires, 
      Argentina; Universidad de Buenos Aires, CONICET, Instituto de Estudios de la 
      Inmunidad Humoral (IDEHU), Buenos Aires, Argentina.
FAU - Gray, Joshua P
AU  - Gray JP
AD  - University of Texas MD Anderson Cancer Center, Department of Cancer Systems 
      Imaging, Houston, TX, USA.
FAU - Green, Douglas R
AU  - Green DR
AD  - St. Jude Children's Research Hospital, Department of Immunology, Memphis, TN, 
      USA.
FAU - Greenhough, Alexander
AU  - Greenhough A
AD  - University of the West of England, Department of Applied Sciences, Bristol, UK.
FAU - Gregory, Stephen L
AU  - Gregory SL
AD  - Flinders University, College of Medicine and Public Health, Adelaide, Australia.
FAU - Griffin, Edward F
AU  - Griffin EF
AD  - University of Alabama at Birmingham,Center for Neurodegeneration and Experimental 
      Therapeutics, Department of Neurology, Birmingham, AL, USA.
FAU - Grinstaff, Mark W
AU  - Grinstaff MW
AD  - Boston University, Departments of Biomedical Engineering, Chemistry, and 
      Medicine, Boston, MA, USA.
FAU - Gros, Frederic
AU  - Gros F
AD  - Université de Strasbourg/CNRS UPR 3572 Institut de Biologie Moléculaire et 
      Cellulaire, Strasbourg, France.
FAU - Grose, Charles
AU  - Grose C
AD  - University of Iowa, Departments of Pediatrics and Microbiology, Iowa City, IA, 
      USA.
FAU - Gross, Angelina S
AU  - Gross AS
AD  - Max Planck Institute for Biology of Ageing, Cologne, Germany.
FAU - Gruber, Florian
AU  - Gruber F
AD  - Medical University of Vienna, Department of Dermatology, Division for Biology and 
      Pathobiology of the Skin, Vienna, Austria.
FAU - Grumati, Paolo
AU  - Grumati P
AD  - Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.
FAU - Grune, Tilman
AU  - Grune T
AD  - German Institute of Human Nutrition, Department of Molecular Toxicology, 
      Nuthetal, Germany.
FAU - Gu, Xueyan
AU  - Gu X
AD  - Lanzhou University, School of Public Health, Lanzhou, Gansu, China.
FAU - Guan, Jun-Lin
AU  - Guan JL
AD  - University of Cincinnati College of Medicine, Department of Cancer Biology, 
      Cincinnati, OH, USA.
FAU - Guardia, Carlos M
AU  - Guardia CM
AD  - National Institutes of Health, Eunice Kennedy Shriver National Institute of Child 
      Health and Human Development, Neurosciences and Cellular and Structural Biology 
      Division (NCSBD), Bethesda, MD, USA.
FAU - Guda, Kishore
AU  - Guda K
AD  - Case Western Reserve University, Comprehensive Cancer Center, Cleveland, OH, USA.
FAU - Guerra, Flora
AU  - Guerra F
AD  - University of Salento, Department of Biological and Environmental Sciences and 
      Technologies, Lecce, Italy.
FAU - Guerri, Consuelo
AU  - Guerri C
AD  - Research Center Principe Felipe, Cellular Pathology Laboratory, Valencia, Spain.
FAU - Guha, Prasun
AU  - Guha P
AD  - Johns Hopkins University School of Medicine, Department of Neuroscience, 
      Baltimore, MD, USA.
FAU - Guillén, Carlos
AU  - Guillén C
AD  - School of Pharmacy, Complutense University, Madrid, Spain; Centro de 
      Investigación Biomédica en Red (CIBER) de Diabetes y Enfermedades Metabólicas 
      Asociadas (CIBERDEM), Madrid, Spain.
FAU - Gujar, Shashi
AU  - Gujar S
AD  - Dalhousie University, Faculty of Medicine, Departments of Pathology, Biology, and 
      Microbiology & Immunology, Halifax, NS, Canada.
FAU - Gukovskaya, Anna
AU  - Gukovskaya A
AD  - David Geffen School of Medicine at UCLA, Department of Medicine, Los Angeles, CA, 
      USA.
FAU - Gukovsky, Ilya
AU  - Gukovsky I
AD  - David Geffen School of Medicine at UCLA, Department of Medicine, Los Angeles, CA, 
      USA.
FAU - Gunst, Jan
AU  - Gunst J
AD  - KU Leuven, Clinical Division and Laboratory of Intensive Care Medicine, 
      Department of Cellular and Molecular Medicine, Leuven, Belgium.
FAU - Günther, Andreas
AU  - Günther A
AD  - Justus-Liebig University, Department of Internal Medicine, Giessen, Germany.
FAU - Guntur, Anyonya R
AU  - Guntur AR
AD  - Center for Molecular Medicine, Maine Medical Center Research Institute, 
      Scarborough, ME, USA.
FAU - Guo, Chuanyong
AU  - Guo C
AD  - Tongji University School of Medicine, Shanghai Tenth People's Hospital, 
      Department of Gastroenterology, Shanghai, China.
FAU - Guo, Chun
AU  - Guo C
AD  - The University of Sheffield, Department of Biomedical Science, Firth Court, 
      Western Bank, Sheffield, UK.
FAU - Guo, Hongqing
AU  - Guo H
AD  - Iowa State University, Department of Genetics, Development, and Cell Biology, 
      Ames, IA, USA.
FAU - Guo, Lian-Wang
AU  - Guo LW
AD  - University of Virginia, School of Medicine, Department of Surgery, 
      Charlottesville, VA, USA.
FAU - Guo, Ming
AU  - Guo M
AD  - University of California, Los Angeles, Department of Neurology, Molecular and 
      Medical Pharmacology, David Geffen School of Medicine, Los Angeles, CA, USA.
FAU - Gupta, Pawan
AU  - Gupta P
AD  - Institute of Microbial Technology, Department of Molecular Biology, Chandigarh, 
      India.
FAU - Gupta, Shashi Kumar
AU  - Gupta SK
AD  - CSIR-Central Drug Research Institute, Lucknow, India.
FAU - Gupta, Swapnil
AU  - Gupta S
AD  - University of Oslo, Institute of Basic Medical Sciences, Oslo, Norway.
FAU - Gupta, Veer Bala
AU  - Gupta VB
AD  - Deakin University, School of Medicine, Faculty of Health, Victoria, Australia.
FAU - Gupta, Vivek
AU  - Gupta V
AD  - Macquarie University, Faculty of Medicine, Health and Human Sciences, New South 
      Wales, Australia.
FAU - Gustafsson, Asa B
AU  - Gustafsson AB
AD  - University of California, San Diego, Skaggs School of Pharmacy and Pharmaceutical 
      Sciences, La Jolla, CA, USA.
FAU - Gutterman, David D
AU  - Gutterman DD
AD  - Medical College of Wisconsin, Department of Medicine and Cardiovascular Center, 
      Milwaukee, WI, USA.
FAU - H B, Ranjitha
AU  - H B R
AD  - ICAR-Indian Veterinary Research Institute, FMD VP Laboratory, Bengaluru, India.
FAU - Haapasalo, Annakaisa
AU  - Haapasalo A
AD  - University of Eastern Finland, A.I. Virtanen Institute for Molecular Sciences, 
      Kuopio, Finland.
FAU - Haber, James E
AU  - Haber JE
AD  - Brandeis University, Department of Biology and Rosenstiel Basic Medical Sciences 
      Research Center, Waltham, MA, USA.
FAU - Hać, Aleksandra
AU  - Hać A
AD  - University of Gdansk, Department of Medical Biology and Genetics, Gdansk, Poland.
FAU - Hadano, Shinji
AU  - Hadano S
AD  - Tokai University School of Medicine, Department of Molecular Life Sciences, 
      Isehara, Kanagawa, Japan.
FAU - Hafrén, Anders J
AU  - Hafrén AJ
AD  - Swedish Agricultural University (SLU), Department of Plant Biology, Uppsala, 
      Sweden.
FAU - Haidar, Mansour
AU  - Haidar M
AD  - Hasselt University, Biomedical Research Institute, Diepenbeek, Belgium.
FAU - Hall, Belinda S
AU  - Hall BS
AD  - University of Surrey, School of Bioscience and Medicine, Department of Microbial 
      Sciences, Stag Hill Campus, Guildford, Surrey, UK.
FAU - Halldén, Gunnel
AU  - Halldén G
AD  - Barts Cancer Institute, Queen Mary University of London, Centre for 
      Biotherapeutics and Biomarkers, London, UK.
FAU - Hamacher-Brady, Anne
AU  - Hamacher-Brady A
AD  - Johns Hopkins University Bloomberg School of Public Health, W. Harry Feinstone 
      Department of Molecular Microbiology and Immunology, Baltimore, MD, USA.
FAU - Hamann, Andrea
AU  - Hamann A
AD  - Goethe University, Institute for Molecular Biosciences, Frankfurt/Main, Germany.
FAU - Hamasaki, Maho
AU  - Hamasaki M
AD  - Osaka University, Graduate School of Medicine, Department of Genetics, Suita, 
      Osaka, Japan.
FAU - Han, Weidong
AU  - Han W
AD  - Zhejiang University, Sir Run Run Shaw Hospital, College of Medicine, Department 
      of Medical Oncology, Zhejiang, Hangzhou, China.
FAU - Hansen, Malene
AU  - Hansen M
AD  - Sanford Burnham Prebys Medical Discovery Institute, Program of Development, Aging 
      and Regeneration, La Jolla, CA, USA.
FAU - Hanson, Phyllis I
AU  - Hanson PI
AD  - University of Michigan, Department of Biological Chemistry, Ann Arbor, MI, USA.
FAU - Hao, Zijian
AU  - Hao Z
AD  - Chinese Academy of Sciences Center for Excellence in Molecular and Cellular 
      Sciences, Shanghai Institute of Biochemistry and Cell Biology, Shanghai, China.
FAU - Harada, Masaru
AU  - Harada M
AD  - Third Department of Internal Medicine, University of Occupational and 
      Environmental Health, Kitakyushu, Japan.
FAU - Harhaji-Trajkovic, Ljubica
AU  - Harhaji-Trajkovic L
AD  - Department of Neurophysiology, Institute for Biological Research "Siniša 
      Stanković" - National Institute of Republic of Serbia, University of Belgrade, 
      Belgrade, Serbia.
FAU - Hariharan, Nirmala
AU  - Hariharan N
AD  - University of California, Davis, School of Medicine, Department of Pharmacology, 
      Davis, CA, USA.
FAU - Haroon, Nigil
AU  - Haroon N
AD  - University of Toronto, Department of Medicine, Toronto, Ontario, Canada.
FAU - Harris, James
AU  - Harris J
AD  - Monash University, School of Clinical Sciences at Monash Health, Centre for 
      Inflammatory Diseases, Rheumatology Group, Clayton, Victoria, Australia.
FAU - Hasegawa, Takafumi
AU  - Hasegawa T
AD  - Tohoku University Graduate School of Medicine, Division of Neurology, Department 
      of Neuroscience & Sensory Organs, Sendai, Japan.
FAU - Hasima Nagoor, Noor
AU  - Hasima Nagoor N
AD  - University of Malaya, Institute of Biological Sciences (Genetics), Kuala Lumpur, 
      Malaysia.
FAU - Haspel, Jeffrey A
AU  - Haspel JA
AD  - Washington University School of Medicine, Division of Pulmonary and Critical Care 
      Medicine, St. Louis, MO, USA.
FAU - Haucke, Volker
AU  - Haucke V
AD  - Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Department of 
      Molecular Pharmacology and Cell Biology, Berlin, Germany.
FAU - Hawkins, Wayne D
AU  - Hawkins WD
AD  - Life Sciences Institute and Department of Molecular, Cellular and Developmental 
      Biology, University of Michigan, Ann Arbor, MI, USA.
FAU - Hay, Bruce A
AU  - Hay BA
AD  - California Institute of Technology, Division of Biology and Biological 
      Engineering, Pasadena, CA, USA.
FAU - Haynes, Cole M
AU  - Haynes CM
AD  - University of Massachusetts Medical School, Molecular, Cell and Cancer Biology, 
      Worcester, MA, USA.
FAU - Hayrabedyan, Soren B
AU  - Hayrabedyan SB
AD  - Bulgarian Academy of Sciences, Institute of Biology and Immunology of 
      Reproduction Acad. Kiril Bratanov, Sofia, Bulgaria.
FAU - Hays, Thomas S
AU  - Hays TS
AD  - University of Minnesota, Department of Genetics, Cell Biology and Development, 
      Minneapolis, MN, USA.
FAU - He, Congcong
AU  - He C
AD  - Northwestern University, Feinberg School of Medicine, Department of Cell and 
      Developmental Biology, Chicago, IL, USA.
FAU - He, Qin
AU  - He Q
AD  - Sichuan University, West China School of Pharmacy, Key Laboratory of 
      Drug-Targeting and Drug Delivery System of the Education Ministry, Chengdu, 
      China.
FAU - He, Rong-Rong
AU  - He RR
AD  - Jinan University, College of Pharmacy, Guangzhou, China.
FAU - He, You-Wen
AU  - He YW
AD  - Department of Immunology, Duke University Medical Center, Durham, NC, USA.
FAU - He, Yu-Ying
AU  - He YY
AD  - University of Chicago, Department of Medicine, Section of Dermatology, Chicago, 
      IL, USA.
FAU - Heakal, Yasser
AU  - Heakal Y
AD  - D'Youville College, School of Pharmacy, Department of Pharmaceutical, Social and 
      Administrative Sciences, Buffalo, NY, USA.
FAU - Heberle, Alexander M
AU  - Heberle AM
AD  - University of Innsbruck, Institute of Biochemistry and Center for Molecular 
      Biosciences Innsbruck, Innsbruck, Austria; University Medical Center Groningen, 
      University of Groningen, Section Systems Medicine of Metabolism and Signaling, 
      Laboratory of Pediatrics, Groningen, The Netherlands.
FAU - Hejtmancik, J Fielding
AU  - Hejtmancik JF
AD  - National Institutes of Health, National Eye Institute, Ophthalmic Genetics and 
      Visual Function Branch, Ophthalmic Molecular Genetics Section, Bethesda, MD, USA.
FAU - Helgason, Gudmundur Vignir
AU  - Helgason GV
AD  - University of Glasgow, Wolfson Wohl Cancer Research Centre, Institute of Cancer 
      Sciences, Glasgow, UK.
FAU - Henkel, Vanessa
AU  - Henkel V
AD  - Goethe University, Institute for Molecular Biosciences, Frankfurt/Main, Germany.
FAU - Herb, Marc
AU  - Herb M
AD  - University of Cologne, Faculty of Medicine and University Hospital Cologne, 
      Institute for Medical Microbiology, Immunology and Hygiene, Cologne, Germany.
FAU - Hergovich, Alexander
AU  - Hergovich A
AD  - University College London, Cancer Institute, London, UK.
FAU - Herman-Antosiewicz, Anna
AU  - Herman-Antosiewicz A
AD  - University of Gdansk, Department of Medical Biology and Genetics, Gdansk, Poland.
FAU - Hernández, Agustín
AU  - Hernández A
AD  - Universidade Federal de São Carlos, Department of Genetics and Evolution, São 
      Carlos (SP), Brazil.
FAU - Hernandez, Carlos
AU  - Hernandez C
AD  - Instituto de Investigación Sanitaria de Navarra (IdISNA), Fundación Miguel 
      Servet, Biomedical Research Center of Navarre-Navarrabiomed, Immunomodulation 
      Group, Pamplona, Spain.
FAU - Hernandez-Diaz, Sergio
AU  - Hernandez-Diaz S
AD  - Université de Bordeaux, Institut des Maladies Neurodégénératives (IMN), CNRS UMR 
      5293, Bordeaux, France.
FAU - Hernandez-Gea, Virginia
AU  - Hernandez-Gea V
AD  - University of Barcelona, Barcelona Hepatic Hemodynamic Unit, Liver Unit, Hospital 
      Clinic, Hospital Clínic-Institut d'Investigacions Biomèdiques (IDIBAPS), Centro 
      de Investigación Biomédica Red de enfermedades Hepáticas y Digestivas (CIBERehd), 
      Barcelona, Spain.
FAU - Herpin, Amaury
AU  - Herpin A
AD  - INRA, UR1037 Laboratory of Fish Physiology and Genomics, Campus de Beaulieu, 
      Rennes, France; Hunan Normal University, College of Life Sciences, State Key 
      Laboratory of Developmental Biology of Freshwater Fish, Changsha, Hunan, China.
FAU - Herreros, Judit
AU  - Herreros J
AD  - University of Lleida, Department of Basic Medical Sciences, IRBLleida, Lleida, 
      Spain.
FAU - Hervás, Javier H
AU  - Hervás JH
AD  - The Francis Crick Institute, Molecular Cell Biology of Autophagy, London, UK.
AD  - Universidad del País Vasco, Instituto Biofisika (CSIC, UPV/EHU) and Departamento 
      de Bioquímica y Biología Molecular, Bilbao, Spain.
FAU - Hesselson, Daniel
AU  - Hesselson D
AD  - Centenary Institute, The University of Sydney, Newtown, New South Wales, 
      Australia; Faculty of Medicine and Health, The University of Sydney, Newtown, New 
      South Wales, Australia.
FAU - Hetz, Claudio
AU  - Hetz C
AD  - University of Chile, Biomedical Neuroscience Institute, Faculty of Medicine, 
      Santiago, Chile; FONDAP Center for Geroscience Brain Health and Metabolism, 
      Santiago, Chile; University of Chile, Institute of Biomedical Science, Program of 
      Cellular and Molecular Biology, Santiago, Chile; Buck Institute for Research on 
      Aging, Novato, CA, USA.
FAU - Heussler, Volker T
AU  - Heussler VT
AD  - University of Bern, Institute of Cell Biology, Bern, Switzerland.
FAU - Higuchi, Yujiro
AU  - Higuchi Y
AD  - Kyushu University, Depatment of Bioscience and Biotechnology, Nishi-ku, Fukuoka, 
      Japan.
FAU - Hilfiker, Sabine
AU  - Hilfiker S
FAU - Hill, Joseph A
AU  - Hill JA
AD  - UT Southwestern Medical Center, Departments of Medicine (Cardiology) and 
      Molecular Biology, Dallas, TX, USA.
FAU - Hlavacek, William S
AU  - Hlavacek WS
AD  - Theoretical Division, Los Alamos National Laboratory, Los Alamos, NM, USA.
FAU - Ho, Emmanuel A
AU  - Ho EA
AD  - University of Waterloo, School of Pharmacy, Kitchener, ON, Canada.
FAU - Ho, Idy H T
AU  - Ho IHT
AD  - The Chinese University of Hong Kong, Department of Anaesthesia and Intensive 
      Care, Hong Kong, China.
FAU - Ho, Philip Wing-Lok
AU  - Ho PW
AD  - University of Hong Kong, Department of Medicine, Division of Neurology, Pokfulam, 
      Hong Kong, China.
FAU - Ho, Shu-Leong
AU  - Ho SL
AD  - University of Hong Kong, Department of Medicine, Division of Neurology, Pokfulam, 
      Hong Kong, China.
FAU - Ho, Wan Yun
AU  - Ho WY
AD  - National University of Singapore, Department of Physiology, Singapore.
FAU - Hobbs, G Aaron
AU  - Hobbs GA
AD  - University of North Carolina at Chapel Hill, Department of Pharmacology, Chapel 
      Hill, NC, USA.
FAU - Hochstrasser, Mark
AU  - Hochstrasser M
AD  - Yale University, Department of Molecular Biophysics and Biochemistry, New Haven, 
      CT, USA.
FAU - Hoet, Peter H M
AU  - Hoet PHM
AD  - KU Leuven, Department of Public Health and Primary Care, Centre Environment & 
      Health, Leuven, Belgium.
FAU - Hofius, Daniel
AU  - Hofius D
AD  - Swedish University of Agricultural Sciences (SLU) and Linnean Center for Plant 
      Biology, Uppsala BioCenter, Department of Plant Biology, Uppsala, Sweden.
FAU - Hofman, Paul
AU  - Hofman P
AD  - University Côte d'Azur, FHU OncoAge, Department of Pathology, Nice, France.
FAU - Höhn, Annika
AU  - Höhn A
AD  - German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Department of 
      Molecular Toxicology, Nuthetal, Germany.
FAU - Holmberg, Carina I
AU  - Holmberg CI
AD  - University of Helsinki, Medicum, Biochemistry and Developmental Biology, 
      Helsinki, Finland.
FAU - Hombrebueno, Jose R
AU  - Hombrebueno JR
AD  - University of Birmingham, College of Medical and Dental Sciences, Institute of 
      Inflammation and Ageing, Birmingham, UK.
FAU - Yi-Ren Hong, Chang-Won Hong
AU  - Yi-Ren Hong CH
AD  - Kyungpook National University, School of Medicine, Department of Physiology, 
      Daegu, Korea.
FAU - Hooper, Lora V
AU  - Hooper LV
AD  - Kaohsiung Medical University, Graduate Institute of Medicine & Department of 
      Biochemistry, Faculty of Medicine, College of Medicine, Kaohsiung, Taiwan.
FAU - Hoppe, Thorsten
AU  - Hoppe T
AD  - University of Cologne, Institute for Genetics and CECAD Research Center, Cologne, 
      Germany.
FAU - Horos, Rastislav
AU  - Horos R
AD  - European Molecular Biology Laboratory, Heidelberg, Germany.
FAU - Hoshida, Yujin
AU  - Hoshida Y
AD  - University of Texas Southwestern Medical Center, Department of Internal Medicine, 
      Dallas, TX, USA.
FAU - Hsin, I-Lun
AU  - Hsin IL
AD  - Chung Shan Medical University, Institute of Medicine, Taiwan.
FAU - Hsu, Hsin-Yun
AU  - Hsu HY
AD  - National Chiao-Tung University, Department of Applied Chemistry and Institute of 
      Molecular Science, Hsinchu, Taiwan.
FAU - Hu, Bing
AU  - Hu B
AD  - University of Plymouth, Faculty of Health: Medicine, Dentistry and Human 
      Sciences, Peninsula Dental School, Plymouth, Devon, UK.
FAU - Hu, Dong
AU  - Hu D
AD  - Anhui University of Science and Technology, Department of Medical Immunology, 
      Huainan, China.
FAU - Hu, Li-Fang
AU  - Hu LF
AD  - Soochow University, Institute of Neuroscience, Suzhou, Jiangsu Province, China.
FAU - Hu, Ming Chang
AU  - Hu MC
AD  - University of Texas Southwestern Medical Center, Department of Internal Medicine, 
      Charles and Jane Center for Mineral Metabolism and Clinical Research, Dallas, TX, 
      USA.
FAU - Hu, Ronggui
AU  - Hu R
AD  - Chinese Academy of Sciences Center for Excellence in Molecular and Cellular 
      Sciences, Shanghai Institute of Biochemistry and Cell Biology, Shanghai, China.
FAU - Hu, Wei
AU  - Hu W
AD  - Southern Medical University, Shenzhen Hospital, Department of Gastroenterology, 
      Shenzhen, Guangdong.
FAU - Hu, Yu-Chen
AU  - Hu YC
AD  - National Tsing Hua University, Department of Chemical Engineering, and Frontier 
      Research Center on Fundamental and Applied Sciences of Matters, Hsinchu, Taiwan.
FAU - Hu, Zhuo-Wei
AU  - Hu ZW
AD  - Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of 
      Materia Medica, State Key Laboratory of Bioactive Substance and Function of 
      Natural Medicines, Molecular Immunology and Cancer Pharmacology Group, Beijing, 
      China.
FAU - Hua, Fang
AU  - Hua F
AD  - Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of 
      Materia Medica, State Key Laboratory of Bioactive Substance and Function of 
      Natural Medicines, Molecular Immunology and Cancer Pharmacology Group, Beijing, 
      China.
FAU - Hua, Jinlian
AU  - Hua J
AD  - Northwest A&F University, College of Veterinary Medicine, Shaanxi Centre of Stem 
      Cells Engineering & Technology, Yangling, Shaanxi, China.
FAU - Hua, Yingqi
AU  - Hua Y
AD  - Shanghai Jiao Tong University School of Medicine, Shanghai General Hospital, 
      Department of Orthopedics, Shanghai, China; Shanghai Bone Tumor Institution, 
      Shanghai, China.
FAU - Huan, Chongmin
AU  - Huan C
AD  - State University of New York, Downstate Health Sciences University, Department of 
      Surgery and Cell Biology, Brooklyn, NY, USA.
FAU - Huang, Canhua
AU  - Huang C
AD  - Sichuan University, and Collaborative Innovation Center for Biotherapy, West 
      China Hospital, West China School of Basic Medical Sciences & Forensic Medicine, 
      and State Key Laboratory of Biotherapy and Cancer Center, Chengdu, China.
FAU - Huang, Chuanshu
AU  - Huang C
AD  - New York University School of Medicine, Department of Environmental Medicine, 
      Urology, Biochemistry and Molecular Pharmacology, New York, NY, USA.
FAU - Huang, Chuanxin
AU  - Huang C
AD  - Shanghai Jiao Tong University School of Medicine, Shanghai Institute of 
      Immunology & Department of Immunology and Microbiology, Shanghai, China.
FAU - Huang, Chunling
AU  - Huang C
AD  - University of Sydney, Kolling Institute, Renal Research Lab, Sydney, New South 
      Wales, Australia.
FAU - Huang, Haishan
AU  - Huang H
AD  - Wenzhou Medical University, School of Laboratory Medicine and Life Sciences, 
      Wenzhou, Zhejiang Province, China.
FAU - Huang, Kun
AU  - Huang K
AD  - Huazhong University of Science and Technology, Tongji Medical College, School of 
      Pharmacy, Wuhan, Hubei, China.
FAU - Huang, Michael L H
AU  - Huang MLH
AD  - University of Sydney, Department of Pathology and Bosch Institute, Sydney, NSW, 
      Australia.
FAU - Huang, Rui
AU  - Huang R
AD  - Chongqing University, School of Medicine, Center for Neurointelligence, 
      Chongqing, China.
FAU - Huang, Shan
AU  - Huang S
AD  - The Second Affiliated Hospital of Xi'an Jiaotong University, Department of 
      Radiation Oncology, Xi'an, Shaan Xi, China.
FAU - Huang, Tianzhi
AU  - Huang T
AD  - Northwestern University Feinberg School of Medicine, Department of Neurology & 
      Lou & Jean Malnati Brain Tumor Institute, Chicago, IL, USA.
FAU - Huang, Xing
AU  - Huang X
AD  - Zhejiang University School of Medicine, The First Affiliated Hospital, Zhejiang 
      Provincial Key Laboratory of Pancreatic Disease, Hangzhou, Zhejiang, China.
FAU - Huang, Yuxiang Jack
AU  - Huang YJ
AD  - Life Sciences Institute and Department of Molecular, Cellular and Developmental 
      Biology, University of Michigan, Ann Arbor, MI, USA.
FAU - Huber, Tobias B
AU  - Huber TB
AD  - III. Department of Medicine, University Medical Center Hamburg-Eppendorf, 
      Hamburg, Germany.
FAU - Hubert, Virginie
AU  - Hubert V
AD  - Medical University of Vienna, Department of Pathology, Vienna, Austria.
FAU - Hubner, Christian A
AU  - Hubner CA
AD  - University Hospital Jena, Institute of Human Genetics, Jena, Thuringia, Germany.
FAU - Hughes, Stephanie M
AU  - Hughes SM
AD  - University of Otago, School of Biomedical Sciences and Brain Health Research 
      Centre, Department of Biochemistry, Dunedin, New Zealand.
FAU - Hughes, William E
AU  - Hughes WE
AD  - Medical College of Wisconsin, Department of Medicine and Cardiovascular Center, 
      Milwaukee, WI, USA.
FAU - Humbert, Magali
AU  - Humbert M
AD  - University of Bern, Institute of Pathology, Bern, Switzerland; TRANSAUTOPHAGY: 
      European network for multidisciplinary research and translation of autophagy 
      knowledge, COST Action CA15138.
FAU - Hummer, Gerhard
AU  - Hummer G
AD  - Max Planck Institute of Biophysics, Department of Theoretical Biophysics, 
      Frankfurt am Main, Germany.
FAU - Hurley, James H
AU  - Hurley JH
AD  - University of California, Berkeley, Department of Molecular and Cell Biology, 
      Berkeley, CA, USA.
FAU - Hussain, Sabah
AU  - Hussain S
AD  - McGill University Health Centre, Montréal, QC, Canada.
FAU - Hussain, Salik
AU  - Hussain S
AD  - West Virginia University, School of Medicine, Department of Physiology and 
      Pharmacology, Morgantown, WV, USA.
FAU - Hussey, Patrick J
AU  - Hussey PJ
AD  - Durham University, Department of Biosciences, Durham, UK.
FAU - Hutabarat, Martina
AU  - Hutabarat M
AD  - University of Indonesia, Faculty of Medicine, Department of Obstetric and 
      Gynecology, Jakarta, Indonesia.
FAU - Hwang, Hui-Yun
AU  - Hwang HY
AD  - Yonsei University, Department of Biotechnology, Seodaemun-gu, Seoul, Korea.
FAU - Hwang, Seungmin
AU  - Hwang S
AD  - The University of Chicago, Department of Pathology, Chicago, IL, USA; present 
      address: VIR Biotechnology, San Francisco, CA, USA.
FAU - Ieni, Antonio
AU  - Ieni A
AD  - University of Messina, Department of Human Pathology in Adult and Developmental 
      Age "Gaetano Barresi", Section of Pathology, Messina, Italy.
FAU - Ikeda, Fumiyo
AU  - Ikeda F
AD  - Kyushu University, Medical Institute of Bioregulation (MIB), Fukuoka, Japan.
FAU - Imagawa, Yusuke
AU  - Imagawa Y
AD  - Osaka International Cancer Institute, Department of Molecular and Cellular 
      Biology, Osaka, Japan.
FAU - Imai, Yuzuru
AU  - Imai Y
AD  - Juntendo University Graduate School of Medicine, Department of Research for 
      Parkinson's Disease, Tokyo, Japan.
FAU - Imbriano, Carol
AU  - Imbriano C
AD  - University of Modena and Reggio Emilia, Department of Life Sciences, Modena, 
      Italy.
FAU - Imoto, Masaya
AU  - Imoto M
AD  - Juntendo University, Juntendo University Graduate School of Medicine, Division 
      for Development of Autophagy Modulating Drugs, Tokyo, Japan.
FAU - Inman, Denise M
AU  - Inman DM
AD  - University of North Texas Health Science Center, North Texas Eye Research 
      Institute and Department of Pharmaceutical Sciences, Fort Worth, TX, USA.
FAU - Inoki, Ken
AU  - Inoki K
AD  - University of Michigan, Life Sciences Institute, Department of Molecular and 
      Integrative Physiology, Ann Arbor, MI, USA.
FAU - Iovanna, Juan
AU  - Iovanna J
AD  - Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 
      7258, Aix-Marseille Université and Institut Paoli-Calmettes, Parc Scientifique et 
      Technologique de Luminy, Marseille, France.
FAU - Iozzo, Renato V
AU  - Iozzo RV
AD  - Thomas Jefferson University, Department of Pathology, Anatomy, and Cell Biology, 
      Philadelphia, PA, USA.
FAU - Ippolito, Giuseppe
AU  - Ippolito G
AD  - National Institute for Infectious Diseases "L. Spallanzani" IRCCS, Rome, Italy.
FAU - Irazoqui, Javier E
AU  - Irazoqui JE
AD  - University of Massachusetts Medical School, Department of Microbiology and 
      Physiological Systems, Worcester, MA, USA.
FAU - Iribarren, Pablo
AU  - Iribarren P
AD  - National University of Córdoba, Clinical Biochemistry Department, CIBICI-CONICET, 
      Córdoba, Argentina.
FAU - Ishaq, Mohd
AU  - Ishaq M
AD  - Stanford University School of Medicine, Department of Pathology, Stanford, CA, 
      USA.
FAU - Ishikawa, Makoto
AU  - Ishikawa M
AD  - Akita University Graduate School of Medicine, Department of Ophthalmology, Akita, 
      Japan.
FAU - Ishimwe, Nestor
AU  - Ishimwe N
AD  - Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, 
      GA, USA; South China University of Technology, Guangzhou First People's Hospital, 
      School of Medicine and Institutes for Life Sciences, Guangzhou, Guangdong, China.
FAU - Isidoro, Ciro
AU  - Isidoro C
AD  - Università del Piemonte Orientale, Department of Health Sciences, Laboratory of 
      Molecular Pathology, Novara, Italy.
FAU - Ismail, Nahed
AU  - Ismail N
AD  - University of Illinois at Chicago, Department of Pathology, College of Medicine, 
      Chicago, IL, USA.
FAU - Issazadeh-Navikas, Shohreh
AU  - Issazadeh-Navikas S
AD  - University of Copenhagen, Copenhagen Biocentre, Faculty of Health and Medical 
      Sciences, Biotech Research & Innovation Centre (BRIC), Neuroinflammation Unit, 
      Copenhagen N, Denmark.
FAU - Itakura, Eisuke
AU  - Itakura E
AD  - Chiba University, Department of Biology, Chiba, Japan.
FAU - Ito, Daisuke
AU  - Ito D
AD  - Keio University School of Medicine, Department of Neurology, Tokyo, Japan.
FAU - Ivankovic, Davor
AU  - Ivankovic D
AD  - University College London, Department of Neuroscience, Physiology and 
      Pharmacology, London, UK.
FAU - Ivanova, Saška
AU  - Ivanova S
AD  - Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; 
      Universitat de Barcelona, Departament de Bioquímica I Biomedicina Molecular, 
      Barcelona, Spain; CIBER de Diabetes y Enfermedades Metabólicas Asociadas 
      (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
AD  - Barcelona Institute of Science and Technology (BIST), Institute for Research in 
      Biomedicine (IRB Barcelona), Barcelona, Spain; CIBER de Diabetes y Enfermedades 
      Metabólicas Asociadas, Barcelona, Spain; Universitat de Barcelona, Facultat de 
      Biologia, Departament de Bioquimica i Biomedicina Molecular, Barcelona, Spain.
FAU - Iyer, Anand Krishnan V
AU  - Iyer AKV
AD  - Hampton University, School of Pharmacy, Department of Pharmaceutical Sciences, 
      Hampton, VA, USA.
FAU - Izquierdo, José M
AU  - Izquierdo JM
AD  - Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones 
      Científicas, Universidad Autónoma de Madrid, Madrid, Spain; Department of Cell 
      Biology and Immunology, Campus de Cantoblanco, Madrid, Spain.
FAU - Izumi, Masanori
AU  - Izumi M
AD  - RIKEN, Center for Sustainable Resource Science, Wako, Saitama, Japan.
FAU - Jäättelä, Marja
AU  - Jäättelä M
AD  - Danish Cancer Society Research Center, Center for Autophagy, Recycling and 
      Disease, Cell Death and Metabolism Unit, Copenhagen, Denmark; University of 
      Copenhagen, Department of Cellular and Molecular Medicine, Copenhagen, Denmark.
FAU - Jabir, Majid Sakhi
AU  - Jabir MS
AD  - University of Technology, Department of applied science, Division of 
      Biotechnology, Baghdad, Iraq.
FAU - Jackson, William T
AU  - Jackson WT
AD  - University of Maryland School of Medicine, Department of Microbiology and 
      Immunology, Baltimore, MD, USA.
FAU - Jacobo-Herrera, Nadia
AU  - Jacobo-Herrera N
AD  - Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Unidad de 
      Bioquimica, Mexico City, Mexico.
FAU - Jacomin, Anne-Claire
AU  - Jacomin AC
AD  - University of Warwick, School of Life Sciences, Coventry, UK.
FAU - Jacquin, Elise
AU  - Jacquin E
AD  - Université Paris-Saclay, INSERM ,UMR-S 1193, Châtenay-Malabry, France.
FAU - Jadiya, Pooja
AU  - Jadiya P
AD  - Lewis Katz School of Medicine at Temple University, Center for Translational 
      Medicine, Philadelphia, PA, USA.
FAU - Jaeschke, Hartmut
AU  - Jaeschke H
AD  - University of Kansas Medical Center, Department of Pharmacology, Toxicology and 
      Therapeutics, Kansas City, KS, USA.
FAU - Jagannath, Chinnaswamy
AU  - Jagannath C
AD  - Houston Methodist Research Institute, Weill-Cornell Medicine, Houston, TX, USA.
FAU - Jakobi, Arjen J
AU  - Jakobi AJ
AD  - Delft University of Technology, Kavli Institute of Nanoscience, Department of 
      Bionanoscience, Delft, The Netherlands.
FAU - Jakobsson, Johan
AU  - Jakobsson J
AD  - Lund University, Department of Experimental Medical Science, Laboratory of 
      Molecular Neurogenetics, Wallenberg Neuroscience Center and Lund Stem Cell 
      Center, Lund, Sweden.
FAU - Janji, Bassam
AU  - Janji B
AD  - Luxembourg Institute of Health, Tumor Immunotherapy and Microenvironment (TIME) 
      group, Department of Oncology, Luxembourg City, Luxembourg.
FAU - Jansen-Dürr, Pidder
AU  - Jansen-Dürr P
AD  - University of Innsbruck, Institute for Biomedical Aging Research, Department of 
      Molecular Biology, Innsbruck, Austria.
FAU - Jansson, Patric J
AU  - Jansson PJ
AD  - Cancer Drug Resistance and Stem Cell Program, University of Sydney, NSW, 
      Australia.
FAU - Jantsch, Jonathan
AU  - Jantsch J
AD  - University Hospital of Regensburg, Institute of Clinical Microbiology and 
      Hygiene, Regensburg , Germany.
FAU - Januszewski, Sławomir
AU  - Januszewski S
AD  - Polish Academy of Sciences, Mossakowski Medical Research Centre, Laboratory of 
      Ischemic and Neurodegenerative Brain Research, Warsaw, Poland.
FAU - Jassey, Alagie
AU  - Jassey A
AD  - Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical 
      University, Taipei, Taiwan; Department of Microbiology and Immunology, School of 
      Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
FAU - Jean, Steve
AU  - Jean S
AD  - Université de Sherbrooke, Département d'immunologie et de biologie cellulaire, 
      Sherbrooke, Québec, Canada.
FAU - Jeltsch-David, Hélène
AU  - Jeltsch-David H
AD  - UMR7242, CNRS, Université de Strasbourg, Strasbourg, France.
FAU - Jendelova, Pavla
AU  - Jendelova P
AD  - Institute of Experimental Medicine CAS, Department of Neuroregeneration, Prague, 
      Czech Republic.
FAU - Jenny, Andreas
AU  - Jenny A
AD  - Albert Einstein College of Medicine, Department of Developmental and Molecular 
      Biology and Department of Genetics, New York, NY, USA.
FAU - Jensen, Thomas E
AU  - Jensen TE
AD  - University of Copenhagen, Department of Nutrition, Exercise and Sports, Section 
      of Molecular Physiology, Copenhagen, Denmark.
FAU - Jessen, Niels
AU  - Jessen N
AD  - Aarhus University Hospital, Steno Diabetes Center Aarhus, Aarhus, Denmark.
FAU - Jewell, Jenna L
AU  - Jewell JL
AD  - University of Texas Southwestern Medical Center, Department of Molecular Biology, 
      Dallas, TX, USA.
FAU - Ji, Jing
AU  - Ji J
AD  - The First Affiliated Hospital of Nanjing Medical University, Department of 
      Neurosurgery, Nanjing, Jiangsu, China.
FAU - Jia, Lijun
AU  - Jia L
AD  - Shanghai University of Traditional Chinese Medicine, Longhua Hospital, Cancer 
      Institute, Shanghai, China.
FAU - Jia, Rui
AU  - Jia R
AD  - National Institutes of Health, Eunice Kennedy Shriver National Institute of Child 
      Health and Human Development, Neurosciences and Cellular and Structural Biology 
      Division (NCSBD), Bethesda, MD, USA.
FAU - Jiang, Liwen
AU  - Jiang L
AD  - The Chinese University of Hong Kong, School of Life Sciences, Centre for Cell & 
      Developmental Biology and State Key Laboratory of Agrobiotechnology, Shatin, New 
      Territories, Hong Kong, China.
FAU - Jiang, Qing
AU  - Jiang Q
AD  - Purdue University, Department of Nutrition Science, West Lafayette, IN, USA.
FAU - Jiang, Richeng
AU  - Jiang R
AD  - Karolinska Institutet, Department of Neurobiology, Care Sciences and Society, 
      Division of Neurogeriatrics, Solna, Stockholm, Sweden.
AD  - The First Hospital of Jilin University, Department of Ear, Nose and Throat, 
      Changchun, Jilin, China.
FAU - Jiang, Teng
AU  - Jiang T
AD  - Nanjing Medical University, Nanjing First Hospital, Department of Neurology, 
      Nanjing, China.
FAU - Jiang, Xuejun
AU  - Jiang X
FAU - Jiang, Yu
AU  - Jiang Y
AD  - University of Pittsburgh, Department of Pharmacology and Chemical Biology, 
      Pittsburgh, PA, USA.
FAU - Jimenez-Sanchez, Maria
AU  - Jimenez-Sanchez M
AD  - King's College London, Institute of Psychiatry, Psychology & Neuroscience, 
      Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience 
      Institute, London, UK.
FAU - Jin, Eun-Jung
AU  - Jin EJ
AD  - Wonkwang Univesity, Department of Biological Sciences, Iksan, Chunbuk, Korea.
FAU - Jin, Fengyan
AU  - Jin F
AD  - The First Hospital of Jilin University, Cancer Center, Department of Hematology, 
      Changchun, Jilin, China.
FAU - Jin, Hongchuan
AU  - Jin H
AD  - ZhejiangUniversity, Sir Run Run Shaw Hospital, School of Medicine, Key Lab of 
      Biotherapy in Zhejiang Province, Hangzhou, China.
FAU - Jin, Li
AU  - Jin L
AD  - Xi'an Jiaotong University, School of Medicine, the First Affiliated Hospital, 
      Department of Nephrology, Xi'an City, Shaanxi Province, China.
FAU - Jin, Luqi
AU  - Jin L
AD  - Zhejiang University, School of Medicine, Department of Cell Biology, Hangzhou, 
      Zhejiang Province, China.
FAU - Jin, Meiyan
AU  - Jin M
AD  - University of California, Berkeley, Department of Molecular and Cell Biology, 
      Berkeley, CA, USA.
FAU - Jin, Si
AU  - Jin S
AD  - Huazhong University of Science and Technology, Liyuan hospital of Tongji Medical 
      College, Department of Endocrinology, Wuhan, Hubei, China.
FAU - Jo, Eun-Kyeong
AU  - Jo EK
AD  - Chungnam National University School of Medicine, Infection Control Convergence 
      Research Center, Daejeon, Korea.
FAU - Joffre, Carine
AU  - Joffre C
AD  - Cancer Research Center of Toulouse (CRCT), INSERM U1037, CNRS ERL5294, University 
      of Toulouse, Toulouse, France.
FAU - Johansen, Terje
AU  - Johansen T
AD  - University of Tromsø - The Arctic University of Norway, Department of Medical 
      Biology, Tromsø, Norway.
FAU - Johnson, Gail V W
AU  - Johnson GVW
AD  - University of Rochester, Department of Anesthesiology and Perioperative Medicine, 
      Rochester, NY, USA.
FAU - Johnston, Simon A
AU  - Johnston SA
AD  - University of Sheffield, Department of Infection, Immunity and Cardiovascular 
      Disease and the Bateson Centre, Sheffield, UK.
FAU - Jokitalo, Eija
AU  - Jokitalo E
AD  - University of Helsinki, Institute of Biotechnology, Cell and Tissue Dynamics 
      Programme and Electron Microscopy Unit, Helsinki, Finland.
FAU - Jolly, Mohit Kumar
AU  - Jolly MK
AD  - Indian Institute of Science, Centre for BioSystems Science and Engineering, 
      Bangalore, India.
FAU - Joosten, Leo A B
AU  - Joosten LAB
AD  - Radboud University Medical Centre, Department of Internal Medicine, Nijmegen, The 
      Netherlands.
FAU - Jordan, Joaquin
AU  - Jordan J
AD  - Universidad Castilla La Mancha, Departmento Ciencias Medicas, Albacete, Spain.
FAU - Joseph, Bertrand
AU  - Joseph B
AD  - Karolinska Institutet, Institute of Environmental Medicine, Stockholm, Sweden.
FAU - Ju, Dianwen
AU  - Ju D
AD  - Fudan University School of Pharmacy, Department of Biological Medicines, 
      Shanghai, China.
FAU - Ju, Jeong-Sun
AU  - Ju JS
AD  - The University of Suwon, Department of Health Science, Hwaseong, Gyeonggi, Korea.
FAU - Ju, Jingfang
AU  - Ju J
AD  - Stony Brook University, Department of Pathology, Stony Brook, NY, USA.
FAU - Juárez, Esmeralda
AU  - Juárez E
AD  - Instituto Nacional de Enfermedades Respiratorias Isamel Cosío Villegas, 
      Departamento de Investigación en Microbiología, Ciudad de México, México.
FAU - Judith, Delphine
AU  - Judith D
AD  - Université Paris Descartes, Institut Cochin, INSERM U1016, CNRS UMR8104, Paris, 
      France.
FAU - Juhász, Gábor
AU  - Juhász G
AD  - Department of Anatomy, Cell and Developmental Biology, Eötvös Loránd University, 
      Budapest, Hungary.
FAU - Jun, Youngsoo
AU  - Jun Y
AD  - Gwangju Institute of Science and Technology, School of Life Sciences, Gwangju, 
      South Korea.
FAU - Jung, Chang Hwa
AU  - Jung CH
AD  - Korea Food Research Institute, Research Group of Natural Material and Metabolism, 
      Jeollabuk-do, Korea.
FAU - Jung, Sung-Chul
AU  - Jung SC
AD  - Ewha Womans University, Department of Biochemistry, College of Medicine, Seoul, 
      Korea.
FAU - Jung, Yong Keun
AU  - Jung YK
AD  - Seoul National University, School of Biological Science, Seoul, Korea.
FAU - Jungbluth, Heinz
AU  - Jungbluth H
AD  - Evelina Children's Hospital, Guy's & St Thomas' NHS Foundation Trust, Children's 
      Neuroscience Centre, London, UK; King's College London, Muscle Signalling 
      Section, Randall Division of Cell and Molecular Biophysics, London, UK; King's 
      College London, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), 
      Department of Basic and Clinical Neuroscience, London, UK.
FAU - Jungverdorben, Johannes
AU  - Jungverdorben J
AD  - Memorial Sloan Kettering Cancer Center, New York, NY, USA.
FAU - Just, Steffen
AU  - Just S
AD  - University of Ulm, Department of Internal Medicine II, Molecular Cardiology, Ulm, 
      Germany.
FAU - Kaarniranta, Kai
AU  - Kaarniranta K
AD  - University of Eastern Finland and Kuopio University Hospital, Department of 
      Ophthalmology, Kuopio, Finland.
FAU - Kaasik, Allen
AU  - Kaasik A
AD  - University Tartu, Department of Pharmacology, Tartu, Estonia.
FAU - Kabuta, Tomohiro
AU  - Kabuta T
AD  - National Institute of Neuroscience, National Center of Neurology and Psychiatry, 
      Department of Degenerative Neurological Diseases, Kodaira, Tokyo, Japan.
FAU - Kaganovich, Daniel
AU  - Kaganovich D
AD  - University Medical Center Gottingen, Department of Experimental 
      Neurodegeneration, Gottingen, Germany.
FAU - Kahana, Alon
AU  - Kahana A
AD  - University of Michigan, Kellogg Eye Center, Department of Ophthalmology and 
      Visual Sciences, Ann Arbor, MI, USA.
FAU - Kain, Renate
AU  - Kain R
AD  - Medical University of Vienna, Department of Pathology, Vienna, Austria.
FAU - Kajimura, Shinjo
AU  - Kajimura S
AD  - University of California, San Francisco UCSF Diabetes Center, Department of Cell 
      and Tissue Biology, San Francisco, CA, USA.
FAU - Kalamvoki, Maria
AU  - Kalamvoki M
AD  - University of Kansas Medical Center, Department of Microbiology, Molecular 
      Genetics and Immunology, Kansas City, KS, USA.
FAU - Kalia, Manjula
AU  - Kalia M
AD  - Regional Centre for Biotechnology, NCR Biotech Science Cluster, Faridabad, India.
FAU - Kalinowski, Danuta S
AU  - Kalinowski DS
AD  - University of Sydney, Department of Pathology and Bosch Institute, Sydney, NSW, 
      Australia.
FAU - Kaludercic, Nina
AU  - Kaludercic N
AD  - National Research Council of Italy (CNR), Neuroscience Institute, Padua, Italy.
FAU - Kalvari, Ioanna
AU  - Kalvari I
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute 
      (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge, UK.
FAU - Kaminska, Joanna
AU  - Kaminska J
AD  - Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, 
      Poland.
FAU - Kaminskyy, Vitaliy O
AU  - Kaminskyy VO
AD  - Karolinska Institutet, Department of Oncology-Pathology, Stockholm, Sweden.
FAU - Kanamori, Hiromitsu
AU  - Kanamori H
AD  - Gifu University Graduate School of Medicine, Department of Cardioligy, Gifu, 
      Japan.
FAU - Kanasaki, Keizo
AU  - Kanasaki K
AD  - Shimane University Faculty of Medicine, Internal Medicine 1, Izumo, Shimane, 
      Japan.
FAU - Kang, Chanhee
AU  - Kang C
AD  - Seoul National University, School of Biological Sciences, Seoul, Korea.
FAU - Kang, Rui
AU  - Kang R
AD  - UT Southwestern Medical Center, Department of Surgery, Dallas, Texas, USA.
FAU - Kang, Sang Sun
AU  - Kang SS
AD  - Chungbuk National University, Department of Biology Education, Seowon-Gu, 
      Cheongju, Chungbuk, Korea.
FAU - Kaniyappan, Senthilvelrajan
AU  - Kaniyappan S
AD  - CAESAR Research Center, Bonn, Germany.
AD  - German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
FAU - Kanki, Tomotake
AU  - Kanki T
AD  - Niigata University Graduate School of Medical and Dental Sciences, Department of 
      Cellular Physiology, Niigata, Japan.
FAU - Kanneganti, Thirumala-Devi
AU  - Kanneganti TD
AD  - St. Jude Children's Research Hospital, Department of Immunology, Memphis, TN, 
      USA.
FAU - Kanthasamy, Anumantha G
AU  - Kanthasamy AG
AD  - Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State 
      University, Ames, IA, USA.
FAU - Kanthasamy, Arthi
AU  - Kanthasamy A
AD  - Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State 
      University, Ames, IA, USA.
FAU - Kantorow, Marc
AU  - Kantorow M
AD  - Florida Atlantic University, Charles E. Schmidt College of Medicine, Department 
      of Biomedical Science, Boca Raton, FL, USA.
FAU - Kapuy, Orsolya
AU  - Kapuy O
AD  - Semmelweis University, Budapest, Hungary.
FAU - Karamouzis, Michalis V
AU  - Karamouzis MV
AD  - National and Kapodistrian University of Athens, Medical School, Division of 
      Molecular Oncology, Department of Biological Chemistry, Athens, Greece.
FAU - Karim, Md Razaul
AU  - Karim MR
AD  - University of Minnesota, Institute for Translational Neuroscience, Department of 
      Neuroscience, Minneapolis, MN, USA.
FAU - Karmakar, Parimal
AU  - Karmakar P
AD  - Jadavpur University, Department of Life Science and Biotechnology, Kolkata, 
      India.
FAU - Katare, Rajesh G
AU  - Katare RG
AD  - University of Otago, Department of Physiology-HeartOtago, Dunedin, Otago, New 
      Zealand.
FAU - Kato, Masaru
AU  - Kato M
AD  - Hokkaido University, Department of Rheumatology, Endocrinology and Nephrology, 
      Sapporo, Japan.
FAU - Kaufmann, Stefan H E
AU  - Kaufmann SHE
AD  - Max Planck Institute for Infection Biology, Berlin, Germany.
FAU - Kauppinen, Anu
AU  - Kauppinen A
AD  - University of Eastern Finland, Faculty of Health Sciences, School of Pharmacy, 
      Kuopio, Finland.
FAU - Kaushal, Gur P
AU  - Kaushal GP
AD  - University of Arkansas for Medical Sciences, Little Rock, AR, USA.
FAU - Kaushik, Susmita
AU  - Kaushik S
AD  - Albert Einstein College of Medicine, Department of Developmental and Molecular 
      Biology, Bronx, NY, USA.
FAU - Kawasaki, Kiyoshi
AU  - Kawasaki K
AD  - Doshisha Women's College of Liberal Arts, Faculty of Pharmaceutical Sciences, 
      Kyotanabe, Kyoto, Japan.
FAU - Kazan, Kemal
AU  - Kazan K
AD  - Commonwealth Scientific and Industrial Research Organization (CSIRO), Agriculture 
      and Food, Brisbane, Queensland, Australia.
FAU - Ke, Po-Yuan
AU  - Ke PY
AD  - Chang Gung University, Department of Biochemistry and Molecular Biology, Taoyuan, 
      Taiwan, Republic of China.
FAU - Keating, Damien J
AU  - Keating DJ
AD  - Flinders University, Flinders Health and Medical Research Institute, Adelaide, 
      Australia.
FAU - Keber, Ursula
AU  - Keber U
AD  - Philipps University and University Hospital of Marburg, Department of 
      Neuropathology, Marburg, Germany.
FAU - Kehrl, John H
AU  - Kehrl JH
AD  - National Institutes of Health, National Institute of Allergy and Infectious 
      Diseases, Laboratory of Immunoregulation, Bethesda, MD, USA.
FAU - Keller, Kate E
AU  - Keller KE
AD  - Oregon Health & Science University, Casey Eye Institute, Portland, OR, USA.
FAU - Keller, Christian W
AU  - Keller CW
AD  - University of Münster, University Hospital, Department of Neurology with 
      Institute of Translational Neurology, Münster, Germany.
FAU - Kemper, Jongsook Kim
AU  - Kemper JK
AD  - University of Illinois at Urbana-Champaign, Department of Molecular and 
      Integrative Physiology, Urbana, IL, USA.
FAU - Kenific, Candia M
AU  - Kenific CM
AD  - Weill Cornell Medicine, Departments of Pediatrics and Cell and Developmental 
      Biology, New York, NY, USA.
FAU - Kepp, Oliver
AU  - Kepp O
AD  - Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer 
      Institute, Villejuif, France; Equipe 11 labellisée Ligue contre le Cancer, Centre 
      de Recherche des Cordeliers, INSERM U 1138, Paris, France.
FAU - Kermorgant, Stephanie
AU  - Kermorgant S
AD  - Queen Mary University of London, Barts Cancer Institute, London, UK.
FAU - Kern, Andreas
AU  - Kern A
AD  - University Medical Center of the Johannes Gutenberg University, Institute of 
      Pathobiochemistry, Mainz, Germany.
FAU - Ketteler, Robin
AU  - Ketteler R
AD  - University College London, MRC Laboratory for Molecular Cell Biology, London, UK.
FAU - Keulers, Tom G
AU  - Keulers TG
AD  - Maastricht University Medical Center, GROW School for Oncology, Department of 
      Radiotherapy, Maastricht|, The Netherlands.
FAU - Khalfin, Boris
AU  - Khalfin B
AD  - Ben-Gurion University of the Negev, Faculty of Health Sciences, Department of 
      Clinical Biochemistry and Pharmacology, Beer Sheva, Israel.
FAU - Khalil, Hany
AU  - Khalil H
AD  - University of Sadat City, Department of Molecular Biology, Genetic Engineering 
      and Biotechnology Research Institute, Sadat City, Egypt.
FAU - Khambu, Bilon
AU  - Khambu B
AD  - Indiana University-Purdue University (IUPUI), Department of Pathology and 
      Laboratory Medicine, Indianapolis, IN, USA.
FAU - Khan, Shahid Y
AU  - Khan SY
AD  - The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, 
      MD, USA.
FAU - Khandelwal, Vinoth Kumar Megraj
AU  - Khandelwal VKM
AD  - University of Eastern Finland, School of Pharmacy, Kuopio, Finland.
FAU - Khandia, Rekha
AU  - Khandia R
AD  - Barkatullah University, Department of Biochemistry & Genetics, Bhopal, India.
FAU - Kho, Widuri
AU  - Kho W
AD  - Charité - Universitätsmedizin Berlin, Department of Anesthesiology and Intensive 
      Care Medicine, Campus Charité Mitte and Campus Virchow-Klinikum, Berlin, Germany.
FAU - Khobrekar, Noopur V
AU  - Khobrekar NV
AD  - Columbia University, Vagelos College of Physicians and Surgeons, Department of 
      Pathology and Cell Biology, New York, NY, USA.
FAU - Khuansuwan, Sataree
AU  - Khuansuwan S
AD  - David Geffen School of Medicine at UCLA, Department of Neurology, Los Angeles, 
      CA, USA.
FAU - Khundadze, Mukhran
AU  - Khundadze M
AD  - Friedrich-Schiller-University Jena, University Hospital Jena, Institute of Human 
      Genetics, Jena, Germany.
FAU - Killackey, Samuel A
AU  - Killackey SA
AD  - University of Toronto, Department of Laboratory Medicine and Pathobiology, 
      Toronto, Ontario, Canada.
FAU - Kim, Dasol
AU  - Kim D
AD  - Yonsei University, Department of Biotechnology, Seodaemun-gu, Seoul, Korea.
FAU - Kim, Deok Ryong
AU  - Kim DR
AD  - Gyeongsang National University School of Medicine, Department of Biochemistry and 
      Convergence Medical Sciences and Institude of Health Sciences, Jinju, Republic of 
      Korea.
FAU - Kim, Do-Hyung
AU  - Kim DH
AD  - University of Minnesota, Department of Biochemistry, Molecular Biology, and 
      Biophysics, Minneapolis, MN, USA.
FAU - Kim, Dong-Eun
AU  - Kim DE
AD  - Konkuk University, Department of Bioscience and Biotechnology, Seoul, Korea.
FAU - Kim, Eun Young
AU  - Kim EY
AD  - Kyungpook National University, School of Medicine, Department of Biochemistry and 
      Cell Biology, Cell and Matrix Research Institute, Daegu, Korea.
FAU - Kim, Eun-Kyoung
AU  - Kim EK
AD  - Daegu Gyeongbuk Institute of Science and Technology (DGIST), Department of Brain 
      and Cognitive Sciences, Daegu, Korea.
FAU - Kim, Hak-Rim
AU  - Kim HR
AD  - Dankook University, College of Medicine, Department of Pharmacology, Cheonan, 
      Chungnam, Korea.
FAU - Kim, Hee-Sik
AU  - Kim HS
AD  - Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cell Factory 
      Research Center, Daejeon, Korea; University of Science and Technology, KRIBB 
      School of Biotechnology, Department of Environmental Biotechnology, Daejeon, 
      Korea.
FAU - Hyung-Ryong Kim
AU  - Hyung-Ryong Kim
AD  - Dankook University, College of Dentistry, Cheonan, Korea.
FAU - Kim, Jeong Hun
AU  - Kim JH
AD  - Seoul National University College of Medicine, Department of Biomedical Sciences, 
      and Ophthalmology, Seoul, Korea.
FAU - Kim, Jin Kyung
AU  - Kim JK
AD  - Chungnam National University School of Medicine, Infection Control Convergence 
      Research Center, Daejeon, Korea.
FAU - Kim, Jin-Hoi
AU  - Kim JH
AD  - Konkuk University, Department of Stem Cell and Regenerative Biotechnology, Seoul, 
      Korea.
FAU - Kim, Joungmok
AU  - Kim J
AD  - Kyung Hee University, Department of Oral Biochemistry and Molecular Biology, 
      School of Dentistry, Seoul, Korea.
FAU - Kim, Ju Hwan
AU  - Kim JH
AD  - Dankook University, College of Medicine, Department of Pharmacology, Cheonan, 
      Chungnam, Korea.
FAU - Kim, Keun Il
AU  - Kim KI
AD  - Sookmyung Women's University, Department of Biological Sciences, Seoul, Korea.
FAU - Kim, Peter K
AU  - Kim PK
AD  - Hospital for Sick Children, Program in Cell Biology Department, Toronto, Canada; 
      University of Toronto, Department of Biochemistry, Toronto, Canada.
FAU - Kim, Seong-Jun
AU  - Kim SJ
AD  - Korea Research Institute of Chemical Technology, Center for Convergent Research 
      of Emerging Virus Infection, Daejeon, Korea.
FAU - Kimball, Scot R
AU  - Kimball SR
AD  - Penn State College of Medicine, Department of Cellular and Molecular Physiology, 
      Hershey, PA, USA.
FAU - Kimchi, Adi
AU  - Kimchi A
AD  - Weizmann Institute of Science, Department of Molecular Genetics, Rehovot, Israel.
FAU - Kimmelman, Alec C
AU  - Kimmelman AC
AD  - New York University School of Medicine, Department of Radiation Oncology, 
      Perlmutter Cancer Center, New York, NY, USA.
FAU - Kimura, Tomonori
AU  - Kimura T
AD  - National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN), 
      Center for Rare Disease Research, Ibaraki, Osaka, Japan.
FAU - King, Matthew A
AU  - King MA
AD  - AstraZeneca, Bioscience, Oncology R&D, Cambridge, UK.
FAU - Kinghorn, Kerri J
AU  - Kinghorn KJ
AD  - University College London, Institute of Healthy Ageing, Department of Genetics, 
      Evolution & Environment, London, UK.
FAU - Kinsey, Conan G
AU  - Kinsey CG
AD  - University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA; 
      University of Utah School of Medicine, Division of Oncology, Department of 
      Internal Medicine, Salt Lake City, UT, USA.
FAU - Kirkin, Vladimir
AU  - Kirkin V
AD  - Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research 
      London, Sutton, UK.
FAU - Kirshenbaum, Lorrie A
AU  - Kirshenbaum LA
AD  - St. Boniface Hospital Albrechtsen Research Centre, Departments of Physiology and 
      Pathophysiology, and Pharmacology and Therapeutics, Max Rady College of Medicine; 
      Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, 
      Canada.
FAU - Kiselev, Sergey L
AU  - Kiselev SL
AD  - Vavilov Institute of General Genetics RAS, Department of Epigenetics, Moscow, 
      Russia.
FAU - Kishi, Shuji
AU  - Kishi S
AD  - S&J Kishi Research Corporation, Jupiter, FL, USA.
FAU - Kitamoto, Katsuhiko
AU  - Kitamoto K
AD  - Nihon Pharmaceutical University, Department of Pharmaceutical and Medical 
      Business Sciences, Bunkyoku, Tokyo, Japan.
FAU - Kitaoka, Yasushi
AU  - Kitaoka Y
AD  - St. Marianna University Graduate School of Medicine, Department of Molecular 
      Neuroscience, Kanagawa, Japan.
FAU - Kitazato, Kaio
AU  - Kitazato K
AD  - Nagasaki University, Institute of Biomedical Sciences, Department of Clinical 
      Research Pharmacy, Nagasaki, Japan.
FAU - Kitsis, Richard N
AU  - Kitsis RN
AD  - Albert Einstein College of Medicine, Departments of Medicine and Cell Biology and 
      Wilf Family Cardiovascular Research Institute, Bronx, NY, USA.
FAU - Kittler, Josef T
AU  - Kittler JT
AD  - University College London, Department of Neuroscience, Physiology and 
      Pharmacology, London, UK.
FAU - Kjaerulff, Ole
AU  - Kjaerulff O
AD  - University of Copenhagen, Department of Neuroscience, Copenhagen, Denmark.
FAU - Klein, Peter S
AU  - Klein PS
AD  - Perelman School of Medicine at the University of Pennsylvania, Department of 
      Medicine (Hematology-Oncology), Philadelphia, PA, USA.
FAU - Klopstock, Thomas
AU  - Klopstock T
AD  - Friedrich-Baur-Institute, Department of Neurology, University of Munich, Munich, 
      Germany.
FAU - Klucken, Jochen
AU  - Klucken J
AD  - University Hospital Erlangen, Department of Molecular Neurology, Erlangen, 
      Germany.
FAU - Knævelsrud, Helene
AU  - Knævelsrud H
AD  - University of Oslo, Centre for Cancer Cell Reprogramming, Institute of Clinical 
      Medicine, Faculty of Medicine, Montebello, Norway; Oslo University Hospital, 
      Department of Molecular Cell Biology, Institute for Cancer Research, Montebello, 
      Norway.
FAU - Knorr, Roland L
AU  - Knorr RL
AD  - Max Planck Institute of Molecular Plant Physiology, Potsdam-Golm, Germany.
AD  - The University of Tokyo, Department of Biochemistry and Molecular Biology, 
      Graduate School of Medicine, Tokyo, Japan.
FAU - Ko, Ben C B
AU  - Ko BCB
AD  - The Hong Kong Polytechnic University, Department of Applied Biology and Chemical 
      Technology, Hong Kong, China.
FAU - Ko, Fred
AU  - Ko F
AD  - Icahn School of Medicine at Mount Sinai, Department of Geriatrics and Palliative 
      Medicine, New York, NY, USA.
FAU - Ko, Jiunn-Liang
AU  - Ko JL
AD  - Chung Shan Medical University, Institute of Medicine, Taiwan.
FAU - Kobayashi, Hotaka
AU  - Kobayashi H
AD  - The University of Tokyo, Institute for Quantitative Biosciences, Laboratory of 
      RNA Function, Tokyo, Japan; Albert Einstein College of Medicine, Department of 
      Anatomy and Structural Biology, Bronx, NY, USA.
FAU - Kobayashi, Satoru
AU  - Kobayashi S
AD  - New York Institute of Technology, College of Osteopathic Medicine, Department of 
      Biomedical Sciences, Old Westbury, NY, USA.
FAU - Koch, Ina
AU  - Koch I
AD  - Johann Wolfgang Goethe-University Frankfurt am Main, Faculty of Computer Science 
      and Mathematics, Institute of Computer Science, Frankfurt am Main, Germany.
FAU - Koch, Jan C
AU  - Koch JC
AD  - University Medicine Göttingen, Clinic for Neurology, Göttingen, Germany.
FAU - Koenig, Ulrich
AU  - Koenig U
AD  - University Hospital Münster (UKM), Institute of Musculoskeletal Medicine, 
      Münster, Germany.
FAU - Kögel, Donat
AU  - Kögel D
AD  - Goethe University Hospital Frankfurt, Neuroscience Center, Experimental 
      Neurosurgery, Frankfurt/Main, Germany.
FAU - Koh, Young Ho
AU  - Koh YH
AD  - Division of Brain Disease Research, Korea National Institute of Health, 
      Cheongju-si, Republic of Korea.
FAU - Koike, Masato
AU  - Koike M
AD  - Juntendo University Graduate School of Medicine, Department of Cell Biology and 
      Neuroscience, Hongo, Bunkyo-ku, Tokyo, Japan.
FAU - Kohlwein, Sepp D
AU  - Kohlwein SD
AD  - University of Graz, Institute of Molecular Biosciences, BioTechMed-Graz, Graz, 
      Austria.
FAU - Kocaturk, Nur M
AU  - Kocaturk NM
AD  - University of Cologne, Faculty of Medicine and University Hospital Cologne, 
      Department of Pediatrics, Cologne, Germany; University of Cologne, Faculty of 
      Medicine and University Hospital Cologne, Center for Molecular Medicine (CMMC), 
      Cologne, Germany.
FAU - Komatsu, Masaaki
AU  - Komatsu M
AD  - Juntendo University School of Medicine, Department of Physiology, Bunkyo-ku, 
      Tokyo, Japan.
FAU - König, Jeannette
AU  - König J
AD  - German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Department of 
      Molecular Toxicology, Nuthetal, Germany.
FAU - Kono, Toru
AU  - Kono T
AD  - Sapporo Higashi Tokushukai Hospital, Advanced Surgery Center, Sapporo, Hokkaido, 
      Japan.
FAU - Kopp, Benjamin T
AU  - Kopp BT
AD  - The Abigail Wexner Research Institute at Nationwide Children's Hospital, Center 
      for Microbial Pathogenesis, Columbus, OH, USA.
FAU - Korcsmaros, Tamas
AU  - Korcsmaros T
AD  - Earlham Institute, Norwich, UK.
FAU - Korkmaz, Gözde
AU  - Korkmaz G
AD  - Koç University School of Medicine, Department of Molecular Biology and Genetics 
      and KUTTAM Research Center for Translational Medicine, Istanbul, Turkey.
FAU - Korolchuk, Viktor I
AU  - Korolchuk VI
AD  - Newcastle University, Ageing Research Laboratories, Institute for Cell and 
      Molecular Biosciences, Newcastle upon Tyne, UK.
FAU - Korsnes, Mónica Suárez
AU  - Korsnes MS
AD  - Norwegian University of Science and Technology (NTNU), Department of 
      Biotechnology and Food Science, Trondheim, Norway; Korsnes Biocomputing (KoBio), 
      Trondheim, Norway.
FAU - Koskela, Ali
AU  - Koskela A
AD  - University of Eastern Finland, Department of Ophthalmology, Kuopio, Finland.
FAU - Kota, Janaiah
AU  - Kota J
AD  - Indiana University School of Medicine, Indianapolis, IN, USA.
FAU - Kotake, Yaichiro
AU  - Kotake Y
AD  - Hiroshima University, Graduate School of Biomedical and Health Sciences, 
      Hiroshima, Japan.
FAU - Kotler, Monica L
AU  - Kotler ML
AD  - Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y 
      Técnicas (CONICET), Instituto de Química Biológica Ciencias Exactas y Naturales 
      (IQUIBICEN), Facultad de Ciencias Exactas y Naturales, Departamento de Química 
      Biológica, Laboratorio de Disfunción Celular en Enfermedades Neurodegenerativas y 
      Nanomedicina, Buenos Aires, Argentina.
FAU - Kou, Yanjun
AU  - Kou Y
AD  - China National Rice Research Institute, State Key Laboratory of Rice Biology, 
      Hangzhou. China.
FAU - Koukourakis, Michael I
AU  - Koukourakis MI
AD  - Democritus University of Thrace, Department of Radiotherapy/Oncology, 
      Alexandroupolis, Greece.
FAU - Koustas, Evangelos
AU  - Koustas E
AD  - National and Kapodistrian University of Athens, Medical School, Division of 
      Molecular Oncology, Department of Biological Chemistry, Athens, Greece.
FAU - Kovacs, Attila L
AU  - Kovacs AL
AD  - Department of Anatomy, Cell and Developmental Biology, Eötvös Loránd University, 
      Budapest, Hungary.
FAU - Kovács, Tibor
AU  - Kovács T
AD  - Eötvös Loránd University (ELTE), Department of Genetics, Budapest, Hungary.
FAU - Koya, Daisuke
AU  - Koya D
AD  - Kanazawa Medical University, Department of Diabetology & Endocrinology, 
      Uchinadacho, Ishikawa, Japan.
FAU - Kozako, Tomohiro
AU  - Kozako T
AD  - Fukuoka University, Faculty of Pharmaceutical Sciences, Department of 
      Biochemistry, Fukuoka, Japan.
FAU - Kraft, Claudine
AU  - Kraft C
AD  - University of Freiburg, Institute of Biochemistry and Molecular Biology, ZBMZ, 
      Faculty of Medicine, Freiburg, Germany; University of Freiburg, CIBSS - Centre 
      for Integrative Biological Signalling Studies, Freiburg, Germany.
FAU - Krainc, Dimitri
AU  - Krainc D
AD  - Northwestern University Feinberg School of Medicine, Department of Neurology, 
      Chicago, IL, USA.
FAU - Krämer, Helmut
AU  - Krämer H
AD  - University of Texas, Southwestern Medical Center, Dallas, TX, USA.
FAU - Krasnodembskaya, Anna D
AU  - Krasnodembskaya AD
AD  - Queen's University of Belfast, Wellcome-Wolfson Institute for Experimental 
      Medicine, Belfast, UK.
FAU - Kretz-Remy, Carole
AU  - Kretz-Remy C
AD  - Université Lyon, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U1217, 
      Institut NeuroMyoGène, Lyon, France.
FAU - Kroemer, Guido
AU  - Kroemer G
AD  - Université de Paris, Sorbonne Université, INSERM U1138, Centre de Recherche des 
      Cordeliers, Equipe labellisée par la Ligue contre le cancer, Paris, France; 
      Institut Gustave Roussy, Metabolomics and Cell Biology Platforms, Villejuif, 
      France; Hôpital Européen Georges Pompidou, AP-HP, Pôle de Biologie, Paris, 
      France; Chinese Academy of Medical Sciences, Suzhou Institute for Systems 
      Medicine, Suzhou, China; Karolinska Institute, Karolinska University Hospital, 
      Department of Women's and Children's Health, Stockholm, Sweden.
FAU - Ktistakis, Nicholas T
AU  - Ktistakis NT
AD  - Babraham Institute, Babraham, Cambridge, UK.
FAU - Kuchitsu, Kazuyuki
AU  - Kuchitsu K
AD  - Tokyo University of Science, Department of Applied Biological Science, Noda, 
      Chiba, Japan.
FAU - Kuenen, Sabine
AU  - Kuenen S
AD  - VIB-KU Leuven Center for Brain & Disease Research, Leuven, Belgium; KU Leuven, 
      Department of Neurosciences, Leuven Brain Institute, Leuven, Belgium.
FAU - Kuerschner, Lars
AU  - Kuerschner L
AD  - University of Bonn, LIMES Institute, Bonn, Germany.
FAU - Kukar, Thomas
AU  - Kukar T
AD  - Emory University, Department of Pharmacology and Chemical Biology, School of 
      Medicine, Atlanta, GA, USA.
FAU - Kumar, Ajay
AU  - Kumar A
AD  - PK-PD-Toxicology and Formulation Division, CSIR-Indian Institute of Integrative 
      Medicine, Jammu, India.
FAU - Kumar, Ashok
AU  - Kumar A
AD  - University of Houston, Department of Pharmacological and Pharmaceutical Sciences, 
      Houston, TX, USA.
FAU - Kumar, Deepak
AU  - Kumar D
AD  - Julius L. Chambers Biomedical/Biotechnology Research Institute (BBRI) and North 
      Carolina Central University, Department of Pharmaceutical Sciences, Durham, NC, 
      USA.
FAU - Kumar, Dhiraj
AU  - Kumar D
AD  - International Centre for Genetic Engineering and Biotechnology, Cellular 
      Immunology Group, Aruna Asaf Ali Marg, New Delhi, India.
FAU - Kumar, Sharad
AU  - Kumar S
AD  - Centre for Cancer Biology, University of South Australia, Adelaide, Australia.
FAU - Kume, Shinji
AU  - Kume S
AD  - Shiga University of Medical Science, Department of Medicine, Otsu, Shiga, Japan.
FAU - Kumsta, Caroline
AU  - Kumsta C
AD  - Sanford Burnham Prebys Medical Discovery Institute, Program of Development, Aging 
      and Regeneration, La Jolla, CA, USA.
FAU - Kundu, Chanakya N
AU  - Kundu CN
AD  - Kalinga institute of industrial technology (KIIT-DU), School of Biotechnology, 
      Campus 11, Patia, Bhubaneswar, Odisha, India.
FAU - Kundu, Mondira
AU  - Kundu M
AD  - St. Jude Children's Research Hospital, Department of Pathology, Memphis, TN, USA.
FAU - Kunnumakkara, Ajaikumar B
AU  - Kunnumakkara AB
AD  - Indian Institute of Technology (IIT) Guwahati, Department of Biosciences and 
      Bioengineering, Guwahati, Assam, India.
FAU - Kurgan, Lukasz
AU  - Kurgan L
AD  - Virginia Commonwealth University, Department of Computer Science, Richmond, VA, 
      USA.
FAU - Kutateladze, Tatiana G
AU  - Kutateladze TG
AD  - University of Colorado Anschutz Medical Campus, Department of Pharmacology, 
      Aurora, CO, USA.
FAU - Kutlu, Ozlem
AU  - Kutlu O
AD  - Sabanci University Nanotechnology Research and Application Center (SUNUM), Tuzla, 
      Istanbul, Turkey.
FAU - Kwak, SeongAe
AU  - Kwak S
AD  - Wonkwang University School of Medicine, Zoonosis Research Center, Iksan, Jeonbuk, 
      Korea.
FAU - Kwon, Ho Jeong
AU  - Kwon HJ
AD  - Yonsei University, Department of Biotechnology, Seodaemun-gu, Seoul, Korea.
FAU - Kwon, Taeg Kyu
AU  - Kwon TK
AD  - Keimyung University, School of Medicine, Department of Immunology, Daegu, Korea.
FAU - Kwon, Yong Tae
AU  - Kwon YT
AD  - Protein Metabolism Medical Research Center and Department of Biomedical Sciences, 
      Seoul National University School of Medicine, Seoul, Korea.
FAU - Kyrmizi, Irene
AU  - Kyrmizi I
AD  - University of Crete, School of Medicine, Laboratory of Clinical Microbiology and 
      Microbial Pathogenesis, Voutes, Heraklion, Crete, Greece; Foundation for Research 
      and Technology, Institute of Molecular Biology and Biotechnology (IMBB), 
      Heraklion, Crete, Greece.
FAU - La Spada, Albert
AU  - La Spada A
AD  - University of California, Irvine School of Medicine, Irvine, CA, USA.
FAU - Labonté, Patrick
AU  - Labonté P
AD  - INRS, INRS-Institut Armand-Frappier. Montréal, QC, Canada.
FAU - Ladoire, Sylvain
AU  - Ladoire S
AD  - University of Burgundy, Centre Georges François Leclerc, Department of Medical 
      Oncology, Dijon, France.
FAU - Laface, Ilaria
AU  - Laface I
AD  - University of Ferrara, Department of Translational Medicine, Ferrara, Italy.
FAU - Lafont, Frank
AU  - Lafont F
AD  - Cellular Microbiology and Physics of Infection Group, Center for Infection and 
      Immunity of Lille, Institut Pasteur de Lille, CNRS, INSERM, CHU Lille, University 
      of Lille, Lille Cedex, France.
FAU - Lagace, Diane C
AU  - Lagace DC
AD  - University of Ottawa, Department of Cellular & Molecular Medicine, Ottawa, 
      Ontario, Canada.
FAU - Lahiri, Vikramjit
AU  - Lahiri V
AD  - Life Sciences Institute and Department of Molecular, Cellular and Developmental 
      Biology, University of Michigan, Ann Arbor, MI, USA.
FAU - Lai, Zhibing
AU  - Lai Z
AD  - Huazhong Agricultural University, National Key Laboratory of Crop Genetic 
      Improvement, Wuhan, China.
FAU - Laird, Angela S
AU  - Laird AS
AD  - Macquarie University, Faculty of Medicine, Health and Human Sciences, Department 
      of Biomedical Science, Centre for Motor Neuron Disease Research, Sydney, NSW, 
      Australia.
FAU - Lakkaraju, Aparna
AU  - Lakkaraju A
AD  - University of California, San Francisco Department of Ophthalmology, San 
      Francisco, CA, USA.
FAU - Lamark, Trond
AU  - Lamark T
AD  - University of Tromsø - The Arctic University of Norway, Department of Medical 
      Biology, Tromsø, Norway.
FAU - Lan, Sheng-Hui
AU  - Lan SH
AD  - National Yang-Ming University, Department of Life Sciences and Institute of 
      Genome Sciences, Taipei, Taiwan.
FAU - Landajuela, Ane
AU  - Landajuela A
AD  - Yale University, Department of Cellular and Molecular Physiology, New Haven, CT, 
      USA.
FAU - Lane, Darius J R
AU  - Lane DJR
AD  - Melbourne Dementia Research Centre, The Florey Institute of Neuroscience & Mental 
      Health, The University of Melbourne, Parkville, VIC, Australia.
FAU - Lane, Jon D
AU  - Lane JD
AD  - School of Biochemistry, University of Bristol, Bristol, UK.
FAU - Lang, Charles H
AU  - Lang CH
AD  - Penn State College Medicine, Department of Cellular and Molecular Physiology, 
      Hershey, PA, USA.
FAU - Lange, Carsten
AU  - Lange C
AD  - University of Greifswald, Institute of Pharmacy, Greifswald, Germany.
FAU - Langel, Ülo
AU  - Langel Ü
AD  - Stockholm University, Department of Biochemistry and Biophysics, Stockholm, 
      Sweden.
FAU - Langer, Rupert
AU  - Langer R
AD  - Johannes Kepler University Linz, Kepler University Hospital GmbH, Institute of 
      Pathology and Molecular Pathology, Linz, Austria.
FAU - Lapaquette, Pierre
AU  - Lapaquette P
AD  - University Bourgogne Franche-Comté, AgroSup Dijon, PAM UMR A 02.102, Dijon, 
      France.
FAU - Laporte, Jocelyn
AU  - Laporte J
AD  - IGBMC, Inserm U1258, Cnrs UMR7104, Strasbourg University, Illkirch, France.
FAU - LaRusso, Nicholas F
AU  - LaRusso NF
AD  - Mayo Clinic, Department of Medicine, Division of Gastroenterology and Hepatology, 
      Rochester, MN, USA.
FAU - Lastres-Becker, Isabel
AU  - Lastres-Becker I
AD  - Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas 
      (CIBERNED), Instituto de Investigación Sanitaria La Paz (IdiPaz), Instituto de 
      Investigaciones Biomédicas Alberto Sols UAM-CSIC, Madrid, Spain; Universidad 
      Autónoma de Madrid, School of Medicine, Department of Biochemistry, Madrid, 
      Spain.
FAU - Lau, Wilson Chun Yu
AU  - Lau WCY
AD  - The Chinese University of Hong Kong, School of Life Sciences, Centre for Cell & 
      Developmental Biology and State Key Laboratory of Agrobiotechnology, Shatin, New 
      Territories, Hong Kong, China.
FAU - Laurie, Gordon W
AU  - Laurie GW
AD  - University of Virginia, Department of Cell Biology, Charlottesville, VA, USA.
FAU - Lavandero, Sergio
AU  - Lavandero S
AD  - University of Chile, Faculty of Chemical and Pharmaceutical Sciences, Advanced 
      Center for Chronic Diseases (ACCDiS), Santiago, Chile.
AD  - UT Southwestern Medical Center, Departments of Medicine (Cardiology) and 
      Molecular Biology, Dallas, TX, USA.
FAU - Law, Betty Yuen Kwan
AU  - Law BYK
AD  - Macau University of Science and Technology, State Key Laboratory of Quality 
      Research in Chinese Medicine, Taipa, Macau, China.
FAU - Law, Helen Ka-Wai
AU  - Law HK
AD  - The Hong Kong Polytechnic University, Faculty of Health and Social Sciences, 
      Department of Health Technology and Informatics, Hunghom, Hong Kong.
FAU - Layfield, Rob
AU  - Layfield R
AD  - University of Nottingham, School of Life Sciences, Nottingham, UK.
FAU - Le, Weidong
AU  - Le W
AD  - Sichuan Academy of Medical Science & Provincial Hospital, Medical School of 
      UESTC, Chengdu, China.
FAU - Le Stunff, Herve
AU  - Le Stunff H
AD  - Université Paris Saclay, Institut des Neurosciences Paris-Saclay (Neuro-PSI)-CNRS 
      UMR 9197, Orsay France.
FAU - Leary, Alexandre Y
AU  - Leary AY
AD  - Imperial College London, Department of Life Sciences, London, UK.
FAU - Lebrun, Jean-Jacques
AU  - Lebrun JJ
AD  - McGill University Health Center, Department of Medicine, Cancer Research Program, 
      Montreal, QC, Canada.
FAU - Leck, Lionel Y W
AU  - Leck LYW
AD  - Cancer Drug Resistance and Stem Cell Program, University of Sydney, NSW, 
      Australia.
FAU - Leduc-Gaudet, Jean-Philippe
AU  - Leduc-Gaudet JP
AD  - Research Institute of the McGill University Health Centre, Meakins-Christie 
      Laboratories and Translational Research in Respiratory Diseases Program, 
      Montréal, Québec, Canada; McGill University, Department of Critical Care and 
      Division of Experimental Medicine, Montréal, Québec, Canada; UQAM, Faculté des 
      Sciences, Département des Sciences de l'activité physique, Montréal, Canada.
FAU - Lee, Changwook
AU  - Lee C
AD  - Ulsan National Institute of Science and Technology, Department of Biological 
      Sciences, Ulsan, Korea.
FAU - Lee, Chung-Pei
AU  - Lee CP
AD  - National Taipei University of Nursing and Health Sciences, School of Nursing, 
      Taipei, Taiwan.
FAU - Lee, Da-Hye
AU  - Lee DH
AD  - University of Minnesota, Department of Biochemistry, Molecular Biology, and 
      Biophysics, Minneapolis, MN, USA.
FAU - Lee, Edward B
AU  - Lee EB
AD  - University of Pennsylvania, Department of Pathology and Laboratory Medicine, 
      Philadelphia, PA, USA.
FAU - Lee, Erinna F
AU  - Lee EF
AD  - La Trobe Institute for Molecular Science, La Trobe University, Melbourne, 
      Victoria, Australia; Olivia Newton-John Cancer Research Institute, Heidelberg, 
      Victoria, Australia; School of Cancer Medicine, La Trobe University, Melbourne, 
      Victoria, Australia.
FAU - Lee, Gyun Min
AU  - Lee GM
AD  - KAIST, Department of Biological Sciences, Daejon, Korea.
FAU - Lee, He-Jin
AU  - Lee HJ
AD  - Konkuk University, School of Medicine, Department of Anatomy, Seoul, Korea.
FAU - Lee, Heung Kyu
AU  - Lee HK
AD  - Korea Advanced Institute of Science and Technology, Graduate School of Medical 
      Science and Engineering, Daejeon, Korea.
FAU - Lee, Jae Man
AU  - Lee JM
AD  - Kyungpook National University, School of Medicine, Department of Biochemistry and 
      Cell Biology, Cell and Matrix Research Institute, Daegu, Korea.
FAU - Lee, Jason S
AU  - Lee JS
AD  - QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
FAU - Lee, Jin-A
AU  - Lee JA
AD  - Hannam University, Department of Biological Sciences and Biotechnology, Daejeon, 
      South Korea.
FAU - Lee, Joo-Yong
AU  - Lee JY
AD  - Chungnam National University, Graduate School of Analytical Science and 
      Technology (GRAST), Daejeon 305-764, Republic of Korea.
FAU - Lee, Jun Hee
AU  - Lee JH
AD  - University of Michigan, Department of Molecular & Integrative Physiology, Ann 
      Arbor, MI, USA.
FAU - Lee, Michael
AU  - Lee M
AD  - Incheon National University, College of Life Sciences and Bioengineering, 
      Division of Life Sciences, Incheon, Korea.
FAU - Lee, Min Goo
AU  - Lee MG
AD  - Yonsei University College of Medicine, Department of Pharmacology, Seoul, Korea.
FAU - Lee, Min Jae
AU  - Lee MJ
AD  - Seoul National University College of Medicine, Department of Biochemistry and 
      Molecular Biology, Seoul, Korea.
FAU - Lee, Myung-Shik
AU  - Lee MS
AD  - Yonsei University College of Medicine, Severance Biomedical Science Institute and 
      Department of Internal Medicine, Seoul, Korea.
FAU - Lee, Sang Yoon
AU  - Lee SY
AD  - Ajou University Graduate School of Medicine, Department of Biomedical Sciences, 
      Suwon, Gyeonggi, Korea.
FAU - Lee, Seung-Jae
AU  - Lee SJ
AD  - Seoul National University College of Medicine, Department of Biomedical Sciences, 
      Neuroscience Research Institute, Seoul, Korea.
FAU - Lee, Stella Y
AU  - Lee SY
AD  - University of Kansas Medical Center, Department of Biochemistry and Molecular 
      Biology, Kansas City, KS, USA.
FAU - Lee, Sung Bae
AU  - Lee SB
AD  - DGIST, Department of Brain & Cognitive Sciences, Daegu, Korea.
FAU - Lee, Won Hee
AU  - Lee WH
AD  - University of Arizona College of Medicine, Department of Basic Medical Sciences, 
      Phoenix, AZ, USA.
FAU - Lee, Ying-Ray
AU  - Lee YR
AD  - Ditmanson Medical Foundation Chia-Yi Christian Hospital, Translational Medicine 
      Research Center, Chiayi City, Taiwan.
FAU - Lee, Yong-Ho
AU  - Lee YH
AD  - Yonsei University College of Medicine, Department of Internal Medicine, Seoul, 
      Korea.
FAU - Lee, Youngil
AU  - Lee Y
AD  - University of West Florida, Department of Movement Sciences and Health, 
      Pensacola, FL, USA.
FAU - Lefebvre, Christophe
AU  - Lefebvre C
AD  - Université Paris-Saclay, CEA, 1035 CNRS, Institute for Integrative Biology of the 
      Cell (I2BC), INSERM U1280, Gif-sur-Yvette, France.
FAU - Legouis, Renaud
AU  - Legouis R
AD  - Université Paris-Saclay, CEA, 1035 CNRS, Institute for Integrative Biology of the 
      Cell (I2BC), INSERM U1280, Gif-sur-Yvette, France.
FAU - Lei, Yu L
AU  - Lei YL
AD  - University of Michigan, Rogel Cancer Center, Department of Periodontics and Oral 
      Medicine, Department of Otolaryngology - Head and Neck Surgery, Ann Arbor, MI, 
      USA.
FAU - Lei, Yuchen
AU  - Lei Y
AD  - Life Sciences Institute and Department of Molecular, Cellular and Developmental 
      Biology, University of Michigan, Ann Arbor, MI, USA.
FAU - Leikin, Sergey
AU  - Leikin S
AD  - National Institutes of Health, Eunice Kennedy Shriver National Institute of Child 
      Health and Human Development, Bethesda, MD, USA.
FAU - Leitinger, Gerd
AU  - Leitinger G
AD  - University of Maribor, Faculty of Medicine, Maribor, Slovenia; University of 
      Maribor, Faculty of Natural Sciences and Mathematics, Department of Biology, 
      Maribor, Slovenia; University of Maribor, Faculty of Chemistry and Chemical 
      Engineering, Maribor, Slovenia; Medical University of Graz, Division of Cell 
      Biology, Histology and Embryology, Gottfried Schatz Research Center, Graz, 
      Austria.
AD  - Medical University of Graz, Division of Cell Biology, Histology and Embryology, 
      Gottfried Schatz Research Center, Graz, Austria.
FAU - Lemus, Leticia
AU  - Lemus L
AD  - University of Seville, Department of Genetics, Seville, Spain.
FAU - Leng, Shuilong
AU  - Leng S
AD  - Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein 
      Modification and Degradation, School of Basic Medical Sciences, Affiliated Cancer 
      Hospital & Institute of Guangzhou Medical University, Guangzhou, China.
FAU - Lenoir, Olivia
AU  - Lenoir O
AD  - Institut National de la Santé et de la Recherche Médicale (Inserm), Université de 
      Paris, Paris Cardiovascular Center - PARCC, Paris, France.
FAU - Lenz, Guido
AU  - Lenz G
AD  - Universidade Federal do Rio Grande do Sul (UFRGS), Center of Biotechnology and 
      Department of Biophysics, Porto Alegre, RS, Brazil.
FAU - Lenz, Heinz Josef
AU  - Lenz HJ
AD  - USC Norris Comprehensive Cancer Center , Los Angeles, CA, USA.
FAU - Lenzi, Paola
AU  - Lenzi P
AD  - University of Pisa, Department of Translational Research and New Technologies in 
      Medicine and Surgery, Pisa, Italy.
FAU - León, Yolanda
AU  - León Y
AD  - Universidad Autónoma de Madrid, Department of Biology, Madrid, Spain.
FAU - Leopoldino, Andréia M
AU  - Leopoldino AM
AD  - University of São Paulo, School of Pharmaceutical Sciences of Ribeirão Preto, 
      Department of Clinical Analyses, Toxicology and Food Sciences, Ribeirão Preto, 
      SP, Brazil.
FAU - Leschczyk, Christoph
AU  - Leschczyk C
AD  - Research Center Borstel, Leibniz Lung Center, Priority Area Infections, Division 
      Cellular Microbiology, Borstel, Germany.
FAU - Leskelä, Stina
AU  - Leskelä S
AD  - University of Eastern Finland, A.I. Virtanen Institute for Molecular Sciences, 
      Kuopio, Finland.
FAU - Letellier, Elisabeth
AU  - Letellier E
AD  - University of Luxembourg, Department of Life Sciences and Medicine, Molecular 
      Disease Mechanisms Group, Belval, Luxembourg.
FAU - Leung, Chi-Ting
AU  - Leung CT
AD  - University of Hong Kong, Department of Medicine, Division of Neurology, Pokfulam, 
      Hong Kong, China.
FAU - Leung, Po Sing
AU  - Leung PS
AD  - The Chinese University of Hong Kong, Faculty of Medicine, School of Biomedical 
      Sciences, Shatin, New Territories, Hong Kong.
FAU - Leventhal, Jeremy S
AU  - Leventhal JS
AD  - Icahn School of Medicine at Mount Sinai, Department of Medicine, New York, NY, 
      USA.
FAU - Levine, Beth
AU  - Levine B
AD  - University of Texas Southwestern Medical Center, Center for Autophagy Research, 
      Department of Internal Medicine and Howard Hughes Medical Institute, Dallas, TX, 
      USA.
FAU - Lewis, Patrick A
AU  - Lewis PA
AD  - Royal Veterinary College, London, UK; UCL Queen Square Institute of Neurology, 
      Department of Neurodegenerative Disease, London, UK.
FAU - Ley, Klaus
AU  - Ley K
AD  - La Jolla Institute for Immunology and University of California San Diego, 
      Laboratory of Inflammation Biology, La Jolla, CA, USA.
FAU - Li, Bin
AU  - Li B
AD  - College of Life Science and Technology, Jinan University, Guangzhou, China.
FAU - Li, Da-Qiang
AU  - Li DQ
AD  - Fudan University, Shanghai Cancer Center and Institutes of Biomedical Sciences, 
      Shanghai, China.
FAU - Li, Jianming
AU  - Li J
AD  - Sun Yat-sen University, Sun Yat-sen Memorial Hospital, Department of Pathology, 
      Guangzhou, Guangdong Province, China.
FAU - Li, Jing
AU  - Li J
AD  - University of Virginia, School of Medicine, Department of Surgery, 
      Charlottesville, VA, USA.
FAU - Li, Jiong
AU  - Li J
AD  - Sichuan University, West China Hospital, State key laboratory of biotherapy, 
      Chengdu, Sichuan, China.
FAU - Li, Ke
AU  - Li K
AD  - Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of 
      Medicinal Biotechnology, Beijing, China.
FAU - Li, Liwu
AU  - Li L
AD  - Virginia Polytechnic Institute, Department of Biological Sciences, Blacksburg, 
      VA, USA.
FAU - Li, Mei
AU  - Li M
AD  - Children's Hospital of Soochow University, Institute of Pediatric Research, 
      Suzhou, China.
FAU - Li, Min
AU  - Li M
AD  - Sun Yat-Sen University, School of Pharmaceutical Sciences, Guangzhou, China.
FAU - Li, Min
AU  - Li M
AD  - Sun Yat-Sen University, School of Pharmaceutical Sciences, Guangzhou, China.
FAU - Li, Ming
AU  - Li M
AD  - Department of Molecular, Cellular and Developmental Biology, University of 
      Michigan, Ann Arbor, MI, USA.
FAU - Li, Mingchuan
AU  - Li M
AD  - Jinan University, College of Life Science and Technology, Department of Biology, 
      Guangzhou, China.
FAU - Li, Pin-Lan
AU  - Li PL
AD  - Virginia Commonwealth University, Departement of Pharmacology and Toxicology, 
      Richmond, VA, USA.
FAU - Li, Ming-Qing
AU  - Li MQ
AD  - Fudan University, Hospital of Obstetrics and Gynecology, Institute of Obstetrics 
      and Gynecology, Laboratory for Reproductive Immunology, Shanghai, China.
FAU - Li, Qing
AU  - Li Q
AD  - The Chinese University of Hong Kong, Department of Anaesthesia and Intensive 
      Care, Hong Kong, China.
FAU - Li, Sheng
AU  - Li S
AD  - South China Normal University, School of Life Sciences, Institute of Insect 
      Science and Technology, Guangdong Provincial Key Laboratory of Insect 
      Developmental Biology and Applied Technology, Guangzhou, China.
FAU - Li, Tiangang
AU  - Li T
AD  - University of Kansas Medical Center, Department of Pharmacology, Toxicology and 
      Therapeutics, Kansas City, KS, USA.
FAU - Li, Wei
AU  - Li W
AD  - Chinese Academy of Sciences, Institute of Zoology, State Key Laboratory of Stem 
      cell and Reproductive Biology, Beijing, China.
FAU - Li, Wenming
AU  - Li W
AD  - Emory University School of Medicine, Department of Pharmacology and Chemical 
      Biology, Atlanta, GA, USA.
FAU - Li, Xue
AU  - Li X
AD  - Boston Children's Hospital, Harvard Medical School, Departments of Urology and 
      Surgery, Boston, MA, USA.
FAU - Li, Yi-Ping
AU  - Li YP
AD  - The University of Texas Health Science Center at Houston, Department of 
      Integrative Biology and Pharmacology, Houston, TX, USA.
FAU - Li, Yuan
AU  - Li Y
AD  - Stanford University, Department of Gastroenterology & Hepatology, Stanford, CA, 
      USA.
FAU - Li, Zhiqiang
AU  - Li Z
AD  - Chinese Academy of Agricultural Sciences, Institute of Plant Protection, State 
      Key Laboratory for Biology of Plant Diseases and Insect Pests, Beijing, China.
FAU - Li, Zhiyong
AU  - Li Z
AD  - Chinese Academy of Agriculture Sciences, Lanzhou Veterinary Research Institute, 
      State Key Laboratory of Veterinary Etiological Biology, Lanzhou, Gansu, China.
FAU - Li, Zhiyuan
AU  - Li Z
AD  - Chinese Academy of Sciences, Hefei Institutes of Physical Science, High Magnetic 
      Field Laboratory, Hefei, Anhui Province, China.
FAU - Lian, Jiqin
AU  - Lian J
AD  - Army Medical University, Department of Bichemistry and Molecular Biology, 
      Chongqing, Chongqing, China.
FAU - Liang, Chengyu
AU  - Liang C
AD  - The Wistar Institute, Molecular and Cellular Oncogenesis Program, Philadelphia, 
      PA, USA.
FAU - Liang, Qiangrong
AU  - Liang Q
AD  - New York Institute of Technology, College of Osteopathic Medicine, Department of 
      Biomedical Sciences, Old Westbury, NY, USA.
FAU - Liang, Weicheng
AU  - Liang W
AD  - Sun Yat-sen University, The 3rd Affiliated Hospital of Sun Yat-sen University, 
      Vaccine Research Institute, Guangzhou, China.
FAU - Liang, Yongheng
AU  - Liang Y
AD  - Nanjing Agricultural University, College of Life Sciences, Key Laboratory of 
      Agricultural Environmental Microbiology of Ministry of Agriculture and Rural 
      Affairs, Nanjing , China.
FAU - Liang, YongTian
AU  - Liang Y
AD  - Free University of Berlin, Department of Biology, Chemistry and Pharmacy, Berlin, 
      Germany.
FAU - Liao, Guanghong
AU  - Liao G
AD  - Chinese Academy of Sciences Center for Excellence in Molecular and Cellular 
      Sciences, Shanghai Institute of Biochemistry and Cell Biology, Shanghai, China.
FAU - Liao, Lujian
AU  - Liao L
AD  - East China Normal University, School of Life Sciences, Shanghai, China.
FAU - Liao, Mingzhi
AU  - Liao M
AD  - Northwest A&F University, College of Life Sciences, Yangling, Shaanxi, China.
FAU - Liao, Yung-Feng
AU  - Liao YF
AD  - Academia Sinica, Institute of Cellular and Organismic Biology, Taipei, Taiwan.
FAU - Librizzi, Mariangela
AU  - Librizzi M
AD  - University of Palermo, Department of Biological, Chemical and and Pharmaceutical 
      Sciences and Technologies, Palermo, Italy.
FAU - Lie, Pearl P Y
AU  - Lie PPY
AD  - Nathan S. Kline Institute, Center for Dementia Research, Orangeburg, NY, USA.
FAU - Lilly, Mary A
AU  - Lilly MA
AD  - National Institute of Child Health and Human Development, National Institutes of 
      Health, Cell Biology and Neurobiology Branch, Bethesda, MD, USA.
FAU - Lim, Hyunjung J
AU  - Lim HJ
AD  - Konkuk University, Department of Veterinary Medicine, Seoul, Korea.
FAU - Lima, Thania R R
AU  - Lima TRR
AD  - São Paulo State University, Botucatu Medical School, Center for Evaluation of 
      Environmental Impact on Human Health (TOXICAM), Department of Pathology, 
      Botucatu, SP, Brazil.
FAU - Limana, Federica
AU  - Limana F
AD  - San Raffaele Open University and IRCCS San Raffaele Pisana, Laboratorio di 
      Patologia Cellulare e Molecolare, Rome, Italy.
FAU - Lin, Chao
AU  - Lin C
AD  - First Affiliated Hospital of Nanjing Medical University, Department of 
      Neurosurgery, Nanjing, China; Jiangsu Province Hospital, Department of 
      Neurosurgery, Nanjing, China.
FAU - Lin, Chih-Wen
AU  - Lin CW
AD  - Division of Gastroenterology and Hepatology, Department of Internal Medicine, 
      E-Da Hospital, Kaohsiung, Taiwan; I-Shou University, College of Medicine, School 
      of Medicine, Kaohsiung, Taiwan.
FAU - Lin, Dar-Shong
AU  - Lin DS
AD  - Mackay Memorial Hospital, Department of Pediatrics, Taipei, Taiwan; Mackay 
      Medical College, Department of Medicine, New Taipei,Taiwan.
FAU - Lin, Fu-Cheng
AU  - Lin FC
AD  - Zhejiang Academy of Agricultural Sciences, Institute of Plant Protection and 
      Microbiology, State Key Laboratory for Managing Biotic and Chemical Treatments to 
      the Quality and Safety of Agro-products, Hangzhou, China; Zhejiang University, 
      Institute of Biotechnology, Hangzhou, China.
FAU - Lin, Jiandie D
AU  - Lin JD
AD  - Life Sciences Institute and Department of Cell & Developmental Biology, 
      University of Michigan, Ann Arbor, MI, USA.
FAU - Lin, Kurt M
AU  - Lin KM
AD  - National Health Research Institutes, Institute of Biomedical Engineering and 
      Nanomedicine, Zhunan, Miaoli, Taiwan.
FAU - Lin, Kwang-Huei
AU  - Lin KH
AD  - Chang Gung Memorial Hospital, Liver Research Center, Linkou, Taoyuan, Taiwan; 
      Chang Gung University, College of Medicine, Graduate Institute of Biomedical 
      Sciences, Taoyuan, Taiwan; Chang Gung University of Science and Technology, 
      College of Human Ecology, Research Center for Chinese Herbal Medicine, Taoyuan, 
      Taiwan.
FAU - Lin, Liang-Tzung
AU  - Lin LT
AD  - Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical 
      University, Taipei, Taiwan; Department of Microbiology and Immunology, School of 
      Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
FAU - Lin, Pei-Hui
AU  - Lin PH
AD  - The Ohio State University, Wexner Medical Center, Department of Surgery, 
      Columbus, OH, USA.
FAU - Lin, Qiong
AU  - Lin Q
AD  - School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China.
FAU - Lin, Shaofeng
AU  - Lin S
AD  - Huazhong University of Science and Technology, College of Life Science and 
      Technology, Hubei Bioinformatics and Molecular Imaging Key Laboratory, Key 
      Laboratory of Molecular Biophysics of Ministry of Education, Wuhan, Hubei, China.
FAU - Lin, Su-Ju
AU  - Lin SJ
FAU - Lin, Wenyu
AU  - Lin W
AD  - Harvard Medical School, Massachusetts General Hospital, Gastrointestinal 
      Unit/Medicine, Boston, MA, USA.
FAU - Lin, Xueying
AU  - Lin X
AD  - Mayo Clinic, Department of Biochemistry and Molecular Biology, Rochester, MN, 
      USA.
FAU - Lin, Yao-Xin
AU  - Lin YX
AD  - Brigham and Women's Hospital, Harvard Medical School, Center for Nanomedicine and 
      Department of Anesthesiology, Boston, MA, USA.
FAU - Lin, Yee-Shin
AU  - Lin YS
AD  - National Cheng Kung University, College of Medicine, Department of Microbiology 
      and Immunology, Tainan, Taiwan.
FAU - Linden, Rafael
AU  - Linden R
AD  - Instituto de Biofisica da UFRJ, Rio de Janeiro, Brazil.
FAU - Lindner, Paula
AU  - Lindner P
AD  - Oslo University Hospital, Institute for Cancer Research, Department of Tumor 
      Biology, Montebello, Oslo, Norway.
FAU - Ling, Shuo-Chien
AU  - Ling SC
AD  - National University of Singapore, Department of Physiology, Singapore.
FAU - Lingor, Paul
AU  - Lingor P
AD  - Technical University of Munich, School of Medicine, Klinikum rechts der Isar, 
      Department of Neurology, Munich, Germany.
FAU - Linnemann, Amelia K
AU  - Linnemann AK
AD  - Indiana University School of Medicine, Department of Pediatrics and Center for 
      Diabetes and Metabolic Diseases, Indianapolis, IN, USA.
FAU - Liou, Yih-Cherng
AU  - Liou YC
AD  - University of Singapore, Department of Biological Sciences, Singapore.
FAU - Lipinski, Marta M
AU  - Lipinski MM
AD  - University of Maryland School of Medicine, Department of Anesthesiology, 
      Baltimore, MD, USA.
FAU - Lipovšek, Saška
AU  - Lipovšek S
AD  - University of Maribor, Faculty of Medicine, Maribor, Slovenia; University of 
      Maribor, Faculty of Natural Sciences and Mathematics, Department of Biology, 
      Maribor, Slovenia; University of Maribor, Faculty of Chemistry and Chemical 
      Engineering, Maribor, Slovenia; Medical University of Graz, Division of Cell 
      Biology, Histology and Embryology, Gottfried Schatz Research Center, Graz, 
      Austria.
FAU - Lira, Vitor A
AU  - Lira VA
AD  - University of Iowa, Fraternal Order of Eagles Diabetes Research Center, Obesity 
      Research and Education Initiative, Abboud Cardiovascular Research Center, 
      Department of Health and Human Physiology, Iowa City, IA, USA.
FAU - Lisiak, Natalia
AU  - Lisiak N
AD  - Poznan University of Medical Sciences, Department of Clinical Chemistry and 
      Molecular Diagnostics, Poznan, Poland.
FAU - Liton, Paloma B
AU  - Liton PB
AD  - Duke University, Department of Ophthalmology, Durham, NC, USA.
FAU - Liu, Chao
AU  - Liu C
AD  - Chinese Academy of Sciences, Institute of Zoology, State Key Laboratory of Stem 
      cell and Reproductive Biology, Beijing, China.
FAU - Liu, Ching-Hsuan
AU  - Liu CH
AD  - Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical 
      University, Taipei, Taiwan; Department of Microbiology and Immunology, School of 
      Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
AD  - Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova 
      Scotia, Canada.
FAU - Liu, Chun-Feng
AU  - Liu CF
AD  - Institute of Neuroscience of Soochow University, Suzhou, China.
FAU - Liu, Cui Hua
AU  - Liu CH
AD  - Chinese Academy of Sciences, Center for Biosafety Mega-Science, Institute of 
      Microbiology, CAS Key Laboratory of Pathogenic Microbiology and Immunology, 
      Chaoyang District, Beijing, China.
FAU - Liu, Fang
AU  - Liu F
AD  - Nankai University, Department of Microbiology, Tianjin, China.
FAU - Liu, Hao
AU  - Liu H
AD  - Guangzhou Medical University, School of Basic Medical Sciences, State Key 
      Laboratory of Respiratory Disease, Guangzhou, China.
FAU - Liu, Hsiao-Sheng
AU  - Liu HS
AD  - National Cheng Kung University, College of Medicine, Department of Microbiology 
      and Immunology, Tainan, Taiwan.
FAU - Liu, Hua-Feng
AU  - Liu HF
AD  - Guangdong Medical University, Institute of Nephrology, and Zhanjiang Key 
      Laboratory of Prevention and Management of Chronic Kidney Disease, Zhanjiang, 
      Guangdong, China.
FAU - Liu, Huifang
AU  - Liu H
AD  - University of Hong Kong, Department of Medicine, Division of Neurology, Pokfulam, 
      Hong Kong, China.
FAU - Liu, Jia
AU  - Liu J
AD  - Capital Medical University, Beijing Institute for Brain Disorders, Beijing, 
      China.
FAU - Liu, Jing
AU  - Liu J
AD  - Central South University, School of Life Sciences, Molecular Biology Research 
      Center, Changsha, Hunan, China.
FAU - Liu, Julia
AU  - Liu J
AD  - Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical 
      University, Taipei, Taiwan; Department of Microbiology and Immunology, School of 
      Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
FAU - Liu, Leyuan
AU  - Liu L
AD  - The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
FAU - Liu, Longhua
AU  - Liu L
AD  - Columbia University, Naomi Berrie Diabetes Center, Department of Pathology and 
      Cell Biology, College of Physicians and Surgeons, New York, NY, USA.
FAU - Liu, Meilian
AU  - Liu M
AD  - University of New Mexico Health Sciences Center, Department of Biochemistry and 
      Molecular Biology, Albuquerque, NM, USA.
FAU - Liu, Qin
AU  - Liu Q
AD  - Henan Academy of Agricultural Sciences, Institute of Plant Nutrition, 
      Agricultural Resources and Environmental Science, Jinshui District, Zhengzhou, 
      Henan, China.
FAU - Liu, Wei
AU  - Liu W
AD  - Zhejiang University School of Medicine, Department of Biochemistry and Department 
      of Cardiology of the Second Affiliated Hospital, Hangzhou, Zhejiang, China.
FAU - Liu, Wende
AU  - Liu W
AD  - Chinese Academy of Agricultural Sciences, Institute of Plant Protection, State 
      Key Laboratory for Biology of Plant Diseases and Insect Pests, Beijing, China.
FAU - Liu, Xiao-Hong
AU  - Liu XH
AD  - Zhejiang University, Biotechnology Institute, State Key Laboratory for Rice 
      Biology, Hangzhou, China.
FAU - Liu, Xiaodong
AU  - Liu X
AD  - The Chinese University of Hong Kong, Department of Anaesthesia and Intensive 
      Care, Hong Kong, China.
FAU - Liu, Xingguo
AU  - Liu X
AD  - CAS Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine 
      and Health, Chinese Academy of Sciences, Guangzhou, China.
FAU - Liu, Xu
AU  - Liu X
AD  - Harvard Medical School, Department of Microbiology; Brigham and Women's Hospital, 
      Division of Infectious Diseases, Boston, MA, USA.
FAU - Liu, Xuedong
AU  - Liu X
AD  - University of Colorado at Boulder, Department of Biochemistry, Boulder, CO, USA.
FAU - Liu, Yanfen
AU  - Liu Y
AD  - ShanghaiTech University, School of Life Science and Technology, Shanghai, China.
FAU - Liu, Yang
AU  - Liu Y
AD  - Saarland University, Department of Neurology, Homburg, Germany.
FAU - Liu, Yang
AU  - Liu Y
AD  - Johns Hopkins University, Department of Biochemistry and Molecular Biology, 
      Baltimore, MD, USA.
FAU - Liu, Yueyang
AU  - Liu Y
AD  - Shenyang Pharmaceutical University, Department of Pharmacology, Shenyang, China.
FAU - Liu, Yule
AU  - Liu Y
AD  - Tsinghua Unversity, School of Life Sciences, Beijing, China.
FAU - Livingston, J Andrew
AU  - Livingston JA
AD  - University of Texas MD Anderson Cancer Center, Department of Sarcoma Medical 
      Oncology, Houston, TX, USA.
FAU - Lizard, Gerard
AU  - Lizard G
AD  - University of Bourgogne Franche-Comté, Team 'Biochemistry of the Peroxisome, 
      Inflammation and Lipid Metabolism (EA7270)/Inserm, Faculty of Sciences Gabriel, 
      Dijon, France.
FAU - Lizcano, Jose M
AU  - Lizcano JM
AD  - Universitat Autonoma de Barcelona, Departament of Biochemistry and Institut 
      Neurosciences, Faculty of Medicine, Bellaterra, Barcelona, Spain.
FAU - Ljubojevic-Holzer, Senka
AU  - Ljubojevic-Holzer S
AD  - Medical University of Graz, Division of Cardiology, Graz, Austria.
FAU - LLeonart, Matilde E
AU  - LLeonart ME
AD  - Vall d´Hebron Research Institute, Barcelona, Spain.
FAU - Llobet-Navàs, David
AU  - Llobet-Navàs D
AD  - Bellvitge Biomedical Research Institute-IDIBELL, Oncobell Program. L'Hospitalet 
      de Llobregat, Barcelona, Spain.
FAU - Llorente, Alicia
AU  - Llorente A
AD  - Oslo University Hospital, Institute for Cancer Research, Department of Molecular 
      Cell Biology, Oslo, Norway.
FAU - Lo, Chih Hung
AU  - Lo CH
AD  - Harvard Medical School, Brigham and Women's Hospital, Department of Neurology, 
      Boston, MA, USA.
FAU - Lobato-Márquez, Damián
AU  - Lobato-Márquez D
AD  - London School of Hygiene & Tropical Medicine, Department of Infection Biology, 
      London, UK.
FAU - Long, Qi
AU  - Long Q
AD  - CAS Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine 
      and Health, Chinese Academy of Sciences, Guangzhou, China.
FAU - Long, Yun Chau
AU  - Long YC
AD  - National University of Singapore, Yong Loo Lin School of Medicine, Department of 
      Biochemistry, Singapore.
FAU - Loos, Ben
AU  - Loos B
AD  - Stellenbosch University, Department of Physiological Sciences, Stellenbosch, 
      Western Cape, South Africa.
FAU - Loos, Julia A
AU  - Loos JA
AD  - University of Mar del Plata, Department of Biology and Chemestry, Mar del Plata, 
      BA, Argentina.
FAU - López, Manuela G
AU  - López MG
AD  - Universidad Autonoma de Madrid, School of Medicine, Department of Pharmacology, 
      Madrid, Spain.
FAU - López-Doménech, Guillermo
AU  - López-Doménech G
AD  - University College London, Department of Neuroscience, Physiology and 
      Pharmacology, London, UK.
FAU - López-Guerrero, José Antonio
AU  - López-Guerrero JA
AD  - Universidad Autónoma de Madrid, Departamento de Biología Molecular, Madrid, Spain 
      and Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Madrid, Spain.
FAU - López-Jiménez, Ana T
AU  - López-Jiménez AT
AD  - London School of Hygiene & Tropical Medicine, Department of Infection Biology, 
      London, UK.
FAU - López-Pérez, Óscar
AU  - López-Pérez Ó
AD  - Universidad de Zaragoza, IA2, IIS, Laboratorio de Genética Bioquímica (LAGENBIO), 
      Zaragoza, Spain; Universidad de Zaragoza, IA2, IIS, Centro de Encefalopatías y 
      Enfermedades Transmisibles Emergentes, Zaragoza, Spain.
FAU - López-Valero, Israel
AU  - López-Valero I
AD  - Complutense University, Instituto de Investigaciones Sanitarias San Carlos 
      (IdISSC), Department of Biochemistry and Molecular Biology, School of Biology, 
      Madrid, Spain.
FAU - Lorenowicz, Magdalena J
AU  - Lorenowicz MJ
AD  - University Medical Center Utrecht, Center for Molecular Medicine, Utrecht, The 
      Netherlands; Regenerative Medicine Center, Utrecht, The Netherlands.
FAU - Lorente, Mar
AU  - Lorente M
AD  - Complutense University, Instituto de Investigaciones Sanitarias San Carlos 
      (IdISSC), Department of Biochemistry and Molecular Biology, School of Biology, 
      Madrid, Spain.
FAU - Lorincz, Peter
AU  - Lorincz P
AD  - Department of Anatomy, Cell and Developmental Biology, Eötvös Loránd University, 
      Budapest, Hungary.
FAU - Lossi, Laura
AU  - Lossi L
AD  - University of Turin, Department of Veterinary Sciences, Grugliasco (TO), Italy.
FAU - Lotersztajn, Sophie
AU  - Lotersztajn S
AD  - Université de Paris, Centre de Recherche sur l'Inflammation (CRI), 
      Inserm-UMR1149, Paris, France.
FAU - Lovat, Penny E
AU  - Lovat PE
AD  - Newcastle University, Institute of Translation and Clinical Studies, Precision 
      Medicine, The Medical School, Newcastle upon Tyne, UK.
FAU - Lovell, Jonathan F
AU  - Lovell JF
AD  - State University of New York at Buffalo, Buffalo, NY, USA.
FAU - Lovy, Alenka
AU  - Lovy A
AD  - Universidad Mayor, Center for Integrative Biology and Geroscience for Brain, 
      Health and Metabolism, Santiago, Chile.
FAU - Lőw, Péter
AU  - Lőw P
AD  - Department of Anatomy, Cell and Developmental Biology, Eötvös Loránd University, 
      Budapest, Hungary.
FAU - Lu, Guang
AU  - Lu G
AD  - National University of Singapore, Yong Loo Lin School of Medicine, Department of 
      Physiology, Singapore.
FAU - Lu, Haocheng
AU  - Lu H
AD  - Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
FAU - Lu, Jia-Hong
AU  - Lu JH
AD  - University of Macau, Institute of Chinese Medical Sciences, State Key Laboratory 
      of Quality Research in Chinese Medicine, Taipa, Macao, China.
FAU - Lu, Jin-Jian
AU  - Lu JJ
AD  - University of Macau, Institute of Chinese Medical Sciences, State Key Laboratory 
      of Quality Research in Chinese Medicine, Taipa, Macao, China.
FAU - Lu, Mengji
AU  - Lu M
AD  - Institute of Virology, University Hospital Essen, Essen, Germany.
FAU - Lu, Shuyan
AU  - Lu S
AD  - Pfizer Inc, DSRD, La Jolla, CA, USA.
FAU - Luciani, Alessandro
AU  - Luciani A
AD  - University of Zurich, Institute of Physiology, Zurich, Switzerland.
FAU - Lucocq, John M
AU  - Lucocq JM
AD  - University of St Andrews, School of Medicine, North Haugh, St Andrews, UK.
FAU - Ludovico, Paula
AU  - Ludovico P
AD  - Life and Health Sciences Research Institute (ICVS), School of Medicine, 
      University of Minho, Braga, Portugal and ICVS/3B's - PT Government Associate 
      Laboratory, Braga/Guimarães, Portugal.
FAU - Luftig, Micah A
AU  - Luftig MA
AD  - Duke University, School of Medicine, Duke Center for Virology, Department of 
      Molecular Genetics and Microbiology, Durham, NC, USA.
FAU - Luhr, Morten
AU  - Luhr M
AD  - Oslo University Hospital, Institute for Cancer Research, Department of Tumor 
      Biology, Montebello, Oslo, Norway.
FAU - Luis-Ravelo, Diego
AU  - Luis-Ravelo D
AD  - University of La Laguna, Institute of Biomedical Technologies, Department of 
      Basic Medical Sciences, La Laguna, Tenerife, Spain.
FAU - Lum, Julian J
AU  - Lum JJ
AD  - BC Cancer, Trev and Joyce Deeley Research Centre, Victoria, BC, Canada; 
      University of Victoria, Department of Biochemistry and Microbiology, Victoria, 
      BC, Canada.
FAU - Luna-Dulcey, Liany
AU  - Luna-Dulcey L
AD  - Federal University of São Carlos, Department of Gerontology, São Carlos, SP, 
      Brazil.
FAU - Lund, Anders H
AU  - Lund AH
AD  - University of Copenhagen, Biotech Research and Innovation Centre, Copenhagen, 
      Denmark.
FAU - Lund, Viktor K
AU  - Lund VK
AD  - University of Copenhagen, Department of Neuroscience, Copenhagen, Denmark.
FAU - Lünemann, Jan D
AU  - Lünemann JD
AD  - University of Münster, University Hospital, Department of Neurology with 
      Institute of Translational Neurology, Münster, Germany.
FAU - Lüningschrör, Patrick
AU  - Lüningschrör P
AD  - University of Würzburg, Institute of Clinical Neurobiology, Würzburg, Germany.
FAU - Luo, Honglin
AU  - Luo H
AD  - University of British Columbia, Centre for Heart Lung Innovation/Department of 
      Pathology and Laboratory Medicine, Vancouver, BC, Canada.
FAU - Luo, Rongcan
AU  - Luo R
AD  - Kunming Institute of Zoology, Key Laboratory of Animal Models and Human Disease 
      Mechanisms of the Chinese Academy of Sciences & Yunnan Province, Kunming, Yunnan, 
      China.
FAU - Luo, Shouqing
AU  - Luo S
AD  - Plymouth University, Peninsula School of Medicine and Dentistry, Plymouth, UK.
FAU - Luo, Zhi
AU  - Luo Z
AD  - Huazhong Agricultural University, Laboratory of Molecular Nutrition for Aquatic 
      Economic Animals, Fishery College, Wuhan, China.
FAU - Luparello, Claudio
AU  - Luparello C
AD  - University of Palermo, Department of Biological, Chemical and and Pharmaceutical 
      Sciences and Technologies, Palermo, Italy.
FAU - Lüscher, Bernhard
AU  - Lüscher B
AD  - RWTH Aachen University, Medical School, Institute of Biochemistry and Molecular 
      Biology, Aachen, Germany.
FAU - Luu, Luan
AU  - Luu L
FAU - Lyakhovich, Alex
AU  - Lyakhovich A
AD  - International Clinical Research Center, St'Anne University Hospital, Brno, Czech 
      Republic; Institute of Molecular Biology and Biophysics, Federal Research Center 
      of Fundamental and Translational Medicine, Novosibirsk, Siberia, Russia.
FAU - Lyamzaev, Konstantin G
AU  - Lyamzaev KG
AD  - Lomonosov Moscow State University, A.N. Belozersky Institute of Physico-Chemical 
      Biology, Moscow, Russia.
FAU - Lystad, Alf Håkon
AU  - Lystad AH
AD  - University of Oslo, Faculty of Medicine, Institute of Basic Medical Sciences, 
      Department of Molecular Medicine, Oslo, Norway; University of Oslo, Faculty of 
      Medicine, Institute of Clinical Medicine, Centre for Cancer Cell Reprogramming, 
      Oslo, Norway.
FAU - Lytvynchuk, Lyubomyr
AU  - Lytvynchuk L
AD  - Justus Liebig University, University Hospital Giessen and Marburg GmbH, 
      Departement of Ophthalmology, Giessen, Germany.
FAU - Ma, Alvin C
AU  - Ma AC
AD  - The Hong Kong Polytechnic University, Department of Health Technology and 
      Informatics, Hong Kong, China.
FAU - Ma, Changle
AU  - Ma C
AD  - Shandong Normal University, Shandong Provincial Key Laboratory of Plant Stress, 
      College of Life Sciences, Jinan, Shandong, China.
FAU - Ma, Mengxiao
AU  - Ma M
AD  - Yale School of Medicine, Department of Cell Biology, New Haven, CT, USA.
FAU - Ma, Ning-Fang
AU  - Ma NF
AD  - Guangzhou Medical University, Department of Histology and Embryology, Guangzhou, 
      China.
FAU - Ma, Quan-Hong
AU  - Ma QH
AD  - Soochow University, Institute of Neuroscience, Jiangsu Key Laboratory of 
      Translational Research and Therapy for Neuro-Psycho-Diseases, Suzhou, Jiangsu, 
      China.
FAU - Ma, Xinliang
AU  - Ma X
AD  - Department of Emergency Medicine, Thomas Jefferson University, Philadelphia, PA, 
      USA.
FAU - Ma, Yueyun
AU  - Ma Y
AD  - Air Force Medical University, Xijing Hospital, Department of Clinical Laboratory, 
      Xi'an, China.
FAU - Ma, Zhenyi
AU  - Ma Z
AD  - Tianjin Medical University, Department of Biochemistry and Molecular Biology; 
      School of Basic Medical Sciences, Tianjin Key Laboratory of Medical Epigenetics, 
      Tianjin, China.
FAU - MacDougald, Ormond A
AU  - MacDougald OA
AD  - University of Michigan, Department of Molecular & Integrative Physiology, Ann 
      Arbor, MI, USA.
FAU - Macian, Fernando
AU  - Macian F
AD  - Albert Einstein College of Medicine, Department of Pathology. Bronx, NY, USA.
FAU - MacIntosh, Gustavo C
AU  - MacIntosh GC
AD  - Iowa State University, Roy J. Carver Department of Biochemistry, Biophysics and 
      Molecular Biology, Ames, IA, USA.
FAU - MacKeigan, Jeffrey P
AU  - MacKeigan JP
AD  - Michigan State University, College of Human Medicine, Grand Rapids, MI, USA.
FAU - Macleod, Kay F
AU  - Macleod KF
AD  - Ben May Department for Cancer Research, University of Chicago, Chicago IL, USA.
FAU - Maday, Sandra
AU  - Maday S
AD  - Perelman School of Medicine at the University of Pennsylvania, Department of 
      Neuroscience, Philadelphia, PA, USA.
FAU - Madeo, Frank
AU  - Madeo F
AD  - University of Graz, Institute of Molecular Biosciences, BioTechMed-Graz, 
      BioHealth, Graz, Austria.
FAU - Madesh, Muniswamy
AU  - Madesh M
AD  - University of Texas Health San Antonio, Department of Medicine, San Antonio, TX, 
      USA.
FAU - Madl, Tobias
AU  - Madl T
AD  - Medical University of Graz, Gottfried Schatz Research Center for Cell Signaling, 
      Metabolism and Aging, Molecular Biology and Biochemistry, Graz, Austria.
FAU - Madrigal-Matute, Julio
AU  - Madrigal-Matute J
AD  - Albert Einstein College of Medicine, Institute for Aging Studies, Department of 
      Developmental and Molecular Biology, Bronx, NY, USA.
FAU - Maeda, Akiko
AU  - Maeda A
AD  - RIKEN, Laboratory for Retinal Regeneration, Kobe, Hyogo, Japan.
FAU - Maejima, Yasuhiro
AU  - Maejima Y
AD  - Tokyo Medical and Dental University, Department of Cardiovascular Medicine, 
      Tokyo, Japan.
FAU - Magarinos, Marta
AU  - Magarinos M
AD  - Universidad Autónoma de Madrid, Department of Biology, Madrid, Spain.
FAU - Mahavadi, Poornima
AU  - Mahavadi P
AD  - Justus-Liebig University, Department of Internal Medicine, Universities of 
      Giessen & Marburg Lung Center (UGMLC), Member of the German Center for Lung 
      Research (DZL), Giessen, Germany.
FAU - Maiani, Emiliano
AU  - Maiani E
AD  - Part overlaps with Costanza Montagna: Danish Cancer Society Research Center, 
      Computational Biology Laboratory, Copenhagen, Denmark; Danish Cancer Society 
      Research Center, Computational Biology Laboratory, Copenhagen, Denmark.
FAU - Maiese, Kenneth
AU  - Maiese K
AD  - Cellular and Molecular Signaling, New York, NY, USA.
FAU - Maiti, Panchanan
AU  - Maiti P
AD  - Central Michigan University, Department of Psychology and Neuroscience Program, 
      Mt. Pleasant, MI, USA.
FAU - Maiuri, Maria Chiara
AU  - Maiuri MC
AD  - Inserm U1138, Centre de Recherche des Cordeliers, Sorbonne Université, Université 
      de Paris, Paris, France.
FAU - Majello, Barbara
AU  - Majello B
AD  - University of Naples Federico II, Department of Biology, Naples, Italy.
FAU - Major, Michael B
AU  - Major MB
AD  - Washington University in St. Louis, Department of Cell Biology and Physiology, 
      St. Louis, MO, USA.
FAU - Makareeva, Elena
AU  - Makareeva E
AD  - National Institutes of Health, Eunice Kennedy Shriver National Institute of Child 
      Health and Human Development, Bethesda, MD, USA.
FAU - Malik, Fayaz
AU  - Malik F
AD  - CSIR - Indian Institute of Integrative Medicine, Department of Cancer 
      Pharmacology, Sanat Nagar, Srinagar, Jammu and Kashmir, India.
FAU - Mallilankaraman, Karthik
AU  - Mallilankaraman K
AD  - National University of Singapore, Yong Loo Lin School of Medicine, Department of 
      Physiology, Mitochondrial Physiology and Metabolism Lab, Singapore; National 
      University of Singapore, NUHS Centre for Healthy Ageing, Singapore.
FAU - Malorni, Walter
AU  - Malorni W
AD  - Center for Global Health, Catholic University of the Sacred Heart, Rome, Italy.
FAU - Maloyan, Alina
AU  - Maloyan A
AD  - Oregon Health and Science University, Knight Cardiovascular Institute, Portland, 
      OR, USA.
FAU - Mammadova, Najiba
AU  - Mammadova N
AD  - Iowa State University, Department of Biomedical Sciences, Ames, IA, USA.
FAU - Man, Gene Chi Wai
AU  - Man GCW
AD  - The Chinese University of Hong Kong, The Prince of Wales Hospital, The Faculty of 
      Medicine, Department of Orthopaedics and Traumatology, New Territories, Shatin, 
      Hong Kong, China.
FAU - Manai, Federico
AU  - Manai F
AD  - University of Pavia, Department of Biology and Biotechnology "L. Spallanzani", 
      Pavia, Italy.
FAU - Mancias, Joseph D
AU  - Mancias JD
AD  - Dana-Farber Cancer Institute, Division of Genomic Stability and DNA Repair, 
      Department of Radiation Oncology, Boston, MA, USA.
FAU - Mandelkow, Eva-Maria
AU  - Mandelkow EM
AD  - German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany; CAESAR 
      Research Center, Bonn, Germany.
FAU - Mandell, Michael A
AU  - Mandell MA
AD  - University of New Mexico Health Sciences Center, Autophagy, Inflamamtion and 
      Metabolism (AIM) Center, Albuquerque, NM, USA.
FAU - Manfredi, Angelo A
AU  - Manfredi AA
AD  - Vita-Salute San Raffaele University & IRCCS San Raffaele Scientific Institute, 
      Division of Immunology, Transplantation and Infectious Diseases, Milano, Italy.
FAU - Manjili, Masoud H
AU  - Manjili MH
AD  - Virginia Commonwealth University School of Medicine, VCU Institute of Molecular 
      Medicine, Massey Cancer Center, Department of Microbiology and Immunology, 
      Richmond, VA, USA.
FAU - Manjithaya, Ravi
AU  - Manjithaya R
AD  - Molecular Biology and Genetics Unit, Jawaharlal Nehru Centre for Advanced 
      Scientific Research, Bangalore, India.
FAU - Manque, Patricio
AU  - Manque P
AD  - Universidad Mayor, Center for Integrative Biology, Santiago, Chile.
FAU - Manshian, Bella B
AU  - Manshian BB
AD  - KU Leuven, Department of Imaging and Pathology, Leuven, Belgium.
FAU - Manzano, Raquel
AU  - Manzano R
AD  - University of Zaragoza, Faculty of Veterinary-IIS Aragón, IA2-CITA, CIBERNED, 
      Laboratory of Genetics and Biochemistry (LAGENBIO), Zaragoza, Spain.
FAU - Manzoni, Claudia
AU  - Manzoni C
AD  - University College London, School of Pharmacy, Department of Pharmacology, 
      London, United Kingdom.
FAU - Mao, Kai
AU  - Mao K
AD  - Massachusetts General Hospital, Department of Molecular Biology, Boston, MA, USA.
FAU - Marchese, Cinzia
AU  - Marchese C
AD  - Sapienza University of Rome, Department of Experimental Medicine, Rome, Italy.
FAU - Marchetti, Sandrine
AU  - Marchetti S
AD  - Université Côte d'Azur, INSERM, C3M, Nice, France.
FAU - Marconi, Anna Maria
AU  - Marconi AM
AD  - Presidio San Paolo Polo Universitario, Dipartimento di Scienze della Salute San 
      Paolo, Milano, Italy.
FAU - Marcucci, Fabrizio
AU  - Marcucci F
AD  - University of Milan, Department of Pharmacological and Biomolecular Sciences, 
      Milan, Italy.
FAU - Mardente, Stefania
AU  - Mardente S
AD  - Sapienza University of Rome, Department of Experimental Medicine, Rome, Italy.
FAU - Mareninova, Olga A
AU  - Mareninova OA
AD  - David Geffen School of Medicine at UCLA, Department of Medicine, Los Angeles, CA, 
      USA.
FAU - Margeta, Marta
AU  - Margeta M
AD  - University of California, San Francisco, Department of Pathology, San Francisco, 
      CA, USA.
FAU - Mari, Muriel
AU  - Mari M
AD  - University of Groningen, University Medical Center of Groningen, Department of 
      Biomedical Sciences of Cells and Systems, Groningen, The Netherlands.
FAU - Marinelli, Sara
AU  - Marinelli S
AD  - Consiglio Nazionale delle Ricerche, Istituto di Biochimica e Biologia Cellulare, 
      Monterotondo scalo (RM), Italy.
FAU - Marinelli, Oliviero
AU  - Marinelli O
AD  - University of Camerino, School of Pharmacy, Camerino, MC, Italy.
FAU - Mariño, Guillermo
AU  - Mariño G
AD  - University of Oviedo, Principality of Asturias Institute for Biomedical Research, 
      Department of Functional Biology, Oviedo, Spain.
FAU - Mariotto, Sofia
AU  - Mariotto S
AD  - University of Verona, Department of Neurosciences, Biomedicine and Movement 
      Sciences, Biological Chemistry Section, Verona, Italy.
FAU - Marshall, Richard S
AU  - Marshall RS
AD  - Washington University in St. Louis, Department of Biology, St. Louis, MO, USA.
FAU - Marten, Mark R
AU  - Marten MR
AD  - UMBC, Department of Chemical, Biochemical and Environmental Engineering, 
      Baltimore, MD, USA.
FAU - Martens, Sascha
AU  - Martens S
AD  - University of Vienna, Max Perutz Labs, Department of Biochemistry and Cell 
      Biology, Vienna BioCenter, Vienna, Austria.
FAU - Martin, Alexandre P J
AU  - Martin APJ
AD  - Harvard Medical School, Department of Biological Chemistry and Molecular 
      Pharmacology, Boston, MA, USA.
FAU - Martin, Katie R
AU  - Martin KR
AD  - Michigan State University, College of Human Medicine, Grand Rapids, MI, USA.
FAU - Martin, Sara
AU  - Martin S
AD  - European Institute of Oncology (IEO) IRCCS, Department of Experimental Oncology, 
      Milan, Italy; University of Milano, Department of Oncology and Hemato-Oncology, 
      Milan, Italy.
FAU - Martin, Shaun
AU  - Martin S
AD  - KU Leuven, Department of cellular and Molecular Medicine, Laboratory of cellular 
      transport systems, Leuven, Belgium.
FAU - Martín-Segura, Adrián
AU  - Martín-Segura A
AD  - Albert Einstein College of Medicine, Department of Developmental and Molecular 
      Biology, Bronx, NY, USA.
FAU - Martín-Acebes, Miguel A
AU  - Martín-Acebes MA
AD  - Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), 
      Department of Biotechnology, Madrid, Spain.
FAU - Martin-Burriel, Inmaculada
AU  - Martin-Burriel I
AD  - Laboratorio de Genética Bioquímica (LAGENBIO), Centro de Encefalopatías y 
      Enfermedades Transmisibles Emergentes, Instituto Agroalimentario de Aragón-IA2, 
      Instituto de Investigación Sanitaria Aragón-IISA, Universidad de Zaragoza, 
      Zaragoza, Spain; Centro de Investigación Biomédica en Red de Enfermedades 
      Neurodegenerativas (CIBERNED), Instituto Carlos III, Zaragoza, Spain.
FAU - Martin-Rincon, Marcos
AU  - Martin-Rincon M
AD  - University of Las Palmas de Gran Canaria, Department of Physical Education and 
      Research Institute of Biomedical and Health Sciences (IUIBS), Las Palmas de Gran 
      Canaria, Spain.
FAU - Martin-Sanz, Paloma
AU  - Martin-Sanz P
AD  - Instituto de Investigaciones Biomédicas "Alberto Sols", CSIC-UAM, Madrid, Spain.
FAU - Martina, José A
AU  - Martina JA
AD  - Cell and Developmental Biology Center, National Heart, Lung, and Blood Institute, 
      National Institutes of Health, Bethesda, MD, USA.
FAU - Martinet, Wim
AU  - Martinet W
AD  - University of Antwerp, Laboratory of Physiopharmacology, Antwerp, Belgium.
FAU - Martinez, Aitor
AU  - Martinez A
AD  - University of Cambridge, MRC Mitochondrial Biology Unit, Cambridge, UK.
FAU - Martinez, Ana
AU  - Martinez A
AD  - Centro de Investigaciones Biológicas Margarita Salas, CSIC, Madrid, Spain.
FAU - Martinez, Jennifer
AU  - Martinez J
AD  - National Institutes of Health, National Institute of Environmental Health 
      Sciences, Research Triangle Park, NC, USA.
FAU - Martinez Velazquez, Moises
AU  - Martinez Velazquez M
AD  - Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de 
      Jalisco, AC, Unidad de Biotecnología Médica y Farmacéutica, Guadalajara, Jalisco, 
      México.
FAU - Martinez-Lopez, Nuria
AU  - Martinez-Lopez N
AD  - Albert Einstein College of Medicine, Radiation Oncology, Bronx, NY, USA.
FAU - Martinez-Vicente, Marta
AU  - Martinez-Vicente M
AD  - Vall d'Hebron research Institute-UAB/Neurodegenerative Diseases Group, Barcelona, 
      Spain.
FAU - Martins, Daniel O
AU  - Martins DO
AD  - University of São Paulo, Institute of Biomedical Sciences, Department of Anatomy, 
      Laboratory of Functional Neuroanatomy of Pain, São Paulo, Brazil.
FAU - Martins, Joilson O
AU  - Martins JO
AD  - Laboratory of Immunoendocrinology, Department of Clinical and Toxicological 
      Analyses, University of São Paulo, São Paulo, Brazil.
FAU - Martins, Waleska K
AU  - Martins WK
AD  - Universidade Anhanguera de São Paulo, Programa de Pós-graduação Stricto sensu e 
      Pesquisa, São Paulo, Brazil.
FAU - Martins-Marques, Tania
AU  - Martins-Marques T
AD  - University of Coimbra, Coimbra Institute for Clinical and Biomedical Research 
      (iCBR), Faculty of Medicine, Coimbra, Portugal; University of Coimbra, Center for 
      Innovative Biomedicine and Biotechnology, Coimbra, Portugal.
FAU - Marzetti, Emanuele
AU  - Marzetti E
AD  - Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, Rome, Italy.
AD  - Università Cattolica del Sacro Cuore, Rome, Italy.
FAU - Masaldan, Shashank
AU  - Masaldan S
AD  - Melbourne Dementia Research Centre, The Florey Institute of Neuroscience & Mental 
      Health, The University of Melbourne, Parkville, VIC, Australia.
FAU - Masclaux-Daubresse, Celine
AU  - Masclaux-Daubresse C
AD  - Institut Jean-Pierre Bourgin, INRAE, AgroParisTech, Université Paris-Saclay, 
      78000 Versailles, France.
FAU - Mashek, Douglas G
AU  - Mashek DG
AD  - University of Minnesota, Department of Biochemistry, Molecular Biology and 
      Biophysics and Department of Medicine, Minneapolis, MN, USA.
FAU - Massa, Valentina
AU  - Massa V
AD  - Università degli Studi di Milano, Dipartimento di Scienze della Salute, Milano, 
      Italy.
FAU - Massieu, Lourdes
AU  - Massieu L
AD  - Universidad Nacional Autónoma de México, Instituto de Fisiología Celular, 
      División de Neurociencias, Departamento de Neuropatología Molecular, Mexico, DF, 
      Mexico.
FAU - Masson, Glenn R
AU  - Masson GR
AD  - MRC Laboratory of Molecular Biology, Cambridge, UK.
FAU - Masuelli, Laura
AU  - Masuelli L
AD  - University of Rome "Sapienza", Department of Experimental Medicine, Rome, Italy.
FAU - Masyuk, Anatoliy I
AU  - Masyuk AI
AD  - Mayo Clinic, Department of Medicine, Division of Gastroenterology and Hepatology, 
      Rochester, MN, USA.
FAU - Masyuk, Tetyana V
AU  - Masyuk TV
AD  - Mayo Clinic, Department of Medicine, Division of Gastroenterology and Hepatology, 
      Rochester, MN, USA.
FAU - Matarrese, Paola
AU  - Matarrese P
AD  - Center for gender-specific medicine, Italian National Health Institute, Rome, 
      Italy.
FAU - Matheu, Ander
AU  - Matheu A
AD  - Biodonostia Health Research Institute, group of Cellular Oncology; IKERBASQUE; 
      CIBERfes, Spain.
FAU - Matoba, Satoaki
AU  - Matoba S
AD  - Kyoto Prefectural University of Medicine, Graduate School of Medical Science, 
      Department of Cardiovascular Medicine, Kyoto, Japan.
FAU - Matsuzaki, Sachiko
AU  - Matsuzaki S
AD  - CHU Clermont-Ferrand, Chirurgie Gynécologique, Clermont-Ferrand, France; 
      Université Clermont Auvergne, Institut Pascal, UMR6602, CNRS/UCA/SIGMA, 
      Clermont-Ferrand, France.
FAU - Mattar, Pamela
AU  - Mattar P
AD  - University of Chile, Institute of Nutrition and Food Technology (INTA), Advanced 
      Center for Chronic Diseases (ACCDiS), Santiago, Chile.
FAU - Matte, Alessandro
AU  - Matte A
AD  - University of Verona, Azienda Ospedaliera Universitaria Integrata-Verona, 
      Department of Medicine, Verona; Italy.
FAU - Mattoscio, Domenico
AU  - Mattoscio D
AD  - University of Chieti-Pescara, Department of Medical, Oral, and Biotechnological 
      Science, Chieti, Italy.
FAU - Mauriz, José L
AU  - Mauriz JL
AD  - University of León, Institute of Biomedicine (IBIOMED) and Centro de 
      Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 
      León, Spain.
FAU - Mauthe, Mario
AU  - Mauthe M
AD  - University of Groningen, University Medical Center of Groningen, Department of 
      Biomedical Sciences of Cells and Systems, Groningen, The Netherlands.
FAU - Mauvezin, Caroline
AU  - Mauvezin C
AD  - Metabolism and Cancer Laboratory, Molecular Mechanisms and Experimental Therapy 
      in Oncology Program (Oncobell), Institut d'Investigació Biomèdica de Bellvitge - 
      IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
FAU - Maverakis, Emanual
AU  - Maverakis E
AD  - University of California, Davis, Department of Dermatology, Sacramento, CA, USA.
FAU - Maycotte, Paola
AU  - Maycotte P
AD  - CONACYT - Centro de Investigación Biomédica de Oriente, Instituto Mexicano del 
      Seguro Social, Puebla, Mexico.
FAU - Mayer, Johanna
AU  - Mayer J
AD  - Karolinska Institutet, Department of Neurobiology, Care Sciences and Society, 
      Division of Neurogeriatrics, Solna, Stockholm, Sweden.
FAU - Mazzoccoli, Gianluigi
AU  - Mazzoccoli G
AD  - IRCCS "Casa Sollievo della Sofferenza", Opera di Padre Pio da Pietrelcina, 
      Division of Internal Medicine and Chronobiology Unit, Department of Medical 
      Sciences, San Giovanni Rotondo (FG), Italy.
FAU - Mazzoni, Cristina
AU  - Mazzoni C
AD  - Sapienza University of Rome, Department of Biology and Biotechnology C. Darwin, 
      Rome, Italy.
FAU - Mazzulli, Joseph R
AU  - Mazzulli JR
AD  - Northwestern University Feinberg School of Medicine, Department of Neurology, 
      Chicago, IL, USA.
FAU - McCarty, Nami
AU  - McCarty N
AD  - University of Texas Health Science Center at Houston, Center for Stem Cell and 
      Regenerative Disease, Institute of Molecular Medicine (IMM), Houston, TX, USA.
FAU - McDonald, Christine
AU  - McDonald C
AD  - Cleveland Clinic, Lerner Research Institute, Department of Inflammation & 
      Immunity, Cleveland, OH, USA.
FAU - McGill, Mitchell R
AU  - McGill MR
AD  - University of Arkansas for Medical Sciences, Fay W. Boozman College of Public 
      Health, Department of Environmental and Occupational Health, Little Rock, AR, 
      USA.
FAU - McKenna, Sharon L
AU  - McKenna SL
AD  - University College Cork, Department of Cancer Research, Cork, Ireland.
FAU - McLaughlin, BethAnn
AU  - McLaughlin B
AD  - Academic Decency, MeTooSTEM, Nashville, TN, USA.
FAU - McLoughlin, Fionn
AU  - McLoughlin F
AD  - Washington University in St. Louis, Department of Biology, St. Louis, MO, USA.
FAU - McNiven, Mark A
AU  - McNiven MA
AD  - Mayo Clinic, Rochester, MN, USA.
FAU - McWilliams, Thomas G
AU  - McWilliams TG
AD  - Translational Stem Cell Biology Metabolism Program, Research Programs Unit, 
      University of Helsinki, Helsinki, Finland.
AD  - Department of Anatomy, Faculty of Medicine, Helsinki, Finland.
FAU - Mechta-Grigoriou, Fatima
AU  - Mechta-Grigoriou F
AD  - PSL Research University, Equipe labelisée par la Ligue Contre le Cancer, Institut 
      Curie, Inserm, U830, Stress and Cancer laboratory, Paris, France.
FAU - Medeiros, Tania Catarina
AU  - Medeiros TC
AD  - Max Planck Institute for Biology of Ageing, Cologne, Germany; University of 
      Cologne, Cologne Excellence Cluster on Cellular Stress Responses in 
      Aging-Associated Diseases (CECAD), Cologne, Germany.
AD  - Max Planck Institute for Biology of Ageing, Cologne, Germany.
FAU - Medina, Diego L
AU  - Medina DL
AD  - Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.
AD  - University of Naples Federico II, Department of Translational Medical Sciences, 
      Naples, Italy.
FAU - Megeney, Lynn A
AU  - Megeney LA
AD  - Sprott Centre for Stem Cell Research, Ottawa Hospital Research Institute, and 
      University of Ottawa, Department of Medicine, Ottawa, ON, Canada.
FAU - Megyeri, Klara
AU  - Megyeri K
AD  - University of Szeged, Department of Medical Microbiology and Immunobiology, 
      Szeged, Hungary.
FAU - Mehrpour, Maryam
AU  - Mehrpour M
AD  - Institut Necker-Enfants Malades (INEM), INSERM U1151/CNRS UMR 8253, Université de 
      Paris, Paris, France.
FAU - Mehta, Jawahar L
AU  - Mehta JL
AD  - University of Arkansas for Medical Sciences and Central Arkansas Veterans 
      Healthcare System, Little Rock, AR, USA.
FAU - Meijer, Alfred J
AU  - Meijer AJ
AD  - University of Amsterdam, Medical Biochemistry, Amsterdam UMC, Amsterdam, The 
      Netherlands.
FAU - Meijer, Annemarie H
AU  - Meijer AH
AD  - Leiden University, Institute of Biology Leiden, Leiden, The Netherlands; The City 
      University of New York, Queens College, The Graduate Center of the City 
      University of New York, Department of Biology, Flushing, NY, USA.
FAU - Mejlvang, Jakob
AU  - Mejlvang J
AD  - UiT The Arctic University of Norway, Department of Pharmacy, Pharmacology 
      Research Group, Tromso, Norway.
FAU - Meléndez, Alicia
AU  - Meléndez A
FAU - Melk, Annette
AU  - Melk A
AD  - Childrens' Hospital, Hannover Medical School, Hannover, Germany.
FAU - Memisoglu, Gonen
AU  - Memisoglu G
AD  - Northwestern University Feinberg School of Medicine, Department of Neurology, 
      Chicago, IL, USA.
FAU - Mendes, Alexandrina F
AU  - Mendes AF
AD  - University of Coimbra, Portugal, CNC - Center for Neuroscience and Cell Biology & 
      Faculty of Pharmacy, Coimbra, Portugal.
FAU - Meng, Delong
AU  - Meng D
AD  - University of Texas Southwestern Medical Center, Department of Molecular Biology, 
      Dallas, TX, USA.
FAU - Meng, Fei
AU  - Meng F
AD  - Anhui Province Key Laboratory of Medical Physics and Technology, Center of 
      Medical Physics and Technology, Hefei Institutes of Physical Science, Chinese 
      Academy of Sciences, Hefei, Anhui, China; University of Science and Technology of 
      China, Anhui, China.
FAU - Meng, Tian
AU  - Meng T
AD  - Guangzhou Medical University, School of Basic Medical Sciences, State Key 
      Laboratory of Respiratory Disease, Guangzhou, China.
FAU - Menna-Barreto, Rubem
AU  - Menna-Barreto R
AD  - Laboratory of Cell Biology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio 
      de Janeiro, Brazil.
FAU - Menon, Manoj B
AU  - Menon MB
AD  - Indian Institute of Technology Delhi, Kusuma School of Biological Sciences, New 
      Delhi, India.
FAU - Mercer, Carol
AU  - Mercer C
AD  - University of Cincinnati, Division of Hematology/Oncology, Cincinnati, OH, USA.
FAU - Mercier, Anne E
AU  - Mercier AE
AD  - University of Pretoria, School of Medicine, Faculty of Health Sciences, 
      Department of Physiology, Pretoria, South Africa.
FAU - Mergny, Jean-Louis
AU  - Mergny JL
AD  - Laboratoire d'Optique et Biosciences, Ecole Polytechnique, CNRS, Inserm, Institut 
      Polytechnique de Paris, Palaiseau, France.
FAU - Merighi, Adalberto
AU  - Merighi A
AD  - University of Turin, Department of Veterinary Sciences, Grugliasco (TO), Italy.
FAU - Merkley, Seth D
AU  - Merkley SD
AD  - University of New Mexico, Clinical and Translational Sciences Center, 
      Albuquerque, NM, USA.
FAU - Merla, Giuseppe
AU  - Merla G
AD  - Division of Medical Genetics, Fondazione IRCCS-Casa Sollievo della Sofferenza, 
      San Giovanni Rotondo, Italy.
FAU - Meske, Volker
AU  - Meske V
AD  - Carité-Universitaetsmedizin Berlin, Campus Mitte, Institut für Integrative 
      Neuroanatomie, Berlin, Germany.
FAU - Mestre, Ana Cecilia
AU  - Mestre AC
AD  - Ruprecht-Karls University of Heidelberg, Women's Hospital, Department of 
      Gynecological Endocrinology and Fertility Disorders, Heidelberg, Germany.
FAU - Metur, Shree Padma
AU  - Metur SP
AD  - Life Sciences Institute and Department of Molecular, Cellular and Developmental 
      Biology, University of Michigan, Ann Arbor, MI, USA.
FAU - Meyer, Christian
AU  - Meyer C
AD  - Institut Jean-Pierre Bourgin, INRA, AgroParisTech, CNRS, Université Paris-Saclay, 
      Versailles, France.
FAU - Meyer, Hemmo
AU  - Meyer H
AD  - University of Duisburg-Essen, Centre for Medical Biotechnology, Faculty of 
      Biology, Essen, Germany.
FAU - Mi, Wenyi
AU  - Mi W
AD  - Tianjin Medical University, Department of Immunology, School of Basic Medical 
      Sciences, Tianjin, China.
FAU - Mialet-Perez, Jeanne
AU  - Mialet-Perez J
AD  - INSERM Institute of Metabolic and Cardiovascular Diseases (I2MC), Université de 
      Toulouse, Toulouse, France.
FAU - Miao, Junying
AU  - Miao J
AD  - Shandong University, School of Life Science, Shandong Provincial Key Laboratory 
      of Animal Cells and Developmental Biology, Qingdao, China.
FAU - Micale, Lucia
AU  - Micale L
AD  - Fondazione IRCCS Casa Sollievo della Sofferenza, Poliambulatorio Giovanni Paolo 
      II, Division of Medical Genetics, San Giovanni Rotondo (FG), Italy.
FAU - Miki, Yasuo
AU  - Miki Y
AD  - Hirosaki University Graduate School of Medicine, Institute of Brain Science, 
      Department of Neuropathology, Hirosaki, Japan; UCL Queen Square Institute of 
      Neurology, Queen Square Brain Bank for Neurological Disorders, London, UK.
FAU - Milan, Enrico
AU  - Milan E
AD  - Ospedale San Raffaele and Vita-Salute San Raffaele University, Division of 
      Genetics and Cell Biology, Milano, Italy.
FAU - Milczarek, Małgorzata
AU  - Milczarek M
AD  - National Medicines Institute, Department of Drug Biotechnology and 
      Bioinformatics, Warszawa, Poland.
FAU - Miller, Dana L
AU  - Miller DL
AD  - University of Washington School of Medicine, Department of Biochemistry, Seattle, 
      WA, USA.
FAU - Miller, Samuel I
AU  - Miller SI
AD  - University of Washington, Departments of Medicine, Microbiology and Genome 
      Sciences, Seattle, WA, USA.
FAU - Miller, Silke
AU  - Miller S
AD  - Sage Therapeutics, Cambridge, MA, USA.
FAU - Millward, Steven W
AU  - Millward SW
AD  - University of Texas MD Anderson Cancer Center, Department of Cancer Systems 
      Imaging, Houston, TX, USA.
FAU - Milosevic, Ira
AU  - Milosevic I
AD  - European Neuroscience Institute (ENI) - A Joint Initiative of the University 
      Medical Center Göttingen and the Max Planck Society, Göttingen, Germany.
FAU - Minina, Elena A
AU  - Minina EA
AD  - Swedish University of Agricultural Sciences and Linnean Center for Plant Biology, 
      Department of Molecular Sciences, Uppsala BioCenter, Uppsala, Sweden; Heidelberg 
      University, Center for Organismal Studies, Neuenheimer Feld, Heidelberg, Germany.
FAU - Mirzaei, Hamed
AU  - Mirzaei H
AD  - Kashan University of Medical Sciences, Research Center for Biochemistry and 
      Nutrition in Metabolic Disease, Kashan, Iran.
FAU - Mirzaei, Hamid Reza
AU  - Mirzaei HR
AD  - Tehran University of Medical Sciences, School of Medicine, Department of Medical 
      Immunology, Tehran, Iran.
FAU - Mirzaei, Mehdi
AU  - Mirzaei M
AD  - Macquarie University, Faculty of Medicine and Health Sciences, New South Wales, 
      Australia.
FAU - Mishra, Amit
AU  - Mishra A
AD  - Indian Institute of Technology Jodhpur, Cellular and Molecular Neurobiology Unit, 
      Jodhpur, Rajasthan, India.
FAU - Mishra, Nandita
AU  - Mishra N
AD  - Amrita Vishwa Vidyapeetham, School of Biotechnology, Kollam, Kerala, India.
FAU - Mishra, Paras Kumar
AU  - Mishra PK
AD  - University of Nebraska Medical Center, Department of Cellular and Integrative 
      Physiology, Omaha, NE, USA.
FAU - Misirkic Marjanovic, Maja
AU  - Misirkic Marjanovic M
AD  - Department of Neurophysiology, Institute for Biological Research "Siniša 
      Stanković" - National Institute of Republic of Serbia, University of Belgrade, 
      Belgrade, Serbia.
FAU - Misasi, Roberta
AU  - Misasi R
AD  - Sapienza University of Rome, Department of Experimental Medicine, Rome, Italy.
FAU - Misra, Amit
AU  - Misra A
AD  - CSIR-Central Drug Research Institute, Lucknow, India.
FAU - Misso, Gabriella
AU  - Misso G
AD  - University of Campania L. Vanvitelli, Department of Precision Medicine, Naples, 
      Italy; Institute of Genetic Research, Biogem scarl, Laboratory of Molecular and 
      Precision Oncology, Ariano Irpino (AV), Italy.
AD  - University of Campania "Luigi Vanvitelli", Department of Precision Medicine, 
      Naples, Italy.
FAU - Mitchell, Claire
AU  - Mitchell C
AD  - University of Pennsylvania, Department of Basic and Translational Sciences, 
      Philadelphia, PA, USA.
FAU - Mitou, Geraldine
AU  - Mitou G
AD  - Université Toulouse III, Toulouse, France.
FAU - Miura, Tetsuji
AU  - Miura T
AD  - Sapporo Medical University, Department of Cardiovascular, Renal and Metabolic 
      Medicine, Sapporo, Japan.
FAU - Miyamoto, Shigeki
AU  - Miyamoto S
AD  - University of California San Diego, Department of Pharmacology, La Jolla, CA, US.
FAU - Miyazaki, Makoto
AU  - Miyazaki M
AD  - University of Colorado Denver, Department of Medicine, Aurora, CO, USA.
FAU - Miyazaki, Mitsunori
AU  - Miyazaki M
AD  - Health Sciences University of Hokkaido, College of Rehabilitation Sciences, 
      Department of Physical Therapy, Ishikari-Tobetsu, Hokkaido, Japan.
FAU - Miyazaki, Taiga
AU  - Miyazaki T
AD  - Nagasaki University Graduate School of Biomedical Sciences, Department of 
      Infectious Diseases, Nagasaki, Japan.
FAU - Miyazawa, Keisuke
AU  - Miyazawa K
AD  - Tokyo Medical University, Department of Biochemistry, Tokyo, Japan.
FAU - Mizushima, Noboru
AU  - Mizushima N
AD  - The University of Tokyo, Department of Biochemistry and Molecular Biology, 
      Graduate School of Medicine, Tokyo, Japan.
FAU - Mogensen, Trine H
AU  - Mogensen TH
AD  - Aarhus University, Department of Biomedicine, Aarhus, Denmark.
FAU - Mograbi, Baharia
AU  - Mograbi B
AD  - Université Côte d'Azur (UCA), Institute for Research on Cancer and Aging of Nice 
      (IRCAN), Centre Antoine Lacassagne, Centre National de la Recherche Scientifique 
      (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM), 
      Fédération Hospitalo-Universitaire (FHU) OncoAge, Nice, France.
FAU - Mohammadinejad, Reza
AU  - Mohammadinejad R
AD  - Kerman University of Medical Sciences, Institute of Neuropharmacology, 
      Pharmaceutics Research Center, Kerman, Iran.
FAU - Mohamud, Yasir
AU  - Mohamud Y
AD  - University of British Columbia, Centre for Heart Lung Innovation/Department of 
      Pathology and Laboratory Medicine, Vancouver, BC, Canada.
FAU - Mohanty, Abhishek
AU  - Mohanty A
AD  - MVR Cancer Hospital and Research Institute, Molecular Oncology, Cancer 
      Genomics/Proteomics, Kerala, India.
FAU - Mohapatra, Sipra
AU  - Mohapatra S
AD  - Ehime University, Department of Aquatic Life Sciences, Ainan, Ehime, Japan.
FAU - Möhlmann, Torsten
AU  - Möhlmann T
AD  - University of Kaiserslautern, Department of Biology, Plant Physiology, 
      Kaiserslautern, Germany.
FAU - Mohmmed, Asif
AU  - Mohmmed A
AD  - International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
FAU - Moles, Anna
AU  - Moles A
AD  - Department of Experimental Pathology, Institute of Biomedical Research of 
      Barcelona, Spanish Research Council (IIBB-CSIC); IDIBAPS and CIBEREHD, Barcelona, 
      Spain.
FAU - Moley, Kelle H
AU  - Moley KH
AD  - Washington University in St. Louis, Professor of Obstetrics and Gynecology, St. 
      Louis, MO, USA.
FAU - Molinari, Maurizio
AU  - Molinari M
AD  - Università della Svizzera italiana (USI), Faculty of Biomedical Sciences, 
      Institute for Research in Biomedicine, Bellinzona, Switzerland; School of Life 
      Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
FAU - Mollace, Vincenzo
AU  - Mollace V
AD  - University "Magna Graecia" of Catanzaro, Department of Health Sciences, 
      Catanzaro, Italy.
FAU - Møller, Andreas Buch
AU  - Møller AB
AD  - Aarhus University Hospital, Steno Diabetes Center Aarhus, Aarhus, Denmark; Aarhus 
      University, Department of Clinical Medicine, Research Laboratory for Biochemical 
      Pathology, Aarhus, Denmark.
FAU - Mollereau, Bertrand
AU  - Mollereau B
AD  - Université de Lyon, ENSL, UCBL, CNRS, LBMC, UMS 3444 Biosciences Lyon Gerland, 
      Lyon, France.
FAU - Mollinedo, Faustino
AU  - Mollinedo F
AD  - Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones 
      Científicas, Department of Molecular Biomedicine, Laboratory of Cell Death and 
      Cancer Therapy, Madrid, Spain.
FAU - Montagna, Costanza
AU  - Montagna C
AD  - Bispebjerg Hospital, Institute of Sports Medicine Copenhagen, Copenhagen,Denmark; 
      UniCamillus, Saint Camillus International University of Health Sciences, Rome, 
      Italy.
FAU - Monteiro, Mervyn J
AU  - Monteiro MJ
AD  - University of Maryland School of Medicine, Center for Biomedical Engineering and 
      Technology, Baltimore, MD, USA.
FAU - Montella, Andrea
AU  - Montella A
AD  - Università degli Studi di Sassari, Dipartimento di Scienze Biomediche, Sassari, 
      Italy.
FAU - Montes, L Ruth
AU  - Montes LR
AD  - University of the Basque Country, Instituto Biofisika (UPV/EHU, CSIC), and 
      Department of Biochemistry and Molecular Biology, Leioa, Spain.
FAU - Montico, Barbara
AU  - Montico B
AD  - Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Immunopathology and 
      Cancer Biomarkers, Aviano, Italy.
FAU - Mony, Vinod K
AU  - Mony VK
AD  - University of Virginia, Department of Biology, Charlottesville, VA, USA.
FAU - Monzio Compagnoni, Giacomo
AU  - Monzio Compagnoni G
AD  - IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Dino Ferrari Center, 
      Neuroscience Section, University of Milan, Department of Pathophysiology and 
      Transplantation, Milan, Italy.
FAU - Moore, Michael N
AU  - Moore MN
AD  - University of Exeter Medical School, European Centre for Environment & Human 
      Health (ECEHH), Knowledge Spa, Royal Cornwall Hospital, Truro, Cornwall, UK; 
      Plymouth Marine Laboratory (PML), Plymouth, UK; University of Plymouth, School of 
      Biological & Marine Sciences, Plymouth, UK.
FAU - Moosavi, Mohammad A
AU  - Moosavi MA
AD  - National Institute of Genetic Engineering and Biotechnology, Institute of Medical 
      Biotechnology, Molecular Medicine Department, Tehran, Iran.
FAU - Mora, Ana L
AU  - Mora AL
AD  - University of Pittsburgh, Department of Medicine, Aging Institute, Pittsburgh, 
      PA, USA.
FAU - Mora, Marina
AU  - Mora M
AD  - Fondazione IRCCS Istituto Neurologico Carlo Besta, Neuromuscular Diseases and 
      Neuroimmunology Unit, Milano, Italy.
FAU - Morales-Alamo, David
AU  - Morales-Alamo D
AD  - University of Las Palmas de Gran Canaria, Department of Physical Education and 
      Research Institute of Biomedical and Health Sciences (IUIBS), Las Palmas de Gran 
      Canaria, Spain; Norwegian School of Sport Sciences, Department of Physical 
      Performance, Oslo, Norway.
AD  - University of Las Palmas de Gran Canaria, Department of Physical Education and 
      Research Institute of Biomedical and Health Sciences (IUIBS), Las Palmas de Gran 
      Canaria, Spain.
FAU - Moratalla, Rosario
AU  - Moratalla R
AD  - Cajal Institute/CSIC and CIBERNED, ISCIII, Madrid, Spain.
FAU - Moreira, Paula I
AU  - Moreira PI
AD  - University of Coimbra, Institute of Physiology, Faculty of Medicine, Coimbra, 
      Portugal and CNC - Center for Neuroscience and Cell Biology, Coimbra, Portugal.
FAU - Morelli, Elena
AU  - Morelli E
AD  - European Institute of Oncology (IEO) IRCCS, Department of Experimental Oncology, 
      Milan, Italy.
FAU - Moreno, Sandra
AU  - Moreno S
AD  - University Roma Tre, Department of Science, LIME, Rome, Italy.
AD  - Laboratory of Neurodevelopment, Neurogenetics and Molecular Neurobiology, IRCCS 
      Fondazione Santa Lucia, Rome, Italy.
FAU - Moreno-Blas, Daniel
AU  - Moreno-Blas D
AD  - National Autonomous University of Mexico (UNAM), Department of Neurodevelopment 
      and Physiology, Institute of Cellular Physiology, Mexico City, Mexico.
FAU - Moresi, Viviana
AU  - Moresi V
AD  - Sapienza University of Rome, Department of Anatomy, Histology, Forensic Medicine 
      & Orthopedics, Histology & Medical Embryology Section, Rome, Italy.
FAU - Morga, Benjamin
AU  - Morga B
AD  - Ifremer, SG2M-LGPMM, Laboratoire de Génétique et Pathologie des Mollusques 
      Marins, La Tremblade, France.
FAU - Morgan, Alwena H
AU  - Morgan AH
AD  - Swansea University Medical School, Molecular Neurobiology group, Swansea, United 
      Kingdom.
FAU - Morin, Fabrice
AU  - Morin F
AD  - Normandie University, UNIROUEN, INSERM U1239, DC2N, Rouen, France; Institute for 
      Research and Innovation in Biomedicine (IRIB), Rouen, France.
FAU - Morishita, Hideaki
AU  - Morishita H
AD  - Juntendo University Graduate School of Medicine, Department of Physiology, Tokyo, 
      Japan.
FAU - Moritz, Orson L
AU  - Moritz OL
AD  - University of British Columbia, Department of Ophthalmology and Visual Sciences, 
      Vancouver, British Columbia, Canada.
FAU - Moriyama, Mariko
AU  - Moriyama M
AD  - Kindai University, Pharmaceutical Research and Technology Institute, 
      Higashi-Osaka, Osaka, Japan.
FAU - Moriyasu, Yuji
AU  - Moriyasu Y
AD  - Saitama University, Department of Regulatory Biology, Saitama, Japan.
FAU - Morleo, Manuela
AU  - Morleo M
AD  - Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.
FAU - Morselli, Eugenia
AU  - Morselli E
AD  - Pontificia Universidad Católica de Chile, Faculty of Biological Sciences, 
      Department of Physiology, Santiago de Chile, Chile.
FAU - Moruno-Manchon, Jose F
AU  - Moruno-Manchon JF
AD  - The University of Texas McGovern Medical School at Houston, Department of 
      Neurology, Houston, TX, USA.
FAU - Moscat, Jorge
AU  - Moscat J
AD  - Weill Cornell Medicine, Rockefeller University Campus, Department of Pathology 
      and Laboratory Medicine, New York, NY, USA.
FAU - Mostowy, Serge
AU  - Mostowy S
AD  - London School of Hygiene & Tropical Medicine, Department of Infection Biology, 
      London, UK.
FAU - Motori, Elisa
AU  - Motori E
AD  - Max Planck Institute for the Biology of Ageing, Cologne, Germany.
FAU - Moura, Andrea Felinto
AU  - Moura AF
AD  - Federal University of Ceara, Drug Research and Development Center, Fortaleza, CE, 
      Brazil.
FAU - Moustaid-Moussa, Naima
AU  - Moustaid-Moussa N
AD  - Texas Tech University, Department of Nutritional Sciences & Obesity Research 
      Institute, Lubbock, TX, USA.
FAU - Mrakovcic, Maria
AU  - Mrakovcic M
AD  - University of Münster, Institute of Medical Microbiology, Münster, Germany.
FAU - Muciño-Hernández, Gabriel
AU  - Muciño-Hernández G
AD  - Universidad Nacional Autónoma de México (UNAM), Instituto de Fisiologia Celular, 
      Ciudad Universitaria, Ciudad de México, México.
FAU - Mukherjee, Anupam
AU  - Mukherjee A
AD  - Indian Council of Medical Research - National AIDS Research Institute, Division 
      of Molecular Virology, Pune, MH, India.
FAU - Mukhopadhyay, Subhadip
AU  - Mukhopadhyay S
AD  - New York University Medical School, Laura and Isaac Perlmutter Cancer Center, 
      Department of Radiation Oncology, New York, NY, USA.
FAU - Mulcahy Levy, Jean M
AU  - Mulcahy Levy JM
AD  - University of Colorado Denver, Children's Hospital Colorado, Morgan Adams 
      Foundation Pediatric Brain Tumor Research Program, Aurora, CO.
FAU - Mulero, Victoriano
AU  - Mulero V
AD  - Departmento de Biología Celular e Histología, Facultad de Biología, Universidad 
      de Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB)-Arrixaca, 
      Murcia, Spain.
FAU - Muller, Sylviane
AU  - Muller S
AD  - CNRS Biotechnology and cell signaling, Ecole Supérieure de Biotechnologie de 
      Strasbourg, Strasbourg University/Laboratory of excellence Medalis; University of 
      Strasbourg Institute for Advanced Study, Strasbourg, France.
FAU - Münch, Christian
AU  - Münch C
AD  - Goethe University, Institute of Biochemistry II, Faculty of Medicine, Frankfurt 
      am Main, Germany.
FAU - Munjal, Ashok
AU  - Munjal A
AD  - Barkatullah University, Department of Biochemistry & Genetics, Bhopal, India.
FAU - Munoz-Canoves, Pura
AU  - Munoz-Canoves P
AD  - ICREA, Pompeu Fabra University (UPF), Department of Experimental and Health 
      Sciences, Ciberned, Barcelona, Spain; Spanish National Cardiovascular Research 
      Center (CNIC), Madrid, Spain.
FAU - Muñoz-Galdeano, Teresa
AU  - Muñoz-Galdeano T
AD  - National Hospital for Paraplagics (Sescam) Research Unit, Molecular 
      Neuroprotection Group, Toledo, Spain.
FAU - Münz, Christian
AU  - Münz C
AD  - University of Zürich, Institute of Experimental Immunology, Viral Immunobiology, 
      Zürich, Switzerland.
FAU - Murakawa, Tomokazu
AU  - Murakawa T
AD  - King's College London, School of Cardiovascular Medicine and Sciences, London, 
      UK.
FAU - Muratori, Claudia
AU  - Muratori C
AD  - Old Dominion University, Frank Reidy Research Center for Bioelectrics, Norfolk, 
      VA, USA.
FAU - Murphy, Brona M
AU  - Murphy BM
AD  - Royal College of Surgeons in Ireland, Department of Physiology & Medical Physics, 
      Dublin 2, Ireland.
FAU - Murphy, J Patrick
AU  - Murphy JP
AD  - University of Prince Edward Island, Charlottetown, Prince Edward Island, Canada.
FAU - Murthy, Aditya
AU  - Murthy A
AD  - Genentech, Inc. Department of Cancer Immunology, South San Francisco, CA, USA.
FAU - Myöhänen, Timo T
AU  - Myöhänen TT
AD  - University of Helsinki, Faculty of Pharmacy, Division of Pharmacology and 
      Pharmacotherapy/Drug Research Program, Helsinki, Finland.
FAU - Mysorekar, Indira U
AU  - Mysorekar IU
AD  - Washington University School of Medicine, Department of Obstetrics and 
      Gynecology, and Department of Pathology and Immunology, St. Louis, MO, USA.
FAU - Mytych, Jennifer
AU  - Mytych J
AD  - University of Rzeszow, Institute of Biology and Biotechnology, Department of 
      Biotechnology, Rzeszow, Poland.
FAU - Nabavi, Seyed Mohammad
AU  - Nabavi SM
AD  - Applied Biotechnology Research Center, Baqiyatallah University of Medical 
      Sciences, Tehran, P.O. Box 19395-5487, Iran.
FAU - Nabissi, Massimo
AU  - Nabissi M
AD  - University of Camerino, School of Pharmacy, Camerino, MC, Italy.
FAU - Nagy, Péter
AU  - Nagy P
AD  - Cornell University, Department of Entomology, Ithaca, NY, USA.
FAU - Nah, Jihoon
AU  - Nah J
AD  - Rutgers-New Jersey Medical School, Department of Cell Biology and Molecular 
      Medicine, Newark, NJ, USA.
FAU - Nahimana, Aimable
AU  - Nahimana A
AD  - University Hospital of Lausanne, Central Laboratory of Hematology, Lausanne, 
      Switzerland.
FAU - Nakagawa, Ichiro
AU  - Nakagawa I
AD  - Kyoto University, Department of Microbiology, Graduate School of Medicine, Kyoto, 
      Japan.
FAU - Nakamura, Ken
AU  - Nakamura K
AD  - Gladstone Institute of Neurological Disease and University of California, San 
      Francisco, Department of Neurology, San Francisco, CA, USA.
FAU - Nakatogawa, Hitoshi
AU  - Nakatogawa H
AD  - Tokyo Institute of Technology, School of Life Science and Technology, Yokohama, 
      Japan.
FAU - Nandi, Shyam S
AU  - Nandi SS
AD  - University of Nebraska Medical Center, Department of Cellular and Integrative 
      Physiology, Omaha, NE, USA.
FAU - Nanjundan, Meera
AU  - Nanjundan M
AD  - University of South Florida, Department of Cell Biology, Microbiology, and 
      Molecular Biology, Tampa, FL, USA.
FAU - Nanni, Monica
AU  - Nanni M
AD  - "Sapienza" University of Rome, Department of Clinical and Molecular Medicine, 
      Laboratory affiliated to Istituto Pasteur Italia Fondazione Cenci Bolognetti, 
      Rome, Italy.
FAU - Napolitano, Gennaro
AU  - Napolitano G
AD  - Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.
AD  - University of Naples Federico II, Department of Translational Medical Sciences, 
      Naples, Italy.
FAU - Nardacci, Roberta
AU  - Nardacci R
AD  - National Institute for Infectious Diseases "L. Spallanzani" IRCCS, Rome, Italy.
FAU - Narita, Masashi
AU  - Narita M
AD  - University of Cambridge, Cancer Research UK Cambridge Institute, Cambridge, UK.
FAU - Nassif, Melissa
AU  - Nassif M
AD  - Universidad Mayor, Center for Integrative Biology, Santiago, Chile.
FAU - Nathan, Ilana
AU  - Nathan I
AD  - Soroka University Medical Center, Institute of Hematology and Ben-Gurion 
      University of the Negev, Faculty of Health Sciences, Department of Clinical 
      Biochemistry and Pharmacology, Beer-Sheva, Israel.
FAU - Natsumeda, Manabu
AU  - Natsumeda M
AD  - Niigata University, Brain Research Institute, Department of Neurosurgery, 
      Niigata, Japan.
FAU - Naude, Ryno J
AU  - Naude RJ
AD  - Nelson Mandela University, Department of Biochemistry and Microbiology, Port 
      Elizabeth, South Africa.
FAU - Naumann, Christin
AU  - Naumann C
AD  - Department of Molecular Signal Processing, Leibniz Institute of Plant 
      Biochemistry, Halle (Saale), Germany.
FAU - Naveiras, Olaia
AU  - Naveiras O
AD  - Ecole Polytechnique Fédérale de Lausanne (EPFL), Institute of Bioengineering 
      (IBI) and Swiss Institute for Experimental Cancer Research (ISREC), Laboratory of 
      Regenerative Hematopoiesis, Lausanne, Switzerland; Centre Hospitalier 
      Universitaire Vaudois (CHUV), Departments of Oncology and Laboratory Medicine, 
      Hematology Service, Lausanne, Switzerland.
FAU - Navid, Fatemeh
AU  - Navid F
AD  - National Institutes of Health, National Institute of Arthritis and 
      Musculoskeletal and Skin Diseases, Pediatric Translational Research Branch, 
      Bethesda, MD, USA.
FAU - Nawrocki, Steffan T
AU  - Nawrocki ST
AD  - University of Arizona, Department of Medicine, Tucson, AZ, USA.
FAU - Nazarko, Taras Y
AU  - Nazarko TY
AD  - Georgia State University, Department of Biology, Atlanta, GA, USA.
FAU - Nazio, Francesca
AU  - Nazio F
AD  - IRCCS Bambino Gesù Children's Hospital, Department of Pediatric Hemato-Oncology 
      and Cell and Gene Therapy, Rome, Italy.
FAU - Negoita, Florentina
AU  - Negoita F
AD  - Lund University, Department of Experimental Medical Science, Laboratory of 
      Molecular Neurogenetics, Wallenberg Neuroscience Center and Lund Stem Cell 
      Center, Lund, Sweden.
AD  - University of Copenhagen, Novo Nordisk Foundation Center for Basic Metabolic 
      Research, Copenhagen, Denmark.
FAU - Neill, Thomas
AU  - Neill T
AD  - Thomas Jefferson University, Department of Pathology, Anatomy, and Cell Biology, 
      Philadelphia, PA, USA.
FAU - Neisch, Amanda L
AU  - Neisch AL
AD  - University of Minnesota, Department of Genetics, Cell Biology and Development, 
      Minneapolis, MN, USA.
FAU - Neri, Luca M
AU  - Neri LM
AD  - University of Ferrara, Department of Translational Medicine, Ferrara, Italy.
FAU - Netea, Mihai G
AU  - Netea MG
AD  - Radboud University Medical Center, Department of Internal Medicine, Nijmegen, The 
      Netherlands.
FAU - Neubert, Patrick
AU  - Neubert P
AD  - University Hospital of Regensburg, Institute of Clinical Microbiology and 
      Hygiene, Regensburg , Germany.
FAU - Neufeld, Thomas P
AU  - Neufeld TP
AD  - University of Minnesota, Department of Genetics, Cell Biology and Development, 
      Minneapolis, MN, USA.
FAU - Neumann, Dietbert
AU  - Neumann D
AD  - Maastricht University Medical Center, CARIM School for Cardiovascular Diseases, 
      Department of Pathology, Maastricht, The Netherlands.
FAU - Neutzner, Albert
AU  - Neutzner A
AD  - University Hospital Basel, Department of Biomedicine, Ocular Pharmacology and 
      Physiology, Basel, Switzerland.
FAU - Newton, Phillip T
AU  - Newton PT
AD  - Karolinska Institutet, Department of Women's and Children's Health, Stockholm, 
      Sweden; Astrid Lindgren Children's Hospital, Karolinska University Hospital, 
      Solna, Sweden.
FAU - Ney, Paul A
AU  - Ney PA
FAU - Nezis, Ioannis P
AU  - Nezis IP
AD  - University of Warwick, School of Life Sciences, Coventry, UK.
FAU - Ng, Charlene C W
AU  - Ng CCW
AD  - King's College London GKT School of Medical Education, London, UK.
FAU - Ng, Tzi Bun
AU  - Ng TB
AD  - The Chinese University of Hong Kong, School of Biomedical Sciences, Hong Kong, 
      China.
FAU - Nguyen, Hang T T
AU  - Nguyen HTT
AD  - University of Clermont Auvergne, M2iSH (Microbes, Intestine, Inflammation and 
      Susceptibility of the Host), UMR 1071 Inserm, INRA USC 2018, CRNH, 
      Clermont-Ferrand, France.
FAU - Nguyen, Long T
AU  - Nguyen LT
AD  - The University of Sydney, Kolling Institute, Renal Medicine, Sydney, New South 
      Wales, Australia.
FAU - Ni, Hong-Min
AU  - Ni HM
AD  - University of Kansas Medical Center. Department of Pharmacology, Toxicology and 
      Thereapeutics, Kansas City, KS, USA.
FAU - Ní Cheallaigh, Clíona
AU  - Ní Cheallaigh C
AD  - Trinity College Dublin, Department of Clinical Medicine, Trinity Centre for 
      Health Sciences, Dublin, Ireland.
FAU - Ni, Zhenhong
AU  - Ni Z
AD  - Army Medical University (Third Military Medical University), Daping Hospital, 
      Center of Bone Metabolism and Repair, State Key Laboratory of Trauma, Burns and 
      Combined Injury, Trauma Center, Research Institute of Surgery, Laboratory for the 
      Prevention and Rehabilitation of Military Training Related Injuries, Chongqing, 
      China.
FAU - Nicolao, M Celeste
AU  - Nicolao MC
AD  - University of Mar del Plata, Department of Biology and Chemestry, Mar del Plata, 
      BA, Argentina.
FAU - Nicoli, Francesco
AU  - Nicoli F
AD  - University of Ferrara, Department of Chemical and Pharmaceutical Sciences, 
      Ferrara, Italy.
FAU - Nieto-Diaz, Manuel
AU  - Nieto-Diaz M
AD  - National Hospital for Paraplegics (SESCAM), Research Unit, Molecular 
      Neuroprotection Group, Toledo, Spain.
FAU - Nilsson, Per
AU  - Nilsson P
AD  - Karolinska Institutet, Department of Neurobiology, Care Sciences and Society, 
      Division of Neurogeriatrics, Solna, Stockholm, Sweden.
FAU - Ning, Shunbin
AU  - Ning S
AD  - East Tennessee State University, Quillen College of Medicine, Center of 
      Excellence for Inflammation, Infectious Diseases, and Immunity, Department of 
      Medicine, Johnson City, TN, USA.
FAU - Niranjan, Rituraj
AU  - Niranjan R
AD  - ICMR-Vector Control Research Center, Unit of Microbiology and Immunology, 
      Puducherry, India.
FAU - Nishimune, Hiroshi
AU  - Nishimune H
AD  - University of Kansas School of Medicine, Department of Anatomy and Cell Biology, 
      Kansas City, KS, USA.
FAU - Niso-Santano, Mireia
AU  - Niso-Santano M
AD  - University of Extremadura, Centro de Investigación Biomedica en Red de 
      Enfermedades Neurodegenerativas (CIBERNED), Instituto de Investigación 
      Biosanitaria de Extremadura (INUBE), Department of Biochemistry, Molecular 
      Biology and Genetics, Faculty of Nursing and Occupational Therapy, Cáceres, 
      Spain.
FAU - Nixon, Ralph A
AU  - Nixon RA
AD  - New York University School of Medicine, Departments of Psychiatry and Cell 
      Biology, and the Nathan Kline Institute, Orangeburg, NY, USA.
FAU - Nobili, Annalisa
AU  - Nobili A
AD  - University Campus Bio-Medico, Department of Medicine, Rome, Italy.
FAU - Nobrega, Clevio
AU  - Nobrega C
AD  - Faculdade de Medicina e Ciências Biomédicas, Universidade do Algarve, Faro, 
      Portugal; ABC-RI, Algarve Biomedical Center Research Institute, Faro, Portugal; 
      Centre for Biomedical Research, Faro, Portugal.
FAU - Noda, Takeshi
AU  - Noda T
AD  - Osaka University, Graduate School of Dentistry, Osaka, Japan.
FAU - Nogueira-Recalde, Uxía
AU  - Nogueira-Recalde U
AD  - Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario 
      Universitario de A Coruña (CHUAC), Sergas, Universidade da Coruña (UDC), A 
      Coruña, Spain.
FAU - Nolan, Trevor M
AU  - Nolan TM
AD  - Duke University, Department of Biology and Howard Hughes Medical Institute, 
      Durham, NC, USA.
FAU - Nombela, Ivan
AU  - Nombela I
AD  - Universidad Miguel Hernández (UMH), Instituto de Investigación, Desarrollo e 
      Innovación en Biotecnología Sanitaria de Elche (IDiBE), Elche, Spain.
FAU - Novak, Ivana
AU  - Novak I
AD  - University of Split, School of Medicine, Split, Croatia.
FAU - Novoa, Beatriz
AU  - Novoa B
AD  - Instituto de Investigaciones Marinas CSIC, Department of Biotechnology and 
      Aquaculture, Immunology and Genomics, Vigo, Spain.
FAU - Nozawa, Takashi
AU  - Nozawa T
AD  - Kyoto University, Department of Microbiology, Graduate School of Medicine, Kyoto, 
      Japan.
FAU - Nukina, Nobuyuki
AU  - Nukina N
AD  - Doshisha University Graduate School of Brain Science, Laboratory of Structural 
      Neuropathology, Kyoto, Japan.
FAU - Nussbaum-Krammer, Carmen
AU  - Nussbaum-Krammer C
AD  - Center for Molecular Biology of Heidelberg University (ZMBH) and German Cancer 
      Research Center (DKFZ), DKFZ-ZMBH Alliance, Heidelberg, Germany.
FAU - Nylandsted, Jesper
AU  - Nylandsted J
AD  - Danish Cancer Society Research Center, Unit for Cell Death and Metabolism, Center 
      for Autophagy, Recycling and Disease, Copenhagen, Denmark; University of 
      Copenhagen, Department of Cellular and Molecular Medicine, Faculty of Health 
      Sciences, Copenhagen N, Denmark.
FAU - O'Donovan, Tracey R
AU  - O'Donovan TR
AD  - University College Cork, Department of Cancer Research, Cork, Ireland.
FAU - O'Leary, Seónadh M
AU  - O'Leary SM
AD  - Trinity College Dublin, Trinity Translational Medicine Institute, Dublin, 
      Ireland.
FAU - O'Rourke, Eyleen J
AU  - O'Rourke EJ
AD  - University of Virginia, Department of Biology, Charlottesville, VA, USA.
FAU - O'Sullivan, Mary P
AU  - O'Sullivan MP
AD  - Trinity College Dublin, Trinity Translational Medicine Institute, Dublin, 
      Ireland.
FAU - O'Sullivan, Timothy E
AU  - O'Sullivan TE
AD  - David Geffen School of Medicine at UCLA, Department of Microbiology, Immunology, 
      and Molecular Genetics, Los Angeles, CA, USA.
FAU - Oddo, Salvatore
AU  - Oddo S
AD  - University of Messina, Sicily, Italy.
FAU - Oehme, Ina
AU  - Oehme I
AD  - Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany; German 
      Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Clinical 
      Cooperation Unit Pediatric Oncology, Im Neuenheimer Feld, Heidelberg, Germany.
FAU - Ogawa, Michinaga
AU  - Ogawa M
AD  - National Institute of Infectious Diseases, Department of Bacteriology I, Toyama, 
      Tokyo, Japan.
FAU - Ogier-Denis, Eric
AU  - Ogier-Denis E
AD  - Université de Paris, Centre de recherche sur l'inflammation, Team Gut 
      Inflammation, Inserm, U1149, CNRS, ERL8252, Paris, France.
FAU - Ogmundsdottir, Margret H
AU  - Ogmundsdottir MH
AD  - University of Iceland, Faculty of Medicine, Biomedical center, Reykjavik, 
      Iceland.
FAU - Ogretmen, Besim
AU  - Ogretmen B
AD  - Hollings Cancer Center, Department of Biochemistry and Molecular Biology, 
      Charleston, SC, USA.
FAU - Oh, Goo Taeg
AU  - Oh GT
AD  - Ewha Womans University, Department of Life Science, Immune and Vascular Cell 
      Network Research Center, National Creative Initiatives, Seoul, Korea.
FAU - Oh, Seon-Hee
AU  - Oh SH
AD  - Chosun University, School of Medicine, Gwangju, Korea.
FAU - Oh, Young J
AU  - Oh YJ
AD  - Yonsei University, Wonju, Korea.
FAU - Ohama, Takashi
AU  - Ohama T
AD  - Yamaguchi University, Joint Faculty of Veterinary Medicine, Laboratory of 
      Veterinary Pharmacology, Yoshida, Yamaguchi, Japan.
FAU - Ohashi, Yohei
AU  - Ohashi Y
AD  - MRC Laboratory of Molecular Biology, Cambridge, UK.
FAU - Ohmuraya, Masaki
AU  - Ohmuraya M
AD  - Hyogo College of Medicine, Department of Genetics, Hyogo, Japan.
FAU - Oikonomou, Vasileios
AU  - Oikonomou V
AD  - University of Perugia, Department of Medicine and Surgery, Perugia, Italy.
FAU - Ojha, Rani
AU  - Ojha R
AD  - Stanford University, School of Medicine, Department of Pathology, CA, USA.
FAU - Okamoto, Koji
AU  - Okamoto K
AD  - Osaka University, Laboratory of Mitochondrial Dynamics, Graduate School of 
      Frontier Biosciences, Osaka, Japan.
FAU - Okazawa, Hitoshi
AU  - Okazawa H
AD  - Tokyo Medical and Dental University, Tokyo, Japan.
FAU - Oku, Masahide
AU  - Oku M
AD  - Kyoto University of Advanced Science, Faculty of Bioenvironmental Science, 
      Kameoka, Kyoto, Japan.
FAU - Oliván, Sara
AU  - Oliván S
AD  - University of Zaragoza, Faculty of Veterinary-IIS Aragón, IA2-CITA, CIBERNED, 
      Laboratory of Genetics and Biochemistry (LAGENBIO), Zaragoza, Spain.
FAU - Oliveira, Jorge M A
AU  - Oliveira JMA
AD  - University of Porto, REQUIMTE/UCIBIO, Faculty of Pharmacy, Porto, Portugal.
FAU - Ollmann, Michael
AU  - Ollmann M
AD  - Amgen Inc., South San Francisco, CA, USA.
FAU - Olzmann, James A
AU  - Olzmann JA
AD  - University of California, Berkeley, Departments of Molecular and Cell Biology and 
      Nutritional Sciences and Toxicology, Berkeley, CA, USA; Chan Zuckerberg Biohub, 
      San Francisco, CA, USA.
FAU - Omari, Shakib
AU  - Omari S
AD  - National Institutes of Health, Eunice Kennedy Shriver National Institute of Child 
      Health and Human Development, Bethesda, MD, USA.
FAU - Omary, M Bishr
AU  - Omary MB
AD  - Rutgers University, Center for Advanced Biotechnology and Medicine, Piscataway, 
      NJ, USA.
FAU - Önal, Gizem
AU  - Önal G
AD  - Hacettepe University, Faculty of Medicine, Department of Medical Biology, Ankara, 
      Turkey.
FAU - Ondrej, Martin
AU  - Ondrej M
AD  - University of Defense, Faculty of Military Health Sciences, Department of 
      Radiobiology, Hradec Kralove, Czech Republic.
FAU - Ong, Sang-Bing
AU  - Ong SB
AD  - The Chinese University of Hong Kong, Lui Che Woo Institute of Innovative 
      Medicine, Centre for Cardiovascular Genomics and Medicine (CCGM), Shatin, Hong 
      Kong, China; The Chinese University of Hong Kong, Faculty of Medicine, Department 
      of Medicine & Therapeutics, Shatin, Hong Kong, China; Hong Kong Hub of Paediatric 
      Excellence (HK HOPE), Hong Kong Children's Hospital, Kowloon, Hong Kong, China; 
      Xiamen University, Xiamen Cardiovascular Hospital, Institute for Translational 
      Medicine, Xiamen, China; Chinese Academy of Sciences, Kunming Institute of 
      Zoology - The Chinese University of Hong Kong (KIZ-CUHK) Joint Laboratory of 
      Bioresources and Molecular Research of Common Diseases, Kunming, Yunnan, China.
FAU - Ong, Sang-Ging
AU  - Ong SG
AD  - The University of Illinois at Chicago College of Medicine, Department of 
      Pharmacology, Chicago, IL, USA.
FAU - Onnis, Anna
AU  - Onnis A
AD  - University of Siena, Department of Life Sciences, Siena, Italy.
FAU - Orellana, Juan A
AU  - Orellana JA
AD  - Pontificia Universidad Católica de Chile, Escuela de Medicina and Centro 
      Interdisciplinario de Neurociencias, Facultad de Medicina, Departamento de 
      Neurología, Santiago, Chile.
FAU - Orellana-Muñoz, Sara
AU  - Orellana-Muñoz S
AD  - The Norwegian Radium Hospital, Institute for Cancer Research, Department of 
      Molecular Cell Biology, Montebello, Oslo, Norway; University of Oslo, Faculty of 
      Mathematics and Natural Sciences, The Department of Biosciences, Oslo, Norway.
AD  - The Norwegian Radium Hospital, Institute for Cancer Research, Department of 
      Molecular Cell Biology, Montebello, Oslo, Norway; University of Oslo, Faculty of 
      Medicine, Institute of Clinical Medicine, Centre for Cancer Cell Reprogramming, 
      Oslo, Norway.
FAU - Ortega-Villaizan, Maria Del Mar
AU  - Ortega-Villaizan MDM
AD  - Universidad Miguel Hernández (UMH), Instituto de Investigación, Desarrollo e 
      Innovación en Biotecnología Sanitaria de Elche (IDiBE), Elche, Spain.
FAU - Ortiz-Gonzalez, Xilma R
AU  - Ortiz-Gonzalez XR
AD  - University of Pennsylvania Perelman School of Medicine and Division of Neurology, 
      The Children's Hospital of Philadelphia, Department of Neurology, Philadelphia, 
      PA, USA.
FAU - Ortona, Elena
AU  - Ortona E
AD  - Center for gender-specific medicine, Italian National Health Institute, Rome, 
      Italy.
FAU - Osiewacz, Heinz D
AU  - Osiewacz HD
AD  - Goethe University, Institute for Molecular Biosciences, Frankfurt/Main, Germany.
FAU - Osman, Abdel-Hamid K
AU  - Osman AK
AD  - Suez Canal University, Faculty of Veterinary Medicine, Ismailia, Egypt.
FAU - Osta, Rosario
AU  - Osta R
AD  - University of Zaragoza, Faculty of Veterinary-IIS Aragón, IA2-CITA, CIBERNED, 
      Laboratory of Genetics and Biochemistry (LAGENBIO), Zaragoza, Spain.
FAU - Otegui, Marisa S
AU  - Otegui MS
AD  - University of Wisconsin-Madison, Center for Quantitative Cell Imaging and 
      Department of Botany, Madison, WI, USA.
FAU - Otsu, Kinya
AU  - Otsu K
AD  - King's College London, School of Cardiovascular Medicine and Sciences, London, 
      UK.
FAU - Ott, Christiane
AU  - Ott C
AD  - German Institute of Human Nutrition Potsdam-Rehbruecke, Department of Molecular 
      Toxicology, Nuthetal, Germany.
FAU - Ottobrini, Luisa
AU  - Ottobrini L
AD  - Department of Pathophysiology and Transplantation, University of Milan, Milan, 
      Italy; Institute of Molecular Bioimaging and Physiology (IBFM), CNR, Milan, 
      Italy.
FAU - Ou, Jing-Hsiung James
AU  - Ou JJ
AD  - University of Southern California, Keck School of Medicine, Department of 
      Molecular Microbiology and Immunology, Los Angeles, CA, USA.
FAU - Outeiro, Tiago F
AU  - Outeiro TF
AD  - University Medical Center Göttingen, Center for Biostructural Imaging of 
      Neurodegeneration, Department of Experimental Neurodegeneration, Göttingen, 
      Germany; Max Planck Institute for Experimental Medicine, Göttingen, Germany; 
      Newcastle University, The Medical School, Institute of Neuroscience, Newcastle 
      upon Tyne, UK.
FAU - Oynebraten, Inger
AU  - Oynebraten I
AD  - Oslo University Hospital and University of Oslo, Department of Pathology, Tumor 
      Immunology Lab, Oslo, Norway.
FAU - Ozturk, Melek
AU  - Ozturk M
AD  - Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Medical Biology 
      Department, Istanbul, Turkey.
FAU - Pagès, Gilles
AU  - Pagès G
AD  - University Côte d'Azur (UCA), Institute for Research on Cancer and Aging of Nice 
      (IRCAN), Centre National de la Recherche Scientifique (CNRS) UMR7284, Institut 
      National de la Santé et de la Recherche Médicale (INSERM) U1081, Nice, France.
FAU - Pahari, Susanta
AU  - Pahari S
AD  - Texas Biomedical Research Institute, Host-Pathogen Interactions Program, San 
      Antonio, TX, USA.
FAU - Pajares, Marta
AU  - Pajares M
AD  - Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas 
      (CIBERNED), Instituto de Investigación Sanitaria La Paz (IdiPaz), Instituto de 
      Investigaciones Biomédicas Alberto Sols UAM-CSIC, Madrid, Spain; Universidad 
      Autónoma de Madrid, School of Medicine, Department of Biochemistry, Madrid, 
      Spain.
FAU - Pajvani, Utpal B
AU  - Pajvani UB
AD  - Columbia University, Department of Medicine, New York, NY, USA.
FAU - Pal, Rituraj
AU  - Pal R
AD  - Baylor College of Medicine, Department of Molecular and Human Genetics, Houston, 
      TX, USA.
FAU - Paladino, Simona
AU  - Paladino S
AD  - University of Naples Federico II, Department of Molecular Medicine and Medical 
      Biotechnology, Naples, Italy.
FAU - Pallet, Nicolas
AU  - Pallet N
AD  - Université de Paris, Centre de Recherche des Cordeliers, Paris, France.
FAU - Palmieri, Michela
AU  - Palmieri M
AD  - Fondazione IRCCS Ospedale San Raffaele, Division of Neuroscience, Milan, Italy.
FAU - Palmisano, Giuseppe
AU  - Palmisano G
AD  - University of São Paulo, Department of Parasitology, São Paulo, Brazil.
FAU - Palumbo, Camilla
AU  - Palumbo C
AD  - University of Rome Tor Vergata, Department of Clinical Sciences and Translational 
      Medicine, Rome, Italy.
FAU - Pampaloni, Francesco
AU  - Pampaloni F
AD  - Goethe University Frankfurt, Buchmann Institute for Molecular Life Sciences 
      (BMLS), Frankfurt am Main, Germany.
FAU - Pan, Lifeng
AU  - Pan L
AD  - Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, 
      China.
FAU - Pan, Qingjun
AU  - Pan Q
AD  - Affiliated Hospital of GuangDong Medical University, Key Laboratory of Prevention 
      and Management of Chronic Kidney Disease of Zhanjiang City, Zhanjiang, Guangdong, 
      China.
FAU - Pan, Wenliang
AU  - Pan W
AD  - Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
FAU - Pan, Xin
AU  - Pan X
AD  - National Center of Biomedical Analysis, Beijing, China.
FAU - Panasyuk, Ganna
AU  - Panasyuk G
AD  - Institut Necker-Enfants Malades (INEM), INSERM U1151/CNRS UMR 8253, Université de 
      Paris, Paris, France.
FAU - Pandey, Rahul
AU  - Pandey R
AD  - The Children's Hospital of Philadelphia, Center for Applied Genomics, 
      Philadelphia, PA, USA.
FAU - Pandey, Udai B
AU  - Pandey UB
AD  - University of Pittsburgh Medical Center, Department of Pediatrics, Pittsburgh, 
      PA, USA.
FAU - Pandya, Vrajesh
AU  - Pandya V
AD  - University of Alberta, Department of Biochemistry, Edmonton, Canada.
FAU - Paneni, Francesco
AU  - Paneni F
AD  - University of Zürich, Schlieren Campus, Center for Molecular Cardiology, 
      Schlieren, Switzerland.
FAU - Pang, Shirley Y
AU  - Pang SY
AD  - University of Hong Kong, Department of Medicine, Division of Neurology, Pokfulam, 
      Hong Kong, China.
FAU - Panzarini, Elisa
AU  - Panzarini E
AD  - University of Salento, Department of Biological and Environmental Sciences and 
      Technologies (Di.S.Te.B.A.), Lecce, Italy.
FAU - Papademetrio, Daniela L
AU  - Papademetrio DL
AD  - Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de 
      Microbiología, Inmunología y Biotecnología, Cátedra de Inmunología, Buenos Aires, 
      Argentina; Universidad de Buenos Aires, CONICET, Instituto de Estudios de la 
      Inmunidad Humoral (IDEHU), Buenos Aires, Argentina.
FAU - Papaleo, Elena
AU  - Papaleo E
AD  - Danish Cancer Society Research Center, Computational Biology Laboratory, 
      Copenhagen, Denmark.
FAU - Papinski, Daniel
AU  - Papinski D
AD  - Max Perutz Labs, University of Vienna, Vienna Biocenter (VBC), Vienna, Austria.
FAU - Papp, Diana
AU  - Papp D
AD  - Quadram Institute Bioscience, Department of Gut, Microbes and Health, Norwich, 
      UK.
FAU - Park, Eun Chan
AU  - Park EC
AD  - Waksman Institute, Department of Genetics, Rutgers University, Piscataway, NJ, 
      USA.
FAU - Park, Hwan Tae
AU  - Park HT
AD  - Dong-A University Medical School, Department of Molecular Neuroscience, Busan, 
      Korea.
FAU - Park, Ji-Man
AU  - Park JM
AD  - University of Minnesota, Department of Biochemistry, Molecular Biology, and 
      Biophysics, Minneapolis, MN, USA.
FAU - Park, Jong-In
AU  - Park JI
AD  - Medical College of Wisconsin, Department of Biochemistry, Milwaukee, WI, USA.
FAU - Park, Joon Tae
AU  - Park JT
AD  - Incheon National University, Division of Life Sciences, College of Life Sciences 
      and Bioengineering, Incheon, Korea.
FAU - Park, Junsoo
AU  - Park J
AD  - Yonsei University, Division of Biological Science and Technology, Wonju, Korea.
FAU - Park, Sang Chul
AU  - Park SC
AD  - Chonnam National University, The Future Life & Society Research Center, Gwangju, 
      Korea.
FAU - Park, Sang-Youel
AU  - Park SY
AD  - Chonbuk National University, Department of VeterinaryMedicine, Iksan, Korea.
FAU - Parola, Abraham H
AU  - Parola AH
AD  - Ben Gurion University of the Negev, Department of Chemistry, Be'er Sheva, Israel.
FAU - Parys, Jan B
AU  - Parys JB
AD  - KU Leuven, Department of Cellular and Molecular Medicine & Leuven Kanker 
      Instituut, Leuven, Belgium.
FAU - Pasquier, Adrien
AU  - Pasquier A
AD  - Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.
FAU - Pasquier, Benoit
AU  - Pasquier B
AD  - Sanofi, Vitry Sur Seine, France.
FAU - Passos, João F
AU  - Passos JF
AD  - Mayo Clinic, Department of Physiology and Biomedical Engineering, Rochester, MN, 
      USA.
FAU - Pastore, Nunzia
AU  - Pastore N
AD  - Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.
AD  - Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy; Baylor 
      College of Medicine, Houston, TX, USA.
AD  - University of Naples Federico II, Department of Translational Medical Sciences, 
      Naples, Italy.
FAU - Patel, Hemal H
AU  - Patel HH
AD  - VA San Diego Healthcare Systems and University of California, San Diego, 
      Department of Anesthesiology, La Jolla, CA, USA.
FAU - Patschan, Daniel
AU  - Patschan D
AD  - Internal Medicine 1, Brandenburg Hospital, Faculty of Health Sciences, Joint 
      Faculty of the Brandenburg University of Technology Cottbus Senftenberg, the 
      Brandenburg Medical School Theodor Fontane and the University of Potsdam, 
      Brandenburg, Germany.
FAU - Pattingre, Sophie
AU  - Pattingre S
AD  - IRCM, Institut de Recherche en Cancérologie de Montpellier, Tumor 
      Microenvironment and Resistance to Treatment Laboratory, INSERM U1194, Université 
      de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France.
FAU - Pedraza-Alva, Gustavo
AU  - Pedraza-Alva G
AD  - Universidad Nacional Autónoma de México, Instituto de Biotecnología, Departamento 
      de Medicina Molecular y Bioprocesos, Laboratorio de Neuroinmunobiología, 
      Cuernavaca, Morelos, México.
FAU - Pedraza-Chaverri, Jose
AU  - Pedraza-Chaverri J
AD  - National Autonomous University of Mexico, Faculty of Chemistry, Department of 
      Biology, Mexico city, Mexico.
FAU - Pedrozo, Zully
AU  - Pedrozo Z
AD  - Universidad de Chile, School of Medicine, Instituto de Ciencias Biomédicas, 
      Santiago de Chile, Chile.
FAU - Pei, Gang
AU  - Pei G
AD  - Friedrich-Loeffler-Institut, Insitute of Immunology, Greifswald - Insel Riem, 
      Germany.
FAU - Pei, Jianming
AU  - Pei J
AD  - The Fourth Military Medical University, National Key Discipline of Cell Biology, 
      Department of Physiology and Pathophysiology, Xi'an, Shaanxi, China.
FAU - Peled-Zehavi, Hadas
AU  - Peled-Zehavi H
AD  - Weizmann Institute of Science, Department of Plant and Environmental Sciences, 
      Rehovot, Israel.
FAU - Pellegrini, Joaquín M
AU  - Pellegrini JM
AD  - Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y 
      Técnicas, Instituto de Química Biológica de la Facultad de Ciencias Exactas y 
      Naturales (IQUIBICEN), Buenos Aires, Argentina.
FAU - Pelletier, Joffrey
AU  - Pelletier J
AD  - Metabolism and Cancer Laboratory, Molecular Mechanisms and Experimental Therapy 
      in Oncology Program (Oncobell), Institut d'Investigació Biomèdica de Bellvitge - 
      IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
FAU - Peñalva, Miguel A
AU  - Peñalva MA
AD  - Centro de Investigaciones Biológicas CSIC, Department of Cellular and Molecular 
      Biology, Madrid, Spain.
FAU - Peng, Di
AU  - Peng D
AD  - Huazhong University of Science and Technology, College of Life Science and 
      Technology, Hubei Bioinformatics and Molecular Imaging Key Laboratory, Key 
      Laboratory of Molecular Biophysics of Ministry of Education, Wuhan, Hubei, China.
FAU - Peng, Ying
AU  - Peng Y
AD  - Sun Yat-Sen University, Sun Yat-sen Memorial Hospital, Department of Neurology, 
      Guangzhou City, Guangdong, China.
FAU - Penna, Fabio
AU  - Penna F
AD  - University of Turin, Department of Clinical and Biological Sciences, Turin, 
      Italy.
FAU - Pennuto, Maria
AU  - Pennuto M
AD  - University of Padova, Department of Biomedical Sciences, Padova, Italy.
FAU - Pentimalli, Francesca
AU  - Pentimalli F
AD  - Fondazione G. Pascale, Istituto Nazionale Tumori IRCCS, Cell Biology and 
      Biotherapy Unit, Naples, Italy.
FAU - Pereira, Cláudia Mf
AU  - Pereira CM
AD  - University of Coimbra, CNC - Center for Neuroscience and Cell Biology & Faculty 
      of Medicine & CIBB - Center for Innovative Biomedicine and Biotechnology, 
      Coimbra, Portugal.
FAU - Pereira, Gustavo J S
AU  - Pereira GJS
AD  - Universidade Federal de São Paulo, Paulista School of Medicine, Departament of 
      Pharmacology, São Paulo, Brazil.
FAU - Pereira, Lilian C
AU  - Pereira LC
AD  - São Paulo State University, College of Agronomy Sciences, Department of 
      Bioprocesses and Biotechnology, Center for Evaluation of Environmental Impact on 
      Human Health (TOXICAM), Botucatu, SP, Brazil.
FAU - Pereira de Almeida, Luis
AU  - Pereira de Almeida L
AD  - University of Coimbra, Portugal, CNC - Center for Neuroscience and Cell Biology & 
      Faculty of Pharmacy, Coimbra, Portugal.
FAU - Perera, Nirma D
AU  - Perera ND
AD  - University of Melbourne, Florey Institute of Neuroscience and Mental Health, 
      Melbourne, VIC, Australia.
FAU - Pérez-Lara, Ángel
AU  - Pérez-Lara Á
AD  - University of Granada, Faculty of Pharmacy, Department of Physical Chemistry, 
      Granada, Spain.
FAU - Perez-Oliva, Ana B
AU  - Perez-Oliva AB
AD  - Departmento de Biología Celular e Histología, Facultad de Biología, Universidad 
      de Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB)-Arrixaca, 
      Murcia, Spain.
FAU - Pérez-Pérez, María Esther
AU  - Pérez-Pérez ME
AD  - CSIC-Universidad de Sevilla, Instituto de Bioquímica Vegetal y Fotosíntesis, 
      Sevilla, Spain.
FAU - Periyasamy, Palsamy
AU  - Periyasamy P
AD  - University of Nebraska Medical Center, Department of Pharmacology and 
      Experimental Neuroscience, Omaha, NE, USA.
FAU - Perl, Andras
AU  - Perl A
AD  - State University of New York, Upstate Medical University, Departments of 
      Medicine, Microbiology and Immunology, Biochemistry and Molecular Biology, 
      Syracuse, NY, USA.
FAU - Perrotta, Cristiana
AU  - Perrotta C
AD  - Università degli Studi di Milano, Department of Biomedical and Clinical Sciences 
      "L. Sacco", Milan, Italy.
FAU - Perrotta, Ida
AU  - Perrotta I
AD  - University of Calabria, Department of Biology, Ecology and Earth Sciences, Centre 
      for Microscopy and Microanalysis (CM2), Rende (CS), Calabria, Italy.
FAU - Pestell, Richard G
AU  - Pestell RG
AD  - Baruch S. Blumberg Institute, Pennsylvania Cancer and Regenerative Medicine 
      Research Center, Wynnewood, PA, USA; Xavier University School of Medicine, 
      Woodbury, NY, USA.
FAU - Petersen, Morten
AU  - Petersen M
AD  - University of Copenhagen, Department of Biology, Copenhagen, Denmark.
FAU - Petrache, Irina
AU  - Petrache I
AD  - National Jewish Health and the University of Colorado, Denver, CO, USA.
FAU - Petrovski, Goran
AU  - Petrovski G
AD  - University of Oslo, Oslo University Hospital and Institute for Clinical Medicine, 
      Department of Ophthalmology, Center for Eye Research, Oslo, Norway.
FAU - Pfirrmann, Thorsten
AU  - Pfirrmann T
AD  - Health and Medical University, Potsdam, Germany.
FAU - Pfister, Astrid S
AU  - Pfister AS
AD  - Ulm University, Institute of Biochemistry and Molecular Biology, Faculty of 
      Medicine, Ulm, Germany.
FAU - Philips, Jennifer A
AU  - Philips JA
AD  - Washington University, Division of Infectious Diseases, Department of Medicine 
      and Molecular Microbiology, St. Louis, MO, USA.
FAU - Pi, Huifeng
AU  - Pi H
AD  - Third Military Medical University, Department of Occupational Health, Chongqing, 
      China.
FAU - Picca, Anna
AU  - Picca A
AD  - Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, Rome, Italy.
FAU - Pickrell, Alicia M
AU  - Pickrell AM
AD  - Virginia Polytechnic Institute and State University, School of Neuroscience, 
      Blacksburg, VA, USA.
FAU - Picot, Sandy
AU  - Picot S
AD  - Ifremer, SG2M-LGPMM, Laboratoire de Génétique et Pathologie des Mollusques 
      Marins, La Tremblade, France.
FAU - Pierantoni, Giovanna M
AU  - Pierantoni GM
AD  - University of Naples Federico II, Department of Molecular Medicine and Medical 
      Biotechnology, Naples, Italy.
FAU - Pierdominici, Marina
AU  - Pierdominici M
AD  - Center for gender-specific medicine, Italian National Health Institute, Rome, 
      Italy.
FAU - Pierre, Philippe
AU  - Pierre P
AD  - Aix Marseille Université, CNRS, INSERM, CIML, 13288 Marseille cedex 9, France; 
      Institute for Research in Biomedicine (iBiMED) and Ilidio Pinho Foundation, 
      Department of Medical Sciences, University of Aveiro, 3810-193 Aveiro, Portugal; 
      Shanghai Institute of Immunology, Department of Microbiology and Immunology, 
      Shanghai Jiao Tong University School of Medicine, Shanghai 200025, PR China.
FAU - Pierrefite-Carle, Valérie
AU  - Pierrefite-Carle V
AD  - Université Côte d'Azur, Université Nice Sophia Antipolis, CEA/DRF/Institut 
      Frédéric Joliot, Faculté de Médecine, UMR E-4320 TIRO-MATOs, Nice, France.
FAU - Pierzynowska, Karolina
AU  - Pierzynowska K
AD  - University of Gdansk, Department of Molecular Biology, Gdansk, Poland.
FAU - Pietrocola, Federico
AU  - Pietrocola F
AD  - Karolinska Institutet, Department of Biosciences and Nutrition, Huddinge, Sweden.
FAU - Pietruczuk, Miroslawa
AU  - Pietruczuk M
AD  - Medical University of Lodz, Department of Laboratory Diagnostics, Lodz, Poland.
FAU - Pignata, Claudio
AU  - Pignata C
AD  - University of Naples Federico II, Department of Translational Medical Sciences, 
      Naples, Italy.
FAU - Pimentel-Muiños, Felipe X
AU  - Pimentel-Muiños FX
AD  - Consejo Superior de Investigaciones Científicas (CSIC), Instituto de Biología 
      Molecular y Celular del Cáncer (IBMCC), Centro de Investigación del Cáncer 
      (CSIC-Universidad de Salamanca), Universidad de Salamanca, Campus Unamuno, 
      Salamanca. Spain.
FAU - Pinar, Mario
AU  - Pinar M
AD  - Centro de Investigaciones Biológicas CSIC, Department of Cellular and Molecular 
      Biology, Madrid, Spain.
FAU - Pinheiro, Roberta O
AU  - Pinheiro RO
AD  - Oswaldo Cruz Foundation, Oswaldo Cruz Institute, Leprosy Laboratory, Rio de 
      Janeiro, Brazil.
FAU - Pinkas-Kramarski, Ronit
AU  - Pinkas-Kramarski R
AD  - Tel Aviv University, School of Neurobiology, Biochemistry and Biophysics, Tel 
      Aviv, Israel.
FAU - Pinton, Paolo
AU  - Pinton P
AD  - University of Ferrara, Department of Morphology, Surgery and Experimental 
      Medicine, Ferrara, Italy.
FAU - Pircs, Karolina
AU  - Pircs K
AD  - Lund University, Department of Experimental Medical Science, Laboratory of 
      Molecular Neurogenetics, Wallenberg Neuroscience Center and Lund Stem Cell 
      Center, Lund, Sweden.
FAU - Piya, Sujan
AU  - Piya S
AD  - The University of Texas MD Anderson Cancer Center, Department of Leukemia, 
      Houston, TX, USA.
FAU - Pizzo, Paola
AU  - Pizzo P
AD  - University of Padua, Department of Biomedical Sciences, Padua, Italy; Italian 
      National Research Council (CNR), Neuroscience Institute, Padua, Italy.
FAU - Plantinga, Theo S
AU  - Plantinga TS
AD  - Radboud University Medical Center, Nijmegen, The Netherlands.
FAU - Platta, Harald W
AU  - Platta HW
AD  - Ruhr-Universität Bochum, Medizinische Fakultät, Biochemie Intrazellulärer 
      Transportprozesse, Bochum, Germany.
FAU - Plaza-Zabala, Ainhoa
AU  - Plaza-Zabala A
AD  - Achucarro Basque Center for Neuroscience, Department of Pharmacology, University 
      of the Basque Country EHU/UPV, Leioa, Bizkaia, Spain.
FAU - Plomann, Markus
AU  - Plomann M
AD  - University of Cologne, Center for Biochemistry, Cologne, Germany.
FAU - Plotnikov, Egor Y
AU  - Plotnikov EY
AD  - Moscow State University, A.N.Belozersky Institute of Physico-Chemical Biology, 
      Laboratory of Structure and function of mitochondria, Moscow, Russia.
FAU - Plun-Favreau, Helene
AU  - Plun-Favreau H
AD  - UCL Queen Square Institute of Neurology, London, UK.
FAU - Pluta, Ryszard
AU  - Pluta R
AD  - Polish Academy of Sciences, Mossakowski Medical Research Centre, Laboratory of 
      Ischemic and Neurodegenerative Brain Research, Warsaw, Poland.
FAU - Pocock, Roger
AU  - Pocock R
AD  - Monash Biomedicine Discovery Institute and Monash University, Department of 
      Anatomy and Developmental Biology, Melbourne, Victoria, Australia.
FAU - Pöggeler, Stefanie
AU  - Pöggeler S
AD  - Georg-August University Göttingen, Institute of Microbiology and Genetics, 
      Department of Genetics of Eukaryotic Microorganisms, Göttingen, Germany.
FAU - Pohl, Christian
AU  - Pohl C
AD  - Buchmann Institute & Institute of Biochemistry II, Medical Faculty, Goethe 
      University, Frankfurt, Germany.
FAU - Poirot, Marc
AU  - Poirot M
AD  - Cancer Research Center of Toulouse, UMR 1037 Inserm-university of Toulouse, 
      Toulouse, France.
FAU - Poletti, Angelo
AU  - Poletti A
AD  - Università degli Studi di Milano, Dipartimento di Scienze Farmacologiche e 
      Biomolecolari, Centro di Eccellenza per lo studio delle Malattie 
      Neurodegenerative, Milano, Italy.
FAU - Ponpuak, Marisa
AU  - Ponpuak M
AD  - Mahidol University, Department of Microbiology, Faculty of Science, Ratchathewi, 
      Bangkok, Thailand.
FAU - Popelka, Hana
AU  - Popelka H
AD  - University of Michigan, Life Sciences Institute, Ann Arbor, MI, USA.
FAU - Popova, Blagovesta
AU  - Popova B
AD  - Georg-August-Universität Göttingen, Institute for Microbiology and Genetics, 
      Department of Molecular Microbiology and Genetics, Göttingen, Germany.
FAU - Porta, Helena
AU  - Porta H
AD  - Universidad Nacional Autónoma de México, Institute of Biotechnology, Plant 
      Molecular Biology Department, Cuernavaca, Morelos, México.
FAU - Porte Alcon, Soledad
AU  - Porte Alcon S
AD  - Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y 
      Técnicas (CONICET), Instituto de Química Biológica Ciencias Exactas y Naturales 
      (IQUIBICEN), Facultad de Ciencias Exactas y Naturales, Departamento de Química 
      Biológica, Laboratorio de Disfunción Celular en Enfermedades Neurodegenerativas y 
      Nanomedicina, Buenos Aires, Argentina.
FAU - Portilla-Fernandez, Eliana
AU  - Portilla-Fernandez E
AD  - Erasmus University Medical Center, Department of Epidemiology; Division of 
      Pharmacology, Department of Internal Medicine, Rotterdam, The Netherlands.
FAU - Post, Martin
AU  - Post M
AD  - The Hospital for Sick Children, Translational Medicine Program, Toronto, Canada.
FAU - Potts, Malia B
AU  - Potts MB
AD  - St. Jude Children's Research Hospital, Department of Cell and Molecular Biology, 
      Memphis, TN, USA.
FAU - Poulton, Joanna
AU  - Poulton J
AD  - University of Oxford, Nuffield Department of Women's and Reproductive Health, 
      Oxford, UK.
FAU - Powers, Ted
AU  - Powers T
AD  - University of California, Davis, Department of Molecular and Cellular Biology, 
      Davis, CA, USA.
FAU - Prahlad, Veena
AU  - Prahlad V
AD  - University of Iowa, Department of Biology, Aging Mind and Brain Initiative, Iowa 
      City, IA, USA.
FAU - Prajsnar, Tomasz K
AU  - Prajsnar TK
AD  - Jagiellonian University, Department of Evolutionary Immunology, Faculty of 
      Biology, Krakow, Poland.
FAU - Praticò, Domenico
AU  - Praticò D
AD  - Temple University, Alzheimer's Center at Temple, Philadelphia, PA, USA.
FAU - Prencipe, Rosaria
AU  - Prencipe R
AD  - University of Naples Federico II, Department of Translational Medical Sciences, 
      Naples, Italy.
FAU - Priault, Muriel
AU  - Priault M
AD  - University of Bordeaux, CNRS, IBGC, UMR 5095, Bordeaux, France.
FAU - Proikas-Cezanne, Tassula
AU  - Proikas-Cezanne T
AD  - Eberhard Karls University Tübingen, Interfaculty Institute of Cell Biology, 
      Tübingen, Germany.
FAU - Promponas, Vasilis J
AU  - Promponas VJ
AD  - University of Cyprus, Department of Biological Sciences, Bioinformatics Research 
      Laboratory, Nicosia, Cyprus.
FAU - Proud, Christopher G
AU  - Proud CG
AD  - Lifelong Health, South Australian Health & Medical Research Institute, North 
      Terrace, Adelaide, Australia.
FAU - Puertollano, Rosa
AU  - Puertollano R
AD  - Cell and Developmental Biology Center, National Heart, Lung, and Blood Institute, 
      National Institutes of Health, Bethesda, MD, USA.
FAU - Puglielli, Luigi
AU  - Puglielli L
AD  - University of Wisconsin-Madison, Department of Medicine and Neuroscience, 
      Madison, WI, USA.
FAU - Pulinilkunnil, Thomas
AU  - Pulinilkunnil T
AD  - Dalhousie University, Department of Biochemistry and Molecular Biology, Dalhousie 
      Medicine New Brunswick, Saint John, NB, Canada.
FAU - Puri, Deepika
AU  - Puri D
AD  - National Center for Cell Science, Pune, India.
FAU - Puri, Rajat
AU  - Puri R
AD  - National Institutes of Health, National Institute of Neurological Disorders and 
      Stroke, Bethesda, MD, USA.
FAU - Puyal, Julien
AU  - Puyal J
AD  - Department of Fundamental Neurosciences, University of Lausanne, Lausanne, 
      Switzerland.
AD  - CURML, University Center of Legal Medicine, Lausanne University Hospital, 
      Lausanne, Switzerland.
FAU - Qi, Xiaopeng
AU  - Qi X
AD  - Chinese Academy of Sciences, Kunming Institute of Zoology, Key Laboratory of 
      Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences, 
      Kunming, Yunnan, China.
FAU - Qi, Yongmei
AU  - Qi Y
AD  - Lanzhou University, School of Life Sciences, Lanzhou, China.
FAU - Qian, Wenbin
AU  - Qian W
AD  - Zhejiang University, College of Medicine, The First Affiliated Hospital, 
      Malignant Lymphoma Diagnosis and Therapy Center, Hangzhou, Zhejiang, China.
FAU - Qiang, Lei
AU  - Qiang L
AD  - China Pharmaceutical University, School of Basic Medicine and Clinical Pharmacy, 
      State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of 
      Carcinogenesis and Intervention, Nanjing, China.
FAU - Qiu, Yu
AU  - Qiu Y
AD  - Sanofi, Biologics Research, 49 New York Ave, Framingham, MA, USA.
FAU - Quadrilatero, Joe
AU  - Quadrilatero J
AD  - University of Waterloo, Department of Kinesiology, Waterloo, Ontario, Canada.
FAU - Quarleri, Jorge
AU  - Quarleri J
AD  - Instituto de Investigaciones Biomedicas en Retrovirus y Sida, Universidad de 
      Buenos Aires-CONICET, Argentina.
FAU - Raben, Nina
AU  - Raben N
AD  - Cell and Developmental Biology Center, National Heart, Lung, and Blood Institute, 
      National Institutes of Health, Bethesda, MD, USA.
FAU - Rabinowich, Hannah
AU  - Rabinowich H
AD  - University of Pittsburgh, Department of Pathology; University of Pittsburgh 
      Cancer Institute, Pittsburgh, PA, USA.
FAU - Ragona, Debora
AU  - Ragona D
AD  - University of Palermo, Department of Biological, Chemical and and Pharmaceutical 
      Sciences and Technologies, Palermo, Italy.
FAU - Ragusa, Michael J
AU  - Ragusa MJ
AD  - Dartmouth College, Department of Chemistry, Hanover, NH, USA.
FAU - Rahimi, Nader
AU  - Rahimi N
AD  - Boston University, Department of Pathology and Laboratory Medicine, Boston, MA, 
      USA.
FAU - Rahmati, Marveh
AU  - Rahmati M
AD  - Tehran University of Medical Sciences, Cancer Biology Research Center, Tehran, 
      Iran.
FAU - Raia, Valeria
AU  - Raia V
AD  - University of Naples Federico II, Department of Translational Medical Sciences, 
      Naples, Italy.
FAU - Raimundo, Nuno
AU  - Raimundo N
AD  - Penn State University College of Medicine, Department of Cellular and Molecular 
      Physiology, Hershey, PA, USA.
FAU - Rajasekaran, Namakkal-Soorappan
AU  - Rajasekaran NS
AD  - University of Alabama at Birmingham, Cardiac Aging & Redox Signaling Laboratory, 
      Molecular and Cellular Pathology, Department of Pathology, Birmingham, AL, USA.
FAU - Ramachandra Rao, Sriganesh
AU  - Ramachandra Rao S
AD  - State University of New York, University at Buffalo, Jacobs School of Medicine 
      and Biomedical Sciences, Departments of Ophthalmology/Biochemistry and 
      Neuroscience Program, Buffalo, NY, USA.
FAU - Rami, Abdelhaq
AU  - Rami A
AD  - Johann Wolfgang Goethe-University, Institute of Anatomy III- 'Cellular and 
      Molecular Anatomy', Frankfurt, Germany.
FAU - Ramírez-Pardo, Ignacio
AU  - Ramírez-Pardo I
AD  - Centro de Investigaciones Biológicas Margarita Salas, CSIC, Madrid, Spain.
FAU - Ramsden, David B
AU  - Ramsden DB
AD  - University of Birmingham, Institute of Metabolism and Systems Research, 
      Birmingham, UK.
FAU - Randow, Felix
AU  - Randow F
AD  - MRC Laboratory of Molecular Biology, Division of Protein and Nucleic Acid 
      Chemistry, Cambridge, UK.
FAU - Rangarajan, Pundi N
AU  - Rangarajan PN
AD  - Indian Institute of Science, Department of Biochemistry, Bangalore, India.
FAU - Ranieri, Danilo
AU  - Ranieri D
AD  - University of Rome "Sapienza", Department of Clinical and Molecular Medicine, 
      Laboratory affiliated to Istituto Pasteur Italia Fondazione Cenci Bolognetti, 
      Rome, Italy.
FAU - Rao, Hai
AU  - Rao H
AD  - School of Medicine, the Southern University of Science and Technology, Shenzhen, 
      China.
FAU - Rao, Lang
AU  - Rao L
AD  - Baylor College of Medicine, Department of Medicine, Houston, TX, USA.
FAU - Rao, Rekha
AU  - Rao R
AD  - The University of Kansas Cancer Center, Division of Hematologic Malignancies and 
      Cellular Therapeutics, Kansas City, KS, USA.
FAU - Rathore, Sumit
AU  - Rathore S
AD  - All India Institute of Medical Sciences, Department of Biotechnology, New Delhi, 
      India.
FAU - Ratnayaka, J Arjuna
AU  - Ratnayaka JA
AD  - University of Southampton, Clinical and Experimental Sciences, Faculty of 
      Medicine, UK.
FAU - Ratovitski, Edward A
AU  - Ratovitski EA
AD  - Johns Hopkins University School of Medicine, Department of Otolaryngology/Head 
      and Neck Surgery, Head and Neck Cancer Research Division, Baltimore, MD, USA.
FAU - Ravanan, Palaniyandi
AU  - Ravanan P
AD  - Central University of Tamil Nadu, Thiruvarur, Tamil Nadu, India.
FAU - Ravegnini, Gloria
AU  - Ravegnini G
AD  - University of Bologna, Department of Pharmacy and Biotechnology, Bologna, Italy.
FAU - Ray, Swapan K
AU  - Ray SK
AD  - University of South Carolina School of Medicine, Department of Pathology, 
      Microbiology, and Immunology, Columbia, SC, USA.
FAU - Razani, Babak
AU  - Razani B
AD  - Washington University School of Medicine, Department of Medicine, Cardiovascular 
      Division,l and John Cochran VA Medical Center, St. Louis, MO, USA.
FAU - Rebecca, Vito
AU  - Rebecca V
AD  - Johns Hopkins University, Bloomberg School of Public Health, Biochemistry and 
      Molecular Biology Department, Baltimore, MD, USA.
FAU - Reggiori, Fulvio
AU  - Reggiori F
AD  - University of Groningen, University Medical Center of Groningen, Department of 
      Biomedical Sciences of Cells and Systems, Groningen, The Netherlands.
FAU - Régnier-Vigouroux, Anne
AU  - Régnier-Vigouroux A
AD  - Johannes Gutenberg University-Mainz, Institute of Developmental Biology and 
      Neurobiology, Mainz, Germany.
FAU - Reichert, Andreas S
AU  - Reichert AS
AD  - Heinrich Heine University Düsseldorf, Medical faculty, Institute of Biochemistry 
      and Molecular Biology I, Düsseldorf, Germany.
FAU - Reigada, David
AU  - Reigada D
AD  - National Hospital for Paraplagics (Sescam) Research Unit, Molecular 
      Neuroprotection Group, Toledo, Spain.
FAU - Reiling, Jan H
AU  - Reiling JH
AD  - The University of Texas MD Anderson Cancer Center, Institute for Applied Cancer 
      Science (IACS), Translational Research to Advance Therapeutics and Innovation in 
      Oncology (TRACTION), Houston, TX, USA.
FAU - Rein, Theo
AU  - Rein T
AD  - Max Planck Institute of Psychiatry, Translational Research in Psychiatry, Munich, 
      Germany.
FAU - Reipert, Siegfried
AU  - Reipert S
AD  - University of Vienna, Cell Imaging and Ultrastructure Research (CIUS), Vienna, 
      Austria.
FAU - Rekha, Rokeya Sultana
AU  - Rekha RS
AD  - Karolinska Institutet, Department of Laboratory Medicine, Division of Clinical 
      Microbiology, Stockholm, Sweden.
FAU - Ren, Hongmei
AU  - Ren H
AD  - Wright State University, Department of Biochemistry & Molecular Biology, Dayton, 
      OH. USA.
FAU - Ren, Jun
AU  - Ren J
AD  - University of Wyoming, College of Health Sciences, Laramie, WY, USA.
FAU - Ren, Weichao
AU  - Ren W
AD  - Qingdao Agricultural University, College of Plant Health and Medicine, Qingdao, 
      Shandong, China.
FAU - Renault, Tristan
AU  - Renault T
AD  - Ifremer, RBE, Département Ressources, La Tremblade, France.
FAU - Renga, Giorgia
AU  - Renga G
AD  - University of Perugia, Department of Medicine and Surgery, Perugia, Italy.
FAU - Reue, Karen
AU  - Reue K
AD  - University of California, Los Angeles, David Geffen School of Medicine, 
      Department of Human Genetics, Los Angeles, CA, USA.
FAU - Rewitz, Kim
AU  - Rewitz K
AD  - University of Copenhagen, Department of Biology, Copenhagen, Denmark.
FAU - Ribeiro de Andrade Ramos, Bruna
AU  - Ribeiro de Andrade Ramos B
AD  - Botucatu Medical School, São Paulo State University, Botucatu, SP, Brazil.
FAU - Riazuddin, S Amer
AU  - Riazuddin SA
AD  - The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, 
      MD, USA.
FAU - Ribeiro-Rodrigues, Teresa M
AU  - Ribeiro-Rodrigues TM
AD  - University of Coimbra, Coimbra Institute for Clinical and Biomedical Research 
      (iCBR), Faculty of Medicine, Coimbra, Portugal; University of Coimbra, Center for 
      Innovative Biomedicine and Biotechnology, Coimbra, Portugal.
FAU - Ricci, Jean-Ehrland
AU  - Ricci JE
AD  - Université Côte d'Azur, INSERM, C3M, Nice, France.
FAU - Ricci, Romeo
AU  - Ricci R
AD  - Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France.
FAU - Riccio, Victoria
AU  - Riccio V
AD  - Hospital for Sick Children, Program in Cell Biology Department, Toronto, Canada; 
      University of Toronto, Department of Biochemistry, Toronto, Canada.
FAU - Richardson, Des R
AU  - Richardson DR
AD  - University of Sydney, Department of Pathology and Bosch Institute, Sydney, NSW, 
      Australia.
FAU - Rikihisa, Yasuko
AU  - Rikihisa Y
AD  - The Ohio State University, College of Veterinary Medicine, Department of 
      Veterinary Biosciences, Columbus, OH, USA.
FAU - Risbud, Makarand V
AU  - Risbud MV
AD  - Thomas Jefferson University, Department of Orthopaedic Surgery and Graduate 
      Program in Cell Biology and Regenerative Medicine, Philadelphia, PA, USA.
FAU - Risueño, Ruth M
AU  - Risueño RM
AD  - Josep Carreras Leukaemia Research Institute, Barcelona, Spain.
FAU - Ritis, Konstantinos
AU  - Ritis K
AD  - Democritus University of Thrace, First Department of Internal Medicine & 
      Laboratory of Molecular Hematology, Alexandroupolis, Greece.
FAU - Rizza, Salvatore
AU  - Rizza S
AD  - Redox Signaling and Oxidative Stress group, Danish Cancer Society Research 
      Center, Copenhagen, Denmark.
FAU - Rizzuto, Rosario
AU  - Rizzuto R
AD  - University of Padua, Department of Biomedical Sciences, Padua, Italy.
FAU - Roberts, Helen C
AU  - Roberts HC
AD  - Middlesex University, Department of Natural Sciences, London, UK.
FAU - Roberts, Luke D
AU  - Roberts LD
AD  - Institute of Life Sciences, School of Medicine, Swansea University, Swansea, 
      Wales, UK.
FAU - Robinson, Katherine J
AU  - Robinson KJ
AD  - Macquarie University, Faculty of Medicine, Health and Human Sciences, Department 
      of Biomedical Science, Centre for Motor Neuron Disease Research, Sydney, NSW, 
      Australia.
FAU - Roccheri, Maria Carmela
AU  - Roccheri MC
AD  - University of Palermo, Dipartimento di Scienze e Tecnologie Biologiche, Chimiche 
      e Farmaceutiche (STEBICEF), Palermo, Italy.
FAU - Rocchi, Stephane
AU  - Rocchi S
AD  - INSERM U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), Nice, France; 
      Université de Nice Sophia Antipolis, UFR de Médecine, Nice, France.
FAU - Rodney, George G
AU  - Rodney GG
AD  - Baylor College of Medicine, Department of Molecular Physiology & Biophysics, 
      Houston, TX, USA.
FAU - Rodrigues, Tiago
AU  - Rodrigues T
AD  - Federal University of ABC (UFABC), Center for Natural and Human Sciences (CCNH), 
      Santo André, SP, Brazil.
FAU - Rodrigues Silva, Vagner Ramon
AU  - Rodrigues Silva VR
AD  - University of Campinas (UNICAMP), School of Applied Science, Department of Sport 
      Sciences, Limeira, Brazil.
FAU - Rodriguez, Amaia
AU  - Rodriguez A
AD  - Clínica Universidad de Navarra, Metabolic Research Laboratory, CIBEROBN, IdiSNA, 
      Pamplona, Spain.
FAU - Rodriguez-Barrueco, Ruth
AU  - Rodriguez-Barrueco R
AD  - University of Barcelona, School of Medicine, Unit of Anatomy, Department of 
      Pathology and Experimental Therapeutics, Barcelona, Spain; L'Hospitalet de 
      Llobregat, Institut d'Investigació Biomèdica de Bellvitge -IDIBELL, Molecular 
      Mechanisms and Experimental Therapy in Oncology Program (oncobell), Barcelona, 
      Spain.
FAU - Rodriguez-Henche, Nieves
AU  - Rodriguez-Henche N
AD  - University of Alcalá, Deparment of Systems Biology, Biochemistry and Molecular 
      Biology, Alcalá de Henares, Madrid, Spain.
FAU - Rodriguez-Rocha, Humberto
AU  - Rodriguez-Rocha H
AD  - Universidad Autonoma de Nuevo Leon, School of Medicine, Department of Histology, 
      Monterrey, Nuevo Leon, Mexico.
FAU - Roelofs, Jeroen
AU  - Roelofs J
AD  - University of Kansas Medical Center, Department of Biochemistry and Molecular 
      Biology, Kansas City, KS, USA.
FAU - Rogers, Robert S
AU  - Rogers RS
AD  - Kansas City University of Medicine and Biosciences, Department of Basic Science, 
      Kansas City, MO, USA.
FAU - Rogov, Vladimir V
AU  - Rogov VV
AD  - Goethe University Frankfurt, Institute of Pharmaceutical Chemistry, Frankfurt am 
      Main, Germany.
FAU - Rojo, Ana I
AU  - Rojo AI
AD  - Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas 
      (CIBERNED), Instituto de Investigación Sanitaria La Paz (IdiPaz), Instituto de 
      Investigaciones Biomédicas Alberto Sols UAM-CSIC, Madrid, Spain; Universidad 
      Autónoma de Madrid, School of Medicine, Department of Biochemistry, Madrid, 
      Spain.
FAU - Rolka, Krzysztof
AU  - Rolka K
AD  - University of Gdansk, Faculty of Chemistry, Gdansk, Poland.
FAU - Romanello, Vanina
AU  - Romanello V
AD  - University of Padova, Department of Biomedical Sciences, Padova, Italy.
FAU - Romani, Luigina
AU  - Romani L
AD  - Department of Medicine and Surgery, University of Perugia, Perugia Italy.
FAU - Romano, Alessandra
AU  - Romano A
AD  - Università degli Studi di Catania, Dipartimento di Chirurgia Generale e 
      Specialità Medico-Chirurgiche, Catania, Italy.
FAU - Romano, Patricia S
AU  - Romano PS
AD  - CONICET-Universidad Nacional de Cuyo, Instituto de Histología y Embriología de 
      Mendoza, Mendoza, Argentina.
FAU - Romeo-Guitart, David
AU  - Romeo-Guitart D
AD  - INSERM U1151, Institut Necker Enfants-Malades (INEM), Team 8, Université Paris 
      Descartes-Sorbonne-Paris Cité, Paris, France.
FAU - Romero, Luis C
AU  - Romero LC
AD  - Consejo Superior de Investigaciones Científicas, Instituto de Bioquímica Vegetal 
      y Fotosíntesis (CSIC-IBVF), Sevilla, Spain.
FAU - Romero, Montserrat
AU  - Romero M
AD  - Barcelona Institute of Science and Technology (BIST), Institute for Research in 
      Biomedicine (IRB Barcelona), Barcelona, Spain; CIBER de Diabetes y Enfermedades 
      Metabólicas Asociadas, Barcelona, Spain; Universitat de Barcelona, Facultat de 
      Biologia, Departament de Bioquimica i Biomedicina Molecular, Barcelona, Spain.
FAU - Roney, Joseph C
AU  - Roney JC
AD  - National Institutes of Health, National Institute of Neurological Disorders and 
      Stroke, Bethesda, MD, USA.
FAU - Rongo, Christopher
AU  - Rongo C
AD  - Waksman Institute, Department of Genetics, Rutgers University, Piscataway, NJ, 
      USA.
FAU - Roperto, Sante
AU  - Roperto S
AD  - Naples University, Department of Veterinary Medicine and Animal Productions, 
      Naples, Italy.
FAU - Rosenfeldt, Mathias T
AU  - Rosenfeldt MT
AD  - University of Würzburg, Institute of Pathology, Würzburg, Germany.
FAU - Rosenstiel, Philip
AU  - Rosenstiel P
AD  - Kiel University and University Hospital Schleswig-Holstein, Campus Kiel, 
      Institute of Clinical Molecular Biology, Kiel, SH, Germany.
FAU - Rosenwald, Anne G
AU  - Rosenwald AG
AD  - Georgetown University, Department of Biology, Washington, DC, USA.
FAU - Roth, Kevin A
AU  - Roth KA
AD  - Columbia University, Department of Pathology and Cell Biology, New York, NY, USA.
FAU - Roth, Lynn
AU  - Roth L
AD  - University of Antwerp, Laboratory of Physiopharmacology, Antwerp, Belgium.
FAU - Roth, Steven
AU  - Roth S
AD  - University of Illinois, Department of Anesthesiology, Chicago, IL, USA.
FAU - Rouschop, Kasper M A
AU  - Rouschop KMA
AD  - Maastricht University Medical Center, GROW School for Oncology, Department of 
      Radiotherapy, Maastricht|, The Netherlands.
FAU - Roussel, Benoit D
AU  - Roussel BD
AD  - Normandy University, UNICAEN, INSERM, UMR-S U1237, Physiopathology and Imaging of 
      Neurological Disorders (PhIND), Institute Blood and Brain @Caen-Normandie (BB@C), 
      GIP Cyceron, Caen, FRANCE.
FAU - Roux, Sophie
AU  - Roux S
AD  - University of Sherbrooke, Division of Rheumatology, Department of Medicine, 
      Sherbrooke, QC, Canada.
FAU - Rovere-Querini, Patrizia
AU  - Rovere-Querini P
AD  - Vita-Salute San Raffaele University & IRCCS San Raffaele Scientific Institute, 
      Division of Immunology, Transplantation and Infectious Diseases, Milano, Italy.
FAU - Roy, Ajit
AU  - Roy A
AD  - Section on Eukaryotic DNA Replication, National Institute of Child Health and 
      Human Development, National Institutes of Health, Bethesda, MD,USA.
FAU - Rozieres, Aurore
AU  - Rozieres A
AD  - Centre International de Recherche en Infectiologie (CIRI), University Lyon, 
      Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS Lyon, Lyon, 
      France.
FAU - Ruano, Diego
AU  - Ruano D
AD  - University of Seville. School of Pharmacy, Instituto de Biomedicina de Sevilla. 
      Sevilla, Spain.
FAU - Rubinsztein, David C
AU  - Rubinsztein DC
AD  - University of Cambridge, Cambridge Institute for Medical Research, UK Dementia 
      Research Institute and Department of Medical Genetics, Cambridge, UK.
FAU - Rubtsova, Maria P
AU  - Rubtsova MP
AD  - Lomonosov Moscow State University, Chemistry Department, Moscow, Russia.
FAU - Ruckdeschel, Klaus
AU  - Ruckdeschel K
AD  - University Medical Center Eppendorf, Institute for Medical Microbiology, Hamburg, 
      Germany.
FAU - Ruckenstuhl, Christoph
AU  - Ruckenstuhl C
AD  - University of Graz, Institute of Molecular Biosciences, NAWI Graz, Graz, Austria.
FAU - Rudolf, Emil
AU  - Rudolf E
AD  - Charles University, Faculty of Medicine in Hradec Kralove, Department of Medical 
      Biology and Genetics, Hradec Kralove, Czech Republic.
FAU - Rudolf, Rüdiger
AU  - Rudolf R
AD  - Mannheim University of Applied Sciences, Faculty of Biotechnology, Mannheim, 
      Germany.
FAU - Ruggieri, Alessandra
AU  - Ruggieri A
AD  - Fondazione IRCCS Istituto Neurologico Carlo Besta, Neuromuscular Disease and 
      Immunology Unit, Milan, Italy; University of Brescia, Unit of Biology and 
      Genetics, Department of Molecular and Translation Medicine, Brescia, Italy.
FAU - Ruparelia, Avnika Ashok
AU  - Ruparelia AA
AD  - Australian Regenerative Medicine Institute, Monash University, Clayton, Victoria, 
      Australia.
FAU - Rusmini, Paola
AU  - Rusmini P
AD  - Università degli Studi di Milano, Dipartimento di Scienze Farmacologiche e 
      Biomolecolari, Centro di Eccellenza per lo studio delle Malattie 
      Neurodegenerative, Milano, Italy.
FAU - Russell, Ryan R
AU  - Russell RR
AD  - University of Ottawa, Department of Cellular and Molecular Medicine, Ottawa, ON, 
      Canada.
FAU - Russo, Gian Luigi
AU  - Russo GL
AD  - National Research Council, Institute of Food Sciences, Avellino, Italy.
AD  - Stazione Zoologica "Anton Dohrn", Napoli, Italy.
FAU - Russo, Maria
AU  - Russo M
AD  - National Research Council, Institute of Food Sciences, Avellino, Italy.
FAU - Russo, Rossella
AU  - Russo R
AD  - University of Calabria, Department of Pharmacy, Health and Nutritional Sciences, 
      Cosenza, Italy.
FAU - Ryabaya, Oxana O
AU  - Ryabaya OO
AD  - N.N. Blokhin National medical research center of oncology, Department of 
      biomarkers and mechanisms of tumor angiogenesis, Moscow, Russia.
FAU - Ryan, Kevin M
AU  - Ryan KM
AD  - Cancer Research UK Beatson Institute, Glasgow, UK.
FAU - Ryu, Kwon-Yul
AU  - Ryu KY
AD  - University of Seoul, Department of Life Science, Seoul, Korea.
FAU - Sabater-Arcis, Maria
AU  - Sabater-Arcis M
AD  - Translational Genomics Group, Incliva Health Research Institute, Burjasot, 
      Valencia, Spain; Interdisciplinary Research Structure for Biotechnology and 
      Biomedicine (ERI BIOTECMED), University of Valencia, Burjasot, Valencia, Spain.
FAU - Sachdev, Ulka
AU  - Sachdev U
AD  - University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
FAU - Sacher, Michael
AU  - Sacher M
AD  - Concordia University, Department of Biology, Montreal, Quebec, Canada; McGill 
      University, Department of Anatomy and Cell Biology, Montreal, Quebec, Canada.
FAU - Sachse, Carsten
AU  - Sachse C
AD  - Ernst-Ruska Centre for Microscopy and Spectroscopy with Electrons 
      (ER-C-3/StructuralBiology), Forschungszentrum Jülich, Jülich, Germany.
FAU - Sadhu, Abhishek
AU  - Sadhu A
AD  - Saitama University, Graduate School of Science and Engineering, Saitama, Japan.
FAU - Sadoshima, Junichi
AU  - Sadoshima J
AD  - Rutgers New Jersey Medical School, Department of Cell Biology and Molecular 
      Medicine, Newark, NJ, USA.
FAU - Safren, Nathaniel
AU  - Safren N
AD  - University of Michigan, Department of Neurology, Ann Arbor, MI, USA.
FAU - Saftig, Paul
AU  - Saftig P
AD  - Christian-Albrechts-University Kiel, Biochemical Institute, Kiel, Germany.
FAU - Sagona, Antonia P
AU  - Sagona AP
AD  - University of Warwick, School of Life Sciences, Coventry, UK.
FAU - Sahay, Gaurav
AU  - Sahay G
AD  - Oregon State University, College of Pharmacy, Department of Pharmaceutical 
      Sciences, Portland, OR, USA.
FAU - Sahebkar, Amirhossein
AU  - Sahebkar A
AD  - Mashhad University of Medical Sciences, Pharmaceutical Technology Institute, 
      Biotechnology Research Center, Mashhad, Iran.
FAU - Sahin, Mustafa
AU  - Sahin M
AD  - Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
FAU - Sahin, Ozgur
AU  - Sahin O
AD  - University of South Carolina, Department of Drug Discovery and Biomedical 
      Sciences, Columbia, SC, USA.
FAU - Sahni, Sumit
AU  - Sahni S
AD  - University of Sydney, Northern Clinical School, Kolling Institute of Medical 
      Research, Sydney, NSW, Australia.
FAU - Saito, Nayuta
AU  - Saito N
AD  - Institute for Research in Biomedicine (IRB Barcelona), Cellular Plasticity and 
      Disease Group, Barcelona, Spain.
FAU - Saito, Shigeru
AU  - Saito S
AD  - University of Toyama, Sugitani, Toyama, Japan.
FAU - Saito, Tsunenori
AU  - Saito T
AD  - Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
FAU - Sakai, Ryohei
AU  - Sakai R
AD  - National Institute of Neuroscience, National Center of Neurology and Psychiatry, 
      Department of Degenerative Neurological Diseases, Kodaira, Tokyo, Japan.
FAU - Sakai, Yasuyoshi
AU  - Sakai Y
AD  - Kyoto University, Graduate School of Agriculture, Division of Applied Life 
      Sciences, Kyoto, Japan.
FAU - Sakamaki, Jun-Ichi
AU  - Sakamaki JI
AD  - The University of Tokyo, Graduate School of Medicine, Department of Biochemistry 
      and Molecular Biology, Tokyo, Japan.
FAU - Saksela, Kalle
AU  - Saksela K
AD  - University of Helsinki and Helsinki University Hospital, Department of Virology, 
      Helsinki, Finland.
FAU - Salazar, Gloria
AU  - Salazar G
AD  - Florida State University, Department of Nutrition, Food and Exercise Sciences, 
      Tallahassee, FL, USA.
FAU - Salazar-Degracia, Anna
AU  - Salazar-Degracia A
AD  - Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Research Group in 
      Critical Disorders (GREPAC), Barcelona, Spain.
FAU - Salekdeh, Ghasem H
AU  - Salekdeh GH
AD  - Agricultural Biotechnology Research Institute of Iran (ABRII), Department of 
      Systems Biology, Karaj, Iran.
FAU - Saluja, Ashok K
AU  - Saluja AK
AD  - University of Miami, Department of Surgery and Sylvester Comprehensive Cancer 
      Center, Miami, FL, USA.
FAU - Sampaio-Marques, Belém
AU  - Sampaio-Marques B
AD  - University of Minho, School of Medicine, Life and Health Sciences Research 
      Institute (ICVS), Braga, Portugal; ICVS/3B's - PT Government Associate 
      Laboratory, Braga/Guimarães, Portugal.
FAU - Sanchez, Maria Cecilia
AU  - Sanchez MC
AD  - National University of Córdoba, Clinical Biochemistry Department, CIBICI-CONICET, 
      Córdoba, Argentina.
FAU - Sanchez-Alcazar, Jose A
AU  - Sanchez-Alcazar JA
AD  - CABD/CSIC/Universidad Pablo de Olavide, Departamento de Fisiología, Anatomía y 
      Biología Celular, Sevilla, Spain.
FAU - Sanchez-Vera, Victoria
AU  - Sanchez-Vera V
AD  - University of Malaga, Department of Molecular Biology and Biochemistry, Malaga, 
      Spain.
FAU - Sancho-Shimizu, Vanessa
AU  - Sancho-Shimizu V
AD  - Imperial College London, Section of Paediatric Infectious Disease & Virology, 
      London, UK.
FAU - Sanderson, J Thomas
AU  - Sanderson JT
AD  - INRS-Institut Armand-Frappier, Laval, QC, Canada.
FAU - Sandri, Marco
AU  - Sandri M
AD  - University of Padova, Department of Biomedical Sciences, Padova, Italy.
FAU - Santaguida, Stefano
AU  - Santaguida S
AD  - European Institute of Oncology (IEO) IRCCS, Department of Experimental Oncology, 
      Milan, Italy; University of Milano, Department of Oncology and Hemato-Oncology, 
      Milan, Italy.
FAU - Santambrogio, Laura
AU  - Santambrogio L
AD  - Weill-Cornell, Englander Institute of Precision Medicine, Department of Radiation 
      Oncology, New York, NY, USA.
FAU - Santana, Magda M
AU  - Santana MM
AD  - CNC - Center for Neuroscience and Cell Biology, Coimbra, IIIUC - Instituto de 
      Investigação Interdisciplinar, University of Coimbra, Coimbra, Portugal.
AD  - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, 
      Coimbra, Portugal.
FAU - Santoni, Giorgio
AU  - Santoni G
AD  - University of Camerino, School of Pharmacy, Experimental Medicine Section, 
      Camerino, Italy.
FAU - Sanz, Alberto
AU  - Sanz A
AD  - University of Glasgow, Institute of Molecular, Cell and Systems Biology, Glasgow, 
      Scotland, United Kingdom.
FAU - Sanz, Pascual
AU  - Sanz P
AD  - Instituto de Biomedicina de Valencia, CSIC, Valencia, Spain.
FAU - Saran, Shweta
AU  - Saran S
AD  - Jawaharlal Nehru University, School of Life Sciences, New Delhi, India.
FAU - Sardiello, Marco
AU  - Sardiello M
AD  - Baylor College of Medicine, Department of Molecular and Human Genetics, Houston, 
      TX, USA.
FAU - Sargeant, Timothy J
AU  - Sargeant TJ
AD  - Hopwood Centre for Neurobiology, Lifelong Health Theme, South Australian Health 
      and Medical Research Institute, Adelaide, Australia.
FAU - Sarin, Apurva
AU  - Sarin A
AD  - Institute for Stem Cell Science & Regenerative Medicine (inStem), Bangalore, 
      Karnataka, India.
FAU - Sarkar, Chinmoy
AU  - Sarkar C
AD  - University of Maryland School of Medicine, Department of Anesthesiology, Shock, 
      Trauma and Anesthesiology Research Center, Baltimore, MD, USA.
FAU - Sarkar, Sovan
AU  - Sarkar S
AD  - University of Birmingham, Institute of Biomedical Research, Institute of Cancer 
      and Genomic Sciences, College of Medical and Dental Sciences, Edgbaston, 
      Birmingham, UK.
FAU - Sarrias, Maria-Rosa
AU  - Sarrias MR
AD  - Health Research Institute Germans Trias i Pujol, Innate Immunity Group, Badalona, 
      Barcelona, Spain.
FAU - Sarkar, Surajit
AU  - Sarkar S
AD  - University of Delhi South Campus, Department of Genetics, New Delhi, India.
FAU - Sarmah, Dipanka Tanu
AU  - Sarmah DT
AD  - NCR Biotech Science Cluster, Translational Health Science and Technology 
      Institute, Complex Analysis Group, Faridabad, India.
FAU - Sarparanta, Jaakko
AU  - Sarparanta J
AD  - Folkhälsan Research Center, Helsinki, Finland.
FAU - Sathyanarayan, Aishwarya
AU  - Sathyanarayan A
AD  - Mayo Clinic, Department of Molecular Medicine, Rochester, MN, USA.
FAU - Sathyanarayanan, Ranganayaki
AU  - Sathyanarayanan R
AD  - National Institute of Mental Health and Neurosciences, Department of 
      Neurochemistry, Bengaluru, Karnataka, India.
FAU - Scaglione, K Matthew
AU  - Scaglione KM
AD  - Duke University, Department of Molecular Genetics and Microbiology, Durham, NC, 
      USA.
FAU - Scatozza, Francesca
AU  - Scatozza F
AD  - Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.
FAU - Schaefer, Liliana
AU  - Schaefer L
AD  - Goethe University, Institute of Pharmacology and Toxicology, Frankfurt, Germany.
FAU - Schafer, Zachary T
AU  - Schafer ZT
AD  - University of Notre Dame, Department of Biological Sciences, Notre Dame, IN ,USA.
FAU - Schaible, Ulrich E
AU  - Schaible UE
AD  - Research Center Borstel, Leibniz Lung Center, Priority Area Infections, Division 
      Cellular Microbiology, Borstel, Germany.
FAU - Schapira, Anthony H V
AU  - Schapira AHV
AD  - UCL Queen Square Institute of Neurology, Department of Clinical and Movement 
      Neurosciences, London, UK.
FAU - Scharl, Michael
AU  - Scharl M
AD  - University Hospital and University of Zürich, Department of Gastroenterology and 
      Hepatology, Zürich, Switzerland.
FAU - Schatzl, Hermann M
AU  - Schatzl HM
AD  - University of Calgary, Department of Comparative Biology & Experimental Medicine, 
      Calgary, AB, Canada.
FAU - Schein, Catherine H
AU  - Schein CH
AD  - Department of Biochemistry and Molecular Biology, Institute for Human Infection 
      and Immunity (IHII), University of Texas Medical Branch at Galveston, Galveston, 
      TX, USA.
FAU - Scheper, Wiep
AU  - Scheper W
AD  - Amsterdam University Medical Centers location VUmc, Department of Clinical 
      Genetics, Amsterdam, The Netherlands.
FAU - Scheuring, David
AU  - Scheuring D
AD  - University of Kaiserslautern, Phytopathology, Kaiserslautern, Germany.
FAU - Schiaffino, Maria Vittoria
AU  - Schiaffino MV
AD  - IRCCS San Raffaele Scientific Institute, Division of Genetics and Cell Biology, 
      Milan, Italy.
FAU - Schiappacassi, Monica
AU  - Schiappacassi M
AD  - Centro di Riferimento Oncologico, CRO-IRCCS, Molecular Oncology Unit, Aviano, 
      Italy.
FAU - Schindl, Rainer
AU  - Schindl R
AD  - Medical University of Graz, Gottfried Schatz research center, Graz, Austria.
FAU - Schlattner, Uwe
AU  - Schlattner U
AD  - University Grenoble Alpes and Inserm U1055, Laboratory of Fundamental and Applied 
      Bioenergetics (LBFA), Grenoble, France.
FAU - Schmidt, Oliver
AU  - Schmidt O
AD  - Medical University of Innsbruck, Institute for Cell Biology, Innsbruck, Austria.
FAU - Schmitt, Roland
AU  - Schmitt R
AD  - Hannover Medical School, Department of Nephrology and Hypertension, Hannover, 
      Germany.
FAU - Schmidt, Stephen D
AU  - Schmidt SD
AD  - National Institutes of Health, National Institute of Allergy and Infectious 
      Disease, Vaccine Research Center, Bethesda, MD, USA.
FAU - Schmitz, Ingo
AU  - Schmitz I
AD  - Ruhr-University Bochum, Department of Molecular Immunology, Bochum, Germany.
FAU - Schmukler, Eran
AU  - Schmukler E
AD  - Tel Aviv University, School of Neurobiology, Biochemistry and Biophysics, Tel 
      Aviv, Israel.
FAU - Schneider, Anja
AU  - Schneider A
AD  - German Center for Neurodegenerative Diseases, DZNE, Bonn, Germany and Department 
      of Neurodegenerative Diseases and Geriatric Psychiatry, University Bonn, Bonn, 
      Germany.
FAU - Schneider, Bianca E
AU  - Schneider BE
AD  - Reseach Center Borstel, Leibniz Lung Center, Priority Research Area Infections, 
      Junior Research Group Coinfection, Borstel, Germany.
FAU - Schober, Romana
AU  - Schober R
AD  - Johannes Kepler University Linz, Institute of Biophysics, Linz, Austria.
FAU - Schoijet, Alejandra C
AU  - Schoijet AC
AD  - Instituto de Investigaciones en Ingeniería Genética y Biología Molecular Dr. 
      Héctor N. Torres, Laboratorio de Señalización y Mecanismos Adaptativos en 
      Tripanosomátidos, Buenos Aires, Argentina; Universidad de Buenos Aires, 
      Departamento de Fisiología, Biología Molecular y Celular, Facultad de Ciencias 
      Exactas y Naturales, Buenos Aires, Argentina.
AD  - Instituto de Investigaciones en Ingeniería Genética y Biología Molecular Dr. 
      Héctor N. Torres, Laboratorio de señalización y mecanismos adaptativos en 
      Tripanosomátidos, Buenos Aires, Argentina; Universidad de Buenos Aires, 
      Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, 
      Buenos Aires, Argentina.
FAU - Schott, Micah B
AU  - Schott MB
AD  - Mayo Clinic, Department of Biochemistry and Molecular Biology, Division of 
      Gastroenterology and Hepatology, Rochester, MN, USA.
FAU - Schramm, Michael
AU  - Schramm M
AD  - University of Cologne, Faculty of Medicine and University Hospital Cologne, 
      Institute for Medical Microbiology, Immunology and Hygiene, Cologne, Germany.
FAU - Schröder, Bernd
AU  - Schröder B
AD  - Technische Universität Dresden, Institute for Physiological Chemistry, Dresden, 
      Germany.
FAU - Schuh, Kai
AU  - Schuh K
AD  - University of Wuerzburg, Department of Vegetative Physiology, Wuerzburg, Germany.
FAU - Schüller, Christoph
AU  - Schüller C
AD  - University of Natural Resources and Life Sciences, Department of Applied Genetics 
      and Cell Biology, Vienna, Austria.
FAU - Schulze, Ryan J
AU  - Schulze RJ
AD  - Mayo Clinic, Division of Gastroenterology and Hepatology, Rochester, MN, USA.
FAU - Schürmanns, Lea
AU  - Schürmanns L
AD  - Goethe University, Institute for Molecular Biosciences, Frankfurt/Main, Germany.
FAU - Schwamborn, Jens C
AU  - Schwamborn JC
AD  - University of Luxembourg, Luxembourg Centre for Systems Biomedicine (LCSB), 
      Esch-sur-Alzette, Luxembourg.
FAU - Schwarten, Melanie
AU  - Schwarten M
AD  - Forschungszentrum Jülich, Institute of Biological Information Processing, IBI-7 
      (Structural Biochemistry), Jülich, Germany.
FAU - Scialo, Filippo
AU  - Scialo F
AD  - University of Campania L. Vanvitelli, Dipartimento di Scienze Mediche 
      Traslazionali, Naples, Italy.
FAU - Sciarretta, Sebastiano
AU  - Sciarretta S
AD  - Department of Medical and Surgical Sciences and Biotechnologies, Sapienza 
      University of Rome, Italy; IRCCS Neuromed, Pozzilli (IS), Italy.
FAU - Scott, Melanie J
AU  - Scott MJ
AD  - University of Pittsburgh, Department of Surgery, Pittsburgh, PA, USA.
FAU - Scotto, Kathleen W
AU  - Scotto KW
AD  - Rutgers Biomedical and Health Sciences, Rutgers University, Robert Wood Johnson 
      Medical School, Department of Pharmacology, New Brunswick , NJ, USA.
FAU - Scovassi, A Ivana
AU  - Scovassi AI
AD  - National Research Council, Institute of Molecular Genetics, Pavia, Italy.
FAU - Scrima, Andrea
AU  - Scrima A
AD  - Helmholtz Centre for Infection Research, Braunschweig, Germany.
FAU - Scrivo, Aurora
AU  - Scrivo A
AD  - Albert Einstein College of Medicine, Department of Developmental and Molecular 
      Biology, Bronx, NY, USA; Albert Einstein College of Medicine, Institute for Aging 
      Studies, Bronx, NY, USA.
FAU - Sebastian, David
AU  - Sebastian D
AD  - Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of 
      Science and Technology, Barcelona, Spain; Departament de Bioquímica i Biomedicina 
      Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain; 
      Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas 
      Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
FAU - Sebti, Salwa
AU  - Sebti S
AD  - University of Texas Southwestern Medical Center, Center for Autophagy Research, 
      Department of Internal Medicine and Howard Hughes Medical Institute, Dallas, TX, 
      USA.
FAU - Sedej, Simon
AU  - Sedej S
AD  - Medical University of Graz, Division of Cardiology, Graz, Austria.
FAU - Segatori, Laura
AU  - Segatori L
AD  - Rice University, Department of Bioengineering, Houston, TX, USA.
FAU - Segev, Nava
AU  - Segev N
AD  - University of Illinois at Chicago, College of Medicine, Department of 
      Biochemistry and Molecular Genetics, Chicago, IL, USA.
FAU - Seglen, Per O
AU  - Seglen PO
AD  - University of Oslo, Centre for Molecular Medicine Norway (NCMM), Oslo, Norway.
FAU - Seiliez, Iban
AU  - Seiliez I
AD  - Université de Pau et des Pays de l'Adour, E2S UPPA, INRAE, UMR1419 Nutrition 
      Métabolisme et Aquaculture, F-64310 Saint-Pée-sur-Nivelle, France.
FAU - Seki, Ekihiro
AU  - Seki E
AD  - Cedars-Sinai Medical Center, Department of Medicine, Division of Digestive and 
      Liver Diseases, Los Angeles, CA, USA.
FAU - Selleck, Scott B
AU  - Selleck SB
AD  - Pennsylvania State University, Department of Biochemistry and Molecular Biology, 
      University Park, PA, USA.
FAU - Sellke, Frank W
AU  - Sellke FW
AD  - Alpert Medical School of Brown University/Rhode Island Hospital, Division of 
      Cardiothoracic Surgery, Providence, RI, USA.
FAU - Selsby, Joshua T
AU  - Selsby JT
AD  - Iowa State University, Animal Science Department, Ames, IA, USA.
FAU - Sendtner, Michael
AU  - Sendtner M
AD  - University of Würzburg, Institute of Clinical Neurobiology, Würzburg, Germany.
FAU - Senturk, Serif
AU  - Senturk S
AD  - Dokuz Eylul University, Izmir International Biomedicine and Genome Institute, 
      Izmir, Turkey.
FAU - Seranova, Elena
AU  - Seranova E
AD  - University of Birmingham, Institute of Biomedical Research, Institute of Cancer 
      and Genomic Sciences, College of Medical and Dental Sciences, Edgbaston, 
      Birmingham, UK.
FAU - Sergi, Consolato
AU  - Sergi C
AD  - University of Alberta, Department of Laboratory Medicine and Pathology, Edmonton, 
      AB, Canada.
FAU - Serra-Moreno, Ruth
AU  - Serra-Moreno R
AD  - University of Rochester Medical Center, Microbiology and Immunology, Rochester, 
      NY, USA.
FAU - Sesaki, Hiromi
AU  - Sesaki H
AD  - Johns Hopkins University School of Medicine, Department of Cell Biology, 
      Baltimore, MD, USA.
FAU - Settembre, Carmine
AU  - Settembre C
AD  - Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.
AD  - University of Naples Federico II, Department of Translational Medical Sciences, 
      Naples, Italy.
FAU - Setty, Subba Rao Gangi
AU  - Setty SRG
AD  - Indian Institute of Science, Department of Microbiology and Cell Biology, 
      Bangalore, KA, India.
FAU - Sgarbi, Gianluca
AU  - Sgarbi G
AD  - University of Bologna, Department of Biomedical and Neuromotor Sciences, Bologna, 
      Italy.
FAU - Sha, Ou
AU  - Sha O
AD  - Shenzhen University Health Science Center, School of Dentistry, Shenzhen, 
      Guangdong Province, China.
FAU - Shacka, John J
AU  - Shacka JJ
AD  - University of Alabama at Birmingham, Department of Pharmacology & Toxicology, 
      Birmingham, AL, USA.
FAU - Shah, Javeed A
AU  - Shah JA
AD  - University of Washington, Department of Medicine, Seattle, WA, USA; VA Puget 
      Sound Health Care System, Seattle, WA, USA.
FAU - Shang, Dantong
AU  - Shang D
AD  - Wuhan University, Hubei Key laboratory of Cell Homeostasis, College of Life 
      Sciences, Wuhan, China.
FAU - Shao, Changshun
AU  - Shao C
AD  - Soochow University, Institutes for Translational Medicine, Suzhou, Jiangsu, 
      China.
FAU - Shao, Feng
AU  - Shao F
AD  - National Institute of Biological Sciences, Beijing, China.
FAU - Sharbati, Soroush
AU  - Sharbati S
AD  - Freie Universitaet Berlin, Department of Veterinary Medicine, Institute of 
      Veterinary Biochemistry, Berlin, Germany.
FAU - Sharkey, Lisa M
AU  - Sharkey LM
AD  - University of Michigan Medical School, Department of Neurology, Ann Arbor, MI, 
      USA.
FAU - Sharma, Dipali
AU  - Sharma D
AD  - Johns Hopkins University, Department of Oncology, Sidney Kimmel Comprehensive 
      Cancer Center, Baltimore, MD, USA.
FAU - Sharma, Gaurav
AU  - Sharma G
AD  - University of Pennsylvania, Abramson Cancer Center, Department of Medicine, PA, 
      USA.
FAU - Sharma, Kulbhushan
AU  - Sharma K
AD  - Division of Stem Cell and Gene Therapy Research, Institute of Nuclear Medicine & 
      Allied Sciences (INMAS), Defence Research and Development Organization (DRDO), 
      Timar Pur, New Delhi, India.
FAU - Sharma, Pawan
AU  - Sharma P
AD  - Thomas Jefferson University, Center for Translational Medicine, Philadelphia, PA, 
      USA.
FAU - Sharma, Surendra
AU  - Sharma S
AD  - Women and Infants Hospital of Rhode Island-Warren Alpert Medical School of Brown 
      University, Department of Pediatrics, Providence, RI, USA.
FAU - Shen, Han-Ming
AU  - Shen HM
AD  - University of Macau, Faculty of Health Sciences, Macau, China.
FAU - Shen, Hongtao
AU  - Shen H
AD  - University of Virginia, School of Medicine, Department of Surgery, 
      Charlottesville, VA, USA.
FAU - Shen, Jiangang
AU  - Shen J
AD  - The University of Hong Kong, School of Chinese Medicine, Hong Kong, China.
FAU - Shen, Ming
AU  - Shen M
AD  - Nanjing Agricultural University, College of Animal Science and Technology, 
      Nanjing, Jiangsu, China.
FAU - Shen, Weili
AU  - Shen W
AD  - Shanghai Jiao Tong University School of Medicine, Department of Hypertension, 
      Ruijin Hospital, Shanghai, China.
FAU - Shen, Zheni
AU  - Shen Z
AD  - Total Toxicology Labs, Southfield, MI, USA.
FAU - Sheng, Rui
AU  - Sheng R
AD  - Soochow University, College of Pharmaceutical Sciences, Department of 
      Pharmacology and Laboratory of Aging and Nervous Diseases, Suzhou, China.
FAU - Sheng, Zhi
AU  - Sheng Z
AD  - Fralin Biomedical Research Institute at VTC, Roanoke, VA, USA.
FAU - Sheng, Zu-Hang
AU  - Sheng ZH
AD  - National Institutes of Health, National Institute of Neurological Disorders and 
      Stroke, Bethesda, MD, USA.
FAU - Shi, Jianjian
AU  - Shi J
AD  - Indiana University School of Medicine, Department of Pediatrics, Indianapolis, 
      IN, USA.
FAU - Shi, Xiaobing
AU  - Shi X
AD  - Van Andel Institute, Center for Epigenetics, Grand Rapids, MI, USA.
FAU - Shi, Ying-Hong
AU  - Shi YH
AD  - Fudan University, Zhongshan Hospital, Liver Cancer Institute, Department of Liver 
      Surgery & Transplantation, Shanghai, China.
FAU - Shiba-Fukushima, Kahori
AU  - Shiba-Fukushima K
AD  - Juntendo University Graduate School of Medicine, Department of Treatment and 
      Research in Multiple Sclerosis and Neuro-intractable Disease, Bunkyo-ku, Tokyo, 
      Japan.
FAU - Shieh, Jeng-Jer
AU  - Shieh JJ
AD  - National Chung-Hsing University, Institute of Biomedical Sciences, Taichung City, 
      Taiwan.
FAU - Shimada, Yohta
AU  - Shimada Y
AD  - Jikei University School of Medicine, Research Center for Medical Sciences, 
      Division of Gene Therapy, Tokyo, Japan.
FAU - Shimizu, Shigeomi
AU  - Shimizu S
AD  - Tokyo Medical and Dental University, Department of Pathological Cell Biology, 
      Tokyo, Japan.
FAU - Shimozawa, Makoto
AU  - Shimozawa M
AD  - Karolinska Institutet, Department of Neurobiology, Care Sciences and Society, 
      Division of Neurogeriatrics, Solna, Stockholm, Sweden.
FAU - Shintani, Takahiro
AU  - Shintani T
AD  - Tohoku University, Graduate School of Agricultural Science, Sendai, Japan.
FAU - Shoemaker, Christopher J
AU  - Shoemaker CJ
AD  - Geisel School of Medicine at Dartmouth, Department of Biochemistry and Cell 
      Biology, Hanover, NH, USA.
FAU - Shojaei, Shahla
AU  - Shojaei S
AD  - Department of Human Anatomy and Cell Science, Max Rady College of Medicine, Rady 
      Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
FAU - Shoji, Ikuo
AU  - Shoji I
AD  - Kobe University Graduate School of Medicine, Center for Infectious Diseases, 
      Division of Infectious Disease Control, Kobe, Japan.
FAU - Shravage, Bhupendra V
AU  - Shravage BV
AD  - MACS - Agharkar Research Institute, Developmental Biology Group, Pune, India; 
      Savitribai Phule Pune University, Ganeshkhind, Pune, Maharashtra, India.
FAU - Shridhar, Viji
AU  - Shridhar V
AD  - Mayo Clinic College of Medicine, Department of Experimental Pathology, Rochester, 
      MN, USA.
FAU - Shu, Chih-Wen
AU  - Shu CW
AD  - National Sun Yat-sen University, Institute of Biopharmaceutical Sciences, 
      Kaohsiung, Taiwan.
FAU - Shu, Hong-Bing
AU  - Shu HB
AD  - Medical Research Institute, Wuhan University, Wuhan, China.
FAU - Shui, Ke
AU  - Shui K
AD  - Huazhong University of Science and Technology, College of Life Science and 
      Technology, Key Laboratory of Molecular Biophysics of Ministry of 
      Education,Wuhan, Hubei, China.
FAU - Shukla, Arvind K
AU  - Shukla AK
AD  - National Institutes of Health, National Institutes of Neurological Disorders and 
      Stroke (NINDS), Bethesda, MD, USA.
FAU - Shutt, Timothy E
AU  - Shutt TE
AD  - University of Calgary, Cumming School of Medicine, Departments of Medical 
      Genetics and Biochemistry & Molecular Biology, Calgary, Alberta, Canada.
FAU - Sica, Valentina
AU  - Sica V
AD  - Department of Experimental and Health Sciences, Pompeu Fabra University (UPF), 
      CIBER on Neurodegenerative diseases (CIBERNED), E-08003 Barcelona, Spain.
FAU - Siddiqui, Aleem
AU  - Siddiqui A
FAU - Sierra, Amanda
AU  - Sierra A
AD  - Achucarro Basque Center for Neuroscience, Department of Neurosciences, University 
      of the Basque Country EHU/UPV, Leioa, Bizkaia, Spain.
FAU - Sierra-Torre, Virginia
AU  - Sierra-Torre V
AD  - Achucarro Basque Center for Neuroscience, Department of Neurosciences, University 
      of the Basque Country EHU/UPV, Leioa, Bizkaia, Spain.
FAU - Signorelli, Santiago
AU  - Signorelli S
AD  - Universidad de la República, Facultad de Agronomía, Departamento de Biología 
      Vegetal, Montevideo, Uruguay.
FAU - Sil, Payel
AU  - Sil P
AD  - National Institutes of Health, NIEHS, RTP, Durham, NC, USA.
FAU - Silva, Bruno J de Andrade
AU  - Silva BJA
AD  - David Geffen School of Medicine at University of California, Los Angeles, 
      Department of Medicine, Division of Dermatology, Los Angeles, CA, USA.
FAU - Silva, Johnatas D
AU  - Silva JD
AD  - Queen's University of Belfast, Wellcome-Wolfson Institute for Experimental 
      Medicine, Belfast, UK.
FAU - Silva-Pavez, Eduardo
AU  - Silva-Pavez E
AD  - Universidad Mayor, Center for Integrative Biology, and Geroscience Center for 
      Brain Health and Metabolism, Santiago, Chile.
FAU - Silvente-Poirot, Sandrine
AU  - Silvente-Poirot S
AD  - Cancer Research Center of Toulouse, UMR 1037 Inserm-university of Toulouse, 
      Toulouse, France.
FAU - Simmonds, Rachel E
AU  - Simmonds RE
AD  - University of Surrey, School of Bioscience and Medicine, Department of Microbial 
      Sciences, Stag Hill Campus, Guildford, Surrey, UK.
FAU - Simon, Anna Katharina
AU  - Simon AK
AD  - University of Oxford, Kennedy Institute of Rheumatology, Oxford, UK.
FAU - Simon, Hans-Uwe
AU  - Simon HU
AD  - University of Bern, Institute of Pharmacology, Bern, Switzerland; Sechenov 
      University, Department of Clinical Immunology and Allergology, Moscow, Russia.
FAU - Simons, Matias
AU  - Simons M
AD  - INSERM UMR1163, Laboratory of Epithelial Biology and Disease, Imagine Institute, 
      Paris Descartes University, Sorbonne Paris Cité, Hôpital Necker-Enfants Malades, 
      Paris, France.
FAU - Singh, Anurag
AU  - Singh A
AD  - Boston University School of Medicine, Division of Hematology & Medical Oncology, 
      Department of Pharmacology & Experimental Therapeutics, Boston, MA, USA.
FAU - Singh, Lalit P
AU  - Singh LP
AD  - Wayne State University School of Medicine, Department of Ophthalmology, Visual 
      and Anatomical Sciences, Detroit, MI, USA.
FAU - Singh, Rajat
AU  - Singh R
AD  - Albert Einstein College of Medicine, Department of Medicine, Bronx, NY, USA.
FAU - Singh, Shivendra V
AU  - Singh SV
AD  - University of Pittsburgh, Department of Pharmacology & Chemical Biology, 
      Pittsburgh, PA, USA.
FAU - Singh, Shrawan K
AU  - Singh SK
AD  - Post Graduate Institute of Medical Education and Research (PGIMER), Department of 
      Urology, Chandigarh, India.
FAU - Singh, Sudha B
AU  - Singh SB
AD  - Biomedical Research Institute of New Mexico, VA Healthcare System, Albuquerque, 
      NM, USA.
FAU - Singh, Sunaina
AU  - Singh S
AD  - Jawaharlal Nehru Centre for Advanced Scientific Research, Molecular Biology and 
      Genetics Unit, and Neuroscience Unit, Autophagy Laboratory, Jakkur, Bangalore, 
      India.
FAU - Singh, Surinder Pal
AU  - Singh SP
AD  - CSIR-National Physical Laboratory, Dr. K. S. Krishnan Marg, New Delhi, India.
FAU - Sinha, Debasish
AU  - Sinha D
AD  - University of Pittsburgh School of Medicine, Departments of Ophthalmology, Cell 
      Biology, and Developmental Biology, Pittsburgh, PA, USA.
FAU - Sinha, Rohit Anthony
AU  - Sinha RA
AD  - Sanjay Gandhi Postgraduate Institute of Medical Sciences, Department of 
      Endocrinology, Lucknow, India.
FAU - Sinha, Sangita
AU  - Sinha S
AD  - North Dakota State University, Department of Chemistry and Biochemistry, Fargo, 
      ND, USA.
FAU - Sirko, Agnieszka
AU  - Sirko A
AD  - Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, 
      Poland.
FAU - Sirohi, Kapil
AU  - Sirohi K
AD  - National Jewish Health, Department of Medicine, Division of Allergy & Immunology, 
      and Division of Pulmonary and Critical Care Medicine, Denver, CO, USA.
FAU - Sivridis, Efthimios L
AU  - Sivridis EL
AD  - Democritus University of Thrace, Medical School, Department of Pathology, 
      Alexandroupolis, Greece.
FAU - Skendros, Panagiotis
AU  - Skendros P
AD  - Democritus University of Thrace, First Department of Internal Medicine & 
      Laboratory of Molecular Hematology, Alexandroupolis, Greece.
FAU - Skirycz, Aleksandra
AU  - Skirycz A
AD  - Max Planck Institute of Molecular Plant Physiology, Potsdam-Golm, Germany.
FAU - Slaninová, Iva
AU  - Slaninová I
AD  - Masaryk University, Faculty of Medicine, Department of Biology, Brno, Czech 
      Republic.
FAU - Smaili, Soraya S
AU  - Smaili SS
AD  - Universidade Federal de São Paulo, Paulista School of Medicine, Departament of 
      Pharmacology, São Paulo, Brazil.
FAU - Smertenko, Andrei
AU  - Smertenko A
AD  - Washington State University, Institute of Biological Chemistry, Pullman, WA, USA.
FAU - Smith, Matthew D
AU  - Smith MD
AD  - Edinburgh Cancer Research UK Centre, MRC Institute of Genetics and Molecular 
      Medicine, University of Edinburgh, Edinburgh, UK.
FAU - Soenen, Stefaan J
AU  - Soenen SJ
AD  - KU Leuven, Department of Imaging and Pathology, Leuven, Belgium.
FAU - Sohn, Eun Jung
AU  - Sohn EJ
AD  - Dong-A University, College of Medicine, Department of Molecular Neuroscience, 
      Peripheral Neuropathy Research Center, Busan, Korea.
FAU - Sok, Sophia P M
AU  - Sok SPM
AD  - University of Malaya, Institute of Biological Sciences (Genetics), Kuala Lumpur, 
      Malaysia.
FAU - Solaini, Giancarlo
AU  - Solaini G
AD  - University of Bologna, Department of Biomedical and Neuromotor Sciences, Bologna, 
      Italy.
FAU - Soldati, Thierry
AU  - Soldati T
AD  - University of Geneva, Department of Biochemistry, Faculty of Science, 
      Switzerland.
FAU - Soleimanpour, Scott A
AU  - Soleimanpour SA
AD  - Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
FAU - Soler, Rosa M
AU  - Soler RM
AD  - Universitat de Lleida, Department of Experimental Medicine, IRBLleida, Lleida, 
      Spain.
FAU - Solovchenko, Alexei
AU  - Solovchenko A
AD  - Lomonosov Moscow State University, Department of Biology, Moscow, Russia.
FAU - Somarelli, Jason A
AU  - Somarelli JA
AD  - Duke University, Department of Medicine, Durham, NC, USA.
FAU - Sonawane, Avinash
AU  - Sonawane A
AD  - Indian Institute of Technology Indore, Discipline of Biosciences and Biomedical 
      Engineering, Indore, Madhya Pradesh, India.
FAU - Song, Fuyong
AU  - Song F
AD  - Shandong University, School of public health, Department of Toxicology and 
      nutrition. Jinan, Shandong, China.
FAU - Song, Hyun Kyu
AU  - Song HK
AD  - Korea University, Department of Life Sciences, Seoul, Korea.
FAU - Song, Ju-Xian
AU  - Song JX
AD  - Guangzhou University of Chinese Medicine, Medical College of 
      Acupuncture-Moxibustion and Rehabilitation, Guangzhou, China; Hong Kong Baptist 
      University, School of Chinese Medicine, Mr. and Mrs. Ko Chi Ming Centre for 
      Parkinson's Disease Research, Hong Kong SAR, China.
FAU - Song, Kunhua
AU  - Song K
AD  - University of Colorado Anschutz Medical Campus, Division of Cardiology, Aurora, 
      CO, USA.
FAU - Song, Zhiyin
AU  - Song Z
AD  - Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan 
      University, Wuhan, Hubei, China.
FAU - Soria, Leandro R
AU  - Soria LR
AD  - Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.
FAU - Sorice, Maurizio
AU  - Sorice M
AD  - Sapienza University of Rome, Department of Experimental Medicine, Rome, Italy.
FAU - Soukas, Alexander A
AU  - Soukas AA
AD  - Massachusetts General Hospital and Harvard Medical School, Department of 
      Medicine, Endocrine Division, Boston, MA, USA.
FAU - Soukup, Sandra-Fausia
AU  - Soukup SF
AD  - Université de Bordeaux, Institut des Maladies Neurodégénératives (IMN), CNRS UMR 
      5293, Bordeaux, France.
FAU - Sousa, Diana
AU  - Sousa D
AD  - Universidade do Porto, i3S-Instituto de Investigação e Inovação em Saúde, Porto, 
      Portugal; IPATIMUP - Institute of Molecular Pathology and Immunology of the 
      University of Porto, Cancer Drug Resistance Group, Porto, Portugal; FFUP - 
      Faculty of Pharmacy of the University of Porto, Department of Biological 
      Sciences, Porto, Portugal.
FAU - Sousa, Nadia
AU  - Sousa N
AD  - Johannes Gutenberg University-Mainz, Institute of Developmental Biology and 
      Neurobiology, Mainz, Germany.
FAU - Spagnuolo, Paul A
AU  - Spagnuolo PA
AD  - University of Guelph, Department of Food Science, Guelph, Canada.
FAU - Spector, Stephen A
AU  - Spector SA
AD  - University of California, San Diego, La Jolla, CA, USA; Rady Children's Hospital 
      San Diego, San Diego, CA, USA.
FAU - Srinivas Bharath, M M
AU  - Srinivas Bharath MM
AD  - Department of Clinical Psychopharmacology and Neurotoxicology, National Institute 
      of Mental Health and Neurosciences, Bengaluru-560029, Karnataka, India.
FAU - St Clair, Daret
AU  - St Clair D
AD  - University of Kentucky, Department of Toxicology and Cancer Biology, Lexington, 
      KY, USA.
FAU - Stagni, Venturina
AU  - Stagni V
AD  - Institute of Molecular Biology and Pathology, National Research Council (CNR), 
      Rome, Italy; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) 
      Fondazione Santa Lucia, Laboratory of Cell Signaling, Rome, Italy.
FAU - Staiano, Leopoldo
AU  - Staiano L
AD  - Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.
FAU - Stalnecker, Clint A
AU  - Stalnecker CA
AD  - University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer 
      Center, Chapel Hill, NC, USA.
FAU - Stankov, Metodi V
AU  - Stankov MV
AD  - Hannover Medical School, Department for Clinical Immunology and Rheumatology, 
      Hannover, Germany.
FAU - Stathopulos, Peter B
AU  - Stathopulos PB
AD  - University of Western Ontario, Department of Physiology and Pharmacology, London, 
      Ontario, Canada.
FAU - Stefan, Katja
AU  - Stefan K
AD  - University of Oslo, Department of Neuro-/Pathology, Oslo, Norway.
FAU - Stefan, Sven Marcel
AU  - Stefan SM
AD  - Cancer Drug Resistance and Stem Cell Program, University of Sydney, NSW, 
      Australia.
AD  - University of Oslo, Department of Neuro-/Pathology, Oslo, Norway.
AD  - University of Bonn, Department of Pharmaceutical & Cellbiological Chemistry, 
      Bonn, Germany.
FAU - Stefanis, Leonidas
AU  - Stefanis L
AD  - Biomedical Research Foundation of the Academy of Athens, Laboratory of 
      Neurodegenerative Diseases, Athens, Greece; National and Kapodistrian University 
      of Athens Medical School, First Department of Neurology, Athens, Greece.
FAU - Steffan, Joan S
AU  - Steffan JS
AD  - University of California, Irvine, Department of Psychiatry and Human Behavior, 
      Irvine, CA, USA.
FAU - Steinkasserer, Alexander
AU  - Steinkasserer A
AD  - Friedrich-Alexander-Universität Erlangen-Nürnberg, Department of Immune 
      Modulation, University Hospital Erlangen, Erlangen, Germany.
FAU - Stenmark, Harald
AU  - Stenmark H
AD  - Oslo University Hospital, Institute for Cancer Research, Department of Molecular 
      Cell Biology, Montebello, Oslo, Norway.
FAU - Sterneckert, Jared
AU  - Sterneckert J
AD  - Technische Universität Dresden, Center for Regenerative Therapies Dresden, 
      Dresden, Germany.
FAU - Stevens, Craig
AU  - Stevens C
AD  - Edinburgh Napier University, School of Applied Sciences, Edinburgh, UK.
FAU - Stoka, Veronika
AU  - Stoka V
AD  - Jožef Stefan Institute, Department of Biochemistry and Molecular and Structural 
      Biology, Ljubljana, Slovenia.
FAU - Storch, Stephan
AU  - Storch S
AD  - University Medical Center Hamburg-Eppendorf, Children's Hospital, University 
      Children's Research@Kinder-UKE, Hamburg, Germany.
FAU - Stork, Björn
AU  - Stork B
AD  - Heinrich-Heine-University, Medical Faculty, Institute of Molecular Medicine I, 
      Düsseldorf, Germany.
FAU - Strappazzon, Flavie
AU  - Strappazzon F
AD  - IRCCS Fondazione Santa Lucia, Rome, Italy.
FAU - Strohecker, Anne Marie
AU  - Strohecker AM
AD  - The Ohio State University, Department of Cancer Biology and Genetics, Columbus, 
      OH, USA.
FAU - Stupack, Dwayne G
AU  - Stupack DG
AD  - University of California San Diego, UCSD Moores Cancer Center, La Jolla, CA, USA.
FAU - Su, Huanxing
AU  - Su H
AD  - University of Macau, Institute of Chinese Medical Sciences, State Key Laboratory 
      of Quality Research in Chinese Medicine, Taipa, Macao, China.
FAU - Su, Ling-Yan
AU  - Su LY
AD  - Kunming Institute of Zoology, Key Laboratory of Animal Models and Human Disease 
      Mechanisms of the Chinese Academy of Sciences & Yunnan Province, Kunming, Yunnan, 
      China.
FAU - Su, Longxiang
AU  - Su L
AD  - Peking Union Medical College and Chinese Academy of Medical Sciences, Peking 
      Union Medical College Hospital, Department of Critical Care Medicine, Beijing, 
      China.
FAU - Suarez-Fontes, Ana M
AU  - Suarez-Fontes AM
AD  - Instituto Oswaldo Cruz, LITEB/IOC, Fundação Oswaldo Cruz, FIOCRUZ, Rio de 
      Janeiro, Brazil.
FAU - Subauste, Carlos S
AU  - Subauste CS
AD  - Case Western Reserve University School of Medicine, Departments of Medicine and 
      Pathology, Cleveland, OH USA.
FAU - Subbian, Selvakumar
AU  - Subbian S
AD  - Rutgers University, New Jersey Medical School and Public Health Research 
      Institute, Newark, NJ, USA.
FAU - Subirada, Paula V
AU  - Subirada PV
AD  - National University of Córdoba, Clinical Biochemistry Department, CIBICI-CONICET, 
      Córdoba, Argentina.
FAU - Sudhandiran, Ganapasam
AU  - Sudhandiran G
AD  - University of Madras, Department of Biochemistry, Guindy Campus, Chennai, India.
FAU - Sue, Carolyn M
AU  - Sue CM
AD  - Kolling Institute, Department of Neurogenetics, University of Sydney and Royal 
      North Shore Hospital, St Leonards NSW, Australia.
FAU - Sui, Xinbing
AU  - Sui X
AD  - Hangzhou Normal University, Affiliated Hospital of Hangzhou Normal University, 
      College of Medicine, Holistic Integrative Pharmacy Institutes and Comprehensive 
      Cancer Diagnosis and Treatment Center, Hangzhou, Zhejiang, China.
FAU - Summers, Corey
AU  - Summers C
AD  - Iowa State University, Department of Kinesiology, Ames, IA, USA.
FAU - Sun, Guangchao
AU  - Sun G
AD  - University of Nebraska Lincoln, Department of Agronomy and Horticulture, Center 
      for Plant Science Innovation, Lincoln, NE, USA.
FAU - Sun, Jun
AU  - Sun J
AD  - University of Illinois at Chicago, Department of Medicine, Chicago, IL, USA.
FAU - Sun, Kang
AU  - Sun K
AD  - Shanghai Jiao Tong University, School of Medicine, Ren Ji Hospital, Center for 
      Reproductive Medicine, Shanghai, China.
FAU - Sun, Meng-Xiang
AU  - Sun MX
AD  - Wuhan University, College of Life Sciences, Wuhan, Hubei, China.
FAU - Sun, Qiming
AU  - Sun Q
AD  - Zhejiang University, School of Medicine, Department of Biochemistry, Hangzhou, 
      Zhejiang, China.
FAU - Sun, Yi
AU  - Sun Y
AD  - Cancer Institute of the Second Affiliated Hospital and Institute of Translational 
      Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
FAU - Sun, Zhongjie
AU  - Sun Z
AD  - University of Tennessee Health Science Center, Department of Physiology, Memphis, 
      TN, USA.
FAU - Sunahara, Karen K S
AU  - Sunahara KKS
AD  - Experimental Physiopathology, Department of Sciences/Experimental Physiopatholgy, 
      Medical School, University of São Paulo, Brazil.
FAU - Sundberg, Eva
AU  - Sundberg E
AD  - Swedish University of Agricultural Sciences, The Linnean Centre of Plant Biology 
      in Uppsala, Department of Plant Biology, Uppsala, Sweden.
FAU - Susztak, Katalin
AU  - Susztak K
AD  - University of Pennsylvania, Perelman School of Medicine, Department of Medicine, 
      Philadelphia, PA, USA.
FAU - Sutovsky, Peter
AU  - Sutovsky P
AD  - University of Missouri, Division of Animal Science and Department of Obstetrics, 
      Gynecology & Women's Health, Columbia, MO, USA.
FAU - Suzuki, Hidekazu
AU  - Suzuki H
AD  - Tokai University School of Medicine, Division of Gastroenterology and Hepatology, 
      Department of Internal Medicine, Isehara, Kanagawa, Japan.
FAU - Sweeney, Gary
AU  - Sweeney G
AD  - York University, Department of Biology, Toronto, Canada.
FAU - Symons, J David
AU  - Symons JD
AD  - University of Utah, Department of Nutrition and Integrative Physiology; Division 
      of Endocrinology, Metabolism, and Diabetes; Investigator, Molecular Medicine 
      Program, Salt Lake City, UT, USA.
FAU - Sze, Stephen Cho Wing
AU  - Sze SCW
AD  - Hong Kong Baptist University, Faculty of Science, Department of Biology, Hong 
      Kong, China; Hong Kong Baptist University, Golden Meditech Centre for 
      NeuroRegeneration Sciences, Hong Kong, China.
FAU - Szewczyk, Nathaniel J
AU  - Szewczyk NJ
AD  - Ohio Musculoskeletal and Neurological Institute (OMNI) and Department of 
      Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, 
      Athens, OH, USA.
FAU - Tabęcka-Łonczynska, Anna
AU  - Tabęcka-Łonczynska A
AD  - University of Rzeszow, Institute of Biology and Biotechnology, Department of 
      Biotechnology, Rzeszow, Poland.
FAU - Tabolacci, Claudio
AU  - Tabolacci C
AD  - Istituto Superiore di Sanità, Department of Oncology and Molecular Medicine, 
      Rome, Italy.
AD  - Istituto Superiore di Sanità, Department of Oncology and Molecular Medicine, 
      Rome, Italy; Fondazione Umberto Veronesi, Milan, Italy.
FAU - Tacke, Frank
AU  - Tacke F
AD  - Charité University Medicine Berlin, Department of Hepatology & Gastroenterology, 
      Berlin, Germany.
FAU - Taegtmeyer, Heinrich
AU  - Taegtmeyer H
AD  - The University of Texas Health Science Center at Houston, McGovern Medical 
      School, Department of Internal Medicine, Cardiology, Houston, TX, USA.
FAU - Tafani, Marco
AU  - Tafani M
AD  - Sapienza University of Rome, Department of Experimental Medicine, Rome, Italy.
FAU - Tagaya, Mitsuo
AU  - Tagaya M
AD  - Tokyo University of Pharmacy and Life Sciences, School of Life Sciences, 
      Hachioji, Horinouchi, Tokyo, Japan.
FAU - Tai, Haoran
AU  - Tai H
AD  - Chengdu Medical College, Department of Anatomy and Histology and Embryology, 
      Development and Regeneration Key Lab of Sichuan Province, Chengdu, China.
FAU - Tait, Stephen W G
AU  - Tait SWG
AD  - University of Glasgow, Institute of Cancer Sciences, Glasgow, UK.
FAU - Takahashi, Yoshinori
AU  - Takahashi Y
AD  - Penn State University College of Medicine, Department of Pediatrics, Hershey, PA, 
      USA.
FAU - Takats, Szabolcs
AU  - Takats S
AD  - Oslo University Hospital, Institute for Cancer Research, Department of Molecular 
      Cell Biology, Oslo, Norway.
FAU - Talwar, Priti
AU  - Talwar P
AD  - VIT University, School of Biosciences and Technology, Vellore, Tamilnadu, India.
FAU - Tam, Chit
AU  - Tam C
AD  - The Chinese University of Hong Kong, School of Biomedical Sciences, Hong Kong, 
      China; The Chinese University of Hong Kong, Department of Obstetrics and 
      Gynecology, Hong Kong, China.
FAU - Tam, Shing Yau
AU  - Tam SY
AD  - The Hong Kong Polytechnic University, Faculty of Health and Social Sciences, 
      Department of Health Technology and Informatics, Hunghom, Hong Kong.
FAU - Tampellini, Davide
AU  - Tampellini D
AD  - Inserm Unit 1195 - University of Paris Saclay, Le Kremlin-Bicetre, France.
FAU - Tamura, Atsushi
AU  - Tamura A
AD  - Tokyo Medical and Dental University (TMDU), Institute of Biomaterials and 
      Bioengineering, Tokyo, Japan.
FAU - Tan, Chong Teik
AU  - Tan CT
AD  - National University of Singapore, Faculty of Sciences, Department of Pharmacy, 
      Singapore.
FAU - Tan, Eng-King
AU  - Tan EK
AD  - National Neuroscience Institute, Duke NUS Medical School, Singapore.
FAU - Tan, Ya-Qin
AU  - Tan YQ
AD  - Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of 
      Stomatology, Wuhan University, Wuhan, Hubei, China.
AD  - The State Key Laboratory Breeding Base of Basic Science of Stomatology 
      (Hubei-MOST), Wuhan University, School and Hospital of Stomatology, Department of 
      Oral Medicine, Wuhan, Hubei, China.
FAU - Tanaka, Masaki
AU  - Tanaka M
AD  - Kyoto Prefectural University of Medicine, Department of Anatomy and Neurobiology, 
      Kyoto, Japan.
FAU - Tanaka, Motomasa
AU  - Tanaka M
AD  - RIKEN Center for Brain Science, Laboratory for Protein Conformation Diseases, 
      Wako, Saitama, Japan.
FAU - Tang, Daolin
AU  - Tang D
AD  - UT Southwestern Medical Center, Department of Surgery, Dallas, Texas, USA.
FAU - Tang, Jingfeng
AU  - Tang J
AD  - Hubei University of Technology, National "111" Center for Cellular Regulation and 
      Molecular Pharmaceutics, Wuhan, China.
FAU - Tang, Tie-Shan
AU  - Tang TS
AD  - State Key Laboratory of Membrane Biology, Institute of Zoology, Institute for 
      Stem Cell and Regeneration, Chinese Academy of Sciences, University of Chinese 
      Academy of Sciences, Beijing, China.
FAU - Tanida, Isei
AU  - Tanida I
AD  - Juntendo University Graduate School of Medicine, Department of Cellular and 
      Molecular Neuropathology, Tokyo, Japan.
FAU - Tao, Zhipeng
AU  - Tao Z
AD  - Harvard Medical School, Massachusetts General Hospital, Cutaneous Biology 
      Research Center, Charlestown, MA, USA.
FAU - Taouis, Mohammed
AU  - Taouis M
AD  - Université Paris Saclay, Institut des Neurosciences Paris-Saclay (Neuro-PSI)-CNRS 
      UMR 9197, Orsay France.
FAU - Tatenhorst, Lars
AU  - Tatenhorst L
AD  - University Medicine Goettingen, Neurology, Department of Translational 
      Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration (BIN), 
      Goettingen, Germany.
FAU - Tavernarakis, Nektarios
AU  - Tavernarakis N
AD  - Foundation for Research and Technology-Hellas, Institute of Molecular Biology and 
      Biotechnology, Heraklion, Crete, Greece; University of Crete, Medical School, 
      Heraklion, Crete, Greece.
FAU - Taylor, Allen
AU  - Taylor A
AD  - Tufts University, USDA Human Nutrition Research Center on Aging, Laboratory for 
      Nutrition and Vision Research, Boston, MA, USA.
FAU - Taylor, Gregory A
AU  - Taylor GA
AD  - Duke University, Department of Medicine; Duke University, Department of Molecular 
      Genetics and Microbiology; Duke University, Department of Immunology, Durham, NC, 
      USA; Geriatric Research, Education, and Clinical Center, VA Health Care Center, 
      Durham, NC, USA.
FAU - Taylor, Joan M
AU  - Taylor JM
AD  - University of North Carolina, Department of Pathology, Chapel Hill, NC, USA.
FAU - Tchetina, Elena
AU  - Tchetina E
AD  - Nasonova Research Institute of Rheumatology, Moscow, Russia.
FAU - Tee, Andrew R
AU  - Tee AR
AD  - Cardiff University, Division of Cancer and Genetics, Heath Park Way, Cardiff, UK.
FAU - Tegeder, Irmgard
AU  - Tegeder I
AD  - Goethe-University, Faculty of Medicine, Department of Clinical Pharmacology, 
      Frankfurt, Germany.
FAU - Teis, David
AU  - Teis D
AD  - Medical University of Innsbruck, Institute for Cell Biology, Innsbruck, Austria.
FAU - Teixeira, Natercia
AU  - Teixeira N
AD  - University of Porto, Faculty of Pharmacy, UCIBIO, REQUIMTE, Porto, Portugal.
FAU - Teixeira-Clerc, Fatima
AU  - Teixeira-Clerc F
AD  - INSERM U955, Team "Virus Hepatology Cancers", Créteil, France; Université 
      Paris-Est, UMR S955, UPEC, Créteil, France.
FAU - Tekirdag, Kumsal A
AU  - Tekirdag KA
AD  - Albert Einstein College of Medicine, Department of Developmental and Molecular 
      Biology, Bronx, NY, USA.
FAU - Tencomnao, Tewin
AU  - Tencomnao T
AD  - Chulalongkorn University, Faculty of Allied Health Sciences, Age-Related 
      Inflammation and Degeneration Research Unit, Department of Clinical Chemistry, 
      Bangkok, Thailand.
FAU - Tenreiro, Sandra
AU  - Tenreiro S
AD  - iNOVA4Health Chronic Diseases Research Center (CEDOC), Faculdade de Ciências 
      Médicas, Universidade Nova de Lisboa, Lisboa, Portugal.
FAU - Tepikin, Alexei V
AU  - Tepikin AV
AD  - University of Liverpool, Department of Cellular and Molecular Physiology, 
      Liverpool, UK.
FAU - Testillano, Pilar S
AU  - Testillano PS
AD  - Centro de Investigaciones Biológicas Margarita Salas, CIB-CSIC, Madrid, Spain.
FAU - Tettamanti, Gianluca
AU  - Tettamanti G
AD  - University of Insubria, Department of Biotechnology and Life Sciences, Varese, 
      Italy.
FAU - Tharaux, Pierre-Louis
AU  - Tharaux PL
AD  - Institut National de la Santé et de la Recherche Médicale (Inserm), Université de 
      Paris, Paris Cardiovascular Center - PARCC, Paris, France.
FAU - Thedieck, Kathrin
AU  - Thedieck K
AD  - University of Innsbruck, Institute of Biochemistry and Center for Molecular 
      Biosciences Innsbruck, Innsbruck, Austria; University Medical Center Groningen, 
      University of Groningen, Section Systems Medicine of Metabolism and Signaling, 
      Laboratory of Pediatrics, Groningen, The Netherlands.
AD  - Carl von Ossietzky University Oldenburg, School of Medicine and Health Sciences, 
      Department for Neuroscience, Oldenburg, Germany.
FAU - Thekkinghat, Arvind A
AU  - Thekkinghat AA
AD  - Indian Institute of Science, Department of Biochemistry, Bangalore, India.
FAU - Thellung, Stefano
AU  - Thellung S
AD  - University of Genova, Department of Internal Medicine, Genova, Italy.
FAU - Thinwa, Josephine W
AU  - Thinwa JW
AD  - University of Texas Southwestern Medical Center, Center for Autophagy Research, 
      Department of Internal Medicine and Howard Hughes Medical Institute, Dallas, TX, 
      USA.
FAU - Thirumalaikumar, V P
AU  - Thirumalaikumar VP
AD  - Max Planck Institute of Molecular Plant Physiology, Potsdam-Golm, Germany.
AD  - Washington University in St. Louis, Department of Biology, St. Louis, MO, USA.
FAU - Thomas, Sufi Mary
AU  - Thomas SM
AD  - University of Kansas Medical Center, Department of Otolaryngology, Kansas City, 
      KS, USA.
FAU - Thomes, Paul G
AU  - Thomes PG
AD  - University of Nebraska Medical Center, Departments of Internal Medicine and 
      Biochemistry and Molecular Biology, Omaha, NE, USA.
FAU - Thorburn, Andrew
AU  - Thorburn A
AD  - University of Colorado School of Medicine, Department of Pharmacology, Aurora, 
      CO, USA.
FAU - Thukral, Lipi
AU  - Thukral L
AD  - CSIR-Institute of Genomics and Integrative Biology, South Campus, New Delhi, 
      India.
FAU - Thum, Thomas
AU  - Thum T
AD  - Hannover Medical School, Institute for Molecular and Therapeutic Strategies 
      (IMTTS), Hannover, Germany.
FAU - Thumm, Michael
AU  - Thumm M
AD  - University Medical Center Göttingen, Institute of Cellular Biochemistry, 
      Göttingen, Germany.
FAU - Tian, Ling
AU  - Tian L
AD  - South China Agricultural University, Guangdong Provincial Key Laboratory of 
      Agro-animal Genomics and Molecular Breeding/Guangdong Provincial Sericulture and 
      Mulberry Engineering Research Center, College of Animal Science, Guangzhou, 
      China.
FAU - Tichy, Ales
AU  - Tichy A
AD  - University of Defense, Faculty of Military Health Sciences, Department of 
      Radiobiology, Hradec Kralove, Czech Republic.
FAU - Till, Andreas
AU  - Till A
AD  - University Hospital of Bonn, Institute of Reconstructive Neurobiology, Bonn, 
      Germany.
FAU - Timmerman, Vincent
AU  - Timmerman V
AD  - University of Antwerp, Department of Biomedical Sciences, Peripheral Neuropathy 
      Research Group, Antwerp, Belgium.
FAU - Titorenko, Vladimir I
AU  - Titorenko VI
AD  - Concordia University, Department of Biology, Montreal, Quebec, Canada.
FAU - Todi, Sokol V
AU  - Todi SV
AD  - Wayne State University School of Medicine, Department of Pharmacology, Detroit, 
      MI, USA.
FAU - Todorova, Krassimira
AU  - Todorova K
AD  - Bulgarian Academy of Sciences, Institute of Biology and Immunology of 
      Reproduction Acad. Kiril Bratanov, Sofia, Bulgaria.
FAU - Toivonen, Janne M
AU  - Toivonen JM
AD  - University of Zaragoza, Faculty of Veterinary-IIS Aragón, IA2-CITA, CIBERNED, 
      Laboratory of Genetics and Biochemistry (LAGENBIO), Zaragoza, Spain.
FAU - Tomaipitinca, Luana
AU  - Tomaipitinca L
AD  - Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
AD  - Sapienza University of Rome, Department of Anatomy, Histology, Forensic Medicine 
      and Orthopedics, Rome, Italy.
FAU - Tomar, Dhanendra
AU  - Tomar D
AD  - Lewis Katz School of Medicine at Temple University, Center for Translational 
      Medicine, Philadelphia, PA, USA.
FAU - Tomas-Zapico, Cristina
AU  - Tomas-Zapico C
AD  - University of Oviedo, Department of Functional Biology, Physiology, Oviedo, 
      Asturias, Spain.
FAU - Tomić, Sergej
AU  - Tomić S
AD  - University of Belgrade, Institute for the Application of Nuclear Energy (INEP), 
      Belgrade, Serbia.
FAU - Tong, Benjamin Chun-Kit
AU  - Tong BC
FAU - Tong, Chao
AU  - Tong C
AD  - Zhejiang University, Life Sciences Institute and Innovation Center for Cell 
      Signaling Network, Hangzhou, China.
FAU - Tong, Xin
AU  - Tong X
AD  - Northwestern University, Feinberg School of Medicine, Department of Pathology, 
      Chicago, IL, USA.
FAU - Tooze, Sharon A
AU  - Tooze SA
AD  - The Francis Crick Institute, Molecular Cell Biology of Autophagy, London, UK.
FAU - Torgersen, Maria L
AU  - Torgersen ML
AD  - Oslo University Hospital, Institute for Cancer Research, Department of Molecular 
      Cell Biology, Oslo, Norway.
FAU - Torii, Satoru
AU  - Torii S
AD  - Tokyo Medical and Dental University, Department of Pathological Cell Biology, 
      Tokyo, Japan.
FAU - Torres-López, Liliana
AU  - Torres-López L
AD  - University of Colima, University Center for Biomedical Research, Colima, Mexico.
FAU - Torriglia, Alicia
AU  - Torriglia A
AD  - Centre de Recherche des Cordeliers, INSERM, Université de Paris, Sorbonne 
      Université, Paris, France.
FAU - Towers, Christina G
AU  - Towers CG
AD  - University of Colorado Anschutz Medical Campus, Department of Pharmacology, 
      Aurora, CO, USA.
FAU - Towns, Roberto
AU  - Towns R
AD  - Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
FAU - Toyokuni, Shinya
AU  - Toyokuni S
AD  - Nagoya University Graduate School of Medicine, Department of Pathology and 
      Biological Responses, Nagoya, Japan.
FAU - Trajkovic, Vladimir
AU  - Trajkovic V
AD  - University of Belgrade, Faculty of Medicine, Institute of Microbiology and 
      Immunology, Belgrade, Serbia.
FAU - Tramontano, Donatella
AU  - Tramontano D
AD  - University Federico II of Naples, Department of Molecular Medicine and Medical 
      Biotechnology, Naples, Italy.
FAU - Tran, Quynh-Giao
AU  - Tran QG
AD  - Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cell Factory 
      Research Center, Daejeon, Korea; University of Science and Technology, KRIBB 
      School of Biotechnology, Department of Environmental Biotechnology, Daejeon, 
      Korea.
FAU - Travassos, Leonardo H
AU  - Travassos LH
AD  - Universidade Federal do Rio de Janeiro, Institute of Biophysics Carlos Chagas 
      Filho, Immunobiology Program, Rio de Janeiro, RJ, Brazil.
FAU - Trelford, Charles B
AU  - Trelford CB
AD  - Western University, Department of Physiology and Pharmacology, London, ON, 
      Canada.
FAU - Tremel, Shirley
AU  - Tremel S
AD  - MRC Laboratory of Molecular Biology, Cambridge, UK.
FAU - Trougakos, Ioannis P
AU  - Trougakos IP
AD  - National and Kapodistrian University of Athens, Faculty of Biology, Department of 
      Cell Biology and Biophysics, Panepistimiopolis, Athens, Greece.
FAU - Tsao, Betty P
AU  - Tsao BP
AD  - Medical University of South Carolina, Department of Medicine, Division of 
      Rheumatology & Immunology, Charleston, SC, USA.
FAU - Tschan, Mario P
AU  - Tschan MP
AD  - University of Bern, Institute of Pathology, Division of Experimental Pathology, 
      Bern, Switzerland.
FAU - Tse, Hung-Fat
AU  - Tse HF
AD  - University of Hong Kong, Cardiology Division, Department of Medicine, Hong Kong, 
      China.
FAU - Tse, Tak Fu
AU  - Tse TF
AD  - The Chinese University of Hong Kong, School of Biomedical Sciences, Hong Kong, 
      China.
FAU - Tsugawa, Hitoshi
AU  - Tsugawa H
AD  - Tokai University School of Medicine, Division of Gastroenterology and Hepatology, 
      Department of Internal Medicine, Isehara, Kanagawa, Japan.
FAU - Tsvetkov, Andrey S
AU  - Tsvetkov AS
AD  - The University of Texas McGovern Medical School at Houston, Department of 
      Neurology, Houston, TX, USA.
FAU - Tumbarello, David A
AU  - Tumbarello DA
AD  - University of Southampton , Biological Sciences, Faculty of Environmental and 
      Life Sciences, Highfield, Southampton, UK.
FAU - Tumtas, Yasin
AU  - Tumtas Y
AD  - Imperial College London, Department of Life Sciences, London, UK.
FAU - Tuñón, María J
AU  - Tuñón MJ
AD  - University of León, Institute of Biomedicine (IBIOMED) and Centro de 
      Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 
      León, Spain.
FAU - Turcotte, Sandra
AU  - Turcotte S
AD  - Universite de Moncton, Department of Chemistry and Biochemistry, Moncton, NB, 
      Canada.
FAU - Turk, Boris
AU  - Turk B
AD  - Jožef Stefan Institute, Department of Biochemistry and Molecular and Structural 
      Biology, Ljubljana, Slovenia.
FAU - Turk, Vito
AU  - Turk V
AD  - Jožef Stefan Institute, Department of Biochemistry and Molecular and Structural 
      Biology, Ljubljana, Slovenia.
FAU - Turner, Bradley J
AU  - Turner BJ
AD  - University of Melbourne, Florey Institute of Neuroscience and Mental Health, 
      Melbourne, VIC, Australia.
FAU - Tuxworth, Richard I
AU  - Tuxworth RI
AD  - University of Birmingham, Institute of Cancer and Genomic Sciences, Birmingham, 
      UK.
FAU - Tyler, Jessica K
AU  - Tyler JK
AD  - Weill Cornell Medicine, Department of Pathology and Laboratory Medicine, New 
      York, NY, USA.
FAU - Tyutereva, Elena V
AU  - Tyutereva EV
AD  - Komarov Botanical Institute RAS, Laboratory of Molecular and Ecological 
      Physiology, Saint Petersburg, Russian Federation.
FAU - Uchiyama, Yasuo
AU  - Uchiyama Y
AD  - Juntendo University Graduate School of Medicine, Department of Cellular and 
      Molecular Neuropathology, Tokyo, Japan.
FAU - Ugun-Klusek, Aslihan
AU  - Ugun-Klusek A
AD  - Nottingham Trent University, School of Science and Technology, Nottingham, UK.
FAU - Uhlig, Holm H
AU  - Uhlig HH
AD  - University of Oxford, John Radcliffe Hospital, Translational Gastroenterology 
      Unit and Department of Paediatrics, Oxford, and Oxford NIHR Biomedical Research 
      Centre, Oxford, UK.
FAU - Ułamek-Kozioł, Marzena
AU  - Ułamek-Kozioł M
AD  - Institute of Psychiatry and Neurology, First Department of Neurology, Warsaw, 
      Poland.
FAU - Ulasov, Ilya V
AU  - Ulasov IV
AD  - Sechenov First Moscow State Medical University, Institute for Regenerative 
      Medicine, Moscow, Russia.
FAU - Umekawa, Midori
AU  - Umekawa M
AD  - Mie University, Graduate School of Bioresources, Tsu, Japan.
FAU - Ungermann, Christian
AU  - Ungermann C
AD  - University of Osnabrück, Department of Biology/Chemistry, and Center of Cellular 
      Nanoanalytics Osnabrück (CellNanOs), Osnabrück, Germany.
FAU - Unno, Rei
AU  - Unno R
AD  - Nagoya City University Graduate School of Medical Sciences, Department of 
      Nephro-urology, Nagoya, Aichi, Japan.
FAU - Urbe, Sylvie
AU  - Urbe S
AD  - University of Liverpool, Institute of Translational Research, Cellular and 
      Molecular Physiology, Liverpool, UK.
AD  - Molecular Physiology and Cell Signaling, Institute of Systems, Molecular and 
      Integrative Biology, University of Liverpool, Liverpool, UK.
FAU - Uribe-Carretero, Elisabet
AU  - Uribe-Carretero E
AD  - University of Extremadura, Centro de Investigación Biomedica en Red de 
      Enfermedades Neurodegenerativas (CIBERNED), Instituto de Investigación 
      Biosanitaria de Extremadura (INUBE), Department of Biochemistry, Molecular 
      Biology and Genetics, Faculty of Nursing and Occupational Therapy, Cáceres, 
      Spain.
FAU - Üstün, Suayib
AU  - Üstün S
AD  - University of Tübingen, Center for Plant Molecular Biology (ZMBP), Tübingen, 
      Germany.
FAU - Uversky, Vladimir N
AU  - Uversky VN
AD  - University of South Florida, Morsani College of Medicine, Department of Molecular 
      Medicine and USF Health Byrd Alzheimer's Research Institute, Tampa, FL, USA; 
      Institute for Biological Instrumentation of Russian Academy of Sciences, 
      Laboratory of New Methods in Biology, Pushchino, Moscow region, Russia.
FAU - Vaccari, Thomas
AU  - Vaccari T
AD  - University of Milan, Department of Biosciences, Milan, Italy.
FAU - Vaccaro, Maria I
AU  - Vaccaro MI
AD  - University of Buenos Aires, Institute of Biochemistry and Molecular Medicine, 
      Pathophysiology Department, School of Pharmacy and Biochemistry, CONICET, Buenos 
      Aires, Argentina.
FAU - Vahsen, Björn F
AU  - Vahsen BF
AD  - University of Oxford, Nuffield Department of Clinical Neurosciences, Oxford, UK.
FAU - Vakifahmetoglu-Norberg, Helin
AU  - Vakifahmetoglu-Norberg H
AD  - Karolinska Institute, Department of Physiology and Pharmacology, Stockholm, 
      Sweden.
FAU - Valdor, Rut
AU  - Valdor R
AD  - University of Murcia, Department of Biochemistry, Molecular Biology B and 
      Immunology; Biomedical Research Institute of Murcia (IMIB-Arrixaca), Unit of 
      Autophagy, Immunity and Cancer, Murcia, Spain.
FAU - Valente, Maria J
AU  - Valente MJ
AD  - University of Porto, Faculty of Pharmacy, UCIBIO, REQUIMTE, Porto, Portugal.
FAU - Valko, Ayelén
AU  - Valko A
AD  - Fundación Instituto Leloir and IIBBA, CONICET, Buenos Aires, Argentina; 
      Laboratorio de Glicobiología Celular y Genética Aplicada de Levaduras, Facultad 
      de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Argentina.
FAU - Vallee, Richard B
AU  - Vallee RB
AD  - Columbia University, Vagelos College of Physicians and Surgeons, Department of 
      Pathology and Cell Biology, New York, NY, USA.
FAU - Valverde, Angela M
AU  - Valverde AM
AD  - Instituto de Investigaciones Biomedicas Alberto Sols (CSIC-UAM), Madrid, Spain; 
      Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas 
      Asociadas (CIBERdem), Instituto de Salud Carlos III, Madrid, Spain.
FAU - Van den Berghe, Greet
AU  - Van den Berghe G
AD  - KU Leuven, Clinical Division and Laboratory of Intensive Care Medicine, 
      Department of Cellular and Molecular Medicine, Leuven, Belgium.
FAU - van der Veen, Stijn
AU  - van der Veen S
AD  - Zhejiang University, School of Medicine, Department of Microbiology and 
      Parasitology, Hangzhou, China.
FAU - Van Kaer, Luc
AU  - Van Kaer L
AD  - Vanderbilt University School of Medicine, Department of Pathology, Microbiology 
      and Immunology, Nashville, TN, USA.
FAU - van Loosdregt, Jorg
AU  - van Loosdregt J
AD  - Center of Translational Immunlogy, University Medical Center Utrecht, Utrecht, 
      The Netherlands.
FAU - van Wijk, Sjoerd J L
AU  - van Wijk SJL
AD  - Goethe University, Institute for Experimental Cancer Research in Pediatrics, 
      Frankfurt am Main, Germany.
FAU - Vandenberghe, Wim
AU  - Vandenberghe W
AD  - University Hospitals Leuven, Department of Neurology, Leuven, Belgium; KU Leuven, 
      Department of Neurosciences, Leuven, Belgium.
FAU - Vanhorebeek, Ilse
AU  - Vanhorebeek I
AD  - KU Leuven, Clinical Division and Laboratory of Intensive Care Medicine, 
      Department of Cellular and Molecular Medicine, Leuven, Belgium.
FAU - Vannier-Santos, Marcos A
AU  - Vannier-Santos MA
AD  - Instituto Oswaldo Cruz, LITEB/IOC, Fundação Oswaldo Cruz, FIOCRUZ, Rio de 
      Janeiro, Brazil.
FAU - Vannini, Nicola
AU  - Vannini N
AD  - Laboratory of Immunosenescence and Stem Cell Metabolism, Department of Oncology, 
      Ludwig Cancer Institute, University of Lausanne, 1066 Epalinges, Switzerland.
FAU - Vanrell, M Cristina
AU  - Vanrell MC
AD  - CONICET-Universidad Nacional de Cuyo, Instituto de Histología y Embriología de 
      Mendoza, Mendoza, Argentina.
FAU - Vantaggiato, Chiara
AU  - Vantaggiato C
AD  - Scientific Institute, IRCCS E. Medea, Laboratory of Molecular Biology, Bosisio 
      Parini, Lecco, Italy.
FAU - Varano, Gabriele
AU  - Varano G
AD  - University of Ferrara, Department of Translational Medicine, Ferrara, Italy.
FAU - Varela-Nieto, Isabel
AU  - Varela-Nieto I
AD  - Instituto de Investigaciones Biomedicas "Alberto Sols" (CSIC-UAM) and CIBERER 
      (CIBER, ISCiii), Madrid, Spain.
FAU - Varga, Máté
AU  - Varga M
AD  - Eötvös Loránd University (ELTE), Department of Genetics, Budapest, Hungary.
FAU - Vasconcelos, M Helena
AU  - Vasconcelos MH
AD  - Universidade do Porto, i3S-Instituto de Investigação e Inovação em Saúde, Porto, 
      Portugal; IPATIMUP - Institute of Molecular Pathology and Immunology of the 
      University of Porto, Cancer Drug Resistance Group, Porto, Portugal; FFUP - 
      Faculty of Pharmacy of the University of Porto, Department of Biological 
      Sciences, Porto, Portugal.
FAU - Vats, Somya
AU  - Vats S
AD  - Jawaharlal Nehru Centre for Advanced Scientific Research, Molecular Biology and 
      Genetics Unit, and Neuroscience Unit, Autophagy Laboratory, Jakkur, Bangalore, 
      India.
FAU - Vavvas, Demetrios G
AU  - Vavvas DG
AD  - Harvard Medical School, Ophthalmology, Boston, MA, USA.
FAU - Vega-Naredo, Ignacio
AU  - Vega-Naredo I
AD  - University of Oviedo, Department of Morphology and Cell Biology, Oviedo, Spain.
FAU - Vega-Rubin-de-Celis, Silvia
AU  - Vega-Rubin-de-Celis S
AD  - Universitätsklinikum Essen, Institute for Cell Biology (Cancer Research), Essen, 
      Germany.
FAU - Velasco, Guillermo
AU  - Velasco G
AD  - Complutense University, Instituto de Investigaciones Sanitarias San Carlos 
      (IdISSC), Department of Biochemistry and Molecular Biology, School of Biology, 
      Madrid, Spain.
FAU - Velázquez, Ariadna P
AU  - Velázquez AP
AD  - Max Planck Institute for Biology of Ageing, Cologne, Germany; University of 
      Cologne, Cologne Excellence Cluster on Cellular Stress Responses in 
      Aging-Associated Diseases (CECAD), Cologne, Germany.
AD  - Max Planck Institute for Biology of Ageing, Cologne, Germany.
FAU - Vellai, Tibor
AU  - Vellai T
AD  - Eötvös Loránd University (ELTE), Department of Genetics, Budapest, Hungary.
FAU - Vellenga, Edo
AU  - Vellenga E
AD  - University of Groningen, University Medical Center Groningen, Department of 
      Hematology, Groningen, The Netherlands.
FAU - Velotti, Francesca
AU  - Velotti F
AD  - Tuscia University, Department of Ecological and Biological Sciences (DEB), 
      Viterbo, Italy.
FAU - Verdier, Mireille
AU  - Verdier M
AD  - EA 3842, Limoges University, Faculty of Medicine, Limoges cedex, France.
FAU - Verginis, Panayotis
AU  - Verginis P
AD  - Biomedical Research Foundation, Academy of Athens, Center of Clinical, 
      Experimental Surgery and Translational Research, Athens, Greece.
FAU - Vergne, Isabelle
AU  - Vergne I
AD  - Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, 
      CNRS, Université Paul Sabatier, Toulouse, France.
FAU - Verkade, Paul
AU  - Verkade P
AD  - School of Biochemistry, Faculty of Life Sciences, University of Bristol, Bristol, 
      UK.
FAU - Verma, Manish
AU  - Verma M
AD  - University of Pittsburgh, Department of Pathology, Pittsburgh, PA, USA.
FAU - Verstreken, Patrik
AU  - Verstreken P
AD  - VIB-KU Leuven Center for Brain & Disease Research, Leuven, Belgium; KU Leuven, 
      Department of Neurosciences, Leuven Brain Institute, Leuven, Belgium.
FAU - Vervliet, Tim
AU  - Vervliet T
AD  - KU Leuven, Department of Cellular & Molecular Medicine, Campus Gasthuisberg, 
      Leuven, Belgium.
FAU - Vervoorts, Jörg
AU  - Vervoorts J
AD  - RWTH Aachen University, Medical School, Institute of Biochemistry and Molecular 
      Biology, Aachen, Germany.
FAU - Vessoni, Alexandre T
AU  - Vessoni AT
AD  - Washington University in St. Louis, Department of Medicine, St. Louis, MO, USA.
FAU - Victor, Victor M
AU  - Victor VM
AD  - Service of Endocrinology, University Hospital Doctor Peset, Foundation for the 
      Promotion of Health and Biomedical Research in the Valencian Region 
      (FISABIO)-Department of Physiology, University of Valencia, Valencia, Spain.
FAU - Vidal, Michel
AU  - Vidal M
AD  - University of Montpellier, UMR 5235, Montpellier, France.
FAU - Vidoni, Chiara
AU  - Vidoni C
AD  - Università del Piemonte Orientale, Department of Health Sciences, Laboratory of 
      Molecular Pathology, Novara, Italy.
FAU - Vieira, Otilia V
AU  - Vieira OV
AD  - Universidade NOVA de Lisboa, CEDOC, NOVA Medical School, Faculdade de Ciências 
      Médicas, Lisboa, Portugal.
FAU - Vierstra, Richard D
AU  - Vierstra RD
AD  - Washington University in St. Louis, Department of Biology, St. Louis, MO, USA.
FAU - Viganó, Sonia
AU  - Viganó S
AD  - European Institute of Oncology (IEO) IRCCS, Department of Experimental Oncology, 
      Milan, Italy; University of Milano, Department of Oncology and Hemato-Oncology, 
      Milan, Italy.
AD  - European Institute of Oncology (IEO) IRCCS, Department of Experimental Oncology, 
      Milan, Italy.
FAU - Vihinen, Helena
AU  - Vihinen H
AD  - University of Helsinki, Institute of Biotechnology, Electron Microscopy Unit, 
      Helsinki, Finland.
FAU - Vijayan, Vinoy
AU  - Vijayan V
AD  - VIB-KU Leuven Center for Brain & Disease Research, Leuven, Belgium; KU Leuven, 
      Department of Neurosciences, Leuven Brain Institute, Leuven, Belgium.
FAU - Vila, Miquel
AU  - Vila M
AD  - Vall d'Hebron Research Institute (VHIR)-Network Center for Biomedical Research in 
      Neurodegenerative Diseases (CIBERNED)-Catalan Institution for Research and 
      Advanced Studies (ICREA), Barcelona, Spain.
FAU - Vilar, Marçal
AU  - Vilar M
AD  - Institute of Biomedicine of Valencia, Spanish Research Council (CSIC), Valencia, 
      Spain.
FAU - Villalba, José M
AU  - Villalba JM
AD  - University of Cordoba, Department of Cell Biology, Physiology and Immunology, 
      Córdoba, Spain.
FAU - Villalobo, Antonio
AU  - Villalobo A
AD  - University Hospital La Paz Research Institute (IdiPAZ), Cancer and Human 
      Molecular Genetics Area Oto-Neurosurgery Research Group, Madrid, Spain.
FAU - Villarejo-Zori, Beatriz
AU  - Villarejo-Zori B
AD  - Centro de Investigaciones Biológicas Margarita Salas, CSIC, Madrid, Spain.
FAU - Villarroya, Francesc
AU  - Villarroya F
AD  - University of Barcelona, Department of Biochemistry and Molecular Biomedicine, 
      and Network Center for Biomedical Research in Pathophysiology of Obesity and 
      Nutrition (CIBEROBN), Barcelona, Spain.
FAU - Villarroya, Joan
AU  - Villarroya J
AD  - University of Barcelona, Department of Biochemistry and Molecular Biomedicine, 
      and Network Center for Biomedical Research in Pathophysiology of Obesity and 
      Nutrition (CIBEROBN), Barcelona, Spain.
FAU - Vincent, Olivier
AU  - Vincent O
AD  - Instituto de Investigaciones Biomédicas Alberto Sols, C.S.I.C./U.A.M., Madrid, 
      Spain.
FAU - Vindis, Cecile
AU  - Vindis C
AD  - University of Toulouse, Institute of Metabolic and cardiovascular Diseases, 
      INSERM UMR 1048, Toulouse, France.
FAU - Viret, Christophe
AU  - Viret C
AD  - Centre International de Recherche en Infectiologie (CIRI), University Lyon, 
      Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS Lyon, Lyon, 
      France.
FAU - Viscomi, Maria Teresa
AU  - Viscomi MT
AD  - Università Cattolica del Sacro Cuore, Department of Life Science and Public 
      Health Section of Histology and Embryology, Rome, Italy.
FAU - Visnjic, Dora
AU  - Visnjic D
AD  - University of Zagreb School of Medicine, Department of Physiology and Croatian 
      Institute for Brain Research, Zagreb, Croatia.
FAU - Vitale, Ilio
AU  - Vitale I
AD  - Italian Institute for Genomic Medicine (IIGM), Candiolo (TO), Italy; Candiolo 
      Cancer Institute, FPO-IRCCS, Candiolo (TO), Italy.
FAU - Vocadlo, David J
AU  - Vocadlo DJ
AD  - Simon Fraser University, Department of Chemistry, Department of Molecular Biology 
      and Biochemistry, Burnaby, British Columbia, Canada.
FAU - Voitsekhovskaja, Olga V
AU  - Voitsekhovskaja OV
AD  - Komarov Botanical Institute RAS, Laboratory of Molecular and Ecological 
      Physiology, Saint Petersburg, Russian Federation.
FAU - Volonté, Cinzia
AU  - Volonté C
AD  - Institute for Systems Analysis and Computer Science "A. Ruberti", National 
      Research Council (IASI-CNR), IRCCS Fondazione Santa Lucia, Rome, Italy.
FAU - Volta, Mattia
AU  - Volta M
AD  - Eurac Research, Institute for Biomedicine, Bolzano, Italy.
FAU - Vomero, Marta
AU  - Vomero M
AD  - Sapienza University of Rome, Department of Clinical, Internal, Anesthesiological 
      and Cardiovascular Sciences, Rome, Italy.
FAU - Von Haefen, Clarissa
AU  - Von Haefen C
AD  - Charité - Universitätsmedizin Berlin, Department of Anesthesiology and Intensive 
      Care Medicine, Campus Charité Mitte and Campus Virchow-Klinikum, Berlin, Germany.
FAU - Vooijs, Marc A
AU  - Vooijs MA
AD  - Maastricht University Medical Center, GROW School for Oncology, Department of 
      Radiotherapy, Maastricht|, The Netherlands.
FAU - Voos, Wolfgang
AU  - Voos W
AD  - Rheinische Friedrich-Wilhelms-Universität, Institut für Biochemie und 
      Molekularbiologie (IBMB), Bonn, Germany.
FAU - Vucicevic, Ljubica
AU  - Vucicevic L
AD  - Department of Neurophysiology, Institute for Biological Research "Siniša 
      Stanković" - National Institute of Republic of Serbia, University of Belgrade, 
      Belgrade, Serbia.
FAU - Wade-Martins, Richard
AU  - Wade-Martins R
AD  - University of Oxford, Oxford Parkinson's Disease Centre, Department of 
      Physiology, Anatomy and Genetics, Oxford, UK.
FAU - Waguri, Satoshi
AU  - Waguri S
AD  - Fukushima Medical University, School of Medicine, Department of Anatomy and 
      Histology, Fukushima, Japan.
FAU - Waite, Kenrick A
AU  - Waite KA
AD  - University of Kansas Medical Center, Department of Biochemistry and Molecular 
      Biology, Kansas City, KS, USA.
FAU - Wakatsuki, Shuji
AU  - Wakatsuki S
AD  - National Institute of Neuroscience, National Center of Neurology and Psychiatry, 
      Department of Peripheral Nervous System Research, Kodaira, Tokyo, Japan.
FAU - Walker, David W
AU  - Walker DW
AD  - University of California, Los Angeles, Department of Integrative Biology and 
      Physiology, Los Angeles, CA, USA.
FAU - Walker, Mark J
AU  - Walker MJ
AD  - The University of Queensland, School of Chemistry and Molecular Biosciences and 
      Australian Infectious Diseases Research Centre, St. Lucia, Brisbane, Queensland, 
      Australia.
FAU - Walker, Simon A
AU  - Walker SA
AD  - Babraham Institute, Cambridge, UK.
FAU - Walter, Jochen
AU  - Walter J
AD  - University of Bonn, Department of Neurology, Molecular Cell Biology Unit, Bonn, 
      Germany.
FAU - Wandosell, Francisco G
AU  - Wandosell FG
AD  - Universidad Autónoma de Madrid, Centro de Biología Molecular Severo Ochoa 
      (CSIC-UAM & CIBERNED), Madrid, Spain.
FAU - Wang, Bo
AU  - Wang B
AD  - St Jude Children's Research Hospital, Department of Pathology, Memphis, TN, USA.
FAU - Wang, Chao-Yung
AU  - Wang CY
AD  - Chang Gung University College of Medicine and Chang Gung Memorial Hospital, 
      Department of Cardiology, Taoyuan City, Taiwan; National Health Research 
      Institutes, Institute of Cellular and System Medicine, Zhunan, Taiwan.
FAU - Wang, Chen
AU  - Wang C
AD  - China Pharmaceutical University, School of Life Science and Technology, Nanjing, 
      Jiangsu, China.
FAU - Wang, Chenran
AU  - Wang C
AD  - University of Cincinnati College of Medicine, Department of Cancer Biology, 
      Cincinnati, OH, USA.
FAU - Wang, Chenwei
AU  - Wang C
AD  - Huazhong University of Science and Technology, College of Life Science and 
      Technology, Hubei Bioinformatics and Molecular Imaging Key Laboratory, Key 
      Laboratory of Molecular Biophysics of Ministry of Education, Wuhan, Hubei, China.
FAU - Wang, Cun-Yu
AU  - Wang CY
AD  - University of California Los Angeles, School of Dentistry, Division of Oral 
      Biology and Medicine, Los Angeles, CA, USA.
FAU - Wang, Dong
AU  - Wang D
AD  - Department of Bioinformatics, School of Basic Medical Sciences, Southern Medical 
      University, Guangzhou, China.
FAU - Wang, Fangyang
AU  - Wang F
AD  - University of Michigan, Department of Internal Medicine, Division of Hematology 
      and Oncology, Ann Arbor, MI, USA.
FAU - Wang, Feng
AU  - Wang F
AD  - Shanghai Ninth People's Hospital, National Clinical Research Center for Oral 
      Disease, Shanghai Jiao Tong Univeristy, School of Medicine, Shanghai, China.
FAU - Wang, Fengming
AU  - Wang F
AD  - Texas A&M College of Dentistry, Department of Endodontics, Dallas, TX, USA.
FAU - Wang, Guansong
AU  - Wang G
AD  - Third Military Medical University of China, Xinqiao Hospital, Institute of 
      Respiratory Diseases, Chongqing, China.
FAU - Wang, Han
AU  - Wang H
AD  - Soochow University, Center for Circadian Clocks; School of Biology & Basic 
      Medical Sciences, Medical College, Suzhou, Jiangsu, China.
FAU - Wang, Hao
AU  - Wang H
AD  - CAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical 
      Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and 
      Technology (NCNST), Zhongguancun, Beijing, China.
FAU - Wang, Hexiang
AU  - Wang H
AD  - China Agricultural University, College of Biological Sciences, State Key 
      Laboratory of Agro-Biotechnology and MOA Key Laboratory of Soil Microbiology, 
      Beijing, China.
FAU - Wang, Hong-Gang
AU  - Wang HG
AD  - Penn State University College of Medicine, Department of Pediatrics, Hershey, PA, 
      USA.
FAU - Wang, Jianrong
AU  - Wang J
AD  - Soochow University, Hematology Center of Cyrus Tang Hematology Institute, School 
      of Medicine, Suzhou, China.
FAU - Wang, Jigang
AU  - Wang J
AD  - China Academy of Chinese Medical Sciences, Artemisinin Research Center and the 
      Institute of Chinese Materia Medica, Beijing, China.
FAU - Wang, Jiou
AU  - Wang J
AD  - Johns Hopkins University, Department of Biochemistry and Molecular Biology, 
      Baltimore, MD, USA.
FAU - Wang, Jundong
AU  - Wang J
AD  - Shanxi Agricultural University, Shanxi Key Laboratory of Ecological Animal 
      Science and Environmental Veterinary Medicine, Taigu, Shanxi, China.
FAU - Wang, Kui
AU  - Wang K
AD  - Sichuan University, West China School of Basic Medical Sciences & Forensic 
      Medicine, Chengdu, China.
FAU - Wang, Lianrong
AU  - Wang L
AD  - Wuhan University, School of Pharmaceutical Sciences, Zhongnan Hospital, Wuhan, 
      China.
FAU - Wang, Liming
AU  - Wang L
AD  - National University of Singapore, Yong Loo Lin School of Medicine, Department of 
      Physiology, Singapore.
AD  - Hunan Key Laboratory of Medical Epigenomics, Department of Dermatology, Second 
      Xiangya Hospital, Central South University, Changsha, China.
FAU - Wang, Maggie Haitian
AU  - Wang MH
AD  - The Chinese University of Hong Kong, School of Public Health and Primary Care, 
      Hong Kong, China.
FAU - Wang, Meiqing
AU  - Wang M
AD  - Fourth Military Medical University, College of Stomatology, Department of Oral 
      Anatomy and Physiology and TMD, Xi'an, China.
FAU - Wang, Nanbu
AU  - Wang N
AD  - The First Affiliated Hospital, Jinan University, Guangzhou, China.
FAU - Wang, Pengwei
AU  - Wang P
AD  - Huazhong Agricultural University, College of Horticulture and Forestry Science, 
      Key Laboratory of Horticultural Plant Biology (Ministry of Education), Wuhan, 
      China.
FAU - Wang, Peipei
AU  - Wang P
AD  - National University of Singapore, Department of Medicine, Cardiovascular Research 
      Institute, Singapore.
FAU - Wang, Ping
AU  - Wang P
AD  - Iowa State University, Department of Genetics, Development, and Cell Biology, 
      Ames, IA, USA.
FAU - Wang, Ping
AU  - Wang P
AD  - Feinstein Institutes for Medical Research, Center for Immunology and 
      Inflammation, Manhasset, NY, USA.
FAU - Wang, Qing Jun
AU  - Wang QJ
AD  - University of Kentucky, Department of Ophthalmology and Visual Sciences, 
      Lexington, KY, USA.
FAU - Wang, Qing
AU  - Wang Q
AD  - Zhujiang Hospital of Southern Medical University, Department of Neurology, 
      Guangzhou, Guangdong Province, China.
FAU - Wang, Qing Kenneth
AU  - Wang QK
AD  - Cleveland Clinic, Department of Cardiovascular Medicine/Heart and Vascular 
      Institute, Cleveland, OH, USA.
FAU - Wang, Qiong A
AU  - Wang QA
AD  - Diabetes and Metabolism Research Institute, Department of Molecular & Cellular 
      Endocrinology; City of Hope Medical Center, Beckman Research Institute, 
      Comprehensive Cancer Center, Duarte, CA, USA.
FAU - Wang, Wen-Tao
AU  - Wang WT
AD  - Sun Yat-sen University, School of Life Science, Guangzhou, China.
FAU - Wang, Wuyang
AU  - Wang W
AD  - Xuzhou Medical University, Department of Anesthesiology, Xuzhou, Jiangsu, China.
FAU - Wang, Xinnan
AU  - Wang X
AD  - Stanford University School of Medicine, Department of Neurosurgery, Palo Alto, 
      CA, USA.
FAU - Wang, Xuejun
AU  - Wang X
AD  - University of South Dakota, Division of Basic Biomedical Sciences, Vermillion, 
      SD, USA.
FAU - Wang, Yan
AU  - Wang Y
AD  - Tsinghua University, School of Life Sciences, Beijing, China.
FAU - Wang, Yanchang
AU  - Wang Y
AD  - Department of Biomedical Sciences, College of Medicine, Florida State University, 
      Tallahassee, FL, USA.
FAU - Wang, Yanzhuang
AU  - Wang Y
AD  - Department of Molecular, Cellular and Developmental Biology, University of 
      Michigan, Ann Arbor, MI, USA.
AD  - Department of Neurology, University of Michigan School of Medicine, Ann Arbor, 
      MI, USA.
FAU - Wang, Yen-Yun
AU  - Wang YY
AD  - Kaohsiung Medical University, School of Dentistry, College of Dental Medicine, 
      Kaohsiung, Taiwan.
FAU - Wang, Yihua
AU  - Wang Y
AD  - University of Southampton, Faculty of Environmental and Life Sciences, Biological 
      Sciences, and the Institute for Life Sciences, Southampton, UK.
FAU - Wang, Yipeng
AU  - Wang Y
AD  - German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany; 
      Max-Planck-Institute for Metabolism Research, Hamburg Outstation, Hamburg, 
      Germany; Shanghai Qiangrui Biotech Co., Ltd., Fengxian District, Shanghai, China.
FAU - Wang, Yu
AU  - Wang Y
AD  - Nanjing Agricultural University, College of Horticulture, Weigang NO. 1, Nanjing, 
      China.
FAU - Wang, Yuqi
AU  - Wang Y
AD  - Saint Louis University, Department of Biology, Saint Louis, MO, USA.
FAU - Wang, Zhe
AU  - Wang Z
AD  - Air Force Medical University, Xijing Hospital and School of Basic Medicine, 
      Department of Pathology, State Key Laboratory of Cancer Biology, Xi'an, China.
FAU - Wang, Zhenyu
AU  - Wang Z
AD  - Affiliated Union Hospital of Fujian Medical University, Fuzhou, Fujian, China.
FAU - Wang, Zhouguang
AU  - Wang Z
AD  - Wenzhou Medical University, Key Laboratory of Biotechnology and Pharmaceutical 
      Engineering, School of Pharmaceutical Sciences, Wenzhou, China.
FAU - Warnes, Gary
AU  - Warnes G
AD  - Queen Mary University, Blizard Institute, Flow Cytometry Core Facility, London, 
      UK.
FAU - Warnsmann, Verena
AU  - Warnsmann V
AD  - Goethe University, Institute for Molecular Biosciences, Frankfurt/Main, Germany.
FAU - Watada, Hirotaka
AU  - Watada H
AD  - Juntendo University Graduate School of Medicine, Department of Metabolism & 
      Endocrinology, Bunkyo-ku, Tokyo, Japan.
FAU - Watanabe, Eizo
AU  - Watanabe E
AD  - Chiba University Graduate School of Medicine, Department of General Medical 
      Science, Chiba, Japan.
FAU - Watchon, Maxinne
AU  - Watchon M
AD  - Macquarie University, Faculty of Medicine, Health and Human Sciences, Department 
      of Biomedical Science, Centre for Motor Neuron Disease Research, Sydney, NSW, 
      Australia.
FAU - Wawrzyńska, Anna
AU  - Wawrzyńska A
AD  - Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, 
      Poland.
FAU - Weaver, Timothy E
AU  - Weaver TE
AD  - University of Cincinnati College of Medicine, Cincinnati Children's Research 
      Foundation, Division of Pulmonary Biology, Department of Pediatrics, Cincinnati, 
      OH, USA.
FAU - Wegrzyn, Grzegorz
AU  - Wegrzyn G
AD  - University of Gdansk, Department of Molecular Biology, Gdansk, Poland.
FAU - Wehman, Ann M
AU  - Wehman AM
AD  - Department of Biological Sciences, University of Denver, Denver, CO, USA.
FAU - Wei, Huafeng
AU  - Wei H
AD  - University of Pennsylvania, Department of Anesthesiology, Philadelphia, PA, USA.
FAU - Wei, Lei
AU  - Wei L
AD  - Indiana University School of Medicine, Department of Pediatrics, Indianapolis, 
      IN, USA.
FAU - Wei, Taotao
AU  - Wei T
AD  - Chinese Academy of Sciences, Institute of Biophysics, Beijing, China.
FAU - Wei, Yongjie
AU  - Wei Y
AD  - Affiliated Cancer Hospital and Institute of Guangzhou Medical University, 
      Guangzhou, China.
FAU - Weiergräber, Oliver H
AU  - Weiergräber OH
AD  - Forschungszentrum Jülich, Institute of Biological Information Processing, IBI-7 
      (Structural Biochemistry), Jülich, Germany.
FAU - Weihl, Conrad C
AU  - Weihl CC
AD  - Washington University School of Medicine, Department of Neurology, St. Louis, MO, 
      USA.
FAU - Weindl, Günther
AU  - Weindl G
AD  - University of Bonn, Pharmaceutical Institute, Section Pharmacology and 
      Toxicology, Bonn, Germany.
FAU - Weiskirchen, Ralf
AU  - Weiskirchen R
AD  - University Hospital RWTH Aachen, Institute of Molecular Pathobiochemistry, 
      Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), Aachen, Germany.
FAU - Wells, Alan
AU  - Wells A
AD  - Univ of Pittsburgh and Pittsburgh VA HealthSystem, Department of Pathology, 
      Pittsburgh, PA, USA.
FAU - Wen, Runxia H
AU  - Wen RH
AD  - Spencer Center for Vision Research, Byers Eye Institute, Stanford University 
      School of Medicine, Stanford, CA, USA.
FAU - Wen, Xin
AU  - Wen X
AD  - Life Sciences Institute and Department of Molecular, Cellular and Developmental 
      Biology, University of Michigan, Ann Arbor, MI, USA.
FAU - Werner, Antonia
AU  - Werner A
AD  - Georg August University Göttingen, Institute of Microbiology and Genetics, 
      Department of Genetics of Eukaryotic Microorganisms, Göttingen, Germany.
FAU - Weykopf, Beatrice
AU  - Weykopf B
AD  - Harvard Medical School and Brigham & Women's Hospital, Precision Neurology 
      Program & APDA Center for Advanced Parkinson Research, Boston, MA, USA.
FAU - Wheatley, Sally P
AU  - Wheatley SP
AD  - University of Nottingham, School of Life Sciences, Queen's Medical Centre, 
      Nottingham, UK.
FAU - Whitton, J Lindsay
AU  - Whitton JL
AD  - Scripps Research Institute, La Jolla, CA, USA.
FAU - Whitworth, Alexander J
AU  - Whitworth AJ
AD  - University of Cambridge, MRC Mitochondrial Biology Unit, Cambridge, UK.
FAU - Wiktorska, Katarzyna
AU  - Wiktorska K
AD  - National Medicines Institute, Department of Drug Biotechnology and 
      Bioinformatics, Warszawa, Poland.
FAU - Wildenberg, Manon E
AU  - Wildenberg ME
AD  - Amsterdam University Medical Centers, Location AMC, Tytgat Institute for 
      Intestinal Research, Department of Gastroenterology and Hepatology, Amsterdam, 
      The Netherlands.
FAU - Wileman, Tom
AU  - Wileman T
AD  - Quadram Institute Bioscience, Norwich Research Park, Norwich, Norfolk, UK.
FAU - Wilkinson, Simon
AU  - Wilkinson S
AD  - University of Edinburgh, MRC Institute of Genetics and Molecular Medicine, 
      Scotland, UK.
FAU - Willbold, Dieter
AU  - Willbold D
AD  - Forschungszentrum Jülich, Institute of Biological Information Processing, IBI-7 
      (Structural Biochemistry), Jülich, Germany.
AD  - Heinrich-Heine-Universität Düsseldorf Institut für Physikalische Biologie, 
      Düsseldorf, Germany.
FAU - Williams, Brett
AU  - Williams B
AD  - Queensland University of Technology, Centre for Tropical Crops and 
      Biocommodities, Science and Engineering Faculty, Brisbane, Queensland, Australia.
FAU - Williams, Robin S B
AU  - Williams RSB
AD  - Royal Holloway University of London, Centre for Biomedical Sciences, Egham, 
      Surrey, UK.
FAU - Williams, Roger L
AU  - Williams RL
AD  - MRC Laboratory of Molecular Biology, Cambridge, UK.
FAU - Williamson, Peter R
AU  - Williamson PR
AD  - National Institutes of Health, Laboratory of Clinical Immunology and 
      Microbiology, National Institute of Allergy and Infectious Diseases, Bethesda, 
      MD, USA.
FAU - Wilson, Richard A
AU  - Wilson RA
AD  - University of Nebraska-Lincoln, Department of Plant Pathology, Lincoln, NE, USA.
FAU - Winner, Beate
AU  - Winner B
AD  - Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Department of Stem Cell 
      Biology, Erlangen, Germany.
FAU - Winsor, Nathaniel J
AU  - Winsor NJ
AD  - University of Toronto, Faculty of Medicine, Department of Immunology, Toronto, 
      ON, Canada.
FAU - Witkin, Steven S
AU  - Witkin SS
AD  - Department of Obstetrics and Gynecology, Weill Cornell Medicine, 1300 York 
      Avenue, Box 35, New York, NY, United States.
FAU - Wodrich, Harald
AU  - Wodrich H
AD  - MFP CNRS UMR 5234, University of Bordeaux, Bordeaux, France.
FAU - Woehlbier, Ute
AU  - Woehlbier U
AD  - Universidad Mayor, Center for Integrative Biology, Santiago, Chile.
FAU - Wollert, Thomas
AU  - Wollert T
AD  - Institut Pasteur, Membrane Biochemistry and Transport, Paris, France.
FAU - Wong, Esther
AU  - Wong E
AD  - National University of Singapore, Yong Loo Lin School of Medicine, Healthy 
      Longevity Translational Research Program, Singapore; National University Health 
      System, Centre for Healthy Longevity, Singapore.
FAU - Wong, Jack Ho
AU  - Wong JH
AD  - School of Medicine, Shenzhen University, Shenzhen, China.
FAU - Wong, Richard W
AU  - Wong RW
AD  - Kanazawa University, WPI-Nano Life Science Institute (WPI-nanoLSI), Kanazawa, 
      Ishikawa, Japan.
FAU - Wong, Vincent Kam Wai
AU  - Wong VKW
AD  - Macau University of Science and Technology, State Key Laboratory of Quality 
      Research in Chinese Medicine, Taipa, Macau, China.
FAU - Wong, W Wei-Lynn
AU  - Wong WW
AD  - University of Zurich, Institute of Experimental Immunology, Switzerland, Zurich.
FAU - Wu, An-Guo
AU  - Wu AG
AD  - Southwest Medical University, Luzhou Key Laboratory of Activity Screening and 
      Druggability Evaluation for Chinese Materia Medica, Jiangyang District, Luzhou, 
      China.
FAU - Wu, Chengbiao
AU  - Wu C
AD  - University of California San Diego, Department of Neurosciences, La Jolla, CA, 
      USA.
FAU - Wu, Jian
AU  - Wu J
AD  - Weizmann Institute of Science, Department of Plant and Environmental Sciences, 
      Rehovot, Israel.
FAU - Wu, Junfang
AU  - Wu J
AD  - University of Maryland School of Medicine, Center for Shock, Trauma and 
      Anesthesiology Research (STAR), Departments of Anesthesiology, Anatomy & 
      Neurobiology, Baltimore, MD, USA.
FAU - Wu, Kenneth K
AU  - Wu KK
AD  - NHRI, Institute of Cellular and System Medicine, Zhunan, Taiwan.
FAU - Wu, Min
AU  - Wu M
AD  - University of North Dakota, Biology School of Medicine and Health Sciences, 
      Department of Biomedical Sciences, Grand Forks, ND, USA.
FAU - Wu, Shan-Ying
AU  - Wu SY
AD  - Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical 
      University, Taipei, Taiwan; Department of Microbiology and Immunology, School of 
      Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
FAU - Wu, Shengzhou
AU  - Wu S
AD  - Wenzhou Medical University, State Key Laboratory of Ophthalmology, Optometry and 
      Visual Science, School of Optometry and Ophthalmology and the Eye Hospital, 
      Wenzhou, China.
FAU - Wu, Shu-Yan
AU  - Wu SY
AD  - Soochow University, Department of Pathogenic Biology, Suzhou, Jiangsu Province, 
      China.
FAU - Wu, Shufang
AU  - Wu S
AD  - First Affiliated Hospital of Xi'an Jiaotong University School of Medicine, Center 
      for Translational Medicine, Xi'an, Shaanxi, China.
FAU - Wu, William K K
AU  - Wu WKK
AD  - The Chinese University of Hong Kong, Department of Anaesthesia and Intensive 
      Care, Hong Kong, China.
FAU - Wu, Xiaohong
AU  - Wu X
AD  - Zhejiang Provincial People's Hospital, Department of Endocrinology, Hangzhou, 
      China.
FAU - Wu, Xiaoqing
AU  - Wu X
AD  - University of Kansas, Department of Molecular Biosciences, and University of 
      Kansas Medical School, University of Kansas Cancer Center, Department of 
      Radiation Oncology, Lawrence, KS, USA.
FAU - Wu, Yao-Wen
AU  - Wu YW
AD  - Umeå University, Umeå Centre for Microbial Research (UCMR), Department of 
      Chemistry, Umeå, Sweden.
FAU - Wu, Yihua
AU  - Wu Y
AD  - Zhejiang University School of Medicine, Department of Toxicology of School of 
      Public Health, and Department of Gynecologic Oncology of Women's Hospital, 
      Hangzhou,China.
FAU - Xavier, Ramnik J
AU  - Xavier RJ
AD  - The Broad Institute of Harvard and MIT, Massachusetts General Hospital, Harvard 
      Medical School, Department of Molecular Biology, Cambridge, MA, USA.
FAU - Xia, Hongguang
AU  - Xia H
AD  - Zhejiang University, Department of Biochemistry in School of Medicine, Hangzhou, 
      Zhejiang Province, China.
FAU - Xia, Lixin
AU  - Xia L
AD  - Shenzhen University, College of Medicine, Shenzhen, Guangdong, China.
FAU - Xia, Zhengyuan
AU  - Xia Z
AD  - The University of Hong Kong, Department of Anesthesiology, Queen Mary Hospital, 
      Hong Kong, China.
FAU - Xiang, Ge
AU  - Xiang G
AD  - CAS Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine 
      and Health, Chinese Academy of Sciences, Guangzhou, China.
FAU - Xiang, Jin
AU  - Xiang J
AD  - Wuhan University, Key Laboratory of Combinatorial Biosynthesis and Drug 
      Discovery, Ministry of Education, School of Pharmaceutical Sciences, Wuhan, 
      China.
FAU - Xiang, Mingliang
AU  - Xiang M
AD  - Shanghai Jiao Tong University School of Medicine, Ruijin Hospital, Department of 
      Otolaryngology & Head and Neck Surgery, Shanghai, China.
FAU - Xiang, Wei
AU  - Xiang W
AD  - Friedrich-Alexander University Erlangen-Nürnberg, University Hospital Erlangen, 
      Department of Molecular Neurology, Erlangen Germany.
FAU - Xiao, Bin
AU  - Xiao B
AD  - Research Department, National Neuroscience Institute, Singapore.
FAU - Xiao, Guozhi
AU  - Xiao G
AD  - Southern University of Science and Technology, Department of Biology, Shenzhen, 
      China.
FAU - Xiao, Hengyi
AU  - Xiao H
AD  - Sichuan University, West China Hospital, Centre of Geriatrics and Gerontology, 
      Chengdu, China.
FAU - Xiao, Hong-Tao
AU  - Xiao HT
AD  - University of Electronic Science and Technology of China, School of Medicine, 
      Chengdu, China; Sichuan Academy of Medical Sciences & Sichuan Provincial People's 
      Hospital, Department of Pharmacy, Chengdu, Sichuan, China.
FAU - Xiao, Jian
AU  - Xiao J
AD  - Wenzhou Medical University, School of Pharmaceutical Sciences, Wenzhou, China.
FAU - Xiao, Lan
AU  - Xiao L
AD  - Queensland University of Technology, Institute of Health and Biomedical 
      Innovation, Kelvin Grove, Brisbane, Queensland, Australia.
FAU - Xiao, Shi
AU  - Xiao S
AD  - Sun Yat-sen University, School of Life Sciences, Guangdong Provincial Key 
      Laboratory of Plant Resources, State Key Laboratory of Biocontrol, Guangzhou, 
      China.
FAU - Xiao, Yin
AU  - Xiao Y
AD  - Queensland University of Technology, Institute of Health and Biomedical 
      Innovation, Kelvin Grove, Brisbane, Queensland, Australia.
FAU - Xie, Baoming
AU  - Xie B
AD  - South China Agricultural University, College of Veterinary Medicine, Guangzhou, 
      Guangdong, China.
FAU - Xie, Chuan-Ming
AU  - Xie CM
AD  - Southwest Hospital, Third Military Medical University (Army Medical University), 
      Key Laboratory of Hepatobiliary and Pancreatic Surgery, Institute of 
      Hepatobiliary Surgery, Chongqing, China.
FAU - Xie, Min
AU  - Xie M
AD  - University of Alabama at Birmingham, Division of Cardiovascular Disease, 
      Department of Medicine, Birmingham, AL, USA.
FAU - Xie, Yuxiang
AU  - Xie Y
AD  - National Institutes of Health, National Institute of Neurological Disorders and 
      Stroke, Bethesda, MD, USA.
FAU - Xie, Zhiping
AU  - Xie Z
AD  - Shanghai Jiao Tong University, School of Life Sciences and Biotechnology, 
      Shanghai, China.
FAU - Xie, Zhonglin
AU  - Xie Z
AD  - Georgia State University, The Center for Molecular and Translation Medicine, 
      Atlanta, GA, USA.
FAU - Xilouri, Maria
AU  - Xilouri M
AD  - Biomedical Research Foundation of the Academy of Athens (BRFAA), Center of 
      Clinical, Experimental Surgery, & Translational Research, Athens, Greece.
FAU - Xu, Congfeng
AU  - Xu C
AD  - Shanghai Sixth People's Hospital, Department of Cardiovascular Medicine, and 
      Shanghai Jiaotong University School of Medicine, Shanghai Institute of 
      Immunology, Shanghai, China.
FAU - Xu, En
AU  - Xu E
AD  - Institute of Neurosciences and Department of Neurology of the Second Affiliated 
      Hospital of Guangzhou Medical University, Guangzhou, China.
FAU - Xu, Haoxing
AU  - Xu H
AD  - Department of Molecular, Cellular and Developmental Biology, University of 
      Michigan, Ann Arbor, MI, USA.
FAU - Xu, Jing
AU  - Xu J
AD  - Shanghai Jiao Tong University School of Medicine, Shanghai General Hospital, 
      Department of Orthopedics, Shanghai, China; Shanghai Bone Tumor Institution, 
      Shanghai, China.
FAU - Xu, JinRong
AU  - Xu J
AD  - Purdue University, Department of Botany and Plant Pathology, West Lafayette, IN, 
      USA.
FAU - Xu, Liang
AU  - Xu L
AD  - University of Kansas, Department of Molecular Biosciences, and University of 
      Kansas Medical School, University of Kansas Cancer Center, Department of 
      Radiation Oncology, Lawrence, KS, USA.
FAU - Xu, Wen Wen
AU  - Xu WW
AD  - Jinan University, College of Life Science and Technology, Guangzhou, China.
FAU - Xu, Xiulong
AU  - Xu X
AD  - Yangzhou University, College of Veterinary Medicine, Jiangsu Province, China.
FAU - Xue, Yu
AU  - Xue Y
AD  - Huazhong University of Science and Technology, College of Life Science and 
      Technology, Hubei Bioinformatics and Molecular Imaging Key Laboratory, Key 
      Laboratory of Molecular Biophysics of Ministry of Education, Wuhan, Hubei, China.
FAU - Yakhine-Diop, Sokhna M S
AU  - Yakhine-Diop SMS
AD  - University of Extremadura, Centro de Investigación Biomedica en Red de 
      Enfermedades Neurodegenerativas (CIBERNED), Instituto de Investigación 
      Biosanitaria de Extremadura (INUBE), Department of Biochemistry, Molecular 
      Biology and Genetics, Faculty of Nursing and Occupational Therapy, Cáceres, 
      Spain.
FAU - Yamaguchi, Masamitsu
AU  - Yamaguchi M
AD  - Kyoto Institute of Technology, Department of Applied Biology, Matsugasaki, 
      Sakyo-ku, Kyoto, Japan.
FAU - Yamaguchi, Osamu
AU  - Yamaguchi O
AD  - Ehime University Graduate School of Medicine, Department of Cardiology, 
      Pulmonology, Hypertension & Nephrology, Shitsukawa, Toon, Ehime, Japan.
FAU - Yamamoto, Ai
AU  - Yamamoto A
AD  - Columbia University, Department of Neurology, and Pathology and Cell Biology, New 
      York, NY, USA.
FAU - Yamashina, Shunhei
AU  - Yamashina S
AD  - Juntendo University School of Medicine, Department of Gastroenterology, 
      Bunkyo-ku, Tokyo, Japan.
FAU - Yan, Shengmin
AU  - Yan S
AD  - Indiana University School of Medicine, Department of Pathology and Laboratory 
      Medicine, Indianapolis, IN, USA.
FAU - Yan, Shian-Jang
AU  - Yan SJ
AD  - National Cheng Kung University, College of Medicine, Department of Physiology, 
      Tainan City, Taiwan.
FAU - Yan, Zhen
AU  - Yan Z
AD  - University of Virginia, Departments of Medicine, Pharmacology, Molecular 
      Physiology & Biological Physics, Center for Skeletal Muscle Research at Robert M. 
      Berne Cardiovascular Research Center, University of Virginia School of Medicine, 
      Charlottesville, VA, USA.
FAU - Yanagi, Yasuo
AU  - Yanagi Y
AD  - Asahikawa Medical University, Department of Ophthalmology, Hokkaido, Japan.
FAU - Yang, Chuanbin
AU  - Yang C
AD  - Hong Kong Baptist University, Mr. and Mrs. Ko Chi Ming Centre for Parkinson's 
      Disease Research, School of Chinese Medicine, Hong Kong, China.
FAU - Yang, Dun-Sheng
AU  - Yang DS
AD  - Nathan Kline Institute for Psychiatric Research, Center for Dementia Research, 
      Orangeburg, NY; New York University Langone Health, Department of Psychiatry, New 
      York, NY, USA.
FAU - Yang, Huan
AU  - Yang H
AD  - University of Wisconsin-Madison, Department of Surgery, Madison, WI, USA.
FAU - Yang, Huang-Tian
AU  - Yang HT
AD  - Chinese Academy of Sciences, Shanghai Institute of Nutrition and Health, CAS Key 
      Laboratory of Tissue Microenvironment & Tumor, Laboratory of Molecular 
      Cardiology, Shanghai, China.
FAU - Yang, Hui
AU  - Yang H
AD  - Capital Medical University, School of Basic Medical Sceinces, Department of 
      Neurobiology, Beijing, China.
FAU - Yang, Jin-Ming
AU  - Yang JM
AD  - University of Kentucky, Department of Cancer Biology & Toxicology, Lexington, KY, 
      USA.
FAU - Yang, Jing
AU  - Yang J
AD  - University of Alabama at Birmingham, Department of Medicine, Division of 
      Cardiovascular Disease, Birmingham, AL, USA.
FAU - Yang, Jingyu
AU  - Yang J
AD  - Shenyang Pharmaceutical University, Department of Pharmacology, Shenyang, China.
FAU - Yang, Ling
AU  - Yang L
AD  - University of Iowa Carver College of Medicine, Fraternal Order of Eagles Diabetes 
      Research Center, Department of Anatomy and Cell Biology, Iowa City, IA, USA.
FAU - Yang, Liu
AU  - Yang L
AD  - The Fourth Military Medical University, Xijing Hospital, Department of 
      Orthopaedics, Xi'an, China.
FAU - Yang, Ming
AU  - Yang M
AD  - Shandong Cancer Hospital and Institute, Cancer Research Center, Jinan, Shandong 
      Province, China.
FAU - Yang, Pei-Ming
AU  - Yang PM
AD  - Taipei Medical University, College of Medical Science and Technology, Graduate 
      Institute of Cancer Biology and Drug Discovery, Taipei, Taiwan.
FAU - Yang, Qian
AU  - Yang Q
AD  - The Fourth Military Medical University, Tangdu Hospital, Department of 
      Experimental Surgery, Xi'an, Shaanxi, China.
FAU - Yang, Seungwon
AU  - Yang S
AD  - University of Chicago, Department of Medicine, Section of Dermatology, Chicago, 
      IL, USA.
FAU - Yang, Shu
AU  - Yang S
AD  - National Institutes of Health, Eunice Kennedy Shriver National Institute of Child 
      Health and Human Development, Neurosciences and Cellular and Structural Biology 
      Division (NCSBD), Bethesda, MD, USA.
FAU - Yang, Shun-Fa
AU  - Yang SF
AD  - Chung Shan Medical University, Institute of Medicine, Taichung, Taiwan.
FAU - Yang, Wannian
AU  - Yang W
AD  - Jiangsu University, School of Medicine, Zhenjiang, Jiangsu, China.
FAU - Yang, Wei Yuan
AU  - Yang WY
AD  - Academia Sinica, Institute of Biological Chemistry, Taipei, Taiwan.
FAU - Yang, Xiaoyong
AU  - Yang X
AD  - Yale University School of Medicine, Department of Comparative Medicine and 
      Department of Cellular and Molecular Physiology, New Haven, CT, USA.
FAU - Yang, Xuesong
AU  - Yang X
AD  - Jinan University, Medical College, Key Laboratory for Regenerative Medicine of 
      the Ministry of Education, Division of Histology and Embryology, Guangzhou, 
      China.
FAU - Yang, Yi
AU  - Yang Y
AD  - Hangzhou Normal University, School of Medicine, College of Pharmacy, Hangzhou, 
      Zhejiang, China.
FAU - Yang, Ying
AU  - Yang Y
AD  - Life Sciences Institute and Department of Molecular, Cellular and Developmental 
      Biology, University of Michigan, Ann Arbor, MI, USA.
FAU - Yao, Honghong
AU  - Yao H
AD  - University of Southeast, School of Medicine, Department of Pharmacology, Nanjing, 
      JiangSu, China.
FAU - Yao, Shenggen
AU  - Yao S
AD  - University of Melbourne, Bio21 Molecular Science and Biotechnology Institute, 
      Parkville, Victoria, Australia.
FAU - Yao, Xiaoqiang
AU  - Yao X
AD  - Chinese University of Hong Kong, School of Biomedical Sciences, Hong Kong, China.
FAU - Yao, Yong-Gang
AU  - Yao YG
AD  - Kunming Institute of Zoology, Key Laboratory of Animal Models and Human Disease 
      Mechanisms of the Chinese Academy of Sciences & Yunnan Province, Kunming, Yunnan, 
      China.
FAU - Yao, Yong-Ming
AU  - Yao YM
AD  - Fourth Medical Center of the Chinese PLA General Hospital, Trauma Research 
      Center, Beijing, China.
FAU - Yasui, Takahiro
AU  - Yasui T
AD  - Nagoya City University Graduate School of Medical Sciences, Department of 
      Nephro-urology, Nagoya, Aichi, Japan.
FAU - Yazdankhah, Meysam
AU  - Yazdankhah M
AD  - University of Pittsburgh School of Medicine, Departments of Ophthalmology, Cell 
      Biology, and Developmental Biology, Pittsburgh, PA, USA.
FAU - Yen, Paul M
AU  - Yen PM
AD  - Duke-NUS Medical School, Cardiovascular and Metabolic Disorders Program, 
      Singapore, Singapore.
FAU - Yi, Cong
AU  - Yi C
AD  - Zhejiang University School of Medicine, Department of Biochemistry, and 
      Department of Hepatobiliary and Pancreatic Surgery of the First Affiliated 
      Hospital, Hangzhou, China.
FAU - Yin, Xiao-Ming
AU  - Yin XM
AD  - Indiana University School of Medicine, Department of Pathology and Laboratory 
      Medicine, Indianapolis, IN, USA.
FAU - Yin, Yanhai
AU  - Yin Y
AD  - Iowa State University, Department of Genetics, Development, and Cell Biology, 
      Ames, IA, USA.
FAU - Yin, Zhangyuan
AU  - Yin Z
AD  - Life Sciences Institute and Department of Molecular, Cellular and Developmental 
      Biology, University of Michigan, Ann Arbor, MI, USA.
FAU - Yin, Ziyi
AU  - Yin Z
AD  - Shandong Agricultural University, College of Plant Protection, Shandong, China.
FAU - Ying, Meidan
AU  - Ying M
AD  - Zhejiang University, College of Pharmaceutical Sciences, Hangzhou, China.
FAU - Ying, Zheng
AU  - Ying Z
AD  - Soochow University, College of Pharmaceutical Sciences, Department of 
      Pharmacology, Suzhou, Jiangsu, China.
FAU - Yip, Calvin K
AU  - Yip CK
AD  - The University of British Columbia, Department of Biochemistry and Molecular 
      Biology, Vancouver, BC, Canada.
FAU - Yiu, Stephanie Pei Tung
AU  - Yiu SPT
AD  - The University of Hong Kong, Queen Mary Hospital, Department of Paediatrics and 
      Adolescent Medicine, Pokfulam, Hong Kong, China.
FAU - Yoo, Young H
AU  - Yoo YH
AD  - Dong-A University College of Medicine, Department of Anatomy and Cell Biology, 
      Busan, Korea.
FAU - Yoshida, Kiyotsugu
AU  - Yoshida K
AD  - The Jikei University School of Medicine, Department of Biochemistry, Minato-ku, 
      Tokyo, Japan.
FAU - Yoshii, Saori R
AU  - Yoshii SR
AD  - ETH Zürich, Institute of Biochemistry, Zürich, Switzerland.
FAU - Yoshimori, Tamotsu
AU  - Yoshimori T
AD  - Osaka University, Graduate School of Medicine, Department of Genetics, Suita, 
      Osaka, Japan.
FAU - Yousefi, Bahman
AU  - Yousefi B
AD  - Tabriz University of Medical Sciences, Molecular Medicine Research Center, 
      Tabriz, Iran.
FAU - Yu, Boxuan
AU  - Yu B
AD  - Hwa Chong Institution, Singapore, Singapore.
FAU - Yu, Haiyang
AU  - Yu H
AD  - Tianjin University of Traditional Chinese Medicine, Tianjin State Key Laboratory 
      of Modern Chinese Medicine, Tianjin, China.
FAU - Yu, Jun
AU  - Yu J
AD  - Temple University, Center for Metabolic Disease Research and Department of 
      Physiology, Philadelphia, PA, USA.
FAU - Yu, Jun
AU  - Yu J
AD  - The Chinese University of Hong Kong, State Key Laboratory of Digestive Disease, 
      Department of Medicine and Therapeutics, Hong Kong, China.
FAU - Yu, Li
AU  - Yu L
AD  - Tsinghua University, School of Life Sciences, Tsinghua University-Peking 
      University Joint Center for Life Sciences, State Key Laboratory of Membrane 
      Biology, Beijing, China.
FAU - Yu, Ming-Lung
AU  - Yu ML
AD  - Hepatobiliary Section, Department of Internal Medicine, Kaohsiung Medical 
      University Hospital, and Hepatitis Research Center, College of Medicine, 
      Kaohsiung Medical University, Kaohsiung, Taiwan.
FAU - Yu, Seong-Woon
AU  - Yu SW
AD  - Daegu Gyeongbuk Institute of Science and Technology (DGIST), Department of Brain 
      and Cognitive Sciences, Daegu, Korea.
FAU - Yu, Victor C
AU  - Yu VC
AD  - National University of Singapore, Faculty of Sciences, Department of Pharmacy, 
      Singapore.
FAU - Yu, W Haung
AU  - Yu WH
AD  - University of Toronto, Centre for Addiction and Mental Health, Toronto, Ontario, 
      Canada.
FAU - Yu, Zhengping
AU  - Yu Z
AD  - Third Military Medical University, Department of Occupational Health, Chongqing, 
      China.
FAU - Yu, Zhou
AU  - Yu Z
AD  - Air Force Medical University, Xijing Hospital, Department of Plastic and 
      Reconstructive Surgery, Xi'an, China.
FAU - Yuan, Junying
AU  - Yuan J
AD  - Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of 
      Organic Chemistry, Chinese Academy of Sciences, 201203 Shanghai, China; 
      Department of Cell Biology, Harvard Medical School, Boston, MA, USA.
FAU - Yuan, Ling-Qing
AU  - Yuan LQ
AD  - Central South University, The Second Xiang-Ya Hospital, National Clinical 
      Research Center for Metabolic Diseases, Department of Metabolism and 
      Endocrinology, Changsha, Hunan, China.
FAU - Yuan, Shilin
AU  - Yuan S
AD  - Chinese Academy of Sciences Center for Excellence in Molecular and Cellular 
      Sciences, Shanghai Institute of Biochemistry and Cell Biology, Shanghai, China.
FAU - Yuan, Shyng-Shiou F
AU  - Yuan SF
AD  - Kaohsiung Medical University, Graduate Institute of Medicine, Kaohsiung, Taiwan.
FAU - Yuan, Yanggang
AU  - Yuan Y
AD  - First Affiliated Hospital of Nanjing Medical University, Jiangsu Province 
      Hospital, Nanjing, China.
FAU - Yuan, Zengqiang
AU  - Yuan Z
AD  - Beijing Institute of Basic Medical Sciences, Beijing, China.
FAU - Yue, Jianbo
AU  - Yue J
AD  - City University of Hong Kong, Department of Biomedical Sciences, Hong Kong, 
      China.
FAU - Yue, Zhenyu
AU  - Yue Z
AD  - Icahn School of Medicine at Mount Sinai, Departments of Neurology and 
      Neuroscience, New York, NY, USA.
FAU - Yun, Jeanho
AU  - Yun J
AD  - Graduate School of Dong-A University, College of Medicine, Department of 
      Translational Biomedical Sciences, Busan, Korea.
FAU - Yung, Raymond L
AU  - Yung RL
AD  - Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
FAU - Zacks, David N
AU  - Zacks DN
AD  - University of Michigan, Department of Ophthalmology and Visual Sciences, Ann 
      Arbor, MI, USA.
FAU - Zaffagnini, Gabriele
AU  - Zaffagnini G
AD  - Centre for Genomic Regulation (CRG), Department of Cell and Developmental 
      Biology, Barcelona, España.
FAU - Zambelli, Vanessa O
AU  - Zambelli VO
AD  - Laboratory of Pain and Signaling, Butantan Institute, Sao Paulo, SP, Brazil; 
      Stanford University, Department of Anesthesiology, Perioperative and Pain 
      Medicine, Stanford, CA, USA.
FAU - Zanella, Isabella
AU  - Zanella I
AD  - University of Brescia, Department of Molecular and Translational Medicine, 
      Brescia, Italy.
FAU - Zang, Qun S
AU  - Zang QS
AD  - University of Texas Southwestern Medical Center, Department of Surgery, Dallas, 
      TX, USA.
FAU - Zanivan, Sara
AU  - Zanivan S
AD  - Cancer Research UK Beatson Institute, Glasgow, UK; University of Glasgow, 
      Institute of Cancer Sciences, Glasgow, UK.
FAU - Zappavigna, Silvia
AU  - Zappavigna S
AD  - University of Campania L. Vanvitelli, Department of Precision Medicine, Naples, 
      Italy; Institute of Genetic Research, Biogem scarl, Laboratory of Molecular and 
      Precision Oncology, Ariano Irpino (AV), Italy.
AD  - University of Campania "Luigi Vanvitelli", Department of Precision Medicine, 
      Naples, Italy.
FAU - Zaragoza, Pilar
AU  - Zaragoza P
AD  - University of Zaragoza, Faculty of Veterinary-IIS Aragón, IA2-CITA, CIBERNED, 
      Laboratory of Genetics and Biochemistry (LAGENBIO), Zaragoza, Spain.
FAU - Zarbalis, Konstantinos S
AU  - Zarbalis KS
AD  - University of California, Davis, Department of Pathology and Laboratory Medicine, 
      Shriners Hospitals for Children, Institute for Pediatric Regenerative Medicine, 
      Sacramento, CA, USA.
FAU - Zarebkohan, Amir
AU  - Zarebkohan A
AD  - Tabriz University of Medical Sciences, Faculty of Advanced Medical Sciences, 
      Department of Medical Nanotechnology, Tabriz, Iran.
FAU - Zarrouk, Amira
AU  - Zarrouk A
AD  - University Monastir, Faculty of Medicine, LR12ES05, Lab-NAFS 'Nutrition - 
      Functional Food & Vascular Health', Monastir, Tunisia.
FAU - Zeitlin, Scott O
AU  - Zeitlin SO
AD  - University of Virginia, Department of Neuroscience, Charlottesville, VA, USA.
FAU - Zeng, Jialiu
AU  - Zeng J
AD  - Boston University, Department of Biomedical Engineering, Boston, MA, USA.
FAU - Zeng, Ju-Deng
AU  - Zeng JD
AD  - The Chinese University of Hong Kong, Department of Anaesthesia and Intensive 
      Care, Hong Kong, China.
FAU - Žerovnik, Eva
AU  - Žerovnik E
AD  - Jožef Stefan Institute, Department of Biochemistry and Molecular and Structural 
      Biology, Ljubljana, Slovenia.
FAU - Zhan, Lixuan
AU  - Zhan L
AD  - Institute of Neurosciences and Department of Neurology of the Second Affiliated 
      Hospital of Guangzhou Medical University, Guangzhou, China.
FAU - Zhang, Bin
AU  - Zhang B
AD  - Army Medical University (Third Military Medical University), Daping Hospital, 
      Center of Bone Metabolism and Repair, State Key Laboratory of Trauma, Burns and 
      Combined Injury, Trauma Center, Research Institute of Surgery, Laboratory for the 
      Prevention and Rehabilitation of Military Training Related Injuries, Chongqing, 
      China.
FAU - Zhang, Donna D
AU  - Zhang DD
AD  - University of Arizona, Department of Pharmacology and Toxicology, Tucson, AZ, 
      USA.
FAU - Zhang, Hanlin
AU  - Zhang H
AD  - University of Oxford, Kennedy Institute of Rheumatology, Oxford, UK.
FAU - Zhang, Hong
AU  - Zhang H
AD  - Peking University First Hospital, Renal Division, Xi Cheng District, Beijing, 
      China.
FAU - Zhang, Hong
AU  - Zhang H
AD  - Chinese Academy of Sciences, Institute of Biophysics, National Laboratory of 
      Biomacromolecules, Beijing, China.
FAU - Zhang, Honghe
AU  - Zhang H
AD  - Zhejiang University School of Medicine, Department of Pathology, Hangzhou, China.
FAU - Zhang, Huafeng
AU  - Zhang H
AD  - University of Science & Technology of China, School of Life Sciences, Hefei, 
      Anhui, China.
FAU - Zhang, Huaye
AU  - Zhang H
AD  - Rutgers Robert Wood Johnson Medical School, Department of Neuroscience and Cell 
      Biology, Piscataway, NJ, USA.
FAU - Zhang, Hui
AU  - Zhang H
AD  - Thomas Jefferson University/Vickie & Jack Farber Institute for Neuroscience, 
      Hospital for Neuroscience, Philadelphia, PA, USA.
FAU - Zhang, Hui-Ling
AU  - Zhang HL
AD  - Soochow University, Department of Pharmacology and Laboratory of Cerebrovascular 
      Pharmacology, College of Pharmaceutical Science, Suzhou, Jiangsu, China.
FAU - Zhang, Jianbin
AU  - Zhang J
AD  - People's Hospital of Hangzhou Medical College, Zhejiang Provincial People's 
      Hospital, Department of Oncology, Hangzhou, China; Zhejiang Provincial People's 
      Hospital, Clinical Research Institute, Key Laboratory of Tumor Molecular 
      Diagnosis and Individualized Medicine of Zhejiang Province, Hangzhou, China.
FAU - Zhang, Jianhua
AU  - Zhang J
AD  - University of Alabama at Birmingham, Department of Pathology, Birmingham, AL, 
      USA.
FAU - Zhang, Jing-Pu
AU  - Zhang JP
AD  - Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of 
      Medicinal Biotechnology, Beijing, China.
FAU - Zhang, Kalin Y B
AU  - Zhang KYB
AD  - The University of Hong Kong, School of Chinese Medicine, Li Ka Shing Faculty of 
      Medicine, Hong Kong, China.
FAU - Zhang, Leshuai W
AU  - Zhang LW
AD  - School of Radiation Medicine and Protection and State Key Laboratory of Radiation 
      Medicine and Protection, Soochow University, Suzhou, China.
FAU - Zhang, Lin
AU  - Zhang L
AD  - The Chinese University of Hong Kong, Department of Medicine and Therapeutics and 
      Department of Anaesthesia and Intensive Care, Hong Kong, China.
FAU - Zhang, Lisheng
AU  - Zhang L
AD  - Huazhong Agricultural University, School of Veterinary Medicine/ Biomedical 
      Center, Hongshan, Wuhan, China.
FAU - Zhang, Lu
AU  - Zhang L
AD  - Henan University of Technology, College of Bioengineering, Zhengzhou, China.
FAU - Zhang, Luoying
AU  - Zhang L
AD  - Huazhong University of Science and Technology, College of Life Science and 
      Technology, Key Laboratory of Molecular Biophysics of Ministry of 
      Education,Wuhan, Hubei, China.
FAU - Zhang, Menghuan
AU  - Zhang M
AD  - Chinese Academy of Sciences Center for Excellence in Molecular and Cellular 
      Sciences, Shanghai Institute of Biochemistry and Cell Biology, Shanghai, China.
FAU - Zhang, Peng
AU  - Zhang P
AD  - University of Utah, Huntsman Cancer Institute and Department of Oncological 
      Sciences, Salt Lake City, UT, USA.
FAU - Zhang, Sheng
AU  - Zhang S
AD  - The University of Texas Health Science Center at Houston (UTHealth), McGovern 
      Medical School, The Brown Foundation Institute of Molecular Medicine, Department 
      of Neurobiology and Anatomy, Programs in Human and Molecular Genetics and 
      Neuroscience of the MD Anderson UTHealth GSBS, Houston, TX, USA.
FAU - Zhang, Wei
AU  - Zhang W
AD  - Wake Forest Baptist Comprehensive Cancer Center, Department of Cancer Biology, 
      Winston-Salem, NC, USA.
AD  - Hungarian Academy of Sciences, Budapest, Hungary; Department of Anatomy, Cell and 
      Developmental Biology, Eötvös Loránd University, Budapest, Hungary.
FAU - Zhang, Xiangnan
AU  - Zhang X
AD  - Zhejiang University, College of Pharmaceutical Sciences, Institute of 
      Pharmacology and Toxicology, Hangzhou, Zhejiang, China.
FAU - Zhang, Xiao-Wei
AU  - Zhang XW
AD  - Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of 
      Materia Medica, State Key Laboratory of Bioactive Substance and Function of 
      Natural Medicines, Molecular Immunology and Cancer Pharmacology Group, Beijing, 
      China.
FAU - Zhang, Xiaolei
AU  - Zhang X
AD  - The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical 
      University, Department of Orthopaedics, Wenzhou, Zhejiang Province, China.
FAU - Zhang, Xiaoyan
AU  - Zhang X
AD  - Department of Molecular, Cellular and Developmental Biology, University of 
      Michigan, Ann Arbor, MI, USA.
AD  - Department of Neurology, University of Michigan School of Medicine, Ann Arbor, 
      MI, USA.
FAU - Zhang, Xin
AU  - Zhang X
AD  - Chinese Academy of Sciences, Hefei Institutes of Physical Science, High Magnetic 
      Field Laboratory, Hefei, Anhui Province, China.
FAU - Zhang, Xinxin
AU  - Zhang X
AD  - College of Respiratory and Critical Care Medicine, Chinese PLA General Hospital, 
      Beijing, China.
FAU - Zhang, Xu Dong
AU  - Zhang XD
AD  - University of Newcastle, School of Biomedical Sciences and Pharmacy, NSW, 
      Australia.
FAU - Zhang, Yang
AU  - Zhang Y
AD  - University of Houston, College of Pharmacy, Department of Pharmacological & 
      Pharmaceutical Sciences, Houston, TX, USA.
FAU - Zhang, Yanjin
AU  - Zhang Y
AD  - University of Maryland, Molecular Virology Laboratory, VA-MD College of 
      Veterinary Medicine, College Park, MD, USA.
FAU - Zhang, Yi
AU  - Zhang Y
AD  - University of Colorado Anschutz Medical Campus, Department of Pharmacology, 
      Aurora, CO, USA.
FAU - Zhang, Ying-Dong
AU  - Zhang YD
AD  - Nanjing Medical University, Nanjing First Hospital, Department of Neurology, 
      Nanjing, China.
FAU - Zhang, Yingmei
AU  - Zhang Y
AD  - Lanzhou University, School of Life Sciences, Lanzhou, China.
FAU - Zhang, Yuan-Yuan
AU  - Zhang YY
AD  - Sichuan University, West China School of Basic Medical Sciences & Forensic 
      Medicine, Chengdu, China.
FAU - Zhang, Yuchen
AU  - Zhang Y
AD  - The Chinese University of Hong Kong, Department of Anaesthesia and Intensive 
      Care, Hong Kong, China.
FAU - Zhang, Zhe
AU  - Zhang Z
AD  - East China Normal University, Key Laboratory of Adolescent Health Assessment and 
      Exercise Intervention of Ministry of Education, Shanghai, China.
FAU - Zhang, Zhengguang
AU  - Zhang Z
AD  - Nanjing Agricultural University, College of Plant Protection, Department of Plant 
      Pathology, Nanjing, China.
FAU - Zhang, Zhibing
AU  - Zhang Z
AD  - Department of Physiology, Department of Obstetrics/Gynecology, Wayne State 
      University, Detroit, MI, USA.
FAU - Zhang, Zhihai
AU  - Zhang Z
AD  - Life Sciences Institute and Department of Molecular, Cellular and Developmental 
      Biology, University of Michigan, Ann Arbor, MI, USA.
FAU - Zhang, Zhiyong
AU  - Zhang Z
AD  - Rutgers University, Department of Surgery, New Brunswick, NJ, USA.
FAU - Zhang, Zili
AU  - Zhang Z
AD  - Nanjing University of Chinese Medicine, Nanjing, China.
FAU - Zhao, Haobin
AU  - Zhao H
AD  - Central China Normal University, College of Life Sciences, Wuhan, Hubei Province, 
      China.
FAU - Zhao, Lei
AU  - Zhao L
AD  - The Fourth Military Medical University, National Key Discipline of Cell Biology, 
      Department of Physiology and Pathophysiology, Xi'an, Shaanxi, China.
AD  - The Fourth Military Medical University, Tangdu Hospital, Department of 
      Neurosurgery, Xi'an, Shaanxi, China.
FAU - Zhao, Shuang
AU  - Zhao S
AD  - Beijing Academy of Agriculture and Forestry Sciences, Institute of Plant and 
      Environment Protection, Beijing, China.
FAU - Zhao, Tongbiao
AU  - Zhao T
AD  - Chinese Academy of Sciences, Institute of Zoology, State Key Laboratory of Stem 
      cell and Reproductive Biology, Beijing, China.
FAU - Zhao, Xiao-Fan
AU  - Zhao XF
AD  - Shandong University, School of Life Sciences, Shandong Provincial Key Laboratory 
      of Animal Cells and Developmental Biology, Qingdao, China.
FAU - Zhao, Ying
AU  - Zhao Y
AD  - Peking University Health Sciences Center, Department of Biochemistry and 
      Molecular Biology, Beijing, China.
FAU - Zhao, Yongchao
AU  - Zhao Y
AD  - Zhejiang University, the First Affiliated Hospital, Hangzhou, Zhejiang, China.
FAU - Zhao, Yongliang
AU  - Zhao Y
AD  - Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.
FAU - Zhao, Yuting
AU  - Zhao Y
AD  - University of Texas Southwestern Medical Center, Center for Autophagy Research, 
      Department of Internal Medicine and Howard Hughes Medical Institute, Dallas, TX, 
      USA.
FAU - Zheng, Guoping
AU  - Zheng G
AD  - University of Sydney, Westmead Institute for Medical Research, Centre for 
      Transplant and Renal Research, Sydney NSW, Australia.
FAU - Zheng, Kai
AU  - Zheng K
AD  - Shenzhen University, Health Science Center, School of Pharmaceutical Sciences, 
      Shenzhen, Guangdong, China.
FAU - Zheng, Ling
AU  - Zheng L
AD  - Wuhan University, Department of Cell Biology, College of Life Sciences, Wuhan, 
      Hubei, China.
FAU - Zheng, Shizhong
AU  - Zheng S
AD  - Nanjing University of Chinese Medicine, Nanjing, China.
FAU - Zheng, Xi-Long
AU  - Zheng XL
AD  - University of Calgary, Cumming School of Medicine, Libin Cardiovascular Institute 
      of Alberta, Departments of Biochemistry & Molecular Biology and Physiology & 
      Pharmacology, Calgary, Alberta, Canada.
FAU - Zheng, Yi
AU  - Zheng Y
AD  - Children's Hospital Medical Center, Division of Experimental Hematology and 
      Cancer Biology, Cincinnati, OH, USA.
FAU - Zheng, Zu-Guo
AU  - Zheng ZG
AD  - China Pharmaceutical University, State Key Laboratory of Natural Medicines, 
      Nanjing, Jiangsu, China.
FAU - Zhivotovsky, Boris
AU  - Zhivotovsky B
AD  - Karolinska Institutet Division of Toxicology, Institute of Environmental 
      Medicine, Stockholm, Sweden; Lomonosov Moscow State University, Faculty of Basic 
      Medicine, Moscow, Russia.
FAU - Zhong, Qing
AU  - Zhong Q
AD  - Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of 
      Education, Department of Pathophysiology, Shanghai Jiao Tong University School of 
      Medicine (SJTU-SM), Shanghai, China.
FAU - Zhou, Ao
AU  - Zhou A
AD  - Southwest Medical University, Department of Medical Cellular Biology, Luzhou, 
      Sichuan, China.
FAU - Zhou, Ben
AU  - Zhou B
AD  - Massachusetts General Hospital, Department of Medicine, Diabetes Unit and Center 
      for Genomic Medicine, Boston, MA, USA; Harvard Medical School, Department of 
      Medicine, Boston, MA, USA.
FAU - Zhou, Cefan
AU  - Zhou C
AD  - Hubei University of Technology, National "111" Center for Cellular Regulation and 
      Molecular Pharmaceutics, Wuhan, China.
FAU - Zhou, Gang
AU  - Zhou G
AD  - Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of 
      Stomatology, Wuhan University, Wuhan, Hubei, China.
FAU - Zhou, Hao
AU  - Zhou H
AD  - Chinese People's Liberation Army General Hospital, Department of Cardiology, 
      Beijing, China.
FAU - Zhou, Hong
AU  - Zhou H
AD  - Third Military Medical University, College of Pharmacy, Department of 
      Pharmacology, Chongqing, China.
FAU - Zhou, Hongbo
AU  - Zhou H
AD  - Huazhong Agricultural University, College of Veterinary Medicine, State Key 
      Laboratory of Agricultural Microbiology, Wuhan, China.
FAU - Zhou, Jie
AU  - Zhou J
AD  - Zhejiang University, Department of Horticulture, Hangzhou, China.
FAU - Zhou, Jing
AU  - Zhou J
AD  - Wenzhou Medical University, State Key Laboratory of Ophthalmology, Optometry and 
      Visual Science, School of Optometry and Ophthalmology and the Eye Hospital, 
      Wenzhou, China.
FAU - Zhou, Jing
AU  - Zhou J
AD  - Guangxi Medical University, School of Preclinical Medicine, Department of 
      Physiology, Nanning,China.
FAU - Zhou, Jiyong
AU  - Zhou J
AD  - Zhejiang University, MOA Key Laboratory of Animal Virology, Hangzhou, Zhejiang, 
      China.
FAU - Zhou, Kailiang
AU  - Zhou K
AD  - The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical 
      University, Department of Orthopaedics, Wenzhou, Zhejiang, China.
FAU - Zhou, Rongjia
AU  - Zhou R
AD  - Wuhan University, Hubei Key laboratory of Cell Homeostasis, College of Life 
      Sciences, Wuhan, China.
FAU - Zhou, Xu-Jie
AU  - Zhou XJ
AD  - Peking University First Hospital, Renal Division, Xi Cheng District, Beijing, 
      China.
FAU - Zhou, Yanshuang
AU  - Zhou Y
AD  - Chinese Academy of Sciences, Guangzhou Institutes of Biomedicine and Health, CAS 
      Key Laboratory of Regenerative Biology, Guangzhou, China.
FAU - Zhou, Yinghong
AU  - Zhou Y
AD  - Queensland University of Technology, Institute of Health and Biomedical 
      Innovation, Brisbane, QLD, Australia.
FAU - Zhou, Yubin
AU  - Zhou Y
AD  - Texas A&M University, Institute of Biosciences and Technology, Houston, TX, USA.
FAU - Zhou, Zheng-Yu
AU  - Zhou ZY
AD  - Soochow University, Laboratory Animal Center, Suzhou, Jiangsu Province, China.
FAU - Zhou, Zhou
AU  - Zhou Z
AD  - Zhejiang University School of Medicine, Department of Environmental Medicine, 
      Hangzhou, Zhejiang Province, China.
FAU - Zhu, Binglin
AU  - Zhu B
AD  - University at Buffalo, The State University of New York, Department of Physiology 
      and Biophysics, Buffalo, NY, USA.
FAU - Zhu, Changlian
AU  - Zhu C
AD  - Zhengzhou University, Third Affiliated Hospital and Institute of Neuroscience, 
      Henan Key Laboratory of Child Brain Injury, Zhengzhou, China; Gothenburg 
      University, Institute of Neuroscience and Physiology, Gothenburg, Sweden.
FAU - Zhu, Guo-Qing
AU  - Zhu GQ
AD  - Nanjing Medical University, Department of Physiology, Nanjing, Jiangsu, China.
FAU - Zhu, Haining
AU  - Zhu H
AD  - University of Kentucky, College of Medicine, Department of Molecular and Cellular 
      Biochemistry, Lexington, KY, USA.
FAU - Zhu, Hongxin
AU  - Zhu H
AD  - Shanghai Jiao Tong University, Bio-X Institutes, Shanghai, China.
FAU - Zhu, Hua
AU  - Zhu H
AD  - The Ohio State University, Department of Surgery, Columbus, OH, USA.
FAU - Zhu, Wei-Guo
AU  - Zhu WG
AD  - Shenzhen University Medical School, Department of Biochemistry and Molecular 
      Biology, Shenzhen, China.
FAU - Zhu, Yanping
AU  - Zhu Y
AD  - Simon Fraser University, Department of Chemistry, Department of Molecular Biology 
      and Biochemistry, Burnaby, British Columbia, Canada.
FAU - Zhu, Yushan
AU  - Zhu Y
AD  - State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of 
      Protein Science, College of Life Sciences, Nankai University, Tianjin, China.
FAU - Zhuang, Haixia
AU  - Zhuang H
AD  - Guangzhou Medical University, School of Basic Medical Sciences, State Key 
      Laboratory of Respiratory Disease, Guangzhou, China.
FAU - Zhuang, Xiaohong
AU  - Zhuang X
AD  - The Chinese University of Hong Kong, School of Life Sciences, Centre for Cell & 
      Developmental Biology and State Key Laboratory of Agrobiotechnology, Shatin, New 
      Territories, Hong Kong, China.
FAU - Zientara-Rytter, Katarzyna
AU  - Zientara-Rytter K
AD  - University California, San Diego, Division of Biological Sciences, Section of 
      Molecular Biology, CA, USA.
FAU - Zimmermann, Christine M
AU  - Zimmermann CM
AD  - University Medical Center of Johannes Gutenberg-University, Institute for 
      Virology, Mainz, Germany.
FAU - Ziviani, Elena
AU  - Ziviani E
AD  - University of Padova, Biology Department, Padova, Italy.
FAU - Zoladek, Teresa
AU  - Zoladek T
AD  - Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, 
      Poland.
FAU - Zong, Wei-Xing
AU  - Zong WX
AD  - Rutgers University, Department of Chemical Biology, Ernest Mario School of 
      Pharmacy, Piscataway, NJ, USA.
FAU - Zorov, Dmitry B
AU  - Zorov DB
AD  - Moscow State University, A.N.Belozersky Institute of Physico-Chemical Biology, 
      Department of Functional Biochemistry of Biopolymers, Moscow, Russia.
FAU - Zorzano, Antonio
AU  - Zorzano A
AD  - Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; 
      Universitat de Barcelona, Departament de Bioquímica I Biomedicina Molecular, 
      Barcelona, Spain; CIBER de Diabetes y Enfermedades Metabólicas Asociadas 
      (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
FAU - Zou, Weiping
AU  - Zou W
AD  - University of Michigan, Departments of Surgery and Pathology, Ann Arbor, MI, USA.
FAU - Zou, Zhen
AU  - Zou Z
AD  - Institute of Life Sciences, Chongqing Medical University, Chongqing, PR China.
FAU - Zou, Zhengzhi
AU  - Zou Z
FAU - Zuryn, Steven
AU  - Zuryn S
AD  - The University of Queensland, Queensland Brain Institute, Clem Jones Centre for 
      Ageing Dementia Research, Brisbane, Australia.
FAU - Zwerschke, Werner
AU  - Zwerschke W
AD  - University of Innsbruck, Division of Cell Metabolism and Differentiation 
      Research, Research Institute for Biomedical Aging Research, Innsbruck, Austria.
FAU - Brand-Saberi, Beate
AU  - Brand-Saberi B
AD  - Inserm U1138, Centre de Recherche des Cordeliers, Sorbonne Université, Université 
      de Paris, Paris, France.
FAU - Dong, X Charlie
AU  - Dong XC
AD  - Indiana University School of Medicine, Department of Biochemistry and Molecular 
      Biology, Indianapolis, IN, USA.
FAU - Kenchappa, Chandra Shekar
AU  - Kenchappa CS
AD  - Swedish University of Agricultural Sciences, Department of Forest Mycology and 
      Plant Pathology, Uppsala, Sweden.
FAU - Li, Zuguo
AU  - Li Z
AD  - Southern Medical University, Shenzhen Hospital, Department of Pathology, Bao'an 
      District, Shenzhen, Guangdong, China.
FAU - Lin, Yong
AU  - Lin Y
AD  - Lovelace Respiratory Research Institute, Molecular Biology and Lung Cancer 
      Program, Albuquerque, NM, USA.
FAU - Oshima, Shigeru
AU  - Oshima S
AD  - Tokyo Medical and Dental University (TMDU), Medical Hospital, Department of 
      Gastroenterology and Hepatology, Bunkyo-ku, Tokyo, Japan.
FAU - Rong, Yueguang
AU  - Rong Y
AD  - Huazhong University of Science and Technology, School of Basic Medicine, Wuhan, 
      HuBei, China.
FAU - Sluimer, Judith C
AU  - Sluimer JC
AD  - Maastricht University Medical Center, School for Cardiovascular disease (CARIM), 
      Department of Pathology, Maastricht, The Netherlands; University of Edinburgh, 
      Centre for Cardiovascular Science, Edinburgh, UK.
FAU - Stallings, Christina L
AU  - Stallings CL
AD  - Department of Molecular Microbiology, Washington University School of Medicine, 
      St. Louis, MO, USA.
FAU - Tong, Chun-Kit
AU  - Tong CK
AD  - Hong Kong Baptist University, School of Chinese Medicine, Hong Kong, China.
AD  - Hong Kong Baptist University, School of Chinese Medicine, Hong Kong, lxChina.
LA  - eng
GR  - R01 HL118558/HL/NHLBI NIH HHS/United States
GR  - R01 AI083387/AI/NIAID NIH HHS/United States
GR  - MRF_C0483/MRF/MRF/United Kingdom
GR  - K08 CA230151/CA/NCI NIH HHS/United States
GR  - R01 CA211070/CA/NCI NIH HHS/United States
GR  - R15 GM122035/GM/NIGMS NIH HHS/United States
GR  - R35 GM127029/GM/NIGMS NIH HHS/United States
GR  - R01 NS105971/NS/NINDS NIH HHS/United States
GR  - R35 GM130331/GM/NIGMS NIH HHS/United States
GR  - R01 DK114401/DK/NIDDK NIH HHS/United States
GR  - P01 CA140043/CA/NCI NIH HHS/United States
GR  - R21 DE028256/DE/NIDCR NIH HHS/United States
GR  - R01 HL126933/HL/NHLBI NIH HHS/United States
GR  - MR/M00869X/2/MRC_/Medical Research Council/United Kingdom
GR  - R01 ES029092/ES/NIEHS NIH HHS/United States
GR  - K08 AI102971/AI/NIAID NIH HHS/United States
GR  - R01 HL088256/HL/NHLBI NIH HHS/United States
GR  - MR/T002220/1/MRC_/Medical Research Council/United Kingdom
GR  - R01 DK057993/DK/NIDDK NIH HHS/United States
GR  - R01 DK110162/DK/NIDDK NIH HHS/United States
GR  - R01 AI130454/AI/NIAID NIH HHS/United States
GR  - R01 CA140964/CA/NCI NIH HHS/United States
GR  - R01 CA229275/CA/NCI NIH HHS/United States
GR  - R35 GM131681/GM/NIGMS NIH HHS/United States
GR  - R35 GM131919/GM/NIGMS NIH HHS/United States
GR  - R01 AR077440/AR/NIAMS NIH HHS/United States
GR  - R01 DK093668/DK/NIDDK NIH HHS/United States
GR  - L30 AI091018/AI/NIAID NIH HHS/United States
GR  - R01 AI087682/AI/NIAID NIH HHS/United States
GR  - T32 HL134621/HL/NHLBI NIH HHS/United States
GR  - RF1 NS083704/NS/NINDS NIH HHS/United States
GR  - R01 AG049780/AG/NIA NIH HHS/United States
GR  - R01 AG061447/AG/NIA NIH HHS/United States
GR  - R15 NS075684/NS/NINDS NIH HHS/United States
GR  - R01 HL107594/HL/NHLBI NIH HHS/United States
GR  - R01 CA252707/CA/NCI NIH HHS/United States
GR  - I01 BX004444/BX/BLRD VA/United States
GR  - R01 NS095634/NS/NINDS NIH HHS/United States
GR  - P01 DK098108/DK/NIDDK NIH HHS/United States
GR  - P30 ES006694/ES/NIEHS NIH HHS/United States
GR  - R21 CA209345/CA/NCI NIH HHS/United States
GR  - R01 NS103981/NS/NINDS NIH HHS/United States
GR  - R01 AI136921/AI/NIAID NIH HHS/United States
GR  - R01 AG057509/AG/NIA NIH HHS/United States
GR  - BBS/E/B/000C0413/BB_/Biotechnology and Biological Sciences Research 
      Council/United Kingdom
GR  - MR/N022696/1/MRC_/Medical Research Council/United Kingdom
GR  - R35 CA232113/CA/NCI NIH HHS/United States
GR  - MR/R009732/1/MRC_/Medical Research Council/United Kingdom
GR  - R01 HL133545/HL/NHLBI NIH HHS/United States
GR  - K08 AG050808/AG/NIA NIH HHS/United States
GR  - G0501003/MRC_/Medical Research Council/United Kingdom
GR  - R01 EY026885/EY/NEI NIH HHS/United States
GR  - MC_UU_00018/2/MRC_/Medical Research Council/United Kingdom
GR  - R01 GM118660/GM/NIGMS NIH HHS/United States
GR  - R01 DK124308/DK/NIDDK NIH HHS/United States
GR  - MR/R025096/1/MRC_/Medical Research Council/United Kingdom
GR  - R15 GM102846/GM/NIGMS NIH HHS/United States
GR  - R01 NS115403/NS/NINDS NIH HHS/United States
GR  - R01 DK112698/DK/NIDDK NIH HHS/United States
GR  - P30 AG024824/AG/NIA NIH HHS/United States
GR  - R01 GM115517/GM/NIGMS NIH HHS/United States
GR  - R01 DK124901/DK/NIDDK NIH HHS/United States
GR  - I01 BX004306/BX/BLRD VA/United States
GR  - R01 CA160417/CA/NCI NIH HHS/United States
GR  - R01 CA184137/CA/NCI NIH HHS/United States
GR  - R35 HL145241/HL/NHLBI NIH HHS/United States
GR  - R01 EY018341/EY/NEI NIH HHS/United States
GR  - R01 CA238457/CA/NCI NIH HHS/United States
GR  - R01 NS042023/NS/NINDS NIH HHS/United States
GR  - R01 EY019643/EY/NEI NIH HHS/United States
GR  - R56 AG063820/AG/NIA NIH HHS/United States
GR  - R01 AI139046/AI/NIAID NIH HHS/United States
GR  - R35 GM136325/GM/NIGMS NIH HHS/United States
GR  - P30 DK089503/DK/NIDDK NIH HHS/United States
GR  - R01 HL141759/HL/NHLBI NIH HHS/United States
GR  - R01 HL085629/HL/NHLBI NIH HHS/United States
GR  - R15 NS104857/NS/NINDS NIH HHS/United States
GR  - R01 HL153614/HL/NHLBI NIH HHS/United States
GR  - P20 GM121176/GM/NIGMS NIH HHS/United States
GR  - R35 GM131689/GM/NIGMS NIH HHS/United States
GR  - R01 ES031253/ES/NIEHS NIH HHS/United States
GR  - R01 HL132318/HL/NHLBI NIH HHS/United States
GR  - I01 BX001516/BX/BLRD VA/United States
GR  - R01 DK108921/DK/NIDDK NIH HHS/United States
GR  - U54 GM104942/GM/NIGMS NIH HHS/United States
GR  - R37 AI042999/AI/NIAID NIH HHS/United States
GR  - R01 HL154147/HL/NHLBI NIH HHS/United States
GR  - R01 GM101972/GM/NIGMS NIH HHS/United States
GR  - MR/S009426/1/MRC_/Medical Research Council/United Kingdom
GR  - R01 AI111935/AI/NIAID NIH HHS/United States
GR  - R01 CA244144/CA/NCI NIH HHS/United States
GR  - R01 AI113919/AI/NIAID NIH HHS/United States
GR  - R01 NS094154/NS/NINDS NIH HHS/United States
GR  - MC_U105184308/MRC_/Medical Research Council/United Kingdom
GR  - R01 AR070837/AR/NIAMS NIH HHS/United States
GR  - IK6 BX005793/BX/BLRD VA/United States
GR  - R01 AG064892/AG/NIA NIH HHS/United States
GR  - R01 GM119160/GM/NIGMS NIH HHS/United States
GR  - R01 CA227838/CA/NCI NIH HHS/United States
GR  - R35 GM119571/GM/NIGMS NIH HHS/United States
GR  - R01 CA247992/CA/NCI NIH HHS/United States
GR  - MR/S032304/1/MRC_/Medical Research Council/United Kingdom
GR  - R01 AA019730/AA/NIAAA NIH HHS/United States
GR  - R01 GM102297/GM/NIGMS NIH HHS/United States
GR  - R01 NS089737/NS/NINDS NIH HHS/United States
GR  - R21 NS102780/NS/NINDS NIH HHS/United States
GR  - BBS/E/F/000PR10355/BB_/Biotechnology and Biological Sciences Research 
      Council/United Kingdom
GR  - R01 NS115876/NS/NINDS NIH HHS/United States
GR  - R01 HL153599/HL/NHLBI NIH HHS/United States
GR  - R01 EY027733/EY/NEI NIH HHS/United States
GR  - R01 NS110943/NS/NINDS NIH HHS/United States
GR  - UKDRI-2002/MRC_/Medical Research Council/United Kingdom
GR  - R01 DK121545/DK/NIDDK NIH HHS/United States
GR  - R01 CA181196/CA/NCI NIH HHS/United States
GR  - R01 GM111295/GM/NIGMS NIH HHS/United States
GR  - R01 AI122176/AI/NIAID NIH HHS/United States
GR  - R01 NS093362/NS/NINDS NIH HHS/United States
GR  - P30 EY001583/EY/NEI NIH HHS/United States
GR  - R01 AG062475/AG/NIA NIH HHS/United States
GR  - R01 DK117965/DK/NIDDK NIH HHS/United States
GR  - P30 CA014236/CA/NCI NIH HHS/United States
GR  - R01 NS118146/NS/NINDS NIH HHS/United States
GR  - R01 NS083704/NS/NINDS NIH HHS/United States
GR  - R01 NS093843/NS/NINDS NIH HHS/United States
GR  - P50 AA011999/AA/NIAAA NIH HHS/United States
GR  - R01 NS110716/NS/NINDS NIH HHS/United States
GR  - R01 CA190370/CA/NCI NIH HHS/United States
GR  - RF1 AG058476/AG/NIA NIH HHS/United States
GR  - P30 DK020572/DK/NIDDK NIH HHS/United States
GR  - R01 DK099558/DK/NIDDK NIH HHS/United States
GR  - R25 NS070682/NS/NINDS NIH HHS/United States
GR  - P30 DK084567/DK/NIDDK NIH HHS/United States
GR  - I01 BX004235/BX/BLRD VA/United States
GR  - R01 AI072648/AI/NIAID NIH HHS/United States
GR  - R35 GM122536/GM/NIGMS NIH HHS/United States
GR  - R01 CA197398/CA/NCI NIH HHS/United States
GR  - R01 DK113170/DK/NIDDK NIH HHS/United States
GR  - R01 HL072166/HL/NHLBI NIH HHS/United States
GR  - R01 DK024031/DK/NIDDK NIH HHS/United States
GR  - R01 CA200310/CA/NCI NIH HHS/United States
GR  - R01 GM127791/GM/NIGMS NIH HHS/United States
GR  - R01 DK107220/DK/NIDDK NIH HHS/United States
GR  - R01 CA233794/CA/NCI NIH HHS/United States
GR  - PG/17/14/32867/BHF_/British Heart Foundation/United Kingdom
GR  - MC_EX_G0800785/MRC_/Medical Research Council/United Kingdom
GR  - P01 AG054407/AG/NIA NIH HHS/United States
GR  - I01 BX000774/BX/BLRD VA/United States
GR  - R01 AG062375/AG/NIA NIH HHS/United States
GR  - R01 AG067664/AG/NIA NIH HHS/United States
GR  - R01 AI132697/AI/NIAID NIH HHS/United States
GR  - P01 AG031782/AG/NIA NIH HHS/United States
GR  - I01 BX003803/BX/BLRD VA/United States
GR  - R01 AI124121/AI/NIAID NIH HHS/United States
GR  - R01 AI054476/AI/NIAID NIH HHS/United States
GR  - R01 AR061370/AR/NIAMS NIH HHS/United States
GR  - R01 HL142879/HL/NHLBI NIH HHS/United States
GR  - R01 EY029675/EY/NEI NIH HHS/United States
GR  - R00 GM117218/GM/NIGMS NIH HHS/United States
GR  - R01 HL123340/HL/NHLBI NIH HHS/United States
PT  - Guideline
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20210208
PL  - United States
TA  - Autophagy
JT  - Autophagy
JID - 101265188
RN  - 0 (Autophagy-Related Proteins)
RN  - 0 (Biomarkers)
SB  - IM
MH  - Animals
MH  - Autophagosomes
MH  - *Autophagy/physiology
MH  - Autophagy-Related Proteins/metabolism
MH  - Biological Assay/standards
MH  - Biomarkers
MH  - Humans
MH  - Lysosomes
PMC - PMC7996087
OTO - NOTNLM
OT  - Autophagosome
OT  - LC3
OT  - cancer
OT  - flux
OT  - lysosome
OT  - macroautophagy
OT  - neurodegeneration
OT  - phagophore
OT  - stress
OT  - vacuole
COIS- No potential conflict of interest was reported by the corresponding author.
EDAT- 2021/02/27 06:00
MHDA- 2022/03/15 06:00
CRDT- 2021/02/26 08:36
PHST- 2021/02/27 06:00 [pubmed]
PHST- 2022/03/15 06:00 [medline]
PHST- 2021/02/26 08:36 [entrez]
AID - 1797280 [pii]
AID - 10.1080/15548627.2020.1797280 [doi]
PST - ppublish
SO  - Autophagy. 2021 Jan;17(1):1-382. doi: 10.1080/15548627.2020.1797280. Epub 2021 
      Feb 8.

PMID- 27099902
STAT- Publisher
CTDT- 20200520
PB  - MDText.com, Inc.
DP  - 2000
TI  - Non-Diabetic Hypoglycemia.
BTI - Endotext
AB  - Objective: To describe the evaluation and management of hypoglycemia in patients 
      without diabetes mellitus. Methods: Review of the literature for the evaluation 
      and management of non-diabetic hypoglycemia using Medline and PubMed. Results: 
      Hypoglycemia (glucose <55 mg/dL [3.0 mmol/L]) is uncommon in people without 
      diabetes. Whipple’s triad (low plasma glucose concentration, clinical 
      signs/symptoms consistent with hypoglycemia, and resolution of signs or symptoms 
      when the plasma glucose concentration increases) should be documented in patients 
      prior to initiating an evaluation. Medications should be reviewed. Critical 
      illnesses, malnutrition, hormone deficiencies especially adrenal insufficiency, 
      and non-islet cell tumors secreting IGF-II need be considered in those who are 
      ill. Hypoglycemia can also follow bariatric surgery. In apparently healthy 
      individuals, endogenous hyperinsulinism due to insulinoma, functional β-cell 
      disorders, or the insulin autoimmune syndrome are possible, as are accidental, 
      surreptitious or factitious causes of hypoglycemia. Tests performed during 
      hypoglycemia can establish the cause in those whom illness or medications are 
      excluded. Testing should be done at the time of spontaneous development of 
      symptoms. If this is not possible, it can be done in the setting of a prolonged 
      supervised fast or during a mixed meal test. Endogenous hyperinsulinism is 
      supported by insulin ≥3 uU/mL, c-peptide ≥0.2 nmol/L, proinsulin ≥5 pmol/L, 
      β-hydroxybutyrate ≤2.7 mmol/L and undetectable sulfonylurea/meglitinide in the 
      setting of hypoglycemia. The use of glucagon tolerance tests, c-peptide 
      suppression tests, anti-insulin antibody testing, and continuous glucose 
      monitoring are discussed. Congenital causes of hypoglycemia, diagnosed primarily 
      in neonates and children, are also reviewed. Treatment of hypoglycemia is 
      tailored to the etiology. Conclusions: Accurate diagnosis is needed to direct 
      nutritional, medical, and/or surgical treatment for non-diabetic hypoglycemia. 
      For complete coverage of all related areas of Endocrinology, please visit our 
      on-line FREE web-text, WWW.ENDOTEXT.ORG.
CI  - Copyright © 2000-2024, MDText.com, Inc.
FED - Feingold, Kenneth R
ED  - Feingold KR
AD  - Professor of Medicine Emeritus, University of California, San Francisco, CA
FED - Anawalt, Bradley
ED  - Anawalt B
AD  - Chief of Medicine at the University of Washington Medical Center and Professor 
      and Vice Chair of the Department of Medicine, University of Washington
FED - Blackman, Marc R
ED  - Blackman MR
AD  - Sr. Physician Scientist, Washington DC VA Medical Center; Professor of Medicine & 
      Rehabilitation Medicine, Georgetown University; Clinical Professor of Medicine, 
      Biochemistry and Molecular Medicine, George Washington University; and Professor 
      of Medicine (Part-time), Johns Hopkins University
FED - Boyce, Alison
ED  - Boyce A
AD  - Pediatric Endocrinologist and Associate Research Physician in the Skeletal 
      Diseases and Mineral Homeostasis Section, National Institute of Dental and 
      Craniofacial Research, National Institutes of Health
FED - Chrousos, George
ED  - Chrousos G
AD  - Professor of Pediatrics and Endocrinology, Division of Endocrinology, Metabolism 
      and Diabetes, First Department of Pediatrics, National and Kapodistrian 
      University of Athens Medical School, "Aghia Sophia" Children's Hospital, Athens, 
      Greece
FED - Corpas, Emiliano
ED  - Corpas E
AD  - M.D. Ph.D in Gerontology. Honorary Professor of Medicine, Universidad de Alcalá, 
      Madrid. Consultant in Endocrinology, Hospital HLA Guadalajara (Spain).
FED - de Herder, Wouter W
ED  - de Herder WW
AD  - Professor of Endocrine Oncology, Erasmus MC and Erasmus MC Cancer Center, 
      Rotterdam, the Netherlands
FED - Dhatariya, Ketan
ED  - Dhatariya K
AD  - Consultant in Diabetes, Endocrinology and General Medicine, Norfolk and Norwich 
      University Hospitals NHS Foundation Trust and University of East Anglia, Norwich, 
      UK.
FED - Dungan, Kathleen
ED  - Dungan K
AD  - Professor of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Ohio 
      State University
FED - Hofland, Johannes
ED  - Hofland J
AD  - Consultant Endocrinologist, Erasmus MC and Erasmus MC Cancer Center, Rotterdam, 
      the Netherlands
FED - Kalra, Sanjay
ED  - Kalra S
AD  - Consultant Endocrinologist, Department of Endocrinology, Bharti Hospital, Karnal, 
      India
FED - Kaltsas, Gregory
ED  - Kaltsas G
AD  - Professor of General Medicine-Endocrinology, 1st Department of Propaedeutic 
      Medicine, National and Kapodistrian University of Athens, Athens, Greece
FED - Kapoor, Nitin
ED  - Kapoor N
AD  - Professor of Endocrinology, Department of Endocrinology, Diabetes and Metabolism, 
      Christian Medical College & Hospital, Vellore, Tamil Nadu, India, Melbourne 
      School of Population and Global Health, Faculty of Medicine, Dentistry and Health 
      Science, The University of Melbourne, Australia.
FED - Koch, Christian
ED  - Koch C
AD  - Professor, The University of Tennessee Health Science Center, Memphis, Tennessee
FED - Kopp, Peter
ED  - Kopp P
AD  - Professor of Medicine and Chief of the Division of Endocrinology, Diabetology and 
      Metabolism, University of Lausanne, Switzerland
FED - Korbonits, Márta
ED  - Korbonits M
AD  - Professor of Endocrinology and Metabolism, Centre Lead for Endocrinology and 
      Deputy Institute Director, William Harvey Research Institute, Barts and the 
      London School of Medicine and Dentistry, Queen Mary University of London, London, 
      England
FED - Kovacs, Christopher S
ED  - Kovacs CS
AD  - University Research Professor and Professor of Medicine (Endocrinology and 
      Metabolism), Obstetrics & Gynecology, and BioMedical Sciences, at Memorial 
      University of Newfoundland in St. John’s, Newfoundland, Canada.
FED - Kuohung, Wendy
ED  - Kuohung W
AD  - Director of the Division of Reproductive Endocrinology at Boston Medical Center 
      and an Associate Professor of Obstetrics and Gynecology at the Boston University 
      School of Medicine
FED - Laferrère, Blandine
ED  - Laferrère B
AD  - Professor of Medicine, New York Nutrition Obesity Research Center, Division of 
      Endocrinology, Department of Medicine, Columbia University Irving Medical Center, 
      New York, NY, USA.
FED - Levy, Miles
ED  - Levy M
AD  - Consultant endocrinologist at University Hospitals of Leicester and Honorary 
      Associate Professor at Leicester University
FED - McGee, Elizabeth A
ED  - McGee EA
AD  - Professor of Obstetrics and Gynecology at the University of Vermont and Director 
      of the Division of Reproductive Endocrinology and Infertility. Burlington, 
      Vermont
FED - McLachlan, Robert
ED  - McLachlan R
AD  - Director of Clinical Research, Hudson Institute of Medical Research; Consultant 
      Endocrinologist, Monash Medical Centre, Melbourne, Australia
FED - New, Maria
ED  - New M
AD  - Professor of Pediatrics, Professor of Genetics and Genomic Sciences, and Chief of 
      the Adrenal Steroid Disorders Program, Icahn School of Medicine, Mount Sinai 
      School of Medicine, New York, NY
FED - Purnell, Jonathan
ED  - Purnell J
AD  - Professor of Medicine, Knight Cardiovascular Institute and the Division of 
      Endocrinology, and Associate Director, Bob and Charlee Moore Institute for 
      Nutrition and Wellness, Oregon Health and Science University, Portland, OR
FED - Sahay, Rakesh
ED  - Sahay R
AD  - Professor and Head of Department of Endocrinology, Osmania Medical College and 
      Osmania General Hospital, Hyderabad, India.
FED - Shah, Amy S
ED  - Shah AS
AD  - Professor of Pediatrics, The University of Cincinnati, Department of Pediatrics 
      and Cincinnati Children’s Hospital Medical Center, Division of Endocrinology, 
      Cincinnati, OH, USA
FED - Singer, Frederick
ED  - Singer F
AD  - Director of the Endocrine/Bone Disease Program, Saint Johns Cancer Institute at 
      Saint John’s Health Center, Santa Monica, CA; Clinical Professor of Medicine, 
      UCLA School of Medicine, Los Angeles, CA
FED - Sperling, Mark A
ED  - Sperling MA
AD  - Professorial Lecturer, Division of Pediatric Endocrinology and Diabetes, Icahn 
      School of Medicine at Mount Sinai, New York, NY. Emeritus Professor and Chair, 
      Department of Pediatrics, University of Pittsburgh.
FED - Stratakis, Constantine A
ED  - Stratakis CA
AD  - CSO, ELPEN, Inc. & Director, Research Institute, Athens, Greece & Senior 
      Investigator, Human Genetics & Precision Medicine, FORTH (ITE), Heraklion, 
      Greece. Emeritus Scientific Director & Senior Investigator, NICHD, NIH, Bethesda, 
      MD, USA
FED - Trence, Dace L
ED  - Trence DL
AD  - Professor of Medicine, Emeritus, University of Washington, Seattle, WA
FED - Wilson, Don P
ED  - Wilson DP
AD  - Endowed Chair, Cardiovascular Health and Risk Prevention, Pediatric Endocrinology 
      and Diabetes, Cook Children's Medical Center, Fort Worth, TX
FAU - Bansal, Nidhi
AU  - Bansal N
AD  - Assistant Professor of Medicine, SUNY Upstate Medical University, Syracuse NY.
FAU - Weinstock, Ruth S
AU  - Weinstock RS
AD  - SUNY Distinguished Service Professor, SUNY Upstate Medical University, Syracuse 
      NY
LA  - eng
PT  - Review
PT  - Book Chapter
PL  - South Dartmouth (MA)
EDAT- 2020/05/20 00:00
CRDT- 2020/05/20 00:00
AID - NBK355894 [bookaccession]

PMID- 35874653
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220726
IS  - 1662-5153 (Print)
IS  - 1662-5153 (Electronic)
IS  - 1662-5153 (Linking)
VI  - 16
DP  - 2022
TI  - Toward Precision Medicine in ADHD.
PG  - 900981
LID - 10.3389/fnbeh.2022.900981 [doi]
LID - 900981
AB  - Attention-Deficit Hyperactivity Disorder (ADHD) is a complex and heterogeneous 
      neurodevelopmental condition for which curative treatments are lacking. Whilst 
      pharmacological treatments are generally effective and safe, there is 
      considerable inter-individual variability among patients regarding treatment 
      response, required dose, and tolerability. Many of the non-pharmacological 
      treatments, which are preferred to drug-treatment by some patients, either lack 
      efficacy for core symptoms or are associated with small effect sizes. No 
      evidence-based decision tools are currently available to allocate pharmacological 
      or psychosocial treatments based on the patient's clinical, environmental, 
      cognitive, genetic, or biological characteristics. We systematically reviewed 
      potential biomarkers that may help in diagnosing ADHD and/or stratifying ADHD 
      into more homogeneous subgroups and/or predict clinical course, treatment 
      response, and long-term outcome across the lifespan. Most work involved 
      exploratory studies with cognitive, actigraphic and EEG diagnostic markers to 
      predict ADHD, along with relatively few studies exploring markers to subtype ADHD 
      and predict response to treatment. There is a critical need for multisite 
      prospective carefully designed experimentally controlled or observational studies 
      to identify biomarkers that index inter-individual variability and/or predict 
      treatment response.
CI  - Copyright © 2022 Buitelaar, Bölte, Brandeis, Caye, Christmann, Cortese, Coghill, 
      Faraone, Franke, Gleitz, Greven, Kooij, Leffa, Rommelse, Newcorn, Polanczyk, 
      Rohde, Simonoff, Stein, Vitiello, Yazgan, Roesler, Doepfner and Banaschewski.
FAU - Buitelaar, Jan
AU  - Buitelaar J
AD  - Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and 
      Behaviour, Radboud University Medical Centre, Nijmegen, Netherlands.
AD  - Karakter Child and Adolescent Psychiatry University Center, Nijmegen, 
      Netherlands.
FAU - Bölte, Sven
AU  - Bölte S
AD  - Center of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research, 
      Department of Women's and Children's Health, Karolinska Institutet, Solna, 
      Sweden.
AD  - Child and Adolescent Psychiatry, Stockholm Health Care Services, Stockholm, 
      Sweden.
AD  - Curtin Autism Research Group, School of Occupational Therapy, Social Work and 
      Speech Pathology, Curtin University, Perth, WA, Australia.
FAU - Brandeis, Daniel
AU  - Brandeis D
AD  - Department of Child and Adolescent Psychiatry and Psychotherapy, Central 
      Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, 
      Mannheim, Germany.
AD  - Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric 
      Hospital, University of Zurich, Zurich, Switzerland.
FAU - Caye, Arthur
AU  - Caye A
AD  - Department of Psychiatry, Hospital de Clinicas de Porto Alegre, Federal 
      University of Rio Grande do Sul, Porto Alegre, Brazil.
AD  - National Institute of Developmental Psychiatry for Children and Adolescents, São 
      Paulo, Brazil.
FAU - Christmann, Nina
AU  - Christmann N
AD  - Department of Child and Adolescent Psychiatry and Psychotherapy, Central 
      Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, 
      Mannheim, Germany.
FAU - Cortese, Samuele
AU  - Cortese S
AD  - Centre for Innovation in Mental Health, Academic Unit of Psychology, Faculty of 
      Environmental and Life Sciences, University of Southampton, Southampton, United 
      Kingdom.
AD  - Clinical and Experimental Sciences (CNS and Psychiatry), Faculty of Medicine, 
      University of Southampton, Southampton, United Kingdom.
AD  - Solent National Health System Trust, Southampton, United Kingdom.
AD  - Hassenfeld Children's Hospital at NYU Langone, New York University Child Study 
      Center, New York, NY, United States.
AD  - Division of Psychiatry and Applied Psychology, School of Medicine, University of 
      Nottingham, Nottingham, United Kingdom.
FAU - Coghill, David
AU  - Coghill D
AD  - Departments of Paediatrics and Psychiatry, Royal Children's Hospital, University 
      of Melbourne, Melbourne, VIC, Australia.
FAU - Faraone, Stephen V
AU  - Faraone SV
AD  - Departments of Psychiatry, Neuroscience and Physiology, SUNY Upstate Medical 
      University, Syracuse, New York, NY, United States.
FAU - Franke, Barbara
AU  - Franke B
AD  - Departments of Human Genetics and Psychiatry, Donders Institute for Brain, 
      Cognition and Behaviour, Radboud University Medical Center, Nijmegen, 
      Netherlands.
FAU - Gleitz, Markus
AU  - Gleitz M
AD  - Medice Arzneimittel Pütter GmbH & Co. KG, Iserlohn, Germany.
FAU - Greven, Corina U
AU  - Greven CU
AD  - Karakter Child and Adolescent Psychiatry University Center, Nijmegen, 
      Netherlands.
AD  - Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and 
      Behaviour, Radboud University Medical Center, Nijmegen, Netherlands.
AD  - King's College London, Social, Genetic and Developmental Psychiatry Centre, 
      Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom.
FAU - Kooij, Sandra
AU  - Kooij S
AD  - Amsterdam University Medical Center, Location VUMc, Amsterdam, Netherlands.
AD  - PsyQ, Expertise Center Adult ADHD, The Hague, Netherlands.
FAU - Leffa, Douglas Teixeira
AU  - Leffa DT
AD  - Department of Psychiatry, Hospital de Clinicas de Porto Alegre, Federal 
      University of Rio Grande do Sul, Porto Alegre, Brazil.
AD  - National Institute of Developmental Psychiatry for Children and Adolescents, São 
      Paulo, Brazil.
FAU - Rommelse, Nanda
AU  - Rommelse N
AD  - Karakter Child and Adolescent Psychiatry University Center, Nijmegen, 
      Netherlands.
AD  - Department of Psychiatry, Donders Institute for Brain, Cognition and Behaviour, 
      Radboud University Medical Center, Nijmegen, Netherlands.
FAU - Newcorn, Jeffrey H
AU  - Newcorn JH
AD  - Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, 
      United States.
FAU - Polanczyk, Guilherme V
AU  - Polanczyk GV
AD  - Department of Psychiatry, Faculdade de Medicina FMUSP, Universidade de São Paulo, 
      São Paulo, Brazil.
FAU - Rohde, Luis Augusto
AU  - Rohde LA
AD  - National Institute of Developmental Psychiatry for Children and Adolescents, São 
      Paulo, Brazil.
AD  - ADHD Outpatient Program and Developmental Psychiatry Program, Hospital de Clinica 
      de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
FAU - Simonoff, Emily
AU  - Simonoff E
AD  - Department of Child and Adolescent Psychiatry, Institute of Psychiatry, 
      Psychology and Neuroscience, King's College London, United Kingdom.
FAU - Stein, Mark
AU  - Stein M
AD  - Department of Psychiatry and Behavioral Sciences, Seattle, WA, United States.
FAU - Vitiello, Benedetto
AU  - Vitiello B
AD  - Department of Public Health and Pediatric Sciences, Section of Child and 
      Adolescent Neuropsychiatry, University of Turin, Turin, Italy.
AD  - Department of Public Health, Johns Hopkins University, Baltimore, MA, United 
      States.
FAU - Yazgan, Yanki
AU  - Yazgan Y
AD  - GuzelGunler Clinic, Istanbul, Turkey.
AD  - Yale Child Study Center, New Haven, CT, United States.
FAU - Roesler, Michael
AU  - Roesler M
AD  - Institute for Forensic Psychology and Psychiatry, Neurocenter, Saarland, Germany.
FAU - Doepfner, Manfred
AU  - Doepfner M
AD  - Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, 
      Medical Faculty of the University of Cologne, Cologne, Germany.
AD  - School for Child and Adolescent Cognitive Behavioural Therapy, University 
      Hospital of Cologne, Cologne, Germany.
FAU - Banaschewski, Tobias
AU  - Banaschewski T
AD  - Department of Child and Adolescent Psychiatry and Psychotherapy, Central 
      Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, 
      Mannheim, Germany.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20220706
PL  - Switzerland
TA  - Front Behav Neurosci
JT  - Frontiers in behavioral neuroscience
JID - 101477952
PMC - PMC9299434
OTO - NOTNLM
OT  - Attention-Deficit Hyperactivity Disorder (ADHD)
OT  - biomarker
OT  - heterogeneity
OT  - inter-individual variability
OT  - precision medicine
COIS- JB has been in the past 3 years a consultant to/member of advisory board of / 
      and/or speaker for Shire, Roche, Medice, and Servier. He is not an employee of 
      any of these companies, and not a stock shareholder of any of these companies. He 
      has no other financial or material support, including expert testimony, patents, 
      royalties. LR has received grant or research support from, served as a consultant 
      to, and served on the speakers' bureau of Eli Lilly and Co., Janssen, Medice, 
      Novartis and Shire. The ADHD and Juvenile Bipolar Disorder Outpatient Programs 
      chaired by LR have received unrestricted educational and research support from 
      the following pharmaceutical companies: Eli Lilly and Co., Janssen, and Novartis. 
      LR has received authorship royalties from Oxford Press and ArtMed and travel 
      grants from Shire to take part in the 2018 APA annual meeting and from Novartis 
      to take part of the 2016 AACAP annual meeting. Barbara Franke has received 
      educational speaking fees from Medice and Shire. SB discloses that he has in the 
      last 5 years acted as an author, consultant or lecturer for Shire, Medice, Roche, 
      Eli Lilly, Prima Psychiatry, GLGroup, System Analytic, Ability Partner, 
      Kompetento, Expo Medica, Clarion Healthcare, and Prophase. He receives royalties 
      for text books and diagnostic tools from Huber/Hogrefe, Kohlhammer and UTB. DB 
      serves as an unpaid scientific advisor for an EU-funded neurofeedback trial 
      unrelated to the present work. TB served in an advisory or consultancy role for 
      Actelion, Hexal Pharma, Lilly, Lundbeck, Medice, Neurim Pharmaceuticals, 
      Novartis, Shire. He received conference support or speaker's fee by Lilly, 
      Medice, Novartis and Shire. He has been involved in clinical trials conducted by 
      Shire & Viforpharma. He received royalties from Hogrefe, Kohlhammer, CIP Medien, 
      Oxford University Press. The present work is unrelated to the above grants and 
      relationships. DC served in an advisory or consultancy role for Medice, Novartis, 
      Shire/Takeda. He received conference support or speaker's fee by Medice, Servier 
      and Shire/Takeda. He has been involved in clinical trials conducted by Shire. He 
      received royalties from Oxford University Press. The present work is unrelated to 
      the above grants and relationships. In the past year, SF received income, 
      potential income, travel expenses continuing education support and/or research 
      support from Tris, Otsuka, Arbor, Ironshore, Shire, Akili, Enzymotec, Sunovion, 
      Supernus and Genomind. With his institution, he has US patent US20130217707 A1 
      for the use of sodium-hydrogen exchange inhibitors in the treatment of ADHD. In 
      previous years, he received support from: Shire, Ironshore, Neurovance, Alcobra, 
      Rhodes, CogCubed, KemPharm, Enzymotec, Akili, Neurolifesciences, Lundbeck/Takeda, 
      Otsuka, McNeil, Janssen, Novartis, Pfizer and Eli Lilly. He also receives 
      royalties from books published by Guilford Press: Straight Talk about Your 
      Child's Mental Health, Oxford University Press: Schizophrenia: The Facts and 
      Elsevier: ADHD: Non-Pharmacologic Interventions. He is principal investigator of 
      www.adhdinadults.com. Guilherme V. Polanczyk has been in the past 3 years a 
      consultant, member of advisory board, and/or speaker for Shire/Takeda and Medice. 
      He received travel expenses for continuing education support from Shire/Takeda 
      and royalties from Editora Manole. In the past three years, Jeffrey Newcorn 
      is/has been an advisor and/or consultant for Adlon Therapeutics, Akili 
      Interactive, Alcobra, Arbor, Cingulate Therapeutics, Enzymotec, KemPharm, 
      Lundbeck/Takeda, Medice, NLS, Rhodes, Shire, and Supernus. He was a DSMB member 
      for Pfizer and Sunovion, and received research funds from Enzymotec, Otsuka, 
      Shire and Supernus. He also has received speaker fees from Shire for 
      disease-state presentations, and served as a consultant for the US National 
      Football League. BV has served as consultant to Medice and Teva Pharm. Markus 
      Gleitz is an employee of Medice Arzneimittel Pütter GmbH & Co. KG. MS received 
      research support from Supernus, Shire, and Akili Interactive labs and in the past 
      year has served in a advisory or consultancy capacity to Genomind, NLS, 
      Shire/Takeda, Supernus, and Sunovian. The remaining authors declare that the 
      research was conducted in the absence of any commercial or financial 
      relationships that could be construed as a potential conflict of interest. The 
      reviewer KAJ declared a shared affiliation with the author DC to the handling 
      editor at the time of review.
EDAT- 2022/07/26 06:00
MHDA- 2022/07/26 06:01
CRDT- 2022/07/25 03:56
PHST- 2022/03/21 00:00 [received]
PHST- 2022/05/16 00:00 [accepted]
PHST- 2022/07/25 03:56 [entrez]
PHST- 2022/07/26 06:00 [pubmed]
PHST- 2022/07/26 06:01 [medline]
AID - 10.3389/fnbeh.2022.900981 [doi]
PST - epublish
SO  - Front Behav Neurosci. 2022 Jul 6;16:900981. doi: 10.3389/fnbeh.2022.900981. 
      eCollection 2022.

PMID- 35396580
OWN - NLM
STAT- MEDLINE
DCOM- 20220422
LR  - 20230115
IS  - 1476-4687 (Electronic)
IS  - 0028-0836 (Print)
IS  - 0028-0836 (Linking)
VI  - 604
IP  - 7906
DP  - 2022 Apr
TI  - Mapping genomic loci implicates genes and synaptic biology in schizophrenia.
PG  - 502-508
LID - 10.1038/s41586-022-04434-5 [doi]
AB  - Schizophrenia has a heritability of 60-80%(1), much of which is attributable to 
      common risk alleles. Here, in a two-stage genome-wide association study of up to 
      76,755 individuals with schizophrenia and 243,649 control individuals, we report 
      common variant associations at 287 distinct genomic loci. Associations were 
      concentrated in genes that are expressed in excitatory and inhibitory neurons of 
      the central nervous system, but not in other tissues or cell types. Using 
      fine-mapping and functional genomic data, we identify 120 genes (106 
      protein-coding) that are likely to underpin associations at some of these loci, 
      including 16 genes with credible causal non-synonymous or untranslated region 
      variation. We also implicate fundamental processes related to neuronal function, 
      including synaptic organization, differentiation and transmission. Fine-mapped 
      candidates were enriched for genes associated with rare disruptive coding 
      variants in people with schizophrenia, including the glutamate receptor subunit 
      GRIN2A and transcription factor SP4, and were also enriched for genes implicated 
      by such variants in neurodevelopmental disorders. We identify biological 
      processes relevant to schizophrenia pathophysiology; show convergence of common 
      and rare variant associations in schizophrenia and neurodevelopmental disorders; 
      and provide a resource of prioritized genes and variants to advance mechanistic 
      studies.
CI  - © 2022. The Author(s), under exclusive licence to Springer Nature Limited.
FAU - Trubetskoy, Vassily
AU  - Trubetskoy V
AD  - Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin, 
      Berlin, Germany.
FAU - Pardiñas, Antonio F
AU  - Pardiñas AF
AD  - MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological 
      Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
FAU - Qi, Ting
AU  - Qi T
AD  - Institute for Molecular Bioscience, University of Queensland, Brisbane, 
      Queensland, Australia.
AD  - School of Life Sciences, Westlake University, Hangzhou, China.
FAU - Panagiotaropoulou, Georgia
AU  - Panagiotaropoulou G
AD  - Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin, 
      Berlin, Germany.
FAU - Awasthi, Swapnil
AU  - Awasthi S
AD  - Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin, 
      Berlin, Germany.
FAU - Bigdeli, Tim B
AU  - Bigdeli TB
AD  - Department of Psychiatry and the Behavioral Sciences, SUNY Downstate Medical 
      Center, New York, NY, USA.
AD  - Institute for Genomic Health, SUNY Downstate Medical Center, New York, NY, USA.
AD  - Department of Psychiatry, Veterans Affairs New York Harbor Healthcare System, New 
      York, NY, USA.
FAU - Bryois, Julien
AU  - Bryois J
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
FAU - Chen, Chia-Yen
AU  - Chen CY
AD  - Biogen, Cambridge, MA, USA.
AD  - Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, 
      MA, USA.
AD  - Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, 
      Massachusetts General Hospital, Boston, MA, USA.
FAU - Dennison, Charlotte A
AU  - Dennison CA
AD  - MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological 
      Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
FAU - Hall, Lynsey S
AU  - Hall LS
AD  - MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological 
      Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
FAU - Lam, Max
AU  - Lam M
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
AD  - Research Division, Institute of Mental Health, Singapore, Republic of Singapore.
AD  - Division of Psychiatry Research, Zucker Hillside Hospital, Glen Oaks, NY, USA.
FAU - Watanabe, Kyoko
AU  - Watanabe K
AD  - Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive 
      Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, The 
      Netherlands.
FAU - Frei, Oleksandr
AU  - Frei O
AD  - NORMENT Centre, Division of Mental Health and Addiction, University of Oslo, 
      Oslo, Norway.
AD  - Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
AD  - Center for Bioinformatics, Department of Informatics, University of Oslo, Oslo, 
      Norway.
FAU - Ge, Tian
AU  - Ge T
AD  - Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, 
      Massachusetts General Hospital, Boston, MA, USA.
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
AD  - Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
FAU - Harwood, Janet C
AU  - Harwood JC
AD  - MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological 
      Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
FAU - Koopmans, Frank
AU  - Koopmans F
AD  - Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and 
      Cognitive Research, Faculty of Science, Amsterdam Neuroscience, Vrije 
      Universiteit, Amsterdam, The Netherlands.
FAU - Magnusson, Sigurdur
AU  - Magnusson S
AD  - deCODE Genetics, Amgen, Reykjavik, Iceland.
FAU - Richards, Alexander L
AU  - Richards AL
AD  - MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological 
      Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
FAU - Sidorenko, Julia
AU  - Sidorenko J
AD  - Institute for Molecular Bioscience, University of Queensland, Brisbane, 
      Queensland, Australia.
FAU - Wu, Yang
AU  - Wu Y
AD  - Institute for Molecular Bioscience, University of Queensland, Brisbane, 
      Queensland, Australia.
FAU - Zeng, Jian
AU  - Zeng J
AD  - Institute for Molecular Bioscience, University of Queensland, Brisbane, 
      Queensland, Australia.
FAU - Grove, Jakob
AU  - Grove J
AD  - The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), 
      Aarhus, Denmark.
AD  - Department of Biomedicine and Centre for Integrative Sequencing (iSEQ), Aarhus 
      University, Aarhus, Denmark.
AD  - Center for Genomics and Personalized Medicine, Aarhus, Denmark.
FAU - Kim, Minsoo
AU  - Kim M
AD  - Department of Psychiatry, Semel Institute, David Geffen School of Medicine, 
      University of California Los Angeles, Los Angeles, CA, USA.
FAU - Li, Zhiqiang
AU  - Li Z
AD  - Affiliated Hospital of Qingdao University and Biomedical Sciences Institute of 
      Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao University, 
      Qingdao, China.
AD  - Bio-X Institutes, Key Laboratory for the Genetics of Developmental and 
      Neuropsychiatric Disorders (Ministry of Education), Collaborative Innovation 
      Center for Brain Science, Shanghai Jiao Tong University, Shanghai, China.
FAU - Voloudakis, Georgios
AU  - Voloudakis G
AD  - Department of Psychiatry, Pamela Sklar Division of Psychiatric Genomics, Friedman 
      Brain Institute, Department of Genetics and Genomic Science and Institute for 
      Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New 
      York, NY, USA.
FAU - Zhang, Wen
AU  - Zhang W
AD  - Department of Psychiatry, Pamela Sklar Division of Psychiatric Genomics, Friedman 
      Brain Institute, Department of Genetics and Genomic Science and Institute for 
      Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New 
      York, NY, USA.
AD  - Department of Genetics and Genomic Sciences and Institute for Genomics and 
      Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
FAU - Adams, Mark
AU  - Adams M
AD  - Division of Psychiatry, Centre for Clinical Brain Sciences, University of 
      Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK.
FAU - Agartz, Ingrid
AU  - Agartz I
AD  - NORMENT Centre, Division of Mental Health and Addiction, University of Oslo, 
      Oslo, Norway.
AD  - Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.
AD  - Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska 
      Institutet and Stockholm Health Care Services, Stockholm Region, Stockholm, 
      Sweden.
FAU - Atkinson, Elizabeth G
AU  - Atkinson EG
AD  - Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, 
      MA, USA.
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
FAU - Agerbo, Esben
AU  - Agerbo E
AD  - The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), 
      Aarhus, Denmark.
AD  - National Centre for Register-based Research, Aarhus University, Aarhus, Denmark.
FAU - Al Eissa, Mariam
AU  - Al Eissa M
AD  - Molecular Psychiatry Laboratory, Division of Psychiatry, University College 
      London, London, UK.
FAU - Albus, Margot
AU  - Albus M
AD  - Comedicum Lindwurmhof, Munich, Germany.
FAU - Alexander, Madeline
AU  - Alexander M
AD  - Center for Depression, Anxiety and Stress Research, McLean Hospital, Belmont, MA, 
      USA.
FAU - Alizadeh, Behrooz Z
AU  - Alizadeh BZ
AD  - University Medical Center Groningen, University Center for Psychiatry, Rob Giel 
      Research Center, University of Groningen, Groningen, The Netherlands.
AD  - Department of Epidemiology, University Medical Center Groningen, University of 
      Groningen, Groningen, The Netherlands.
FAU - Alptekin, Köksal
AU  - Alptekin K
AD  - Department of Psychiatry, Dokuz Eylül University School of Medicine, Izmir, 
      Turkey.
AD  - Department of Neuroscience, Dokuz Eylül University Graduate School of Health 
      Sciences, Izmir, Turkey.
FAU - Als, Thomas D
AU  - Als TD
AD  - The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), 
      Aarhus, Denmark.
AD  - Department of Biomedicine and Centre for Integrative Sequencing (iSEQ), Aarhus 
      University, Aarhus, Denmark.
AD  - Center for Genomics and Personalized Medicine, Aarhus, Denmark.
FAU - Amin, Farooq
AU  - Amin F
AD  - Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA, 
      USA.
FAU - Arolt, Volker
AU  - Arolt V
AD  - Department of Psychiatry, University of Münster, Münster, Germany.
FAU - Arrojo, Manuel
AU  - Arrojo M
AD  - Servizo de Psiquiatría, Complexo Hospitalario Universitario de Santiago de 
      Compostela, Servizo Galego de Saúde (SERGAS), Santiago de Compostela, Spain.
FAU - Athanasiu, Lavinia
AU  - Athanasiu L
AD  - NORMENT Centre, Division of Mental Health and Addiction, University of Oslo, 
      Oslo, Norway.
AD  - Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
FAU - Azevedo, Maria Helena
AU  - Azevedo MH
AD  - Institute of Medical Psychology, Faculty of Medicine, University of Coimbra, 
      Coimbra, Portugal.
FAU - Bacanu, Silviu A
AU  - Bacanu SA
AD  - Virginia Institute for Psychiatric and Behavioral Genetics, Department of 
      Psychiatry, Virginia Commonwealth University, Richmond, VA, USA.
FAU - Bass, Nicholas J
AU  - Bass NJ
AD  - Molecular Psychiatry Laboratory, Division of Psychiatry, University College 
      London, London, UK.
FAU - Begemann, Martin
AU  - Begemann M
AD  - Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Göttingen, 
      Germany.
FAU - Belliveau, Richard A
AU  - Belliveau RA
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
FAU - Bene, Judit
AU  - Bene J
AD  - Department of Medical Genetics, Medical School, University of Pécs, Pécs, 
      Hungary.
FAU - Benyamin, Beben
AU  - Benyamin B
AD  - Australian Centre for Precision Health, University of South Australia Cancer 
      Research Institute, University of South Australia, Adelaide, South Australia, 
      Australia.
AD  - UniSA Allied Health and Human Performance, University of South Australia, 
      Adelaide, South Australia, Australia.
AD  - South Australian Health and Medical Research Institute, Adelaide, South 
      Australia, Australia.
FAU - Bergen, Sarah E
AU  - Bergen SE
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
FAU - Blasi, Giuseppe
AU  - Blasi G
AD  - Department of Basic Medical Science, Neuroscience and Sense Organs, University of 
      Bari 'Aldo Moro', Bari, Italy.
FAU - Bobes, Julio
AU  - Bobes J
AD  - Área de Psiquiatría-Universidad de Oviedo, Hospital Universitario Central de 
      Asturias (HUCA), Asturias, Spain.
AD  - Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, 
      Asturias, Spain.
AD  - Centro de Investigación Biomédica en Red de Salud Mental, Oviedo, Asturias, 
      Spain.
FAU - Bonassi, Stefano
AU  - Bonassi S
AD  - Unit of Clinical and Molecular Epidemiology, IRCCS San Raffaele Roma and San 
      Raffaele University, Rome, Italy.
FAU - Braun, Alice
AU  - Braun A
AD  - Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin, 
      Berlin, Germany.
FAU - Bressan, Rodrigo Affonseca
AU  - Bressan RA
AD  - Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil.
AD  - Laboratory of Integrative Neuroscience, Universidade Federal de São Paulo, São 
      Paulo, Brazil.
FAU - Bromet, Evelyn J
AU  - Bromet EJ
AD  - Department of Psychiatry and Behavioural Health, Stony Brook University, Stony 
      Brook, NY, USA.
FAU - Bruggeman, Richard
AU  - Bruggeman R
AD  - University Medical Center Groningen, University Center for Psychiatry, Rob Giel 
      Research Center, University of Groningen, Groningen, The Netherlands.
AD  - Department of Clinical and Developmental Neuropsychology, University of 
      Groningen, Groningen, The Netherlands.
FAU - Buckley, Peter F
AU  - Buckley PF
AD  - Health Science Center, University of Tennessee, Memphis, TN, USA.
FAU - Buckner, Randy L
AU  - Buckner RL
AD  - Department of Psychology, Harvard University, Cambridge, MA, USA.
FAU - Bybjerg-Grauholm, Jonas
AU  - Bybjerg-Grauholm J
AD  - The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), 
      Aarhus, Denmark.
AD  - Center for Neonatal Screening, Department for Congenital Disorders, Statens Serum 
      Institut, Copenhagen, Denmark.
FAU - Cahn, Wiepke
AU  - Cahn W
AD  - University Medical Center Utrecht, Department of Psychiatry, Rudolf Magnus 
      Institute of Neuroscience, Utrecht, The Netherlands.
AD  - Altrecht, General Menthal Health Care, Utrecht, The Netherlands.
FAU - Cairns, Murray J
AU  - Cairns MJ
AD  - School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, 
      New South Wales, Australia.
AD  - Hunter Medical Research Institute, Newcastle, New South Wales, Australia.
AD  - Centre for Brain and Mental Health Research, University of Newcastle, Newcastle, 
      New South Wales, Australia.
FAU - Calkins, Monica E
AU  - Calkins ME
AD  - Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
FAU - Carr, Vaughan J
AU  - Carr VJ
AD  - School of Psychiatry, University of New South Wales, Sydney, New South Wales, 
      Australia.
AD  - Department of Psychiatry, Monash University, Melbourne, Victoria, Australia.
AD  - Neuroscience Research Australia, Sydney, New South Wales, Australia.
FAU - Castle, David
AU  - Castle D
AD  - Department of Psychiatry, University of Melbourne, Parkville, Victoria, 
      Australia.
AD  - St Vincent's Hospital, Melbourne, Victoria, Australia.
FAU - Catts, Stanley V
AU  - Catts SV
AD  - Brain and Mind Centre, The University of Sydney, Sydney, New South Wales, 
      Australia.
AD  - School of Medicine, University of Queensland, Herston, Queensland, Australia.
FAU - Chambert, Kimberley D
AU  - Chambert KD
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
FAU - Chan, Raymond C K
AU  - Chan RCK
AD  - Institute of Psychology, Chinese Academy of Science, Beijing, China.
AD  - Department of Psychology, University of Chinese Academy of Sciences, Beijing, 
      China.
FAU - Chaumette, Boris
AU  - Chaumette B
AD  - INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, Université de 
      Paris, GHU Paris Psychiatrie & Neurosciences, Paris, France.
AD  - Department of Psychiatry, McGill University, Montreal, Québec, Canada.
FAU - Cheng, Wei
AU  - Cheng W
AD  - Department of Computer Science, University of North Carolina, Chapel Hill, NC, 
      USA.
FAU - Cheung, Eric F C
AU  - Cheung EFC
AD  - Castle Peak Hospital, Hong Kong, China.
FAU - Chong, Siow Ann
AU  - Chong SA
AD  - Research Division, Institute of Mental Health, Singapore, Republic of Singapore.
AD  - Saw Swee Hock School of Public Health, National University of Singapore, 
      Singapore, Republic of Singapore.
FAU - Cohen, David
AU  - Cohen D
AD  - Faculté de Médecine Sorbonne Université, Groupe de Recherche Clinique no. 15 - 
      Troubles Psychiatriques et Développement (PSYDEV), Department of Child and 
      Adolescent Psychiatry, Hôpital Universitaire de la Pitié-Salpêtrière, Paris, 
      France.
AD  - Centre de Référence des Maladies Rares à Expression Psychiatrique, Department of 
      Child and Adolescent Psychiatry, AP-HP Sorbonne Université, Hôpital Universitaire 
      de la Pitié-Salpêtrière, Paris, France.
AD  - Institut des Systèmes Intelligents et de Robotique (ISIR), CNRS UMR7222, Faculté 
      des Sciences et Ingénierie, Sorbonne Université, Paris, France.
FAU - Consoli, Angèle
AU  - Consoli A
AD  - Faculté de Médecine Sorbonne Université, Groupe de Recherche Clinique no. 15 - 
      Troubles Psychiatriques et Développement (PSYDEV), Department of Child and 
      Adolescent Psychiatry, Hôpital Universitaire de la Pitié-Salpêtrière, Paris, 
      France.
AD  - Centre de Référence des Maladies Rares à Expression Psychiatrique, Department of 
      Child and Adolescent Psychiatry, AP-HP Sorbonne Université, Hôpital Universitaire 
      de la Pitié-Salpêtrière, Paris, France.
FAU - Cordeiro, Quirino
AU  - Cordeiro Q
AD  - Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo, 
      São Paulo, Brazil.
FAU - Costas, Javier
AU  - Costas J
AD  - Instituto de Investigación Sanitaria (IDIS) de Santiago de Compostela, Complexo 
      Hospitalario Universitario de Santiago de Compostela (CHUS), Servizo Galego de 
      Saúde (SERGAS), Santiago de Compostela, Spain.
FAU - Curtis, Charles
AU  - Curtis C
AD  - Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, 
      Psychology and Neuroscience, King's College London, London, UK.
AD  - National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre 
      at South London and Maudsley NHS Foundation Trust and King's College London, 
      London, UK.
FAU - Davidson, Michael
AU  - Davidson M
AD  - University of Nicosia Medical School, Nicosia, Cyprus.
FAU - Davis, Kenneth L
AU  - Davis KL
AD  - Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, 
      USA.
FAU - de Haan, Lieuwe
AU  - de Haan L
AD  - Department of Psychiatry, Academic Medical Centre, University of Amsterdam, 
      Amsterdam, The Netherlands.
AD  - Arkin, Institute for Mental Health, Amsterdam, The Netherlands.
FAU - Degenhardt, Franziska
AU  - Degenhardt F
AD  - Institute of Human Genetics, University of Bonn, Bonn, Germany.
FAU - DeLisi, Lynn E
AU  - DeLisi LE
AD  - Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
AD  - Cambridge Health Alliance, Cambridge, MA, USA.
FAU - Demontis, Ditte
AU  - Demontis D
AD  - The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), 
      Aarhus, Denmark.
AD  - Department of Biomedicine and Centre for Integrative Sequencing (iSEQ), Aarhus 
      University, Aarhus, Denmark.
AD  - Center for Genomics and Personalized Medicine, Aarhus, Denmark.
FAU - Dickerson, Faith
AU  - Dickerson F
AD  - Sheppard Pratt Health System, Baltimore, MD, USA.
FAU - Dikeos, Dimitris
AU  - Dikeos D
AD  - First Department of Psychiatry, Medical School, National and Kapodistrian 
      University of Athens, Eginition Hospital, Athens, Greece.
FAU - Dinan, Timothy
AU  - Dinan T
AD  - Department of Psychiatry and Neurobehavioural Sciences, University College Cork, 
      Cork, Ireland.
AD  - APC Microbiome Ireland, University College Cork, Cork, Ireland.
FAU - Djurovic, Srdjan
AU  - Djurovic S
AD  - NORMENT Centre, Department of Clinical Science, University of Bergen, Bergen, 
      Norway.
AD  - Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
FAU - Duan, Jubao
AU  - Duan J
AD  - Center for Psychiatric Genetics, NorthShore University HealthSystem, Evanston, 
      IL, USA.
AD  - Department of Psychiatry and Behavioral Neurosciences, The University of Chicago, 
      Chicago, IL, USA.
FAU - Ducci, Giuseppe
AU  - Ducci G
AD  - Department of Mental Health, ASL Rome 1, Rome, Italy.
FAU - Dudbridge, Frank
AU  - Dudbridge F
AD  - Department of Health Sciences, University of Leicester, Leicester, UK.
FAU - Eriksson, Johan G
AU  - Eriksson JG
AD  - Department of General Practice and Primary Health Care, University of Helsinki 
      and Helsinki University Hospital, Helsinki, Finland.
AD  - Folkhälsan Research Center, Helsinki, Finland.
AD  - Department of Obstetrics and Gynecology, Yong Loo Lin School of Medicine, 
      National University of Singapore, Singapore, Republic of Singapore.
FAU - Fañanás, Lourdes
AU  - Fañanás L
AD  - Department of Evolutionary Biology, Ecology and Environmental Sciences, Faculty 
      of Biology, University of Barcelona, Barcelona, Spain.
AD  - Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Madrid, 
      Spain.
FAU - Faraone, Stephen V
AU  - Faraone SV
AD  - Departments of Psychiatry and Neuroscience and Physiology, SUNY Upstate Medical 
      University, Syracuse, NY, USA.
FAU - Fiorentino, Alessia
AU  - Fiorentino A
AD  - Molecular Psychiatry Laboratory, Division of Psychiatry, University College 
      London, London, UK.
FAU - Forstner, Andreas
AU  - Forstner A
AD  - Institute of Human Genetics, University of Bonn, Bonn, Germany.
AD  - Centre for Human Genetics, University of Marburg, Marburg, Germany.
FAU - Frank, Josef
AU  - Frank J
AD  - Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental 
      Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
FAU - Freimer, Nelson B
AU  - Freimer NB
AD  - Department of Human Genetics, David Geffen School of Medicine, University of 
      California Los Angeles, Los Angeles, CA, USA.
AD  - Department of Psychiatry and Biobehavioral Sciences, University of California Los 
      Angeles, Los Angeles, CA, USA.
FAU - Fromer, Menachem
AU  - Fromer M
AD  - Division of Psychiatric Genomics, Department of Psychiatry, Icahn School of 
      Medicine at Mount Sinai, New York, NY, USA.
FAU - Frustaci, Alessandra
AU  - Frustaci A
AD  - Barnet, Enfield and Haringey Mental Health NHS Trust, St Ann's Hospital, London, 
      UK.
FAU - Gadelha, Ary
AU  - Gadelha A
AD  - Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil.
AD  - Laboratory of Integrative Neuroscience, Universidade Federal de São Paulo, São 
      Paulo, Brazil.
FAU - Genovese, Giulio
AU  - Genovese G
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
FAU - Gershon, Elliot S
AU  - Gershon ES
AD  - Departments of Psychiatry and Human Genetics, University of Chicago, Chicago, IL, 
      USA.
FAU - Giannitelli, Marianna
AU  - Giannitelli M
AD  - Faculté de Médecine Sorbonne Université, Groupe de Recherche Clinique no. 15 - 
      Troubles Psychiatriques et Développement (PSYDEV), Department of Child and 
      Adolescent Psychiatry, Hôpital Universitaire de la Pitié-Salpêtrière, Paris, 
      France.
AD  - Centre de Référence des Maladies Rares à Expression Psychiatrique, Department of 
      Child and Adolescent Psychiatry, AP-HP Sorbonne Université, Hôpital Universitaire 
      de la Pitié-Salpêtrière, Paris, France.
FAU - Giegling, Ina
AU  - Giegling I
AD  - Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, 
      Austria.
FAU - Giusti-Rodríguez, Paola
AU  - Giusti-Rodríguez P
AD  - Department of Genetics, University of North Carolina, Chapel Hill, NC, USA.
FAU - Godard, Stephanie
AU  - Godard S
AD  - Departments of Psychiatry and Human and Molecular Genetics, INSERM, Institut de 
      Myologie, Hôpital de la Pitiè-Salpêtrière, Paris, France.
FAU - Goldstein, Jacqueline I
AU  - Goldstein JI
AD  - Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, 
      MA, USA.
FAU - González Peñas, Javier
AU  - González Peñas J
AD  - Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Madrid, 
      Spain.
AD  - Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental 
      Health, General Universitario Gregorio Marañón, School of Medicine, Universidad 
      Complutense, IiSGM, Madrid, Spain.
FAU - González-Pinto, Ana
AU  - González-Pinto A
AD  - Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Madrid, 
      Spain.
AD  - BIOARABA Health Research Institute, OSI Araba, University Hospital, University of 
      the Basque Country, Vitoria, Spain.
FAU - Gopal, Srihari
AU  - Gopal S
AD  - Neuroscience Therapeutic Area, Janssen Research and Development, Titusville, NJ, 
      USA.
FAU - Gratten, Jacob
AU  - Gratten J
AD  - Institute for Molecular Bioscience, University of Queensland, Brisbane, 
      Queensland, Australia.
AD  - Mater Research Institute, University of Queensland, Brisbane, Queensland, 
      Australia.
FAU - Green, Michael F
AU  - Green MF
AD  - Department of Psychiatry and Biobehavioral Sciences, Geffen School of Medicine, 
      University of California Los Angeles, Los Angeles, CA, USA.
AD  - VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
FAU - Greenwood, Tiffany A
AU  - Greenwood TA
AD  - Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.
FAU - Guillin, Olivier
AU  - Guillin O
AD  - INSERM, Rouen, France.
AD  - Centre Hospitalier du Rouvray, Rouen, France.
AD  - UFR Santé, Université de Rouen Normandie, Rouen, France.
FAU - Gülöksüz, Sinan
AU  - Gülöksüz S
AD  - Department of Psychiatry and Neuropsychology, School for Mental Health and 
      Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.
AD  - Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
FAU - Gur, Raquel E
AU  - Gur RE
AD  - Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
FAU - Gur, Ruben C
AU  - Gur RC
AD  - Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
FAU - Gutiérrez, Blanca
AU  - Gutiérrez B
AD  - Department of Psychiatry, Faculty of Medicine and Biomedical Research Centre 
      (CIBM), University of Granada, Granada, Spain.
FAU - Hahn, Eric
AU  - Hahn E
AD  - Department of Psychiatry, Charité - Universitätsmedizin, Berlin, Germany.
FAU - Hakonarson, Hakon
AU  - Hakonarson H
AD  - Children's Hospital of Philadelphia, Leonard Madlyn Abramson Research Center, 
      Philadelphia, PA, USA.
FAU - Haroutunian, Vahram
AU  - Haroutunian V
AD  - Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, 
      USA.
AD  - Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, 
      NY, USA.
AD  - Mental Illness Research Clinical and Education Center (MIRECC), JJ Peters VA 
      Medical Center, New York, NY, USA.
FAU - Hartmann, Annette M
AU  - Hartmann AM
AD  - Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, 
      Austria.
FAU - Harvey, Carol
AU  - Harvey C
AD  - Department of Psychiatry, University of Melbourne, Parkville, Victoria, 
      Australia.
AD  - NorthWestern Mental Health, Melbourne, Victoria, Australia.
FAU - Hayward, Caroline
AU  - Hayward C
AD  - MRC Human Genetics Unit, University of Edinburgh, Institute of Genetics and 
      Cancer, Western General Hospital, Edinburgh, UK.
FAU - Henskens, Frans A
AU  - Henskens FA
AD  - School of Medicine and Public Health, University of Newcastle, Newcastle, New 
      South Wales, Australia.
FAU - Herms, Stefan
AU  - Herms S
AD  - Division of Medical Genetics, Department of Biomedicine, University of Basel, 
      Basel, Switzerland.
FAU - Hoffmann, Per
AU  - Hoffmann P
AD  - Division of Medical Genetics, Department of Biomedicine, University of Basel, 
      Basel, Switzerland.
FAU - Howrigan, Daniel P
AU  - Howrigan DP
AD  - Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, 
      MA, USA.
AD  - Broad Institute of MIT and Harvard, Cambridge, MA, USA.
FAU - Ikeda, Masashi
AU  - Ikeda M
AD  - Department of Psychiatry, Fujita Health University School of Medicine, Toyoake 
      Aichi, Japan.
FAU - Iyegbe, Conrad
AU  - Iyegbe C
AD  - Department of Psychosis Studies, Institute of Psychiatry, Psychology and 
      Neuroscience, King's College London, London, UK.
FAU - Joa, Inge
AU  - Joa I
AD  - Regional Centre for Clinical Research in Psychosis, Department of Psychiatry, 
      Stavanger University Hospital, Stavanger, Norway.
FAU - Julià, Antonio
AU  - Julià A
AD  - Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.
FAU - Kähler, Anna K
AU  - Kähler AK
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
FAU - Kam-Thong, Tony
AU  - Kam-Thong T
AD  - Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche 
      Innovation Center Basel, F. Hoffman-La Roche, Basel, Switzerland.
FAU - Kamatani, Yoichiro
AU  - Kamatani Y
AD  - Laboratory of Complex Trait Genomics, Department of Computational Biology and 
      Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, 
      Tokyo, Japan.
AD  - Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical 
      Sciences, Yokohama, Japan.
FAU - Karachanak-Yankova, Sena
AU  - Karachanak-Yankova S
AD  - Department of Medical Genetics, Medical University, Sofia, Bulgaria.
AD  - Department of Genetics, Faculty of Biology, Sofia University "St. Kliment 
      Ohridski", Sofia, Bulgaria.
FAU - Kebir, Oussama
AU  - Kebir O
AD  - INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, Université de 
      Paris, GHU Paris Psychiatrie & Neurosciences, Paris, France.
FAU - Keller, Matthew C
AU  - Keller MC
AD  - Institute for Behavioural Genetics, University of Colorado Boulder, Boulder, CO, 
      USA.
FAU - Kelly, Brian J
AU  - Kelly BJ
AD  - School of Medicine and Public Health, University of Newcastle, Newcastle, New 
      South Wales, Australia.
FAU - Khrunin, Andrey
AU  - Khrunin A
AD  - Institute of Molecular Genetics of National Research Centre "Kurchatov 
      Institute", Moscow, Russia.
FAU - Kim, Sung-Wan
AU  - Kim SW
AD  - Department of Psychiatry, Chonnam National University Medical School, Gwangju, 
      Korea.
FAU - Klovins, Janis
AU  - Klovins J
AD  - Latvian Biomedical Research and Study Centre, Riga, Latvia.
FAU - Kondratiev, Nikolay
AU  - Kondratiev N
AD  - Mental Health Research Center, Moscow, Russian Federation.
FAU - Konte, Bettina
AU  - Konte B
AD  - Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, 
      Austria.
FAU - Kraft, Julia
AU  - Kraft J
AD  - Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin, 
      Berlin, Germany.
AD  - Berlin School of Mind and Brain, Humboldt-Universität zu Berlin, Berlin, Germany.
FAU - Kubo, Michiaki
AU  - Kubo M
AD  - RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
FAU - Kučinskas, Vaidutis
AU  - Kučinskas V
AD  - Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
FAU - Kučinskiene, Zita Ausrele
AU  - Kučinskiene ZA
AD  - Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
FAU - Kusumawardhani, Agung
AU  - Kusumawardhani A
AD  - Psychiatry Department, University of Indonesia - Cipto Mangunkusumo National 
      General Hospital, Jakarta, Indonesia.
FAU - Kuzelova-Ptackova, Hana
AU  - Kuzelova-Ptackova H
AD  - Department of Psychiatry, 1st Faculty of Medicine and General University 
      Hospital, Prague, Czech Republic.
FAU - Landi, Stefano
AU  - Landi S
AD  - Dipartimento di Biologia, Universita' di Pisa, Pisa, Italy.
FAU - Lazzeroni, Laura C
AU  - Lazzeroni LC
AD  - Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, 
      CA, USA.
AD  - Department of Biomedical Data Science, Stanford University, Stanford, CA, USA.
FAU - Lee, Phil H
AU  - Lee PH
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
AD  - Psychiatric and Neurodevelopmental Genetics Unit, Department of Psychiatry and 
      Center for Genomic Medicine, Massachusetts General Hospital, Harvard Medical 
      School, Boston, MA, USA.
FAU - Legge, Sophie E
AU  - Legge SE
AD  - MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological 
      Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
FAU - Lehrer, Douglas S
AU  - Lehrer DS
AD  - Department of Psychiatry, Wright State University, Dayton, OH, USA.
FAU - Lencer, Rebecca
AU  - Lencer R
AD  - Department of Psychiatry, University of Münster, Münster, Germany.
FAU - Lerer, Bernard
AU  - Lerer B
AD  - Department of Psychiatry, Hadassah-Hebrew University Medical Center, Jerusalem, 
      Israel.
FAU - Li, Miaoxin
AU  - Li M
AD  - Zhongshan School of Medicine and Key Laboratory of Tropical Diseases Control 
      (SYSU), Sun Yat-sen University, Guangzhou, China.
FAU - Lieberman, Jeffrey
AU  - Lieberman J
AD  - Department of Psychiatry, Columbia University, New York, NY, USA.
FAU - Light, Gregory A
AU  - Light GA
AD  - Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.
AD  - VISN 22, Mental Illness Research, Education and Clinical Center (MIRECC), VA San 
      Diego Healthcare System, San Diego, CA, USA.
FAU - Limborska, Svetlana
AU  - Limborska S
AD  - Institute of Molecular Genetics of National Research Centre "Kurchatov 
      Institute", Moscow, Russia.
FAU - Liu, Chih-Min
AU  - Liu CM
AD  - Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan.
AD  - Neurobiology and Cognitive Science Center, National Taiwan University, Taipei, 
      Taiwan.
FAU - Lönnqvist, Jouko
AU  - Lönnqvist J
AD  - Mental Health Unit, Department of Public Health Solutions, National Institute for 
      Health and Welfare, Helsinki, Finland.
AD  - Department of Psychiatry, University of Helsinki, Helsinki, Finland.
FAU - Loughland, Carmel M
AU  - Loughland CM
AD  - Hunter New England Health and University of Newcastle, Newcastle, New South 
      Wales, Australia.
FAU - Lubinski, Jan
AU  - Lubinski J
AD  - Department of Genetics and Pathology, International Hereditary Cancer Center, 
      Pomeranian Medical University in Szczecin, Szczecin, Poland.
FAU - Luykx, Jurjen J
AU  - Luykx JJ
AD  - Department of Psychiatry and Neuropsychology, School for Mental Health and 
      Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.
AD  - Department of Psychiatry, UMC Utrecht Brain Center, University Medical Centre 
      Utrecht, Utrecht University, Utrecht, The Netherlands.
AD  - Department of Translational Neuroscience, UMC Utrecht Brain Center, University 
      Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
AD  - Second Opinion Outpatient Clinic, GGNet Mental Health, Warnsveld, The 
      Netherlands.
FAU - Lynham, Amy
AU  - Lynham A
AD  - MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological 
      Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
FAU - Macek, Milan Jr
AU  - Macek M Jr
AD  - Department of Biology and Medical Genetics, 2nd Faculty of Medicine and 
      University Hospital Motol, Prague, Czech Republic.
FAU - Mackinnon, Andrew
AU  - Mackinnon A
AD  - Black Dog Institute, University of New South Wales, Randwick, New South Wales, 
      Australia.
AD  - Melbourne School of Population and Global Health, University of Melbourne, 
      Melbourne, Victoria, Australia.
FAU - Magnusson, Patrik K E
AU  - Magnusson PKE
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
FAU - Maher, Brion S
AU  - Maher BS
AD  - Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins 
      University, Baltimore, MD, USA.
FAU - Maier, Wolfgang
AU  - Maier W
AD  - Department for Neurodegenerative Diseases and Geriatric Psychiatry, University 
      Hospital Bonn, Bonn, Germany.
FAU - Malaspina, Dolores
AU  - Malaspina D
AD  - Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, 
      USA.
AD  - Department of Genetics and Genomics, Icahn School of Medicine at Mount Sinai, New 
      York, NY, USA.
FAU - Mallet, Jacques
AU  - Mallet J
AD  - Asfalia Biologics, iPEPS-ICM, Hôpital Universitaire de la Pitié-Salpêtrière, 
      Paris, France.
FAU - Marder, Stephen R
AU  - Marder SR
AD  - Semel Institute for Neurosciene, University of California Los Angeles, Los 
      Angeles, CA, USA.
FAU - Marsal, Sara
AU  - Marsal S
AD  - Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.
FAU - Martin, Alicia R
AU  - Martin AR
AD  - Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, 
      MA, USA.
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
AD  - Department of Medicine, Harvard Medical School, Boston, MA, USA.
FAU - Martorell, Lourdes
AU  - Martorell L
AD  - Hospital Universitari Institut Pere Mata, IISPV, Universitat Rovira i Virgili, 
      CIBERSAM, Reus, Spain.
FAU - Mattheisen, Manuel
AU  - Mattheisen M
AD  - Department of Biomedicine and Centre for Integrative Sequencing (iSEQ), Aarhus 
      University, Aarhus, Denmark.
AD  - Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
AD  - Department of Community Health and Epidemiology, Dalhousie University, Halifax, 
      Nova Scotia, Canada.
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, Germany.
FAU - McCarley, Robert W
AU  - McCarley RW
AD  - VA Boston Health Care System, Brockton, MA, USA.
FAU - McDonald, Colm
AU  - McDonald C
AD  - Centre for Neuroimaging, Cognition and Genomics (NICOG), National University of 
      Ireland Galway, Galway, Ireland.
FAU - McGrath, John J
AU  - McGrath JJ
AD  - National Centre for Register-based Research, Aarhus University, Aarhus, Denmark.
AD  - Queensland Brain Institute, University of Queensland, Brisbane, Queensland, 
      Australia.
AD  - Queensland Centre for Mental Health Research, The Park Centre for Mental Health, 
      Brisbane, Queensland, Australia.
FAU - Medeiros, Helena
AU  - Medeiros H
AD  - Department of Psychiatry and the Behavioral Sciences, Keck School of Medicine, 
      University of Southern California, Los Angeles, CA, USA.
AD  - College of Medicine, SUNY Downstate Health Sciences University, New York, NY, 
      USA.
FAU - Meier, Sandra
AU  - Meier S
AD  - Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
AD  - Department of Biomedicine, Aarhus University, Aarhus, Denmark.
FAU - Melegh, Bela
AU  - Melegh B
AD  - Department of Medical Genetics, University of Pécs, School of Medicine, Pécs, 
      Hungary.
FAU - Melle, Ingrid
AU  - Melle I
AD  - NORMENT Centre, Division of Mental Health and Addiction, University of Oslo, 
      Oslo, Norway.
AD  - Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
FAU - Mesholam-Gately, Raquelle I
AU  - Mesholam-Gately RI
AD  - Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
AD  - Massachusetts Mental Health Center Public Psychiatry Division of the Beth Israel 
      Deaconess Medical Center, Boston, MA, USA.
FAU - Metspalu, Andres
AU  - Metspalu A
AD  - Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, 
      Estonia.
FAU - Michie, Patricia T
AU  - Michie PT
AD  - School of Psychology, University of Newcastle, Newcastle, New South Wales, 
      Australia.
FAU - Milani, Lili
AU  - Milani L
AD  - Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, 
      Estonia.
FAU - Milanova, Vihra
AU  - Milanova V
AD  - Psychiatric Clinic, Alexandrovska University Hospital, Sofia, Bulgaria.
FAU - Mitjans, Marina
AU  - Mitjans M
AD  - Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Göttingen, 
      Germany.
FAU - Molden, Espen
AU  - Molden E
AD  - Department of Pharmacy, University of Oslo, Oslo, Norway.
AD  - Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway.
FAU - Molina, Esther
AU  - Molina E
AD  - Department of Nursing, Faculty of Health Sciences and Biomedical Research Centre 
      (CIBM), University of Granada, Granada, Spain.
FAU - Molto, María Dolores
AU  - Molto MD
AD  - Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Madrid, 
      Spain.
AD  - Department of Genetics, Faculty of Biological Sciences, Universidad de Valencia, 
      Valencia, Spain.
AD  - Biomedical Research Institute INCLIVA, Valencia, Spain.
FAU - Mondelli, Valeria
AU  - Mondelli V
AD  - National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre 
      at South London and Maudsley NHS Foundation Trust and King's College London, 
      London, UK.
AD  - Department of Psychological Medicine, Institute of Psychiatry, Psychology, and 
      Neuroscience, King's College London, London, UK.
FAU - Moreno, Carmen
AU  - Moreno C
AD  - Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Madrid, 
      Spain.
AD  - Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental 
      Health, General Universitario Gregorio Marañón, School of Medicine, Universidad 
      Complutense, IiSGM, Madrid, Spain.
FAU - Morley, Christopher P
AU  - Morley CP
AD  - Departments of Public Health and Preventive Medicine, Family Medicine, and 
      Psychiatry and Behavioral Sciences, State University of New York, Upstate Medical 
      University, Syracuse, NY, USA.
FAU - Muntané, Gerard
AU  - Muntané G
AD  - Hospital Universitari Institut Pere Mata, IISPV, Universitat Rovira i Virgili, 
      CIBERSAM, Reus, Spain.
AD  - Institut de Biologia Evolutiva (UPF-CSIC), Departament de Ciències Experimentals 
      i de la Salut, Universitat Pompeu Fabra, PRBB, Barcelona, Spain.
FAU - Murphy, Kieran C
AU  - Murphy KC
AD  - Department of Psychiatry, Royal College of Surgeons in Ireland, Dublin, Ireland.
FAU - Myin-Germeys, Inez
AU  - Myin-Germeys I
AD  - Department for Neurosciences, Center for Contextual Psychiatry, KU Leuven, 
      Leuven, Belgium.
FAU - Nenadić, Igor
AU  - Nenadić I
AD  - Cognitive Neuropsychiatry Laboratory, Department of Psychiatry and Psychotherapy, 
      Philipps Universität Marburg, Marburg, Germany.
AD  - Department of Psychiatry and Psychotherapy, Jena University Hospital, Jena, 
      Germany.
FAU - Nestadt, Gerald
AU  - Nestadt G
AD  - Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School 
      of Medicine, Baltimore, MD, USA.
FAU - Nikitina-Zake, Liene
AU  - Nikitina-Zake L
AD  - Latvian Biomedical Research and Study Centre, Riga, Latvia.
FAU - Noto, Cristiano
AU  - Noto C
AD  - Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil.
AD  - Laboratory of Integrative Neuroscience, Universidade Federal de São Paulo, São 
      Paulo, Brazil.
FAU - Nuechterlein, Keith H
AU  - Nuechterlein KH
AD  - Department of Psychiatry and Biobehavioral Sciences, Geffen School of Medicine, 
      University of California Los Angeles, Los Angeles, CA, USA.
FAU - O'Brien, Niamh Louise
AU  - O'Brien NL
AD  - Molecular Psychiatry Laboratory, Division of Psychiatry, University College 
      London, London, UK.
FAU - O'Neill, F Anthony
AU  - O'Neill FA
AD  - Centre for Public Health, Institute of Clinical Sciences, Queen's University 
      Belfast, Belfast, UK.
FAU - Oh, Sang-Yun
AU  - Oh SY
AD  - Department of Statistics and Applied Probability, University of California at 
      Santa Barbara, Santa Barbara, CA, USA.
AD  - Computational Research Division, Lawrence Berkeley National Laboratory, Berkeley, 
      CA, USA.
FAU - Olincy, Ann
AU  - Olincy A
AD  - Department of Psychiatry, University of Colorado Denver, Aurora, CO, USA.
FAU - Ota, Vanessa Kiyomi
AU  - Ota VK
AD  - Laboratory of Integrative Neuroscience, Universidade Federal de São Paulo, São 
      Paulo, Brazil.
AD  - Department of Morphology and Genetics, Laboratorio de Genetica, Universidade 
      Federal de São Paulo, São Paulo, Brazil.
FAU - Pantelis, Christos
AU  - Pantelis C
AD  - NorthWestern Mental Health, Melbourne, Victoria, Australia.
AD  - Melbourne Neuropsychiatry Centre, University of Melbourne and Melbourne Health, 
      Melbourne, Victoria, Australia.
AD  - The Florey Institute of Neuroscience and Mental Health, University of Melbourne, 
      Parkville, Victoria, Australia.
AD  - Department of Psychiatry, Melbourne Medical School, University of Melbourne, 
      Parkville, Victoria, Australia.
FAU - Papadimitriou, George N
AU  - Papadimitriou GN
AD  - First Department of Psychiatry, Medical School, National and Kapodistrian 
      University of Athens, Eginition Hospital, Athens, Greece.
FAU - Parellada, Mara
AU  - Parellada M
AD  - Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Madrid, 
      Spain.
AD  - Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental 
      Health, General Universitario Gregorio Marañón, School of Medicine, Universidad 
      Complutense, IiSGM, Madrid, Spain.
FAU - Paunio, Tiina
AU  - Paunio T
AD  - Department of Public Health Solutions, Genomics and Biomarkers Unit, National 
      Institute for Health and Welfare, Helsinki, Finland.
AD  - Department of Psychiatry and SleepWell Research Program, Faculty of Medicine, 
      University of Helsinki and Helsinki University Central Hospital, Helsinki, 
      Finland.
FAU - Pellegrino, Renata
AU  - Pellegrino R
AD  - Children's Hospital of Philadelphia, Leonard Madlyn Abramson Research Center, 
      Philadelphia, PA, USA.
FAU - Periyasamy, Sathish
AU  - Periyasamy S
AD  - Queensland Brain Institute, University of Queensland, Brisbane, Queensland, 
      Australia.
AD  - Queensland Centre for Mental Health Research, University of Queensland, Brisbane, 
      Queensland, Australia.
FAU - Perkins, Diana O
AU  - Perkins DO
AD  - Department of Psychiatry, University of North Carolina, Chapel Hill, NC, USA.
FAU - Pfuhlmann, Bruno
AU  - Pfuhlmann B
AD  - Clinic of Psychiatry and Psychotherapy, Weißer Hirsch, Dresden, Germany.
FAU - Pietiläinen, Olli
AU  - Pietiläinen O
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      MA, USA.
AD  - Institute for Molecular Medicine Finland (FIMM), University of Helsinki, 
      Helsinki, Finland.
FAU - Pimm, Jonathan
AU  - Pimm J
AD  - Molecular Psychiatry Laboratory, Division of Psychiatry, University College 
      London, London, UK.
FAU - Porteous, David
AU  - Porteous D
AD  - Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular 
      Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK.
FAU - Powell, John
AU  - Powell J
AD  - Department of Basic and Clinical Neuroscience, Institute of Psychiatry, 
      Psychology and Neuroscience, King's College London, London, UK.
FAU - Quattrone, Diego
AU  - Quattrone D
AD  - Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, 
      Psychology and Neuroscience, King's College London, London, UK.
AD  - National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre 
      at South London and Maudsley NHS Foundation Trust and King's College London, 
      London, UK.
AD  - South London and Maudsley NHS Mental Health Foundation Trust, London, UK.
FAU - Quested, Digby
AU  - Quested D
AD  - Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, UK.
AD  - Department of Psychiatry, University of Oxford, Oxford, UK.
FAU - Radant, Allen D
AU  - Radant AD
AD  - Department of Psychiatry and Behavioral Sciences, University of Washington, 
      Seattle, WA, USA.
AD  - VA Puget Sound Health Care System, Seattle, WA, USA.
FAU - Rampino, Antonio
AU  - Rampino A
AD  - Department of Basic Medical Science, Neuroscience and Sense Organs, University of 
      Bari 'Aldo Moro', Bari, Italy.
FAU - Rapaport, Mark H
AU  - Rapaport MH
AD  - Huntsman Mental Health Institute, Department of Psychiatry, University of Utah 
      School of Medicine, Salt Lake City, UT, USA.
FAU - Rautanen, Anna
AU  - Rautanen A
AD  - Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche 
      Innovation Center Basel, F. Hoffman-La Roche, Basel, Switzerland.
FAU - Reichenberg, Abraham
AU  - Reichenberg A
AD  - Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, 
      USA.
FAU - Roe, Cheryl
AU  - Roe C
AD  - SUNY Upstate Medical University, Syracuse, NY, USA.
FAU - Roffman, Joshua L
AU  - Roffman JL
AD  - Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
FAU - Roth, Julian
AU  - Roth J
AD  - Department of Psychiatry, Psychosomatics and Psychotherapy, 
      Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
FAU - Rothermundt, Matthias
AU  - Rothermundt M
AD  - Department of Psychiatry, University of Münster, Münster, Germany.
FAU - Rutten, Bart P F
AU  - Rutten BPF
AD  - Department of Psychiatry and Neuropsychology, School for Mental Health and 
      Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.
FAU - Saker-Delye, Safaa
AU  - Saker-Delye S
AD  - Généthon, Evry, France.
FAU - Salomaa, Veikko
AU  - Salomaa V
AD  - THL-Finnish Institute for Health and Welfare, Helsinki, Finland.
FAU - Sanjuan, Julio
AU  - Sanjuan J
AD  - Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Madrid, 
      Spain.
AD  - Biomedical Research Institute INCLIVA, Valencia, Spain.
AD  - Department of Psychiatry, School of Medicine, University of Valencia, Hospital 
      Clínico Universitario de Valencia, Valencia, Spain.
FAU - Santoro, Marcos Leite
AU  - Santoro ML
AD  - Laboratory of Integrative Neuroscience, Universidade Federal de São Paulo, São 
      Paulo, Brazil.
AD  - Department of Morphology and Genetics, Laboratorio de Genetica, Universidade 
      Federal de São Paulo, São Paulo, Brazil.
FAU - Savitz, Adam
AU  - Savitz A
AD  - Neuroscience Therapeutic Area, Janssen Research and Development, Titusville, NJ, 
      USA.
FAU - Schall, Ulrich
AU  - Schall U
AD  - Hunter Medical Research Institute, Newcastle, New South Wales, Australia.
AD  - Priority Centre for Brain and Mental Health Research, University of Newcastle, 
      Mater Hospital, McAuley Centre, Newcastle, New South Wales, Australia.
FAU - Scott, Rodney J
AU  - Scott RJ
AD  - School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, 
      New South Wales, Australia.
AD  - Hunter Medical Research Institute, Newcastle, New South Wales, Australia.
AD  - Division of Molecular Medicine, NSW Health Pathology North, Newcastle, New South 
      Wales, Australia.
FAU - Seidman, Larry J
AU  - Seidman LJ
AD  - Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
AD  - Massachusetts Mental Health Center Public Psychiatry Division of the Beth Israel 
      Deaconess Medical Center, Boston, MA, USA.
FAU - Sharp, Sally Isabel
AU  - Sharp SI
AD  - Molecular Psychiatry Laboratory, Division of Psychiatry, University College 
      London, London, UK.
FAU - Shi, Jianxin
AU  - Shi J
AD  - Division of Cancer Epidemiology and Genetics, National Cancer Institute, 
      Bethesda, MD, USA.
FAU - Siever, Larry J
AU  - Siever LJ
AD  - Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, 
      USA.
AD  - James J. Peters VA Medical Center, Bronx, NY, USA.
FAU - Sigurdsson, Engilbert
AU  - Sigurdsson E
AD  - Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
AD  - Department of Psychiatry, Landspitali University Hospital, Reykjavik, Iceland.
FAU - Sim, Kang
AU  - Sim K
AD  - West Region, Institute of Mental Health, Singapore, Singapore.
AD  - Yoo Loo Lin School of Medicine, National University of Singapore, Singapore, 
      Singapore.
AD  - Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, 
      Singapore.
FAU - Skarabis, Nora
AU  - Skarabis N
AD  - Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin, 
      Berlin, Germany.
FAU - Slominsky, Petr
AU  - Slominsky P
AD  - Institute of Molecular Genetics of National Research Centre "Kurchatov 
      Institute", Moscow, Russia.
FAU - So, Hon-Cheong
AU  - So HC
AD  - School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, 
      China.
AD  - Department of Psychiatry, The Chinese University of Hong Kong, Hong Kong, China.
FAU - Sobell, Janet L
AU  - Sobell JL
AD  - Department of Psychiatry and the Behavioral Sciences, Keck School of Medicine, 
      University of Southern California, Los Angeles, CA, USA.
FAU - Söderman, Erik
AU  - Söderman E
AD  - Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska 
      Institutet and Stockholm Health Care Services, Stockholm Region, Stockholm, 
      Sweden.
FAU - Stain, Helen J
AU  - Stain HJ
AD  - School of Social and Health Sciences, Leeds Trinity University, Leeds, UK.
AD  - TIPS - Network for Clinical Research in Psychosis, Stavanger University Hospital, 
      Stavanger, Norway.
FAU - Steen, Nils Eiel
AU  - Steen NE
AD  - Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
AD  - NORMENT Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
FAU - Steixner-Kumar, Agnes A
AU  - Steixner-Kumar AA
AD  - Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Göttingen, 
      Germany.
FAU - Stögmann, Elisabeth
AU  - Stögmann E
AD  - Department of Neurology, Medical University of Vienna, Vienna, Austria.
FAU - Stone, William S
AU  - Stone WS
AD  - Harvard Medical School Department of Psychiatry at Beth Israel Deaconess Medical 
      Center, Boston, MA, USA.
AD  - Massachusetts Mental Health Center, Boston, MA, USA.
FAU - Straub, Richard E
AU  - Straub RE
AD  - Lieber Institute for Brain Development, Baltimore, MD, USA.
FAU - Streit, Fabian
AU  - Streit F
AD  - Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental 
      Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
FAU - Strengman, Eric
AU  - Strengman E
AD  - Department of Medical Genetics, University Medical Centre Utrecht, Utrecht, The 
      Netherlands.
FAU - Stroup, T Scott
AU  - Stroup TS
AD  - Department of Psychiatry, Columbia University, New York, NY, USA.
FAU - Subramaniam, Mythily
AU  - Subramaniam M
AD  - Research Division, Institute of Mental Health, Singapore, Republic of Singapore.
AD  - Saw Swee Hock School of Public Health, National University of Singapore, 
      Singapore, Republic of Singapore.
FAU - Sugar, Catherine A
AU  - Sugar CA
AD  - Department of Psychiatry and Biobehavioral Sciences, Geffen School of Medicine, 
      University of California Los Angeles, Los Angeles, CA, USA.
AD  - Department of Biostatistics, Fielding School of Public Health, University of 
      California Los Angeles, Los Angeles, CA, USA.
FAU - Suvisaari, Jaana
AU  - Suvisaari J
AD  - THL-Finnish Institute for Health and Welfare, Helsinki, Finland.
FAU - Svrakic, Dragan M
AU  - Svrakic DM
AD  - Department of Psychiatry, Washington University, St Louis, MO, USA.
FAU - Swerdlow, Neal R
AU  - Swerdlow NR
AD  - Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.
FAU - Szatkiewicz, Jin P
AU  - Szatkiewicz JP
AD  - Department of Genetics, University of North Carolina, Chapel Hill, NC, USA.
FAU - Ta, Thi Minh Tam
AU  - Ta TMT
AD  - Department of Psychiatry, Charité - Universitätsmedizin Berlin, Berlin, Germany.
AD  - Berlin Institute of Health (BIH), Berlin, Germany.
FAU - Takahashi, Atsushi
AU  - Takahashi A
AD  - Laboratory for Statistical and Translational Genetics, RIKEN Center for 
      Integrative Medical Sciences, Yokohama, Japan.
FAU - Terao, Chikashi
AU  - Terao C
AD  - Laboratory for Statistical and Translational Genetics, RIKEN Center for 
      Integrative Medical Sciences, Yokohama, Japan.
FAU - Thibaut, Florence
AU  - Thibaut F
AD  - Université de Paris, Faculté de Médecine, Hôpital Cochin-Tarnier, Paris, France.
AD  - INSERM U1266, Institut de Psychiatrie et de Neurosciences, Paris, France.
FAU - Toncheva, Draga
AU  - Toncheva D
AD  - Department of Medical Genetics, Medical University, Sofia, Bulgaria.
AD  - Bulgarian Academy of Science, Sofia, Bulgaria.
FAU - Tooney, Paul A
AU  - Tooney PA
AD  - School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, 
      New South Wales, Australia.
AD  - Hunter Medical Research Institute, Newcastle, New South Wales, Australia.
AD  - Centre for Brain and Mental Health Research, University of Newcastle, Newcastle, 
      New South Wales, Australia.
FAU - Torretta, Silvia
AU  - Torretta S
AD  - Department of Basic Medical Science, Neuroscience and Sense Organs, University of 
      Bari 'Aldo Moro', Bari, Italy.
FAU - Tosato, Sarah
AU  - Tosato S
AD  - Department of Neuroscience, Biomedicine and Movement Sciences, Section of 
      Psychiatry, University of Verona, Verona, Italy.
FAU - Tura, Gian Battista
AU  - Tura GB
AD  - Psychiatry Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, 
      Brescia, Italy.
FAU - Turetsky, Bruce I
AU  - Turetsky BI
AD  - Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
FAU - Üçok, Alp
AU  - Üçok A
AD  - Department of Psychiatry, Faculty of Medicine, Istanbul University, Istanbul, 
      Turkey.
FAU - Vaaler, Arne
AU  - Vaaler A
AD  - Division of Mental Health, St. Olav's Hospital, Trondheim University Hospital, 
      Trondheim, Norway.
AD  - Department of Mental Health, Norwegian University of Science and Technology, 
      Trondheim, Norway.
FAU - van Amelsvoort, Therese
AU  - van Amelsvoort T
AD  - National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre 
      at South London and Maudsley NHS Foundation Trust and King's College London, 
      London, UK.
AD  - Department of Psychiatry and Neuropsychology, School for Mental Health and 
      Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.
FAU - van Winkel, Ruud
AU  - van Winkel R
AD  - Department of Psychiatry and Neuropsychology, School for Mental Health and 
      Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.
AD  - Department of Neurosciences, Center for Clinical Psychiatry, KU Leuven, Leuven, 
      Belgium.
FAU - Veijola, Juha
AU  - Veijola J
AD  - Department of Psychiatry, Research Unit of Clinical Neuroscience, University of 
      Oulu, Oulu, Finland.
AD  - Medical Research Center Oulu, Oulu University Hospital and University of Oulu, 
      Oulu, Finland.
FAU - Waddington, John
AU  - Waddington J
AD  - Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, 
      Dublin, Ireland.
FAU - Walter, Henrik
AU  - Walter H
AD  - Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin, 
      Berlin, Germany.
FAU - Waterreus, Anna
AU  - Waterreus A
AD  - Neuropsychiatric Epidemiology Research Unit, School of Population and Global 
      Health, University of Western Australia, Perth, Western Australia, Australia.
AD  - Centre for Clinical Research in Neuropsychiatry, University of Western Australia, 
      Perth, Western Australia, Australia.
FAU - Webb, Bradley T
AU  - Webb BT
AD  - Virginia Institute for Psychiatric and Behavioral Genetics, Department of 
      Psychiatry, Virginia Commonwealth University, Richmond, VA, USA.
FAU - Weiser, Mark
AU  - Weiser M
AD  - Sheba Medical Center, Tel Hashomer, Israel.
FAU - Williams, Nigel M
AU  - Williams NM
AD  - MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological 
      Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
FAU - Witt, Stephanie H
AU  - Witt SH
AD  - Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental 
      Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
FAU - Wormley, Brandon K
AU  - Wormley BK
AD  - Virginia Institute for Psychiatric and Behavioral Genetics, Department of 
      Psychiatry, Virginia Commonwealth University, Richmond, VA, USA.
FAU - Wu, Jing Qin
AU  - Wu JQ
AD  - Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
FAU - Xu, Zhida
AU  - Xu Z
AD  - Department of Psychiatry, GGz Centraal, Utrecht, The Netherlands.
FAU - Yolken, Robert
AU  - Yolken R
AD  - Stanley Neurovirology Laboratory, Johns Hopkins University School of Medicine, 
      Baltimore, MD, USA.
FAU - Zai, Clement C
AU  - Zai CC
AD  - Campbell Family Mental Health Research Institute, Centre for Addiction and Mental 
      Health, Toronto, Ontario, Canada.
AD  - Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
FAU - Zhou, Wei
AU  - Zhou W
AD  - Bio-X Institutes, Key Laboratory for the Genetics of Developmental and 
      Neuropsychiatric Disorders (Ministry of Education), Collaborative Innovation 
      Center for Brain Science, Shanghai Jiao Tong University, Shanghai, China.
FAU - Zhu, Feng
AU  - Zhu F
AD  - Department of Psychiatry, The First Affiliated Hospital of Xi'an Jiaotong 
      University, Xi'an, China.
AD  - Center for Translational Medicine, The First Affiliated Hospital of Xi'an 
      Jiaotong University, Xi'an, China.
FAU - Zimprich, Fritz
AU  - Zimprich F
AD  - Department of Neurology, Medical University of Vienna, Vienna, Austria.
FAU - Atbaşoğlu, Eşref Cem
AU  - Atbaşoğlu EC
AD  - Department of Genetics and Genomics, Icahn School of Medicine at Mount Sinai, New 
      York, NY, USA.
AD  - Department of Psychiatry, School of Medicine, Ankara University, Ankara, Turkey.
FAU - Ayub, Muhammad
AU  - Ayub M
AD  - Department of Psychiatry, Queens University Kingston, Kingston, Ontario, Canada.
FAU - Benner, Christian
AU  - Benner C
AD  - Institute for Molecular Medicine Finland (FIMM), University of Helsinki, 
      Helsinki, Finland.
FAU - Bertolino, Alessandro
AU  - Bertolino A
AD  - Department of Basic Medical Science, Neuroscience and Sense Organs, University of 
      Bari 'Aldo Moro', Bari, Italy.
FAU - Black, Donald W
AU  - Black DW
AD  - Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa 
      City, IA, USA.
FAU - Bray, Nicholas J
AU  - Bray NJ
AD  - MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological 
      Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
FAU - Breen, Gerome
AU  - Breen G
AD  - Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, 
      Psychology and Neuroscience, King's College London, London, UK.
FAU - Buccola, Nancy G
AU  - Buccola NG
AD  - School of Nursing, Louisiana State University Health Sciences Center, New 
      Orleans, LA, USA.
FAU - Byerley, William F
AU  - Byerley WF
AD  - Department of Psychiatry, University of California San Francisco, San Francisco, 
      CA, USA.
FAU - Chen, Wei J
AU  - Chen WJ
AD  - Center for Neuropsychiatric Research, National Health Research Institutes, Zhunan 
      Town, Taiwan.
AD  - Institute of Epidemiology and Preventive Medicine, College of Public Health, 
      National Taiwan University, Taipei, Taiwan.
FAU - Cloninger, C Robert
AU  - Cloninger CR
AD  - Department of Psychiatry, Washington University, St Louis, MO, USA.
FAU - Crespo-Facorro, Benedicto
AU  - Crespo-Facorro B
AD  - University of Sevilla, CIBERSAM IBiS, Seville, Spain.
AD  - Hospital Universitario Virgen del Rocio, Department of Psychiatry, Universidad 
      del Sevilla, Seville, Spain.
FAU - Donohoe, Gary
AU  - Donohoe G
AD  - Centre for Neuroimaging, Cognition and Genomics (NICOG), National University of 
      Ireland Galway, Galway, Ireland.
FAU - Freedman, Robert
AU  - Freedman R
AD  - Department of Psychiatry, University of Colorado Denver, Aurora, CO, USA.
FAU - Galletly, Cherrie
AU  - Galletly C
AD  - Discipline of Psychiatry, Adelaide Medical School, University of Adelaide, 
      Adelaide, South Australia, Australia.
AD  - Ramsay Health Care (SA) Mental Health, Adelaide, South Australia, Australia.
AD  - Northern Adelaide Local Health Network, Adelaide, South Australia, Australia.
FAU - Gandal, Michael J
AU  - Gandal MJ
AD  - Department of Psychiatry, Semel Institute, David Geffen School of Medicine, 
      University of California Los Angeles, Los Angeles, CA, USA.
FAU - Gennarelli, Massimo
AU  - Gennarelli M
AD  - Department of Molecular and Translational Medicine, University of Brescia, 
      Brescia, Italy.
AD  - Genetic Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, 
      Brescia, Italy.
FAU - Hougaard, David M
AU  - Hougaard DM
AD  - The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), 
      Aarhus, Denmark.
AD  - Center for Neonatal Screening, Department for Congenital Disorders, Statens Serum 
      Institut, Copenhagen, Denmark.
FAU - Hwu, Hai-Gwo
AU  - Hwu HG
AD  - Neurobiology and Cognitive Science Center, National Taiwan University, Taipei, 
      Taiwan.
AD  - Department of Psychiatry, College of Medicine and National Taiwan University 
      Hospital, National Taiwan University, Taipei, Taiwan.
FAU - Jablensky, Assen V
AU  - Jablensky AV
AD  - Centre for Clinical Research in Neuropsychiatry, University of Western Australia, 
      Perth, Western Australia, Australia.
FAU - McCarroll, Steven A
AU  - McCarroll SA
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
FAU - Moran, Jennifer L
AU  - Moran JL
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
AD  - Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
FAU - Mors, Ole
AU  - Mors O
AD  - The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), 
      Aarhus, Denmark.
AD  - Psychosis Research Unit, Aarhus University Hospital, Aarhus, Denmark.
FAU - Mortensen, Preben B
AU  - Mortensen PB
AD  - The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), 
      Aarhus, Denmark.
AD  - National Centre for Register-based Research, Aarhus University, Aarhus, Denmark.
FAU - Müller-Myhsok, Bertram
AU  - Müller-Myhsok B
AD  - Max Planck Institute of Psychiatry, Munich, Germany.
AD  - Munich Cluster for Systems Neurology, Munich, Germany.
AD  - Department of Health Data Science, University of Liverpool, Liverpool, UK.
FAU - Neil, Amanda L
AU  - Neil AL
AD  - Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, 
      Australia.
FAU - Nordentoft, Merete
AU  - Nordentoft M
AD  - The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), 
      Aarhus, Denmark.
AD  - Mental Health Services in the Capital Region of Denmark, Mental Health Center 
      Copenhagen, University of Copenhagen, Copenhagen, Denmark.
FAU - Pato, Michele T
AU  - Pato MT
AD  - Rutgers University, Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
AD  - Rutgers University, New Jersey Medical School, Newark, NJ, USA.
FAU - Petryshen, Tracey L
AU  - Petryshen TL
AD  - Psychiatric and Neurodevelopmental Genetics Unit, Department of Psychiatry and 
      Center for Genomic Medicine, Massachusetts General Hospital, Harvard Medical 
      School, Boston, MA, USA.
FAU - Pirinen, Matti
AU  - Pirinen M
AD  - Institute for Molecular Medicine Finland (FIMM), University of Helsinki, 
      Helsinki, Finland.
AD  - Department of Mathematics and Statistics, University of Helsinki, Helsinki, 
      Finland.
AD  - Department of Public Health, University of Helsinki, Helsinki, Finland.
FAU - Pulver, Ann E
AU  - Pulver AE
AD  - Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School 
      of Medicine, Baltimore, MD, USA.
FAU - Schulze, Thomas G
AU  - Schulze TG
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, Germany.
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Syracuse, NY, USA.
AD  - Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, 
      Göttingen, Germany.
AD  - Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University, 
      Baltimore, MD, USA.
FAU - Silverman, Jeremy M
AU  - Silverman JM
AD  - Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, 
      USA.
AD  - James J. Peters VA Medical Center, Bronx, NY, USA.
FAU - Smoller, Jordan W
AU  - Smoller JW
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
AD  - Psychiatric and Neurodevelopmental Genetics Unit, Department of Psychiatry and 
      Center for Genomic Medicine, Massachusetts General Hospital, Harvard Medical 
      School, Boston, MA, USA.
FAU - Stahl, Eli A
AU  - Stahl EA
AD  - Division of Psychiatric Genomics, Department of Psychiatry, Icahn School of 
      Medicine at Mount Sinai, New York, NY, USA.
AD  - Program in Medical and Population Genetics, The Broad Institute of MIT and 
      Harvard, Cambridge, MA, USA.
AD  - Regeneron Genetics Center, Orange, CA, USA.
FAU - Tsuang, Debby W
AU  - Tsuang DW
AD  - Department of Psychiatry and Behavioral Sciences, University of Washington, 
      Seattle, WA, USA.
AD  - VA Puget Sound Health Care System, Seattle, WA, USA.
FAU - Vilella, Elisabet
AU  - Vilella E
AD  - Hospital Universitari Institut Pere Mata, IISPV, Universitat Rovira i Virgili, 
      CIBERSAM, Reus, Spain.
FAU - Wang, Shi-Heng
AU  - Wang SH
AD  - College of Public Health, China Medical University, Taichung, Taiwan.
FAU - Xu, Shuhua
AU  - Xu S
AD  - State Key Laboratory of Genetic Engineering and Ministry of Education (MOE) Key 
      Laboratory of Contemporary Anthropology, Collaborative Innovation Center of 
      Genetics and Development, Human Phenome Institute, School of Life Sciences, Fudan 
      University, Shanghai, China.
AD  - School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
AD  - Center for Excellence in Animal Evolution and Genetics, Chinese Academy of 
      Sciences, Kunming, China.
CN  - Indonesia Schizophrenia Consortium
CN  - PsychENCODE
CN  - Psychosis Endophenotypes International Consortium
CN  - SynGO Consortium
FAU - Adolfsson, Rolf
AU  - Adolfsson R
AD  - Department of Clinical Sciences, Psychiatry, Umeå University, Umeå, Sweden.
FAU - Arango, Celso
AU  - Arango C
AD  - Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Madrid, 
      Spain.
AD  - Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental 
      Health, General Universitario Gregorio Marañón, School of Medicine, Universidad 
      Complutense, IiSGM, Madrid, Spain.
FAU - Baune, Bernhard T
AU  - Baune BT
AD  - Department of Psychiatry, University of Münster, Münster, Germany.
AD  - The Florey Institute of Neuroscience and Mental Health, University of Melbourne, 
      Parkville, Victoria, Australia.
AD  - Department of Psychiatry, Melbourne Medical School, University of Melbourne, 
      Parkville, Victoria, Australia.
FAU - Belangero, Sintia Iole
AU  - Belangero SI
AD  - Laboratory of Integrative Neuroscience, Universidade Federal de São Paulo, São 
      Paulo, Brazil.
AD  - Department of Morphology and Genetics, Laboratorio de Genetica, Universidade 
      Federal de São Paulo, São Paulo, Brazil.
FAU - Børglum, Anders D
AU  - Børglum AD
AD  - The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), 
      Aarhus, Denmark.
AD  - Department of Biomedicine and Centre for Integrative Sequencing (iSEQ), Aarhus 
      University, Aarhus, Denmark.
AD  - Center for Genomics and Personalized Medicine, Aarhus, Denmark.
FAU - Braff, David
AU  - Braff D
AD  - Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.
AD  - VISN 22, Mental Illness Research, Education and Clinical Center (MIRECC), VA San 
      Diego Healthcare System, San Diego, CA, USA.
FAU - Bramon, Elvira
AU  - Bramon E
AD  - Division of Psychiatry, Department of Mental Health Neuroscience, University 
      College London, London, UK.
FAU - Buxbaum, Joseph D
AU  - Buxbaum JD
AD  - Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, 
      USA.
FAU - Campion, Dominique
AU  - Campion D
AD  - INSERM, Rouen, France.
AD  - Centre Hospitalier du Rouvray, Rouen, France.
FAU - Cervilla, Jorge A
AU  - Cervilla JA
AD  - Department of Psychiatry, San Cecilio University Hospital, University of Granada, 
      Granada, Spain.
FAU - Cichon, Sven
AU  - Cichon S
AD  - Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, 
      Switzerland.
AD  - Department of Biomedicine, University of Basel, Basel, Switzerland.
AD  - Institute of Neuroscience and Medicine (INM-1), Research Center Juelich, Juelich, 
      Germany.
FAU - Collier, David A
AU  - Collier DA
AD  - Eli Lilly and Company, Windlesham, UK.
FAU - Corvin, Aiden
AU  - Corvin A
AD  - Neuropsychiatric Genetics Research Group, Department of Psychiatry, Trinity 
      College Dublin, Dublin, Ireland.
FAU - Curtis, David
AU  - Curtis D
AD  - UCL Genetics Institute, University College London, London, UK.
AD  - Centre for Psychiatry, Queen Mary University London, London, UK.
FAU - Forti, Marta Di
AU  - Forti MD
AD  - Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, 
      Psychology and Neuroscience, King's College London, London, UK.
AD  - National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre 
      at South London and Maudsley NHS Foundation Trust and King's College London, 
      London, UK.
AD  - South London and Maudsley NHS Mental Health Foundation Trust, London, UK.
FAU - Domenici, Enrico
AU  - Domenici E
AD  - Department of Cellular, Computational and Integrative Biology, University of 
      Trento, Trento, Italy.
FAU - Ehrenreich, Hannelore
AU  - Ehrenreich H
AD  - Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Göttingen, 
      Germany.
FAU - Escott-Price, Valentina
AU  - Escott-Price V
AD  - MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological 
      Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
AD  - Dementia Research Institute, Cardiff University, Cardiff, UK.
FAU - Esko, Tõnu
AU  - Esko T
AD  - Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, 
      Estonia.
AD  - Program in Medical and Population Genetics, The Broad Institute of MIT and 
      Harvard, Cambridge, MA, USA.
FAU - Fanous, Ayman H
AU  - Fanous AH
AD  - Department of Psychiatry, Veterans Affairs New York Harbor Healthcare System, New 
      York, NY, USA.
AD  - Department of Psychiatry, Phoenix VA Healthcare System, Phoenix, AZ, USA.
AD  - Banner-University Medical Center, Phoenix, AZ, USA.
FAU - Gareeva, Anna
AU  - Gareeva A
AD  - Department of Human Molecular Genetics of the Institute of Biochemistry and 
      Genetics of the Ufa Federal Research Center of the Russian Academy of Sciences 
      (IBG UFRC RAS), Ufa, Russia.
AD  - Federal State Educational Institution of Highest Education Bashkir State Medical 
      University of Public Health Ministry of Russian Federation (BSMU), Ufa, Russia.
FAU - Gawlik, Micha
AU  - Gawlik M
AD  - Department of Psychiatry, Psychosomatics and Psychotherapy, 
      Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
FAU - Gejman, Pablo V
AU  - Gejman PV
AD  - Center for Psychiatric Genetics, NorthShore University HealthSystem, Evanston, 
      IL, USA.
AD  - Department of Psychiatry and Behavioral Neurosciences, The University of Chicago, 
      Chicago, IL, USA.
FAU - Gill, Michael
AU  - Gill M
AD  - Neuropsychiatric Genetics Research Group, Department of Psychiatry, Trinity 
      College Dublin, Dublin, Ireland.
FAU - Glatt, Stephen J
AU  - Glatt SJ
AD  - Psychiatric Genetic Epidemiology and Neurobiology Laboratory (PsychGENe lab), 
      Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Syracuse, NY, USA.
FAU - Golimbet, Vera
AU  - Golimbet V
AD  - Mental Health Research Center, Moscow, Russian Federation.
FAU - Hong, Kyung Sue
AU  - Hong KS
AD  - Department of Psychiatry, Sungkyunkwan University School of Medicine, Samsung 
      Medical Center, Seoul, Korea.
FAU - Hultman, Christina M
AU  - Hultman CM
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
FAU - Hyman, Steven E
AU  - Hyman SE
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      MA, USA.
FAU - Iwata, Nakao
AU  - Iwata N
AD  - Department of Psychiatry, Fujita Health University School of Medicine, Toyoake 
      Aichi, Japan.
FAU - Jönsson, Erik G
AU  - Jönsson EG
AD  - Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska 
      Institutet and Stockholm Health Care Services, Stockholm Region, Stockholm, 
      Sweden.
AD  - NORMENT Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
FAU - Kahn, René S
AU  - Kahn RS
AD  - University Medical Center Utrecht, Department of Psychiatry, Rudolf Magnus 
      Institute of Neuroscience, Utrecht, The Netherlands.
AD  - Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, 
      USA.
FAU - Kennedy, James L
AU  - Kennedy JL
AD  - Campbell Family Mental Health Research Institute, Centre for Addiction and Mental 
      Health, Toronto, Ontario, Canada.
AD  - Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
FAU - Khusnutdinova, Elza
AU  - Khusnutdinova E
AD  - Department of Human Molecular Genetics of the Institute of Biochemistry and 
      Genetics of the Ufa Federal Research Center of the Russian Academy of Sciences 
      (IBG UFRC RAS), Ufa, Russia.
AD  - Federal State Educational Institution of Highest Education Bashkir State Medical 
      University of Public Health Ministry of Russian Federation (BSMU), Ufa, Russia.
FAU - Kirov, George
AU  - Kirov G
AD  - MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological 
      Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
FAU - Knowles, James A
AU  - Knowles JA
AD  - Department of Psychiatry and Zilkha Neurogenetics Institute, Keck School of 
      Medicine at University of Southern California, Los Angeles, CA, USA.
AD  - Department of Cell Biology, State University of New York, Downstate Health 
      Sciences University, New York, NY, USA.
FAU - Krebs, Marie-Odile
AU  - Krebs MO
AD  - INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, Université de 
      Paris, GHU Paris Psychiatrie & Neurosciences, Paris, France.
FAU - Laurent-Levinson, Claudine
AU  - Laurent-Levinson C
AD  - Faculté de Médecine Sorbonne Université, Groupe de Recherche Clinique no. 15 - 
      Troubles Psychiatriques et Développement (PSYDEV), Department of Child and 
      Adolescent Psychiatry, Hôpital Universitaire de la Pitié-Salpêtrière, Paris, 
      France.
AD  - Centre de Référence des Maladies Rares à Expression Psychiatrique, Department of 
      Child and Adolescent Psychiatry, AP-HP Sorbonne Université, Hôpital Universitaire 
      de la Pitié-Salpêtrière, Paris, France.
FAU - Lee, Jimmy
AU  - Lee J
AD  - Department of Psychosis, Institute of Mental Health, Singapore, Singapore.
AD  - Neuroscience and Mental Health, Lee Kong Chian School of Medicine, Nanyang 
      Technological University, Singapore, Singapore.
FAU - Lencz, Todd
AU  - Lencz T
AD  - Division of Psychiatry Research, Zucker Hillside Hospital, Glen Oaks, NY, USA.
AD  - Institute of Behavioral Science, Feinstein Institutes for Medical Research, 
      Manhasset, NY, USA.
AD  - Department of Psychiatry, Zucker School of Medicine at Hofstra/Northwell, 
      Hempstead, NY, USA.
FAU - Levinson, Douglas F
AU  - Levinson DF
AD  - Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, 
      CA, USA.
FAU - Li, Qingqin S
AU  - Li QS
AD  - Neuroscience Therapeutic Area, Janssen Research and Development, Titusville, NJ, 
      USA.
FAU - Liu, Jianjun
AU  - Liu J
AD  - Human Genetics, Genome Institute of Singapore, A*STAR, Singapore, Singapore.
AD  - Department of Medicine, Yong Loo Lin School of Medicine, National University of 
      Singapore, Singapore, Singapore.
FAU - Malhotra, Anil K
AU  - Malhotra AK
AD  - Division of Psychiatry Research, Zucker Hillside Hospital, Glen Oaks, NY, USA.
AD  - Institute of Behavioral Science, Feinstein Institutes for Medical Research, 
      Manhasset, NY, USA.
AD  - Department of Psychiatry, Zucker School of Medicine at Hofstra/Northwell, 
      Hempstead, NY, USA.
FAU - Malhotra, Dheeraj
AU  - Malhotra D
AD  - Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. 
      Hoffman-La Roche, Basel, Switzerland.
FAU - McIntosh, Andrew
AU  - McIntosh A
AD  - Division of Psychiatry, Centre for Clinical Brain Sciences, University of 
      Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK.
FAU - McQuillin, Andrew
AU  - McQuillin A
AD  - Molecular Psychiatry Laboratory, Division of Psychiatry, University College 
      London, London, UK.
FAU - Menezes, Paulo R
AU  - Menezes PR
AD  - Department of Preventative Medicine, Faculdade de Medicina FMUSP, University of 
      São Paulo, São Paulo, Brazil.
FAU - Morgan, Vera A
AU  - Morgan VA
AD  - Neuropsychiatric Epidemiology Research Unit, School of Population and Global 
      Health, University of Western Australia, Perth, Western Australia, Australia.
AD  - Centre for Clinical Research in Neuropsychiatry, University of Western Australia, 
      Perth, Western Australia, Australia.
FAU - Morris, Derek W
AU  - Morris DW
AD  - Centre for Neuroimaging, Cognition and Genomics (NICOG), National University of 
      Ireland Galway, Galway, Ireland.
FAU - Mowry, Bryan J
AU  - Mowry BJ
AD  - Queensland Brain Institute, University of Queensland, Brisbane, Queensland, 
      Australia.
AD  - Queensland Centre for Mental Health Research, University of Queensland, Brisbane, 
      Queensland, Australia.
FAU - Murray, Robin M
AU  - Murray RM
AD  - National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre 
      at South London and Maudsley NHS Foundation Trust and King's College London, 
      London, UK.
FAU - Nimgaonkar, Vishwajit
AU  - Nimgaonkar V
AD  - Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.
FAU - Nöthen, Markus M
AU  - Nöthen MM
AD  - Institute of Human Genetics, University of Bonn, Bonn, Germany.
FAU - Ophoff, Roel A
AU  - Ophoff RA
AD  - Department of Human Genetics, David Geffen School of Medicine, University of 
      California Los Angeles, Los Angeles, CA, USA.
AD  - Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human 
      Behavior, University of California Los Angeles, Los Angeles, CA, USA.
AD  - Department of Psychiatry, Erasmus University Medical Center, Rotterdam, The 
      Netherlands.
FAU - Paciga, Sara A
AU  - Paciga SA
AD  - Early Clinical Development, Pfizer Worldwide Research and Development, Groton, 
      CT, USA.
FAU - Palotie, Aarno
AU  - Palotie A
AD  - Institute for Molecular Medicine Finland (FIMM), University of Helsinki, 
      Helsinki, Finland.
AD  - Analytic and Translational Genetics Unit, Department of Medicine, Department of 
      Neurology and Department of Psychiatry, Massachusetts General Hospital, Boston, 
      MA, USA.
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
FAU - Pato, Carlos N
AU  - Pato CN
AD  - Rutgers University, Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
AD  - Rutgers University, New Jersey Medical School, Newark, NJ, USA.
FAU - Qin, Shengying
AU  - Qin S
AD  - Bio-X Institutes, Key Laboratory for the Genetics of Developmental and 
      Neuropsychiatric Disorders (Ministry of Education), Collaborative Innovation 
      Center for Brain Science, Shanghai Jiao Tong University, Shanghai, China.
AD  - Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, 
      Shanghai Jiao Tong University School of Medicine, Shanghai, China.
FAU - Rietschel, Marcella
AU  - Rietschel M
AD  - Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental 
      Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
FAU - Riley, Brien P
AU  - Riley BP
AD  - Virginia Institute for Psychiatric and Behavioral Genetics, Department of 
      Psychiatry, Virginia Commonwealth University, Richmond, VA, USA.
FAU - Rivera, Margarita
AU  - Rivera M
AD  - Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, 
      University of Granada, Granada, Spain.
AD  - Institute of Neurosciences, Biomedical Research Center (CIBM), University of 
      Granada, Granada, Spain.
FAU - Rujescu, Dan
AU  - Rujescu D
AD  - Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, 
      Austria.
FAU - Saka, Meram C
AU  - Saka MC
AD  - Department of Psychiatry, School of Medicine, Ankara University, Ankara, Turkey.
FAU - Sanders, Alan R
AU  - Sanders AR
AD  - Center for Psychiatric Genetics, NorthShore University HealthSystem, Evanston, 
      IL, USA.
AD  - Department of Psychiatry and Behavioral Neurosciences, The University of Chicago, 
      Chicago, IL, USA.
FAU - Schwab, Sibylle G
AU  - Schwab SG
AD  - Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, 
      New South Wales, Australia.
AD  - Illawarra Health and Medical Research Institute, Wollongong, New South Wales, 
      Australia.
FAU - Serretti, Alessandro
AU  - Serretti A
AD  - Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, 
      Italy.
FAU - Sham, Pak C
AU  - Sham PC
AD  - Centre for PanorOmic Sciences, LKS Faculty of Medicine, The University of Hong 
      Kong, Hong Kong, China.
AD  - State Key Laboratory of Brain and Cognitive Sciences, LKS Faculty of Medicine, 
      The University of Hong Kong, Hong Kong, China.
AD  - Department of Psychiatry, LKS Faculty of Medicine, The University of Hong Kong, 
      Hong Kong, China.
FAU - Shi, Yongyong
AU  - Shi Y
AD  - Affiliated Hospital of Qingdao University and Biomedical Sciences Institute of 
      Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao University, 
      Qingdao, China.
AD  - Bio-X Institutes, Key Laboratory for the Genetics of Developmental and 
      Neuropsychiatric Disorders (Ministry of Education), Collaborative Innovation 
      Center for Brain Science, Shanghai Jiao Tong University, Shanghai, China.
FAU - St Clair, David
AU  - St Clair D
AD  - Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK.
FAU - Stefánsson, Hreinn
AU  - Stefánsson H
AD  - deCODE Genetics, Amgen, Reykjavik, Iceland.
FAU - Stefansson, Kari
AU  - Stefansson K
AD  - deCODE Genetics, Amgen, Reykjavik, Iceland.
FAU - Tsuang, Ming T
AU  - Tsuang MT
AD  - Center for Behavioral Genomics, Department of Psychiatry, University of 
      California San Diego, La Jolla, CA, USA.
AD  - Institute of Genomic Medicine, University of California San Diego, La Jolla, CA, 
      USA.
FAU - van Os, Jim
AU  - van Os J
AD  - Department of Psychosis Studies, Institute of Psychiatry, Psychology and 
      Neuroscience, King's College London, London, UK.
AD  - University Medical Center Utrecht, Department of Psychiatry, Utrecht, The 
      Netherlands.
FAU - Vawter, Marquis P
AU  - Vawter MP
AD  - Department of Psychiatry and Human Behavior, School of Medicine, University of 
      California Irvine, Irvine, CA, USA.
FAU - Weinberger, Daniel R
AU  - Weinberger DR
AD  - Lieber Institute for Brain Development, Baltimore, MD, USA.
FAU - Werge, Thomas
AU  - Werge T
AD  - Institute of Biological Psychiatry, Mental Health Services, Copenhagen University 
      Hospital, Copenhagen, Denmark.
AD  - Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
AD  - Center for GeoGenetics, GLOBE Institute, University of Copenhagen, Copenhagen, 
      Denmark.
AD  - The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, 
      Copenhagen, Denmark.
FAU - Wildenauer, Dieter B
AU  - Wildenauer DB
AD  - School of Psychiatry and Clinical Neurosciences, University of Western Australia, 
      Perth, Western Australia, Australia.
FAU - Yu, Xin
AU  - Yu X
AD  - Peking University Sixth Hospital, Peking University Institute of Mental Health, 
      Beijing, China.
AD  - National Clinical Research Center for Mental Disorders, NHC Key Laboratory of 
      Mental Health (Peking University) and Chinese Academy of Medical Sciences 
      Research Unit, Beijing, China.
FAU - Yue, Weihua
AU  - Yue W
AD  - Peking University Sixth Hospital, Peking University Institute of Mental Health, 
      Beijing, China.
AD  - National Clinical Research Center for Mental Disorders, NHC Key Laboratory of 
      Mental Health (Peking University) and Chinese Academy of Medical Sciences 
      Research Unit, Beijing, China.
AD  - PKU-IDG/McGovern Institute for Brain Research, Peking University, Beijing, China.
FAU - Holmans, Peter A
AU  - Holmans PA
AD  - MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological 
      Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
FAU - Pocklington, Andrew J
AU  - Pocklington AJ
AD  - MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological 
      Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
FAU - Roussos, Panos
AU  - Roussos P
AD  - Department of Psychiatry, Pamela Sklar Division of Psychiatric Genomics, Friedman 
      Brain Institute, Department of Genetics and Genomic Science and Institute for 
      Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New 
      York, NY, USA.
AD  - Mental Illness Research, Education, and Clinical Center (VISN 2 South), James J. 
      Peters VA Medical Center, New York, NY, USA.
FAU - Vassos, Evangelos
AU  - Vassos E
AD  - Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, 
      Psychology and Neuroscience, King's College London, London, UK.
AD  - National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre 
      at South London and Maudsley NHS Foundation Trust and King's College London, 
      London, UK.
AD  - Oxford Health NHS Foundation Trust, Oxford, UK.
FAU - Verhage, Matthijs
AU  - Verhage M
AD  - Department of Clinical Genetics, Center for Neurogenomics and Cognitive Research, 
      University Medical Center Amsterdam, Amsterdam, The Netherlands.
AD  - Department of Functional Genomics, Faculty of Exact Science, Center for 
      Neurogenomics and Cognitive Research, VU University Amsterdam and VU Medical 
      Center, Amsterdam, The Netherlands.
FAU - Visscher, Peter M
AU  - Visscher PM
AD  - Institute for Molecular Bioscience, University of Queensland, Brisbane, 
      Queensland, Australia.
FAU - Yang, Jian
AU  - Yang J
AD  - Institute for Molecular Bioscience, University of Queensland, Brisbane, 
      Queensland, Australia.
AD  - School of Life Sciences, Westlake University, Hangzhou, China.
AD  - Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China.
FAU - Posthuma, Danielle
AU  - Posthuma D
AD  - Department of Functional Genomics, Faculty of Exact Science, Center for 
      Neurogenomics and Cognitive Research, VU University Amsterdam and VU Medical 
      Center, Amsterdam, The Netherlands.
FAU - Andreassen, Ole A
AU  - Andreassen OA
AD  - NORMENT Centre, Division of Mental Health and Addiction, University of Oslo, 
      Oslo, Norway.
AD  - Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
FAU - Kendler, Kenneth S
AU  - Kendler KS
AD  - Virginia Institute for Psychiatric and Behavioral Genetics, Department of 
      Psychiatry, Virginia Commonwealth University, Richmond, VA, USA.
FAU - Owen, Michael J
AU  - Owen MJ
AD  - MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological 
      Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
FAU - Wray, Naomi R
AU  - Wray NR
AD  - Institute for Molecular Bioscience, University of Queensland, Brisbane, 
      Queensland, Australia.
AD  - Queensland Brain Institute, University of Queensland, Brisbane, Queensland, 
      Australia.
FAU - Daly, Mark J
AU  - Daly MJ
AD  - Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, 
      MA, USA.
AD  - Broad Institute of MIT and Harvard, Cambridge, MA, USA.
AD  - Institute for Molecular Medicine Finland (FIMM), University of Helsinki, 
      Helsinki, Finland.
FAU - Huang, Hailiang
AU  - Huang H
AD  - Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, 
      MA, USA.
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
AD  - Department of Medicine, Harvard Medical School, Boston, MA, USA.
FAU - Neale, Benjamin M
AU  - Neale BM
AD  - Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, 
      MA, USA.
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
FAU - Sullivan, Patrick F
AU  - Sullivan PF
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
AD  - Department of Genetics, University of North Carolina, Chapel Hill, NC, USA.
AD  - Department of Psychiatry, University of North Carolina, Chapel Hill, NC, USA.
FAU - Ripke, Stephan
AU  - Ripke S
AD  - Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin, 
      Berlin, Germany. sripke@broadinstitute.org.
AD  - Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, 
      MA, USA. sripke@broadinstitute.org.
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA. sripke@broadinstitute.org.
FAU - Walters, James T R
AU  - Walters JTR
AD  - MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological 
      Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK. 
      WaltersJT@cardiff.ac.uk.
FAU - O'Donovan, Michael C
AU  - O'Donovan MC
AD  - MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological 
      Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK. 
      ODonovanMC@cardiff.ac.uk.
CN  - Schizophrenia Working Group of the Psychiatric Genomics Consortium
LA  - eng
GR  - R01 MH116281/MH/NIMH NIH HHS/United States
GR  - 5R01 MH101519/NH/NIH HHS/United States
GR  - 085475/B/08/Z/WT_/Wellcome Trust/United Kingdom
GR  - R01 MH124873/MH/NIMH NIH HHS/United States
GR  - U01 MH109536/MH/NIMH NIH HHS/United States
GR  - R01 MH101519/MH/NIMH NIH HHS/United States
GR  - MC_UU_00007/10/MRC_/Medical Research Council/United Kingdom
GR  - WT_/Wellcome Trust/United Kingdom
GR  - MR/L010305/1/MRC_/Medical Research Council/United Kingdom
GR  - G0901310/MRC_/Medical Research Council/United Kingdom
GR  - 085475/Z/08/Z/WT_/Wellcome Trust/United Kingdom
GR  - R01 MH119243/MH/NIMH NIH HHS/United States
GR  - G0800509/MRC_/Medical Research Council/United Kingdom
GR  - R01 MH106575/MH/NIMH NIH HHS/United States
GR  - R37 NS036715/NS/NINDS NIH HHS/United States
GR  - K01 MH121659/MH/NIMH NIH HHS/United States
GR  - U01 MH109514/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20220408
PL  - England
TA  - Nature
JT  - Nature
JID - 0410462
SB  - IM
CIN - Nature. 2022 Apr;604(7906):433-435. PMID: 35411108
MH  - Alleles
MH  - Genetic Predisposition to Disease/genetics
MH  - *Genome-Wide Association Study
MH  - Genomics
MH  - Humans
MH  - Polymorphism, Single Nucleotide/genetics
MH  - *Schizophrenia/genetics
PMC - PMC9392466
MID - NIHMS1824605
FIR - Dai, Nan
IR  - Dai N
FIR - Wenwen, Qin
IR  - Wenwen Q
FIR - Wildenauer, D B
IR  - Wildenauer DB
FIR - Agiananda, Feranindhya
IR  - Agiananda F
FIR - Amir, Nurmiati
IR  - Amir N
FIR - Antoni, Ronald
IR  - Antoni R
FIR - Arsianti, Tiana
IR  - Arsianti T
FIR - Asmarahadi, Asmarahadi
IR  - Asmarahadi A
FIR - Diatri, H
IR  - Diatri H
FIR - Djatmiko, Prianto
IR  - Djatmiko P
FIR - Irmansyah, Irmansyah
IR  - Irmansyah I
FIR - Khalimah, Siti
IR  - Khalimah S
FIR - Kusumadewi, Irmia
IR  - Kusumadewi I
FIR - Kusumaningrum, Profitasari
IR  - Kusumaningrum P
FIR - Lukman, Petrin R
IR  - Lukman PR
FIR - Nasrun, Martina W
IR  - Nasrun MW
FIR - Safyuni, N S
IR  - Safyuni NS
FIR - Prasetyawan, Prasetyawan
IR  - Prasetyawan P
FIR - Semen, G
IR  - Semen G
FIR - Siste, Kristiana
IR  - Siste K
FIR - Tobing, Heriani
IR  - Tobing H
FIR - Widiasih, Natalia
IR  - Widiasih N
FIR - Wiguna, Tjhin
IR  - Wiguna T
FIR - Wulandari, D
IR  - Wulandari D
FIR - Evalina, None
IR  - Evalina N
FIR - Hananto, A J
IR  - Hananto AJ
FIR - Ismoyo, Joni H
IR  - Ismoyo JH
FIR - Marini, T M
IR  - Marini TM
FIR - Henuhili, Supiyani
IR  - Henuhili S
FIR - Reza, Muhammad
IR  - Reza M
FIR - Yusnadewi, Suzy
IR  - Yusnadewi S
FIR - Abyzov, Alexej
IR  - Abyzov A
FIR - Akbarian, Schahram
IR  - Akbarian S
FIR - Ashley-Koch, Allison
IR  - Ashley-Koch A
FIR - van Bakel, Harm
IR  - van Bakel H
FIR - Breen, Michael
IR  - Breen M
FIR - Brown, Miguel
IR  - Brown M
FIR - Bryois, Julien
IR  - Bryois J
FIR - Carlyle, Becky
IR  - Carlyle B
FIR - Charney, Alex
IR  - Charney A
FIR - Coetzee, Gerard
IR  - Coetzee G
FIR - Crawford, Gregory
IR  - Crawford G
FIR - Dracheva, Stella
IR  - Dracheva S
FIR - Emani, Prashant
IR  - Emani P
FIR - Farnham, Peggy
IR  - Farnham P
FIR - Fromer, Menachem
IR  - Fromer M
FIR - Galeev, Timur
IR  - Galeev T
FIR - Gandal, Mike
IR  - Gandal M
FIR - Gerstein, Mark
IR  - Gerstein M
FIR - Giase, Gina
IR  - Giase G
FIR - Girdhar, Kiran
IR  - Girdhar K
FIR - Goes, Fernando
IR  - Goes F
FIR - Grennan, Kay
IR  - Grennan K
FIR - Gu, Mengting
IR  - Gu M
FIR - Guerra, Brittney
IR  - Guerra B
FIR - Gursoy, Gamze
IR  - Gursoy G
FIR - Hoffman, Gabriel
IR  - Hoffman G
FIR - Hyde, Thomas
IR  - Hyde T
FIR - Jaffe, Andrew
IR  - Jaffe A
FIR - Jiang, Shan
IR  - Jiang S
FIR - Jiang, Yan
IR  - Jiang Y
FIR - Kefi, Amira
IR  - Kefi A
FIR - Kim, Yunjung
IR  - Kim Y
FIR - Kitchen, Robert
IR  - Kitchen R
FIR - Knowles, James A
IR  - Knowles JA
FIR - Lay, Fides
IR  - Lay F
FIR - Lee, Donghoon
IR  - Lee D
FIR - Li, Mingfeng
IR  - Li M
FIR - Liu, Chunyu
IR  - Liu C
FIR - Liu, Shuang
IR  - Liu S
FIR - Mattei, Eugenio
IR  - Mattei E
FIR - Navarro, Fabio
IR  - Navarro F
FIR - Pan, Xinghua
IR  - Pan X
FIR - Peters, Mette A
IR  - Peters MA
FIR - Pinto, Dalila
IR  - Pinto D
FIR - Pochareddy, Sirisha
IR  - Pochareddy S
FIR - Polioudakis, Damon
IR  - Polioudakis D
FIR - Purcaro, Michael
IR  - Purcaro M
FIR - Purcell, Shaun
IR  - Purcell S
FIR - Pratt, Henry
IR  - Pratt H
FIR - Reddy, Tim
IR  - Reddy T
FIR - Rhie, Suhn
IR  - Rhie S
FIR - Roussos, Panagiotis
IR  - Roussos P
FIR - Rozowsky, Joel
IR  - Rozowsky J
FIR - Sanders, Stephan
IR  - Sanders S
FIR - Sestan, Nenad
IR  - Sestan N
FIR - Sethi, Anurag
IR  - Sethi A
FIR - Shi, Xu
IR  - Shi X
FIR - Shieh, Annie
IR  - Shieh A
FIR - Swarup, Vivek
IR  - Swarup V
FIR - Szekely, Anna
IR  - Szekely A
FIR - Wang, Daifeng
IR  - Wang D
FIR - Warrell, Jonathan
IR  - Warrell J
FIR - Weissman, Sherman
IR  - Weissman S
FIR - Weng, Zhiping
IR  - Weng Z
FIR - White, Kevin
IR  - White K
FIR - Wiseman, Jennifer
IR  - Wiseman J
FIR - Witt, Heather
IR  - Witt H
FIR - Won, Hyejung
IR  - Won H
FIR - Wood, Shannon
IR  - Wood S
FIR - Wu, Feinan
IR  - Wu F
FIR - Xu, Xuming
IR  - Xu X
FIR - Yao, Lijing
IR  - Yao L
FIR - Zandi, Peter
IR  - Zandi P
FIR - Arranz, Maria J
IR  - Arranz MJ
FIR - Bakker, Steven
IR  - Bakker S
FIR - Bender, Stephan
IR  - Bender S
FIR - Bramon, Elvira
IR  - Bramon E
FIR - Collier, David A
IR  - Collier DA
FIR - Crepo-Facorro, Benedicto
IR  - Crepo-Facorro B
FIR - Hall, Jeremy
IR  - Hall J
FIR - Iyegbe, Conrad
IR  - Iyegbe C
FIR - Kahn, René
IR  - Kahn R
FIR - Lawrie, Stephen
IR  - Lawrie S
FIR - Lewis, Cathryn
IR  - Lewis C
FIR - Lin, Kuang
IR  - Lin K
FIR - Linszen, Don H
IR  - Linszen DH
FIR - Mata, Ignacio
IR  - Mata I
FIR - McIntosh, Andrew
IR  - McIntosh A
FIR - Murray, Robin M
IR  - Murray RM
FIR - Ophoff, Roel A
IR  - Ophoff RA
FIR - van Os, Jim
IR  - van Os J
FIR - Powell, John
IR  - Powell J
FIR - Rujescu, Dan
IR  - Rujescu D
FIR - Walshe, Muriel
IR  - Walshe M
FIR - Weisbrod, Matthias
IR  - Weisbrod M
FIR - Achsel, Tilmann
IR  - Achsel T
FIR - Andres-Alonso, Maria
IR  - Andres-Alonso M
FIR - Bagni, Claudia
IR  - Bagni C
FIR - Bayés, Àlex
IR  - Bayés À
FIR - Biederer, Thomas
IR  - Biederer T
FIR - Brose, Nils
IR  - Brose N
FIR - Brown, Tyler C
IR  - Brown TC
FIR - Chua, John Jia En
IR  - Chua JJE
FIR - Coba, Marcelo P
IR  - Coba MP
FIR - Cornelisse, L Niels
IR  - Cornelisse LN
FIR - de Jong, Arthur P H
IR  - de Jong APH
FIR - de Juan-Sanz, Jaime
IR  - de Juan-Sanz J
FIR - Dieterich, Daniela C
IR  - Dieterich DC
FIR - Feng, Guoping
IR  - Feng G
FIR - Goldschmidt, Hana L
IR  - Goldschmidt HL
FIR - Gundelfinger, Eckart D
IR  - Gundelfinger ED
FIR - Hoogenraad, Casper
IR  - Hoogenraad C
FIR - Huganir, Richard L
IR  - Huganir RL
FIR - Hyman, Steven E
IR  - Hyman SE
FIR - Imig, Cordelia
IR  - Imig C
FIR - Jahn, Reinhard
IR  - Jahn R
FIR - Jung, Hwajin
IR  - Jung H
FIR - Kaeser, Pascal S
IR  - Kaeser PS
FIR - Kim, Eunjoon
IR  - Kim E
FIR - Koopmans, Frank
IR  - Koopmans F
FIR - Kreutz, Michael R
IR  - Kreutz MR
FIR - Lipstein, Noa
IR  - Lipstein N
FIR - MacGillavry, Harold D
IR  - MacGillavry HD
FIR - Malenka, Robert
IR  - Malenka R
FIR - McPherson, Peter S
IR  - McPherson PS
FIR - O'Connor, Vincent
IR  - O'Connor V
FIR - Pielot, Rainer
IR  - Pielot R
FIR - Ryan, Timothy A
IR  - Ryan TA
FIR - Sahasrabudhe, Dnyanada
IR  - Sahasrabudhe D
FIR - Sala, Carlo
IR  - Sala C
FIR - Sheng, Morgan
IR  - Sheng M
FIR - Smalla, Karl-Heinz
IR  - Smalla KH
FIR - Smit, August B
IR  - Smit AB
FIR - Südhof, Thomas C
IR  - Südhof TC
FIR - Thomas, Paul D
IR  - Thomas PD
FIR - Toonen, Ruud F
IR  - Toonen RF
FIR - van Weering, Jan R T
IR  - van Weering JRT
FIR - Verhage, Matthijs
IR  - Verhage M
FIR - Verpelli, Chiara
IR  - Verpelli C
FIR - de Haan, Lieuwe
IR  - de Haan L
FIR - van Amelsvoort, Therese
IR  - van Amelsvoort T
FIR - van Winkel, Ruud
IR  - van Winkel R
FIR - Gareeva, Anna
IR  - Gareeva A
FIR - Sham, Pak C
IR  - Sham PC
FIR - Shi, Yongyong
IR  - Shi Y
FIR - St Clair, David
IR  - St Clair D
FIR - van Os, Jim
IR  - van Os J
EDAT- 2022/04/10 06:00
MHDA- 2022/04/23 06:00
CRDT- 2022/04/09 05:20
PHST- 2020/08/12 00:00 [received]
PHST- 2022/01/10 00:00 [accepted]
PHST- 2022/04/10 06:00 [pubmed]
PHST- 2022/04/23 06:00 [medline]
PHST- 2022/04/09 05:20 [entrez]
AID - 10.1038/s41586-022-04434-5 [pii]
AID - 10.1038/s41586-022-04434-5 [doi]
PST - ppublish
SO  - Nature. 2022 Apr;604(7906):502-508. doi: 10.1038/s41586-022-04434-5. Epub 2022 
      Apr 8.

PMID- 29930110
OWN - NLM
STAT- MEDLINE
DCOM- 20180822
LR  - 20230519
IS  - 1095-9203 (Electronic)
IS  - 0036-8075 (Print)
IS  - 0036-8075 (Linking)
VI  - 360
IP  - 6395
DP  - 2018 Jun 22
TI  - Analysis of shared heritability in common disorders of the brain.
LID - 10.1126/science.aap8757 [doi]
LID - eaap8757
AB  - Disorders of the brain can exhibit considerable epidemiological comorbidity and 
      often share symptoms, provoking debate about their etiologic overlap. We 
      quantified the genetic sharing of 25 brain disorders from genome-wide association 
      studies of 265,218 patients and 784,643 control participants and assessed their 
      relationship to 17 phenotypes from 1,191,588 individuals. Psychiatric disorders 
      share common variant risk, whereas neurological disorders appear more distinct 
      from one another and from the psychiatric disorders. We also identified 
      significant sharing between disorders and a number of brain phenotypes, including 
      cognitive measures. Further, we conducted simulations to explore how statistical 
      power, diagnostic misclassification, and phenotypic heterogeneity affect genetic 
      correlations. These results highlight the importance of common genetic variation 
      as a risk factor for brain disorders and the value of heritability-based methods 
      in understanding their etiology.
CI  - Copyright © 2018 The Authors, some rights reserved; exclusive licensee American 
      Association for the Advancement of Science. No claim to original U.S. Government 
      Works.
CN  - Brainstorm Consortium
FAU - Anttila, Verneri
AU  - Anttila V
AUID- ORCID: 0000-0002-0073-4675
AD  - Analytic Translational Genetics Unit, Massachusetts General Hospital Harvard 
      Medical School, Boston, Massachusetts, USA. verneri.anttila@gmail.com 
      acorvin@tcd.ie bneale@broadinstitute.org.
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
FAU - Bulik-Sullivan, Brendan
AU  - Bulik-Sullivan B
AD  - Analytic Translational Genetics Unit, Massachusetts General Hospital Harvard 
      Medical School, Boston, Massachusetts, USA.
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
FAU - Finucane, Hilary K
AU  - Finucane HK
AUID- ORCID: 0000-0003-3864-9828
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Department of Mathematics, Massachusetts Institute of Technology, Cambridge, 
      Massachusetts, USA.
AD  - Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, 
      Massachusetts, USA.
FAU - Walters, Raymond K
AU  - Walters RK
AUID- ORCID: 0000-0001-8422-6530
AD  - Analytic Translational Genetics Unit, Massachusetts General Hospital Harvard 
      Medical School, Boston, Massachusetts, USA.
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
FAU - Bras, Jose
AU  - Bras J
AD  - UK Dementia Research Institute, University College London, London, UK.
AD  - Department of Molecular Neuroscience, Institute of Neurology, University College 
      London, London, UK.
FAU - Duncan, Laramie
AU  - Duncan L
AUID- ORCID: 0000-0003-1131-661X
AD  - Analytic Translational Genetics Unit, Massachusetts General Hospital Harvard 
      Medical School, Boston, Massachusetts, USA.
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Department of Psychiatry and Behavioral Science, Stanford University, Stanford, 
      California, USA.
FAU - Escott-Price, Valentina
AU  - Escott-Price V
AUID- ORCID: 0000-0003-1784-5483
AD  - Cardiff University, Medical Research Council Center for Neuropsychiatric Genetics 
      & Genomics, Institute of Psychology, Medicine & Clinical Neuroscience, Cardiff, 
      UK.
AD  - Dementia Research Institute, Cardiff University, Cardiff, UK.
FAU - Falcone, Guido J
AU  - Falcone GJ
AUID- ORCID: 0000-0002-6407-0302
AD  - Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
AD  - Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
AD  - Harvard Medical School, Boston, MA, USA.
FAU - Gormley, Padhraig
AU  - Gormley P
AUID- ORCID: 0000-0002-8908-6968
AD  - Analytic Translational Genetics Unit, Massachusetts General Hospital Harvard 
      Medical School, Boston, Massachusetts, USA.
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
FAU - Malik, Rainer
AU  - Malik R
AUID- ORCID: 0000-0001-9212-2520
AD  - Institute for Stroke and Dementia Research (ISD), University Hospital, LMU 
      Munich, Munich, Germany.
FAU - Patsopoulos, Nikolaos A
AU  - Patsopoulos NA
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Department of Neurology, Brigham & Women's Hospital, Harvard Medical School, 
      Boston, MA, USA.
FAU - Ripke, Stephan
AU  - Ripke S
AUID- ORCID: 0000-0003-3622-835X
AD  - Analytic Translational Genetics Unit, Massachusetts General Hospital Harvard 
      Medical School, Boston, Massachusetts, USA.
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Charite Universitatsmedizin Berlin, Berlin, Germany.
FAU - Wei, Zhi
AU  - Wei Z
AUID- ORCID: 0000-0001-6059-4267
AD  - Department of Computer Science, New Jersey Institute of Technology, New Jersey, 
      USA.
FAU - Yu, Dongmei
AU  - Yu D
AUID- ORCID: 0000-0001-7901-4365
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
FAU - Lee, Phil H
AU  - Lee PH
AUID- ORCID: 0000-0003-1770-3100
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
FAU - Turley, Patrick
AU  - Turley P
AD  - Analytic Translational Genetics Unit, Massachusetts General Hospital Harvard 
      Medical School, Boston, Massachusetts, USA.
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
FAU - Grenier-Boley, Benjamin
AU  - Grenier-Boley B
AD  - INSERM U1167 LabEx DISTALZ, Lille, France.
AD  - Institut Pasteur de Lille, U1167, Lille, France.
AD  - Université de Lille, U1167, RID-AGE, Risk Factors and Molecular Determinants of 
      Aging-Related Diseases, Lille, France.
FAU - Chouraki, Vincent
AU  - Chouraki V
AD  - INSERM U1167 LabEx DISTALZ, Lille, France.
AD  - Institut Pasteur de Lille, U1167, Lille, France.
AD  - Université de Lille, U1167, RID-AGE, Risk Factors and Molecular Determinants of 
      Aging-Related Diseases, Lille, France.
AD  - Centre Hosp. Univ Lille, Lille, France.
FAU - Kamatani, Yoichiro
AU  - Kamatani Y
AD  - Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical 
      Sciences, Yokohama, Japan.
AD  - Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, 
      Japan.
FAU - Berr, Claudine
AU  - Berr C
AD  - INSERM U1061 - Neuropsychiatry: Epidemiological and Clinical Research, 
      Montpellier, France.
AD  - University of Montpellier, Montpellier, France.
AD  - Memory Research and Resources Center, Department of Neurology, Montpellier 
      University Hospital Gui de Chauliac, Montpellier, France.
FAU - Letenneur, Luc
AU  - Letenneur L
AD  - INSERM, UMR 1219, Bordeaux, France.
AD  - University of Bordeaux, Bordeaux, France.
FAU - Hannequin, Didier
AU  - Hannequin D
AD  - Rouen University Hospital, Rouen, France.
AD  - Inserm U1245, Rouen, France.
FAU - Amouyel, Philippe
AU  - Amouyel P
AD  - INSERM U1167 LabEx DISTALZ, Lille, France.
AD  - Institut Pasteur de Lille, U1167, Lille, France.
AD  - Université de Lille, U1167, RID-AGE, Risk Factors and Molecular Determinants of 
      Aging-Related Diseases, Lille, France.
AD  - Centre Hosp. Univ Lille, Lille, France.
FAU - Boland, Anne
AU  - Boland A
AD  - Centre National de Recherche en Génomique Humaine (CNRGH), Institut de biologie 
      François Jacob, CEA, Evry, France.
FAU - Deleuze, Jean-François
AU  - Deleuze JF
AD  - Centre National de Recherche en Génomique Humaine (CNRGH), Institut de biologie 
      François Jacob, CEA, Evry, France.
FAU - Duron, Emmanuelle
AU  - Duron E
AD  - Department of Gerontology, Hôpital Broca, AH-HP, Paris, France.
AD  - Hôpital Paul Brousse Université Paris Sud XI, Le Kremlin-Bicêtre, Paris, France.
FAU - Vardarajan, Badri N
AU  - Vardarajan BN
AD  - Gertrude H. Sergievsky Center and Dept of Neurology, Columbia University, New 
      York, NY, USA.
FAU - Reitz, Christiane
AU  - Reitz C
AD  - Columbia University, New York, NY, USA.
FAU - Goate, Alison M
AU  - Goate AM
AD  - Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, 
      NY, USA.
FAU - Huentelman, Matthew J
AU  - Huentelman MJ
AD  - Translational Genomics Research Institute, Neurogenomics Division, Phoenix, AZ, 
      USA.
FAU - Kamboh, M Ilyas
AU  - Kamboh MI
AD  - University of Pittsburgh, Pittsburgh, PA, USA.
FAU - Larson, Eric B
AU  - Larson EB
AD  - Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
AD  - Department of Medicine, University of Washington, WA, USA.
FAU - Rogaeva, Ekaterina
AU  - Rogaeva E
AD  - Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, 
      Toronto, Canada.
FAU - St George-Hyslop, Peter
AU  - St George-Hyslop P
AD  - Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, 
      Toronto, Canada.
AD  - Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.
FAU - Hakonarson, Hakon
AU  - Hakonarson H
AD  - Center for Applied Genomics of The Children's Hospital of Philadelphia, 
      Philadelphia, PA, USA.
AD  - Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, 
      PA, USA.
AD  - Department of Pediatrics, The Perelman School of Medicine, University of 
      Pennsylvania, Philadelphia, PA, USA.
FAU - Kukull, Walter A
AU  - Kukull WA
AD  - National Alzheimer Coordinating Center (NACC), Department of Epidemiology, 
      University of Washington, Seattle, WA, USA.
FAU - Farrer, Lindsay A
AU  - Farrer LA
AD  - Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
FAU - Barnes, Lisa L
AU  - Barnes LL
AD  - Rush Alzheimers Disease Center, Chicago, IL, USA.
AD  - Department of Neurological Sciences, Rush Medical College, Chicago, IL, USA.
AD  - Department of Behavioral Sciences, Rush Medical College, Chicago, IL, USA.
FAU - Beach, Thomas G
AU  - Beach TG
AD  - Banner Sun Health Research Institute, Sun City, AZ, USA.
FAU - Demirci, F Yesim
AU  - Demirci FY
AD  - University of Pittsburgh, Pittsburgh, PA, USA.
FAU - Head, Elizabeth
AU  - Head E
AD  - Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
FAU - Hulette, Christine M
AU  - Hulette CM
AD  - Department of Pathology, Duke University School of Medicine, Durham, NC, USA.
FAU - Jicha, Gregory A
AU  - Jicha GA
AD  - College of Medicine, University of Kentucky, Lexington, KY, USA.
FAU - Kauwe, John S K
AU  - Kauwe JSK
AD  - Department of Biology, Brigham Young University, Provo, UT, USA.
FAU - Kaye, Jeffrey A
AU  - Kaye JA
AD  - Layton Aging & Alzheimer's Disease Center, Oregon Health & Science University, 
      Portland, OR, USA.
FAU - Leverenz, James B
AU  - Leverenz JB
AD  - Lou Ruvo Center for Brain Health, Neurological Institute, Cleveland Clinic, 
      Cleveland, OH, USA.
FAU - Levey, Allan I
AU  - Levey AI
AD  - Department of Neurology, School of Medicine, Emory University, Atlanta, GA, USA.
FAU - Lieberman, Andrew P
AU  - Lieberman AP
AD  - Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, 
      USA.
FAU - Pankratz, Vernon S
AU  - Pankratz VS
AD  - University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
FAU - Poon, Wayne W
AU  - Poon WW
AD  - Institute for Memory Impairments and Neurological Disorders, University of 
      California, Irvine, CA, USA.
FAU - Quinn, Joseph F
AU  - Quinn JF
AD  - Department of Neurology, Oregon Health and Science University, Portland, OR, USA.
AD  - Department of Neurology and Parkinson's Disease Research Education and Clinical 
      Care Center (PADRECC), Portland Veterans Affairs Medical Center, Portland, OR, 
      USA.
FAU - Saykin, Andrew J
AU  - Saykin AJ
AD  - Indiana Alzheimer Disease Center, Indiana University School of Medicine, 
      Indianapolis, IN, USA.
FAU - Schneider, Lon S
AU  - Schneider LS
AD  - Keck School of Medicine of the University of Southern California, Los Angeles, 
      CA, USA.
FAU - Smith, Amanda G
AU  - Smith AG
AD  - Byrd Alzheimer's Institute, University of South Florida, Tampa, FL, USA.
FAU - Sonnen, Joshua A
AU  - Sonnen JA
AD  - Department of Pathology, University of Utah, Salt Lake City, UT, USA.
AD  - Department of Pathology, University of Washington, Seattle, WA, USA.
FAU - Stern, Robert A
AU  - Stern RA
AD  - Boston University School of Medicine, Boston, MA, USA.
FAU - Van Deerlin, Vivianna M
AU  - Van Deerlin VM
AD  - Department of Pathology and Laboratory Medicine, Perelman School of Medicine, 
      University of Pennsylvania, Philadelphia, PA, USA.
FAU - Van Eldik, Linda J
AU  - Van Eldik LJ
AD  - Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
FAU - Harold, Denise
AU  - Harold D
AD  - School of Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland.
FAU - Russo, Giancarlo
AU  - Russo G
AD  - Functional Genomics Center Zurich, ETH/UZH-Zurich, Zurich, Switzerland.
FAU - Rubinsztein, David C
AU  - Rubinsztein DC
AD  - Department of Medical Genetics, Cambridge Institute for Medical Research, 
      Cambridge, UK.
AD  - UK Dementia Research Institute, Cambridge, UK.
FAU - Bayer, Anthony
AU  - Bayer A
AD  - School of Medicine, Cardiff University, Cardiff, UK.
FAU - Tsolaki, Magda
AU  - Tsolaki M
AD  - 1st and 3rd Departments of Neurology, Aristotle University of Thessaloniki, 
      Thessaloniki, Greece.
AD  - Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, 
      Greece.
FAU - Proitsi, Petra
AU  - Proitsi P
AD  - Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology 
      and Neuroscience, King's College London, London, UK.
FAU - Fox, Nick C
AU  - Fox NC
AD  - Dementia Research Centre, UCL Institute of Neurology, London, UK.
AD  - UK Dementia Research Institute, University College London, London, UK.
FAU - Hampel, Harald
AU  - Hampel H
AD  - Sorbonne University, GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, 
      Pitié-Salpêtrière Hospital, Paris, France.
AD  - Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, 
      Pitié-Salpêtrière Hospital, AP-HP, Paris, France.
AD  - Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France.
AD  - AXA Research Fund & Sorbonne University Chair, Paris, France .
FAU - Owen, Michael J
AU  - Owen MJ
AD  - MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, 
      Cardiff, UK.
AD  - Institute of Psychological Medicine and Clinical Neurosciences, School of 
      Medicine, Cardiff University, Cardiff, UK.
FAU - Mead, Simon
AU  - Mead S
AD  - Institute of Prion Diseases and MRC Prion Unit, University College London, 
      London, UK.
FAU - Passmore, Peter
AU  - Passmore P
AD  - Centre for Public Health, Queens University Belfast, Belfast, UK.
FAU - Morgan, Kevin
AU  - Morgan K
AD  - Human Genetics, School of Life Sciences, University of Nottingham, Nottingham UK.
FAU - Nöthen, Markus M
AU  - Nöthen MM
AD  - Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.
AD  - Institute of Human Genetics, School of Medicine, University of Bonn & University 
      Hospital Bonn, Bonn, Germany.
FAU - Rossor, Martin
AU  - Rossor M
AD  - Department of Neurodegeneration, UCL Institute of Neurology, London, UK.
FAU - Lupton, Michelle K
AU  - Lupton MK
AD  - QIMR Berghofer Medical Research Institute, Brisbane, Australia.
AD  - Institute of Psychiatry Psychology and Neuroscience, Kings College London, UK.
FAU - Hoffmann, Per
AU  - Hoffmann P
AD  - Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.
AD  - Institute of Human Genetics, School of Medicine, University of Bonn & University 
      Hospital Bonn, Bonn, Germany.
AD  - Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, 
      Switzerland.
AD  - Human Genomics Research Group, Department of Biomedicine, University of Basel, 
      Basel, Switzerland.
FAU - Kornhuber, Johannes
AU  - Kornhuber J
AD  - Department of Psychiatry and Psychotherapy, Friedrich-Alexander-Universität 
      Erlangen-Nürnberg University Hospital, Erlangen, Germany.
FAU - Lawlor, Brian
AU  - Lawlor B
AD  - Department of Psychiatry and Global Brain Health Institute, Trinity College, 
      Dublin, Ireland.
FAU - McQuillin, Andrew
AU  - McQuillin A
AD  - Division of Psychiatry, Molecular Psychiatry Laboratory,University College 
      London, London, UK.
FAU - Al-Chalabi, Ammar
AU  - Al-Chalabi A
AD  - Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical 
      Neuroscience, King's College London, London, UK.
AD  - King's College Hospital, London, UK.
FAU - Bis, Joshua C
AU  - Bis JC
AD  - Cardiovascular Health Research Unit, Department of Medicine, University of 
      Washington, Seattle, WA, USA.
FAU - Ruiz, Agustin
AU  - Ruiz A
AD  - Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona, Spain and 
      Universitat Internacional de Catalunya, Barcelona, Spain.
AD  - Facultat de Medicina i Ciències de la Salut, Universitat Internacional de 
      Catalunya (UIC), Barcelona, Spain.
FAU - Boada, Mercè
AU  - Boada M
AD  - Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona, Spain and 
      Universitat Internacional de Catalunya, Barcelona, Spain.
FAU - Seshadri, Sudha
AU  - Seshadri S
AD  - Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University 
      of Texas Health Sciences Center, San Antonio, Texas, USA.
AD  - Neurology and Neurogenetics Core, Framingham Heart Study, Framingham, MA, USA.
AD  - School of Medicine, Boston University, Boston, MA, USA.
FAU - Beiser, Alexa
AU  - Beiser A
AD  - School of Public Health, Boston University, Boston, MA, USA.
AD  - Framingham Heart Study, Framingham, MA, USA.
AD  - School of Medicine, Boston University, Boston, MA, USA.
FAU - Rice, Kenneth
AU  - Rice K
AD  - Department of Biostatistics, University of Washington, Seattle, WA, USA.
FAU - van der Lee, Sven J
AU  - van der Lee SJ
AD  - Department of Epidemiology, Erasmus Medical Centre, Rotterdam, the Netherlands.
FAU - De Jager, Philip L
AU  - De Jager PL
AD  - Center for Translational & Computational Neuroimmunology, Columbia University 
      Medical Center, New York, NY, USA.
FAU - Geschwind, Daniel H
AU  - Geschwind DH
AD  - Neurogenetics Program, Departments of Neurology and Human Genetics, David Geffen 
      School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
AD  - Center For Autism Research and Treatment, Semel Institute, David Geffen School of 
      Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
AD  - Institute for Precision Health, University of California, Los Angeles, Los 
      Angeles, CA, USA.
FAU - Riemenschneider, Matthias
AU  - Riemenschneider M
AD  - Department of Psychiatry, Saarland University Hospital, Homburg, Germany.
FAU - Riedel-Heller, Steffi
AU  - Riedel-Heller S
AD  - Institute of Social Medicine, Occupational Health and Public Health (ISAP), 
      University of Leipzig, Leipzig, Germany.
FAU - Rotter, Jerome I
AU  - Rotter JI
AD  - Institute for Translational Genomics and Population Sciences, Departments of 
      Pediatrics and Medicine, LABioMed at Harbor-UCLA Medical Center, Torrance, CA, 
      USA.
FAU - Ransmayr, Gerhard
AU  - Ransmayr G
AD  - Department of Neurology II, Kepler University Clinic, Johannes Kepler University, 
      Linz, Austria.
FAU - Hyman, Bradley T
AU  - Hyman BT
AD  - Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
AD  - Harvard Medical School, Boston, MA, USA.
FAU - Cruchaga, Carlos
AU  - Cruchaga C
AD  - Washington University School of Medicine, St. Louis, MO, USA.
FAU - Alegret, Montserrat
AU  - Alegret M
AD  - Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona, Spain and 
      Universitat Internacional de Catalunya, Barcelona, Spain.
FAU - Winsvold, Bendik
AU  - Winsvold B
AD  - Communication and Research Unit for Musculoskeletal Disorders (FORMI), Oslo 
      University Hospital, Oslo, Norway.
AD  - Department of Neurology, Oslo University Hospital, Oslo, Norway.
FAU - Palta, Priit
AU  - Palta P
AD  - Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, 
      Helsinki, Finland.
AD  - Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, 
      Estonia.
FAU - Farh, Kai-How
AU  - Farh KH
AD  - Illumina Inc., San Diego, CA, USA.
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
FAU - Cuenca-Leon, Ester
AU  - Cuenca-Leon E
AD  - Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
FAU - Furlotte, Nicholas
AU  - Furlotte N
AD  - 23andMe Inc., Mountain View, CA, US.
FAU - Kurth, Tobias
AU  - Kurth T
AD  - Institute of Public Health, Charité - Universitätsmedizin Berlin, Berlin, 
      Germany.
FAU - Ligthart, Lannie
AU  - Ligthart L
AD  - Department of Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, The 
      Netherlands.
FAU - Terwindt, Gisela M
AU  - Terwindt GM
AD  - Department of Neurology, Leiden University Medical Center, Leiden, The 
      Netherlands.
FAU - Freilinger, Tobias
AU  - Freilinger T
AD  - Institute for Stroke and Dementia Research, Klinikum der Universitaet Muenchen, 
      Munich, Germany.
AD  - Department of Neurology and Epileptology, Hertie Institute for Clinical Brain 
      Research, University of Tuebingen, Tuebingen, Germany.
FAU - Ran, Caroline
AU  - Ran C
AD  - Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
FAU - Gordon, Scott D
AU  - Gordon SD
AD  - QIMR Berghofer Medical Research Institute, Brisbane, Australia.
FAU - Borck, Guntram
AU  - Borck G
AD  - Institute of Human Genetics, University of Ulm, Ulm, Germany.
FAU - Adams, Hieab H H
AU  - Adams HHH
AD  - Department of Epidemiology, Erasmus Medical Centre, Rotterdam, the Netherlands.
AD  - Department of Radiology and Nuclear Medicine, Erasmus Medical Centre, Rotterdam, 
      the Netherlands.
FAU - Lehtimäki, Terho
AU  - Lehtimäki T
AD  - Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular 
      Research Center-Tampere, Faculty of Medicine and Life Sciences, University of 
      Tampere, Tampere, Finland.
FAU - Wedenoja, Juho
AU  - Wedenoja J
AD  - Department of Ophthalmology, University of Helsinki and Helsinki University 
      Hospital, Helsinki, Finland.
AD  - Department of Public Health, University of Helsinki, Helsinki, Finland.
FAU - Buring, Julie E
AU  - Buring JE
AD  - Brigham and Women's Hospital, Boston, MA.
FAU - Schürks, Markus
AU  - Schürks M
AD  - Department of Neurology, University Hospital Essen, Germany.
FAU - Hrafnsdottir, Maria
AU  - Hrafnsdottir M
AD  - Landspitali National University Hospital, Reykjavik, Iceland.
FAU - Hottenga, Jouke-Jan
AU  - Hottenga JJ
AD  - Department of Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, The 
      Netherlands.
AD  - Avera Institute for Human Genetics, Sioux Falls, SD, USA.
FAU - Penninx, Brenda
AU  - Penninx B
AD  - Department of Psychiatry, VU University Medical Center, Amsterdam, The 
      Netherlands.
FAU - Artto, Ville
AU  - Artto V
AD  - Department of Neurology, Helsinki University Central Hospital, Helsinki, Finland.
FAU - Kaunisto, Mari
AU  - Kaunisto M
AD  - Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, 
      Helsinki, Finland.
FAU - Vepsäläinen, Salli
AU  - Vepsäläinen S
AD  - Department of Neurology, Helsinki University Central Hospital, Helsinki, Finland.
FAU - Martin, Nicholas G
AU  - Martin NG
AD  - QIMR Berghofer Medical Research Institute, Brisbane, Australia.
FAU - Montgomery, Grant W
AU  - Montgomery GW
AD  - QIMR Berghofer Medical Research Institute, Brisbane, Australia.
AD  - Institute for Molecular Bioscience, University of Queensland, Brisbane, 
      Australia.
FAU - Kurki, Mitja I
AU  - Kurki MI
AD  - Analytic Translational Genetics Unit, Massachusetts General Hospital Harvard 
      Medical School, Boston, Massachusetts, USA.
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
AD  - Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, 
      Helsinki, Finland.
FAU - Hämäläinen, Eija
AU  - Hämäläinen E
AD  - Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, 
      Helsinki, Finland.
FAU - Huang, Hailiang
AU  - Huang H
AD  - Analytic Translational Genetics Unit, Massachusetts General Hospital Harvard 
      Medical School, Boston, Massachusetts, USA.
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Department of Medicine, Harvard Medical School, Boston, MA, USA.
FAU - Huang, Jie
AU  - Huang J
AD  - Boston VA Research Institute, Boston, MA, USA.
AD  - Brigham Women's Hospital Division of Aging, Harvard Medical School, Boston, MA, 
      USA.
FAU - Sandor, Cynthia
AU  - Sandor C
AD  - Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.
FAU - Webber, Caleb
AU  - Webber C
AD  - Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.
AD  - Dementia Research Institute, Cardiff University, Cardiff, UK.
FAU - Muller-Myhsok, Bertram
AU  - Muller-Myhsok B
AD  - Max Planck Institute of Psychiatry, Munich, Germany.
AD  - Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
AD  - Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
FAU - Schreiber, Stefan
AU  - Schreiber S
AD  - Institute of Clinical Molecular Biology, Kiel University and University Hospital 
      Schleswig-Holstein, Kiel, Germany.
AD  - Clinic of Internal Medicine I, University Hospital Schleswig-Holstein, Kiel, 
      Germany.
FAU - Salomaa, Veikko
AU  - Salomaa V
AD  - National Institute for Health and Welfare, Helsinki, Finland.
FAU - Loehrer, Elizabeth
AU  - Loehrer E
AD  - Department of Environmental Health, Harvard T.H. Chan School of Public Health, 
      Boston, MA, USA.
FAU - Göbel, Hartmut
AU  - Göbel H
AD  - Kiel Pain and Headache Center, Kiel, Germany.
FAU - Macaya, Alfons
AU  - Macaya A
AD  - Pediatric Neurology Research Group, Vall d'Hebron Research Institute, Autonomous 
      University of Barcelona, Barcelona, Spain.
FAU - Pozo-Rosich, Patricia
AU  - Pozo-Rosich P
AD  - Headache Unit, Neurology Department, Hospital Vall d'Hebron, Barcelona, Spain.
AD  - Headache Research Group, VHIR, Autonomous University of Barcelona, Barcelona, 
      Spain.
FAU - Hansen, Thomas
AU  - Hansen T
AD  - Danish Headache Center, Rigshospitalet Glostrup and University of Copenhagen, 
      Copenhagen, Denmark.
AD  - Institute of Biological Psychiatry, Roskilde, Denmark.
FAU - Werge, Thomas
AU  - Werge T
AD  - Institute of Biological Psychiatry, Roskilde, Denmark.
AD  - Department of Clinical Sciences, University of Copenhagen, Copenhagen, Denmark.
AD  - Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, 
      Aarhus, Denmark.
FAU - Kaprio, Jaakko
AU  - Kaprio J
AD  - Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, 
      Helsinki, Finland.
AD  - Department of Public Health, University of Helsinki, Helsinki, Finland.
FAU - Metspalu, Andres
AU  - Metspalu A
AD  - Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, 
      Estonia.
FAU - Kubisch, Christian
AU  - Kubisch C
AD  - Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, 
      Hamburg, Germany.
FAU - Ferrari, Michel D
AU  - Ferrari MD
AD  - Department of Neurology, Leiden University Medical Center, Leiden, The 
      Netherlands.
FAU - Belin, Andrea C
AU  - Belin AC
AD  - Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
FAU - van den Maagdenberg, Arn M J M
AU  - van den Maagdenberg AMJM
AD  - Department of Human Genetics, Leiden University Medical Center, Leiden, The 
      Netherlands.
AD  - Department of Neurology, Leiden University Medical Center, Leiden, The 
      Netherlands.
FAU - Zwart, John-Anker
AU  - Zwart JA
AD  - Division of Clinical Neuroscience, Oslo University Hospital and University of 
      Oslo, Oslo, Norway.
FAU - Boomsma, Dorret
AU  - Boomsma D
AD  - Netherlands Twin Register, Vrije Universiteit, Amsterdam, the Netherlands.
AD  - Department of Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, The 
      Netherlands.
FAU - Eriksson, Nicholas
AU  - Eriksson N
AD  - 23andMe Inc., Mountain View, CA, US.
FAU - Olesen, Jes
AU  - Olesen J
AD  - Danish Headache Center, Rigshospitalet Glostrup and University of Copenhagen, 
      Copenhagen, Denmark.
FAU - Chasman, Daniel I
AU  - Chasman DI
AD  - Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, USA.
AD  - Harvard Medical School, Boston, MA, USA.
FAU - Nyholt, Dale R
AU  - Nyholt DR
AD  - Statistical and Genomic Epidemiology Laboratory, Institute of Health and 
      Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, 
      Australia.
FAU - Avbersek, Andreja
AU  - Avbersek A
AD  - Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, 
      London, UK.
FAU - Baum, Larry
AU  - Baum L
AD  - Centre for Genomic Sciences, University of Hong Kong, Hong Kong.
FAU - Berkovic, Samuel
AU  - Berkovic S
AD  - Epilepsy Research Centre, University of Melbourne, Heidelberg, Australia.
FAU - Bradfield, Jonathan
AU  - Bradfield J
AD  - Quantinuum Research LLC, San Diego, CA, USA.
FAU - Buono, Russell J
AU  - Buono RJ
AD  - Cooper Medical School of Rowan University, Camden, NJ, USA.
AD  - Thomas Jefferson University Hospital, Philadelphia, PA, USA.
AD  - Children's Hospital of Philadelphia, Philadelphia, PA, USA.
FAU - Catarino, Claudia B
AU  - Catarino CB
AD  - Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, 
      London, UK.
AD  - Epilepsy Society, Chalfont-St-Peter, Bucks, UK.
FAU - Cossette, Patrick
AU  - Cossette P
AD  - Centre de Recherche du Centre Hospitalier de l'Universite de Montreal and 
      Department of Neurosciences, Université de Montréal, Montréal, Canada.
FAU - De Jonghe, Peter
AU  - De Jonghe P
AD  - Neurogenetics Group, VIB-CMN, Antwerp, Belgium.
AD  - University of Antwerp, Antwerp, Belgium.
AD  - Department of Neurology, Antwerp University Hospital, Antwerp, Belgium.
FAU - Depondt, Chantal
AU  - Depondt C
AD  - Department of Neurology, Hôpital Erasme, Université Libre de Bruxelles, Brussels, 
      Belgium.
FAU - Dlugos, Dennis
AU  - Dlugos D
AD  - Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, 
      USA.
AD  - Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 
      USA.
FAU - Ferraro, Thomas N
AU  - Ferraro TN
AD  - Department of Biomedical Sciences, Cooper Medical School of Rowan University, 
      Camden, NJ, USA.
AD  - Department of Psychiatry, Center for Neurobiology and Behavior, Perelman School 
      of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
FAU - French, Jacqueline
AU  - French J
AD  - NYU School of Medicine, New York, NY, USA.
FAU - Hjalgrim, Helle
AU  - Hjalgrim H
AD  - Amplexa Genetics A/S, Odense, Denmark.
FAU - Jamnadas-Khoda, Jennifer
AU  - Jamnadas-Khoda J
AD  - Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, 
      London, UK.
AD  - Institute of Mental Health, University of Nottingham, Nottingham, UK.
FAU - Kälviäinen, Reetta
AU  - Kälviäinen R
AD  - Epilepsy Center/Neurocenter, Kuopio University Hospital, Kuopio, Finland.
AD  - Institute of Clinical Medicine, School of Medicine, Faculty of Health Sciences, 
      University of Eastern Finland, Kuopio, Finland.
FAU - Kunz, Wolfram S
AU  - Kunz WS
AD  - Department of Epileptology, University Bonn Medical Center, Bonn, Germany.
AD  - Institute of Experimental Epileptology and Cognition Research, University Bonn 
      Medical Center, Bonn, Germany.
FAU - Lerche, Holger
AU  - Lerche H
AD  - Department of Neurology and Epileptology, Hertie Institute for Clinical Brain 
      Research, University of Tuebingen, Tuebingen, Germany.
FAU - Leu, Costin
AU  - Leu C
AD  - Department of Clinical and Experimental Epilepsy, NIHR University College London 
      Hospitals Biomedical Research Centre, UCL Institute of Neurology, London.
FAU - Lindhout, Dick
AU  - Lindhout D
AD  - Department of Genetics, University Medical Center Utrecht, the Netherlands.
AD  - Epilepsy Foundation in the Netherlands (SEIN), Heemstede, the Netherlands.
FAU - Lo, Warren
AU  - Lo W
AD  - Departments of Pediatrics and Neurology, Ohio State University, Columbus, OH, 
      USA.
AD  - Nationwide Children's Hospital, Columbus, OH, USA.
FAU - Lowenstein, Daniel
AU  - Lowenstein D
AD  - Department of Neurology, University of California, San Francisco, CA, USA.
FAU - McCormack, Mark
AU  - McCormack M
AD  - Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in 
      Ireland, Dublin, Ireland.
AD  - Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, the 
      Netherlands.
FAU - Møller, Rikke S
AU  - Møller RS
AD  - Danish Epilepsy Centre, Filadelfia, Dianalund, Denmark.
AD  - Institute for Regional Health Services, University of Southern Denmark, Odense, 
      Denmark.
FAU - Molloy, Anne
AU  - Molloy A
AD  - Trinity College Dublin, Dublin, Ireland.
FAU - Ng, Ping-Wing
AU  - Ng PW
AD  - United Christian Hospital, Hong Kong.
AD  - Hong Kong Sanatorium and Hospital, Hong Kong.
FAU - Oliver, Karen
AU  - Oliver K
AD  - Epilepsy Research Centre, University of Melbourne, Austin Health, Heidelberg, 
      Australia.
FAU - Privitera, Michael
AU  - Privitera M
AD  - Department of Neurology, University of Cincinnati, Cincinnati, OH, USA.
AD  - UC Gardner Neuroscience Institute, Cincinnati, OH, USA.
FAU - Radtke, Rodney
AU  - Radtke R
AD  - Department of Neurology, Duke University School of Medicine, Durham, NC, USA.
FAU - Ruppert, Ann-Kathrin
AU  - Ruppert AK
AD  - Cologne Center for Genomics (CCG), University of Cologne, Cologne, Germany.
FAU - Sander, Thomas
AU  - Sander T
AD  - Cologne Center for Genomics (CCG), University of Cologne, Cologne, Germany.
FAU - Schachter, Steven
AU  - Schachter S
AD  - Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
AD  - Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
AD  - Harvard Medical School, Boston, MA, USA.
FAU - Schankin, Christoph
AU  - Schankin C
AD  - Department of Neurology, Inselspital, Bern University Hospital, University of 
      Bern, Switzerland.
AD  - Department of Neurology, University of Munich Hospital, Grosshadern, University 
      of Munich, Germany.
FAU - Scheffer, Ingrid
AU  - Scheffer I
AD  - Department of Medicine, The University of Melbourne, Austin Health, Melbourne, 
      Victoria, Australia.
AD  - Department of Paediatrics, Royal Children's Hospital, The University of 
      Melbourne, Melbourne, Victoria, Australia.
AD  - Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, 
      Australia.
FAU - Schoch, Susanne
AU  - Schoch S
AD  - Institute of Neuropathology, Bonn University Medical School, Bonn, Germany.
FAU - Sisodiya, Sanjay M
AU  - Sisodiya SM
AD  - UCL Institute of Neurology, London, UK.
AD  - Chalfont Centre for Epilepsy, Bucks, UK.
FAU - Smith, Philip
AU  - Smith P
AD  - University Hospital of Wales, Cardiff, UK.
FAU - Sperling, Michael
AU  - Sperling M
AD  - Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA.
FAU - Striano, Pasquale
AU  - Striano P
AD  - Pediatric Neurology and Muscular Diseases Unit-Department of Neurosciences, 
      Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health University of 
      Genoa, "G. Gaslini" Institute, Genova, Italy.
FAU - Surges, Rainer
AU  - Surges R
AD  - Department of Epileptology, University Hospital Bonn, Bonn, Germany.
AD  - Section of Epileptology, Department of Neurology, University Hospital RWTH 
      Aachen, Aachen, Germany.
FAU - Thomas, G Neil
AU  - Thomas GN
AD  - Institute of Applied Health Research, University of Birmingham, UK.
FAU - Visscher, Frank
AU  - Visscher F
AD  - Department of Neurology, Admiraal De Ruyter Hospital, Goes, The Netherlands.
FAU - Whelan, Christopher D
AU  - Whelan CD
AD  - Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in 
      Ireland, Dublin, Ireland.
FAU - Zara, Federico
AU  - Zara F
AD  - Laboratory of Neurogenetics, G. Gaslini Institute, Genova, Italy.
FAU - Heinzen, Erin L
AU  - Heinzen EL
AD  - Institute for Genomic Medicine, Columbia University Medical Center, New York, NY, 
      USA.
FAU - Marson, Anthony
AU  - Marson A
AD  - University of Liverpool, Liverpool, UK.
AD  - Walton Centre NHS Foundation Trust, Liverpool, UK.
FAU - Becker, Felicitas
AU  - Becker F
AD  - Department of Neurology and Epileptology, University Hospital Tuebingen, 
      Tuebingen, Germany.
AD  - Department of Neurology, University of Ulm, Ulm, Germany.
FAU - Stroink, Hans
AU  - Stroink H
AD  - CWZ Hospital, Nijmegen, Netherlands.
FAU - Zimprich, Fritz
AU  - Zimprich F
AD  - Department of Neurology, Medical University of Vienna, Austria.
FAU - Gasser, Thomas
AU  - Gasser T
AD  - Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, 
      Germany.
AD  - German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
FAU - Gibbs, Raphael
AU  - Gibbs R
AD  - Laboratory of Neurogenetics, National Institute on Aging, National Institutes of 
      Health, Bethesda, MD, USA.
FAU - Heutink, Peter
AU  - Heutink P
AD  - German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
AD  - Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, 
      Germany.
FAU - Martinez, Maria
AU  - Martinez M
AD  - INSERM U1220, IRSD, Toulouse, France.
AD  - Université Paul Sabatier, Toulouse, France.
FAU - Morris, Huw R
AU  - Morris HR
AD  - UCL Institute of Neurology, London, UK.
FAU - Sharma, Manu
AU  - Sharma M
AD  - Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied 
      Biometery, University of Tubingen, Germany.
FAU - Ryten, Mina
AU  - Ryten M
AD  - UCL Institute of Neurology, London, UK.
FAU - Mok, Kin Y
AU  - Mok KY
AD  - Department of Molecular Neuroscience, Institute of Neurology, University College 
      London, London, UK.
AD  - Division of Life Science, Hong Kong University of Science and Technology, Hong 
      Kong Special Administrative Region, China.
FAU - Pulit, Sara
AU  - Pulit S
AD  - Department of Genetics, Center for Molecular Medicine, University Medical Center 
      Utrecht, Utrecht, The Netherlands.
AD  - Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, 
      University of Oxford, Oxford, UK.
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
FAU - Bevan, Steve
AU  - Bevan S
AD  - University of Lincoln, Lincoln, UK.
FAU - Holliday, Elizabeth
AU  - Holliday E
AD  - Faculty of Health and Medicine, University of Newcastle, Callaghan, Australia.
FAU - Attia, John
AU  - Attia J
AD  - University of Newcastle, Callaghan, Australia.
AD  - Hunter Medical Research Institute, Newcastle, Australia.
FAU - Battey, Thomas
AU  - Battey T
AD  - Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
AD  - Division of Neurocritical Care and Emergency Neurology, Massachusetts General 
      Hospital, Boston, MA, USA.
FAU - Boncoraglio, Giorgio
AU  - Boncoraglio G
AD  - Department of Cerebrovascular Diseases, Fondazione IRCCS Istituto Neurologico 
      Carlo Besta, Milano, Italy.
AD  - PhD Program in Neuroscience, University Milano-Bicocca, Monza, Italy.
FAU - Thijs, Vincent
AU  - Thijs V
AD  - Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, 
      Australia.
AD  - Austin Health, Heidelberg, Australia.
FAU - Chen, Wei-Min
AU  - Chen WM
AD  - University of Virginia Center for Public Health Genomics, University of Virginia, 
      Charlottesville, VA, USA.
FAU - Mitchell, Braxton
AU  - Mitchell B
AD  - Dept of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
AD  - Geriatrics Research and Education Clinical Center, Baltimore Veterans 
      Administration Medical Center, Baltimore, MD, USA.
FAU - Rothwell, Peter
AU  - Rothwell P
AD  - Centre for Prevention of Stroke and Dementia, Nuffield Department of Clinical 
      Neurosciences, University of Oxford, Oxford, UK.
FAU - Sharma, Pankaj
AU  - Sharma P
AD  - Institute of Cardiovascular Research, Royal Holloway University of London, 
      London, UK .
AD  - Ashford & St Peters NHS Foundation Trust, Surrey, UK.
FAU - Sudlow, Cathie
AU  - Sudlow C
AD  - University of Edinburgh, Edinburgh, UK.
FAU - Vicente, Astrid
AU  - Vicente A
AD  - Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa, Portugal.
AD  - Biosystems and Integrative Sciences Institute - BioISI, University of Lisboa, 
      Lisboa, Portugal.
FAU - Markus, Hugh
AU  - Markus H
AD  - Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
FAU - Kourkoulis, Christina
AU  - Kourkoulis C
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Massachusetts General Hospital, Boston, MA, USA.
AD  - Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
FAU - Pera, Joana
AU  - Pera J
AD  - Department of Neurology, Jagiellonian University Medical College, Kraków, Poland.
FAU - Raffeld, Miriam
AU  - Raffeld M
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
AD  - Massachusetts General Hospital, Boston, MA, USA.
AD  - The Warren Alpert Medical School of Brown University, Providence, RI, USA.
FAU - Silliman, Scott
AU  - Silliman S
AD  - Department of Neurology, College of Medicine-Jacksonville, University of Florida, 
      Jacksonville, FL, USA.
FAU - Boraska Perica, Vesna
AU  - Boraska Perica V
AD  - University of Split School of Medicine, Split, Croatia.
FAU - Thornton, Laura M
AU  - Thornton LM
AD  - University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
FAU - Huckins, Laura M
AU  - Huckins LM
AD  - Icahn School of Medicine at Mount Sinai, New York, NY, USA.
FAU - William Rayner, N
AU  - William Rayner N
AD  - Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University 
      of Oxford, Oxford, UK.
AD  - Oxford Centre for Diabetes, Endocrinology and Metabolism, Nuffield Department of 
      Medicine, University of Oxford, Oxford, UK.
AD  - Department of Human Genetics, Wellcome Sanger Institute, Hinxton, Cambridgeshire, 
      UK.
FAU - Lewis, Cathryn M
AU  - Lewis CM
AD  - MRC Social, Genetic and Developmental Psychiatry Centre, King's College London, 
      London, UK.
FAU - Gratacos, Monica
AU  - Gratacos M
AD  - Genes and Disease Programme, Centre for Genomic Regulation (CRG), Barcelona, 
      Spain.
FAU - Rybakowski, Filip
AU  - Rybakowski F
AD  - Department of Adult Psychiatry, Poznan University of Medical Sciences, Poland.
FAU - Keski-Rahkonen, Anna
AU  - Keski-Rahkonen A
AD  - Clinicum, Department of Public Health, University of Helsinki, Finland.
FAU - Raevuori, Anu
AU  - Raevuori A
AD  - Department of Adolescent Psychiatry, Helsinki University Central Hospital, 
      Helsinki, Finland.
AD  - Clinicum, Department of Public Health, University of Helsinki, Finland.
FAU - Hudson, James I
AU  - Hudson JI
AD  - Harvard Medical School/McLean Hospital, Belmont, MA, USA.
FAU - Reichborn-Kjennerud, Ted
AU  - Reichborn-Kjennerud T
AD  - Norwegian Institute of Public Health, Oslo, Norway.
AD  - University of Oslo, Oslo, Norway.
FAU - Monteleone, Palmiero
AU  - Monteleone P
AD  - Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", 
      University of Salerno,Italy.
FAU - Karwautz, Andreas
AU  - Karwautz A
AD  - Eating Disorders Unit, Department of Child and Adolescent Psychiatry, Medical 
      University of Vienna, Vienna, Austria.
FAU - Mannik, Katrin
AU  - Mannik K
AD  - Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, 
      Estonia.
AD  - Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.
FAU - Baker, Jessica H
AU  - Baker JH
AD  - University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
FAU - O'Toole, Julie K
AU  - O'Toole JK
AD  - Kartini Clinic, Portland, OR, USA.
FAU - Trace, Sara E
AU  - Trace SE
AD  - Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel 
      Hill, NC, USA.
FAU - Davis, Oliver S P
AU  - Davis OSP
AD  - MRC Integrative Epidemiology Unit and Bristol Medical School, University of 
      Bristol, Bristol, UK.
FAU - Helder, Sietske G
AU  - Helder SG
AD  - Zorg op Orde BV, Leidschendam, The Netherlands.
AD  - MRC Social, Genetic and Developmental Psychiatry Centre, King's College London, 
      London, UK.
FAU - Ehrlich, Stefan
AU  - Ehrlich S
AD  - Division of Psychological & Social Medicine and Developmental Neurosciences, 
      Faculty of Medicine, Technischen Universität Dresden, Dresden, Germany.
FAU - Herpertz-Dahlmann, Beate
AU  - Herpertz-Dahlmann B
AD  - Department of Child & Adolescent Psychiatry & Psychosomatic Medicine of 
      University Clinics, RWTH Aachen, Aachen, Germany .
FAU - Danner, Unna N
AU  - Danner UN
AD  - Altrecht Eating Disorders Rintveld, Altrecht Mental Health Institute, Zeist, The 
      Netherlands.
AD  - Faculty of Social Sciences, University of Utrecht, Utrecht, the Netherlands.
FAU - van Elburg, Annemarie A
AU  - van Elburg AA
AD  - Altrecht Eating Disorders Rintveld, Altrecht Mental Health Institute, Zeist, The 
      Netherlands.
AD  - Faculty of Social Sciences, University of Utrecht, Utrecht, the Netherlands.
FAU - Clementi, Maurizio
AU  - Clementi M
AD  - Medical Genetics Unit, Department SDB, University of Padova, Padova, Italy.
FAU - Forzan, Monica
AU  - Forzan M
AD  - UOC Genetica ed Epidemiologica Clinica Az. Ospedaliera, Padova, Italy.
FAU - Docampo, Elisa
AU  - Docampo E
AD  - Department of Human Genetics, CHU Sart-Tilman, University of Liège, Liège, 
      Belgium.
AD  - Department of Rheumatology, CHU Sart-Tilman, University of Liège, Liège, Belgium.
FAU - Lissowska, Jolanta
AU  - Lissowska J
AD  - Department of Cancer Epidemiology and Prevention, Cancer Center and M. 
      Sklodowska-Curie Institute of Oncology, Warsaw, Poland.
FAU - Hauser, Joanna
AU  - Hauser J
AD  - Department of Psychiatry, University of Medical Sciences, Poznan, Poland.
FAU - Tortorella, Alfonso
AU  - Tortorella A
AD  - Department of Psychiatry, University of Perugia, Perugia, Italy.
FAU - Maj, Mario
AU  - Maj M
AD  - Department of Mental and Physical Health and Preventive Medicine, University of 
      Campania "luigi Vanvitelli", Naples, Italy.
FAU - Gonidakis, Fragiskos
AU  - Gonidakis F
AD  - Eating Disorders Unit, 1st Psychiatric Department, National and Kapodistrian 
      University of Athens, Athens, Greece.
FAU - Tziouvas, Konstantinos
AU  - Tziouvas K
AD  - Aglaia Kyriakou Childrens Hospital, Athens, Greece.
FAU - Papezova, Hana
AU  - Papezova H
AD  - Eating Disorders Unit, Department of Psychiatry, First Faculty of Medicine, 
      Charles University, Prague, Czech Republic.
AD  - General University Hospital, Prague, Czech Republic.
FAU - Yilmaz, Zeynep
AU  - Yilmaz Z
AD  - University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
FAU - Wagner, Gudrun
AU  - Wagner G
AD  - Medical University of Vienna, Austria.
FAU - Cohen-Woods, Sarah
AU  - Cohen-Woods S
AD  - School of Psychology, Flinders University, Adelaide, Australia.
FAU - Herms, Stefan
AU  - Herms S
AD  - Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.
AD  - Institute of Human Genetics, School of Medicine, University of Bonn & University 
      Hospital Bonn, Bonn, Germany.
AD  - Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, 
      Switzerland.
AD  - Human Genomics Research Group, Department of Biomedicine, University of Basel, 
      Basel, Switzerland.
FAU - Julià, Antonio
AU  - Julià A
AD  - Vall d'Hebron Research Institute, Barcelona, Spain.
FAU - Rabionet, Raquel
AU  - Rabionet R
AD  - Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
AD  - Institut de Biomedicina de la Universitat de Barcelona (IBUB), Barcelona, Spain.
AD  - Department of Genetics, Microbiology & Statistics, Faculty of Biology, University 
      of Barcelona, Barcelona, Spain.
AD  - Centre for Genomic Regulation (CRG), Barcelona, Spain.
FAU - Dick, Danielle M
AU  - Dick DM
AD  - Departments of Psychology and Human & Molecular Genetics, College Behavioral and 
      Emotional Health Institute, Virginia Commonwealth University, Richmond, Virginia.
FAU - Ripatti, Samuli
AU  - Ripatti S
AD  - Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, 
      Helsinki, Finland.
AD  - Department of Public Health, University of Helsinki, Helsinki, Finland.
AD  - Broad Institute of MIT and Harvard, Cambridge, USA.
FAU - Andreassen, Ole A
AU  - Andreassen OA
AD  - NORMENT, Div. of Mental Health and Addiction, University of Oslo, Oslo, Norway.
AD  - Oslo University Hospital, Oslo, Norway.
FAU - Espeseth, Thomas
AU  - Espeseth T
AD  - NORMENT, Div. of Mental Health and Addiction, University of Oslo, Oslo, Norway.
AD  - Department of Psychology, University of Oslo, Norway.
AD  - K. G. Jebsen Centre for Research on Neuropsychiatric Disorders, University of 
      Bergen, Bergen, Norway.
FAU - Lundervold, Astri J
AU  - Lundervold AJ
AD  - Department of Biological and Medical Psychology, University of Bergen, Bergen, 
      Norway.
AD  - K. G. Jebsen Centre for Research on Neuropsychiatric Disorders, University of 
      Bergen, Bergen, Norway.
FAU - Steen, Vidar M
AU  - Steen VM
AD  - NORMENT, K.G. Jebsen Center for Psychosis Research, Department of Clinical 
      Science, University of Bergen, Norway.
AD  - Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
FAU - Pinto, Dalila
AU  - Pinto D
AD  - Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, 
      USA.
AD  - Seaver Autism Center for Research and Treatment, Icahn School of Medicine at 
      Mount Sinai, New York, NY, USA.
AD  - Department of Genetics and Genomic Sciences, and Institute for Genomics and 
      Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
AD  - The Mindich Child Health & Development Institute, Icahn School of Medicine at 
      Mount Sinai, New York, NY, USA.
FAU - Scherer, Stephen W
AU  - Scherer SW
AD  - McLaughlin Centre and Department of Molecular Genetics, University of Toronto, 
      Toronto, Canada.
AD  - The Centre for Applied Genomics, Hospital for Sick Children, Toronto, Canada.
FAU - Aschauer, Harald
AU  - Aschauer H
AD  - Biopsychosocial Corporation, Vienna, Austria.
FAU - Schosser, Alexandra
AU  - Schosser A
AD  - Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, 
      Austria.
AD  - Zentren für Seelische Gesundheit, BBRZ-Med, Vienna, Austria.
FAU - Alfredsson, Lars
AU  - Alfredsson L
AD  - Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
FAU - Padyukov, Leonid
AU  - Padyukov L
AD  - Rheumatology Unit, Department of Medicine, Karolinska Institutet and Karolinska 
      University Hospital, Solna, Sweden.
FAU - Halmi, Katherine A
AU  - Halmi KA
AD  - Weill Cornell Medical College, New York, New York, USA.
FAU - Mitchell, James
AU  - Mitchell J
AD  - School of Medicine, University of North Dakota, Grand Forks, ND, USA.
AD  - Neuropsychiatric Research Institute, Fargo, ND, USA.
FAU - Strober, Michael
AU  - Strober M
AD  - Department of Psychiatry & Biobehavioral Sciences, Semel Institute for 
      Neuroscience & Human Behavior, David Geffen School of Medicine, University of 
      California at Los Angeles, Los Angeles, CA, USA.
FAU - Bergen, Andrew W
AU  - Bergen AW
AD  - BioRealm, Walnut, California, USA.
AD  - Oregon Research Institute, Eugene, OR, USA.
FAU - Kaye, Walter
AU  - Kaye W
AD  - Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.
FAU - Szatkiewicz, Jin Peng
AU  - Szatkiewicz JP
AD  - University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
FAU - Cormand, Bru
AU  - Cormand B
AD  - Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
AD  - Institut de Biomedicina de la Universitat de Barcelona (IBUB), Barcelona, Spain.
AD  - Department of Genetics, Microbiology & Statistics, Faculty of Biology, University 
      of Barcelona, Barcelona, Spain.
AD  - Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 
      Instituto de Salud Carlos III, Madrid, Spain.
FAU - Ramos-Quiroga, Josep Antoni
AU  - Ramos-Quiroga JA
AD  - Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
AD  - Psychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addiction, Vall 
      d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, 
      Spain.
AD  - Biomedical Network Research Centre on Mental Health (CIBERSAM), Instituto de 
      Salud Carlos III, Madrid, Spain.
AD  - Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, 
      Barcelona, Spain.
FAU - Sánchez-Mora, Cristina
AU  - Sánchez-Mora C
AD  - Psychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addiction, Vall 
      d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, 
      Spain.
AD  - Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
AD  - Biomedical Network Research Centre on Mental Health (CIBERSAM), Instituto de 
      Salud Carlos III, Madrid, Spain.
FAU - Ribasés, Marta
AU  - Ribasés M
AD  - Psychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addiction, Vall 
      d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, 
      Spain.
AD  - Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
AD  - Biomedical Network Research Centre on Mental Health (CIBERSAM), Instituto de 
      Salud Carlos III, Madrid, Spain.
FAU - Casas, Miguel
AU  - Casas M
AD  - Universitat Autònoma de Barcelona, Barcelona, Spain.
AD  - Programa Corporatiu "Neurodevelopment Disorders along Life Span", Institut Català 
      de la Salut, Barcelona, Spain.
AD  - Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
AD  - Clinica Galatea y PAIMM, Mental Health Program for Impaired Physicians, 
      Barcelona, Spain.
FAU - Hervas, Amaia
AU  - Hervas A
AD  - Child and Adolescent Mental Health Unit, Hospital Universitario Mútua de 
      Terrassa, Barcelona, Spain.
FAU - Arranz, Maria Jesús
AU  - Arranz MJ
AD  - Fundació Docència i Recerca Mútua Terrassa.
FAU - Haavik, Jan
AU  - Haavik J
AD  - K.G. Jebsen Centre for Neuropsychiatric Disorders, Department of Biomedicine, 
      University of Bergen, Norway.
AD  - Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.
FAU - Zayats, Tetyana
AU  - Zayats T
AD  - K.G. Jebsen Centre for Neuropsychiatric Disorders, Department of Biomedicine, 
      University of Bergen, Norway.
AD  - Analytic Translational Genetics Unit, Massachusetts General Hospital Harvard 
      Medical School, Boston, Massachusetts, USA.
FAU - Johansson, Stefan
AU  - Johansson S
AD  - K.G. Jebsen Centre for Neuropsychiatric Disorders, Department of Clinical 
      Science, University of Bergen, Norway.
AD  - Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
FAU - Williams, Nigel
AU  - Williams N
AD  - Cardiff University, Medical Research Council Center for Neuropsychiatric Genetics 
      & Genomics, Institute of Psychology, Medicine & Clinical Neuroscience, Cardiff, 
      UK.
FAU - Dempfle, Astrid
AU  - Dempfle A
AD  - Institute of Medical Informatics and Statistics, Kiel University, Kiel, Germany.
FAU - Rothenberger, Aribert
AU  - Rothenberger A
AD  - Child and Adolescent Psychiatry/Psychotherapy, University Medical Center, 
      Goettingen, Germany.
FAU - Kuntsi, Jonna
AU  - Kuntsi J
AD  - Institute of Psychiatry, Psychology and Neuroscience, King's College London, 
      London, UK.
FAU - Oades, Robert D
AU  - Oades RD
AD  - Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of 
      Duisburg-Essen, Essen, Germany.
FAU - Banaschewski, Tobias
AU  - Banaschewski T
AD  - Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental 
      Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
FAU - Franke, Barbara
AU  - Franke B
AD  - Department of Human Genetics, Radboud University Medical Center, Nijmegen, The 
      Netherlands.
AD  - Department of Psychiatry, Radboud University Medical Center, Nijmegen, The 
      Netherlands.
AD  - Donders Institute for Brain, Cognition and Behaviour, Radboud University, 
      Nijmegen, The Netherlands.
FAU - Buitelaar, Jan K
AU  - Buitelaar JK
AD  - Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and 
      Behavior, Radboud University Medical Centre, Nijmegen, The Netherlands.
AD  - Karakter Child and Adolescent Psychiatry University Center, Nijmegen, The 
      Netherlands.
FAU - Arias Vasquez, Alejandro
AU  - Arias Vasquez A
AD  - Department of Psychiatry & Human Genetics, Donders Institute for Brain, Cognition 
      and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
FAU - Doyle, Alysa E
AU  - Doyle AE
AD  - Massachusetts General Hospital, Boston, MA, USA.
AD  - Harvard Medical School, Boston, MA, USA.
FAU - Reif, Andreas
AU  - Reif A
AD  - Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University 
      Hospital Frankfurt, Frankfurt am Main, Germany.
FAU - Lesch, Klaus-Peter
AU  - Lesch KP
AD  - Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, I.M. 
      Sechenov First Moscow State Medical University, Moscow, Russia.
AD  - Department of Translational Psychiatry, School for Mental Health and Neuroscience 
      (MHeNS), Maastricht University, Maastricht, The Netherlands.
AD  - Division of Molecular Psychiatry, Center of Mental Health, University of 
      Wuerzburg, Wuerzburg, Germany.
FAU - Freitag, Christine
AU  - Freitag C
AD  - Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, 
      University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
FAU - Rivero, Olga
AU  - Rivero O
AD  - Division of Molecular Psychiatry, Center of Mental Health, University of 
      Wuerzburg, Wuerzburg, Germany.
FAU - Palmason, Haukur
AU  - Palmason H
AD  - Landspitali National University Hospital, Reykjavik, Iceland.
FAU - Romanos, Marcel
AU  - Romanos M
AD  - Center of Mental Health, Department of Child and Adolescent Psychiatry, 
      Psychosomatics and Psychotherapy, University Hospital of Wuerzburg, Wuerzburg, 
      Germany.
FAU - Langley, Kate
AU  - Langley K
AD  - School of Psychology, Cardiff University, UK.
AD  - MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, 
      Cardiff, UK.
FAU - Rietschel, Marcella
AU  - Rietschel M
AD  - Central Institute of Mental Health, Department of Genetic Epidemiology in 
      Psychiatry, Medical Faculty Mannheim, University of Heidelberg, Mannheim, 
      Germany.
FAU - Witt, Stephanie H
AU  - Witt SH
AD  - Central Institute of Mental Health, Department of Genetic Epidemiology in 
      Psychiatry, Medical Faculty Mannheim, University of Heidelberg, Mannheim, 
      Germany.
FAU - Dalsgaard, Soeren
AU  - Dalsgaard S
AD  - National Centre for Register-based Research, Aarhus University, Aarhus, Denmark.
AD  - Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, 
      Aarhus, Denmark.
AD  - Hospital of Telemark, Kragerø, Norway.
FAU - Børglum, Anders D
AU  - Børglum AD
AD  - Department of Biomedicine and Human Genetics, Aarhus University, Aarhus, Denmark.
AD  - Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, 
      Aarhus, Denmark.
AD  - Center for Integrative Sequencing (iSEQ), Aarhus University, Aarhus, Denmark.
AD  - Aarhus Genome Center, Aarhus, Denmark.
FAU - Waldman, Irwin
AU  - Waldman I
AD  - Department of Psychology, Emory University, Atlanta, GA, USA.
FAU - Wilmot, Beth
AU  - Wilmot B
AD  - Department of Medical Informatics and Clinical Epidemiology, Oregon Health & 
      Science University, Portland, OR, USA.
FAU - Molly, Nikolas
AU  - Molly N
AD  - Department of Psychological and Brain Sciences, University of Iowa, Iowa City, 
      IA, USA.
FAU - Bau, Claiton H D
AU  - Bau CHD
AD  - Departamento de Genética, Universidade Federal do Rio Grande do Sul, Porto 
      Alegre, Brazil.
AD  - ADHD Outpatient Clinic, Hospital de Clínicas de Porto Alegre, Porto Alegre, 
      Brazil.
FAU - Crosbie, Jennifer
AU  - Crosbie J
AD  - Neurosciences and Mental Health Program, Research Institute, Hospital for Sick 
      Children, Toronto, Canada.
AD  - University of Toronto, Toronto, Canada.
FAU - Schachar, Russell
AU  - Schachar R
AD  - Hospital for Sick Children, Toronto, Canada.
AD  - University of Toronto, Toronto, Canada.
FAU - Loo, Sandra K
AU  - Loo SK
AD  - Department of Psychiatry, University of California, Los Angeles, Los Angeles, CA, 
      USA.
FAU - McGough, James J
AU  - McGough JJ
AD  - Semel Institute for Neuroscience & Human Behavior, David Geffen School of 
      Medicine, University of California at Los Angeles, Los Angeles, CA, USA.
FAU - Grevet, Eugenio H
AU  - Grevet EH
AD  - ADHD Outpatient Clinic, Hospital de Clínicas de Porto Alegre, Porto Alegre, 
      Brazil.
AD  - Department of Psychiatry, Faculdade de Medicina, Universidade Federal do Rio 
      Grande do Sul, Porto Alegre, Brazil.
FAU - Medland, Sarah E
AU  - Medland SE
AD  - QIMR Berghofer Medical Research Institute, Brisbane, Australia.
FAU - Robinson, Elise
AU  - Robinson E
AD  - Analytic Translational Genetics Unit, Massachusetts General Hospital Harvard 
      Medical School, Boston, Massachusetts, USA.
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, 
      Massachusetts, USA.
FAU - Weiss, Lauren A
AU  - Weiss LA
AD  - Department of Psychiatry, University of California, San Francisco, San Francisco, 
      CA, USA.
AD  - Institute for Human Genetics, University of California, San Francisco, San 
      Francisco, CA, USA.
AD  - Weill Institute for Neurosciences, University of California, San Francisco, San 
      Francisco, CA, USA.
FAU - Bacchelli, Elena
AU  - Bacchelli E
AD  - Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
FAU - Bailey, Anthony
AU  - Bailey A
AD  - Department of Psychiatry, University of British Columbia, Vancouver, Canada.
AD  - Institute of Mental Health, University of British Columbia, Vancouver, Canada.
FAU - Bal, Vanessa
AU  - Bal V
AD  - Department of Psychiatry, University of California, San Francisco, San Francisco, 
      CA, USA.
AD  - Institute for Human Genetics, University of California, San Francisco, San 
      Francisco, CA, USA.
AD  - Weill Institute for Neurosciences, University of California, San Francisco, San 
      Francisco, CA, USA.
FAU - Battaglia, Agatino
AU  - Battaglia A
AD  - Stella Maris Clinical Research Institute for Child and Adolescent 
      Neuropsychiatry, Pisa, Italy.
FAU - Betancur, Catalina
AU  - Betancur C
AD  - Sorbonne Université, INSERM, CNRS, Neuroscience Paris Seine, Institut de Biologie 
      Paris Seine, Paris, France.
FAU - Bolton, Patrick
AU  - Bolton P
AD  - Institute of Psychiatry, Psychology and Neuroscience, King's College London, 
      London, UK.
AD  - NIHR Biomedical Research Centre in Mental Health Maudsley Hospital, London, UK.
FAU - Cantor, Rita
AU  - Cantor R
AD  - Department of Human Genetics, David Geffen School of Medicine, University of 
      California at Los Angeles, Los Angeles, CA, USA.
FAU - Celestino-Soper, Patrícia
AU  - Celestino-Soper P
AD  - LifeOmic, Indianapolis, IN, USA.
FAU - Dawson, Geraldine
AU  - Dawson G
AD  - Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, 
      USA.
FAU - De Rubeis, Silvia
AU  - De Rubeis S
AD  - Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, 
      USA.
AD  - Seaver Autism Center for Research and Treatment, Icahn School of Medicine at 
      Mount Sinai, New York, NY, USA.
AD  - Mindich Child Health and Development Institute, Icahn School of Medicine at Mount 
      Sinai, New York, NY, USA.
FAU - Duque, Frederico
AU  - Duque F
AD  - Child Developmental Center, Hospital Pediátrico, Centro Hospitalar e 
      Universitário de Coimbra, Coimbra, Portugal.
AD  - University Clinic of Pediatrics, Faculty of Medicine, University of Coimbra, 
      Coimbra, Portugal.
FAU - Green, Andrew
AU  - Green A
AD  - Dept of Clinical Genetics, Our Lady's Children's Hospital, Crumlin, Dublin, 
      Ireland.
AD  - School of Medicine and Medical Science, University College Dublin, Dublin, 
      Ireland.
FAU - Klauck, Sabine M
AU  - Klauck SM
AD  - Division of Molecular Genome Analysis and Division of Cancer Genome Research, 
      German Cancer Research Center (DKFZ), Heidelberg, Germany.
FAU - Leboyer, Marion
AU  - Leboyer M
AD  - Inserm U955, Psychiatrie Translationnelle, Créteil, France.
AD  - Faculté de Médecine, Université Paris Est, Créteil, France.
AD  - Fondation FondaMental, Créteil, France.
FAU - Levitt, Pat
AU  - Levitt P
AD  - Children's Hospital Los Angeles, Los Angeles, CA, USA .
AD  - Keck School of Medicine of the University of Southern California, Los Angeles, 
      CA, USA.
FAU - Maestrini, Elena
AU  - Maestrini E
AD  - Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
FAU - Mane, Shrikant
AU  - Mane S
AD  - Yale Center for Genome Analysis, Yale University, New Haven, CT, USA.
AD  - Department of Genetics, Yale University School of Medicine, New Haven, CT, USA.
FAU - De-Luca, Daniel Moreno-
AU  - De-Luca DM
AD  - Division of Child and Adolescent Psychiatry, Department of Psychiatry and Human 
      Behavior, Brown University, Providence, RI, USA.
FAU - Parr, Jeremy
AU  - Parr J
AD  - Institute of Neuroscience, Newcastle University, Newcastle, UK.
AD  - Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
AD  - Northumberland, Tyne & Wear NHS Foundation Trust, Northumberland, UK.
FAU - Regan, Regina
AU  - Regan R
AD  - School of Medicine and Medical Science, University College Dublin, Dublin, 
      Ireland.
AD  - Genomics Medicine Ireland, Dublin, Ireland.
FAU - Reichenberg, Abraham
AU  - Reichenberg A
AD  - Icahn School of Medicine at Mount Sinai, New York, NY, USA.
FAU - Sandin, Sven
AU  - Sandin S
AD  - Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, 
      USA.
AD  - Seaver Autism Center for Research and Treatment, Icahn School of Medicine at 
      Mount Sinai, New York, NY, USA.
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
FAU - Vorstman, Jacob
AU  - Vorstman J
AD  - Department of Psychiatry, Hospital for Sick Children and University of Toronto, 
      Toronto, Canada.
AD  - Program in Genetics and Genome Biology, Hospital for Sick Children, Toronto, 
      Canada.
FAU - Wassink, Thomas
AU  - Wassink T
AD  - Department of Psychiatry, Carver College of Medicine, University of Iowa, Iowa 
      City, IA, USA.
FAU - Wijsman, Ellen
AU  - Wijsman E
AD  - Division of Medical Genetics, Department of Medicine, University of Washington, 
      Seattle, WA, USA.
AD  - Department of Biostatistics, University of Washington, Seattle, WA, USA.
FAU - Cook, Edwin
AU  - Cook E
AD  - Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA.
FAU - Santangelo, Susan
AU  - Santangelo S
AD  - Center for Psychiatric Research, Maine Medical Center Research Institute, 
      Portland, ME, USA.
AD  - Department of Psychiatry, Tufts University School of Medicine, Boston, MA, USA.
FAU - Delorme, Richard
AU  - Delorme R
AD  - Child and Adolescent Psychiatry Department, Robert Debre Hospital, APHP, Paris, 
      France.
AD  - Human Genetics and Cognitive Functions, Institut Pasteur, Paris, France.
FAU - Rogé, Bernadette
AU  - Rogé B
AD  - Centre d'Etudes et de Recherches en Psychopathologie et Psychologie de la Santé 
      (CERPPS), Université Toulouse Jean Jaurès, Toulouse, France.
AD  - CERESA, Toulouse, France.
AD  - Institut Universitaire de France, Paris, France.
FAU - Magalhaes, Tiago
AU  - Magalhaes T
AD  - Genomics Medicine Ireland, Dublin, Ireland.
AD  - Academic Centre on Rare Diseases University College Dublin (ACoRD/UCD), Dublin, 
      Ireland.
FAU - Arking, Dan
AU  - Arking D
AD  - McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School 
      of Medicine, Baltimore, MD, USA.
FAU - Schulze, Thomas G
AU  - Schulze TG
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, Germany.
AD  - Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, 
      Göttingen, Germany.
AD  - Central Institute of Mental Health, Department of Genetic Epidemiology in 
      Psychiatry, Medical Faculty Mannheim, University of Heidelberg, Mannheim, 
      Germany.
AD  - Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, 
      Baltimore, MD, USA.
AD  - Human Genetics Branch, National Institute of Mental Health, National Institutes 
      of Health, US Department of Health and Human Services, Bethesda, MD, USA.
FAU - Thompson, Robert C
AU  - Thompson RC
AD  - Molecular and Behavioral Neuroscience Institute, University of Michigan, Ann 
      Arbor, MI, USA.
AD  - Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
FAU - Strohmaier, Jana
AU  - Strohmaier J
AD  - Central Institute of Mental Health, Department of Genetic Epidemiology in 
      Psychiatry, Medical Faculty Mannheim, University of Heidelberg, Mannheim, 
      Germany.
AD  - SRH University Heidelberg, Academy for Psychotherapy, Heidelberg, Germany.
FAU - Matthews, Keith
AU  - Matthews K
AD  - Division of Neuroscience, School of Medicine, University of Dundee, Dundee, UK.
AD  - Advanced Interventions Service, NHS Tayside, Dundee, UK.
FAU - Melle, Ingrid
AU  - Melle I
AD  - NORMENT, K.G. Jebsen Centre for Psychosis Research, Institute of Clinical 
      Medicine, University of Oslo, Oslo, Norway.
AD  - Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
FAU - Morris, Derek
AU  - Morris D
AD  - Cognitive Genetics and Cognitive Therapy Group, Neuroimaging, Cognition and 
      Genomics (NICOG) Centre, School of Psychology and Discipline of Biochemistry, 
      National University of Ireland Galway, Galway, Ireland.
FAU - Blackwood, Douglas
AU  - Blackwood D
AD  - Division of Psychiatry, University of Edinburgh, Edinburgh, UK.
FAU - McIntosh, Andrew
AU  - McIntosh A
AD  - Division of Psychiatry, University of Edinburgh, Edinburgh, UK.
FAU - Bergen, Sarah E
AU  - Bergen SE
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
FAU - Schalling, Martin
AU  - Schalling M
AD  - Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, 
      Sweden.
AD  - Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
FAU - Jamain, Stéphane
AU  - Jamain S
AD  - Inserm U955, Psychiatrie Translationnelle, Créteil, France.
AD  - Faculté de Médecine, Université Paris Est, Créteil, France.
AD  - Fondation FondaMental, Créteil, France.
FAU - Maaser, Anna
AU  - Maaser A
AD  - Institute of Human Genetics, School of Medicine, University of Bonn & University 
      Hospital Bonn, Bonn, Germany.
AD  - Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.
FAU - Fischer, Sascha B
AU  - Fischer SB
AD  - Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, 
      Switzerland.
AD  - Department of Biomedicine, University of Basel, Basel, Switzerland.
FAU - Reinbold, Céline S
AU  - Reinbold CS
AD  - Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, 
      Switzerland.
AD  - Department of Biomedicine, University of Basel, Basel, Switzerland.
FAU - Fullerton, Janice M
AU  - Fullerton JM
AD  - Neuroscience Research Australia, Sydney, Australia.
AD  - School of Medical Sciences, University of New South Wales, Sydney, Australia.
FAU - Guzman-Parra, José
AU  - Guzman-Parra J
AD  - Unidad de Salud Mental, Hospital Regional Universitario de Malaga, Malaga, Spain.
AD  - Instituto de Investigación Biomédica de Málaga (IBIMA), Malaga, Spain.
FAU - Mayoral, Fermin
AU  - Mayoral F
AD  - Unidad de Salud Mental, Hospital Regional Universitario de Malaga, Malaga, Spain.
AD  - Instituto de Investigación Biomédica de Málaga (IBIMA), Malaga, Spain.
FAU - Schofield, Peter R
AU  - Schofield PR
AD  - Neuroscience Research Australia, Sydney, Australia.
AD  - School of Medical Sciences, University of New South Wales, Sydney, Australia.
FAU - Cichon, Sven
AU  - Cichon S
AD  - Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, 
      Switzerland.
AD  - Department of Biomedicine, University of Basel, Basel, Switzerland.
AD  - Institute of Neuroscience and Medicine (INM-1), Research Centre Jülich, Jülich, 
      Germany.
FAU - Mühleisen, Thomas W
AU  - Mühleisen TW
AD  - Institute of Neuroscience and Medicine (INM-1), Research Centre Jülich, Jülich, 
      Germany.
AD  - Department of Biomedicine, University of Basel, Basel, Switzerland.
FAU - Degenhardt, Franziska
AU  - Degenhardt F
AD  - Institute of Human Genetics, University of Bonn, Bonn, Germany.
FAU - Schumacher, Johannes
AU  - Schumacher J
AD  - Institute of Human Genetics, University of Bonn, Bonn, Germany.
FAU - Bauer, Michael
AU  - Bauer M
AD  - Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav 
      Carus, Technische Universität Dresden, Dresden, Germany.
FAU - Mitchell, Philip B
AU  - Mitchell PB
AD  - School of Psychiatry, University of New South Wales, Sydney, Australia.
AD  - Black Dog Institute, Sydney, Australia.
FAU - Gershon, Elliot S
AU  - Gershon ES
AD  - University of Chicago, Chicago, IL, USA.
FAU - Rice, John
AU  - Rice J
AD  - Washington University, St. Louis, MO, USA.
FAU - Potash, James B
AU  - Potash JB
AD  - Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, 
      Baltimore, MD, USA.
FAU - Zandi, Peter P
AU  - Zandi PP
AD  - Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, MD, USA.
FAU - Craddock, Nick
AU  - Craddock N
AD  - MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, 
      Cardiff, UK.
FAU - Ferrier, I Nicol
AU  - Ferrier IN
AD  - Institute of Neuroscience, Newcastle University, Newcastle, UK.
FAU - Alda, Martin
AU  - Alda M
AD  - Department of Psychiatry, Dalhousie University, Halifax, Canada.
AD  - National Institute of Mental Health, Klecany, Czech Republic.
FAU - Rouleau, Guy A
AU  - Rouleau GA
AD  - Montreal Neurological Institute, McGill University, Montréal, Canada.
AD  - Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.
FAU - Turecki, Gustavo
AU  - Turecki G
AD  - Department of Psychiatry, McGill University, Montréal, Canada.
FAU - Ophoff, Roel
AU  - Ophoff R
AD  - Center for Neurobehavioral Genetics, Semel Institute for Neuroscience & Human 
      Behavior, University of California at Los Angeles, Los Angeles, CA, USA.
AD  - UMC Utrecht, Utrecht, The Netherlands.
FAU - Pato, Carlos
AU  - Pato C
AD  - SUNY Downstate Medical Center, Brooklyn, NY, USA.
FAU - Anjorin, Adebayo
AU  - Anjorin A
AD  - University College London, London, UK.
FAU - Stahl, Eli
AU  - Stahl E
AD  - Icahn School of Medicine at Mount Sinai, New York, NY, USA.
AD  - Broad Institute of MIT and Harvard, Cambridge, USA.
FAU - Leber, Markus
AU  - Leber M
AD  - Hospital for Psychiatry and Psychotherapy, Cologne, Germany.
FAU - Czerski, Piotr M
AU  - Czerski PM
AD  - Laboratory of Psychiatric Genetics, Department of Psychiatry, Poznan University 
      of Medical Sciences, Poznan, Poland.
FAU - Cruceanu, Cristiana
AU  - Cruceanu C
AD  - Douglas Mental Health University Institute, McGill University, Montreal, Canada.
AD  - Department of Translational Research in Psychiatry, Max-Planck Institute of 
      Psychiatry, Munich, Germany.
FAU - Jones, Ian R
AU  - Jones IR
AD  - National Centre for Mental Health, MRC Centre for Neuropsychiatric Genetics and 
      Genomics, Cardiff University, Cardiff, UK.
FAU - Posthuma, Danielle
AU  - Posthuma D
AD  - Department Complex Trait Genetics, Center for Neurogenomics and Cognitive 
      Research, VU University, Amsterdam, The Netherlands.
AD  - Department Clinical Genetics, VU University Medical Center, Amsterdam 
      Neuroscience, Amsterdam, The Netherlands.
FAU - Andlauer, Till F M
AU  - Andlauer TFM
AD  - Max Planck Institute of Psychiatry, Munich, Germany.
AD  - Department of Neurology, Klinikum rechts der Isar, Technical University of 
      Munich, Munich, Germany.
FAU - Forstner, Andreas J
AU  - Forstner AJ
AD  - Institute of Human Genetics, School of Medicine, University of Bonn & University 
      Hospital Bonn, Bonn, Germany.
AD  - Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.
AD  - Human Genomics Research Group, Department of Biomedicine, University of Basel, 
      Basel, Switzerland.
AD  - Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, 
      Switzerland.
AD  - Department of Psychiatry (UPK), University of Basel, Basel, Switzerland.
FAU - Streit, Fabian
AU  - Streit F
AD  - Central Institute of Mental Health, Department of Genetic Epidemiology in 
      Psychiatry, Medical Faculty Mannheim, University of Heidelberg, Mannheim, 
      Germany.
FAU - Baune, Bernhard T
AU  - Baune BT
AD  - Discipline of Psychiatry, University of Adelaide, Adelaide, Australia.
FAU - Air, Tracy
AU  - Air T
AD  - Discipline of Psychiatry, University of Adelaide, Adelaide, Australia.
FAU - Sinnamon, Grant
AU  - Sinnamon G
AD  - Bela Menso Brain and Behaviour Centre, James Cook University, Varsity Lakes, 
      Australia.
AD  - Bond University, Faculty of Society and Design, Robina, Australia.
FAU - Wray, Naomi R
AU  - Wray NR
AD  - Institute for Molecular Bioscience, University of Queensland, Brisbane, 
      Australia.
AD  - Queensland Brain Institute, University of Queensland, Brisbane, Australia.
FAU - MacIntyre, Donald J
AU  - MacIntyre DJ
AD  - Division of Psychiatry, Centre for Clinical Brain Sciences, University of 
      Edinburgh, Edinburgh, UK.
FAU - Porteous, David
AU  - Porteous D
AD  - Centre for Genomic and Experimental Medicine, University of Edinburgh, Edinburgh, 
      UK.
FAU - Homuth, Georg
AU  - Homuth G
AD  - Interfaculty Institute for Genetics and Functional Genomics, University Medicine 
      Greifswald, Greifswald, Germany.
FAU - Rivera, Margarita
AU  - Rivera M
AD  - Department of Biochemistry and Molecular Biology II, Institute of Neurosciences, 
      Center for Biomedical Research, University of Granada, Granada, Spain.
AD  - MRC Social, Genetic and Developmental Psychiatry Centre, King's College London, 
      London, UK.
FAU - Grove, Jakob
AU  - Grove J
AD  - Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, 
      Aarhus, Denmark.
AD  - Center for Integrative Sequencing (iSEQ), Aarhus University, Aarhus, Denmark.
AD  - Department of Biomedicine and Human Genetics, Aarhus University, Aarhus, Denmark.
AD  - Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark.
FAU - Middeldorp, Christel M
AU  - Middeldorp CM
AD  - Child Health Research Centre, University of Queensland, Brisbane, Australia.
AD  - Child and Youth Mental Health Service, Children's Health Queensland Health and 
      Hospital Service, Brisbane, Australia.
AD  - Department of Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, The 
      Netherlands.
FAU - Hickie, Ian
AU  - Hickie I
AD  - Brain and Mind Centre, University of Sydney, Sydney, Australia.
FAU - Pergadia, Michele
AU  - Pergadia M
AD  - Washington University School of Medicine, St. Louis, MO, USA.
FAU - Mehta, Divya
AU  - Mehta D
AD  - School of Psychology and Counselling, Faculty of Health, Institute of Health and 
      Biomedical Innovation, Queensland University of Technology, Queensland, 
      Australia.
AD  - University of Queensland, Brisbane, Australia.
FAU - Smit, Johannes H
AU  - Smit JH
AD  - Department of Psychiatry, VU University Medical Center, Amsterdam, The 
      Netherlands.
AD  - Amsterdam Public Health Research Institute, VU Medical Center, Amsterdam, the 
      Netherlands.
AD  - Department of Research and Innovation, GGZ Ingeest, Specialized Mental Health 
      Care, Amsterdam, the Netherlands.
FAU - Jansen, Rick
AU  - Jansen R
AD  - Department of Psychiatry, VU University Medical Center, Amsterdam, The 
      Netherlands.
FAU - de Geus, Eco
AU  - de Geus E
AD  - Department of Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, The 
      Netherlands.
AD  - Amsterdam Public Health Research Institute, VU Medical Center, Amsterdam, the 
      Netherlands.
FAU - Dunn, Erin
AU  - Dunn E
AD  - Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
AD  - Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
FAU - Li, Qingqin S
AU  - Li QS
AD  - Janssen Research & Development LLC, Titusville, NJ, USA.
FAU - Nauck, Matthias
AU  - Nauck M
AD  - Institute of Clinical Chemistry and Laboratory Medicine, University Medicine 
      Greifswald, Greifswald, Germany .
AD  - German Centre for Cardiovascular Research (DZHK e.V.), Partner Site Greifswald, 
      Greifswald, Germany.
FAU - Schoevers, Robert A
AU  - Schoevers RA
AD  - Research School of Behavioural and Cognitive Neurosciences, Department of 
      Psychiatry, University Medical Center Groningen, University of Groningen, 
      Groningen, the Netherlands.
FAU - Beekman, Aartjan Tf
AU  - Beekman AT
AD  - Department of Psychiatry, VU University Medical Center, Amsterdam, The 
      Netherlands.
AD  - Department of Psychiatry GGZ INGEEST, Amsterdam, the Netherlands.
FAU - Knowles, James A
AU  - Knowles JA
AD  - Department of Cell Biology, SUNY Downstate Medical Center, Brooklyn, NY, USA.
FAU - Viktorin, Alexander
AU  - Viktorin A
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
FAU - Arnold, Paul
AU  - Arnold P
AD  - Mathison Centre for Mental Health Research & Education, Hotchkiss Brain 
      Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada.
AD  - Departments of Psychiatry and Medical Genetics, Cumming School of Medicine, 
      University of Calgary, Calgary, Canada.
AD  - Program in Genetics and Genome Biology, Hospital for Sick Children, Toronto, 
      Canada.
FAU - Barr, Cathy L
AU  - Barr CL
AD  - Krembil Research Institute, University Health Network, Toronto, Canada.
AD  - Hospital for Sick Children, Toronto, Canada.
AD  - University of Toronto, Toronto, Canada.
FAU - Bedoya-Berrio, Gabriel
AU  - Bedoya-Berrio G
AD  - Grupo de Genética Molecular, Instituto de Biología, Facultad de Ciencias Exactas 
      y Naturales, Universidad de Antioquia, Medellín, Colombia.
FAU - Bienvenu, O Joseph
AU  - Bienvenu OJ
AD  - Johns Hopkins University School of Medicine, Baltimore, MD, USA.
FAU - Brentani, Helena
AU  - Brentani H
AD  - Department of Psychiatry, Sao Paulo Medical School, University of Sao Paulo, Sao 
      Paulo, Brazil.
FAU - Burton, Christie
AU  - Burton C
AD  - Hospital for Sick Children, Toronto, Canada.
FAU - Camarena, Beatriz
AU  - Camarena B
AD  - Depto. Farmacogenética, Instituto Nacional de Psiquiatria Ramon de la Fuente 
      Muñiz, Mexico City, Mexico.
FAU - Cappi, Carolina
AU  - Cappi C
AD  - Department of Psychiatry, Sao Paulo Medical School, University of Sao Paulo, Sao 
      Paulo, Brazil.
FAU - Cath, Danielle
AU  - Cath D
AD  - Department of Psychiatry, University of Groningen and University Medical Center, 
      Groningen, the Netherlands.
AD  - Department of Specialized Trainings, GGZ Drenthe Mental Health Care Services, 
      Assen, the Netherlands.
FAU - Cavallini, Maria
AU  - Cavallini M
AD  - Ospedale San Raffaele, Milano, Italy.
FAU - Cusi, Daniele
AU  - Cusi D
AD  - Bio4Dreams Srl, Milan, Italy.
FAU - Darrow, Sabrina
AU  - Darrow S
AD  - University of California, San Francisco, CA, USA.
FAU - Denys, Damiaan
AU  - Denys D
AD  - Department of Psychiatry, Academic Medical Center, University of Amsterdam, 
      Amsterdam, the Netherlands.
AD  - Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and 
      Sciences, Amsterdam, the Netherlands.
FAU - Derks, Eske M
AU  - Derks EM
AD  - QIMR Berghofer Medical Research Institute, Brisbane, Australia.
FAU - Dietrich, Andrea
AU  - Dietrich A
AD  - University of Groningen, Groningen, the Netherlands.
AD  - Department of Child and Adolescent Psychiatry, University Medical Center 
      Groningen, University of Groningen, Groningen, The Netherlands.
FAU - Fernandez, Thomas
AU  - Fernandez T
AD  - Yale University School of Medicine, New Haven, CT, USA.
FAU - Figee, Martijn
AU  - Figee M
AD  - Department of Psychiatry, Academic Medical Center, University of Amsterdam, 
      Amsterdam, the Netherlands.
AD  - Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, 
      USA.
FAU - Freimer, Nelson
AU  - Freimer N
AD  - Center for Neurobehavioral Genetics, Semel Institute for Neuroscience & Human 
      Behavior, University of California at Los Angeles, Los Angeles, CA, USA.
FAU - Gerber, Gloria
AU  - Gerber G
AD  - Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
FAU - Grados, Marco
AU  - Grados M
AD  - Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, 
      Baltimore, MD, USA.
FAU - Greenberg, Erica
AU  - Greenberg E
AD  - Massachusetts General Hospital, Boston, MA, USA.
FAU - Hanna, Gregory L
AU  - Hanna GL
AD  - Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
FAU - Hartmann, Andreas
AU  - Hartmann A
AD  - Centre National Maladie 'Syndrome Rare Gilles de la Tourette', Groupe Hospitalier 
      Pitié-Salpêtrière, Paris, France.
AD  - Assistance Publique-Hôpitaux de Paris, Départment de Neurologie, Groupe 
      Hospitalier Pitié-Salpêtrière, Paris, France.
AD  - Sorbonne Universités, UPMC Université Paris 06, UMR S 1127, CNRS UMR 7225, ICM, 
      Paris, France.
FAU - Hirschtritt, Matthew E
AU  - Hirschtritt ME
AD  - Department of Psychiatry, University of California, San Francisco, San Francisco, 
      CA, USA.
AD  - Weill Institute for Neurosciences, University of California, San Francisco, San 
      Francisco, CA, USA.
FAU - Hoekstra, Pieter J
AU  - Hoekstra PJ
AD  - Department of Child and Adolescent Psychiatry, University Medical Center 
      Groningen, University of Groningen, Groningen, The Netherlands.
FAU - Huang, Alden
AU  - Huang A
AD  - Bioinformatics Interdepartmental Program, University of California, Los Angeles, 
      Los Angeles, CA, USA.
AD  - Semel Institute for Neuroscience & Human Behavior, David Geffen School of 
      Medicine, University of California at Los Angeles, Los Angeles, CA, USA.
FAU - Huyser, Chaim
AU  - Huyser C
AD  - De Bascule, Amsterdam, The Netherlands.
AD  - Department of Child and Adolescent Psychiatry, Academic Medical Center, 
      University of Amsterdam, Amsterdam, the Netherlands.
FAU - Illmann, Cornelia
AU  - Illmann C
AD  - Massachusetts General Hospital, Boston, MA, USA.
FAU - Jenike, Michael
AU  - Jenike M
AD  - Harvard Medical School, Boston, MA, USA.
FAU - Kuperman, Samuel
AU  - Kuperman S
AD  - Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
FAU - Leventhal, Bennett
AU  - Leventhal B
AD  - University of California, San Francisco, CA, USA.
FAU - Lochner, Christine
AU  - Lochner C
AD  - MRC Unit on Risk & Resilience in Mental Disorders, Department of Psychiatry, 
      University of Cape Town, Cape Town, South Africa.
FAU - Lyon, Gholson J
AU  - Lyon GJ
AD  - Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
FAU - Macciardi, Fabio
AU  - Macciardi F
AD  - Department of Psychiatry and Human Behavior, University of California, Irvine, 
      Irvine, CA, USA.
FAU - Madruga-Garrido, Marcos
AU  - Madruga-Garrido M
AD  - Sección de Neuropediatría, Instituto de Biomedicina de Sevilla, Hospital 
      Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.
FAU - Malaty, Irene A
AU  - Malaty IA
AD  - Department of Neurology, University of Florida, Gainesville, FL, USA.
FAU - Maras, Athanasios
AU  - Maras A
AD  - Yulius Academy, Yulius Mental Health Organization, Barendrecht, The Netherlands.
FAU - McGrath, Lauren
AU  - McGrath L
AD  - Department of Psychology, University of Denver, Denver, CO, USA.
FAU - Miguel, Eurípedes C
AU  - Miguel EC
AD  - Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo, Brazil.
FAU - Mir, Pablo
AU  - Mir P
AD  - Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología 
      Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del 
      Rocío/CSIC/Universidad de Sevilla, Seville, Spain.
AD  - Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas 
      (CIBERNED), Madrid, Spain.
FAU - Nestadt, Gerald
AU  - Nestadt G
AD  - Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, 
      Baltimore, MD, USA.
FAU - Nicolini, Humberto
AU  - Nicolini H
AD  - National Institute of Genomic Medicine (INMEGEN), Ciudad de México, Mexico.
AD  - Clinical Research, Grupo Médico Carracci, Mexico City, Mexico.
FAU - Okun, Michael S
AU  - Okun MS
AD  - Departments of Neurology and Neurosurgery, University of Florida, Gainesville, 
      FL, USA.
AD  - Fixel Center for Neurological Diseases, University of Florida, Gainesville, FL, 
      USA.
AD  - McKnight Brain Institute, University of Florida, Gainesville, FL, USA.
FAU - Pakstis, Andrew
AU  - Pakstis A
AD  - Department of Genetics, Yale University School of Medicine, New Haven, CT, USA.
FAU - Paschou, Peristera
AU  - Paschou P
AD  - Department of Biological Sciences, Purdue University, West Lafayette, Indiana, 
      USA.
FAU - Piacentini, John
AU  - Piacentini J
AD  - Semel Institute for Neuroscience & Human Behavior, David Geffen School of 
      Medicine, University of California at Los Angeles, Los Angeles, CA, USA.
FAU - Pittenger, Christopher
AU  - Pittenger C
AD  - Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
FAU - Plessen, Kerstin
AU  - Plessen K
AD  - Division of Adolescent and Child Psychiatry, Department of Psychiatry, Lausanne 
      University Hospital, Lausanne, Switzerland.
AD  - Child and Adolescent Mental Health Centre, Mental Health Services Capital Region 
      Copenhagen, University of Copenhagen, Copenhagen, Denmark.
FAU - Ramensky, Vasily
AU  - Ramensky V
AD  - Moscow Institute of Physics and Technology, Dolgoprudny, Institusky 9, Moscow, 
      Russia.
FAU - Ramos, Eliana M
AU  - Ramos EM
AD  - Department of Psychiatry, David Geffen School of Medicine, University of 
      California at Los Angeles, Los Angeles, CA, USA.
FAU - Reus, Victor
AU  - Reus V
AD  - Department of Psychiatry, University of California, San Francisco, San Francisco, 
      CA, USA.
AD  - Weill Institute for Neurosciences, University of California, San Francisco, San 
      Francisco, CA, USA.
FAU - Richter, Margaret A
AU  - Richter MA
AD  - Frederick W. Thompson Anxiety Disorders Centre, Sunnybrook Health Sciences 
      Centre, Toronto, Canada.
AD  - Department of Psychiatry, University of Toronto, Toronto, Canada.
FAU - Riddle, Mark A
AU  - Riddle MA
AD  - Johns Hopkins University School of Medicine, Baltimore, MD, USA.
FAU - Robertson, Mary M
AU  - Robertson MM
AD  - Division of Neuropsychiatry, University College London, London, UK.
FAU - Roessner, Veit
AU  - Roessner V
AD  - Department of Child and Adolescent Psychiatry, Faculty of Medicine, Technischen 
      Universität Dresden, Dresden, Germany.
FAU - Rosário, Maria
AU  - Rosário M
AD  - Child and Adolescent Psychiatry Unit (UPIA), Department of Psychiatry, Federal 
      University of São Paulo, Brazil.
AD  - Yale Child Study Center, Yale University School of Medicine, New Haven, CT, USA.
FAU - Samuels, Jack F
AU  - Samuels JF
AD  - Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, 
      Baltimore, MD, USA.
FAU - Sandor, Paul
AU  - Sandor P
AD  - Department of Psychiatry, University of Toronto, Toronto, Canada.
AD  - University Health Network, University of Toronto, Toronto, Canada.
AD  - Youthdale Treatment Centers, Toronto, Canada.
FAU - Stein, Dan J
AU  - Stein DJ
AD  - Groote Schuur Hospital, Cape Town, South Africa.
AD  - MRC Unit on Risk & Resilience in Mental Disorders, Department of Psychiatry, 
      University of Cape Town, Cape Town, South Africa.
FAU - Tsetsos, Fotis
AU  - Tsetsos F
AD  - Department of Molecular Biology and Genetics, Democritus University of Thrace, 
      Alexandroupolis, Greece.
FAU - Van Nieuwerburgh, Filip
AU  - Van Nieuwerburgh F
AD  - Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium.
FAU - Weatherall, Sarah
AU  - Weatherall S
AD  - Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
FAU - Wendland, Jens R
AU  - Wendland JR
AD  - Pfizer, Inc., New York, NY, USA.
FAU - Wolanczyk, Tomasz
AU  - Wolanczyk T
AD  - Department of Child Psychiatry, Medical University of Warsaw, Warsaw, Poland.
FAU - Worbe, Yulia
AU  - Worbe Y
AD  - Sorbonne Université, Faculty of Médecine, Paris, France.
AD  - Reference center for Gilles de la Tourette syndrome, Pitie-Salpetriere Hospital, 
      Paris, France.
AD  - Department of Physiology, Saint Antoine Hospital, Paris, France.
FAU - Zai, Gwyneth
AU  - Zai G
AD  - Department of Psychiatry, University of Toronto, Toronto, Canada.
FAU - Goes, Fernando S
AU  - Goes FS
AD  - Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, 
      Baltimore, MD, USA.
FAU - McLaughlin, Nicole
AU  - McLaughlin N
AD  - Butler Hospital, Providence, RI, USA.
AD  - Alpert Medical School of Brown University, Providence, RI, USA.
FAU - Nestadt, Paul S
AU  - Nestadt PS
AD  - Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, 
      Baltimore, MD, USA.
FAU - Grabe, Hans-Jorgen
AU  - Grabe HJ
AD  - Department of Psychiatry and Psychotherapy, University Medicine Greifswald, 
      Greifswald, Germany.
FAU - Depienne, Christel
AU  - Depienne C
AD  - Institute of Human Genetics, University Hospital Essen, University 
      Duisburg-Essen, Essen, Germany.
AD  - INSERM, U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 
      1127, Paris, France.
AD  - IGBMC, CNRS UMR 7104/INSERM U964/Université de Strasbourg, Illkirch, France.
FAU - Konkashbaev, Anuar
AU  - Konkashbaev A
AD  - Vanderbilt University Medical Center, Nashville, TN, USA.
FAU - Lanzagorta, Nuria
AU  - Lanzagorta N
AD  - Clinical Research, Grupo Médico Carracci, Mexico City, Mexico.
FAU - Valencia-Duarte, Ana
AU  - Valencia-Duarte A
AD  - Escuela de Ciencias de la Salud, Universidad Pontificia Bolivariana, Medellín, 
      Colombia.
AD  - Laboratorio de Genética Molecular, SIU, Universidad de Antioquia, Medellín, 
      Colombia.
FAU - Bramon, Elvira
AU  - Bramon E
AD  - Division of Psychiatry, Molecular Psychiatry Laboratory,University College 
      London, London, UK.
FAU - Buccola, Nancy
AU  - Buccola N
AD  - School of Nursing, Louisiana State University Health Sciences Center, New 
      Orleans, LA, USA.
FAU - Cahn, Wiepke
AU  - Cahn W
AD  - Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The 
      Netherlands.
FAU - Cairns, Murray
AU  - Cairns M
AD  - School of Biomedical Sciences and Pharmacy, The University of Newcastle, 
      Callaghan, Australia.
AD  - Priority Research Centre for Brain and Mental Health Research, Hunter Medical 
      Research Institute, Newcastle, Australia.
AD  - Schizophrenia Research Institute, Sydney, Australia.
FAU - Chong, Siow A
AU  - Chong SA
AD  - Institute of Mental Health, Singapore, Singapore.
FAU - Cohen, David
AU  - Cohen D
AD  - Assistance Publique - Hopitaux de Paris, GH Pitié-Salpêtrière, Paris, France.
AD  - Sorbonne Université, CNRS UMR 7222 Institut des Systèmes Intelligents et 
      Robotiques, Paris, France.
FAU - Crespo-Facorro, Benedicto
AU  - Crespo-Facorro B
AD  - Departments of Medicine and Psychiatry, School of Medicine University of 
      Cantabria-IDIVAL, University Hospital Marqués de Valdecilla, Santander, Spain.
AD  - Biomedical Network Research Centre on Mental Health (CIBERSAM), Instituto de 
      Salud Carlos III, Madrid, Spain.
FAU - Crowley, James
AU  - Crowley J
AD  - Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel 
      Hill, NC, USA.
FAU - Davidson, Michael
AU  - Davidson M
AD  - Minerva Neurosciences Inc., Waltham, MA, USA.
AD  - Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
FAU - DeLisi, Lynn
AU  - DeLisi L
AD  - VA Boston Healthcare System, Boston, MA, USA.
AD  - Harvard Medical School, Boston, MA, USA.
FAU - Dinan, Timothy
AU  - Dinan T
AD  - APC Microbiome Ireland, University College Cork, Cork, Ireland.
AD  - Department of Psychiatry, University College Cork, Cork, Ireland.
FAU - Donohoe, Gary
AU  - Donohoe G
AD  - Neuroimaging, Cognition and Genomics (NICOG) Centre, School of Psychology, 
      National University of Ireland Galway, Galway, Ireland.
FAU - Drapeau, Elodie
AU  - Drapeau E
AD  - Icahn School of Medicine at Mount Sinai, New York, NY, USA.
AD  - Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, 
      USA.
AD  - Seaver Autism Center for Research and Treatment, Icahn School of Medicine at 
      Mount Sinai, New York, NY, USA.
FAU - Duan, Jubao
AU  - Duan J
AD  - Center for Psychiatric Genetics, NorthShore University HealthSystem Research 
      Institute, Evanston, IL, USA.
AD  - Department of Psychiatry and Behavioral Neuroscience, University of Chicago, 
      Chicago, IL, USA.
FAU - Haan, Lieuwe
AU  - Haan L
AD  - Department of Psychiatry, Academic Medical Center, University of Amsterdam, 
      Amsterdam, the Netherlands.
AD  - Arkin, Amsterdam, the Netherlands.
FAU - Hougaard, David
AU  - Hougaard D
AD  - Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.
FAU - Karachanak-Yankova, Sena
AU  - Karachanak-Yankova S
AD  - Department of Medical Genetics, Medical University, Sofia, Bulgaria.
FAU - Khrunin, Andrey
AU  - Khrunin A
AD  - Department of Molecular Bases of Human Genetics, Institute of Molecular Genetics, 
      Russian Academy of Sciences, Moscow, Russia.
FAU - Klovins, Janis
AU  - Klovins J
AD  - Latvian Biomedical Research and Study Centre, Riga, Latvia.
FAU - Kučinskas, Vaidutis
AU  - Kučinskas V
AD  - Vilnius University, Vilnius, Lithuania.
FAU - Lee Chee Keong, Jimmy
AU  - Lee Chee Keong J
AD  - Institute of Mental Health, Lee Kong Chian School of Medicine, Nanyang 
      Technological University, Singapore, Singapore.
FAU - Limborska, Svetlana
AU  - Limborska S
AD  - Department of Human Genetics, Institute of Molecular Genetics, Russian Academy of 
      Sciences, Moscow, Russia.
FAU - Loughland, Carmel
AU  - Loughland C
AD  - Hunter New England Local Health District, Newcastle, Australia.
AD  - University of Newcastle, Callaghan, Australia.
FAU - Lönnqvist, Jouko
AU  - Lönnqvist J
AD  - National Institute for Health and Welfare, Helsinki, Finland.
AD  - Department of Psychiatry, University of Helsinki, Helsinki, Finland.
FAU - Maher, Brion
AU  - Maher B
AD  - Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, MD, USA.
FAU - Mattheisen, Manuel
AU  - Mattheisen M
AD  - Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental 
      Health, University Hospital Wuerzburg, Wuerzburg, Germany.
AD  - Department of Biomedicine, Aarhus University, Aarhus, Denmark.
AD  - Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska 
      Institutet, Stockholm, Sweden.
FAU - McDonald, Colm
AU  - McDonald C
AD  - Centre for Neuroimaging and Cognitive Genomics (NICOG), National University of 
      Ireland, Galway, Galway, Ireland.
AD  - NCBES Galway Neuroscience Centre, National University of Ireland, Galway, Galway, 
      Ireland.
FAU - Murphy, Kieran C
AU  - Murphy KC
AD  - Department of Psychiatry, Royal College of Surgeons in Ireland, Dublin, Ireland.
FAU - Nenadic, Igor
AU  - Nenadic I
AD  - Philipps-Universität Marburg and Marburg University Hospital UKGM, Marburg, 
      Germany.
AD  - Department of Psychiatry and Psychotherapy, Jena University Hospital, Jena, 
      Germany.
FAU - van Os, Jim
AU  - van Os J
AD  - Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The 
      Netherlands.
AD  - Maastricht University Medical Centre, Maastricht, the Netherlands.
AD  - Department of Psychosis Studies, Institute of Psychiatry, King's College London, 
      London, UK.
FAU - Pantelis, Christos
AU  - Pantelis C
AD  - Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of 
      Melbourne & Melbourne Health, Victoria, Australia.
AD  - Centre for Neural Engineering, Department of Electrical and Electronic 
      Engineering, University of Melbourne, Victoria, Australia.
AD  - Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, 
      Australia.
FAU - Pato, Michele
AU  - Pato M
AD  - SUNY Downstate Medical Center, Brooklyn, NY, USA.
FAU - Petryshen, Tracey
AU  - Petryshen T
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
FAU - Quested, Digby
AU  - Quested D
AD  - Oxford Health NHS Foundation Trust, Oxford, UK.
AD  - Department of Psychiatry, University of Oxford, Oxford, UK.
FAU - Roussos, Panos
AU  - Roussos P
AD  - Icahn School of Medicine at Mount Sinai, New York, NY, USA.
FAU - Sanders, Alan R
AU  - Sanders AR
AD  - Department of Psychiatry and Behavioral Sciences, NorthShore University 
      HealthSystem Research Institute, Evanston, IL, USA.
AD  - Department of Psychiatry and Behavioral Neuroscience, University of Chicago, 
      Chicago, IL, USA.
FAU - Schall, Ulrich
AU  - Schall U
AD  - University of Newcastle, Callaghan, Australia.
FAU - Schwab, Sibylle G
AU  - Schwab SG
AD  - Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, 
      Australia.
FAU - Sim, Kang
AU  - Sim K
AD  - Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
AD  - Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, 
      Singapore.
AD  - Institute of Mental Health, Singapore, Singapore.
FAU - So, Hon-Cheong
AU  - So HC
AD  - School of Biomedical Sciences, Chinese University of Hong Kong, Shatin, Hong 
      Kong.
AD  - KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research of Common 
      Diseases, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, 
      China.
AD  - Chinese University of Hong Kong, Hong Kong.
FAU - Stögmann, Elisabeth
AU  - Stögmann E
AD  - Department of Neurology, Medical University of Vienna, Austria.
FAU - Subramaniam, Mythily
AU  - Subramaniam M
AD  - Institute of Mental Health, Singapore, Singapore.
AD  - Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, 
      Singapore.
FAU - Toncheva, Draga
AU  - Toncheva D
AD  - Department of Medical Genetics, Medical University, Sofia, Bulgaria.
FAU - Waddington, John
AU  - Waddington J
AD  - Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in 
      Ireland, Dublin, Ireland.
FAU - Walters, James
AU  - Walters J
AD  - MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, 
      Cardiff, UK.
AD  - Institute of Psychological Medicine and Clinical Neurosciences, School of 
      Medicine, Cardiff University, Cardiff, UK.
FAU - Weiser, Mark
AU  - Weiser M
AD  - Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
AD  - Sheba Medical Center, Ramat Gan, Israel.
FAU - Cheng, Wei
AU  - Cheng W
AD  - University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
FAU - Cloninger, Robert
AU  - Cloninger R
AD  - Departments of Psychiatry and Genetics, Washington University School of Medicine, 
      St. Louis, MO, USA.
FAU - Curtis, David
AU  - Curtis D
AD  - UCL Genetics Institute, University College London, London, UK.
AD  - Centre for Psychiatry, Barts and the London School of Medicine and Dentistry, 
      London, UK.
FAU - Gejman, Pablo V
AU  - Gejman PV
AD  - Department of Psychiatry and Behavioral Neuroscience, University of Chicago, 
      Chicago, IL, USA.
AD  - Department of Psychiatry and Behavioral Sciences, NorthShore University 
      HealthSystem Research Institute, Evanston, IL, USA.
FAU - Henskens, Frans
AU  - Henskens F
AD  - School of Medicine & Public Health, University of Newcastle, Callaghan, 
      Australia.
AD  - Priority Research Centre for Health Behaviour, University of Newcastle, 
      Callaghan, Australia.
AD  - Hunter Medical Research Institute, Newcastle, Australia.
FAU - Mattingsdal, Morten
AU  - Mattingsdal M
AD  - NORMENT, K.G. Jebsen Centre for Psychosis Research, Institute of Clinical 
      Medicine, University of Oslo, Oslo, Norway.
AD  - Research Unit, Sørlandet Hospital, Kristiansand, Norway.
FAU - Oh, Sang-Yun
AU  - Oh SY
AD  - Department of Statistics and Applied Probability, University of California, Santa 
      Barbara, CA, USA.
AD  - Computational Research Division, Lawrence Berkeley National Laboratory, 
      University of California at Berkeley, Berkeley, CA, USA.
FAU - Scott, Rodney
AU  - Scott R
AD  - University of Newcastle, Callaghan, Australia.
AD  - Hunter Medical Research Institute, Newcastle, Australia.
AD  - NSW Health Pathology, Newcastle, Australia.
FAU - Webb, Bradley
AU  - Webb B
AD  - Virginia Institute for Psychiatric and Behavioral Genetics, Department of 
      Psychiatry, Virginia Commonwealth University, Richmond, VA, USA.
FAU - Breen, Gerome
AU  - Breen G
AUID- ORCID: 0000-0003-2053-1792
AD  - Institute of Psychiatry, Psychology & Neuroscience, Social Genetics & 
      Developmental Psychiatry Center, MRC, Kings College London, London, UK.
AD  - NIHR Maudsley Biomedical Research Centre, South London & Maudsley NHS Trust & 
      King's College London, London, UK.
FAU - Churchhouse, Claire
AU  - Churchhouse C
AD  - Analytic Translational Genetics Unit, Massachusetts General Hospital Harvard 
      Medical School, Boston, Massachusetts, USA.
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
FAU - Bulik, Cynthia M
AU  - Bulik CM
AUID- ORCID: 0000-0001-7772-3264
AD  - Departments of Psychiatry and Nutrition, University of North Carolina at Chapel 
      Hill, Chapel Hill, NC, USA.
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
FAU - Daly, Mark
AU  - Daly M
AUID- ORCID: 0000-0002-0949-8752
AD  - Analytic Translational Genetics Unit, Massachusetts General Hospital Harvard 
      Medical School, Boston, Massachusetts, USA.
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
FAU - Dichgans, Martin
AU  - Dichgans M
AUID- ORCID: 0000-0002-0654-387X
AD  - Institute for Stroke and Dementia Research (ISD), University Hospital, LMU 
      Munich, Munich, Germany.
AD  - Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
FAU - Faraone, Stephen V
AU  - Faraone SV
AUID- ORCID: 0000-0002-9217-3982
AD  - Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate 
      Medical University, Syracuse, NY, USA.
FAU - Guerreiro, Rita
AU  - Guerreiro R
AD  - UK Dementia Research Institute, University College London, London, UK.
AD  - Department of Molecular Neuroscience, Institute of Neurology, University College 
      London, London, UK.
FAU - Holmans, Peter
AU  - Holmans P
AUID- ORCID: 0000-0003-0870-9412
AD  - Cardiff University, Medical Research Council Center for Neuropsychiatric Genetics 
      & Genomics, Institute of Psychology, Medicine & Clinical Neuroscience, Cardiff, 
      UK.
FAU - Kendler, Kenneth S
AU  - Kendler KS
AD  - Department of Psychiatry, Virginia Commonwealth University, Richmond, VA, USA.
FAU - Koeleman, Bobby
AU  - Koeleman B
AUID- ORCID: 0000-0001-7749-182X
AD  - Division Biomedical Genetics, University Medical Center Utrecht, Utrecht, the 
      Netherlands.
FAU - Mathews, Carol A
AU  - Mathews CA
AUID- ORCID: 0000-0003-2208-7058
AD  - Department of Psychiatry and UF Genetics Institute, University of Florida, 
      Gainesville, FL, USA.
AD  - McKnight Brain Institute, University of Florida, Gainesville, FL, USA.
FAU - Price, Alkes
AU  - Price A
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, 
      Massachusetts, USA.
FAU - Scharf, Jeremiah
AU  - Scharf J
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
AD  - Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
AD  - Division of Cognitive and Behavioral Neurology, Brigham and Women's Hospital, 
      Boston, MA, USA.
AD  - Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
AD  - Harvard Medical School, Boston, MA, USA.
FAU - Sklar, Pamela
AU  - Sklar P
AUID- ORCID: 0000-0001-9715-4943
AD  - Icahn School of Medicine at Mount Sinai, New York, NY, USA.
FAU - Williams, Julie
AU  - Williams J
AUID- ORCID: 0000-0002-4069-0259
AD  - Cardiff University, Medical Research Council Center for Neuropsychiatric Genetics 
      & Genomics, Institute of Psychology, Medicine & Clinical Neuroscience, Cardiff, 
      UK.
AD  - Dementia Research Institute, Cardiff University, Cardiff, UK.
FAU - Wood, Nicholas W
AU  - Wood NW
AUID- ORCID: 0000-0002-9500-3348
AD  - Department of Molecular Neuroscience, Institute of Neurology, University College 
      London, London, UK.
AD  - UCL Genetics Institute, University College London, London, UK.
FAU - Cotsapas, Chris
AU  - Cotsapas C
AUID- ORCID: 0000-0002-7772-5910
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Department of Neurology, Yale School of Medicine, New Haven, CT, USA.
FAU - Palotie, Aarno
AU  - Palotie A
AD  - Analytic Translational Genetics Unit, Massachusetts General Hospital Harvard 
      Medical School, Boston, Massachusetts, USA.
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
AD  - Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
AD  - Harvard Medical School, Boston, MA, USA.
AD  - Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, 
      Helsinki, Finland.
FAU - Smoller, Jordan W
AU  - Smoller JW
AUID- ORCID: 0000-0002-0381-6334
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
FAU - Sullivan, Patrick
AU  - Sullivan P
AUID- ORCID: 0000-0002-6619-873X
AD  - Departments of Psychiatry and Nutrition, University of North Carolina at Chapel 
      Hill, Chapel Hill, NC, USA.
AD  - Department of Genetics and Psychiatry, University of North Carolina School of 
      Medicine, Chapel Hill, North Carolina, USA.
FAU - Rosand, Jonathan
AU  - Rosand J
AUID- ORCID: 0000-0002-1014-9138
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
AD  - Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
AD  - Harvard Medical School, Boston, MA, USA.
FAU - Corvin, Aiden
AU  - Corvin A
AUID- ORCID: 0000-0001-6717-4089
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA. verneri.anttila@gmail.com acorvin@tcd.ie 
      bneale@broadinstitute.org.
AD  - Neuropsychiatric Genetics Research Group, Department of Psychiatry, Trinity 
      College Dublin, Dublin, Ireland.
FAU - Neale, Benjamin M
AU  - Neale BM
AUID- ORCID: 0000-0003-1513-6077
AD  - Analytic Translational Genetics Unit, Massachusetts General Hospital Harvard 
      Medical School, Boston, Massachusetts, USA. verneri.anttila@gmail.com 
      acorvin@tcd.ie bneale@broadinstitute.org.
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, Massachusetts, USA.
FAU - Schott, Jonathan M
AU  - Schott JM
AD  - Dementia Research Centre, UCL Institute of Neurology, London, UK.
FAU - Anney, Richard
AU  - Anney R
AD  - MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, 
      Cardiff, UK.
AD  - Institute of Psychological Medicine and Clinical Neurosciences, School of 
      Medicine, Cardiff University, Cardiff, UK.
FAU - Elia, Josephine
AU  - Elia J
AD  - Department of Pediatrics, Nemours A.I. duPont Hospital for Children, Wilmington, 
      DE, USA.
AD  - Department of Psychiatry, Sidney Kimmel Medical College, Thomas Jefferson 
      University, Philadelphia, PA, USA.
FAU - Grigoroiu-Serbanescu, Maria
AU  - Grigoroiu-Serbanescu M
AD  - Alexandru Obregia Clinical Psychiatric Hospital, Biometric Psychiatric Genetics 
      Research Unit, Bucharest, Romania.
FAU - Edenberg, Howard J
AU  - Edenberg HJ
AD  - Department of Biochemistry and Molecular Biology, Indiana University School of 
      Medicine, Indianapolis, IN, USA.
FAU - Murray, Robin
AU  - Murray R
AD  - Institute of Psychiatry, Psychology and Neuroscience, King's College London, 
      London, UK.
LA  - eng
GR  - K07 AG043587/AG/NIA NIH HHS/United States
GR  - R01 MH100027/MH/NIMH NIH HHS/United States
GR  - P01 AG026276/AG/NIA NIH HHS/United States
GR  - MR/N008324/1/MRC_/Medical Research Council/United Kingdom
GR  - P30 AG021342/AG/NIA NIH HHS/United States
GR  - P30 AG008017/AG/NIA NIH HHS/United States
GR  - P30 AG010161/AG/NIA NIH HHS/United States
GR  - MR/R024804/1/MRC_/Medical Research Council/United Kingdom
GR  - R01 AG041718/AG/NIA NIH HHS/United States
GR  - G0401207/MRC_/Medical Research Council/United Kingdom
GR  - R01 NS017950/NS/NINDS NIH HHS/United States
GR  - G0800637/MRC_/Medical Research Council/United Kingdom
GR  - MR/L501529/1/MRC_/Medical Research Council/United Kingdom
GR  - R01 AG054076/AG/NIA NIH HHS/United States
GR  - K01 MH109782/MH/NIMH NIH HHS/United States
GR  - 203249/Z/16/Z/WT_/Wellcome Trust/United Kingdom
GR  - R01 MH104964/MH/NIMH NIH HHS/United States
GR  - UL1 TR002369/TR/NCATS NIH HHS/United States
GR  - R25 MH077823/MH/NIMH NIH HHS/United States
GR  - MR/L010305/1/MRC_/Medical Research Council/United Kingdom
GR  - Z99 AG999999/ImNIH/Intramural NIH HHS/United States
GR  - MR/L501554/1/MRC_/Medical Research Council/United Kingdom
GR  - MC_UU_00024/1/MRC_/Medical Research Council/United Kingdom
GR  - U01 AG016976/AG/NIA NIH HHS/United States
GR  - PDA/02/06/016/DH_/Department of Health/United Kingdom
GR  - P01 AG003991/AG/NIA NIH HHS/United States
GR  - R01 MH115958/MH/NIMH NIH HHS/United States
GR  - P50 AG005681/AG/NIA NIH HHS/United States
GR  - P50 AG005136/AG/NIA NIH HHS/United States
GR  - G0300189/MRC_/Medical Research Council/United Kingdom
GR  - U01 MH109536/MH/NIMH NIH HHS/United States
GR  - R01 MH106490/MH/NIMH NIH HHS/United States
GR  - R01 MH115961/MH/NIMH NIH HHS/United States
GR  - P50 AG005133/AG/NIA NIH HHS/United States
GR  - T32 MH076694/MH/NIMH NIH HHS/United States
GR  - R01 MH085548/MH/NIMH NIH HHS/United States
GR  - G0901310/MRC_/Medical Research Council/United Kingdom
GR  - U24 MH068457/MH/NIMH NIH HHS/United States
GR  - MR/P005748/1/MRC_/Medical Research Council/United Kingdom
GR  - R00 MH101367/MH/NIMH NIH HHS/United States
GR  - J-0901/PUK_/Parkinson's UK/United Kingdom
GR  - R01 MH123451/MH/NIMH NIH HHS/United States
GR  - MC_G1000735/MRC_/Medical Research Council/United Kingdom
GR  - UKDRI-2002/MRC_/Medical Research Council/United Kingdom
GR  - ALCHALABI-DOBSON/APR14/829-791/MNDA_/Motor Neurone Disease Association/United 
      Kingdom
GR  - U01 AG052409/AG/NIA NIH HHS/United States
GR  - R01 AG030653/AG/NIA NIH HHS/United States
GR  - R01 MH107649/MH/NIMH NIH HHS/United States
GR  - R01 MH092293/MH/NIMH NIH HHS/United States
GR  - P30 AG010129/AG/NIA NIH HHS/United States
GR  - U01 MH094432/MH/NIMH NIH HHS/United States
GR  - MR/L023784/2/MRC_/Medical Research Council/United Kingdom
GR  - MR/K026992/1/MRC_/Medical Research Council/United Kingdom
GR  - U01 AG049505/AG/NIA NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Science
JT  - Science (New York, N.Y.)
JID - 0404511
SB  - IM
CIN - Science. 2018 Sep 28;361(6409):1323-1324. PMID: 30262491
MH  - Brain Diseases/classification/diagnosis/*genetics
MH  - Genetic Variation
MH  - Genome-Wide Association Study
MH  - Humans
MH  - Mental Disorders/classification/diagnosis/*genetics
MH  - Phenotype
MH  - Quantitative Trait, Heritable
MH  - Risk Factors
PMC - PMC6097237
MID - NIHMS979389
COIS- Competing interests: The authors declare no competing interests.
EDAT- 2018/06/23 06:00
MHDA- 2018/08/23 06:00
CRDT- 2018/06/23 06:00
PHST- 2016/04/15 00:00 [received]
PHST- 2017/02/07 00:00 [revised]
PHST- 2018/04/24 00:00 [accepted]
PHST- 2018/06/23 06:00 [entrez]
PHST- 2018/06/23 06:00 [pubmed]
PHST- 2018/08/23 06:00 [medline]
AID - 360/6395/eaap8757 [pii]
AID - 10.1126/science.aap8757 [doi]
PST - ppublish
SO  - Science. 2018 Jun 22;360(6395):eaap8757. doi: 10.1126/science.aap8757.

PMID- 35948633
OWN - NLM
STAT- MEDLINE
DCOM- 20220819
LR  - 20221117
IS  - 1476-4687 (Electronic)
IS  - 0028-0836 (Print)
IS  - 0028-0836 (Linking)
VI  - 608
IP  - 7923
DP  - 2022 Aug
TI  - Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.
PG  - 609-617
LID - 10.1038/s41586-022-05066-5 [doi]
AB  - Somatic hotspot mutations and structural amplifications and fusions that affect 
      fibroblast growth factor receptor 2 (encoded by FGFR2) occur in multiple types of 
      cancer(1). However, clinical responses to FGFR inhibitors have remained 
      variable(1-9), emphasizing the need to better understand which FGFR2 alterations 
      are oncogenic and therapeutically targetable. Here we apply transposon-based 
      screening(10,11) and tumour modelling in mice(12,13), and find that the 
      truncation of exon 18 (E18) of Fgfr2 is a potent driver mutation. Human 
      oncogenomic datasets revealed a diverse set of FGFR2 alterations, including 
      rearrangements, E1-E17 partial amplifications, and E18 nonsense and frameshift 
      mutations, each causing the transcription of E18-truncated FGFR2 (FGFR2(ΔE18)). 
      Functional in vitro and in vivo examination of a compendium of FGFR2(ΔE18) and 
      full-length variants pinpointed FGFR2-E18 truncation as single-driver alteration 
      in cancer. By contrast, the oncogenic competence of FGFR2 full-length 
      amplifications depended on a distinct landscape of cooperating driver genes. This 
      suggests that genomic alterations that generate stable FGFR2(ΔE18) variants are 
      actionable therapeutic targets, which we confirmed in preclinical mouse and human 
      tumour models, and in a clinical trial. We propose that cancers containing any 
      FGFR2 variant with a truncated E18 should be considered for FGFR-targeted 
      therapies.
CI  - © 2022. The Author(s), under exclusive licence to Springer Nature Limited.
FAU - Zingg, Daniel
AU  - Zingg D
AUID- ORCID: 0000-0001-6450-2534
AD  - Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
AD  - Oncode Institute, Utrecht, The Netherlands.
FAU - Bhin, Jinhyuk
AU  - Bhin J
AUID- ORCID: 0000-0001-8898-4531
AD  - Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
AD  - Oncode Institute, Utrecht, The Netherlands.
AD  - Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, 
      The Netherlands.
FAU - Yemelyanenko, Julia
AU  - Yemelyanenko J
AUID- ORCID: 0000-0001-9697-2039
AD  - Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
AD  - Oncode Institute, Utrecht, The Netherlands.
FAU - Kas, Sjors M
AU  - Kas SM
AD  - Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
AD  - Oncode Institute, Utrecht, The Netherlands.
FAU - Rolfs, Frank
AU  - Rolfs F
AD  - Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
AD  - Oncode Institute, Utrecht, The Netherlands.
AD  - OncoProteomics Laboratory, Department of Medical Oncology, Cancer Center 
      Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The 
      Netherlands.
FAU - Lutz, Catrin
AU  - Lutz C
AD  - Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
AD  - Oncode Institute, Utrecht, The Netherlands.
FAU - Lee, Jessica K
AU  - Lee JK
AUID- ORCID: 0000-0002-4333-5092
AD  - Foundation Medicine, Cambridge, MA, USA.
FAU - Klarenbeek, Sjoerd
AU  - Klarenbeek S
AUID- ORCID: 0000-0002-1891-1940
AD  - Experimental Animal Pathology, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
FAU - Silverman, Ian M
AU  - Silverman IM
AUID- ORCID: 0000-0003-3819-6726
AD  - Incyte Research Institute, Wilmington, DE, USA.
FAU - Annunziato, Stefano
AU  - Annunziato S
AD  - Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
AD  - Oncode Institute, Utrecht, The Netherlands.
FAU - Chan, Chang S
AU  - Chan CS
AUID- ORCID: 0000-0001-9897-4759
AD  - Department of Medicine, Division of Medical Oncology, Rutgers Cancer Institute of 
      New Jersey, New Brunswick, NJ, USA.
AD  - Department of Medicine and Pharmacology, Rutgers University, Piscataway, NJ, USA.
FAU - Piersma, Sander R
AU  - Piersma SR
AD  - OncoProteomics Laboratory, Department of Medical Oncology, Cancer Center 
      Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The 
      Netherlands.
FAU - Eijkman, Timo
AU  - Eijkman T
AD  - Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
AD  - Oncode Institute, Utrecht, The Netherlands.
FAU - Badoux, Madelon
AU  - Badoux M
AD  - Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
AD  - Oncode Institute, Utrecht, The Netherlands.
FAU - Gogola, Ewa
AU  - Gogola E
AD  - Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
AD  - Oncode Institute, Utrecht, The Netherlands.
FAU - Siteur, Bjørn
AU  - Siteur B
AD  - Mouse Clinic for Cancer and Aging, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
FAU - Sprengers, Justin
AU  - Sprengers J
AD  - Mouse Clinic for Cancer and Aging, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
FAU - de Klein, Bim
AU  - de Klein B
AD  - Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
AD  - Oncode Institute, Utrecht, The Netherlands.
FAU - de Goeij-de Haas, Richard R
AU  - de Goeij-de Haas RR
AD  - OncoProteomics Laboratory, Department of Medical Oncology, Cancer Center 
      Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The 
      Netherlands.
FAU - Riedlinger, Gregory M
AU  - Riedlinger GM
AD  - Department of Medicine and Pharmacology, Rutgers University, Piscataway, NJ, USA.
AD  - Department of Pathology, Rutgers Cancer Institute of New Jersey, New Brunswick, 
      NJ, USA.
FAU - Ke, Hua
AU  - Ke H
AD  - Department of Medicine, Division of Medical Oncology, Rutgers Cancer Institute of 
      New Jersey, New Brunswick, NJ, USA.
AD  - Department of Medicine and Pharmacology, Rutgers University, Piscataway, NJ, USA.
FAU - Madison, Russell
AU  - Madison R
AUID- ORCID: 0000-0002-7838-2526
AD  - Foundation Medicine, Cambridge, MA, USA.
FAU - Drenth, Anne Paulien
AU  - Drenth AP
AD  - Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
AD  - Oncode Institute, Utrecht, The Netherlands.
FAU - van der Burg, Eline
AU  - van der Burg E
AD  - Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
AD  - Oncode Institute, Utrecht, The Netherlands.
FAU - Schut, Eva
AU  - Schut E
AD  - Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
AD  - Oncode Institute, Utrecht, The Netherlands.
FAU - Henneman, Linda
AU  - Henneman L
AD  - Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
AD  - Oncode Institute, Utrecht, The Netherlands.
AD  - Mouse Clinic for Cancer and Aging, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
FAU - van Miltenburg, Martine H
AU  - van Miltenburg MH
AD  - Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
AD  - Oncode Institute, Utrecht, The Netherlands.
FAU - Proost, Natalie
AU  - Proost N
AD  - Mouse Clinic for Cancer and Aging, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
FAU - Zhen, Huiling
AU  - Zhen H
AD  - Incyte, Wilmington, DE, USA.
FAU - Wientjens, Ellen
AU  - Wientjens E
AD  - Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
AD  - Oncode Institute, Utrecht, The Netherlands.
FAU - de Bruijn, Roebi
AU  - de Bruijn R
AD  - Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
AD  - Oncode Institute, Utrecht, The Netherlands.
AD  - Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, 
      The Netherlands.
FAU - de Ruiter, Julian R
AU  - de Ruiter JR
AD  - Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
AD  - Oncode Institute, Utrecht, The Netherlands.
AD  - Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, 
      The Netherlands.
FAU - Boon, Ute
AU  - Boon U
AD  - Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
AD  - Oncode Institute, Utrecht, The Netherlands.
FAU - de Korte-Grimmerink, Renske
AU  - de Korte-Grimmerink R
AD  - Mouse Clinic for Cancer and Aging, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
FAU - van Gerwen, Bastiaan
AU  - van Gerwen B
AD  - Mouse Clinic for Cancer and Aging, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
FAU - Féliz, Luis
AU  - Féliz L
AUID- ORCID: 0000-0003-0659-229X
AD  - Incyte Biosciences International, Morges, Switzerland.
FAU - Abou-Alfa, Ghassan K
AU  - Abou-Alfa GK
AD  - Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 
      USA.
AD  - Department of Medicine, Weill Medical College at Cornell University, New York, 
      NY, USA.
FAU - Ross, Jeffrey S
AU  - Ross JS
AD  - Foundation Medicine, Cambridge, MA, USA.
AD  - Upstate University Hospital, Upstate Medical University, Syracuse, NY, USA.
FAU - van de Ven, Marieke
AU  - van de Ven M
AD  - Mouse Clinic for Cancer and Aging, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
FAU - Rottenberg, Sven
AU  - Rottenberg S
AUID- ORCID: 0000-0003-2044-9844
AD  - Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands.
AD  - Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, 
      Switzerland.
AD  - Bern Center for Precision Medicine, University of Bern, Bern, Switzerland.
FAU - Cuppen, Edwin
AU  - Cuppen E
AD  - Oncode Institute, Utrecht, The Netherlands.
AD  - Hartwig Medical Foundation, Amsterdam, The Netherlands.
AD  - Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The 
      Netherlands.
FAU - Chessex, Anne Vaslin
AU  - Chessex AV
AD  - Debiopharm International, Lausanne, Switzerland.
FAU - Ali, Siraj M
AU  - Ali SM
AUID- ORCID: 0000-0001-7477-4023
AD  - Foundation Medicine, Cambridge, MA, USA.
FAU - Burn, Timothy C
AU  - Burn TC
AUID- ORCID: 0000-0001-6648-4333
AD  - Incyte Research Institute, Wilmington, DE, USA.
FAU - Jimenez, Connie R
AU  - Jimenez CR
AD  - OncoProteomics Laboratory, Department of Medical Oncology, Cancer Center 
      Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The 
      Netherlands.
FAU - Ganesan, Shridar
AU  - Ganesan S
AD  - Department of Medicine, Division of Medical Oncology, Rutgers Cancer Institute of 
      New Jersey, New Brunswick, NJ, USA. ganesash@cinj.rutgers.edu.
AD  - Department of Medicine and Pharmacology, Rutgers University, Piscataway, NJ, USA. 
      ganesash@cinj.rutgers.edu.
FAU - Wessels, Lodewyk F A
AU  - Wessels LFA
AUID- ORCID: 0000-0002-1656-6995
AD  - Oncode Institute, Utrecht, The Netherlands. l.wessels@nki.nl.
AD  - Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, 
      The Netherlands. l.wessels@nki.nl.
FAU - Jonkers, Jos
AU  - Jonkers J
AUID- ORCID: 0000-0002-9264-9792
AD  - Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The 
      Netherlands. j.jonkers@nki.nl.
AD  - Oncode Institute, Utrecht, The Netherlands. j.jonkers@nki.nl.
LA  - eng
GR  - WT_/Wellcome Trust/United Kingdom
GR  - P30 CA008748/CA/NCI NIH HHS/United States
GR  - P30 CA072720/CA/NCI NIH HHS/United States
PT  - Clinical Trial
PT  - Journal Article
DEP - 20220810
PL  - England
TA  - Nature
JT  - Nature
JID - 0410462
RN  - 0 (Protein Kinase Inhibitors)
RN  - EC 2.7.10.1 (FGFR2 protein, human)
RN  - EC 2.7.10.1 (Receptor, Fibroblast Growth Factor, Type 2)
SB  - IM
EIN - Nature. 2022 Sep;609(7929):E13. PMID: 36050473
MH  - Animals
MH  - *Exons/genetics
MH  - *Gene Deletion
MH  - Humans
MH  - Mice
MH  - *Molecular Targeted Therapy
MH  - *Neoplasms/drug therapy/genetics/pathology
MH  - *Oncogenes/genetics
MH  - *Protein Kinase Inhibitors/pharmacology/therapeutic use
MH  - *Receptor, Fibroblast Growth Factor, Type 2/antagonists & 
      inhibitors/genetics/metabolism
PMC - PMC9436779
COIS- J.K.L. and R.M are employees of Foundation Medicine and have equity in Roche. 
      I.M.S., H.Z., L.F. and T.C.B. are employees of and have equity in Incyte. 
      G.K.A.-A. has performed research for ActaBiologica, Agios, Astra Zeneca, Bayer, 
      Beigene, Berry Genomics, BMS, Casi, Celgene, Exelixis, Genentech/Roche, Halozyme, 
      Incyte, Mabvax, Puma, QED, Sillajen and Yiviva, and has consulted for Agios, 
      Astra Zeneca, Autem, Bayer, Beigene, Berry Genomics, Celgene, CytomX, Debio, 
      Eisai, Eli Lilly, Exelixis, Flatiron, Genentech/Roche, Gilead, Helio, Incyte, 
      Ipsen, Loxo, Merck, MINA, Polaris, QED, Redhill, Silenseed, Sillajen, Sobi, 
      Therabionics, Twoxar, Vector and Yiviva. J.S.R. is an employee of Foundation 
      Medicine, has equity in Roche and is a board member of Celsius Therapeutics. 
      A.V.C. is an employee of Debiopharm International. S.M.A. is an employee of and 
      has equity in EQRX, is a former employee of Foundation Medicine, is a scientific 
      advisory board member of iN Therapeutics and has consulted for Takeda. S.G. has 
      received research funding from M2Gen, has equity in Inspirata and Silagene, and 
      has consulted for Foghorn Therapeutics, Foundation Medicine, Inspirata, Merck, 
      Novartis, Roche and Silagene; his spouse is an employee of and has equity in 
      Merck. The other authors declare no competing interests.
EDAT- 2022/08/11 06:00
MHDA- 2022/08/20 06:00
CRDT- 2022/08/10 23:22
PHST- 2021/01/19 00:00 [received]
PHST- 2022/07/03 00:00 [accepted]
PHST- 2022/08/11 06:00 [pubmed]
PHST- 2022/08/20 06:00 [medline]
PHST- 2022/08/10 23:22 [entrez]
AID - 10.1038/s41586-022-05066-5 [pii]
AID - 5066 [pii]
AID - 10.1038/s41586-022-05066-5 [doi]
PST - ppublish
SO  - Nature. 2022 Aug;608(7923):609-617. doi: 10.1038/s41586-022-05066-5. Epub 2022 
      Aug 10.

PMID- 32198361
OWN - NLM
STAT- MEDLINE
DCOM- 20210618
LR  - 20231115
IS  - 2158-3188 (Electronic)
IS  - 2158-3188 (Linking)
VI  - 10
IP  - 1
DP  - 2020 Mar 20
TI  - ENIGMA and global neuroscience: A decade of large-scale studies of the brain in 
      health and disease across more than 40 countries.
PG  - 100
LID - 10.1038/s41398-020-0705-1 [doi]
LID - 100
AB  - This review summarizes the last decade of work by the ENIGMA (Enhancing 
      NeuroImaging Genetics through Meta Analysis) Consortium, a global alliance of 
      over 1400 scientists across 43 countries, studying the human brain in health and 
      disease. Building on large-scale genetic studies that discovered the first 
      robustly replicated genetic loci associated with brain metrics, ENIGMA has 
      diversified into over 50 working groups (WGs), pooling worldwide data and 
      expertise to answer fundamental questions in neuroscience, psychiatry, neurology, 
      and genetics. Most ENIGMA WGs focus on specific psychiatric and neurological 
      conditions, other WGs study normal variation due to sex and gender differences, 
      or development and aging; still other WGs develop methodological pipelines and 
      tools to facilitate harmonized analyses of "big data" (i.e., genetic and 
      epigenetic data, multimodal MRI, and electroencephalography data). These 
      international efforts have yielded the largest neuroimaging studies to date in 
      schizophrenia, bipolar disorder, major depressive disorder, post-traumatic stress 
      disorder, substance use disorders, obsessive-compulsive disorder, 
      attention-deficit/hyperactivity disorder, autism spectrum disorders, epilepsy, 
      and 22q11.2 deletion syndrome. More recent ENIGMA WGs have formed to study 
      anxiety disorders, suicidal thoughts and behavior, sleep and insomnia, eating 
      disorders, irritability, brain injury, antisocial personality and conduct 
      disorder, and dissociative identity disorder. Here, we summarize the first decade 
      of ENIGMA's activities and ongoing projects, and describe the successes and 
      challenges encountered along the way. We highlight the advantages of 
      collaborative large-scale coordinated data analyses for testing reproducibility 
      and robustness of findings, offering the opportunity to identify brain systems 
      involved in clinical syndromes across diverse samples and associated genetic, 
      environmental, demographic, cognitive, and psychosocial factors.
FAU - Thompson, Paul M
AU  - Thompson PM
AD  - Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics 
      Institute, Keck School of Medicine, University of Southern California, Marina del 
      Rey, CA, USA. pthomp@usc.edu.
FAU - Jahanshad, Neda
AU  - Jahanshad N
AUID- ORCID: 0000-0003-4401-8950
AD  - Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics 
      Institute, Keck School of Medicine, University of Southern California, Marina del 
      Rey, CA, USA.
FAU - Ching, Christopher R K
AU  - Ching CRK
AD  - Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics 
      Institute, Keck School of Medicine, University of Southern California, Marina del 
      Rey, CA, USA.
FAU - Salminen, Lauren E
AU  - Salminen LE
AUID- ORCID: 0000-0002-0684-9991
AD  - Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics 
      Institute, Keck School of Medicine, University of Southern California, Marina del 
      Rey, CA, USA.
FAU - Thomopoulos, Sophia I
AU  - Thomopoulos SI
AUID- ORCID: 0000-0002-0046-4070
AD  - Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics 
      Institute, Keck School of Medicine, University of Southern California, Marina del 
      Rey, CA, USA.
FAU - Bright, Joanna
AU  - Bright J
AD  - Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics 
      Institute, Keck School of Medicine, University of Southern California, Marina del 
      Rey, CA, USA.
FAU - Baune, Bernhard T
AU  - Baune BT
AD  - Department of Psychiatry, University of Münster, Münster, Germany.
AD  - Department of Psychiatry, The University of Melbourne, Melbourne, VIC, Australia.
AD  - The Florey Institute of Neuroscience and Mental Health, The University of 
      Melbourne, Melbourne, VIC, Australia.
FAU - Bertolín, Sara
AU  - Bertolín S
AD  - Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical 
      Research Institute-IDIBELL, Barcelona, Spain.
FAU - Bralten, Janita
AU  - Bralten J
AD  - Department of Human Genetics, Radboud University Medical Center, Nijmegen, The 
      Netherlands.
AD  - Donders Institute for Brain, Cognition and Behaviour, Radboud University, 
      Nijmegen, The Netherlands.
FAU - Bruin, Willem B
AU  - Bruin WB
AD  - Department of Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam 
      Neuroscience, Amsterdam, The Netherlands.
FAU - Bülow, Robin
AU  - Bülow R
AD  - Institute for Diagnostic Radiology and Neuroradiology, University Medicine 
      Greifswald, Greifswald, Germany.
FAU - Chen, Jian
AU  - Chen J
AD  - Department of Computer Science and Engineering, The Ohio State University, 
      Columbus, OH, USA.
FAU - Chye, Yann
AU  - Chye Y
AD  - Turner Institute for Brain and Mental Health, School of Psychological Sciences, 
      Monash University, Clayton, VIC, Australia.
FAU - Dannlowski, Udo
AU  - Dannlowski U
AD  - Department of Psychiatry, University of Münster, Münster, Germany.
FAU - de Kovel, Carolien G F
AU  - de Kovel CGF
AD  - Biometris Wageningen University and Research, Wageningen, The Netherlands.
AD  - Language & Genetics Department, Max Planck Institute for Psycholinguistics, 
      Nijmegen, The Netherlands.
FAU - Donohoe, Gary
AU  - Donohoe G
AD  - The Center for Neuroimaging and Cognitive Genomics, School of Psychology, 
      National University of Ireland, Galway, Ireland.
FAU - Eyler, Lisa T
AU  - Eyler LT
AD  - Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA.
AD  - Desert-Pacific Mental Illness Research, Education, and Clinical Center, VA San 
      Diego Healthcare System, San Diego, CA, USA.
FAU - Faraone, Stephen V
AU  - Faraone SV
AD  - Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate 
      Medical University, Syracuse, NY, USA.
FAU - Favre, Pauline
AU  - Favre P
AD  - INSERM Unit 955 Team 15 'Translational Psychiatry', Créteil, France.
AD  - NeuroSpin, UNIACT Lab, Psychiatry Team, CEA Saclay, Gif-Sur-Yvette, France.
FAU - Filippi, Courtney A
AU  - Filippi CA
AD  - National Institute of Mental Health, National of Health, Bethesda, MD, USA.
FAU - Frodl, Thomas
AU  - Frodl T
AD  - Department of Psychiatry and Psychotherapy, Otto von Guericke University 
      Magdeburg, Magdeburg, Germany.
AD  - Department of Psychiatry, Trinity College Dublin, Dublin, Ireland.
AD  - German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
FAU - Garijo, Daniel
AU  - Garijo D
AD  - Information Sciences Institute, University of Southern California, Marina del 
      Rey, CA, USA.
FAU - Gil, Yolanda
AU  - Gil Y
AD  - Information Sciences Institute, University of Southern California, Marina del 
      Rey, CA, USA.
AD  - Department of Computer Science, University of Southern California, Los Angeles, 
      CA, USA.
FAU - Grabe, Hans J
AU  - Grabe HJ
AD  - Department of Psychiatry and Psychotherapy, University Medicine Greifswald, 
      Greifswald, Germany.
AD  - German Center for Neurodegenerative Diseases (DZNE), Site Rostock/Greifswald, 
      Greifswald, Germany.
FAU - Grasby, Katrina L
AU  - Grasby KL
AD  - Psychiatric Genetics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, 
      Australia.
FAU - Hajek, Tomas
AU  - Hajek T
AD  - Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
AD  - National Institute of Mental Health, Klecany, Czech Republic.
FAU - Han, Laura K M
AU  - Han LKM
AD  - Department of Psychiatry, Amsterdam University Medical Centers, VU University 
      Medical Center, GGZ inGeest, Amsterdam Neuroscience, Amsterdam, The Netherlands.
FAU - Hatton, Sean N
AU  - Hatton SN
AD  - Center for Multimodal Imaging and Genetics, University of California, San Diego, 
      La Jolla, CA, USA.
AD  - Brain and Mind Centre, University of Sydney, Sydney, Australia.
FAU - Hilbert, Kevin
AU  - Hilbert K
AD  - Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany.
FAU - Ho, Tiffany C
AU  - Ho TC
AD  - Department of Psychiatry & Behavioral Sciences, Stanford University, Stanford, 
      CA, USA.
AD  - Department of Psychiatry & Weill Institute for Neurosciences, University of 
      California, San Francisco, San Francisco, CA, USA.
FAU - Holleran, Laurena
AU  - Holleran L
AD  - The Center for Neuroimaging and Cognitive Genomics, School of Psychology, 
      National University of Ireland, Galway, Ireland.
FAU - Homuth, Georg
AU  - Homuth G
AD  - Interfaculty Institute for Genetics and Functional Genomics, University Medicine 
      Greifswald, Greifswald, Germany.
FAU - Hosten, Norbert
AU  - Hosten N
AD  - Institute for Diagnostic Radiology and Neuroradiology, University Medicine 
      Greifswald, Greifswald, Germany.
FAU - Houenou, Josselin
AU  - Houenou J
AD  - INSERM Unit 955 Team 15 'Translational Psychiatry', Créteil, France.
AD  - NeuroSpin, UNIACT Lab, Psychiatry Team, CEA Saclay, Gif-Sur-Yvette, France.
AD  - APHP, Mondor University Hospitals, School of Medicine, DMU Impact, Psychiatry 
      Department, Créteil, France.
FAU - Ivanov, Iliyan
AU  - Ivanov I
AD  - Icahn School of Medicine at Mount Sinai, New York, NY, USA.
FAU - Jia, Tianye
AU  - Jia T
AD  - Institute of Science and Technology for Brain-Inspired Intelligence, Fudan 
      University, Shanghai, China.
AD  - MOE Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence, 
      Fudan University, Shanghai, China.
AD  - Centre for Population Neuroscience and Precision Medicine (PONS), MRC SGDP 
      Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College 
      London, London, UK.
FAU - Kelly, Sinead
AU  - Kelly S
AD  - Department of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical 
      School, Boston, MA, USA.
AD  - Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, USA.
FAU - Klein, Marieke
AU  - Klein M
AD  - Department of Human Genetics, Radboud University Medical Center, Nijmegen, The 
      Netherlands.
AD  - Donders Institute for Brain, Cognition and Behaviour, Radboud University, 
      Nijmegen, The Netherlands.
AD  - Department of Psychiatry, UMC Brain Center, University Medical Center Utrecht, 
      Utrecht University, Utrecht, The Netherlands.
FAU - Kwon, Jun Soo
AU  - Kwon JS
AD  - Department of Psychiatry, Seoul National University College of Medicine, Seoul, 
      Republic of Korea.
AD  - Department of Brain and Cognitive Sciences, Seoul National University College of 
      Natural Sciences, Seoul, Republic of Korea.
FAU - Laansma, Max A
AU  - Laansma MA
AD  - Department of Anatomy & Neurosciences, Amsterdam UMC, Location VUmc, Amsterdam 
      Neuroscience, Amsterdam, The Netherlands.
FAU - Leerssen, Jeanne
AU  - Leerssen J
AD  - Department of Sleep and Cognition, Netherlands Institute for Neuroscience, 
      Amsterdam, The Netherlands.
FAU - Lueken, Ulrike
AU  - Lueken U
AD  - Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany.
FAU - Nunes, Abraham
AU  - Nunes A
AD  - Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
AD  - Faculty of Computer Science, Dalhousie University, Halifax, NS, Canada.
FAU - Neill, Joseph O'
AU  - Neill JO
AD  - Child & Adolescent Psychiatry, University of California, Los Angeles, Los 
      Angeles, CA, USA.
FAU - Opel, Nils
AU  - Opel N
AD  - Department of Psychiatry, University of Münster, Münster, Germany.
FAU - Piras, Fabrizio
AU  - Piras F
AD  - Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy.
FAU - Piras, Federica
AU  - Piras F
AD  - Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy.
FAU - Postema, Merel C
AU  - Postema MC
AD  - Language & Genetics Department, Max Planck Institute for Psycholinguistics, 
      Nijmegen, The Netherlands.
FAU - Pozzi, Elena
AU  - Pozzi E
AD  - Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of 
      Melbourne, Melbourne, VIC, Australia.
AD  - Orygen, The National Centre of Excellence in Youth Mental Health, Melbourne, VIC, 
      Australia.
FAU - Shatokhina, Natalia
AU  - Shatokhina N
AD  - Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics 
      Institute, Keck School of Medicine, University of Southern California, Marina del 
      Rey, CA, USA.
FAU - Soriano-Mas, Carles
AU  - Soriano-Mas C
AD  - Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical 
      Research Institute-IDIBELL, Barcelona, Spain.
AD  - CIBERSAM-G17, Madrid, Spain.
AD  - Department of Psychobiology and Methodology in Health Sciences, Universitat 
      Autònoma de Barcelona, Barcelona, Spain.
FAU - Spalletta, Gianfranco
AU  - Spalletta G
AD  - Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy.
AD  - Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, 
      Houston, TX, USA.
FAU - Sun, Daqiang
AU  - Sun D
AD  - Department of Psychiatry and Biobehavioral Sciences, Semel Institute for 
      Neuroscience and Human Behavior, University of California, Los Angeles, Los 
      Angeles, CA, USA.
AD  - Department of Mental Health, Veterans Affairs Greater Los Angeles Healthcare 
      System, Los Angeles, CA, USA.
FAU - Teumer, Alexander
AU  - Teumer A
AD  - Institute for Community Medicine, University Medicine Greifswald, Greifswald, 
      Germany.
FAU - Tilot, Amanda K
AU  - Tilot AK
AD  - Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics 
      Institute, Keck School of Medicine, University of Southern California, Marina del 
      Rey, CA, USA.
FAU - Tozzi, Leonardo
AU  - Tozzi L
AD  - Department of Psychiatry & Behavioral Sciences, Stanford University, Stanford, 
      CA, USA.
FAU - van der Merwe, Celia
AU  - van der Merwe C
AD  - Stanley Center for Psychiatric Research, The Broad Institute, Cambridge, MA, USA.
AD  - Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, 
      MA, USA.
FAU - Van Someren, Eus J W
AU  - Van Someren EJW
AD  - Department of Sleep and Cognition, Netherlands Institute for Neuroscience, 
      Amsterdam, The Netherlands.
AD  - Psychiatry and Integrative Neurophysiology, VU University, Amsterdam UMC, 
      Amsterdam, The Netherlands.
FAU - van Wingen, Guido A
AU  - van Wingen GA
AD  - Department of Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam 
      Neuroscience, Amsterdam, The Netherlands.
FAU - Völzke, Henry
AU  - Völzke H
AD  - Institute for Community Medicine, University Medicine Greifswald, Greifswald, 
      Germany.
AD  - German Centre for Cardiovascular Research, Partner Site Greifswald, Greifswald, 
      Germany.
FAU - Walton, Esther
AU  - Walton E
AD  - Department of Psychology, University of Bath, Bath, UK.
FAU - Wang, Lei
AU  - Wang L
AD  - Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of 
      Medicine, Chicago, IL, USA.
AD  - Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
FAU - Winkler, Anderson M
AU  - Winkler AM
AD  - National Institute of Mental Health, National of Health, Bethesda, MD, USA.
FAU - Wittfeld, Katharina
AU  - Wittfeld K
AD  - Department of Psychiatry and Psychotherapy, University Medicine Greifswald, 
      Greifswald, Germany.
AD  - German Center for Neurodegenerative Diseases (DZNE), Site Rostock/Greifswald, 
      Greifswald, Germany.
FAU - Wright, Margaret J
AU  - Wright MJ
AD  - Queensland Brain Institute, University of Queensland, Brisbane, QLD, Australia.
AD  - Centre for Advanced Imaging, University of Queensland, Brisbane, QLD, Australia.
FAU - Yun, Je-Yeon
AU  - Yun JY
AD  - Seoul National University Hospital, Seoul, Republic of Korea.
AD  - Yeongeon Student Support Center, Seoul National University College of Medicine, 
      Seoul, Republic of Korea.
FAU - Zhang, Guohao
AU  - Zhang G
AD  - Department of Computer Science and Electrical Engineering, University of 
      Maryland, Baltimore County, MD, USA.
FAU - Zhang-James, Yanli
AU  - Zhang-James Y
AD  - Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate 
      Medical University, Syracuse, NY, USA.
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Syracuse, NY, USA.
FAU - Adhikari, Bhim M
AU  - Adhikari BM
AD  - Department of Psychiatry, University of Maryland School of Medicine, Baltimore, 
      MD, USA.
FAU - Agartz, Ingrid
AU  - Agartz I
AD  - Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental 
      Health & Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, 
      Norway.
AD  - Department of Clinical Neuroscience, Centre for Psychiatric Research, Karolinska 
      Institutet, Stockholm, Sweden.
AD  - Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.
FAU - Aghajani, Moji
AU  - Aghajani M
AD  - Department of Psychiatry, Amsterdam UMC, Location VUmc, Amsterdam Neuroscience, 
      Amsterdam, The Netherlands.
AD  - Department of Research & Innovation, GGZ InGeest, Amsterdam, The Netherlands.
FAU - Aleman, André
AU  - Aleman A
AD  - University of Groningen, University Medical Center Groningen, Groningen, The 
      Netherlands.
FAU - Althoff, Robert R
AU  - Althoff RR
AD  - Psychiatry, Pediatrics, and Psychological Sciences, University of Vermont, 
      Burlington, VT, USA.
FAU - Altmann, Andre
AU  - Altmann A
AD  - Centre for Medical Image Computing (CMIC), Department of Medical Physics and 
      Biomedical Engineering, University College London, London, UK.
FAU - Andreassen, Ole A
AU  - Andreassen OA
AD  - Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental 
      Health & Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, 
      Norway.
AD  - Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
FAU - Baron, David A
AU  - Baron DA
AD  - Provost and Senior Vice President, Western University of Health Sciences, Pomona, 
      CA, USA.
FAU - Bartnik-Olson, Brenda L
AU  - Bartnik-Olson BL
AD  - Department of Radiology, Loma Linda University Medical Center, Loma Linda, CA, 
      USA.
FAU - Marie Bas-Hoogendam, Janna
AU  - Marie Bas-Hoogendam J
AD  - Institute of Psychology, Leiden University, Leiden, The Netherlands.
AD  - Department of Psychiatry, Leiden University Medical Center, Leiden, The 
      Netherlands.
AD  - Leiden Institute for Brain and Cognition, Leiden, The Netherlands.
FAU - Baskin-Sommers, Arielle R
AU  - Baskin-Sommers AR
AD  - Department of Psychology, Yale University, New Haven, CT, USA.
FAU - Bearden, Carrie E
AU  - Bearden CE
AD  - Department of Psychiatry and Biobehavioral Sciences, Semel Institute for 
      Neuroscience and Human Behavior, University of California, Los Angeles, Los 
      Angeles, CA, USA.
AD  - Department of Psychology, University of California, Los Angeles, CA, USA.
FAU - Berner, Laura A
AU  - Berner LA
AD  - Icahn School of Medicine at Mount Sinai, New York, NY, USA.
FAU - Boedhoe, Premika S W
AU  - Boedhoe PSW
AD  - Department of Psychiatry, Amsterdam UMC, Location VUmc, Amsterdam Neuroscience, 
      Amsterdam, The Netherlands.
FAU - Brouwer, Rachel M
AU  - Brouwer RM
AD  - Department of Psychiatry, UMC Brain Center, University Medical Center Utrecht, 
      Utrecht University, Utrecht, The Netherlands.
FAU - Buitelaar, Jan K
AU  - Buitelaar JK
AD  - Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and 
      Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
FAU - Caeyenberghs, Karen
AU  - Caeyenberghs K
AD  - Cognitive Neuroscience Unit, School of Psychology, Deakin University, Burwood, 
      VIC, Australia.
FAU - Cecil, Charlotte A M
AU  - Cecil CAM
AD  - Department of Child and Adolescent Psychiatry/Psychology, Erasmus Medical Centre, 
      Rotterdam, The Netherlands.
AD  - Department of Epidemiology, Erasmus Medical Centre, Rotterdam, The Netherlands.
FAU - Cohen, Ronald A
AU  - Cohen RA
AD  - Center for Cognitive Aging and Memory, University of Florida, Gainesville, FL, 
      USA.
AD  - Clinical and Health Psychology, Gainesville, FL, USA.
FAU - Cole, James H
AU  - Cole JH
AD  - Centre for Medical Image Computing (CMIC), Department of Computer Science, 
      University College London, London, UK.
AD  - Dementia Research Centre, Institute of Neurology, University College London, 
      London, UK.
FAU - Conrod, Patricia J
AU  - Conrod PJ
AD  - Universite de Montreal, Centre de Recherche CHU Ste-Justine, Montreal, QC, 
      Canada.
FAU - De Brito, Stephane A
AU  - De Brito SA
AD  - School of Psychology and Centre for Human Brain Health, University of Birmingham, 
      Birmingham, UK.
FAU - de Zwarte, Sonja M C
AU  - de Zwarte SMC
AD  - Department of Psychiatry, UMC Brain Center, University Medical Center Utrecht, 
      Utrecht University, Utrecht, The Netherlands.
FAU - Dennis, Emily L
AU  - Dennis EL
AD  - Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics 
      Institute, Keck School of Medicine, University of Southern California, Marina del 
      Rey, CA, USA.
AD  - Department of Neurology, University of Utah, Salt Lake City, UT, USA.
AD  - Psychiatry Neuroimaging Laboratory, Brigham & Women's Hospital, Harvard Medical 
      School, Boston, MA, USA.
FAU - Desrivieres, Sylvane
AU  - Desrivieres S
AD  - Social, Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, 
      Psychology & Neuroscience, King's College London, London, UK.
FAU - Dima, Danai
AU  - Dima D
AD  - Department of Psychology, School of Arts and Social Sciences, City, University of 
      London, London, UK.
AD  - Department of Neuroimaging, Institute of Psychology, Psychiatry and 
      Neurosciences, King's College London, London, UK.
FAU - Ehrlich, Stefan
AU  - Ehrlich S
AD  - Division of Psychological and Social Medicine and Developmental Neurosciences, 
      Faculty of Medicine, TU Dresden, Dresden, Germany.
FAU - Esopenko, Carrie
AU  - Esopenko C
AD  - Department of Rehabilitation and Movement Sciences, School of Health Professions, 
      Rutgers Biomedical Health Sciences, Newark, NJ, USA.
FAU - Fairchild, Graeme
AU  - Fairchild G
AD  - Department of Psychology, University of Bath, Bath, UK.
FAU - Fisher, Simon E
AU  - Fisher SE
AD  - Donders Institute for Brain, Cognition and Behaviour, Radboud University, 
      Nijmegen, The Netherlands.
AD  - Language & Genetics Department, Max Planck Institute for Psycholinguistics, 
      Nijmegen, The Netherlands.
FAU - Fouche, Jean-Paul
AU  - Fouche JP
AD  - Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, 
      South Africa.
AD  - SU/UCT MRC Unit on Risk & Resilience in Mental Disorders, University of 
      Stellenbosch, Stellenbosch, South Africa.
FAU - Francks, Clyde
AU  - Francks C
AD  - Donders Institute for Brain, Cognition and Behaviour, Radboud University, 
      Nijmegen, The Netherlands.
AD  - Language & Genetics Department, Max Planck Institute for Psycholinguistics, 
      Nijmegen, The Netherlands.
FAU - Frangou, Sophia
AU  - Frangou S
AD  - Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, 
      USA.
AD  - University of British Columbia, Vancouver, Canada.
FAU - Franke, Barbara
AU  - Franke B
AD  - Department of Human Genetics, Radboud University Medical Center, Nijmegen, The 
      Netherlands.
AD  - Donders Institute for Brain, Cognition and Behaviour, Radboud University, 
      Nijmegen, The Netherlands.
AD  - Department of Psychiatry, Radboud University Medical Center, Nijmegen, The 
      Netherlands.
FAU - Garavan, Hugh P
AU  - Garavan HP
AD  - Department of Psychiatry, University of Vermont, Burlington, VT, USA.
FAU - Glahn, David C
AU  - Glahn DC
AD  - Department of Psychiatry, Boston Children's Hospital and Harvard Medical School, 
      Boston, MA, USA.
AD  - Olin Neuropsychiatric Research Center, Institute of Living, Hartford, CT, USA.
FAU - Groenewold, Nynke A
AU  - Groenewold NA
AD  - Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, 
      South Africa.
FAU - Gurholt, Tiril P
AU  - Gurholt TP
AD  - Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental 
      Health & Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, 
      Norway.
AD  - Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
FAU - Gutman, Boris A
AU  - Gutman BA
AD  - Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA.
AD  - Institute for Information Transmission Problems, Kharkevich Institute, Moscow, 
      Russian Federation.
FAU - Hahn, Tim
AU  - Hahn T
AD  - Department of Psychiatry, University of Münster, Münster, Germany.
FAU - Harding, Ian H
AU  - Harding IH
AD  - Turner Institute for Brain and Mental Health & School of Psychological Sciences, 
      Monash University, Melbourne, VIC, Australia.
FAU - Hernaus, Dennis
AU  - Hernaus D
AD  - Department of Psychiatry & Neuropsychology, School for Mental Health and 
      Neuroscience, Maastricht University, Maastricht, The Netherlands.
FAU - Hibar, Derrek P
AU  - Hibar DP
AD  - Genentech, Inc., South San Francisco, CA, USA.
FAU - Hillary, Frank G
AU  - Hillary FG
AD  - Department of Psychology, Penn State University, University Park, PA, USA.
AD  - Social Life and Engineering Sciences Imaging Center, University Park, PA, USA.
FAU - Hoogman, Martine
AU  - Hoogman M
AD  - Department of Human Genetics, Radboud University Medical Center, Nijmegen, The 
      Netherlands.
AD  - Donders Institute for Brain, Cognition and Behaviour, Radboud University, 
      Nijmegen, The Netherlands.
FAU - Hulshoff Pol, Hilleke E
AU  - Hulshoff Pol HE
AD  - Department of Psychiatry, UMC Brain Center, University Medical Center Utrecht, 
      Utrecht University, Utrecht, The Netherlands.
FAU - Jalbrzikowski, Maria
AU  - Jalbrzikowski M
AD  - Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.
FAU - Karkashadze, George A
AU  - Karkashadze GA
AD  - Research and Scientific Institute of Pediatrics and Child Health, CCH RAS, 
      Ministry of Science and Higher Education, Moscow, Russian Federation.
FAU - Klapwijk, Eduard T
AU  - Klapwijk ET
AD  - Institute of Psychology, Leiden University, Leiden, The Netherlands.
AD  - Leiden Institute for Brain and Cognition, Leiden, The Netherlands.
FAU - Knickmeyer, Rebecca C
AU  - Knickmeyer RC
AD  - Department of Pediatrics, Michigan State University, East Lansing, MI, USA.
AD  - Institute for Quantitative Health Science and Engineering, East Lansing, MI, USA.
AD  - Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel 
      Hill, NC, USA.
FAU - Kochunov, Peter
AU  - Kochunov P
AD  - Department of Psychiatry, University of Maryland School of Medicine, Baltimore, 
      MD, USA.
FAU - Koerte, Inga K
AU  - Koerte IK
AD  - Psychiatry Neuroimaging Laboratory, Brigham & Women's Hospital, Harvard Medical 
      School, Boston, MA, USA.
AD  - CBRAIN, Department of Child and Adolescent Psychiatry, Psychosomatics, and 
      Psychotherapy, Ludwig-Maximilians-Universität München, Munich, Germany.
FAU - Kong, Xiang-Zhen
AU  - Kong XZ
AD  - Language & Genetics Department, Max Planck Institute for Psycholinguistics, 
      Nijmegen, The Netherlands.
FAU - Liew, Sook-Lei
AU  - Liew SL
AD  - Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, 
      University of Southern California, Los Angeles, CA, USA.
AD  - Chan Division of Occupational Science and Occupational Therapy, Los Angeles, CA, 
      USA.
FAU - Lin, Alexander P
AU  - Lin AP
AD  - Center for Clinical Spectroscopy, Brigham and Women's Hospital, Boston, MA, USA.
AD  - Harvard Medical School, Boston, MA, USA.
FAU - Logue, Mark W
AU  - Logue MW
AD  - National Center for PTSD at Boston VA Healthcare System, Boston, MA, USA.
AD  - Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA.
AD  - Biomedical Genetics, Boston University School of Medicine, Boston, MA, USA.
FAU - Luders, Eileen
AU  - Luders E
AD  - School of Psychology, University of Auckland, Auckland, New Zealand.
AD  - Laboratory of Neuro Imaging, Mark and Mary Stevens Neuroimaging and Informatics 
      Institute, Keck School of Medicine, University of Southern California, Los 
      Angeles, CA, USA.
FAU - Macciardi, Fabio
AU  - Macciardi F
AD  - Department of Psychiatry and Human Behavior, University of California, Irvine, 
      Irvine, CA, USA.
FAU - Mackey, Scott
AU  - Mackey S
AD  - Department of Psychiatry, University of Vermont, Burlington, VT, USA.
FAU - Mayer, Andrew R
AU  - Mayer AR
AD  - Mind Research Network, Albuquerque, NM, USA.
FAU - McDonald, Carrie R
AU  - McDonald CR
AD  - Center for Multimodal Imaging and Genetics, University of California, San Diego, 
      La Jolla, CA, USA.
AD  - Psychiatry, San Diego, CA, USA.
FAU - McMahon, Agnes B
AU  - McMahon AB
AD  - Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics 
      Institute, Keck School of Medicine, University of Southern California, Marina del 
      Rey, CA, USA.
AD  - The Kavli Foundation, Los Angeles, CA, USA.
FAU - Medland, Sarah E
AU  - Medland SE
AD  - Psychiatric Genetics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, 
      Australia.
FAU - Modinos, Gemma
AU  - Modinos G
AD  - Department of Neuroimaging, Institute of Psychology, Psychiatry and 
      Neurosciences, King's College London, London, UK.
AD  - Department of Psychosis Studies, Institute of Psychiatry, Psychology & 
      Neuroscience, King's College London, London, UK.
FAU - Morey, Rajendra A
AU  - Morey RA
AD  - Department of Psychiatry, Duke University School of Medicine, Durham, NC, USA.
AD  - Mental Illness Research Education and Clinical Center, Durham VA Medical Center, 
      Durham, NC, USA.
FAU - Mueller, Sven C
AU  - Mueller SC
AD  - Experimental Clinical & Health Psychology, Ghent University, Ghent, Belgium.
AD  - Department of Personality, Psychological Assessment and Treatment, University of 
      Deusto, Bilbao, Spain.
FAU - Mukherjee, Pratik
AU  - Mukherjee P
AD  - Radiology and Biomedical Imaging, San Francisco, CA, USA.
FAU - Namazova-Baranova, Leyla
AU  - Namazova-Baranova L
AD  - Research and Scientific Institute of Pediatrics and Child Health, CCH RAS, 
      Ministry of Science and Higher Education, Moscow, Russian Federation.
AD  - Department of Pediatrics, Russian National Research Medical University MoH RF, 
      Moscow, Russian Federation.
FAU - Nir, Talia M
AU  - Nir TM
AD  - Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics 
      Institute, Keck School of Medicine, University of Southern California, Marina del 
      Rey, CA, USA.
FAU - Olsen, Alexander
AU  - Olsen A
AD  - Department of Psychology, Norwegian University of Science and Technology, 
      Trondheim, Norway.
AD  - Department of Physical Medicine and Rehabilitation, St. Olavs Hospital, Trondheim 
      University Hospital, Trondheim, Norway.
FAU - Paschou, Peristera
AU  - Paschou P
AD  - Biological Sciences, Purdue University, West Lafayette, IN, USA.
FAU - Pine, Daniel S
AU  - Pine DS
AD  - National Institute of Mental Health Intramural Research Program, Bethesda, MD, 
      USA.
FAU - Pizzagalli, Fabrizio
AU  - Pizzagalli F
AD  - Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics 
      Institute, Keck School of Medicine, University of Southern California, Marina del 
      Rey, CA, USA.
FAU - Rentería, Miguel E
AU  - Rentería ME
AD  - Department of Genetics and Computational Biology, QIMR Berghofer Medical Research 
      Institute, Brisbane, QLD, Australia.
FAU - Rohrer, Jonathan D
AU  - Rohrer JD
AD  - Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, 
      London, UK.
FAU - Sämann, Philipp G
AU  - Sämann PG
AD  - Max Planck Institute of Psychiatry, Munich, Germany.
FAU - Schmaal, Lianne
AU  - Schmaal L
AD  - Orygen, The National Centre of Excellence in Youth Mental Health, Melbourne, VIC, 
      Australia.
AD  - Centre for Youth Mental Health, The University of Melbourne, Melbourne, VIC, 
      Australia.
FAU - Schumann, Gunter
AU  - Schumann G
AD  - Centre for Population Neuroscience and Precision Medicine (PONS), MRC SGDP 
      Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College 
      London, London, UK.
AD  - Department of Psychiatry and Psychotherapy, Charite, Humboldt University, Berlin, 
      Germany.
FAU - Shiroishi, Mark S
AU  - Shiroishi MS
AD  - Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics 
      Institute, Keck School of Medicine, University of Southern California, Marina del 
      Rey, CA, USA.
AD  - Department of Radiology, Keck School of Medicine of USC, University of Southern 
      California, Los Angeles, CA, USA.
FAU - Sisodiya, Sanjay M
AU  - Sisodiya SM
AD  - Department of Clinical and Experimental Epilepsy, University College London, 
      London, UK.
AD  - Chalfont Centre for Epilepsy, Chalfont St Peter, UK.
FAU - Smit, Dirk J A
AU  - Smit DJA
AD  - Department of Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam 
      Neuroscience, Amsterdam, The Netherlands.
FAU - Sønderby, Ida E
AU  - Sønderby IE
AD  - Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental 
      Health & Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, 
      Norway.
AD  - Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
AD  - Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
FAU - Stein, Dan J
AU  - Stein DJ
AD  - Department of Psychiatry & Neuroscience Institute, SA MRC Unit on Risk & 
      Resilience in Mental Disorders, Cape Town, South Africa.
FAU - Stein, Jason L
AU  - Stein JL
AD  - Department of Genetics & UNC Neuroscience Center, University of North Carolina at 
      Chapel Hill, Chapel Hill, NC, USA.
FAU - Tahmasian, Masoud
AU  - Tahmasian M
AD  - Institute of Medical Science and Technology, Shahid Beheshti University, Tehran, 
      I. R., Iran.
FAU - Tate, David F
AU  - Tate DF
AD  - Department of Neurology, TBI and Concussion Center, Salt Lake City, UT, USA.
AD  - Missouri Institute of Mental Health, Berkeley, MO, USA.
FAU - Turner, Jessica A
AU  - Turner JA
AD  - Psychology Department & Neuroscience Institute, Georgia State University, 
      Atlanta, GA, USA.
FAU - van den Heuvel, Odile A
AU  - van den Heuvel OA
AD  - Department of Anatomy & Neurosciences, Amsterdam UMC, Location VUmc, Amsterdam 
      Neuroscience, Amsterdam, The Netherlands.
AD  - Department of Psychiatry, Amsterdam UMC, Location VUmc, Amsterdam Neuroscience, 
      Amsterdam, The Netherlands.
FAU - van der Wee, Nic J A
AU  - van der Wee NJA
AD  - Department of Psychiatry, Leiden University Medical Center, Leiden, The 
      Netherlands.
AD  - Leiden Institute for Brain and Cognition, Leiden, The Netherlands.
FAU - van der Werf, Ysbrand D
AU  - van der Werf YD
AD  - Department of Anatomy & Neurosciences, Amsterdam UMC, Location VUmc, Amsterdam 
      Neuroscience, Amsterdam, The Netherlands.
FAU - van Erp, Theo G M
AU  - van Erp TGM
AD  - Clinical Translational Neuroscience Laboratory, Department of Psychiatry and 
      Human Behavior, University of California Irvine, Irvine, CA, USA.
AD  - Center for the Neurobiology of Learning and Memory, University of California, 
      Irvine, Irvine, CA, USA.
FAU - van Haren, Neeltje E M
AU  - van Haren NEM
AD  - Department of Psychiatry, UMC Brain Center, University Medical Center Utrecht, 
      Utrecht University, Utrecht, The Netherlands.
AD  - Department of Child and Adolescent Psychiatry/Psychology, Erasmus Medical Centre, 
      Rotterdam, The Netherlands.
FAU - van Rooij, Daan
AU  - van Rooij D
AD  - Donders Centre for Cognitive Neuroimaging, Radboud University Medical Centre, 
      Nijmegen, The Netherlands.
FAU - van Velzen, Laura S
AU  - van Velzen LS
AD  - Orygen, The National Centre of Excellence in Youth Mental Health, Melbourne, VIC, 
      Australia.
AD  - Centre for Youth Mental Health, The University of Melbourne, Melbourne, VIC, 
      Australia.
FAU - Veer, Ilya M
AU  - Veer IM
AD  - Division of Mind and Brain Research, Department of Psychiatry and Psychotherapy 
      CCM, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität 
      Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, 
      Germany.
FAU - Veltman, Dick J
AU  - Veltman DJ
AD  - Department of Psychiatry, Amsterdam UMC, Location VUmc, Amsterdam Neuroscience, 
      Amsterdam, The Netherlands.
FAU - Villalon-Reina, Julio E
AU  - Villalon-Reina JE
AD  - Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics 
      Institute, Keck School of Medicine, University of Southern California, Marina del 
      Rey, CA, USA.
FAU - Walter, Henrik
AU  - Walter H
AD  - Division of Mind and Brain Research, Department of Psychiatry and Psychotherapy 
      CCM, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität 
      Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, 
      Germany.
FAU - Whelan, Christopher D
AU  - Whelan CD
AD  - Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, 
      Dublin, Ireland.
AD  - Research and Early Development, Biogen Inc, Cambridge, MA, USA.
FAU - Wilde, Elisabeth A
AU  - Wilde EA
AD  - Department of Neurology, University of Utah, Salt Lake City, UT, USA.
AD  - VA Salt Lake City Healthcare System, Salt Lake City, UT, USA.
AD  - Department of Physical Medicine and Rehabilitation, Baylor College of Medicine, 
      Houston, TX, USA.
FAU - Zarei, Mojtaba
AU  - Zarei M
AD  - Institute of Medical Science and Technology, Shahid Beheshti University, Tehran, 
      I. R., Iran.
FAU - Zelman, Vladimir
AU  - Zelman V
AD  - Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
AD  - Skolkovo Institute of Science and Technology, Moscow, Russian Federation.
CN  - ENIGMA Consortium
LA  - eng
GR  - R01 EB015611/EB/NIBIB NIH HHS/United States
GR  - T32 AG058507/AG/NIA NIH HHS/United States
GR  - MR/L016311/1/MRC_/Medical Research Council/United Kingdom
GR  - R01 DA047119/DA/NIDA NIH HHS/United States
GR  - S10 OD023696/OD/NIH HHS/United States
GR  - MRF_MRF-058-0009-RG-DESR-C0759/MRF/MRF/United Kingdom
GR  - R21 NS107739/NS/NINDS NIH HHS/United States
GR  - R01 NS115845/NS/NINDS NIH HHS/United States
GR  - UL1 TR001863/TR/NCATS NIH HHS/United States
GR  - MRF_MRF-058-0004-RG-DESRI/MRF/MRF/United Kingdom
GR  - R21 MH116473/MH/NIMH NIH HHS/United States
GR  - K01 HD091283/HD/NICHD NIH HHS/United States
GR  - R01 MH085953/MH/NIMH NIH HHS/United States
GR  - R01 MH111671/MH/NIMH NIH HHS/United States
GR  - S10 OD023696/CD/ODCDC CDC HHS/United States
GR  - MR/R00465X/1/MRC_/Medical Research Council/United Kingdom
GR  - R01 MH116147/MH/NIMH NIH HHS/United States
GR  - R01 MH117601/MH/NIMH NIH HHS/United States
GR  - U01 MH108148/MH/NIMH NIH HHS/United States
GR  - U54 EB020403/EB/NIBIB NIH HHS/United States
GR  - R01 AG059874/AG/NIA NIH HHS/United States
GR  - R56 AG058854/AG/NIA NIH HHS/United States
GR  - R01 NS110347/NS/NINDS NIH HHS/United States
GR  - MR/S020306/1/MRC_/Medical Research Council/United Kingdom
PT  - Journal Article
PT  - Meta-Analysis
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Review
DEP - 20200320
PL  - United States
TA  - Transl Psychiatry
JT  - Translational psychiatry
JID - 101562664
SB  - IM
MH  - Brain/diagnostic imaging
MH  - *Depressive Disorder, Major/genetics
MH  - Humans
MH  - Magnetic Resonance Imaging
MH  - Neuroimaging
MH  - Reproducibility of Results
PMC - PMC7083923
COIS- Individual authors’ disclosures and conflicts of interest are listed in 
      Supplementary Appendix C.
EDAT- 2020/03/22 06:00
MHDA- 2021/06/22 06:00
CRDT- 2020/03/22 06:00
PHST- 2019/07/03 00:00 [received]
PHST- 2019/12/20 00:00 [accepted]
PHST- 2019/12/11 00:00 [revised]
PHST- 2020/03/22 06:00 [entrez]
PHST- 2020/03/22 06:00 [pubmed]
PHST- 2021/06/22 06:00 [medline]
AID - 10.1038/s41398-020-0705-1 [pii]
AID - 705 [pii]
AID - 10.1038/s41398-020-0705-1 [doi]
PST - epublish
SO  - Transl Psychiatry. 2020 Mar 20;10(1):100. doi: 10.1038/s41398-020-0705-1.

PMID- 34861974
OWN - NLM
STAT- MEDLINE
DCOM- 20220128
LR  - 20230905
IS  - 1873-2402 (Electronic)
IS  - 0006-3223 (Print)
IS  - 0006-3223 (Linking)
VI  - 91
IP  - 3
DP  - 2022 Feb 1
TI  - Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric 
      Disorders, and Known Risk Factors.
PG  - 313-327
LID - S0006-3223(21)01570-5 [pii]
LID - 10.1016/j.biopsych.2021.05.029 [doi]
AB  - BACKGROUND: Suicide is a leading cause of death worldwide, and nonfatal suicide 
      attempts, which occur far more frequently, are a major source of disability and 
      social and economic burden. Both have substantial genetic etiology, which is 
      partially shared and partially distinct from that of related psychiatric 
      disorders. METHODS: We conducted a genome-wide association study (GWAS) of 29,782 
      suicide attempt (SA) cases and 519,961 controls in the International Suicide 
      Genetics Consortium (ISGC). The GWAS of SA was conditioned on psychiatric 
      disorders using GWAS summary statistics via multitrait-based conditional and 
      joint analysis, to remove genetic effects on SA mediated by psychiatric 
      disorders. We investigated the shared and divergent genetic architectures of SA, 
      psychiatric disorders, and other known risk factors. RESULTS: Two loci reached 
      genome-wide significance for SA: the major histocompatibility complex and an 
      intergenic locus on chromosome 7, the latter of which remained associated with SA 
      after conditioning on psychiatric disorders and replicated in an independent 
      cohort from the Million Veteran Program. This locus has been implicated in 
      risk-taking behavior, smoking, and insomnia. SA showed strong genetic correlation 
      with psychiatric disorders, particularly major depression, and also with smoking, 
      pain, risk-taking behavior, sleep disturbances, lower educational attainment, 
      reproductive traits, lower socioeconomic status, and poorer general health. After 
      conditioning on psychiatric disorders, the genetic correlations between SA and 
      psychiatric disorders decreased, whereas those with nonpsychiatric traits 
      remained largely unchanged. CONCLUSIONS: Our results identify a risk locus that 
      contributes more strongly to SA than other phenotypes and suggest a shared 
      underlying biology between SA and known risk factors that is not mediated by 
      psychiatric disorders.
CI  - Copyright © 2021 Society of Biological Psychiatry. All rights reserved.
FAU - Mullins, Niamh
AU  - Mullins N
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount 
      Sinai, New York, New York; Department of Psychiatry, Icahn School of Medicine at 
      Mount Sinai, New York, New York. Electronic address: niamh.mullins@mssm.edu.
FAU - Kang, JooEun
AU  - Kang J
AD  - Division of Genetic Medicine, Department of Medicine, Vanderbilt Genetics 
      Institute, Vanderbilt University Medical Center, Nashville, Tennessee.
FAU - Campos, Adrian I
AU  - Campos AI
AD  - Department of Genetics and Computational Biology, QIMR Berghofer Medical Research 
      Institute, Brisbane, Queensland, Australia; School of Biomedical Sciences, 
      Faculty of Medicine, The University of Queensland, Brisbane, Queensland, 
      Australia.
FAU - Coleman, Jonathan R I
AU  - Coleman JRI
AD  - National Institute for Health Research Maudsley Biomedical Research Centre at 
      South London and Maudsley NHS Foundation Trust, London, United Kingdom; Social 
      Genetic and Developmental Psychiatry Centre, King's College London, London, 
      United Kingdom.
FAU - Edwards, Alexis C
AU  - Edwards AC
AD  - Department of Psychiatry, Virginia Commonwealth University, Richmond, Virginia.
FAU - Galfalvy, Hanga
AU  - Galfalvy H
AD  - Department of Biostatistics, Columbia University, New York, New York; Department 
      of Psychiatry, Columbia University, New York, New York.
FAU - Levey, Daniel F
AU  - Levey DF
AD  - Department of Psychiatry, Veterans Affairs Connecticut Healthcare Center, West 
      Haven, Connecticut; Division of Human Genetics, Department of Psychiatry, Yale 
      University School of Medicine, New Haven, Connecticut.
FAU - Lori, Adriana
AU  - Lori A
AD  - Department of Psychiatry and Behavioral Sciences, Emory University School of 
      Medicine, Atlanta, Georgia.
FAU - Shabalin, Andrey
AU  - Shabalin A
AD  - Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, 
      Utah.
FAU - Starnawska, Anna
AU  - Starnawska A
AD  - Centre for Genomics and Personalized Medicine, Aarhus University, Aarhus, 
      Denmark; Centre for Integrative Sequencing, Aarhus University, Aarhus, Denmark; 
      Department of Biomedicine, Aarhus University, Aarhus, Denmark; Lundbeck 
      Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus 
      University, Aarhus, Denmark.
FAU - Su, Mei-Hsin
AU  - Su MH
AD  - Institute of Epidemiology and Preventive Medicine, College of Public Health, 
      National Taiwan University, Taipei, Taiwan.
FAU - Watson, Hunna J
AU  - Watson HJ
AD  - School of Psychology, Curtin University, Perth, Western Australia, Australia; 
      Division of Paediatrics, The University of Western Australia, Perth, Western 
      Australia, Australia; Department of Psychiatry, University of North Carolina at 
      Chapel Hill, Chapel Hill, North Carolina.
FAU - Adams, Mark
AU  - Adams M
AD  - Division of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
FAU - Awasthi, Swapnil
AU  - Awasthi S
AD  - Department of Psychiatry and Psychotherapy, Universitätsmedizin Berlin, Berlin, 
      Germany.
FAU - Gandal, Michael
AU  - Gandal M
AD  - Department of Psychiatry and Biobehavioral Sciences, Semel Institute, David 
      Geffen School of Medicine, University of California Los Angeles, Los Angeles, 
      California.
FAU - Hafferty, Jonathan D
AU  - Hafferty JD
AD  - Division of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
FAU - Hishimoto, Akitoyo
AU  - Hishimoto A
AD  - Department of Psychiatry, Yokohama City University Graduate School of Medicine, 
      Yokohama, Japan.
FAU - Kim, Minsoo
AU  - Kim M
AD  - Department of Psychiatry and Biobehavioral Sciences, Semel Institute, David 
      Geffen School of Medicine, University of California Los Angeles, Los Angeles, 
      California.
FAU - Okazaki, Satoshi
AU  - Okazaki S
AD  - Department of Psychiatry, Kobe University Graduate School of Medicine, Kobe, 
      Japan.
FAU - Otsuka, Ikuo
AU  - Otsuka I
AD  - Department of Psychiatry, Columbia University, New York, New York; Department of 
      Psychiatry, Kobe University Graduate School of Medicine, Kobe, Japan.
FAU - Ripke, Stephan
AU  - Ripke S
AD  - Department of Psychiatry and Psychotherapy, Universitätsmedizin Berlin, Berlin, 
      Germany; Stanley Center for Psychiatric Research, Broad Institute, Cambridge, 
      Massachusetts; Analytical and Translational Genetics Unit, Massachusetts General 
      Hospital, Boston, Massachusetts.
FAU - Ware, Erin B
AU  - Ware EB
AD  - Population Studies Center, Institute for Social Research, University of Michigan, 
      Ann Arbor, Michigan; Survery Research Center, Institute for Social Research, 
      University of Michigan, Ann Arbor, Michigan.
FAU - Bergen, Andrew W
AU  - Bergen AW
AD  - BioRealm, LLC, Walnut, California; Oregon Research Institute, Eugene, Oregon.
FAU - Berrettini, Wade H
AU  - Berrettini WH
AD  - Department of Psychiatry, Center for Neurobiology and Behavior, Perelman School 
      of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
FAU - Bohus, Martin
AU  - Bohus M
AD  - Department of Psychosomatic Medicine and Psychotherapy, Central Institute of 
      Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, 
      Germany.
FAU - Brandt, Harry
AU  - Brandt H
AD  - Center for Eating Disorders at Sheppard Pratt, Baltimore, Maryland.
FAU - Chang, Xiao
AU  - Chang X
AD  - Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, 
      Pennsylvania.
FAU - Chen, Wei J
AU  - Chen WJ
AD  - Institute of Epidemiology and Preventive Medicine, College of Public Health, 
      National Taiwan University, Taipei, Taiwan; Department of Psychiatry, National 
      Taiwan University Hospital, Taipei, Taiwan; Center for Neuropsychiatric Research, 
      National Health Research Institutes, Miaoli County, Taiwan.
FAU - Chen, Hsi-Chung
AU  - Chen HC
AD  - Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan.
FAU - Crawford, Steven
AU  - Crawford S
AD  - Center for Eating Disorders at Sheppard Pratt, Baltimore, Maryland.
FAU - Crow, Scott
AU  - Crow S
AD  - Department of Psychiatry, University of Minnesota, Minneapolis, Minnesota.
FAU - DiBlasi, Emily
AU  - DiBlasi E
AD  - Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, 
      Utah.
FAU - Duriez, Philibert
AU  - Duriez P
AD  - Hôpital Sainte-Anne, GHU Paris Psychiatrie et Neurosciences, Paris, France; 
      Institute of Psychiatry and Neuroscience of Paris, INSERM U1266, Université de 
      Paris, Paris, France.
FAU - Fernández-Aranda, Fernando
AU  - Fernández-Aranda F
AD  - Department of Psychiatry, University Hospital Bellvitge-IDIBELL and CIBEROBN, 
      Barcelona, Spain.
FAU - Fichter, Manfred M
AU  - Fichter MM
AD  - Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University, 
      Munich, Germany; Schön Klinik Roseneck affiliated with the Medical Faculty of the 
      University of Munich, Munich, Germany.
FAU - Gallinger, Steven
AU  - Gallinger S
AD  - Department of Surgery, Faculty of Medicine, University of Toronto, Toronto, 
      Ontario, Canada.
FAU - Glatt, Stephen J
AU  - Glatt SJ
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Syracuse, New York.
FAU - Gorwood, Philip
AU  - Gorwood P
AD  - Hôpital Sainte-Anne, GHU Paris Psychiatrie et Neurosciences, Paris, France; 
      Institute of Psychiatry and Neuroscience of Paris, INSERM U1266, Université de 
      Paris, Paris, France.
FAU - Guo, Yiran
AU  - Guo Y
AD  - Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, 
      Pennsylvania.
FAU - Hakonarson, Hakon
AU  - Hakonarson H
AD  - Perelman School of Medicine, University of Pennsylvania, Philadelphia, 
      Pennsylvania; Center for Applied Genomics, Children's Hospital of Philadelphia, 
      Philadelphia, Pennsylvania.
FAU - Halmi, Katherine A
AU  - Halmi KA
AD  - Department of Psychiatry, Weill Cornell Medical College, New York, New York.
FAU - Hwu, Hai-Gwo
AU  - Hwu HG
AD  - Department of Psychiatry, National Taiwan University Hospital and College of 
      Medicine, Taipei, Taiwan.
FAU - Jain, Sonia
AU  - Jain S
AD  - Biostatistics Research Center, Herbert Wertheim School of Public Health and Human 
      Longevity Science, La Jolla, California.
FAU - Jamain, Stéphane
AU  - Jamain S
AD  - Inserm U955, Institut Mondor de recherches Biomédicales, Laboratoire, 
      Neuro-Psychiatrie Translationnelle, and Fédération Hospitalo-Universitaire de 
      Précision Médecine en Addictologie et Psychiatrie, University Paris-Est-Créteil, 
      Créteil, France.
FAU - Jiménez-Murcia, Susana
AU  - Jiménez-Murcia S
AD  - Department of Psychiatry, University Hospital Bellvitge-IDIBELL and CIBEROBN, 
      Barcelona, Spain.
FAU - Johnson, Craig
AU  - Johnson C
AD  - Eating Recovery Center, Denver, Colorado.
FAU - Kaplan, Allan S
AU  - Kaplan AS
AD  - Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; 
      Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada; 
      Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
FAU - Kaye, Walter H
AU  - Kaye WH
AD  - Department of Psychiatry, Department of Psychiatry, University of California San 
      Diego, San Diego, California.
FAU - Keel, Pamela K
AU  - Keel PK
AD  - Department of Psychology, Florida State University, Tallahassee, Florida.
FAU - Kennedy, James L
AU  - Kennedy JL
AD  - Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; 
      Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada; 
      Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
FAU - Klump, Kelly L
AU  - Klump KL
AD  - Department of Psychology, Michigan State University, Lansing, Michigan.
FAU - Li, Dong
AU  - Li D
AD  - Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, 
      Pennsylvania.
FAU - Liao, Shih-Cheng
AU  - Liao SC
AD  - Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan.
FAU - Lieb, Klaus
AU  - Lieb K
AD  - Department of Psychiatry and Psychotherapy, University Medical Center, Mainz, 
      Germany.
FAU - Lilenfeld, Lisa
AU  - Lilenfeld L
AD  - Department of Clinical Psychology, The Chicago School of Professional Psychology, 
      Washington, DC.
FAU - Liu, Chih-Min
AU  - Liu CM
AD  - Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan.
FAU - Magistretti, Pierre J
AU  - Magistretti PJ
AD  - BESE Division, King Abdullah University of Science and Technology, Thuwal, Saudi 
      Arabia; Department of Psychiatry, Lausanne University Hospital and University of 
      Lausanne, Lausanne, Switzerland.
FAU - Marshall, Christian R
AU  - Marshall CR
AD  - Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, 
      Toronto, Ontario, Canada.
FAU - Mitchell, James E
AU  - Mitchell JE
AD  - Department of Psychiatry and Behavioral Science, University of North Dakota 
      School of Medicine and Health Sciences, Fargo, North Dakota.
FAU - Monson, Eric T
AU  - Monson ET
AD  - Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, 
      Utah.
FAU - Myers, Richard M
AU  - Myers RM
AD  - HudsonAlpha Institute for Biotechnology, Huntsville, Alabama.
FAU - Pinto, Dalila
AU  - Pinto D
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount 
      Sinai, New York, New York; Department of Psychiatry, Icahn School of Medicine at 
      Mount Sinai, New York, New York.
FAU - Powers, Abigail
AU  - Powers A
AD  - Department of Psychiatry and Behavioral Sciences, Emory University School of 
      Medicine, Atlanta, Georgia.
FAU - Ramoz, Nicolas
AU  - Ramoz N
AD  - Institute of Psychiatry and Neuroscience of Paris, INSERM U1266, Université de 
      Paris, Paris, France.
FAU - Roepke, Stefan
AU  - Roepke S
AD  - Department of Psychiatry, Universitätsmedizin Berlin, Corporate Member of Freie 
      Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 
      Campus Benjamin Franklin, Berlin, Germany.
FAU - Rozanov, Vsevolod
AU  - Rozanov V
AD  - Department of Psychology, St. Petersburg State University, Saint Petersburg, 
      Russian Federation; Department of Borderline Disorders and Psychotherapy, V.M. 
      Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint 
      Petersburg, Russian Federation.
FAU - Scherer, Stephen W
AU  - Scherer SW
AD  - Department of Genetics and Genomic Biology, The Hospital for Sick Children, 
      Toronto, Ontario, Canada.
FAU - Schmahl, Christian
AU  - Schmahl C
AD  - Department of Psychosomatic Medicine and Psychotherapy, Central Institute of 
      Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, 
      Germany.
FAU - Sokolowski, Marcus
AU  - Sokolowski M
AD  - National Centre for Suicide Research and Prevention of Mental Ill-Health, LIME, 
      Karolinska Institutet, Stockholm, Sweden.
FAU - Strober, Michael
AU  - Strober M
AD  - David Geffen School of Medicine, University of California Los Angeles, Los 
      Angeles, California; Department of Psychiatry and Biobehavioral Sciences, Semel 
      Institute for Neuroscience and Human Behavior, University of California Los 
      Angeles, Los Angeles, California.
FAU - Thornton, Laura M
AU  - Thornton LM
AD  - Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel 
      Hill, North Carolina.
FAU - Treasure, Janet
AU  - Treasure J
AD  - Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological 
      Medicine, London, United Kingdom; National Institute for Health Research 
      Biomedical Research Centre, King's College London and South London and Maudsley 
      National Health Service Foundation Trust, London, United Kingdom.
FAU - Tsuang, Ming T
AU  - Tsuang MT
AD  - Center for Behavioral Genomics, Department of Psychiatry, University of 
      California San Diego, San Diego, California.
FAU - Witt, Stephanie H
AU  - Witt SH
AD  - Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental 
      Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
FAU - Woodside, D Blake
AU  - Woodside DB
AD  - Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; 
      Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada; 
      Centre for Mental Health, University Health Network, Toronto, Ontario, Canada; 
      Program for Eating Disorders, University Health Network, Toronto, Ontario, 
      Canada.
FAU - Yilmaz, Zeynep
AU  - Yilmaz Z
AD  - National Centre for Register-Based Research, Aarhus University, Aarhus, Denmark; 
      Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel 
      Hill, North Carolina; Department of Genetics, University of North Carolina at 
      Chapel Hill, Chapel Hill, North Carolina.
FAU - Zillich, Lea
AU  - Zillich L
AD  - Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental 
      Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
FAU - Adolfsson, Rolf
AU  - Adolfsson R
AD  - Department of Clinical Sciences, Psychiatry, Umeå University Medical Faculty, 
      Umeå, Sweden.
FAU - Agartz, Ingrid
AU  - Agartz I
AD  - Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska 
      Institutet, Stockholm, Sweden; Department of Psychiatric Research, Diakonhjemmet 
      Hospital, Oslo, Norway; NORMENT, Institute of Clinical Medicine, University of 
      Oslo, Oslo, Norway.
FAU - Air, Tracy M
AU  - Air TM
AD  - Discipline of Psychiatry, University of Adelaide, Adelaide, South Australia, 
      Australia.
FAU - Alda, Martin
AU  - Alda M
AD  - Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada; 
      National Institute of Mental Health, Klecany, Czech Republic.
FAU - Alfredsson, Lars
AU  - Alfredsson L
AD  - Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; 
      Institut of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
FAU - Andreassen, Ole A
AU  - Andreassen OA
AD  - Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; 
      NORMENT, University of Oslo, Oslo, Norway.
FAU - Anjorin, Adebayo
AU  - Anjorin A
AD  - Psychiatry, Berkshire Healthcare NHS Foundation Trust, Bracknell, United Kingdom.
FAU - Appadurai, Vivek
AU  - Appadurai V
AD  - Institute of Biological Psychiatry, Copenhagen Mental Health Services, Copenhagen 
      University Hospital, Copenhagen, Denmark; Lundbeck Foundation Initiative for 
      Integrative Psychiatric Research, iPSYCH, Copenhagen, Denmark.
FAU - Soler Artigas, María
AU  - Soler Artigas M
AD  - Department of Psychiatry, Hospital Universitari Vall d'Hebrón, Barcelona, Spain; 
      Department of Genetics, Microbiology & Statistics, University of Barcelona, 
      Barcelona, Spain; Psychiatric Genetics Unit, Group of Psychiatry, Mental Health 
      and Addiction, Vall d'Hebron Research Institute, Universitat Autònoma de 
      Barcelona, Barcelona, Spain; Biomedical Network Research Centre on Mental Health, 
      Instituto de Salud Carlos III, Madrid, Spain.
FAU - Van der Auwera, Sandra
AU  - Van der Auwera S
AD  - Department of Psychiatry and Psychotherapy, University Medicine Greifswald, 
      Greifswald, Mecklenburg-Vorpommern, Germany.
FAU - Azevedo, M Helena
AU  - Azevedo MH
AD  - Department of Psychiatry, University of Coimbra, Coimbra, Portugal.
FAU - Bass, Nicholas
AU  - Bass N
AD  - Division of Psychiatry, University College London, London, United Kingdom.
FAU - Bau, Claiton H D
AU  - Bau CHD
AD  - Laboratory of Developmental Psychiatry, Adult Division, Hospital de Clínicas de 
      Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil; Department of Genetics, 
      Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, 
      Brazil.
FAU - Baune, Bernhard T
AU  - Baune BT
AD  - Department of Psychiatry, Melbourne Medical School, University of Melbourne, 
      Melbourne, Victoria, Australia; Department of Psychiatry, University of Münster, 
      Münster, Nordrhein-Westfalen, Germany.
FAU - Bellivier, Frank
AU  - Bellivier F
AD  - Department of Psychiatry and Addiction Medicine, Assistance Publique Hôpitaux de 
      Paris, Paris, France; Paris Bipolar and TRD Expert Centres, FondaMental 
      Foundation, Paris, France; UMR-S1144 Team 1: Biomarkers of relapse and 
      therapeutic response in addiction and mood disorders, INSERM, Paris, France; 
      Psychiatry, Université Paris Diderot, Paris, France.
FAU - Berger, Klaus
AU  - Berger K
AD  - Institute of Epidemiology and Social Medicine, University of Münster, Münster, 
      Nordrhein-Westfalen, Germany.
FAU - Biernacka, Joanna M
AU  - Biernacka JM
AD  - Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
FAU - Bigdeli, Tim B
AU  - Bigdeli TB
AD  - Department of Psychiatry and Behavioral Sciences, State University of New York 
      Downstate Medical Center, New York, New York; Department of Psychiatry, Virginia 
      Commonwealth University, Richmond, Virginia.
FAU - Binder, Elisabeth B
AU  - Binder EB
AD  - Department of Psychiatry and Behavioral Sciences, Emory University School of 
      Medicine, Atlanta, Georgia; Department of Translational Research in Psychiatry, 
      Max Planck Institute of Psychiatry, Munich, Germany.
FAU - Boehnke, Michael
AU  - Boehnke M
AD  - Center for Statistical Genetics and Department of Biostatistics, Institute for 
      Social Research, University of Michigan, Ann Arbor, Michigan.
FAU - Boks, Marco P
AU  - Boks MP
AD  - Department of Psychiatry, UMC Utrecht Hersencentrum, Utrecht, the Netherlands.
FAU - Bosch, Rosa
AU  - Bosch R
AD  - Department of Psychiatry, Hospital Universitari Vall d'Hebrón, Barcelona, Spain; 
      Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, 
      Barcelona, Spain; Biomedical Network Research Centre on Mental Health, Instituto 
      de Salud Carlos III, Madrid, Spain.
FAU - Braff, David L
AU  - Braff DL
AD  - Department of Psychiatry, University of California San Diego, La Jolla, 
      California.
FAU - Bryant, Richard
AU  - Bryant R
AD  - School of Psychology, University of New South Wales, Sydney, New South Wales, 
      Australia.
FAU - Budde, Monika
AU  - Budde M
AD  - Institute of Psychiatric Phenomics and Genomics, University Hospital, 
      Ludwig-Maximilians-University, Munich, Germany.
FAU - Byrne, Enda M
AU  - Byrne EM
AD  - Institute for Molecular Bioscience, The University of Queensland, Brisbane, 
      Queensland, Australia; Centre for Children's Health Research, The University of 
      Queensland, Brisbane, Queensland, Australia.
FAU - Cahn, Wiepke
AU  - Cahn W
AD  - Department of Psychiatry, UMC Utrecht Hersencentrum, Utrecht, the Netherlands.
FAU - Casas, Miguel
AU  - Casas M
AD  - Department of Psychiatry, Hospital Universitari Vall d'Hebrón, Barcelona, Spain; 
      Psychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addiction, Vall 
      d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain; 
      Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, 
      Barcelona, Spain; Biomedical Network Research Centre on Mental Health, Instituto 
      de Salud Carlos III, Madrid, Spain.
FAU - Castelao, Enrique
AU  - Castelao E
AD  - Department of Psychiatry, Lausanne University Hospital and University of 
      Lausanne, Lausanne, Switzerland.
FAU - Cervilla, Jorge A
AU  - Cervilla JA
AD  - Mental Health Unit, Department of Psychiatry, Faculty of Medicine, Granada 
      University Hospital Complex, Biomedical Research Centre, University of Granada, 
      Granada, Spain.
FAU - Chaumette, Boris
AU  - Chaumette B
AD  - Institut de Psychiatrie, CNRS GDR 3557, Paris, France; Department of Evaluation, 
      Prevention and Therapeutic innovation, GHU Paris Psychiatrie et Neurosciences, 
      Paris, France; Team Pathophysiology of psychiatric diseases, Université de Paris, 
      Institute of Psychiatry and Neuroscience of Paris, INSERM U1266, Paris, France.
FAU - Cichon, Sven
AU  - Cichon S
AD  - Institute of Neuroscience and Medicine, Research Centre Jülich, Jülich, Germany; 
      Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, 
      Switzerland; Department of Biomedicine, University Hospital Basel, Basel, 
      Switzerland; Institute of Human Genetics, University of Bonn, School of Medicine 
      & University Hospital Bonn, Bonn, Germany.
FAU - Corvin, Aiden
AU  - Corvin A
AD  - Neuropsychiatric Genetics Research Group, Department of Psychiatry and Trinity 
      Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland.
FAU - Craddock, Nicholas
AU  - Craddock N
AD  - Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, 
      Division of Psychological Medicine and Clinical Neurosciences, Cardiff 
      University, Cardiff, United Kingdom.
FAU - Craig, David
AU  - Craig D
AD  - Department of Translational Genomics, University of Southern California, 
      Pasadena, California.
FAU - Degenhardt, Franziska
AU  - Degenhardt F
AD  - Institute of Human Genetics, University of Bonn, School of Medicine & University 
      Hospital Bonn, Bonn, Germany.
FAU - Djurovic, Srdjan
AU  - Djurovic S
AD  - Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; NORMENT, 
      KG Jebsen Centre for Psychosis Research, Department of Clinical Science, 
      University of Bergen, Bergen, Norway.
FAU - Edenberg, Howard J
AU  - Edenberg HJ
AD  - Department of Medical & Molecular Genetics, Indiana University, Indianapolis, 
      Indiana; Biochemistry and Molecular Biology, Indiana University School of 
      Medicine, Indianapolis, Indiana.
FAU - Fanous, Ayman H
AU  - Fanous AH
AD  - Department of Psychiatry and Behavioral Sciences, State University of New York 
      Downstate Medical Center, New York, New York; Department of Psychiatry, Virginia 
      Commonwealth University, Richmond, Virginia.
FAU - Foo, Jerome C
AU  - Foo JC
AD  - Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental 
      Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
FAU - Forstner, Andreas J
AU  - Forstner AJ
AD  - Institute of Neuroscience and Medicine, Research Centre Jülich, Jülich, Germany; 
      Institute of Human Genetics, University of Bonn, School of Medicine & University 
      Hospital Bonn, Bonn, Germany; Centre for Human Genetics, University of Marburg, 
      Marburg, Germany.
FAU - Frye, Mark
AU  - Frye M
AD  - Department of Psychiatry & Psychology, Mayo Clinic, Rochester, Minnesota.
FAU - Fullerton, Janice M
AU  - Fullerton JM
AD  - School of Medical Sciences, University of New South Wales, Sydney, New South 
      Wales, Australia; Neuroscience Research Australia, Sydney, New South Wales, 
      Australia.
FAU - Gatt, Justine M
AU  - Gatt JM
AD  - School of Psychology, University of New South Wales, Sydney, New South Wales, 
      Australia; Neuroscience Research Australia, Sydney, New South Wales, Australia.
FAU - Gejman, Pablo V
AU  - Gejman PV
AD  - Department of Psychiatry and Behavioral Sciences, NorthShore University 
      HealthSystem, Evanston, Illinois; Department of Psychiatry and Behavioral 
      Neuroscience, University of Chicago, Chicago, Illinois.
FAU - Giegling, Ina
AU  - Giegling I
AD  - Department of Psychiatry, University of Munich, Munich, Germany; Department of 
      Psychiatry, Psychotherapy and Psychosomatics, Martin-Luther-University 
      Halle-Wittenberg, Halle, Germany.
FAU - Grabe, Hans J
AU  - Grabe HJ
AD  - Department of Psychiatry and Psychotherapy, University Medicine Greifswald, 
      Greifswald, Mecklenburg-Vorpommern, Germany.
FAU - Green, Melissa J
AU  - Green MJ
AD  - School of Psychiatry, University of New South Wales, Sydney, New South Wales, 
      Australia; Neuroscience Research Australia, Sydney, New South Wales, Australia.
FAU - Grevet, Eugenio H
AU  - Grevet EH
AD  - ADHD Outpatient Program, Adult Division, Hospital de Clínicas de Porto Alegre, 
      Porto Alegre, Rio Grande do Sul, Brazil; Department of Psychiatry, Universidade 
      Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
FAU - Grigoroiu-Serbanescu, Maria
AU  - Grigoroiu-Serbanescu M
AD  - Biometric Psychiatric Genetics Research Unit, Alexandru Obregia Clinical 
      Psychiatric Hospital, Bucharest, Romania.
FAU - Gutierrez, Blanca
AU  - Gutierrez B
AD  - Department of Psychiatry, Biomedical Research Centre, University of Granada, 
      Granada, Spain.
FAU - Guzman-Parra, Jose
AU  - Guzman-Parra J
AD  - Mental Health Department, University Regional Hospital, Biomedicine Institute, 
      Málaga, Spain.
FAU - Hamilton, Steven P
AU  - Hamilton SP
AD  - Psychiatry, Kaiser Permanente Northern California, San Francisco, California.
FAU - Hamshere, Marian L
AU  - Hamshere ML
AD  - Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, 
      Division of Psychological Medicine and Clinical Neurosciences, Cardiff 
      University, Cardiff, United Kingdom.
FAU - Hartmann, Annette
AU  - Hartmann A
AD  - Department of Psychiatry, Psychotherapy and Psychosomatics, 
      Martin-Luther-University Halle-Wittenberg, Halle, Germany.
FAU - Hauser, Joanna
AU  - Hauser J
AD  - Department of Psychiatry, Laboratory of Psychiatric Genetics, Poznan University 
      of Medical Sciences, Poznań, Poland.
FAU - Heilmann-Heimbach, Stefanie
AU  - Heilmann-Heimbach S
AD  - Institute of Human Genetics, University of Bonn, School of Medicine & University 
      Hospital Bonn, Bonn, Germany.
FAU - Hoffmann, Per
AU  - Hoffmann P
AD  - Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, 
      Switzerland; Department of Biomedicine, University Hospital Basel, Basel, 
      Switzerland; Institute of Human Genetics, University of Bonn, School of Medicine 
      & University Hospital Bonn, Bonn, Germany.
FAU - Ising, Marcus
AU  - Ising M
AD  - Max Planck Institute of Psychiatry, Munich, Germany.
FAU - Jones, Ian
AU  - Jones I
AD  - Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, 
      Division of Psychological Medicine and Clinical Neurosciences, Cardiff 
      University, Cardiff, United Kingdom.
FAU - Jones, Lisa A
AU  - Jones LA
AD  - Department of Psychological Medicine, University of Worcester, Worcester, United 
      Kingdom.
FAU - Jonsson, Lina
AU  - Jonsson L
AD  - Department of Psychiatry and Neuroscience, University of Gothenburg, Gothenburg, 
      Sweden.
FAU - Kahn, René S
AU  - Kahn RS
AD  - Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New 
      York; Department of Psychiatry, UMC Utrecht Hersencentrum, Utrecht, the 
      Netherlands.
FAU - Kelsoe, John R
AU  - Kelsoe JR
AD  - Department of Psychiatry, University of California San Diego, La Jolla, 
      California; Institute for Genomic Medicine, University of California San Diego, 
      La Jolla, California.
FAU - Kendler, Kenneth S
AU  - Kendler KS
AD  - Department of Psychiatry, Virginia Commonwealth University, Richmond, Virginia.
FAU - Kloiber, Stefan
AU  - Kloiber S
AD  - Max Planck Institute of Psychiatry, Munich, Germany; Department of Psychiatry, 
      University of Toronto, Toronto, Ontario, Canada; Centre for Addiction and Mental 
      Health, Toronto, Ontario, Canada.
FAU - Koenen, Karestan C
AU  - Koenen KC
AD  - Stanley Center for Psychiatric Research, Broad Institute, Cambridge, 
      Massachusetts; Department of Psychiatry, Massachusetts General Hospital, Boston, 
      Massachusetts; Department of Epidemiology, Harvard TH Chan School of Public 
      Health, Boston, Massachusetts.
FAU - Kogevinas, Manolis
AU  - Kogevinas M
AD  - Center for Research in Environmental Epidemiology, Barcelona, Spain.
FAU - Konte, Bettina
AU  - Konte B
AD  - Department of Psychiatry, Psychotherapy and Psychosomatics, 
      Martin-Luther-University Halle-Wittenberg, Halle, Germany.
FAU - Krebs, Marie-Odile
AU  - Krebs MO
AD  - Institut de Psychiatrie, CNRS GDR 3557, Paris, France; Department of Evaluation, 
      Prevention and Therapeutic innovation, GHU Paris Psychiatrie et Neurosciences, 
      Paris, France; Team Pathophysiology of psychiatric diseases, Université de Paris, 
      Institute of Psychiatry and Neuroscience of Paris, INSERM U1266, Paris, France.
FAU - Landén, Mikael
AU  - Landén M
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden; Department of Psychiatry and Neuroscience, University of 
      Gothenburg, Gothenburg, Sweden.
FAU - Lawrence, Jacob
AU  - Lawrence J
AD  - Psychiatry, North East London NHS Foundation Trust, Ilford, Cheshire, United 
      Kingdom.
FAU - Leboyer, Marion
AU  - Leboyer M
AD  - Faculté de Médecine, University Paris-Est-Créteil, Créteil, France; Department of 
      Psychiatry and Addiction Medicine, Assistance Publique Hôpitaux de Paris, Paris, 
      France; INSERM, Paris, France.
FAU - Lee, Phil H
AU  - Lee PH
AD  - Stanley Center for Psychiatric Research, Broad Institute, Cambridge, 
      Massachusetts; Analytical and Translational Genetics Unit, Massachusetts General 
      Hospital, Boston, Massachusetts; Psychiatric and Neurodevelopmental Genetics 
      Unit, Massachusetts General Hospital, Boston, Massachusetts.
FAU - Levinson, Douglas F
AU  - Levinson DF
AD  - Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, 
      California.
FAU - Liao, Calwing
AU  - Liao C
AD  - Department of Human Genetics, Faculty of Medicine, McGill University, Montreal, 
      Québec, Canada; Montreal Neurological Institute and Hospital, Montreal, Québec, 
      Canada.
FAU - Lissowska, Jolanta
AU  - Lissowska J
AD  - Cancer Epidemiology and Prevention, Sklodowska-Curie Cancer Center and Institute 
      of Oncology, Warsaw, Poland.
FAU - Lucae, Susanne
AU  - Lucae S
AD  - Max Planck Institute of Psychiatry, Munich, Germany.
FAU - Mayoral, Fermin
AU  - Mayoral F
AD  - Mental Health Department, University Regional Hospital, Biomedicine Institute, 
      Málaga, Spain.
FAU - McElroy, Susan L
AU  - McElroy SL
AD  - Research Institute, Lindner Center of HOPE, Mason, Ohio.
FAU - McGrath, Patrick
AU  - McGrath P
AD  - Department of Psychiatry, Columbia University College of Physicians and Surgeons, 
      New York, New York.
FAU - McGuffin, Peter
AU  - McGuffin P
AD  - Social Genetic and Developmental Psychiatry Centre, King's College London, 
      London, United Kingdom.
FAU - McQuillin, Andrew
AU  - McQuillin A
AD  - Division of Psychiatry, University College London, London, United Kingdom.
FAU - Medland, Sarah E
AU  - Medland SE
AD  - Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, 
      Brisbane, Queensland, Australia.
FAU - Mehta, Divya
AU  - Mehta D
AD  - Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, 
      Australia; School of Psychology and Counseling, Queensland University of 
      Technology, Brisbane, Queensland, Australia.
FAU - Melle, Ingrid
AU  - Melle I
AD  - Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; 
      Division of Mental Health and Addiction, University of Oslo, Institute of 
      Clinical Medicine, Oslo, Norway.
FAU - Milaneschi, Yuri
AU  - Milaneschi Y
AD  - Department of Psychiatry, Amsterdam UMC, Vrije Universiteit and GGZ inGeest, 
      Amsterdam, Netherlands.
FAU - Mitchell, Philip B
AU  - Mitchell PB
AD  - School of Psychiatry, University of New South Wales, Sydney, New South Wales, 
      Australia.
FAU - Molina, Esther
AU  - Molina E
AD  - Department of Nursing, Faculty of Medicine, Biomedical Research Centre, 
      University of Granada, Granada, Spain.
FAU - Morken, Gunnar
AU  - Morken G
AD  - Mental Health, Faculty of Medicine and Health Sciences, Norwegian University of 
      Science and Technology, NTNU, Trondheim, Norway; Psychiatry, St. Olavs University 
      Hospital, Trondheim, Norway.
FAU - Mortensen, Preben Bo
AU  - Mortensen PB
AD  - Centre for Integrative Sequencing, Aarhus University, Aarhus, Denmark; National 
      Centre for Register-Based Research, Aarhus University, Aarhus, Denmark; Centre 
      for Integrated Register-based Research, Aarhus University, Aarhus, Denmark; 
      Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, 
      Copenhagen, Denmark.
FAU - Müller-Myhsok, Bertram
AU  - Müller-Myhsok B
AD  - Department of Translational Research in Psychiatry, Max Planck Institute of 
      Psychiatry, Munich, Germany; Munich Cluster for Systems Neurology, Munich, 
      Germany; University of Liverpool, Liverpool, United Kingdom.
FAU - Nievergelt, Caroline
AU  - Nievergelt C
AD  - Department of Psychiatry, University of California San Diego, La Jolla, 
      California.
FAU - Nimgaonkar, Vishwajit
AU  - Nimgaonkar V
AD  - Psychiatry and Human Genetics, University of Pittsburgh, Pittsburgh, 
      Pennsylvania.
FAU - Nöthen, Markus M
AU  - Nöthen MM
AD  - Institute of Human Genetics, University of Bonn, School of Medicine & University 
      Hospital Bonn, Bonn, Germany.
FAU - O'Donovan, Michael C
AU  - O'Donovan MC
AD  - Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, 
      Division of Psychological Medicine and Clinical Neurosciences, Cardiff 
      University, Cardiff, United Kingdom.
FAU - Ophoff, Roel A
AU  - Ophoff RA
AD  - Jane and Terry Semel Institute for Neuroscience and Human Behavior, Los Angeles, 
      California; Psychiatry, Erasmus University Medical Center, Rotterdam, the 
      Netherlands.
FAU - Owen, Michael J
AU  - Owen MJ
AD  - Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, 
      Division of Psychological Medicine and Clinical Neurosciences, Cardiff 
      University, Cardiff, United Kingdom.
FAU - Pato, Carlos
AU  - Pato C
AD  - College of Medicine Institute for Genomic Health, SUNY Downstate Medical Center 
      College of Medicine, Brooklyn, New York; Institute for Genomic Health, SUNY 
      Downstate Medical Center College of Medicine, Brooklyn, New York.
FAU - Pato, Michele T
AU  - Pato MT
AD  - Institute for Genomic Health, SUNY Downstate Medical Center College of Medicine, 
      Brooklyn, New York.
FAU - Penninx, Brenda W J H
AU  - Penninx BWJH
AD  - Department of Psychiatry, Amsterdam UMC, Vrije Universiteit and GGZ inGeest, 
      Amsterdam, Netherlands.
FAU - Pimm, Jonathan
AU  - Pimm J
AD  - Division of Psychiatry, University College London, London, United Kingdom.
FAU - Pistis, Giorgio
AU  - Pistis G
AD  - Department of Psychiatry, Lausanne University Hospital and University of 
      Lausanne, Lausanne, Switzerland.
FAU - Potash, James B
AU  - Potash JB
AD  - Department of Psychiatry, University of Iowa, Iowa City, Iowa.
FAU - Power, Robert A
AU  - Power RA
AD  - Social Genetic and Developmental Psychiatry Centre, King's College London, 
      London, United Kingdom; Genetics, BioMarin Pharmaceuticals, London, United 
      Kingdom; University of Oxford, St. Edmund Hall, Oxford, United Kingdom.
FAU - Preisig, Martin
AU  - Preisig M
AD  - Department of Psychiatry, Lausanne University Hospital and University of 
      Lausanne, Lausanne, Switzerland.
FAU - Quested, Digby
AU  - Quested D
AD  - Department of Psychiatry, University of Oxford, Oxford, United Kingdom.
FAU - Ramos-Quiroga, Josep Antoni
AU  - Ramos-Quiroga JA
AD  - Department of Psychiatry, Hospital Universitari Vall d'Hebrón, Barcelona, Spain; 
      Psychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addiction, Vall 
      d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain; 
      Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, 
      Barcelona, Spain; Biomedical Network Research Centre on Mental Health, Instituto 
      de Salud Carlos III, Madrid, Spain.
FAU - Reif, Andreas
AU  - Reif A
AD  - Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University 
      Hospital Frankfurt, Frankfurt, Germany.
FAU - Ribasés, Marta
AU  - Ribasés M
AD  - Department of Psychiatry, Hospital Universitari Vall d'Hebrón, Barcelona, Spain; 
      Department of Genetics, Microbiology & Statistics, University of Barcelona, 
      Barcelona, Spain; Psychiatric Genetics Unit, Group of Psychiatry, Mental Health 
      and Addiction, Vall d'Hebron Research Institute, Universitat Autònoma de 
      Barcelona, Barcelona, Spain; Biomedical Network Research Centre on Mental Health, 
      Instituto de Salud Carlos III, Madrid, Spain.
FAU - Richarte, Vanesa
AU  - Richarte V
AD  - Department of Psychiatry, Hospital Universitari Vall d'Hebrón, Barcelona, Spain; 
      Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, 
      Barcelona, Spain; Biomedical Network Research Centre on Mental Health, Instituto 
      de Salud Carlos III, Madrid, Spain.
FAU - Rietschel, Marcella
AU  - Rietschel M
AD  - Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental 
      Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
FAU - Rivera, Margarita
AU  - Rivera M
AD  - Social Genetic and Developmental Psychiatry Centre, King's College London, 
      London, United Kingdom; Department of Biochemistry and Molecular Biology II and 
      Institute of Neurosciences, Biomedical Research Centre, University of Granada, 
      Granada, Spain.
FAU - Roberts, Andrea
AU  - Roberts A
AD  - Department of Environmental Health, Harvard TH Chan School of Public Health, 
      Boston, Massachusetts.
FAU - Roberts, Gloria
AU  - Roberts G
AD  - School of Psychiatry, University of New South Wales, Sydney, New South Wales, 
      Australia.
FAU - Rouleau, Guy A
AU  - Rouleau GA
AD  - Department of Neurology and Neurosurgery, Faculty of Medicine, McGill University, 
      Montreal, Québec, Canada; Montreal Neurological Institute and Hospital, Montreal, 
      Québec, Canada.
FAU - Rovaris, Diego L
AU  - Rovaris DL
AD  - Department of Physiology and Biophysics, Instituto de Ciencias Biomedicas 
      Universidade de Sao Paulo, São Paulo, Brazil.
FAU - Rujescu, Dan
AU  - Rujescu D
AD  - Department of Psychiatry, Psychotherapy and Psychosomatics, 
      Martin-Luther-University Halle-Wittenberg, Halle, Germany.
FAU - Sánchez-Mora, Cristina
AU  - Sánchez-Mora C
AD  - Department of Psychiatry, Hospital Universitari Vall d'Hebrón, Barcelona, Spain; 
      Department of Genetics, Microbiology & Statistics, University of Barcelona, 
      Barcelona, Spain; Psychiatric Genetics Unit, Group of Psychiatry, Mental Health 
      and Addiction, Vall d'Hebron Research Institute, Universitat Autònoma de 
      Barcelona, Barcelona, Spain; Biomedical Network Research Centre on Mental Health, 
      Instituto de Salud Carlos III, Madrid, Spain.
FAU - Sanders, Alan R
AU  - Sanders AR
AD  - Department of Psychiatry and Behavioral Sciences, NorthShore University 
      HealthSystem, Evanston, Illinois; Department of Psychiatry and Behavioral 
      Neuroscience, University of Chicago, Chicago, Illinois.
FAU - Schofield, Peter R
AU  - Schofield PR
AD  - School of Medical Sciences, University of New South Wales, Sydney, New South 
      Wales, Australia; Neuroscience Research Australia, Sydney, New South Wales, 
      Australia.
FAU - Schulze, Thomas G
AU  - Schulze TG
AD  - Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental 
      Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; 
      Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School 
      of Medicine, Baltimore, Maryland; Institute of Psychiatric Phenomics and 
      Genomics, University Hospital, Ludwig-Maximilians-University, Munich, Germany; 
      Human Genetics Branch, Intramural Research Program, National Institute of Mental 
      Health, Bethesda, Maryland; Department of Psychiatry and Psychotherapy, 
      University Medical Center Göttingen, Göttingen, Germany.
FAU - Scott, Laura J
AU  - Scott LJ
AD  - Center for Statistical Genetics and Department of Biostatistics, Institute for 
      Social Research, University of Michigan, Ann Arbor, Michigan.
FAU - Serretti, Alessandro
AU  - Serretti A
AD  - Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, 
      Italy.
FAU - Shi, Jianxin
AU  - Shi J
AD  - Division of Cancer Epidemiology and Genetics, National Cancer Institute, 
      Bethesda, Maryland.
FAU - Shyn, Stanley I
AU  - Shyn SI
AD  - Behavioral Health Services, Kaiser Permanente Washington, Seattle, Washington, 
      DC.
FAU - Sirignano, Lea
AU  - Sirignano L
AD  - Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental 
      Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
FAU - Sklar, Pamela
AU  - Sklar P
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount 
      Sinai, New York, New York; Department of Neuroscience, Icahn School of Medicine 
      at Mount Sinai, New York, New York; Department of Psychiatry, Icahn School of 
      Medicine at Mount Sinai, New York, New York.
FAU - Smeland, Olav B
AU  - Smeland OB
AD  - Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; 
      NORMENT, University of Oslo, Oslo, Norway.
FAU - Smoller, Jordan W
AU  - Smoller JW
AD  - Stanley Center for Psychiatric Research, Broad Institute, Cambridge, 
      Massachusetts; Department of Psychiatry, Massachusetts General Hospital, Boston, 
      Massachusetts; Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts 
      General Hospital, Boston, Massachusetts.
FAU - Sonuga-Barke, Edmund J S
AU  - Sonuga-Barke EJS
AD  - Institute of Psychology, Psychiatry & Neuroscience, King's College London, 
      London, United Kingdom.
FAU - Spalletta, Gianfranco
AU  - Spalletta G
AD  - Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of 
      Medicine, Houston, Texas; Laboratory of Neuropsychiatry, IRCCS Santa Lucia 
      Foundation, Rome, Italy.
FAU - Strauss, John S
AU  - Strauss JS
AD  - Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Centre 
      for Addiction and Mental Health, Toronto, Ontario, Canada.
FAU - Świątkowska, Beata
AU  - Świątkowska B
AD  - Department of Environmental Epidemiology, Nofer Institute of Occupational 
      Medicine, Lódz, Poland.
FAU - Trzaskowski, Maciej
AU  - Trzaskowski M
AD  - Institute for Molecular Bioscience, The University of Queensland, Brisbane, 
      Queensland, Australia.
FAU - Turecki, Gustavo
AU  - Turecki G
AD  - Department of Psychiatry, Faculty of Medicine, McGill University, Montreal, 
      Québec, Canada.
FAU - Vilar-Ribó, Laura
AU  - Vilar-Ribó L
AD  - Department of Psychiatry, Hospital Universitari Vall d'Hebrón, Barcelona, Spain; 
      Psychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addiction, Vall 
      d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
FAU - Vincent, John B
AU  - Vincent JB
AD  - Molecular Brain Science, Centre for Addiction and Mental Health, Toronto, 
      Ontario, Canada.
FAU - Völzke, Henry
AU  - Völzke H
AD  - Institute for Community Medicine, University Medicine Greifswald, Greifswald, 
      Mecklenburg-Vorpommern, Germany.
FAU - Walters, James T R
AU  - Walters JTR
AD  - Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, 
      Division of Psychological Medicine and Clinical Neurosciences, Cardiff 
      University, Cardiff, United Kingdom.
FAU - Shannon Weickert, Cynthia
AU  - Shannon Weickert C
AD  - School of Psychiatry, University of New South Wales, Sydney, New South Wales, 
      Australia; Neuroscience Research Australia, Sydney, New South Wales, Australia.
FAU - Weickert, Thomas W
AU  - Weickert TW
AD  - School of Psychiatry, University of New South Wales, Sydney, New South Wales, 
      Australia; Neuroscience Research Australia, Sydney, New South Wales, Australia.
FAU - Weissman, Myrna M
AU  - Weissman MM
AD  - Columbia University College of Physicians and Surgeons, New York, New York; 
      Division of Translational Epidemiology, New York State Psychiatric Institute, New 
      York, New York.
FAU - Williams, Leanne M
AU  - Williams LM
AD  - Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, 
      California.
FAU - Wray, Naomi R
AU  - Wray NR
AD  - Institute for Molecular Bioscience, The University of Queensland, Brisbane, 
      Queensland, Australia; Queensland Brain Institute, The University of Queensland, 
      Brisbane, Queensland, Australia.
FAU - Zai, Clement C
AU  - Zai CC
AD  - Stanley Center for Psychiatric Research, Broad Institute, Cambridge, 
      Massachusetts; Department of Epidemiology, Harvard TH Chan School of Public 
      Health, Boston, Massachusetts; Department of Psychiatry, University of Toronto, 
      Toronto, Ontario, Canada; Laboratory Medicine and Pathobiology, University of 
      Toronto, Toronto, Ontario, Canada; Institute of Medical Sciences, University of 
      Toronto, Toronto, Ontario, Canada; Molecular Brain Science, Campbell Family 
      Mental Health Research Institute, Centre for Addiction and Mental Health, 
      Toronto, Ontario, Canada.
FAU - Ashley-Koch, Allison E
AU  - Ashley-Koch AE
AD  - Duke Molecular Physiology Institute, Duke University Medical Center, Durham, 
      North Carolina.
FAU - Beckham, Jean C
AU  - Beckham JC
AD  - Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, 
      Durham, North Carolina; VISN 6 Mid-Atlantic Mental Illness Research, Durham 
      Veterans Affairs Health Care System, Durham, North Carolina.
FAU - Hauser, Elizabeth R
AU  - Hauser ER
AD  - Duke Molecular Physiology Institute, Duke University Medical Center, Durham, 
      North Carolina; Cooperative Studies Program Epidemiology Center, Education, and 
      Clinical Center, Durham Veterans Affairs Health Care System, Durham, North 
      Carolina.
FAU - Hauser, Michael A
AU  - Hauser MA
AD  - Duke Molecular Physiology Institute, Duke University Medical Center, Durham, 
      North Carolina.
FAU - Kimbrel, Nathan A
AU  - Kimbrel NA
AD  - Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, 
      Durham, North Carolina; VISN 6 Mid-Atlantic Mental Illness Research, Durham 
      Veterans Affairs Health Care System, Durham, North Carolina.
FAU - Lindquist, Jennifer H
AU  - Lindquist JH
AD  - VA Health Services Research and Development Center of Innovation to Accelerate 
      Discovery and Practice Transformation, Durham Veterans Affairs Health Care 
      System, Durham, North Carolina.
FAU - McMahon, Benjamin
AU  - McMahon B
AD  - Theoretical Division, Los Alamos National Laboratory, Los Alamos National 
      Laboratory, Los Alamos, New Mexico.
FAU - Oslin, David W
AU  - Oslin DW
AD  - Department of Psychiatry, Perelman School of Medicine, University of 
      Pennsylvania, Philadelphia, Pennsylvania; VISN 4 Mental Illness Research, 
      Education, and Clinical Center, Corporal Michael J. Crescenz VA Medical Center, 
      Philadelphia, Pennsylvania.
FAU - Qin, Xuejun
AU  - Qin X
AD  - Duke Molecular Physiology Institute, Duke University Medical Center, Durham, 
      North Carolina.
CN  - Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium
CN  - Bipolar Disorder Working Group of the Psychiatric Genomics Consortium
CN  - Eating Disorders Working Group of the Psychiatric Genomics Consortium
CN  - German Borderline Genomics Consortium
CN  - MVP Suicide Exemplar Workgroup
CN  - VA Million Veteran Program
FAU - Agerbo, Esben
AU  - Agerbo E
AD  - National Centre for Register-Based Research, Aarhus University, Aarhus, Denmark; 
      Centre for Integrated Register-based Research, Aarhus University, Aarhus, 
      Denmark; Lundbeck Foundation Initiative for Integrative Psychiatric Research, 
      iPSYCH, Aarhus, Denmark.
FAU - Børglum, Anders D
AU  - Børglum AD
AD  - Centre for Genomics and Personalized Medicine, Aarhus University, Aarhus, 
      Denmark; Centre for Integrative Sequencing, Aarhus University, Aarhus, Denmark; 
      Department of Biomedicine, Aarhus University, Aarhus, Denmark; Lundbeck 
      Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus 
      University, Aarhus, Denmark.
FAU - Breen, Gerome
AU  - Breen G
AD  - National Institute for Health Research Maudsley Biomedical Research Centre at 
      South London and Maudsley NHS Foundation Trust, London, United Kingdom; Social 
      Genetic and Developmental Psychiatry Centre, King's College London, London, 
      United Kingdom.
FAU - Erlangsen, Annette
AU  - Erlangsen A
AD  - Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, 
      Aarhus University, Aarhus, Denmark; Department of Mental Health, Johns Hopkins 
      University School of Medicine, Baltimore, Maryland; Danish Research Institute for 
      Suicide Prevention, Mental Health Centre Copenhagen, Copenhagen, Denmark; Center 
      of Mental Health Research, Australian National University, Canberra, Australia.
FAU - Esko, Tõnu
AU  - Esko T
AD  - Program in Medical and Population Genetics, Broad Institute, Cambridge, 
      Massachusetts; Estonian Genome Center, Institute of Genomics, University of 
      Tartu, Tartu, Estonia.
FAU - Gelernter, Joel
AU  - Gelernter J
AD  - Department of Psychiatry, Veterans Affairs Connecticut Healthcare Center, West 
      Haven, Connecticut; Division of Human Genetics, Department of Psychiatry, Yale 
      University School of Medicine, New Haven, Connecticut.
FAU - Hougaard, David M
AU  - Hougaard DM
AD  - Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, 
      Aarhus, Denmark; Center for Neonatal Screening, Department for Congenital 
      Disorders, Statens Serum Institut, Copenhagen, Denmark.
FAU - Kessler, Ronald C
AU  - Kessler RC
AD  - Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.
FAU - Kranzler, Henry R
AU  - Kranzler HR
AD  - Department of Psychiatry, Perelman School of Medicine, University of 
      Pennsylvania, Philadelphia, Pennsylvania; VISN 4 Mental Illness Research, 
      Education, and Clinical Center, Corporal Michael J. Crescenz VA Medical Center, 
      Philadelphia, Pennsylvania.
FAU - Li, Qingqin S
AU  - Li QS
AD  - Neuroscience, Janssen Research & Development, LLC, Titusville, New Jersey.
FAU - Martin, Nicholas G
AU  - Martin NG
AD  - Department of Genetics and Computational Biology, QIMR Berghofer Medical Research 
      Institute, Herston, Brisbane, Queensland, Australia.
FAU - McIntosh, Andrew M
AU  - McIntosh AM
AD  - Division of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
FAU - Mors, Ole
AU  - Mors O
AD  - Psychosis Research Unit, Aarhus University, Aarhus, Denmark; Lundbeck Foundation 
      Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
FAU - Nordentoft, Merete
AU  - Nordentoft M
AD  - Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, 
      Aarhus, Denmark; Mental Health Center Copenhagen, Copenhagen University Hospital, 
      Copenhagen, Denmark.
FAU - Olsen, Catherine M
AU  - Olsen CM
AD  - Department of Population Health, QIMR Berghofer Medical Research Institute, 
      Herston, Brisbane, Queensland, Australia.
FAU - Porteous, David
AU  - Porteous D
AD  - Institute for Genetics and Molecular Medicine, University of Edinburgh, 
      Edinburgh, United Kingdom.
FAU - Ursano, Robert J
AU  - Ursano RJ
AD  - Department of Psychiatry, Uniformed University of the Health Sciences, Bethesda, 
      Maryland.
FAU - Wasserman, Danuta
AU  - Wasserman D
AD  - National Centre for Suicide Research and Prevention of Mental Ill-Health, LIME, 
      Karolinska Institutet, Stockholm, Sweden.
FAU - Werge, Thomas
AU  - Werge T
AD  - Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, 
      Aarhus, Denmark; Institute of Biological Psychiatry, Copenhagen Mental Health 
      Services, Copenhagen University Hospital, Copenhagen, Denmark; Department of 
      Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; Lundbeck 
      Foundation GeoGenetics Centre, GLOBE Institute, University of Copenhagen, 
      Copenhagen, Denmark.
FAU - Whiteman, David C
AU  - Whiteman DC
AD  - Department of Population Health, QIMR Berghofer Medical Research Institute, 
      Herston, Brisbane, Queensland, Australia.
FAU - Bulik, Cynthia M
AU  - Bulik CM
AD  - Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel 
      Hill, North Carolina; Department of Nutrition, University of North Carolina at 
      Chapel Hill, Chapel Hill, North Carolina; Department of Medical Epidemiology and 
      Biostatistics, Karolinska Institutet, Stockholm, Sweden.
FAU - Coon, Hilary
AU  - Coon H
AD  - Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, 
      Utah; Biomedical Informatics, University of Utah School of Medicine, Salt Lake 
      City, Utah.
FAU - Demontis, Ditte
AU  - Demontis D
AD  - Centre for Genomics and Personalized Medicine, Aarhus University, Aarhus, 
      Denmark; Centre for Integrative Sequencing, Aarhus University, Aarhus, Denmark; 
      Department of Biomedicine, Aarhus University, Aarhus, Denmark; Lundbeck 
      Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus 
      University, Aarhus, Denmark.
FAU - Docherty, Anna R
AU  - Docherty AR
AD  - Department of Psychiatry, Virginia Commonwealth University, Richmond, Virginia; 
      Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, 
      Utah.
FAU - Kuo, Po-Hsiu
AU  - Kuo PH
AD  - Institute of Epidemiology and Preventive Medicine, College of Public Health, 
      National Taiwan University, Taipei, Taiwan; Department of Psychiatry, National 
      Taiwan University Hospital, Taipei, Taiwan.
FAU - Lewis, Cathryn M
AU  - Lewis CM
AD  - Department of Medical & Molecular Genetics, King's College London, London, United 
      Kingdom; Social Genetic and Developmental Psychiatry Centre, King's College 
      London, London, United Kingdom.
FAU - Mann, J John
AU  - Mann JJ
AD  - Departments of Psychiatry and Radiology, Columbia University, New York, New York.
FAU - Rentería, Miguel E
AU  - Rentería ME
AD  - Department of Genetics and Computational Biology, QIMR Berghofer Medical Research 
      Institute, Brisbane, Queensland, Australia; School of Biomedical Sciences, 
      Faculty of Medicine, The University of Queensland, Brisbane, Queensland, 
      Australia.
FAU - Smith, Daniel J
AU  - Smith DJ
AD  - Institute of Health and Wellbeing, University of Glasgow, Glasgow, United 
      Kingdom.
FAU - Stahl, Eli A
AU  - Stahl EA
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount 
      Sinai, New York, New York; Department of Psychiatry, Icahn School of Medicine at 
      Mount Sinai, New York, New York; Program in Medical and Population Genetics, 
      Broad Institute, Cambridge, Massachusetts.
FAU - Stein, Murray B
AU  - Stein MB
AD  - Department of Psychiatry and School of Public Health, University of California 
      San Diego, La Jolla, California.
FAU - Streit, Fabian
AU  - Streit F
AD  - Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental 
      Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
FAU - Willour, Virginia
AU  - Willour V
AD  - Department of Psychiatry, University of Iowa, Iowa City, Iowa.
FAU - Ruderfer, Douglas M
AU  - Ruderfer DM
AD  - Division of Genetic Medicine, Department of Medicine, Vanderbilt Genetics 
      Institute, Vanderbilt University Medical Center, Nashville, Tennessee; Department 
      of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, 
      Tennessee; Department of Psychiatry and Behavioral Sciences, Vanderbilt 
      University Medical Center, Nashville, Tennessee. Electronic address: 
      douglas.ruderfer@vanderbilt.edu.
LA  - eng
GR  - R01 MH121455/MH/NIMH NIH HHS/United States
GR  - R01 MH104964/MH/NIMH NIH HHS/United States
GR  - R01 MH123489/MH/NIMH NIH HHS/United States
GR  - R01 MH124873/MH/NIMH NIH HHS/United States
GR  - T32 GM007347/GM/NIGMS NIH HHS/United States
GR  - R01 MH123451/MH/NIMH NIH HHS/United States
GR  - MRF_C0396/MRF/MRF/United Kingdom
GR  - R01 MH116269/MH/NIMH NIH HHS/United States
GR  - G0200243/MRC_/Medical Research Council/United Kingdom
GR  - MR/L010305/1/MRC_/Medical Research Council/United Kingdom
GR  - S10 OD018522/OD/NIH HHS/United States
GR  - MR/J000914/1/MRC_/Medical Research Council/United Kingdom
GR  - R01 AA027522/AA/NIAAA NIH HHS/United States
GR  - S10 OD026880/OD/NIH HHS/United States
GR  - R01 MH119243/MH/NIMH NIH HHS/United States
GR  - R01 MH123619/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20210909
PL  - United States
TA  - Biol Psychiatry
JT  - Biological psychiatry
JID - 0213264
SB  - IM
MH  - *Depressive Disorder, Major/genetics
MH  - Genome-Wide Association Study
MH  - Humans
MH  - *Mental Disorders/genetics
MH  - Polymorphism, Single Nucleotide
MH  - Risk Factors
MH  - Suicide, Attempted
PMC - PMC8851871
MID - NIHMS1760998
OTO - NOTNLM
OT  - Genetic correlation
OT  - Genome-wide association study
OT  - Pleiotropy
OT  - Polygenicity
OT  - Suicide
OT  - Suicide attempt
FIR - Wray, Naomi R
IR  - Wray NR
FIR - Ripke, Stephan
IR  - Ripke S
FIR - Mattheisen, Manuel
IR  - Mattheisen M
FIR - Trzaskowski, Maciej
IR  - Trzaskowski M
FIR - Byrne, Enda M
IR  - Byrne EM
FIR - Abdellaoui, Abdel
IR  - Abdellaoui A
FIR - Adams, Mark J
IR  - Adams MJ
FIR - Agerbo, Esben
IR  - Agerbo E
FIR - Air, Tracy M
IR  - Air TM
FIR - Andlauer, Till F M
IR  - Andlauer TFM
FIR - Bacanu, Silviu-Alin
IR  - Bacanu SA
FIR - Bækvad-Hansen, Marie
IR  - Bækvad-Hansen M
FIR - Beekman, Aartjan T F
IR  - Beekman ATF
FIR - Bigdeli, Tim B
IR  - Bigdeli TB
FIR - Binder, Elisabeth B
IR  - Binder EB
FIR - Bryois, Julien
IR  - Bryois J
FIR - Buttenschøn, Henriette N
IR  - Buttenschøn HN
FIR - Bybjerg-Grauholm, Jonas
IR  - Bybjerg-Grauholm J
FIR - Cai, Na
IR  - Cai N
FIR - Castelao, Enrique
IR  - Castelao E
FIR - Christensen, Jane Hvarregaard
IR  - Christensen JH
FIR - Clarke, Toni-Kim
IR  - Clarke TK
FIR - Coleman, Jonathan R I
IR  - Coleman JRI
FIR - Colodro-Conde, Lucía
IR  - Colodro-Conde L
FIR - Couvy-Duchesne, Baptiste
IR  - Couvy-Duchesne B
FIR - Craddock, Nick
IR  - Craddock N
FIR - Crawford, Gregory E
IR  - Crawford GE
FIR - Davies, Gail
IR  - Davies G
FIR - Degenhardt, Franziska
IR  - Degenhardt F
FIR - Derks, Eske M
IR  - Derks EM
FIR - Direk, Nese
IR  - Direk N
FIR - Dolan, Conor V
IR  - Dolan CV
FIR - Dunn, Erin C
IR  - Dunn EC
FIR - Eley, Thalia C
IR  - Eley TC
FIR - Escott-Price, Valentina
IR  - Escott-Price V
FIR - Hassan Kiadeh, Farnush Farhadi
IR  - Hassan Kiadeh FF
FIR - Finucane, Hilary K
IR  - Finucane HK
FIR - Foo, Jerome C
IR  - Foo JC
FIR - Forstner, Andreas J
IR  - Forstner AJ
FIR - Frank, Josef
IR  - Frank J
FIR - Gaspar, Héléna A
IR  - Gaspar HA
FIR - Gill, Michael
IR  - Gill M
FIR - Goes, Fernando S
IR  - Goes FS
FIR - Gordon, Scott D
IR  - Gordon SD
FIR - Weinsheimer, Shantel Marie
IR  - Weinsheimer SM
FIR - Wellmann, Jürgen
IR  - Wellmann J
FIR - Willemsen, Gonneke
IR  - Willemsen G
FIR - Witt, Stephanie H
IR  - Witt SH
FIR - Wu, Yang
IR  - Wu Y
FIR - Xi, Hualin S
IR  - Xi HS
FIR - Yang, Jian
IR  - Yang J
FIR - Zhang, Futao
IR  - Zhang F
FIR - Arolt, Volker
IR  - Arolt V
FIR - Baune, Bernhard T
IR  - Baune BT
FIR - Berger, Klaus
IR  - Berger K
FIR - Boomsma, Dorret I
IR  - Boomsma DI
FIR - Cichon, Sven
IR  - Cichon S
FIR - Dannlowski, Udo
IR  - Dannlowski U
FIR - de Geus, E J C
IR  - de Geus EJC
FIR - Depaulo, J Raymond
IR  - Depaulo JR
FIR - Domenici, Enrico
IR  - Domenici E
FIR - Domschke, Katharina
IR  - Domschke K
FIR - Esko, Tõnu
IR  - Esko T
FIR - Grabe, Hans J
IR  - Grabe HJ
FIR - Hamilton, Steven P
IR  - Hamilton SP
FIR - Grove, Jakob
IR  - Grove J
FIR - Hall, Lynsey S
IR  - Hall LS
FIR - Hansen, Christine Søholm
IR  - Hansen CS
FIR - Hansen, Thomas F
IR  - Hansen TF
FIR - Herms, Stefan
IR  - Herms S
FIR - Hickie, Ian B
IR  - Hickie IB
FIR - Hoffmann, Per
IR  - Hoffmann P
FIR - Homuth, Georg
IR  - Homuth G
FIR - Horn, Carsten
IR  - Horn C
FIR - Hottenga, Jouke-Jan
IR  - Hottenga JJ
FIR - Hougaard, David M
IR  - Hougaard DM
FIR - Howard, David M
IR  - Howard DM
FIR - Ising, Marcus
IR  - Ising M
FIR - Jansen, Rick
IR  - Jansen R
FIR - Jones, Ian
IR  - Jones I
FIR - Jones, Lisa A
IR  - Jones LA
FIR - Jorgenson, Eric
IR  - Jorgenson E
FIR - Knowles, James A
IR  - Knowles JA
FIR - Kohane, Isaac S
IR  - Kohane IS
FIR - Kraft, Julia
IR  - Kraft J
FIR - Kretzschmar, Warren W
IR  - Kretzschmar WW
FIR - Kutalik, Zoltán
IR  - Kutalik Z
FIR - Li, Yihan
IR  - Li Y
FIR - Lind, Penelope A
IR  - Lind PA
FIR - MacIntyre, Donald J
IR  - MacIntyre DJ
FIR - MacKinnon, Dean F
IR  - MacKinnon DF
FIR - Maier, Robert M
IR  - Maier RM
FIR - Maier, Wolfgang
IR  - Maier W
FIR - Marchini, Jonathan
IR  - Marchini J
FIR - Mbarek, Hamdi
IR  - Mbarek H
FIR - McGrath, Patrick
IR  - McGrath P
FIR - McGuffin, Peter
IR  - McGuffin P
FIR - Medland, Sarah E
IR  - Medland SE
FIR - Mehta, Divya
IR  - Mehta D
FIR - Middeldorp, Christel M
IR  - Middeldorp CM
FIR - Mihailov, Evelin
IR  - Mihailov E
FIR - Milaneschi, Yuri
IR  - Milaneschi Y
FIR - Milani, Lili
IR  - Milani L
FIR - Mondimore, Francis M
IR  - Mondimore FM
FIR - Montgomery, Grant W
IR  - Montgomery GW
FIR - Mostafavi, Sara
IR  - Mostafavi S
FIR - Mullins, Niamh
IR  - Mullins N
FIR - Nauck, Matthias
IR  - Nauck M
FIR - Ng, Bernard
IR  - Ng B
FIR - Nivard, Michel G
IR  - Nivard MG
FIR - Nyholt, Dale R
IR  - Nyholt DR
FIR - O'Reilly, Paul F
IR  - O'Reilly PF
FIR - Oskarsson, Hogni
IR  - Oskarsson H
FIR - Hayward, Caroline
IR  - Hayward C
FIR - Heath, Andrew C
IR  - Heath AC
FIR - Kendler, Kenneth S
IR  - Kendler KS
FIR - Kloiber, Stefan
IR  - Kloiber S
FIR - Lewis, Glyn
IR  - Lewis G
FIR - Li, Qingqin S
IR  - Li QS
FIR - Lucae, Susanne
IR  - Lucae S
FIR - Madden, Pamela A F
IR  - Madden PAF
FIR - Magnusson, Patrik K
IR  - Magnusson PK
FIR - Martin, Nicholas G
IR  - Martin NG
FIR - McIntosh, Andrew M
IR  - McIntosh AM
FIR - Metspalu, Andres
IR  - Metspalu A
FIR - Mors, Ole
IR  - Mors O
FIR - Mortensen, Preben Bo
IR  - Mortensen PB
FIR - Müller-Myhsok, Bertram
IR  - Müller-Myhsok B
FIR - Nordentoft, Merete
IR  - Nordentoft M
FIR - Nöthen, Markus M
IR  - Nöthen MM
FIR - O'Donovan, Michael C
IR  - O'Donovan MC
FIR - Paciga, Sara A
IR  - Paciga SA
FIR - Pedersen, Nancy L
IR  - Pedersen NL
FIR - Owen, Michael J
IR  - Owen MJ
FIR - Painter, Jodie N
IR  - Painter JN
FIR - Pedersen, Carsten Bøcker
IR  - Pedersen CB
FIR - Pedersen, Marianne Giørtz
IR  - Pedersen MG
FIR - Peterson, Roseann E
IR  - Peterson RE
FIR - Peyrot, Wouter J
IR  - Peyrot WJ
FIR - Pistis, Giorgio
IR  - Pistis G
FIR - Posthuma, Danielle
IR  - Posthuma D
FIR - Quiroz, Jorge A
IR  - Quiroz JA
FIR - Qvist, Per
IR  - Qvist P
FIR - Rice, John P
IR  - Rice JP
FIR - Riley, Brien P
IR  - Riley BP
FIR - Rivera, Margarita
IR  - Rivera M
FIR - Mirza, Saira Saeed
IR  - Mirza SS
FIR - Schoevers, Robert
IR  - Schoevers R
FIR - Schulte, Eva C
IR  - Schulte EC
FIR - Shen, Ling
IR  - Shen L
FIR - Shi, Jianxin
IR  - Shi J
FIR - Shyn, Stanley I
IR  - Shyn SI
FIR - Sigurdsson, Engilbert
IR  - Sigurdsson E
FIR - Sinnamon, Grant C B
IR  - Sinnamon GCB
FIR - Smit, Johannes H
IR  - Smit JH
FIR - Smith, Daniel J
IR  - Smith DJ
FIR - Stefansson, Hreinn
IR  - Stefansson H
FIR - Steinberg, Stacy
IR  - Steinberg S
FIR - Streit, Fabian
IR  - Streit F
FIR - Strohmaier, Jana
IR  - Strohmaier J
FIR - Tansey, Katherine E
IR  - Tansey KE
FIR - Teismann, Henning
IR  - Teismann H
FIR - Teumer, Alexander
IR  - Teumer A
FIR - Thompson, Wesley
IR  - Thompson W
FIR - Thomson, Pippa A
IR  - Thomson PA
FIR - Thorgeirsson, Thorgeir E
IR  - Thorgeirsson TE
FIR - Traylor, Matthew
IR  - Traylor M
FIR - Treutlein, Jens
IR  - Treutlein J
FIR - Trubetskoy, Vassily
IR  - Trubetskoy V
FIR - Uitterlinden, André G
IR  - Uitterlinden AG
FIR - Umbricht, Daniel
IR  - Umbricht D
FIR - der Auwera, Sandra Van
IR  - der Auwera SV
FIR - van Hemert, Albert M
IR  - van Hemert AM
FIR - Viktorin, Alexander
IR  - Viktorin A
FIR - Visscher, Peter M
IR  - Visscher PM
FIR - Wang, Yunpeng
IR  - Wang Y
FIR - Webb, Bradley T
IR  - Webb BT
FIR - Penninx, Brenda W J H
IR  - Penninx BWJH
FIR - Perlis, Roy H
IR  - Perlis RH
FIR - Porteous, David J
IR  - Porteous DJ
FIR - Potash, James B
IR  - Potash JB
FIR - Preisig, Martin
IR  - Preisig M
FIR - Rietschel, Marcella
IR  - Rietschel M
FIR - Schaefer, Catherine
IR  - Schaefer C
FIR - Schulze, Thomas G
IR  - Schulze TG
FIR - Smoller, Jordan W
IR  - Smoller JW
FIR - Stefansson, Kari
IR  - Stefansson K
FIR - Tiemeier, Henning
IR  - Tiemeier H
FIR - Uher, Rudolf
IR  - Uher R
FIR - Völzke, Henry
IR  - Völzke H
FIR - Weissman, Myrna M
IR  - Weissman MM
FIR - Werge, Thomas
IR  - Werge T
FIR - Lewis, Cathryn M
IR  - Lewis CM
FIR - Levinson, Douglas F
IR  - Levinson DF
FIR - Breen, Gerome
IR  - Breen G
FIR - Børglum, Anders D
IR  - Børglum AD
FIR - Sullivan, Patrick F
IR  - Sullivan PF
FIR - Mullins, Niamh
IR  - Mullins N
FIR - Forstner, Andreas J
IR  - Forstner AJ
FIR - O'Connell, Kevin S
IR  - O'Connell KS
FIR - Coombes, Brandon
IR  - Coombes B
FIR - Coleman, Jonathan R I
IR  - Coleman JRI
FIR - Qiao, Zhen
IR  - Qiao Z
FIR - Als, Thomas D
IR  - Als TD
FIR - Bigdeli, Tim B
IR  - Bigdeli TB
FIR - Børte, Sigrid
IR  - Børte S
FIR - Bryois, Julien
IR  - Bryois J
FIR - Charney, Alexander W
IR  - Charney AW
FIR - Drange, Ole Kristian
IR  - Drange OK
FIR - Gandal, Michael J
IR  - Gandal MJ
FIR - Hagenaars, Saskia P
IR  - Hagenaars SP
FIR - Ikeda, Masashi
IR  - Ikeda M
FIR - Kamitaki, Nolan
IR  - Kamitaki N
FIR - Kim, Minsoo
IR  - Kim M
FIR - Krebs, Kristi
IR  - Krebs K
FIR - Panagiotaropoulou, Georgia
IR  - Panagiotaropoulou G
FIR - Schilder, Brian M
IR  - Schilder BM
FIR - Sloofman, Laura G
IR  - Sloofman LG
FIR - Steinberg, Stacy
IR  - Steinberg S
FIR - Trubetskoy, Vassily
IR  - Trubetskoy V
FIR - Winsvold, Bendik S
IR  - Winsvold BS
FIR - Won, Hong-Hee
IR  - Won HH
FIR - Abramova, Liliya
IR  - Abramova L
FIR - Adorjan, Kristina
IR  - Adorjan K
FIR - Agerbo, Esben
IR  - Agerbo E
FIR - Al Eissa, Mariam
IR  - Al Eissa M
FIR - Albani, Diego
IR  - Albani D
FIR - Alliey-Rodriguez, Ney
IR  - Alliey-Rodriguez N
FIR - Anjorin, Adebayo
IR  - Anjorin A
FIR - Antilla, Verneri
IR  - Antilla V
FIR - Antoniou, Anastasia
IR  - Antoniou A
FIR - Awasthi, Swapnil
IR  - Awasthi S
FIR - Baek, Ji Hyun
IR  - Baek JH
FIR - Bækvad-Hansen, Marie
IR  - Bækvad-Hansen M
FIR - Bass, Nicholas
IR  - Bass N
FIR - Bauer, Michael
IR  - Bauer M
FIR - Beins, Eva C
IR  - Beins EC
FIR - Bergen, Sarah E
IR  - Bergen SE
FIR - Birner, Armin
IR  - Birner A
FIR - Pedersen, Carsten Bøcker
IR  - Pedersen CB
FIR - Bøen, Erlend
IR  - Bøen E
FIR - Boks, Marco P
IR  - Boks MP
FIR - Bosch, Rosa
IR  - Bosch R
FIR - Brum, Murielle
IR  - Brum M
FIR - Brumpton, Ben M
IR  - Brumpton BM
FIR - Brunkhorst-Kanaan, Nathalie
IR  - Brunkhorst-Kanaan N
FIR - Budde, Monika
IR  - Budde M
FIR - Bybjerg-Grauholm, Jonas
IR  - Bybjerg-Grauholm J
FIR - Byerley, William
IR  - Byerley W
FIR - Cairns, Murray
IR  - Cairns M
FIR - Casas, Miquel
IR  - Casas M
FIR - Cervantes, Pablo
IR  - Cervantes P
FIR - Clarke, Toni-Kim
IR  - Clarke TK
FIR - Cruceanu, Cristiana
IR  - Cruceanu C
FIR - Cuellar-Barboza, Alfredo
IR  - Cuellar-Barboza A
FIR - Cunningham, Julie
IR  - Cunningham J
FIR - Curtis, David
IR  - Curtis D
FIR - Czerski, Piotr M
IR  - Czerski PM
FIR - Dale, Anders M
IR  - Dale AM
FIR - Dalkner, Nina
IR  - Dalkner N
FIR - David, Friederike S
IR  - David FS
FIR - Degenhardt, Franziska
IR  - Degenhardt F
FIR - Djurovic, Srdjan
IR  - Djurovic S
FIR - Dobbyn, Amanda L
IR  - Dobbyn AL
FIR - Douzenis, Athanassios
IR  - Douzenis A
FIR - Elvsåshagen, Torbjørn
IR  - Elvsåshagen T
FIR - Escott-Price, Valentina
IR  - Escott-Price V
FIR - Ferrier, I Nicol
IR  - Ferrier IN
FIR - Fiorentino, Alessia
IR  - Fiorentino A
FIR - Foroud, Tatiana M
IR  - Foroud TM
FIR - Forty, Liz
IR  - Forty L
FIR - Frank, Josef
IR  - Frank J
FIR - Frei, Oleksandr
IR  - Frei O
FIR - Freimer, Nelson B
IR  - Freimer NB
FIR - Frisén, Louise
IR  - Frisén L
FIR - Gade, Katrin
IR  - Gade K
FIR - Garnham, Julie
IR  - Garnham J
FIR - Gelernter, Joel
IR  - Gelernter J
FIR - Pedersen, Marianne Giørtz
IR  - Pedersen MG
FIR - Gizer, Ian R
IR  - Gizer IR
FIR - Gordon, Scott D
IR  - Gordon SD
FIR - Gordon-Smith, Katherine
IR  - Gordon-Smith K
FIR - Greenwood, Tiffany A
IR  - Greenwood TA
FIR - Grove, Jakob
IR  - Grove J
FIR - Guzman-Parra, José
IR  - Guzman-Parra J
FIR - Ha, Kyooseob
IR  - Ha K
FIR - Haraldsson, Magnus
IR  - Haraldsson M
FIR - Hautzinger, Martin
IR  - Hautzinger M
FIR - Heilbronner, Urs
IR  - Heilbronner U
FIR - Hellgren, Dennis
IR  - Hellgren D
FIR - Herms, Stefan
IR  - Herms S
FIR - Hoffmann, Per
IR  - Hoffmann P
FIR - Holmans, Peter A
IR  - Holmans PA
FIR - Huckins, Laura
IR  - Huckins L
FIR - Jamain, Stéphane
IR  - Jamain S
FIR - Johnson, Jessica S
IR  - Johnson JS
FIR - Kalman, Janos L
IR  - Kalman JL
FIR - Kamatani, Yoichiro
IR  - Kamatani Y
FIR - Kennedy, James L
IR  - Kennedy JL
FIR - Kittel-Schneider, Sarah
IR  - Kittel-Schneider S
FIR - Knowles, James A
IR  - Knowles JA
FIR - Kogevinas, Manolis
IR  - Kogevinas M
FIR - Koromina, Maria
IR  - Koromina M
FIR - Kranz, Thorsten M
IR  - Kranz TM
FIR - Kranzler, Henry R
IR  - Kranzler HR
FIR - Kubo, Michiaki
IR  - Kubo M
FIR - Kupka, Ralph
IR  - Kupka R
FIR - Kushner, Steven A
IR  - Kushner SA
FIR - Lavebratt, Catharina
IR  - Lavebratt C
FIR - Lawrence, Jacob
IR  - Lawrence J
FIR - Leber, Markus
IR  - Leber M
FIR - Lee, Heon-Jeong
IR  - Lee HJ
FIR - Lee, Phil H
IR  - Lee PH
FIR - Levy, Shawn E
IR  - Levy SE
FIR - Lewis, Catrin
IR  - Lewis C
FIR - Liao, Calwing
IR  - Liao C
FIR - Lucae, Susanne
IR  - Lucae S
FIR - Lundberg, Martin
IR  - Lundberg M
FIR - MacIntyre, Donald J
IR  - MacIntyre DJ
FIR - Magnusson, Sigurdur H
IR  - Magnusson SH
FIR - Maier, Wolfgang
IR  - Maier W
FIR - Maihofer, Adam
IR  - Maihofer A
FIR - Malaspina, Dolores
IR  - Malaspina D
FIR - Maratou, Eirini
IR  - Maratou E
FIR - Martinsson, Lina
IR  - Martinsson L
FIR - Mattheisen, Manuel
IR  - Mattheisen M
FIR - McGregor, Nathaniel W
IR  - McGregor NW
FIR - McGuffin, Peter
IR  - McGuffin P
FIR - McKay, James D
IR  - McKay JD
FIR - Medeiros, Helena
IR  - Medeiros H
FIR - Medland, Sarah E
IR  - Medland SE
FIR - Millischer, Vincent
IR  - Millischer V
FIR - Montgomery, Grant W
IR  - Montgomery GW
FIR - Moran, Jennifer L
IR  - Moran JL
FIR - Morris, Derek W
IR  - Morris DW
FIR - Mühleisen, Thomas W
IR  - Mühleisen TW
FIR - O'Brien, Niamh
IR  - O'Brien N
FIR - O'Donovan, Claire
IR  - O'Donovan C
FIR - Olde Loohuis, Loes M
IR  - Olde Loohuis LM
FIR - Oruc, Lilijana
IR  - Oruc L
FIR - Papiol, Sergi
IR  - Papiol S
FIR - Pardiñas, Antonio F
IR  - Pardiñas AF
FIR - Perry, Amy
IR  - Perry A
FIR - Pfennig, Andrea
IR  - Pfennig A
FIR - Porichi, Evgenia
IR  - Porichi E
FIR - Potash, James B
IR  - Potash JB
FIR - Quested, Digby
IR  - Quested D
FIR - Raj, Towfique
IR  - Raj T
FIR - Rapaport, Mark H
IR  - Rapaport MH
FIR - DePaulo, J Raymond
IR  - DePaulo JR
FIR - Regeer, Eline J
IR  - Regeer EJ
FIR - Rice, John P
IR  - Rice JP
FIR - Rivas, Fabio
IR  - Rivas F
FIR - Rivera, Margarita
IR  - Rivera M
FIR - Roth, Julian
IR  - Roth J
FIR - Roussos, Panos
IR  - Roussos P
FIR - Ruderfer, Douglas M
IR  - Ruderfer DM
FIR - Sánchez-Mora, Cristina
IR  - Sánchez-Mora C
FIR - Schulte, Eva C
IR  - Schulte EC
FIR - Senner, Fanny
IR  - Senner F
FIR - Sharp, Sally
IR  - Sharp S
FIR - Shilling, Paul D
IR  - Shilling PD
FIR - Sigurdsson, Engilbert
IR  - Sigurdsson E
FIR - Sirignano, Lea
IR  - Sirignano L
FIR - Slaney, Claire
IR  - Slaney C
FIR - Smeland, Olav B
IR  - Smeland OB
FIR - Smith, Daniel J
IR  - Smith DJ
FIR - Sobell, Janet L
IR  - Sobell JL
FIR - Hansen, Christine Søholm
IR  - Hansen CS
FIR - Artigas, Maria Soler
IR  - Artigas MS
FIR - Spijker, Anne T
IR  - Spijker AT
FIR - Stein, Dan J
IR  - Stein DJ
FIR - Strauss, John S
IR  - Strauss JS
FIR - Świątkowska, Beata
IR  - Świątkowska B
FIR - Terao, Chikashi
IR  - Terao C
FIR - Thorgeirsson, Thorgeir E
IR  - Thorgeirsson TE
FIR - Toma, Claudio
IR  - Toma C
FIR - Tooney, Paul
IR  - Tooney P
FIR - Tsermpini, Evangelia-Eirini
IR  - Tsermpini EE
FIR - Vawter, Marquis P
IR  - Vawter MP
FIR - Vedder, Helmut
IR  - Vedder H
FIR - Walters, James T R
IR  - Walters JTR
FIR - Witt, Stephanie H
IR  - Witt SH
FIR - Xi, Simon
IR  - Xi S
FIR - Xu, Wei
IR  - Xu W
FIR - Kay Yang, Jessica Mei
IR  - Kay Yang JM
FIR - Young, Allan H
IR  - Young AH
FIR - Young, Hannah
IR  - Young H
FIR - Zandi, Peter P
IR  - Zandi PP
FIR - Zhou, Hang
IR  - Zhou H
FIR - Zillich, Lea
IR  - Zillich L
FIR - Hunt All-In Psychiatry
IR  - Hunt All-In Psychiatry
FIR - Adolfsson, Rolf
IR  - Adolfsson R
FIR - Agartz, Ingrid
IR  - Agartz I
FIR - Alda, Martin
IR  - Alda M
FIR - Alfredsson, Lars
IR  - Alfredsson L
FIR - Babadjanova, Gulja
IR  - Babadjanova G
FIR - Backlund, Lena
IR  - Backlund L
FIR - Baune, Bernhard T
IR  - Baune BT
FIR - Bellivier, Frank
IR  - Bellivier F
FIR - Bengesser, Susanne
IR  - Bengesser S
FIR - Berrettini, Wade H
IR  - Berrettini WH
FIR - Blackwood, Douglas H R
IR  - Blackwood DHR
FIR - Boehnke, Michael
IR  - Boehnke M
FIR - Børglum, Anders D
IR  - Børglum AD
FIR - Breen, Gerome
IR  - Breen G
FIR - Carr, Vaughan J
IR  - Carr VJ
FIR - Catts, Stanley
IR  - Catts S
FIR - Corvin, Aiden
IR  - Corvin A
FIR - Craddock, Nicholas
IR  - Craddock N
FIR - Dannlowski, Udo
IR  - Dannlowski U
FIR - Dikeos, Dimitris
IR  - Dikeos D
FIR - Esko, Tõnu
IR  - Esko T
FIR - Etain, Bruno
IR  - Etain B
FIR - Ferentinos, Panagiotis
IR  - Ferentinos P
FIR - Frye, Mark
IR  - Frye M
FIR - Fullerton, Janice M
IR  - Fullerton JM
FIR - Gawlik, Micha
IR  - Gawlik M
FIR - Gershon, Elliot S
IR  - Gershon ES
FIR - Goes, Fernando S
IR  - Goes FS
FIR - Green, Melissa J
IR  - Green MJ
FIR - Grigoroiu-Serbanescu, Maria
IR  - Grigoroiu-Serbanescu M
FIR - Hauser, Joanna
IR  - Hauser J
FIR - Henskens, Frans
IR  - Henskens F
FIR - Hillert, Jan
IR  - Hillert J
FIR - Hong, Kyung Sue
IR  - Hong KS
FIR - Hougaard, David M
IR  - Hougaard DM
FIR - Hultman, Christina M
IR  - Hultman CM
FIR - Hveem, Kristian
IR  - Hveem K
FIR - Iwata, Nakao
IR  - Iwata N
FIR - Jablensky, Assen V
IR  - Jablensky AV
FIR - Jones, Ian
IR  - Jones I
FIR - Jones, Lisa A
IR  - Jones LA
FIR - Kahn, René S
IR  - Kahn RS
FIR - Kelsoe, John R
IR  - Kelsoe JR
FIR - Kirov, George
IR  - Kirov G
FIR - Landén, Mikael
IR  - Landén M
FIR - Leboyer, Marion
IR  - Leboyer M
FIR - Lewis, Cathryn M
IR  - Lewis CM
FIR - Li, Qingqin S
IR  - Li QS
FIR - Lissowska, Jolanta
IR  - Lissowska J
FIR - Lochner, Christine
IR  - Lochner C
FIR - Loughland, Carmel
IR  - Loughland C
FIR - Martin, Nicholas G
IR  - Martin NG
FIR - Mathews, Carol A
IR  - Mathews CA
FIR - Mayoral, Fermin
IR  - Mayoral F
FIR - McElroy, Susan L
IR  - McElroy SL
FIR - McIntosh, Andrew M
IR  - McIntosh AM
FIR - McMahon, Francis J
IR  - McMahon FJ
FIR - Melle, Ingrid
IR  - Melle I
FIR - Michie, Patricia
IR  - Michie P
FIR - Milani, Lili
IR  - Milani L
FIR - Mitchell, Philip B
IR  - Mitchell PB
FIR - Morken, Gunnar
IR  - Morken G
FIR - Mors, Ole
IR  - Mors O
FIR - Mortensen, Preben Bo
IR  - Mortensen PB
FIR - Mowry, Bryan
IR  - Mowry B
FIR - Müller-Myhsok, Bertram
IR  - Müller-Myhsok B
FIR - Myers, Richard M
IR  - Myers RM
FIR - Neale, Benjamin M
IR  - Neale BM
FIR - Nievergelt, Caroline M
IR  - Nievergelt CM
FIR - Nordentoft, Merete
IR  - Nordentoft M
FIR - Nöthen, Markus M
IR  - Nöthen MM
FIR - O'Donovan, Michael C
IR  - O'Donovan MC
FIR - Oedegaard, Ketil J
IR  - Oedegaard KJ
FIR - Olsson, Tomas
IR  - Olsson T
FIR - Owen, Michael J
IR  - Owen MJ
FIR - Paciga, Sara A
IR  - Paciga SA
FIR - Pantelis, Chris
IR  - Pantelis C
FIR - Pato, Carlos
IR  - Pato C
FIR - Pato, Michele T
IR  - Pato MT
FIR - Patrinos, George P
IR  - Patrinos GP
FIR - Perlis, Roy H
IR  - Perlis RH
FIR - Posthuma, Danielle
IR  - Posthuma D
FIR - Ramos-Quiroga, Josep Antoni
IR  - Ramos-Quiroga JA
FIR - Reif, Andreas
IR  - Reif A
FIR - Reininghaus, Eva Z
IR  - Reininghaus EZ
FIR - Ribasés, Marta
IR  - Ribasés M
FIR - Rietschel, Marcella
IR  - Rietschel M
FIR - Ripke, Stephan
IR  - Ripke S
FIR - Rouleau, Guy A
IR  - Rouleau GA
FIR - Saito, Takeo
IR  - Saito T
FIR - Schall, Ulrich
IR  - Schall U
FIR - Schalling, Martin
IR  - Schalling M
FIR - Schofield, Peter R
IR  - Schofield PR
FIR - Schulze, Thomas G
IR  - Schulze TG
FIR - Scott, Laura J
IR  - Scott LJ
FIR - Scott, Rodney J
IR  - Scott RJ
FIR - Serretti, Alessandro
IR  - Serretti A
FIR - Weickert, Cynthia Shannon
IR  - Weickert CS
FIR - Smoller, Jordan W
IR  - Smoller JW
FIR - Stefansson, Hreinn
IR  - Stefansson H
FIR - Stefansson, Kari
IR  - Stefansson K
FIR - Stordal, Eystein
IR  - Stordal E
FIR - Streit, Fabian
IR  - Streit F
FIR - Sullivan, Patrick F
IR  - Sullivan PF
FIR - Turecki, Gustavo
IR  - Turecki G
FIR - Vaaler, Arne E
IR  - Vaaler AE
FIR - Vieta, Eduard
IR  - Vieta E
FIR - Vincent, John B
IR  - Vincent JB
FIR - Waldman, Irwin D
IR  - Waldman ID
FIR - Weickert, Thomas W
IR  - Weickert TW
FIR - Werge, Thomas
IR  - Werge T
FIR - Wray, Naomi R
IR  - Wray NR
FIR - Zwart, John-Anker
IR  - Zwart JA
FIR - Biernacka, Joanna M
IR  - Biernacka JM
FIR - Nurnberger, John I
IR  - Nurnberger JI
FIR - Cichon, Sven
IR  - Cichon S
FIR - Edenberg, Howard J
IR  - Edenberg HJ
FIR - Stahl, Eli A
IR  - Stahl EA
FIR - McQuillin, Andrew
IR  - McQuillin A
FIR - Di Florio, Arianna
IR  - Di Florio A
FIR - Ophoff, Roel A
IR  - Ophoff RA
FIR - Andreassen, Ole A
IR  - Andreassen OA
FIR - Adan, Roger A H
IR  - Adan RAH
FIR - Alfredsson, Lars
IR  - Alfredsson L
FIR - Ando, Tetsuya
IR  - Ando T
FIR - Andreassen, Ole A
IR  - Andreassen OA
FIR - Aschauer, Harald
IR  - Aschauer H
FIR - Baker, Jessica H
IR  - Baker JH
FIR - Bencko, Vladimir
IR  - Bencko V
FIR - Bergen, Andrew W
IR  - Bergen AW
FIR - Berrettini, Wade H
IR  - Berrettini WH
FIR - Birgegård, Andreas
IR  - Birgegård A
FIR - Boden, Joseph M
IR  - Boden JM
FIR - Boehm, Ilka
IR  - Boehm I
FIR - Boni, Claudette
IR  - Boni C
FIR - Perica, Vesna Boraska
IR  - Perica VB
FIR - Brandt, Harry
IR  - Brandt H
FIR - Breen, Gerome
IR  - Breen G
FIR - Bryois, Julien
IR  - Bryois J
FIR - Buehren, Katharina
IR  - Buehren K
FIR - Bulik, Cynthia M
IR  - Bulik CM
FIR - Burghardt, Roland
IR  - Burghardt R
FIR - Carlberg, Laura
IR  - Carlberg L
FIR - Cassina, Matteo
IR  - Cassina M
FIR - Cichon, Sven
IR  - Cichon S
FIR - Clementi, Maurizio
IR  - Clementi M
FIR - Coleman, Jonathan R I
IR  - Coleman JRI
FIR - Cone, Roger D
IR  - Cone RD
FIR - Courtet, Philippe
IR  - Courtet P
FIR - Crawford, Steven
IR  - Crawford S
FIR - Crow, Scott
IR  - Crow S
FIR - Crowley, James J
IR  - Crowley JJ
FIR - Danner, Unna N
IR  - Danner UN
FIR - Davis, Oliver S P
IR  - Davis OSP
FIR - de Zwaan, Martina
IR  - de Zwaan M
FIR - Dedoussis, George
IR  - Dedoussis G
FIR - Degortes, Daniela
IR  - Degortes D
FIR - DeSocio, Janiece E
IR  - DeSocio JE
FIR - Dick, Danielle M
IR  - Dick DM
FIR - Dikeos, Dimitris
IR  - Dikeos D
FIR - Dina, Christian
IR  - Dina C
FIR - Dmitrzak-Weglarz, Monika
IR  - Dmitrzak-Weglarz M
FIR - Martinez, Elisa Docampo
IR  - Martinez ED
FIR - Duncan, Laramie E
IR  - Duncan LE
FIR - Egberts, Karin
IR  - Egberts K
FIR - Marshall, Christian R
IR  - Marshall CR
FIR - Martin, Nicholas G
IR  - Martin NG
FIR - Mattheisen, Manuel
IR  - Mattheisen M
FIR - Mattingsdal, Morten
IR  - Mattingsdal M
FIR - McDevitt, Sara
IR  - McDevitt S
FIR - McGuffin, Peter
IR  - McGuffin P
FIR - Medland, Sarah E
IR  - Medland SE
FIR - Metspalu, Andres
IR  - Metspalu A
FIR - Meulenbelt, Ingrid
IR  - Meulenbelt I
FIR - Micali, Nadia
IR  - Micali N
FIR - Mitchell, James
IR  - Mitchell J
FIR - Mitchell, Karen
IR  - Mitchell K
FIR - Monteleone, Palmiero
IR  - Monteleone P
FIR - Monteleone, Alessio Maria
IR  - Monteleone AM
FIR - Montgomery, Grant W
IR  - Montgomery GW
FIR - Mortensen, Preben Bo
IR  - Mortensen PB
FIR - Munn-Chernoff, Melissa A
IR  - Munn-Chernoff MA
FIR - Nacmias, Benedetta
IR  - Nacmias B
FIR - Navratilova, Marie
IR  - Navratilova M
FIR - Ntalla, Ioanna
IR  - Ntalla I
FIR - Olsen, Catherine M
IR  - Olsen CM
FIR - Ophoff, Roel A
IR  - Ophoff RA
FIR - O'Toole, Julie K
IR  - O'Toole JK
FIR - Padyukov, Leonid
IR  - Padyukov L
FIR - Palotie, Aarno
IR  - Palotie A
FIR - Pantel, Jacques
IR  - Pantel J
FIR - Papezova, Hana
IR  - Papezova H
FIR - Parker, Richard
IR  - Parker R
FIR - Pearson, John F
IR  - Pearson JF
FIR - Pedersen, Nancy L
IR  - Pedersen NL
FIR - Ehrlich, Stefan
IR  - Ehrlich S
FIR - Escaramís, Geòrgia
IR  - Escaramís G
FIR - Esko, Tõnu
IR  - Esko T
FIR - Espeseth, Thomas
IR  - Espeseth T
FIR - Estivill, Xavier
IR  - Estivill X
FIR - Farmer, Anne
IR  - Farmer A
FIR - Favaro, Angela
IR  - Favaro A
FIR - Fernández-Aranda, Fernando
IR  - Fernández-Aranda F
FIR - Fichter, Manfred M
IR  - Fichter MM
FIR - Fischer, Krista
IR  - Fischer K
FIR - Floyd, James A B
IR  - Floyd JAB
FIR - Föcker, Manuel
IR  - Föcker M
FIR - Foretova, Lenka
IR  - Foretova L
FIR - Forstner, Andreas J
IR  - Forstner AJ
FIR - Forzan, Monica
IR  - Forzan M
FIR - Franklin, Christopher S
IR  - Franklin CS
FIR - Gallinger, Steven
IR  - Gallinger S
FIR - Gambaro, Giovanni
IR  - Gambaro G
FIR - Gaspar, Héléna A
IR  - Gaspar HA
FIR - Giegling, Ina
IR  - Giegling I
FIR - Giuranna, Johanna
IR  - Giuranna J
FIR - Giusti-Rodríquez, Paola
IR  - Giusti-Rodríquez P
FIR - Gonidakis, Fragiskos
IR  - Gonidakis F
FIR - Gordon, Scott
IR  - Gordon S
FIR - Gorwood, Philip
IR  - Gorwood P
FIR - Mayora, Monica Gratacos
IR  - Mayora MG
FIR - Grove, Jakob
IR  - Grove J
FIR - Guillaume, Sébastien
IR  - Guillaume S
FIR - Guo, Yiran
IR  - Guo Y
FIR - Hakonarson, Hakon
IR  - Hakonarson H
FIR - Halmi, Katherine A
IR  - Halmi KA
FIR - Hanscombe, Ken B
IR  - Hanscombe KB
FIR - Hatzikotoulas, Konstantinos
IR  - Hatzikotoulas K
FIR - Hauser, Joanna
IR  - Hauser J
FIR - Hebebrand, Johannes
IR  - Hebebrand J
FIR - Helder, Sietske G
IR  - Helder SG
FIR - Henders, Anjali K
IR  - Henders AK
FIR - Herms, Stefan
IR  - Herms S
FIR - Herpertz-Dahlmann, Beate
IR  - Herpertz-Dahlmann B
FIR - Herzog, Wolfgang
IR  - Herzog W
FIR - Hinney, Anke
IR  - Hinney A
FIR - Horwood, L John
IR  - Horwood LJ
FIR - Hübel, Christopher
IR  - Hübel C
FIR - Petersen, Liselotte V
IR  - Petersen LV
FIR - Pinto, Dalila
IR  - Pinto D
FIR - Purves, Kirstin L
IR  - Purves KL
FIR - Raevuori, Anu
IR  - Raevuori A
FIR - Ramoz, Nicolas
IR  - Ramoz N
FIR - Reichborn-Kjennerud, Ted
IR  - Reichborn-Kjennerud T
FIR - Ricca, Valdo
IR  - Ricca V
FIR - Ripatti, Samuli
IR  - Ripatti S
FIR - Ripke, Stephan
IR  - Ripke S
FIR - Ritschel, Franziska
IR  - Ritschel F
FIR - Roberts, Marion
IR  - Roberts M
FIR - Rujescu, Dan
IR  - Rujescu D
FIR - Rybakowski, Filip
IR  - Rybakowski F
FIR - Santonastaso, Paolo
IR  - Santonastaso P
FIR - Scherag, André
IR  - Scherag A
FIR - Scherer, Stephen W
IR  - Scherer SW
FIR - Schmidt, Ulrike
IR  - Schmidt U
FIR - Schork, Nicholas J
IR  - Schork NJ
FIR - Schosser, Alexandra
IR  - Schosser A
FIR - Seitz, Jochen
IR  - Seitz J
FIR - Slachtova, Lenka
IR  - Slachtova L
FIR - Slagboom, P Eline
IR  - Slagboom PE
FIR - Slof-Op 't Landt, Margarita C T
IR  - Slof-Op 't Landt MCT
FIR - Slopien, Agnieszka
IR  - Slopien A
FIR - Soranzo, Nicole
IR  - Soranzo N
FIR - Sorbi, Sandro
IR  - Sorbi S
FIR - Southam, Lorraine
IR  - Southam L
FIR - Steen, Vidar W
IR  - Steen VW
FIR - Strober, Michael
IR  - Strober M
FIR - Huckins, Laura M
IR  - Huckins LM
FIR - Hudson, James I
IR  - Hudson JI
FIR - Imgart, Hartmut
IR  - Imgart H
FIR - Inoko, Hidetoshi
IR  - Inoko H
FIR - Janout, Vladimir
IR  - Janout V
FIR - Jiménez-Murcia, Susana
IR  - Jiménez-Murcia S
FIR - Johnson, Craig
IR  - Johnson C
FIR - Jordan, Jennifer
IR  - Jordan J
FIR - Julià, Antonio
IR  - Julià A
FIR - Kalsi, Gursharan
IR  - Kalsi G
FIR - Kaminská, Deborah
IR  - Kaminská D
FIR - Kaplan, Allan S
IR  - Kaplan AS
FIR - Kaprio, Jaakko
IR  - Kaprio J
FIR - Karhunen, Leila
IR  - Karhunen L
FIR - Karwautz, Andreas
IR  - Karwautz A
FIR - Kas, Martien J H
IR  - Kas MJH
FIR - Kaye, Walter H
IR  - Kaye WH
FIR - Kennedy, James L
IR  - Kennedy JL
FIR - Kennedy, Martin A
IR  - Kennedy MA
FIR - Keski-Rahkonen, Anna
IR  - Keski-Rahkonen A
FIR - Kiezebrink, Kirsty
IR  - Kiezebrink K
FIR - Kim, Youl-Ri
IR  - Kim YR
FIR - Kirk, Katherine M
IR  - Kirk KM
FIR - Klareskog, Lars
IR  - Klareskog L
FIR - Klump, Kelly L
IR  - Klump KL
FIR - Knudsen, Gun Peggy S
IR  - Knudsen GPS
FIR - Landén, Mikael
IR  - Landén M
FIR - Larsen, Janne T
IR  - Larsen JT
FIR - Le Hellard, Stephanie
IR  - Le Hellard S
FIR - Leppä, Virpi M
IR  - Leppä VM
FIR - Li, Dong
IR  - Li D
FIR - Lichtenstein, Paul
IR  - Lichtenstein P
FIR - Lilenfeld, Lisa
IR  - Lilenfeld L
FIR - Lin, Bochao Danae
IR  - Lin BD
FIR - Lissowska, Jolanta
IR  - Lissowska J
FIR - Lundervold, Astri
IR  - Lundervold A
FIR - Luykx, Jurjen
IR  - Luykx J
FIR - Magistretti, Pierre J
IR  - Magistretti PJ
FIR - Maj, Mario
IR  - Maj M
FIR - Mannik, Katrin
IR  - Mannik K
FIR - Marsal, Sara
IR  - Marsal S
FIR - Stuber, Garret D
IR  - Stuber GD
FIR - Sullivan, Patrick F
IR  - Sullivan PF
FIR - Świątkowska, Beata
IR  - Świątkowska B
FIR - Szatkiewicz, Jin P
IR  - Szatkiewicz JP
FIR - Tachmazidou, Ioanna
IR  - Tachmazidou I
FIR - Tenconi, Elena
IR  - Tenconi E
FIR - Thornton, Laura M
IR  - Thornton LM
FIR - Tortorella, Alfonso
IR  - Tortorella A
FIR - Tozzi, Federica
IR  - Tozzi F
FIR - Treasure, Janet
IR  - Treasure J
FIR - Tsitsika, Artemis
IR  - Tsitsika A
FIR - Tyszkiewicz-Nwafor, Marta
IR  - Tyszkiewicz-Nwafor M
FIR - Tziouvas, Konstantinos
IR  - Tziouvas K
FIR - van Elburg, Annemarie A
IR  - van Elburg AA
FIR - van Furth, Eric F
IR  - van Furth EF
FIR - Wade, Tracey D
IR  - Wade TD
FIR - Wagner, Gudrun
IR  - Wagner G
FIR - Walton, Esther
IR  - Walton E
FIR - Watson, Hunna J
IR  - Watson HJ
FIR - Werge, Thomas
IR  - Werge T
FIR - Whiteman, David C
IR  - Whiteman DC
FIR - Wichmann, H Erich
IR  - Wichmann HE
FIR - Widen, Elisabeth
IR  - Widen E
FIR - Woodside, D Blake
IR  - Woodside DB
FIR - Yao, Shuyang
IR  - Yao S
FIR - Yilmaz, Zeynep
IR  - Yilmaz Z
FIR - Zeggini, Eleftheria
IR  - Zeggini E
FIR - Zerwas, Stephanie
IR  - Zerwas S
FIR - Zipfel, Stephan
IR  - Zipfel S
FIR - Witt, Stephanie H
IR  - Witt SH
FIR - Streit, Fabian
IR  - Streit F
FIR - Jungkunz, Martin
IR  - Jungkunz M
FIR - Frank, Josef
IR  - Frank J
FIR - Awasthi, Swapnil
IR  - Awasthi S
FIR - Treutlein, Jens
IR  - Treutlein J
FIR - Dietl, Lydie
IR  - Dietl L
FIR - Schwarze, Cornelia E
IR  - Schwarze CE
FIR - Dahmen, Norbert
IR  - Dahmen N
FIR - Schott, Björn H
IR  - Schott BH
FIR - Nöthen, Markus M
IR  - Nöthen MM
FIR - Ripke, Stephan
IR  - Ripke S
FIR - Mobascher, Arian
IR  - Mobascher A
FIR - Rujescu, Dan
IR  - Rujescu D
FIR - Lieb, Klaus
IR  - Lieb K
FIR - Roepke, Stefan
IR  - Roepke S
FIR - Schmahl, Christian
IR  - Schmahl C
FIR - Bohus, Martin
IR  - Bohus M
FIR - Rietschel, Marcella
IR  - Rietschel M
FIR - Crivelli, Silvia
IR  - Crivelli S
FIR - Dennis, Michelle F
IR  - Dennis MF
FIR - Harvey, Phillip D
IR  - Harvey PD
FIR - Carter, Bruce W
IR  - Carter BW
FIR - Huffman, Jennifer E
IR  - Huffman JE
FIR - Jacobson, Daniel
IR  - Jacobson D
FIR - Madduri, Ravi
IR  - Madduri R
FIR - Olsen, Maren K
IR  - Olsen MK
FIR - Pestian, John
IR  - Pestian J
FIR - Gaziano, J Michael
IR  - Gaziano JM
FIR - Muralidhar, Sumitra
IR  - Muralidhar S
FIR - Ramoni, Rachel
IR  - Ramoni R
FIR - Beckham, Jean
IR  - Beckham J
FIR - Chang, Kyong-Mi
IR  - Chang KM
FIR - O'Donnell, Christopher J
IR  - O'Donnell CJ
FIR - Tsao, Philip S
IR  - Tsao PS
FIR - Breeling, James
IR  - Breeling J
FIR - Huang, Grant
IR  - Huang G
FIR - Romero, J P Casas
IR  - Romero JPC
FIR - Muralidhar, Sumitra
IR  - Muralidhar S
FIR - Moser, Jennifer
IR  - Moser J
FIR - Whitbourne, Stacey B
IR  - Whitbourne SB
FIR - Brewer, Jessica V
IR  - Brewer JV
FIR - Aslan, Mihaela
IR  - Aslan M
FIR - Connor, Todd
IR  - Connor T
FIR - Argyres, Dean P
IR  - Argyres DP
FIR - Tsao, Philip S
IR  - Tsao PS
FIR - Gaziano, J Michael
IR  - Gaziano JM
FIR - Stephens, Brady
IR  - Stephens B
FIR - Brophy, Mary T
IR  - Brophy MT
FIR - Humphries, Donald E
IR  - Humphries DE
FIR - Selva, Luis E
IR  - Selva LE
FIR - Do, Nhan
IR  - Do N
FIR - Shayan, Shahpoor
IR  - Shayan S
FIR - Cho, Kelly
IR  - Cho K
FIR - O'Donnell, Christopher J
IR  - O'Donnell CJ
FIR - O'Donnell, Christopher J
IR  - O'Donnell CJ
FIR - Pyarajan, Saiju
IR  - Pyarajan S
FIR - Tsao, Philip S
IR  - Tsao PS
FIR - Cho, Kelly
IR  - Cho K
FIR - Pyarajan, Saiju
IR  - Pyarajan S
FIR - Hauser, Elizabeth
IR  - Hauser E
FIR - Sun, Yan
IR  - Sun Y
FIR - Zhao, Hongyu
IR  - Zhao H
FIR - Wilson, Peter
IR  - Wilson P
FIR - McArdle, Rachel
IR  - McArdle R
FIR - Dellitalia, Louis
IR  - Dellitalia L
FIR - Mattocks, Kristin
IR  - Mattocks K
FIR - Harley, John
IR  - Harley J
FIR - Zablocki, Clement J
IR  - Zablocki CJ
FIR - Whittle, Jeffrey
IR  - Whittle J
FIR - Jacono, Frank
IR  - Jacono F
FIR - Beckham, Jean
IR  - Beckham J
FIR - Gutierrez, Salvador
IR  - Gutierrez S
FIR - Gibson, Gretchen
IR  - Gibson G
FIR - Hammer, Kimberly
IR  - Hammer K
FIR - Kaminsky, Laurence
IR  - Kaminsky L
FIR - Villareal, Gerardo
IR  - Villareal G
FIR - Kinlay, Scott
IR  - Kinlay S
FIR - Xu, Junzhe
IR  - Xu J
FIR - Hamner, Mark
IR  - Hamner M
FIR - Mathew, Roy
IR  - Mathew R
FIR - Bhushan, Sujata
IR  - Bhushan S
FIR - Iruvanti, Pran
IR  - Iruvanti P
FIR - Godschalk, Michael
IR  - Godschalk M
FIR - Ballas, Zuhair
IR  - Ballas Z
FIR - Ivins, Douglas
IR  - Ivins D
FIR - Mastorides, Stephen
IR  - Mastorides S
FIR - Moorman, Jonathan
IR  - Moorman J
FIR - Gappy, Saib
IR  - Gappy S
FIR - Klein, Jon
IR  - Klein J
FIR - Ratcliffe, Nora
IR  - Ratcliffe N
FIR - Florez, Hermes
IR  - Florez H
FIR - Okusaga, Olaoluwa
IR  - Okusaga O
FIR - Murdoch, Maureen
IR  - Murdoch M
FIR - Sriram, Peruvemba
IR  - Sriram P
FIR - Yeh, Shing Shing
IR  - Yeh SS
FIR - Tandon, Neeraj
IR  - Tandon N
FIR - Jhala, Darshana
IR  - Jhala D
FIR - Aguayo, Samuel
IR  - Aguayo S
FIR - Cohen, David
IR  - Cohen D
FIR - Sharma, Satish
IR  - Sharma S
FIR - Liangpunsakul, Suthat
IR  - Liangpunsakul S
FIR - Oursler, Kris Ann
IR  - Oursler KA
FIR - Whooley, Mary
IR  - Whooley M
FIR - Ahuja, Sunil
IR  - Ahuja S
FIR - Constans, Joseph
IR  - Constans J
FIR - Meyer, Paul
IR  - Meyer P
FIR - Greco, Jennifer
IR  - Greco J
FIR - Rauchman, Michael
IR  - Rauchman M
FIR - Servatius, Richard
IR  - Servatius R
FIR - Gaddy, Melinda
IR  - Gaddy M
FIR - Wallbom, Agnes
IR  - Wallbom A
FIR - Morgan, Timothy
IR  - Morgan T
FIR - Stapley, Todd
IR  - Stapley T
FIR - Sherman, Scott
IR  - Sherman S
FIR - Ross, George
IR  - Ross G
FIR - Tsao, Philip
IR  - Tsao P
FIR - Strollo, Patrick Jr
IR  - Strollo P Jr
FIR - Boyko, Edward
IR  - Boyko E
FIR - Meyer, Laurence
IR  - Meyer L
FIR - Gupta, Samir
IR  - Gupta S
FIR - Huq, Mostaqul
IR  - Huq M
FIR - Fayad, Joseph
IR  - Fayad J
FIR - Hung, Adriana
IR  - Hung A
FIR - Lichy, Jack
IR  - Lichy J
FIR - Hurley, Robin
IR  - Hurley R
FIR - Robey, Brooks
IR  - Robey B
FIR - Striker, Robert
IR  - Striker R
EDAT- 2021/12/05 06:00
MHDA- 2022/01/29 06:00
CRDT- 2021/12/04 05:28
PHST- 2021/01/05 00:00 [received]
PHST- 2021/05/07 00:00 [revised]
PHST- 2021/05/26 00:00 [accepted]
PHST- 2021/12/05 06:00 [pubmed]
PHST- 2022/01/29 06:00 [medline]
PHST- 2021/12/04 05:28 [entrez]
AID - S0006-3223(21)01570-5 [pii]
AID - 10.1016/j.biopsych.2021.05.029 [doi]
PST - ppublish
SO  - Biol Psychiatry. 2022 Feb 1;91(3):313-327. doi: 10.1016/j.biopsych.2021.05.029. 
      Epub 2021 Sep 9.

PMID- 31740837
OWN - NLM
STAT- MEDLINE
DCOM- 20200117
LR  - 20221207
IS  - 1546-1718 (Electronic)
IS  - 1061-4036 (Print)
IS  - 1061-4036 (Linking)
VI  - 51
IP  - 12
DP  - 2019 Dec
TI  - Comparative genetic architectures of schizophrenia in East Asian and European 
      populations.
PG  - 1670-1678
LID - 10.1038/s41588-019-0512-x [doi]
AB  - Schizophrenia is a debilitating psychiatric disorder with approximately 1% 
      lifetime risk globally. Large-scale schizophrenia genetic studies have reported 
      primarily on European ancestry samples, potentially missing important biological 
      insights. Here, we report the largest study to date of East Asian participants 
      (22,778 schizophrenia cases and 35,362 controls), identifying 21 
      genome-wide-significant associations in 19 genetic loci. Common genetic variants 
      that confer risk for schizophrenia have highly similar effects between East Asian 
      and European ancestries (genetic correlation = 0.98 ± 0.03), indicating that the 
      genetic basis of schizophrenia and its biology are broadly shared across 
      populations. A fixed-effect meta-analysis including individuals from East Asian 
      and European ancestries identified 208 significant associations in 176 genetic 
      loci (53 novel). Trans-ancestry fine-mapping reduced the sets of candidate causal 
      variants in 44 loci. Polygenic risk scores had reduced performance when 
      transferred across ancestries, highlighting the importance of including 
      sufficient samples of major ancestral groups to ensure their generalizability 
      across populations.
FAU - Lam, Max
AU  - Lam M
AUID- ORCID: 0000-0002-4256-7844
AD  - Bio-X Institutes, Shanghai Jiao Tong University and Research Division, Institute 
      of Mental Health Singapore, Singapore, Singapore.
AD  - Human Genetics, Genome Institute of Singapore, Singapore, Singapore.
AD  - Division of Psychiatry Research, the Zucker Hillside Hospital, Northwell Health, 
      Glen Oaks, NY, USA.
AD  - Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, 
      MA, USA.
AD  - Stanley Center for Psychiatric Research, the Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
AD  - Research Division, Institute of Mental Health Singapore, Singapore, Singapore.
FAU - Chen, Chia-Yen
AU  - Chen CY
AD  - Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, 
      MA, USA.
AD  - Stanley Center for Psychiatric Research, the Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
AD  - Department of Medicine, Harvard Medical School, Boston, MA, USA.
AD  - Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital, 
      Boston, MA, USA.
AD  - Biogen, Cambridge, MA, USA.
FAU - Li, Zhiqiang
AU  - Li Z
AUID- ORCID: 0000-0002-0174-9254
AD  - Biomedical Sciences Institute of Qingdao University, Qingdao Branch of Shanghai 
      Jiao Tong University Bio-X Institutes and the Affiliated Hospital of Qingdao 
      University, Qingdao, China.
AD  - Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders 
      (Ministry of Education) and the Collaborative Innovation Center for Brain 
      Science, Bio-X Institutes, Shanghai Jiao Tong University, Shanghai, China.
FAU - Martin, Alicia R
AU  - Martin AR
AUID- ORCID: 0000-0003-0241-3522
AD  - Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, 
      MA, USA.
AD  - Stanley Center for Psychiatric Research, the Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
AD  - Department of Medicine, Harvard Medical School, Boston, MA, USA.
FAU - Bryois, Julien
AU  - Bryois J
AUID- ORCID: 0000-0002-4747-2166
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
FAU - Ma, Xixian
AU  - Ma X
AD  - Key Laboratory of Computational Biology, CAS-MPG Partner Institute for 
      Computational Biology, Shanghai Institute of Nutrition and Health, Shanghai 
      Institutes for Biological Sciences, University of Chinese Academy of Sciences, 
      Chinese Academy of Sciences, Shanghai, China.
FAU - Gaspar, Helena
AU  - Gaspar H
AUID- ORCID: 0000-0002-5540-2707
AD  - Social Genetic and Developmental Psychiatry, King's College London, London, UK.
FAU - Ikeda, Masashi
AU  - Ikeda M
AD  - Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, 
      Japan.
FAU - Benyamin, Beben
AU  - Benyamin B
AUID- ORCID: 0000-0001-5608-2293
AD  - Australian Centre for Precision Health, School of Health Sciences, University of 
      South Australia Cancer Research Institute, Adelaide, South Australia, Australia.
AD  - Institute for Molecular Bioscience, The University of Queensland, Brisbane, 
      Queensland, Australia.
AD  - South Australian Health and Medical Research Institute, Adelaide, South 
      Australia, Australia.
FAU - Brown, Brielin C
AU  - Brown BC
AD  - Data Science Institute, Columbia University, New York, NY, USA.
AD  - New York Genome Center, New York, NY, USA.
FAU - Liu, Ruize
AU  - Liu R
AD  - Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, 
      MA, USA.
AD  - Stanley Center for Psychiatric Research, the Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
FAU - Zhou, Wei
AU  - Zhou W
AD  - Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders 
      (Ministry of Education) and the Collaborative Innovation Center for Brain 
      Science, Bio-X Institutes, Shanghai Jiao Tong University, Shanghai, China.
AD  - Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, 
      Shanghai Jiao Tong University School of Medicine, Shanghai, China.
FAU - Guan, Lili
AU  - Guan L
AD  - Peking University Sixth Hospital and Institute of Mental Health, Beijing, China.
AD  - National Health Commission Key Laboratory of Mental Health (Peking University), 
      Beijing, China.
AD  - National Clinical Research Center for Mental Disorders (Peking University Sixth 
      Hospital), Beijing, China.
FAU - Kamatani, Yoichiro
AU  - Kamatani Y
AUID- ORCID: 0000-0001-8748-5597
AD  - Laboratory of Complex Trait Genomics, Graduate School of Frontier Sciences, 
      University of Tokyo, Tokyo, Japan.
AD  - Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical 
      Sciences, Yokohama, Japan.
FAU - Kim, Sung-Wan
AU  - Kim SW
AD  - Department of Psychiatry, Chonnam National University Medical School, Gwangju, 
      Republic of Korea.
FAU - Kubo, Michiaki
AU  - Kubo M
AD  - RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
FAU - Kusumawardhani, Agung A A A
AU  - Kusumawardhani AAAA
AD  - Department of Psychiatry, Cipto Mangunkusumo General Hospital, Universitas 
      Indonesia, Jakarta, Indonesia.
FAU - Liu, Chih-Min
AU  - Liu CM
AUID- ORCID: 0000-0001-7016-8990
AD  - Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan.
AD  - Department of Psychiatry, National Taiwan University College of Medicine, Taipei, 
      Taiwan.
FAU - Ma, Hong
AU  - Ma H
AD  - Peking University Sixth Hospital and Institute of Mental Health, Beijing, China.
AD  - National Health Commission Key Laboratory of Mental Health (Peking University), 
      Beijing, China.
AD  - National Clinical Research Center for Mental Disorders (Peking University Sixth 
      Hospital), Beijing, China.
FAU - Periyasamy, Sathish
AU  - Periyasamy S
AUID- ORCID: 0000-0002-8132-5717
AD  - Queensland Brain Institute The University of Queensland, Brisbane, Queensland, 
      Australia.
AD  - Queensland Center for Mental Health Research, The University of Queensland, 
      Wacol, Queensland, Australia.
FAU - Takahashi, Atsushi
AU  - Takahashi A
AUID- ORCID: 0000-0001-7099-8767
AD  - Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical 
      Sciences, Yokohama, Japan.
AD  - Department of Genomic Medicine, Research Institute, National Cerebral and 
      Cardiovascular Center, Osaka, Japan.
FAU - Xu, Zhida
AU  - Xu Z
AD  - Department of Psychiatry, University Medical Center Utrecht, Utrecht, the 
      Netherlands.
FAU - Yu, Hao
AU  - Yu H
AUID- ORCID: 0000-0002-9785-8489
AD  - Peking University Sixth Hospital and Institute of Mental Health, Beijing, China.
AD  - National Health Commission Key Laboratory of Mental Health (Peking University), 
      Beijing, China.
AD  - National Clinical Research Center for Mental Disorders (Peking University Sixth 
      Hospital), Beijing, China.
FAU - Zhu, Feng
AU  - Zhu F
AD  - Center for Translational Medicine, The First Affiliated Hospital of Xi'an 
      Jiaotong University, Xi'an, China.
AD  - Department of Psychiatry, The First Affiliated Hospital of Xi'an Jiaotong 
      University, Xi'an, China.
AD  - Center for Brain Science, The First Affiliated Hospital of Xi'an Jiaotong 
      University, Xi'an, China.
CN  - Schizophrenia Working Group of the Psychiatric Genomics Consortium
CN  - Indonesia Schizophrenia Consortium
CN  - Genetic REsearch on schizophreniA neTwork-China and the Netherlands (GREAT-CN)
FAU - Chen, Wei J
AU  - Chen WJ
AD  - Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan.
AD  - Department of Psychiatry, National Taiwan University College of Medicine, Taipei, 
      Taiwan.
AD  - Institute of Epidemiology and Preventive Medicine, College of Public Health, 
      National Taiwan University, Taipei, Taiwan.
FAU - Faraone, Stephen
AU  - Faraone S
AD  - The State University of New York, Syracuse, NY, USA.
FAU - Glatt, Stephen J
AU  - Glatt SJ
AD  - Psychiatric Genetic Epidemiology and Neurobiology Laboratory (PsychGENe lab), 
      Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Syracuse, NY, USA.
FAU - He, Lin
AU  - He L
AD  - Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders 
      (Ministry of Education) and the Collaborative Innovation Center for Brain 
      Science, Bio-X Institutes, Shanghai Jiao Tong University, Shanghai, China.
AD  - Shanghai Center for Women and Children's Health, Shanghai, China.
AD  - Baoan Maternal and Child Health Hospital, Jinan University, Shenzhen, China.
FAU - Hyman, Steven E
AU  - Hyman SE
AD  - Stanley Center for Psychiatric Research, the Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      MA, USA.
FAU - Hwu, Hai-Gwo
AU  - Hwu HG
AD  - Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan.
AD  - Department of Psychiatry, National Taiwan University College of Medicine, Taipei, 
      Taiwan.
AD  - Institute of Epidemiology and Preventive Medicine, College of Public Health, 
      National Taiwan University, Taipei, Taiwan.
FAU - McCarroll, Steven A
AU  - McCarroll SA
AD  - Stanley Center for Psychiatric Research, the Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
AD  - Department of Genetics, Harvard Medical School, Boston, MA, USA.
FAU - Neale, Benjamin M
AU  - Neale BM
AD  - Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, 
      MA, USA.
AD  - Stanley Center for Psychiatric Research, the Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
AD  - Department of Medicine, Harvard Medical School, Boston, MA, USA.
FAU - Sklar, Pamela
AU  - Sklar P
AD  - Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, 
      NY, USA.
FAU - Wildenauer, Dieter B
AU  - Wildenauer DB
AD  - University of Western Australia, Perth, Western Australia, Australia.
FAU - Yu, Xin
AU  - Yu X
AD  - Peking University Sixth Hospital and Institute of Mental Health, Beijing, China.
AD  - National Health Commission Key Laboratory of Mental Health (Peking University), 
      Beijing, China.
AD  - National Clinical Research Center for Mental Disorders (Peking University Sixth 
      Hospital), Beijing, China.
FAU - Zhang, Dai
AU  - Zhang D
AD  - Peking University Sixth Hospital and Institute of Mental Health, Beijing, China.
AD  - National Health Commission Key Laboratory of Mental Health (Peking University), 
      Beijing, China.
AD  - National Clinical Research Center for Mental Disorders (Peking University Sixth 
      Hospital), Beijing, China.
FAU - Mowry, Bryan J
AU  - Mowry BJ
AD  - Queensland Brain Institute The University of Queensland, Brisbane, Queensland, 
      Australia.
AD  - Queensland Center for Mental Health Research, The University of Queensland, 
      Wacol, Queensland, Australia.
FAU - Lee, Jimmy
AU  - Lee J
AD  - Institute of Mental Health, Singapore, Singapore.
FAU - Holmans, Peter
AU  - Holmans P
AD  - MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological 
      Medicine and Clinical Neurosciences, School of Medicine , Cardiff University, 
      Cardiff, UK.
FAU - Xu, Shuhua
AU  - Xu S
AD  - Key Laboratory of Computational Biology, CAS-MPG Partner Institute for 
      Computational Biology, Shanghai Institute of Nutrition and Health, Shanghai 
      Institutes for Biological Sciences, University of Chinese Academy of Sciences, 
      Chinese Academy of Sciences, Shanghai, China.
AD  - School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
AD  - Center for Excellence in Animal Evolution and Genetics, Chinese Academy of 
      Sciences, Kunming, China.
AD  - Collaborative Innovation Center of Genetics and Development, Shanghai, China.
FAU - Sullivan, Patrick F
AU  - Sullivan PF
AD  - Department of Genetics, The University of North Carolina at Chapel Hill, Chapel 
      Hill, NC, USA.
FAU - Ripke, Stephan
AU  - Ripke S
AD  - Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, 
      MA, USA.
AD  - Stanley Center for Psychiatric Research, the Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
AD  - Department of Psychiatry and Psychotherapy Charité - Universitätsmedizin, Berlin, 
      Germany.
FAU - O'Donovan, Michael C
AU  - O'Donovan MC
AD  - MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological 
      Medicine and Clinical Neurosciences, School of Medicine , Cardiff University, 
      Cardiff, UK.
FAU - Daly, Mark J
AU  - Daly MJ
AD  - Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, 
      MA, USA.
AD  - Stanley Center for Psychiatric Research, the Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
AD  - Department of Medicine, Harvard Medical School, Boston, MA, USA.
AD  - Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland.
FAU - Qin, Shengying
AU  - Qin S
AD  - Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders 
      (Ministry of Education) and the Collaborative Innovation Center for Brain 
      Science, Bio-X Institutes, Shanghai Jiao Tong University, Shanghai, China.
AD  - Collaborative Innovation Center, Jining Medical University, Jining, China.
FAU - Sham, Pak
AU  - Sham P
AD  - State Key Laboratory of Brain and Cognitive Sciences, Centre for Genomic 
      Sciences, The University of Hong Kong, Hong Kong, China.
AD  - Department of Psychiatry, Li Ka Shing Faculty of Medicine, The University of Hong 
      Kong, Hong Kong, China.
FAU - Iwata, Nakao
AU  - Iwata N
AD  - Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, 
      Japan.
FAU - Hong, Kyung S
AU  - Hong KS
AD  - Department of Psychiatry, Sungkyunkwan University School of Medicine, Samsung 
      Medical Center, Seoul, Korea.
FAU - Schwab, Sibylle G
AU  - Schwab SG
AUID- ORCID: 0000-0002-9370-9080
AD  - Molecular Horizons and School of Chemistry and Molecular Bioscience, University 
      of Wollongong, Wollongong, New South Wales, Australia.
AD  - Illawarra Health and Medical Research Institute, Wollongong, New South Wales, 
      Australia.
FAU - Yue, Weihua
AU  - Yue W
AD  - Peking University Sixth Hospital and Institute of Mental Health, Beijing, China. 
      dryue@bjmu.edu.cn.
AD  - National Health Commission Key Laboratory of Mental Health (Peking University), 
      Beijing, China. dryue@bjmu.edu.cn.
AD  - National Clinical Research Center for Mental Disorders (Peking University Sixth 
      Hospital), Beijing, China. dryue@bjmu.edu.cn.
AD  - IDG/McGovern Institute for Brain Research at Peking University, Beijing, China. 
      dryue@bjmu.edu.cn.
FAU - Tsuang, Ming
AU  - Tsuang M
AD  - Center for Behavioral Genomics, Department of Psychiatry, University of 
      California, San Diego, San Diego, CA, USA. mtsuang@ucsd.edu.
FAU - Liu, Jianjun
AU  - Liu J
AD  - Human Genetics, Genome Institute of Singapore, Singapore, Singapore. 
      liuj3@gis.astar.edu.sg.
AD  - Department of Medicine, Yong Loo Lin School of Medicine, National University of 
      Singapore, Singapore, Singapore. liuj3@gis.astar.edu.sg.
FAU - Ma, Xiancang
AU  - Ma X
AD  - Department of Psychiatry, The First Affiliated Hospital of Xi'an Jiaotong 
      University, Xi'an, China. maxiancang@163.com.
AD  - Center for Brain Science, The First Affiliated Hospital of Xi'an Jiaotong 
      University, Xi'an, China. maxiancang@163.com.
AD  - Clinical Research Center for Mental Disease of Shaanxi Province, The First 
      Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. 
      maxiancang@163.com.
FAU - Kahn, René S
AU  - Kahn RS
AD  - Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, 
      USA. rene.kahn@mssm.edu.
AD  - Behavioral Health System, Icahn School of Medicine at Mount Sinai, New York, NY, 
      USA. rene.kahn@mssm.edu.
AD  - Department of Psychiatry, Brain Center Rudolf Magnus, UMC Utrecht, Utrecht, the 
      Netherlands. rene.kahn@mssm.edu.
FAU - Shi, Yongyong
AU  - Shi Y
AD  - Bio-X Institutes, Shanghai Jiao Tong University and Research Division, Institute 
      of Mental Health Singapore, Singapore, Singapore. shiyongyong@gmail.com.
AD  - Biomedical Sciences Institute of Qingdao University, Qingdao Branch of Shanghai 
      Jiao Tong University Bio-X Institutes and the Affiliated Hospital of Qingdao 
      University, Qingdao, China. shiyongyong@gmail.com.
AD  - Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders 
      (Ministry of Education) and the Collaborative Innovation Center for Brain 
      Science, Bio-X Institutes, Shanghai Jiao Tong University, Shanghai, China. 
      shiyongyong@gmail.com.
AD  - Department of Psychiatry, First Teaching Hospital of Xinjiang Medical University, 
      Ürümqi, China. shiyongyong@gmail.com.
FAU - Huang, Hailiang
AU  - Huang H
AD  - Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, 
      MA, USA. hhuang@broadinstitute.org.
AD  - Stanley Center for Psychiatric Research, the Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA. hhuang@broadinstitute.org.
AD  - Department of Medicine, Harvard Medical School, Boston, MA, USA. 
      hhuang@broadinstitute.org.
LA  - eng
GR  - U54 HG003067/HG/NHGRI NIH HHS/United States
GR  - K01 DK114379/DK/NIDDK NIH HHS/United States
GR  - MR/P005748/1/MRC_/Medical Research Council/United Kingdom
GR  - U01 MH109536/MH/NIMH NIH HHS/United States
GR  - U01 MH109514/MH/NIMH NIH HHS/United States
GR  - K99 MH117229/MH/NIMH NIH HHS/United States
GR  - U01 MH109532/MH/NIMH NIH HHS/United States
GR  - U01 MH109539/MH/NIMH NIH HHS/United States
GR  - R21 AI139012/AI/NIAID NIH HHS/United States
GR  - G0800509/MRC_/Medical Research Council/United Kingdom
GR  - U01 MH109528/MH/NIMH NIH HHS/United States
GR  - R01 MH085560/MH/NIMH NIH HHS/United States
GR  - MR/L010305/1/MRC_/Medical Research Council/United Kingdom
GR  - R01 MH085521/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20191118
PL  - United States
TA  - Nat Genet
JT  - Nature genetics
JID - 9216904
SB  - IM
MH  - Asian People/*genetics
MH  - Case-Control Studies
MH  - Asia, Eastern
MH  - Genetics, Population
MH  - Genome-Wide Association Study
MH  - Humans
MH  - *Polymorphism, Single Nucleotide
MH  - Schizophrenia/*genetics
MH  - White People/*genetics
PMC - PMC6885121
MID - NIHMS1539625
EDAT- 2019/11/20 06:00
MHDA- 2020/01/18 06:00
CRDT- 2019/11/20 06:00
PHST- 2019/01/09 00:00 [received]
PHST- 2019/09/10 00:00 [accepted]
PHST- 2019/11/20 06:00 [pubmed]
PHST- 2020/01/18 06:00 [medline]
PHST- 2019/11/20 06:00 [entrez]
AID - 10.1038/s41588-019-0512-x [pii]
AID - 10.1038/s41588-019-0512-x [doi]
PST - ppublish
SO  - Nat Genet. 2019 Dec;51(12):1670-1678. doi: 10.1038/s41588-019-0512-x. Epub 2019 
      Nov 18.

PMID- 28384801
OWN - NLM
STAT- MEDLINE
DCOM- 20170630
LR  - 20220408
IS  - 2168-6238 (Electronic)
IS  - 2168-622X (Print)
IS  - 2168-622X (Linking)
VI  - 74
IP  - 5
DP  - 2017 May 1
TI  - The World Health Organization Adult Attention-Deficit/Hyperactivity Disorder 
      Self-Report Screening Scale for DSM-5.
PG  - 520-527
LID - 10.1001/jamapsychiatry.2017.0298 [doi]
AB  - IMPORTANCE: Recognition that adult attention-deficit/hyperactivity disorder 
      (ADHD) is common, seriously impairing, and usually undiagnosed has led to the 
      development of adult ADHD screening scales for use in community, workplace, and 
      primary care settings. However, these scales are all calibrated to DSM-IV 
      criteria, which are narrower than the recently developed DSM-5 criteria. 
      OBJECTIVES: To update for DSM-5 criteria and improve the operating 
      characteristics of the widely used World Health Organization Adult ADHD 
      Self-Report Scale (ASRS) for screening. DESIGN, SETTING, AND PARTICIPANTS: 
      Probability subsamples of participants in 2 general population surveys (2001-2003 
      household survey [n = 119] and 2004-2005 managed care subscriber survey 
      [n = 218]) who completed the full 29-question self-report ASRS, with both 
      subsamples over-sampling ASRS-screened positives, were blindly administered a 
      semistructured research diagnostic interview for DSM-5 adult ADHD. In 2016, the 
      Risk-Calibrated Supersparse Linear Integer Model, a novel machine-learning 
      algorithm designed to create screening scales with optimal integer weights and 
      limited numbers of screening questions, was applied to the pooled data to create 
      a DSM-5 version of the ASRS screening scale. The accuracy of the new scale was 
      then confirmed in an independent 2011-2012 clinical sample of patients seeking 
      evaluation at the New York University Langone Medical Center Adult ADHD Program 
      (NYU Langone) and 2015-2016 primary care controls (n = 300). Data analysis was 
      conducted from April 4, 2016, to September 22, 2016. MAIN OUTCOMES AND MEASURES: 
      The sensitivity, specificity, area under the curve (AUC), and positive predictive 
      value (PPV) of the revised ASRS. RESULTS: Of the total 637 participants, 44 
      (37.0%) household survey respondents, 51 (23.4%) managed care respondents, and 
      173 (57.7%) NYU Langone respondents met DSM-5 criteria for adult ADHD in the 
      semistructured diagnostic interview. Of the respondents who met DSM-5 criteria 
      for adult ADHD, 123 were male (45.9%); mean (SD) age was 33.1 (11.4) years. A 
      6-question screening scale was found to be optimal in distinguishing cases from 
      noncases in the first 2 samples. Operating characteristics were excellent at the 
      diagnostic threshold in the weighted (to the 8.2% DSM-5/Adult ADHD Clinical 
      Diagnostic Scale population prevalence) data (sensitivity, 91.4%; specificity, 
      96.0%; AUC, 0.94; PPV, 67.3%). Operating characteristics were similar despite a 
      much higher prevalence (57.7%) when the scale was applied to the NYU Langone 
      clinical sample (sensitivity, 91.9%; specificity, 74.0%; AUC, 0.83; PPV, 82.8%). 
      CONCLUSIONS AND RELEVANCE: The new ADHD screening scale is short, easily scored, 
      detects the vast majority of general population cases at a threshold that also 
      has high specificity and PPV, and could be used as a screening tool in specialty 
      treatment settings.
FAU - Ustun, Berk
AU  - Ustun B
AD  - Department of Electrical Engineering and Computer Science, Massachusetts 
      Institute of Technology, Cambridge.
FAU - Adler, Lenard A
AU  - Adler LA
AD  - Department of Psychiatry, New York University Langone School of Medicine, New 
      York.
AD  - Department of Child and Adolescent Psychiatry, New York University Langone School 
      of Medicine.
FAU - Rudin, Cynthia
AU  - Rudin C
AD  - Department of Computer Science, Duke University, Durham, North Carolina.
AD  - Department of Electrical and Computer Engineering, Duke University, Durham, North 
      Carolina.
FAU - Faraone, Stephen V
AU  - Faraone SV
AD  - Department of Psychiatry, State University of New York Upstate Medical 
      University, Syracuse.
AD  - Department of Neuroscience and Physiology, State University of New York Upstate 
      Medical University, Syracuse.
FAU - Spencer, Thomas J
AU  - Spencer TJ
AD  - Department of Psychiatry, Massachusetts General Hospital and Harvard Medical 
      School, Boston.
FAU - Berglund, Patricia
AU  - Berglund P
AD  - Institute for Social Research, University of Michigan, Ann Arbor.
FAU - Gruber, Michael J
AU  - Gruber MJ
AD  - Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.
FAU - Kessler, Ronald C
AU  - Kessler RC
AD  - Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.
LA  - eng
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - JAMA Psychiatry
JT  - JAMA psychiatry
JID - 101589550
SB  - IM
CIN - JAMA Psychiatry. 2017 May 1;74(5):527. PMID: 28384652
EIN - JAMA Psychiatry. 2017 Dec 1;74(12):1279. PMID: 29071343
EIN - JAMA Psychiatry. 2019 Nov 1;76(11):1213. PMID: 31577334
MH  - Adolescent
MH  - Adult
MH  - Attention Deficit Disorder with Hyperactivity/*diagnosis
MH  - *Diagnostic and Statistical Manual of Mental Disorders
MH  - Female
MH  - Humans
MH  - *Machine Learning
MH  - Male
MH  - Psychiatric Status Rating Scales/*standards
MH  - Psychometrics/*instrumentation
MH  - Reproducibility of Results
MH  - Self Report
MH  - Sensitivity and Specificity
MH  - *World Health Organization
MH  - Young Adult
PMC - PMC5470397
COIS- Conflict of Interest Disclosures: Dr Adler has received grant and research 
      support from Sunovion Pharmaceuticals, Purdue Pharmaceuticals, Enzymotec, Shire 
      Pharmaceuticals, and Lundbeck; served as a consultant for Enzymotec, Alcobra 
      Pharmaceuticals, Rhodes Pharmaceuticals, Shire Pharmaceuticals, National Football 
      League, and Major League Baseball; and has received royalty payments (as 
      inventor) from New York University for license of adult 
      attention-deficit/hyperactivity disorder (ADHD) scales and training materials 
      since 2004. With his institution, Dr Faraone has US patent US20130217707 A1 for 
      the use of sodium-hydrogen exchange inhibitors in the treatment of ADHD and has 
      received income, potential income, travel expenses, and/or research support from 
      Rhodes Pharmaceuticals, Arbor Pharmaceuticals, Pfizer, Ironshore, Shire, Akili 
      Interactive Labs, CogCubed, Alcobra, VAYA Pharma, NeuroLifeSciences, and NACE. Dr 
      Spencer receives research support from or is a consultant for Alcobra Pharma, 
      Avekshan, Heptares Therapeutics, Impax Laboratories, Ironshore, Lundbeck, Shire 
      Pharmaceuticals, Sunovion Pharmaceuticals, VAYA Pharma, the US Food and Drug 
      Administration, and the US Department of Defense; serves on an advisory board for 
      Alcobra Pharmaceuticals; receives research support from Royalties and Licensing 
      fees on copyrighted ADHD scales through Massachusetts General Hospital (MGH) 
      Corporate Sponsored Research and Licensing; and has a US Patent Application 
      pending (provisional number 61/233,686), through MGH corporate licensing on a 
      method to prevent stimulant abuse; consultant fees are paid to the MGH Clinical 
      Trials Network and not directly to Dr Spencer. Dr Kessler has received support 
      for his epidemiologic studies from Sanofi; was a consultant for Johnson & Johnson 
      Wellness and Prevention, Shire Pharmaceuticals, and Takeda Pharmaceuticals; 
      served on an advisory board for the Johnson & Johnson Services Inc Lake Nona Life 
      Project; and is a co-owner of DataStat, Inc, a market research firm that carries 
      out healthcare research. No other conflicts were reported.
EDAT- 2017/04/07 06:00
MHDA- 2017/07/01 06:00
CRDT- 2017/04/07 06:00
PHST- 2017/04/07 06:00 [pubmed]
PHST- 2017/07/01 06:00 [medline]
PHST- 2017/04/07 06:00 [entrez]
AID - 2616166 [pii]
AID - yoi170010 [pii]
AID - 10.1001/jamapsychiatry.2017.0298 [doi]
PST - ppublish
SO  - JAMA Psychiatry. 2017 May 1;74(5):520-527. doi: 10.1001/jamapsychiatry.2017.0298.

PMID- 35122753
OWN - NLM
STAT- MEDLINE
DCOM- 20220302
LR  - 20230206
IS  - 1474-547X (Electronic)
IS  - 0140-6736 (Print)
IS  - 0140-6736 (Linking)
VI  - 399
IP  - 10324
DP  - 2022 Feb 5
TI  - Responding to the opioid crisis in North America and beyond: recommendations of 
      the Stanford-Lancet Commission.
PG  - 555-604
LID - S0140-6736(21)02252-2 [pii]
LID - 10.1016/S0140-6736(21)02252-2 [doi]
FAU - Humphreys, Keith
AU  - Humphreys K
AD  - Department of Psychiatry and Behavioral Sciences, Stanford University School of 
      Medicine, Stanford, CA, USA; Veterans Affairs Palo Alto Health Care System, Palo 
      Alto, CA, USA. Electronic address: knh@stanford.edu.
FAU - Shover, Chelsea L
AU  - Shover CL
AD  - Division of General Internal Medicine and Health Services Research, University of 
      California Los Angeles David Geffen School of Medicine, Los Angeles, CA, USA.
FAU - Andrews, Christina M
AU  - Andrews CM
AD  - Department of Health Services Policy and Management, Arnold School of Public 
      Health, University of South Carolina, Columbia, SC, USA.
FAU - Bohnert, Amy S B
AU  - Bohnert ASB
AD  - Department of Psychiatry and Department of Anesthesiology, University of Michigan 
      Health System, Ann Arbor, MI, USA; Veterans Affairs Center for Clinical 
      Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI, 
      USA.
FAU - Brandeau, Margaret L
AU  - Brandeau ML
AD  - Department of Management Science and Engineering, Huang Engineering Center, 
      Stanford University, Stanford, CA USA.
FAU - Caulkins, Jonathan P
AU  - Caulkins JP
AD  - Heinz College, Carnegie Mellon University, Pittsburgh, PA, USA.
FAU - Chen, Jonathan H
AU  - Chen JH
AD  - Stanford Center for Biomedical Informatics Research, Stanford University School 
      of Medicine, Stanford, CA, USA; Division of Hospital Medicine, Stanford 
      University School of Medicine, Stanford, CA, USA.
FAU - Cuéllar, Mariano-Florentino
AU  - Cuéllar MF
AD  - Stanford Law School, Stanford, CA, USA.
FAU - Hurd, Yasmin L
AU  - Hurd YL
AD  - Addiction Institute, Icahn School of Medicine, New York, NY, USA.
FAU - Juurlink, David N
AU  - Juurlink DN
AD  - Sunnybrook Health Sciences Centre, Toronto, ON, Canada; Department of Medicine, 
      University of Toronto, Toronto, ON, Canada.
FAU - Koh, Howard K
AU  - Koh HK
AD  - Department of Health Policy and Management, Harvard T H Chan School of Public 
      Health, Boston, MA, USA.
FAU - Krebs, Erin E
AU  - Krebs EE
AD  - Department of Medicine, University of Minnesota, Minneapolis, MN, USA; Center for 
      Care Delivery and Outcomes Research, Veterans Affairs Minneapolis Health Care 
      System, Minneapolis, MN, USA.
FAU - Lembke, Anna
AU  - Lembke A
AD  - Department of Psychiatry and Behavioral Sciences, Stanford University School of 
      Medicine, Stanford, CA, USA.
FAU - Mackey, Sean C
AU  - Mackey SC
AD  - Department of Anesthesiology, Perioperative and Pain Medicine, Stanford 
      University School of Medicine, Palo Alto, CA, USA.
FAU - Larrimore Ouellette, Lisa
AU  - Larrimore Ouellette L
AD  - Stanford Law School, Stanford, CA, USA.
FAU - Suffoletto, Brian
AU  - Suffoletto B
AD  - Department of Emergency Medicine, Stanford University School of Medicine, 
      Stanford, CA, USA.
FAU - Timko, Christine
AU  - Timko C
AD  - Department of Psychiatry and Behavioral Sciences, Stanford University School of 
      Medicine, Stanford, CA, USA; Veterans Affairs Palo Alto Health Care System, Palo 
      Alto, CA, USA.
LA  - eng
GR  - I01 HX001288/HX/HSRD VA/United States
GR  - K01 DA050771/DA/NIDA NIH HHS/United States
GR  - R56 DA015446/DA/NIDA NIH HHS/United States
GR  - U01 CE002780/CE/NCIPC CDC HHS/United States
GR  - R01 DA043247/DA/NIDA NIH HHS/United States
GR  - P50 MH115838/MH/NIMH NIH HHS/United States
GR  - R21 DA043181/DA/NIDA NIH HHS/United States
GR  - R01 AT008561/AT/NCCIH NIH HHS/United States
GR  - R01 DA035484/DA/NIDA NIH HHS/United States
GR  - R01 DA045027/DA/NIDA NIH HHS/United States
GR  - R01 DA045705/DA/NIDA NIH HHS/United States
GR  - I01 HX003063/HX/HSRD VA/United States
GR  - R56 LM013365/LM/NLM NIH HHS/United States
GR  - UG1 DA015815/DA/NIDA NIH HHS/United States
GR  - P30 AG059307/AG/NIA NIH HHS/United States
GR  - R01 AA023650/AA/NIAAA NIH HHS/United States
GR  - R01 AA024136/AA/NIAAA NIH HHS/United States
GR  - UG3 AT009765/AT/NCCIH NIH HHS/United States
GR  - I01 HX002737/HX/HSRD VA/United States
GR  - U01 DK123816/DK/NIDDK NIH HHS/United States
GR  - P01 DA008227/DA/NIDA NIH HHS/United States
GR  - K23 AA023284/AA/NIAAA NIH HHS/United States
GR  - R01 DA015446/DA/NIDA NIH HHS/United States
GR  - R03 HD094577/HD/NICHD NIH HHS/United States
GR  - U2C DA050097/DA/NIDA NIH HHS/United States
GR  - K01 DA041628/DA/NIDA NIH HHS/United States
GR  - UG3 DA050323/DA/NIDA NIH HHS/United States
GR  - R61 NS118651/NS/NINDS NIH HHS/United States
GR  - I01 HX001752/HX/HSRD VA/United States
GR  - I01 HX000911/HX/HSRD VA/United States
GR  - R01 NS109450/NS/NINDS NIH HHS/United States
GR  - R01 DA048613/DA/NIDA NIH HHS/United States
GR  - I01 HX002714/HX/HSRD VA/United States
GR  - R01 DA034634/DA/NIDA NIH HHS/United States
GR  - R01 DA030359/DA/NIDA NIH HHS/United States
GR  - R01 DA049776/DA/NIDA NIH HHS/United States
GR  - R01 AT008387/AT/NCCIH NIH HHS/United States
GR  - R01 DA037317/DA/NIDA NIH HHS/United States
GR  - T32 DA035165/DA/NIDA NIH HHS/United States
GR  - UG3 AT009761/AT/NCCIH NIH HHS/United States
GR  - R37 DA015612/DA/NIDA NIH HHS/United States
PT  - Journal Article
PT  - Review
DEP - 20220202
PL  - England
TA  - Lancet
JT  - Lancet (London, England)
JID - 2985213R
RN  - 0 (Analgesics, Opioid)
SB  - IM
CIN - Lancet. 2022 Oct 22;400(10361):1401-1402. PMID: 36273474
CIN - Lancet. 2022 Oct 22;400(10361):1402. PMID: 36273475
CIN - Lancet. 2022 Oct 22;400(10361):1402-1403. PMID: 36273476
CIN - Lancet. 2022 Oct 22;400(10361):1403-1404. PMID: 36273477
CIN - Lancet. 2022 Oct 22;400(10361):1404. PMID: 36273479
MH  - Analgesics, Opioid/therapeutic use
MH  - COVID-19/epidemiology
MH  - Female
MH  - Global Health
MH  - Health Policy
MH  - Humans
MH  - Male
MH  - North America
MH  - *Opioid Epidemic
MH  - Opioid-Related Disorders/*epidemiology
MH  - Pain/drug therapy
MH  - Practice Guidelines as Topic
PMC - PMC9261968
MID - NIHMS1818225
COIS- Declaration of interests KH has been supported by the Esther Ting Memorial 
      Professorship at Stanford University School of Medicine and research grants from 
      the US Veterans Administration Health Services Research and Development Service 
      (RCS 04-141-3, HX-12-001, and HX002714-01A2), the US National Institute on Drug 
      Abuse (3UG1 DA015815-17S4 and 2UG1DA015815-19), the US Food and Drug 
      Administration, Wu Tsai Neurosciences Institute, the Silicon Valley Community 
      Foundation, the County of Santa Clara California, and the American Board of 
      Family Medicine. He has received speaking honoraria and travel expenses from the 
      American College of Medical Toxicology, Arizona State University, Barclays Bank, 
      Caron Foundation, the University of Florida, the New York Museum of Modern Art, 
      Syracuse University, West Virginia University School of Medicine, and the West 
      Virginia Medical Professionals Health Program. He has received writing honoraria 
      or royalties from the Association of Psychological Science, American Academy of 
      Political and Social Science, Brookings Institution, Cambridge University Press, 
      and Washington Monthly. He has been a paid consultant to AELIS Pharma, Harvard 
      Medical School, and Harvard University Press. CLS has been employed by Stanford 
      University, the University of California, Los Angeles (UCLA), the Los Angeles 
      County Department of Public Health, Heluna Health, and the Los Angeles LGBT 
      Center. She has received research funding or stipends from the US National 
      Institute on Drug Abuse (K01DA050771, T32DA035165), the RAND Opioid Policy Tools 
      and Information Center), Wu Tsai Neurosciences Institute, and UCLA David Geffen 
      School of Medicine, and speaking honoraria or travel expenses from Emory 
      University, New York University, UCLA, the University of North Carolina at Chapel 
      Hill, the University of Southern California, the University of Pittsburgh, the 
      University of Chicago, the University of Western Ontario, the Nevada State 
      Medical Association, RAND, the University of California, Irvine, the US Centers 
      for Disease Control and Prevention, College on Problems of Drug Dependence, the 
      Conference on Retroviruses and Opportunistic Infections, HIV Research for 
      Prevention, Addiction Health Services Research, and the American 
      Psychopathological Association. CMA has been supported by the Arnold School of 
      Public Health at the University of South Carolina, and by research grants from 
      the US National Institute on Drug Abuse (R01DA034634, K01DA041628, U2CDA050097, 
      R01DA049776, and R01DA052425), the US National Institute on Alcoholism and 
      Alcohol Abuse (R01AA029097 and R01AA029821), and the South Carolina Department of 
      Alcohol and Other Drug Abuse Services, and has been a paid consultant to the 
      Robert Wood Johnson Foundation, RTI International, the Medical University of 
      South Carolina, the State of Pennsylvania Department of Public Health, and the 
      State of Illinois Division of Health Care and Family Services. ASBB has been 
      supported by grants from the US National Institutes for Health (R01 DA045705), 
      the US Veterans Health Administration (IIR 13-322 and C19 21-278), the US Centers 
      for Disease Control and Prevention (U01CE002780), Blue Cross Blue Shield of 
      Michigan, the US Department of Defense, the Patient-Centered Outcomes Research 
      Institute, the Michigan Health Endowment Fund, and the Substance Abuse and Mental 
      Health Services Administration via sub-contracts from the Michigan Department of 
      Health and Human Services, has received speaker honoraria or travel expenses from 
      the Illinois Health and Hospital Association, the International Summit on Suicide 
      Research, the Washington State Department of Labor & Industries, the American 
      Psychopathological Association, and the High Intensity Drug Trafficking Area 
      program, has been paid as a consultant by New York University, and has received 
      products from Fitbit at a reduced cost and Headspace for free for research 
      purposes. MLB has been supported by research grants from the US Department of 
      Veterans Affairs and the US National Institute on Drug Abuse (R37-DA15612), and a 
      Koret Foundation gift for Smart Cities and Digital Living, has received travel 
      expenses from the University of Maryland, the University of Auckland, 
      Massachusetts Institute of Technology, the European Working Group on Stochastic 
      Modeling, INSEAD, the University of Michigan, and the University of Oklahoma, and 
      has been a paid consultant to Compass Lexecon and DE Shaw. JPC has received a 
      National Science Foundation EAGER Grant on Detecting and Disrupting Illicit 
      Supply Networks via Traffic Distribution Systems, is a consultant to the RAND 
      Corporation's Drug Policy Research Center, has consulted with or received 
      honoraria from the Actis—Norwegian Policy Network on Alcohol and Drugs, the 
      Arnold Foundation, Bank of Montreal, Boston University, the Foreign Affairs, 
      Justice Research and Statistics Association, Lisbon Addictions Conference, 
      Massachusetts Institute of Technology, National Affairs, the National Institute 
      of Justice, Oxford University Press, Pew, PIRE, the Russell Sage Foundation, 
      Springer Verlag, Stanford University, the US State Department, Texas Research 
      Society on Alcoholism, the US Veteran's Administration, Washington Monthly, and 
      the WT Grant Foundation. JHC has received research support or funding from the US 
      National Institutes of Health and National Library of Medicine (R56LM013365), the 
      Gordon and Betty Moore Foundation (GBMF8040), the US National Science Foundation 
      (SPO181514); Google (SPO13604), the Stanford Clinical Excellence Research Center, 
      the Stanford Department of Medicine and Department of Pathology, and the Stanford 
      Aging and Ethnogeriatrics Research Center (P30AG059307), which is part of the 
      Resource Centers for Minority Aging Research programme led by the US National 
      Institute on Aging at the National Institutes of Health, is the co-founder of 
      Reaction Explorer (which develops and licenses organic chemistry education 
      software), and has been paid consulting or speaker fees by the US National 
      Institute of Drug Abuse Clinical Trials Network, Tuolc, Roche, and Younker Hyde 
      MacFarlane. M-FC has served as president of the Carnegie Endowment for 
      International Peace, a justice of the Supreme Court of California, the Herman 
      Phleger Professor at Stanford Law School, a distinguished visiting jurist at the 
      New York University School of Law, the Castle Distinguished Lecturer in Ethics, 
      Politics, and Economics at Yale University, a member of the President & Fellows 
      of Harvard College (the Harvard Corporation), a member of the board of directors 
      of the William and Flora Hewlett Foundation, a member of the Council of the 
      American Law Institute, chair of the board of directors of the Center for 
      Advanced Study in the Behavioral Sciences, chair of the advisory board of the 
      Seed Initiative at the Stanford Graduate School of Business, and a member of the 
      advisory board at the Stanford Human-Centered Artificial Intelligence Institute. 
      His work has been supported by Stanford Law School and by a grant from the 
      Stanford Human-Centered Artificial Intelligence Institute, and he was previously 
      chair of the advisory board of the AI Now Institute at New York University. YLH 
      has received research grants from the US National Institute on Drug Abuse 
      (DA050323, DA048613, DA008227, DA043247, DA030359, DA037317, and DA15446), 
      research funding from GW Pharmaceuticals, speaking honoraria or travel expenses, 
      or both, from the University of North Carolina, the American Society for the 
      Advancement of Science, the Society for Neuroscience Public Education & 
      Communication Committee, Washington University in St Louis, Temple University, 
      Tufts School of Medicine, Indiana University, the American College of 
      Neuropsychopharmacology, the Iowa Neuroscience Institute, the Franklin Institute, 
      State University of New York Upstate Medical University, the Canadian Consortium 
      for the Investigation of Cannabinoids, the University of Michigan, Cold Spring 
      Harbor Laboratory, the US National Institutes of Health, Penn State Hershey 
      College of Medicine, the US National Academy of Medicine, the Mediterranean 
      Neuroscience Society, the Wu Tsai Neurosciences Institute, Society of Biological 
      Psychiatry, International College of Neuropharmacology, the Federation of 
      European Neuroscience Societies, Gordon Research Conference, the National 
      Institutes of Health Center for Scientific Research Council, and the Society of 
      Neuroscience. DNJ has received research grants from the Canadian Institutes for 
      Health Research and the Ontario Ministry of Health, financial support from the 
      departments of medicine at both the University of Toronto and Sunnybrook Health 
      Sciences Centre, travel expenses or speaking honoraria from Dalhousie University, 
      the University of Ottawa, the University of Saskatchewan, the University of 
      Calgary, the Bloomberg Johns Hopkins School of Public Health, the American 
      College of Physicians, the University of Alabama at Birmingham, the American 
      Society of Nephrology, the Canadian Society of Internal Medicine, the Canadian 
      Anesthesiologists' Society, The Canadian Society of Obstetricians and 
      Gynecologists, the Western Canada Addiction Forum, and the Canadian House of 
      Commons Standing Committee on Health, and payment for expert witness testimony 
      from (and has been retained by) Sanis, a generic drug manufacturer and 
      distributor to provide advice related to an ongoing Canadian class action, and is 
      a volunteer member of Physicians for Responsible Opioid Prescribing. HKK has been 
      supported by grants from the Robert Wood Johnson Foundation (77667, 74275, and 
      73359), the John Templeton Foundation (52125), the JPB Foundation (1085 and 439), 
      and the Association of State and Territorial Health Officers (1584), has received 
      honoraria from Jefferson University, Jefferson Health, the Perelman School of 
      Medicine at the University of Pennsylvania, MaineHealth Center for Tobacco 
      Independence, Harvard University Memorial Church, the Association of State and 
      Territorial Health Officials, the University of Wisconsin Medical School, Wake 
      Forest Baptist Health (in partnership with Shaw University), the Robert Wood 
      Johnson Foundation advisory committee, the American College of Gastroenterology, 
      and Tufts University School of Medicine, has been a consultant to the 
      Commonwealth Fund, and is a member of the Community COVID Coalition Advisory 
      Group, Phillips Academy Public Health Expert Advisory Panel, the Policy Advisory 
      Group, the board of the Bipartisan Policy Center, the Palliative and Advanced 
      Illness Research Center External Advisory Board (at the Perelman School of 
      Medicine), the American Cancer Society Eastern New England Area Council of 
      Advisors, the American University of Beirut International Advisory Council, the 
      US National Advisory Board, the Culture of Health Year in Review Advisory 
      Committee and Culture of Health as a Business Imperative Initiative of the Robert 
      Wood Johnson Foundation, the editorial board of the Journal of the American 
      Medical Association, the New England Donor Services board of trustees, the Josiah 
      Macy Jr Foundation board of directors, and the Lancet–O'Neill Institute, 
      Georgetown University Commission on Global Health and the Law. EEK has received 
      research funding from the US Department of Veterans Affairs Health Services 
      Research and Development (COR 19-489, 1I01HX003063-01A1, 5I01HX001752-05, 
      5I01HX002737-02, 5I01HX001288-05, and 5I01HX000911-06), the Patient Centered 
      Outcomes Research Institute (OPD-1511-33052), the US National Center for 
      Complementary and Integrative Health (5R01AT008387-04, 5UH3AT009761- 
      04/5UG3AT009761-02, and 4UH3AT009765-03/5UG3AT009765-02), and the US National 
      Institute of Diabetes and Digestive and Kidney Diseases (1U01DK123816-01), and 
      travel expenses from the law firm Nix Patterson representing the state of 
      Oklahoma (to serve as an expert witness in support of the state's litigation 
      against opioid manufacturers), the American Society of Health-System Pharmacists, 
      the Association of Academic Physiatrists, the Australian Pain Society, the 
      Cleveland VA Medical Research and Education Foundation, the Duke-Margolis Center 
      for Health Policy, the Foundation for Medical Excellence, the Foundation for 
      Opioid Response Efforts, the Friends of VA Medical Care and Health Research, the 
      Hennepin Healthcare Research Institute, the Indiana Institute for Medical 
      Research, the US National Academies of Medicine, the US National Center for 
      Complementary and Integrative Health, the National Governors Association, the 
      North American Spine Society, the Patient Centered Outcomes Research Institute at 
      Stanford University, the US Food and Drug Administration, and the Washington 
      State Department of Labor & Industries. AL has received consulting fees for her 
      work as a medical expert witness in federal and state litigation against opioid 
      manufacturers, distributors, and pharmacies, book royalties from Johns Hopkins 
      University Press and Dutton Penguin Random House, speaking honoraria or travel 
      expenses, or both, from the Vanderbilt University School of Medicine, the Ohio 
      State University School of Medicine, the University of Kansas School of Medicine 
      (sponsorship of the Alpha Omega Alpha Visiting Professorship), the Oregon Pain 
      Guidance, the Indiana Prosecuting Attorneys Council, the Perrin's Opioid 
      Litigation Conference, the Public Funds Forum, the Baton Rouge Health District, 
      the Montrose Colorado Annual Continuing Medical Education Conference, the 
      PerformRX Pharmacy Benefits Manager Annual Conference, the American Academy of 
      Psychiatry and the Law, the Psych Congress, the 69th Annual Canadian Refresher 
      Course for Family Physicians, the Ohio State University Inter-Professional 
      Summit, the University of Texas, the Geminus Community Partners Annual Conference 
      of Indiana, the National Council on Alcoholism and Drug Abuse, the Stanford 
      Sierra Camp Womens' Alumni Wellness Retreat, the American Psychiatric 
      Association, the Association for Medical Education and Research in Substance 
      Abuse, and the Southwestern Gynecologic Assembly. SCM has been supported by the 
      Redlich Professorship and the Rosekrans Pain Research Endowment Fund at Stanford 
      University School of Medicine and research grants awarded to Stanford University 
      from the US National Institutes of Health (R61NS118651, R03HD094577, R01DA045027, 
      R01NS109450, R01AT008561, K24DA02926207, R01DA035484, and P01AT00665105), the 
      Patient Centered Outcomes Research Institute (PCORI OPD-1610- 370707), the 
      Stanford Wu Tsai Neurosciences Institute, and the University of California, San 
      Francisco–Stanford Center of Excellence in Regulatory Science and Innovation 
      (FDA) (2U01FD005978-06), has received speaking honoraria or travel expenses from 
      Walter Reed, Harvard University, the American Academy of Pain Medicine, 
      Washington University, the US Food and Drug Administration, the US National 
      Institutes of Health, the US National Institute of Neurological Disorders and 
      Stroke, the University of Washington, George Washington University, New York 
      University, Weill Cornell Medical College, Duke University, the University of 
      Utah, the World Institute of Pain, and the Canadian Pain Society, has received 
      payment for testimony (unrelated to opioids) from Lauria Tokunaga Gates and Linn, 
      and has received payment for consulting (unrelated to opioids) from the American 
      Society of Anesthesiology; Favros Law; Fain Anderson VanDerhoef Rosendahl 
      O'Halloran Spillane; Cox, Wootton, Lerner, Griffin & Hansen; Lewis Brisbois 
      Bisgaard & Smith; Muro & Lampe; McCormick Barstow; Schmid & Voiles; and the 
      University of Oklahoma Health Sciences Center. LLO has received travel expenses 
      or honoraria from Cardozo Law School, Claremont McKenna College, Duke University, 
      ETH Zürich, Georgetown University, Harvard University, the Los Angeles 
      Intellectual Property Law Association, Michigan State University, New York 
      University, Northwestern University, the University of Chicago, the University of 
      Houston, the University of Kansas, the University of Nebraska, the University of 
      San Diego, the University of Texas, the University of Villanova, the World 
      Intellectual Property Organization, and Yale University, has received a writing 
      honoraria from the Brookings Institution (to write a policy proposal for the 
      Hamilton Project), and is a paid consultant to the MITRE Corporation (to assist 
      with evaluations of the US Patent and Trademark Office requested by the 
      Department of Commerce). BS has received research support from the US National 
      Institute on Alcohol Abuse and Alcoholism (R01 AA023650 and K23 AA023284), the US 
      National Institute of Drug Abuse (R21 DA043181), the US National Institute of 
      Mental Health (P50MH115838), and the US National Highway Transportation Safety 
      Authority, has received royalties from a software licence to healthStratica, and 
      has several invention disclosures with the University of Pittsburgh for digital 
      behavioral interventions. CT has been supported by the US Department of Veterans 
      Affairs (VA HSR&D IIR 15-298, IIR 18-253, IIR 20-058, and PPO 16-337) and the US 
      National Institutes of Health (NIAAA 1R01AA024136-01).
EDAT- 2022/02/06 06:00
MHDA- 2022/03/03 06:00
CRDT- 2022/02/05 20:12
PHST- 2020/12/22 00:00 [received]
PHST- 2021/08/01 00:00 [revised]
PHST- 2021/10/06 00:00 [accepted]
PHST- 2022/02/06 06:00 [pubmed]
PHST- 2022/03/03 06:00 [medline]
PHST- 2022/02/05 20:12 [entrez]
AID - S0140-6736(21)02252-2 [pii]
AID - 10.1016/S0140-6736(21)02252-2 [doi]
PST - ppublish
SO  - Lancet. 2022 Feb 5;399(10324):555-604. doi: 10.1016/S0140-6736(21)02252-2. Epub 
      2022 Feb 2.

PMID- 29615459
OWN - NLM
STAT- MEDLINE
DCOM- 20191119
LR  - 20200101
IS  - 1557-3265 (Electronic)
IS  - 1078-0432 (Print)
IS  - 1078-0432 (Linking)
VI  - 24
IP  - 13
DP  - 2018 Jul 1
TI  - Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers.
PG  - 3059-3068
LID - 10.1158/1078-0432.CCR-18-0373 [doi]
AB  - Purpose: To define the genetic landscape of advanced differentiated and 
      anaplastic thyroid cancer (ATC) and identify genetic alterations of potential 
      diagnostic, prognostic, and therapeutic significance.Experimental Design: The 
      genetic profiles of 583 advanced differentiated and 196 ATCs generated with 
      targeted next-generation sequencing cancer-associated gene panels MSK-IMPACT and 
      FoundationOne were analyzed.Results: ATC had more genetic alterations per tumor, 
      and pediatric papillary thyroid cancer had fewer genetic alterations per tumor 
      when compared with other thyroid cancer types. DNA mismatch repair deficit and 
      activity of APOBEC cytidine deaminases were identified as mechanisms associated 
      with high mutational burden in a subset of differentiated thyroid cancers and 
      ATCs. Copy number losses and mutations of CDKN2A and CDKN2B, amplification of 
      CCNE1, amplification of receptor tyrosine kinase genes KDR, KIT, and PDGFRA, 
      amplification of immune evasion genes CD274, PDCD1LG2, and JAK2, and activating 
      point mutations in small GTPase RAC1 were associated with ATC. An association of 
      KDR, KIT, and PDGFRA amplification with the sensitivity of thyroid cancer cells 
      to lenvatinib was shown in vitro Three genetically distinct types of ATCs are 
      proposed.Conclusions: This large-scale analysis describes genetic alterations in 
      a cohort of thyroid cancers enriched in advanced cases. Many novel genetic events 
      previously not seen in thyroid cancer were found. Genetic alterations associated 
      with anaplastic transformation were identified. An updated schematic of thyroid 
      cancer genetic evolution is proposed. Clin Cancer Res; 24(13); 3059-68. ©2018 
      AACR.
CI  - ©2018 American Association for Cancer Research.
FAU - Pozdeyev, Nikita
AU  - Pozdeyev N
AD  - Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, 
      University of Colorado Anschutz Medical Campus, Aurora, Colorado. 
      nikitapozdeyev@gmail.com.
AD  - Division of Biomedical Informatics and Personalized Medicine, Department of 
      Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
AD  - Department of Pharmaceutical Sciences, Skaags School of Pharmacy and 
      Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, 
      Colorado.
FAU - Gay, Laurie M
AU  - Gay LM
AD  - Division of Medical Oncology, Department of Medicine, University of Colorado 
      Anschutz Medical Campus, Aurora, Colorado.
FAU - Sokol, Ethan S
AU  - Sokol ES
AD  - Division of Medical Oncology, Department of Medicine, University of Colorado 
      Anschutz Medical Campus, Aurora, Colorado.
FAU - Hartmaier, Ryan
AU  - Hartmaier R
AD  - Division of Medical Oncology, Department of Medicine, University of Colorado 
      Anschutz Medical Campus, Aurora, Colorado.
FAU - Deaver, Kelsi E
AU  - Deaver KE
AD  - Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, 
      University of Colorado Anschutz Medical Campus, Aurora, Colorado.
FAU - Davis, Stephanie
AU  - Davis S
AD  - Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, 
      University of Colorado Anschutz Medical Campus, Aurora, Colorado.
AD  - University of Colorado Cancer Center, Aurora, Colorado.
FAU - French, Jena D
AU  - French JD
AD  - Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, 
      University of Colorado Anschutz Medical Campus, Aurora, Colorado.
AD  - Department of Pharmaceutical Sciences, Skaags School of Pharmacy and 
      Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, 
      Colorado.
FAU - Borre, Pierre Vanden
AU  - Borre PV
AD  - Division of Medical Oncology, Department of Medicine, University of Colorado 
      Anschutz Medical Campus, Aurora, Colorado.
FAU - LaBarbera, Daniel V
AU  - LaBarbera DV
AD  - Department of Pharmaceutical Sciences, Skaags School of Pharmacy and 
      Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, 
      Colorado.
AD  - Foundation Medicine Inc., Cambridge, Massachusetts.
FAU - Tan, Aik-Choon
AU  - Tan AC
AD  - Department of Pharmaceutical Sciences, Skaags School of Pharmacy and 
      Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, 
      Colorado.
AD  - Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, 
      Colorado.
FAU - Schweppe, Rebecca E
AU  - Schweppe RE
AD  - Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, 
      University of Colorado Anschutz Medical Campus, Aurora, Colorado.
AD  - Department of Pharmaceutical Sciences, Skaags School of Pharmacy and 
      Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, 
      Colorado.
FAU - Fishbein, Lauren
AU  - Fishbein L
AD  - Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, 
      University of Colorado Anschutz Medical Campus, Aurora, Colorado.
AD  - Division of Biomedical Informatics and Personalized Medicine, Department of 
      Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
AD  - Department of Pharmaceutical Sciences, Skaags School of Pharmacy and 
      Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, 
      Colorado.
FAU - Ross, Jeffrey S
AU  - Ross JS
AD  - Division of Medical Oncology, Department of Medicine, University of Colorado 
      Anschutz Medical Campus, Aurora, Colorado.
AD  - Departments of Pathology and Urology, Upstate Medical University, Syracuse, New 
      York.
FAU - Haugen, Bryan R
AU  - Haugen BR
AD  - Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, 
      University of Colorado Anschutz Medical Campus, Aurora, Colorado.
AD  - Department of Pharmaceutical Sciences, Skaags School of Pharmacy and 
      Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, 
      Colorado.
FAU - Bowles, Daniel W
AU  - Bowles DW
AD  - Department of Pharmaceutical Sciences, Skaags School of Pharmacy and 
      Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, 
      Colorado.
AD  - Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, 
      Colorado.
LA  - eng
GR  - P30 CA046934/CA/NCI NIH HHS/United States
GR  - RC1 CA147371/CA/NCI NIH HHS/United States
GR  - T32 DK007446/DK/NIDDK NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20180403
PL  - United States
TA  - Clin Cancer Res
JT  - Clinical cancer research : an official journal of the American Association for 
      Cancer Research
JID - 9502500
RN  - 0 (Biomarkers, Tumor)
RN  - 0 (Tumor Suppressor Proteins)
SB  - IM
MH  - Algorithms
MH  - *Biomarkers, Tumor
MH  - Computational Biology/methods
MH  - DNA Mismatch Repair
MH  - Gene Frequency
MH  - Genetic Testing
MH  - *Genetic Variation
MH  - Humans
MH  - Mutation
MH  - Neoplasm Grading
MH  - Neoplasm Staging
MH  - Oncogenes
MH  - Pharmacogenomic Variants
MH  - Prognosis
MH  - Promoter Regions, Genetic
MH  - Thyroid Carcinoma, Anaplastic/*diagnosis/drug therapy/*genetics
MH  - Tumor Suppressor Proteins/genetics
PMC - PMC6030480
MID - NIHMS956033
COIS- Conflict of interest. Nikita Pozdeyev, Kelsi E. Deaver, Stephanie Davis, Jena D. 
      French, Daniel V. LaBarbera, Aik-Choon Tan, Rebecca E. Schweppe, Lauren Fishbein, 
      Bryan R. Haugen and Daniel W. Bowles declare no conflicts of interest. Laurie M. 
      Gay, Ethan Sokol, Pierre Vanden Borre and Jeffrey S. Ross are employees and 
      shareholders of Foundation Medicine Inc. Ryan Hartmaier was an employee and 
      shareholder of Foundation Medicine Inc. at a time this study was done.
EDAT- 2018/04/05 06:00
MHDA- 2019/11/20 06:00
CRDT- 2018/04/05 06:00
PHST- 2018/01/30 00:00 [received]
PHST- 2018/03/12 00:00 [revised]
PHST- 2018/03/22 00:00 [accepted]
PHST- 2018/04/05 06:00 [pubmed]
PHST- 2019/11/20 06:00 [medline]
PHST- 2018/04/05 06:00 [entrez]
AID - 1078-0432.CCR-18-0373 [pii]
AID - 10.1158/1078-0432.CCR-18-0373 [doi]
PST - ppublish
SO  - Clin Cancer Res. 2018 Jul 1;24(13):3059-3068. doi: 10.1158/1078-0432.CCR-18-0373. 
      Epub 2018 Apr 3.

PMID- 31011206
OWN - NLM
STAT- MEDLINE
DCOM- 20190710
LR  - 20210109
IS  - 1546-170X (Electronic)
IS  - 1078-8956 (Print)
IS  - 1078-8956 (Linking)
VI  - 25
IP  - 5
DP  - 2019 May
TI  - Molecular profiling of cancer patients enables personalized combination therapy: 
      the I-PREDICT study.
PG  - 744-750
LID - 10.1038/s41591-019-0407-5 [doi]
AB  - Cancer treatments have evolved from indiscriminate cytotoxic agents to selective 
      genome- and immune-targeted drugs that have transformed the outcomes of some 
      malignancies(1). Tumor complexity and heterogeneity suggest that the 'precision 
      medicine' paradigm of cancer therapy requires treatment to be personalized to the 
      individual patient(2-6). To date, precision oncology trials have been based on 
      molecular matching with predetermined monotherapies(7-14). Several of these 
      trials have been hindered by very low matching rates, often in the 5-10% 
      range(15), and low response rates. Low matching rates may be due to the use of 
      limited gene panels, restrictive molecular matching algorithms, lack of drug 
      availability, or the deterioration and death of end-stage patients before therapy 
      can be implemented. We hypothesized that personalized treatment with combination 
      therapies would improve outcomes in patients with refractory malignancies. As a 
      first test of this concept, we implemented a cross-institutional prospective 
      study (I-PREDICT, NCT02534675 ) that used tumor DNA sequencing and timely 
      recommendations for individualized treatment with combination therapies. We found 
      that administration of customized multidrug regimens was feasible, with 49% of 
      consented patients receiving personalized treatment. Targeting of a larger 
      fraction of identified molecular alterations, yielding a higher 'matching score', 
      was correlated with significantly improved disease control rates, as well as 
      longer progression-free and overall survival rates, compared to targeting of 
      fewer somatic alterations. Our findings suggest that the current clinical trial 
      paradigm for precision oncology, which pairs one driver mutation with one drug, 
      may be optimized by treating molecularly complex and heterogeneous cancers with 
      combinations of customized agents.
FAU - Sicklick, Jason K
AU  - Sicklick JK
AUID- ORCID: 0000-0003-4403-0271
AD  - Division of Surgical Oncology, Department of Surgery, University of California, 
      San Diego, La Jolla, CA, USA. jsicklick@ucsd.edu.
AD  - Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA. 
      jsicklick@ucsd.edu.
AD  - Center for Personalized Cancer Therapy, University of California, San Diego, La 
      Jolla, CA, USA. jsicklick@ucsd.edu.
FAU - Kato, Shumei
AU  - Kato S
AD  - Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
AD  - Center for Personalized Cancer Therapy, University of California, San Diego, La 
      Jolla, CA, USA.
AD  - Division of Hematology Oncology, Department of Medicine, University of 
      California, San Diego, La Jolla, CA, USA.
FAU - Okamura, Ryosuke
AU  - Okamura R
AUID- ORCID: 0000-0001-7352-8621
AD  - Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
AD  - Center for Personalized Cancer Therapy, University of California, San Diego, La 
      Jolla, CA, USA.
AD  - Division of Hematology Oncology, Department of Medicine, University of 
      California, San Diego, La Jolla, CA, USA.
FAU - Schwaederle, Maria
AU  - Schwaederle M
AD  - Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
AD  - Center for Personalized Cancer Therapy, University of California, San Diego, La 
      Jolla, CA, USA.
AD  - Division of Hematology Oncology, Department of Medicine, University of 
      California, San Diego, La Jolla, CA, USA.
FAU - Hahn, Michael E
AU  - Hahn ME
AD  - Department of Radiology, University of California, San Diego, La Jolla, CA, USA.
FAU - Williams, Casey B
AU  - Williams CB
AD  - Avera Cancer Institute, Sioux Falls, SD, USA.
FAU - De, Pradip
AU  - De P
AD  - Avera Cancer Institute, Sioux Falls, SD, USA.
FAU - Krie, Amy
AU  - Krie A
AD  - Avera Cancer Institute, Sioux Falls, SD, USA.
FAU - Piccioni, David E
AU  - Piccioni DE
AD  - Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
AD  - Center for Personalized Cancer Therapy, University of California, San Diego, La 
      Jolla, CA, USA.
AD  - Division of Neuro-oncology, Department of Neurosciences, University of 
      California, San Diego, La Jolla, CA, USA.
FAU - Miller, Vincent A
AU  - Miller VA
AD  - Foundation Medicine, Inc., Cambridge, MA, USA.
FAU - Ross, Jeffrey S
AU  - Ross JS
AD  - Foundation Medicine, Inc., Cambridge, MA, USA.
AD  - Department of Pathology, SUNY Upstate Medical University, Syracuse, NY, USA.
FAU - Benson, Adam
AU  - Benson A
AD  - Scipher Medicine, Waltham, MA, USA.
FAU - Webster, Jennifer
AU  - Webster J
AD  - Foundation Medicine, Inc., Cambridge, MA, USA.
FAU - Stephens, Philip J
AU  - Stephens PJ
AD  - GRAIL, Inc., Menlo Park, CA, USA.
FAU - Lee, J Jack
AU  - Lee JJ
AUID- ORCID: 0000-0001-5469-9214
AD  - Department of Biostatistics, University of Texas MD Anderson Cancer Center, 
      Houston, TX, USA.
FAU - Fanta, Paul T
AU  - Fanta PT
AD  - Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
AD  - Center for Personalized Cancer Therapy, University of California, San Diego, La 
      Jolla, CA, USA.
AD  - Division of Hematology Oncology, Department of Medicine, University of 
      California, San Diego, La Jolla, CA, USA.
FAU - Lippman, Scott M
AU  - Lippman SM
AD  - Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
AD  - Center for Personalized Cancer Therapy, University of California, San Diego, La 
      Jolla, CA, USA.
AD  - Division of Hematology Oncology, Department of Medicine, University of 
      California, San Diego, La Jolla, CA, USA.
FAU - Leyland-Jones, Brian
AU  - Leyland-Jones B
AD  - Avera Cancer Institute, Sioux Falls, SD, USA.
FAU - Kurzrock, Razelle
AU  - Kurzrock R
AUID- ORCID: 0000-0003-4110-1214
AD  - Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA. 
      rkurzrock@ucsd.edu.
AD  - Center for Personalized Cancer Therapy, University of California, San Diego, La 
      Jolla, CA, USA. rkurzrock@ucsd.edu.
AD  - Division of Hematology Oncology, Department of Medicine, University of 
      California, San Diego, La Jolla, CA, USA. rkurzrock@ucsd.edu.
LA  - eng
GR  - K08 CA168999/CA/NCI NIH HHS/United States
GR  - P30 CA016672/CA/NCI NIH HHS/United States
GR  - P30 CA023100/CA/NCI NIH HHS/United States
GR  - R21 CA192072/CA/NCI NIH HHS/United States
PT  - Clinical Trial
PT  - Journal Article
PT  - Multicenter Study
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20190422
PL  - United States
TA  - Nat Med
JT  - Nature medicine
JID - 9502015
SB  - IM
CIN - Nat Med. 2019 May;25(5):711-712. PMID: 31036881
CIN - Cancer Cell. 2019 Jun 10;35(6):825-826. PMID: 31185208
CIN - Cancer Discov. 2019 Aug;9(8):OF8. PMID: 31242995
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Combined Modality Therapy
MH  - Female
MH  - Gene Expression Profiling
MH  - High-Throughput Nucleotide Sequencing
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Molecular Targeted Therapy
MH  - Neoplasms/*genetics/*therapy
MH  - Precision Medicine
MH  - Progression-Free Survival
MH  - Prospective Studies
MH  - Young Adult
PMC - PMC6553618
MID - NIHMS1522524
COIS- COMPETING INTERESTS: Jason Sicklick receives research funds from Foundation 
      Medicine Inc., Novartis Pharmaceuticals, Blueprint Medicines, and Amgen, as well 
      as consultant fees from Loxo, Biotheranostics, and Grand Rounds. Michael Hahn 
      receives research funds from General Electric and is an equity holder in 
      Illumina, Inc. Casey Williams receives research support from Takeda, Tesaro, and 
      Pfizer, as well as consultant fees from Takeda. Vincent Miller, Jeffrey Ross, and 
      Jennifer Webster are employees and equity holders in Foundation Medicine Inc. 
      Vincent Miller is also on the Board of Directors for Revolution Medicines (equity 
      and compensation >$10,000) and has patent royalties for EGFR T790M testing issued 
      to Memorial Sloan Kettering Cancer Center. Adam Benson is formerly an employee 
      and is an equity holder in Foundation Medicine Inc. He is now an employee of 
      Scipher Medicine. Philip J. Stephens is formerly an employee and is formerly an 
      equity holder in Foundation Medicine Inc. He is now an employee of Grail, Inc. J. 
      Jack Lee served on the Statistical Advisory Board of AbbVie. Razelle Kurzrock has 
      research funding from Incyte, Genentech, Merck Serono, Pfizer, Sequenom, Grifols, 
      Omniseq, Foundation Medicine Inc., Guardant Health, and Konica Minolta, as well 
      as consultant fees from Loxo, Actuate Therapeutics, Roche, Xbiotech and NeoMed. 
      She serves as an advisor to Soluventis. She receives speaker fees from Roche, and 
      has an equity interest in IDbyDNA, Curematch, Inc., and Soluventis. All other 
      authors have no relationships to disclose.
EDAT- 2019/04/24 06:00
MHDA- 2019/07/11 06:00
CRDT- 2019/04/24 06:00
PHST- 2018/04/23 00:00 [received]
PHST- 2019/02/22 00:00 [accepted]
PHST- 2019/04/24 06:00 [pubmed]
PHST- 2019/07/11 06:00 [medline]
PHST- 2019/04/24 06:00 [entrez]
AID - 10.1038/s41591-019-0407-5 [pii]
AID - 10.1038/s41591-019-0407-5 [doi]
PST - ppublish
SO  - Nat Med. 2019 May;25(5):744-750. doi: 10.1038/s41591-019-0407-5. Epub 2019 Apr 
      22.

PMID- 28723019
STAT- Publisher
CTDT- 20230807
PB  - StatPearls Publishing
DP  - 2024 Jan
TI  - Wilson Disease.
BTI - StatPearls
AB  - Wilson disease or hepatolenticular degeneration is an autosomal recessive disease 
      which results in an excess copper build up in the body. It primarily affects the 
      liver and basal ganglia of the brain, but it can affect other organ systems too. 
      Symptoms usually are related to the brain and liver. Liver-related symptoms 
      include vomiting, weakness, ascites, swelling of the legs, yellowish skin, and 
      itchiness. Brain or neurological symptoms include tremors, muscle stiffness, 
      trouble speaking, personality changes, anxiety, and auditory or visual 
      hallucinations. Wilson disease is an autosomal recessive condition caused by a 
      mutation in the Wilson disease protein (ATP7B) gene. For a person to be 
      affected,  a copy of the gene from each parent need to be inherited. Diagnosis is 
      difficult and involves blood tests, urine tests, and a liver biopsy along with 
      the clinical evaluation. Genetic testing may be used to screen the family members 
      of those affected. The genetic defect is localized to long arm of chromosome 13 
      (13q), which has been shown to alter the copper transporting ATP gene in the 
      liver. The majority of patients with Wilson disease present within the first 
      decade of life with liver dysfunction. The neuropsychiatric features are seen in 
      the third/fourth decade of life. Wilson disease is rare but if not recognized and 
      treated, it is fatal.
CI  - Copyright © 2024, StatPearls Publishing LLC.
FAU - Chaudhry, Hammad S
AU  - Chaudhry HS
FAU - Anilkumar, Arayamparambil C
AU  - Anilkumar AC
AD  - SUNY Upstate Medical University
LA  - eng
PT  - Study Guide
PT  - Book Chapter
PL  - Treasure Island (FL)
COIS- Disclosure: Hammad Chaudhry declares no relevant financial relationships with 
      ineligible companies. Disclosure: Arayamparambil Anilkumar declares no relevant 
      financial relationships with ineligible companies.
EDAT- 2023/08/07 00:00
CRDT- 2023/08/07 00:00
AID - NBK441990 [bookaccession]

PMID- 36700653
OWN - NLM
STAT- MEDLINE
DCOM- 20230424
LR  - 20231201
IS  - 2379-5042 (Electronic)
IS  - 2379-5042 (Linking)
VI  - 8
IP  - 2
DP  - 2023 Apr 20
TI  - Virology under the Microscope-a Call for Rational Discourse.
PG  - e0003423
LID - 10.1128/msphere.00034-23 [doi]
LID - e00034-23
AB  - Viruses have brought humanity many challenges: respiratory infection, cancer, 
      neurological impairment and immunosuppression to name a few. Virology research 
      over the last 60+ years has responded to reduce this disease burden with vaccines 
      and antivirals. Despite this long history, the COVID-19 pandemic has brought 
      unprecedented attention to the field of virology. Some of this attention is 
      focused on concern about the safe conduct of research with human pathogens. A 
      small but vocal group of individuals has seized upon these concerns - conflating 
      legitimate questions about safely conducting virus-related research with 
      uncertainties over the origins of SARS-CoV-2. The result has fueled public 
      confusion and, in many instances, ill-informed condemnation of virology. With 
      this article, we seek to promote a return to rational discourse. We explain the 
      use of gain-of-function approaches in science, discuss the possible origins of 
      SARS-CoV-2 and outline current regulatory structures that provide oversight for 
      virological research in the United States. By offering our expertise, we - a 
      broad group of working virologists - seek to aid policy makers in navigating 
      these controversial issues. Balanced, evidence-based discourse is essential to 
      addressing public concern while maintaining and expanding much-needed research in 
      virology.
FAU - Goodrum, Felicia
AU  - Goodrum F
AUID- ORCID: 0000-0002-6646-7290
AD  - Department of Immunobiology, BIO5 Institute, University of Arizona, Tucson, 
      Arizona, USA.
FAU - Lowen, Anice C
AU  - Lowen AC
AUID- ORCID: 0000-0002-9829-112X
AD  - Department of Microbiology and Immunology, Emory University School of Medicine, 
      Atlanta, Georgia, USA.
FAU - Lakdawala, Seema
AU  - Lakdawala S
AUID- ORCID: 0000-0002-7679-2150
AD  - Department of Microbiology and Immunology, Emory University School of Medicine, 
      Atlanta, Georgia, USA.
FAU - Alwine, James
AU  - Alwine J
AD  - Department of Immunobiology, BIO5 Institute, University of Arizona, Tucson, 
      Arizona, USA.
AD  - Department of Cancer Biology, University of Pennsylvania, Philadelphia, 
      Pennsylvania, USA.
FAU - Casadevall, Arturo
AU  - Casadevall A
AUID- ORCID: 0000-0002-9402-9167
AD  - Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg 
      School of Public Health, Baltimore, Maryland, USA.
FAU - Imperiale, Michael J
AU  - Imperiale MJ
AD  - Department of Microbiology and Immunology, University of Michigan, Ann Arbor, 
      Michigan, USA.
FAU - Atwood, Walter
AU  - Atwood W
AUID- ORCID: 0000-0002-3763-9073
AD  - Brown University, Providence, Rhode Island, USA.
FAU - Avgousti, Daphne
AU  - Avgousti D
AD  - Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
FAU - Baines, Joel
AU  - Baines J
AUID- ORCID: 0000-0002-6397-2830
AD  - Cornell University, Ithaca, New York, USA.
FAU - Banfield, Bruce
AU  - Banfield B
AUID- ORCID: 0000-0002-5989-6695
AD  - Queen's University, Kingston, Ontario, Canada.
FAU - Banks, Lawrence
AU  - Banks L
AD  - International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
FAU - Bhaduri-McIntosh, Sumita
AU  - Bhaduri-McIntosh S
AUID- ORCID: 0000-0003-2946-9497
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Bhattacharya, Deepta
AU  - Bhattacharya D
AD  - University of Arizona, Tucson, Arizona, USA.
FAU - Blanco-Melo, Daniel
AU  - Blanco-Melo D
AD  - Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
FAU - Bloom, David
AU  - Bloom D
AUID- ORCID: 0000-0001-5935-8494
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Boon, Adrianus
AU  - Boon A
AUID- ORCID: 0000-0002-4700-8224
AD  - University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
FAU - Boulant, Steeve
AU  - Boulant S
AUID- ORCID: 0000-0001-8614-4993
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Brandt, Curtis
AU  - Brandt C
AD  - University of Wisconsin-Madison, Madison, Wisconsin, USA.
FAU - Broadbent, Andrew
AU  - Broadbent A
AUID- ORCID: 0000-0002-4716-1835
AD  - University of Maryland, College Park, Maryland, USA.
FAU - Brooke, Christopher
AU  - Brooke C
AUID- ORCID: 0000-0002-6815-1193
AD  - University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
FAU - Cameron, Craig
AU  - Cameron C
AD  - University of North Carolina, Chapel Hill, North Carolina, USA.
FAU - Campos, Samuel
AU  - Campos S
AUID- ORCID: 0000-0003-1540-9821
AD  - University of Arizona, Tucson, Arizona, USA.
FAU - Caposio, Patrizia
AU  - Caposio P
AUID- ORCID: 0000-0001-7579-849X
AD  - Oregon Health and Science University, Beaverton, Oregon, USA.
FAU - Chan, Gary
AU  - Chan G
AUID- ORCID: 0000-0001-8209-9777
AD  - SUNY Upstate Medical University, Syracuse, New York, USA.
FAU - Cliffe, Anna
AU  - Cliffe A
AUID- ORCID: 0000-0003-1136-5171
AD  - University of Virginia, Charlottesville, Virginia, USA.
FAU - Coffin, John
AU  - Coffin J
AD  - Tufts University, Boston, Massachusetts, USA.
FAU - Collins, Kathleen
AU  - Collins K
AD  - University of Michigan, Ann Arbor, Michigan, USA.
FAU - Damania, Blossom
AU  - Damania B
AUID- ORCID: 0000-0002-9205-1774
AD  - University of North Carolina, Chapel Hill, North Carolina, USA.
FAU - Daugherty, Matthew
AU  - Daugherty M
AD  - University of California, San Diego, La Jolla, California, USA.
FAU - Debbink, Kari
AU  - Debbink K
AD  - Johns Hopkins University, Baltimore, Maryland, USA.
FAU - DeCaprio, James
AU  - DeCaprio J
AUID- ORCID: 0000-0002-0896-167X
AD  - Harvard Medical School, Boston, Massachusetts, USA.
FAU - Dermody, Terence
AU  - Dermody T
AUID- ORCID: 0000-0003-1853-8741
AD  - University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
FAU - Dikeakos, Jimmy
AU  - Dikeakos J
AUID- ORCID: 0000-0001-8141-5395
AD  - Western University, London, Ontario, Canada.
FAU - DiMaio, Daniel
AU  - DiMaio D
AUID- ORCID: 0000-0002-2060-5977
AD  - Yale University, New Haven, Connecticut, USA.
FAU - Dinglasan, Rhoel
AU  - Dinglasan R
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Duprex, W Paul
AU  - Duprex WP
AUID- ORCID: 0000-0003-1716-6376
AD  - University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
FAU - Dutch, Rebecca
AU  - Dutch R
AUID- ORCID: 0000-0002-5220-8247
AD  - University of Kentucky, Lexington, Kentucky, USA.
FAU - Elde, Nels
AU  - Elde N
AD  - University of Utah, Salt Lake City, Utah, USA.
FAU - Emerman, Michael
AU  - Emerman M
AUID- ORCID: 0000-0002-4181-6335
AD  - Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
FAU - Enquist, Lynn
AU  - Enquist L
AUID- ORCID: 0000-0001-9968-8586
AD  - Princeton University, Princeton, New Jersey, USA.
FAU - Fane, Bentley
AU  - Fane B
AUID- ORCID: 0000-0002-3984-1726
AD  - University of Arizona, Tucson, Arizona, USA.
FAU - Fernandez-Sesma, Ana
AU  - Fernandez-Sesma A
AD  - Icahn School of Medicine at Mount Sinai, New York, New York, USA.
FAU - Flenniken, Michelle
AU  - Flenniken M
AD  - Montana State University, Bozeman, Montana, USA.
FAU - Frappier, Lori
AU  - Frappier L
AUID- ORCID: 0000-0003-0110-5472
AD  - University of Toronto, Toronto, Ontario, Canada.
FAU - Frieman, Matthew
AU  - Frieman M
AUID- ORCID: 0000-0003-0107-0775
AD  - University of Maryland, College Park, Maryland, USA.
FAU - Frueh, Klaus
AU  - Frueh K
AD  - Oregon Health and Science University, Beaverton, Oregon, USA.
FAU - Gack, Michaela
AU  - Gack M
AUID- ORCID: 0000-0002-2163-2598
AD  - Florida Research and Innovation Center, Port Saint Lucie, Florida, USA.
FAU - Gaglia, Marta
AU  - Gaglia M
AUID- ORCID: 0000-0002-1791-0663
AD  - University of Wisconsin-Madison, Madison, Wisconsin, USA.
FAU - Gallagher, Tom
AU  - Gallagher T
AUID- ORCID: 0000-0002-8601-5961
AD  - Loyola University, Maywood, Illinois, USA.
FAU - Galloway, Denise
AU  - Galloway D
AD  - Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
FAU - García-Sastre, Adolfo
AU  - García-Sastre A
AUID- ORCID: 0000-0002-6551-1827
AD  - Icahn School of Medicine at Mount Sinai, New York, New York, USA.
FAU - Geballe, Adam
AU  - Geballe A
AUID- ORCID: 0000-0002-9279-6653
AD  - Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
FAU - Glaunsinger, Britt
AU  - Glaunsinger B
AUID- ORCID: 0000-0003-0479-9377
AD  - University of California, Berkeley, Berkeley, California, USA.
FAU - Goff, Stephen
AU  - Goff S
AUID- ORCID: 0000-0002-9679-0582
AD  - Columbia University, New York, New York, USA.
FAU - Greninger, Alexander
AU  - Greninger A
AUID- ORCID: 0000-0002-7443-0527
AD  - University of Washington, Seattle, Washington, USA.
FAU - Hancock, Meaghan
AU  - Hancock M
AUID- ORCID: 0000-0003-2945-0147
AD  - Oregon Health and Science University, Beaverton, Oregon, USA.
FAU - Harris, Eva
AU  - Harris E
AUID- ORCID: 0000-0002-7238-4037
AD  - University of California, Berkeley, Berkeley, California, USA.
FAU - Heaton, Nicholas
AU  - Heaton N
AUID- ORCID: 0000-0002-5307-3428
AD  - Duke University, Durham, North Carolina, USA.
FAU - Heise, Mark
AU  - Heise M
AUID- ORCID: 0000-0001-5829-8477
AD  - University of North Carolina, Chapel Hill, North Carolina, USA.
FAU - Heldwein, Ekaterina
AU  - Heldwein E
AUID- ORCID: 0000-0003-3113-6958
AD  - Tufts University, Boston, Massachusetts, USA.
FAU - Hogue, Brenda
AU  - Hogue B
AD  - Arizona State University, Tempe, Arizona, USA.
FAU - Horner, Stacy
AU  - Horner S
AUID- ORCID: 0000-0002-9351-7409
AD  - Duke University, Durham, North Carolina, USA.
FAU - Hutchinson, Edward
AU  - Hutchinson E
AD  - MRC-University of Glasgow, Glasgow, United Kingdom.
FAU - Hyser, Joseph
AU  - Hyser J
AD  - Baylor University, Houston, Texas, USA.
FAU - Jackson, William
AU  - Jackson W
AUID- ORCID: 0000-0002-9832-0584
AD  - Arizona State University, Tempe, Arizona, USA.
FAU - Kalejta, Robert
AU  - Kalejta R
AUID- ORCID: 0000-0002-7116-3355
AD  - Duke University, Durham, North Carolina, USA.
FAU - Kamil, Jeremy
AU  - Kamil J
AUID- ORCID: 0000-0001-8422-7656
AD  - Louisiana State University, Shreveport, Louisiana, USA.
FAU - Karst, Stephanie
AU  - Karst S
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Kirchhoff, Frank
AU  - Kirchhoff F
AUID- ORCID: 0000-0002-7052-2360
AD  - Ulm University, Ulm, Germany.
FAU - Knipe, David
AU  - Knipe D
AUID- ORCID: 0000-0003-1554-6236
AD  - Harvard Medical School, Boston, Massachusetts, USA.
FAU - Kowalik, Timothy
AU  - Kowalik T
AD  - University of Massachusetts, Worcester, Massachusetts, USA.
FAU - Lagunoff, Michael
AU  - Lagunoff M
AD  - University of Washington, Seattle, Washington, USA.
FAU - Laimins, Laimonis
AU  - Laimins L
AUID- ORCID: 0000-0002-6314-623X
AD  - Northwestern University, Chicago, Illinois, USA.
FAU - Langlois, Ryan
AU  - Langlois R
AD  - University of Minnesota, Minneapolis, Minnesota, USA.
FAU - Lauring, Adam
AU  - Lauring A
AD  - University of Michigan, Ann Arbor, Michigan, USA.
FAU - Lee, Benhur
AU  - Lee B
AUID- ORCID: 0000-0003-0760-1709
AD  - Icahn School of Medicine at Mount Sinai, New York, New York, USA.
FAU - Leib, David
AU  - Leib D
AD  - Dartmouth College, Lebanon, New Hampshire, USA.
FAU - Liu, Shan-Lu
AU  - Liu SL
AUID- ORCID: 0000-0003-1620-3817
AD  - The Ohio State University, Columbus, Ohio, USA.
FAU - Longnecker, Richard
AU  - Longnecker R
AUID- ORCID: 0000-0001-7175-6217
AD  - Northwestern University, Chicago, Illinois, USA.
FAU - Lopez, Carolina
AU  - Lopez C
AUID- ORCID: 0000-0002-7669-6572
AD  - Washington University, St. Louis, Missouri, USA.
FAU - Luftig, Micah
AU  - Luftig M
AUID- ORCID: 0000-0002-2964-1907
AD  - Duke University, Durham, North Carolina, USA.
FAU - Lund, Jennifer
AU  - Lund J
AUID- ORCID: 0000-0003-3284-979X
AD  - Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
FAU - Manicassamy, Balaji
AU  - Manicassamy B
AUID- ORCID: 0000-0003-1964-0967
AD  - University of Iowa, Iowa City, Iowa, USA.
FAU - McFadden, Grant
AU  - McFadden G
AUID- ORCID: 0000-0002-2556-3526
AD  - Arizona State University, Tempe, Arizona, USA.
FAU - McIntosh, Michael
AU  - McIntosh M
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Mehle, Andrew
AU  - Mehle A
AUID- ORCID: 0000-0001-6060-4330
AD  - University of Wisconsin-Madison, Madison, Wisconsin, USA.
FAU - Miller, W Allen
AU  - Miller WA
AUID- ORCID: 0000-0003-0603-2751
AD  - Iowa State University, Ames, Iowa, USA.
FAU - Mohr, Ian
AU  - Mohr I
AD  - New York University, New York, New York, USA.
FAU - Moody, Cary
AU  - Moody C
AUID- ORCID: 0000-0002-1991-0640
AD  - University of North Carolina, Chapel Hill, North Carolina, USA.
FAU - Moorman, Nathaniel
AU  - Moorman N
AD  - University of North Carolina, Chapel Hill, North Carolina, USA.
FAU - Moscona, Anne
AU  - Moscona A
AUID- ORCID: 0000-0002-1796-8320
AD  - Columbia University, New York, New York, USA.
FAU - Mounce, Bryan
AU  - Mounce B
AUID- ORCID: 0000-0003-1710-5362
AD  - Loyola University, Maywood, Illinois, USA.
FAU - Munger, Joshua
AU  - Munger J
AUID- ORCID: 0000-0001-5379-9440
AD  - University of Rochester, Rochester, New York, USA.
FAU - Münger, Karl
AU  - Münger K
AD  - Tufts University, Boston, Massachusetts, USA.
FAU - Murphy, Eain
AU  - Murphy E
AUID- ORCID: 0000-0003-3449-5024
AD  - SUNY Upstate Medical University, Syracuse, New York, USA.
FAU - Naghavi, Mojgan
AU  - Naghavi M
AD  - Northwestern University, Chicago, Illinois, USA.
FAU - Nelson, Jay
AU  - Nelson J
AD  - Oregon Health and Science University, Beaverton, Oregon, USA.
FAU - Neufeldt, Christopher
AU  - Neufeldt C
AD  - Emory University, Atlanta, Georgia, USA.
FAU - Nikolich, Janko
AU  - Nikolich J
AD  - University of Arizona, Tucson, Arizona, USA.
FAU - O'Connor, Christine
AU  - O'Connor C
AUID- ORCID: 0000-0003-4943-3774
AD  - Cleveland Clinic, Cleveland, Ohio, USA.
FAU - Ono, Akira
AU  - Ono A
AUID- ORCID: 0000-0001-7841-851X
AD  - University of Michigan, Ann Arbor, Michigan, USA.
FAU - Orenstein, Walter
AU  - Orenstein W
AD  - Emory University, Atlanta, Georgia, USA.
FAU - Ornelles, David
AU  - Ornelles D
AD  - Wake Forest University, Winston-Salem, North Carolina, USA.
FAU - Ou, Jing-Hsiung
AU  - Ou JH
AUID- ORCID: 0000-0002-8274-5705
AD  - University of Southern California, Los Angeles, California, USA.
FAU - Parker, John
AU  - Parker J
AUID- ORCID: 0000-0003-4487-4175
AD  - Cornell University, Ithaca, New York, USA.
FAU - Parrish, Colin
AU  - Parrish C
AUID- ORCID: 0000-0002-1836-6655
AD  - Cornell University, Ithaca, New York, USA.
FAU - Pekosz, Andrew
AU  - Pekosz A
AUID- ORCID: 0000-0003-3248-1761
AD  - Johns Hopkins University, Baltimore, Maryland, USA.
FAU - Pellett, Philip
AU  - Pellett P
AUID- ORCID: 0000-0002-8536-8343
AD  - Wayne State University, Detroit, Michigan, USA.
FAU - Pfeiffer, Julie
AU  - Pfeiffer J
AUID- ORCID: 0000-0003-2973-4895
AD  - University of Texas, Dallas, Texas, USA.
FAU - Plemper, Richard
AU  - Plemper R
AD  - Georgia State University, Atlanta, Georgia, USA.
FAU - Polyak, Stephen
AU  - Polyak S
AUID- ORCID: 0000-0001-7475-9827
AD  - University of Washington, Seattle, Washington, USA.
FAU - Purdy, John
AU  - Purdy J
AUID- ORCID: 0000-0001-7460-7567
AD  - University of Arizona, Tucson, Arizona, USA.
FAU - Pyeon, Dohun
AU  - Pyeon D
AUID- ORCID: 0000-0003-1970-844X
AD  - Michigan State University, East Lansing, Michigan, USA.
FAU - Quinones-Mateu, Miguel
AU  - Quinones-Mateu M
AD  - Western University, London, Ontario, Canada.
FAU - Renne, Rolf
AU  - Renne R
AUID- ORCID: 0000-0001-7391-8806
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Rice, Charles
AU  - Rice C
AD  - The Rockefeller University, New York, New York, USA.
FAU - Schoggins, John
AU  - Schoggins J
AUID- ORCID: 0000-0002-7944-6800
AD  - University of Texas, Dallas, Texas, USA.
FAU - Roller, Richard
AU  - Roller R
AUID- ORCID: 0000-0001-8340-3224
AD  - University of Iowa, Iowa City, Iowa, USA.
FAU - Russell, Charles
AU  - Russell C
AUID- ORCID: 0000-0001-5683-3990
AD  - St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
FAU - Sandri-Goldin, Rozanne
AU  - Sandri-Goldin R
AD  - University of California, Irvine, Irvine, California, USA.
FAU - Sapp, Martin
AU  - Sapp M
AUID- ORCID: 0000-0003-3916-8890
AD  - Louisiana State University, Shreveport, Louisiana, USA.
FAU - Schang, Luis
AU  - Schang L
AUID- ORCID: 0000-0002-5789-8590
AD  - Cornell University, Ithaca, New York, USA.
FAU - Schmid, Scott
AU  - Schmid S
AD  - University of Colorado, Boulder, Colorado, USA.
FAU - Schultz-Cherry, Stacey
AU  - Schultz-Cherry S
AUID- ORCID: 0000-0002-2021-727X
AD  - St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
FAU - Semler, Bert
AU  - Semler B
AUID- ORCID: 0000-0002-2424-5155
AD  - University of California, Irvine, Irvine, California, USA.
FAU - Shenk, Thomas
AU  - Shenk T
AD  - Princeton University, Princeton, New Jersey, USA.
FAU - Silvestri, Guido
AU  - Silvestri G
AD  - University of Kentucky, Lexington, Kentucky, USA.
FAU - Simon, Viviana
AU  - Simon V
AD  - Icahn School of Medicine at Mount Sinai, New York, New York, USA.
FAU - Smith, Gregory
AU  - Smith G
AUID- ORCID: 0000-0001-9644-8472
AD  - Northwestern University, Chicago, Illinois, USA.
FAU - Smith, Jason
AU  - Smith J
AUID- ORCID: 0000-0001-6727-5269
AD  - University of Washington, Seattle, Washington, USA.
FAU - Spindler, Katherine
AU  - Spindler K
AUID- ORCID: 0000-0002-9829-6051
AD  - University of Minnesota, Minneapolis, Minnesota, USA.
FAU - Stanifer, Megan
AU  - Stanifer M
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Subbarao, Kanta
AU  - Subbarao K
AUID- ORCID: 0000-0003-1713-3056
AD  - The Peter Doherty Institute, Melbourne, Victoria, Australia.
FAU - Sundquist, Wesley
AU  - Sundquist W
AD  - University of Utah, Salt Lake City, Utah, USA.
FAU - Suthar, Mehul
AU  - Suthar M
AUID- ORCID: 0000-0002-2686-8380
AD  - Emory University, Atlanta, Georgia, USA.
FAU - Sutton, Troy
AU  - Sutton T
AUID- ORCID: 0000-0002-7880-4784
AD  - The Pennsylvania State University, University Park, Pennsylvania, USA.
FAU - Tai, Andrew
AU  - Tai A
AUID- ORCID: 0000-0002-6877-450X
AD  - University of Michigan, Ann Arbor, Michigan, USA.
FAU - Tarakanova, Vera
AU  - Tarakanova V
AUID- ORCID: 0000-0002-9499-088X
AD  - Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
FAU - tenOever, Benjamin
AU  - tenOever B
AUID- ORCID: 0000-0003-0324-3078
AD  - New York University, New York, New York, USA.
FAU - Tibbetts, Scott
AU  - Tibbetts S
AUID- ORCID: 0000-0001-8889-1642
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Tompkins, Stephen
AU  - Tompkins S
AUID- ORCID: 0000-0002-1523-5588
AD  - University of Georgia, Athens, Georgia, USA.
FAU - Toth, Zsolt
AU  - Toth Z
AUID- ORCID: 0000-0001-6628-3945
AD  - University of Florida, Gainesville, Florida, USA.
FAU - van Doorslaer, Koenraad
AU  - van Doorslaer K
AUID- ORCID: 0000-0002-2985-0733
AD  - University of Arizona, Tucson, Arizona, USA.
FAU - Vignuzzi, Marco
AU  - Vignuzzi M
AD  - A*STAR Infectious Diseases Labs, Singapore.
FAU - Wallace, Nicholas
AU  - Wallace N
AUID- ORCID: 0000-0002-3971-716X
AD  - Kansas State University, Manhattan, Kansas, USA.
FAU - Walsh, Derek
AU  - Walsh D
AUID- ORCID: 0000-0002-8756-4655
AD  - Northwestern University, Chicago, Illinois, USA.
FAU - Weekes, Michael
AU  - Weekes M
AD  - University of Cambridge, Cambridge, United Kingdom.
FAU - Weinberg, Jason
AU  - Weinberg J
AUID- ORCID: 0000-0002-4768-4361
AD  - University of Michigan, Ann Arbor, Michigan, USA.
FAU - Weitzman, Matthew
AU  - Weitzman M
AUID- ORCID: 0000-0001-9713-167X
AD  - University of Pennsylvania, Philadelphia, Pennsylvania, USA.
FAU - Weller, Sandra
AU  - Weller S
AUID- ORCID: 0000-0002-4519-6276
AD  - University of Connecticut, Farmington, Connecticut, USA.
FAU - Whelan, Sean
AU  - Whelan S
AUID- ORCID: 0000-0003-1564-8590
AD  - Washington University, St. Louis, Missouri, USA.
FAU - White, Elizabeth
AU  - White E
AUID- ORCID: 0000-0001-7378-7690
AD  - University of Pennsylvania, Philadelphia, Pennsylvania, USA.
FAU - Williams, Bryan
AU  - Williams B
AD  - Monash University, Clayton, Victoria, Australia.
FAU - Wobus, Christiane
AU  - Wobus C
AUID- ORCID: 0000-0001-5286-0924
AD  - University of Michigan, Ann Arbor, Michigan, USA.
FAU - Wong, Scott
AU  - Wong S
AD  - Oregon Health and Science University, Beaverton, Oregon, USA.
FAU - Yurochko, Andrew
AU  - Yurochko A
AUID- ORCID: 0000-0002-6452-5813
AD  - Louisiana State University, Shreveport, Louisiana, USA.
LA  - eng
GR  - R35 GM133633/GM/NIGMS NIH HHS/United States
GR  - P30 CA086862/CA/NCI NIH HHS/United States
GR  - R01 AI152543/AI/NIAID NIH HHS/United States
GR  - R01 AI073898/AI/NIAID NIH HHS/United States
GR  - P01 CA214091/CA/NCI NIH HHS/United States
GR  - P51 OD011132/OD/NIH HHS/United States
GR  - R01 GM056927/GM/NIGMS NIH HHS/United States
PT  - Journal Article
DEP - 20230126
PL  - United States
TA  - mSphere
JT  - mSphere
JID - 101674533
RN  - 0 (Antiviral Agents)
SB  - IM
MH  - Humans
MH  - *COVID-19/prevention & control
MH  - SARS-CoV-2
MH  - Pandemics/prevention & control
MH  - *Viruses
MH  - Antiviral Agents
PMC - PMC10117089
OTO - NOTNLM
OT  - COVID-19
OT  - Coronavirus
OT  - DURC
OT  - Gain of function
OT  - SARS-CoV-2
OT  - biosafety
OT  - influenza
OT  - pandemic
OT  - vaccines
OT  - zoonosis
COIS- The authors declare a conflict of interest. Sana Biotechnology has licensed 
      intellectual property of D.B. and Washington University in St. Louis. Gilead 
      Sciences has licensed intellectual property of D.B. and Stanford University. D.B. 
      is a co-founder of Clade Therapeutics. D.B. previously served on an advisory 
      panel for GlaxoSmithKline. D.B. and The University of Arizona hold a patent on 
      SARS-CoV-2 serological assays. K.C. is a special government employee and a member 
      of the Office of AIDS Research Advisory Committee. T.S.D.: Board of Directors, 
      Burroughs Wellcome Fund; Editor, Annual Review of Virology. D.D. is on the 
      scientific advisory board of Theriva. W.P.D. receives support from Moderna. M. F. 
      receives funding from National Institute of Allergy and Infectious Diseases 
      (NIAID), Biomedical Advanced Research and Development Authority (BARDA), Defense 
      Advanced Research Projects Agency (DARPA), Gates Foundation, Aikido Pharma, 
      Emergent, Astrazeneca, Novavax, Regeneron, and the CDC, outside the submitted 
      work. M. F. received royalties/licenses from Aikido Pharma for antiviral drug 
      patent licensing, consulting fees from Aikido Pharma, Observatory Group, for 
      consulting for COVID-19, and participation on Scientific Advisory Board for 
      Aikido Pharma, outside the submitted work. K.F. has substantial financial 
      interest in Vir Biotechnology, Inc., and is a co-founder of the company. K.F. is 
      co-inventor of patents licensed to Vir and receives compensation for consulting 
      for Vir. The potential conflicts of interest have been reviewed and managed by 
      OHSU. D.G. is on the HPV Global Advisory Board for Merck. The A.G.-S. laboratory 
      has received research support from GSK, Pfizer, Senhwa Biosciences, Kenall 
      Manufacturing, Blade Therapeutics, Avimex, Johnson & Johnson, Dynavax, 7Hills 
      Pharma, Pharmamar, ImmunityBio, Accurius, Nanocomposix, Hexamer, N-fold LLC, 
      Model Medicines, Atea Pharma, Applied Biological Laboratories and Merck. A.G.-S. 
      has consulting agreements for the following companies involving cash and/or 
      stock: Castlevax, Amovir, Vivaldi Biosciences, Contrafect, 7Hills Pharma, Avimex, 
      Pagoda, Accurius, Esperovax, Farmak, Applied Biological Laboratories, Pharmamar, 
      CureLab Oncology, CureLab Veterinary, Synairgen and Pfizer. A.G.-S. has been an 
      invited speaker in meeting events organized by Seqirus, Janssen, Abbott and 
      Astrazeneca. A.G.-S. is inventor on patents and patent applications on the use of 
      antivirals and vaccines for the treatment and prevention of virus infections and 
      cancer, owned by the Icahn School of Medicine at Mount Sinai, New York. B.A.G. is 
      on the scientific advisory board for IMUNON. A.L.G. reports central testing 
      contracts from Pfizer, Janssen, Novavax, Sanofi, Abbott, Hologic, Cepheid, and 
      Quidel, and research support from Gilead. E.E.H. is co-founder of Thyreos Inc. 
      E.C.H. has carried out research work in collaboration with AstraZeneca and 
      received honoraria for consultancy work for the Center for Open Science and 
      Seqirus. M.J.I. consults for Gilead Sciences and Via Nova Therapeutics. D.M.K. is 
      a consultant, Replay Bio. T.K. receives funding from Moderna related to CMV. 
      A.S.L. is a paid member of steering committee for clinical trial of baloxavir 
      (Roche). A.C.L. is an inventor on the patent Influenza Vaccines and Uses Thereof, 
      owned by the Icahn School of Medicine at Mount Sinai. G.M. is co-founder of a 
      biotech company devoted to oncolytic virotherapy. W.A.M. is co-inventor of a 
      pending patent application on improved mRNA vaccines. A. Moscona is scientific 
      founder of Thylacine Biotherapeutics, a startup company for antiviral 
      therapeutics. J.A.N., Vir Biotechnology. W.A.O., uncompensated member, Moderna 
      Scientific Advisory Board. D.A.O., Defense Threat Reduction Agency. L.M.S. is a 
      virologist performing research on potential antivirals. L.M.S. is the 
      president-elect of the International Society for Antiviral Research, the 
      membership of which includes people working in companies working on antivirals. 
      L.M.S. has performed paid and non-paid consultantships with private companies 
      developing antivirals or virucidals. L.M.S. is a founder member of a start-up 
      company that had an interest in antivirals. L.M.S. has received funding to work 
      on antivirals. S.S. is Contract Consultant for Curevo Vaccines. J.W.S. consults 
      for the Federal Trade Commission on matters related to COVID-19. The Icahn School 
      of Medicine at Mount Sinai has filed patent applications relating to SARS-CoV-2 
      serological assays which list V.S. as co-inventor. G.A.S. is President of 
      Thyreos, Inc. M.S.S. serves an advisory role with Moderna and Ocugen. S.K.W. is 
      co-founder of startup Quercus Molecular Design. C.M.R.: Founder, Apath LLC; 
      Advisor, SAB, and Research Support, Vir Biotechnology; Research support, GSK; SAB 
      Invisishield; SAB Arbutus. C.R.B. is consultant for Ocular Services On Demand 
      (OSOD) located in Madison, WI, and a collaborator with Amebagone a small biotech 
      company in Madison, Wisconsin. C.R.B. has no financial interest in Amebagone and 
      is not owner or part owner of OSOD. All other authors report no conflicts of 
      interest.
EDAT- 2023/01/27 06:00
MHDA- 2023/04/24 06:42
CRDT- 2023/01/26 09:04
PHST- 2023/04/24 06:42 [medline]
PHST- 2023/01/27 06:00 [pubmed]
PHST- 2023/01/26 09:04 [entrez]
AID - 00034-23 [pii]
AID - msphere.00034-23 [pii]
AID - 10.1128/msphere.00034-23 [doi]
PST - ppublish
SO  - mSphere. 2023 Apr 20;8(2):e0003423. doi: 10.1128/msphere.00034-23. Epub 2023 Jan 
      26.

PMID- 36977797
OWN - NLM
STAT- MEDLINE
DCOM- 20230705
LR  - 20230713
IS  - 1759-4820 (Electronic)
IS  - 1759-4812 (Linking)
VI  - 20
IP  - 7
DP  - 2023 Jul
TI  - Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower 
      tract and metastatic disease.
PG  - 406-419
LID - 10.1038/s41585-023-00725-2 [doi]
AB  - Precision medicine has transformed the way urothelial carcinoma is managed. 
      However, current practices are limited by the availability of tissue samples for 
      genomic profiling and the spatial and temporal molecular heterogeneity observed 
      in many studies. Among rapidly advancing genomic sequencing technologies, 
      non-invasive liquid biopsy has emerged as a promising diagnostic tool to 
      reproduce tumour genomics, and has shown potential to be integrated in several 
      aspects of clinical care. In urothelial carcinoma, liquid biopsies such as plasma 
      circulating tumour DNA (ctDNA) and urinary tumour DNA (utDNA) have been 
      investigated as a surrogates for tumour biopsies and might bridge many shortfalls 
      currently faced by clinicians. Both ctDNA and utDNA seem really promising in 
      urothelial carcinoma diagnosis, staging and prognosis, response to therapy 
      monitoring, detection of minimal residual disease and surveillance. The use of 
      liquid biopsies in patients with urothelial carcinoma could further advance 
      precision medicine in this population, facilitating personalized patient 
      monitoring through non-invasive assays.
CI  - © 2023. Springer Nature Limited.
FAU - Rose, Kyle M
AU  - Rose KM
AUID- ORCID: 0000-0001-7728-1144
AD  - Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, 
      USA.
FAU - Huelster, Heather L
AU  - Huelster HL
AUID- ORCID: 0000-0001-5411-3148
AD  - Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, 
      USA.
FAU - Meeks, Joshua J
AU  - Meeks JJ
AD  - Department of Urology, Northwestern University, Chicago, IL, USA.
FAU - Faltas, Bishoy M
AU  - Faltas BM
AD  - Department of Hematology/Oncology, Weill-Cornell Medicine, New York, NY, USA.
FAU - Sonpavde, Guru P
AU  - Sonpavde GP
AUID- ORCID: 0000-0002-1010-9611
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
FAU - Lerner, Seth P
AU  - Lerner SP
AD  - Department of Urology, Baylor College of Medicine, Houston, TX, USA.
FAU - Ross, Jeffrey S
AU  - Ross JS
AD  - Foundation Medicine, Inc, Cambridge, MA, USA.
AD  - Departments of Urology and Pathology, Upstate Medical University, Syracuse, NY, 
      USA.
FAU - Spiess, Philippe E
AU  - Spiess PE
AD  - Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, 
      USA.
AD  - Department of Radiation Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
FAU - Grass, G Daniel
AU  - Grass GD
AD  - Department of Radiation Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
FAU - Jain, Rohit K
AU  - Jain RK
AD  - Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, 
      USA.
FAU - Kamat, Ashish M
AU  - Kamat AM
AUID- ORCID: 0000-0003-3546-9928
AD  - Department of Urology, MD Anderson Cancer Center, Houston, TX, USA.
FAU - Vosoughi, Aram
AU  - Vosoughi A
AD  - Department of Anatomic Pathology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
FAU - Wang, Liang
AU  - Wang L
AD  - Department of Tumour Biology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
FAU - Wang, Xuefeng
AU  - Wang X
AUID- ORCID: 0000-0001-5775-408X
AD  - Department of Biostatistics/Bioinformatics, H. Lee Moffitt Cancer Center, Tampa, 
      FL, USA.
FAU - Li, Roger
AU  - Li R
AUID- ORCID: 0000-0003-1274-7200
AD  - Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, 
      USA. Roger.Li@moffit.org.
AD  - Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, FL, USA. 
      Roger.Li@moffit.org.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20230328
PL  - England
TA  - Nat Rev Urol
JT  - Nature reviews. Urology
JID - 101500082
RN  - 0 (DNA, Neoplasm)
RN  - 0 (Circulating Tumor DNA)
RN  - 0 (Biomarkers, Tumor)
SB  - IM
EIN - Nat Rev Urol. 2023 May 22;:. PMID: 37217696
MH  - Humans
MH  - *Urinary Bladder Neoplasms/diagnosis/genetics/pathology
MH  - *Carcinoma, Transitional Cell/diagnosis/genetics
MH  - DNA, Neoplasm/genetics
MH  - *Urologic Neoplasms/diagnosis/genetics
MH  - *Circulating Tumor DNA/genetics
MH  - Biomarkers, Tumor/genetics
EDAT- 2023/03/29 06:00
MHDA- 2023/07/05 06:42
CRDT- 2023/03/28 23:22
PHST- 2023/01/11 00:00 [accepted]
PHST- 2023/07/05 06:42 [medline]
PHST- 2023/03/29 06:00 [pubmed]
PHST- 2023/03/28 23:22 [entrez]
AID - 10.1038/s41585-023-00725-2 [pii]
AID - 10.1038/s41585-023-00725-2 [doi]
PST - ppublish
SO  - Nat Rev Urol. 2023 Jul;20(7):406-419. doi: 10.1038/s41585-023-00725-2. Epub 2023 
      Mar 28.

PMID- 25905360
STAT- Publisher
CTDT- 20180505
PB  - MDText.com, Inc.
DP  - 2000
TI  - Hypoglycemia.
BTI - Endotext
AB  - Hypoglycemia is uncommon in people who are not being treated for diabetes 
      mellitus. Low blood glucose concentrations lead to adrenergic activation and 
      neuroglycopenia (Table 1). Symptomatic hypoglycemia is diagnosed clinically using 
      Whipple’s triad: symptoms of hypoglycemia, plasma glucose concentration<55 mg/dl 
      (3.0 mmol/l), and resolution of those symptoms after the plasma glucose 
      concentration is raised. Capillary blood glucose measurements should not be used 
      in the evaluation of hypoglycemia due to poor accuracy.
CI  - Copyright © 2000-2024, MDText.com, Inc.
FED - Feingold, Kenneth R
ED  - Feingold KR
AD  - Professor of Medicine Emeritus, University of California, San Francisco, CA
FED - Anawalt, Bradley
ED  - Anawalt B
AD  - Chief of Medicine at the University of Washington Medical Center and Professor 
      and Vice Chair of the Department of Medicine, University of Washington
FED - Blackman, Marc R
ED  - Blackman MR
AD  - Sr. Physician Scientist, Washington DC VA Medical Center; Professor of Medicine & 
      Rehabilitation Medicine, Georgetown University; Clinical Professor of Medicine, 
      Biochemistry and Molecular Medicine, George Washington University; and Professor 
      of Medicine (Part-time), Johns Hopkins University
FED - Boyce, Alison
ED  - Boyce A
AD  - Pediatric Endocrinologist and Associate Research Physician in the Skeletal 
      Diseases and Mineral Homeostasis Section, National Institute of Dental and 
      Craniofacial Research, National Institutes of Health
FED - Chrousos, George
ED  - Chrousos G
AD  - Professor of Pediatrics and Endocrinology, Division of Endocrinology, Metabolism 
      and Diabetes, First Department of Pediatrics, National and Kapodistrian 
      University of Athens Medical School, "Aghia Sophia" Children's Hospital, Athens, 
      Greece
FED - Corpas, Emiliano
ED  - Corpas E
AD  - M.D. Ph.D in Gerontology. Honorary Professor of Medicine, Universidad de Alcalá, 
      Madrid. Consultant in Endocrinology, Hospital HLA Guadalajara (Spain).
FED - de Herder, Wouter W
ED  - de Herder WW
AD  - Professor of Endocrine Oncology, Erasmus MC and Erasmus MC Cancer Center, 
      Rotterdam, the Netherlands
FED - Dhatariya, Ketan
ED  - Dhatariya K
AD  - Consultant in Diabetes, Endocrinology and General Medicine, Norfolk and Norwich 
      University Hospitals NHS Foundation Trust and University of East Anglia, Norwich, 
      UK.
FED - Dungan, Kathleen
ED  - Dungan K
AD  - Professor of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Ohio 
      State University
FED - Hofland, Johannes
ED  - Hofland J
AD  - Consultant Endocrinologist, Erasmus MC and Erasmus MC Cancer Center, Rotterdam, 
      the Netherlands
FED - Kalra, Sanjay
ED  - Kalra S
AD  - Consultant Endocrinologist, Department of Endocrinology, Bharti Hospital, Karnal, 
      India
FED - Kaltsas, Gregory
ED  - Kaltsas G
AD  - Professor of General Medicine-Endocrinology, 1st Department of Propaedeutic 
      Medicine, National and Kapodistrian University of Athens, Athens, Greece
FED - Kapoor, Nitin
ED  - Kapoor N
AD  - Professor of Endocrinology, Department of Endocrinology, Diabetes and Metabolism, 
      Christian Medical College & Hospital, Vellore, Tamil Nadu, India, Melbourne 
      School of Population and Global Health, Faculty of Medicine, Dentistry and Health 
      Science, The University of Melbourne, Australia.
FED - Koch, Christian
ED  - Koch C
AD  - Professor, The University of Tennessee Health Science Center, Memphis, Tennessee
FED - Kopp, Peter
ED  - Kopp P
AD  - Professor of Medicine and Chief of the Division of Endocrinology, Diabetology and 
      Metabolism, University of Lausanne, Switzerland
FED - Korbonits, Márta
ED  - Korbonits M
AD  - Professor of Endocrinology and Metabolism, Centre Lead for Endocrinology and 
      Deputy Institute Director, William Harvey Research Institute, Barts and the 
      London School of Medicine and Dentistry, Queen Mary University of London, London, 
      England
FED - Kovacs, Christopher S
ED  - Kovacs CS
AD  - University Research Professor and Professor of Medicine (Endocrinology and 
      Metabolism), Obstetrics & Gynecology, and BioMedical Sciences, at Memorial 
      University of Newfoundland in St. John’s, Newfoundland, Canada.
FED - Kuohung, Wendy
ED  - Kuohung W
AD  - Director of the Division of Reproductive Endocrinology at Boston Medical Center 
      and an Associate Professor of Obstetrics and Gynecology at the Boston University 
      School of Medicine
FED - Laferrère, Blandine
ED  - Laferrère B
AD  - Professor of Medicine, New York Nutrition Obesity Research Center, Division of 
      Endocrinology, Department of Medicine, Columbia University Irving Medical Center, 
      New York, NY, USA.
FED - Levy, Miles
ED  - Levy M
AD  - Consultant endocrinologist at University Hospitals of Leicester and Honorary 
      Associate Professor at Leicester University
FED - McGee, Elizabeth A
ED  - McGee EA
AD  - Professor of Obstetrics and Gynecology at the University of Vermont and Director 
      of the Division of Reproductive Endocrinology and Infertility. Burlington, 
      Vermont
FED - McLachlan, Robert
ED  - McLachlan R
AD  - Director of Clinical Research, Hudson Institute of Medical Research; Consultant 
      Endocrinologist, Monash Medical Centre, Melbourne, Australia
FED - New, Maria
ED  - New M
AD  - Professor of Pediatrics, Professor of Genetics and Genomic Sciences, and Chief of 
      the Adrenal Steroid Disorders Program, Icahn School of Medicine, Mount Sinai 
      School of Medicine, New York, NY
FED - Purnell, Jonathan
ED  - Purnell J
AD  - Professor of Medicine, Knight Cardiovascular Institute and the Division of 
      Endocrinology, and Associate Director, Bob and Charlee Moore Institute for 
      Nutrition and Wellness, Oregon Health and Science University, Portland, OR
FED - Sahay, Rakesh
ED  - Sahay R
AD  - Professor and Head of Department of Endocrinology, Osmania Medical College and 
      Osmania General Hospital, Hyderabad, India.
FED - Shah, Amy S
ED  - Shah AS
AD  - Professor of Pediatrics, The University of Cincinnati, Department of Pediatrics 
      and Cincinnati Children’s Hospital Medical Center, Division of Endocrinology, 
      Cincinnati, OH, USA
FED - Singer, Frederick
ED  - Singer F
AD  - Director of the Endocrine/Bone Disease Program, Saint Johns Cancer Institute at 
      Saint John’s Health Center, Santa Monica, CA; Clinical Professor of Medicine, 
      UCLA School of Medicine, Los Angeles, CA
FED - Sperling, Mark A
ED  - Sperling MA
AD  - Professorial Lecturer, Division of Pediatric Endocrinology and Diabetes, Icahn 
      School of Medicine at Mount Sinai, New York, NY. Emeritus Professor and Chair, 
      Department of Pediatrics, University of Pittsburgh.
FED - Stratakis, Constantine A
ED  - Stratakis CA
AD  - CSO, ELPEN, Inc. & Director, Research Institute, Athens, Greece & Senior 
      Investigator, Human Genetics & Precision Medicine, FORTH (ITE), Heraklion, 
      Greece. Emeritus Scientific Director & Senior Investigator, NICHD, NIH, Bethesda, 
      MD, USA
FED - Trence, Dace L
ED  - Trence DL
AD  - Professor of Medicine, Emeritus, University of Washington, Seattle, WA
FED - Wilson, Don P
ED  - Wilson DP
AD  - Endowed Chair, Cardiovascular Health and Risk Prevention, Pediatric Endocrinology 
      and Diabetes, Cook Children's Medical Center, Fort Worth, TX
FAU - Desimone, Marisa E
AU  - Desimone ME
AD  - Assistant Professor of Medicine, SUNY Upstate Medical University, Syracuse NY
FAU - Weinstock, Ruth S
AU  - Weinstock RS
AD  - SUNY Distinguished Service Professor, SUNY Upstate Medical University, Syracuse 
      NY
LA  - eng
PT  - Review
PT  - Book Chapter
PL  - South Dartmouth (MA)
EDAT- 2018/05/05 00:00
CRDT- 2018/05/05 00:00
AID - NBK279137 [bookaccession]

PMID- 25905219
STAT- Publisher
CTDT- 20210316
PB  - MDText.com, Inc.
DP  - 2000
TI  - Pancreatic Islet Function Tests.
BTI - Endotext
AB  - Objective: To describe testing indications and protocols for the evaluation of 
      pancreatic islet function. Methods: A review of the literature and consensus 
      guidelines concerning testing of pancreatic islet function was performed. 
      Results: Indications for screening for diabetes mellitus are reviewed. Diagnostic 
      criteria for diagnosis are fasting plasma glucose ≥ 126 mg/dl (7.0 mmol/l) or 
      random glucose ≥200 mg/dl (11.1 mmol/l) with hyperglycemic symptoms, hemoglobin 
      A1c (HbA1c) ≥6.5%, and oral glucose tolerance testing (OGTT) 2-h glucose ≥200 
      mg/dl (11.1 mmol/l) after 75 g of glucose. One-step and two-step strategies for 
      diagnosing gestational diabetes using pregnancy-specific criteria as well as use 
      of the 2-h 75-g OGTT for the postpartum testing of women with gestational 
      diabetes (4-12 weeks after delivery) are described. Testing for other forms of 
      diabetes with unique features are reviewed, including the recommendation to use 
      the 2-h 75 g OGTT to screen for cystic fibrosis-related diabetes and 
      post-transplantation diabetes, fasting glucose test for HIV positive individuals, 
      and genetic testing for monogenic diabetes syndromes including neonatal diabetes 
      and maturity-onset diabetes of the young (MODY). Elevated measurements of 
      pancreatic islet autoantibodies (e.g., to the 65-KDa isoform of glutamic acid 
      decarboxylase (GAD65), tyrosine phosphatase related islet antigen 2 (IA-2), 
      insulin (IAA), and zinc transporter (ZnT8)) suggest autoimmune type 1 diabetes 
      (vs type 2 diabetes). IAA is primarily measured in youth. The use of autoantibody 
      testing in diabetes screening programs are recommended only in first degree 
      relatives of an individual with type 1 diabetes or in research protocols. 
      C-peptide measurements >3 years after clinician diagnosis of type 1 diabetes in 
      adults can be helpful in identifying those who have type 1 diabetes (low or 
      undetectable c-peptide) from those who may have type 2 or monogenic diabetes. Use 
      of OGTTs to examine insulin secretory reserve and intravenous glucose tolerance 
      testing are also reviewed. These tests are primarily used in research studies. 
      Evaluation of glycemic control is discussed, with special attention to hemoglobin 
      A1c (HbA1c) and its correlation with mean blood glucose levels as well as assays 
      of other glycated serum proteins. Finally, protocols used to evaluate 
      hypoglycemia (glucose < 55 mg/dl (3.1 mmol/l)) are described, such as the 
      supervised prolonged fast, during which measurements of glucose, insulin, 
      c-peptide, oral insulin secretagogues, proinsulin, and beta-hydroxybutyrate are 
      obtained. Insulinoma is suggested by elevated insulin, proinsulin and c-peptide 
      levels, beta-hydroxybutyrate < 2.7 mmol/l, and undetectable insulin 
      secretagogues. Use of a modified OGTT in the evaluation of the dumping syndrome 
      is also described, as are the mixed meal test, glucagon tolerance test, c-peptide 
      suppression test and evaluation of autoimmune hypoglycemia. For complete coverage 
      of all related areas of Endocrinology, please visit our on-line FREE web-text, 
      WWW.ENDOTEXT.ORG.
CI  - Copyright © 2000-2024, MDText.com, Inc.
FED - Feingold, Kenneth R
ED  - Feingold KR
AD  - Professor of Medicine Emeritus, University of California, San Francisco, CA
FED - Anawalt, Bradley
ED  - Anawalt B
AD  - Chief of Medicine at the University of Washington Medical Center and Professor 
      and Vice Chair of the Department of Medicine, University of Washington
FED - Blackman, Marc R
ED  - Blackman MR
AD  - Sr. Physician Scientist, Washington DC VA Medical Center; Professor of Medicine & 
      Rehabilitation Medicine, Georgetown University; Clinical Professor of Medicine, 
      Biochemistry and Molecular Medicine, George Washington University; and Professor 
      of Medicine (Part-time), Johns Hopkins University
FED - Boyce, Alison
ED  - Boyce A
AD  - Pediatric Endocrinologist and Associate Research Physician in the Skeletal 
      Diseases and Mineral Homeostasis Section, National Institute of Dental and 
      Craniofacial Research, National Institutes of Health
FED - Chrousos, George
ED  - Chrousos G
AD  - Professor of Pediatrics and Endocrinology, Division of Endocrinology, Metabolism 
      and Diabetes, First Department of Pediatrics, National and Kapodistrian 
      University of Athens Medical School, "Aghia Sophia" Children's Hospital, Athens, 
      Greece
FED - Corpas, Emiliano
ED  - Corpas E
AD  - M.D. Ph.D in Gerontology. Honorary Professor of Medicine, Universidad de Alcalá, 
      Madrid. Consultant in Endocrinology, Hospital HLA Guadalajara (Spain).
FED - de Herder, Wouter W
ED  - de Herder WW
AD  - Professor of Endocrine Oncology, Erasmus MC and Erasmus MC Cancer Center, 
      Rotterdam, the Netherlands
FED - Dhatariya, Ketan
ED  - Dhatariya K
AD  - Consultant in Diabetes, Endocrinology and General Medicine, Norfolk and Norwich 
      University Hospitals NHS Foundation Trust and University of East Anglia, Norwich, 
      UK.
FED - Dungan, Kathleen
ED  - Dungan K
AD  - Professor of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Ohio 
      State University
FED - Hofland, Johannes
ED  - Hofland J
AD  - Consultant Endocrinologist, Erasmus MC and Erasmus MC Cancer Center, Rotterdam, 
      the Netherlands
FED - Kalra, Sanjay
ED  - Kalra S
AD  - Consultant Endocrinologist, Department of Endocrinology, Bharti Hospital, Karnal, 
      India
FED - Kaltsas, Gregory
ED  - Kaltsas G
AD  - Professor of General Medicine-Endocrinology, 1st Department of Propaedeutic 
      Medicine, National and Kapodistrian University of Athens, Athens, Greece
FED - Kapoor, Nitin
ED  - Kapoor N
AD  - Professor of Endocrinology, Department of Endocrinology, Diabetes and Metabolism, 
      Christian Medical College & Hospital, Vellore, Tamil Nadu, India, Melbourne 
      School of Population and Global Health, Faculty of Medicine, Dentistry and Health 
      Science, The University of Melbourne, Australia.
FED - Koch, Christian
ED  - Koch C
AD  - Professor, The University of Tennessee Health Science Center, Memphis, Tennessee
FED - Kopp, Peter
ED  - Kopp P
AD  - Professor of Medicine and Chief of the Division of Endocrinology, Diabetology and 
      Metabolism, University of Lausanne, Switzerland
FED - Korbonits, Márta
ED  - Korbonits M
AD  - Professor of Endocrinology and Metabolism, Centre Lead for Endocrinology and 
      Deputy Institute Director, William Harvey Research Institute, Barts and the 
      London School of Medicine and Dentistry, Queen Mary University of London, London, 
      England
FED - Kovacs, Christopher S
ED  - Kovacs CS
AD  - University Research Professor and Professor of Medicine (Endocrinology and 
      Metabolism), Obstetrics & Gynecology, and BioMedical Sciences, at Memorial 
      University of Newfoundland in St. John’s, Newfoundland, Canada.
FED - Kuohung, Wendy
ED  - Kuohung W
AD  - Director of the Division of Reproductive Endocrinology at Boston Medical Center 
      and an Associate Professor of Obstetrics and Gynecology at the Boston University 
      School of Medicine
FED - Laferrère, Blandine
ED  - Laferrère B
AD  - Professor of Medicine, New York Nutrition Obesity Research Center, Division of 
      Endocrinology, Department of Medicine, Columbia University Irving Medical Center, 
      New York, NY, USA.
FED - Levy, Miles
ED  - Levy M
AD  - Consultant endocrinologist at University Hospitals of Leicester and Honorary 
      Associate Professor at Leicester University
FED - McGee, Elizabeth A
ED  - McGee EA
AD  - Professor of Obstetrics and Gynecology at the University of Vermont and Director 
      of the Division of Reproductive Endocrinology and Infertility. Burlington, 
      Vermont
FED - McLachlan, Robert
ED  - McLachlan R
AD  - Director of Clinical Research, Hudson Institute of Medical Research; Consultant 
      Endocrinologist, Monash Medical Centre, Melbourne, Australia
FED - New, Maria
ED  - New M
AD  - Professor of Pediatrics, Professor of Genetics and Genomic Sciences, and Chief of 
      the Adrenal Steroid Disorders Program, Icahn School of Medicine, Mount Sinai 
      School of Medicine, New York, NY
FED - Purnell, Jonathan
ED  - Purnell J
AD  - Professor of Medicine, Knight Cardiovascular Institute and the Division of 
      Endocrinology, and Associate Director, Bob and Charlee Moore Institute for 
      Nutrition and Wellness, Oregon Health and Science University, Portland, OR
FED - Sahay, Rakesh
ED  - Sahay R
AD  - Professor and Head of Department of Endocrinology, Osmania Medical College and 
      Osmania General Hospital, Hyderabad, India.
FED - Shah, Amy S
ED  - Shah AS
AD  - Professor of Pediatrics, The University of Cincinnati, Department of Pediatrics 
      and Cincinnati Children’s Hospital Medical Center, Division of Endocrinology, 
      Cincinnati, OH, USA
FED - Singer, Frederick
ED  - Singer F
AD  - Director of the Endocrine/Bone Disease Program, Saint Johns Cancer Institute at 
      Saint John’s Health Center, Santa Monica, CA; Clinical Professor of Medicine, 
      UCLA School of Medicine, Los Angeles, CA
FED - Sperling, Mark A
ED  - Sperling MA
AD  - Professorial Lecturer, Division of Pediatric Endocrinology and Diabetes, Icahn 
      School of Medicine at Mount Sinai, New York, NY. Emeritus Professor and Chair, 
      Department of Pediatrics, University of Pittsburgh.
FED - Stratakis, Constantine A
ED  - Stratakis CA
AD  - CSO, ELPEN, Inc. & Director, Research Institute, Athens, Greece & Senior 
      Investigator, Human Genetics & Precision Medicine, FORTH (ITE), Heraklion, 
      Greece. Emeritus Scientific Director & Senior Investigator, NICHD, NIH, Bethesda, 
      MD, USA
FED - Trence, Dace L
ED  - Trence DL
AD  - Professor of Medicine, Emeritus, University of Washington, Seattle, WA
FED - Wilson, Don P
ED  - Wilson DP
AD  - Endowed Chair, Cardiovascular Health and Risk Prevention, Pediatric Endocrinology 
      and Diabetes, Cook Children's Medical Center, Fort Worth, TX
FAU - Katta, Sai
AU  - Katta S
AD  - Clinical Assistant Instructor, Department of Medicine, SUNY Upstate Medical 
      University, Syracuse NY 13210
FAU - Desimone, Marisa E
AU  - Desimone ME
AD  - Associate Professor, Department of Medicine, SUNY Upstate Medical University, 
      Syracuse NY 13210.
FAU - Weinstock, Ruth S
AU  - Weinstock RS
AD  - Distinguished Service Professor, Department of Medicine, SUNY Upstate Medical 
      University, Syracuse NY 13210
LA  - eng
PT  - Review
PT  - Book Chapter
PL  - South Dartmouth (MA)
EDAT- 2021/03/16 00:00
CRDT- 2021/03/16 00:00
AID - NBK278985 [bookaccession]

PMID- 30775438
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20200410
LR  - 20200410
IS  - 2375-2548 (Electronic)
IS  - 2375-2548 (Linking)
VI  - 5
IP  - 2
DP  - 2019 Feb
TI  - The gut microbiome from patients with schizophrenia modulates the 
      glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice.
PG  - eaau8317
LID - 10.1126/sciadv.aau8317 [doi]
LID - eaau8317
AB  - Schizophrenia (SCZ) is a devastating mental disorder with poorly defined 
      underlying molecular mechanisms. The gut microbiome can modulate brain function 
      and behaviors through the microbiota-gut-brain axis. Here, we found that 
      unmedicated and medicated patients with SCZ had a decreased microbiome 
      α-diversity index and marked disturbances of gut microbial composition versus 
      healthy controls (HCs). Several unique bacterial taxa (e.g., Veillonellaceae and 
      Lachnospiraceae) were associated with SCZ severity. A specific microbial panel 
      (Aerococcaceae, Bifidobacteriaceae, Brucellaceae, Pasteurellaceae, and 
      Rikenellaceae) enabled discriminating patients with SCZ from HCs with 0.769 area 
      under the curve. Compared to HCs, germ-free mice receiving SCZ microbiome fecal 
      transplants had lower glutamate and higher glutamine and GABA in the hippocampus 
      and displayed SCZ-relevant behaviors similar to other mouse models of SCZ 
      involving glutamatergic hypofunction. Together, our findings suggest that the SCZ 
      microbiome itself can alter neurochemistry and neurologic function in ways that 
      may be relevant to SCZ pathology.
FAU - Zheng, Peng
AU  - Zheng P
AD  - Department of Neurology, The First Affiliated Hospital of Chongqing Medical 
      University, Chongqing, China.
AD  - Institute of Neuroscience and the Collaborative Innovation Center for Brain 
      Science, Chongqing Medical University, Chongqing, China.
AD  - Chongqing Key Laboratory of Neurobiology, Chongqing, China.
FAU - Zeng, Benhua
AU  - Zeng B
AD  - Department of Laboratory Animal Science, College of Basic Medical Sciences, Third 
      Military Medical University, Chongqing, China.
FAU - Liu, Meiling
AU  - Liu M
AD  - Department of Gastroenterology, The First Affiliated Hospital of Chongqing 
      Medical University, Chongqing, China.
FAU - Chen, Jianjun
AU  - Chen J
AD  - College of Life Sciences, Chongqing Medical University, Chongqing, China.
FAU - Pan, Junxi
AU  - Pan J
AD  - Institute of Neuroscience and the Collaborative Innovation Center for Brain 
      Science, Chongqing Medical University, Chongqing, China.
AD  - Chongqing Key Laboratory of Neurobiology, Chongqing, China.
AD  - The M.O.E. Key Laboratory of Laboratory Medical Diagnostics, the College of 
      Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China.
FAU - Han, Yu
AU  - Han Y
AD  - Department of Neurology, The First Affiliated Hospital of Chongqing Medical 
      University, Chongqing, China.
AD  - Institute of Neuroscience and the Collaborative Innovation Center for Brain 
      Science, Chongqing Medical University, Chongqing, China.
AD  - Chongqing Key Laboratory of Neurobiology, Chongqing, China.
FAU - Liu, Yiyun
AU  - Liu Y
AD  - Department of Neurology, The First Affiliated Hospital of Chongqing Medical 
      University, Chongqing, China.
AD  - Institute of Neuroscience and the Collaborative Innovation Center for Brain 
      Science, Chongqing Medical University, Chongqing, China.
AD  - Chongqing Key Laboratory of Neurobiology, Chongqing, China.
FAU - Cheng, Ke
AU  - Cheng K
AD  - Department of Neurology, The First Affiliated Hospital of Chongqing Medical 
      University, Chongqing, China.
AD  - Institute of Neuroscience and the Collaborative Innovation Center for Brain 
      Science, Chongqing Medical University, Chongqing, China.
AD  - Chongqing Key Laboratory of Neurobiology, Chongqing, China.
FAU - Zhou, Chanjuan
AU  - Zhou C
AD  - Institute of Neuroscience and the Collaborative Innovation Center for Brain 
      Science, Chongqing Medical University, Chongqing, China.
AD  - Chongqing Key Laboratory of Neurobiology, Chongqing, China.
FAU - Wang, Haiyang
AU  - Wang H
AD  - Department of Neurology, The First Affiliated Hospital of Chongqing Medical 
      University, Chongqing, China.
AD  - Institute of Neuroscience and the Collaborative Innovation Center for Brain 
      Science, Chongqing Medical University, Chongqing, China.
AD  - Chongqing Key Laboratory of Neurobiology, Chongqing, China.
FAU - Zhou, Xinyu
AU  - Zhou X
AD  - Department of Neurology, The First Affiliated Hospital of Chongqing Medical 
      University, Chongqing, China.
AD  - Institute of Neuroscience and the Collaborative Innovation Center for Brain 
      Science, Chongqing Medical University, Chongqing, China.
AD  - Chongqing Key Laboratory of Neurobiology, Chongqing, China.
FAU - Gui, Siwen
AU  - Gui S
AD  - Department of Neurology, The First Affiliated Hospital of Chongqing Medical 
      University, Chongqing, China.
AD  - Institute of Neuroscience and the Collaborative Innovation Center for Brain 
      Science, Chongqing Medical University, Chongqing, China.
AD  - Chongqing Key Laboratory of Neurobiology, Chongqing, China.
FAU - Perry, Seth W
AU  - Perry SW
AD  - Department of Psychiatry, College of Medicine, SUNY Upstate Medical University, 
      Syracuse, NY, USA.
FAU - Wong, Ma-Li
AU  - Wong ML
AUID- ORCID: 0000-0003-1512-3073
AD  - Department of Psychiatry, College of Medicine, SUNY Upstate Medical University, 
      Syracuse, NY, USA.
FAU - Licinio, Julio
AU  - Licinio J
AUID- ORCID: 0000-0001-6905-5884
AD  - Department of Psychiatry, College of Medicine, SUNY Upstate Medical University, 
      Syracuse, NY, USA.
FAU - Wei, Hong
AU  - Wei H
AD  - Precision Medicine Institute, The First Affiliated Hospital, Sun Yat-sen 
      University, Guangzhou, Guangdong 510080, China.
FAU - Xie, Peng
AU  - Xie P
AD  - Department of Neurology, The First Affiliated Hospital of Chongqing Medical 
      University, Chongqing, China.
AD  - Institute of Neuroscience and the Collaborative Innovation Center for Brain 
      Science, Chongqing Medical University, Chongqing, China.
AD  - Chongqing Key Laboratory of Neurobiology, Chongqing, China.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20190206
PL  - United States
TA  - Sci Adv
JT  - Science advances
JID - 101653440
SB  - IM
EIN - Sci Adv. 2019 Jun 21;5(6):eaay2759. PMID: 31245543
PMC - PMC6365110
EDAT- 2019/02/19 06:00
MHDA- 2019/02/19 06:01
CRDT- 2019/02/19 06:00
PHST- 2018/07/20 00:00 [received]
PHST- 2018/12/20 00:00 [accepted]
PHST- 2019/02/19 06:00 [entrez]
PHST- 2019/02/19 06:00 [pubmed]
PHST- 2019/02/19 06:01 [medline]
AID - aau8317 [pii]
AID - 10.1126/sciadv.aau8317 [doi]
PST - epublish
SO  - Sci Adv. 2019 Feb 6;5(2):eaau8317. doi: 10.1126/sciadv.aau8317. eCollection 2019 
      Feb.

PMID- 36696101
OWN - NLM
STAT- MEDLINE
DCOM- 20230303
LR  - 20230405
IS  - 2168-6238 (Electronic)
IS  - 2168-622X (Print)
IS  - 2168-622X (Linking)
VI  - 80
IP  - 3
DP  - 2023 Mar 1
TI  - Lipid Alteration Signature in the Blood Plasma of Individuals With Schizophrenia, 
      Depression, and Bipolar Disorder.
PG  - 250-259
LID - 10.1001/jamapsychiatry.2022.4350 [doi]
AB  - IMPORTANCE: No clinically applicable diagnostic test exists for severe mental 
      disorders. Lipids harbor potential as disease markers. OBJECTIVE: To define a 
      reproducible profile of lipid alterations in the blood plasma of patients with 
      schizophrenia (SCZ) independent of demographic and environmental variables and to 
      investigate its specificity in association with other psychiatric disorders, ie, 
      major depressive disorder (MDD) and bipolar disorder (BPD). DESIGN, SETTING, AND 
      PARTICIPANTS: This was a multicohort case-control diagnostic analysis involving 
      plasma samples from psychiatric patients and control individuals collected 
      between July 17, 2009, and May 18, 2018. Study participants were recruited as 
      consecutive and volunteer samples at multiple inpatient and outpatient mental 
      health hospitals in Western Europe (Germany and Austria [DE-AT]), China (CN), and 
      Russia (RU). Individuals with DSM-IV or International Statistical Classification 
      of Diseases and Related Health Problems, Tenth Revision diagnoses of SCZ, MDD, 
      BPD, or a first psychotic episode, as well as age- and sex-matched healthy 
      controls without a mental health-related diagnosis were included in the study. 
      Samples and data were analyzed from January 2018 to September 2020. MAIN OUTCOMES 
      AND MEASURES: Plasma lipidome composition was assessed using liquid 
      chromatography coupled with untargeted mass spectrometry. RESULTS: Blood lipid 
      levels were assessed in 980 individuals (mean [SD] age, 36 [13] years; 510 male 
      individuals [52%]) diagnosed with SCZ, BPD, MDD, or those with a first psychotic 
      episode and in 572 controls (mean [SD] age, 34 [13] years; 323 male individuals 
      [56%]). A total of 77 lipids were found to be significantly altered between those 
      with SCZ (n = 436) and controls (n = 478) in all 3 sample cohorts. Alterations 
      were consistent between cohorts (CN and RU: [Pearson correlation] r = 0.75; DE-AT 
      and CN: r = 0.78; DE-AT and RU: r = 0.82; P < 10-38). A lipid-based predictive 
      model separated patients with SCZ from controls with high diagnostic ability 
      (area under the receiver operating characteristic curve = 0.86-0.95). Lipidome 
      alterations in BPD and MDD, assessed in 184 and 256 individuals, respectively, 
      were found to be similar to those of SCZ (BPD: r = 0.89; MDD: r = 0.92; 
      P < 10-79). Assessment of detected alterations in individuals with a first 
      psychotic episode, as well as patients with SCZ not receiving medication, 
      demonstrated only limited association with medication restricted to particular 
      lipids. CONCLUSIONS AND RELEVANCE: In this study, SCZ was accompanied by a 
      reproducible profile of plasma lipidome alterations, not associated with symptom 
      severity, medication, and demographic and environmental variables, and largely 
      shared with BPD and MDD. This lipid alteration signature may represent a trait 
      marker of severe psychiatric disorders, indicating its potential to be 
      transformed into a clinically applicable testing procedure.
FAU - Tkachev, Anna
AU  - Tkachev A
AD  - Vladimir Zelman Center for Neurobiology and Brain Rehabilitation, Skolkovo 
      Institute of Science and Technology, Moscow, Russia.
AD  - Institute for Information Transmission Problems, Russian Academy of Sciences, 
      Moscow, Russia.
FAU - Stekolshchikova, Elena
AU  - Stekolshchikova E
AD  - Vladimir Zelman Center for Neurobiology and Brain Rehabilitation, Skolkovo 
      Institute of Science and Technology, Moscow, Russia.
FAU - Vanyushkina, Anna
AU  - Vanyushkina A
AD  - Vladimir Zelman Center for Neurobiology and Brain Rehabilitation, Skolkovo 
      Institute of Science and Technology, Moscow, Russia.
FAU - Zhang, Hanping
AU  - Zhang H
AD  - NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The 
      First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
AD  - Department of Neurology, The First Affiliated Hospital of Chongqing Medical 
      University, Chongqing, China.
FAU - Morozova, Anna
AU  - Morozova A
AD  - Department Basic and Applied Neurobiology, V. Serbsky Federal Medical Research 
      Centre of Psychiatry and Narcology, Moscow, Russia.
AD  - Moscow Psychiatric Hospital No. 1, named after N.A. Alekseev, Moscow, Russia.
FAU - Zozulya, Svetlana
AU  - Zozulya S
AD  - Mental Health Research Center, Moscow, Russia.
FAU - Kurochkin, Ilia
AU  - Kurochkin I
AD  - Vladimir Zelman Center for Neurobiology and Brain Rehabilitation, Skolkovo 
      Institute of Science and Technology, Moscow, Russia.
FAU - Anikanov, Nickolay
AU  - Anikanov N
AD  - Vladimir Zelman Center for Neurobiology and Brain Rehabilitation, Skolkovo 
      Institute of Science and Technology, Moscow, Russia.
FAU - Egorova, Alina
AU  - Egorova A
AD  - Vladimir Zelman Center for Neurobiology and Brain Rehabilitation, Skolkovo 
      Institute of Science and Technology, Moscow, Russia.
FAU - Yushina, Ekaterina
AU  - Yushina E
AD  - Vladimir Zelman Center for Neurobiology and Brain Rehabilitation, Skolkovo 
      Institute of Science and Technology, Moscow, Russia.
AD  - FSBSI N.P. Bochkov Research Center of Medical Genetics, Moscow, Russia.
FAU - Vogl, Thomas
AU  - Vogl T
AD  - Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig 
      Maximilian University of Munich, Munich, Germany.
FAU - Senner, Fanny
AU  - Senner F
AD  - Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig 
      Maximilian University of Munich, Munich, Germany.
AD  - Department of Psychiatry and Psychotherapy, University Hospital, Ludwig 
      Maximilian University of Munich, Munich, Germany.
FAU - Schaupp, Sabrina K
AU  - Schaupp SK
AD  - Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig 
      Maximilian University of Munich, Munich, Germany.
FAU - Reich-Erkelenz, Daniela
AU  - Reich-Erkelenz D
AD  - Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig 
      Maximilian University of Munich, Munich, Germany.
FAU - Papiol, Sergi
AU  - Papiol S
AD  - Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig 
      Maximilian University of Munich, Munich, Germany.
AD  - Department of Psychiatry and Psychotherapy, University Hospital, Ludwig 
      Maximilian University of Munich, Munich, Germany.
FAU - Kohshour, Mojtaba Oraki
AU  - Kohshour MO
AD  - Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig 
      Maximilian University of Munich, Munich, Germany.
AD  - Department of Immunology, Faculty of Medicine, Ahvaz Jundishapur University of 
      Medical Sciences, Ahvaz, Iran.
FAU - Klöhn-Saghatolislam, Farahnaz
AU  - Klöhn-Saghatolislam F
AD  - Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig 
      Maximilian University of Munich, Munich, Germany.
FAU - Kalman, Janos L
AU  - Kalman JL
AD  - Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig 
      Maximilian University of Munich, Munich, Germany.
AD  - Department of Psychiatry and Psychotherapy, University Hospital, Ludwig 
      Maximilian University of Munich, Munich, Germany.
FAU - Heilbronner, Urs
AU  - Heilbronner U
AD  - Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig 
      Maximilian University of Munich, Munich, Germany.
FAU - Heilbronner, Maria
AU  - Heilbronner M
AD  - Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig 
      Maximilian University of Munich, Munich, Germany.
FAU - Gade, Katrin
AU  - Gade K
AD  - Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, 
      Göttingen, Germany.
FAU - Comes, Ashley L
AU  - Comes AL
AD  - Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig 
      Maximilian University of Munich, Munich, Germany.
FAU - Budde, Monika
AU  - Budde M
AD  - Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig 
      Maximilian University of Munich, Munich, Germany.
FAU - Anderson-Schmidt, Heike
AU  - Anderson-Schmidt H
AD  - Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, 
      Göttingen, Germany.
FAU - Adorjan, Kristina
AU  - Adorjan K
AD  - Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig 
      Maximilian University of Munich, Munich, Germany.
AD  - Department of Psychiatry and Psychotherapy, University Hospital, Ludwig 
      Maximilian University of Munich, Munich, Germany.
FAU - Wiltfang, Jens
AU  - Wiltfang J
AD  - Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, 
      Göttingen, Germany.
AD  - German Center for Neurodegenerative Diseases, Göttingen, Germany.
AD  - Neurosciences and Signaling Group, Institute of Medicine, Department of Medical 
      Sciences, University of Aveiro, Aveiro, Portugal.
FAU - Reininghaus, Eva Z
AU  - Reininghaus EZ
AD  - Department of Psychiatry and Psychotherapeutic Medicine, Research Unit for 
      Neurobiology and Anthropometrics in Bipolar Affective Disorder, Medical 
      University of Graz, Graz, Austria.
FAU - Juckel, Georg
AU  - Juckel G
AD  - Department of Psychiatry, Ruhr University Bochum, LWL University Hospital, 
      Bochum, Germany.
FAU - Dannlowski, Udo
AU  - Dannlowski U
AD  - Institute for Translational Psychiatry, University of Münster, Münster, Germany.
FAU - Fallgatter, Andreas
AU  - Fallgatter A
AD  - Department of Psychiatry and Psychotherapy, Tübingen Center for Mental Health, 
      University Tübingen, Tübingen, Germany.
FAU - Spitzer, Carsten
AU  - Spitzer C
AD  - Department of Psychosomatic Medicine and Psychotherapy, University Medical Center 
      Rostock, Rostock, Germany.
FAU - Schmauß, Max
AU  - Schmauß M
AD  - Department of Psychiatry and Psychotherapy, Bezirkskrankenhaus Augsburg, 
      Augsburg, Germany.
FAU - von Hagen, Martin
AU  - von Hagen M
AD  - Clinic for Psychiatry and Psychotherapy, Clinical Center Werra-Meißner, Eschwege, 
      Germany.
FAU - Zorkina, Yana
AU  - Zorkina Y
AD  - Department Basic and Applied Neurobiology, V. Serbsky Federal Medical Research 
      Centre of Psychiatry and Narcology, Moscow, Russia.
AD  - Moscow Psychiatric Hospital No. 1, named after N.A. Alekseev, Moscow, Russia.
FAU - Reznik, Alexander
AU  - Reznik A
AD  - Moscow Psychiatric Hospital No. 1, named after N.A. Alekseev, Moscow, Russia.
AD  - Moscow State University of Food Production, Moscow, Russia.
FAU - Barkhatova, Aleksandra
AU  - Barkhatova A
AD  - Mental Health Research Center, Moscow, Russia.
FAU - Lisov, Roman
AU  - Lisov R
AD  - Institute for Information Transmission Problems, Russian Academy of Sciences, 
      Moscow, Russia.
AD  - Moscow Institute of Physics and Technology, Dolgoprudny, Russia.
FAU - Mokrov, Nikita
AU  - Mokrov N
AD  - Moscow Institute of Physics and Technology, Dolgoprudny, Russia.
AD  - Center for Artificial Intelligence Technologies, Skolkovo Institute of Science 
      and Technology, Moscow, Russia.
FAU - Panov, Maxim
AU  - Panov M
AD  - Technology Innovation Institute, Abu Dhabi, United Arab Emirates.
FAU - Zubkov, Dmitri
AU  - Zubkov D
AD  - Vladimir Zelman Center for Neurobiology and Brain Rehabilitation, Skolkovo 
      Institute of Science and Technology, Moscow, Russia.
FAU - Petrova, Daria
AU  - Petrova D
AD  - Vladimir Zelman Center for Neurobiology and Brain Rehabilitation, Skolkovo 
      Institute of Science and Technology, Moscow, Russia.
FAU - Zhou, Chanjuan
AU  - Zhou C
AD  - NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The 
      First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
AD  - Department of Neurology, Yongchuan Hospital of Chongqing Medical University, 
      Chongqing, China.
FAU - Liu, Yiyun
AU  - Liu Y
AD  - NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The 
      First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
FAU - Pu, Juncai
AU  - Pu J
AD  - NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The 
      First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
FAU - Falkai, Peter
AU  - Falkai P
AD  - Department of Psychiatry and Psychotherapy, University Hospital, Ludwig 
      Maximilian University of Munich, Munich, Germany.
FAU - Kostyuk, Georgiy
AU  - Kostyuk G
AD  - Moscow Psychiatric Hospital No. 1, named after N.A. Alekseev, Moscow, Russia.
FAU - Klyushnik, Tatiana
AU  - Klyushnik T
AD  - Mental Health Research Center, Moscow, Russia.
FAU - Schulze, Thomas G
AU  - Schulze TG
AD  - Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig 
      Maximilian University of Munich, Munich, Germany.
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Syracuse, New York.
AD  - Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, 
      Baltimore, Maryland.
FAU - Xie, Peng
AU  - Xie P
AD  - NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The 
      First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
AD  - Department of Neurology, The First Affiliated Hospital of Chongqing Medical 
      University, Chongqing, China.
AD  - Chongqing Key Laboratory of Neurobiology, Chongqing, China.
FAU - Schulte, Eva C
AU  - Schulte EC
AD  - Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig 
      Maximilian University of Munich, Munich, Germany.
AD  - Department of Psychiatry and Psychotherapy, University Hospital, Ludwig 
      Maximilian University of Munich, Munich, Germany.
AD  - Department of Psychiatry and Psychotherapy, University Hospital Bonn, medical 
      Faculty University of Bonn, Bonn, Germany.
FAU - Khaitovich, Philipp
AU  - Khaitovich P
AD  - Vladimir Zelman Center for Neurobiology and Brain Rehabilitation, Skolkovo 
      Institute of Science and Technology, Moscow, Russia.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - JAMA Psychiatry
JT  - JAMA psychiatry
JID - 101589550
SB  - IM
MH  - Humans
MH  - Male
MH  - Adult
MH  - *Bipolar Disorder/diagnosis
MH  - *Schizophrenia/diagnosis
MH  - *Depressive Disorder, Major/psychology
MH  - Depression
MH  - *Psychotic Disorders/diagnosis
PMC - PMC9878436
COIS- Conflict of Interest Disclosures: Dr Heilbronner reported receiving grants from 
      the German Research Foundation during the conduct of the study. Dr Budde reported 
      working as a consultant for the World Psychiatric Association (for the project 
      PSY-PGx, funded from the European Union’s Horizon 2020 research and innovation 
      program under grant agreement 945151). Dr Wiltfang reported receiving grants from 
      the German Federal Ministry of Education and Research during the conduct of the 
      study; personal fees from Abbott, Biogen, Boehringer Ingelheim, Immungenetics, 
      Janssen, Lilly, MSD Sharp & Dohme, Pfizer, Roche Pharma, Actelion, Amgen, Beejing 
      Yibai Science and Technology Ltd, and Roboscreen outside the submitted work; in 
      addition, Dr Wiltfang reported having a patent for PCT/EP 2011 001724 and a 
      patent for PCT/EP 2015 052945. Dr Dannlowski reported receiving grants from the 
      German Research Foundation during the conduct of the study. Dr Fallgatter 
      reported receiving grants from the University of Tübingen during the conduct of 
      the study. Dr Schmauss reported receiving grants from Bezirkskrankenhaus Augsburg 
      during the conduct of the study. No other disclosures were reported.
EDAT- 2023/01/26 06:00
MHDA- 2023/03/04 06:00
PMCR- 2024/01/25
CRDT- 2023/01/25 11:33
PHST- 2024/01/25 00:00 [pmc-release]
PHST- 2023/01/26 06:00 [pubmed]
PHST- 2023/03/04 06:00 [medline]
PHST- 2023/01/25 11:33 [entrez]
AID - 2800311 [pii]
AID - yoi220085 [pii]
AID - 10.1001/jamapsychiatry.2022.4350 [doi]
PST - ppublish
SO  - JAMA Psychiatry. 2023 Mar 1;80(3):250-259. doi: 10.1001/jamapsychiatry.2022.4350.

PMID- 28219628
OWN - NLM
STAT- MEDLINE
DCOM- 20190628
LR  - 20220129
IS  - 2215-0374 (Electronic)
IS  - 2215-0366 (Print)
IS  - 2215-0366 (Linking)
VI  - 4
IP  - 4
DP  - 2017 Apr
TI  - Subcortical brain volume differences in participants with attention deficit 
      hyperactivity disorder in children and adults: a cross-sectional mega-analysis.
PG  - 310-319
LID - S2215-0366(17)30049-4 [pii]
LID - 10.1016/S2215-0366(17)30049-4 [doi]
AB  - BACKGROUND: Neuroimaging studies have shown structural alterations in several 
      brain regions in children and adults with attention deficit hyperactivity 
      disorder (ADHD). Through the formation of the international ENIGMA ADHD Working 
      Group, we aimed to address weaknesses of previous imaging studies and 
      meta-analyses, namely inadequate sample size and methodological heterogeneity. We 
      aimed to investigate whether there are structural differences in children and 
      adults with ADHD compared with those without this diagnosis. METHODS: In this 
      cross-sectional mega-analysis, we used the data from the international ENIGMA 
      Working Group collaboration, which in the present analysis was frozen at Feb 8, 
      2015. Individual sites analysed structural T1-weighted MRI brain scans with 
      harmonised protocols of individuals with ADHD compared with those who do not have 
      this diagnosis. Our primary outcome was to assess case-control differences in 
      subcortical structures and intracranial volume through pooling of all individual 
      data from all cohorts in this collaboration. For this analysis, p values were 
      significant at the false discovery rate corrected threshold of p=0·0156. 
      FINDINGS: Our sample comprised 1713 participants with ADHD and 1529 controls from 
      23 sites with a median age of 14 years (range 4-63 years). The volumes of the 
      accumbens (Cohen's d=-0·15), amygdala (d=-0·19), caudate (d=-0·11), hippocampus 
      (d=-0·11), putamen (d=-0·14), and intracranial volume (d=-0·10) were smaller in 
      individuals with ADHD compared with controls in the mega-analysis. There was no 
      difference in volume size in the pallidum (p=0·95) and thalamus (p=0·39) between 
      people with ADHD and controls. Exploratory lifespan modelling suggested a delay 
      of maturation and a delay of degeneration, as effect sizes were highest in most 
      subgroups of children (<15 years) versus adults (>21 years): in the accumbens 
      (Cohen's d=-0·19 vs -0·10), amygdala (d=-0·18 vs -0·14), caudate (d=-0·13 vs 
      -0·07), hippocampus (d=-0·12 vs -0·06), putamen (d=-0·18 vs -0·08), and 
      intracranial volume (d=-0·14 vs 0·01). There was no difference between children 
      and adults for the pallidum (p=0·79) or thalamus (p=0·89). Case-control 
      differences in adults were non-significant (all p>0·03). Psychostimulant 
      medication use (all p>0·15) or symptom scores (all p>0·02) did not influence 
      results, nor did the presence of comorbid psychiatric disorders (all p>0·5). 
      INTERPRETATION: With the largest dataset to date, we add new knowledge about 
      bilateral amygdala, accumbens, and hippocampus reductions in ADHD. We extend the 
      brain maturation delay theory for ADHD to include subcortical structures and 
      refute medication effects on brain volume suggested by earlier meta-analyses. 
      Lifespan analyses suggest that, in the absence of well powered longitudinal 
      studies, the ENIGMA cross-sectional sample across six decades of ages provides a 
      means to generate hypotheses about lifespan trajectories in brain phenotypes. 
      FUNDING: National Institutes of Health.
CI  - Copyright © 2017 Elsevier Ltd. All rights reserved.
FAU - Hoogman, Martine
AU  - Hoogman M
AD  - Department of Human Genetics, Radboud University Medical Center, Nijmegen, 
      Netherlands; Donders Institute for Brain, Cognition and Behaviour, Nijmegen, 
      Netherlands. Electronic address: martine.hoogman@radboudumc.nl.
FAU - Bralten, Janita
AU  - Bralten J
AD  - Department of Human Genetics, Radboud University Medical Center, Nijmegen, 
      Netherlands; Donders Institute for Brain, Cognition and Behaviour, Nijmegen, 
      Netherlands.
FAU - Hibar, Derrek P
AU  - Hibar DP
AD  - Imaging Genetics Center, Mark and Mary Stevens Institute for Neuroimaging and 
      Informatics, Keck School of Medicine of USC, University of Southern California, 
      Marina del Rey, CA, USA.
FAU - Mennes, Maarten
AU  - Mennes M
AD  - Donders Institute for Brain, Cognition and Behaviour, Nijmegen, Netherlands.
FAU - Zwiers, Marcel P
AU  - Zwiers MP
AD  - Donders Institute for Brain, Cognition and Behaviour, Nijmegen, Netherlands.
FAU - Schweren, Lizanne S J
AU  - Schweren LSJ
AD  - Department of Psychiatry, University Medical Center Groningen, University of 
      Groningen, Groningen, Netherlands.
FAU - van Hulzen, Kimm J E
AU  - van Hulzen KJE
AD  - Department of Human Genetics, Radboud University Medical Center, Nijmegen, 
      Netherlands; Donders Institute for Brain, Cognition and Behaviour, Nijmegen, 
      Netherlands.
FAU - Medland, Sarah E
AU  - Medland SE
AD  - QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
FAU - Shumskaya, Elena
AU  - Shumskaya E
AD  - Department of Human Genetics, Radboud University Medical Center, Nijmegen, 
      Netherlands; Donders Institute for Brain, Cognition and Behaviour, Nijmegen, 
      Netherlands.
FAU - Jahanshad, Neda
AU  - Jahanshad N
AD  - Imaging Genetics Center, Mark and Mary Stevens Institute for Neuroimaging and 
      Informatics, Keck School of Medicine of USC, University of Southern California, 
      Marina del Rey, CA, USA.
FAU - Zeeuw, Patrick de
AU  - Zeeuw P
AD  - NICHE-lab, Brain Center Rudolf Magnus, Department of Psychiatry, University 
      Medical Center Utrecht, Utrecht, Netherlands.
FAU - Szekely, Eszter
AU  - Szekely E
AD  - Neurobehavioral Clinical Research Section, National Human Genome Research 
      Institute, Bethesda, MD, USA.
FAU - Sudre, Gustavo
AU  - Sudre G
AD  - Neurobehavioral Clinical Research Section, National Human Genome Research 
      Institute, Bethesda, MD, USA.
FAU - Wolfers, Thomas
AU  - Wolfers T
AD  - Department of Human Genetics, Radboud University Medical Center, Nijmegen, 
      Netherlands; Donders Institute for Brain, Cognition and Behaviour, Nijmegen, 
      Netherlands.
FAU - Onnink, Alberdingk M H
AU  - Onnink AMH
AD  - Department of Human Genetics, Radboud University Medical Center, Nijmegen, 
      Netherlands; Donders Institute for Brain, Cognition and Behaviour, Nijmegen, 
      Netherlands.
FAU - Dammers, Janneke T
AU  - Dammers JT
AD  - Department of Psychiatry, Radboud University Medical Center, Nijmegen, 
      Netherlands; Donders Institute for Brain, Cognition and Behaviour, Nijmegen, 
      Netherlands.
FAU - Mostert, Jeanette C
AU  - Mostert JC
AD  - Department of Human Genetics, Radboud University Medical Center, Nijmegen, 
      Netherlands; Donders Institute for Brain, Cognition and Behaviour, Nijmegen, 
      Netherlands.
FAU - Vives-Gilabert, Yolanda
AU  - Vives-Gilabert Y
AD  - Asociación para la Innovación en Análisis, Gestión y Procesamiento de Datos 
      Científicos y Tecnológicos, Barcelona, Spain.
FAU - Kohls, Gregor
AU  - Kohls G
AD  - Child Neuropsychology Section, University Hospital Aachen, Aachen, Germany.
FAU - Oberwelland, Eileen
AU  - Oberwelland E
AD  - Child Neuropsychology Section, University Hospital Aachen, Aachen, Germany; JARA 
      Translational Brain Medicine, Research Center Juelich, Aachen, Germany.
FAU - Seitz, Jochen
AU  - Seitz J
AD  - Department of Child and Adolescent Psychiatry, University Hospital Aachen, 
      Aachen, Germany.
FAU - Schulte-Rüther, Martin
AU  - Schulte-Rüther M
AD  - Child Neuropsychology Section, University Hospital Aachen, Aachen, Germany; JARA 
      Translational Brain Medicine, Research Center Juelich, Aachen, Germany.
FAU - Ambrosino, Sara
AU  - Ambrosino S
AD  - NICHE-lab, Brain Center Rudolf Magnus, Department of Psychiatry, University 
      Medical Center Utrecht, Utrecht, Netherlands.
FAU - Doyle, Alysa E
AU  - Doyle AE
AD  - Department of Psychiatry and Center for Human Genetics Research, Massachusetts 
      General Hospital, Harvard Medical School, Boston, MA, USA; Stanley Center for 
      Psychiatric Research at the Broad Institute, Cambridge, MA, USA.
FAU - Høvik, Marie F
AU  - Høvik MF
AD  - Department of Clinical Medicine, University of Bergen, Bergen, Norway.
FAU - Dramsdahl, Margaretha
AU  - Dramsdahl M
AD  - Psychiatry, Region Zealand, Denmark.
FAU - Tamm, Leanne
AU  - Tamm L
AD  - Department of Pediatrics, Cincinnati Children's Hospital Medical Center, 
      Cincinnati, OH, USA.
FAU - van Erp, Theo G M
AU  - van Erp TGM
AD  - Department of Psychiatry and Human Behavior, University of California, Irvine, 
      CA, USA.
FAU - Dale, Anders
AU  - Dale A
AD  - Departments of Neurosciences and Radiology, University of California, San Diego, 
      San Diego, CA, USA; UCSD Center for Translational Imaging and Precision Medicine, 
      San Diego, CA, USA.
FAU - Schork, Andrew
AU  - Schork A
AD  - Department of Cognitive Science, UC San Diego, La Jolla, CA, USA.
FAU - Conzelmann, Annette
AU  - Conzelmann A
AD  - Department of Child and Adolescent Psychiatry and Psychotherapy, University of 
      Tübingen, Tübingen, Germany; Department of Psychology, University of Würzburg, 
      Würzburg, Germany.
FAU - Zierhut, Kathrin
AU  - Zierhut K
AD  - Department of Medical Psychology and Psychotherapy, Medical Sociology and 
      Rehabilitation Sciences, University of Würzburg, Würzburg, Germany; Department of 
      Psychology, University of Würzburg, Würzburg, Germany.
FAU - Baur, Ramona
AU  - Baur R
AD  - Department of Psychology, University of Würzburg, Würzburg, Germany.
FAU - McCarthy, Hazel
AU  - McCarthy H
AD  - Department of Psychiatry, University of Dublin, Trinity College Dublin, Dublin, 
      Ireland.
FAU - Yoncheva, Yuliya N
AU  - Yoncheva YN
AD  - The Child Study Center at NYU Langone Medical Center, New York, NY, USA.
FAU - Cubillo, Ana
AU  - Cubillo A
AD  - Department of Child and Adolescent Psychiatry, Institute of Psychiatry, 
      Psychology and Neuroscience, King's College London, London, UK.
FAU - Chantiluke, Kaylita
AU  - Chantiluke K
AD  - Department of Child and Adolescent Psychiatry, Institute of Psychiatry, 
      Psychology and Neuroscience, King's College London, London, UK.
FAU - Mehta, Mitul A
AU  - Mehta MA
AD  - Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, 
      King's College London, London, UK.
FAU - Paloyelis, Yannis
AU  - Paloyelis Y
AD  - Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, 
      King's College London, London, UK.
FAU - Hohmann, Sarah
AU  - Hohmann S
AD  - Department of Child and Adolescent Psychiatry and Psychotherapy, Central 
      Institute of Mental Health Medical Faculty Mannheim, Heidelberg University, 
      Mannheim, Germany.
FAU - Baumeister, Sarah
AU  - Baumeister S
AD  - Department of Child and Adolescent Psychiatry and Psychotherapy, Central 
      Institute of Mental Health Medical Faculty Mannheim, Heidelberg University, 
      Mannheim, Germany.
FAU - Bramati, Ivanei
AU  - Bramati I
AD  - D'Or Institute for Research and Education, Rio de Janeiro, Brazil.
FAU - Mattos, Paulo
AU  - Mattos P
AD  - D'Or Institute for Research and Education, Rio de Janeiro, Brazil; Institute of 
      Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
FAU - Tovar-Moll, Fernanda
AU  - Tovar-Moll F
AD  - D'Or Institute for Research and Education, Rio de Janeiro, Brazil; Morphological 
      Sciences Program, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
FAU - Douglas, Pamela
AU  - Douglas P
AD  - Department of Psychiatry, University of California, Los Angeles, CA, USA.
FAU - Banaschewski, Tobias
AU  - Banaschewski T
AD  - Department of Child and Adolescent Psychiatry and Psychotherapy, Central 
      Institute of Mental Health Medical Faculty Mannheim, Heidelberg University, 
      Mannheim, Germany.
FAU - Brandeis, Daniel
AU  - Brandeis D
AD  - Department of Child and Adolescent Psychiatry and Psychotherapy, Central 
      Institute of Mental Health Medical Faculty Mannheim, Heidelberg University, 
      Mannheim, Germany; Department of Child and Adolescent Psychiatry, Psychiatric 
      Hospital, University of Zurich, Zurich, Switzerland; Zurich Center for 
      Integrative Human Physiology, University of Zurich, Zurich, Switzerland; 
      Neuroscience Centre Zurich, University of Zurich, Zurich, Switzerland; ETH 
      Zurich, Zurich, Switzerland.
FAU - Kuntsi, Jonna
AU  - Kuntsi J
AD  - Social Genetic and Developmental Psychiatry, Institute of Psychiatry, Psychology 
      and Neuroscience, King's College London, London, UK.
FAU - Asherson, Philip
AU  - Asherson P
AD  - Social Genetic and Developmental Psychiatry, Institute of Psychiatry, Psychology 
      and Neuroscience, King's College London, London, UK.
FAU - Rubia, Katya
AU  - Rubia K
AD  - Department of Child and Adolescent Psychiatry, Institute of Psychiatry, 
      Psychology and Neuroscience, King's College London, London, UK.
FAU - Kelly, Clare
AU  - Kelly C
AD  - Department of Psychiatry, University of Dublin, Trinity College Dublin, Dublin, 
      Ireland; The Child Study Center at NYU Langone Medical Center, New York, NY, USA; 
      Trinity College Institute of Neuroscience, Dublin, Ireland.
FAU - Martino, Adriana Di
AU  - Martino AD
AD  - The Child Study Center at NYU Langone Medical Center, New York, NY, USA.
FAU - Milham, Michael P
AU  - Milham MP
AD  - Center for the Developing Brain, Child Mind Institute, New York, NY, USA; Center 
      for Biomedical Imaging and Neuromodulation, Nathan Kline Institute for 
      Psychiatric Research, Orangeburg, NY, USA.
FAU - Castellanos, Francisco X
AU  - Castellanos FX
AD  - The Child Study Center at NYU Langone Medical Center, New York, NY, USA; Division 
      of Child and Adolescent Psychiatric Research, Nathan Kline Institute for 
      Psychiatric Research, Orangeburg, NY, USA.
FAU - Frodl, Thomas
AU  - Frodl T
AD  - Department of Psychiatry, University of Dublin, Trinity College Dublin, Dublin, 
      Ireland; Department of Psychiatry and Psychotherapy, University Hospital, 
      Otto-von-Guericke-University, Magdeburg, Germany.
FAU - Zentis, Mariam
AU  - Zentis M
AD  - Department of Psychiatry and Psychotherapy, University Hospital, 
      Otto-von-Guericke-University, Magdeburg, Germany.
FAU - Lesch, Klaus-Peter
AU  - Lesch KP
AD  - Division of Molecular Psychiatry, Center of Mental Health, University of 
      Würzburg, Würzburg, Germany; Department of Translational Neuroscience, School for 
      Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands.
FAU - Reif, Andreas
AU  - Reif A
AD  - Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University 
      Hospital Frankfurt, Frankfurt, Germany.
FAU - Pauli, Paul
AU  - Pauli P
AD  - Department of Psychology, University of Würzburg, Würzburg, Germany.
FAU - Jernigan, Terry L
AU  - Jernigan TL
AD  - Departments of Cognitive Science, Psychiatry, Radiology, and Center for Human 
      Development, University of California, San Diego, CA, USA.
FAU - Haavik, Jan
AU  - Haavik J
AD  - KG Jebsen Centre for Neuropsychiatric Disorders, Department of Biomedicine, 
      University of Bergen, Bergen, Norway; Department of Psychiatry, Haukeland 
      University Hospital, Bergen, Norway.
FAU - Plessen, Kerstin J
AU  - Plessen KJ
AD  - Child and Adolescent Mental Health Center, Capital Region, Denmark.
FAU - Lundervold, Astri J
AU  - Lundervold AJ
AD  - Department of Biological and Medical Psychology, University of Bergen, Bergen, 
      Norway.
FAU - Hugdahl, Kenneth
AU  - Hugdahl K
AD  - Department of Psychiatry, Haukeland University Hospital, Bergen, Norway; 
      Department of Radiology, Haukeland University Hospital, Bergen, Norway; 
      Department of Biological and Medical Psychology, University of Bergen, Bergen, 
      Norway.
FAU - Seidman, Larry J
AU  - Seidman LJ
AD  - Department of Psychiatry, Harvard Medical School, Boston, MA, USA; Beth Israel 
      Deaconess Medical Center, Boston, MA, USA.
FAU - Biederman, Joseph
AU  - Biederman J
AD  - Department of Psychiatry, Harvard Medical School, Boston, MA, USA; Clinical and 
      Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts 
      General Hospital, Boston, MA, USA.
FAU - Rommelse, Nanda
AU  - Rommelse N
AD  - Department of Psychiatry, Radboud University Medical Center, Nijmegen, 
      Netherlands; Karakter Child and Adolescent Psychiatry, Nijmegen, Netherlands.
FAU - Heslenfeld, Dirk J
AU  - Heslenfeld DJ
AD  - Department of Cognitive Psychology, VU University Amsterdam, Amsterdam, 
      Netherlands; Department of Clinical Neuropsychology, VU University Amsterdam, 
      Amsterdam, Netherlands.
FAU - Hartman, Catharina A
AU  - Hartman CA
AD  - Department of Psychiatry, University Medical Center Groningen, University of 
      Groningen, Groningen, Netherlands.
FAU - Hoekstra, Pieter J
AU  - Hoekstra PJ
AD  - Department of Psychiatry, University Medical Center Groningen, University of 
      Groningen, Groningen, Netherlands.
FAU - Oosterlaan, Jaap
AU  - Oosterlaan J
AD  - Department of Clinical Neuropsychology, VU University Amsterdam, Amsterdam, 
      Netherlands.
FAU - Polier, Georg von
AU  - Polier GV
AD  - Child Neuropsychology Section, University Hospital Aachen, Aachen, Germany.
FAU - Konrad, Kerstin
AU  - Konrad K
AD  - Child Neuropsychology Section, University Hospital Aachen, Aachen, Germany.
FAU - Vilarroya, Oscar
AU  - Vilarroya O
AD  - Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, 
      Barcelona, Spain; Fundació IMIM, Barcelona, Spain.
FAU - Ramos-Quiroga, Josep Antoni
AU  - Ramos-Quiroga JA
AD  - Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, 
      Barcelona, Spain; Department of Psychiatry, Hospital Universitari Vall d'Hebron, 
      CIBERSAM, Barcelona, Spain.
FAU - Soliva, Joan Carles
AU  - Soliva JC
AD  - Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, 
      Barcelona, Spain.
FAU - Durston, Sarah
AU  - Durston S
AD  - NICHE-lab, Brain Center Rudolf Magnus, Department of Psychiatry, University 
      Medical Center Utrecht, Utrecht, Netherlands.
FAU - Buitelaar, Jan K
AU  - Buitelaar JK
AD  - Department of Cognitive Neuroscience, Radboud University Medical Center, 
      Nijmegen, Netherlands; Donders Institute for Brain, Cognition and Behaviour, 
      Nijmegen, Netherlands; Karakter Child and Adolescent Psychiatry, Nijmegen, 
      Netherlands.
FAU - Faraone, Stephen V
AU  - Faraone SV
AD  - KG Jebsen Centre for Neuropsychiatric Disorders, Department of Biomedicine, 
      University of Bergen, Bergen, Norway; Department of Psychiatry, SUNY Upstate 
      Medical University, Syracuse, NY, USA.
FAU - Shaw, Philip
AU  - Shaw P
AD  - Neurobehavioral Clinical Research Section, National Human Genome Research 
      Institute, Bethesda, MD, USA; National Institute of Mental Health, Bethesda, MD, 
      USA.
FAU - Thompson, Paul M
AU  - Thompson PM
AD  - Imaging Genetics Center, Mark and Mary Stevens Institute for Neuroimaging and 
      Informatics, Keck School of Medicine of USC, University of Southern California, 
      Marina del Rey, CA, USA.
FAU - Franke, Barbara
AU  - Franke B
AD  - Department of Human Genetics, Radboud University Medical Center, Nijmegen, 
      Netherlands; Department of Psychiatry, Radboud University Medical Center, 
      Nijmegen, Netherlands; Donders Institute for Brain, Cognition and Behaviour, 
      Nijmegen, Netherlands.
LA  - eng
GR  - P41 EB015922/EB/NIBIB NIH HHS/United States
GR  - R01 MH062152/MH/NIMH NIH HHS/United States
GR  - R01 MH081803/MH/NIMH NIH HHS/United States
GR  - G0300189/MRC_/Medical Research Council/United Kingdom
GR  - K01 MH110645/MH/NIMH NIH HHS/United States
GR  - U54 EB020403/EB/NIBIB NIH HHS/United States
GR  - R21 MH091461/MH/NIMH NIH HHS/United States
GR  - K23 MH087770/MH/NIMH NIH HHS/United States
GR  - T32 MH067763/MH/NIMH NIH HHS/United States
GR  - U01 MH099059/MH/NIMH NIH HHS/United States
GR  - R01 MH062873/MH/NIMH NIH HHS/United States
GR  - HHSN271200800009C/DA/NIDA NIH HHS/United States
GR  - R01 MH083246/MH/NIMH NIH HHS/United States
GR  - R01 MH094639/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Meta-Analysis
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20170216
PL  - England
TA  - Lancet Psychiatry
JT  - The lancet. Psychiatry
JID - 101638123
SB  - IM
CIN - Lancet Psychiatry. 2017 Apr;4(4):266-268. PMID: 28216024
CIN - Lancet Psychiatry. 2017 Jun;4(6):437. PMID: 28495546
CIN - Lancet Psychiatry. 2017 Jun;4(6):440-441. PMID: 28495548
CIN - Lancet Psychiatry. 2017 Jun;4(6):439. PMID: 28495550
CIN - Lancet Psychiatry. 2017 Jun;4(6):438-439. PMID: 28495551
CIN - Lancet Psychiatry. 2017 Jun;4(6):437-438. PMID: 28495552
EIN - Lancet Psychiatry. 2017 Jun;4(6):436. PMID: 28506628
MH  - Adolescent
MH  - Adult
MH  - Attention Deficit Disorder with Hyperactivity/*pathology/physiopathology
MH  - Brain/*pathology/physiopathology
MH  - Case-Control Studies
MH  - Child
MH  - Child, Preschool
MH  - Cross-Sectional Studies
MH  - Female
MH  - Humans
MH  - Linear Models
MH  - Longitudinal Studies
MH  - *Magnetic Resonance Imaging
MH  - Male
MH  - Middle Aged
MH  - Neuroimaging
MH  - Young Adult
PMC - PMC5933934
MID - NIHMS854669
EDAT- 2017/02/22 06:00
MHDA- 2019/06/30 06:00
CRDT- 2017/02/22 06:00
PHST- 2016/09/26 00:00 [received]
PHST- 2017/01/04 00:00 [revised]
PHST- 2017/01/09 00:00 [accepted]
PHST- 2017/02/22 06:00 [pubmed]
PHST- 2019/06/30 06:00 [medline]
PHST- 2017/02/22 06:00 [entrez]
AID - S2215-0366(17)30049-4 [pii]
AID - 10.1016/S2215-0366(17)30049-4 [doi]
PST - ppublish
SO  - Lancet Psychiatry. 2017 Apr;4(4):310-319. doi: 10.1016/S2215-0366(17)30049-4. 
      Epub 2017 Feb 16.

PMID- 33268356
OWN - NLM
STAT- MEDLINE
DCOM- 20220415
LR  - 20220910
IS  - 2375-2548 (Electronic)
IS  - 2375-2548 (Linking)
VI  - 6
IP  - 49
DP  - 2020 Dec
TI  - Histone H3.3 beyond cancer: Germline mutations in Histone 3 Family 3A and 3B 
      cause a previously unidentified neurodegenerative disorder in 46 patients.
LID - 10.1126/sciadv.abc9207 [doi]
LID - eabc9207
AB  - Although somatic mutations in Histone 3.3 (H3.3) are well-studied drivers of 
      oncogenesis, the role of germline mutations remains unreported. We analyze 46 
      patients bearing de novo germline mutations in histone 3 family 3A (H3F3A) or 
      H3F3B with progressive neurologic dysfunction and congenital anomalies without 
      malignancies. Molecular modeling of all 37 variants demonstrated clear 
      disruptions in interactions with DNA, other histones, and histone chaperone 
      proteins. Patient histone posttranslational modifications (PTMs) analysis 
      revealed notably aberrant local PTM patterns distinct from the somatic lysine 
      mutations that cause global PTM dysregulation. RNA sequencing on patient cells 
      demonstrated up-regulated gene expression related to mitosis and cell division, 
      and cellular assays confirmed an increased proliferative capacity. A zebrafish 
      model showed craniofacial anomalies and a defect in Foxd3-derived glia. These 
      data suggest that the mechanism of germline mutations are distinct from 
      cancer-associated somatic histone mutations but may converge on control of cell 
      proliferation.
CI  - Copyright © 2020 The Authors, some rights reserved; exclusive licensee American 
      Association for the Advancement of Science. No claim to original U.S. Government 
      Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 
      (CC BY-NC).
FAU - Bryant, Laura
AU  - Bryant L
AUID- ORCID: 0000-0001-8483-8940
AD  - Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, 
      PA 19104, USA.
FAU - Li, Dong
AU  - Li D
AUID- ORCID: 0000-0002-2265-6727
AD  - Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, 
      PA 19104, USA.
FAU - Cox, Samuel G
AU  - Cox SG
AD  - Department of Stem Cell Biology and Regenerative Medicine, Keck School of 
      Medicine, University of Southern California, CA 90033, USA.
FAU - Marchione, Dylan
AU  - Marchione D
AD  - Epigenetics Institute, Department of Biochemistry and Biophysics, Perelman School 
      of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
FAU - Joiner, Evan F
AU  - Joiner EF
AD  - Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 
      10032, USA.
FAU - Wilson, Khadija
AU  - Wilson K
AD  - Epigenetics Institute, Department of Biochemistry and Biophysics, Perelman School 
      of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
FAU - Janssen, Kevin
AU  - Janssen K
AD  - Epigenetics Institute, Department of Biochemistry and Biophysics, Perelman School 
      of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
FAU - Lee, Pearl
AU  - Lee P
AD  - Abramson Family Cancer Research Institute, Perelman School of Medicine, 
      University of Pennsylvania, Philadelphia, PA 19104, USA.
FAU - March, Michael E
AU  - March ME
AD  - Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, 
      PA 19104, USA.
FAU - Nair, Divya
AU  - Nair D
AD  - Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, 
      PA 19104, USA.
FAU - Sherr, Elliott
AU  - Sherr E
AUID- ORCID: 0000-0002-4118-5385
AD  - Department of Neurology, University of California, San Francisco, San Francisco, 
      CA 94158, USA.
FAU - Fregeau, Brieana
AU  - Fregeau B
AD  - Department of Neurology, University of California, San Francisco, San Francisco, 
      CA 94158, USA.
FAU - Wierenga, Klaas J
AU  - Wierenga KJ
AD  - Department of Clinical Genomics, Mayo Clinic Florida, Jacksonville, FL 32224, 
      USA.
FAU - Wadley, Alexandrea
AU  - Wadley A
AD  - Department of Clinical Genomics, Mayo Clinic Florida, Jacksonville, FL 32224, 
      USA.
FAU - Mancini, Grazia M S
AU  - Mancini GMS
AD  - Department of Clinical Genetics, Erasmus University Medical Center, 3015 CN 
      Rotterdam, Netherlands.
FAU - Powell-Hamilton, Nina
AU  - Powell-Hamilton N
AD  - Department of Medical Genetics, Alfred I. duPont Hospital for Children, 
      Wilmington, DE 19810, USA.
FAU - van de Kamp, Jiddeke
AU  - van de Kamp J
AD  - Department of Clinical Genetics, VU Medical Center, Amsterdam, Netherlands.
FAU - Grebe, Theresa
AU  - Grebe T
AD  - Division of Genetics and Metabolism, Phoenix Children's Hospital, Phoenix, AZ 
      85016, USA.
FAU - Dean, John
AU  - Dean J
AUID- ORCID: 0000-0003-3841-0841
AD  - Department of Medical Genetics, Aberdeen Royal Infirmary, Aberdeen, Scotland, UK.
FAU - Ross, Alison
AU  - Ross A
AD  - Department of Medical Genetics, Aberdeen Royal Infirmary, Aberdeen, Scotland, UK.
FAU - Crawford, Heather P
AU  - Crawford HP
AD  - Clinical and Metabolic Genetics, Cook Children's Medical Center, Fort Worth, TX 
      76104, USA.
FAU - Powis, Zoe
AU  - Powis Z
AD  - Department of Emerging Genetic Medicine, Ambry Genetics, Aliso Viejo, CA 92656, 
      USA.
FAU - Cho, Megan T
AU  - Cho MT
AD  - GeneDx, 207 Perry Parkway, Gaithersburg, MD 20877, USA.
FAU - Willing, Marcia C
AU  - Willing MC
AD  - Division of Genetics and Genomic Medicine, Department of Pediatrics, Washington 
      University in St. Louis, School of Medicine, St. Louis, MO 63110, USA.
FAU - Manwaring, Linda
AU  - Manwaring L
AD  - Division of Genetics and Genomic Medicine, Department of Pediatrics, Washington 
      University in St. Louis, School of Medicine, St. Louis, MO 63110, USA.
FAU - Schot, Rachel
AU  - Schot R
AD  - Department of Clinical Genetics, Erasmus University Medical Center, 3015 CN 
      Rotterdam, Netherlands.
FAU - Nava, Caroline
AU  - Nava C
AD  - Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Inserm U 1127, CNRS UMR 
      7225, ICM, Paris, France.
AD  - AP-HP, Hôpital de la Pitié-Salpêtrière, Département de Génétique, F-75013 Paris, 
      France.
FAU - Afenjar, Alexandra
AU  - Afenjar A
AD  - Service de génétique, CRMR des malformations et maladies congénitales du cervelet 
      et CRMR déficience intellectuelle, hôpital Trousseau, AP-HP, France.
FAU - Lessel, Davor
AU  - Lessel D
AUID- ORCID: 0000-0003-4496-244X
AD  - Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 
      Hamburg, Germany.
AD  - Undiagnosed Disease Program at the University Medical Center Hamburg-Eppendorf 
      (UDP-UKE), Martinistrasse 52, 20246 Hamburg, Germany.
FAU - Wagner, Matias
AU  - Wagner M
AD  - Institut für Neurogenomik, Helmholtz Zentrum München, Munich, Germany.
AD  - Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany.
AD  - Institut für Humangenetik, Technische Universität München, Munich, Germany.
FAU - Klopstock, Thomas
AU  - Klopstock T
AUID- ORCID: 0000-0003-2805-4652
AD  - Friedrich-Baur-Institute, Department of Neurology, Ludwig-Maximilians University, 
      Ziemssenstr. 1a, 80336 Munich, Germany.
AD  - German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
AD  - Munich Cluster for Systems Neurology, SyNergy, Munich, Germany.
FAU - Winkelmann, Juliane
AU  - Winkelmann J
AD  - Institut für Neurogenomik, Helmholtz Zentrum München, Munich, Germany.
AD  - Institut für Humangenetik, Technische Universität München, Munich, Germany.
AD  - Munich Cluster for Systems Neurology, SyNergy, Munich, Germany.
AD  - Klinik und Poliklinik für Neurologie, Klinikum rechts der Isar, Technische 
      Universität München, Munich, Germany.
FAU - Catarino, Claudia B
AU  - Catarino CB
AD  - Friedrich-Baur-Institute, Department of Neurology, Ludwig-Maximilians University, 
      Ziemssenstr. 1a, 80336 Munich, Germany.
FAU - Retterer, Kyle
AU  - Retterer K
AD  - GeneDx, 207 Perry Parkway, Gaithersburg, MD 20877, USA.
FAU - Schuette, Jane L
AU  - Schuette JL
AD  - Division of Genetics, Metabolism, and Genomic Medicine, Department of Pediatrics 
      and Communicable Diseases, University of Michigan, Ann Arbor, MI 48109, USA.
FAU - Innis, Jeffrey W
AU  - Innis JW
AD  - Division of Genetics, Metabolism, and Genomic Medicine, Department of Pediatrics 
      and Communicable Diseases, University of Michigan, Ann Arbor, MI 48109, USA.
FAU - Pizzino, Amy
AU  - Pizzino A
AD  - Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA 
      19104, USA.
AD  - Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19103, 
      USA.
FAU - Lüttgen, Sabine
AU  - Lüttgen S
AD  - Department of Pediatrics, University Medical Center Eppendorf, 20246 Hamburg, 
      Germany.
FAU - Denecke, Jonas
AU  - Denecke J
AD  - Department of Pediatrics, University Medical Center Eppendorf, 20246 Hamburg, 
      Germany.
FAU - Strom, Tim M
AU  - Strom TM
AD  - Institut für Neurogenomik, Helmholtz Zentrum München, Munich, Germany.
AD  - Institut für Humangenetik, Technische Universität München, Munich, Germany.
FAU - Monaghan, Kristin G
AU  - Monaghan KG
AD  - GeneDx, 207 Perry Parkway, Gaithersburg, MD 20877, USA.
CN  - DDD Study
FAU - Yuan, Zuo-Fei
AU  - Yuan ZF
AD  - Epigenetics Institute, Department of Biochemistry and Biophysics, Perelman School 
      of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
FAU - Dubbs, Holly
AU  - Dubbs H
AD  - Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA 
      19104, USA.
AD  - Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19103, 
      USA.
FAU - Bend, Renee
AU  - Bend R
AD  - Greenwood Genetic Center, Greenwood, SC 29646, USA.
FAU - Lee, Jennifer A
AU  - Lee JA
AD  - Greenwood Genetic Center, Greenwood, SC 29646, USA.
FAU - Lyons, Michael J
AU  - Lyons MJ
AD  - Greenwood Genetic Center, Greenwood, SC 29646, USA.
FAU - Hoefele, Julia
AU  - Hoefele J
AD  - Institut für Humangenetik, Technische Universität München, Munich, Germany.
FAU - Günthner, Roman
AU  - Günthner R
AD  - Department of Nephrology, Klinikum Rechts der Isar, Technical University Munich, 
      Munich, Germany.
AD  - Institute of Human Genetics, Klinikum Rechts der Isar, Technical University 
      Munich, Munich, Germany.
FAU - Reutter, Heiko
AU  - Reutter H
AD  - Department of Neonatology and Pediatric Intensive Care, Children's Hospital, 
      University Hospital Bonn & Institute of Human Genetics, University Hospital Bonn, 
      Bonn, Germany.
FAU - Keren, Boris
AU  - Keren B
AD  - AP-HP, Hôpital de la Pitié-Salpêtrière, Département de Génétique, F-75013 Paris, 
      France.
FAU - Radtke, Kelly
AU  - Radtke K
AD  - Department of Clinical Genomics, Ambry Genetics, Aliso Viejo, CA 92656, USA.
FAU - Sherbini, Omar
AU  - Sherbini O
AD  - Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA 
      19104, USA.
AD  - Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19103, 
      USA.
FAU - Mrokse, Cameron
AU  - Mrokse C
AD  - Department of Clinical Genomics, Ambry Genetics, Aliso Viejo, CA 92656, USA.
FAU - Helbig, Katherine L
AU  - Helbig KL
AD  - Department of Clinical Genomics, Ambry Genetics, Aliso Viejo, CA 92656, USA.
FAU - Odent, Sylvie
AU  - Odent S
AD  - CHU Rennes, Service de Génétique Clinique, CNRS UMR6290, University Rennes1, 
      Rennes, France.
FAU - Cogne, Benjamin
AU  - Cogne B
AD  - CHU Nantes, Service de Génétique Médicale, 9 quai Moncousu, 44093 Nantes, France.
AD  - INSERM, CNRS, UNIV Nantes, CHU Nantes, l'institut du thorax, 44007 Nantes, 
      France.
FAU - Mercier, Sandra
AU  - Mercier S
AD  - CHU Nantes, Service de Génétique Médicale, 9 quai Moncousu, 44093 Nantes, France.
AD  - INSERM, CNRS, UNIV Nantes, CHU Nantes, l'institut du thorax, 44007 Nantes, 
      France.
FAU - Bezieau, Stephane
AU  - Bezieau S
AD  - CHU Nantes, Service de Génétique Médicale, 9 quai Moncousu, 44093 Nantes, France.
AD  - INSERM, CNRS, UNIV Nantes, CHU Nantes, l'institut du thorax, 44007 Nantes, 
      France.
FAU - Besnard, Thomas
AU  - Besnard T
AD  - CHU Nantes, Service de Génétique Médicale, 9 quai Moncousu, 44093 Nantes, France.
AD  - INSERM, CNRS, UNIV Nantes, CHU Nantes, l'institut du thorax, 44007 Nantes, 
      France.
FAU - Kury, Sebastien
AU  - Kury S
AUID- ORCID: 0000-0001-5497-0465
AD  - CHU Nantes, Service de Génétique Médicale, 9 quai Moncousu, 44093 Nantes, France.
AD  - INSERM, CNRS, UNIV Nantes, CHU Nantes, l'institut du thorax, 44007 Nantes, 
      France.
FAU - Redon, Richard
AU  - Redon R
AD  - INSERM, CNRS, UNIV Nantes, CHU Nantes, l'institut du thorax, 44007 Nantes, 
      France.
FAU - Reinson, Karit
AU  - Reinson K
AD  - Department of Clinical Genetics, United Laboratories, Tartu University Hospital, 
      Tartu, Estonia.
AD  - Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
FAU - Wojcik, Monica H
AU  - Wojcik MH
AD  - Division of Genetics and Genomics and Division of Newborn Medicine, Department of 
      Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, 
      USA.
AD  - Broad Institute, Cambridge, MA 02142, USA.
FAU - Õunap, Katrin
AU  - Õunap K
AD  - Department of Clinical Genetics, United Laboratories, Tartu University Hospital, 
      Tartu, Estonia.
AD  - Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
FAU - Ilves, Pilvi
AU  - Ilves P
AD  - Radiology Department of Tartu University Hospital and Institute of Clinical 
      Medicine, University of Tartu, Tartu, Estonia.
FAU - Innes, A Micheil
AU  - Innes AM
AD  - Alberta Children's Hospital Research Institute, Department of Medical Genetics, 
      Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
FAU - Kernohan, Kristin D
AU  - Kernohan KD
AD  - Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario 
      K1H8L1, Canada.
AD  - Newborn Screening Ontario (NSO), Children's Hospital of Eastern Ontario, Ottawa, 
      Ontario, Canada.
CN  - Care4Rare Canada Consortium
FAU - Costain, Gregory
AU  - Costain G
AD  - Division of Clinical and Metabolic Genetics, Department of Pediatrics, University 
      of Toronto, The Hospital for Sick Children, Toronto, Ontario, Canada.
FAU - Meyn, M Stephen
AU  - Meyn MS
AD  - Division of Clinical and Metabolic Genetics, Department of Pediatrics, University 
      of Toronto, The Hospital for Sick Children, Toronto, Ontario, Canada.
AD  - The Center for Human Genomics and Precision Medicine, School of Medicine and 
      Public Health, University of Wisconsin - Madison, Madison, Wisconsin 53705, USA.
FAU - Chitayat, David
AU  - Chitayat D
AD  - Division of Clinical and Metabolic Genetics, Department of Pediatrics, University 
      of Toronto, The Hospital for Sick Children, Toronto, Ontario, Canada.
AD  - The Prenatal Diagnosis and Medical Genetics Program, Mount Sinai Hospital, 
      Toronto, Ontario, Canada.
FAU - Zackai, Elaine
AU  - Zackai E
AD  - Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA 
      19104, USA.
FAU - Lehman, Anna
AU  - Lehman A
AD  - Department of Medical Genetics, University of British Columbia, Vancouver, 
      Canada.
FAU - Kitson, Hilary
AU  - Kitson H
AD  - Department of Pediatrics, University of British Columbia, Vancouver, Canada.
CN  - CAUSES Study
FAU - Martin, Martin G
AU  - Martin MG
AD  - Division of Gastroenterology and Nutrition, Department of Pediatrics, Mattel 
      Children's Hospital, Los Angeles, CA 90095, USA.
AD  - Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and 
      the David Geffen School of Medicine, UCLA, Los Angeles, CA 90095, USA.
FAU - Martinez-Agosto, Julian A
AU  - Martinez-Agosto JA
AD  - Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, 
      CA 90095, USA.
AD  - Division of Medical Genetics, Department of Pediatrics, David Geffen School of 
      Medicine, UCLA, Los Angeles, CA 90095, USA.
CN  - Undiagnosed Diseases Network
FAU - Nelson, Stan F
AU  - Nelson SF
AD  - Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, 
      CA 90095, USA.
AD  - Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, 
      UCLA, Los Angeles, CA 90095, USA.
FAU - Palmer, Christina G S
AU  - Palmer CGS
AD  - Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, 
      CA 90095, USA.
AD  - Institute for Society and Genetics, Department of Psychiatry and Biobehavioral 
      Sciences, David Geffen School of Medicine, UCLA, Los Angeles, CA 90095, USA.
FAU - Papp, Jeanette C
AU  - Papp JC
AD  - Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, 
      CA 90095, USA.
FAU - Parker, Neil H
AU  - Parker NH
AD  - David Geffen School of Medicine, Los Angeles, CA 90095, USA.
FAU - Sinsheimer, Janet S
AU  - Sinsheimer JS
AD  - Institute for Society and Genetics, Departments of Human Genetics, 
      Biomathematics, and Biostatistics, David Geffen School of Medicine, UCLA, Los 
      Angeles, CA 90095, USA.
FAU - Vilain, Eric
AU  - Vilain E
AD  - Center for Genetic Medicine Research, Children's National Medical Center, 
      Washington, DC 20010, USA.
FAU - Wan, Jijun
AU  - Wan J
AD  - Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, 
      CA 90095, USA.
FAU - Yoon, Amanda J
AU  - Yoon AJ
AD  - Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, 
      CA 90095, USA.
FAU - Zheng, Allison
AU  - Zheng A
AD  - Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, 
      CA 90095, USA.
FAU - Brimble, Elise
AU  - Brimble E
AD  - Department of Neurology and Neurological Sciences, Stanford Medicine, Stanford, 
      CA 94305, USA.
FAU - Ferrero, Giovanni Battista
AU  - Ferrero GB
AD  - Department of Public Health and Pediatrics, University of Torino, Turin, Italy.
FAU - Radio, Francesca Clementina
AU  - Radio FC
AD  - Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, 
      Rome, Italy.
FAU - Carli, Diana
AU  - Carli D
AD  - Department of Public Health and Pediatrics, University of Torino, Turin, Italy.
FAU - Barresi, Sabina
AU  - Barresi S
AD  - Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, 
      Rome, Italy.
FAU - Brusco, Alfredo
AU  - Brusco A
AUID- ORCID: 0000-0002-8318-7231
AD  - Department of Medical Sciences, University of Torino, Turin, Italy.
FAU - Tartaglia, Marco
AU  - Tartaglia M
AD  - Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, 
      Rome, Italy.
FAU - Thomas, Jennifer Muncy
AU  - Thomas JM
AD  - Pediatrics and Neurology and Neurotherapeutics, UT Southwestern Medical Center, 
      Dallas, TX 75390, USA.
FAU - Umana, Luis
AU  - Umana L
AD  - Genetics and Metabolism, UT Southwestern Medical Center, Dallas, TX 75390, USA.
FAU - Weiss, Marjan M
AU  - Weiss MM
AD  - Department of Clinical Genetics, VU Medical Center, Amsterdam, Netherlands.
FAU - Gotway, Garrett
AU  - Gotway G
AD  - Genetics and Metabolism, UT Southwestern Medical Center, Dallas, TX 75390, USA.
FAU - Stuurman, K E
AU  - Stuurman KE
AD  - Department of Clinical Genetics, Erasmus University Medical Center, 3015 CN 
      Rotterdam, Netherlands.
FAU - Thompson, Michelle L
AU  - Thompson ML
AD  - HudsonAlpha Institute for Biotechnology, Huntsville, AL 35806, USA.
FAU - McWalter, Kirsty
AU  - McWalter K
AUID- ORCID: 0000-0002-1654-9036
AD  - GeneDx, 207 Perry Parkway, Gaithersburg, MD 20877, USA.
FAU - Stumpel, Constance T R M
AU  - Stumpel CTRM
AD  - Department of Clinical Genetics, Maastricht University Medical Center, 
      Maastricht, Netherlands.
FAU - Stevens, Servi J C
AU  - Stevens SJC
AUID- ORCID: 0000-0001-8769-3150
AD  - Department of Clinical Genetics, Maastricht University Medical Center, 
      Maastricht, Netherlands.
FAU - Stegmann, Alexander P A
AU  - Stegmann APA
AD  - Department of Clinical Genetics, Maastricht University Medical Center, 
      Maastricht, Netherlands.
FAU - Tveten, Kristian
AU  - Tveten K
AD  - Department of Medical Genetics, Telemark Hospital Trust, 3710 Skien, Norway.
FAU - Vøllo, Arve
AU  - Vøllo A
AD  - Department of Pediatrics, Hospital of Østfold, 1714 Grålum, Norway.
FAU - Prescott, Trine
AU  - Prescott T
AD  - Department of Medical Genetics, Telemark Hospital Trust, 3710 Skien, Norway.
FAU - Fagerberg, Christina
AU  - Fagerberg C
AD  - Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
FAU - Laulund, Lone Walentin
AU  - Laulund LW
AD  - H.C. Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.
FAU - Larsen, Martin J
AU  - Larsen MJ
AD  - Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
FAU - Byler, Melissa
AU  - Byler M
AD  - SUNY Upstate Medical University, Syracuse, NY 13210, USA.
FAU - Lebel, Robert Roger
AU  - Lebel RR
AD  - SUNY Upstate Medical University, Syracuse, NY 13210, USA.
FAU - Hurst, Anna C
AU  - Hurst AC
AD  - University of Alabama at Birmingham, Birmingham, AL 35294, USA.
FAU - Dean, Joy
AU  - Dean J
AD  - University of Alabama at Birmingham, Birmingham, AL 35294, USA.
FAU - Schrier Vergano, Samantha A
AU  - Schrier Vergano SA
AD  - Division of Medical Genetics and Metabolism, Children's Hospital of The King's 
      Daughters, Norfolk VA 23507, USA.
FAU - Norman, Jennifer
AU  - Norman J
AD  - INTEGRIS Pediatric Neurology, Oklahoma City, OK 73112, USA.
FAU - Mercimek-Andrews, Saadet
AU  - Mercimek-Andrews S
AD  - Division of Clinical and Metabolic Genetics, Department of Pediatrics, University 
      of Toronto, The Hospital for Sick Children, Toronto, Ontario, Canada.
FAU - Neira, Juanita
AU  - Neira J
AD  - Department of Human Genetics, Emory University, Atlanta, GA 30322, USA.
FAU - Van Allen, Margot I
AU  - Van Allen MI
AD  - Department of Medical Genetics, University of British Columbia, Vancouver, 
      Canada.
AD  - Medical Genetics Programs, Provincial Health Shared Services BC and Vancouver 
      Island Health Shared Services BC, Canada.
FAU - Longo, Nicola
AU  - Longo N
AD  - Division of Medical Genetics, Department of Pediatrics, University of Utah, Salt 
      Lake City, UT 84112, USA.
FAU - Sellars, Elizabeth
AU  - Sellars E
AD  - University of Arkansas for Medical Sciences, Little Rock, AR 72701, USA.
FAU - Louie, Raymond J
AU  - Louie RJ
AD  - Greenwood Genetic Center, Greenwood, SC 29646, USA.
FAU - Cathey, Sara S
AU  - Cathey SS
AD  - Greenwood Genetic Center, Greenwood, SC 29646, USA.
FAU - Brokamp, Elly
AU  - Brokamp E
AD  - Vanderbilt University, Nashville, TN 37203, USA.
FAU - Heron, Delphine
AU  - Heron D
AD  - AP-HP, Hôpital de la Pitié-Salpêtrière, Département de Génétique, F-75013 Paris, 
      France.
FAU - Snyder, Molly
AU  - Snyder M
AD  - Child Neurology, UT Southwestern Medical Center, Dallas, TX 75390, USA.
FAU - Vanderver, Adeline
AU  - Vanderver A
AD  - Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA 
      19104, USA.
AD  - Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19103, 
      USA.
FAU - Simon, Celeste
AU  - Simon C
AD  - Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 
      10032, USA.
FAU - de la Cruz, Xavier
AU  - de la Cruz X
AD  - Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, 
      Barcelona, Spain.
AD  - Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
FAU - Padilla, Natália
AU  - Padilla N
AD  - Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, 
      Barcelona, Spain.
FAU - Crump, J Gage
AU  - Crump JG
AUID- ORCID: 0000-0002-3209-0026
AD  - Department of Stem Cell Biology and Regenerative Medicine, Keck School of 
      Medicine, University of Southern California, CA 90033, USA.
FAU - Chung, Wendy
AU  - Chung W
AD  - Departments of Pediatrics and Medicine, Columbia University Irving Medical 
      Center, New York, NY 10032, USA.
FAU - Garcia, Benjamin
AU  - Garcia B
AD  - Department of Stem Cell Biology and Regenerative Medicine, Keck School of 
      Medicine, University of Southern California, CA 90033, USA.
AD  - Epigenetics Institute, Department of Biochemistry and Biophysics, Perelman School 
      of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
FAU - Hakonarson, Hakon H
AU  - Hakonarson HH
AUID- ORCID: 0000-0003-2814-7461
AD  - Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, 
      PA 19104, USA.
FAU - Bhoj, Elizabeth J
AU  - Bhoj EJ
AUID- ORCID: 0000-0001-5748-3507
AD  - Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, 
      PA 19104, USA. bhoje@email.chop.edu.
LA  - eng
GR  - T32 GM008275/GM/NIGMS NIH HHS/United States
GR  - R35 DE027550/DE/NIDCR NIH HHS/United States
GR  - K12 HD043245/HD/NICHD NIH HHS/United States
GR  - T35 DK093430/DK/NIDDK NIH HHS/United States
GR  - T32 HD07466/HD/NICHD NIH HHS/United States
GR  - R01 NS058721/NS/NINDS NIH HHS/United States
GR  - P01 CA196539/CA/NCI NIH HHS/United States
GR  - GM110174/GM/NIGMS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20201202
PL  - United States
TA  - Sci Adv
JT  - Science advances
JID - 101653440
RN  - 0 (Forkhead Transcription Factors)
RN  - 0 (H3-3A protein, human)
RN  - 0 (Histones)
RN  - 0 (Zebrafish Proteins)
RN  - 0 (foxd3 protein, zebrafish)
SB  - IM
MH  - Animals
MH  - Forkhead Transcription Factors/genetics
MH  - Germ-Line Mutation
MH  - *Histones/genetics/metabolism
MH  - Humans
MH  - *Neurodegenerative Diseases/genetics
MH  - Zebrafish/genetics/metabolism
MH  - Zebrafish Proteins/metabolism
PMC - PMC7821880
EDAT- 2020/12/04 06:00
MHDA- 2022/04/16 06:00
CRDT- 2020/12/03 05:39
PHST- 2020/05/21 00:00 [received]
PHST- 2020/10/19 00:00 [accepted]
PHST- 2020/12/03 05:39 [entrez]
PHST- 2020/12/04 06:00 [pubmed]
PHST- 2022/04/16 06:00 [medline]
AID - 6/49/eabc9207 [pii]
AID - abc9207 [pii]
AID - 10.1126/sciadv.abc9207 [doi]
PST - epublish
SO  - Sci Adv. 2020 Dec 2;6(49):eabc9207. doi: 10.1126/sciadv.abc9207. Print 2020 Dec.

PMID- 32636358
OWN - NLM
STAT- MEDLINE
DCOM- 20210618
LR  - 20210618
IS  - 2158-3188 (Electronic)
IS  - 2158-3188 (Linking)
VI  - 10
IP  - 1
DP  - 2020 Jul 7
TI  - Designing m-Health interventions for precision mental health support.
PG  - 222
LID - 10.1038/s41398-020-00895-2 [doi]
LID - 222
AB  - Mobile health (m-Health) resources are emerging as a significant tool to overcome 
      mental health support access barriers due to their ability to rapidly reach and 
      provide support to individuals in need of mental health support. m-Health 
      provides an approach to adapt and initiate mental health support at precise 
      moments, when they are most likely to be effective for the individual. However, 
      poor adoption of mental health apps in the real world suggests that new 
      approaches to optimising the quality of m-Health interventions are critically 
      needed in order to realise the potential translational benefits for mental health 
      support. The micro-randomised trial is an experimental approach for optimising 
      and adapting m-Health resources. This trial design provides data to construct and 
      optimise m-Health interventions. The data can be used to inform when and what 
      type of m-Health interventions should be initiated, and thus serve to integrate 
      interventions into daily routines with precision. Here, we illustrate this 
      approach in a case study, review implementation issues that need to be considered 
      while conducting an MRT, and provide a checklist for mental health m-Health 
      intervention developers.
FAU - Bidargaddi, N
AU  - Bidargaddi N
AUID- ORCID: 0000-0003-2868-9260
AD  - College of Medicine & Public Health, Flinders University, Adelaide, Australia. 
      niranjan.bidargaddi@flinders.edu.au.
FAU - Schrader, G
AU  - Schrader G
AD  - College of Medicine & Public Health, Flinders University, Adelaide, Australia.
FAU - Klasnja, P
AU  - Klasnja P
AD  - School of Information, University of Michigan, Ann Arbor, MI, USA.
FAU - Licinio, J
AU  - Licinio J
AD  - Departments of Psychiatry, Pharmacology, Medicine and Neuroscience & Physiology, 
      State University of New York Upstate Medical University, Syracuse, New York, USA.
FAU - Murphy, S
AU  - Murphy S
AD  - Departments of Statistics & Computer Science, Harvard University, Boston, MA, 
      USA.
LA  - eng
GR  - P50 DA039838/DA/NIDA NIH HHS/United States
GR  - R01 AA023187/AA/NIAAA NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Review
DEP - 20200707
PL  - United States
TA  - Transl Psychiatry
JT  - Translational psychiatry
JID - 101562664
SB  - IM
MH  - Humans
MH  - *Mental Health
MH  - *Telemedicine
PMC - PMC7341865
COIS- G.S., P.K., J.L. and S.M. declare that they have no conflict of interest. N.B. is 
      a shareholder of goAct.
EDAT- 2020/07/09 06:00
MHDA- 2021/06/22 06:00
CRDT- 2020/07/09 06:00
PHST- 2019/12/15 00:00 [received]
PHST- 2020/05/28 00:00 [accepted]
PHST- 2020/05/25 00:00 [revised]
PHST- 2020/07/09 06:00 [entrez]
PHST- 2020/07/09 06:00 [pubmed]
PHST- 2021/06/22 06:00 [medline]
AID - 10.1038/s41398-020-00895-2 [pii]
AID - 895 [pii]
AID - 10.1038/s41398-020-00895-2 [doi]
PST - epublish
SO  - Transl Psychiatry. 2020 Jul 7;10(1):222. doi: 10.1038/s41398-020-00895-2.

PMID- 28969442
OWN - NLM
STAT- MEDLINE
DCOM- 20180207
LR  - 20210109
IS  - 1535-7228 (Electronic)
IS  - 0002-953X (Print)
IS  - 0002-953X (Linking)
VI  - 175
IP  - 1
DP  - 2018 Jan 1
TI  - Psychiatric Genomics: An Update and an Agenda.
PG  - 15-27
LID - 10.1176/appi.ajp.2017.17030283 [doi]
AB  - The Psychiatric Genomics Consortium (PGC) is the largest consortium in the 
      history of psychiatry. This global effort is dedicated to rapid progress and open 
      science, and in the past decade it has delivered an increasing flow of new 
      knowledge about the fundamental basis of common psychiatric disorders. The PGC 
      has recently commenced a program of research designed to deliver "actionable" 
      findings-genomic results that 1) reveal fundamental biology, 2) inform clinical 
      practice, and 3) deliver new therapeutic targets. The central idea of the PGC is 
      to convert the family history risk factor into biologically, clinically, and 
      therapeutically meaningful insights. The emerging findings suggest that we are 
      entering a phase of accelerated genetic discovery for multiple psychiatric 
      disorders. These findings are likely to elucidate the genetic portions of these 
      truly complex traits, and this knowledge can then be mined for its relevance for 
      improved therapeutics and its impact on psychiatric practice within a precision 
      medicine framework. [AJP at 175: Remembering Our Past As We Envision Our Future 
      November 1946: The Genetic Theory of Schizophrenia Franz Kallmann's influential 
      twin study of schizophrenia in 691 twin pairs was the largest in the field for 
      nearly four decades. (Am J Psychiatry 1946; 103:309-322 )].
FAU - Sullivan, Patrick F
AU  - Sullivan PF
AD  - From the Department of Medical Epidemiology and Biostatistics, Karolinska 
      Institutet, Stockholm; the Departments of Genetics, Psychiatry, and Nutrition, 
      University of North Carolina, Chapel Hill, N.C.; the Department of Psychiatry, 
      Washington University School of Medicine, St Louis; the Norwegian Centre for 
      Mental Disorders Research (NORMENT), K.G. Jebsen Centre for Research on 
      Neuropsychiatric Disorders, University of Oslo and Oslo University Hospital, 
      Oslo; the Lundbeck Foundation Initiative for Integrative Psychiatric Research 
      (iPSYCH), Aarhus, Denmark; the Center for Integrative Sequencing (iSEQ), Aarhus 
      University, Aarhus, Denmark; the Department of Biomedicine-Human Genetics, Aarhus 
      University, Aarhus, Denmark; the Institute of Psychiatry, Psychology and 
      Neuroscience, MRC Social, Genetic and Developmental Psychiatry Centre, King's 
      College London, London; the National Institute for Health Research Biomedical 
      Research Centre, South London and Maudsley National Health Service Trust, London; 
      the Division of Medical Genetics, Department of Biomedicine, University of Basel, 
      Basel, Switzerland; the Institute of Human Genetics, University of Bonn, Bonn, 
      Germany; the Department of Genomics, Life and Brain Center, Bonn, Germany; the 
      Institute of Neuroscience and Medicine, Juelich, Germany; the Department of 
      Biochemistry and Molecular Biology, Indiana University School of Medicine, 
      Indianapolis; the Departments of Psychiatry and of Neuroscience and Physiology, 
      SUNY Upstate Medical University, Syracuse, N.Y.; the Department of Psychiatry, 
      Yale University, New Haven, Conn.; the Department of Psychiatry and the Genetics 
      Institute, University of Florida, Gainesville; the Department of Psychiatry, 
      University of California-San Diego, La Jolla, Calif., the Psychiatric and 
      Neurodevelopmental Genetics Unit, Center for Genomic Medicine, and the Department 
      of Psychiatry, Massachusetts General Hospital, Boston; the Stanley Center for 
      Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Mass.; and 
      the MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of 
      Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff 
      University, Cardiff, U.K.
FAU - Agrawal, Arpana
AU  - Agrawal A
AD  - From the Department of Medical Epidemiology and Biostatistics, Karolinska 
      Institutet, Stockholm; the Departments of Genetics, Psychiatry, and Nutrition, 
      University of North Carolina, Chapel Hill, N.C.; the Department of Psychiatry, 
      Washington University School of Medicine, St Louis; the Norwegian Centre for 
      Mental Disorders Research (NORMENT), K.G. Jebsen Centre for Research on 
      Neuropsychiatric Disorders, University of Oslo and Oslo University Hospital, 
      Oslo; the Lundbeck Foundation Initiative for Integrative Psychiatric Research 
      (iPSYCH), Aarhus, Denmark; the Center for Integrative Sequencing (iSEQ), Aarhus 
      University, Aarhus, Denmark; the Department of Biomedicine-Human Genetics, Aarhus 
      University, Aarhus, Denmark; the Institute of Psychiatry, Psychology and 
      Neuroscience, MRC Social, Genetic and Developmental Psychiatry Centre, King's 
      College London, London; the National Institute for Health Research Biomedical 
      Research Centre, South London and Maudsley National Health Service Trust, London; 
      the Division of Medical Genetics, Department of Biomedicine, University of Basel, 
      Basel, Switzerland; the Institute of Human Genetics, University of Bonn, Bonn, 
      Germany; the Department of Genomics, Life and Brain Center, Bonn, Germany; the 
      Institute of Neuroscience and Medicine, Juelich, Germany; the Department of 
      Biochemistry and Molecular Biology, Indiana University School of Medicine, 
      Indianapolis; the Departments of Psychiatry and of Neuroscience and Physiology, 
      SUNY Upstate Medical University, Syracuse, N.Y.; the Department of Psychiatry, 
      Yale University, New Haven, Conn.; the Department of Psychiatry and the Genetics 
      Institute, University of Florida, Gainesville; the Department of Psychiatry, 
      University of California-San Diego, La Jolla, Calif., the Psychiatric and 
      Neurodevelopmental Genetics Unit, Center for Genomic Medicine, and the Department 
      of Psychiatry, Massachusetts General Hospital, Boston; the Stanley Center for 
      Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Mass.; and 
      the MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of 
      Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff 
      University, Cardiff, U.K.
FAU - Bulik, Cynthia M
AU  - Bulik CM
AD  - From the Department of Medical Epidemiology and Biostatistics, Karolinska 
      Institutet, Stockholm; the Departments of Genetics, Psychiatry, and Nutrition, 
      University of North Carolina, Chapel Hill, N.C.; the Department of Psychiatry, 
      Washington University School of Medicine, St Louis; the Norwegian Centre for 
      Mental Disorders Research (NORMENT), K.G. Jebsen Centre for Research on 
      Neuropsychiatric Disorders, University of Oslo and Oslo University Hospital, 
      Oslo; the Lundbeck Foundation Initiative for Integrative Psychiatric Research 
      (iPSYCH), Aarhus, Denmark; the Center for Integrative Sequencing (iSEQ), Aarhus 
      University, Aarhus, Denmark; the Department of Biomedicine-Human Genetics, Aarhus 
      University, Aarhus, Denmark; the Institute of Psychiatry, Psychology and 
      Neuroscience, MRC Social, Genetic and Developmental Psychiatry Centre, King's 
      College London, London; the National Institute for Health Research Biomedical 
      Research Centre, South London and Maudsley National Health Service Trust, London; 
      the Division of Medical Genetics, Department of Biomedicine, University of Basel, 
      Basel, Switzerland; the Institute of Human Genetics, University of Bonn, Bonn, 
      Germany; the Department of Genomics, Life and Brain Center, Bonn, Germany; the 
      Institute of Neuroscience and Medicine, Juelich, Germany; the Department of 
      Biochemistry and Molecular Biology, Indiana University School of Medicine, 
      Indianapolis; the Departments of Psychiatry and of Neuroscience and Physiology, 
      SUNY Upstate Medical University, Syracuse, N.Y.; the Department of Psychiatry, 
      Yale University, New Haven, Conn.; the Department of Psychiatry and the Genetics 
      Institute, University of Florida, Gainesville; the Department of Psychiatry, 
      University of California-San Diego, La Jolla, Calif., the Psychiatric and 
      Neurodevelopmental Genetics Unit, Center for Genomic Medicine, and the Department 
      of Psychiatry, Massachusetts General Hospital, Boston; the Stanley Center for 
      Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Mass.; and 
      the MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of 
      Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff 
      University, Cardiff, U.K.
FAU - Andreassen, Ole A
AU  - Andreassen OA
AD  - From the Department of Medical Epidemiology and Biostatistics, Karolinska 
      Institutet, Stockholm; the Departments of Genetics, Psychiatry, and Nutrition, 
      University of North Carolina, Chapel Hill, N.C.; the Department of Psychiatry, 
      Washington University School of Medicine, St Louis; the Norwegian Centre for 
      Mental Disorders Research (NORMENT), K.G. Jebsen Centre for Research on 
      Neuropsychiatric Disorders, University of Oslo and Oslo University Hospital, 
      Oslo; the Lundbeck Foundation Initiative for Integrative Psychiatric Research 
      (iPSYCH), Aarhus, Denmark; the Center for Integrative Sequencing (iSEQ), Aarhus 
      University, Aarhus, Denmark; the Department of Biomedicine-Human Genetics, Aarhus 
      University, Aarhus, Denmark; the Institute of Psychiatry, Psychology and 
      Neuroscience, MRC Social, Genetic and Developmental Psychiatry Centre, King's 
      College London, London; the National Institute for Health Research Biomedical 
      Research Centre, South London and Maudsley National Health Service Trust, London; 
      the Division of Medical Genetics, Department of Biomedicine, University of Basel, 
      Basel, Switzerland; the Institute of Human Genetics, University of Bonn, Bonn, 
      Germany; the Department of Genomics, Life and Brain Center, Bonn, Germany; the 
      Institute of Neuroscience and Medicine, Juelich, Germany; the Department of 
      Biochemistry and Molecular Biology, Indiana University School of Medicine, 
      Indianapolis; the Departments of Psychiatry and of Neuroscience and Physiology, 
      SUNY Upstate Medical University, Syracuse, N.Y.; the Department of Psychiatry, 
      Yale University, New Haven, Conn.; the Department of Psychiatry and the Genetics 
      Institute, University of Florida, Gainesville; the Department of Psychiatry, 
      University of California-San Diego, La Jolla, Calif., the Psychiatric and 
      Neurodevelopmental Genetics Unit, Center for Genomic Medicine, and the Department 
      of Psychiatry, Massachusetts General Hospital, Boston; the Stanley Center for 
      Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Mass.; and 
      the MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of 
      Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff 
      University, Cardiff, U.K.
FAU - Børglum, Anders D
AU  - Børglum AD
AD  - From the Department of Medical Epidemiology and Biostatistics, Karolinska 
      Institutet, Stockholm; the Departments of Genetics, Psychiatry, and Nutrition, 
      University of North Carolina, Chapel Hill, N.C.; the Department of Psychiatry, 
      Washington University School of Medicine, St Louis; the Norwegian Centre for 
      Mental Disorders Research (NORMENT), K.G. Jebsen Centre for Research on 
      Neuropsychiatric Disorders, University of Oslo and Oslo University Hospital, 
      Oslo; the Lundbeck Foundation Initiative for Integrative Psychiatric Research 
      (iPSYCH), Aarhus, Denmark; the Center for Integrative Sequencing (iSEQ), Aarhus 
      University, Aarhus, Denmark; the Department of Biomedicine-Human Genetics, Aarhus 
      University, Aarhus, Denmark; the Institute of Psychiatry, Psychology and 
      Neuroscience, MRC Social, Genetic and Developmental Psychiatry Centre, King's 
      College London, London; the National Institute for Health Research Biomedical 
      Research Centre, South London and Maudsley National Health Service Trust, London; 
      the Division of Medical Genetics, Department of Biomedicine, University of Basel, 
      Basel, Switzerland; the Institute of Human Genetics, University of Bonn, Bonn, 
      Germany; the Department of Genomics, Life and Brain Center, Bonn, Germany; the 
      Institute of Neuroscience and Medicine, Juelich, Germany; the Department of 
      Biochemistry and Molecular Biology, Indiana University School of Medicine, 
      Indianapolis; the Departments of Psychiatry and of Neuroscience and Physiology, 
      SUNY Upstate Medical University, Syracuse, N.Y.; the Department of Psychiatry, 
      Yale University, New Haven, Conn.; the Department of Psychiatry and the Genetics 
      Institute, University of Florida, Gainesville; the Department of Psychiatry, 
      University of California-San Diego, La Jolla, Calif., the Psychiatric and 
      Neurodevelopmental Genetics Unit, Center for Genomic Medicine, and the Department 
      of Psychiatry, Massachusetts General Hospital, Boston; the Stanley Center for 
      Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Mass.; and 
      the MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of 
      Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff 
      University, Cardiff, U.K.
FAU - Breen, Gerome
AU  - Breen G
AD  - From the Department of Medical Epidemiology and Biostatistics, Karolinska 
      Institutet, Stockholm; the Departments of Genetics, Psychiatry, and Nutrition, 
      University of North Carolina, Chapel Hill, N.C.; the Department of Psychiatry, 
      Washington University School of Medicine, St Louis; the Norwegian Centre for 
      Mental Disorders Research (NORMENT), K.G. Jebsen Centre for Research on 
      Neuropsychiatric Disorders, University of Oslo and Oslo University Hospital, 
      Oslo; the Lundbeck Foundation Initiative for Integrative Psychiatric Research 
      (iPSYCH), Aarhus, Denmark; the Center for Integrative Sequencing (iSEQ), Aarhus 
      University, Aarhus, Denmark; the Department of Biomedicine-Human Genetics, Aarhus 
      University, Aarhus, Denmark; the Institute of Psychiatry, Psychology and 
      Neuroscience, MRC Social, Genetic and Developmental Psychiatry Centre, King's 
      College London, London; the National Institute for Health Research Biomedical 
      Research Centre, South London and Maudsley National Health Service Trust, London; 
      the Division of Medical Genetics, Department of Biomedicine, University of Basel, 
      Basel, Switzerland; the Institute of Human Genetics, University of Bonn, Bonn, 
      Germany; the Department of Genomics, Life and Brain Center, Bonn, Germany; the 
      Institute of Neuroscience and Medicine, Juelich, Germany; the Department of 
      Biochemistry and Molecular Biology, Indiana University School of Medicine, 
      Indianapolis; the Departments of Psychiatry and of Neuroscience and Physiology, 
      SUNY Upstate Medical University, Syracuse, N.Y.; the Department of Psychiatry, 
      Yale University, New Haven, Conn.; the Department of Psychiatry and the Genetics 
      Institute, University of Florida, Gainesville; the Department of Psychiatry, 
      University of California-San Diego, La Jolla, Calif., the Psychiatric and 
      Neurodevelopmental Genetics Unit, Center for Genomic Medicine, and the Department 
      of Psychiatry, Massachusetts General Hospital, Boston; the Stanley Center for 
      Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Mass.; and 
      the MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of 
      Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff 
      University, Cardiff, U.K.
FAU - Cichon, Sven
AU  - Cichon S
AD  - From the Department of Medical Epidemiology and Biostatistics, Karolinska 
      Institutet, Stockholm; the Departments of Genetics, Psychiatry, and Nutrition, 
      University of North Carolina, Chapel Hill, N.C.; the Department of Psychiatry, 
      Washington University School of Medicine, St Louis; the Norwegian Centre for 
      Mental Disorders Research (NORMENT), K.G. Jebsen Centre for Research on 
      Neuropsychiatric Disorders, University of Oslo and Oslo University Hospital, 
      Oslo; the Lundbeck Foundation Initiative for Integrative Psychiatric Research 
      (iPSYCH), Aarhus, Denmark; the Center for Integrative Sequencing (iSEQ), Aarhus 
      University, Aarhus, Denmark; the Department of Biomedicine-Human Genetics, Aarhus 
      University, Aarhus, Denmark; the Institute of Psychiatry, Psychology and 
      Neuroscience, MRC Social, Genetic and Developmental Psychiatry Centre, King's 
      College London, London; the National Institute for Health Research Biomedical 
      Research Centre, South London and Maudsley National Health Service Trust, London; 
      the Division of Medical Genetics, Department of Biomedicine, University of Basel, 
      Basel, Switzerland; the Institute of Human Genetics, University of Bonn, Bonn, 
      Germany; the Department of Genomics, Life and Brain Center, Bonn, Germany; the 
      Institute of Neuroscience and Medicine, Juelich, Germany; the Department of 
      Biochemistry and Molecular Biology, Indiana University School of Medicine, 
      Indianapolis; the Departments of Psychiatry and of Neuroscience and Physiology, 
      SUNY Upstate Medical University, Syracuse, N.Y.; the Department of Psychiatry, 
      Yale University, New Haven, Conn.; the Department of Psychiatry and the Genetics 
      Institute, University of Florida, Gainesville; the Department of Psychiatry, 
      University of California-San Diego, La Jolla, Calif., the Psychiatric and 
      Neurodevelopmental Genetics Unit, Center for Genomic Medicine, and the Department 
      of Psychiatry, Massachusetts General Hospital, Boston; the Stanley Center for 
      Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Mass.; and 
      the MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of 
      Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff 
      University, Cardiff, U.K.
FAU - Edenberg, Howard J
AU  - Edenberg HJ
AD  - From the Department of Medical Epidemiology and Biostatistics, Karolinska 
      Institutet, Stockholm; the Departments of Genetics, Psychiatry, and Nutrition, 
      University of North Carolina, Chapel Hill, N.C.; the Department of Psychiatry, 
      Washington University School of Medicine, St Louis; the Norwegian Centre for 
      Mental Disorders Research (NORMENT), K.G. Jebsen Centre for Research on 
      Neuropsychiatric Disorders, University of Oslo and Oslo University Hospital, 
      Oslo; the Lundbeck Foundation Initiative for Integrative Psychiatric Research 
      (iPSYCH), Aarhus, Denmark; the Center for Integrative Sequencing (iSEQ), Aarhus 
      University, Aarhus, Denmark; the Department of Biomedicine-Human Genetics, Aarhus 
      University, Aarhus, Denmark; the Institute of Psychiatry, Psychology and 
      Neuroscience, MRC Social, Genetic and Developmental Psychiatry Centre, King's 
      College London, London; the National Institute for Health Research Biomedical 
      Research Centre, South London and Maudsley National Health Service Trust, London; 
      the Division of Medical Genetics, Department of Biomedicine, University of Basel, 
      Basel, Switzerland; the Institute of Human Genetics, University of Bonn, Bonn, 
      Germany; the Department of Genomics, Life and Brain Center, Bonn, Germany; the 
      Institute of Neuroscience and Medicine, Juelich, Germany; the Department of 
      Biochemistry and Molecular Biology, Indiana University School of Medicine, 
      Indianapolis; the Departments of Psychiatry and of Neuroscience and Physiology, 
      SUNY Upstate Medical University, Syracuse, N.Y.; the Department of Psychiatry, 
      Yale University, New Haven, Conn.; the Department of Psychiatry and the Genetics 
      Institute, University of Florida, Gainesville; the Department of Psychiatry, 
      University of California-San Diego, La Jolla, Calif., the Psychiatric and 
      Neurodevelopmental Genetics Unit, Center for Genomic Medicine, and the Department 
      of Psychiatry, Massachusetts General Hospital, Boston; the Stanley Center for 
      Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Mass.; and 
      the MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of 
      Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff 
      University, Cardiff, U.K.
FAU - Faraone, Stephen V
AU  - Faraone SV
AD  - From the Department of Medical Epidemiology and Biostatistics, Karolinska 
      Institutet, Stockholm; the Departments of Genetics, Psychiatry, and Nutrition, 
      University of North Carolina, Chapel Hill, N.C.; the Department of Psychiatry, 
      Washington University School of Medicine, St Louis; the Norwegian Centre for 
      Mental Disorders Research (NORMENT), K.G. Jebsen Centre for Research on 
      Neuropsychiatric Disorders, University of Oslo and Oslo University Hospital, 
      Oslo; the Lundbeck Foundation Initiative for Integrative Psychiatric Research 
      (iPSYCH), Aarhus, Denmark; the Center for Integrative Sequencing (iSEQ), Aarhus 
      University, Aarhus, Denmark; the Department of Biomedicine-Human Genetics, Aarhus 
      University, Aarhus, Denmark; the Institute of Psychiatry, Psychology and 
      Neuroscience, MRC Social, Genetic and Developmental Psychiatry Centre, King's 
      College London, London; the National Institute for Health Research Biomedical 
      Research Centre, South London and Maudsley National Health Service Trust, London; 
      the Division of Medical Genetics, Department of Biomedicine, University of Basel, 
      Basel, Switzerland; the Institute of Human Genetics, University of Bonn, Bonn, 
      Germany; the Department of Genomics, Life and Brain Center, Bonn, Germany; the 
      Institute of Neuroscience and Medicine, Juelich, Germany; the Department of 
      Biochemistry and Molecular Biology, Indiana University School of Medicine, 
      Indianapolis; the Departments of Psychiatry and of Neuroscience and Physiology, 
      SUNY Upstate Medical University, Syracuse, N.Y.; the Department of Psychiatry, 
      Yale University, New Haven, Conn.; the Department of Psychiatry and the Genetics 
      Institute, University of Florida, Gainesville; the Department of Psychiatry, 
      University of California-San Diego, La Jolla, Calif., the Psychiatric and 
      Neurodevelopmental Genetics Unit, Center for Genomic Medicine, and the Department 
      of Psychiatry, Massachusetts General Hospital, Boston; the Stanley Center for 
      Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Mass.; and 
      the MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of 
      Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff 
      University, Cardiff, U.K.
FAU - Gelernter, Joel
AU  - Gelernter J
AD  - From the Department of Medical Epidemiology and Biostatistics, Karolinska 
      Institutet, Stockholm; the Departments of Genetics, Psychiatry, and Nutrition, 
      University of North Carolina, Chapel Hill, N.C.; the Department of Psychiatry, 
      Washington University School of Medicine, St Louis; the Norwegian Centre for 
      Mental Disorders Research (NORMENT), K.G. Jebsen Centre for Research on 
      Neuropsychiatric Disorders, University of Oslo and Oslo University Hospital, 
      Oslo; the Lundbeck Foundation Initiative for Integrative Psychiatric Research 
      (iPSYCH), Aarhus, Denmark; the Center for Integrative Sequencing (iSEQ), Aarhus 
      University, Aarhus, Denmark; the Department of Biomedicine-Human Genetics, Aarhus 
      University, Aarhus, Denmark; the Institute of Psychiatry, Psychology and 
      Neuroscience, MRC Social, Genetic and Developmental Psychiatry Centre, King's 
      College London, London; the National Institute for Health Research Biomedical 
      Research Centre, South London and Maudsley National Health Service Trust, London; 
      the Division of Medical Genetics, Department of Biomedicine, University of Basel, 
      Basel, Switzerland; the Institute of Human Genetics, University of Bonn, Bonn, 
      Germany; the Department of Genomics, Life and Brain Center, Bonn, Germany; the 
      Institute of Neuroscience and Medicine, Juelich, Germany; the Department of 
      Biochemistry and Molecular Biology, Indiana University School of Medicine, 
      Indianapolis; the Departments of Psychiatry and of Neuroscience and Physiology, 
      SUNY Upstate Medical University, Syracuse, N.Y.; the Department of Psychiatry, 
      Yale University, New Haven, Conn.; the Department of Psychiatry and the Genetics 
      Institute, University of Florida, Gainesville; the Department of Psychiatry, 
      University of California-San Diego, La Jolla, Calif., the Psychiatric and 
      Neurodevelopmental Genetics Unit, Center for Genomic Medicine, and the Department 
      of Psychiatry, Massachusetts General Hospital, Boston; the Stanley Center for 
      Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Mass.; and 
      the MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of 
      Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff 
      University, Cardiff, U.K.
FAU - Mathews, Carol A
AU  - Mathews CA
AD  - From the Department of Medical Epidemiology and Biostatistics, Karolinska 
      Institutet, Stockholm; the Departments of Genetics, Psychiatry, and Nutrition, 
      University of North Carolina, Chapel Hill, N.C.; the Department of Psychiatry, 
      Washington University School of Medicine, St Louis; the Norwegian Centre for 
      Mental Disorders Research (NORMENT), K.G. Jebsen Centre for Research on 
      Neuropsychiatric Disorders, University of Oslo and Oslo University Hospital, 
      Oslo; the Lundbeck Foundation Initiative for Integrative Psychiatric Research 
      (iPSYCH), Aarhus, Denmark; the Center for Integrative Sequencing (iSEQ), Aarhus 
      University, Aarhus, Denmark; the Department of Biomedicine-Human Genetics, Aarhus 
      University, Aarhus, Denmark; the Institute of Psychiatry, Psychology and 
      Neuroscience, MRC Social, Genetic and Developmental Psychiatry Centre, King's 
      College London, London; the National Institute for Health Research Biomedical 
      Research Centre, South London and Maudsley National Health Service Trust, London; 
      the Division of Medical Genetics, Department of Biomedicine, University of Basel, 
      Basel, Switzerland; the Institute of Human Genetics, University of Bonn, Bonn, 
      Germany; the Department of Genomics, Life and Brain Center, Bonn, Germany; the 
      Institute of Neuroscience and Medicine, Juelich, Germany; the Department of 
      Biochemistry and Molecular Biology, Indiana University School of Medicine, 
      Indianapolis; the Departments of Psychiatry and of Neuroscience and Physiology, 
      SUNY Upstate Medical University, Syracuse, N.Y.; the Department of Psychiatry, 
      Yale University, New Haven, Conn.; the Department of Psychiatry and the Genetics 
      Institute, University of Florida, Gainesville; the Department of Psychiatry, 
      University of California-San Diego, La Jolla, Calif., the Psychiatric and 
      Neurodevelopmental Genetics Unit, Center for Genomic Medicine, and the Department 
      of Psychiatry, Massachusetts General Hospital, Boston; the Stanley Center for 
      Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Mass.; and 
      the MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of 
      Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff 
      University, Cardiff, U.K.
FAU - Nievergelt, Caroline M
AU  - Nievergelt CM
AD  - From the Department of Medical Epidemiology and Biostatistics, Karolinska 
      Institutet, Stockholm; the Departments of Genetics, Psychiatry, and Nutrition, 
      University of North Carolina, Chapel Hill, N.C.; the Department of Psychiatry, 
      Washington University School of Medicine, St Louis; the Norwegian Centre for 
      Mental Disorders Research (NORMENT), K.G. Jebsen Centre for Research on 
      Neuropsychiatric Disorders, University of Oslo and Oslo University Hospital, 
      Oslo; the Lundbeck Foundation Initiative for Integrative Psychiatric Research 
      (iPSYCH), Aarhus, Denmark; the Center for Integrative Sequencing (iSEQ), Aarhus 
      University, Aarhus, Denmark; the Department of Biomedicine-Human Genetics, Aarhus 
      University, Aarhus, Denmark; the Institute of Psychiatry, Psychology and 
      Neuroscience, MRC Social, Genetic and Developmental Psychiatry Centre, King's 
      College London, London; the National Institute for Health Research Biomedical 
      Research Centre, South London and Maudsley National Health Service Trust, London; 
      the Division of Medical Genetics, Department of Biomedicine, University of Basel, 
      Basel, Switzerland; the Institute of Human Genetics, University of Bonn, Bonn, 
      Germany; the Department of Genomics, Life and Brain Center, Bonn, Germany; the 
      Institute of Neuroscience and Medicine, Juelich, Germany; the Department of 
      Biochemistry and Molecular Biology, Indiana University School of Medicine, 
      Indianapolis; the Departments of Psychiatry and of Neuroscience and Physiology, 
      SUNY Upstate Medical University, Syracuse, N.Y.; the Department of Psychiatry, 
      Yale University, New Haven, Conn.; the Department of Psychiatry and the Genetics 
      Institute, University of Florida, Gainesville; the Department of Psychiatry, 
      University of California-San Diego, La Jolla, Calif., the Psychiatric and 
      Neurodevelopmental Genetics Unit, Center for Genomic Medicine, and the Department 
      of Psychiatry, Massachusetts General Hospital, Boston; the Stanley Center for 
      Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Mass.; and 
      the MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of 
      Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff 
      University, Cardiff, U.K.
FAU - Smoller, Jordan W
AU  - Smoller JW
AD  - From the Department of Medical Epidemiology and Biostatistics, Karolinska 
      Institutet, Stockholm; the Departments of Genetics, Psychiatry, and Nutrition, 
      University of North Carolina, Chapel Hill, N.C.; the Department of Psychiatry, 
      Washington University School of Medicine, St Louis; the Norwegian Centre for 
      Mental Disorders Research (NORMENT), K.G. Jebsen Centre for Research on 
      Neuropsychiatric Disorders, University of Oslo and Oslo University Hospital, 
      Oslo; the Lundbeck Foundation Initiative for Integrative Psychiatric Research 
      (iPSYCH), Aarhus, Denmark; the Center for Integrative Sequencing (iSEQ), Aarhus 
      University, Aarhus, Denmark; the Department of Biomedicine-Human Genetics, Aarhus 
      University, Aarhus, Denmark; the Institute of Psychiatry, Psychology and 
      Neuroscience, MRC Social, Genetic and Developmental Psychiatry Centre, King's 
      College London, London; the National Institute for Health Research Biomedical 
      Research Centre, South London and Maudsley National Health Service Trust, London; 
      the Division of Medical Genetics, Department of Biomedicine, University of Basel, 
      Basel, Switzerland; the Institute of Human Genetics, University of Bonn, Bonn, 
      Germany; the Department of Genomics, Life and Brain Center, Bonn, Germany; the 
      Institute of Neuroscience and Medicine, Juelich, Germany; the Department of 
      Biochemistry and Molecular Biology, Indiana University School of Medicine, 
      Indianapolis; the Departments of Psychiatry and of Neuroscience and Physiology, 
      SUNY Upstate Medical University, Syracuse, N.Y.; the Department of Psychiatry, 
      Yale University, New Haven, Conn.; the Department of Psychiatry and the Genetics 
      Institute, University of Florida, Gainesville; the Department of Psychiatry, 
      University of California-San Diego, La Jolla, Calif., the Psychiatric and 
      Neurodevelopmental Genetics Unit, Center for Genomic Medicine, and the Department 
      of Psychiatry, Massachusetts General Hospital, Boston; the Stanley Center for 
      Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Mass.; and 
      the MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of 
      Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff 
      University, Cardiff, U.K.
FAU - O'Donovan, Michael C
AU  - O'Donovan MC
AD  - From the Department of Medical Epidemiology and Biostatistics, Karolinska 
      Institutet, Stockholm; the Departments of Genetics, Psychiatry, and Nutrition, 
      University of North Carolina, Chapel Hill, N.C.; the Department of Psychiatry, 
      Washington University School of Medicine, St Louis; the Norwegian Centre for 
      Mental Disorders Research (NORMENT), K.G. Jebsen Centre for Research on 
      Neuropsychiatric Disorders, University of Oslo and Oslo University Hospital, 
      Oslo; the Lundbeck Foundation Initiative for Integrative Psychiatric Research 
      (iPSYCH), Aarhus, Denmark; the Center for Integrative Sequencing (iSEQ), Aarhus 
      University, Aarhus, Denmark; the Department of Biomedicine-Human Genetics, Aarhus 
      University, Aarhus, Denmark; the Institute of Psychiatry, Psychology and 
      Neuroscience, MRC Social, Genetic and Developmental Psychiatry Centre, King's 
      College London, London; the National Institute for Health Research Biomedical 
      Research Centre, South London and Maudsley National Health Service Trust, London; 
      the Division of Medical Genetics, Department of Biomedicine, University of Basel, 
      Basel, Switzerland; the Institute of Human Genetics, University of Bonn, Bonn, 
      Germany; the Department of Genomics, Life and Brain Center, Bonn, Germany; the 
      Institute of Neuroscience and Medicine, Juelich, Germany; the Department of 
      Biochemistry and Molecular Biology, Indiana University School of Medicine, 
      Indianapolis; the Departments of Psychiatry and of Neuroscience and Physiology, 
      SUNY Upstate Medical University, Syracuse, N.Y.; the Department of Psychiatry, 
      Yale University, New Haven, Conn.; the Department of Psychiatry and the Genetics 
      Institute, University of Florida, Gainesville; the Department of Psychiatry, 
      University of California-San Diego, La Jolla, Calif., the Psychiatric and 
      Neurodevelopmental Genetics Unit, Center for Genomic Medicine, and the Department 
      of Psychiatry, Massachusetts General Hospital, Boston; the Stanley Center for 
      Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Mass.; and 
      the MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of 
      Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff 
      University, Cardiff, U.K.
CN  - Psychiatric Genomics Consortium
AD  - From the Department of Medical Epidemiology and Biostatistics, Karolinska 
      Institutet, Stockholm; the Departments of Genetics, Psychiatry, and Nutrition, 
      University of North Carolina, Chapel Hill, N.C.; the Department of Psychiatry, 
      Washington University School of Medicine, St Louis; the Norwegian Centre for 
      Mental Disorders Research (NORMENT), K.G. Jebsen Centre for Research on 
      Neuropsychiatric Disorders, University of Oslo and Oslo University Hospital, 
      Oslo; the Lundbeck Foundation Initiative for Integrative Psychiatric Research 
      (iPSYCH), Aarhus, Denmark; the Center for Integrative Sequencing (iSEQ), Aarhus 
      University, Aarhus, Denmark; the Department of Biomedicine-Human Genetics, Aarhus 
      University, Aarhus, Denmark; the Institute of Psychiatry, Psychology and 
      Neuroscience, MRC Social, Genetic and Developmental Psychiatry Centre, King's 
      College London, London; the National Institute for Health Research Biomedical 
      Research Centre, South London and Maudsley National Health Service Trust, London; 
      the Division of Medical Genetics, Department of Biomedicine, University of Basel, 
      Basel, Switzerland; the Institute of Human Genetics, University of Bonn, Bonn, 
      Germany; the Department of Genomics, Life and Brain Center, Bonn, Germany; the 
      Institute of Neuroscience and Medicine, Juelich, Germany; the Department of 
      Biochemistry and Molecular Biology, Indiana University School of Medicine, 
      Indianapolis; the Departments of Psychiatry and of Neuroscience and Physiology, 
      SUNY Upstate Medical University, Syracuse, N.Y.; the Department of Psychiatry, 
      Yale University, New Haven, Conn.; the Department of Psychiatry and the Genetics 
      Institute, University of Florida, Gainesville; the Department of Psychiatry, 
      University of California-San Diego, La Jolla, Calif., the Psychiatric and 
      Neurodevelopmental Genetics Unit, Center for Genomic Medicine, and the Department 
      of Psychiatry, Massachusetts General Hospital, Boston; the Stanley Center for 
      Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Mass.; and 
      the MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of 
      Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff 
      University, Cardiff, U.K.
LA  - eng
GR  - U01 MH085520/MH/NIMH NIH HHS/United States
GR  - K02 DA032573/DA/NIDA NIH HHS/United States
GR  - MR/P005748/1/MRC_/Medical Research Council/United Kingdom
GR  - U01 MH109536/MH/NIMH NIH HHS/United States
GR  - U01 MH109514/MH/NIMH NIH HHS/United States
GR  - R01 MH101519/MH/NIMH NIH HHS/United States
GR  - U01 MH109532/MH/NIMH NIH HHS/United States
GR  - U01 MH094421/MH/NIMH NIH HHS/United States
GR  - MR/L010305/1/MRC_/Medical Research Council/United Kingdom
GR  - U01 MH109528/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Review
DEP - 20171003
PL  - United States
TA  - Am J Psychiatry
JT  - The American journal of psychiatry
JID - 0370512
RN  - 0 (Psychotropic Drugs)
SB  - IM
CIN - Am J Psychiatry. 2018 Jan 1;175(1):1. PMID: 29301421
MH  - Genome-Wide Association Study
MH  - Genomics/*methods
MH  - Humans
MH  - *Mental Disorders/drug therapy/genetics
MH  - Pharmacogenomic Variants
MH  - Psychiatry/methods
MH  - Psychotropic Drugs/*pharmacology
PMC - PMC5756100
MID - NIHMS888920
OTO - NOTNLM
OT  - Biological Markers
OT  - Genetics
EDAT- 2017/10/04 06:00
MHDA- 2018/02/08 06:00
CRDT- 2017/10/04 06:00
PHST- 2017/10/04 06:00 [pubmed]
PHST- 2018/02/08 06:00 [medline]
PHST- 2017/10/04 06:00 [entrez]
AID - 10.1176/appi.ajp.2017.17030283 [doi]
PST - ppublish
SO  - Am J Psychiatry. 2018 Jan 1;175(1):15-27. doi: 10.1176/appi.ajp.2017.17030283. 
      Epub 2017 Oct 3.

PMID- 37861755
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231031
IS  - 2731-4383 (Electronic)
IS  - 2731-4383 (Linking)
VI  - 1
IP  - 1
DP  - 2021 Sep 23
TI  - Climate change and mental health: a commentary.
PG  - 1
LID - 10.1007/s44192-021-00001-y [doi]
LID - 1
AB  - Climate change represents a major global challenge. Some hallmarks of climate 
      change that have been connected to human activity include an increase of 
      0.8-1.2 °C in global temperatures as well as the warming of upper ocean water. 
      Importantly, approximately 500 million people worldwide face the consequences of 
      desertification. Simultaneously, the world population has grown from 1.6 billion 
      in 1900 to 7.7 billion today, greatly exacerbating the human toll of devastating 
      environmental disasters, which result in increasingly larger and more common mass 
      migrations that also fuel human trafficking and modern-day slavery. The mental 
      health outcomes are staggering and include, in the context of chronic stress, 
      addiction, anxiety disorders, post-traumatic stress disorder (PTSD), bipolar 
      disorder, major depression, and suicidality. Mental health practitioners, 
      healthcare systems, and governments across the world need to be prepared to 
      address the mental health sequelae of climate change.
CI  - © 2021. The Author(s).
FAU - Licinio, Julio
AU  - Licinio J
AD  - Precision Medicine Laboratory in Psychiatry (PMLP), SUNY Upstate Medical 
      University, Institute for Human Performance, 505 Irving Ave 3302, Syracuse, NY, 
      13203, USA. juliolicinio@gmail.com.
FAU - Wong, Ma-Li
AU  - Wong ML
AD  - Precision Medicine Laboratory in Psychiatry (PMLP), SUNY Upstate Medical 
      University, Institute for Human Performance, 505 Irving Ave 3302, Syracuse, NY, 
      13203, USA.
LA  - eng
PT  - Editorial
DEP - 20210923
PL  - Switzerland
TA  - Discov Ment Health
JT  - Discover mental health
JID - 9918350483906676
PMC - PMC10498147
EDAT- 2021/09/23 00:00
MHDA- 2021/09/23 00:01
CRDT- 2023/10/20 11:06
PHST- 2021/09/23 00:01 [medline]
PHST- 2021/09/23 00:00 [pubmed]
PHST- 2023/10/20 11:06 [entrez]
AID - 10.1007/s44192-021-00001-y [pii]
AID - 1 [pii]
AID - 10.1007/s44192-021-00001-y [doi]
PST - epublish
SO  - Discov Ment Health. 2021 Sep 23;1(1):1. doi: 10.1007/s44192-021-00001-y.

PMID- 35580292
OWN - NLM
STAT- MEDLINE
DCOM- 20220519
LR  - 20220519
IS  - 1548-8756 (Electronic)
IS  - 1548-8748 (Linking)
VI  - 42
DP  - 2022 Apr
TI  - Artificial Intelligence in Kidney Cancer.
PG  - 1-11
LID - 10.1200/EDBK_350862 [doi]
AB  - Artificial intelligence is rapidly expanding into nearly all facets of life, 
      particularly within the field of medicine. The diagnosis, characterization, 
      management, and treatment of kidney cancer is ripe with areas for improvement 
      that may be met with the promises of artificial intelligence. Here, we explore 
      the impact of current research work in artificial intelligence for clinicians 
      caring for patients with renal cancer, with a focus on the perspectives of 
      radiologists, pathologists, and urologists. Promising preliminary results 
      indicate that artificial intelligence may assist in the diagnosis and risk 
      stratification of newly discovered renal masses and help guide the clinical 
      treatment of patients with kidney cancer. However, much of the work in this field 
      is still in its early stages, limited in its broader applicability, and hampered 
      by small datasets, the varied appearance and presentation of kidney cancers, and 
      the intrinsic limitations of the rigidly structured tasks artificial intelligence 
      algorithms are trained to complete. Nonetheless, the continued exploration of 
      artificial intelligence holds promise toward improving the clinical care of 
      patients with kidney cancer.
FAU - Rasmussen, Robert
AU  - Rasmussen R
AD  - Department of Radiology, The University of Texas Southwestern Medical Center, 
      Dallas, TX.
FAU - Sanford, Thomas
AU  - Sanford T
AD  - Department of Urology, Upstate Medical University, Syracuse, NY.
FAU - Parwani, Anil V
AU  - Parwani AV
AD  - Department of Pathology, The Ohio State University, Columbus, OH.
FAU - Pedrosa, Ivan
AU  - Pedrosa I
AD  - Department of Radiology, The University of Texas Southwestern Medical Center, 
      Dallas, TX.
AD  - Department of Urology, The University of Texas Southwestern Medical Center, 
      Dallas, TX.
AD  - Advanced Imaging Research Center, The University of Texas Southwestern Medical 
      Center, Dallas, TX.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Am Soc Clin Oncol Educ Book
JT  - American Society of Clinical Oncology educational book. American Society of 
      Clinical Oncology. Annual Meeting
JID - 101233985
SB  - IM
MH  - Algorithms
MH  - *Artificial Intelligence
MH  - Humans
MH  - *Kidney Neoplasms/diagnosis/therapy
MH  - Pathologists
EDAT- 2022/05/18 06:00
MHDA- 2022/05/20 06:00
CRDT- 2022/05/17 16:03
PHST- 2022/05/17 16:03 [entrez]
PHST- 2022/05/18 06:00 [pubmed]
PHST- 2022/05/20 06:00 [medline]
AID - 10.1200/EDBK_350862 [doi]
PST - ppublish
SO  - Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-11. doi: 10.1200/EDBK_350862.

PMID- 35602491
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220524
IS  - 2296-858X (Print)
IS  - 2296-858X (Electronic)
IS  - 2296-858X (Linking)
VI  - 9
DP  - 2022
TI  - Editorial: Clinical Application of Artificial Intelligence in Emergency and 
      Critical Care Medicine, Volume II.
PG  - 910163
LID - 10.3389/fmed.2022.910163 [doi]
LID - 910163
FAU - Zhang, Zhongheng
AU  - Zhang Z
AD  - Department of Emergency Medicine, Sir Run Run Shaw Hospital, Zhejiang University 
      School of Medicine, Hangzhou, China.
FAU - Kashyap, Rahul
AU  - Kashyap R
AD  - Critical Care Independent Multidisciplinary Program, Mayo Clinic, Rochester, MN, 
      United States.
AD  - Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, 
      MN, United States.
FAU - Liu, Nan
AU  - Liu N
AD  - Programme in Health Services and Systems Research, Duke-National University of 
      Singapore Medical School, Singapore, Singapore.
FAU - Su, Longxiang
AU  - Su L
AD  - State Key Laboratory of Complex Severe and Rare Diseases, Department of Critical 
      Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical 
      Science, Peking Union Medical College, Beijing, China.
FAU - Meng, Qinghe
AU  - Meng Q
AD  - Department of Surgery, SUNY Upstate Medical University, Syracuse, NY, United 
      States.
LA  - eng
PT  - Editorial
DEP - 20220506
PL  - Switzerland
TA  - Front Med (Lausanne)
JT  - Frontiers in medicine
JID - 101648047
CON - Editorial on the Research Topic Clinical Application of Artificial Intelligence 
      in Emergency and Critical Care Medicine, Volume II
PMC - PMC9121731
OTO - NOTNLM
OT  - artificial intelligence
OT  - critical care
OT  - emergency and critical care
OT  - heterogeneity
OT  - prediction model
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2022/05/24 06:00
MHDA- 2022/05/24 06:01
CRDT- 2022/05/23 04:26
PHST- 2022/04/01 00:00 [received]
PHST- 2022/04/08 00:00 [accepted]
PHST- 2022/05/23 04:26 [entrez]
PHST- 2022/05/24 06:00 [pubmed]
PHST- 2022/05/24 06:01 [medline]
AID - 10.3389/fmed.2022.910163 [doi]
PST - epublish
SO  - Front Med (Lausanne). 2022 May 6;9:910163. doi: 10.3389/fmed.2022.910163. 
      eCollection 2022.

PMID- 36600889
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230111
IS  - 2296-858X (Print)
IS  - 2296-858X (Electronic)
IS  - 2296-858X (Linking)
VI  - 9
DP  - 2022
TI  - Editorial: Clinical application of artificial intelligence in emergency and 
      critical care medicine, volume III.
PG  - 1075023
LID - 10.3389/fmed.2022.1075023 [doi]
LID - 1075023
FAU - Zhang, Zhongheng
AU  - Zhang Z
AD  - Department of Emergency Medicine, Key Laboratory of Precision Medicine in 
      Diagnosis and Monitoring Research of Zhejiang Province, Sir Run Run Shaw 
      Hospital, Zhejiang University School of Medicine, Hangzhou, China.
AD  - Key Laboratory of Digital Technology in Medical Diagnostics of Zhejiang Province, 
      Hangzhou, China.
FAU - Kashyap, Rahul
AU  - Kashyap R
AD  - Critical Care Independent Multidisciplinary Program, Mayo Clinic, Rochester, MN, 
      United States.
AD  - Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, 
      MN, United States.
FAU - Su, Longxiang
AU  - Su L
AD  - State Key Laboratory of Complex Severe and Rare Diseases, Department of Critical 
      Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical 
      Science and Peking Union Medical College, Beijing, China.
FAU - Meng, Qinghe
AU  - Meng Q
AD  - Department of Surgery, State University of New York Upstate Medical University, 
      Syracuse, NY, United States.
LA  - eng
PT  - Editorial
DEP - 20221219
PL  - Switzerland
TA  - Front Med (Lausanne)
JT  - Frontiers in medicine
JID - 101648047
CON - Editorial on the Research Topic Clinical application of artificial intelligence 
      in emergency and critical care medicine, volume III
PMC - PMC9806846
OTO - NOTNLM
OT  - artificial intelligence
OT  - critical care
OT  - diagnosis
OT  - heterogeneity
OT  - prediction
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2023/01/06 06:00
MHDA- 2023/01/06 06:01
CRDT- 2023/01/05 02:17
PHST- 2022/10/20 00:00 [received]
PHST- 2022/11/04 00:00 [accepted]
PHST- 2023/01/05 02:17 [entrez]
PHST- 2023/01/06 06:00 [pubmed]
PHST- 2023/01/06 06:01 [medline]
AID - 10.3389/fmed.2022.1075023 [doi]
PST - epublish
SO  - Front Med (Lausanne). 2022 Dec 19;9:1075023. doi: 10.3389/fmed.2022.1075023. 
      eCollection 2022.

PMID- 34055839
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20210601
IS  - 2296-858X (Print)
IS  - 2296-858X (Electronic)
IS  - 2296-858X (Linking)
VI  - 8
DP  - 2021
TI  - Artificial Intelligence for Clinical Decision Support in Sepsis.
PG  - 665464
LID - 10.3389/fmed.2021.665464 [doi]
LID - 665464
AB  - Sepsis is one of the main causes of death in critically ill patients. Despite the 
      continuous development of medical technology in recent years, its morbidity and 
      mortality are still high. This is mainly related to the delay in starting 
      treatment and non-adherence of clinical guidelines. Artificial intelligence (AI) 
      is an evolving field in medicine, which has been used to develop a variety of 
      innovative Clinical Decision Support Systems. It has shown great potential in 
      predicting the clinical condition of patients and assisting in clinical 
      decision-making. AI-derived algorithms can be applied to multiple stages of 
      sepsis, such as early prediction, prognosis assessment, mortality prediction, and 
      optimal management. This review describes the latest literature on AI for 
      clinical decision support in sepsis, and outlines the application of AI in the 
      prediction, diagnosis, subphenotyping, prognosis assessment, and clinical 
      management of sepsis. In addition, we discussed the challenges of implementing 
      and accepting this non-traditional methodology for clinical purposes.
CI  - Copyright © 2021 Wu, Du, Gu and Wei.
FAU - Wu, Miao
AU  - Wu M
AD  - Department of Emergency, Renmin Hospital of Wuhan University, Wuhan, China.
FAU - Du, Xianjin
AU  - Du X
AD  - Department of Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, 
      China.
FAU - Gu, Raymond
AU  - Gu R
AD  - Department of Surgery, State University of New York Upstate Medical University, 
      Syracuse, NY, United States.
FAU - Wei, Jie
AU  - Wei J
AD  - Department of Emergency, Renmin Hospital of Wuhan University, Wuhan, China.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20210513
PL  - Switzerland
TA  - Front Med (Lausanne)
JT  - Frontiers in medicine
JID - 101648047
PMC - PMC8155362
OTO - NOTNLM
OT  - artificial intelligence
OT  - deep learning
OT  - early prediction
OT  - machine learning
OT  - sepsis
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2021/06/01 06:00
MHDA- 2021/06/01 06:01
CRDT- 2021/05/31 06:18
PHST- 2021/02/08 00:00 [received]
PHST- 2021/04/06 00:00 [accepted]
PHST- 2021/05/31 06:18 [entrez]
PHST- 2021/06/01 06:00 [pubmed]
PHST- 2021/06/01 06:01 [medline]
AID - 10.3389/fmed.2021.665464 [doi]
PST - epublish
SO  - Front Med (Lausanne). 2021 May 13;8:665464. doi: 10.3389/fmed.2021.665464. 
      eCollection 2021.

PMID- 36474001
OWN - NLM
STAT- MEDLINE
DCOM- 20230106
LR  - 20230724
IS  - 1476-5578 (Electronic)
IS  - 1359-4184 (Print)
IS  - 1359-4184 (Linking)
VI  - 28
IP  - 1
DP  - 2023 Jan
TI  - Microglia-containing human brain organoids for the study of brain development and 
      pathology.
PG  - 96-107
LID - 10.1038/s41380-022-01892-1 [doi]
AB  - Microglia are resident immune cells in the central nervous system, playing 
      critical roles in brain development and homeostasis. Increasing evidence has 
      implicated microglia dysfunction in the pathogenesis of various brain disorders 
      ranging from psychiatric disorders to neurodegenerative diseases. Using a human 
      cell-based model to illuminate the functional mechanisms of microglia will 
      promote pathological studies and drug development. The recently developed 
      microglia-containing human brain organoids (MC-HBOs), in-vitro three-dimensional 
      cell cultures that recapitulate key features of the human brain, have provided a 
      new avenue to model brain development and pathology. However, MC-HBOs generated 
      from different methods differ in the origin, proportion, and fidelity of 
      microglia within the organoids, and may have produced inconsistent results. To 
      help researchers to develop a robust and reproducible model that recapitulates 
      in-vivo signatures of human microglia to study brain development and pathology, 
      this review summarized the current methods used to generate MC-HBOs and provided 
      opinions on the use of MC-HBOs for disease modeling and functional studies.
CI  - © 2022. The Author(s).
FAU - Zhang, Wendiao
AU  - Zhang W
AD  - The First Affiliated Hospital, Multi-Omics Research Center for Brain Disorders, 
      Hengyang Medical School, University of South China, 421001, Hengyang, Hunan, 
      China.
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, and Department of Psychiatry, The Second Xiangya Hospital, Central 
      South University, 410008, Changsha, Hunan, China.
AD  - The First Affiliated Hospital, Clinical Research Center for Immune-Related 
      Encephalopathy of Hunan Province, Hengyang Medical School, University of South 
      China, 421001, Hengyang, Hunan, China.
FAU - Jiang, Jiamei
AU  - Jiang J
AD  - The First Affiliated Hospital, Multi-Omics Research Center for Brain Disorders, 
      Hengyang Medical School, University of South China, 421001, Hengyang, Hunan, 
      China.
AD  - The First Affiliated Hospital, Clinical Research Center for Immune-Related 
      Encephalopathy of Hunan Province, Hengyang Medical School, University of South 
      China, 421001, Hengyang, Hunan, China.
FAU - Xu, Zhenhong
AU  - Xu Z
AD  - The First Affiliated Hospital, Multi-Omics Research Center for Brain Disorders, 
      Hengyang Medical School, University of South China, 421001, Hengyang, Hunan, 
      China.
AD  - The First Affiliated Hospital, Clinical Research Center for Immune-Related 
      Encephalopathy of Hunan Province, Hengyang Medical School, University of South 
      China, 421001, Hengyang, Hunan, China.
AD  - The First Affiliated Hospital, Department of Neurology, Hengyang Medical School, 
      University of South China, 421001, Hengyang, Hunan, China.
FAU - Yan, Hongye
AU  - Yan H
AD  - The First Affiliated Hospital, Multi-Omics Research Center for Brain Disorders, 
      Hengyang Medical School, University of South China, 421001, Hengyang, Hunan, 
      China.
AD  - The First Affiliated Hospital, Clinical Research Center for Immune-Related 
      Encephalopathy of Hunan Province, Hengyang Medical School, University of South 
      China, 421001, Hengyang, Hunan, China.
AD  - The First Affiliated Hospital, Department of Neurology, Hengyang Medical School, 
      University of South China, 421001, Hengyang, Hunan, China.
FAU - Tang, Beisha
AU  - Tang B
AUID- ORCID: 0000-0003-2120-1576
AD  - The First Affiliated Hospital, Multi-Omics Research Center for Brain Disorders, 
      Hengyang Medical School, University of South China, 421001, Hengyang, Hunan, 
      China.
AD  - Department of Neurology, Xiangya Hospital, Central South University, 410008, 
      Changsha, Hunan, China.
FAU - Liu, Chunyu
AU  - Liu C
AUID- ORCID: 0000-0002-5986-4415
AD  - Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, 13210, 
      USA. liuch@upstate.edu.
FAU - Chen, Chao
AU  - Chen C
AUID- ORCID: 0000-0002-5114-2282
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, and Department of Psychiatry, The Second Xiangya Hospital, Central 
      South University, 410008, Changsha, Hunan, China. chenchao@sklmg.edu.cn.
AD  - Hunan Key Laboratory of Animal Models for Human Diseases, Central South 
      University, 410008, Changsha, Hunan, China. chenchao@sklmg.edu.cn.
AD  - Hunan Key Laboratory of Molecular Precision Medicine, Central South University, 
      410008, Changsha, Hunan, China. chenchao@sklmg.edu.cn.
FAU - Meng, Qingtuan
AU  - Meng Q
AUID- ORCID: 0000-0002-6421-162X
AD  - The First Affiliated Hospital, Multi-Omics Research Center for Brain Disorders, 
      Hengyang Medical School, University of South China, 421001, Hengyang, Hunan, 
      China. mengqingtuan@glmc.edu.cnD.
AD  - The First Affiliated Hospital, Clinical Research Center for Immune-Related 
      Encephalopathy of Hunan Province, Hengyang Medical School, University of South 
      China, 421001, Hengyang, Hunan, China. mengqingtuan@glmc.edu.cnD.
AD  - The First Affiliated Hospital, Department of Neurology, Hengyang Medical School, 
      University of South China, 421001, Hengyang, Hunan, China. 
      mengqingtuan@glmc.edu.cnD.
LA  - eng
GR  - R01 MH110920/MH/NIMH NIH HHS/United States
GR  - U01 MH103340/MH/NIMH NIH HHS/United States
GR  - U01 MH116489/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Review
DEP - 20221206
PL  - England
TA  - Mol Psychiatry
JT  - Molecular psychiatry
JID - 9607835
SB  - IM
MH  - Humans
MH  - *Microglia/physiology
MH  - Brain/pathology
MH  - Central Nervous System/physiology
MH  - *Neurodegenerative Diseases
MH  - Organoids/pathology
PMC - PMC9734443
COIS- The authors declare no competing interests.
EDAT- 2022/12/07 06:00
MHDA- 2023/01/07 06:00
CRDT- 2022/12/06 23:35
PHST- 2022/07/19 00:00 [received]
PHST- 2022/11/16 00:00 [accepted]
PHST- 2022/11/16 00:00 [revised]
PHST- 2022/12/07 06:00 [pubmed]
PHST- 2023/01/07 06:00 [medline]
PHST- 2022/12/06 23:35 [entrez]
AID - 10.1038/s41380-022-01892-1 [pii]
AID - 1892 [pii]
AID - 10.1038/s41380-022-01892-1 [doi]
PST - ppublish
SO  - Mol Psychiatry. 2023 Jan;28(1):96-107. doi: 10.1038/s41380-022-01892-1. Epub 2022 
      Dec 6.

PMID- 35567418
OWN - NLM
STAT- MEDLINE
DCOM- 20220913
LR  - 20221120
IS  - 1552-6569 (Electronic)
IS  - 1051-2284 (Linking)
VI  - 32
IP  - 5
DP  - 2022 Sep
TI  - Patient and procedure selection for mechanical thrombectomy: Toward personalized 
      medicine and the role of artificial intelligence.
PG  - 798-807
LID - 10.1111/jon.13003 [doi]
AB  - Mechanical thrombectomy (MT) for ischemic stroke due to large vessel occlusion is 
      standard of care. Evidence-based guidelines on eligibility for MT have been 
      outlined and evidence to extend the treatment benefit to more patients, 
      particularly those at the extreme ends of a stroke clinical severity spectrum, is 
      currently awaited. As patient selection continues to be explored, there is 
      growing focus on procedure selection including the tools and techniques of 
      thrombectomy and associated outcomes. Artificial intelligence (AI) has been 
      instrumental in the area of patient selection for MT with a role in diagnosis and 
      delivery of acute stroke care. Machine learning algorithms have been developed to 
      detect cerebral ischemia and early infarct core, presence of large vessel 
      occlusion, and perfusion deficit in acute ischemic stroke. Several available deep 
      learning AI applications provide ready visualization and interpretation of 
      cervical and cerebral arteries. Further enhancement of AI techniques to 
      potentially include automated vessel probe tools in suspected large vessel 
      occlusions is proposed. Value of AI may be extended to assist in procedure 
      selection including both the tools and technique of thrombectomy. Delivering 
      personalized medicine is the wave of the future and tailoring the MT treatment to 
      a stroke patient is in line with this trend.
CI  - © 2022 American Society of Neuroimaging.
FAU - Al Saiegh, Fadi
AU  - Al Saiegh F
AD  - Department of Neurosurgery, Thomas Jefferson University, Philadelphia, 
      Pennsylvania, USA.
FAU - Munoz, Alfredo
AU  - Munoz A
AD  - Department of Neurosurgery, Thomas Jefferson University, Philadelphia, 
      Pennsylvania, USA.
FAU - Velagapudi, Lohit
AU  - Velagapudi L
AD  - Department of Neurosurgery, Thomas Jefferson University, Philadelphia, 
      Pennsylvania, USA.
FAU - Theofanis, Thana
AU  - Theofanis T
AD  - Department of Neurosurgery, Thomas Jefferson University, Philadelphia, 
      Pennsylvania, USA.
FAU - Suryadevara, Neil
AU  - Suryadevara N
AD  - Department of Neurology, Upstate Medical University, Syracuse, New York, USA.
FAU - Patel, Priyadarshee
AU  - Patel P
AD  - Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, 
      USA.
FAU - Jabre, Roland
AU  - Jabre R
AUID- ORCID: 0000-0003-4102-2006
AD  - Department of Neurosurgery, Thomas Jefferson University, Philadelphia, 
      Pennsylvania, USA.
FAU - Chen, Ching-Jen
AU  - Chen CJ
AD  - Department of Neurosurgery, Thomas Jefferson University, Philadelphia, 
      Pennsylvania, USA.
FAU - Shehabeldin, Mohamed
AU  - Shehabeldin M
AD  - Department of Neurosurgery, Thomas Jefferson University, Philadelphia, 
      Pennsylvania, USA.
FAU - Gooch, Michael Reid
AU  - Gooch MR
AD  - Department of Neurosurgery, Thomas Jefferson University, Philadelphia, 
      Pennsylvania, USA.
FAU - Jabbour, Pascal
AU  - Jabbour P
AD  - Department of Neurosurgery, Thomas Jefferson University, Philadelphia, 
      Pennsylvania, USA.
FAU - Tjoumakaris, Stavropoula
AU  - Tjoumakaris S
AD  - Department of Neurosurgery, Thomas Jefferson University, Philadelphia, 
      Pennsylvania, USA.
FAU - Rosenwasser, Robert H
AU  - Rosenwasser RH
AD  - Department of Neurosurgery, Thomas Jefferson University, Philadelphia, 
      Pennsylvania, USA.
FAU - Herial, Nabeel A
AU  - Herial NA
AUID- ORCID: 0000-0002-5790-783X
AD  - Department of Neurosurgery, Thomas Jefferson University, Philadelphia, 
      Pennsylvania, USA.
AD  - Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, 
      USA.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20220514
PL  - United States
TA  - J Neuroimaging
JT  - Journal of neuroimaging : official journal of the American Society of 
      Neuroimaging
JID - 9102705
SB  - IM
MH  - Artificial Intelligence
MH  - *Brain Ischemia/therapy
MH  - Humans
MH  - *Ischemic Stroke
MH  - Precision Medicine
MH  - Retrospective Studies
MH  - *Stroke/diagnostic imaging/surgery
MH  - Thrombectomy/methods
MH  - Treatment Outcome
OTO - NOTNLM
OT  - artificial intelligence
OT  - mechanical thrombectomy
OT  - stroke
EDAT- 2022/05/15 06:00
MHDA- 2022/09/14 06:00
CRDT- 2022/05/14 06:12
PHST- 2022/04/27 00:00 [revised]
PHST- 2022/02/14 00:00 [received]
PHST- 2022/04/29 00:00 [accepted]
PHST- 2022/05/15 06:00 [pubmed]
PHST- 2022/09/14 06:00 [medline]
PHST- 2022/05/14 06:12 [entrez]
AID - 10.1111/jon.13003 [doi]
PST - ppublish
SO  - J Neuroimaging. 2022 Sep;32(5):798-807. doi: 10.1111/jon.13003. Epub 2022 May 14.

PMID- 29309283
OWN - NLM
STAT- MEDLINE
DCOM- 20190208
LR  - 20190215
IS  - 1532-5520 (Electronic)
IS  - 0009-9201 (Linking)
VI  - 61
IP  - 1
DP  - 2018 Mar
TI  - HIV Infection: Antepartum Treatment and Management.
PG  - 122-136
LID - 10.1097/GRF.0000000000000330 [doi]
AB  - Human immunodeficiency virus (HIV) is a retrovirus which became pandemic in the 
      early 1980s. Since its initial characterization, advancements in diagnosis and 
      management have transformed HIV infection from a terminal diagnosis to a chronic, 
      manageable condition. Effective antiretroviral therapy, acting at multiple steps 
      in the viral lifecycle, durably suppresses viral replication, preserves maternal 
      health and prevents mother to child HIV transmission. Here, we review the salient 
      clinical and ethical considerations of managing HIV infection during pregnancy 
      and delivery.
FAU - Bernstein, Helene B
AU  - Bernstein HB
AD  - Departments of Obstetrics and Gynecology.
AD  - Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, New York.
FAU - Wegman, Adam D
AU  - Wegman AD
AD  - Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, New York.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Clin Obstet Gynecol
JT  - Clinical obstetrics and gynecology
JID - 0070014
RN  - 0 (Anti-Retroviral Agents)
SB  - IM
MH  - Anti-Retroviral Agents/therapeutic use
MH  - Coinfection
MH  - Counseling
MH  - Delivery, Obstetric
MH  - Female
MH  - Genetic Testing
MH  - HIV Infections/*diagnosis/*therapy/transmission
MH  - Hepatitis B, Chronic/diagnosis
MH  - Hepatitis C, Chronic/diagnosis
MH  - Humans
MH  - Infectious Disease Transmission, Vertical/*prevention & control
MH  - Insemination, Artificial
MH  - Postnatal Care
MH  - Preconception Care
MH  - Pregnancy
MH  - Pregnancy Complications, Infectious/*diagnosis/*therapy
MH  - *Prenatal Care
MH  - Safe Sex
MH  - Sexual Partners
MH  - Vaccination
MH  - Viral Load
EDAT- 2018/01/09 06:00
MHDA- 2019/02/09 06:00
CRDT- 2018/01/09 06:00
PHST- 2018/01/09 06:00 [pubmed]
PHST- 2019/02/09 06:00 [medline]
PHST- 2018/01/09 06:00 [entrez]
AID - 10.1097/GRF.0000000000000330 [doi]
PST - ppublish
SO  - Clin Obstet Gynecol. 2018 Mar;61(1):122-136. doi: 10.1097/GRF.0000000000000330.

PMID- 25909217
OWN - NLM
STAT- MEDLINE
DCOM- 20160208
LR  - 20231104
IS  - 1949-2553 (Electronic)
IS  - 1949-2553 (Linking)
VI  - 6
IP  - 11
DP  - 2015 Apr 20
TI  - Targeting Hsp90 in urothelial carcinoma.
PG  - 8454-73
AB  - Urothelial carcinoma, or transitional cell carcinoma, is the most common urologic 
      malignancy that carries significant morbidity, mortality, recurrence risk and 
      associated health care costs. Despite use of current chemotherapies and 
      immunotherapies, long-term remission in patients with muscle-invasive or 
      metastatic disease remains low, and disease recurrence is common. The molecular 
      chaperone Heat Shock Protein-90 (Hsp90) may offer an ideal treatment target, as 
      it is a critical signaling hub in urothelial carcinoma pathogenesis and 
      potentiates chemoradiation. Preclinical testing with Hsp90 inhibitors has 
      demonstrated reduced proliferation, enhanced apoptosis and synergism with 
      chemotherapies and radiation. Despite promising preclinical data, clinical trials 
      utilizing Hsp90 inhibitors for other malignancies had modest efficacy. Therefore, 
      we propose that Hsp90 inhibition would best serve as an adjuvant treatment in 
      advanced muscle-invasive or metastatic bladder cancers to potentiate other 
      therapies. An overview of bladder cancer biology, current treatments, molecular 
      targeted therapies, and the role for Hsp90 inhibitors in the treatment of 
      urothelial carcinoma is the focus of this review.
FAU - Chehab, Mahmoud
AU  - Chehab M
AD  - Department of Urology, SUNY Upstate Medical University, Syracuse, NY 13210, USA.
FAU - Caza, Tiffany
AU  - Caza T
AD  - Department of Pathology, SUNY Upstate Medical University, Syracuse, NY 13210, 
      USA.
FAU - Skotnicki, Kamil
AU  - Skotnicki K
AD  - Department of Urology, SUNY Upstate Medical University, Syracuse, NY 13210, USA.
FAU - Landas, Steve
AU  - Landas S
AD  - Department of Urology, SUNY Upstate Medical University, Syracuse, NY 13210, USA.
AD  - Department of Pathology, SUNY Upstate Medical University, Syracuse, NY 13210, 
      USA.
FAU - Bratslavsky, Gennady
AU  - Bratslavsky G
AD  - Department of Urology, SUNY Upstate Medical University, Syracuse, NY 13210, USA.
AD  - Upstate Cancer Research Institute, SUNY Upstate Medical University, Syracuse, NY 
      13210, USA.
FAU - Mollapour, Mehdi
AU  - Mollapour M
AD  - Department of Urology, SUNY Upstate Medical University, Syracuse, NY 13210, USA.
AD  - Upstate Cancer Research Institute, SUNY Upstate Medical University, Syracuse, NY 
      13210, USA.
AD  - Department of Biochemistry and Molecular Biology, SUNY Upstate Medical 
      University, Syracuse, NY 13210, USA.
FAU - Bourboulia, Dimitra
AU  - Bourboulia D
AD  - Department of Urology, SUNY Upstate Medical University, Syracuse, NY 13210, USA.
AD  - Upstate Cancer Research Institute, SUNY Upstate Medical University, Syracuse, NY 
      13210, USA.
AD  - Department of Biochemistry and Molecular Biology, SUNY Upstate Medical 
      University, Syracuse, NY 13210, USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Review
PL  - United States
TA  - Oncotarget
JT  - Oncotarget
JID - 101532965
RN  - 0 (Angiogenesis Inhibitors)
RN  - 0 (Antineoplastic Agents)
RN  - 0 (BCG Vaccine)
RN  - 0 (Drugs, Investigational)
RN  - 0 (HSP90 Heat-Shock Proteins)
RN  - 0 (Neoplasm Proteins)
RN  - 0 (Protein Kinase Inhibitors)
SB  - IM
MH  - Angiogenesis Inhibitors/therapeutic use
MH  - Antineoplastic Agents/therapeutic use
MH  - Apoptosis
MH  - BCG Vaccine/therapeutic use
MH  - Carcinoma, Transitional Cell/epidemiology/metabolism/pathology/*therapy
MH  - Cell Cycle/drug effects
MH  - Cell Division
MH  - Cell Transformation, Neoplastic
MH  - Chemoradiotherapy
MH  - Chemotherapy, Adjuvant
MH  - Clinical Trials as Topic
MH  - Combined Modality Therapy
MH  - Cystectomy
MH  - Drug Resistance, Neoplasm
MH  - Drugs, Investigational/therapeutic use
MH  - HSP90 Heat-Shock Proteins/*antagonists & inhibitors/chemistry/physiology
MH  - Histone Code/drug effects
MH  - Humans
MH  - Models, Biological
MH  - *Molecular Targeted Therapy
MH  - Muscle, Smooth/pathology
MH  - Neoplasm Invasiveness
MH  - Neoplasm Proteins/*antagonists & inhibitors/physiology
MH  - Protein Kinase Inhibitors/therapeutic use
MH  - Signal Transduction/drug effects
MH  - Transcription, Genetic/drug effects
MH  - Urologic Neoplasms/epidemiology/metabolism/pathology/*therapy
PMC - PMC4496161
OTO - NOTNLM
OT  - Hsp90 inhibitors
OT  - bladder cancer treatments
OT  - heat shock protein-90
OT  - pathogenesis
OT  - urothelial carcinoma
EDAT- 2015/04/25 06:00
MHDA- 2016/02/09 06:00
CRDT- 2015/04/25 06:00
PHST- 2014/11/13 00:00 [received]
PHST- 2015/03/09 00:00 [accepted]
PHST- 2015/04/25 06:00 [entrez]
PHST- 2015/04/25 06:00 [pubmed]
PHST- 2016/02/09 06:00 [medline]
AID - 3502 [pii]
AID - 10.18632/oncotarget.3502 [doi]
PST - ppublish
SO  - Oncotarget. 2015 Apr 20;6(11):8454-73. doi: 10.18632/oncotarget.3502.

PMID- 34938754
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20211224
IS  - 2296-858X (Print)
IS  - 2296-858X (Electronic)
IS  - 2296-858X (Linking)
VI  - 8
DP  - 2021
TI  - Editorial: Clinical Application of Artificial Intelligence in Emergency and 
      Critical Care Medicine, Volume I.
PG  - 809478
LID - 10.3389/fmed.2021.809478 [doi]
LID - 809478
FAU - Zhang, Zhongheng
AU  - Zhang Z
AD  - Department of Emergency Medicine, Sir Run Run Shaw Hospital, Zhejiang University 
      School of Medicine, Hangzhou, China.
FAU - Liu, Nan
AU  - Liu N
AD  - Programme in Health Services and Systems Research, Duke-National University of 
      Singapore Medical School, Singapore, Singapore.
FAU - Meng, Qinghe
AU  - Meng Q
AD  - Department of Surgery, State University of New York Upstate Medical University, 
      Syracuse, NY, United States.
FAU - Su, Longxiang
AU  - Su L
AD  - State Key Laboratory of Complex Severe and Rare Diseases, Department of Critical 
      Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical 
      Science and Peking Union Medical College, Beijing, China.
LA  - eng
PT  - Editorial
DEP - 20211206
PL  - Switzerland
TA  - Front Med (Lausanne)
JT  - Frontiers in medicine
JID - 101648047
CON - Editorial on the Research Topic Clinical Application of Artificial Intelligence 
      in Emergency and Critical Care Medicine, Volume I
PMC - PMC8685312
OTO - NOTNLM
OT  - artificial intelligence
OT  - critical Care
OT  - emergency medicine
OT  - precise medicine
OT  - prediction
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2021/12/24 06:00
MHDA- 2021/12/24 06:01
CRDT- 2021/12/23 05:53
PHST- 2021/11/05 00:00 [received]
PHST- 2021/11/22 00:00 [accepted]
PHST- 2021/12/23 05:53 [entrez]
PHST- 2021/12/24 06:00 [pubmed]
PHST- 2021/12/24 06:01 [medline]
AID - 10.3389/fmed.2021.809478 [doi]
PST - epublish
SO  - Front Med (Lausanne). 2021 Dec 6;8:809478. doi: 10.3389/fmed.2021.809478. 
      eCollection 2021.

PMID- 29931654
OWN - NLM
STAT- MEDLINE
DCOM- 20191011
LR  - 20191011
IS  - 1534-6277 (Electronic)
IS  - 1534-6277 (Linking)
VI  - 19
IP  - 8
DP  - 2018 Jun 21
TI  - Precision Neuro-oncology: the Role of Genomic Testing in the Management of Adult 
      and Pediatric Gliomas.
PG  - 41
LID - 10.1007/s11864-018-0559-4 [doi]
AB  - In recent years, large-scale genomic studies have expanded our knowledge 
      regarding genomic drivers in tumors of the central nervous system. While 
      histopathologic analysis of brain tumors remains the primary method for tumor 
      classification, the clinical utility of molecular and genomic testing to support 
      and/or complement tumor classification continues to expand. This approach 
      enhances diagnostic accuracy and provides clinicians with objective data to 
      facilitate discussions regarding prognosis and treatment decisions, including 
      selection of clinical trials. Ensuring accurate diagnoses is fundamental to the 
      management of brain tumor patients. However, given the morphologic overlap among 
      primary brain tumors, genomic data can be used to help distinguish tumor lineage. 
      In its clearest form, we have embraced the concept of an integrated diagnosis, 
      which combines traditional histopathology findings with molecular and genomic 
      data. Patient prognosis varies significantly based on a tumor's genomic profile. 
      For neuro-oncology patients, outcome studies linking diagnoses with genomic 
      profiles show significant differences based on tumor biomarkers such as IDH1/2, 
      H3F3A, BRAF, and CDKN2A and TERT status. Therefore, easy access to reliable 
      genomic data is important in understanding a patient's disease and developing a 
      clinical strategy wherein targeted molecular or immune therapies can be 
      incorporated into the discussion.
FAU - Ramkissoon, Lori A
AU  - Ramkissoon LA
AD  - University of North Carolina School of Medicine, Chapel Hill, NC, USA.
FAU - Britt, Nicholas
AU  - Britt N
AD  - Foundation Medicine, Inc, 7010 Kit Creek Road, Morrisville, NC, 27560, USA.
FAU - Guevara, Alexander
AU  - Guevara A
AD  - Foundation Medicine, Inc, 7010 Kit Creek Road, Morrisville, NC, 27560, USA.
FAU - Whitt, Emily
AU  - Whitt E
AD  - Foundation Medicine, Inc, 7010 Kit Creek Road, Morrisville, NC, 27560, USA.
FAU - Severson, Eric
AU  - Severson E
AD  - Foundation Medicine, Inc, 7010 Kit Creek Road, Morrisville, NC, 27560, USA.
FAU - Sathyan, Pratheesh
AU  - Sathyan P
AD  - Foundation Medicine, Inc, Cambridge, MA, USA.
FAU - Gay, Laurie
AU  - Gay L
AD  - Foundation Medicine, Inc, Cambridge, MA, USA.
FAU - Elvin, Julia
AU  - Elvin J
AD  - Foundation Medicine, Inc, Cambridge, MA, USA.
FAU - Ross, Jeffrey S
AU  - Ross JS
AD  - Foundation Medicine, Inc, Cambridge, MA, USA.
AD  - SUNY Upstate Medical University, Syracuse, NY, USA.
FAU - Brown, Charlotte
AU  - Brown C
AD  - Foundation Medicine, Inc, 7010 Kit Creek Road, Morrisville, NC, 27560, USA.
FAU - Stogner-Underwood, Kimberly
AU  - Stogner-Underwood K
AD  - Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
FAU - Mott, Ryan
AU  - Mott R
AD  - Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
FAU - Kram, David
AU  - Kram D
AD  - Section of Pediatric Hematology-Oncology, Department of Pediatrics, Wake Forest 
      School of Medicine, Winston-Salem, NC, USA.
FAU - Strowd, Roy
AU  - Strowd R
AD  - Section of Hematology-Oncology, Wake Forest School of Medicine, Winston-Salem, 
      NC, USA.
FAU - Lesser, Glenn J
AU  - Lesser GJ
AD  - Section of Hematology-Oncology, Wake Forest School of Medicine, Winston-Salem, 
      NC, USA.
FAU - Ramkissoon, Shakti H
AU  - Ramkissoon SH
AD  - Foundation Medicine, Inc, 7010 Kit Creek Road, Morrisville, NC, 27560, USA. 
      sramkissoon@foundationmedicine.com.
AD  - Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, USA. 
      sramkissoon@foundationmedicine.com.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20180621
PL  - United States
TA  - Curr Treat Options Oncol
JT  - Current treatment options in oncology
JID - 100900946
RN  - 0 (Biomarkers, Tumor)
SB  - IM
MH  - Age Factors
MH  - Biomarkers, Tumor
MH  - Brain Neoplasms/*diagnosis/genetics/mortality/*therapy
MH  - Clinical Trials as Topic
MH  - Combined Modality Therapy
MH  - Disease Management
MH  - Genetic Predisposition to Disease
MH  - Genetic Testing
MH  - Genomics/methods
MH  - Glioma/*diagnosis/genetics/mortality/*therapy
MH  - Humans
MH  - Immunotherapy
MH  - Molecular Targeted Therapy
MH  - Neoplasm Grading
MH  - Neoplasm Staging
MH  - *Precision Medicine/methods
MH  - Prognosis
MH  - Treatment Outcome
OTO - NOTNLM
OT  - Comprehensive genomic profiling
OT  - Glioma
OT  - Immunotherapy
OT  - Targeted therapy
EDAT- 2018/06/23 06:00
MHDA- 2019/10/12 06:00
CRDT- 2018/06/23 06:00
PHST- 2018/06/23 06:00 [entrez]
PHST- 2018/06/23 06:00 [pubmed]
PHST- 2019/10/12 06:00 [medline]
AID - 10.1007/s11864-018-0559-4 [pii]
AID - 10.1007/s11864-018-0559-4 [doi]
PST - epublish
SO  - Curr Treat Options Oncol. 2018 Jun 21;19(8):41. doi: 10.1007/s11864-018-0559-4.

PMID- 37953324
OWN - NLM
STAT- MEDLINE
DCOM- 20240108
LR  - 20240116
IS  - 1362-4962 (Electronic)
IS  - 0305-1048 (Print)
IS  - 0305-1048 (Linking)
VI  - 52
IP  - D1
DP  - 2024 Jan 5
TI  - The Human Phenotype Ontology in 2024: phenotypes around the world.
PG  - D1333-D1346
LID - 10.1093/nar/gkad1005 [doi]
AB  - The Human Phenotype Ontology (HPO) is a widely used resource that comprehensively 
      organizes and defines the phenotypic features of human disease, enabling 
      computational inference and supporting genomic and phenotypic analyses through 
      semantic similarity and machine learning algorithms. The HPO has widespread 
      applications in clinical diagnostics and translational research, including 
      genomic diagnostics, gene-disease discovery, and cohort analytics. In recent 
      years, groups around the world have developed translations of the HPO from 
      English to other languages, and the HPO browser has been internationalized, 
      allowing users to view HPO term labels and in many cases synonyms and definitions 
      in ten languages in addition to English. Since our last report, a total of 2239 
      new HPO terms and 49235 new HPO annotations were developed, many in collaboration 
      with external groups in the fields of psychiatry, arthrogryposis, immunology and 
      cardiology. The Medical Action Ontology (MAxO) is a new effort to model 
      treatments and other measures taken for clinical management. Finally, the HPO 
      consortium is contributing to efforts to integrate the HPO and the GA4GH 
      Phenopacket Schema into electronic health records (EHRs) with the goal of more 
      standardized and computable integration of rare disease data in EHRs.
CI  - © The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic 
      Acids Research.
FAU - Gargano, Michael A
AU  - Gargano MA
AUID- ORCID: 0000-0002-2157-3591
AD  - The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
FAU - Matentzoglu, Nicolas
AU  - Matentzoglu N
AUID- ORCID: 0000-0002-7356-1779
AD  - Semanticly, Athens, Greece.
FAU - Coleman, Ben
AU  - Coleman B
AUID- ORCID: 0000-0002-4422-1708
AD  - The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
FAU - Addo-Lartey, Eunice B
AU  - Addo-Lartey EB
AD  - Rare Disease Ghana Initiative, Accra, Ghana.
FAU - Anagnostopoulos, Anna V
AU  - Anagnostopoulos AV
AUID- ORCID: 0000-0002-6490-7723
AD  - The Jackson Laboratory, Bar Harbor, ME, USA.
FAU - Anderton, Joel
AU  - Anderton J
AUID- ORCID: 0009-0003-0577-5120
AD  - Center for Craniofacial and Dental Genetics, Department of Oral and Craniofacial 
      Sciences, School of Dental Medicine, University of Pittsburgh, Pittsburgh, PA, 
      USA.
FAU - Avillach, Paul
AU  - Avillach P
AUID- ORCID: 0000-0002-0235-7543
AD  - Harvard Medical School, Boston, MA, USA.
FAU - Bagley, Anita M
AU  - Bagley AM
AUID- ORCID: 0000-0001-9118-8798
AD  - Shriners Children's Northern California, Sacramento, CA, USA.
FAU - Bakštein, Eduard
AU  - Bakštein E
AUID- ORCID: 0000-0002-4672-4923
AD  - National Institute of Mental Health, Klecany, Czech Republic.
FAU - Balhoff, James P
AU  - Balhoff JP
AUID- ORCID: 0000-0002-8688-6599
AD  - Renaissance Computing Institute, University of North Carolina, Chapel Hill, 
      NC 27517, USA.
FAU - Baynam, Gareth
AU  - Baynam G
AD  - Rare Care Centre, Perth Children's Hospital, Perth, Australia.
FAU - Bello, Susan M
AU  - Bello SM
AUID- ORCID: 0000-0003-4606-0597
AD  - The Jackson Laboratory, Bar Harbor, ME, USA.
FAU - Berk, Michael
AU  - Berk M
AUID- ORCID: 0000-0002-5554-6946
AD  - Deakin University, IMPACT - the Institute for Mental and Physical Health and 
      Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia.
FAU - Bertram, Holli
AU  - Bertram H
AUID- ORCID: 0000-0001-9446-5121
AD  - Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
FAU - Bishop, Somer
AU  - Bishop S
AUID- ORCID: 0000-0002-2592-4715
AD  - Department of Psychiatry and Behavioral Sciences, UCSF Weil Institute for 
      Neuroscience, San Francisco, CA, USA.
FAU - Blau, Hannah
AU  - Blau H
AUID- ORCID: 0000-0003-4557-5492
AD  - The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
FAU - Bodenstein, David F
AU  - Bodenstein DF
AUID- ORCID: 0000-0003-4618-6544
AD  - Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, 
      Canada.
FAU - Botas, Pablo
AU  - Botas P
AUID- ORCID: 0000-0001-7090-9648
AD  - Nostos Genomics GmbH, Berlin, Germany.
FAU - Boztug, Kaan
AU  - Boztug K
AUID- ORCID: 0000-0001-8387-9185
AD  - St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
FAU - Čady, Jolana
AU  - Čady J
AUID- ORCID: 0009-0007-2341-9591
AD  - Institute of Health Information and Statistics of the Czech Republic, Prague, 
      Czech Republic.
FAU - Callahan, Tiffany J
AU  - Callahan TJ
AUID- ORCID: 0000-0002-8169-9049
AD  - Department of Biomedical Informatics, Columbia University Irving Medical Center, 
      NY, NY, USA.
FAU - Cameron, Rhiannon
AU  - Cameron R
AUID- ORCID: 0000-0002-9578-0788
AD  - Simon Fraser University, Burnaby, BC, Canada.
FAU - Carbon, Seth J
AU  - Carbon SJ
AUID- ORCID: 0000-0001-8244-1536
AD  - Division of Environmental Genomics and Systems Biology, Lawrence Berkeley 
      National Laboratory, Berkeley, CA 94720, USA.
FAU - Castellanos, Francisco
AU  - Castellanos F
AUID- ORCID: 0009-0002-9789-9595
AD  - The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
FAU - Caufield, J Harry
AU  - Caufield JH
AUID- ORCID: 0000-0001-5705-7831
AD  - Division of Environmental Genomics and Systems Biology, Lawrence Berkeley 
      National Laboratory, Berkeley, CA 94720, USA.
FAU - Chan, Lauren E
AU  - Chan LE
AUID- ORCID: 0000-0002-7463-6306
AD  - College of Public Health and Human Sciences, Oregon State University, Corvallis, 
      OR 97331, USA.
FAU - Chute, Christopher G
AU  - Chute CG
AUID- ORCID: 0000-0001-5437-2545
AD  - Schools of Medicine, Public Health, and Nursing, Johns Hopkins University, 
      Baltimore, MD 21287, USA.
FAU - Cruz-Rojo, Jaime
AU  - Cruz-Rojo J
AUID- ORCID: 0000-0002-8999-2821
AD  - UDISGEN (Dysmorphology and Genetics Unit), 12 de Octubre Hospital, Madrid, Spain.
FAU - Dahan-Oliel, Noémi
AU  - Dahan-Oliel N
AUID- ORCID: 0000-0001-8567-7173
AD  - Department of Clinical Research, Shriners Hospitals for Children, Montreal, 
      Quebec, Canada.
FAU - Davids, Jon R
AU  - Davids JR
AUID- ORCID: 0000-0002-1639-6519
AD  - Shriners Children's Northern California, Sacramento, CA, USA.
FAU - de Dieuleveult, Maud
AU  - de Dieuleveult M
AUID- ORCID: 0000-0002-3387-1836
AD  - Département I&D, AP-HP, Banque Nationale de Données Maladies Rares, Paris, 
      France.
FAU - de Souza, Vinicius
AU  - de Souza V
AD  - European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, 
      Hinxton CB10 1SD, UK.
FAU - de Vries, Bert B A
AU  - de Vries BBA
AUID- ORCID: 0000-0002-0000-2917
AD  - Department of Human Genetics, Donders Institute for Brain, Cognition and 
      Behaviour, Radboud University Medical Center, Nijmegen, Netherlands.
FAU - de Vries, Esther
AU  - de Vries E
AUID- ORCID: 0000-0003-4311-3550
AD  - Tranzo, TSB, Tilburg University, Netherlands.
FAU - DePaulo, J Raymond
AU  - DePaulo JR
AUID- ORCID: 0000-0001-9221-9226
AD  - Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School 
      of Medicine, Baltimore, MD 21287, USA.
FAU - Derfalvi, Beata
AU  - Derfalvi B
AUID- ORCID: 0000-0001-7272-7119
AD  - Department of Pediatrics, Dalhousie University, Halifax, NS, Canada.
FAU - Dhombres, Ferdinand
AU  - Dhombres F
AUID- ORCID: 0000-0003-3246-8727
AD  - Fetal Medicine Department, Armand Trousseau Hospital, Sorbonne University, GRC26, 
      INSERM, Limics, Paris, France.
FAU - Diaz-Byrd, Claudia
AU  - Diaz-Byrd C
AUID- ORCID: 0000-0002-4487-3589
AD  - Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
FAU - Dingemans, Alexander J M
AU  - Dingemans AJM
AUID- ORCID: 0000-0002-5648-2155
AD  - Department of Human Genetics, Donders Institute for Brain, Cognition and 
      Behaviour, Radboud University Medical Center, Nijmegen, Netherlands.
FAU - Donadille, Bruno
AU  - Donadille B
AUID- ORCID: 0000-0002-5507-4782
AD  - St Antoine Hospital, Reference Center for Rare Growth Endocrine Disorders, 
      Sorbonne University, AP-HP, INSERM, US14 - Orphanet, Plateforme Maladies Rares, 
      Paris, France.
FAU - Duyzend, Michael
AU  - Duyzend M
AUID- ORCID: 0000-0002-3941-6447
AD  - Massachusetts General Hospital, Boston, MA, USA.
FAU - Elfeky, Reem
AU  - Elfeky R
AUID- ORCID: 0000-0001-9382-150X
AD  - Department of Immunology, GOS Hospital for Children NHS Foundation Trust, 
      University College London, London, UK.
FAU - Essaid, Shahim
AU  - Essaid S
AUID- ORCID: 0000-0003-2338-2550
AD  - Department of Biomedical Informatics, University of Colorado Anschutz Medical 
      Campus, Aurora, CO 80045, USA.
FAU - Fabrizzi, Carolina
AU  - Fabrizzi C
AUID- ORCID: 0009-0005-6714-5727
AD  - INSERM, US14 - Orphanet, Plateforme Maladies Rares, Paris, France.
FAU - Fico, Giovanna
AU  - Fico G
AUID- ORCID: 0000-0003-1785-7126
AD  - Bipolar and Depressive Disorders Unit, Institute of Neuroscience, Hospital 
      Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
FAU - Firth, Helen V
AU  - Firth HV
AUID- ORCID: 0000-0002-6410-0882
AD  - Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, UK.
FAU - Freudenberg-Hua, Yun
AU  - Freudenberg-Hua Y
AUID- ORCID: 0000-0003-3398-7270
AD  - Department of Psychiatry, Feinstein Institutes for Medical Research, Northwell 
      Health, Manhasset, NY, USA.
FAU - Fullerton, Janice M
AU  - Fullerton JM
AUID- ORCID: 0000-0003-4014-4490
AD  - Neuroscience Research Australia, Sydney, NSW, Australia.
FAU - Gabriel, Davera L
AU  - Gabriel DL
AD  - School of Medicine, Johns Hopkins University, Baltimore, MD 21287, USA.
FAU - Gilmour, Kimberly
AU  - Gilmour K
AUID- ORCID: 0000-0003-0285-3958
AD  - Immunology, NIHR Great Ormond Street Hospital BRC, London, UK.
FAU - Giordano, Jessica
AU  - Giordano J
AUID- ORCID: 0000-0002-2265-0691
AD  - Department of Obstetrics and Gynecology, Columbia University Irving Medical 
      Center, New York, NY, USA.
FAU - Goes, Fernando S
AU  - Goes FS
AUID- ORCID: 0000-0001-6262-8264
AD  - Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School 
      of Medicine, Baltimore, MD 21287, USA.
FAU - Moses, Rachel Gore
AU  - Moses RG
AUID- ORCID: 0000-0002-8253-5441
AD  - National Institute of Allergy and Infectious Diseases, National Institutes of 
      Health, Bethesda, MD 20892, USA.
FAU - Green, Ian
AU  - Green I
AD  - SNOMED International, London W2 6BD, UK.
FAU - Griese, Matthias
AU  - Griese M
AUID- ORCID: 0000-0003-0113-912X
AD  - Department of Pediatrics, Dr. von Hauner Children's Hospital, University 
      Hospital, LMU Munich, German center for Lung research (DZL), Munich, Germany.
FAU - Groza, Tudor
AU  - Groza T
AUID- ORCID: 0000-0003-2267-8333
AD  - Rare Care Centre, Perth Children's Hospital, Perth, Australia.
FAU - Gu, Weihong
AU  - Gu W
AD  - Chinese HPO Consortium, Beijing, China.
FAU - Guthrie, Julia
AU  - Guthrie J
AUID- ORCID: 0000-0003-3411-9598
AD  - Department of Structural and Computational Biology, University of Vienna; Max 
      Perutz Labs, Vienna, Austria.
FAU - Gyori, Benjamin
AU  - Gyori B
AUID- ORCID: 0000-0001-9439-5346
AD  - Khoury College of Computer Sciences, Northeastern University, Boston, MA, USA.
FAU - Hamosh, Ada
AU  - Hamosh A
AUID- ORCID: 0000-0002-1780-5230
AD  - Department of Genetic Medicine, Johns Hopkins University School of Medicine, 
      Baltimore, MD 21287, USA.
FAU - Hanauer, Marc
AU  - Hanauer M
AUID- ORCID: 0000-0002-6758-2506
AD  - INSERM, US14 - Orphanet, Plateforme Maladies Rares, Paris, France.
FAU - Hanušová, Kateřina
AU  - Hanušová K
AUID- ORCID: 0009-0006-9032-1490
AD  - Institute of Health Information and Statistics of the Czech Republic, Prague, 
      Czech Republic.
FAU - He, Yongqun Oliver
AU  - He YO
AUID- ORCID: 0000-0001-9189-9661
AD  - University of Michigan Medical School, Ann Arbor, MI, USA.
FAU - Hegde, Harshad
AU  - Hegde H
AUID- ORCID: 0000-0002-2411-565X
AD  - Division of Environmental Genomics and Systems Biology, Lawrence Berkeley 
      National Laboratory, Berkeley, CA 94720, USA.
FAU - Helbig, Ingo
AU  - Helbig I
AUID- ORCID: 0000-0001-8486-0558
AD  - Neurology, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
FAU - Holasová, Kateřina
AU  - Holasová K
AUID- ORCID: 0000-0002-7896-7057
AD  - Institute of Health Information and Statistics of the Czech Republic, Prague, 
      Czech Republic.
FAU - Hoyt, Charles Tapley
AU  - Hoyt CT
AUID- ORCID: 0000-0003-4423-4370
AD  - Khoury College of Computer Sciences, Northeastern University, Boston, MA, USA.
FAU - Huang, Shangzhi
AU  - Huang S
AD  - Chinese HPO Consortium, Beijing, China.
FAU - Hurwitz, Eric
AU  - Hurwitz E
AUID- ORCID: 0000-0002-6581-7754
AD  - University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
FAU - Jacobsen, Julius O B
AU  - Jacobsen JOB
AUID- ORCID: 0000-0002-3265-1591
AD  - William Harvey Research Institute, Queen Mary University of London, London, UK.
FAU - Jiang, Xiaofeng
AU  - Jiang X
AD  - Chinese HPO Consortium, Beijing, China.
FAU - Joseph, Lisa
AU  - Joseph L
AUID- ORCID: 0000-0001-6862-3616
AD  - Neurodevelopmental and Behavioral Phenotyping Service, National Institute of 
      Mental Health, Bethesda, MD, USA.
FAU - Keramatian, Kamyar
AU  - Keramatian K
AUID- ORCID: 0000-0003-4958-6025
AD  - Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.
FAU - King, Bryan
AU  - King B
AUID- ORCID: 0000-0003-3777-1389
AD  - Department of Psychiatry and Behavioral Sciences, UCSF Weil Institute for 
      Neuroscience, San Francisco, CA, USA.
FAU - Knoflach, Katrin
AU  - Knoflach K
AUID- ORCID: 0000-0002-0104-692X
AD  - Department of Pediatrics, Dr. von Hauner Children's Hospital, University 
      Hospital, LMU Munich, German center for Lung research (DZL), Munich, Germany.
FAU - Koolen, David A
AU  - Koolen DA
AUID- ORCID: 0000-0002-2152-4626
AD  - Department of Human Genetics, Donders Institute for Brain, Cognition and 
      Behaviour, Radboud University Medical Center, Nijmegen, Netherlands.
FAU - Kraus, Megan L
AU  - Kraus ML
AUID- ORCID: 0000-0003-4830-7530
AD  - University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
FAU - Kroll, Carlo
AU  - Kroll C
AD  - William Harvey Research Institute, Queen Mary University of London, London, UK.
FAU - Kusters, Maaike
AU  - Kusters M
AUID- ORCID: 0000-0001-7601-9822
AD  - Immunology, NIHR Great Ormond Street Hospital BRC, London, UK.
FAU - Ladewig, Markus S
AU  - Ladewig MS
AUID- ORCID: 0000-0002-6601-4486
AD  - Department of Ophthalmology, University Clinic Marburg - Campus Fulda, Fulda, 
      Germany.
FAU - Lagorce, David
AU  - Lagorce D
AUID- ORCID: 0000-0002-7356-7986
AD  - INSERM, US14 - Orphanet, Plateforme Maladies Rares, Paris, France.
FAU - Lai, Meng-Chuan
AU  - Lai MC
AUID- ORCID: 0000-0002-9593-5508
AD  - Campbell Family Mental Health Research Institute, Centre for Addiction and Mental 
      Health, Toronto, ON, Canada.
FAU - Lapunzina, Pablo
AU  - Lapunzina P
AUID- ORCID: 0000-0002-6324-4825
AD  - Institute of Medical and Molecular Genetics, Hospital Univ. La Paz, Madrid, 
      Spain.
FAU - Laraway, Bryan
AU  - Laraway B
AUID- ORCID: 0000-0002-0450-7074
AD  - University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
FAU - Lewis-Smith, David
AU  - Lewis-Smith D
AUID- ORCID: 0000-0002-1735-8178
AD  - Translational and Clinical Research Institute, Henry Wellcome Building, 
      Framlington Place, Newcastle University, Newcastle-Upon-Tyne NE14LP, UK.
FAU - Li, Xiarong
AU  - Li X
AD  - Chinese HPO Consortium, Beijing, China.
FAU - Lucano, Caterina
AU  - Lucano C
AUID- ORCID: 0009-0008-3646-7469
AD  - INSERM, US14 - Orphanet, Plateforme Maladies Rares, Paris, France.
FAU - Majd, Marzieh
AU  - Majd M
AUID- ORCID: 0000-0002-7367-663X
AD  - Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, 
      Boston, MA, USA.
FAU - Marazita, Mary L
AU  - Marazita ML
AUID- ORCID: 0000-0002-2648-2832
AD  - Center for Craniofacial and Dental Genetics, Department of Oral and Craniofacial 
      Sciences, School of Dental Medicine, University of Pittsburgh, Pittsburgh, PA, 
      USA.
FAU - Martinez-Glez, Victor
AU  - Martinez-Glez V
AUID- ORCID: 0000-0002-4680-881X
AD  - Center for Genomic Medicine, Parc Taulí Hospital Universitari, Institut 
      d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Sabadell, Spain.
FAU - McHenry, Toby H
AU  - McHenry TH
AD  - Center for Craniofacial and Dental Genetics, Department of Oral and Craniofacial 
      Sciences, School of Dental Medicine, University of Pittsburgh, Pittsburgh, PA, 
      USA.
FAU - McInnis, Melvin G
AU  - McInnis MG
AUID- ORCID: 0000-0002-0375-6247
AD  - Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
FAU - McMurry, Julie A
AU  - McMurry JA
AUID- ORCID: 0000-0002-9353-5498
AD  - University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
FAU - Mihulová, Michaela
AU  - Mihulová M
AUID- ORCID: 0000-0003-0213-0530
AD  - Department of Biology and Medical Genetics, 2nd Medical Faculty of Charles 
      University and University Hospital Motol, Prague, Czech Republic.
FAU - Millett, Caitlin E
AU  - Millett CE
AUID- ORCID: 0000-0003-0072-5522
AD  - Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA.
FAU - Mitchell, Philip B
AU  - Mitchell PB
AUID- ORCID: 0000-0002-7954-5235
AD  - Discipline of Psychiatry & Mental Health, School of Clinical Medicine, Faculty of 
      Medicine & Health, University of New South Wales, Sydney, NSW, Australia.
FAU - Moslerová, Veronika
AU  - Moslerová V
AUID- ORCID: 0000-0003-0194-8162
AD  - Department of Biology and Medical Genetics, 2nd Medical Faculty of Charles 
      University and University Hospital Motol, Prague, Czech Republic.
FAU - Narutomi, Kenji
AU  - Narutomi K
AD  - Okinawa Prefectural Nanbu Medical Center & Children's Medical Center.
FAU - Nematollahi, Shahrzad
AU  - Nematollahi S
AUID- ORCID: 0000-0003-1248-7306
AD  - School of Physical and Occupational Therapy, McGill University, Montreal, Quebec, 
      Canada.
FAU - Nevado, Julian
AU  - Nevado J
AUID- ORCID: 0000-0001-5611-2659
AD  - Institute of Medical and Molecular Genetics, Hospital Univ. La Paz, Madrid, 
      Spain.
FAU - Nierenberg, Andrew A
AU  - Nierenberg AA
AUID- ORCID: 0000-0003-2897-0458
AD  - Dauten Family Center for Bipolar Treatment Innovation, Massachusetts General 
      Hospital, Boston, MA, USA.
FAU - Čajbiková, Nikola Novák
AU  - Čajbiková NN
AUID- ORCID: 0009-0009-4232-1420
AD  - Department of Biology and Medical Genetics, 2nd Medical Faculty of Charles 
      University and University Hospital Motol, Prague, Czech Republic.
FAU - Nurnberger, John I Jr
AU  - Nurnberger JI Jr
AUID- ORCID: 0000-0002-7674-1767
AD  - Stark Neurosciences Research Institute, Departments of Psychiatry and Medical and 
      Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.
FAU - Ogishima, Soichi
AU  - Ogishima S
AUID- ORCID: 0000-0001-8613-2562
AD  - INGEM/ToMMo, Tohoku University, Sendai, Japan.
FAU - Olson, Daniel
AU  - Olson D
AUID- ORCID: 0000-0002-8134-1207
AD  - Data Collaboration Center, Data Science, Critical Path Institute, Tucson, AZ, 
      USA.
FAU - Ortiz, Abigail
AU  - Ortiz A
AUID- ORCID: 0000-0001-6886-767X
AD  - Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
FAU - Pachajoa, Harry
AU  - Pachajoa H
AUID- ORCID: 0000-0003-2672-0439
AD  - Centro de Investigaciones en Anomalías Congénitas y Enfermedades Raras (CIACER), 
      Universidad Icesi, Cali, Colombia.
FAU - Perez de Nanclares, Guiomar
AU  - Perez de Nanclares G
AUID- ORCID: 0000-0002-2424-5294
AD  - Molecular (epi) genetics lab, Bioaraba Health Research Institute, Araba 
      University Hospital, Vitoria-Gasteiz, Spain.
FAU - Peters, Amy
AU  - Peters A
AUID- ORCID: 0000-0003-0224-647X
AD  - Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
FAU - Putman, Tim
AU  - Putman T
AUID- ORCID: 0000-0002-4291-0737
AD  - University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
FAU - Rapp, Christina K
AU  - Rapp CK
AD  - Department of Pediatrics, Dr. von Hauner Children's Hospital, University 
      Hospital, LMU Munich, German center for Lung research (DZL), Munich, Germany.
FAU - Rath, Ana
AU  - Rath A
AUID- ORCID: 0000-0003-4308-6337
AD  - INSERM, US14 - Orphanet, Plateforme Maladies Rares, Paris, France.
FAU - Reese, Justin
AU  - Reese J
AUID- ORCID: 0000-0002-2170-2250
AD  - Division of Environmental Genomics and Systems Biology, Lawrence Berkeley 
      National Laboratory, Berkeley, CA 94720, USA.
FAU - Rekerle, Lauren
AU  - Rekerle L
AUID- ORCID: 0000-0003-2598-6622
AD  - The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
FAU - Roberts, Angharad M
AU  - Roberts AM
AD  - National Heart & Lung Institute & MRC London Institute of Medical Sciences, 
      Imperial College London, London W12 0HS, UK.
FAU - Roy, Suzy
AU  - Roy S
AD  - SNOMED International, London W2 6BD, UK.
FAU - Sanders, Stephan J
AU  - Sanders SJ
AUID- ORCID: 0000-0001-9112-5148
AD  - Department of Paediatrics, Institute of Developmental and Regenerative Medicine, 
      University of Oxford, Oxford, UK.
FAU - Schuetz, Catharina
AU  - Schuetz C
AUID- ORCID: 0000-0001-8731-8924
AD  - Universitätsklinikum Carl Gustav Carus, Medizinische Fakultät, TU, Dresden, 
      Germany.
FAU - Schulte, Eva C
AU  - Schulte EC
AUID- ORCID: 0000-0003-3105-5672
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, 
      LMU Munich, Munich, Germany.
FAU - Schulze, Thomas G
AU  - Schulze TG
AUID- ORCID: 0000-0001-6624-2975
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Syracuse, NY, USA.
FAU - Schwarz, Martin
AU  - Schwarz M
AUID- ORCID: 0000-0002-5585-8376
AD  - Department of Biology and Medical Genetics, 2nd Medical Faculty of Charles 
      University and University Hospital Motol, Prague, Czech Republic.
FAU - Scott, Katie
AU  - Scott K
AUID- ORCID: 0000-0001-5395-5036
AD  - Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
FAU - Seelow, Dominik
AU  - Seelow D
AUID- ORCID: 0000-0002-9746-4412
AD  - Exploratory Diagnostic Sciences, Berliner Institut für Gesundheitsforschung - 
      Charité, Berlin, Germany.
FAU - Seitz, Berthold
AU  - Seitz B
AUID- ORCID: 0000-0001-9701-8204
AD  - Department of Ophthalmology, Saarland University Medical Center UKS, 
      Homburg/Saar, Germany.
FAU - Shen, Yiping
AU  - Shen Y
AD  - Chinese HPO Consortium, Beijing, China.
FAU - Similuk, Morgan N
AU  - Similuk MN
AUID- ORCID: 0000-0002-0403-2689
AD  - National Institute of Allergy and Infectious Diseases, National Institutes of 
      Health, Bethesda, MD 20892, USA.
FAU - Simon, Eric S
AU  - Simon ES
AUID- ORCID: 0000-0002-4691-7362
AD  - Eisenberg Family Depression Center, University of Michigan, Ann Arbor, MI, USA.
FAU - Singh, Balwinder
AU  - Singh B
AUID- ORCID: 0000-0001-7062-8192
AD  - Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
FAU - Smedley, Damian
AU  - Smedley D
AUID- ORCID: 0000-0002-5836-9850
AD  - William Harvey Research Institute, Queen Mary University of London, London, UK.
FAU - Smith, Cynthia L
AU  - Smith CL
AUID- ORCID: 0000-0003-3691-0324
AD  - The Jackson Laboratory, Bar Harbor, ME, USA.
FAU - Smolinsky, Jake T
AU  - Smolinsky JT
AUID- ORCID: 0009-0004-0873-4444
AD  - Human Genetics Institute of New Jersey, Rutgers University, Piscataway, NJ, USA.
FAU - Sperry, Sarah
AU  - Sperry S
AUID- ORCID: 0000-0002-1111-7357
AD  - Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
FAU - Stafford, Elizabeth
AU  - Stafford E
AUID- ORCID: 0000-0002-2414-5605
AD  - The National Alliance on Mental Illness, Arlington, VA, USA.
FAU - Stefancsik, Ray
AU  - Stefancsik R
AUID- ORCID: 0000-0001-8314-2140
AD  - European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, 
      Hinxton CB10 1SD, UK.
FAU - Steinhaus, Robin
AU  - Steinhaus R
AUID- ORCID: 0000-0001-6613-4675
AD  - Exploratory Diagnostic Sciences, Berliner Institut für Gesundheitsforschung - 
      Charité, Berlin, Germany.
FAU - Strawbridge, Rebecca
AU  - Strawbridge R
AUID- ORCID: 0000-0002-2984-1124
AD  - Department of Psychological Medicine, Institute of Psychiatry, Psychology & 
      Neuroscience, King's College London, London, UK.
FAU - Sundaramurthi, Jagadish Chandrabose
AU  - Sundaramurthi JC
AUID- ORCID: 0000-0002-6670-9157
AD  - The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
FAU - Talapova, Polina
AU  - Talapova P
AUID- ORCID: 0000-0003-4147-1485
AD  - Institute for Research and Health Policy Studies, Tufts Medicine, Boston, 
      MA 2111, USA.
FAU - Tenorio Castano, Jair A
AU  - Tenorio Castano JA
AUID- ORCID: 0000-0002-5308-2316
AD  - Institute of Medical and Molecular Genetics, Hospital Univ. La Paz, Madrid, 
      Spain.
FAU - Tesner, Pavel
AU  - Tesner P
AUID- ORCID: 0000-0001-6033-2953
AD  - Department of Biology and Medical Genetics, 2nd Medical Faculty of Charles 
      University and University Hospital Motol, Prague, Czech Republic.
FAU - Thomas, Rhys H
AU  - Thomas RH
AUID- ORCID: 0000-0003-2062-8623
AD  - Translational and Clinical Research Institute, Henry Wellcome Building, 
      Framlington Place, Newcastle University, Newcastle-Upon-Tyne NE14LP, UK.
FAU - Thurm, Audrey
AU  - Thurm A
AUID- ORCID: 0000-0002-0489-9485
AD  - Neurodevelopmental and Behavioral Phenotyping Service, National Institute of 
      Mental Health, Bethesda, MD, USA.
FAU - Turnovec, Marek
AU  - Turnovec M
AUID- ORCID: 0000-0001-9497-3919
AD  - Department of Biology and Medical Genetics, 2nd Medical Faculty of Charles 
      University and University Hospital Motol, Prague, Czech Republic.
FAU - van Gijn, Marielle E
AU  - van Gijn ME
AUID- ORCID: 0000-0002-1073-0539
AD  - Department of Genetics, University Medical Center Groningen, Groningen, 
      Netherlands.
FAU - Vasilevsky, Nicole A
AU  - Vasilevsky NA
AUID- ORCID: 0000-0001-5208-3432
AD  - Critical Path Institute, Tucson, AZ, USA.
FAU - Vlčková, Markéta
AU  - Vlčková M
AUID- ORCID: 0000-0002-1496-392X
AD  - Department of Biology and Medical Genetics, 2nd Medical Faculty of Charles 
      University and University Hospital Motol, Prague, Czech Republic.
FAU - Walden, Anita
AU  - Walden A
AUID- ORCID: 0000-0002-3327-7423
AD  - Department of Biomedical Informatics, University of Colorado Anschutz Medical 
      Campus, Aurora, CO 80045, USA.
FAU - Wang, Kai
AU  - Wang K
AUID- ORCID: 0000-0002-5585-982X
AD  - Chinese HPO Consortium, Beijing, China.
FAU - Wapner, Ron
AU  - Wapner R
AUID- ORCID: 0000-0003-0727-1244
AD  - Department of Obstetrics and Gynecology, Columbia University Irving Medical 
      Center, New York, NY, USA.
FAU - Ware, James S
AU  - Ware JS
AUID- ORCID: 0000-0002-6110-5880
AD  - National Heart & Lung Institute & MRC London Institute of Medical Sciences, 
      Imperial College London, London W12 0HS, UK.
FAU - Wiafe, Addo A
AU  - Wiafe AA
AD  - Rare Disease Ghana Initiative, Accra, Ghana.
FAU - Wiafe, Samuel A
AU  - Wiafe SA
AUID- ORCID: 0000-0003-2125-2285
AD  - Rare Disease Ghana Initiative, Accra, Ghana.
FAU - Wiggins, Lisa D
AU  - Wiggins LD
AUID- ORCID: 0000-0001-9283-7294
AD  - National Center on Birth Defects and Developmental Disabilities, Centers for 
      Disease Control and Prevention, Atlanta, GA, USA.
FAU - Williams, Andrew E
AU  - Williams AE
AUID- ORCID: 0000-0002-0692-412X
AD  - Institute for Research and Health Policy Studies, Tufts Medicine, Boston, 
      MA 2111, USA.
FAU - Wu, Chen
AU  - Wu C
AD  - Chinese HPO Consortium, Beijing, China.
FAU - Wyrwoll, Margot J
AU  - Wyrwoll MJ
AUID- ORCID: 0000-0002-7651-2403
AD  - Centre for Regenerative Medicine, Institute for Regeneration and Repair, 
      Institute for Stem Cell Research, University of Edinburgh, Edinburgh, UK.
FAU - Xiong, Hui
AU  - Xiong H
AD  - Chinese HPO Consortium, Beijing, China.
FAU - Yalin, Nefize
AU  - Yalin N
AUID- ORCID: 0000-0003-4298-5074
AD  - Department of Psychological Medicine, Institute of Psychiatry, Psychology & 
      Neuroscience, King's College London, London, UK.
FAU - Yamamoto, Yasunori
AU  - Yamamoto Y
AUID- ORCID: 0000-0002-6943-6887
AD  - Database Center for Life Science, Joint Support-Center for Data Science Research, 
      Research Organization of Information and Systems, Japan.
FAU - Yatham, Lakshmi N
AU  - Yatham LN
AUID- ORCID: 0000-0002-7405-0954
AD  - Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.
FAU - Yocum, Anastasia K
AU  - Yocum AK
AUID- ORCID: 0000-0002-1592-0825
AD  - Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
FAU - Young, Allan H
AU  - Young AH
AUID- ORCID: 0000-0003-2291-6952
AD  - Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, 
      King's College London & South London and Maudsley NHS Foundation Trust, Bethlem 
      Royal Hospital, Monks Orchard Road, Beckenham, Kent, London SE5 8AF, UK.
FAU - Yüksel, Zafer
AU  - Yüksel Z
AUID- ORCID: 0000-0002-2085-5773
AD  - Department of Human Genetics, Bioscientia Healthcare GmbH, Ingelheim, Germany.
FAU - Zandi, Peter P
AU  - Zandi PP
AUID- ORCID: 0000-0001-8423-2623
AD  - Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School 
      of Medicine, Baltimore, MD 21287, USA.
FAU - Zankl, Andreas
AU  - Zankl A
AUID- ORCID: 0000-0001-8612-1062
AD  - Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia.
FAU - Zarante, Ignacio
AU  - Zarante I
AUID- ORCID: 0000-0002-0729-6866
AD  - Institute of Human Genetics, Pontificia Universidad Javeriana, Bogotá, Colombia.
FAU - Zvolský, Miroslav
AU  - Zvolský M
AUID- ORCID: 0000-0001-9252-7317
AD  - Institute of Health Information and Statistics of the Czech Republic, Prague, 
      Czech Republic.
FAU - Toro, Sabrina
AU  - Toro S
AUID- ORCID: 0000-0002-4142-7153
AD  - University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
FAU - Carmody, Leigh C
AU  - Carmody LC
AUID- ORCID: 0000-0001-7941-2961
AD  - The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
FAU - Harris, Nomi L
AU  - Harris NL
AUID- ORCID: 0000-0001-6315-3707
AD  - Division of Environmental Genomics and Systems Biology, Lawrence Berkeley 
      National Laboratory, Berkeley, CA 94720, USA.
FAU - Munoz-Torres, Monica C
AU  - Munoz-Torres MC
AUID- ORCID: 0000-0001-8430-6039
AD  - Department of Biomedical Informatics, University of Colorado Anschutz Medical 
      Campus, Aurora, CO 80045, USA.
FAU - Danis, Daniel
AU  - Danis D
AUID- ORCID: 0000-0003-0900-3411
AD  - The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
FAU - Mungall, Christopher J
AU  - Mungall CJ
AUID- ORCID: 0000-0002-6601-2165
AD  - Division of Environmental Genomics and Systems Biology, Lawrence Berkeley 
      National Laboratory, Berkeley, CA 94720, USA.
FAU - Köhler, Sebastian
AU  - Köhler S
AUID- ORCID: 0000-0002-5316-1399
AD  - Ada Health GmbH, Berlin, Germany.
FAU - Haendel, Melissa A
AU  - Haendel MA
AUID- ORCID: 0000-0001-9114-8737
AD  - University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
FAU - Robinson, Peter N
AU  - Robinson PN
AUID- ORCID: 0000-0002-0736-9199
AD  - The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
LA  - eng
GR  - T15 LM007079/LM/NLM NIH HHS/United States
GR  - NCATS U24 TR002306/TR/NCATS NIH HHS/United States
GR  - 7RM1HG010860-02/HG/NHGRI NIH HHS/United States
GR  - 203914/Z/16/Z/WT_/Wellcome Trust/United Kingdom
GR  - R03 DE032062/DE/NIDCR NIH HHS/United States
GR  - R01HD105266/HD/NICHD NIH HHS/United States
GR  - WT_/Wellcome Trust/United Kingdom
GR  - RM1 HG010860/HG/NHGRI NIH HHS/United States
GR  - T15LM009451/LM/NLM NIH HHS/United States
GR  - R03-DE032062/DE/NIDCR NIH HHS/United States
GR  - R01 HD105266/HD/NICHD NIH HHS/United States
GR  - U24 MH068457/MH/NIMH NIH HHS/United States
GR  - U24 TR002306/TR/NCATS NIH HHS/United States
GR  - K08 AG054727/AG/NIA NIH HHS/United States
GR  - 5U24HG011449-03/GF/NIH HHS/United States
PT  - Journal Article
PL  - England
TA  - Nucleic Acids Res
JT  - Nucleic acids research
JID - 0411011
SB  - IM
MH  - Humans
MH  - *Biological Ontologies
MH  - Phenotype
MH  - Genomics
MH  - Algorithms
MH  - Rare Diseases
PMC - PMC10767975
EDAT- 2023/11/13 00:42
MHDA- 2024/01/08 06:41
CRDT- 2023/11/12 23:43
PHST- 2023/10/19 00:00 [accepted]
PHST- 2023/10/12 00:00 [revised]
PHST- 2023/09/13 00:00 [received]
PHST- 2024/01/08 06:41 [medline]
PHST- 2023/11/13 00:42 [pubmed]
PHST- 2023/11/12 23:43 [entrez]
AID - 7416384 [pii]
AID - gkad1005 [pii]
AID - 10.1093/nar/gkad1005 [doi]
PST - ppublish
SO  - Nucleic Acids Res. 2024 Jan 5;52(D1):D1333-D1346. doi: 10.1093/nar/gkad1005.

PMID- 30660171
OWN - NLM
STAT- MEDLINE
DCOM- 20210630
LR  - 20210630
IS  - 0125-877X (Print)
IS  - 0125-877X (Linking)
VI  - 38
IP  - 3
DP  - 2020 Sep
TI  - Dengue vaccine: Global development update.
PG  - 178-185
LID - 10.12932/AP-100518-0309 [doi]
AB  - The first licensed dengue vaccine, CYD-TDV (Dengvaxia®), has received regulatory 
      approval in a number of countries. However, this vaccine has some limitations. 
      Its efficacy against DENV2 was consistently lower than other serotypes. 
      Protective efficacy also depended on prior dengue sero-status of the vaccinees. 
      Lower efficacy was observed in children with < 9 years old and dengue-na?ve 
      individuals. More importantly, risk of hospitalization and severe dengue was 
      increased in the youngest vaccine recipients (2-5 years) compared to controls. 
      Thus, the quest of a better vaccine candidate continues. There are two 
      live-attenuated vaccine candidates currently testing in phase III trial including 
      DENVax, developed by US CDC and Inviragen (now licensed to Takeda) and 
      TV003/TV005, constructed by US NIAID. In addition, there are several phase I-II 
      as well as preclinical phase studies evaluating vaccines for safety and 
      immunogenicity, this include other live-attenuated platform/strategy, 
      purified-inactivated viruses formulated with adjuvants, DNA vaccine, subunit 
      vaccine, viral vector and also heterologous prime/boost strategies. The major 
      difficulties of dengue vaccine development are included the lack of the best 
      animal model, various immune status of individual especially in endemic areas and 
      clear cut off of protective immunity. Several research and development efforts 
      are ongoing to find a better effective and accessible dengue vaccine for people 
      needed.
FAU - Prompetchara, Eakachai
AU  - Prompetchara E
AD  - Department of Biochemistry and Microbiology, Faculty of Pharmaceutical Sciences, 
      Chulalongkorn University, Bangkok, Thailand.
AD  - Vaccine and Therapeutic Protein Research Group, Special Task Force for Activating 
      Research (STAR), Chulalongkorn University, Bangkok, Thailand.
AD  - Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University, 
      Bangkok, Thailand.
FAU - Ketloy, Chutitorn
AU  - Ketloy C
AD  - Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University, 
      Bangkok, Thailand.
AD  - Chula Vaccine Research Center, Faculty of Medicine, Chulalongkorn University, 
      Bangkok, Thailand.
FAU - Thomas, Stephen J
AU  - Thomas SJ
AD  - State University of New York Upstate Medical University, Syracuse, United States.
FAU - Ruxrungtham, Kiat
AU  - Ruxrungtham K
AD  - Chula Vaccine Research Center, Faculty of Medicine, Chulalongkorn University, 
      Bangkok, Thailand.
AD  - Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, 
      Thailand.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - Thailand
TA  - Asian Pac J Allergy Immunol
JT  - Asian Pacific journal of allergy and immunology
JID - 8402034
RN  - 0 (Adjuvants, Immunologic)
RN  - 0 (Dengue Vaccines)
SB  - IM
MH  - Adjuvants, Immunologic
MH  - Animals
MH  - Centers for Disease Control and Prevention, U.S.
MH  - Child, Preschool
MH  - Clinical Trials as Topic
MH  - Dengue/*immunology
MH  - Dengue Vaccines/*immunology
MH  - Dengue Virus/*physiology
MH  - Genetic Vectors
MH  - Humans
MH  - Risk
MH  - United States
EDAT- 2019/01/21 06:00
MHDA- 2021/07/01 06:00
CRDT- 2019/01/21 06:00
PHST- 2019/01/21 06:00 [pubmed]
PHST- 2021/07/01 06:00 [medline]
PHST- 2019/01/21 06:00 [entrez]
AID - 10.12932/AP-100518-0309 [doi]
PST - ppublish
SO  - Asian Pac J Allergy Immunol. 2020 Sep;38(3):178-185. doi: 
      10.12932/AP-100518-0309.

PMID- 35932095
OWN - NLM
STAT- MEDLINE
DCOM- 20220928
LR  - 20230104
IS  - 1478-3231 (Electronic)
IS  - 1478-3223 (Print)
IS  - 1478-3223 (Linking)
VI  - 42
IP  - 11
DP  - 2022 Nov
TI  - Predictors of serious adverse events and non-response in cirrhotic patients with 
      primary biliary cholangitis treated with obeticholic acid.
PG  - 2453-2465
LID - 10.1111/liv.15386 [doi]
AB  - BACKGROUND & AIMS: Obeticholic acid (OCA) has recently been restricted in 
      patients with primary biliary cholangitis (PBC) with "advanced cirrhosis" because 
      of its narrow therapeutic index. We aimed to better define the predicting factors 
      of hepatic serious adverse events (SAEs) and non-response in cirrhotic patients 
      undergoing OCA therapy. METHODS: Safety and efficacy of treatment were evaluated 
      in a cohort of consecutive PBC cirrhotic patients started with OCA. OCA response 
      was evaluated according to the Poise criteria. Risk factors for hepatic SAEs and 
      non-response were reported as risk ratios (RR) with 95% confidence intervals 
      (CIs). RESULTS: One hundred PBC cirrhotics were included, 97 Child-Pugh class A 
      and 3 class B. Thirty-one had oesophageal varices and 5 had a history of ascites. 
      Thirty-three per cent and 32% of patients achieved a biochemical response at 6 
      and 12 months respectively. Male sex (adjusted-RR 1.75, 95%CI 1.42-2.12), INR 
      (1.37, 1.00-1.87), Child-Pugh score (1.79, 1.28-2.50), MELD (1.17, 1.04-1.30) and 
      bilirubin (1.83, 1.11-3.01) were independently associated with non-response to 
      OCA. Twenty-two patients discontinued OCA within 12 months: 10 for pruritus, 9 
      for hepatic SAEs (5 for jaundice and/or ascitic decompensation; 4 for upper 
      digestive bleeding). INR (adjusted-RR 1.91, 95%CI 1.10-3.36), lower albumin 
      levels (0.18, 0.06-0.51), Child-Pugh score (2.43, 1.50-4.04), history of ascites 
      (3.5, 1.85-6.5) and bilirubin (1.30, 1.05-1.56), were associated with hepatic 
      SAEs. A total bilirubin≥1.4 mg/dl at baseline was the most accurate biochemical 
      predictor of hepatic SAEs under OCA. CONCLUSIONS: An accurate baseline assessment 
      is crucial to select cirrhotic patients who can benefit from OCA. Although OCA is 
      effective in one third of cirrhotics, bilirubin level ≥1.4 mg/dl should 
      discourage from its use.
CI  - © 2022 The Authors. Liver International published by John Wiley & Sons Ltd.
FAU - De Vincentis, Antonio
AU  - De Vincentis A
AUID- ORCID: 0000-0003-0220-0500
AD  - Internal Medicine and Hepatology, University Campus Bio-Medico of Rome, Rome, 
      Italy.
FAU - D'Amato, Daphne
AU  - D'Amato D
AD  - Gastroenterology Unit, Città della salute e della scienza, Turin, Italy.
FAU - Cristoferi, Laura
AU  - Cristoferi L
AD  - Division of Gastroenterology, Centre for Autoimmune Liver Diseases, Department of 
      Medicine and Surgery, University of Milano-Bicocca, European Reference Network on 
      Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
FAU - Gerussi, Alessio
AU  - Gerussi A
AD  - Division of Gastroenterology, Centre for Autoimmune Liver Diseases, Department of 
      Medicine and Surgery, University of Milano-Bicocca, European Reference Network on 
      Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
FAU - Malinverno, Federica
AU  - Malinverno F
AD  - Division of Gastroenterology, Centre for Autoimmune Liver Diseases, Department of 
      Medicine and Surgery, University of Milano-Bicocca, European Reference Network on 
      Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
FAU - Lleo, Ana
AU  - Lleo A
AUID- ORCID: 0000-0002-0561-7902
AD  - Internal Medicine and Hepatology, Humanitas Clinical and Research Center IRCCS, 
      Humanitas University, Milan, Italy.
FAU - Colapietro, Francesca
AU  - Colapietro F
AUID- ORCID: 0000-0002-7520-744X
AD  - Internal Medicine and Hepatology, Humanitas Clinical and Research Center IRCCS, 
      Humanitas University, Milan, Italy.
FAU - Marra, Fabio
AU  - Marra F
AUID- ORCID: 0000-0001-8629-0878
AD  - Internal Medicine and Hepatology Unit, Department of Experimental and Clinical 
      Medicine, University of Firenze, Firenze, Italy.
FAU - Galli, Andrea
AU  - Galli A
AD  - Department of Experimental and Clinical Biochemical Sciences, University of 
      Florence, Florence, Italy.
FAU - Fiorini, Cecilia
AU  - Fiorini C
AD  - Department of Experimental and Clinical Biochemical Sciences, University of 
      Florence, Florence, Italy.
FAU - Coco, Barbara
AU  - Coco B
AD  - Hepatology Unit, University Hospital of Pisa, Pisa, Italy.
FAU - Brunetto, Maurizia
AU  - Brunetto M
AUID- ORCID: 0000-0001-8364-9152
AD  - Hepatology Unit, University Hospital of Pisa, Pisa, Italy.
FAU - Niro, Grazia Anna
AU  - Niro GA
AD  - Gastroenterology Unit, Fondazione Casa Sollievo Della Sofferenza IRCCS, San 
      Giovanni Rotondo, Italy.
FAU - Cotugno, Rosa
AU  - Cotugno R
AD  - Gastroenterology Unit, Fondazione Casa Sollievo Della Sofferenza IRCCS, San 
      Giovanni Rotondo, Italy.
FAU - Saitta, Carlo
AU  - Saitta C
AD  - Division of Medicine and Hepatology, University Hospital of Messina "Policlinico 
      G. Martino", Messina, Italy.
FAU - Cozzolongo, Raffaele
AU  - Cozzolongo R
AD  - Gastroenterology Unit, National Institute of Gastroenterology "S de Bellis" 
      Research Hospital, Castellana Grotte, Italy.
FAU - Losito, Francesco
AU  - Losito F
AD  - Gastroenterology Unit, National Institute of Gastroenterology "S de Bellis" 
      Research Hospital, Castellana Grotte, Italy.
FAU - Giannini, Edoardo Giovanni
AU  - Giannini EG
AUID- ORCID: 0000-0001-8526-837X
AD  - Gastroenterology Unit, Department of Internal Medicine, University of Genova, 
      IRCCS Ospedale Policlinico San Martino, Genova, Italy.
FAU - Labanca, Sara
AU  - Labanca S
AD  - Gastroenterology Unit, Department of Internal Medicine, University of Genova, 
      IRCCS Ospedale Policlinico San Martino, Genova, Italy.
FAU - Marzioni, Marco
AU  - Marzioni M
AD  - Clinic of Gastroenterology and Hepatology, Università Politecnica delle Marche, 
      Ancona, Italy.
FAU - Marconi, Giulia
AU  - Marconi G
AD  - Clinic of Gastroenterology and Hepatology, Università Politecnica delle Marche, 
      Ancona, Italy.
FAU - Morgando, Anna
AU  - Morgando A
AD  - Gastroenterology Unit, Città della salute e della scienza, Turin, Italy.
FAU - Pellicano, Rinaldo
AU  - Pellicano R
AD  - Gastroenterology Unit, Città della salute e della scienza, Turin, Italy.
FAU - Vanni, Ester
AU  - Vanni E
AD  - Gastroenterology Unit, Città della salute e della scienza, Turin, Italy.
FAU - Cazzagon, Nora
AU  - Cazzagon N
AD  - Gastroenterology Unit, Department of Surgery, Oncology and Gastroenterology, 
      Padua University Hospital, Padua, Italy.
FAU - Floreani, Annarosa
AU  - Floreani A
AD  - Gastroenterology Unit, Department of Surgery, Oncology and Gastroenterology, 
      Padua University Hospital, Padua, Italy.
FAU - Chessa, Luchino
AU  - Chessa L
AUID- ORCID: 0000-0002-9474-0995
AD  - Liver Unit, University Hospital of Cagliari, Cagliari, Italy.
FAU - Morelli, Olivia
AU  - Morelli O
AD  - Clinic of Gastroenterology and Hepatology, Department of Medicine, Università 
      degli Studi di Perugia, Perugia, Italy.
FAU - Muratori, Luigi
AU  - Muratori L
AUID- ORCID: 0000-0002-8748-8031
AD  - DIMEC Università di Bologna, Policlinico di Sant'Orsola, Bologna, Italy.
FAU - Pellicelli, Adriano
AU  - Pellicelli A
AUID- ORCID: 0000-0001-5845-6703
AD  - Liver Unit, San Camillo Hospital, Rome, Italy.
FAU - Pompili, Maurizio
AU  - Pompili M
AD  - Internal Medicine and Hepatology Unit, Policlinico Gemelli, Sapienza University, 
      Rome, Italy.
FAU - Ponziani, Francesca
AU  - Ponziani F
AUID- ORCID: 0000-0002-5924-6238
AD  - Internal Medicine and Hepatology Unit, Policlinico Gemelli, Sapienza University, 
      Rome, Italy.
FAU - Tortora, Annalisa
AU  - Tortora A
AD  - Internal Medicine and Hepatology Unit, Policlinico Gemelli, Sapienza University, 
      Rome, Italy.
FAU - Rosina, Floriano
AU  - Rosina F
AD  - Medical Team Torino, Torino, Italy.
FAU - Russello, Maurizio
AU  - Russello M
AD  - Liver Unit, Arnas Garibaldi, Catania, Italy.
FAU - Cannavò, Mariarita
AU  - Cannavò M
AD  - Liver Unit, Arnas Garibaldi, Catania, Italy.
FAU - Simone, Loredana
AU  - Simone L
AD  - Department of Gastroenterology, University Hospital Sant'Anna, Ferrara, Italy.
FAU - Storato, Silvia
AU  - Storato S
AD  - IRCCS Sacro Cuore Institute Don Calabria, Gastroenterology, Negrar, Italy.
FAU - Viganò, Mauro
AU  - Viganò M
AUID- ORCID: 0000-0003-0769-1767
AD  - Hepatology Unit, San Giuseppe Hospital, Milan, Italy.
FAU - Abenavoli, Ludovico
AU  - Abenavoli L
AD  - Department of Health Sciences, University "Magna Graecia" of Catanzaro, Italy.
FAU - D'Antò, Maria
AU  - D'Antò M
AD  - Hepatology Unit, Santa Maria delle Grazie Hospital, Pozzuoli, Italy.
FAU - De Gasperi, Elisabetta
AU  - De Gasperi E
AUID- ORCID: 0000-0002-9899-4669
AD  - Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico - Division of 
      Gastroenterology and Hepatology - CRC "A.M. and A. Migliavacca" Center for Liver 
      Disease, Milan, Italy.
FAU - Distefano, Marco
AU  - Distefano M
AD  - Department of Infectious Diseases, Umberto I Hospital, Syracuse, Italy.
FAU - Scifo, Gaetano
AU  - Scifo G
AD  - Department of Infectious Diseases, Umberto I Hospital, Syracuse, Italy.
FAU - Zolfino, Teresa
AU  - Zolfino T
AD  - Department of Gastroenterology, Brotzu Hospital, Cagliari, Italy.
FAU - Calvaruso, Vincenza
AU  - Calvaruso V
AUID- ORCID: 0000-0002-0287-1059
AD  - Gastroenterology and Hepatology Unit, University of Palermo, Palermo, Italy.
FAU - Cuccorese, Giuseppe
AU  - Cuccorese G
AD  - Internal Medicine Ospedale "R. Dimiccoli", Barletta, Italy.
FAU - Palitti, Valeria Pace
AU  - Palitti VP
AD  - Hepatology Unit, Santo Spirito Hospital, Pescara, Italy.
FAU - Sacco, Rodolfo
AU  - Sacco R
AD  - Gastroenterology Unit, Ospedali Riuniti, Foggia, Italy.
FAU - Bertino, Gaetano
AU  - Bertino G
AD  - Gastroenterology and Hepatology Unit, University Hospital Policlinico Vittorio 
      Emanuele, Catania, Italy.
FAU - Frazzetto, Evelise
AU  - Frazzetto E
AD  - Gastroenterology and Hepatology Unit, University Hospital Policlinico Vittorio 
      Emanuele, Catania, Italy.
FAU - Alvaro, Domenico
AU  - Alvaro D
AD  - Department of Translational and Precision Medicine, University La Sapienza, Rome, 
      Italy.
FAU - Mulinacci, Giacomo
AU  - Mulinacci G
AD  - Division of Gastroenterology, Centre for Autoimmune Liver Diseases, Department of 
      Medicine and Surgery, University of Milano-Bicocca, European Reference Network on 
      Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
FAU - Palermo, Andrea
AU  - Palermo A
AD  - Division of Gastroenterology, Centre for Autoimmune Liver Diseases, Department of 
      Medicine and Surgery, University of Milano-Bicocca, European Reference Network on 
      Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
FAU - Scaravaglio, Miki
AU  - Scaravaglio M
AD  - Division of Gastroenterology, Centre for Autoimmune Liver Diseases, Department of 
      Medicine and Surgery, University of Milano-Bicocca, European Reference Network on 
      Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
FAU - Terracciani, Francesca
AU  - Terracciani F
AD  - Internal Medicine and Hepatology, University Campus Bio-Medico of Rome, Rome, 
      Italy.
FAU - Galati, Giovanni
AU  - Galati G
AD  - Internal Medicine and Hepatology, University Campus Bio-Medico of Rome, Rome, 
      Italy.
FAU - Ronca, Vincenzo
AU  - Ronca V
AD  - Division of Gastroenterology, Centre for Autoimmune Liver Diseases, Department of 
      Medicine and Surgery, University of Milano-Bicocca, European Reference Network on 
      Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
FAU - Zuin, Massimo
AU  - Zuin M
AD  - Liver and Gastroenterology Unit, Department of Health Sciences, Universita' degli 
      Studi di Milano, Milan, Italy.
AD  - ASST Santi Paolo e Carlo, University Hospital San Paolo, Milan, Italy.
FAU - Claar, Ernesto
AU  - Claar E
AD  - Department of Hepatology, Betania Hospital, Napoli, Italy.
FAU - Izzi, Antonio
AU  - Izzi A
AD  - Department of Infectious Diseases, D. Cotugno Hospital, Napoli, Italy.
FAU - Picardi, Antonio
AU  - Picardi A
AD  - Internal Medicine and Hepatology, University Campus Bio-Medico of Rome, Rome, 
      Italy.
FAU - Invernizzi, Pietro
AU  - Invernizzi P
AUID- ORCID: 0000-0003-3262-1998
AD  - Division of Gastroenterology, Centre for Autoimmune Liver Diseases, Department of 
      Medicine and Surgery, University of Milano-Bicocca, European Reference Network on 
      Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
FAU - Vespasiani-Gentilucci, Umberto
AU  - Vespasiani-Gentilucci U
AUID- ORCID: 0000-0002-1138-1967
AD  - Internal Medicine and Hepatology, University Campus Bio-Medico of Rome, Rome, 
      Italy.
FAU - Carbone, Marco
AU  - Carbone M
AUID- ORCID: 0000-0003-1445-0443
AD  - Division of Gastroenterology, Centre for Autoimmune Liver Diseases, Department of 
      Medicine and Surgery, University of Milano-Bicocca, European Reference Network on 
      Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
CN  - on behalf of the Club Epatologi Ospedalieri (CLEO)/Associazione Italiana 
      Gastroenterologi ed Endoscopisti Digestivi Ospedalieri (AIGO) PBC Study Group 
      and, the Italian PBC Registry
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20220823
PL  - United States
TA  - Liver Int
JT  - Liver international : official journal of the International Association for the 
      Study of the Liver
JID - 101160857
RN  - 0 (Albumins)
RN  - 0462Z4S4OZ (obeticholic acid)
RN  - 0GEI24LG0J (Chenodeoxycholic Acid)
RN  - RFM9X3LJ49 (Bilirubin)
SB  - IM
CIN - Liver Int. 2022 Nov;42(11):2356-2359. PMID: 36162085
MH  - Albumins/therapeutic use
MH  - Ascites/drug therapy/etiology
MH  - Bilirubin
MH  - Chenodeoxycholic Acid/analogs & derivatives
MH  - Humans
MH  - Liver Cirrhosis/complications/drug therapy
MH  - *Liver Cirrhosis, Biliary/complications/drug therapy
MH  - Male
PMC - PMC9804305
OTO - NOTNLM
OT  - decision curve analysis
OT  - efficacy
OT  - liver decompensation
OT  - safety
OT  - total bilirubin
COIS- UVG received speaking fees from Intercept, Shionogi, MSD and Gilead. MC consults 
      for and advices for Intercept, Cymabay, Moderna, Perspectum, Albireo, Echosense, 
      Mayoly. All other authors deny any personal and financial conflict of interests 
      with the present work.
FIR - Feletti, Valentina
IR  - Feletti V
FIR - Mussetto, Alessandro
IR  - Mussetto A
FIR - Venere, Rosanna
IR  - Venere R
FIR - Bernaccioni, Giulia
IR  - Bernaccioni G
FIR - Graciella Pigozzi, Marie
IR  - Graciella Pigozzi M
FIR - Fagiuoli, Stefano
IR  - Fagiuoli S
FIR - Terreni, Natalia
IR  - Terreni N
FIR - Pozzoni, Pietro
IR  - Pozzoni P
FIR - Baiocchi, Leonardo
IR  - Baiocchi L
FIR - Grassi, Giuseppe
IR  - Grassi G
FIR - Vinci, Maria
IR  - Vinci M
FIR - Bellia, Valentina
IR  - Bellia V
FIR - Boldizzoni, Roberto
IR  - Boldizzoni R
FIR - Casella, Silvia
IR  - Casella S
FIR - Omazzi, Barbara
IR  - Omazzi B
FIR - Poggi, Guido
IR  - Poggi G
EDAT- 2022/08/07 06:00
MHDA- 2022/09/28 06:00
CRDT- 2022/08/06 00:02
PHST- 2022/05/24 00:00 [revised]
PHST- 2022/02/17 00:00 [received]
PHST- 2022/06/23 00:00 [accepted]
PHST- 2022/08/07 06:00 [pubmed]
PHST- 2022/09/28 06:00 [medline]
PHST- 2022/08/06 00:02 [entrez]
AID - LIV15386 [pii]
AID - 10.1111/liv.15386 [doi]
PST - ppublish
SO  - Liver Int. 2022 Nov;42(11):2453-2465. doi: 10.1111/liv.15386. Epub 2022 Aug 23.

PMID- 36375329
OWN - NLM
STAT- MEDLINE
DCOM- 20221208
LR  - 20230104
IS  - 1872-7123 (Electronic)
IS  - 0165-1781 (Linking)
VI  - 318
DP  - 2022 Dec
TI  - Predicting efficacy of viloxazine extended-release treatment in adults with ADHD 
      using an early change in ADHD symptoms: Machine learning Post Hoc analysis of a 
      phase 3 clinical trial.
PG  - 114922
LID - S0165-1781(22)00513-3 [pii]
LID - 10.1016/j.psychres.2022.114922 [doi]
AB  - Early response to viloxazine extended-release (viloxazine ER, Qelbree®) treatment 
      predicted efficacy outcome in pediatric subjects with 
      attention-deficit/hyperactivity disorder (ADHD). This study sought to determine 
      whether the machine learning lasso model used in the pediatric study would 
      predict response to viloxazine ER in an adult population based on early 
      improvements in ADHD symptoms. We used data from a double-blind, 
      placebo-controlled, flexible-dose (200-600 mg) study of viloxazine ER (N = 354; 
      18 to 60 years old). Area under the Receiver Operating Characteristic Curve (ROC 
      AUC) statistics were computed using the lasso model from pediatric data to 
      predict responder status in adults. Response was defined as ≥50% reduction from 
      baseline in the Adult ADHD Investigator Symptoms Rating Scale (AISRS) Total score 
      at Week 6. The adult study sample included 127 viloxazine ER-treated subjects 
      with Week 6 data. Fifty-one subjects (40.2%) were categorized as responders. The 
      ROC curves indicated that data collected up to Week 2 were sufficient to 
      accurately predict treatment response at Week 6 with 68% positive predictive 
      power, 80% sensitivity, and 74% specificity. This analysis demonstrated that the 
      predictive model estimated from the child data generalizes to adults with ADHD, 
      further supporting the consistency of viloxazine ER treatment across age groups.
CI  - Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.
FAU - Faraone, Stephen V
AU  - Faraone SV
AD  - Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate 
      Medical University, Syracuse, NY, USA.
FAU - Gomeni, Roberto
AU  - Gomeni R
AD  - Pharmacometrica, Lieu-dit Longcol, La Fouillade, France.
FAU - Hull, Joseph T
AU  - Hull JT
AD  - Supernus Pharmaceuticals, Inc., Rockville, MD, USA.
FAU - Chaturvedi, Soumya A
AU  - Chaturvedi SA
AD  - Supernus Pharmaceuticals, Inc., Rockville, MD, USA.
FAU - Busse, Gregory D
AU  - Busse GD
AD  - Supernus Pharmaceuticals, Inc., Rockville, MD, USA.
FAU - Melyan, Zare
AU  - Melyan Z
AD  - Supernus Pharmaceuticals, Inc., Rockville, MD, USA.
FAU - O'Neal, Welton
AU  - O'Neal W
AD  - Supernus Pharmaceuticals, Inc., Rockville, MD, USA.
FAU - Rubin, Jonathan
AU  - Rubin J
AD  - Supernus Pharmaceuticals, Inc., Rockville, MD, USA.
FAU - Nasser, Azmi
AU  - Nasser A
AD  - Supernus Pharmaceuticals, Inc., Rockville, MD, USA. Electronic address: 
      anasser@supernus.com.
LA  - eng
PT  - Clinical Trial, Phase III
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
DEP - 20221023
PL  - Ireland
TA  - Psychiatry Res
JT  - Psychiatry research
JID - 7911385
RN  - 0 (Central Nervous System Stimulants)
RN  - 0 (Delayed-Action Preparations)
RN  - 5I5Y2789ZF (Viloxazine)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Child
MH  - Humans
MH  - Middle Aged
MH  - Young Adult
MH  - *Attention Deficit Disorder with Hyperactivity/drug therapy/diagnosis
MH  - *Central Nervous System Stimulants/therapeutic use
MH  - Delayed-Action Preparations/therapeutic use
MH  - Dose-Response Relationship, Drug
MH  - Double-Blind Method
MH  - Machine Learning
MH  - Treatment Outcome
MH  - *Viloxazine/therapeutic use
OTO - NOTNLM
OT  - ADHD
OT  - AISRS
OT  - Machine learning
OT  - Predictor
OT  - Qelbree®
OT  - Treatment response
EDAT- 2022/11/15 06:00
MHDA- 2022/12/03 06:00
CRDT- 2022/11/14 18:24
PHST- 2022/07/07 00:00 [received]
PHST- 2022/10/22 00:00 [accepted]
PHST- 2022/11/15 06:00 [pubmed]
PHST- 2022/12/03 06:00 [medline]
PHST- 2022/11/14 18:24 [entrez]
AID - S0165-1781(22)00513-3 [pii]
AID - 10.1016/j.psychres.2022.114922 [doi]
PST - ppublish
SO  - Psychiatry Res. 2022 Dec;318:114922. doi: 10.1016/j.psychres.2022.114922. Epub 
      2022 Oct 23.

PMID- 35879236
OWN - NLM
STAT- MEDLINE
DCOM- 20220727
LR  - 20220826
IS  - 1445-5994 (Electronic)
IS  - 1444-0903 (Linking)
VI  - 52
IP  - 7
DP  - 2022 Jul
TI  - Professionalism and clinical short answer question marking with machine learning.
PG  - 1268-1271
LID - 10.1111/imj.15839 [doi]
AB  - Machine learning may assist in medical student evaluation. This study involved 
      scoring short answer questions administered at three centres. Bidirectional 
      encoder representations from transformers were particularly effective for 
      professionalism question scoring (accuracy ranging from 41.6% to 92.5%). In the 
      scoring of 3-mark professionalism questions, as compared with clinical questions, 
      machine learning had a lower classification accuracy (P < 0.05). The role of 
      machine learning in medical professionalism evaluation warrants further 
      investigation.
CI  - © 2022 Royal Australasian College of Physicians.
FAU - Lam, Antoinette
AU  - Lam A
AD  - University of Adelaide, Adelaide, South Australia, Australia.
FAU - Lam, Lydia
AU  - Lam L
AD  - University of Adelaide, Adelaide, South Australia, Australia.
FAU - Blacketer, Charlotte
AU  - Blacketer C
AD  - University of Adelaide, Adelaide, South Australia, Australia.
AD  - Royal Adelaide Hospital, Adelaide, South Australia, Australia.
FAU - Parnis, Roger
AU  - Parnis R
AD  - University of Adelaide, Adelaide, South Australia, Australia.
AD  - Royal Darwin Hospital, Darwin, Northern Territory, Australia.
FAU - Franke, Kyle
AU  - Franke K
AD  - University of Adelaide, Adelaide, South Australia, Australia.
FAU - Wagner, Morganne
AU  - Wagner M
AD  - State University of New York (SUNY) Upstate Medical University, Syracuse, New 
      York, USA.
FAU - Wang, David
AU  - Wang D
AD  - University of Otago, Dunedin, New Zealand.
FAU - Tan, Yiran
AU  - Tan Y
AD  - University of Adelaide, Adelaide, South Australia, Australia.
AD  - Royal Adelaide Hospital, Adelaide, South Australia, Australia.
FAU - Oakden-Rayner, Lauren
AU  - Oakden-Rayner L
AD  - University of Adelaide, Adelaide, South Australia, Australia.
AD  - Royal Adelaide Hospital, Adelaide, South Australia, Australia.
FAU - Gallagher, Steve
AU  - Gallagher S
AD  - University of Otago, Dunedin, New Zealand.
FAU - Perry, Seth W
AU  - Perry SW
AD  - State University of New York (SUNY) Upstate Medical University, Syracuse, New 
      York, USA.
FAU - Licinio, Julio
AU  - Licinio J
AD  - State University of New York (SUNY) Upstate Medical University, Syracuse, New 
      York, USA.
FAU - Symonds, Ian
AU  - Symonds I
AD  - University of Adelaide, Adelaide, South Australia, Australia.
FAU - Thomas, Josephine
AU  - Thomas J
AD  - University of Adelaide, Adelaide, South Australia, Australia.
AD  - Royal Adelaide Hospital, Adelaide, South Australia, Australia.
FAU - Duggan, Paul
AU  - Duggan P
AD  - University of Adelaide, Adelaide, South Australia, Australia.
AD  - Royal Adelaide Hospital, Adelaide, South Australia, Australia.
FAU - Bacchi, Stephen
AU  - Bacchi S
AUID- ORCID: 0000-0001-5130-8628
AD  - University of Adelaide, Adelaide, South Australia, Australia.
AD  - Royal Adelaide Hospital, Adelaide, South Australia, Australia.
LA  - eng
PT  - Journal Article
PL  - Australia
TA  - Intern Med J
JT  - Internal medicine journal
JID - 101092952
SB  - IM
MH  - Humans
MH  - Machine Learning
MH  - *Professionalism
MH  - *Students, Medical
OTO - NOTNLM
OT  - artificial intelligence
OT  - medical education
OT  - natural language processing
OT  - performance evaluation
EDAT- 2022/07/26 06:00
MHDA- 2022/07/28 06:00
CRDT- 2022/07/25 22:12
PHST- 2022/01/05 00:00 [received]
PHST- 2022/04/14 00:00 [accepted]
PHST- 2022/07/25 22:12 [entrez]
PHST- 2022/07/26 06:00 [pubmed]
PHST- 2022/07/28 06:00 [medline]
AID - 10.1111/imj.15839 [doi]
PST - ppublish
SO  - Intern Med J. 2022 Jul;52(7):1268-1271. doi: 10.1111/imj.15839.

PMID- 33185950
OWN - NLM
STAT- MEDLINE
DCOM- 20210910
LR  - 20210910
IS  - 1756-5391 (Electronic)
IS  - 1756-5391 (Linking)
VI  - 13
IP  - 4
DP  - 2020 Nov
TI  - Analytics with artificial intelligence to advance the treatment of acute 
      respiratory distress syndrome.
PG  - 301-312
LID - 10.1111/jebm.12418 [doi]
AB  - Artificial intelligence (AI) has found its way into clinical studies in the era 
      of big data. Acute respiratory distress syndrome (ARDS) or acute lung injury 
      (ALI) is a clinical syndrome that encompasses a heterogeneous population. 
      Management of such heterogeneous patient population is a big challenge for 
      clinicians. With accumulating ALI datasets being publicly available, more 
      knowledge could be discovered with sophisticated analytics. We reviewed 
      literatures with big data analytics to understand the role of AI for improving 
      the caring of patients with ALI/ARDS. Many studies have utilized the electronic 
      medical records (EMR) data for the identification and prognostication of ARDS 
      patients. As increasing number of ARDS clinical trials data is open to public, 
      secondary analysis on these combined datasets provide a powerful way of finding 
      solution to clinical questions with a new perspective. AI techniques such as 
      Classification and Regression Tree (CART) and artificial neural networks (ANN) 
      have also been successfully used in the investigation of ARDS problems. 
      Individualized treatment of ARDS could be implemented with a support from AI as 
      we are now able to classify ARDS into many subphenotypes by unsupervised machine 
      learning algorithms. Interestingly, these subphenotypes show different responses 
      to a certain intervention. However, current analytics involving ARDS have not 
      fully incorporated information from omics such as transcriptome, proteomics, 
      daily activities and environmental conditions. AI technology is assisting us to 
      interpret complex data of ARDS patients and enable us to further improve the 
      management of ARDS patients in future with individual treatment plans.
CI  - © 2020 Chinese Cochrane Center, West China Hospital of Sichuan University and 
      John Wiley & Sons Australia, Ltd.
FAU - Zhang, Zhongheng
AU  - Zhang Z
AUID- ORCID: 0000-0002-2336-5323
AD  - Department of Emergency Medicine, Sir Run Run Shaw Hospital, Zhejiang University 
      School of Medicine, Hangzhou, China.
FAU - Navarese, Eliano Pio
AU  - Navarese EP
AD  - Interventional Cardiology and Cardiovascular Medicine Research, Department of 
      Cardiology and Internal Medicine, Nicolaus Copernicus University, Bydgoszcz, 
      Poland.
AD  - Faculty of Medicine, University of Alberta, Edmonton, Canada.
FAU - Zheng, Bin
AU  - Zheng B
AD  - Department of Surgery, 2D, Walter C Mackenzie Health Sciences Centre, University 
      of Alberta, Edmonton, Alberta, Canada.
FAU - Meng, Qinghe
AU  - Meng Q
AD  - Department of Surgery, State University of New York Upstate Medical University, 
      Syracuse, New York.
FAU - Liu, Nan
AU  - Liu N
AD  - Programme in Health Services and Systems Research, Duke-NUS Medical School, 
      Singapore.
FAU - Ge, Huiqing
AU  - Ge H
AD  - Department of Respiratory Care, Sir Run Run Shaw Hospital, Zhejiang University 
      School of Medicine, Hangzhou, China.
FAU - Pan, Qing
AU  - Pan Q
AD  - College of Information Engineering, Zhejiang University of Technology, Hangzhou, 
      China.
FAU - Yu, Yuetian
AU  - Yu Y
AD  - Department of Critical Care Medicine, Ren Ji Hospital, School of Medicine, 
      Shanghai Jiao Tong University, Shanghai, China.
FAU - Ma, Xuelei
AU  - Ma X
AD  - Department of biotherapy, State Key Laboratory of Biotherapy, Cancer Center, West 
      China Hospital, Sichuan University, Chengdu, China.
LA  - eng
GR  - 81901929/National Natural Science Foundation of China/
GR  - 2021KY745/Health Science and Technology Plan of Zhejiang Province/
PT  - Journal Article
PT  - Review
DEP - 20201113
PL  - England
TA  - J Evid Based Med
JT  - Journal of evidence-based medicine
JID - 101497477
SB  - IM
MH  - *Artificial Intelligence
MH  - Clinical Trials as Topic/statistics & numerical data
MH  - Decision Trees
MH  - Electronic Health Records/statistics & numerical data
MH  - Humans
MH  - Machine Learning
MH  - Respiratory Distress Syndrome/etiology/*therapy
MH  - Risk Factors
MH  - Surgical Procedures, Operative/adverse effects
MH  - Transfusion Reaction/complications
OTO - NOTNLM
OT  - acute respiratory distress syndrome
OT  - artificial intelligence
OT  - big data
OT  - electronic medical records
EDAT- 2020/11/14 06:00
MHDA- 2021/09/11 06:00
CRDT- 2020/11/13 12:12
PHST- 2020/09/12 00:00 [received]
PHST- 2020/10/21 00:00 [accepted]
PHST- 2020/11/14 06:00 [pubmed]
PHST- 2021/09/11 06:00 [medline]
PHST- 2020/11/13 12:12 [entrez]
AID - 10.1111/jebm.12418 [doi]
PST - ppublish
SO  - J Evid Based Med. 2020 Nov;13(4):301-312. doi: 10.1111/jebm.12418. Epub 2020 Nov 
      13.

PMID- 37523715
OWN - NLM
STAT- MEDLINE
DCOM- 20231023
LR  - 20231108
IS  - 1535-4970 (Electronic)
IS  - 1073-449X (Print)
IS  - 1073-449X (Linking)
VI  - 208
IP  - 7
DP  - 2023 Oct 1
TI  - A Polygenic Risk Score for Idiopathic Pulmonary Fibrosis and Interstitial Lung 
      Abnormalities.
PG  - 791-801
LID - 10.1164/rccm.202212-2257OC [doi]
AB  - Rationale: In addition to rare genetic variants and the MUC5B locus, common 
      genetic variants contribute to idiopathic pulmonary fibrosis (IPF) risk. The 
      predictive power of common variants outside the MUC5B locus for IPF and 
      interstitial lung abnormalities (ILAs) is unknown. Objectives: We tested the 
      predictive value of IPF polygenic risk scores (PRSs) with and without the MUC5B 
      region on IPF, ILA, and ILA progression. Methods: We developed PRSs that included 
      (PRS-M5B) and excluded (PRS-NO-M5B) the MUC5B region (500-kb window around 
      rs35705950-T) using an IPF genome-wide association study. We assessed PRS 
      associations with area under the receiver operating characteristic curve (AUC) 
      metrics for IPF, ILA, and ILA progression. Measurements and Main Results: We 
      included 14,650 participants (1,970 IPF; 1,068 ILA) from six multi-ancestry 
      population-based and case-control cohorts. In cases excluded from genome-wide 
      association study, the PRS-M5B (odds ratio [OR] per SD of the score, 3.1; 
      P = 7.1 × 10(-95)) and PRS-NO-M5B (OR per SD, 2.8; P = 2.5 × 10(-87)) were 
      associated with IPF. Participants in the top PRS-NO-M5B quintile had ∼sevenfold 
      odds for IPF compared with those in the first quintile. A clinical model 
      predicted IPF (AUC, 0.61); rs35705950-T and PRS-NO-M5B demonstrated higher AUCs 
      (0.73 and 0.7, respectively), and adding both genetic predictors to a clinical 
      model yielded the highest performance (AUC, 0.81). The PRS-NO-M5B was associated 
      with ILA (OR, 1.25) and ILA progression (OR, 1.16) in European ancestry 
      participants. Conclusions: A common genetic variant risk score complements the 
      MUC5B variant to identify individuals at high risk of interstitial lung 
      abnormalities and pulmonary fibrosis.
FAU - Moll, Matthew
AU  - Moll M
AD  - Division of Pulmonary and Critical Care Medicine, and.
AD  - Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard 
      Medical School, Boston, Massachusetts.
FAU - Peljto, Anna L
AU  - Peljto AL
AUID- ORCID: 0000-0002-8389-0736
AD  - Department of Medicine and.
AD  - Department of Immunology, Division of Pulmonary Medicine, University of Colorado, 
      Aurora, Colorado.
FAU - Kim, John S
AU  - Kim JS
AD  - Division of Pulmonary and Critical Care Medicine, Department of Medicine, 
      University of Virginia, Charlottesville, Virginia.
FAU - Xu, Hanfei
AU  - Xu H
AD  - Department of Biostatistics, Boston University School of Public Health, Boston, 
      Massachusetts.
FAU - Debban, Catherine L
AU  - Debban CL
AD  - Center for Public Health Genomics, University of Virginia School of Medicine, 
      Charlottesville, Virginia.
FAU - Chen, Xianfeng
AU  - Chen X
AD  - Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo 
      Clinic, Phoenix, Arizona.
FAU - Menon, Aravind
AU  - Menon A
AUID- ORCID: 0000-0002-0211-4509
AD  - Division of Pulmonary and Critical Care Medicine, and.
FAU - Putman, Rachel K
AU  - Putman RK
AD  - Division of Pulmonary and Critical Care Medicine, and.
FAU - Ghosh, Auyon J
AU  - Ghosh AJ
AD  - Department of Medicine, Division of Pulmonary and Critical Care Medicine, State 
      University of New York Upstate Medical Center, Syracuse, New York.
FAU - Saferali, Aabida
AU  - Saferali A
AD  - Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard 
      Medical School, Boston, Massachusetts.
FAU - Nishino, Mizuki
AU  - Nishino M
AD  - Center for Pulmonary Functional Imaging, Department of Radiology.
FAU - Hatabu, Hiroto
AU  - Hatabu H
AD  - Center for Pulmonary Functional Imaging, Department of Radiology.
FAU - Hobbs, Brian D
AU  - Hobbs BD
AD  - Division of Pulmonary and Critical Care Medicine, and.
AD  - Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard 
      Medical School, Boston, Massachusetts.
FAU - Hecker, Julian
AU  - Hecker J
AD  - Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard 
      Medical School, Boston, Massachusetts.
FAU - McDermott, Gregory
AU  - McDermott G
AD  - Division of Rheumatology, Department of Medicine, Brigham and Women's Hospital, 
      Boston, Massachusetts.
FAU - Sparks, Jeffrey A
AU  - Sparks JA
AD  - Division of Rheumatology, Department of Medicine, Brigham and Women's Hospital, 
      Boston, Massachusetts.
FAU - Wain, Louise V
AU  - Wain LV
AD  - Department of Health Sciences, University of Leicester, Leicester, United 
      Kingdom.
AD  - National Institute for Health Research, Leicester Respiratory Biomedical Research 
      Centre, Glenfield Hospital, Leicester, United Kingdom.
FAU - Allen, Richard J
AU  - Allen RJ
AD  - Department of Health Sciences, University of Leicester, Leicester, United 
      Kingdom.
AD  - National Institute for Health Research, Leicester Respiratory Biomedical Research 
      Centre, Glenfield Hospital, Leicester, United Kingdom.
FAU - Tobin, Martin D
AU  - Tobin MD
AD  - Department of Health Sciences, University of Leicester, Leicester, United 
      Kingdom.
AD  - National Institute for Health Research, Leicester Respiratory Biomedical Research 
      Centre, Glenfield Hospital, Leicester, United Kingdom.
FAU - Raby, Benjamin A
AU  - Raby BA
AD  - Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard 
      Medical School, Boston, Massachusetts.
AD  - Department of Pediatrics.
AD  - Division of Pulmonary Medicine, Boston Children's Hospital, Harvard Medical 
      School, Boston, Massachusetts.
FAU - Chun, Sung
AU  - Chun S
AD  - Division of Pulmonary Medicine, Boston Children's Hospital, Harvard Medical 
      School, Boston, Massachusetts.
FAU - Silverman, Edwin K
AU  - Silverman EK
AD  - Division of Pulmonary and Critical Care Medicine, and.
AD  - Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard 
      Medical School, Boston, Massachusetts.
FAU - Zamora, Ana C
AU  - Zamora AC
AD  - Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo 
      Clinic, Phoenix, Arizona.
FAU - Ortega, Victor E
AU  - Ortega VE
AD  - Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo 
      Clinic, Phoenix, Arizona.
FAU - Garcia, Christine K
AU  - Garcia CK
AUID- ORCID: 0000-0002-0771-1249
AD  - Division of Pulmonary and Critical Care Medicine, Department of Medicine, 
      Columbia University Irving Medical Center, New York, New York.
FAU - Barr, R Graham
AU  - Barr RG
AD  - Department of Medicine and.
AD  - Division of General Medicine, Department of Epidemiology, Columbia University 
      Medical Center, New York, New York.
FAU - Bleecker, Eugene R
AU  - Bleecker ER
AD  - Division of Genetics, Genomics, and Precision Medicine, Department of Medicine, 
      University of Arizona, Tucson, Arizona.
FAU - Meyers, Deborah A
AU  - Meyers DA
AD  - Division of Genetics, Genomics, and Precision Medicine, Department of Medicine, 
      University of Arizona, Tucson, Arizona.
FAU - Kaner, Robert J
AU  - Kaner RJ
AD  - Division of Pulmonary Medicine, Weill Cornell School of Medicine, New York, New 
      York.
FAU - Rich, Stephen S
AU  - Rich SS
AD  - Center for Public Health Genomics, University of Virginia School of Medicine, 
      Charlottesville, Virginia.
FAU - Manichaikul, Ani
AU  - Manichaikul A
AD  - Center for Public Health Genomics, University of Virginia School of Medicine, 
      Charlottesville, Virginia.
FAU - Rotter, Jerome I
AU  - Rotter JI
AD  - The Institute for Translational Genomics and Population Sciences, Department of 
      Pediatrics, The Lundquist Institute for Biomedical Innovation at 
      Harbor-University of California, Los Angeles Medical Center, Torrance, 
      California.
FAU - Dupuis, Josée
AU  - Dupuis J
AD  - Department of Biostatistics, Boston University School of Public Health, Boston, 
      Massachusetts.
AD  - Department of Epidemiology, Biostatistics and Occupational Health, School of 
      Population and Global Health, McGill University Faculty of Medicine and Health 
      Sciences, Montreal, Quebec, Canada.
FAU - O'Connor, George T
AU  - O'Connor GT
AD  - Department of Medicine, Pulmonary Center, Boston University School of Medicine, 
      Boston, Massachusetts; and.
FAU - Fingerlin, Tasha E
AU  - Fingerlin TE
AD  - The National Jewish Health Cohen Family Asthma Institute, Division of Allergy and 
      Immunology, National Jewish Health, Denver, Colorado.
FAU - Hunninghake, Gary M
AU  - Hunninghake GM
AD  - Division of Pulmonary and Critical Care Medicine, and.
FAU - Schwartz, David A
AU  - Schwartz DA
AD  - Department of Medicine and.
AD  - Department of Immunology, Division of Pulmonary Medicine, University of Colorado, 
      Aurora, Colorado.
FAU - Cho, Michael H
AU  - Cho MH
AD  - Division of Pulmonary and Critical Care Medicine, and.
AD  - Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard 
      Medical School, Boston, Massachusetts.
LA  - eng
GR  - R01 HL152728/HL/NHLBI NIH HHS/United States
GR  - N01HC95163/HL/NHLBI NIH HHS/United States
GR  - R01 HL133135/HL/NHLBI NIH HHS/United States
GR  - RC1 HL100543/HL/NHLBI NIH HHS/United States
GR  - P30 DK063491/DK/NIDDK NIH HHS/United States
GR  - N01HC95165/HL/NHLBI NIH HHS/United States
GR  - UG3 HL151865/HL/NHLBI NIH HHS/United States
GR  - P01 HL132825/HL/NHLBI NIH HHS/United States
GR  - P01 HL114501/HL/NHLBI NIH HHS/United States
GR  - HHSN268201500003C/HL/NHLBI NIH HHS/United States
GR  - HHSN268200900019C/HL/NHLBI NIH HHS/United States
GR  - P01 HL092870/HL/NHLBI NIH HHS/United States
GR  - N01HC95160/HL/NHLBI NIH HHS/United States
GR  - R01 HL120393/HL/NHLBI NIH HHS/United States
GR  - HHSN268201500001C/HL/NHLBI NIH HHS/United States
GR  - UL1 TR001079/TR/NCATS NIH HHS/United States
GR  - R01 HL158668/HL/NHLBI NIH HHS/United States
GR  - N01HC95169/HL/NHLBI NIH HHS/United States
GR  - R01 HL130974/HL/NHLBI NIH HHS/United States
GR  - U01 HL120393/HL/NHLBI NIH HHS/United States
GR  - R01 HL153248/HL/NHLBI NIH HHS/United States
GR  - U01 HL089897/HL/NHLBI NIH HHS/United States
GR  - R01 HL077612/HL/NHLBI NIH HHS/United States
GR  - DH_/Department of Health/United Kingdom
GR  - R01 HL111527/HL/NHLBI NIH HHS/United States
GR  - R01 HL147148/HL/NHLBI NIH HHS/United States
GR  - N01HC95164/HL/NHLBI NIH HHS/United States
GR  - R01 HL089856/HL/NHLBI NIH HHS/United States
GR  - N02HL64278/HL/NHLBI NIH HHS/United States
GR  - T32 AR007530/AR/NIAMS NIH HHS/United States
GR  - N01HC95162/HL/NHLBI NIH HHS/United States
GR  - HHSN268201000021C/HL/NHLBI NIH HHS/United States
GR  - R01 HL093081/HL/NHLBI NIH HHS/United States
GR  - N02 HL64278/HL/NHLBI NIH HHS/United States
GR  - N01HC95168/HL/NHLBI NIH HHS/United States
GR  - R01 HL111024/HL/NHLBI NIH HHS/United States
GR  - U01 HL089856/HL/NHLBI NIH HHS/United States
GR  - HHSN268200900015C/HL/NHLBI NIH HHS/United States
GR  - HHSN268200900016C/HL/NHLBI NIH HHS/United States
GR  - R01 HL135142/HL/NHLBI NIH HHS/United States
GR  - I01 BX005295/BX/BLRD VA/United States
GR  - HHSN268201800001C/HL/NHLBI NIH HHS/United States
GR  - R01 HL121270/HL/NHLBI NIH HHS/United States
GR  - U01 HL137880/HL/NHLBI NIH HHS/United States
GR  - N01HC95159/HL/NHLBI NIH HHS/United States
GR  - HHSN268201500001I/HL/NHLBI NIH HHS/United States
GR  - N01HC95161/HL/NHLBI NIH HHS/United States
GR  - UL1 TR001420/TR/NCATS NIH HHS/United States
GR  - K08 HL159318/HL/NHLBI NIH HHS/United States
GR  - R01 HL137927/HL/NHLBI NIH HHS/United States
GR  - K08 HL136928/HL/NHLBI NIH HHS/United States
GR  - R01 HL142992/HL/NHLBI NIH HHS/United States
GR  - HHSN268201500003I/HL/NHLBI NIH HHS/United States
GR  - HHSN268200900018C/HL/NHLBI NIH HHS/United States
GR  - N01HC95167/HL/NHLBI NIH HHS/United States
GR  - UH3 HL151865/HL/NHLBI NIH HHS/United States
GR  - N01HC25195/HL/NHLBI NIH HHS/United States
GR  - HHSN268200900017C/HL/NHLBI NIH HHS/United States
GR  - 75N92019D00031/HL/NHLBI NIH HHS/United States
GR  - HHSN268200900013C/HL/NHLBI NIH HHS/United States
GR  - UL1 TR000040/TR/NCATS NIH HHS/United States
GR  - WT_/Wellcome Trust/United Kingdom
GR  - R01 HL117626/HL/NHLBI NIH HHS/United States
GR  - R01 CA203636/CA/NCI NIH HHS/United States
GR  - K23 HL150301/HL/NHLBI NIH HHS/United States
GR  - U01 CA209414/CA/NCI NIH HHS/United States
GR  - N01HC95166/HL/NHLBI NIH HHS/United States
GR  - UL1 TR001881/TR/NCATS NIH HHS/United States
GR  - HHSN268200900014C/HL/NHLBI NIH HHS/United States
GR  - R01 HL149836/HL/NHLBI NIH HHS/United States
GR  - T32 HL007427/HL/NHLBI NIH HHS/United States
GR  - HHSN268201000001I/HL/NHLBI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PL  - United States
TA  - Am J Respir Crit Care Med
JT  - American journal of respiratory and critical care medicine
JID - 9421642
RN  - 0 (Mucin-5B)
SB  - IM
CIN - Am J Respir Crit Care Med. 2023 Oct 1;208(7):750-752. PMID: 37607347
MH  - Humans
MH  - *Genome-Wide Association Study
MH  - *Idiopathic Pulmonary Fibrosis/genetics
MH  - Risk Factors
MH  - Lung
MH  - Mucin-5B/genetics
MH  - Genetic Predisposition to Disease
PMC - PMC10563194
OTO - NOTNLM
OT  - MUC5B
OT  - idiopathic pulmonary fibrosis
OT  - interstitial lung abnormalities
OT  - polygenic risk score
EDAT- 2023/07/31 19:15
MHDA- 2023/10/23 00:43
PMCR- 2024/10/01
CRDT- 2023/07/31 17:03
PHST- 2024/10/01 00:00 [pmc-release]
PHST- 2023/10/23 00:43 [medline]
PHST- 2023/07/31 19:15 [pubmed]
PHST- 2023/07/31 17:03 [entrez]
AID - 10.1164/rccm.202212-2257OC [doi]
PST - ppublish
SO  - Am J Respir Crit Care Med. 2023 Oct 1;208(7):791-801. doi: 
      10.1164/rccm.202212-2257OC.

PMID- 30903561
OWN - NLM
STAT- MEDLINE
DCOM- 20201127
LR  - 20201127
IS  - 1573-3432 (Electronic)
IS  - 0162-3257 (Print)
IS  - 0162-3257 (Linking)
VI  - 50
IP  - 9
DP  - 2020 Sep
TI  - Parent Perspectives Towards Genetic and Epigenetic Testing for Autism Spectrum 
      Disorder.
PG  - 3114-3125
LID - 10.1007/s10803-019-03990-6 [doi]
AB  - Examining community views on genetic/epigenetic research allows collaborative 
      technology development. Parent perspectives toward genetic/epigenetic testing for 
      autism spectrum disorder (ASD) are not well-studied. Parents of children with ASD 
      (n = 131), non-ASD developmental delay (n = 39), and typical development (n = 74) 
      completed surveys assessing genetic/epigenetic knowledge, genetic/epigenetic 
      concerns, motives for research participation, and attitudes/preferences toward 
      ASD testing. Most parents (96%) were interested in saliva-based molecular testing 
      for ASD. Some had concerns about privacy (14%) and insurance-status (10%). None 
      (0%) doubted scientific evidence behind genetic/epigenetic testing. Most reported 
      familiarity with genetics (88%), but few understood differences from epigenetics 
      (19%). Child developmental status impacted insurance concerns (p = 0.01). There 
      is broad parent interest in a genetic/epigenetic test for ASD. It will be crucial 
      to carefully consider and address bioethical issues surrounding this sensitive 
      topic while developing such technology.
FAU - Wagner, Kayla E
AU  - Wagner KE
AD  - Quadrant Biosciences Inc., Syracuse, USA.
AD  - Departments of Neuroscience & Physiology, Psychiatry, Biochemistry & Molecular 
      Biology, Pediatrics, State University of New York Upstate Medical University, 
      Syracuse, USA.
FAU - McCormick, Jennifer B
AU  - McCormick JB
AD  - Department of Humanities, Penn State College of Medicine, 500 University Drive 
      Mail Code H134, Hershey, USA.
FAU - Barns, Sarah
AU  - Barns S
AD  - Quadrant Biosciences Inc., Syracuse, USA.
AD  - Departments of Neuroscience & Physiology, Psychiatry, Biochemistry & Molecular 
      Biology, Pediatrics, State University of New York Upstate Medical University, 
      Syracuse, USA.
FAU - Carney, Molly
AU  - Carney M
AD  - Department of Pediatrics, Penn State College of Medicine, 500 University Drive, 
      Mail Code HS83, Hershey, USA.
FAU - Middleton, Frank A
AU  - Middleton FA
AD  - Departments of Neuroscience & Physiology, Psychiatry, Biochemistry & Molecular 
      Biology, Pediatrics, State University of New York Upstate Medical University, 
      Syracuse, USA.
FAU - Hicks, Steven D
AU  - Hicks SD
AUID- ORCID: 0000-0002-9579-6798
AD  - Department of Pediatrics, Penn State College of Medicine, 500 University Drive, 
      Mail Code HS83, Hershey, USA. shicks1@pennstatehealth.psu.edu.
LA  - eng
GR  - KL2 TR002015/TR/NCATS NIH HHS/United States
GR  - R42 MH111347/MH/NIMH NIH HHS/United States
GR  - R41 MH111347-0/MH/NIMH NIH HHS/United States
GR  - UL1 TR002014/TR/NCATS NIH HHS/United States
GR  - R41 MH111347/MH/NIMH NIH HHS/United States
GR  - R41 MH111347-0/MH/NIMH NIH HHS/United States
PT  - Journal Article
PL  - United States
TA  - J Autism Dev Disord
JT  - Journal of autism and developmental disorders
JID - 7904301
SB  - IM
MH  - Attitude
MH  - Autism Spectrum Disorder/diagnosis/*genetics
MH  - Child
MH  - Child, Preschool
MH  - Epigenesis, Genetic
MH  - Female
MH  - *Genetic Testing
MH  - Humans
MH  - Male
MH  - Motivation
MH  - Parents/*psychology
MH  - Surveys and Questionnaires
PMC - PMC6755071
MID - NIHMS1046827
OTO - NOTNLM
OT  - Autism
OT  - Bioethics
OT  - Diagnosis
OT  - Epigenetics
OT  - Parent perspectives
COIS- SDH and FAM are co-inventors of patent applications for RNA biomarkers in autism 
      spectrum disorder that is assigned to The Research Foundation for the State 
      University of New York, The Penn State Research Foundation and Quadrant 
      Biosciences Inc., and licensed to Quadrant Biosciences Inc. SDH is a paid 
      consultant for Quadrant Biosciences Inc. These conflicts of interest are actively 
      managed by the Penn State College of Medicine. KW and SB are employees of 
      Quadrant Biosciences Inc.
EDAT- 2019/03/25 06:00
MHDA- 2020/11/28 06:00
CRDT- 2019/03/24 06:00
PHST- 2019/03/25 06:00 [pubmed]
PHST- 2020/11/28 06:00 [medline]
PHST- 2019/03/24 06:00 [entrez]
AID - 10.1007/s10803-019-03990-6 [pii]
AID - 3990 [pii]
AID - 10.1007/s10803-019-03990-6 [doi]
PST - ppublish
SO  - J Autism Dev Disord. 2020 Sep;50(9):3114-3125. doi: 10.1007/s10803-019-03990-6.

PMID- 37962958
OWN - NLM
STAT- MEDLINE
DCOM- 20240103
LR  - 20240116
IS  - 1558-8238 (Electronic)
IS  - 0021-9738 (Print)
IS  - 0021-9738 (Linking)
VI  - 134
IP  - 1
DP  - 2024 Jan 2
TI  - Spliceosome malfunction causes neurodevelopmental disorders with overlapping 
      features.
LID - 10.1172/JCI171235 [doi]
LID - e171235
AB  - Pre-mRNA splicing is a highly coordinated process. While its dysregulation has 
      been linked to neurological deficits, our understanding of the underlying 
      molecular and cellular mechanisms remains limited. We implicated pathogenic 
      variants in U2AF2 and PRPF19, encoding spliceosome subunits in neurodevelopmental 
      disorders (NDDs), by identifying 46 unrelated individuals with 23 de novo U2AF2 
      missense variants (including 7 recurrent variants in 30 individuals) and 6 
      individuals with de novo PRPF19 variants. Eight U2AF2 variants dysregulated 
      splicing of a model substrate. Neuritogenesis was reduced in human neurons 
      differentiated from human pluripotent stem cells carrying two U2AF2 
      hyper-recurrent variants. Neural loss of function (LoF) of the Drosophila 
      orthologs U2af50 and Prp19 led to lethality, abnormal mushroom body (MB) 
      patterning, and social deficits, which were differentially rescued by wild-type 
      and mutant U2AF2 or PRPF19. Transcriptome profiling revealed splicing substrates 
      or effectors (including Rbfox1, a third splicing factor), which rescued MB 
      defects in U2af50-deficient flies. Upon reanalysis of negative clinical exomes 
      followed by data sharing, we further identified 6 patients with NDD who carried 
      RBFOX1 missense variants which, by in vitro testing, showed LoF. Our study 
      implicates 3 splicing factors as NDD-causative genes and establishes a genetic 
      network with hierarchy underlying human brain development and function.
FAU - Li, Dong
AU  - Li D
AD  - Center for Applied Genomics, and.
AD  - Division of Human Genetics, The Children's Hospital of Philadelphia, 
      Philadelphia, Pennsylvania, USA.
AD  - Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, 
      Philadelphia, Pennsylvania, USA.
FAU - Wang, Qin
AU  - Wang Q
AD  - Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Children's 
      Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
FAU - Bayat, Allan
AU  - Bayat A
AD  - Department of Regional Health Research, University of Southern Denmark, Odense, 
      Denmark.
AD  - Department for Epilepsy Genetics and Personalized Medicine, Danish Epilepsy 
      Centre, Dianalund, Denmark.
AD  - Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, 
      Denmark.
FAU - Battig, Mark R
AU  - Battig MR
AD  - Center for Applied Genomics, and.
FAU - Zhou, Yijing
AU  - Zhou Y
AD  - Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Children's 
      Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
FAU - Bosch, Daniëlle Gm
AU  - Bosch DG
AD  - Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The 
      Netherlands.
FAU - van Haaften, Gijs
AU  - van Haaften G
AD  - Department of Genetics, Center for Molecular Medicine, University Medical Center 
      Utrecht, Utrecht University, Utrecht, The Netherlands.
FAU - Granger, Leslie
AU  - Granger L
AD  - Department of Genetics and Metabolism, Randall Children's Hospital at Legacy 
      Emanuel Medical Center, Portland, Oregon, USA.
FAU - Petersen, Andrea K
AU  - Petersen AK
AD  - Department of Genetics and Metabolism, Randall Children's Hospital at Legacy 
      Emanuel Medical Center, Portland, Oregon, USA.
FAU - Pérez-Jurado, Luis A
AU  - Pérez-Jurado LA
AD  - Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII, Madrid, 
      Spain.
AD  - Genetic Service, Hospital del Mar Research Institute (IMIM), Barcelona, Spain.
AD  - Universitat Pompeu Fabra, Barcelona, Spain.
FAU - Aznar-Laín, Gemma
AU  - Aznar-Laín G
AD  - Universitat Pompeu Fabra, Barcelona, Spain.
AD  - Pediatric Neurology, Hospital del Mar Research Institute (IMIM), Barcelona, 
      Spain.
FAU - Aneja, Anushree
AU  - Aneja A
AD  - Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Children's 
      Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
FAU - Hancarova, Miroslava
AU  - Hancarova M
AD  - Department of Biology and Medical Genetics, Charles University Second Faculty of 
      Medicine and University Hospital Motol, Prague, Czech Republic.
FAU - Bendova, Sarka
AU  - Bendova S
AD  - Department of Biology and Medical Genetics, Charles University Second Faculty of 
      Medicine and University Hospital Motol, Prague, Czech Republic.
FAU - Schwarz, Martin
AU  - Schwarz M
AD  - Department of Biology and Medical Genetics, Charles University Second Faculty of 
      Medicine and University Hospital Motol, Prague, Czech Republic.
FAU - Kremlikova Pourova, Radka
AU  - Kremlikova Pourova R
AD  - Department of Biology and Medical Genetics, Charles University Second Faculty of 
      Medicine and University Hospital Motol, Prague, Czech Republic.
FAU - Sedlacek, Zdenek
AU  - Sedlacek Z
AD  - Department of Biology and Medical Genetics, Charles University Second Faculty of 
      Medicine and University Hospital Motol, Prague, Czech Republic.
FAU - Keena, Beth A
AU  - Keena BA
AD  - Division of Human Genetics, The Children's Hospital of Philadelphia, 
      Philadelphia, Pennsylvania, USA.
FAU - March, Michael E
AU  - March ME
AD  - Center for Applied Genomics, and.
FAU - Hou, Cuiping
AU  - Hou C
AD  - Center for Applied Genomics, and.
FAU - O'Connor, Nora
AU  - O'Connor N
AD  - Center for Applied Genomics, and.
FAU - Bhoj, Elizabeth J
AU  - Bhoj EJ
AD  - Center for Applied Genomics, and.
AD  - Division of Human Genetics, The Children's Hospital of Philadelphia, 
      Philadelphia, Pennsylvania, USA.
AD  - Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, 
      Philadelphia, Pennsylvania, USA.
FAU - Harr, Margaret H
AU  - Harr MH
AD  - Center for Applied Genomics, and.
FAU - Lemire, Gabrielle
AU  - Lemire G
AD  - Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, 
      Ottawa, Ontario, Canada.
FAU - Boycott, Kym M
AU  - Boycott KM
AD  - Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, 
      Ottawa, Ontario, Canada.
FAU - Towne, Meghan
AU  - Towne M
AD  - Ambry Genetics, Aliso Viejo, California, USA.
FAU - Li, Megan
AU  - Li M
AD  - Invitae, San Francisco, California, USA.
FAU - Tarnopolsky, Mark
AU  - Tarnopolsky M
AD  - Division of Neuromuscular and Neurometabolic Disorders, Department of 
      Paediatrics, McMaster University Children's Hospital, Hamilton, Ontario, Canada.
FAU - Brady, Lauren
AU  - Brady L
AD  - Division of Neuromuscular and Neurometabolic Disorders, Department of 
      Paediatrics, McMaster University Children's Hospital, Hamilton, Ontario, Canada.
FAU - Parker, Michael J
AU  - Parker MJ
AD  - Department of Clinical Genetics, Sheffield Children's Hospital, Sheffield, United 
      Kingdom.
FAU - Faghfoury, Hanna
AU  - Faghfoury H
AD  - University Health Network, Toronto, Ontario, Canada.
FAU - Parsley, Lea Kristin
AU  - Parsley LK
AD  - University of Illinois College of Medicine, Mercy Health Systems, Rockford, 
      Illinois, USA.
FAU - Agolini, Emanuele
AU  - Agolini E
AD  - Laboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino 
      Gesù Children's Hospital, IRCCS, Rome, Italy.
FAU - Dentici, Maria Lisa
AU  - Dentici ML
AD  - Medical Genetics Unit, Academic Department of Pediatrics, IRCCS, Ospedale 
      Pediatrico Bambino Gesù, Rome, Italy.
AD  - Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, 
      IRCCS, Rome, Italy.
FAU - Novelli, Antonio
AU  - Novelli A
AD  - Laboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino 
      Gesù Children's Hospital, IRCCS, Rome, Italy.
FAU - Wright, Meredith
AU  - Wright M
AD  - Rady Children's Institute for Genomic Medicine, San Diego, California, USA.
FAU - Palmquist, Rachel
AU  - Palmquist R
AD  - Division of Pediatric Neurology, Department of Pediatrics, University of Utah 
      School of Medicine, Salt Lake City, Utah, USA.
FAU - Lai, Khanh
AU  - Lai K
AD  - Division of Pediatric Pulmonary and Sleep Medicine, University of Utah, Salt Lake 
      City, Utah, USA.
FAU - Scala, Marcello
AU  - Scala M
AD  - Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal 
      and Child Health, Università Degli Studi di Genova, Genoa, Italy.
AD  - Pediatric Neurology and Muscular Diseases Unit, and.
FAU - Striano, Pasquale
AU  - Striano P
AD  - Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal 
      and Child Health, Università Degli Studi di Genova, Genoa, Italy.
AD  - Pediatric Neurology and Muscular Diseases Unit, and.
FAU - Iacomino, Michele
AU  - Iacomino M
AD  - Medical Genetics Unit, IRCCS, Istituto Giannina Gaslini, Genoa, Italy.
FAU - Zara, Federico
AU  - Zara F
AD  - Medical Genetics Unit, IRCCS, Istituto Giannina Gaslini, Genoa, Italy.
FAU - Cooper, Annina
AU  - Cooper A
AD  - Department of Genetics, Southern California Permanente Medical Group, Kaiser 
      Permanente, San Diego, California, USA.
FAU - Maarup, Timothy J
AU  - Maarup TJ
AD  - Department of Genetics, Kaiser Permanente, Los Angeles, California, USA.
FAU - Byler, Melissa
AU  - Byler M
AD  - Center for Development, Behavior and Genetics, SUNY Upstate Medical University, 
      Syracuse, New York, USA.
FAU - Lebel, Robert Roger
AU  - Lebel RR
AD  - Center for Development, Behavior and Genetics, SUNY Upstate Medical University, 
      Syracuse, New York, USA.
FAU - Balci, Tugce B
AU  - Balci TB
AD  - Division of Genetics, Department of Paediatrics, London Health Sciences Centre, 
      London, Ontario, Canada.
FAU - Louie, Raymond
AU  - Louie R
AD  - Greenwood Genetic Center, Greenwood, South Carolina, USA.
FAU - Lyons, Michael
AU  - Lyons M
AD  - Greenwood Genetic Center, Greenwood, South Carolina, USA.
FAU - Douglas, Jessica
AU  - Douglas J
AD  - Division of Genetics and Genomics, Boston Children's Hospital, Boston, 
      Massachusetts, USA.
FAU - Nowak, Catherine
AU  - Nowak C
AD  - Division of Genetics and Metabolism, Mass General Hospital for Children, Boston, 
      Massachusetts, USA.
FAU - Afenjar, Alexandra
AU  - Afenjar A
AD  - APHP. SU, Reference Center for Intellectual Disabilities Caused by Rare Causes, 
      Department of Genetics and Medical Embryology, Hôpital Trousseau, Paris, France.
FAU - Hoyer, Juliane
AU  - Hoyer J
AD  - Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, 
      Erlangen, Germany.
FAU - Keren, Boris
AU  - Keren B
AD  - Department of Genetics, Hospital Pitié-Salpêtrière, Paris, France.
FAU - Maas, Saskia M
AU  - Maas SM
AD  - Department of Human Genetics, Academic Medical Center, and.
FAU - Motazacker, Mahdi M
AU  - Motazacker MM
AD  - Laboratory of Genome Diagnostics, Department of Human Genetics, Amsterdam UMC, 
      University of Amsterdam, Amsterdam, The Netherlands.
FAU - Martinez-Agosto, Julian A
AU  - Martinez-Agosto JA
AD  - Division of Medical Genetics, Department of Pediatrics, UCLA, Los Angeles, 
      California, USA.
FAU - Rabani, Ahna M
AU  - Rabani AM
AD  - Division of Medical Genetics, Department of Pediatrics, UCLA, Los Angeles, 
      California, USA.
FAU - McCormick, Elizabeth M
AU  - McCormick EM
AD  - Mitochondrial Medicine Frontier Program, Division of Human Genetics, Department 
      of Pediatrics.
FAU - Falk, Marni J
AU  - Falk MJ
AD  - Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, 
      Philadelphia, Pennsylvania, USA.
AD  - Mitochondrial Medicine Frontier Program, Division of Human Genetics, Department 
      of Pediatrics.
FAU - Ruggiero, Sarah M
AU  - Ruggiero SM
AD  - Division of Neurology, and.
AD  - The Epilepsy NeuroGenetics Initiative (ENGIN), Children's Hospital of 
      Philadelphia, Philadelphia, Pennsylvania, USA.
FAU - Helbig, Ingo
AU  - Helbig I
AD  - Division of Neurology, and.
AD  - The Epilepsy NeuroGenetics Initiative (ENGIN), Children's Hospital of 
      Philadelphia, Philadelphia, Pennsylvania, USA.
AD  - Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, 
      USA.
AD  - Department of Biomedical and Health Informatics (DBHi), Children's Hospital of 
      Philadelphia, Philadelphia, Pennsylvania, USA.
FAU - Møller, Rikke S
AU  - Møller RS
AD  - Department of Regional Health Research, University of Southern Denmark, Odense, 
      Denmark.
AD  - Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy 
      Centre, Dianalund, Denmark.
FAU - Tessarollo, Lino
AU  - Tessarollo L
AD  - Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer 
      Institute (NCI), Frederick, Maryland, USA.
FAU - Tomassoni Ardori, Francesco
AU  - Tomassoni Ardori F
AD  - Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer 
      Institute (NCI), Frederick, Maryland, USA.
FAU - Palko, Mary Ellen
AU  - Palko ME
AD  - Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer 
      Institute (NCI), Frederick, Maryland, USA.
FAU - Hsieh, Tzung-Chien
AU  - Hsieh TC
AD  - Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, 
      Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
FAU - Krawitz, Peter M
AU  - Krawitz PM
AD  - Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, 
      Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
FAU - Ganapathi, Mythily
AU  - Ganapathi M
AD  - New York Genome Center, New York, New York, USA.
AD  - Department of Pathology, Columbia University Irving Medical Center, New York, New 
      York, USA.
FAU - Gelb, Bruce D
AU  - Gelb BD
AD  - Mindich Child Health and Development Institute and the Departments of Pediatrics 
      and Genetics and Genomic Sciences, Icahn School of Medicine, New York, New York, 
      USA.
FAU - Jobanputra, Vaidehi
AU  - Jobanputra V
AD  - New York Genome Center, New York, New York, USA.
AD  - Department of Pathology, Columbia University Irving Medical Center, New York, New 
      York, USA.
FAU - Wilson, Ashley
AU  - Wilson A
AD  - New York Genome Center, New York, New York, USA.
FAU - Greally, John
AU  - Greally J
AD  - Department of Genetics, Albert Einstein College of Medicine, Bronx, New York, 
      USA.
FAU - Jacquemont, Sébastien
AU  - Jacquemont S
AD  - Division of Genetics and Genomics, CHU Ste-Justine Hospital and CHU 
      Sainte-Justine Research Centre, University of Montreal, Montreal, Quebec, Canada.
FAU - Jizi, Khadijé
AU  - Jizi K
AD  - Division of Genetics and Genomics, CHU Ste-Justine Hospital and CHU 
      Sainte-Justine Research Centre, University of Montreal, Montreal, Quebec, Canada.
FAU - Bruel, Ange-Line
AU  - Bruel AL
AD  - INSERM UMR 1231, Genetics of Developmental Anomalies, Université de Bourgogne 
      Franche-Comté, Dijon, France.
AD  - UF Innovation en Diagnostic Génomique des Maladies Rares, CHU Dijon Bourgogne, 
      Dijon, France.
AD  - FHU-TRANSLAD, Fédération Hospitalo-Universitaire Translational Medicine in 
      Developmental Anomalies, CHU Dijon Bourgogne, Dijon, France.
FAU - Quelin, Chloé
AU  - Quelin C
AD  - Medical Genetics Department, Centre de Référence Maladies Rares CLAD-Ouest, CHU 
      Hôpital Sud, Rennes, France.
FAU - Misra, Vinod K
AU  - Misra VK
AD  - Division of Genetic, Genomic, and Metabolic Disorders, Children's Hospital of 
      Michigan, Detroit, Michigan, USA.
AD  - Central Michigan University College of Medicine, Discipline of Pediatrics, Mount 
      Pleasant, Michigan, USA.
FAU - Chick, Erika
AU  - Chick E
AD  - Division of Genetic, Genomic, and Metabolic Disorders, Children's Hospital of 
      Michigan, Detroit, Michigan, USA.
FAU - Romano, Corrado
AU  - Romano C
AD  - Research Unit of Rare Diseases and Neurodevelopmental Disorders, Oasi Research 
      Institute-IRCCS, Troina, Italy.
AD  - Medical Genetics, Department of Biomedical and Biotechnological Sciences, 
      University of Catania, Catania, Italy.
FAU - Greco, Donatella
AU  - Greco D
AD  - Oasi Research Institute-IRCCS, Troina, Italy.
FAU - Arena, Alessia
AU  - Arena A
AD  - Oasi Research Institute-IRCCS, Troina, Italy.
FAU - Morleo, Manuela
AU  - Morleo M
AD  - Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.
AD  - Department of Precision Medicine, University of Campania "Luigi Vanvitelli", 
      Naples, Italy.
FAU - Nigro, Vincenzo
AU  - Nigro V
AD  - Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.
AD  - Department of Precision Medicine, University of Campania "Luigi Vanvitelli", 
      Naples, Italy.
FAU - Seyama, Rie
AU  - Seyama R
AD  - Department of Human Genetics, Yokohama City University Graduate School of 
      Medicine, Yokohama, Japan.
AD  - Department of Obstetrics and Gynecology, Juntendo University, Tokyo, Japan.
FAU - Uchiyama, Yuri
AU  - Uchiyama Y
AD  - Department of Human Genetics, Yokohama City University Graduate School of 
      Medicine, Yokohama, Japan.
AD  - Department of Rare Disease Genomics, Yokohama City University Hospital, Yokohama, 
      Japan.
FAU - Matsumoto, Naomichi
AU  - Matsumoto N
AD  - Department of Human Genetics, Yokohama City University Graduate School of 
      Medicine, Yokohama, Japan.
FAU - Taira, Ryoji
AU  - Taira R
AD  - Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, 
      Fukuoka, Japan.
FAU - Tashiro, Katsuya
AU  - Tashiro K
AD  - Department of Pediatrics, Karatsu Red Cross Hospital, Saga, Japan.
FAU - Sakai, Yasunari
AU  - Sakai Y
AD  - Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, 
      Fukuoka, Japan.
FAU - Yigit, Gökhan
AU  - Yigit G
AD  - Institute of Human Genetics, University Medical Center Göttingen, Göttingen, 
      Germany.
AD  - DZHK (German Center for Cardiovascular Research), partner site Göttingen, 
      Göttingen, Germany.
FAU - Wollnik, Bernd
AU  - Wollnik B
AD  - Institute of Human Genetics, University Medical Center Göttingen, Göttingen, 
      Germany.
AD  - DZHK (German Center for Cardiovascular Research), partner site Göttingen, 
      Göttingen, Germany.
AD  - Cluster of Excellence "Multiscale Bioimaging: from Molecular Machines to Networks 
      of Excitable Cells" (MBExC), University of Göttingen, Göttingen, Germany.
FAU - Wagner, Michael
AU  - Wagner M
AD  - Kinderzentrum Oldenburg, Sozialpädiatrisches Zentrum, Diakonisches Werk 
      Oldenburg, Oldenburg, Germany.
FAU - Kutsche, Barbara
AU  - Kutsche B
AD  - Kinderzentrum Oldenburg, Sozialpädiatrisches Zentrum, Diakonisches Werk 
      Oldenburg, Oldenburg, Germany.
FAU - Hurst, Anna Ce
AU  - Hurst AC
AD  - Department of Genetics, University of Alabama at Birmingham, Birmingham, Alabama, 
      USA.
FAU - Thompson, Michelle L
AU  - Thompson ML
AD  - HudsonAlpha Institute for Biotechnology, Huntsville, Alabama, USA.
FAU - Schmidt, Ryan
AU  - Schmidt R
AD  - Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, 
      Los Angeles, California, USA.
AD  - Keck School of Medicine of the University of Southern California, Los Angeles, 
      California, USA.
FAU - Randolph, Linda
AU  - Randolph L
AD  - Keck School of Medicine of the University of Southern California, Los Angeles, 
      California, USA.
AD  - Division of Medical Genetics, Children's Hospital Los Angeles, California, USA.
FAU - Spillmann, Rebecca C
AU  - Spillmann RC
AD  - Department of Pediatrics-Medical Genetics, Duke University School of Medicine, 
      Durham, North Carolina, USA.
FAU - Shashi, Vandana
AU  - Shashi V
AD  - Department of Pediatrics-Medical Genetics, Duke University School of Medicine, 
      Durham, North Carolina, USA.
FAU - Higginbotham, Edward J
AU  - Higginbotham EJ
AD  - Genome Diagnostics, Department of Paediatric Laboratory Medicine, and.
FAU - Cordeiro, Dawn
AU  - Cordeiro D
AD  - Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, 
      Toronto, Ontario, Canada.
FAU - Carnevale, Amanda
AU  - Carnevale A
AD  - Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, 
      Toronto, Ontario, Canada.
FAU - Costain, Gregory
AU  - Costain G
AD  - Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, 
      Toronto, Ontario, Canada.
FAU - Khan, Tayyaba
AU  - Khan T
AD  - Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, 
      Toronto, Ontario, Canada.
FAU - Funalot, Benoît
AU  - Funalot B
AD  - Department of Genetics, Hôpital Henri-Mondor APHP and CHI Creteil, University 
      Paris Est Creteil, IMRB, Inserm U.955, Creteil, France.
FAU - Tran Mau-Them, Frederic
AU  - Tran Mau-Them F
AD  - INSERM UMR 1231, Genetics of Developmental Anomalies, Université de Bourgogne 
      Franche-Comté, Dijon, France.
AD  - UF Innovation en Diagnostic Génomique des Maladies Rares, CHU Dijon Bourgogne, 
      Dijon, France.
FAU - Fernandez Garcia Moya, Luis
AU  - Fernandez Garcia Moya L
AD  - Institute of Medical and Molecular Genetics (INGEMM), Hospital Universitario La 
      Paz, Madrid, Spain.
FAU - García-Miñaúr, Sixto
AU  - García-Miñaúr S
AD  - Institute of Medical and Molecular Genetics (INGEMM), Hospital Universitario La 
      Paz, Madrid, Spain.
FAU - Osmond, Matthew
AU  - Osmond M
AD  - Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, 
      Ottawa, Ontario, Canada.
FAU - Chad, Lauren
AU  - Chad L
AD  - Department of Pediatrics, Division of Clinical and Metabolic Genetics, The 
      Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
FAU - Quercia, Nada
AU  - Quercia N
AD  - Department of Genetic Counselling, Division of Clinical and Metabolic Genetics, 
      Hospital for Sick Children, Ottawa, Ontario, Canada.
AD  - Department of Molecular Genetics, University of Toronto, Toronto, Ontario, 
      Canada.
FAU - Carrasco, Diana
AU  - Carrasco D
AD  - Department of Clinical Genetics, Cook Children's Hospital, Fort Worth, Texas, 
      USA.
FAU - Li, Chumei
AU  - Li C
AD  - Division of Genetics, Department of Paediatrics, McMaster University, Hamilton, 
      Ontario, Canada.
FAU - Sanchez-Valle, Amarilis
AU  - Sanchez-Valle A
AD  - Division of Genetics and Metabolism, Department of Pediatrics, University of 
      South Florida, Tampa, Florida, USA.
FAU - Kelley, Meghan
AU  - Kelley M
AD  - Division of Genetics and Metabolism, Department of Pediatrics, University of 
      South Florida, Tampa, Florida, USA.
FAU - Nizon, Mathilde
AU  - Nizon M
AD  - Nantes Université, CHU Nantes, Medical Genetics Department, Nantes, France.
AD  - Nantes Université, CNRS, INSERM, l'Institut du Thorax, Nantes, France.
FAU - Jensson, Brynjar O
AU  - Jensson BO
AD  - deCODE genetics/Amgen Inc., Reykjavik, Iceland.
FAU - Sulem, Patrick
AU  - Sulem P
AD  - deCODE genetics/Amgen Inc., Reykjavik, Iceland.
FAU - Stefansson, Kari
AU  - Stefansson K
AD  - deCODE genetics/Amgen Inc., Reykjavik, Iceland.
AD  - Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, 
      Iceland.
FAU - Gorokhova, Svetlana
AU  - Gorokhova S
AD  - Aix Marseille University, Inserm, U1251-MMG, Marseille Medical Genetics, 
      Marseille, France.
AD  - Department of Medical Genetics, Timone Hospital, APHM, Marseille, France.
FAU - Busa, Tiffany
AU  - Busa T
AD  - Department of Medical Genetics, Timone Hospital, APHM, Marseille, France.
FAU - Rio, Marlène
AU  - Rio M
AD  - Department of Genomic Medicine of Rare Disorders, Necker Hospital, APHP Center, 
      University Paris Cité, Paris, France.
FAU - Hadj Habdallah, Hamza
AU  - Hadj Habdallah H
AD  - Department of Genomic Medicine of Rare Disorders, Necker Hospital, APHP Center, 
      University Paris Cité, Paris, France.
FAU - Lesieur-Sebellin, Marion
AU  - Lesieur-Sebellin M
AD  - Department of Genomic Medicine of Rare Disorders, Necker Hospital, APHP Center, 
      University Paris Cité, Paris, France.
FAU - Amiel, Jeanne
AU  - Amiel J
AD  - Rare Disease Genetics Department, APHP, Hôpital Necker, Paris, France.
AD  - Université Paris Cité, Inserm, Institut Imagine, Embryology and Genetics of 
      Malformations Laboratory, Paris, France.
FAU - Pingault, Véronique
AU  - Pingault V
AD  - Rare Disease Genetics Department, APHP, Hôpital Necker, Paris, France.
AD  - Université Paris Cité, Inserm, Institut Imagine, Embryology and Genetics of 
      Malformations Laboratory, Paris, France.
AD  - Laboratoire de Biologie Médicale Multi-Sites SeqOIA (laboratoire-seqoia.fr), 
      Paris, France.
FAU - Mercier, Sandra
AU  - Mercier S
AD  - Nantes Université, CHU Nantes, Medical Genetics Department, Nantes, France.
AD  - Nantes Université, CNRS, INSERM, l'Institut du Thorax, Nantes, France.
FAU - Vincent, Marie
AU  - Vincent M
AD  - Nantes Université, CHU Nantes, Medical Genetics Department, Nantes, France.
AD  - Nantes Université, CNRS, INSERM, l'Institut du Thorax, Nantes, France.
FAU - Philippe, Christophe
AU  - Philippe C
AD  - INSERM UMR 1231, Genetics of Developmental Anomalies, Université de Bourgogne 
      Franche-Comté, Dijon, France.
FAU - Fatus-Fauconnier, Clemence
AU  - Fatus-Fauconnier C
AD  - Reference Center for Hereditary Metabolic Diseases, CHU Dijon Bourgogne, Dijon, 
      France.
FAU - Friend, Kathryn
AU  - Friend K
AD  - Genetics and Molecular Pathology, SA Pathology, Adelaide, South Australia, 
      Australia.
FAU - Halligan, Rebecca K
AU  - Halligan RK
AD  - Metabolic Clinic, and.
FAU - Biswas, Sunita
AU  - Biswas S
AD  - Metabolic Clinic, and.
FAU - Rosser, Jane
AU  - Rosser J
AD  - Department of General Medicine, Women's and Children's Hospital, Adelaide, South 
      Australia, Australia.
FAU - Shoubridge, Cheryl
AU  - Shoubridge C
AD  - Adelaide Medical School and Robinson Research Institute, The University of 
      Adelaide, South Australia, Australia.
FAU - Corbett, Mark
AU  - Corbett M
AD  - Adelaide Medical School and Robinson Research Institute, The University of 
      Adelaide, South Australia, Australia.
FAU - Barnett, Christopher
AU  - Barnett C
AD  - Adelaide Medical School and Robinson Research Institute, The University of 
      Adelaide, South Australia, Australia.
AD  - Pediatric and Reproductive Genetics Unit, Women's and Children's Hospital, North 
      Adelaide, South Australia, Australia.
FAU - Gecz, Jozef
AU  - Gecz J
AD  - Adelaide Medical School and Robinson Research Institute, The University of 
      Adelaide, South Australia, Australia.
AD  - South Australian Health and Medical Research Institute, Adelaide, South 
      Australia, Australia.
FAU - Leppig, Kathleen
AU  - Leppig K
AD  - Genetic Services, Kaiser Permenante of Washington, Seattle, Washington, USA.
FAU - Slavotinek, Anne
AU  - Slavotinek A
AD  - Department of Pediatrics, Cincinnati Children's Hospital Medical Center, 
      Cincinnati, Ohio, USA.
FAU - Marcelis, Carlo
AU  - Marcelis C
AD  - Department of Human Genetics, Donders Institute for Brain, Cognition and 
      Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
FAU - Pfundt, Rolph
AU  - Pfundt R
AD  - Department of Human Genetics, Donders Institute for Brain, Cognition and 
      Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
FAU - de Vries, Bert Ba
AU  - de Vries BB
AD  - Department of Human Genetics, Donders Institute for Brain, Cognition and 
      Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
FAU - van Slegtenhorst, Marjon A
AU  - van Slegtenhorst MA
AD  - Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The 
      Netherlands.
FAU - Brooks, Alice S
AU  - Brooks AS
AD  - Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The 
      Netherlands.
FAU - Cogne, Benjamin
AU  - Cogne B
AD  - Nantes Université, CHU Nantes, Medical Genetics Department, Nantes, France.
AD  - Nantes Université, CNRS, INSERM, l'Institut du Thorax, Nantes, France.
AD  - Laboratoire de Biologie Médicale Multi-Sites SeqOIA (laboratoire-seqoia.fr), 
      Paris, France.
FAU - Rambaud, Thomas
AU  - Rambaud T
AD  - Laboratoire de Biologie Médicale Multi-Sites SeqOIA (laboratoire-seqoia.fr), 
      Paris, France.
FAU - Tümer, Zeynep
AU  - Tümer Z
AD  - Kennedy Center, Department of Clinical Genetics, Copenhagen University Hospital, 
      Rigshospitalet, Glostrup, Denmark.
AD  - Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
FAU - Zackai, Elaine H
AU  - Zackai EH
AD  - Division of Human Genetics, The Children's Hospital of Philadelphia, 
      Philadelphia, Pennsylvania, USA.
AD  - Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, 
      Philadelphia, Pennsylvania, USA.
FAU - Akizu, Naiara
AU  - Akizu N
AD  - Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Children's 
      Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
AD  - Department of Pathology and Laboratory Medicine, University of Pennsylvania, 
      Philadelphia, Pennsylvania, USA.
FAU - Song, Yuanquan
AU  - Song Y
AD  - Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Children's 
      Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
AD  - Department of Pathology and Laboratory Medicine, University of Pennsylvania, 
      Philadelphia, Pennsylvania, USA.
FAU - Hakonarson, Hakon
AU  - Hakonarson H
AD  - Center for Applied Genomics, and.
AD  - Division of Human Genetics, The Children's Hospital of Philadelphia, 
      Philadelphia, Pennsylvania, USA.
AD  - Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, 
      Philadelphia, Pennsylvania, USA.
LA  - eng
GR  - P50 HD105354/HD/NICHD NIH HHS/United States
GR  - R01 NS107392/NS/NINDS NIH HHS/United States
GR  - U01 HG007672/HG/NHGRI NIH HHS/United States
GR  - WT_/Wellcome Trust/United Kingdom
GR  - U01 HG007301/HG/NHGRI NIH HHS/United States
GR  - U01 HG009610/HG/NHGRI NIH HHS/United States
PT  - Journal Article
DEP - 20240102
PL  - United States
TA  - J Clin Invest
JT  - The Journal of clinical investigation
JID - 7802877
RN  - 0 (RNA Splicing Factors)
RN  - EC 6.5.1.- (PRPF19 protein, human)
RN  - 0 (Nuclear Proteins)
RN  - EC 6.5.1.- (DNA Repair Enzymes)
SB  - IM
MH  - Humans
MH  - *Spliceosomes/genetics
MH  - Gene Regulatory Networks
MH  - *Neurodevelopmental Disorders/genetics
MH  - Mutation, Missense
MH  - RNA Splicing
MH  - RNA Splicing Factors/genetics
MH  - Nuclear Proteins/genetics
MH  - DNA Repair Enzymes/genetics
PMC - PMC10760965
OTO - NOTNLM
OT  - Development
OT  - Genetic diseases
OT  - Genetics
OT  - Neurodevelopment
OT  - iPS cells
EDAT- 2023/11/14 18:42
MHDA- 2024/01/03 09:43
CRDT- 2023/11/14 12:03
PHST- 2023/04/06 00:00 [received]
PHST- 2023/10/31 00:00 [accepted]
PHST- 2024/01/03 09:43 [medline]
PHST- 2023/11/14 18:42 [pubmed]
PHST- 2023/11/14 12:03 [entrez]
AID - 171235 [pii]
AID - 10.1172/JCI171235 [doi]
PST - epublish
SO  - J Clin Invest. 2024 Jan 2;134(1):e171235. doi: 10.1172/JCI171235.

PMID- 34541769
OWN - NLM
STAT- MEDLINE
DCOM- 20211025
LR  - 20211025
IS  - 1445-5994 (Electronic)
IS  - 1444-0903 (Linking)
VI  - 51
IP  - 9
DP  - 2021 Sep
TI  - Medical student knowledge and critical appraisal of machine learning: a 
      multicentre international cross-sectional study.
PG  - 1539-1542
LID - 10.1111/imj.15479 [doi]
AB  - To utilise effectively tools that employ machine learning (ML) in clinical 
      practice medical students and doctors will require a degree of understanding of 
      ML models. To evaluate current levels of understanding, a formative examination 
      and survey was conducted across three centres in Australia, New Zealand and the 
      United States. Of the 245 individuals who participated in the study (response 
      rate = 45.4%), the majority had difficulty with identifying weaknesses in model 
      performance analysis. Further studies examining educational interventions 
      addressing such ML topics are warranted.
CI  - © 2021 Royal Australasian College of Physicians.
FAU - Blacketer, Charlotte
AU  - Blacketer C
AD  - University of Adelaide, Adelaide, South Australia, Australia.
AD  - Royal Adelaide Hospital, Adelaide, South Australia, Australia.
FAU - Parnis, Roger
AU  - Parnis R
AD  - University of Adelaide, Adelaide, South Australia, Australia.
AD  - Royal Darwin Hospital, Darwin, Northern Territory, Australia.
FAU - B Franke, Kyle
AU  - B Franke K
AD  - University of Adelaide, Adelaide, South Australia, Australia.
FAU - Wagner, Morganne
AU  - Wagner M
AD  - State University of New York (SUNY) Upstate Medical University, Syracuse, New 
      York, USA.
FAU - Wang, David
AU  - Wang D
AD  - University of Otago, Dunedin, New Zealand.
FAU - Tan, Yiran
AU  - Tan Y
AD  - University of Adelaide, Adelaide, South Australia, Australia.
AD  - Royal Adelaide Hospital, Adelaide, South Australia, Australia.
FAU - Oakden-Rayner, Luke
AU  - Oakden-Rayner L
AD  - University of Adelaide, Adelaide, South Australia, Australia.
AD  - Royal Adelaide Hospital, Adelaide, South Australia, Australia.
FAU - Gallagher, Steve
AU  - Gallagher S
AD  - University of Otago, Dunedin, New Zealand.
FAU - Perry, Seth W
AU  - Perry SW
AD  - State University of New York (SUNY) Upstate Medical University, Syracuse, New 
      York, USA.
FAU - Licinio, Julio
AU  - Licinio J
AD  - State University of New York (SUNY) Upstate Medical University, Syracuse, New 
      York, USA.
FAU - Symonds, Ian
AU  - Symonds I
AD  - University of Adelaide, Adelaide, South Australia, Australia.
AD  - International Medical University, Malaysia.
FAU - Thomas, Josephine
AU  - Thomas J
AD  - University of Adelaide, Adelaide, South Australia, Australia.
AD  - Royal Adelaide Hospital, Adelaide, South Australia, Australia.
FAU - Duggan, Paul
AU  - Duggan P
AD  - University of Adelaide, Adelaide, South Australia, Australia.
AD  - Royal Adelaide Hospital, Adelaide, South Australia, Australia.
FAU - Bacchi, Stephen
AU  - Bacchi S
AUID- ORCID: 0000-0001-5130-8628
AD  - University of Adelaide, Adelaide, South Australia, Australia.
AD  - Royal Adelaide Hospital, Adelaide, South Australia, Australia.
LA  - eng
PT  - Journal Article
PT  - Multicenter Study
PL  - Australia
TA  - Intern Med J
JT  - Internal medicine journal
JID - 101092952
SB  - IM
MH  - Australia/epidemiology
MH  - Cross-Sectional Studies
MH  - Curriculum
MH  - *Education, Medical, Undergraduate
MH  - Humans
MH  - Machine Learning
MH  - *Students, Medical
MH  - United States
OTO - NOTNLM
OT  - artificial intelligence
OT  - curriculum
OT  - deep learning
OT  - formative examination
OT  - medical education
OT  - medical school
EDAT- 2021/09/21 06:00
MHDA- 2021/10/26 06:00
CRDT- 2021/09/20 06:37
PHST- 2021/02/20 00:00 [revised]
PHST- 2020/12/07 00:00 [received]
PHST- 2021/02/28 00:00 [accepted]
PHST- 2021/09/20 06:37 [entrez]
PHST- 2021/09/21 06:00 [pubmed]
PHST- 2021/10/26 06:00 [medline]
AID - 10.1111/imj.15479 [doi]
PST - ppublish
SO  - Intern Med J. 2021 Sep;51(9):1539-1542. doi: 10.1111/imj.15479.

PMID- 37404783
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230718
IS  - 2638-6135 (Electronic)
IS  - 2638-6135 (Linking)
VI  - 5
IP  - 3
DP  - 2023 Jun
TI  - Radiology: Cardiothoracic Imaging Highlights 2022.
PG  - e230042
LID - 10.1148/ryct.230042 [doi]
LID - e230042
AB  - Since its inaugural issue in 2019, Radiology: Cardiothoracic Imaging has 
      disseminated the latest scientific advances and technical developments in 
      cardiac, vascular, and thoracic imaging. In this review, we highlight select 
      articles published in this journal between October 2021 and October 2022. The 
      scope of the review encompasses various aspects of coronary artery and congenital 
      heart diseases, vascular diseases, thoracic imaging, and health services 
      research. Key highlights include changes in the revised Coronary Artery Disease 
      Reporting and Data System 2.0, the value of coronary CT angiography in informing 
      prognosis and guiding treatment decisions, cardiac MRI findings after COVID-19 
      vaccination or infection, high-risk features at CT angiography to identify 
      patients with aortic dissection at risk for late adverse events, and CT-guided 
      fiducial marker placement for preoperative planning for pulmonary nodules. 
      Ongoing research and future directions include photon-counting CT and artificial 
      intelligence applications in cardiovascular imaging. Keywords: Pediatrics, CT 
      Angiography, CT-Perfusion, CT-Spectral Imaging, MR Angiography, PET/CT, 
      Transcatheter Aortic Valve Implantation/Replacement (TAVI/TAVR), Cardiac, 
      Pulmonary, Vascular, Aorta, Coronary Arteries © RSNA, 2023.
CI  - © 2023 by the Radiological Society of North America, Inc.
FAU - Mastrodicasa, Domenico
AU  - Mastrodicasa D
AUID- ORCID: 0000-0001-8227-0757
AD  - From the Department of Radiology, Stanford University School of Medicine, Center 
      for Academic Medicine, Stanford, 453 Quarry Rd, Palo Alto, CA 94304-5659 (D.M., 
      D.F.); Stanford Cardiovascular Institute, Stanford University School of Medicine, 
      Stanford, Calif (D.M., D.F.); Department of Radiology, SUNY Upstate Medical 
      University, Syracuse, NY (G.J.A.); Department of Radiology, University of 
      Washington, Seattle, Wash (K.G.O.); Department of Radiology, University of 
      Colorado, Aurora, Colo (D.V.); Department of Radiology, UT Southwestern Medical 
      Center, Dallas, Tex (S.A.); Department of Medical Imaging, University Medical 
      Imaging Toronto, University of Toronto, Toronto, ON, Canada (K.H.); and Peter 
      Munk Cardiac Centre, Toronto General Hospital, University Health Network, 
      University of Toronto, Toronto, ON, Canada (K.H.).
FAU - Aquino, Gilberto J
AU  - Aquino GJ
AUID- ORCID: 0000-0002-3707-8114
AD  - From the Department of Radiology, Stanford University School of Medicine, Center 
      for Academic Medicine, Stanford, 453 Quarry Rd, Palo Alto, CA 94304-5659 (D.M., 
      D.F.); Stanford Cardiovascular Institute, Stanford University School of Medicine, 
      Stanford, Calif (D.M., D.F.); Department of Radiology, SUNY Upstate Medical 
      University, Syracuse, NY (G.J.A.); Department of Radiology, University of 
      Washington, Seattle, Wash (K.G.O.); Department of Radiology, University of 
      Colorado, Aurora, Colo (D.V.); Department of Radiology, UT Southwestern Medical 
      Center, Dallas, Tex (S.A.); Department of Medical Imaging, University Medical 
      Imaging Toronto, University of Toronto, Toronto, ON, Canada (K.H.); and Peter 
      Munk Cardiac Centre, Toronto General Hospital, University Health Network, 
      University of Toronto, Toronto, ON, Canada (K.H.).
FAU - Ordovas, Karen G
AU  - Ordovas KG
AUID- ORCID: 0000-0001-5438-4669
AD  - From the Department of Radiology, Stanford University School of Medicine, Center 
      for Academic Medicine, Stanford, 453 Quarry Rd, Palo Alto, CA 94304-5659 (D.M., 
      D.F.); Stanford Cardiovascular Institute, Stanford University School of Medicine, 
      Stanford, Calif (D.M., D.F.); Department of Radiology, SUNY Upstate Medical 
      University, Syracuse, NY (G.J.A.); Department of Radiology, University of 
      Washington, Seattle, Wash (K.G.O.); Department of Radiology, University of 
      Colorado, Aurora, Colo (D.V.); Department of Radiology, UT Southwestern Medical 
      Center, Dallas, Tex (S.A.); Department of Medical Imaging, University Medical 
      Imaging Toronto, University of Toronto, Toronto, ON, Canada (K.H.); and Peter 
      Munk Cardiac Centre, Toronto General Hospital, University Health Network, 
      University of Toronto, Toronto, ON, Canada (K.H.).
FAU - Vargas, Daniel
AU  - Vargas D
AD  - From the Department of Radiology, Stanford University School of Medicine, Center 
      for Academic Medicine, Stanford, 453 Quarry Rd, Palo Alto, CA 94304-5659 (D.M., 
      D.F.); Stanford Cardiovascular Institute, Stanford University School of Medicine, 
      Stanford, Calif (D.M., D.F.); Department of Radiology, SUNY Upstate Medical 
      University, Syracuse, NY (G.J.A.); Department of Radiology, University of 
      Washington, Seattle, Wash (K.G.O.); Department of Radiology, University of 
      Colorado, Aurora, Colo (D.V.); Department of Radiology, UT Southwestern Medical 
      Center, Dallas, Tex (S.A.); Department of Medical Imaging, University Medical 
      Imaging Toronto, University of Toronto, Toronto, ON, Canada (K.H.); and Peter 
      Munk Cardiac Centre, Toronto General Hospital, University Health Network, 
      University of Toronto, Toronto, ON, Canada (K.H.).
FAU - Fleischmann, Dominik
AU  - Fleischmann D
AUID- ORCID: 0000-0003-0715-0952
AD  - From the Department of Radiology, Stanford University School of Medicine, Center 
      for Academic Medicine, Stanford, 453 Quarry Rd, Palo Alto, CA 94304-5659 (D.M., 
      D.F.); Stanford Cardiovascular Institute, Stanford University School of Medicine, 
      Stanford, Calif (D.M., D.F.); Department of Radiology, SUNY Upstate Medical 
      University, Syracuse, NY (G.J.A.); Department of Radiology, University of 
      Washington, Seattle, Wash (K.G.O.); Department of Radiology, University of 
      Colorado, Aurora, Colo (D.V.); Department of Radiology, UT Southwestern Medical 
      Center, Dallas, Tex (S.A.); Department of Medical Imaging, University Medical 
      Imaging Toronto, University of Toronto, Toronto, ON, Canada (K.H.); and Peter 
      Munk Cardiac Centre, Toronto General Hospital, University Health Network, 
      University of Toronto, Toronto, ON, Canada (K.H.).
FAU - Abbara, Suhny
AU  - Abbara S
AD  - From the Department of Radiology, Stanford University School of Medicine, Center 
      for Academic Medicine, Stanford, 453 Quarry Rd, Palo Alto, CA 94304-5659 (D.M., 
      D.F.); Stanford Cardiovascular Institute, Stanford University School of Medicine, 
      Stanford, Calif (D.M., D.F.); Department of Radiology, SUNY Upstate Medical 
      University, Syracuse, NY (G.J.A.); Department of Radiology, University of 
      Washington, Seattle, Wash (K.G.O.); Department of Radiology, University of 
      Colorado, Aurora, Colo (D.V.); Department of Radiology, UT Southwestern Medical 
      Center, Dallas, Tex (S.A.); Department of Medical Imaging, University Medical 
      Imaging Toronto, University of Toronto, Toronto, ON, Canada (K.H.); and Peter 
      Munk Cardiac Centre, Toronto General Hospital, University Health Network, 
      University of Toronto, Toronto, ON, Canada (K.H.).
FAU - Hanneman, Kate
AU  - Hanneman K
AUID- ORCID: 0000-0002-3077-2218
AD  - From the Department of Radiology, Stanford University School of Medicine, Center 
      for Academic Medicine, Stanford, 453 Quarry Rd, Palo Alto, CA 94304-5659 (D.M., 
      D.F.); Stanford Cardiovascular Institute, Stanford University School of Medicine, 
      Stanford, Calif (D.M., D.F.); Department of Radiology, SUNY Upstate Medical 
      University, Syracuse, NY (G.J.A.); Department of Radiology, University of 
      Washington, Seattle, Wash (K.G.O.); Department of Radiology, University of 
      Colorado, Aurora, Colo (D.V.); Department of Radiology, UT Southwestern Medical 
      Center, Dallas, Tex (S.A.); Department of Medical Imaging, University Medical 
      Imaging Toronto, University of Toronto, Toronto, ON, Canada (K.H.); and Peter 
      Munk Cardiac Centre, Toronto General Hospital, University Health Network, 
      University of Toronto, Toronto, ON, Canada (K.H.).
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20230615
PL  - United States
TA  - Radiol Cardiothorac Imaging
JT  - Radiology. Cardiothoracic imaging
JID - 101748663
PMC - PMC10316293
OTO - NOTNLM
OT  - Aorta
OT  - CT Angiography
OT  - CT-Perfusion
OT  - CT–Spectral Imaging
OT  - Cardiac
OT  - Coronary Arteries
OT  - MR Angiography
OT  - PET/CT
OT  - Pediatrics
OT  - Pulmonary
OT  - Transcatheter Aortic Valve Implantation/Replacement (TAVI/TAVR)
OT  - Vascular
COIS- Disclosures of conflicts of interest: D.M. Grants or contracts from the National 
      Institute of Biomedical Imaging and Bioengineering (no. 5T32EB009035); consulting 
      fees from Segmed; stock or stock options in Segmed; member of Radiology: 
      Cardiothoracic Imaging trainee editorial board. G.J.A. Member of Radiology: 
      Cardiothoracic Imaging trainee editorial board. K.G.O. Payment or honoraria from 
      Grand Rounds for lectures, presentations, speakers bureaus, manuscript writing, 
      or educational events; president of the Society of Cardiovascular Magnetic 
      Resonance; associate editor for Radiology: Cardiothoracic Imaging. D.V. Treasurer 
      of the North American Society for Cardiovascular Imaging; member of Radiology: 
      Cardiothoracic Imaging editorial board; mentor for Radiology: Cardiothoracic 
      Imaging trainee editorial board. D.F. Deputy editor for Radiology: Cardiothoracic 
      Imaging. S.A. Royalties from Elsevier for textbook authorship; member of the 
      board of directors of the Society of Cardiovascular Computed Tomography; editor 
      of Radiology: Cardiothoracic Imaging. K.H. Payment or honoraria from Sanofi 
      Genzyme for lectures, presentations, speakers bureaus, manuscript writing, or 
      educational events; associate editor and trainee editorial board lead for 
      Radiology: Cardiothoracic Imaging.
EDAT- 2023/07/05 13:05
MHDA- 2023/07/05 13:06
CRDT- 2023/07/05 10:42
PHST- 2023/02/15 00:00 [received]
PHST- 2023/04/07 00:00 [revised]
PHST- 2023/05/08 00:00 [accepted]
PHST- 2023/07/05 13:06 [medline]
PHST- 2023/07/05 13:05 [pubmed]
PHST- 2023/07/05 10:42 [entrez]
AID - 10.1148/ryct.230042 [doi]
PST - epublish
SO  - Radiol Cardiothorac Imaging. 2023 Jun 15;5(3):e230042. doi: 10.1148/ryct.230042. 
      eCollection 2023 Jun.

PMID- 35498827
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220716
IS  - 2046-2069 (Electronic)
IS  - 2046-2069 (Linking)
VI  - 10
IP  - 28
DP  - 2020 Apr 23
TI  - Machine learning model for fast prediction of the natural frequencies of protein 
      molecules.
PG  - 16607-16615
LID - 10.1039/c9ra04186a [doi]
AB  - Natural vibrations and resonances are intrinsic features of protein structures 
      and enable differentiation of one structure from another. These nanoscale 
      features are important to help to understand the dynamics of a protein molecule 
      and identify the effects of small sequence or other geometric alterations that 
      may not cause significant visible structural changes, such as point mutations 
      associated with disease or drug design. Although normal mode analysis provides a 
      powerful way to accurately extract the natural frequencies of a protein, it must 
      meet several critical conditions, including availability of high-resolution 
      structures, availability of good chemical force fields and memory-intensive 
      large-scale computing resources. Here, we study the natural frequency of over 
      100 000 known protein molecular structures from the Protein Data Bank and use 
      this dataset to carefully investigate the correlation between their structural 
      features and these natural frequencies by using a machine learning model composed 
      of a Feedforward Neural Network made of four hidden layers that predicts the 
      natural frequencies in excellent agreement with full-atomistic normal mode 
      calculations, but is significantly more computationally efficient. In addition to 
      the computational advance, we demonstrate that this model can be used to directly 
      obtain the natural frequencies by merely using five structural features of 
      protein molecules as predictor variables, including the largest and smallest 
      diameter, and the ratio of amino acid residues with alpha-helix, beta strand and 
      3-10 helix domains. These structural features can be either experimentally or 
      computationally obtained, and do not require a full-atomistic model of a protein 
      of interest. This method is helpful in predicting the absorption and resonance 
      functions of an unknown protein molecule without solving its full atomic 
      structure.
CI  - This journal is © The Royal Society of Chemistry.
FAU - Qin, Zhao
AU  - Qin Z
AUID- ORCID: 0000-0001-5696-8553
AD  - Laboratory for Atomistic and Molecular Mechanics (LAMM), Department of Civil and 
      Environmental Engineering, Massachusetts Institute of Technology 77 Massachusetts 
      Ave. Cambridge Massachusetts 02139 USA mbuehler@mit.edu +1 617 452 2750.
FAU - Yu, Qingyi
AU  - Yu Q
AD  - Dereck Bok Center for Teaching and Learning, Harvard University 125 Mount Auburn 
      Street Cambridge MA 02138 USA.
AD  - Department of Educational Psychology, Counseling and Special Education, State 
      University of New York at Oneonta 108 Ravine Pkwy Oneonta NY 13820 USA.
AD  - Barnes Center at The Arch, Syracuse University 150 Sims Drive Syracuse NY 13244 
      USA.
FAU - Buehler, Markus J
AU  - Buehler MJ
AUID- ORCID: 0000-0002-4173-9659
AD  - Laboratory for Atomistic and Molecular Mechanics (LAMM), Department of Civil and 
      Environmental Engineering, Massachusetts Institute of Technology 77 Massachusetts 
      Ave. Cambridge Massachusetts 02139 USA mbuehler@mit.edu +1 617 452 2750.
LA  - eng
PT  - Journal Article
DEP - 20200427
PL  - England
TA  - RSC Adv
JT  - RSC advances
JID - 101581657
PMC - PMC9053087
COIS- There are no conflicts to declare.
EDAT- 2020/04/27 00:00
MHDA- 2020/04/27 00:01
CRDT- 2022/05/02 07:15
PHST- 2019/06/03 00:00 [received]
PHST- 2020/04/03 00:00 [accepted]
PHST- 2022/05/02 07:15 [entrez]
PHST- 2020/04/27 00:00 [pubmed]
PHST- 2020/04/27 00:01 [medline]
AID - c9ra04186a [pii]
AID - 10.1039/c9ra04186a [doi]
PST - epublish
SO  - RSC Adv. 2020 Apr 27;10(28):16607-16615. doi: 10.1039/c9ra04186a. eCollection 
      2020 Apr 23.

PMID- 34598869
OWN - NLM
STAT- MEDLINE
DCOM- 20220718
LR  - 20231017
IS  - 1878-4046 (Electronic)
IS  - 1076-6332 (Print)
IS  - 1076-6332 (Linking)
VI  - 29
IP  - 8
DP  - 2022 Aug
TI  - A Cascaded Deep Learning-Based Artificial Intelligence Algorithm for Automated 
      Lesion Detection and Classification on Biparametric Prostate Magnetic Resonance 
      Imaging.
PG  - 1159-1168
LID - S1076-6332(21)00377-9 [pii]
LID - 10.1016/j.acra.2021.08.019 [doi]
AB  - RATIONALE AND OBJECTIVES: Prostate MRI improves detection of clinically 
      significant prostate cancer; however, its diagnostic performance has wide 
      variation. Artificial intelligence (AI) has the potential to assist radiologists 
      in the detection and classification of prostatic lesions. Herein, we aimed to 
      develop and test a cascaded deep learning detection and classification system 
      trained on biparametric prostate MRI using PI-RADS for assisting radiologists 
      during prostate MRI read out. MATERIALS AND METHODS: T2-weighted, 
      diffusion-weighted (ADC maps, high b value DWI) MRI scans obtained at 3 Tesla 
      from two institutions (n = 1043 in-house and n = 347 Prostate-X, respectively) 
      acquired between 2015 to 2019 were used for model training, validation, testing. 
      All scans were retrospectively reevaluated by one radiologist. Suspicious lesions 
      were contoured and assigned a PI-RADS category. A 3D U-Net-based deep neural 
      network was used to train an algorithm for automated detection and segmentation 
      of prostate MRI lesions. Two 3D residual neural network were used for a 4-class 
      classification task to predict PI-RADS categories 2 to 5 and BPH. Training and 
      validation used 89% (n = 1290 scans) of the data using 5 fold cross-validation, 
      the remaining 11% (n = 150 scans) were used for independent testing. Algorithm 
      performance at lesion level was assessed using sensitivities, positive predictive 
      values (PPV), false discovery rates (FDR), classification accuracy, Dice 
      similarity coefficient (DSC). Additional analysis was conducted to compare AI 
      algorithm's lesion detection performance with targeted biopsy results. RESULTS: 
      Median age was 66 years (IQR = 60-71), PSA 6.7 ng/ml (IQR = 4.7-9.9) from 
      in-house cohort. In the independent test set, algorithm correctly detected 111 of 
      198 lesions leading to 56.1% (49.3%-62.6%) sensitivity. PPV was 62.7% (95% CI 
      54.7%-70.7%) with FDR of 37.3% (95% CI 29.3%-45.3%). Of 79 true positive lesions, 
      82.3% were tumor positive at targeted biopsy, whereas of 57 false negative 
      lesions, 50.9% were benign at targeted biopsy. Median DSC for lesion segmentation 
      was 0.359. Overall PI-RADS classification accuracy was 30.8% (95% CI 
      24.6%-37.8%). CONCLUSION: Our cascaded U-Net, residual network architecture can 
      detect, classify cancer suspicious lesions at prostate MRI with good detection, 
      reasonable classification performance metrics.
CI  - Published by Elsevier Inc.
FAU - Mehralivand, Sherif
AU  - Mehralivand S
AD  - Molecular Imaging Branch, National Cancer Institute, National Institutes of 
      Health, 10 Center Dr., MSC 1182, Building 10, Room B3B85, Bethesda, Maryland.
FAU - Yang, Dong
AU  - Yang D
AD  - NVIDIA Corporation, Santa Clara, California.
FAU - Harmon, Stephanie A
AU  - Harmon SA
AD  - Molecular Imaging Branch, National Cancer Institute, National Institutes of 
      Health, 10 Center Dr., MSC 1182, Building 10, Room B3B85, Bethesda, Maryland.
FAU - Xu, Daguang
AU  - Xu D
AD  - NVIDIA Corporation, Santa Clara, California.
FAU - Xu, Ziyue
AU  - Xu Z
AD  - NVIDIA Corporation, Santa Clara, California.
FAU - Roth, Holger
AU  - Roth H
AD  - NVIDIA Corporation, Santa Clara, California.
FAU - Masoudi, Samira
AU  - Masoudi S
AD  - Molecular Imaging Branch, National Cancer Institute, National Institutes of 
      Health, 10 Center Dr., MSC 1182, Building 10, Room B3B85, Bethesda, Maryland.
FAU - Sanford, Thomas H
AU  - Sanford TH
AD  - Department of Urology, SUNY Upstate Medical University, Syracuse, New Yor.
FAU - Kesani, Deepak
AU  - Kesani D
AD  - Molecular Imaging Branch, National Cancer Institute, National Institutes of 
      Health, 10 Center Dr., MSC 1182, Building 10, Room B3B85, Bethesda, Maryland.
FAU - Lay, Nathan S
AU  - Lay NS
AD  - Molecular Imaging Branch, National Cancer Institute, National Institutes of 
      Health, 10 Center Dr., MSC 1182, Building 10, Room B3B85, Bethesda, Maryland.
FAU - Merino, Maria J
AU  - Merino MJ
AD  - Laboratory of Pathology, National Cancer Institute, National Institutes of 
      Health, Bethesda, Maryland.
FAU - Wood, Bradford J
AU  - Wood BJ
AD  - Center for Interventional Oncology, National Cancer Institute, National 
      Institutes of Health, Bethesda, Maryland; Department of Radiology, Clinical 
      Center, National Institutes of Health, Bethesda, Maryland.
FAU - Pinto, Peter A
AU  - Pinto PA
AD  - Urologic Oncology Branch, National Cancer Institute, National Institutes of 
      Health, Bethesda, Maryland.
FAU - Choyke, Peter L
AU  - Choyke PL
AD  - Molecular Imaging Branch, National Cancer Institute, National Institutes of 
      Health, 10 Center Dr., MSC 1182, Building 10, Room B3B85, Bethesda, Maryland.
FAU - Turkbey, Baris
AU  - Turkbey B
AD  - Molecular Imaging Branch, National Cancer Institute, National Institutes of 
      Health, 10 Center Dr., MSC 1182, Building 10, Room B3B85, Bethesda, Maryland. 
      Electronic address: turkbeyi@mail.nih.gov.
LA  - eng
GR  - ZIH BC012032/ImNIH/Intramural NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20210928
PL  - United States
TA  - Acad Radiol
JT  - Academic radiology
JID - 9440159
SB  - IM
MH  - Aged
MH  - Algorithms
MH  - Artificial Intelligence
MH  - *Deep Learning
MH  - Humans
MH  - Magnetic Resonance Imaging
MH  - Male
MH  - Prostate/diagnostic imaging/pathology
MH  - *Prostatic Neoplasms/diagnostic imaging/pathology
MH  - Retrospective Studies
PMC - PMC10575564
MID - NIHMS1931735
OTO - NOTNLM
OT  - Prostate cancer
OT  - artificial intelligence
OT  - biparametric
OT  - detection
OT  - magnetic resonance imaging
EDAT- 2021/10/03 06:00
MHDA- 2022/07/19 06:00
CRDT- 2021/10/02 05:30
PHST- 2021/07/11 00:00 [received]
PHST- 2021/08/08 00:00 [revised]
PHST- 2021/08/21 00:00 [accepted]
PHST- 2021/10/03 06:00 [pubmed]
PHST- 2022/07/19 06:00 [medline]
PHST- 2021/10/02 05:30 [entrez]
AID - S1076-6332(21)00377-9 [pii]
AID - 10.1016/j.acra.2021.08.019 [doi]
PST - ppublish
SO  - Acad Radiol. 2022 Aug;29(8):1159-1168. doi: 10.1016/j.acra.2021.08.019. Epub 2021 
      Sep 28.

PMID- 35025710
OWN - NLM
STAT- MEDLINE
DCOM- 20220405
LR  - 20230202
IS  - 1747-6356 (Electronic)
IS  - 1747-6348 (Print)
IS  - 1747-6348 (Linking)
VI  - 16
IP  - 2
DP  - 2022 Feb
TI  - Recent advancements in understanding the genetic involvement of alpha-1 
      antitrypsin deficiency associated lung disease: a look at future precision 
      medicine approaches.
PG  - 173-182
LID - 10.1080/17476348.2022.2027755 [doi]
AB  - INTRODUCTION: Alpha-1 antitrypsin deficiency occurs in individuals with 
      deleterious genetic mutations on both chromosomes (maternal and paternal) in 
      SERPINA1, the gene encoding the alpha-1 antitrypsin protein. There has been 
      substantial progress in understanding the genetic variation that underlies the 
      heterogeneous penetrance of lung disease in alpha-1 antitrypsin deficiency. AREAS 
      COVERED: This review will cover SERPINA1 gene structure and genetic variation, 
      population genetics, genome-wide genetic modifiers of lung disease, alternative 
      mechanisms of disease, and emerging therapeutics - including gene and cell 
      therapy - related to alpha-1 antitrypsin deficiency-associated lung disease. 
      EXPERT OPINION: There remains ample opportunity to employ precision medicine in 
      the diagnosis, prognosis, and therapy of alpha-1 antitrypsin 
      deficiency-associated lung disease. In particular, a genome-wide association 
      study and subsequent polygenic risk score is an important first step in 
      identifying genome-wide genetic modifiers contributing to the variability of lung 
      disease in severe alpha-1 antitrypsin deficiency.
FAU - Ghosh, Auyon J
AU  - Ghosh AJ
AUID- ORCID: 0000-0003-0334-4039
AD  - Division of Pulmonary, Critical Care, and Sleep Medicine, SUNY Upstate Medical 
      University, Syracuse, NY, USA.
FAU - Hobbs, Brian D
AU  - Hobbs BD
AUID- ORCID: 0000-0001-9564-0745
AD  - Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, 
      USA.
AD  - Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, 
      Boston, MA, USA.
AD  - Harvard Medical School, Boston, MA, USA.
LA  - eng
GR  - K08 HL136928/HL/NHLBI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Review
DEP - 20220113
PL  - England
TA  - Expert Rev Respir Med
JT  - Expert review of respiratory medicine
JID - 101278196
RN  - 0 (SERPINA1 protein, human)
RN  - 0 (alpha 1-Antitrypsin)
SB  - IM
MH  - Genome-Wide Association Study
MH  - Humans
MH  - Lung
MH  - *Lung Diseases/etiology/genetics
MH  - Precision Medicine
MH  - alpha 1-Antitrypsin/genetics
MH  - *alpha 1-Antitrypsin Deficiency/diagnosis/genetics/therapy
PMC - PMC8983484
MID - NIHMS1772649
OTO - NOTNLM
OT  - Alpha-1 antitrypsin deficiency
OT  - COPD
OT  - genetic modifiers
OT  - polygenic risk score
OT  - precision medicine
COIS- Declaration of Interests The authors have nothing to declare.
EDAT- 2022/01/14 06:00
MHDA- 2022/04/06 06:00
CRDT- 2022/01/13 17:20
PHST- 2022/01/14 06:00 [pubmed]
PHST- 2022/04/06 06:00 [medline]
PHST- 2022/01/13 17:20 [entrez]
AID - 10.1080/17476348.2022.2027755 [doi]
PST - ppublish
SO  - Expert Rev Respir Med. 2022 Feb;16(2):173-182. doi: 
      10.1080/17476348.2022.2027755. Epub 2022 Jan 13.

PMID- 32536571
OWN - NLM
STAT- MEDLINE
DCOM- 20210810
LR  - 20211204
IS  - 1873-7862 (Electronic)
IS  - 0924-977X (Linking)
VI  - 36
DP  - 2020 Jul
TI  - Translating big data to better treatment in bipolar disorder - a manifesto for 
      coordinated action.
PG  - 121-136
LID - S0924-977X(20)30180-2 [pii]
LID - 10.1016/j.euroneuro.2020.05.006 [doi]
AB  - Bipolar disorder (BD) is a major healthcare and socio-economic challenge. Despite 
      its substantial burden on society, the research activity in BD is much smaller 
      than its economic impact appears to demand. There is a consensus that the 
      accurate identification of the underlying pathophysiology for BD is fundamental 
      to realize major health benefits through better treatment and preventive 
      regimens. However, to achieve these goals requires coordinated action and 
      innovative approaches to boost the discovery of the neurobiological underpinnings 
      of BD, and rapid translation of research findings into development and testing of 
      better and more specific treatments. To this end, we here propose that only a 
      large-scale coordinated action can be successful in integrating international 
      big-data approaches with real-world clinical interventions. This could be 
      achieved through the creation of a Global Bipolar Disorder Foundation, which 
      could bring government, industry and philanthropy together in common cause. A 
      global initiative for BD research would come at a highly opportune time given the 
      seminal advances promised for our understanding of the genetic and brain basis of 
      the disease and the obvious areas of unmet clinical need. Such an endeavour would 
      embrace the principles of open science and see the strong involvement of user 
      groups and integration of dissemination and public involvement with the research 
      programs. We believe the time is right for a step change in our approach to 
      understanding, treating and even preventing BD effectively.
CI  - Copyright © 2020. Published by Elsevier B.V.
FAU - Manchia, Mirko
AU  - Manchia M
AD  - Section of Psychiatry, Department of Medical Sciences and Public Health, 
      University of Cagliari, Cagliari, Italy; Unit of Clinical Psychiatry, University 
      Hospital Agency of Cagliari, Cagliari, Italy; Department of Pharmacology, 
      Dalhousie University, Halifax, Nova Scotia, Canada.
FAU - Vieta, Eduard
AU  - Vieta E
AD  - Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, 
      CIBERSAM, Barcelona, Catalonia, Spain.
FAU - Smeland, Olav B
AU  - Smeland OB
AD  - NORMENT, Institute of Clinical Medicine, University of Oslo and Division of 
      Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
FAU - Altimus, Cara
AU  - Altimus C
AD  - Milken Institute, New York, US.
FAU - Bechdolf, Andreas
AU  - Bechdolf A
AD  - Vivantes Klinikum im Friedrichshain, Department of Psychiatry, Psychotherapy and 
      Psychosomatic Medicine, Charité-Universitätsmedizin, Berlin, Germany; Department 
      of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany; ORYGEN, 
      The National Centre of Excellence in Youth Mental Health, Melbourne, Victoria, 
      Australia.
FAU - Bellivier, Frank
AU  - Bellivier F
AD  - Université de Paris and INSERM UMRS 1144, Paris, France; AP-HP, Groupe 
      Hospitalo-Universitaire AP-HP Nord, Hopital Fernand Widal, DMU Neurosciences, 
      Département de Psychiatrie et de Médecine Addictologique, Paris, France.
FAU - Bergink, Veerle
AU  - Bergink V
AD  - Department of Psychiatry - Erasmus Medical Center, Rotterdam, the Netherlands; 
      Department of Psychiatry, Department of Obstetrics, Icahn School of Medicine at 
      Mount Sinai, New York, USA.
FAU - Fagiolini, Andrea
AU  - Fagiolini A
AD  - Department of Molecular Medicine, University of Siena, Siena, Italy.
FAU - Geddes, John R
AU  - Geddes JR
AD  - Department of Psychiatry and Oxford Health NHS Foundation Trust, University of 
      Oxford, Oxford, United Kingdom.
FAU - Hajek, Tomas
AU  - Hajek T
AD  - Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada; 
      National Institute of Mental Health, Klecany, Czech Republic.
FAU - Henry, Chantal
AU  - Henry C
AD  - Department of Psychiatry, Service Hospitalo-Universitaire, GHU Paris Psychiatrie 
      & Neurosciences, F-75014 Paris, France.
FAU - Kupka, Ralph
AU  - Kupka R
AD  - Amsterdam UMC, Vrije Universiteit, Department of Psychiatry, Amsterdam, 
      Netherlands.
FAU - Lagerberg, Trine V
AU  - Lagerberg TV
AD  - NORMENT, Institute of Clinical Medicine, University of Oslo and Division of 
      Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
FAU - Licht, Rasmus W
AU  - Licht RW
AD  - Department of Clinical Medicine, Aalborg University, Aalborg, Denmark; Psychiatry 
      - Aalborg University Hospital, Aalborg, Denmark.
FAU - Martinez-Cengotitabengoa, Monica
AU  - Martinez-Cengotitabengoa M
AD  - Hospital Universitario de Alava. BIOARABA, UPV/EHU. CIBERSAM. Vitoria, Spain.
FAU - Morken, Gunnar
AU  - Morken G
AD  - Østmarka Department of Psychiatry, St Olav University Hospital, Trondheim, 
      Norway; Department of Mental Health, Faculty of Medicine and Healthsciences, 
      Norwegian University of Science and Technology, Trondheim, Norway.
FAU - Nielsen, René E
AU  - Nielsen RE
AD  - Department of Clinical Medicine, Aalborg University, Aalborg, Denmark; Psychiatry 
      - Aalborg University Hospital, Aalborg, Denmark.
FAU - Pinto, Ana Gonzalez
AU  - Pinto AG
AD  - Hospital Universitario de Alava. BIOARABA, UPV/EHU. CIBERSAM. Vitoria, Spain.
FAU - Reif, Andreas
AU  - Reif A
AD  - Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University 
      Hospital Frankfurt, Frankfurt am Main, Germany and German Society for Bipolar 
      Disorders (DGBS), Frankfurt am Main, Germany.
FAU - Rietschel, Marcella
AU  - Rietschel M
AD  - Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental 
      Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
FAU - Ritter, Phillip
AU  - Ritter P
AD  - Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav 
      Carus, Technische Universität Dresden, Dresden, Germany.
FAU - Schulze, Thomas G
AU  - Schulze TG
AD  - Institute of Psychiatric Phenomics and Genomics, University Hospital, 
      Ludwig-Maximilian University of Munich, Munich, Germany; Department of Psychiatry 
      and Psychotherapy, Ludwig-Maximilian University of Munich, Munich, Germany; 
      Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, 
      Baltimore, Maryland, USA; Department of Psychiatry and Behavioral Sciences, SUNY 
      Upstate Medical University, Syracuse, NY, USA.
FAU - Scott, Jan
AU  - Scott J
AD  - AP-HP, Groupe Hospitalo-Universitaire AP-HP Nord, Hopital Fernand Widal, DMU 
      Neurosciences, Département de Psychiatrie et de Médecine Addictologique, Paris, 
      France; Department of Mental Health, Faculty of Medicine and Healthsciences, 
      Norwegian University of Science and Technology, Trondheim, Norway; Academic 
      Psychiatry, Institute of Neuroscience, Newcastle University, UK.
FAU - Severus, Emanuel
AU  - Severus E
AD  - Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav 
      Carus, Technische Universität Dresden, Dresden, Germany.
FAU - Yildiz, Aysegul
AU  - Yildiz A
AD  - Dokuz Eylül University Department of Psychiatry, Izmir, Turkey.
FAU - Kessing, Lars Vedel
AU  - Kessing LV
AD  - Psychiatric Center Copenhagen and University of Copenhagen, Faculty of Health and 
      Medical Sciences, Denmark.
FAU - Bauer, Michael
AU  - Bauer M
AD  - Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav 
      Carus, Technische Universität Dresden, Dresden, Germany.
FAU - Goodwin, Guy M
AU  - Goodwin GM
AD  - Department of Psychiatry and Oxford Health NHS Foundation Trust, University of 
      Oxford, Oxford, United Kingdom.
FAU - Andreassen, Ole A
AU  - Andreassen OA
AD  - NORMENT, Institute of Clinical Medicine, University of Oslo and Division of 
      Mental Health and Addiction, Oslo University Hospital, Oslo, Norway. Electronic 
      address: o.a.andreassen@medisin.uio.no.
CN  - European College of Neuropsychopharmacology (ECNP) Bipolar Disorders Network
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Review
DEP - 20200612
PL  - Netherlands
TA  - Eur Neuropsychopharmacol
JT  - European neuropsychopharmacology : the journal of the European College of 
      Neuropsychopharmacology
JID - 9111390
SB  - IM
EIN - Eur Neuropsychopharmacol. 2021 Mar;44:121-122. PMID: 33495109
MH  - *Big Data
MH  - Bipolar Disorder/diagnosis/epidemiology/*therapy
MH  - Clinical Trials as Topic/methods
MH  - *Global Health
MH  - Humans
MH  - Machine Learning/*trends
MH  - Translational Research, Biomedical/methods/*trends
MH  - Treatment Outcome
OTO - NOTNLM
OT  - Machine learning
OT  - Open science
OT  - Philanthropy
OT  - Precision medicine
OT  - Risk prediction
EDAT- 2020/06/17 06:00
MHDA- 2021/08/11 06:00
CRDT- 2020/06/16 06:00
PHST- 2020/02/25 00:00 [received]
PHST- 2020/05/15 00:00 [revised]
PHST- 2020/05/24 00:00 [accepted]
PHST- 2020/06/17 06:00 [pubmed]
PHST- 2021/08/11 06:00 [medline]
PHST- 2020/06/16 06:00 [entrez]
AID - S0924-977X(20)30180-2 [pii]
AID - 10.1016/j.euroneuro.2020.05.006 [doi]
PST - ppublish
SO  - Eur Neuropsychopharmacol. 2020 Jul;36:121-136. doi: 
      10.1016/j.euroneuro.2020.05.006. Epub 2020 Jun 12.

PMID- 33328030
OWN - NLM
STAT- MEDLINE
DCOM- 20210127
LR  - 20220716
IS  - 2589-7500 (Electronic)
IS  - 2589-7500 (Linking)
VI  - 2
IP  - 12
DP  - 2020 Dec
TI  - Time to reality check the promises of machine learning-powered precision 
      medicine.
PG  - e677-e680
LID - S2589-7500(20)30200-4 [pii]
LID - 10.1016/S2589-7500(20)30200-4 [doi]
AB  - Machine learning methods, combined with large electronic health databases, could 
      enable a personalised approach to medicine through improved diagnosis and 
      prediction of individual responses to therapies. If successful, this strategy 
      would represent a revolution in clinical research and practice. However, although 
      the vision of individually tailored medicine is alluring, there is a need to 
      distinguish genuine potential from hype. We argue that the goal of personalised 
      medical care faces serious challenges, many of which cannot be addressed through 
      algorithmic complexity, and call for collaboration between traditional 
      methodologists and experts in medical machine learning to avoid extensive 
      research waste.
CI  - Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access 
      article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights 
      reserved.
FAU - Wilkinson, Jack
AU  - Wilkinson J
AD  - Centre for Biostatistics, Manchester Academic Health Science Centre, Division of 
      Population Health, Health Services Research and Primary Care, University of 
      Manchester, Manchester, UK. Electronic address: jack.wilkinson@manchester.ac.uk.
FAU - Arnold, Kellyn F
AU  - Arnold KF
AD  - Leeds Institute for Data Analytics, University of Leeds, Leeds, UK; Faculty of 
      Medicine and Health, University of Leeds, Leeds, UK.
FAU - Murray, Eleanor J
AU  - Murray EJ
AD  - Department of Epidemiology, Boston University School of Public Health, Boston, 
      MA, USA.
FAU - van Smeden, Maarten
AU  - van Smeden M
AD  - Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, 
      Netherlands.
FAU - Carr, Kareem
AU  - Carr K
AD  - Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA, 
      USA.
FAU - Sippy, Rachel
AU  - Sippy R
AD  - Institute for Global Health and Translational Science, SUNY Upstate Medical 
      University, Syracuse, NY, USA; Department of Geography, University of Florida, 
      Gainesville, FL, USA; Emerging Pathogens Institute, University of Florida, 
      Gainesville, FL, USA.
FAU - de Kamps, Marc
AU  - de Kamps M
AD  - Leeds Institute for Data Analytics, University of Leeds, Leeds, UK; School of 
      Computing, University of Leeds, Leeds, UK.
FAU - Beam, Andrew
AU  - Beam A
AD  - Department of Epidemiology, Boston University School of Public Health, Boston, 
      MA, USA.
FAU - Konigorski, Stefan
AU  - Konigorski S
AD  - Digital Health & Machine Learning Research Group, Hasso Plattner Institut for 
      Digital Engineering, Potsdam, Germany; Hasso Plattner Institute for Digital 
      Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY, 
      USA.
FAU - Lippert, Christoph
AU  - Lippert C
AD  - Digital Health & Machine Learning Research Group, Hasso Plattner Institut for 
      Digital Engineering, Potsdam, Germany; Hasso Plattner Institute for Digital 
      Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY, 
      USA.
FAU - Gilthorpe, Mark S
AU  - Gilthorpe MS
AD  - Leeds Institute for Data Analytics, University of Leeds, Leeds, UK; Faculty of 
      Medicine and Health, University of Leeds, Leeds, UK; Alan Turing Institute, 
      London, UK.
FAU - Tennant, Peter W G
AU  - Tennant PWG
AD  - Leeds Institute for Data Analytics, University of Leeds, Leeds, UK; Faculty of 
      Medicine and Health, University of Leeds, Leeds, UK; Alan Turing Institute, 
      London, UK.
LA  - eng
GR  - WT_/Wellcome Trust/United Kingdom
GR  - K01 HL141771/HL/NHLBI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20200916
PL  - England
TA  - Lancet Digit Health
JT  - The Lancet. Digital health
JID - 101751302
SB  - IM
MH  - Delivery of Health Care/*methods
MH  - Humans
MH  - *Machine Learning
MH  - Precision Medicine/*methods
PMC - PMC9060421
MID - NIHMS1702565
COIS- Declaration of interests We declare no competing interests.
EDAT- 2020/12/18 06:00
MHDA- 2021/01/28 06:00
CRDT- 2020/12/17 05:31
PHST- 2020/06/24 00:00 [received]
PHST- 2020/07/29 00:00 [revised]
PHST- 2020/08/07 00:00 [accepted]
PHST- 2020/12/17 05:31 [entrez]
PHST- 2020/12/18 06:00 [pubmed]
PHST- 2021/01/28 06:00 [medline]
AID - S2589-7500(20)30200-4 [pii]
AID - 10.1016/S2589-7500(20)30200-4 [doi]
PST - ppublish
SO  - Lancet Digit Health. 2020 Dec;2(12):e677-e680. doi: 
      10.1016/S2589-7500(20)30200-4. Epub 2020 Sep 16.

PMID- 36651494
OWN - NLM
STAT- MEDLINE
DCOM- 20230125
LR  - 20231116
IS  - 1557-1246 (Electronic)
IS  - 1087-0547 (Linking)
VI  - 27
IP  - 4
DP  - 2023 Feb
TI  - Machine Learning and MRI-based Diagnostic Models for ADHD: Are We There Yet?
PG  - 335-353
LID - 10.1177/10870547221146256 [doi]
AB  - OBJECTIVE: Machine learning (ML) has been applied to develop magnetic resonance 
      imaging (MRI)-based diagnostic classifiers for attention-deficit/hyperactivity 
      disorder (ADHD). This systematic review examines this literature to clarify its 
      clinical significance and to assess the implications of the various analytic 
      methods applied. METHODS: A comprehensive literature search on MRI-based 
      diagnostic classifiers for ADHD was performed and data regarding the utilized 
      models and samples were gathered. RESULTS: We found that, although most studies 
      reported the classification accuracies, they varied in choice of MRI modalities, 
      ML models, cross-validation and testing methods, and sample sizes. We found that 
      the accuracies of cross-validation methods inflated the performance estimation 
      compared with those of a held-out test, compromising the model generalizability. 
      Test accuracies have increased with publication year but were not associated with 
      training sample sizes. Improved test accuracy over time was likely due to the use 
      of better ML methods along with strategies to deal with data imbalances. 
      CONCLUSION: Ultimately, large multi-modal imaging datasets, and potentially the 
      combination with other types of data, like cognitive data and/or genetics, will 
      be essential to achieve the goal of developing clinically useful imaging 
      classification tools for ADHD in the future.
FAU - Zhang-James, Yanli
AU  - Zhang-James Y
AD  - SUNY Upstate Medical University, Syracuse, New York, USA.
FAU - Razavi, Ali Shervin
AU  - Razavi AS
AD  - SUNY Upstate Medical University, Syracuse, New York, USA.
FAU - Hoogman, Martine
AU  - Hoogman M
AD  - Radboud University Medical Center, Nijmegen, The Netherlands.
AD  - Donders Institute for Brain, Cognition and Behavior, Nijmegen, The Netherlands.
FAU - Franke, Barbara
AU  - Franke B
AD  - Radboud University Medical Center, Nijmegen, The Netherlands.
AD  - Donders Institute for Brain, Cognition and Behavior, Nijmegen, The Netherlands.
FAU - Faraone, Stephen V
AU  - Faraone SV
AUID- ORCID: 0000-0002-9217-3982
AD  - SUNY Upstate Medical University, Syracuse, New York, USA.
LA  - eng
PT  - Journal Article
PT  - Systematic Review
DEP - 20230118
PL  - United States
TA  - J Atten Disord
JT  - Journal of attention disorders
JID - 9615686
SB  - IM
MH  - Humans
MH  - *Attention Deficit Disorder with Hyperactivity/diagnosis
MH  - Magnetic Resonance Imaging/methods
MH  - Machine Learning
MH  - Clinical Relevance
MH  - Brain
OTO - NOTNLM
OT  - MRI
OT  - attention deficit hyperactivity disorder
OT  - biomarkers
OT  - classification
OT  - imaging classifier
OT  - machine learning
EDAT- 2023/01/19 06:00
MHDA- 2023/01/26 06:00
CRDT- 2023/01/18 06:53
PHST- 2023/01/19 06:00 [pubmed]
PHST- 2023/01/26 06:00 [medline]
PHST- 2023/01/18 06:53 [entrez]
AID - 10.1177/10870547221146256 [doi]
PST - ppublish
SO  - J Atten Disord. 2023 Feb;27(4):335-353. doi: 10.1177/10870547221146256. Epub 2023 
      Jan 18.

PMID- 28921928
OWN - NLM
STAT- MEDLINE
DCOM- 20180626
LR  - 20191210
IS  - 1949-3592 (Electronic)
IS  - 1949-3584 (Print)
IS  - 1949-3592 (Linking)
VI  - 74
IP  - 11
DP  - 2017 Nov
TI  - Inverted formins: A subfamily of atypical formins.
PG  - 405-419
LID - 10.1002/cm.21409 [doi]
AB  - Formins are a family of regulators of actin and microtubule dynamics that are 
      present in almost all eukaryotes. These proteins are involved in many cellular 
      processes, including cytokinesis, stress fiber formation, and cell polarization. 
      Here we review one subfamily of formins, the inverted formins. Inverted formins 
      as a group break several formin stereotypes, having atypical biochemical 
      properties and domain organization, and they have been linked to kidney disease 
      and neuropathy in humans. In this review, we will explore recent research on 
      members of the inverted formin sub-family in mammals, zebrafish, fruit flies, and 
      worms.
CI  - © 2017 Wiley Periodicals, Inc.
FAU - Hegsted, Anna
AU  - Hegsted A
AD  - Department of Cell and Developmental Biology, SUNY Upstate Medical University, 
      Syracuse, New York 13210.
FAU - Yingling, Curtis V
AU  - Yingling CV
AD  - Department of Cell and Developmental Biology, SUNY Upstate Medical University, 
      Syracuse, New York 13210.
FAU - Pruyne, David
AU  - Pruyne D
AUID- ORCID: 0000-0002-2873-0035
AD  - Department of Cell and Developmental Biology, SUNY Upstate Medical University, 
      Syracuse, New York 13210.
LA  - eng
GR  - R01 AR064760/AR/NIAMS NIH HHS/United States
PT  - Journal Article
PT  - Review
DEP - 20170929
PL  - United States
TA  - Cytoskeleton (Hoboken)
JT  - Cytoskeleton (Hoboken, N.J.)
JID - 101523844
RN  - 0 (Actins)
RN  - 0 (Cytoskeletal Proteins)
RN  - 0 (FMNL1 protein, human)
RN  - 0 (Formins)
RN  - 0 (Nuclear Proteins)
SB  - IM
MH  - Actins/*metabolism
MH  - Animals
MH  - Cytoskeletal Proteins/genetics/*metabolism
MH  - Formins
MH  - Humans
MH  - Mice
MH  - Nuclear Proteins/*metabolism
PMC - PMC5752148
MID - NIHMS929096
OTO - NOTNLM
OT  - Charcot-Marie-Tooth disease
OT  - FHDC1
OT  - INF2
OT  - actin
OT  - focal segmental glomerulosclerosis
COIS- Conflict of Interest: CVY owns stock in Invitae (San Francisco, CA 94103), a 
      company that offers human genetic testing, including of inf2 as part of a 
      Charcot-Marie-Tooth disease panel.
EDAT- 2017/09/19 06:00
MHDA- 2018/06/27 06:00
CRDT- 2017/09/19 06:00
PHST- 2017/06/13 00:00 [received]
PHST- 2017/08/22 00:00 [revised]
PHST- 2017/08/31 00:00 [accepted]
PHST- 2017/09/19 06:00 [pubmed]
PHST- 2018/06/27 06:00 [medline]
PHST- 2017/09/19 06:00 [entrez]
AID - 10.1002/cm.21409 [doi]
PST - ppublish
SO  - Cytoskeleton (Hoboken). 2017 Nov;74(11):405-419. doi: 10.1002/cm.21409. Epub 2017 
      Sep 29.

PMID- 36311710
OWN - NLM
STAT- MEDLINE
DCOM- 20221101
LR  - 20230222
IS  - 1664-3224 (Electronic)
IS  - 1664-3224 (Linking)
VI  - 13
DP  - 2022
TI  - Editorial: New biomarkers for the diagnosis and treatment of systemic lupus 
      erythematosus.
PG  - 1009038
LID - 10.3389/fimmu.2022.1009038 [doi]
LID - 1009038
FAU - Perl, Andras
AU  - Perl A
AD  - Department of Medicine, College of Medicine, State University of New York, 
      Upstate Medical University, Syracuse, NY, United States.
AD  - Department of Biochemistry and Molecular Biology, College of Medicine, State 
      University of New York, Upstate Medical University, Syracuse, NY, United States.
AD  - Department of Microbiology and Immunology, College of Medicine, State University 
      of New York, Upstate Medical University, Syracuse, NY, United States.
FAU - Agmon-Levin, Nancy
AU  - Agmon-Levin N
AD  - The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Ramat Gan, 
      Israel.
FAU - Crispín, José C
AU  - Crispín JC
AD  - Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas 
      y Nutrición Salvador Zubirán, Mexico City, Mexico.
AD  - Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey, 
      Mexico.
FAU - Jorgensen, Trine N
AU  - Jorgensen TN
AD  - Department of Inflammation & Immunity, Lerner Research Institute, Cleveland 
      Clinic, Cleveland, OH, United States.
LA  - eng
GR  - R01 AT004332/AT/NCCIH NIH HHS/United States
GR  - R01 AI122176/AI/NIAID NIH HHS/United States
GR  - R34 AI141304/AI/NIAID NIH HHS/United States
GR  - U01 AR076092/AR/NIAMS NIH HHS/United States
GR  - R01 AI118774/AI/NIAID NIH HHS/United States
GR  - R01 AI048079/AI/NIAID NIH HHS/United States
GR  - R01 AI072648/AI/NIAID NIH HHS/United States
PT  - Editorial
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20221012
PL  - Switzerland
TA  - Front Immunol
JT  - Frontiers in immunology
JID - 101560960
RN  - 0 (Biomarkers)
SB  - IM
CON - Editorial on the Research Topic New biomarkers for the diagnosis and treatment of 
      systemic lupus erythematosus
MH  - Humans
MH  - *Lupus Erythematosus, Systemic/diagnosis/therapy
MH  - *Lupus Nephritis
MH  - Biomarkers
PMC - PMC9599399
OTO - NOTNLM
OT  - biomarker
OT  - lupus (SLE)
OT  - machine learning
OT  - multi-omics analyses
OT  - systems biology
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2022/11/01 06:00
MHDA- 2022/11/02 06:00
CRDT- 2022/10/31 04:26
PHST- 2022/08/01 00:00 [received]
PHST- 2022/09/20 00:00 [accepted]
PHST- 2022/10/31 04:26 [entrez]
PHST- 2022/11/01 06:00 [pubmed]
PHST- 2022/11/02 06:00 [medline]
AID - 10.3389/fimmu.2022.1009038 [doi]
PST - epublish
SO  - Front Immunol. 2022 Oct 12;13:1009038. doi: 10.3389/fimmu.2022.1009038. 
      eCollection 2022.

PMID- 35304245
OWN - NLM
STAT- MEDLINE
DCOM- 20220428
LR  - 20220428
IS  - 1873-3476 (Electronic)
IS  - 0378-5173 (Linking)
VI  - 619
DP  - 2022 May 10
TI  - Disintegration testing augmented by computer Vision technology.
PG  - 121668
LID - S0378-5173(22)00223-X [pii]
LID - 10.1016/j.ijpharm.2022.121668 [doi]
AB  - Oral solid dosage forms, specifically immediate release tablets, are prevalent in 
      the pharmaceutical industry. Disintegration testing is often the first step of 
      commercialization and large-scale production of these dosage forms. Current 
      disintegration testing in the pharmaceutical industry, according to United States 
      Pharmacopeia (USP) chapter 〈701〉, only gives information about the duration of 
      the tablet disintegration process. This information is subjective, variable, and 
      prone to human error due to manual or physical data collection methods via the 
      human eye or contact disks. To lessen the data integrity risk associated with 
      this process, efforts have been made to automate the analysis of the 
      disintegration process using digital lens and other imaging technologies. This 
      would provide a non-invasive method to quantitatively determine disintegration 
      time through computer algorithms. The main challenges associated with developing 
      such a system involve visualization of tablet pieces through cloudy and turbid 
      liquid. The Computer Vision for Disintegration (CVD) system has been developed to 
      be used along with traditional pharmaceutical disintegration testing devices to 
      monitor tablet pieces and distinguish them from the surrounding liquid. The 
      software written for CVD utilizes data captured by cameras or other lenses then 
      uses mobile SSD and CNN, with an OpenCV and FRCNN machine learning model, to 
      analyze and interpret the data. This technology is capable of consistently 
      identifying tablets with ≥ 99.6% accuracy. Not only is the data produced by CVD 
      more reliable, but it opens the possibility of a deeper understanding of 
      disintegration rates and mechanisms in addition to duration.
CI  - Copyright © 2022 Elsevier B.V. All rights reserved.
FAU - Floryanzia, Sydney
AU  - Floryanzia S
AD  - Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA, USA; North Carolina State 
      University, Raleigh, NC 27695, United States.
FAU - Ramesh, Preethi
AU  - Ramesh P
AD  - Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA, USA; Syracuse University, 
      Syracuse, NY 13244, United States.
FAU - Mills, Madeline
AU  - Mills M
AD  - Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA, USA; Purdue University, 
      West Lafayette, IN 47907, United States.
FAU - Kulkarni, Sanjana
AU  - Kulkarni S
AD  - Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA, USA; California Institute 
      of Technology, Pasadena, CA 91125, United States.
FAU - Chen, Grace
AU  - Chen G
AD  - Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA, USA. Electronic address: 
      Grace_Chen2@Merck.com.
FAU - Shah, Prashant
AU  - Shah P
AD  - Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA, USA.
FAU - Lavrich, David
AU  - Lavrich D
AD  - Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA, USA.
LA  - eng
PT  - Journal Article
DEP - 20220315
PL  - Netherlands
TA  - Int J Pharm
JT  - International journal of pharmaceutics
JID - 7804127
RN  - 0 (Tablets)
SB  - IM
MH  - *Cardiovascular Diseases
MH  - *Chemistry, Pharmaceutical/methods
MH  - Computers
MH  - Humans
MH  - Solubility
MH  - Tablets
MH  - Technology
MH  - Technology, Pharmaceutical/methods
OTO - NOTNLM
OT  - Disintegration
OT  - Disintegration Test
OT  - Machine Learning
OT  - Neural Networks
OT  - Oral Solid Dosage Forms
EDAT- 2022/03/20 06:00
MHDA- 2022/04/29 06:00
CRDT- 2022/03/19 05:29
PHST- 2021/06/30 00:00 [received]
PHST- 2022/03/08 00:00 [revised]
PHST- 2022/03/11 00:00 [accepted]
PHST- 2022/03/20 06:00 [pubmed]
PHST- 2022/04/29 06:00 [medline]
PHST- 2022/03/19 05:29 [entrez]
AID - S0378-5173(22)00223-X [pii]
AID - 10.1016/j.ijpharm.2022.121668 [doi]
PST - ppublish
SO  - Int J Pharm. 2022 May 10;619:121668. doi: 10.1016/j.ijpharm.2022.121668. Epub 
      2022 Mar 15.

PMID- 35817312
OWN - NLM
STAT- MEDLINE
DCOM- 20220719
LR  - 20220809
IS  - 1872-7972 (Electronic)
IS  - 0304-3940 (Linking)
VI  - 785
DP  - 2022 Aug 10
TI  - Lithium response in bipolar disorder: Genetics, genomics, and beyond.
PG  - 136786
LID - S0304-3940(22)00347-0 [pii]
LID - 10.1016/j.neulet.2022.136786 [doi]
AB  - Lithium is an effective mood stabilizer in bipolar disorder (BD). There is, 
      however, high variability in treatment response to lithium and only 20-30% of 
      individuals with BD are excellent responders. This subgroup has been shown to 
      have specific phenotypic characteristics, and family studies have implicated 
      genetics as an important factor. However, candidate gene studies did not find 
      evidence for major effect genes. Genome-wide association studies (GWAS) have 
      emphasized that lithium response is a polygenic trait. GWAS based on larger 
      sample sizes and non-European ancestries are likely to shed light on the genomic 
      architecture of this trait. Furthermore, induced pluripotent stem cells, 
      transcriptomics, epigenetics, the integration of multiple omics data, and their 
      combination with advanced machine learning techniques hold promise for the 
      understanding of the complex biological underpinnings of lithium treatment 
      response.
CI  - Copyright © 2022 Elsevier B.V. All rights reserved.
FAU - Papiol, Sergi
AU  - Papiol S
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich 80336, Germany; Department of Psychiatry and Psychotherapy, 
      University Hospital, LMU Munich, Munich 80336, Germany. Electronic address: 
      sergi.papiol@med.uni-muenchen.de.
FAU - Schulze, Thomas G
AU  - Schulze TG
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich 80336, Germany; Department of Psychiatry and Behavioral Sciences, 
      Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of 
      Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, Syracuse, 
      NY, USA.
FAU - Heilbronner, Urs
AU  - Heilbronner U
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich 80336, Germany.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Review
DEP - 20220708
PL  - Ireland
TA  - Neurosci Lett
JT  - Neuroscience letters
JID - 7600130
RN  - 0 (Lithium Compounds)
RN  - 9FN79X2M3F (Lithium)
SB  - IM
MH  - *Bipolar Disorder/drug therapy/genetics
MH  - Genome-Wide Association Study
MH  - Genomics
MH  - Humans
MH  - Lithium/pharmacology/therapeutic use
MH  - Lithium Compounds/pharmacology/therapeutic use
OTO - NOTNLM
OT  - Genome-wide association studies
OT  - Mood-stabilizer
OT  - Polygenic risk score
OT  - iPSC
EDAT- 2022/07/12 06:00
MHDA- 2022/07/20 06:00
CRDT- 2022/07/11 19:27
PHST- 2022/04/01 00:00 [received]
PHST- 2022/07/01 00:00 [revised]
PHST- 2022/07/06 00:00 [accepted]
PHST- 2022/07/12 06:00 [pubmed]
PHST- 2022/07/20 06:00 [medline]
PHST- 2022/07/11 19:27 [entrez]
AID - S0304-3940(22)00347-0 [pii]
AID - 10.1016/j.neulet.2022.136786 [doi]
PST - ppublish
SO  - Neurosci Lett. 2022 Aug 10;785:136786. doi: 10.1016/j.neulet.2022.136786. Epub 
      2022 Jul 8.

PMID- 29722360
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20200930
IS  - 1361-6382 (Electronic)
IS  - 0264-9381 (Print)
IS  - 0264-9381 (Linking)
VI  - 34
IP  - No 6
DP  - 2017
TI  - Gravity Spy: integrating advanced LIGO detector characterization, machine 
      learning, and citizen science.
LID - 064003 [pii]
LID - 10.1088/1361-6382/aa5cea [doi]
AB  - With the first direct detection of gravitational waves, the advanced laser 
      interferometer gravitational-wave observatory (LIGO) has initiated a new field of 
      astronomy by providing an alternative means of sensing the universe. The extreme 
      sensitivity required to make such detections is achieved through exquisite 
      isolation of all sensitive components of LIGO from non-gravitational-wave 
      disturbances. Nonetheless, LIGO is still susceptible to a variety of instrumental 
      and environmental sources of noise that contaminate the data. Of particular 
      concern are noise features known as glitches, which are transient and 
      non-Gaussian in their nature, and occur at a high enough rate so that accidental 
      coincidence between the two LIGO detectors is non-negligible. Glitches come in a 
      wide range of time-frequency-amplitude morphologies, with new morphologies 
      appearing as the detector evolves. Since they can obscure or mimic true 
      gravitational-wave signals, a robust characterization of glitches is paramount in 
      the effort to achieve the gravitational-wave detection rates that are predicted 
      by the design sensitivity of LIGO. This proves a daunting task for members of the 
      LIGO Scientific Collaboration alone due to the sheer amount of data. In this 
      paper we describe an innovative project that combines crowdsourcing with machine 
      learning to aid in the challenging task of categorizing all of the glitches 
      recorded by the LIGO detectors. Through the Zooniverse platform, we engage and 
      recruit volunteers from the public to categorize images of time-frequency 
      representations of glitches into pre-identified morphological classes and to 
      discover new classes that appear as the detectors evolve. In addition, machine 
      learning algorithms are used to categorize images after being trained on 
      human-classified examples of the morphological classes. Leveraging the strengths 
      of both classification methods, we create a combined method with the aim of 
      improving the efficiency and accuracy of each individual classifier. The 
      resulting classification and characterization should help LIGO scientists to 
      identify causes of glitches and subsequently eliminate them from the data or the 
      detector entirely, thereby improving the rate and accuracy of gravitational-wave 
      observations. We demonstrate these methods using a small subset of data from 
      LIGO's first observing run.
FAU - Zevin, M
AU  - Zevin M
AD  - Center for Interdisciplinary Exploration and Research in Astrophysics (CIERA) and 
      Deptartment of Physics and Astronomy, Northwestern University, 2145 Sheridan Rd, 
      Evanston, IL 60208, United States of America.
FAU - Coughlin, S
AU  - Coughlin S
AD  - Center for Interdisciplinary Exploration and Research in Astrophysics (CIERA) and 
      Deptartment of Physics and Astronomy, Northwestern University, 2145 Sheridan Rd, 
      Evanston, IL 60208, United States of America.
FAU - Bahaadini, S
AU  - Bahaadini S
AD  - Electrical Engineering and Computer Science, Northwestern University, Evanston, 
      IL 60201, United States of America.
FAU - Besler, E
AU  - Besler E
AD  - Electrical Engineering and Computer Science, Northwestern University, Evanston, 
      IL 60201, United States of America.
FAU - Rohani, N
AU  - Rohani N
AD  - Electrical Engineering and Computer Science, Northwestern University, Evanston, 
      IL 60201, United States of America.
FAU - Allen, S
AU  - Allen S
AD  - Adler Planetarium, Chicago, IL 60605, United States of America.
FAU - Cabero, M
AU  - Cabero M
AD  - Max-Planck-Institut für Gravitationsphysik, Callinstrasse 38, D-30167 Hannover, 
      Germany.
FAU - Crowston, K
AU  - Crowston K
AD  - School of Information Studies, Syracuse University, Syracuse, NY 13210, United 
      States of America.
FAU - Katsaggelos, A K
AU  - Katsaggelos AK
AD  - Electrical Engineering and Computer Science, Northwestern University, Evanston, 
      IL 60201, United States of America.
FAU - Larson, S L
AU  - Larson SL
AD  - Center for Interdisciplinary Exploration and Research in Astrophysics (CIERA) and 
      Deptartment of Physics and Astronomy, Northwestern University, 2145 Sheridan Rd, 
      Evanston, IL 60208, United States of America.
AD  - Adler Planetarium, Chicago, IL 60605, United States of America.
FAU - Lee, T K
AU  - Lee TK
AD  - Department of Communication, University of Utah, Salt Lake City, UT 84112, United 
      States of America.
FAU - Lintott, C
AU  - Lintott C
AD  - Department of Physics, University of Oxford, Oxford, United Kingdom.
FAU - Littenberg, T B
AU  - Littenberg TB
AD  - NASA/Marshall Space Flight Center, Huntsville, AL 35812, United States of 
      America.
FAU - Lundgren, A
AU  - Lundgren A
AD  - Max-Planck-Institut für Gravitationsphysik, Callinstrasse 38, D-30167 Hannover, 
      Germany.
FAU - Østerlund, C
AU  - Østerlund C
AD  - School of Information Studies, Syracuse University, Syracuse, NY 13210, United 
      States of America.
FAU - Smith, J R
AU  - Smith JR
AD  - Department of Physics, California State University Fullerton, Fullerton, CA 
      92831, United States of America.
FAU - Trouille, L
AU  - Trouille L
AD  - Center for Interdisciplinary Exploration and Research in Astrophysics (CIERA) and 
      Deptartment of Physics and Astronomy, Northwestern University, 2145 Sheridan Rd, 
      Evanston, IL 60208, United States of America.
AD  - Adler Planetarium, Chicago, IL 60605, United States of America.
FAU - Kalogera, V
AU  - Kalogera V
AD  - Center for Interdisciplinary Exploration and Research in Astrophysics (CIERA) and 
      Deptartment of Physics and Astronomy, Northwestern University, 2145 Sheridan Rd, 
      Evanston, IL 60208, United States of America.
LA  - eng
GR  - Marshall Space Flight Center NASA/United States
GR  - N-999999/Intramural NASA/United States
PT  - Journal Article
DEP - 20170228
PL  - England
TA  - Class Quantum Gravity
JT  - Classical and quantum gravity
JID - 101725215
PMC - PMC5927381
MID - NIHMS952746
OTO - NOTNLM
OT  - LIGO
OT  - citizen science
OT  - detector characterization
OT  - gravitational waves
OT  - machine learning
EDAT- 2017/01/01 00:00
MHDA- 2017/01/01 00:01
CRDT- 2018/05/04 06:00
PHST- 2018/05/04 06:00 [entrez]
PHST- 2017/01/01 00:00 [pubmed]
PHST- 2017/01/01 00:01 [medline]
AID - 064003 [pii]
AID - 10.1088/1361-6382/aa5cea [doi]
PST - ppublish
SO  - Class Quantum Gravity. 2017;34(No 6):064003. doi: 10.1088/1361-6382/aa5cea. Epub 
      2017 Feb 28.

PMID- 36411744
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20221123
IS  - 1179-1322 (Print)
IS  - 1179-1322 (Electronic)
IS  - 1179-1322 (Linking)
VI  - 14
DP  - 2022
TI  - Role of Rucaparib in the Treatment of Prostate Cancer: Clinical Perspectives and 
      Considerations.
PG  - 3159-3174
LID - 10.2147/CMAR.S353411 [doi]
AB  - Prostate cancer is one of the most common types of cancer worldwide and has 
      strong genetic associations. This is important for the development of 
      therapeutics for the condition, as metastatic castrate-resistant prostate cancer 
      (mCRPC) is resistant to standard androgen deprivation therapy (ADT) and has a 
      relatively poor prognosis. We conducted a literature review on rucaparib, a 
      poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitor that is currently 
      indicated for the treatment of patients with mCRPC who harbor mutations in 
      BRCA1/2 (homologous recombination repair [HRR] genes) and who have already tried 
      androgen receptor-axis-targeted therapies (ARAT) and a taxane chemotherapy. We 
      describe rucaparib's FDA approval, which was based on the results of the 
      single-arm, open-label, Phase II TRITON2 clinical trial, which found an objective 
      response rate (ORR) of 43.5%, a duration of response (DOR) of over six months in 
      length and an acceptable safety profile. Rucaparib's dosage and clinical 
      considerations for use were also discussed. We also compared rucaparib's use and 
      safety profile with Olaparib, niraparib and talazoparib, three other PARP 
      inhibitors tested for the treatment of mCRPC. Overall, initial results show that 
      the safety profile of all four drugs in mCRPC was relatively similar, and further 
      testing is currently indicated for all four. Differences in their metabolism, 
      however, also warrant further research. The clinical validity of rucaparib will 
      be tested by the follow-up TRITON3 clinical trial, which is comparing the effect 
      of rucaparib compared to standard therapies for mCRPC harboring BRCA1/2 or ATM 
      mutations. Other than TRITON3, other clinical trials are testing rucaparib's 
      ability against other cancers (prostate or otherwise) with HRR mutations, and 
      also the efficacy of combination therapies involving rucaparib. Finally, more 
      research is needed to elucidate rucaparib's effect on HRR mutations other than 
      BRCA1/2. Advancements in understanding the genetic landscape of mCRPC will also 
      assist in understanding rucaparib's full therapeutic potential.
CI  - © 2022 Wu and Goldberg.
FAU - Wu, Maximillian S
AU  - Wu MS
AUID- ORCID: 0000-0003-2283-4893
AD  - Department of Urology, SUNY Upstate Medical University, Syracuse, NY, USA.
FAU - Goldberg, Hanan
AU  - Goldberg H
AUID- ORCID: 0000-0002-5777-2138
AD  - Department of Urology, SUNY Upstate Medical University, Syracuse, NY, USA.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20221115
PL  - New Zealand
TA  - Cancer Manag Res
JT  - Cancer management and research
JID - 101512700
PMC - PMC9675324
OTO - NOTNLM
OT  - PARP inhibitors
OT  - homologous recombination repair
OT  - literature review
OT  - metastatic castrate-resistant prostate cancer
COIS- The authors report no conflicts of interest in this work.
EDAT- 2022/11/23 06:00
MHDA- 2022/11/23 06:01
CRDT- 2022/11/22 01:43
PHST- 2022/08/09 00:00 [received]
PHST- 2022/11/05 00:00 [accepted]
PHST- 2022/11/22 01:43 [entrez]
PHST- 2022/11/23 06:00 [pubmed]
PHST- 2022/11/23 06:01 [medline]
AID - 353411 [pii]
AID - 10.2147/CMAR.S353411 [doi]
PST - epublish
SO  - Cancer Manag Res. 2022 Nov 15;14:3159-3174. doi: 10.2147/CMAR.S353411. 
      eCollection 2022.

PMID- 32352709
OWN - NLM
STAT- MEDLINE
DCOM- 20210520
LR  - 20221005
IS  - 2155-384X (Electronic)
IS  - 2155-384X (Linking)
VI  - 11
IP  - 3
DP  - 2020 Mar
TI  - Theranostic Gastrointestinal Endoscopy: Bringing Healing Light to the Lumen.
PG  - e00119
LID - 10.14309/ctg.0000000000000119 [doi]
LID - e00119
AB  - Current conventional endoscopes have restricted the accuracy of treatment 
      delivery and monitoring. Over the past decade, there have been major developments 
      in nanotechnology and light triggered therapy, potentially allowing a better 
      detection of challenging lesions and targeted treatment of malignancies in the 
      gastrointestinal tract. Theranostics is a developing form of personalized 
      medicine because it combines diagnosis and targeted treatment delivered in one 
      step using advances in nanotechnology. This review describes the light-triggered 
      therapies (including photodynamic, photothermal, and photoimmunotherapies), 
      nanotechnological advances with nanopowder, nanostent, nanogels, and 
      nanoparticles, enhancements brought to endoscopic ultrasound, in addition to 
      experimental endoscopic techniques, combining both enhanced diagnoses and 
      therapies, including a developed prototype of a "smart" multifunctional endoscope 
      for localized colorectal cancer, near-infrared laser endoscope targeting the 
      gastrointestinal stromal tumors, the concept of endocapsule for obscure 
      gastrointestinal bleed, and a proof-of-concept therapeutic capsule using 
      ultrasound-mediated targeted drug delivery. Hence, the following term has been 
      proposed encompassing these technologies: "Theranostic gastrointestinal 
      endoscopy." Future efforts for integration of these technologies into clinical 
      practice would be directed toward translational and clinical trials translating 
      into a more personalized and interdisciplinary diagnosis and treatment, shorter 
      procedural time, higher precision, higher cost-effectiveness, and less need for 
      repetitive procedures.
FAU - Nassani, Najib
AU  - Nassani N
AD  - Division of Gastroenterology and Hepatology, Department of Medicine, University 
      of Illinois at Chicago, Chicago, Illinois, USA.
FAU - Alsheikh, Mira
AU  - Alsheikh M
AD  - Department of Medicine, Zucker SOM at Hofstra/Northwell at Staten Island 
      University Hospital, Staten Island, New York, USA.
FAU - Carroll, Bobby
AU  - Carroll B
AD  - Department of Physics, Syracuse University, Syracuse, New York, USA.
FAU - Nguyen, Diep
AU  - Nguyen D
AD  - Department of Visual Information Processing, Institut de la Vision, Sorbonne 
      Université, INSERM, CNRS, Paris, France.
FAU - Carroll, Robert E
AU  - Carroll RE
AD  - Division of Gastroenterology and Hepatology, Department of Medicine, University 
      of Illinois at Chicago, Chicago, Illinois, USA.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Clin Transl Gastroenterol
JT  - Clinical and translational gastroenterology
JID - 101532142
SB  - IM
MH  - Cost-Benefit Analysis
MH  - Endoscopy, Gastrointestinal/economics/instrumentation/*methods
MH  - Endosonography/instrumentation/methods
MH  - Gastric Mucosa/diagnostic imaging/drug effects/radiation effects
MH  - Gastrointestinal Diseases/diagnosis/economics/*therapy
MH  - Humans
MH  - Intestinal Mucosa/diagnostic imaging/drug effects/radiation effects
MH  - Light
MH  - Nanostructures/*administration & dosage
MH  - Phototherapy/economics/instrumentation/*methods
MH  - Theranostic Nanomedicine/economics/instrumentation/*methods
PMC - PMC7145051
EDAT- 2020/05/01 06:00
MHDA- 2021/05/21 06:00
CRDT- 2020/05/01 06:00
PHST- 2020/05/01 06:00 [entrez]
PHST- 2020/05/01 06:00 [pubmed]
PHST- 2021/05/21 06:00 [medline]
AID - 01720094-202003000-00005 [pii]
AID - CTG-19-0319 [pii]
AID - 10.14309/ctg.0000000000000119 [doi]
PST - ppublish
SO  - Clin Transl Gastroenterol. 2020 Mar;11(3):e00119. doi: 
      10.14309/ctg.0000000000000119.

PMID- 27017833
OWN - NLM
STAT- MEDLINE
DCOM- 20170928
LR  - 20180218
IS  - 1744-8352 (Electronic)
IS  - 1473-7159 (Linking)
VI  - 16
IP  - 6
DP  - 2016 Jun
TI  - The potential of genetic and gene expression analysis in the diagnosis of 
      neuropsychiatric disorders.
PG  - 677-95
LID - 10.1586/14737159.2016.1171714 [doi]
AB  - Neuropsychiatric disorders are difficult to diagnose because of phenotypic 
      heterogeneity within and symptomatic overlap between disorders. This review 
      describes how genomics and blood-based gene expression have shown potential as 
      biomarkers for neuropsychiatric disorders (schizophrenia, bipolar disorder, and 
      major depressive disorder) yet also discusses how a complex genetic landscape has 
      limited sole genetic diagnostic tools for these disorders. In addition to their 
      potential use as classifiers for neuropsychiatric disorders, genomic and 
      blood-based biomarkers have revealed clues to the molecular pathways contributing 
      to etiology. A comprehensive overview of studies to date has been given, and the 
      authors provide suggestions for steps to be taken to ultimately move the 
      laboratory-based classifiers towards application in a clinical setting. 
      Furthermore, they share their vision for the future of these classifiers, both in 
      clinical application and in opening up new ways to gain insights into the 
      underlying biology.
FAU - van de Leemput, Joyce
AU  - van de Leemput J
AD  - a Center for Behavioral Genomics, Department of Psychiatry , University of 
      California , San Diego, La Jolla , CA , USA.
FAU - Glatt, Stephen J
AU  - Glatt SJ
AD  - b Psychiatric Genetic Epidemiology & Neurobiology Laboratory (PsychGENe Lab), 
      Department of Psychiatry and Behavioral Sciences, Department of Neuroscience and 
      Physiology , SUNY Upstate Medical University , Syracuse , NY , USA.
FAU - Tsuang, Ming T
AU  - Tsuang MT
AD  - a Center for Behavioral Genomics, Department of Psychiatry , University of 
      California , San Diego, La Jolla , CA , USA.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20160426
PL  - England
TA  - Expert Rev Mol Diagn
JT  - Expert review of molecular diagnostics
JID - 101120777
SB  - IM
MH  - Animals
MH  - Bipolar Disorder/diagnosis/*genetics
MH  - Depression/diagnosis/*genetics
MH  - Gene Expression Profiling/methods
MH  - Genetic Testing/methods
MH  - Humans
MH  - Molecular Diagnostic Techniques/*methods
MH  - Schizophrenia/diagnosis/*genetics
OTO - NOTNLM
OT  - Neuropsychiatric disorders
OT  - bipolar disorder
OT  - blood-based gene expression
OT  - diagnostic classifiers
OT  - genomics
OT  - major depressive disorder
OT  - schizophrenia
EDAT- 2016/03/29 06:00
MHDA- 2017/09/29 06:00
CRDT- 2016/03/29 06:00
PHST- 2016/03/29 06:00 [entrez]
PHST- 2016/03/29 06:00 [pubmed]
PHST- 2017/09/29 06:00 [medline]
AID - 10.1586/14737159.2016.1171714 [doi]
PST - ppublish
SO  - Expert Rev Mol Diagn. 2016 Jun;16(6):677-95. doi: 10.1586/14737159.2016.1171714. 
      Epub 2016 Apr 26.

PMID- 30915218
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20201001
IS  - 2050-3121 (Print)
IS  - 2050-3121 (Electronic)
IS  - 2050-3121 (Linking)
VI  - 7
DP  - 2019
TI  - Sepsis: The evolution in definition, pathophysiology, and management.
PG  - 2050312119835043
LID - 10.1177/2050312119835043 [doi]
LID - 2050312119835043
AB  - There has been a significant evolution in the definition and management of sepsis 
      over the last three decades. This is driven in part due to the advances made in 
      our understanding of its pathophysiology. There is evidence to show that the 
      manifestations of sepsis can no longer be attributed only to the infectious agent 
      and the immune response it engenders, but also to significant alterations in 
      coagulation, immunosuppression, and organ dysfunction. A revolutionary change in 
      the way we manage sepsis has been the adoption of early goal-directed therapy. 
      This involves the early identification of at-risk patients and prompt treatment 
      with antibiotics, hemodynamic optimization, and appropriate supportive care. This 
      has contributed significantly to the overall improved outcomes with sepsis. 
      Investigation into clinically relevant biomarkers of sepsis are ongoing and have 
      yet to yield effective results. Scoring systems such as the sequential organ 
      failure assessment and Acute Physiology and Chronic Health Evaluation help 
      risk-stratify patients with sepsis. Advances in precision medicine techniques and 
      the development of targeted therapy directed at limiting the excesses of the 
      inflammatory and coagulatory cascades offer potentially viable avenues for future 
      research. This review summarizes the progress made in the diagnosis and 
      management of sepsis over the past two decades and examines promising avenues for 
      future research.
FAU - Gyawali, Bishal
AU  - Gyawali B
AD  - Department of Medicine, SUNY Upstate Medical University, Syracuse, NY, USA.
FAU - Ramakrishna, Karan
AU  - Ramakrishna K
AD  - Department of Medicine, SUNY Upstate Medical University, Syracuse, NY, USA.
FAU - Dhamoon, Amit S
AU  - Dhamoon AS
AUID- ORCID: 0000-0002-2775-8925
AD  - Department of Medicine, SUNY Upstate Medical University, Syracuse, NY, USA.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20190321
PL  - England
TA  - SAGE Open Med
JT  - SAGE open medicine
JID - 101624744
PMC - PMC6429642
OTO - NOTNLM
OT  - Critical care/emergency medicine
OT  - hematology
OT  - infectious diseases
COIS- Declaration of conflicting interests: The author(s) declared no potential 
      conflicts of interest with respect to the research, authorship, and/or 
      publication of this article.
EDAT- 2019/03/28 06:00
MHDA- 2019/03/28 06:01
CRDT- 2019/03/28 06:00
PHST- 2018/09/09 00:00 [received]
PHST- 2019/02/11 00:00 [accepted]
PHST- 2019/03/28 06:00 [entrez]
PHST- 2019/03/28 06:00 [pubmed]
PHST- 2019/03/28 06:01 [medline]
AID - 10.1177_2050312119835043 [pii]
AID - 10.1177/2050312119835043 [doi]
PST - epublish
SO  - SAGE Open Med. 2019 Mar 21;7:2050312119835043. doi: 10.1177/2050312119835043. 
      eCollection 2019.

PMID- 34228319
OWN - NLM
STAT- MEDLINE
DCOM- 20211015
LR  - 20230207
IS  - 2168-4804 (Electronic)
IS  - 2168-4790 (Print)
IS  - 2168-4790 (Linking)
VI  - 55
IP  - 6
DP  - 2021 Nov
TI  - Radiologists and Clinical Trials: Part 1 The Truth About Reader Disagreements.
PG  - 1111-1121
LID - 10.1007/s43441-021-00316-6 [doi]
AB  - The debate over human visual perception and how medical images should be 
      interpreted have persisted since X-rays were the only imaging technique 
      available. Concerns over rates of disagreement between expert image readers are 
      associated with much of the clinical research and at times driven by the belief 
      that any image endpoint variability is problematic. The deeper understanding of 
      the reasons, value, and risk of disagreement are somewhat siloed, leading, at 
      times, to costly and risky approaches, especially in clinical trials. Although 
      artificial intelligence promises some relief from mistakes, its routine 
      application for assessing tumors within cancer trials is still an aspiration. Our 
      consortium of international experts in medical imaging for drug development 
      research, the Pharma Imaging Network for Therapeutics and Diagnostics (PINTAD), 
      tapped the collective knowledge of its members to ground expectations, summarize 
      common reasons for reader discordance, identify what factors can be controlled 
      and which actions are likely to be effective in reducing discordance. Reinforced 
      by an exhaustive literature review, our work defines the forces that shape reader 
      variability. This review article aims to produce a singular authoritative 
      resource outlining reader performance's practical realities within cancer trials, 
      whether they occur within a clinical or an independent central review.
CI  - © 2021. The Drug Information Association, Inc.
FAU - Schmid, Annette M
AU  - Schmid AM
AD  - Takeda, 300 Massachusetts Ave, Cambridge, MA, 02139, USA.
FAU - Raunig, David L
AU  - Raunig DL
AUID- ORCID: 0000-0003-4549-1280
AD  - Takeda, 300 Massachusetts Ave, Cambridge, MA, 02139, USA. draunig@snet.net.
FAU - Miller, Colin G
AU  - Miller CG
AD  - The Bracken Group, Newtown, PA, USA.
FAU - Walovitch, Richard C
AU  - Walovitch RC
AD  - WorldCare Clinical, Boston, MA, USA.
FAU - Ford, Robert W
AU  - Ford RW
AD  - Thomas Jefferson University Hospital, Philadelphia, PA, USA.
FAU - O'Connor, Michael
AU  - O'Connor M
AD  - Parexel, Billerica, MA, USA.
FAU - Brueggenwerth, Guenther
AU  - Brueggenwerth G
AD  - Bayer AG, Berlin, Germany.
FAU - Breuer, Josy
AU  - Breuer J
AD  - Consultant, Lutherstadt Wittenberg, Saxony-Anhalt, Germany.
FAU - Kuney, Liz
AU  - Kuney L
AD  - Kuney Consulting, LLC, Syracuse, NY, USA.
FAU - Ford, Robert R
AU  - Ford RR
AD  - Bioclinica, LLC, Princeton, NJ, USA.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20210706
PL  - Switzerland
TA  - Ther Innov Regul Sci
JT  - Therapeutic innovation & regulatory science
JID - 101597411
SB  - IM
MH  - *Artificial Intelligence
MH  - Humans
MH  - *Radiologists
PMC - PMC8259547
OTO - NOTNLM
OT  - Clinical trials
OT  - Image interpretation
OT  - Independent review
OT  - Radiology
OT  - Reader disagreement
OT  - Visual perception
COIS- Annette M. Schmid, David L. Raunig, Colin G. Miller, Richard C. Walovitch, Robert 
      W. Ford, Michael O’Connor, Guenther Brueggenwerth, Josy Breuer, Liz Kuney, Robert 
      R. Ford declare that there are no conflicts of interest.
EDAT- 2021/07/07 06:00
MHDA- 2021/10/16 06:00
CRDT- 2021/07/06 13:24
PHST- 2020/10/11 00:00 [received]
PHST- 2021/06/18 00:00 [accepted]
PHST- 2021/07/07 06:00 [pubmed]
PHST- 2021/10/16 06:00 [medline]
PHST- 2021/07/06 13:24 [entrez]
AID - 10.1007/s43441-021-00316-6 [pii]
AID - 316 [pii]
AID - 10.1007/s43441-021-00316-6 [doi]
PST - ppublish
SO  - Ther Innov Regul Sci. 2021 Nov;55(6):1111-1121. doi: 10.1007/s43441-021-00316-6. 
      Epub 2021 Jul 6.

PMID- 37561425
OWN - NLM
STAT- Publisher
LR  - 20231019
IS  - 2374-2445 (Electronic)
IS  - 2374-2437 (Linking)
VI  - 9
IP  - 10
DP  - 2023 Oct 1
TI  - Immunotherapy in the Treatment of Localized Genitourinary Cancers.
PG  - 1447-1454
LID - 10.1001/jamaoncol.2023.2174 [doi]
AB  - IMPORTANCE: A true revolution in the management of advanced genitourinary cancers 
      has occurred with the discovery and adoption of immunotherapy (IO). The 
      therapeutic benefits of IO were recently observed not to be solely confined to 
      patients with disseminated disease but also in select patients with localized and 
      locally advanced genitourinary neoplasms. OBSERVATIONS: KEYNOTE-057 demonstrated 
      the benefit of pembrolizumab monotherapy for treating high-risk nonmuscle 
      invasive bladder cancer unresponsive to bacillus Calmette-Guérin (BCG), resulting 
      in recent US Food and Drug Administration approval. Furthermore, a current phase 
      3 trial (Checkmate274) demonstrated a disease-free survival benefit with the 
      administration of adjuvant nivolumab vs placebo in muscle-invasive urothelial 
      carcinoma after radical cystectomy. In addition, the recent highly publicized 
      phase 3 KEYNOTE 564 trial demonstrated a recurrence-free survival benefit of 
      adjuvant pembrolizumab in patients with high-risk localized/locally advanced 
      kidney cancer. CONCLUSIONS AND RELEVANCE: The adoption and integration of IO in 
      the management of localized genitourinary cancers exhibiting aggressive 
      phenotypes are becoming an emerging therapeutic paradigm. Clinical oncologists 
      and scientists should become familiar with these trials and indications because 
      they are likely to dramatically change our treatment strategies in the months and 
      years to come.
FAU - Necchi, Andrea
AU  - Necchi A
AD  - Vita-Salute San Raffaele University; IRCCS San Raffaele Hospital, Milan, Italy.
FAU - Faltas, Bishoy M
AU  - Faltas BM
AD  - Englander Institute for Precision Medicine, Weill Cornell Medicine-NewYork 
      Presbyterian Hospital. New York, New York.
FAU - Slovin, Susan F
AU  - Slovin SF
AD  - Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for 
      Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, 
      New York.
FAU - Meeks, Joshua J
AU  - Meeks JJ
AD  - Departments of Pathology, Urology, Biochemistry and Molecular Genetics, 
      Northwestern University School of Medicine, Chicago, Illinois.
FAU - Pal, Sumanta K
AU  - Pal SK
AD  - Department of Medical Oncology & Experimental Therapeutics, City of Hope 
      Comprehensive Cancer Center, Duarte, California.
FAU - Schwartz, Lawrence H
AU  - Schwartz LH
AD  - Department of Radiology, Columbia University College of Physicians and Surgeons, 
      New York, New York.
AD  - Department of Radiology, New York Presbyterian Hospital, New York, New York.
FAU - Huang, Richard S P
AU  - Huang RSP
AD  - Foundation Medicine, Cambridge, Massachusetts.
FAU - Li, Roger
AU  - Li R
AD  - Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, 
      Florida.
FAU - Manley, Brandon
AU  - Manley B
AD  - Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, 
      Florida.
FAU - Chahoud, Jad
AU  - Chahoud J
AD  - Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, 
      Florida.
FAU - Ross, Jeffrey S
AU  - Ross JS
AD  - Foundation Medicine, Cambridge, Massachusetts.
AD  - Departments of Pathology, Urology and Medicine (Oncology), Upstate Medical 
      University, Syracuse, NY USA.
FAU - Spiess, Philippe E
AU  - Spiess PE
AD  - Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, 
      Florida.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - JAMA Oncol
JT  - JAMA oncology
JID - 101652861
SB  - IM
EDAT- 2023/08/10 12:42
MHDA- 2023/08/10 12:42
CRDT- 2023/08/10 11:32
PHST- 2023/08/10 12:42 [pubmed]
PHST- 2023/08/10 12:42 [medline]
PHST- 2023/08/10 11:32 [entrez]
AID - 2808224 [pii]
AID - 10.1001/jamaoncol.2023.2174 [doi]
PST - ppublish
SO  - JAMA Oncol. 2023 Oct 1;9(10):1447-1454. doi: 10.1001/jamaoncol.2023.2174.

PMID- 37832631
OWN - NLM
STAT- MEDLINE
DCOM- 20231030
LR  - 20231030
IS  - 1879-0631 (Electronic)
IS  - 0024-3205 (Linking)
VI  - 333
DP  - 2023 Nov 15
TI  - CRISPR-based precision medicine for hematologic disorders: Advancements, 
      challenges, and prospects.
PG  - 122165
LID - S0024-3205(23)00800-7 [pii]
LID - 10.1016/j.lfs.2023.122165 [doi]
AB  - The development of programmable nucleases to introduce defined alterations in 
      genomic sequences has been a powerful tool for precision medicine. While several 
      nucleases such as zinc-finger nucleases (ZFN), transcriptor activator-like 
      effector nucleases (TALEN), and meganucleases have been explored, the advent of 
      CRISPR/Cas9 technology has revolutionized the field of genome engineering. In 
      addition to disease modeling, the CRISPR/Cas9 technology has contributed to safer 
      and more effective treatment strategies for hematologic diseases and personalized 
      T-cell-based therapies. Here we discuss the applications of the CRISPR technology 
      in the treatment of hematologic diseases, their efficacy, and ongoing clinical 
      trials. We examine the obstacles to their successful use and the approaches 
      investigated to overcome these challenges. Finally, we provide our perspectives 
      to improve this genome editing tool for targeted therapies.
CI  - Copyright © 2023 Elsevier Inc. All rights reserved.
FAU - Sahu, Sounak
AU  - Sahu S
AD  - Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer 
      Institute, 1050 Boyles Street, Building 560, Room 32-04, Frederick, MD 21702, 
      USA. Electronic address: sounak.sahu@nih.gov.
FAU - Poplawska, Maria
AU  - Poplawska M
AD  - Department of Medicine (Division of Hematology and Oncology), State University of 
      New York Downstate Health Sciences University, Brooklyn, NY 11203, USA.
FAU - Lim, Seah H
AU  - Lim SH
AD  - Department of Medicine (Division of Hematology and Oncology), State University of 
      New York Upstate Medical University, 750 E Adams, Syracuse, NY 13210, USA.
FAU - Dutta, Dibyendu
AU  - Dutta D
AD  - Department of Medicine (Division of Hematology and Oncology), State University of 
      New York Upstate Medical University, 750 E Adams, Syracuse, NY 13210, USA. 
      Electronic address: duttad@upstate.edu.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20231011
PL  - Netherlands
TA  - Life Sci
JT  - Life sciences
JID - 0375521
RN  - EC 3.1.- (Endonucleases)
SB  - IM
MH  - Humans
MH  - *CRISPR-Cas Systems/genetics
MH  - Precision Medicine
MH  - Gene Editing
MH  - Genome
MH  - *Hematologic Diseases/genetics/therapy
MH  - Endonucleases/genetics
OTO - NOTNLM
OT  - CAR T cells
OT  - Gene therapy
OT  - Genome editing
OT  - Hematological diseases
OT  - Hemophilia
OT  - Sickle cell disease
COIS- Declaration of competing interest The authors declare no conflicts of interest to 
      disclose.
EDAT- 2023/10/14 10:42
MHDA- 2023/10/30 06:46
CRDT- 2023/10/13 19:24
PHST- 2023/08/22 00:00 [received]
PHST- 2023/10/04 00:00 [revised]
PHST- 2023/10/07 00:00 [accepted]
PHST- 2023/10/30 06:46 [medline]
PHST- 2023/10/14 10:42 [pubmed]
PHST- 2023/10/13 19:24 [entrez]
AID - S0024-3205(23)00800-7 [pii]
AID - 10.1016/j.lfs.2023.122165 [doi]
PST - ppublish
SO  - Life Sci. 2023 Nov 15;333:122165. doi: 10.1016/j.lfs.2023.122165. Epub 2023 Oct 
      11.

PMID- 36172513
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220930
IS  - 1664-0640 (Print)
IS  - 1664-0640 (Electronic)
IS  - 1664-0640 (Linking)
VI  - 13
DP  - 2022
TI  - Structural brain morphometry as classifier and predictor of ADHD and 
      reward-related comorbidities.
PG  - 869627
LID - 10.3389/fpsyt.2022.869627 [doi]
LID - 869627
AB  - Attention deficit/hyperactivity disorder (ADHD) is one of the most common 
      neurodevelopmental disorders, and around two-thirds of affected children report 
      persisting problems in adulthood. This negative trajectory is associated with 
      high comorbidity with disorders like obesity, depression, or substance use 
      disorder (SUD). Decreases in cortical volume and thickness have also been 
      reported in depression, SUD, and obesity, but it is unclear whether structural 
      brain alterations represent unique disorder-specific profiles. A transdiagnostic 
      exploration of ADHD and typical comorbid disorders could help to understand 
      whether specific morphometric brain changes are due to ADHD or, alternatively, to 
      the comorbid disorders. In the current study, we studied the brain morphometry of 
      136 subjects with ADHD with and without comorbid depression, SUD, and obesity to 
      test whether there are unique or common brain alterations. We employed a 
      machine-learning-algorithm trained to classify subjects with ADHD in the large 
      ENIGMA-ADHD dataset and used it to predict the diagnostic status of subjects with 
      ADHD and/or comorbidities. The parcellation analysis demonstrated decreased 
      cortical thickness in medial prefrontal areas that was associated with presence 
      of any comorbidity. However, these results did not survive correction for 
      multiple comparisons. Similarly, the machine learning analysis indicated that the 
      predictive algorithm grouped most of our ADHD participants as belonging to the 
      ADHD-group, but no systematic differences between comorbidity status came up. In 
      sum, neither a classical comparison of segmented structural brain metrics nor an 
      ML model based on the ADHD ENIGMA data differentiate between ADHD with and 
      without comorbidities. As the ML model is based in part on adolescent brains, 
      this might indicate that comorbid disorders and their brain changes are not 
      captured by the ML model because it represents a different developmental brain 
      trajectory.
CI  - Copyright © 2022 van Rooij, Zhang-James, Buitelaar, Faraone, Reif and Grimm.
FAU - van Rooij, Daan
AU  - van Rooij D
AD  - Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and 
      Behavior, Radboud University Medical Center, Nijmegen, Netherlands.
FAU - Zhang-James, Yanli
AU  - Zhang-James Y
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Syracuse, NY, United States.
FAU - Buitelaar, Jan
AU  - Buitelaar J
AD  - Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and 
      Behavior, Radboud University Medical Center, Nijmegen, Netherlands.
FAU - Faraone, Stephen V
AU  - Faraone SV
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Syracuse, NY, United States.
FAU - Reif, Andreas
AU  - Reif A
AD  - Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University 
      Hospital, Goethe University, Frankfurt, Germany.
FAU - Grimm, Oliver
AU  - Grimm O
AD  - Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University 
      Hospital, Goethe University, Frankfurt, Germany.
LA  - eng
PT  - Journal Article
DEP - 20220912
PL  - Switzerland
TA  - Front Psychiatry
JT  - Frontiers in psychiatry
JID - 101545006
PMC - PMC9512052
OTO - NOTNLM
OT  - ADHD
OT  - SUD
OT  - comorbidity
OT  - depression
OT  - machine learning (ML)
OT  - morphometry
COIS- AR has received a research grant from Medice and served on advisory board and/or 
      speaker's bureau for Medice, Shire/Takeda, Janssen, Servier, and Neuraxpharm. OG 
      has served on advisory board and/or speaker's bureau for Medice Arzneimittel 
      Pütter GmbH and Shire/Takeda and has served on advisory board and/or speaker's 
      bureau for Medice Arzneimittel Pütter GmbH. JB declares that he has been, for the 
      past 3 years, a consultant /member of the advisory board of/and/or speaker for 
      Janssen Cilag BV, Eli Lilly, Medice, Shire, Roche, and Servier. The remaining 
      authors declare that the research was conducted in the absence of any commercial 
      or financial relationships that could be construed as a potential conflict of 
      interest.
EDAT- 2022/09/30 06:00
MHDA- 2022/09/30 06:01
CRDT- 2022/09/29 02:20
PHST- 2022/02/04 00:00 [received]
PHST- 2022/08/01 00:00 [accepted]
PHST- 2022/09/29 02:20 [entrez]
PHST- 2022/09/30 06:00 [pubmed]
PHST- 2022/09/30 06:01 [medline]
AID - 10.3389/fpsyt.2022.869627 [doi]
PST - epublish
SO  - Front Psychiatry. 2022 Sep 12;13:869627. doi: 10.3389/fpsyt.2022.869627. 
      eCollection 2022.

PMID- 33748314
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20210324
IS  - 2327-4697 (Print)
IS  - 2327-4697 (Electronic)
IS  - 2327-4697 (Linking)
VI  - 6
IP  - 4
DP  - 2019 Oct-Dec
TI  - Efficient Privacy-preserving Machine Learning in Hierarchical Distributed System.
PG  - 599-612
LID - 10.1109/tnse.2018.2859420 [doi]
AB  - With the dramatic growth of data in both amount and scale, distributed machine 
      learning has become an important tool for the massive data to finish the tasks as 
      prediction, classification, etc. However, due to the practical physical 
      constraints and the potention privacy leakage of data, it is infeasible to 
      aggregate raw data from all data owners for the learning purpose. To tackle this 
      problem, the distributed privacy-preserving learning approaches are introduced to 
      learn over all distributed data without exposing the real information. However, 
      existing approaches have limits on the complicated distributed system. On the one 
      hand, traditional privacy-preserving learning approaches rely on heavy 
      cryptographic primitives on training data, in which the learning speed is 
      dramatically slowed down due to the computation overheads. On the other hand, the 
      complicated system architecture becomes a barrier in the practical distributed 
      system. In this paper, we propose an efficient privacy-preserving machine 
      learning scheme for hierarchical distributed systems. We modify and improve the 
      collaborative learning algorithm. The proposed scheme not only reduces the 
      overhead for the learning process but also provides the comprehensive protection 
      for each layer of the hierarchical distributed system. In addition, based on the 
      analysis of the collaborative convergency in different learning groups, we also 
      propose an asynchronous strategy to further improve the learning efficiency of 
      hierarchical distributed system. At the last, extensive experiments on real-world 
      data are implemented to evaluate the privacy, efficacy, and efficiency of our 
      proposed schemes.
FAU - Jia, Qi
AU  - Jia Q
AD  - Department of Electrical and Computer Engineering, Binghamton University, 
      Binghamton, NY, 13850.
FAU - Guo, Linke
AU  - Guo L
AD  - Department of Electrical and Computer Engineering, Binghamton University, 
      Binghamton, NY, 13850.
FAU - Fang, Yuguang
AU  - Fang Y
AD  - Department of Electrical and Computer Engineering, University of Florida, 
      Gainesville, FL, 32611.
FAU - Wang, Guirong
AU  - Wang G
AD  - Department of Surgery, SUNY Upstate Medical University, Syracuse, NY, 13210.
LA  - eng
GR  - R01 HL136706/HL/NHLBI NIH HHS/United States
PT  - Journal Article
DEP - 20180724
PL  - United States
TA  - IEEE Trans Netw Sci Eng
JT  - IEEE transactions on network science and engineering
JID - 101696455
PMC - PMC7970733
MID - NIHMS1545932
OTO - NOTNLM
OT  - Efficiency
OT  - Hierarchical Distributed System
OT  - Machine Learning
OT  - Privacy
EDAT- 2019/10/01 00:00
MHDA- 2019/10/01 00:01
CRDT- 2021/03/22 08:23
PHST- 2021/03/22 08:23 [entrez]
PHST- 2019/10/01 00:00 [pubmed]
PHST- 2019/10/01 00:01 [medline]
AID - 10.1109/tnse.2018.2859420 [doi]
PST - ppublish
SO  - IEEE Trans Netw Sci Eng. 2019 Oct-Dec;6(4):599-612. doi: 
      10.1109/tnse.2018.2859420. Epub 2018 Jul 24.

PMID- 34353116
OWN - NLM
STAT- MEDLINE
DCOM- 20220819
LR  - 20230128
IS  - 2162-1918 (Print)
IS  - 2162-1934 (Electronic)
IS  - 2162-1918 (Linking)
VI  - 11
IP  - 11
DP  - 2022 Nov
TI  - Hematopoietic Stem Cells in Wound Healing Response.
PG  - 598-621
LID - 10.1089/wound.2021.0065 [doi]
AB  - Significance: Emerging evidence has shown a link between the status of 
      hematopoietic stem cells (HSCs) and wound healing responses. Thus, better 
      understanding HSCs will contribute to further advances in wound healing research. 
      Recent Advances: Myeloid cells such as neutrophils and monocyte-derived 
      macrophages are critical players in the process of wound healing. HSCs actively 
      respond to wound injury and other tissue insults, including infection and produce 
      the effector myeloid cells, and a failing of the HSC response can result in 
      impaired wound healing. Technological advances such as transcriptome at 
      single-cell resolution, epigenetics, three-dimensional imaging, transgenic 
      animals, and animal models, have provided novel concepts of myeloid generation 
      (myelopoiesis) from HSCs, and have revealed cell-intrinsic and -extrinsic 
      mechanisms that can impact HSC functions in the context of health conditions. 
      Critical Issues: The newer concepts include-the programmed cellular fate at a 
      differentiation stage that is used to be considered as the multilineage, the 
      signaling pathways that can activate HSCs directly and indirectly, the mechanisms 
      that can deteriorate HSCs, the roles and remodeling of the surrounding 
      environment for HSCs and their progenitors (the niche). Future Directions: The 
      researches on HSCs, which produce blood cells, should contribute to the 
      development of blood biomarkers predicting a risk of chronic wounds, which may 
      transform clinical practice of wound care with precision medicine for patients at 
      high risk of poor healing.
FAU - Urao, Norifumi
AU  - Urao N
AUID- ORCID: 0000-0001-9750-8406
AD  - Department of Pharmacology, State University of New York Upstate Medical 
      University, Syracuse, New York, USA.
FAU - Liu, Jinghua
AU  - Liu J
AD  - Department of Pharmacology, State University of New York Upstate Medical 
      University, Syracuse, New York, USA.
FAU - Takahashi, Kentaro
AU  - Takahashi K
AD  - Department of Pharmacology, State University of New York Upstate Medical 
      University, Syracuse, New York, USA.
FAU - Ganesh, Gayathri
AU  - Ganesh G
AD  - Department of Pharmacology, State University of New York Upstate Medical 
      University, Syracuse, New York, USA.
LA  - eng
GR  - R01 DK111489/DK/NIDDK NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20210909
PL  - United States
TA  - Adv Wound Care (New Rochelle)
JT  - Advances in wound care
JID - 101590593
SB  - IM
MH  - Animals
MH  - Cell Differentiation
MH  - *Hematopoietic Stem Cells/physiology
MH  - Myeloid Cells
MH  - Myelopoiesis
MH  - *Wound Healing/physiology
PMC - PMC9419985
OTO - NOTNLM
OT  - bone marrow
OT  - hematopoietic stem cell
OT  - immune memory
OT  - myeloid progenitor
OT  - myelopoiesis
OT  - niche
COIS- The authors have no competing financial interests. The content of this article 
      was written entirely by the authors listed. No ghostwriters were used to write 
      this article.
EDAT- 2021/08/07 06:00
MHDA- 2022/08/20 06:00
CRDT- 2021/08/06 05:28
PHST- 2021/08/07 06:00 [pubmed]
PHST- 2022/08/20 06:00 [medline]
PHST- 2021/08/06 05:28 [entrez]
AID - 10.1089/wound.2021.0065 [pii]
AID - 10.1089/wound.2021.0065 [doi]
PST - ppublish
SO  - Adv Wound Care (New Rochelle). 2022 Nov;11(11):598-621. doi: 
      10.1089/wound.2021.0065. Epub 2021 Sep 9.

PMID- 32162711
OWN - NLM
STAT- MEDLINE
DCOM- 20200824
LR  - 20210602
IS  - 1554-527X (Electronic)
IS  - 0736-0266 (Print)
IS  - 0736-0266 (Linking)
VI  - 38
IP  - 6
DP  - 2020 Jun
TI  - Fracture risk assessment and clinical decision making for patients with 
      metastatic bone disease.
PG  - 1175-1190
LID - 10.1002/jor.24660 [doi]
AB  - Metastatic breast, prostate, lung, and other cancers often affect bone, causing 
      pain, increasing fracture risk, and decreasing function. Management of metastatic 
      bone disease (MBD) is clinically challenging when there is potential but 
      uncertain risk of pathological fracture. Management of MBD has become a major 
      focus within orthopedic oncology with respect to fracture and impending fracture 
      care. If impending skeletal-related events (SREs), particularly pathologic 
      fracture, could be predicted, increasing evidence suggests that prophylactic 
      surgical treatment improves patient outcomes. However, current fracture risk 
      assessment and radiographic metrics do not have high accuracy and have not been 
      combined with relevant patient survival tools. This review first explores the 
      prevalence, incidence, and morbidity of MBD and associated SREs for different 
      cancer types. Strengths and limitations of current fracture risk scoring systems 
      for spinal stability and long bone fracture are highlighted. More recent computed 
      tomography (CT)-based structural rigidity analysis (CTRA) and finite element (FE) 
      analysis methods offer advantages of increased specificity (true negative rate), 
      but are limited in availability. Other fracture prediction approaches including 
      parametric response mapping and positron emission tomography/computed tomography 
      measures show early promise. Substantial new information to inform clinical 
      decision-making includes measures of survival, clinical benefits, and economic 
      analysis of prophylactic treatment compared to after-fracture stabilization. 
      Areas of future research include use of big data and machine learning to predict 
      SREs, greater access and refinement of CTRA/FE approaches, combination of 
      clinical survival prediction tools with radiographically based fracture risk 
      assessment, and net benefit analysis for fracture risk assessment and 
      prophylactic treatment.
CI  - © 2020 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.
FAU - Damron, Timothy A
AU  - Damron TA
AUID- ORCID: 0000-0001-9403-4030
AD  - Department of Orthopedic Surgery, Institute for Human Performance, SUNY Upstate 
      Medical University, Syracuse, New York.
FAU - Mann, Kenneth A
AU  - Mann KA
AUID- ORCID: 0000-0003-1150-0740
AD  - Department of Orthopedic Surgery, Institute for Human Performance, SUNY Upstate 
      Medical University, Syracuse, New York.
LA  - eng
GR  - R01 AR065419/AR/NIAMS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Review
DEP - 20200323
PL  - United States
TA  - J Orthop Res
JT  - Journal of orthopaedic research : official publication of the Orthopaedic 
      Research Society
JID - 8404726
SB  - IM
MH  - Bone Neoplasms/*complications/epidemiology/*secondary
MH  - *Clinical Decision-Making
MH  - Finite Element Analysis
MH  - Fractures, Spontaneous/*etiology
MH  - Humans
MH  - Morbidity
MH  - *Risk Assessment
MH  - Tomography, X-Ray Computed
PMC - PMC7225068
MID - NIHMS1577718
OTO - NOTNLM
OT  - clinical decision making
OT  - fracture risk
OT  - metastatic bone disease
OT  - prophylactic stabilization
OT  - skeletal-related events
EDAT- 2020/03/13 06:00
MHDA- 2020/08/25 06:00
CRDT- 2020/03/13 06:00
PHST- 2019/10/09 00:00 [received]
PHST- 2020/01/17 00:00 [revised]
PHST- 2020/02/29 00:00 [accepted]
PHST- 2020/03/13 06:00 [pubmed]
PHST- 2020/08/25 06:00 [medline]
PHST- 2020/03/13 06:00 [entrez]
AID - 10.1002/jor.24660 [doi]
PST - ppublish
SO  - J Orthop Res. 2020 Jun;38(6):1175-1190. doi: 10.1002/jor.24660. Epub 2020 Mar 23.

PMID- 37423513
OWN - NLM
STAT- MEDLINE
DCOM- 20230904
LR  - 20230905
IS  - 1090-2139 (Electronic)
IS  - 0889-1591 (Linking)
VI  - 113
DP  - 2023 Oct
TI  - Inflammatory subgroups of schizophrenia and their association with brain 
      structure: A semi-supervised machine learning examination of heterogeneity.
PG  - 166-175
LID - S0889-1591(23)00167-8 [pii]
LID - 10.1016/j.bbi.2023.06.023 [doi]
AB  - OBJECTIVE: Immune system dysfunction is hypothesised to contribute to structural 
      brain changes through aberrant synaptic pruning in schizophrenia. However, 
      evidence is mixed and there is a lack of evidence of inflammation and its effect 
      on grey matter volume (GMV) in patients. We hypothesised that inflammatory 
      subgroups can be identified and that the subgroups will show distinct 
      neuroanatomical and neurocognitive profiles. METHODS: The total sample consisted 
      of 1067 participants (chronic patients with schizophrenia n = 467 and healthy 
      controls (HCs) n = 600) from the Australia Schizophrenia Research Bank (ASRB) 
      dataset, together with 218 recent-onset patients with schizophrenia from the 
      external Benefit of Minocycline on Negative Symptoms of Psychosis: Extent and 
      Mechanism (BeneMin) dataset. HYDRA (HeterogeneitY through DiscRiminant Analysis) 
      was used to separate schizophrenia from HC and define disease-related subgroups 
      based on inflammatory markers. Voxel-based morphometry and inferential statistics 
      were used to explore GMV alterations and neurocognitive deficits in these 
      subgroups. RESULTS: An optimal clustering solution revealed five main 
      schizophrenia groups separable from HC: Low Inflammation, Elevated CRP, Elevated 
      IL-6/IL-8, Elevated IFN-γ, and Elevated IL-10 with an adjusted Rand index of 
      0.573. When compared with the healthy controls, the IL-6/IL-8 cluster showed the 
      most widespread, including the anterior cingulate, GMV reduction. The IFN-γ 
      inflammation cluster showed the least GMV reduction and impairment of cognitive 
      performance. The CRP and the Low Inflammation clusters dominated in the younger 
      external dataset. CONCLUSIONS: Inflammation in schizophrenia may not be merely a 
      case of low vs high, but rather there are pluripotent, heterogeneous mechanisms 
      at play which could be reliably identified based on accessible, peripheral 
      measures. This could inform the successful development of targeted interventions.
CI  - Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.
FAU - Alexandros Lalousis, Paris
AU  - Alexandros Lalousis P
AD  - Institute for Mental Health, University of Birmingham, Birmingham, United 
      Kingdom; Centre for Human Brain Health, University of Birmingham, Birmingham, 
      United Kingdom; Department of Psychosis Studies, Institute of Psychiatry, 
      Psychology & Neuroscience, King's College London, London, United Kingdom. 
      Electronic address: paris.lalousis@kcl.ac.uk.
FAU - Schmaal, Lianne
AU  - Schmaal L
AD  - Orygen, Parkville, Australia; Centre for Youth Mental Health, The University of 
      Melbourne, Parkville, Australia.
FAU - Wood, Stephen J
AU  - Wood SJ
AD  - Institute for Mental Health, University of Birmingham, Birmingham, United 
      Kingdom; Orygen, Parkville, Australia; Centre for Youth Mental Health, The 
      University of Melbourne, Parkville, Australia.
FAU - L E P Reniers, Renate
AU  - L E P Reniers R
AD  - Institute for Mental Health, University of Birmingham, Birmingham, United 
      Kingdom; Centre for Human Brain Health, University of Birmingham, Birmingham, 
      United Kingdom; Institute of Clinical Sciences, University of Birmingham, United 
      Kingdom.
FAU - Cropley, Vanessa L
AU  - Cropley VL
AD  - Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of 
      Melbourne, Melbourne, Australia.
FAU - Watson, Andrew
AU  - Watson A
AD  - The Department of Clinical and Motor Neuroscience, UCL Queen Square Institute of 
      Neurology, London, United Kingdom.
FAU - Pantelis, Christos
AU  - Pantelis C
AD  - Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of 
      Melbourne, Melbourne, Australia; NorthWestern Mental Health, Western Hospital 
      Sunshine, St. Albans, Vicroria, Australia.
FAU - Suckling, John
AU  - Suckling J
AD  - Brain Mapping Unit, Department of Psychiatry, Herchel Smith Building for Brain 
      and Mind Sciences, University of Cambridge, United Kingdom; Cambridgeshire & 
      Peterborough NHS Foundation Trust, Cambridge, United Kingdom.
FAU - Barnes, Nicholas M
AU  - Barnes NM
AD  - Institute for Clinical Sciences, University of Birmingham, Birmingham, United 
      Kingdom.
FAU - Pariante, Carmine
AU  - Pariante C
AD  - Stress, Psychiatry and Immunology Lab & Perinatal Psychiatry, The Maurice Wohl 
      Clinical Neuroscience Institute, King's College London, London, United Kingdom.
FAU - Jones, Peter B
AU  - Jones PB
AD  - Brain Mapping Unit, Department of Psychiatry, Herchel Smith Building for Brain 
      and Mind Sciences, University of Cambridge, United Kingdom; Cambridgeshire & 
      Peterborough NHS Foundation Trust, Cambridge, United Kingdom.
FAU - Joyce, Eileen
AU  - Joyce E
AD  - The Department of Clinical and Motor Neuroscience, UCL Queen Square Institute of 
      Neurology, London, United Kingdom.
FAU - Barnes, Thomas R E
AU  - Barnes TRE
AD  - Division of Psychiatry, Imperial College London, London United Kingdom.
FAU - Lawrie, Stephen M
AU  - Lawrie SM
AD  - Division of Psychiatry, Centre for Clinical Brain Sciences, University of 
      Edinburgh, Edinburgh, United Kingdom.
FAU - Husain, Nusrat
AU  - Husain N
AD  - Division of Psychology and Mental Health, University of Manchester & Mersey Care 
      NHS Foundation Trust.
FAU - Dazzan, Paola
AU  - Dazzan P
AD  - Department of Psychological Medicine, Institute of Psychiatry, Psychology and 
      Neuroscience, King's College London, London, United Kingdom.
FAU - Deakin, Bill
AU  - Deakin B
AD  - Division of Neuroscience and Experimental Psychology, University of Manchester, 
      Manchester, United Kingdom.
FAU - Shannon Weickert, Cynthia
AU  - Shannon Weickert C
AD  - Department of Neuroscience and Physiology, Upstate Medical University, Syracuse, 
      NY, USA; Schizophrenia Research Laboratory, Neuroscience Research Australia, 
      Sydney, New South Wales, Australia; School of Psychiatry, University of New South 
      Wales, Sydney, New South Wales, Australia.
FAU - Upthegrove, Rachel
AU  - Upthegrove R
AD  - Institute for Mental Health, University of Birmingham, Birmingham, United 
      Kingdom; Centre for Human Brain Health, University of Birmingham, Birmingham, 
      United Kingdom; Birmingham Early Interventions Service, Birmingham Women's and 
      Children's NHS Foundation Trust, United Kingdom.
LA  - eng
GR  - MR/S037675/1/MRC_/Medical Research Council/United Kingdom
GR  - DH_/Department of Health/United Kingdom
PT  - Case Reports
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20230707
PL  - Netherlands
TA  - Brain Behav Immun
JT  - Brain, behavior, and immunity
JID - 8800478
RN  - 0 (Interleukin-6)
RN  - 0 (Interleukin-8)
SB  - IM
MH  - Humans
MH  - *Schizophrenia
MH  - Interleukin-6
MH  - Interleukin-8
MH  - Magnetic Resonance Imaging
MH  - Brain/diagnostic imaging
MH  - Gray Matter
MH  - Supervised Machine Learning
OTO - NOTNLM
OT  - Inflammation
OT  - MRI
OT  - Machine learning
OT  - Schizophrenia
COIS- Declaration of Competing Interest The authors declare the following financial 
      interests/personal relationships which may be considered as potential competing 
      interests: Paris Alexandros Lalousis has received honoraria for talks presented 
      at educational meetings organised by Boehringer-Ingelheim. Rachel Upthegrove 
      reports grants from Medical Research Council, grants from National Institute for 
      Health Research: Health Technology Assessment, grants from European Commission - 
      Research: The Seventh Framework Programme, and personal speaker fees from 
      Sunovion, outside the submitted work. This study was supported by grant UKRI 
      MR/S037675/1 from the MRC Psychosis Immune Mechanism Stratified Medicine Study 
      (PIMS). It was also supported by the NIHR Oxford Health Biomedical Research 
      Centre. The views expressed are those of the author(s) and not necessarily those 
      of the NIHR or the Department of Health and Social Care. Christos Pantelis was 
      supported by a National Health and Medical Research Council (NHMRC) Senior 
      Principal Research Fellowship (1105825), an NHMRC L3 Investigator Grant 
      (1196508), and NHMRC-EU grant (1075379); he has participated on Advisory Boards 
      for Janssen-Cilag, Astra-Zeneca, Lundbeck, and Servier; and has received 
      honoraria for talks presented at educational meetings organised by Astra-Zeneca, 
      Janssen-Cilag, Eli-Lilly, Pfizer, Lundbeck and Shire. Nusrat Husain is a past 
      Trustee of Manchester Global Foundation (MGF), The Pakistan Institute of Living 
      and Learning (PILL), Abaseen Foundation UK and Lancashire Mind UK. He is 
      executive member of the Academic Faculty of the Royal College of Psychiatrists, 
      London. He is a NIHR Senior Investigator. In the last five years he has attended 
      educational events organized by various pharmaceutical industries.
EDAT- 2023/07/10 00:42
MHDA- 2023/09/04 06:42
CRDT- 2023/07/09 19:28
PHST- 2022/10/06 00:00 [received]
PHST- 2023/05/15 00:00 [revised]
PHST- 2023/06/26 00:00 [accepted]
PHST- 2023/09/04 06:42 [medline]
PHST- 2023/07/10 00:42 [pubmed]
PHST- 2023/07/09 19:28 [entrez]
AID - S0889-1591(23)00167-8 [pii]
AID - 10.1016/j.bbi.2023.06.023 [doi]
PST - ppublish
SO  - Brain Behav Immun. 2023 Oct;113:166-175. doi: 10.1016/j.bbi.2023.06.023. Epub 
      2023 Jul 7.

PMID- 33537772
OWN - NLM
STAT- MEDLINE
DCOM- 20211124
LR  - 20220119
IS  - 1527-974X (Electronic)
IS  - 1067-5027 (Print)
IS  - 1067-5027 (Linking)
VI  - 28
IP  - 6
DP  - 2021 Jun 12
TI  - Federated learning improves site performance in multicenter deep learning without 
      data sharing.
PG  - 1259-1264
LID - 10.1093/jamia/ocaa341 [doi]
AB  - OBJECTIVE: To demonstrate enabling multi-institutional training without 
      centralizing or sharing the underlying physical data via federated learning (FL). 
      MATERIALS AND METHODS: Deep learning models were trained at each participating 
      institution using local clinical data, and an additional model was trained using 
      FL across all of the institutions. RESULTS: We found that the FL model exhibited 
      superior performance and generalizability to the models trained at single 
      institutions, with an overall performance level that was significantly better 
      than that of any of the institutional models alone when evaluated on held-out 
      test sets from each institution and an outside challenge dataset. DISCUSSION: The 
      power of FL was successfully demonstrated across 3 academic institutions while 
      avoiding the privacy risk associated with the transfer and pooling of patient 
      data. CONCLUSION: Federated learning is an effective methodology that merits 
      further study to enable accelerated development of models across institutions, 
      enabling greater generalizability in clinical use.
CI  - © The Author(s) 2021. Published by Oxford University Press on behalf of the 
      American Medical Informatics Association.
FAU - Sarma, Karthik V
AU  - Sarma KV
AUID- ORCID: 0000-0002-7442-9526
AD  - Department of Radiological Sciences, University of California, Los Angeles, Los 
      Angeles, California, USA.
AD  - Department of Bioengineering, University of California, Los Angeles, Los Angeles, 
      California, USA.
FAU - Harmon, Stephanie
AU  - Harmon S
AD  - National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 
      USA.
AD  - Clinical Monitoring Research Program Directorate, Frederick National Laboratory 
      for Cancer Research, Frederick, Maryland, USA.
FAU - Sanford, Thomas
AU  - Sanford T
AD  - Department of Urology, SUNY Upstate Medical Center, Syracuse, New York, USA.
FAU - Roth, Holger R
AU  - Roth HR
AD  - NVIDIA Corporation, Bethesda, Maryland, USA.
FAU - Xu, Ziyue
AU  - Xu Z
AD  - NVIDIA Corporation, Bethesda, Maryland, USA.
FAU - Tetreault, Jesse
AU  - Tetreault J
AD  - NVIDIA Corporation, Bethesda, Maryland, USA.
FAU - Xu, Daguang
AU  - Xu D
AD  - NVIDIA Corporation, Bethesda, Maryland, USA.
FAU - Flores, Mona G
AU  - Flores MG
AD  - NVIDIA Corporation, Bethesda, Maryland, USA.
FAU - Raman, Alex G
AU  - Raman AG
AD  - Department of Radiological Sciences, University of California, Los Angeles, Los 
      Angeles, California, USA.
FAU - Kulkarni, Rushikesh
AU  - Kulkarni R
AD  - Department of Radiological Sciences, University of California, Los Angeles, Los 
      Angeles, California, USA.
FAU - Wood, Bradford J
AU  - Wood BJ
AD  - National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 
      USA.
FAU - Choyke, Peter L
AU  - Choyke PL
AD  - National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 
      USA.
FAU - Priester, Alan M
AU  - Priester AM
AD  - Department of Bioengineering, University of California, Los Angeles, Los Angeles, 
      California, USA.
AD  - Department of Urology, University of California, Los Angeles, Los Angeles, 
      California, USA.
FAU - Marks, Leonard S
AU  - Marks LS
AD  - Department of Urology, University of California, Los Angeles, Los Angeles, 
      California, USA.
FAU - Raman, Steven S
AU  - Raman SS
AD  - Department of Radiological Sciences, University of California, Los Angeles, Los 
      Angeles, California, USA.
FAU - Enzmann, Dieter
AU  - Enzmann D
AD  - Department of Radiological Sciences, University of California, Los Angeles, Los 
      Angeles, California, USA.
FAU - Turkbey, Baris
AU  - Turkbey B
AD  - National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 
      USA.
FAU - Speier, William
AU  - Speier W
AUID- ORCID: 0000-0002-0890-8684
AD  - Department of Radiological Sciences, University of California, Los Angeles, Los 
      Angeles, California, USA.
FAU - Arnold, Corey W
AU  - Arnold CW
AD  - Department of Radiological Sciences, University of California, Los Angeles, Los 
      Angeles, California, USA.
AD  - Department of Bioengineering, University of California, Los Angeles, Los Angeles, 
      California, USA.
AD  - Department of Pathology and Laboratory Medicine University of California, Los 
      Angeles, Los Angeles, California, USA.
LA  - eng
GR  - R21 CA220352/CA/NCI NIH HHS/United States
GR  - T32 GM008042/GM/NIGMS NIH HHS/United States
GR  - ZIA CL040015/ImNIH/Intramural NIH HHS/United States
GR  - R01 CA158627/CA/NCI NIH HHS/United States
GR  - T32 EB016640/EB/NIBIB NIH HHS/United States
GR  - F30 CA210329/CA/NCI NIH HHS/United States
GR  - R01 CA195505/CA/NCI NIH HHS/United States
GR  - HHSN261200800001E/CA/NCI NIH HHS/United States
GR  - P50 CA092131/CA/NCI NIH HHS/United States
GR  - P30 CA016042/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Multicenter Study
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, N.I.H., Intramural
PT  - Research Support, Non-U.S. Gov't
PL  - England
TA  - J Am Med Inform Assoc
JT  - Journal of the American Medical Informatics Association : JAMIA
JID - 9430800
SB  - IM
MH  - *Deep Learning
MH  - Humans
MH  - *Information Dissemination
MH  - Privacy
PMC - PMC8200268
OTO - NOTNLM
OT  - deep learning
OT  - federated learning
OT  - generalizability
OT  - privacy
OT  - prostate
EDAT- 2021/02/05 06:00
MHDA- 2021/11/25 06:00
CRDT- 2021/02/04 05:54
PHST- 2020/07/06 00:00 [received]
PHST- 2020/11/30 00:00 [revised]
PHST- 2020/12/23 00:00 [accepted]
PHST- 2021/02/05 06:00 [pubmed]
PHST- 2021/11/25 06:00 [medline]
PHST- 2021/02/04 05:54 [entrez]
AID - 6127556 [pii]
AID - ocaa341 [pii]
AID - 10.1093/jamia/ocaa341 [doi]
PST - ppublish
SO  - J Am Med Inform Assoc. 2021 Jun 12;28(6):1259-1264. doi: 10.1093/jamia/ocaa341.

PMID- 32286748
OWN - NLM
STAT- MEDLINE
DCOM- 20200512
LR  - 20230322
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
VI  - 382
IP  - 18
DP  - 2020 Apr 30
TI  - Artificial Intelligence to Detect Papilledema from Ocular Fundus Photographs.
PG  - 1687-1695
LID - 10.1056/NEJMoa1917130 [doi]
AB  - BACKGROUND: Nonophthalmologist physicians do not confidently perform direct 
      ophthalmoscopy. The use of artificial intelligence to detect papilledema and 
      other optic-disk abnormalities from fundus photographs has not been well studied. 
      METHODS: We trained, validated, and externally tested a deep-learning system to 
      classify optic disks as being normal or having papilledema or other abnormalities 
      from 15,846 retrospectively collected ocular fundus photographs that had been 
      obtained with pharmacologic pupillary dilation and various digital cameras in 
      persons from multiple ethnic populations. Of these photographs, 14,341 from 19 
      sites in 11 countries were used for training and validation, and 1505 photographs 
      from 5 other sites were used for external testing. Performance at classifying the 
      optic-disk appearance was evaluated by calculating the area under the 
      receiver-operating-characteristic curve (AUC), sensitivity, and specificity, as 
      compared with a reference standard of clinical diagnoses by 
      neuro-ophthalmologists. RESULTS: The training and validation data sets from 6779 
      patients included 14,341 photographs: 9156 of normal disks, 2148 of disks with 
      papilledema, and 3037 of disks with other abnormalities. The percentage 
      classified as being normal ranged across sites from 9.8 to 100%; the percentage 
      classified as having papilledema ranged across sites from zero to 59.5%. In the 
      validation set, the system discriminated disks with papilledema from normal disks 
      and disks with nonpapilledema abnormalities with an AUC of 0.99 (95% confidence 
      interval [CI], 0.98 to 0.99) and normal from abnormal disks with an AUC of 0.99 
      (95% CI, 0.99 to 0.99). In the external-testing data set of 1505 photographs, the 
      system had an AUC for the detection of papilledema of 0.96 (95% CI, 0.95 to 
      0.97), a sensitivity of 96.4% (95% CI, 93.9 to 98.3), and a specificity of 84.7% 
      (95% CI, 82.3 to 87.1). CONCLUSIONS: A deep-learning system using fundus 
      photographs with pharmacologically dilated pupils differentiated among optic 
      disks with papilledema, normal disks, and disks with nonpapilledema 
      abnormalities. (Funded by the Singapore National Medical Research Council and the 
      SingHealth Duke-NUS Ophthalmology and Visual Sciences Academic Clinical 
      Program.).
CI  - Copyright © 2020 Massachusetts Medical Society.
FAU - Milea, Dan
AU  - Milea D
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Najjar, Raymond P
AU  - Najjar RP
AUID- ORCID: 0000-0002-3770-2300
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Zhubo, Jiang
AU  - Zhubo J
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Ting, Daniel
AU  - Ting D
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Vasseneix, Caroline
AU  - Vasseneix C
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Xu, Xinxing
AU  - Xu X
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Aghsaei Fard, Masoud
AU  - Aghsaei Fard M
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Fonseca, Pedro
AU  - Fonseca P
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Vanikieti, Kavin
AU  - Vanikieti K
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Lagrèze, Wolf A
AU  - Lagrèze WA
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - La Morgia, Chiara
AU  - La Morgia C
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Cheung, Carol Y
AU  - Cheung CY
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Hamann, Steffen
AU  - Hamann S
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Chiquet, Christophe
AU  - Chiquet C
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Sanda, Nicolae
AU  - Sanda N
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Yang, Hui
AU  - Yang H
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Mejico, Luis J
AU  - Mejico LJ
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Rougier, Marie-Bénédicte
AU  - Rougier M-B
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Kho, Richard
AU  - Kho R
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Thi Ha Chau, Tran
AU  - Thi Ha Chau T
AUID- ORCID: 0000-0001-9066-7092
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Singhal, Shweta
AU  - Singhal S
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Gohier, Philippe
AU  - Gohier P
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Clermont-Vignal, Catherine
AU  - Clermont-Vignal C
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Cheng, Ching-Yu
AU  - Cheng C-Y
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Jonas, Jost B
AU  - Jonas JB
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Yu-Wai-Man, Patrick
AU  - Yu-Wai-Man P
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Fraser, Clare L
AU  - Fraser CL
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Chen, John J
AU  - Chen JJ
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Ambika, Selvakumar
AU  - Ambika S
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Miller, Neil R
AU  - Miller NR
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Liu, Yong
AU  - Liu Y
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Newman, Nancy J
AU  - Newman NJ
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Wong, Tien Y
AU  - Wong TY
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
FAU - Biousse, Valérie
AU  - Biousse V
AD  - From the Singapore National Eye Center (D.M., D.T., S.S., C.-Y.C., T.Y.W.), 
      Singapore Eye Research Institute (D.M., R.P.N., D.T., C.V., S.S., C.-Y.C., 
      T.Y.W.), Duke-NUS Medical School (D.M., R.P.N., D.T., S.S., C.-Y.C., T.Y.W.), 
      Institute of High Performance Computing, Agency for Science, Technology, and 
      Research (J.Z., X.X., Y.L.), and Yong Loo Lin School of Medicine, National 
      University of Singapore (S.S., T.Y.W.) - all in Singapore; Farabi Eye Hospital, 
      Tehran University of Medical Science, Tehran, Iran (M.A.F.); the Department of 
      Ophthalmology, Centro Hospitalar e Universitário de Coimbra, and the Coimbra 
      Institute for Biomedical Imaging and Translational Research, University of 
      Coimbra, Coimbra, Portugal (P.F.); the Department of Ophthalmology, Ramathibodi 
      Hospital, Mahidol University, Bangkok, Thailand (K.V.); the Eye Center, Medical 
      Center, University of Freiburg, Freiburg (W.A.L.), and the Department of 
      Ophthalmology, Ruprecht Karl University of Heidelberg, Mannheim (J.B.J.) - both 
      in Germany; IRCCS Istituto delle Scienze Neurologiche di Bologna, Unità Operativa 
      Complessa Clinica Neurologica, and Dipartimento di Scienze Biomediche e 
      Neuromotorie, Università di Bologna, Bologna, Italy (C.L.M.); the Department of 
      Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 
      (C.Y.C.), and Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 
      (H.Y.) - both in China; the Department of Ophthalmology, Rigshospitalet, 
      University of Copenhagen, Glostrup, Denmark (S.H.); the Department of 
      Ophthalmology, University Hospital of Grenoble-Alpes, and Grenoble-Alpes 
      University, HP2 Laboratory, INSERM Unité 1042, Grenoble (C.C.), Service 
      d'Ophtalmologie, Unité Rétine-Uvéites-Neuro-Ophtalmologie, Hôpital Pellegrin, 
      Centre Hospitalier Universitaire de Bordeaux, Bordeaux (M.-B.R.), the Department 
      of Ophthalmology, Lille Catholic Hospital, Lille Catholic University, and INSERM 
      Unité 1171, Lille (T.T.H.C.), the Department of Ophthalmology, University 
      Hospital Angers, Angers (P.G.), and Rothschild Foundation Hospital, Paris 
      (C.C.-V.) - all in France; the Department of Clinical Neurosciences, Geneva 
      University Hospital, Geneva (N.S.); the Department of Neurology, SUNY Upstate 
      Medical University, Syracuse, NY (L.J.M.); the American Eye Center, Mandaluyong 
      City, Philippines (R.K.); Moorfields Eye Hospital NHS Foundation Trust and UCL 
      Institute of Ophthalmology, University College London, London (P.Y.-W.-M.), and 
      Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, and 
      Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial 
      Biology Unit, Department of Clinical Neurosciences, University of Cambridge, 
      Cambridge (P.Y.-W.-M.) - all in the United Kingdom; the Save Sight Institute, 
      Faculty of Health and Medicine, University of Sydney, Sydney (C.L.F.); the 
      Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN (J.J.C.); 
      the Department of Neuro-ophthalmology, Sankara Nethralaya, Medical Research 
      Foundation, Chennai, India (S.A.); the Departments of Ophthalmology, Neurology, 
      and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore 
      (N.R.M.); and the Departments of Ophthalmology and Neurology, Emory University 
      School of Medicine, Atlanta (N.J.N., V.B.).
CN  - BONSAI Group
LA  - eng
GR  - G1002570/MRC_/Medical Research Council/United Kingdom
GR  - CIRG18Nov-0013/US/United States/United States
GR  - CIRG18Nov-0013/National Medical Research Council/International
GR  - Duke-NUS Ophthalmology and Visual Sciences Academi/US/United States/United States
GR  - Duke-NUS Ophthalmology and Visual Sciences Academi/National Medical Research 
      Council/International
GR  - G0701386/MRC_/Medical Research Council/United Kingdom
PT  - Journal Article
PT  - Multicenter Study
PT  - Research Support, Non-U.S. Gov't
PT  - Validation Study
DEP - 20200414
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
SB  - IM
CIN - N Engl J Med. 2020 Apr 30;382(18):1760-1761. PMID: 32286747
MH  - Algorithms
MH  - Area Under Curve
MH  - Datasets as Topic
MH  - *Deep Learning
MH  - Diagnosis, Differential
MH  - *Fundus Oculi
MH  - Humans
MH  - *Neural Networks, Computer
MH  - Ophthalmoscopy/*methods
MH  - Papilledema/*diagnosis
MH  - *Photography
MH  - Predictive Value of Tests
MH  - ROC Curve
MH  - Retina/*diagnostic imaging/pathology
MH  - Retrospective Studies
MH  - Sensitivity and Specificity
FIR - Milea, Dan
IR  - Milea D
FIR - Biousse, Valérie
IR  - Biousse V
FIR - Newman, Nancy J
IR  - Newman NJ
FIR - Najjar, Raymond P
IR  - Najjar RP
FIR - Wong, Tien Y
IR  - Wong TY
FIR - Ting, Daniel
IR  - Ting D
FIR - Liu, Yong
IR  - Liu Y
FIR - Gohier, Philippe
IR  - Gohier P
FIR - Rondet-Courbis, Barnabé
IR  - Rondet-Courbis B
FIR - Vasseneix, Caroline
IR  - Vasseneix C
FIR - Miller, Neil
IR  - Miller N
FIR - Padungkiatsagul, Tanyatuth
IR  - Padungkiatsagul T
FIR - Poonyathalang, Anuchit
IR  - Poonyathalang A
FIR - Suwan, Yanin
IR  - Suwan Y
FIR - Vanikieti, Kavin
IR  - Vanikieti K
FIR - Amore, Giulia
IR  - Amore G
FIR - Barboni, Piero
IR  - Barboni P
FIR - Carbonelli, Michele
IR  - Carbonelli M
FIR - Carelli, Valerio
IR  - Carelli V
FIR - La Morgia, Chiara
IR  - La Morgia C
FIR - Romagnoli, Martina
IR  - Romagnoli M
FIR - Rougier, Marie-Bénédicte
IR  - Rougier M-B
FIR - Ambika, Selvakumar
IR  - Ambika S
FIR - Komma, Swetha
IR  - Komma S
FIR - Fonseca, Pedro
IR  - Fonseca P
FIR - Raimundo, Miguel
IR  - Raimundo M
FIR - Hamann, Steffen
IR  - Hamann S
FIR - Karlesand, Isabelle
IR  - Karlesand I
FIR - Fuhrmann, Lars
IR  - Fuhrmann L
FIR - Küchlin, Sebastian
IR  - Küchlin S
FIR - Lagrèze, Wolf Alexander
IR  - Lagrèze WA
FIR - Sanda, Nicolae
IR  - Sanda N
FIR - Thumann, Gabriele
IR  - Thumann G
FIR - Aptel, Florent
IR  - Aptel F
FIR - Chiquet, Christophe
IR  - Chiquet C
FIR - Liu, Kaiqun
IR  - Liu K
FIR - Yang, Hui
IR  - Yang H
FIR - Chan, Carmen K M
IR  - Chan CKM
FIR - Chan, Noel C Y
IR  - Chan NCY
FIR - Cheung, Carol Y
IR  - Cheung CY
FIR - Tran, Thi Ha Chau
IR  - Tran THC
FIR - Acheson, James
IR  - Acheson J
FIR - Habib, Maged S
IR  - Habib MS
FIR - Jurkute, Neringa
IR  - Jurkute N
FIR - Yu-Wai-Man, Patrick
IR  - Yu-Wai-Man P
FIR - Kho, Richard
IR  - Kho R
FIR - Jonas, Jost B
IR  - Jonas JB
FIR - Chen, John J
IR  - Chen JJ
FIR - Sabbagh, Nouran
IR  - Sabbagh N
FIR - Vignal-Clermont, Catherine
IR  - Vignal-Clermont C
FIR - Hage, Rabih
IR  - Hage R
FIR - Khanna, Raoul Kanav
IR  - Khanna RK
FIR - Aung, Tin
IR  - Aung T
FIR - Cheng, Ching-Yu
IR  - Cheng C-Y
FIR - Lamoureux, Ecosse
IR  - Lamoureux E
FIR - Loo, Jing Liang
IR  - Loo JL
FIR - Schmetterer, Leopold
IR  - Schmetterer L
FIR - Singhal, Shweta
IR  - Singhal S
FIR - Tow, Sharon
IR  - Tow S
FIR - Xu, Xinxing
IR  - Xu X
FIR - Jiang, Zhubo
IR  - Jiang Z
FIR - Fraser, Clare L
IR  - Fraser CL
FIR - Mejico, Luis J
IR  - Mejico LJ
FIR - Orenberg, Andrew L
IR  - Orenberg AL
FIR - Aghsaei Fard, Masoud
IR  - Aghsaei Fard M
EDAT- 2020/04/15 06:00
MHDA- 2020/05/13 06:00
CRDT- 2020/04/15 06:00
PHST- 2020/04/15 06:00 [pubmed]
PHST- 2020/05/13 06:00 [medline]
PHST- 2020/04/15 06:00 [entrez]
AID - 10.1056/NEJMoa1917130 [doi]
PST - ppublish
SO  - N Engl J Med. 2020 Apr 30;382(18):1687-1695. doi: 10.1056/NEJMoa1917130. Epub 
      2020 Apr 14.

PMID- 31770722
OWN - NLM
STAT- MEDLINE
DCOM- 20201005
LR  - 20210327
IS  - 1945-4589 (Electronic)
IS  - 1945-4589 (Linking)
VI  - 11
IP  - 22
DP  - 2019 Nov 21
TI  - Latest advances in aging research and drug discovery.
PG  - 9971-9981
LID - 10.18632/aging.102487 [doi]
AB  - An increasing aging population poses a significant challenge to societies 
      worldwide. A better understanding of the molecular, cellular, organ, tissue, 
      physiological, psychological, and even sociological changes that occur with aging 
      is needed in order to treat age-associated diseases. The field of aging research 
      is rapidly expanding with multiple advances transpiring in many previously 
      disconnected areas. Several major pharmaceutical, biotechnology, and consumer 
      companies made aging research a priority and are building internal expertise, 
      integrating aging research into traditional business models and exploring new 
      go-to-market strategies. Many of these efforts are spearheaded by the latest 
      advances in artificial intelligence, namely deep learning, including generative 
      and reinforcement learning. To facilitate these trends, the Center for Healthy 
      Aging at the University of Copenhagen and Insilico Medicine are building a 
      community of Key Opinion Leaders (KOLs) in these areas and launched the annual 
      conference series titled "Aging Research and Drug Discovery (ARDD)" held in the 
      capital of the pharmaceutical industry, Basel, Switzerland (www.agingpharma.org). 
      This ARDD collection contains summaries from the 6(th) annual meeting that 
      explored aging mechanisms and new interventions in age-associated diseases. The 
      7(th) annual ARDD exhibition will transpire 2(nd)-4(th) of September, 2020, in 
      Basel.
FAU - Bakula, Daniela
AU  - Bakula D
AD  - Center for Healthy Aging, Department of Cellular and Molecular Medicine, 
      University of Copenhagen, Copenhagen, Denmark.
FAU - Ablasser, Andrea
AU  - Ablasser A
AD  - Global Health Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), 
      Lausanne, Switzerland.
FAU - Aguzzi, Adriano
AU  - Aguzzi A
AD  - Institute of Neuropathology, University of Zurich, Zurich, Switzerland.
FAU - Antebi, Adam
AU  - Antebi A
AD  - Max Planck Institute for Biology of Ageing, Cologne, Germany.
AD  - Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated 
      Diseases (CECAD), University of Cologne, Cologne, Germany.
FAU - Barzilai, Nir
AU  - Barzilai N
AD  - Department of Medicine, Institute for Aging Research, Albert Einstein College of 
      Medicine, Bronx, NY 10461, USA.
FAU - Bittner, Martin-Immanuel
AU  - Bittner MI
AD  - Arctoris, Oxford, UK.
FAU - Jensen, Martin Borch
AU  - Jensen MB
AD  - Gordian Biotechnology, San Francisco, CA 94107, USA.
FAU - Calkhoven, Cornelis F
AU  - Calkhoven CF
AD  - European Research Institute for the Biology of Ageing (ERIBA), University Medical 
      Center Groningen, University of Groningen, AD Groningen, The Netherlands.
FAU - Chen, Danica
AU  - Chen D
AD  - Program in Metabolic Biology, Nutritional Sciences and Toxicology, University of 
      California, Berkeley, CA 94720, USA.
FAU - Grey, Aubrey D N J de
AU  - Grey ADNJ
AD  - SENS Research Foundation, Mountain View, CA 94041, USA.
FAU - Feige, Jerome N
AU  - Feige JN
AD  - Nestlé Research, EPFL Innovation Park, Lausanne, Switzerland.
AD  - School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 
      Lausanne, Switzerland.
FAU - Georgievskaya, Anastasia
AU  - Georgievskaya A
AD  - Haut.AI, Tallinn, Estonia.
FAU - Gladyshev, Vadim N
AU  - Gladyshev VN
AD  - Division of Genetics, Department of Medicine, Brigham and Women's Hospital, 
      Harvard Medical School, Boston, MA 02115, USA.
FAU - Golato, Tyler
AU  - Golato T
AD  - Molecule, Basel, Switzerland.
FAU - Gudkov, Andrei V
AU  - Gudkov AV
AD  - Roswell Park Comprehensive Cancer Center and Genome Protection, Inc., Buffalo, NY 
      14203, USA.
FAU - Hoppe, Thorsten
AU  - Hoppe T
AD  - Institute for Genetics and CECAD Research Center, University of Cologne, Cologne, 
      Germany.
FAU - Kaeberlein, Matt
AU  - Kaeberlein M
AD  - Department of Pathology, School of Medicine, University of Washington, Seattle, 
      WA 98195, USA.
AD  - Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
FAU - Katajisto, Pekka
AU  - Katajisto P
AD  - Department of Biosciences and Nutrition, Center for Innovative Medicine, 
      Karolinska Institutet, Huddinge, Sweden.
AD  - Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
FAU - Kennedy, Brian K
AU  - Kennedy BK
AD  - Departments of Biochemistry and Physiology, Yong Loo Lin School of Medicine, 
      National University Singapore, Singapore.
AD  - Centre for Healthy Ageing, National University Healthy System, Singapore.
AD  - Buck Institute for Research on Aging, Novato, CA 94945, USA.
FAU - Lal, Unmesh
AU  - Lal U
AD  - Frost and Sullivan, Frankfurt am Main, Germany.
FAU - Martin-Villalba, Ana
AU  - Martin-Villalba A
AD  - Molecular Neurobiology, German Cancer Research Center, Heidelberg, Germany.
FAU - Moskalev, Alexey A
AU  - Moskalev AA
AD  - Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 
      Russia.
AD  - Institute of Biology of Komi Science Center of Ural Branch of RAS, Syktyvkar, 
      Russia.
AD  - Moscow Institute of Physics and Technology, Dolgoprudny, Russia.
FAU - Ozerov, Ivan
AU  - Ozerov I
AD  - Pharmaceutical Artificial Intelligence Department, Insilico Medicine, Inc., 
      Rockville, MD 20850, USA.
FAU - Petr, Michael A
AU  - Petr MA
AD  - Center for Healthy Aging, Department of Cellular and Molecular Medicine, 
      University of Copenhagen, Copenhagen, Denmark.
FAU - Reason
AU  - Reason
AD  - Repair Biotechnologies, Inc., Syracuse, NY 13210, USA.
FAU - Rubinsztein, David C
AU  - Rubinsztein DC
AD  - Department of Medical Genetics, Cambridge Institute for Medical Research, The 
      Keith Peters Building, Cambridge CB2 0XY, UK.
AD  - UK Dementia Research Institute, The Keith Peters Building, Cambridge Biomedical 
      Campus, Cambridge, UK.
FAU - Tyshkovskiy, Alexander
AU  - Tyshkovskiy A
AD  - Division of Genetics, Department of Medicine, Brigham and Women's Hospital, 
      Harvard Medical School, Boston, MA 02115, USA.
AD  - Belozersky Institute of Physico-Chemical Biology, Moscow State University, 
      Moscow, Russia.
FAU - Vanhaelen, Quentin
AU  - Vanhaelen Q
AD  - Pharmaceutical Artificial Intelligence Department, Insilico Medicine, Inc., 
      Rockville, MD 20850, USA.
FAU - Zhavoronkov, Alex
AU  - Zhavoronkov A
AD  - Pharmaceutical Artificial Intelligence Department, Insilico Medicine, Inc., 
      Rockville, MD 20850, USA.
FAU - Scheibye-Knudsen, Morten
AU  - Scheibye-Knudsen M
AD  - Center for Healthy Aging, Department of Cellular and Molecular Medicine, 
      University of Copenhagen, Copenhagen, Denmark.
LA  - eng
GR  - R01 DK101885/DK/NIDDK NIH HHS/United States
GR  - P01 AG001751/AG/NIA NIH HHS/United States
GR  - P30 AG013280/AG/NIA NIH HHS/United States
GR  - UKDRI-2002/MRC_/Medical Research Council/United Kingdom
GR  - R01 AG063389/AG/NIA NIH HHS/United States
GR  - R01 AG063404/AG/NIA NIH HHS/United States
GR  - R01 DK117481/DK/NIDDK NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20191121
PL  - United States
TA  - Aging (Albany NY)
JT  - Aging
JID - 101508617
SB  - IM
MH  - *Aging
MH  - *Drug Discovery
MH  - Drug Industry
MH  - Humans
MH  - *Research
PMC - PMC6914421
OTO - NOTNLM
OT  - aging
OT  - artificial intelligence
OT  - drug discovery
COIS- CONFLICTS OF INTEREST: The authors declare no conflicts of interest.
EDAT- 2019/11/27 06:00
MHDA- 2020/10/06 06:00
CRDT- 2019/11/27 06:00
PHST- 2019/10/30 00:00 [received]
PHST- 2019/11/09 00:00 [accepted]
PHST- 2019/11/27 06:00 [pubmed]
PHST- 2020/10/06 06:00 [medline]
PHST- 2019/11/27 06:00 [entrez]
AID - 102487 [pii]
AID - 10.18632/aging.102487 [doi]
PST - ppublish
SO  - Aging (Albany NY). 2019 Nov 21;11(22):9971-9981. doi: 10.18632/aging.102487. Epub 
      2019 Nov 21.

PMID- 36700642
OWN - NLM
STAT- MEDLINE
DCOM- 20230302
LR  - 20231201
IS  - 2150-7511 (Electronic)
VI  - 14
IP  - 1
DP  - 2023 Feb 28
TI  - Virology under the Microscope-a Call for Rational Discourse.
PG  - e0018823
LID - 10.1128/mbio.00188-23 [doi]
LID - e00188-23
AB  - Viruses have brought humanity many challenges: respiratory infection, cancer, 
      neurological impairment and immunosuppression to name a few. Virology research 
      over the last 60+ years has responded to reduce this disease burden with vaccines 
      and antivirals. Despite this long history, the COVID-19 pandemic has brought 
      unprecedented attention to the field of virology. Some of this attention is 
      focused on concern about the safe conduct of research with human pathogens. A 
      small but vocal group of individuals has seized upon these concerns - conflating 
      legitimate questions about safely conducting virus-related research with 
      uncertainties over the origins of SARS-CoV-2. The result has fueled public 
      confusion and, in many instances, ill-informed condemnation of virology. With 
      this article, we seek to promote a return to rational discourse. We explain the 
      use of gain-of-function approaches in science, discuss the possible origins of 
      SARS-CoV-2 and outline current regulatory structures that provide oversight for 
      virological research in the United States. By offering our expertise, we - a 
      broad group of working virologists - seek to aid policy makers in navigating 
      these controversial issues. Balanced, evidence-based discourse is essential to 
      addressing public concern while maintaining and expanding much-needed research in 
      virology.
FAU - Goodrum, Felicia
AU  - Goodrum F
AUID- ORCID: 0000-0002-6646-7290
AD  - Department of Immunobiology, BIO5 Institute, University of Arizona, Tucson, 
      Arizona, USA.
FAU - Lowen, Anice C
AU  - Lowen AC
AUID- ORCID: 0000-0002-9829-112X
AD  - Department of Microbiology and Immunology, Emory University School of Medicine, 
      Atlanta, Georgia, USA.
FAU - Lakdawala, Seema
AU  - Lakdawala S
AUID- ORCID: 0000-0002-7679-2150
AD  - Department of Microbiology and Immunology, Emory University School of Medicine, 
      Atlanta, Georgia, USA.
FAU - Alwine, James
AU  - Alwine J
AD  - Department of Immunobiology, BIO5 Institute, University of Arizona, Tucson, 
      Arizona, USA.
AD  - Department of Cancer Biology, University of Pennsylvania, Philadelphia, 
      Pennsylvania, USA.
FAU - Casadevall, Arturo
AU  - Casadevall A
AUID- ORCID: 0000-0002-9402-9167
AD  - Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg 
      School of Public Health, Baltimore, Maryland, USA.
FAU - Imperiale, Michael J
AU  - Imperiale MJ
AD  - Department of Microbiology and Immunology, University of Michigan, Ann Arbor, 
      Michigan, USA.
FAU - Atwood, Walter
AU  - Atwood W
AUID- ORCID: 0000-0002-3763-9073
AD  - Brown University, Providence, Rhode Island, USA.
FAU - Avgousti, Daphne
AU  - Avgousti D
AD  - Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
FAU - Baines, Joel
AU  - Baines J
AUID- ORCID: 0000-0002-6397-2830
AD  - Cornell University, Ithaca, New York, USA.
FAU - Banfield, Bruce
AU  - Banfield B
AUID- ORCID: 0000-0002-5989-6695
AD  - Queen's University, Kingston, Ontario, Canada.
FAU - Banks, Lawrence
AU  - Banks L
AD  - International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
FAU - Bhaduri-McIntosh, Sumita
AU  - Bhaduri-McIntosh S
AUID- ORCID: 0000-0003-2946-9497
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Bhattacharya, Deepta
AU  - Bhattacharya D
AD  - University of Arizona, Tucson, Arizona, USA.
FAU - Blanco-Melo, Daniel
AU  - Blanco-Melo D
AD  - Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
FAU - Bloom, David
AU  - Bloom D
AUID- ORCID: 0000-0001-5935-8494
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Boon, Adrianus
AU  - Boon A
AUID- ORCID: 0000-0002-4700-8224
AD  - University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
FAU - Boulant, Steeve
AU  - Boulant S
AUID- ORCID: 0000-0001-8614-4993
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Brandt, Curtis
AU  - Brandt C
AD  - University of Wisconsin-Madison, Madison, Wisconsin, USA.
FAU - Broadbent, Andrew
AU  - Broadbent A
AUID- ORCID: 0000-0002-4716-1835
AD  - University of Maryland, College Park, Maryland, USA.
FAU - Brooke, Christopher
AU  - Brooke C
AUID- ORCID: 0000-0002-6815-1193
AD  - University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
FAU - Cameron, Craig
AU  - Cameron C
AD  - University of North Carolina, Chapel Hill, North Carolina, USA.
FAU - Campos, Samuel
AU  - Campos S
AUID- ORCID: 0000-0003-1540-9821
AD  - University of Arizona, Tucson, Arizona, USA.
FAU - Caposio, Patrizia
AU  - Caposio P
AUID- ORCID: 0000-0001-7579-849X
AD  - Oregon Health and Science University, Beaverton, Oregon, USA.
FAU - Chan, Gary
AU  - Chan G
AUID- ORCID: 0000-0001-8209-9777
AD  - SUNY Upstate Medical University, Syracuse, New York, USA.
FAU - Cliffe, Anna
AU  - Cliffe A
AUID- ORCID: 0000-0003-1136-5171
AD  - University of Virginia, Charlottesville, Virginia, USA.
FAU - Coffin, John
AU  - Coffin J
AD  - Tufts University, Boston, Massachusetts, USA.
FAU - Collins, Kathleen
AU  - Collins K
AD  - University of Michigan, Ann Arbor, Michigan, USA.
FAU - Damania, Blossom
AU  - Damania B
AUID- ORCID: 0000-0002-9205-1774
AD  - University of North Carolina, Chapel Hill, North Carolina, USA.
FAU - Daugherty, Matthew
AU  - Daugherty M
AD  - University of California, San Diego, La Jolla, California, USA.
FAU - Debbink, Kari
AU  - Debbink K
AD  - Johns Hopkins University, Baltimore, Maryland, USA.
FAU - DeCaprio, James
AU  - DeCaprio J
AUID- ORCID: 0000-0002-0896-167X
AD  - Harvard Medical School, Boston, Massachusetts, USA.
FAU - Dermody, Terence
AU  - Dermody T
AUID- ORCID: 0000-0003-1853-8741
AD  - University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
FAU - Dikeakos, Jimmy
AU  - Dikeakos J
AUID- ORCID: 0000-0001-8141-5395
AD  - Western University, London, Ontario, Canada.
FAU - DiMaio, Daniel
AU  - DiMaio D
AUID- ORCID: 0000-0002-2060-5977
AD  - Yale University, New Haven, Connecticut, USA.
FAU - Dinglasan, Rhoel
AU  - Dinglasan R
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Duprex, W Paul
AU  - Duprex WP
AUID- ORCID: 0000-0003-1716-6376
AD  - University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
FAU - Dutch, Rebecca
AU  - Dutch R
AUID- ORCID: 0000-0002-5220-8247
AD  - University of Kentucky, Lexington, Kentucky, USA.
FAU - Elde, Nels
AU  - Elde N
AD  - University of Utah, Salt Lake City, Utah, USA.
FAU - Emerman, Michael
AU  - Emerman M
AUID- ORCID: 0000-0002-4181-6335
AD  - Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
FAU - Enquist, Lynn
AU  - Enquist L
AUID- ORCID: 0000-0001-9968-8586
AD  - Princeton University, Princeton, New Jersey, USA.
FAU - Fane, Bentley
AU  - Fane B
AUID- ORCID: 0000-0002-3984-1726
AD  - University of Arizona, Tucson, Arizona, USA.
FAU - Fernandez-Sesma, Ana
AU  - Fernandez-Sesma A
AD  - Icahn School of Medicine at Mount Sinai, New York, New York, USA.
FAU - Flenniken, Michelle
AU  - Flenniken M
AD  - Montana State University, Bozeman, Montana, USA.
FAU - Frappier, Lori
AU  - Frappier L
AUID- ORCID: 0000-0003-0110-5472
AD  - University of Toronto, Toronto, Ontario, Canada.
FAU - Frieman, Matthew
AU  - Frieman M
AUID- ORCID: 0000-0003-0107-0775
AD  - University of Maryland, College Park, Maryland, USA.
FAU - Frueh, Klaus
AU  - Frueh K
AD  - Oregon Health and Science University, Beaverton, Oregon, USA.
FAU - Gack, Michaela
AU  - Gack M
AUID- ORCID: 0000-0002-2163-2598
AD  - Florida Research and Innovation Center, Port Saint Lucie, Florida, USA.
FAU - Gaglia, Marta
AU  - Gaglia M
AUID- ORCID: 0000-0002-1791-0663
AD  - University of Wisconsin-Madison, Madison, Wisconsin, USA.
FAU - Gallagher, Tom
AU  - Gallagher T
AUID- ORCID: 0000-0002-8601-5961
AD  - Loyola University, Maywood, Illinois, USA.
FAU - Galloway, Denise
AU  - Galloway D
AD  - Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
FAU - García-Sastre, Adolfo
AU  - García-Sastre A
AUID- ORCID: 0000-0002-6551-1827
AD  - Icahn School of Medicine at Mount Sinai, New York, New York, USA.
FAU - Geballe, Adam
AU  - Geballe A
AUID- ORCID: 0000-0002-9279-6653
AD  - Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
FAU - Glaunsinger, Britt
AU  - Glaunsinger B
AUID- ORCID: 0000-0003-0479-9377
AD  - University of California, Berkeley, Berkeley, California, USA.
FAU - Goff, Stephen
AU  - Goff S
AUID- ORCID: 0000-0002-9679-0582
AD  - Columbia University, New York, New York, USA.
FAU - Greninger, Alexander
AU  - Greninger A
AUID- ORCID: 0000-0002-7443-0527
AD  - University of Washington, Seattle, Washington, USA.
FAU - Hancock, Meaghan
AU  - Hancock M
AUID- ORCID: 0000-0003-2945-0147
AD  - Oregon Health and Science University, Beaverton, Oregon, USA.
FAU - Harris, Eva
AU  - Harris E
AUID- ORCID: 0000-0002-7238-4037
AD  - University of California, Berkeley, Berkeley, California, USA.
FAU - Heaton, Nicholas
AU  - Heaton N
AUID- ORCID: 0000-0002-5307-3428
AD  - Duke University, Durham, North Carolina, USA.
FAU - Heise, Mark
AU  - Heise M
AUID- ORCID: 0000-0001-5829-8477
AD  - University of North Carolina, Chapel Hill, North Carolina, USA.
FAU - Heldwein, Ekaterina
AU  - Heldwein E
AUID- ORCID: 0000-0003-3113-6958
AD  - Tufts University, Boston, Massachusetts, USA.
FAU - Hogue, Brenda
AU  - Hogue B
AD  - Arizona State University, Tempe, Arizona, USA.
FAU - Horner, Stacy
AU  - Horner S
AUID- ORCID: 0000-0002-9351-7409
AD  - Duke University, Durham, North Carolina, USA.
FAU - Hutchinson, Edward
AU  - Hutchinson E
AD  - MRC-University of Glasgow, Glasgow, United Kingdom.
FAU - Hyser, Joseph
AU  - Hyser J
AD  - Baylor University, Houston, Texas, USA.
FAU - Jackson, William
AU  - Jackson W
AUID- ORCID: 0000-0002-9832-0584
AD  - Arizona State University, Tempe, Arizona, USA.
FAU - Kalejta, Robert
AU  - Kalejta R
AUID- ORCID: 0000-0002-7116-3355
AD  - Duke University, Durham, North Carolina, USA.
FAU - Kamil, Jeremy
AU  - Kamil J
AUID- ORCID: 0000-0001-8422-7656
AD  - Louisiana State University, Shreveport, Louisiana, USA.
FAU - Karst, Stephanie
AU  - Karst S
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Kirchhoff, Frank
AU  - Kirchhoff F
AUID- ORCID: 0000-0002-7052-2360
AD  - Ulm University, Ulm, Germany.
FAU - Knipe, David
AU  - Knipe D
AUID- ORCID: 0000-0003-1554-6236
AD  - Harvard Medical School, Boston, Massachusetts, USA.
FAU - Kowalik, Timothy
AU  - Kowalik T
AD  - University of Massachusetts, Worcester, Massachusetts, USA.
FAU - Lagunoff, Michael
AU  - Lagunoff M
AD  - University of Washington, Seattle, Washington, USA.
FAU - Laimins, Laimonis
AU  - Laimins L
AUID- ORCID: 0000-0002-6314-623X
AD  - Northwestern University, Chicago, Illinois, USA.
FAU - Langlois, Ryan
AU  - Langlois R
AD  - University of Minnesota, Minneapolis, Minnesota, USA.
FAU - Lauring, Adam
AU  - Lauring A
AD  - University of Michigan, Ann Arbor, Michigan, USA.
FAU - Lee, Benhur
AU  - Lee B
AUID- ORCID: 0000-0003-0760-1709
AD  - Icahn School of Medicine at Mount Sinai, New York, New York, USA.
FAU - Leib, David
AU  - Leib D
AD  - Dartmouth College, Lebanon, New Hampshire, USA.
FAU - Liu, Shan-Lu
AU  - Liu SL
AUID- ORCID: 0000-0003-1620-3817
AD  - The Ohio State University, Columbus, Ohio, USA.
FAU - Longnecker, Richard
AU  - Longnecker R
AUID- ORCID: 0000-0001-7175-6217
AD  - Northwestern University, Chicago, Illinois, USA.
FAU - Lopez, Carolina
AU  - Lopez C
AUID- ORCID: 0000-0002-7669-6572
AD  - Washington University, St. Louis, Missouri, USA.
FAU - Luftig, Micah
AU  - Luftig M
AUID- ORCID: 0000-0002-2964-1907
AD  - Duke University, Durham, North Carolina, USA.
FAU - Lund, Jennifer
AU  - Lund J
AUID- ORCID: 0000-0003-3284-979X
AD  - Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
FAU - Manicassamy, Balaji
AU  - Manicassamy B
AUID- ORCID: 0000-0003-1964-0967
AD  - University of Iowa, Iowa City, Iowa, USA.
FAU - McFadden, Grant
AU  - McFadden G
AUID- ORCID: 0000-0002-2556-3526
AD  - Arizona State University, Tempe, Arizona, USA.
FAU - McIntosh, Michael
AU  - McIntosh M
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Mehle, Andrew
AU  - Mehle A
AUID- ORCID: 0000-0001-6060-4330
AD  - University of Wisconsin-Madison, Madison, Wisconsin, USA.
FAU - Miller, W Allen
AU  - Miller WA
AUID- ORCID: 0000-0003-0603-2751
AD  - Iowa State University, Ames, Iowa, USA.
FAU - Mohr, Ian
AU  - Mohr I
AD  - New York University, New York, New York, USA.
FAU - Moody, Cary
AU  - Moody C
AUID- ORCID: 0000-0002-1991-0640
AD  - University of North Carolina, Chapel Hill, North Carolina, USA.
FAU - Moorman, Nathaniel
AU  - Moorman N
AD  - University of North Carolina, Chapel Hill, North Carolina, USA.
FAU - Moscona, Anne
AU  - Moscona A
AUID- ORCID: 0000-0002-1796-8320
AD  - Columbia University, New York, New York, USA.
FAU - Mounce, Bryan
AU  - Mounce B
AUID- ORCID: 0000-0003-1710-5362
AD  - Loyola University, Maywood, Illinois, USA.
FAU - Munger, Joshua
AU  - Munger J
AUID- ORCID: 0000-0001-5379-9440
AD  - University of Rochester, Rochester, New York, USA.
FAU - Münger, Karl
AU  - Münger K
AD  - Tufts University, Boston, Massachusetts, USA.
FAU - Murphy, Eain
AU  - Murphy E
AUID- ORCID: 0000-0003-3449-5024
AD  - SUNY Upstate Medical University, Syracuse, New York, USA.
FAU - Naghavi, Mojgan
AU  - Naghavi M
AD  - Northwestern University, Chicago, Illinois, USA.
FAU - Nelson, Jay
AU  - Nelson J
AD  - Oregon Health and Science University, Beaverton, Oregon, USA.
FAU - Neufeldt, Christopher
AU  - Neufeldt C
AD  - Emory University, Atlanta, Georgia, USA.
FAU - Nikolich, Janko
AU  - Nikolich J
AD  - University of Arizona, Tucson, Arizona, USA.
FAU - O'Connor, Christine
AU  - O'Connor C
AUID- ORCID: 0000-0003-4943-3774
AD  - Cleveland Clinic, Cleveland, Ohio, USA.
FAU - Ono, Akira
AU  - Ono A
AUID- ORCID: 0000-0001-7841-851X
AD  - University of Michigan, Ann Arbor, Michigan, USA.
FAU - Orenstein, Walter
AU  - Orenstein W
AD  - Emory University, Atlanta, Georgia, USA.
FAU - Ornelles, David
AU  - Ornelles D
AD  - Wake Forest University, Winston-Salem, North Carolina, USA.
FAU - Ou, Jing-Hsiung
AU  - Ou JH
AUID- ORCID: 0000-0002-8274-5705
AD  - University of Southern California, Los Angeles, California, USA.
FAU - Parker, John
AU  - Parker J
AUID- ORCID: 0000-0003-4487-4175
AD  - Cornell University, Ithaca, New York, USA.
FAU - Parrish, Colin
AU  - Parrish C
AUID- ORCID: 0000-0002-1836-6655
AD  - Cornell University, Ithaca, New York, USA.
FAU - Pekosz, Andrew
AU  - Pekosz A
AUID- ORCID: 0000-0003-3248-1761
AD  - Johns Hopkins University, Baltimore, Maryland, USA.
FAU - Pellett, Philip
AU  - Pellett P
AUID- ORCID: 0000-0002-8536-8343
AD  - Wayne State University, Detroit, Michigan, USA.
FAU - Pfeiffer, Julie
AU  - Pfeiffer J
AUID- ORCID: 0000-0003-2973-4895
AD  - University of Texas, Dallas, Texas, USA.
FAU - Plemper, Richard
AU  - Plemper R
AD  - Georgia State University, Atlanta, Georgia, USA.
FAU - Polyak, Stephen
AU  - Polyak S
AUID- ORCID: 0000-0001-7475-9827
AD  - University of Washington, Seattle, Washington, USA.
FAU - Purdy, John
AU  - Purdy J
AUID- ORCID: 0000-0001-7460-7567
AD  - University of Arizona, Tucson, Arizona, USA.
FAU - Pyeon, Dohun
AU  - Pyeon D
AUID- ORCID: 0000-0003-1970-844X
AD  - Michigan State University, East Lansing, Michigan, USA.
FAU - Quinones-Mateu, Miguel
AU  - Quinones-Mateu M
AD  - Western University, London, Ontario, Canada.
FAU - Renne, Rolf
AU  - Renne R
AUID- ORCID: 0000-0001-7391-8806
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Rice, Charles
AU  - Rice C
AD  - The Rockefeller University, New York, New York, USA.
FAU - Schoggins, John
AU  - Schoggins J
AUID- ORCID: 0000-0002-7944-6800
AD  - University of Texas, Dallas, Texas, USA.
FAU - Roller, Richard
AU  - Roller R
AUID- ORCID: 0000-0001-8340-3224
AD  - University of Iowa, Iowa City, Iowa, USA.
FAU - Russell, Charles
AU  - Russell C
AUID- ORCID: 0000-0001-5683-3990
AD  - St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
FAU - Sandri-Goldin, Rozanne
AU  - Sandri-Goldin R
AD  - University of California, Irvine, Irvine, California, USA.
FAU - Sapp, Martin
AU  - Sapp M
AUID- ORCID: 0000-0003-3916-8890
AD  - Louisiana State University, Shreveport, Louisiana, USA.
FAU - Schang, Luis
AU  - Schang L
AUID- ORCID: 0000-0002-5789-8590
AD  - Cornell University, Ithaca, New York, USA.
FAU - Schmid, Scott
AU  - Schmid S
AD  - University of Colorado, Boulder, Colorado, USA.
FAU - Schultz-Cherry, Stacey
AU  - Schultz-Cherry S
AUID- ORCID: 0000-0002-2021-727X
AD  - St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
FAU - Semler, Bert
AU  - Semler B
AUID- ORCID: 0000-0002-2424-5155
AD  - University of California, Irvine, Irvine, California, USA.
FAU - Shenk, Thomas
AU  - Shenk T
AD  - Princeton University, Princeton, New Jersey, USA.
FAU - Silvestri, Guido
AU  - Silvestri G
AD  - University of Kentucky, Lexington, Kentucky, USA.
FAU - Simon, Viviana
AU  - Simon V
AD  - Icahn School of Medicine at Mount Sinai, New York, New York, USA.
FAU - Smith, Gregory
AU  - Smith G
AUID- ORCID: 0000-0001-9644-8472
AD  - Northwestern University, Chicago, Illinois, USA.
FAU - Smith, Jason
AU  - Smith J
AUID- ORCID: 0000-0001-6727-5269
AD  - University of Washington, Seattle, Washington, USA.
FAU - Spindler, Katherine
AU  - Spindler K
AUID- ORCID: 0000-0002-9829-6051
AD  - University of Minnesota, Minneapolis, Minnesota, USA.
FAU - Stanifer, Megan
AU  - Stanifer M
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Subbarao, Kanta
AU  - Subbarao K
AUID- ORCID: 0000-0003-1713-3056
AD  - The Peter Doherty Institute, Melbourne, Victoria, Australia.
FAU - Sundquist, Wesley
AU  - Sundquist W
AD  - University of Utah, Salt Lake City, Utah, USA.
FAU - Suthar, Mehul
AU  - Suthar M
AUID- ORCID: 0000-0002-2686-8380
AD  - Emory University, Atlanta, Georgia, USA.
FAU - Sutton, Troy
AU  - Sutton T
AUID- ORCID: 0000-0002-7880-4784
AD  - The Pennsylvania State University, University Park, Pennsylvania, USA.
FAU - Tai, Andrew
AU  - Tai A
AUID- ORCID: 0000-0002-6877-450X
AD  - University of Michigan, Ann Arbor, Michigan, USA.
FAU - Tarakanova, Vera
AU  - Tarakanova V
AUID- ORCID: 0000-0002-9499-088X
AD  - Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
FAU - tenOever, Benjamin
AU  - tenOever B
AUID- ORCID: 0000-0003-0324-3078
AD  - New York University, New York, New York, USA.
FAU - Tibbetts, Scott
AU  - Tibbetts S
AUID- ORCID: 0000-0001-8889-1642
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Tompkins, Stephen
AU  - Tompkins S
AUID- ORCID: 0000-0002-1523-5588
AD  - University of Georgia, Athens, Georgia, USA.
FAU - Toth, Zsolt
AU  - Toth Z
AUID- ORCID: 0000-0001-6628-3945
AD  - University of Florida, Gainesville, Florida, USA.
FAU - van Doorslaer, Koenraad
AU  - van Doorslaer K
AUID- ORCID: 0000-0002-2985-0733
AD  - University of Arizona, Tucson, Arizona, USA.
FAU - Vignuzzi, Marco
AU  - Vignuzzi M
AD  - A*STAR Infectious Diseases Labs, Singapore.
FAU - Wallace, Nicholas
AU  - Wallace N
AUID- ORCID: 0000-0002-3971-716X
AD  - Kansas State University, Manhattan, Kansas, USA.
FAU - Walsh, Derek
AU  - Walsh D
AUID- ORCID: 0000-0002-8756-4655
AD  - Northwestern University, Chicago, Illinois, USA.
FAU - Weekes, Michael
AU  - Weekes M
AD  - University of Cambridge, Cambridge, United Kingdom.
FAU - Weinberg, Jason
AU  - Weinberg J
AUID- ORCID: 0000-0002-4768-4361
AD  - University of Michigan, Ann Arbor, Michigan, USA.
FAU - Weitzman, Matthew
AU  - Weitzman M
AUID- ORCID: 0000-0001-9713-167X
AD  - University of Pennsylvania, Philadelphia, Pennsylvania, USA.
FAU - Weller, Sandra
AU  - Weller S
AUID- ORCID: 0000-0002-4519-6276
AD  - University of Connecticut, Farmington, Connecticut, USA.
FAU - Whelan, Sean
AU  - Whelan S
AUID- ORCID: 0000-0003-1564-8590
AD  - Washington University, St. Louis, Missouri, USA.
FAU - White, Elizabeth
AU  - White E
AUID- ORCID: 0000-0001-7378-7690
AD  - University of Pennsylvania, Philadelphia, Pennsylvania, USA.
FAU - Williams, Bryan
AU  - Williams B
AD  - Monash University, Clayton, Victoria, Australia.
FAU - Wobus, Christiane
AU  - Wobus C
AUID- ORCID: 0000-0001-5286-0924
AD  - University of Michigan, Ann Arbor, Michigan, USA.
FAU - Wong, Scott
AU  - Wong S
AD  - Oregon Health and Science University, Beaverton, Oregon, USA.
FAU - Yurochko, Andrew
AU  - Yurochko A
AUID- ORCID: 0000-0002-6452-5813
AD  - Louisiana State University, Shreveport, Louisiana, USA.
LA  - eng
GR  - R35 GM133633/GM/NIGMS NIH HHS/United States
GR  - R01 GM056927/GM/NIGMS NIH HHS/United States
GR  - MC_UU_12014/9/MRC_/Medical Research Council/United Kingdom
GR  - R03 DE030211/DE/NIDCR NIH HHS/United States
GR  - R01 AI165638/AI/NIAID NIH HHS/United States
GR  - R21 AI173916/AI/NIAID NIH HHS/United States
GR  - R01 AI152543/AI/NIAID NIH HHS/United States
GR  - R01 AI073898/AI/NIAID NIH HHS/United States
GR  - P01 CA214091/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20230126
PL  - United States
TA  - mBio
JT  - mBio
JID - 101519231
SB  - IM
MH  - Humans
MH  - *COVID-19/prevention & control
MH  - SARS-CoV-2
MH  - Pandemics/prevention & control
MH  - *Viruses/genetics
MH  - *Respiratory Tract Infections
PMC - PMC9973315
OTO - NOTNLM
OT  - COVID-19
OT  - Coronavirus
OT  - DURC
OT  - Gain of function
OT  - SARS-CoV-2
OT  - biosafety
OT  - influenza
OT  - pandemic
OT  - vaccines
OT  - zoonosis
COIS- The authors declare a conflict of interest. Sana Biotechnology has licensed 
      intellectual property of D.B. and Washington University in St. Louis. Gilead 
      Sciences has licensed intellectual property of D.B. and Stanford University. D.B. 
      is a co-founder of Clade Therapeutics. D.B. previously served on an advisory 
      panel for GlaxoSmithKline. D.B. and The University of Arizona hold a patent on 
      SARS-CoV-2 serological assays. K.C. is a special government employee and a member 
      of the Office of AIDS Research Advisory Committee. T.S.D.: Board of Directors, 
      Burroughs Wellcome Fund; Editor, Annual Review of Virology. D.D. is on the 
      scientific advisory board of Theriva. W.P.D. receives support from Moderna. M. F. 
      receives funding from National Institute of Allergy and Infectious Diseases 
      (NIAID), Biomedical Advanced Research and Development Authority (BARDA), Defense 
      Advanced Research Projects Agency (DARPA), Gates Foundation, Aikido Pharma, 
      Emergent, Astrazeneca, Novavax, Regeneron, and the CDC, outside the submitted 
      work. M. F. received royalties/licenses from Aikido Pharma for antiviral drug 
      patent licensing, consulting fees from Aikido Pharma, Observatory Group, for 
      consulting for COVID-19, and participation on Scientific Advisory Board for 
      Aikido Pharma, outside the submitted work. K.F. has substantial financial 
      interest in Vir Biotechnology, Inc., and is a co-founder of the company. K.F. is 
      co-inventor of patents licensed to Vir and receives compensation for consulting 
      for Vir. The potential conflicts of interest have been reviewed and managed by 
      OHSU. D.G. is on the HPV Global Advisory Board for Merck. The A.G.-S. laboratory 
      has received research support from GSK, Pfizer, Senhwa Biosciences, Kenall 
      Manufacturing, Blade Therapeutics, Avimex, Johnson & Johnson, Dynavax, 7Hills 
      Pharma, Pharmamar, ImmunityBio, Accurius, Nanocomposix, Hexamer, N-fold LLC, 
      Model Medicines, Atea Pharma, Applied Biological Laboratories and Merck. A.G.-S. 
      has consulting agreements for the following companies involving cash and/or 
      stock: Castlevax, Amovir, Vivaldi Biosciences, Contrafect, 7Hills Pharma, Avimex, 
      Pagoda, Accurius, Esperovax, Farmak, Applied Biological Laboratories, Pharmamar, 
      CureLab Oncology, CureLab Veterinary, Synairgen and Pfizer. A.G.-S. has been an 
      invited speaker in meeting events organized by Seqirus, Janssen, Abbott and 
      Astrazeneca. A.G.-S. is inventor on patents and patent applications on the use of 
      antivirals and vaccines for the treatment and prevention of virus infections and 
      cancer, owned by the Icahn School of Medicine at Mount Sinai, New York. B.A.G. is 
      on the scientific advisory board for IMUNON. A.L.G. reports central testing 
      contracts from Pfizer, Janssen, Novavax, Sanofi, Abbott, Hologic, Cepheid, and 
      Quidel, and research support from Gilead. E.E.H. is co-founder of Thyreos Inc. 
      E.C.H. has carried out research work in collaboration with AstraZeneca and 
      received honoraria for consultancy work for the Center for Open Science and 
      Seqirus. M.J.I. consults for Gilead Sciences and Via Nova Therapeutics. D.M.K. is 
      a consultant, Replay Bio. T.K. receives funding from Moderna related to CMV. 
      A.S.L. is a paid member of steering committee for clinical trial of baloxavir 
      (Roche). A.C.L. is an inventor on the patent Influenza Vaccines and Uses Thereof, 
      owned by the Icahn School of Medicine at Mount Sinai. G.M. is co-founder of a 
      biotech company devoted to oncolytic virotherapy. W.A.M. is co-inventor of a 
      pending patent application on improved mRNA vaccines. A. Moscona is scientific 
      founder of Thylacine Biotherapeutics, a startup company for antiviral 
      therapeutics. J.A.N., Vir Biotechnology. W.A.O., uncompensated member, Moderna 
      Scientific Advisory Board. D.A.O., Defense Threat Reduction Agency. L.M.S. is a 
      virologist performing research on potential antivirals. L.M.S. is the 
      president-elect of the International Society for Antiviral Research, the 
      membership of which includes people working in companies working on antivirals. 
      L.M.S. has performed paid and non-paid consultantships with private companies 
      developing antivirals or virucidals. L.M.S. is a founder member of a start-up 
      company that had an interest in antivirals. L.M.S. has received funding to work 
      on antivirals. S.S. is Contract Consultant for Curevo Vaccines. J.W.S. consults 
      for the Federal Trade Commission on matters related to COVID-19. The Icahn School 
      of Medicine at Mount Sinai has filed patent applications relating to SARS-CoV-2 
      serological assays which list V.S. as co-inventor. G.A.S. is President of 
      Thyreos, Inc. M.S.S. serves an advisory role with Moderna and Ocugen. S.K.W. is 
      co-founder of startup Quercus Molecular Design. C.M.R.: Founder, Apath LLC; 
      Advisor, SAB, and Research Support, Vir Biotechnology; Research support, GSK; SAB 
      Invisishield; SAB Arbutus. C.R.B. is consultant for Ocular Services On Demand 
      (OSOD) located in Madison, WI, and a collaborator with Amebagone a small biotech 
      company in Madison, Wisconsin. C.R.B. has no financial interest in Amebagone and 
      is not owner or part owner of OSOD. All other authors report no conflicts of 
      interest.
EDAT- 2023/01/27 06:00
MHDA- 2023/03/03 06:00
CRDT- 2023/01/26 09:04
PHST- 2023/01/27 06:00 [pubmed]
PHST- 2023/03/03 06:00 [medline]
PHST- 2023/01/26 09:04 [entrez]
AID - 00188-23 [pii]
AID - mbio.00188-23 [pii]
AID - 10.1128/mbio.00188-23 [doi]
PST - ppublish
SO  - mBio. 2023 Feb 28;14(1):e0018823. doi: 10.1128/mbio.00188-23. Epub 2023 Jan 26.

PMID- 36700640
OWN - NLM
STAT- MEDLINE
DCOM- 20230307
LR  - 20231201
IS  - 1098-5514 (Electronic)
IS  - 0022-538X (Print)
IS  - 0022-538X (Linking)
VI  - 97
IP  - 2
DP  - 2023 Feb 28
TI  - Virology under the Microscope-a Call for Rational Discourse.
PG  - e0008923
LID - 10.1128/jvi.00089-23 [doi]
LID - e00089-23
AB  - Viruses have brought humanity many challenges: respiratory infection, cancer, 
      neurological impairment and immunosuppression to name a few. Virology research 
      over the last 60+ years has responded to reduce this disease burden with vaccines 
      and antivirals. Despite this long history, the COVID-19 pandemic has brought 
      unprecedented attention to the field of virology. Some of this attention is 
      focused on concern about the safe conduct of research with human pathogens. A 
      small but vocal group of individuals has seized upon these concerns - conflating 
      legitimate questions about safely conducting virus-related research with 
      uncertainties over the origins of SARS-CoV-2. The result has fueled public 
      confusion and, in many instances, ill-informed condemnation of virology. With 
      this article, we seek to promote a return to rational discourse. We explain the 
      use of gain-of-function approaches in science, discuss the possible origins of 
      SARS-CoV-2 and outline current regulatory structures that provide oversight for 
      virological research in the United States. By offering our expertise, we - a 
      broad group of working virologists - seek to aid policy makers in navigating 
      these controversial issues. Balanced, evidence-based discourse is essential to 
      addressing public concern while maintaining and expanding much-needed research in 
      virology.
FAU - Goodrum, Felicia
AU  - Goodrum F
AUID- ORCID: 0000-0002-6646-7290
AD  - Department of Immunobiology, BIO5 Institute, University of Arizona, Tucson, 
      Arizona, USA.
FAU - Lowen, Anice C
AU  - Lowen AC
AUID- ORCID: 0000-0002-9829-112X
AD  - Department of Microbiology and Immunology, Emory University School of Medicine, 
      Atlanta, Georgia, USA.
FAU - Lakdawala, Seema
AU  - Lakdawala S
AUID- ORCID: 0000-0002-7679-2150
AD  - Department of Microbiology and Immunology, Emory University School of Medicine, 
      Atlanta, Georgia, USA.
FAU - Alwine, James
AU  - Alwine J
AD  - Department of Immunobiology, BIO5 Institute, University of Arizona, Tucson, 
      Arizona, USA.
AD  - Department of Cancer Biology, University of Pennsylvania, Philadelphia, 
      Pennsylvania, USA.
FAU - Casadevall, Arturo
AU  - Casadevall A
AUID- ORCID: 0000-0002-9402-9167
AD  - Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg 
      School of Public Health, Baltimore, Maryland, USA.
FAU - Imperiale, Michael J
AU  - Imperiale MJ
AD  - Department of Microbiology and Immunology, University of Michigan, Ann Arbor, 
      Michigan, USA.
FAU - Atwood, Walter
AU  - Atwood W
AUID- ORCID: 0000-0002-3763-9073
AD  - Brown University, Providence, Rhode Island, USA.
FAU - Avgousti, Daphne
AU  - Avgousti D
AD  - Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
FAU - Baines, Joel
AU  - Baines J
AUID- ORCID: 0000-0002-6397-2830
AD  - Cornell University, Ithaca, New York, USA.
FAU - Banfield, Bruce
AU  - Banfield B
AUID- ORCID: 0000-0002-5989-6695
AD  - Queen's University, Kingston, Ontario, Canada.
FAU - Banks, Lawrence
AU  - Banks L
AD  - International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
FAU - Bhaduri-McIntosh, Sumita
AU  - Bhaduri-McIntosh S
AUID- ORCID: 0000-0003-2946-9497
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Bhattacharya, Deepta
AU  - Bhattacharya D
AD  - University of Arizona, Tucson, Arizona, USA.
FAU - Blanco-Melo, Daniel
AU  - Blanco-Melo D
AD  - Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
FAU - Bloom, David
AU  - Bloom D
AUID- ORCID: 0000-0001-5935-8494
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Boon, Adrianus
AU  - Boon A
AUID- ORCID: 0000-0002-4700-8224
AD  - University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
FAU - Boulant, Steeve
AU  - Boulant S
AUID- ORCID: 0000-0001-8614-4993
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Brandt, Curtis
AU  - Brandt C
AD  - University of Wisconsin-Madison, Madison, Wisconsin, USA.
FAU - Broadbent, Andrew
AU  - Broadbent A
AUID- ORCID: 0000-0002-4716-1835
AD  - University of Maryland, College Park, Maryland, USA.
FAU - Brooke, Christopher
AU  - Brooke C
AUID- ORCID: 0000-0002-6815-1193
AD  - University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
FAU - Cameron, Craig
AU  - Cameron C
AD  - University of North Carolina, Chapel Hill, North Carolina, USA.
FAU - Campos, Samuel
AU  - Campos S
AUID- ORCID: 0000-0003-1540-9821
AD  - University of Arizona, Tucson, Arizona, USA.
FAU - Caposio, Patrizia
AU  - Caposio P
AUID- ORCID: 0000-0001-7579-849X
AD  - Oregon Health and Science University, Beaverton, Oregon, USA.
FAU - Chan, Gary
AU  - Chan G
AUID- ORCID: 0000-0001-8209-9777
AD  - SUNY Upstate Medical University, Syracuse, New York, USA.
FAU - Cliffe, Anna
AU  - Cliffe A
AUID- ORCID: 0000-0003-1136-5171
AD  - University of Virginia, Charlottesville, Virginia, USA.
FAU - Coffin, John
AU  - Coffin J
AD  - Tufts University, Boston, Massachusetts, USA.
FAU - Collins, Kathleen
AU  - Collins K
AD  - University of Michigan, Ann Arbor, Michigan, USA.
FAU - Damania, Blossom
AU  - Damania B
AUID- ORCID: 0000-0002-9205-1774
AD  - University of North Carolina, Chapel Hill, North Carolina, USA.
FAU - Daugherty, Matthew
AU  - Daugherty M
AD  - University of California, San Diego, La Jolla, California, USA.
FAU - Debbink, Kari
AU  - Debbink K
AD  - Johns Hopkins University, Baltimore, Maryland, USA.
FAU - DeCaprio, James
AU  - DeCaprio J
AUID- ORCID: 0000-0002-0896-167X
AD  - Harvard Medical School, Boston, Massachusetts, USA.
FAU - Dermody, Terence
AU  - Dermody T
AUID- ORCID: 0000-0003-1853-8741
AD  - University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
FAU - Dikeakos, Jimmy
AU  - Dikeakos J
AUID- ORCID: 0000-0001-8141-5395
AD  - Western University, London, Ontario, Canada.
FAU - DiMaio, Daniel
AU  - DiMaio D
AUID- ORCID: 0000-0002-2060-5977
AD  - Yale University, New Haven, Connecticut, USA.
FAU - Dinglasan, Rhoel
AU  - Dinglasan R
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Duprex, W Paul
AU  - Duprex WP
AUID- ORCID: 0000-0003-1716-6376
AD  - University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
FAU - Dutch, Rebecca
AU  - Dutch R
AUID- ORCID: 0000-0002-5220-8247
AD  - University of Kentucky, Lexington, Kentucky, USA.
FAU - Elde, Nels
AU  - Elde N
AD  - University of Utah, Salt Lake City, Utah, USA.
FAU - Emerman, Michael
AU  - Emerman M
AUID- ORCID: 0000-0002-4181-6335
AD  - Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
FAU - Enquist, Lynn
AU  - Enquist L
AUID- ORCID: 0000-0001-9968-8586
AD  - Princeton University, Princeton, New Jersey, USA.
FAU - Fane, Bentley
AU  - Fane B
AUID- ORCID: 0000-0002-3984-1726
AD  - University of Arizona, Tucson, Arizona, USA.
FAU - Fernandez-Sesma, Ana
AU  - Fernandez-Sesma A
AD  - Icahn School of Medicine at Mount Sinai, New York, New York, USA.
FAU - Flenniken, Michelle
AU  - Flenniken M
AD  - Montana State University, Bozeman, Montana, USA.
FAU - Frappier, Lori
AU  - Frappier L
AUID- ORCID: 0000-0003-0110-5472
AD  - University of Toronto, Toronto, Ontario, Canada.
FAU - Frieman, Matthew
AU  - Frieman M
AUID- ORCID: 0000-0003-0107-0775
AD  - University of Maryland, College Park, Maryland, USA.
FAU - Frueh, Klaus
AU  - Frueh K
AD  - Oregon Health and Science University, Beaverton, Oregon, USA.
FAU - Gack, Michaela
AU  - Gack M
AUID- ORCID: 0000-0002-2163-2598
AD  - Florida Research and Innovation Center, Port Saint Lucie, Florida, USA.
FAU - Gaglia, Marta
AU  - Gaglia M
AUID- ORCID: 0000-0002-1791-0663
AD  - University of Wisconsin-Madison, Madison, Wisconsin, USA.
FAU - Gallagher, Tom
AU  - Gallagher T
AUID- ORCID: 0000-0002-8601-5961
AD  - Loyola University, Maywood, Illinois, USA.
FAU - Galloway, Denise
AU  - Galloway D
AD  - Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
FAU - García-Sastre, Adolfo
AU  - García-Sastre A
AUID- ORCID: 0000-0002-6551-1827
AD  - Icahn School of Medicine at Mount Sinai, New York, New York, USA.
FAU - Geballe, Adam
AU  - Geballe A
AUID- ORCID: 0000-0002-9279-6653
AD  - Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
FAU - Glaunsinger, Britt
AU  - Glaunsinger B
AUID- ORCID: 0000-0003-0479-9377
AD  - University of California, Berkeley, Berkeley, California, USA.
FAU - Goff, Stephen
AU  - Goff S
AUID- ORCID: 0000-0002-9679-0582
AD  - Columbia University, New York, New York, USA.
FAU - Greninger, Alexander
AU  - Greninger A
AUID- ORCID: 0000-0002-7443-0527
AD  - University of Washington, Seattle, Washington, USA.
FAU - Hancock, Meaghan
AU  - Hancock M
AUID- ORCID: 0000-0003-2945-0147
AD  - Oregon Health and Science University, Beaverton, Oregon, USA.
FAU - Harris, Eva
AU  - Harris E
AUID- ORCID: 0000-0002-7238-4037
AD  - University of California, Berkeley, Berkeley, California, USA.
FAU - Heaton, Nicholas
AU  - Heaton N
AUID- ORCID: 0000-0002-5307-3428
AD  - Duke University, Durham, North Carolina, USA.
FAU - Heise, Mark
AU  - Heise M
AUID- ORCID: 0000-0001-5829-8477
AD  - University of North Carolina, Chapel Hill, North Carolina, USA.
FAU - Heldwein, Ekaterina
AU  - Heldwein E
AUID- ORCID: 0000-0003-3113-6958
AD  - Tufts University, Boston, Massachusetts, USA.
FAU - Hogue, Brenda
AU  - Hogue B
AD  - Arizona State University, Tempe, Arizona, USA.
FAU - Horner, Stacy
AU  - Horner S
AUID- ORCID: 0000-0002-9351-7409
AD  - Duke University, Durham, North Carolina, USA.
FAU - Hutchinson, Edward
AU  - Hutchinson E
AD  - MRC-University of Glasgow, Glasgow, United Kingdom.
FAU - Hyser, Joseph
AU  - Hyser J
AD  - Baylor University, Houston, Texas, USA.
FAU - Jackson, William
AU  - Jackson W
AUID- ORCID: 0000-0002-9832-0584
AD  - Arizona State University, Tempe, Arizona, USA.
FAU - Kalejta, Robert
AU  - Kalejta R
AUID- ORCID: 0000-0002-7116-3355
AD  - Duke University, Durham, North Carolina, USA.
FAU - Kamil, Jeremy
AU  - Kamil J
AUID- ORCID: 0000-0001-8422-7656
AD  - Louisiana State University, Shreveport, Louisiana, USA.
FAU - Karst, Stephanie
AU  - Karst S
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Kirchhoff, Frank
AU  - Kirchhoff F
AUID- ORCID: 0000-0002-7052-2360
AD  - Ulm University, Ulm, Germany.
FAU - Knipe, David
AU  - Knipe D
AUID- ORCID: 0000-0003-1554-6236
AD  - Harvard Medical School, Boston, Massachusetts, USA.
FAU - Kowalik, Timothy
AU  - Kowalik T
AD  - University of Massachusetts, Worcester, Massachusetts, USA.
FAU - Lagunoff, Michael
AU  - Lagunoff M
AD  - University of Washington, Seattle, Washington, USA.
FAU - Laimins, Laimonis
AU  - Laimins L
AUID- ORCID: 0000-0002-6314-623X
AD  - Northwestern University, Chicago, Illinois, USA.
FAU - Langlois, Ryan
AU  - Langlois R
AD  - University of Minnesota, Minneapolis, Minnesota, USA.
FAU - Lauring, Adam
AU  - Lauring A
AD  - University of Michigan, Ann Arbor, Michigan, USA.
FAU - Lee, Benhur
AU  - Lee B
AUID- ORCID: 0000-0003-0760-1709
AD  - Icahn School of Medicine at Mount Sinai, New York, New York, USA.
FAU - Leib, David
AU  - Leib D
AD  - Dartmouth College, Lebanon, New Hampshire, USA.
FAU - Liu, Shan-Lu
AU  - Liu SL
AUID- ORCID: 0000-0003-1620-3817
AD  - The Ohio State University, Columbus, Ohio, USA.
FAU - Longnecker, Richard
AU  - Longnecker R
AUID- ORCID: 0000-0001-7175-6217
AD  - Northwestern University, Chicago, Illinois, USA.
FAU - Lopez, Carolina
AU  - Lopez C
AUID- ORCID: 0000-0002-7669-6572
AD  - Washington University, St. Louis, Missouri, USA.
FAU - Luftig, Micah
AU  - Luftig M
AUID- ORCID: 0000-0002-2964-1907
AD  - Duke University, Durham, North Carolina, USA.
FAU - Lund, Jennifer
AU  - Lund J
AUID- ORCID: 0000-0003-3284-979X
AD  - Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
FAU - Manicassamy, Balaji
AU  - Manicassamy B
AUID- ORCID: 0000-0003-1964-0967
AD  - University of Iowa, Iowa City, Iowa, USA.
FAU - McFadden, Grant
AU  - McFadden G
AUID- ORCID: 0000-0002-2556-3526
AD  - Arizona State University, Tempe, Arizona, USA.
FAU - McIntosh, Michael
AU  - McIntosh M
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Mehle, Andrew
AU  - Mehle A
AUID- ORCID: 0000-0001-6060-4330
AD  - University of Wisconsin-Madison, Madison, Wisconsin, USA.
FAU - Miller, W Allen
AU  - Miller WA
AUID- ORCID: 0000-0003-0603-2751
AD  - Iowa State University, Ames, Iowa, USA.
FAU - Mohr, Ian
AU  - Mohr I
AD  - New York University, New York, New York, USA.
FAU - Moody, Cary
AU  - Moody C
AUID- ORCID: 0000-0002-1991-0640
AD  - University of North Carolina, Chapel Hill, North Carolina, USA.
FAU - Moorman, Nathaniel
AU  - Moorman N
AD  - University of North Carolina, Chapel Hill, North Carolina, USA.
FAU - Moscona, Anne
AU  - Moscona A
AUID- ORCID: 0000-0002-1796-8320
AD  - Columbia University, New York, New York, USA.
FAU - Mounce, Bryan
AU  - Mounce B
AUID- ORCID: 0000-0003-1710-5362
AD  - Loyola University, Maywood, Illinois, USA.
FAU - Munger, Joshua
AU  - Munger J
AUID- ORCID: 0000-0001-5379-9440
AD  - University of Rochester, Rochester, New York, USA.
FAU - Münger, Karl
AU  - Münger K
AD  - Tufts University, Boston, Massachusetts, USA.
FAU - Murphy, Eain
AU  - Murphy E
AUID- ORCID: 0000-0003-3449-5024
AD  - SUNY Upstate Medical University, Syracuse, New York, USA.
FAU - Naghavi, Mojgan
AU  - Naghavi M
AD  - Northwestern University, Chicago, Illinois, USA.
FAU - Nelson, Jay
AU  - Nelson J
AD  - Oregon Health and Science University, Beaverton, Oregon, USA.
FAU - Neufeldt, Christopher
AU  - Neufeldt C
AD  - Emory University, Atlanta, Georgia, USA.
FAU - Nikolich, Janko
AU  - Nikolich J
AD  - University of Arizona, Tucson, Arizona, USA.
FAU - O'Connor, Christine
AU  - O'Connor C
AUID- ORCID: 0000-0003-4943-3774
AD  - Cleveland Clinic, Cleveland, Ohio, USA.
FAU - Ono, Akira
AU  - Ono A
AUID- ORCID: 0000-0001-7841-851X
AD  - University of Michigan, Ann Arbor, Michigan, USA.
FAU - Orenstein, Walter
AU  - Orenstein W
AD  - Emory University, Atlanta, Georgia, USA.
FAU - Ornelles, David
AU  - Ornelles D
AD  - Wake Forest University, Winston-Salem, North Carolina, USA.
FAU - Ou, Jing-Hsiung
AU  - Ou JH
AUID- ORCID: 0000-0002-8274-5705
AD  - University of Southern California, Los Angeles, California, USA.
FAU - Parker, John
AU  - Parker J
AUID- ORCID: 0000-0003-4487-4175
AD  - Cornell University, Ithaca, New York, USA.
FAU - Parrish, Colin
AU  - Parrish C
AUID- ORCID: 0000-0002-1836-6655
AD  - Cornell University, Ithaca, New York, USA.
FAU - Pekosz, Andrew
AU  - Pekosz A
AUID- ORCID: 0000-0003-3248-1761
AD  - Johns Hopkins University, Baltimore, Maryland, USA.
FAU - Pellett, Philip
AU  - Pellett P
AUID- ORCID: 0000-0002-8536-8343
AD  - Wayne State University, Detroit, Michigan, USA.
FAU - Pfeiffer, Julie
AU  - Pfeiffer J
AUID- ORCID: 0000-0003-2973-4895
AD  - University of Texas, Dallas, Texas, USA.
FAU - Plemper, Richard
AU  - Plemper R
AD  - Georgia State University, Atlanta, Georgia, USA.
FAU - Polyak, Stephen
AU  - Polyak S
AUID- ORCID: 0000-0001-7475-9827
AD  - University of Washington, Seattle, Washington, USA.
FAU - Purdy, John
AU  - Purdy J
AUID- ORCID: 0000-0001-7460-7567
AD  - University of Arizona, Tucson, Arizona, USA.
FAU - Pyeon, Dohun
AU  - Pyeon D
AUID- ORCID: 0000-0003-1970-844X
AD  - Michigan State University, East Lansing, Michigan, USA.
FAU - Quinones-Mateu, Miguel
AU  - Quinones-Mateu M
AD  - Western University, London, Ontario, Canada.
FAU - Renne, Rolf
AU  - Renne R
AUID- ORCID: 0000-0001-7391-8806
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Rice, Charles
AU  - Rice C
AD  - The Rockefeller University, New York, New York, USA.
FAU - Schoggins, John
AU  - Schoggins J
AUID- ORCID: 0000-0002-7944-6800
AD  - University of Texas, Dallas, Texas, USA.
FAU - Roller, Richard
AU  - Roller R
AUID- ORCID: 0000-0001-8340-3224
AD  - University of Iowa, Iowa City, Iowa, USA.
FAU - Russell, Charles
AU  - Russell C
AUID- ORCID: 0000-0001-5683-3990
AD  - St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
FAU - Sandri-Goldin, Rozanne
AU  - Sandri-Goldin R
AD  - University of California, Irvine, Irvine, California, USA.
FAU - Sapp, Martin
AU  - Sapp M
AUID- ORCID: 0000-0003-3916-8890
AD  - Louisiana State University, Shreveport, Louisiana, USA.
FAU - Schang, Luis
AU  - Schang L
AUID- ORCID: 0000-0002-5789-8590
AD  - Cornell University, Ithaca, New York, USA.
FAU - Schmid, Scott
AU  - Schmid S
AD  - University of Colorado, Boulder, Colorado, USA.
FAU - Schultz-Cherry, Stacey
AU  - Schultz-Cherry S
AUID- ORCID: 0000-0002-2021-727X
AD  - St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
FAU - Semler, Bert
AU  - Semler B
AUID- ORCID: 0000-0002-2424-5155
AD  - University of California, Irvine, Irvine, California, USA.
FAU - Shenk, Thomas
AU  - Shenk T
AD  - Princeton University, Princeton, New Jersey, USA.
FAU - Silvestri, Guido
AU  - Silvestri G
AD  - University of Kentucky, Lexington, Kentucky, USA.
FAU - Simon, Viviana
AU  - Simon V
AD  - Icahn School of Medicine at Mount Sinai, New York, New York, USA.
FAU - Smith, Gregory
AU  - Smith G
AUID- ORCID: 0000-0001-9644-8472
AD  - Northwestern University, Chicago, Illinois, USA.
FAU - Smith, Jason
AU  - Smith J
AUID- ORCID: 0000-0001-6727-5269
AD  - University of Washington, Seattle, Washington, USA.
FAU - Spindler, Katherine
AU  - Spindler K
AUID- ORCID: 0000-0002-9829-6051
AD  - University of Minnesota, Minneapolis, Minnesota, USA.
FAU - Stanifer, Megan
AU  - Stanifer M
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Subbarao, Kanta
AU  - Subbarao K
AUID- ORCID: 0000-0003-1713-3056
AD  - The Peter Doherty Institute, Melbourne, Victoria, Australia.
FAU - Sundquist, Wesley
AU  - Sundquist W
AD  - University of Utah, Salt Lake City, Utah, USA.
FAU - Suthar, Mehul
AU  - Suthar M
AUID- ORCID: 0000-0002-2686-8380
AD  - Emory University, Atlanta, Georgia, USA.
FAU - Sutton, Troy
AU  - Sutton T
AUID- ORCID: 0000-0002-7880-4784
AD  - The Pennsylvania State University, University Park, Pennsylvania, USA.
FAU - Tai, Andrew
AU  - Tai A
AUID- ORCID: 0000-0002-6877-450X
AD  - University of Michigan, Ann Arbor, Michigan, USA.
FAU - Tarakanova, Vera
AU  - Tarakanova V
AUID- ORCID: 0000-0002-9499-088X
AD  - Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
FAU - tenOever, Benjamin
AU  - tenOever B
AUID- ORCID: 0000-0003-0324-3078
AD  - New York University, New York, New York, USA.
FAU - Tibbetts, Scott
AU  - Tibbetts S
AUID- ORCID: 0000-0001-8889-1642
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Tompkins, Stephen
AU  - Tompkins S
AUID- ORCID: 0000-0002-1523-5588
AD  - University of Georgia, Athens, Georgia, USA.
FAU - Toth, Zsolt
AU  - Toth Z
AUID- ORCID: 0000-0001-6628-3945
AD  - University of Florida, Gainesville, Florida, USA.
FAU - van Doorslaer, Koenraad
AU  - van Doorslaer K
AUID- ORCID: 0000-0002-2985-0733
AD  - University of Arizona, Tucson, Arizona, USA.
FAU - Vignuzzi, Marco
AU  - Vignuzzi M
AD  - A*STAR Infectious Diseases Labs, Singapore.
FAU - Wallace, Nicholas
AU  - Wallace N
AUID- ORCID: 0000-0002-3971-716X
AD  - Kansas State University, Manhattan, Kansas, USA.
FAU - Walsh, Derek
AU  - Walsh D
AUID- ORCID: 0000-0002-8756-4655
AD  - Northwestern University, Chicago, Illinois, USA.
FAU - Weekes, Michael
AU  - Weekes M
AD  - University of Cambridge, Cambridge, United Kingdom.
FAU - Weinberg, Jason
AU  - Weinberg J
AUID- ORCID: 0000-0002-4768-4361
AD  - University of Michigan, Ann Arbor, Michigan, USA.
FAU - Weitzman, Matthew
AU  - Weitzman M
AUID- ORCID: 0000-0001-9713-167X
AD  - University of Pennsylvania, Philadelphia, Pennsylvania, USA.
FAU - Weller, Sandra
AU  - Weller S
AUID- ORCID: 0000-0002-4519-6276
AD  - University of Connecticut, Farmington, Connecticut, USA.
FAU - Whelan, Sean
AU  - Whelan S
AUID- ORCID: 0000-0003-1564-8590
AD  - Washington University, St. Louis, Missouri, USA.
FAU - White, Elizabeth
AU  - White E
AUID- ORCID: 0000-0001-7378-7690
AD  - University of Pennsylvania, Philadelphia, Pennsylvania, USA.
FAU - Williams, Bryan
AU  - Williams B
AD  - Monash University, Clayton, Victoria, Australia.
FAU - Wobus, Christiane
AU  - Wobus C
AUID- ORCID: 0000-0001-5286-0924
AD  - University of Michigan, Ann Arbor, Michigan, USA.
FAU - Wong, Scott
AU  - Wong S
AD  - Oregon Health and Science University, Beaverton, Oregon, USA.
FAU - Yurochko, Andrew
AU  - Yurochko A
AUID- ORCID: 0000-0002-6452-5813
AD  - Louisiana State University, Shreveport, Louisiana, USA.
LA  - eng
GR  - R35 GM133633/GM/NIGMS NIH HHS/United States
GR  - R01 GM056927/GM/NIGMS NIH HHS/United States
GR  - R01 AI152543/AI/NIAID NIH HHS/United States
GR  - R01 AI073898/AI/NIAID NIH HHS/United States
GR  - P01 CA214091/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20230126
PL  - United States
TA  - J Virol
JT  - Journal of virology
JID - 0113724
SB  - IM
CIN - J Virol. 2023 May 31;97(5):e0045123. PMID: 37097023
CIN - mBio. 2023 Jun 27;14(3):e0081523. PMID: 37097032
MH  - Humans
MH  - COVID-19/prevention & control
MH  - Information Dissemination
MH  - Pandemics/prevention & control
MH  - Policy Making
MH  - *Research/standards/trends
MH  - SARS-CoV-2
MH  - *Virology/standards/trends
MH  - *Virus Diseases/prevention & control/virology
MH  - Viruses
PMC - PMC9972907
OTO - NOTNLM
OT  - COVID-19
OT  - Coronavirus
OT  - DURC
OT  - Gain of function
OT  - SARS-CoV-2
OT  - biosafety
OT  - influenza
OT  - pandemic
OT  - vaccines
OT  - zoonosis
COIS- The authors declare a conflict of interest. Sana Biotechnology has licensed 
      intellectual property of D.B. and Washington University in St. Louis. Gilead 
      Sciences has licensed intellectual property of D.B. and Stanford University. D.B. 
      is a co-founder of Clade Therapeutics. D.B. previously served on an advisory 
      panel for GlaxoSmithKline. D.B. and The University of Arizona hold a patent on 
      SARS-CoV-2 serological assays. K.C. is a special government employee and a member 
      of the Office of AIDS Research Advisory Committee. T.S.D.: Board of Directors, 
      Burroughs Wellcome Fund; Editor, Annual Review of Virology. D.D. is on the 
      scientific advisory board of Theriva. W.P.D. receives support from Moderna. M. F. 
      receives funding from National Institute of Allergy and Infectious Diseases 
      (NIAID), Biomedical Advanced Research and Development Authority (BARDA), Defense 
      Advanced Research Projects Agency (DARPA), Gates Foundation, Aikido Pharma, 
      Emergent, Astrazeneca, Novavax, Regeneron, and the CDC, outside the submitted 
      work. M. F. received royalties/licenses from Aikido Pharma for antiviral drug 
      patent licensing, consulting fees from Aikido Pharma, Observatory Group, for 
      consulting for COVID-19, and participation on Scientific Advisory Board for 
      Aikido Pharma, outside the submitted work. K.F. has substantial financial 
      interest in Vir Biotechnology, Inc., and is a co-founder of the company. K.F. is 
      co-inventor of patents licensed to Vir and receives compensation for consulting 
      for Vir. The potential conflicts of interest have been reviewed and managed by 
      OHSU. D.G. is on the HPV Global Advisory Board for Merck. The A.G.-S. laboratory 
      has received research support from GSK, Pfizer, Senhwa Biosciences, Kenall 
      Manufacturing, Blade Therapeutics, Avimex, Johnson & Johnson, Dynavax, 7Hills 
      Pharma, Pharmamar, ImmunityBio, Accurius, Nanocomposix, Hexamer, N-fold LLC, 
      Model Medicines, Atea Pharma, Applied Biological Laboratories and Merck. A.G.-S. 
      has consulting agreements for the following companies involving cash and/or 
      stock: Castlevax, Amovir, Vivaldi Biosciences, Contrafect, 7Hills Pharma, Avimex, 
      Pagoda, Accurius, Esperovax, Farmak, Applied Biological Laboratories, Pharmamar, 
      CureLab Oncology, CureLab Veterinary, Synairgen and Pfizer. A.G.-S. has been an 
      invited speaker in meeting events organized by Seqirus, Janssen, Abbott and 
      Astrazeneca. A.G.-S. is inventor on patents and patent applications on the use of 
      antivirals and vaccines for the treatment and prevention of virus infections and 
      cancer, owned by the Icahn School of Medicine at Mount Sinai, New York. B.A.G. is 
      on the scientific advisory board for IMUNON. A.L.G. reports central testing 
      contracts from Pfizer, Janssen, Novavax, Sanofi, Abbott, Hologic, Cepheid, and 
      Quidel, and research support from Gilead. E.E.H. is co-founder of Thyreos Inc. 
      E.C.H. has carried out research work in collaboration with AstraZeneca and 
      received honoraria for consultancy work for the Center for Open Science and 
      Seqirus. M.J.I. consults for Gilead Sciences and Via Nova Therapeutics. D.M.K. is 
      a consultant, Replay Bio. T.K. receives funding from Moderna related to CMV. 
      A.S.L. is a paid member of steering committee for clinical trial of baloxavir 
      (Roche). A.C.L. is an inventor on the patent Influenza Vaccines and Uses Thereof, 
      owned by the Icahn School of Medicine at Mount Sinai. G.M. is co-founder of a 
      biotech company devoted to oncolytic virotherapy. W.A.M. is co-inventor of a 
      pending patent application on improved mRNA vaccines. A. Moscona is scientific 
      founder of Thylacine Biotherapeutics, a startup company for antiviral 
      therapeutics. J.A.N., Vir Biotechnology. W.A.O., uncompensated member, Moderna 
      Scientific Advisory Board. D.A.O., Defense Threat Reduction Agency. L.M.S. is a 
      virologist performing research on potential antivirals. L.M.S. is the 
      president-elect of the International Society for Antiviral Research, the 
      membership of which includes people working in companies working on antivirals. 
      L.M.S. has performed paid and non-paid consultantships with private companies 
      developing antivirals or virucidals. L.M.S. is a founder member of a start-up 
      company that had an interest in antivirals. L.M.S. has received funding to work 
      on antivirals. S.S. is Contract Consultant for Curevo Vaccines. J.W.S. consults 
      for the Federal Trade Commission on matters related to COVID-19. The Icahn School 
      of Medicine at Mount Sinai has filed patent applications relating to SARS-CoV-2 
      serological assays which list V.S. as co-inventor. G.A.S. is President of 
      Thyreos, Inc. M.S.S. serves an advisory role with Moderna and Ocugen. S.K.W. is 
      co-founder of startup Quercus Molecular Design. C.M.R.: Founder, Apath LLC; 
      Advisor, SAB, and Research Support, Vir Biotechnology; Research support, GSK; SAB 
      Invisishield; SAB Arbutus. C.R.B. is consultant for Ocular Services On Demand 
      (OSOD) located in Madison, WI, and a collaborator with Amebagone a small biotech 
      company in Madison, Wisconsin. C.R.B. has no financial interest in Amebagone and 
      is not owner or part owner of OSOD. All other authors report no conflicts of 
      interest.
EDAT- 2023/01/27 06:00
MHDA- 2023/03/03 06:00
CRDT- 2023/01/26 09:04
PHST- 2023/01/27 06:00 [pubmed]
PHST- 2023/03/03 06:00 [medline]
PHST- 2023/01/26 09:04 [entrez]
AID - 00089-23 [pii]
AID - jvi.00089-23 [pii]
AID - 10.1128/jvi.00089-23 [doi]
PST - ppublish
SO  - J Virol. 2023 Feb 28;97(2):e0008923. doi: 10.1128/jvi.00089-23. Epub 2023 Jan 26.

PMID- 36236511
OWN - NLM
STAT- MEDLINE
DCOM- 20221017
LR  - 20230308
IS  - 1424-8220 (Electronic)
IS  - 1424-8220 (Linking)
VI  - 22
IP  - 19
DP  - 2022 Sep 29
TI  - Association between Self-Reported Prior Night's Sleep and Single-Task Gait in 
      Healthy, Young Adults: A Study Using Machine Learning.
LID - 10.3390/s22197406 [doi]
LID - 7406
AB  - Failure to obtain the recommended 7−9 h of sleep has been associated with 
      injuries in youth and adults. However, most research on the influence of prior 
      night’s sleep and gait has been conducted on older adults and clinical 
      populations. Therefore, the objective of this study was to identify individuals 
      who experience partial sleep deprivation and/or sleep extension the prior night 
      using single task gait. Participants (n = 123, age 24.3 ± 4.0 years; 65% female) 
      agreed to participate in this study. Self-reported sleep duration of the night 
      prior to testing was collected. Gait data was collected with inertial sensors 
      during a 2 min walk test. Group differences (<7 h and >9 h, poor sleepers; 7−9 h, 
      good sleepers) in gait characteristics were assessed using machine learning and a 
      post-hoc ANCOVA. Results indicated a correlation (r = 0.79) between gait 
      parameters and prior night’s sleep. The most accurate machine learning model was 
      a Random Forest Classifier using the top 9 features, which had a mean accuracy of 
      65.03%. Our findings suggest that good sleepers had more asymmetrical gait 
      patterns and were better at maintaining gait speed than poor sleepers. Further 
      research with larger subject sizes is needed to develop more accurate machine 
      learning models to identify prior night’s sleep using single-task gait.
FAU - Boolani, Ali
AU  - Boolani A
AUID- ORCID: 0000-0002-2261-4498
AD  - Honors Program, Clarkson University, Potsdam, NY 13699, USA.
FAU - Martin, Joel
AU  - Martin J
AUID- ORCID: 0000-0002-8579-0480
AD  - Sports Medicine Assessment Research & Testing (SMART) Laboratory, George Mason 
      University, Manassas, VA 20110, USA.
FAU - Huang, Haikun
AU  - Huang H
AUID- ORCID: 0000-0002-5962-0533
AD  - Department of Computer Science, George Mason University, Manassas, VA 20110, USA.
FAU - Yu, Lap-Fai
AU  - Yu LF
AD  - Department of Computer Science, George Mason University, Manassas, VA 20110, USA.
FAU - Stark, Maggie
AU  - Stark M
AD  - Department of Medicine, Lake Erie College of Osteopathic Medicine, Elmira, NY 
      14901, USA.
FAU - Grin, Zachary
AU  - Grin Z
AD  - Honors Program, Clarkson University, Potsdam, NY 13699, USA.
FAU - Roy, Marissa
AU  - Roy M
AD  - Sports Medicine Assessment Research & Testing (SMART) Laboratory, George Mason 
      University, Manassas, VA 20110, USA.
FAU - Yager, Chelsea
AU  - Yager C
AD  - Latham Medical Group, Latham, NY 12110, USA.
FAU - Teymouri, Seema
AU  - Teymouri S
AD  - Department of Engineering and Technology, State University of New York Canton, 
      Canton, NY 13617, USA.
FAU - Bradley, Dylan
AU  - Bradley D
AUID- ORCID: 0000-0003-1042-3624
AD  - Department of Physical Therapy, Hanover College, Hanover, IN 47243, USA.
FAU - Martin, Rebecca
AU  - Martin R
AD  - Department of Neurology, St. Joseph's Hospital Health Center, Syracuse, NY 13203, 
      USA.
FAU - Fulk, George
AU  - Fulk G
AD  - Department of Physical Therapy, Emory University School of Medicine, Atlanta, GA 
      30322, USA.
FAU - Kakar, Rumit Singh
AU  - Kakar RS
AD  - Human Movement Science Department, Oakland University, Rochester, MI 48309, USA.
LA  - eng
PT  - Journal Article
DEP - 20220929
PL  - Switzerland
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
JID - 101204366
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Female
MH  - Gait
MH  - Humans
MH  - Machine Learning
MH  - Male
MH  - Self Report
MH  - *Sleep
MH  - *Sleep Deprivation
MH  - Young Adult
PMC - PMC9572361
OTO - NOTNLM
OT  - gait assessment
OT  - lower extremity kinematics
OT  - partial sleep deprivation
OT  - sleep extension
COIS- The authors declare no conflict of interest.
EDAT- 2022/10/15 06:00
MHDA- 2022/10/18 06:00
CRDT- 2022/10/14 02:37
PHST- 2022/08/22 00:00 [received]
PHST- 2022/09/18 00:00 [revised]
PHST- 2022/09/22 00:00 [accepted]
PHST- 2022/10/14 02:37 [entrez]
PHST- 2022/10/15 06:00 [pubmed]
PHST- 2022/10/18 06:00 [medline]
AID - s22197406 [pii]
AID - sensors-22-07406 [pii]
AID - 10.3390/s22197406 [doi]
PST - epublish
SO  - Sensors (Basel). 2022 Sep 29;22(19):7406. doi: 10.3390/s22197406.

PMID- 35900716
OWN - NLM
STAT- MEDLINE
DCOM- 20221028
LR  - 20230126
IS  - 1534-6269 (Electronic)
IS  - 1523-3790 (Linking)
VI  - 24
IP  - 11
DP  - 2022 Nov
TI  - Older Patients with Lung Cancer: a Summary of Seminal Contributions to Optimal 
      Patient Care.
PG  - 1607-1618
LID - 10.1007/s11912-022-01307-y [doi]
AB  - PURPOSE OF REVIEW: This review aspires to summarize the landmark advancements in 
      the management of the non-small cell lung cancer (NSCLC), both historically and 
      contemporarily with special focus in older adults. RECENT FINDINGS: The past two 
      decades have witnessed remarkable improvements in the diagnosis and management of 
      lung cancer. Screening recommendations now facilitate earlier diagnosis in 
      high-risk individuals, PET/CT scans have improved radiologic accuracy in 
      identifying sites of disease, and surgical management with minimally invasive 
      techniques has rendered surgery safer in those with limited physiologic reserve. 
      Radiation enhancements, especially radiosurgery, have extended the reach and 
      safety of radiation among high-risk populations. Finally, the revolution in 
      precision medicine with identification of numerous actionable mutations, the 
      advent of immunotherapy, and enhanced supportive care have revolutionized the 
      outcomes in patients with advanced lung cancer. Older adults who represent a 
      majority of patients battling lung cancer have not benefitted to the same extent 
      as their younger counterparts. This special population is only expected to grow 
      in coming days. Hence, addressing major gaps in the management of older adults 
      with NSCLC and optimizing the care are much needed.
CI  - © 2022. The Author(s), under exclusive licence to Springer Science+Business 
      Media, LLC, part of Springer Nature.
FAU - Basnet, Alina
AU  - Basnet A
AD  - Department of Medicine, SUNY Upstate Medical University, 750 E Adams Street, 
      Syracuse, NY, 13210, USA.
FAU - Alahmadi, Asrar
AU  - Alahmadi A
AD  - Division of Medical Oncology, Department of Internal Medicine, The Ohio State 
      University Comprehensive Cancer Center, Columbus, OH, USA.
FAU - Gajra, Ajeet
AU  - Gajra A
AUID- ORCID: 0000-0002-5929-0466
AD  - Department of Medicine, SUNY Upstate Medical University, 750 E Adams Street, 
      Syracuse, NY, 13210, USA. AjeetGajra@Gmail.com.
AD  - Hematology Oncology Associates of Central New York, 5008 Brittonfield Pkwy, E 
      Syracuse, NY, 13057, USA. AjeetGajra@Gmail.com.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20220728
PL  - United States
TA  - Curr Oncol Rep
JT  - Current oncology reports
JID - 100888967
SB  - IM
MH  - Humans
MH  - Aged
MH  - *Lung Neoplasms/therapy/surgery
MH  - *Carcinoma, Non-Small-Cell Lung/diagnosis/genetics/therapy
MH  - Positron Emission Tomography Computed Tomography
MH  - *Radiosurgery/methods
MH  - Patient Care
OTO - NOTNLM
OT  - Chronological age
OT  - Driver mutations
OT  - Geriatric assessment
OT  - Immune checkpoint inhibitors
OT  - Lung cancer
OT  - Non-small cell lung cancer
OT  - Older adults
OT  - Palliative care
OT  - Screening
OT  - Stereotactic ablative radiotherapy
OT  - Targeted therapy
EDAT- 2022/07/29 06:00
MHDA- 2022/10/29 06:00
CRDT- 2022/07/28 11:35
PHST- 2022/05/31 00:00 [accepted]
PHST- 2022/07/29 06:00 [pubmed]
PHST- 2022/10/29 06:00 [medline]
PHST- 2022/07/28 11:35 [entrez]
AID - 10.1007/s11912-022-01307-y [pii]
AID - 10.1007/s11912-022-01307-y [doi]
PST - ppublish
SO  - Curr Oncol Rep. 2022 Nov;24(11):1607-1618. doi: 10.1007/s11912-022-01307-y. Epub 
      2022 Jul 28.

PMID- 35964688
OWN - NLM
STAT- MEDLINE
DCOM- 20221013
LR  - 20230214
IS  - 1558-349X (Electronic)
IS  - 1546-1440 (Linking)
VI  - 19
IP  - 10
DP  - 2022 Oct
TI  - Predicting Patient Demographics From Chest Radiographs With Deep Learning.
PG  - 1151-1161
LID - S1546-1440(22)00544-0 [pii]
LID - 10.1016/j.jacr.2022.06.008 [doi]
AB  - BACKGROUND: Deep learning models are increasingly informing medical decision 
      making, for instance, in the detection of acute intracranial hemorrhage and 
      pulmonary embolism. However, many models are trained on medical image databases 
      that poorly represent the diversity of the patients they serve. In turn, many 
      artificial intelligence models may not perform as well on assisting providers 
      with important medical decisions for underrepresented populations. PURPOSE: 
      Assessment of the ability of deep learning models to classify the self-reported 
      gender, age, self-reported ethnicity, and insurance status of an individual 
      patient from a given chest radiograph. METHODS: Models were trained and tested 
      with 55,174 radiographs in the MIMIC Chest X-ray (MIMIC-CXR) database. External 
      validation data came from two separate databases, one from CheXpert and another 
      from a multihospital urban health care system after institutional review board 
      approval. Macro-averaged area under the curve (AUC) values were used to evaluate 
      performance of models. Code used for this study is open-source and available at 
      https://github.com/ai-bias/cxr-bias, and 
      pixelstopatients.com/models/demographics. RESULTS: Accuracy of models to predict 
      gender was nearly perfect, with 0.999 (95% confidence interval: 0.99-0.99) AUC on 
      held-out test data and 0.994 (0.99-0.99) and 0.997 (0.99-0.99) on external 
      validation data. There was high accuracy to predict age and ethnicity, ranging 
      from 0.854 (0.80-0.91) to 0.911 (0.88-0.94) AUC, and moderate accuracy to predict 
      insurance status, with AUC ranging from 0.705 (0.60-0.81) on held-out test data 
      to 0.675 (0.54-0.79) on external validation data. CONCLUSIONS: Deep learning 
      models can predict the age, self-reported gender, self-reported ethnicity, and 
      insurance status of a patient from a chest radiograph. Visualization techniques 
      are useful to ensure deep learning models function as intended and to demonstrate 
      anatomical regions of interest. These models can be used to ensure that training 
      data are diverse, thereby ensuring artificial intelligence models that work on 
      diverse populations.
CI  - Copyright © 2022 American College of Radiology. Published by Elsevier Inc. All 
      rights reserved.
FAU - Adleberg, Jason
AU  - Adleberg J
AD  - Department of Radiology, Mount Sinai Health System, New York, New York. 
      Electronic address: Jason.Adleberg@mountsinai.org.
FAU - Wardeh, Amr
AU  - Wardeh A
AD  - Deaprtment of Radiology, Upstate University Hospital, Syracuse, New York.
FAU - Doo, Florence X
AU  - Doo FX
AD  - Department of Radiology, Mount Sinai Health System, New York, New York.
FAU - Marinelli, Brett
AU  - Marinelli B
AD  - Department of Radiology, Mount Sinai Health System, New York, New York.
FAU - Cook, Tessa S
AU  - Cook TS
AD  - Director, 3D and Advanced Imaging Laboratory and Director, Center for Practice 
      Transformation in Radiology, Department of Radiology, Perelman School of 
      Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
FAU - Mendelson, David S
AU  - Mendelson DS
AD  - Vice Chair, Informatics, Department of Radiology, Icahn School of Medicine at 
      Mount Sinai, New York, New York.
FAU - Kagen, Alexander
AU  - Kagen A
AD  - Site Chair, Department of Radiology, Mount Sinai West and Mount Sinai St. Luke's 
      Hospitals, Icahn School of Medicine at Mount Sinai, New York, New York.
LA  - eng
PT  - Journal Article
DEP - 20220811
PL  - United States
TA  - J Am Coll Radiol
JT  - Journal of the American College of Radiology : JACR
JID - 101190326
SB  - IM
CIN - J Am Coll Radiol. 2022 Dec;19(12):1345-1346. PMID: 36208841
MH  - Artificial Intelligence
MH  - *Deep Learning
MH  - Ethnicity
MH  - Humans
MH  - Radiography
MH  - Radiography, Thoracic/methods
OTO - NOTNLM
OT  - AI bias
OT  - artificial intelligence
OT  - chest radiographs
OT  - data science
EDAT- 2022/08/15 06:00
MHDA- 2022/10/14 06:00
CRDT- 2022/08/14 19:23
PHST- 2022/03/09 00:00 [received]
PHST- 2022/06/13 00:00 [revised]
PHST- 2022/06/21 00:00 [accepted]
PHST- 2022/08/15 06:00 [pubmed]
PHST- 2022/10/14 06:00 [medline]
PHST- 2022/08/14 19:23 [entrez]
AID - S1546-1440(22)00544-0 [pii]
AID - 10.1016/j.jacr.2022.06.008 [doi]
PST - ppublish
SO  - J Am Coll Radiol. 2022 Oct;19(10):1151-1161. doi: 10.1016/j.jacr.2022.06.008. 
      Epub 2022 Aug 11.

PMID- 35237397
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220304
IS  - 2040-6207 (Print)
IS  - 2040-6215 (Electronic)
IS  - 2040-6207 (Linking)
VI  - 13
DP  - 2022
TI  - Mantle cell lymphoma management trends and novel agents: where are we going?
PG  - 20406207221080743
LID - 10.1177/20406207221080743 [doi]
LID - 20406207221080743
AB  - The heterogeneity in disease pathology, the unpredictability in disease 
      prognosis, and the variability in response to therapy make mantle cell lymphoma 
      (MCL) a focus of novel therapeutic development. MCL is characterized by 
      dysregulated expression of cyclin D1 through a chromosome t(11;14) translocation. 
      MCL international prognostic index (MIPI), ki-67 proliferation index, and TP53 
      mutation status are currently utilized for prognostication. With advances in 
      pharmacokinetic analysis and drug discovery, treatment strategy has evolved from 
      chemotherapy to combination of targeted, epigenetic, and immune therapies. In 
      this review, we discuss investigational and newly approved treatment approaches. 
      In a short time, the US Food and Drug Administration (FDA) has approved five 
      agents for the treatment of MCL: lenalidomide, an immunomodulatory agent; 
      bortezomib, a proteasome inhibitor; and ibrutinib, acalabrutinib, and 
      zanubrutinib, all Bruton kinase inhibitors. Epigenetic agents (e.g. cladribine 
      and vorinostat), mammalian target of rapamycin (mTOR) inhibitors (e.g. 
      temsirolimus and everolimus), and monoclonal antibodies and/or antibody-drug 
      conjugates (e.g. obinutuzumab, polatuzumab, and ublituximab) are promising 
      therapeutic agents currently under clinical trial investigation. Most recently, 
      chimeric antigen receptor (CAR)-T cell therapy and bispecific T-cell engager 
      (BiTE) therapy even open a new venue for MCL treatment. However, due to its 
      intricate pathology nature and high relapse incidence, there are still unmet 
      needs in developing optimal therapeutic strategies for both frontline and 
      relapsed/refractory settings. The ultimate goal is to develop innovative 
      personalized combination therapy approaches for the purpose of delivering 
      precision medicine to cure this disease.
CI  - © The Author(s), 2022.
FAU - Pu, Jeffrey J
AU  - Pu JJ
AUID- ORCID: 0000-0001-7498-3159
AD  - University of Arizona Cancer Center, 1515 N Campbell Avenue, Room #1968C, Tucson, 
      AZ 85724, USA.
FAU - Savani, Malvi
AU  - Savani M
AD  - University of Arizona Cancer Center, Tucson, AZ, USA.
FAU - Huang, Nick
AU  - Huang N
AD  - State University of New York Upstate Medical University, Syracuse, NY, USA.
FAU - Epner, Elliot M
AU  - Epner EM
AD  - Penn State Hershey Cancer Institute, 100 University Drive, Hershey, PA, USA.
LA  - eng
PT  - Journal Article
DEP - 20220226
PL  - England
TA  - Ther Adv Hematol
JT  - Therapeutic advances in hematology
JID - 101549589
PMC - PMC8882940
OTO - NOTNLM
OT  - BiTE therapy
OT  - CAR-T therapy
OT  - allogeneic hematopoietic stem cell transplant
OT  - cyclin D1
OT  - epigenetics
OT  - immunotherapy
OT  - mantle cell lymphoma
OT  - targeted therapies
COIS- Conflict of interest statement: The authors declare that there is no conflict of 
      interest.
EDAT- 2022/03/04 06:00
MHDA- 2022/03/04 06:01
CRDT- 2022/03/03 05:35
PHST- 2021/11/21 00:00 [received]
PHST- 2022/01/31 00:00 [accepted]
PHST- 2022/03/03 05:35 [entrez]
PHST- 2022/03/04 06:00 [pubmed]
PHST- 2022/03/04 06:01 [medline]
AID - 10.1177_20406207221080743 [pii]
AID - 10.1177/20406207221080743 [doi]
PST - epublish
SO  - Ther Adv Hematol. 2022 Feb 26;13:20406207221080743. doi: 
      10.1177/20406207221080743. eCollection 2022.

PMID- 37433967
OWN - NLM
STAT- Publisher
LR  - 20230720
IS  - 1476-5578 (Electronic)
IS  - 1359-4184 (Linking)
DP  - 2023 Jul 11
TI  - Association of polygenic score and the involvement of cholinergic and 
      glutamatergic pathways with lithium treatment response in patients with bipolar 
      disorder.
LID - 10.1038/s41380-023-02149-1 [doi]
AB  - Lithium is regarded as the first-line treatment for bipolar disorder (BD), a 
      severe and disabling mental health disorder that affects about 1% of the 
      population worldwide. Nevertheless, lithium is not consistently effective, with 
      only 30% of patients showing a favorable response to treatment. To provide 
      personalized treatment options for bipolar patients, it is essential to identify 
      prediction biomarkers such as polygenic scores. In this study, we developed a 
      polygenic score for lithium treatment response (Li(+)(PGS)) in patients with BD. 
      To gain further insights into lithium's possible molecular mechanism of action, 
      we performed a genome-wide gene-based analysis. Using polygenic score modeling, 
      via methods incorporating Bayesian regression and continuous shrinkage priors, 
      Li(+)(PGS) was developed in the International Consortium of Lithium Genetics 
      cohort (ConLi(+)Gen: N = 2367) and replicated in the combined PsyCourse (N = 89) 
      and BipoLife (N = 102) studies. The associations of Li(+)(PGS) and lithium 
      treatment response - defined in a continuous ALDA scale and a categorical outcome 
      (good response vs. poor response) were tested using regression models, each 
      adjusted for the covariates: age, sex, and the first four genetic principal 
      components. Statistical significance was determined at P < 0.05. Li(+)(PGS) was 
      positively associated with lithium treatment response in the ConLi(+)Gen cohort, 
      in both the categorical (P = 9.8 × 10(-)(12), R(2) = 1.9%) and continuous 
      (P = 6.4 × 10(-)(9), R(2) = 2.6%) outcomes. Compared to bipolar patients in the 
      1(st) decile of the risk distribution, individuals in the 10(th) decile had 
      3.47-fold (95%CI: 2.22-5.47) higher odds of responding favorably to lithium. The 
      results were replicated in the independent cohorts for the categorical treatment 
      outcome (P = 3.9 × 10(-)(4), R(2) = 0.9%), but not for the continuous outcome 
      (P = 0.13). Gene-based analyses revealed 36 candidate genes that are enriched in 
      biological pathways controlled by glutamate and acetylcholine. Li(+)(PGS) may be 
      useful in the development of pharmacogenomic testing strategies by enabling a 
      classification of bipolar patients according to their response to treatment.
CI  - © 2023. The Author(s).
FAU - Amare, Azmeraw T
AU  - Amare AT
AUID- ORCID: 0000-0002-7940-0335
AD  - Discipline of Psychiatry, School of Medicine, University of Adelaide, Adelaide, 
      SA, Australia. azmeraw.amare@adelaide.edu.au.
FAU - Thalamuthu, Anbupalam
AU  - Thalamuthu A
AD  - Centre for Healthy Brain Ageing (CHeBA), Discipline of Psychiatry and Mental 
      Health, UNSW Medicine & Health, University of New South Wales, Sydney, Australia.
FAU - Schubert, Klaus Oliver
AU  - Schubert KO
AUID- ORCID: 0000-0003-1690-0209
AD  - Discipline of Psychiatry, School of Medicine, University of Adelaide, Adelaide, 
      SA, Australia.
AD  - Northern Adelaide Local Health Network, Mental Health Services, Adelaide, SA, 
      Australia.
FAU - Fullerton, Janice M
AU  - Fullerton JM
AUID- ORCID: 0000-0003-4014-4490
AD  - Neuroscience Research Australia, Sydney, NSW, Australia.
AD  - School of Medical Sciences, University of New South Wales, Sydney, NSW, 
      Australia.
FAU - Ahmed, Muktar
AU  - Ahmed M
AD  - Discipline of Psychiatry, School of Medicine, University of Adelaide, Adelaide, 
      SA, Australia.
FAU - Hartmann, Simon
AU  - Hartmann S
AUID- ORCID: 0000-0001-9689-0594
AD  - Discipline of Psychiatry, School of Medicine, University of Adelaide, Adelaide, 
      SA, Australia.
FAU - Papiol, Sergi
AU  - Papiol S
AUID- ORCID: 0000-0001-9366-8728
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, Germany.
AD  - Department of Psychiatry and Psychotherapy, University Hospital, 
      Ludwig-Maximilian-University Munich, Munich, Germany.
FAU - Heilbronner, Urs
AU  - Heilbronner U
AUID- ORCID: 0000-0001-7135-762X
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, Germany.
FAU - Degenhardt, Franziska
AU  - Degenhardt F
AD  - Institute of Human Genetics, University of Bonn, School of Medicine & University 
      Hospital Bonn, Bonn, Germany.
AD  - Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, 
      LVR Klinikum Essen, University of Duisburg-Essen, Rheinische Kliniken, Essen, 
      Germany.
FAU - Tekola-Ayele, Fasil
AU  - Tekola-Ayele F
AD  - Epidemiology Branch, Division of Population Health Research, Division of 
      Intramural Research, Eunice Kennedy Shriver National Institute of Child Health 
      and Human Development, National Institutes of Health, Bethesda, MD, USA.
FAU - Hou, Liping
AU  - Hou L
AD  - Intramural Research Program, National Institute of Mental Health, National 
      Institutes of Health, US Department of Health & Human Services, Bethesda, MD, 
      USA.
FAU - Hsu, Yi-Hsiang
AU  - Hsu YH
AD  - HSL Institute for Aging Research, Harvard Medical School, Boston, MA, USA.
AD  - Program for Quantitative Genomics, Harvard School of Public Health, Boston, MA, 
      USA.
FAU - Shekhtman, Tatyana
AU  - Shekhtman T
AD  - Department of Psychiatry, University of California San Diego, San Diego, CA, USA.
FAU - Adli, Mazda
AU  - Adli M
AD  - Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, 
      Campus Charité Mitte, Berlin, Germany.
FAU - Akula, Nirmala
AU  - Akula N
AD  - Intramural Research Program, National Institute of Mental Health, National 
      Institutes of Health, US Department of Health & Human Services, Bethesda, MD, 
      USA.
FAU - Akiyama, Kazufumi
AU  - Akiyama K
AD  - Department of Biological Psychiatry and Neuroscience, Dokkyo Medical University 
      School of Medicine, Mibu, Tochigi, Japan.
FAU - Ardau, Raffaella
AU  - Ardau R
AD  - Unit of Clinical Pharmacology, Hospital University Agency of Cagliari, Cagliari, 
      Italy.
FAU - Arias, Bárbara
AU  - Arias B
AUID- ORCID: 0000-0001-9181-2132
AD  - Unitat de Zoologia i Antropologia Biològica (Dpt. Biologia Evolutiva, Ecologia i 
      Ciències Ambientals), Facultat de Biologia and Institut de Biomedicina (IBUB), 
      University of Barcelona, CIBERSAM, Barcelona, Spain.
FAU - Aubry, Jean-Michel
AU  - Aubry JM
AD  - Department of Psychiatry, Mood Disorders Unit, HUG - Geneva University Hospitals, 
      Geneva, Switzerland.
FAU - Hasler, Roland
AU  - Hasler R
AD  - Department of Psychiatry, Mood Disorders Unit, HUG - Geneva University Hospitals, 
      Geneva, Switzerland.
FAU - Richard-Lepouriel, Hélène
AU  - Richard-Lepouriel H
AD  - Department of Psychiatry, Mood Disorders Unit, HUG - Geneva University Hospitals, 
      Geneva, Switzerland.
FAU - Perroud, Nader
AU  - Perroud N
AD  - Department of Psychiatry, Mood Disorders Unit, HUG - Geneva University Hospitals, 
      Geneva, Switzerland.
FAU - Backlund, Lena
AU  - Backlund L
AD  - Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, 
      Sweden.
AD  - Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
FAU - Bhattacharjee, Abesh Kumar
AU  - Bhattacharjee AK
AD  - Department of Psychiatry, University of California San Diego, San Diego, CA, USA.
FAU - Bellivier, Frank
AU  - Bellivier F
AD  - INSERM UMR-S 1144, Université Paris Cité, Département de Psychiatrie et de 
      Médecine Addictologique, AP-HP, Groupe Hospitalier 
      Saint-Louis-Lariboisière-F.Widal, Paris, France.
FAU - Benabarre, Antonio
AU  - Benabarre A
AD  - Bipolar and Depressive Disorders Program,, Institute of Neuroscience, Hospital 
      Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
FAU - Bengesser, Susanne
AU  - Bengesser S
AD  - Department of Psychiatry and Psychotherapeutic Medicine, Research Unit for 
      bipolar affective disorder, Medical University of Graz, Graz, Austria.
FAU - Biernacka, Joanna M
AU  - Biernacka JM
AUID- ORCID: 0000-0001-9350-4440
AD  - Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
AD  - Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
FAU - Birner, Armin
AU  - Birner A
AD  - Department of Psychiatry and Psychotherapeutic Medicine, Research Unit for 
      bipolar affective disorder, Medical University of Graz, Graz, Austria.
FAU - Marie-Claire, Cynthia
AU  - Marie-Claire C
AUID- ORCID: 0000-0002-2282-134X
AD  - INSERM UMR-S 1144, Université Paris Cité, Département de Psychiatrie et de 
      Médecine Addictologique, AP-HP, Groupe Hospitalier 
      Saint-Louis-Lariboisière-F.Widal, Paris, France.
AD  - Université Paris Cité, Inserm, Optimisation Thérapeutique en 
      Neuropsychopharmacologie, F-75006, Paris, France.
FAU - Cervantes, Pablo
AU  - Cervantes P
AD  - The Neuromodulation Unit, McGill University Health Centre, Montreal, Canada.
FAU - Chen, Hsi-Chung
AU  - Chen HC
AUID- ORCID: 0000-0003-3191-0093
AD  - Department of Psychiatry & Center of Sleep Disorders, National Taiwan University 
      Hospital, Taipei, Taiwan.
FAU - Chillotti, Caterina
AU  - Chillotti C
AD  - Unit of Clinical Pharmacology, Hospital University Agency of Cagliari, Cagliari, 
      Italy.
FAU - Cichon, Sven
AU  - Cichon S
AUID- ORCID: 0000-0002-9475-086X
AD  - Institute of Human Genetics, University of Bonn, School of Medicine & University 
      Hospital Bonn, Bonn, Germany.
AD  - Department of Biomedicine, University Hospital Basel, Basel, Switzerland.
AD  - Institute of Neuroscience and Medicine (INM-1), Research Center Jülich, Jülich, 
      Germany.
FAU - Cruceanu, Cristiana
AU  - Cruceanu C
AUID- ORCID: 0000-0002-7799-5531
AD  - Douglas Mental Health University Institute, McGill University, Montreal, Canada.
FAU - Czerski, Piotr M
AU  - Czerski PM
AUID- ORCID: 0000-0003-0745-5916
AD  - Psychiatric Genetic Unit, Poznan University of Medical Sciences, Poznan, Poland.
FAU - Dalkner, Nina
AU  - Dalkner N
AD  - Department of Psychiatry and Psychotherapeutic Medicine, Research Unit for 
      bipolar affective disorder, Medical University of Graz, Graz, Austria.
FAU - Del Zompo, Maria
AU  - Del Zompo M
AUID- ORCID: 0000-0001-9491-5938
AD  - Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
FAU - DePaulo, J Raymond
AU  - DePaulo JR
AUID- ORCID: 0000-0001-9221-9226
AD  - Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, 
      Baltimore, MD, USA.
FAU - Étain, Bruno
AU  - Étain B
AUID- ORCID: 0000-0002-5377-1488
AD  - INSERM UMR-S 1144, Université Paris Cité, Département de Psychiatrie et de 
      Médecine Addictologique, AP-HP, Groupe Hospitalier 
      Saint-Louis-Lariboisière-F.Widal, Paris, France.
FAU - Jamain, Stephane
AU  - Jamain S
AUID- ORCID: 0000-0002-4321-4100
AD  - Inserm U955, Translational Psychiatry laboratory, Fondation FondaMental, Créteil, 
      France.
FAU - Falkai, Peter
AU  - Falkai P
AD  - Department of Psychiatry and Psychotherapy, University Hospital, 
      Ludwig-Maximilian-University Munich, Munich, Germany.
AD  - Max Planck Institute of Psychiatry, Munich, Germany.
FAU - Forstner, Andreas J
AU  - Forstner AJ
AUID- ORCID: 0000-0002-1876-6368
AD  - Institute of Human Genetics, University of Bonn, School of Medicine & University 
      Hospital Bonn, Bonn, Germany.
AD  - Institute of Neuroscience and Medicine (INM-1), Research Center Jülich, Jülich, 
      Germany.
FAU - Frisen, Louise
AU  - Frisen L
AD  - Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, 
      Sweden.
AD  - Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
FAU - Frye, Mark A
AU  - Frye MA
AUID- ORCID: 0000-0001-6997-4215
AD  - Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
FAU - Gard, Sébastien
AU  - Gard S
AD  - Pôle de Psychiatrie Générale Universitaire, Hôpital Charles Perrens, Bordeaux, 
      France.
FAU - Garnham, Julie S
AU  - Garnham JS
AUID- ORCID: 0000-0002-7987-4995
AD  - Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
FAU - Goes, Fernando S
AU  - Goes FS
AUID- ORCID: 0000-0001-6262-8264
AD  - Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, 
      Baltimore, MD, USA.
FAU - Grigoroiu-Serbanescu, Maria
AU  - Grigoroiu-Serbanescu M
AUID- ORCID: 0000-0002-1304-6687
AD  - Biometric Psychiatric Genetics Research Unit, Alexandru Obregia Clinical 
      Psychiatric Hospital, Bucharest, Romania.
FAU - Fallgatter, Andreas J
AU  - Fallgatter AJ
AD  - University Department of Psychiatry and Psychotherapy Tuebingen, University of 
      Tübingen, Tuebingen, Germany.
FAU - Stegmaier, Sophia
AU  - Stegmaier S
AD  - Department of General Psychiatry, University of Tuebingen, Tuebingen, Germany.
FAU - Ethofer, Thomas
AU  - Ethofer T
AD  - Department of General Psychiatry, University of Tuebingen, Tuebingen, Germany.
AD  - Department of Biomedical Resonance, University of Tuebingen, Tuebingen, Germany.
FAU - Biere, Silvia
AU  - Biere S
AD  - Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital 
      of Frankfurt, Goethe University, Frankfurt, Germany.
FAU - Petrova, Kristiyana
AU  - Petrova K
AD  - Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital 
      of Frankfurt, Goethe University, Frankfurt, Germany.
FAU - Schuster, Ceylan
AU  - Schuster C
AD  - Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital 
      of Frankfurt, Goethe University, Frankfurt, Germany.
FAU - Adorjan, Kristina
AU  - Adorjan K
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, Germany.
AD  - Department of Psychiatry and Psychotherapy, University Hospital, 
      Ludwig-Maximilian-University Munich, Munich, Germany.
FAU - Budde, Monika
AU  - Budde M
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, Germany.
FAU - Heilbronner, Maria
AU  - Heilbronner M
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, Germany.
FAU - Kalman, Janos L
AU  - Kalman JL
AUID- ORCID: 0000-0003-0930-4214
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, Germany.
AD  - Department of Psychiatry and Psychotherapy, University Hospital, 
      Ludwig-Maximilian-University Munich, Munich, Germany.
FAU - Kohshour, Mojtaba Oraki
AU  - Kohshour MO
AUID- ORCID: 0000-0002-1357-2636
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, Germany.
AD  - Department of Immunology, Faculty of Medicine, Ahvaz Jundishapur University of 
      Medical Sciences, Ahvaz, Iran.
FAU - Reich-Erkelenz, Daniela
AU  - Reich-Erkelenz D
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, Germany.
FAU - Schaupp, Sabrina K
AU  - Schaupp SK
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, Germany.
FAU - Schulte, Eva C
AU  - Schulte EC
AUID- ORCID: 0000-0003-3105-5672
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, Germany.
AD  - Department of Psychiatry and Psychotherapy, University Hospital, 
      Ludwig-Maximilian-University Munich, Munich, Germany.
FAU - Senner, Fanny
AU  - Senner F
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, Germany.
AD  - Department of Psychiatry and Psychotherapy, University Hospital, 
      Ludwig-Maximilian-University Munich, Munich, Germany.
FAU - Vogl, Thomas
AU  - Vogl T
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, Germany.
FAU - Anghelescu, Ion-George
AU  - Anghelescu IG
AD  - Department of Psychiatry and Psychotherapy, Mental Health Institute Berlin, 
      Berlin, Germany.
FAU - Arolt, Volker
AU  - Arolt V
AD  - Institute for Translational Psychiatry, University of Münster, Münster, Germany.
FAU - Dannlowski, Udo
AU  - Dannlowski U
AD  - Institute for Translational Psychiatry, University of Münster, Münster, Germany.
FAU - Dietrich, Detlef
AU  - Dietrich D
AD  - AMEOS Clinical Center Hildesheim, Hildesheim, Germany.
AD  - Center for Systems Neuroscience (ZSN), Hannover, Germany.
FAU - Figge, Christian
AU  - Figge C
AD  - Karl-Jaspers Clinic, European Medical School Oldenburg-Groningen, Oldenburg, 
      26160, Germany.
FAU - Jäger, Markus
AU  - Jäger M
AD  - Department of Psychiatry II, Ulm University, Bezirkskrankenhaus Günzburg, 
      Günzburg, Germany.
FAU - Lang, Fabian U
AU  - Lang FU
AD  - Department of Psychiatry II, Ulm University, Bezirkskrankenhaus Günzburg, 
      Günzburg, Germany.
FAU - Juckel, Georg
AU  - Juckel G
AD  - Department of Psychiatry, Ruhr University Bochum, LWL University Hospital, 
      Bochum, Germany.
FAU - Konrad, Carsten
AU  - Konrad C
AD  - Department of Psychiatry and Psychotherapy, Agaplesion Diakonieklinikum, 
      Rotenburg, Germany.
FAU - Reimer, Jens
AU  - Reimer J
AUID- ORCID: 0009-0007-5406-5319
AD  - Department of Psychiatry and Psychotherapy, University Medical Center 
      Hamburg-Eppendorf, Hamburg, Germany.
AD  - Department of Psychiatry, Health North Hospital Group, Bremen, Germany.
FAU - Schmauß, Max
AU  - Schmauß M
AD  - Department of Psychiatry and Psychotherapy, Bezirkskrankenhaus Augsburg, 
      Augsburg, Germany.
FAU - Schmitt, Andrea
AU  - Schmitt A
AD  - Department of Psychiatry and Psychotherapy, University Hospital, 
      Ludwig-Maximilian-University Munich, Munich, Germany.
AD  - Laboratory of Neuroscience (LIM27), Institute of Psychiatry, University of Sao 
      Paulo, São Paulo, Brazil.
FAU - Spitzer, Carsten
AU  - Spitzer C
AD  - Department of Psychosomatic Medicine and Psychotherapy, University Medical Center 
      Rostock, Rostock, Germany.
FAU - von Hagen, Martin
AU  - von Hagen M
AD  - Clinic for Psychiatry and Psychotherapy, Clinical Center Werra-Meißner, Eschwege, 
      Germany.
FAU - Wiltfang, Jens
AU  - Wiltfang J
AUID- ORCID: 0000-0003-1492-5330
AD  - Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, 
      Göttingen, Germany.
AD  - German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.
FAU - Zimmermann, Jörg
AU  - Zimmermann J
AD  - Psychiatrieverbund Oldenburger Land gGmbH, Karl-Jaspers-Klinik, Bad Zwischenahn, 
      Germany.
FAU - Andlauer, Till F M
AU  - Andlauer TFM
AUID- ORCID: 0000-0002-2917-5889
AD  - Department of Neurology, University Hospital rechts der Isar, School of Medicine, 
      Technical University of Munich, Munich, Germany.
FAU - Fischer, Andre
AU  - Fischer A
AD  - German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.
FAU - Bermpohl, Felix
AU  - Bermpohl F
AD  - Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, 
      Campus Charité Mitte, Berlin, Germany.
FAU - Ritter, Philipp
AU  - Ritter P
AUID- ORCID: 0000-0003-4286-5830
AD  - Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav 
      Carus, Medical Faculty, Technische Universität Dresden, Dresden, Germany.
FAU - Matura, Silke
AU  - Matura S
AD  - Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital 
      of Frankfurt, Goethe University, Frankfurt, Germany.
FAU - Gryaznova, Anna
AU  - Gryaznova A
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, Germany.
FAU - Falkenberg, Irina
AU  - Falkenberg I
AD  - Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, 
      Germany.
FAU - Yildiz, Cüneyt
AU  - Yildiz C
AUID- ORCID: 0000-0002-8386-6189
AD  - Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, 
      Germany.
FAU - Kircher, Tilo
AU  - Kircher T
AD  - Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, 
      Germany.
FAU - Schmidt, Julia
AU  - Schmidt J
AUID- ORCID: 0000-0002-5942-2924
AD  - Institute for Medical Informatics, University Medical Center Göttingen, 
      Göttingen, Germany.
FAU - Koch, Marius
AU  - Koch M
AUID- ORCID: 0000-0002-0908-7478
AD  - Institute for Medical Informatics, University Medical Center Göttingen, 
      Göttingen, Germany.
FAU - Gade, Kathrin
AU  - Gade K
AUID- ORCID: 0000-0001-8629-0579
AD  - Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, 
      Göttingen, Germany.
FAU - Trost, Sarah
AU  - Trost S
AD  - Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, 
      Göttingen, Germany.
FAU - Haussleiter, Ida S
AU  - Haussleiter IS
AD  - Department of Psychiatry, Ruhr University Bochum, LWL University Hospital, 
      Bochum, Germany.
FAU - Lambert, Martin
AU  - Lambert M
AD  - Department of Psychiatry and Psychotherapy, University Medical Center 
      Hamburg-Eppendorf, Hamburg, Germany.
FAU - Rohenkohl, Anja C
AU  - Rohenkohl AC
AD  - Department of Psychiatry and Psychotherapy, University Medical Center 
      Hamburg-Eppendorf, Hamburg, Germany.
FAU - Kraft, Vivien
AU  - Kraft V
AD  - Department of Psychiatry and Psychotherapy, University Medical Center 
      Hamburg-Eppendorf, Hamburg, Germany.
FAU - Grof, Paul
AU  - Grof P
AD  - Mood Disorders Center of Ottawa, Ontario, Canada.
FAU - Hashimoto, Ryota
AU  - Hashimoto R
AD  - Department of Pathology of Mental Diseases, National Institute of Mental Health, 
      National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo, 
      187-8553, Japan.
FAU - Hauser, Joanna
AU  - Hauser J
AUID- ORCID: 0000-0002-6621-3493
AD  - Psychiatric Genetic Unit, Poznan University of Medical Sciences, Poznan, Poland.
FAU - Herms, Stefan
AU  - Herms S
AD  - Institute of Human Genetics, University of Bonn, School of Medicine & University 
      Hospital Bonn, Bonn, Germany.
AD  - Department of Biomedicine, University Hospital Basel, Basel, Switzerland.
FAU - Hoffmann, Per
AU  - Hoffmann P
AD  - Institute of Human Genetics, University of Bonn, School of Medicine & University 
      Hospital Bonn, Bonn, Germany.
AD  - Department of Biomedicine, University Hospital Basel, Basel, Switzerland.
FAU - Jiménez, Esther
AU  - Jiménez E
AD  - Bipolar and Depressive Disorders Program,, Institute of Neuroscience, Hospital 
      Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
FAU - Kahn, Jean-Pierre
AU  - Kahn JP
AD  - Service de Psychiatrie et Psychologie Clinique, Centre Psychothérapique de Nancy 
      - Université de Lorraine, Nancy, France.
FAU - Kassem, Layla
AU  - Kassem L
AD  - Intramural Research Program, National Institute of Mental Health, National 
      Institutes of Health, US Department of Health & Human Services, Bethesda, MD, 
      USA.
FAU - Kuo, Po-Hsiu
AU  - Kuo PH
AUID- ORCID: 0000-0003-0365-3587
AD  - Department of Public Health & Institute of Epidemiology and Preventive Medicine, 
      College of Public Health, National Taiwan University, Taipei, Taiwan.
FAU - Kato, Tadafumi
AU  - Kato T
AD  - Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Brain Science 
      Institute, Saitama, Japan.
FAU - Kelsoe, John
AU  - Kelsoe J
AD  - Department of Psychiatry, University of California San Diego, San Diego, CA, USA.
FAU - Kittel-Schneider, Sarah
AU  - Kittel-Schneider S
AUID- ORCID: 0000-0003-3057-6150
AD  - Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University 
      Hospital Frankfurt, Frankfurt, Germany.
AD  - Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, University 
      Hospital of Würzburg, Wurzburg, Germany.
FAU - Ferensztajn-Rochowiak, Ewa
AU  - Ferensztajn-Rochowiak E
AD  - Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, 
      Poland.
FAU - König, Barbara
AU  - König B
AD  - Department of Psychiatry and Psychotherapeutic Medicine, Landesklinikum 
      Neunkirchen, Neunkirchen, Austria.
FAU - Kusumi, Ichiro
AU  - Kusumi I
AUID- ORCID: 0000-0002-8747-5070
AD  - Department of Psychiatry, Hokkaido University Graduate School of Medicine, 
      Sapporo, Japan.
FAU - Laje, Gonzalo
AU  - Laje G
AD  - Intramural Research Program, National Institute of Mental Health, National 
      Institutes of Health, US Department of Health & Human Services, Bethesda, MD, 
      USA.
FAU - Landén, Mikael
AU  - Landén M
AUID- ORCID: 0000-0002-4496-6451
AD  - Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the 
      Gothenburg University, Gothenburg, Sweden.
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
FAU - Lavebratt, Catharina
AU  - Lavebratt C
AUID- ORCID: 0000-0003-4987-2718
AD  - Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, 
      Sweden.
AD  - Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
FAU - Leboyer, Marion
AU  - Leboyer M
AUID- ORCID: 0000-0001-5473-3697
AD  - Inserm U955, Translational Psychiatry laboratory, Université Paris-Est-Créteil, 
      Department of Psychiatry and Addictology of Mondor University Hospital, AP-HP, 
      Fondation FondaMental, Créteil, France.
FAU - Leckband, Susan G
AU  - Leckband SG
AD  - Office of Mental Health, VA San Diego Healthcare System, San Diego, CA, USA.
FAU - Tortorella, Alfonso
AU  - Tortorella A
AUID- ORCID: 0000-0002-8095-2305
AD  - Department of Psychiatry, University of Perugia, Perugia, Italy.
FAU - Manchia, Mirko
AU  - Manchia M
AD  - Section of Psychiatry, Department of Medical Sciences and Public Health, 
      University of Cagliari, Cagliari, Italy.
AD  - Department of Pharmacology, Dalhousie University, Halifax, NS, Canada.
FAU - Martinsson, Lina
AU  - Martinsson L
AD  - Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden.
FAU - McCarthy, Michael J
AU  - McCarthy MJ
AUID- ORCID: 0000-0001-6219-4945
AD  - Department of Psychiatry, University of California San Diego, San Diego, CA, USA.
AD  - Department of Psychiatry, VA San Diego Healthcare System, San Diego, CA, USA.
FAU - McElroy, Susan
AU  - McElroy S
AD  - Department of Psychiatry, Lindner Center of Hope / University of Cincinnati, 
      Mason, OH, USA.
FAU - Colom, Francesc
AU  - Colom F
AUID- ORCID: 0000-0002-9516-9030
AD  - Mental Health Research Group, IMIM-Hospital del Mar, Barcelona, Catalonia, Spain.
AD  - Department of Genetics, Microbiology and Statistics, Faculty of Biology, 
      University of Barcelona, Barcelona, Spain.
FAU - Millischer, Vincent
AU  - Millischer V
AUID- ORCID: 0000-0003-1919-9649
AD  - Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, 
      Sweden.
AD  - Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
AD  - Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, 
      Austria.
FAU - Mitjans, Marina
AU  - Mitjans M
AD  - Department of Genetics, Microbiology and Statistics, Faculty of Biology, 
      University of Barcelona, Barcelona, Spain.
AD  - Institut de Biomedicina de la Universitat de Barcelona (IBUB), Barcelona, Spain.
AD  - Centro de Investigación Biomédica en Salud Mental (CIBERSAM), Instituto de Salud 
      Carlos III, Madrid, Spain.
FAU - Mondimore, Francis M
AU  - Mondimore FM
AD  - Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, 
      Baltimore, MD, USA.
FAU - Monteleone, Palmiero
AU  - Monteleone P
AUID- ORCID: 0000-0002-5287-3829
AD  - Neurosciences Section, Department of Medicine, Surgery and Dentistry "Scuola 
      Medica Salernitana", University of Salerno, Salerno, Italy.
AD  - Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, 
      Italy.
FAU - Nievergelt, Caroline M
AU  - Nievergelt CM
AD  - Department of Psychiatry, University of California San Diego, San Diego, CA, USA.
FAU - Nöthen, Markus M
AU  - Nöthen MM
AUID- ORCID: 0000-0002-8770-2464
AD  - Institute of Human Genetics, University of Bonn, School of Medicine & University 
      Hospital Bonn, Bonn, Germany.
FAU - Novák, Tomas
AU  - Novák T
AUID- ORCID: 0000-0001-9156-9654
AD  - National Institute of Mental Health, Klecany, Czech Republic.
FAU - O'Donovan, Claire
AU  - O'Donovan C
AD  - Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
FAU - Ozaki, Norio
AU  - Ozaki N
AD  - Department of Psychiatry & Department of Child and Adolescent Psychiatry, Nagoya 
      University Graduate School of Medicine, Nagoya, Japan.
FAU - Pfennig, Andrea
AU  - Pfennig A
AD  - Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav 
      Carus, Medical Faculty, Technische Universität Dresden, Dresden, Germany.
FAU - Pisanu, Claudia
AU  - Pisanu C
AUID- ORCID: 0000-0002-9151-4319
AD  - Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
FAU - Potash, James B
AU  - Potash JB
AD  - Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, 
      Baltimore, MD, USA.
FAU - Reif, Andreas
AU  - Reif A
AUID- ORCID: 0000-0002-0992-634X
AD  - Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University 
      Hospital Frankfurt, Frankfurt, Germany.
FAU - Reininghaus, Eva
AU  - Reininghaus E
AUID- ORCID: 0000-0001-5964-4087
AD  - Department of Psychiatry and Psychotherapeutic Medicine, Research Unit for 
      bipolar affective disorder, Medical University of Graz, Graz, Austria.
FAU - Rouleau, Guy A
AU  - Rouleau GA
AUID- ORCID: 0000-0001-8403-1418
AD  - Montreal Neurological Institute and Hospital, McGill University, Montreal, 
      Canada.
FAU - Rybakowski, Janusz K
AU  - Rybakowski JK
AUID- ORCID: 0000-0003-0577-0381
AD  - Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, 
      Poland.
FAU - Schalling, Martin
AU  - Schalling M
AUID- ORCID: 0000-0001-5011-2922
AD  - Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, 
      Sweden.
AD  - Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
FAU - Schofield, Peter R
AU  - Schofield PR
AUID- ORCID: 0000-0003-2967-9662
AD  - Neuroscience Research Australia, Sydney, NSW, Australia.
AD  - School of Medical Sciences, University of New South Wales, Sydney, NSW, 
      Australia.
FAU - Schweizer, Barbara W
AU  - Schweizer BW
AD  - Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, 
      Baltimore, MD, USA.
FAU - Severino, Giovanni
AU  - Severino G
AUID- ORCID: 0000-0002-6354-2662
AD  - Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
FAU - Shilling, Paul D
AU  - Shilling PD
AD  - Department of Psychiatry, University of California San Diego, San Diego, CA, USA.
FAU - Shimoda, Katzutaka
AU  - Shimoda K
AUID- ORCID: 0000-0002-9663-6243
AD  - Department of Psychiatry, Dokkyo Medical University School of Medicine, Mibu, 
      Tochigi, Japan.
FAU - Simhandl, Christian
AU  - Simhandl C
AD  - Bipolar Center Wiener Neustadt, Sigmund Freud University, Medical Faculty, 
      Vienna, Austria.
FAU - Slaney, Claire M
AU  - Slaney CM
AD  - Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
FAU - Squassina, Alessio
AU  - Squassina A
AUID- ORCID: 0000-0001-7415-7607
AD  - Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
FAU - Stamm, Thomas
AU  - Stamm T
AD  - Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, 
      Campus Charité Mitte, Berlin, Germany.
AD  - Department of Clinical Psychiatry and Psychotherapy, Brandenburg Medical School, 
      Brandenburg, Germany.
FAU - Stopkova, Pavla
AU  - Stopkova P
AUID- ORCID: 0000-0003-2712-3652
AD  - National Institute of Mental Health, Klecany, Czech Republic.
FAU - Maj, Mario
AU  - Maj M
AD  - Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, 
      Italy.
FAU - Turecki, Gustavo
AU  - Turecki G
AUID- ORCID: 0000-0003-4075-2736
AD  - Douglas Mental Health University Institute, McGill University, Montreal, Canada.
FAU - Vieta, Eduard
AU  - Vieta E
AUID- ORCID: 0000-0002-0548-0053
AD  - Bipolar and Depressive Disorders Program,, Institute of Neuroscience, Hospital 
      Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
FAU - Veeh, Julia
AU  - Veeh J
AD  - Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University 
      Hospital Frankfurt, Frankfurt, Germany.
FAU - Witt, Stephanie H
AU  - Witt SH
AUID- ORCID: 0000-0002-1571-1468
AD  - Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental 
      Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
FAU - Wright, Adam
AU  - Wright A
AD  - School of Psychiatry, University of New South Wales, and Black Dog Institute, 
      Sydney, Australia.
FAU - Zandi, Peter P
AU  - Zandi PP
AUID- ORCID: 0000-0001-8423-2623
AD  - Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, MD, USA.
FAU - Mitchell, Philip B
AU  - Mitchell PB
AD  - School of Psychiatry, University of New South Wales, and Black Dog Institute, 
      Sydney, Australia.
FAU - Bauer, Michael
AU  - Bauer M
AD  - Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav 
      Carus, Medical Faculty, Technische Universität Dresden, Dresden, Germany.
FAU - Alda, Martin
AU  - Alda M
AUID- ORCID: 0000-0001-9544-3944
AD  - Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
AD  - National Institute of Mental Health, Klecany, Czech Republic.
FAU - Rietschel, Marcella
AU  - Rietschel M
AUID- ORCID: 0000-0002-5236-6149
AD  - Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental 
      Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
FAU - McMahon, Francis J
AU  - McMahon FJ
AUID- ORCID: 0000-0002-9469-305X
AD  - Intramural Research Program, National Institute of Mental Health, National 
      Institutes of Health, US Department of Health & Human Services, Bethesda, MD, 
      USA.
FAU - Schulze, Thomas G
AU  - Schulze TG
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, Germany.
AD  - Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, 
      Baltimore, MD, USA.
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Norton College of Medicine, Syracuse, NY, USA.
FAU - Clark, Scott R
AU  - Clark SR
AUID- ORCID: 0000-0003-1640-5611
AD  - Discipline of Psychiatry, School of Medicine, University of Adelaide, Adelaide, 
      SA, Australia.
FAU - Baune, Bernhard T
AU  - Baune BT
AD  - Department of Psychiatry and Psychotherapy, University of Münster, Münster, 
      Germany.
AD  - Department of Psychiatry, Melbourne Medical School, University of Melbourne, 
      Parkville, VIC, Australia.
AD  - The Florey Institute of Neuroscience and Mental Health, The University of 
      Melbourne, Parkville, VIC, Australia.
LA  - eng
GR  - Emerging Leadership Investigator Grant 2021 - 2008000/Department of Health | 
      National Health and Medical Research Council (NHMRC)/
PT  - Journal Article
DEP - 20230711
PL  - England
TA  - Mol Psychiatry
JT  - Molecular psychiatry
JID - 9607835
SB  - IM
UOF - Res Sq. 2023 Feb 14;:. PMID: 36824922
EDAT- 2023/07/12 01:07
MHDA- 2023/07/12 01:07
CRDT- 2023/07/11 23:30
PHST- 2023/02/12 00:00 [received]
PHST- 2023/06/16 00:00 [accepted]
PHST- 2023/05/31 00:00 [revised]
PHST- 2023/07/12 01:07 [medline]
PHST- 2023/07/12 01:07 [pubmed]
PHST- 2023/07/11 23:30 [entrez]
AID - 10.1038/s41380-023-02149-1 [pii]
AID - 10.1038/s41380-023-02149-1 [doi]
PST - aheadofprint
SO  - Mol Psychiatry. 2023 Jul 11. doi: 10.1038/s41380-023-02149-1.

PMID- 36274531
OWN - NLM
STAT- MEDLINE
DCOM- 20221215
LR  - 20230314
IS  - 1879-1379 (Electronic)
IS  - 0022-3956 (Print)
IS  - 0022-3956 (Linking)
VI  - 156
DP  - 2022 Dec
TI  - Can machine learning identify childhood characteristics that predict future 
      development of bipolar disorder a decade later?
PG  - 261-267
LID - S0022-3956(22)00542-8 [pii]
LID - 10.1016/j.jpsychires.2022.09.051 [doi]
AB  - Early identification of bipolar disorder may provide appropriate support and 
      treatment, however there is no current evidence for statistically predicting 
      whether a child will develop bipolar disorder. Machine learning methods offer an 
      opportunity for developing empirically-based predictors of bipolar disorder. This 
      study examined whether bipolar disorder can be predicted using clinical data and 
      machine learning algorithms. 492 children, ages 6-18 at baseline, were recruited 
      from longitudinal case-control family studies. Participants were assessed at 
      baseline, then followed-up after 10 years. In addition to sociodemographic data, 
      children were assessed with psychometric scales, structured diagnostic 
      interviews, and cognitive and social functioning assessments. Using the Balanced 
      Random Forest algorithm, we examined whether the diagnostic outcome of full or 
      subsyndromal bipolar disorder could be predicted from baseline data. 45 children 
      (10%) developed bipolar disorder at follow-up. The model predicted subsequent 
      bipolar disorder with 75% sensitivity, 76% specificity, and an Area Under the 
      Receiver Operating Characteristics of 75%. Predictors best differentiating 
      between children who did or did not develop bipolar disorder were the Child 
      Behavioral Checklist Externalizing and Internalizing behaviors, the Child 
      Behavioral Checklist Total t-score, problematic school functions indexed through 
      the Child Behavioral Checklist School Competence scale, and the Child Behavioral 
      Checklist Anxiety/Depression and Aggression scales. Our study provides the first 
      quantitative model to predict bipolar disorder. Longitudinal prediction may help 
      clinicians assess children with emergent psychopathology for future risk of 
      bipolar disorder, an area of clinical and scientific importance. Machine learning 
      algorithms could be implemented to alert clinicians to risk for bipolar disorder.
CI  - Copyright © 2022 Elsevier Ltd. All rights reserved.
FAU - Uchida, Mai
AU  - Uchida M
AD  - Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, 
      Massachusetts General Hospital, Boston, MA, USA; Department of Psychiatry, 
      Harvard Medical School, Boston, MA, USA. Electronic address: 
      muchida@partners.org.
FAU - Bukhari, Qasim
AU  - Bukhari Q
AD  - Department of Brain and Cognitive Sciences and McGovern Institute for Brain 
      Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
FAU - DiSalvo, Maura
AU  - DiSalvo M
AD  - Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, 
      Massachusetts General Hospital, Boston, MA, USA.
FAU - Green, Allison
AU  - Green A
AD  - Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, 
      Massachusetts General Hospital, Boston, MA, USA; Department of Psychological and 
      Brain Sciences, Indiana University, Bloomington, IN, USA.
FAU - Serra, Giulia
AU  - Serra G
AD  - Department of Neuroscience, Child Neuropsychiatry Unit, I.R.C.C.S. Children 
      Hospital Bambino Gesù, Rome, Italy.
FAU - Hutt Vater, Chloe
AU  - Hutt Vater C
AD  - Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, 
      Massachusetts General Hospital, Boston, MA, USA.
FAU - Ghosh, Satrajit S
AU  - Ghosh SS
AD  - Department of Brain and Cognitive Sciences and McGovern Institute for Brain 
      Research, Massachusetts Institute of Technology, Cambridge, MA, USA; Department 
      of Otolaryngology Head and Neck Surgery, Harvard Medical School, USA.
FAU - Faraone, Stephen V
AU  - Faraone SV
AD  - Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate 
      Medical University, Syracuse, NY, USA.
FAU - Gabrieli, John D E
AU  - Gabrieli JDE
AD  - Department of Brain and Cognitive Sciences and McGovern Institute for Brain 
      Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
FAU - Biederman, Joseph
AU  - Biederman J
AD  - Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, 
      Massachusetts General Hospital, Boston, MA, USA; Department of Psychiatry, 
      Harvard Medical School, Boston, MA, USA.
LA  - eng
GR  - K23 MH122667/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20221013
PL  - England
TA  - J Psychiatr Res
JT  - Journal of psychiatric research
JID - 0376331
SB  - IM
MH  - Child
MH  - Humans
MH  - Adolescent
MH  - *Bipolar Disorder/diagnosis
MH  - Machine Learning
PMC - PMC9999264
MID - NIHMS1875951
OTO - NOTNLM
OT  - Bipolar disorder
OT  - Machine learning
OT  - Mood disorders
OT  - Pediatric bipolar disorder
COIS- Declaration of competing interest Dr. Mai Uchida is partially supported by a K 
      award, grant number 1K23MH122667-01. Dr. Uchida also provided a one-time 
      consultation to the Moderna scientific advisory board. Allison Green received 
      funding from the Eunice Kennedy Shriver National Institute of Child Health & 
      Human Development of the National Institutes of Health under award number 
      T32HD007475. In the past year, Dr. Faraone received income, potential income, 
      travel expenses continuing education support and/or research support from 
      Aardvark, Akili, Genomind, Ironshore, KemPharm/Corium, Noven, Ondosis, Otsuka, 
      Rhodes, Supernus, Takeda, Tris and Vallon. With his institution, he has US patent 
      US20130217707 A1 for the use of sodium-hydrogen exchange inhibitors in the 
      treatment of ADHD. In previous years, he received support from: Alcobra, Arbor, 
      Aveksham, CogCubed, Eli Lilly, Enzymotec, Impact, Janssen, Lundbeck/Takeda, 
      McNeil, NeuroLifeSciences, Neurovance, Novartis, Pfizer, Shire, and Sunovion. He 
      also receives royalties from books published by Guilford Press: Straight Talk 
      about Your Child's Mental Health; Oxford University Press: Schizophrenia: The 
      Facts; and Elsevier: ADHD: Non-Pharmacologic Interventions. He is also Program 
      Director of www.adhdinadults.com. Dr. Faraone is supported by the European 
      Union's Horizon 2020 research and innovation programme under grant agreement No 
      965381; NIMH grants U01AR076092-01A1, 1R21MH1264940, R01MH116037; Oregon Health 
      and Science University, Otsuka Pharmaceuticals, Noven Pharmaceuticals 
      Incorporated, and Supernus Pharmaceutical Company. Dr. Joseph Biederman is 
      currently receiving research support from the following sources: AACAP, Feinstein 
      Institute for Medical Research, Genentech, Headspace Inc., NIDA, Pfizer 
      Pharmaceuticals, Roche TCRC Inc., Sunovion Pharmaceuticals Inc., Takeda/Shire 
      Pharmaceuticals Inc., Tris, and NIH. Dr. Biederman and his program have received 
      royalties from a copyrighted rating scale used for ADHD diagnoses, paid by 
      Biomarin, Bracket Global, Cogstate, Ingenix, Medavent Prophase, Shire/Takeda, 
      Sunovion, and Theravance; these royalties were paid to the Department of 
      Psychiatry at MGH. Through Partners Healthcare Innovation, Dr. Biederman has a 
      partnership with MEMOTEXT to commercialize a digital health intervention to 
      improve adherence in ADHD. Through MGH corporate licensing, Dr. Biederman has a 
      US Patent (#14/027,676) for a non-stimulant treatment for ADHD, a US Patent 
      (#10,245,271 B2) on a treatment of impaired cognitive flexibility, and a patent 
      pending (#61/233,686) on a method to prevent stimulant abuse. In 2022: Dr. 
      Biederman received honoraria from the MGH Psychiatry Academy for tuition-funded 
      CME courses. In 2021: Dr. Biederman received an honorarium for a scientific 
      presentation from Multi-Health Systems, and a one-time consultation for Cowen 
      Healthcare Investments. He received honoraria from AACAP, the American 
      Psychiatric Nurses Association, BIAL - Portela & C(a). S.A. (Portugal), Medscape 
      Education, and MGH Psychiatry Academy for tuition-funded CME courses. In 2020: 
      Dr. Biederman received an honorarium for a scientific presentation from Tris and 
      from the Institute of Integrated Sciences – INI (Brazil), and research support 
      from the Food & Drug Administration. He received honoraria from Medlearning Inc, 
      NYU, and MGH Psychiatry Academy for tuition-funded CME courses. In 2019, Dr. 
      Biederman was a consultant for Akili, Avekshan, Jazz Pharma, and Shire/Takeda. He 
      received research support from Lundbeck AS and Neurocentria Inc. Through MGH 
      CTNI, he participated in a scientific advisory board for Supernus. He received 
      honoraria from the MGH Psychiatry Academy for tuition-funded CME courses. Dr. 
      Qasim Bukhari, Ms. Maura DiSalvo, Dr. Guilla Serra, Ms. Chloe Hutt Vater, Dr. 
      Satrajit Ghosh, and Dr. John Gabrieli do not have any financial relationships to 
      disclose.
EDAT- 2022/10/25 06:00
MHDA- 2022/12/15 06:00
CRDT- 2022/10/24 03:23
PHST- 2022/06/24 00:00 [received]
PHST- 2022/08/26 00:00 [revised]
PHST- 2022/09/24 00:00 [accepted]
PHST- 2022/10/25 06:00 [pubmed]
PHST- 2022/12/15 06:00 [medline]
PHST- 2022/10/24 03:23 [entrez]
AID - S0022-3956(22)00542-8 [pii]
AID - 10.1016/j.jpsychires.2022.09.051 [doi]
PST - ppublish
SO  - J Psychiatr Res. 2022 Dec;156:261-267. doi: 10.1016/j.jpsychires.2022.09.051. 
      Epub 2022 Oct 13.

PMID- 37708996
OWN - NLM
STAT- MEDLINE
DCOM- 20231002
LR  - 20231011
IS  - 1879-016X (Electronic)
IS  - 0163-7258 (Linking)
VI  - 250
DP  - 2023 Oct
TI  - Use of big data and machine learning algorithms to extract possible treatment 
      targets in neurodevelopmental disorders.
PG  - 108530
LID - S0163-7258(23)00194-8 [pii]
LID - 10.1016/j.pharmthera.2023.108530 [doi]
AB  - Neurodevelopmental disorders (NDDs) impact multiple aspects of an individual's 
      functioning, including social interactions, communication, and behaviors. The 
      underlying biological mechanisms of NDDs are not yet fully understood, and 
      pharmacological treatments have been limited in their effectiveness, in part due 
      to the complex nature of these disorders and the heterogeneity of symptoms across 
      individuals. Identifying genetic loci associated with NDDs can help in 
      understanding biological mechanisms and potentially lead to the development of 
      new treatments. However, the polygenic nature of these complex disorders has made 
      identifying new treatment targets from genome-wide association studies (GWAS) 
      challenging. Recent advances in the fields of big data and high-throughput tools 
      have provided radically new insights into the underlying biological mechanism of 
      NDDs. This paper reviews various big data approaches, including classical and 
      more recent techniques like deep learning, which can identify potential treatment 
      targets from GWAS and other omics data, with a particular emphasis on NDDs. We 
      also emphasize the increasing importance of explainable and causal machine 
      learning (ML) methods that can aid in identifying genes, molecular pathways, and 
      more complex biological processes that may be future targets of intervention in 
      these disorders. We conclude that these new developments in genetics and ML hold 
      promise for advancing our understanding of NDDs and identifying novel treatment 
      targets.
CI  - Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
FAU - Malik, Muhammad Ammar
AU  - Malik MA
AD  - Computational Biology Unit, Department of Informatics, University of Bergen, PO 
      BOX 7803, 5020 Bergen, Norway.
FAU - Faraone, Stephen V
AU  - Faraone SV
AD  - Department of Psychiatry, Norton College of Medicine at SUNY Upstate Medical 
      University, 13210, NY, USA.
FAU - Michoel, Tom
AU  - Michoel T
AD  - Computational Biology Unit, Department of Informatics, University of Bergen, PO 
      BOX 7803, 5020 Bergen, Norway.
FAU - Haavik, Jan
AU  - Haavik J
AD  - Department of Biomedicine, University of Bergen, PO BOX 7804, 5020 Bergen, 
      Norway; Bergen Center for Brain Plasticity, Division of Psychiatry, Haukeland 
      University Hospital, PO BOX 1400, 5021 Bergen, Norway. Electronic address: 
      Jan.Haavik@uib.no.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Review
DEP - 20230912
PL  - England
TA  - Pharmacol Ther
JT  - Pharmacology & therapeutics
JID - 7905840
SB  - IM
MH  - Humans
MH  - *Genome-Wide Association Study
MH  - Big Data
MH  - *Neurodevelopmental Disorders/drug therapy/genetics
MH  - Algorithms
MH  - Machine Learning
OTO - NOTNLM
OT  - Drug repurposing
OT  - Genomics
OT  - Machine learning
OT  - Neurodevelopmental disorders
OT  - Neuropsychiatric disorders
OT  - Therapeutic targets
COIS- Declaration of Competing Interest The authors declare that there are no conflicts 
      of interest.
EDAT- 2023/09/15 00:42
MHDA- 2023/10/02 06:42
CRDT- 2023/09/14 19:14
PHST- 2023/04/13 00:00 [received]
PHST- 2023/08/30 00:00 [revised]
PHST- 2023/09/11 00:00 [accepted]
PHST- 2023/10/02 06:42 [medline]
PHST- 2023/09/15 00:42 [pubmed]
PHST- 2023/09/14 19:14 [entrez]
AID - S0163-7258(23)00194-8 [pii]
AID - 10.1016/j.pharmthera.2023.108530 [doi]
PST - ppublish
SO  - Pharmacol Ther. 2023 Oct;250:108530. doi: 10.1016/j.pharmthera.2023.108530. Epub 
      2023 Sep 12.

PMID- 31595035
OWN - NLM
STAT- MEDLINE
DCOM- 20201207
LR  - 20210310
IS  - 1476-5578 (Electronic)
IS  - 1359-4184 (Linking)
VI  - 25
IP  - 2
DP  - 2020 Feb
TI  - Extracorporeal apheresis therapy for Alzheimer disease-targeting lipids, stress, 
      and inflammation.
PG  - 275-282
LID - 10.1038/s41380-019-0542-x [doi]
AB  - Current therapeutic approaches to Alzheimer disease (AD) remain disappointing 
      and, hence, there is an urgent need for effective treatments. Here, we provide a 
      perspective review on the emerging role of "metabolic inflammation" and stress as 
      a key factor in the pathogenesis of AD and propose a novel rationale for 
      correction of metabolic inflammation, increase resilience and potentially 
      slow-down or halt the progression of the neurodegenerative process. Based on 
      recent evidence and observations of an early pilot trial, we posit a potential 
      use of extracorporeal apheresis in the prevention and treatment of AD. 
      Apolipoprotein E, lipoprotein(a), oxidized LDL (low density lipoprotein)'s and 
      large LDL particles, as well as other proinflammatory lipids and stress hormones 
      such as cortisol, have been recognized as key factors in amyloid plaque formation 
      and aggravation of AD. Extracorporeal lipoprotein apheresis systems employ 
      well-established, powerful methods to provide an acute, reliable 60-80% reduction 
      in the circulating concentration of these lipid classes and reduce acute cortisol 
      levels. Following a double-membrane extracorporeal apheresis in patients with AD, 
      there was a significant reduction of proinflammatory lipids, circulating 
      cytokines, immune complexes, proinflammatory metals and toxic chaperones in 
      patients with AD. On the basis of the above, we suggest designing clinical trials 
      to assess the promising potential of such "cerebropheresis" treatment in patients 
      with AD and, possibly, other neurodegenerative diseases.
FAU - Bornstein, Stefan R
AU  - Bornstein SR
AD  - Department of Medicine III, University Hospital Carl Gustav Carus, Dresden, 
      Germany. stefan.bornstein@ukdd.de.
AD  - Division of Diabetes & Nutritional Sciences, Faculty of Life Sciences & Medicine, 
      King's College London, London, UK. stefan.bornstein@ukdd.de.
AD  - Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, University 
      Hospital, Zürich, Switzerland. stefan.bornstein@ukdd.de.
FAU - Voit-Bak, Karin
AU  - Voit-Bak K
AD  - Zentrums für Apherese- und Hämofiltration am INUS Tagesklinikum, Cham, Germany.
FAU - Rosenthal, Peter
AU  - Rosenthal P
AD  - Facharzt für Nervenheilkunde, Facharzt Psychiatrie und Psychotherapie, 
      Paulmannshöher Strasse 17, 58515, Lüdenscheid, Germany.
FAU - Tselmin, Sergey
AU  - Tselmin S
AD  - Department of Medicine III, University Hospital Carl Gustav Carus, Dresden, 
      Germany.
FAU - Julius, Ulrich
AU  - Julius U
AD  - Department of Medicine III, University Hospital Carl Gustav Carus, Dresden, 
      Germany.
FAU - Schatz, Ulrike
AU  - Schatz U
AD  - Department of Medicine III, University Hospital Carl Gustav Carus, Dresden, 
      Germany.
FAU - Boehm, Bernhard O
AU  - Boehm BO
AD  - Lee Kong Chian School of Medicine, NTU Nanyang Technological University, 
      Singapore, Singapore.
FAU - Thuret, Sandrine
AU  - Thuret S
AUID- ORCID: 0000-0003-1260-8083
AD  - Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical 
      Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's 
      College London, London, UK.
FAU - Kempermann, Gerd
AU  - Kempermann G
AUID- ORCID: 0000-0002-5304-4061
AD  - Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, 
      01307, Dresden, Germany.
AD  - German Center for Neurodegenerative Diseases (DZNE) Dresden, 01307, Dresden, 
      Germany.
FAU - Reichmann, Heinz
AU  - Reichmann H
AD  - Department of Neurology University Hospital Carl Gustav Carus, Technische 
      Universität Dresden, 01307, Dresden, Germany.
FAU - Chrousos, George P
AU  - Chrousos GP
AD  - Department of Medicine III, University Hospital Carl Gustav Carus, Dresden, 
      Germany.
AD  - University Research Institute of Maternal and Child Health & Precision Medicine, 
      National and Kapodistrian University of Athens, Athens, Greece.
FAU - Licinio, Julio
AU  - Licinio J
AD  - State University of New York Upstate Medical University, Syracuse, NY, USA.
FAU - Wong, Ma-Li
AU  - Wong ML
AUID- ORCID: 0000-0003-1512-3073
AD  - State University of New York Upstate Medical University, Syracuse, NY, USA.
FAU - Schally, Andrew V
AU  - Schally AV
AD  - Departments of Pathology, Department of Medicine, Sylvester Comprehensive Cancer 
      Center, Miller School of Medicine, University of Miami, Miami, FL, USA.
AD  - Veterans Affairs Medical Center, Miami, FL, USA.
FAU - Straube, Richard
AU  - Straube R
AD  - Zentrums für Apherese- und Hämofiltration am INUS Tagesklinikum, Cham, Germany.
LA  - eng
GR  - MC_PC_18052/MRC_/Medical Research Council/United Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Review
DEP - 20191008
PL  - England
TA  - Mol Psychiatry
JT  - Molecular psychiatry
JID - 9607835
RN  - 0 (Cholesterol, LDL)
RN  - 0 (Lipids)
RN  - 0 (Lipoproteins, LDL)
RN  - 0 (oxidized low density lipoprotein)
SB  - IM
MH  - Alzheimer Disease/*therapy
MH  - Blood Component Removal/*methods
MH  - Cholesterol, LDL/blood
MH  - Humans
MH  - Inflammation/metabolism
MH  - Lipid Metabolism/physiology
MH  - Lipids/physiology
MH  - Lipoproteins, LDL/blood
MH  - Stress, Psychological/physiopathology
EDAT- 2019/10/09 06:00
MHDA- 2020/12/15 06:00
CRDT- 2019/10/10 06:00
PHST- 2019/06/17 00:00 [received]
PHST- 2019/09/24 00:00 [accepted]
PHST- 2019/09/13 00:00 [revised]
PHST- 2019/10/09 06:00 [pubmed]
PHST- 2020/12/15 06:00 [medline]
PHST- 2019/10/10 06:00 [entrez]
AID - 10.1038/s41380-019-0542-x [pii]
AID - 10.1038/s41380-019-0542-x [doi]
PST - ppublish
SO  - Mol Psychiatry. 2020 Feb;25(2):275-282. doi: 10.1038/s41380-019-0542-x. Epub 2019 
      Oct 8.

PMID- 37864295
OWN - NLM
STAT- MEDLINE
DCOM- 20240117
LR  - 20240117
IS  - 1477-4054 (Electronic)
IS  - 1467-5463 (Print)
IS  - 1467-5463 (Linking)
VI  - 24
IP  - 6
DP  - 2023 Sep 22
TI  - Generative models for protein sequence modeling: recent advances and future 
      directions.
LID - 10.1093/bib/bbad358 [doi]
LID - bbad358
AB  - The widespread adoption of high-throughput omics technologies has exponentially 
      increased the amount of protein sequence data involved in many salient disease 
      pathways and their respective therapeutics and diagnostics. Despite the 
      availability of large-scale sequence data, the lack of experimental fitness 
      annotations underpins the need for self-supervised and unsupervised machine 
      learning (ML) methods. These techniques leverage the meaningful features encoded 
      in abundant unlabeled sequences to accomplish complex protein engineering tasks. 
      Proficiency in the rapidly evolving fields of protein engineering and generative 
      AI is required to realize the full potential of ML models as a tool for protein 
      fitness landscape navigation. Here, we support this work by (i) providing an 
      overview of the architecture and mathematical details of the most successful ML 
      models applicable to sequence data (e.g. variational autoencoders, autoregressive 
      models, generative adversarial neural networks, and diffusion models), (ii) 
      guiding how to effectively implement these models on protein sequence data to 
      predict fitness or generate high-fitness sequences and (iii) highlighting several 
      successful studies that implement these techniques in protein engineering (from 
      paratope regions and subcellular localization prediction to high-fitness 
      sequences and protein design rules generation). By providing a comprehensive 
      survey of model details, novel architecture developments, comparisons of model 
      applications, and current challenges, this study intends to provide structured 
      guidance and robust framework for delivering a prospective outlook in the 
      ML-driven protein engineering field.
CI  - © The Author(s) 2023. Published by Oxford University Press.
FAU - Mardikoraem, Mehrsa
AU  - Mardikoraem M
AD  - Michigan State University (MSU)'s Department of Chemical Engineering and 
      Materials Science.
FAU - Wang, Zirui
AU  - Wang Z
AD  - Regeneron Pharmaceuticals, Inc. Having received his B.S. in Chemical Engineering 
      from MSU, he is currently pursuing a M.S. in Computer Science from Syracuse 
      University.
FAU - Pascual, Nathaniel
AU  - Pascual N
AD  - B.S. in Chemical Engineering from MSU.
FAU - Woldring, Daniel
AU  - Woldring D
AD  - MSU's Department of Chemical Engineering and Materials Science and a member of 
      MSU's Institute for Quantitative Health Sciences and Engineering.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Review
PL  - England
TA  - Brief Bioinform
JT  - Briefings in bioinformatics
JID - 100912837
RN  - 0 (Proteins)
SB  - IM
MH  - Amino Acid Sequence
MH  - Exercise
MH  - *Neural Networks, Computer
MH  - Proteins/genetics
MH  - *Unsupervised Machine Learning
PMC - PMC10589401
OTO - NOTNLM
OT  - diffusion models
OT  - generative adversarial neural networks (GANs)
OT  - generative machine learning (ML) models
OT  - natural language processing (NLP)
OT  - protein engineering
OT  - variational autoencoders (VAE)
EDAT- 2023/10/21 10:42
MHDA- 2023/11/02 12:43
CRDT- 2023/10/21 00:33
PHST- 2023/06/13 00:00 [received]
PHST- 2023/09/08 00:00 [revised]
PHST- 2023/09/12 00:00 [accepted]
PHST- 2023/11/02 12:43 [medline]
PHST- 2023/10/21 10:42 [pubmed]
PHST- 2023/10/21 00:33 [entrez]
AID - 7325909 [pii]
AID - bbad358 [pii]
AID - 10.1093/bib/bbad358 [doi]
PST - ppublish
SO  - Brief Bioinform. 2023 Sep 22;24(6):bbad358. doi: 10.1093/bib/bbad358.

PMID- 34343338
OWN - NLM
STAT- MEDLINE
DCOM- 20220309
LR  - 20221102
IS  - 1097-0142 (Electronic)
IS  - 0008-543X (Print)
IS  - 0008-543X (Linking)
VI  - 127
IP  - 21
DP  - 2021 Nov 1
TI  - Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus 
      statement.
PG  - 3957-3966
LID - 10.1002/cncr.33679 [doi]
AB  - BACKGROUND: Although renal cell carcinoma (RCC) is believed to have a strong 
      hereditary component, there is a paucity of published guidelines for genetic risk 
      assessment. A panel of experts was convened to gauge current opinions. METHODS: A 
      North American multidisciplinary panel with expertise in hereditary RCC, 
      including urologists, medical oncologists, clinical geneticists, genetic 
      counselors, and patient advocates, was convened. Before the summit, a modified 
      Delphi methodology was used to generate, review, and curate a set of consensus 
      questions regarding RCC genetic risk assessment. Uniform consensus was defined as 
      ≥85% agreement on particular questions. RESULTS: Thirty-three panelists, 
      including urologists (n = 13), medical oncologists (n = 12), genetic counselors 
      and clinical geneticists (n = 6), and patient advocates (n = 2), reviewed 53 
      curated consensus questions. Uniform consensus was achieved on 30 statements in 
      specific areas that addressed for whom, what, when, and how genetic testing 
      should be performed. Topics of consensus included the family history criteria, 
      which should trigger further assessment, the need for risk assessment in those 
      with bilateral or multifocal disease and/or specific histology, the utility of 
      multigene panel testing, and acceptance of clinician-based counseling and testing 
      by those who have experience with hereditary RCC. CONCLUSIONS: In the first ever 
      consensus panel on RCC genetic risk assessment, 30 consensus statements were 
      reached. Areas that require further research and discussion were also identified, 
      with a second future meeting planned. This consensus statement may provide 
      further guidance for clinicians when considering RCC genetic risk assessment. LAY 
      SUMMARY: The contribution of germline genetics to the development of renal cell 
      carcinoma (RCC) has long been recognized. However, there is a paucity of 
      guidelines to define how and when genetic risk assessment should be performed for 
      patients with known or suspected hereditary RCC. Without guidelines, clinicians 
      struggle to define who requires further evaluation, when risk assessment or 
      testing should be done, which genes should be considered, and how counseling 
      and/or testing should be performed. To this end, a multidisciplinary panel of 
      national experts was convened to gauge current opinion on genetic risk assessment 
      in RCC and to enumerate a set of recommendations to guide clinicians when 
      evaluating individuals with suspected hereditary kidney cancer.
CI  - © 2021 American Cancer Society.
FAU - Bratslavsky, Gennady
AU  - Bratslavsky G
AD  - Department of Urology, State University of New York (SUNY, Upstate Medical 
      University, Syracuse, New York.
FAU - Mendhiratta, Neil
AU  - Mendhiratta N
AUID- ORCID: 0000-0002-4071-3094
AD  - Department of Urology, University of California Los Angeles, Los Angeles, 
      California.
FAU - Daneshvar, Michael
AU  - Daneshvar M
AD  - Department of Urology, State University of New York (SUNY, Upstate Medical 
      University, Syracuse, New York.
AD  - Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, 
      Bethesda, Maryland.
FAU - Brugarolas, James
AU  - Brugarolas J
AD  - Department of Medicine, Division of Hematology-Oncology, University of Texas (UT) 
      Southwestern Medical Center, Dallas, Texas.
FAU - Ball, Mark W
AU  - Ball MW
AUID- ORCID: 0000-0003-1780-2627
AD  - Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, 
      Bethesda, Maryland.
FAU - Metwalli, Adam
AU  - Metwalli A
AD  - Department of Surgery, Division of Urology, Howard University Hospital, 
      Washington, District of Columbia.
FAU - Nathanson, Katherine L
AU  - Nathanson KL
AD  - Division of Human Genetics and Translational Medicine, Department of Medicine, 
      Perelman School of Medicine, University of Pennsylvania, Philadelphia, 
      Pennsylvania.
AD  - Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, 
      Philadelphia, Pennsylvania.
FAU - Pierorazio, Phillip M
AU  - Pierorazio PM
AD  - Brady Urological Institute and Department of Urology, Johns Hopkins School of 
      Medicine, Baltimore, Maryland.
FAU - Boris, Ronald S
AU  - Boris RS
AD  - Indiana University School of Medicine, Indianapolis, Indiana.
FAU - Singer, Eric A
AU  - Singer EA
AD  - Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey, New 
      Brunswick, New Jersey.
FAU - Carlo, Maria I
AU  - Carlo MI
AD  - Memorial Sloan Kettering Cancer Center, New York, New York.
FAU - Daly, Mary B
AU  - Daly MB
AD  - Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, 
      Pennsylvania.
FAU - Henske, Elizabeth P
AU  - Henske EP
AD  - Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 
      Boston, Massachusetts.
FAU - Hyatt, Colette
AU  - Hyatt C
AD  - Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, 
      Pennsylvania.
FAU - Middleton, Lindsay
AU  - Middleton L
AD  - Department of Medicine, Division of Hematology-Oncology, University of Texas (UT) 
      Southwestern Medical Center, Dallas, Texas.
FAU - Morris, Gloria
AU  - Morris G
AD  - Department of Urology, State University of New York (SUNY, Upstate Medical 
      University, Syracuse, New York.
FAU - Jeong, Anhyo
AU  - Jeong A
AD  - Department of Urology, University of California Los Angeles, Los Angeles, 
      California.
FAU - Narayan, Vivek
AU  - Narayan V
AD  - Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, 
      Philadelphia, Pennsylvania.
AD  - Division of Hematology/Oncology, Department of Medicine, Perelman School of 
      Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
FAU - Rathmell, W Kimryn
AU  - Rathmell WK
AD  - Department of Medicine, Vanderbilt University, Nashville, Tennessee.
FAU - Vaishampayan, Ulka
AU  - Vaishampayan U
AUID- ORCID: 0000-0001-5800-4571
AD  - Department of Oncology, Karmanos Cancer Center/Wayne State University, Detroit, 
      Michigan.
FAU - Lee, Bruce H
AU  - Lee BH
AD  - Driven To Cure, Silver Spring, Maryland.
FAU - Battle, Dena
AU  - Battle D
AD  - The Kidney Cancer Research Alliance, Leesburg, Virginia.
FAU - Hall, Michael J
AU  - Hall MJ
AD  - Department of Surgery, Division of Urology, Fox Chase Cancer Center, 
      Philadelphia, Pennsylvania.
FAU - Hafez, Khaled
AU  - Hafez K
AD  - Department of Urology, University of Michigan, Ann Arbor, Michigan.
FAU - Jewett, Michael A S
AU  - Jewett MAS
AD  - Division of Urology, Department of Surgery, Princess Margaret Cancer Center, 
      Toronto, Ontario, Canada.
FAU - Karamboulas, Christina
AU  - Karamboulas C
AD  - Division of Urology, Department of Surgery, Princess Margaret Cancer Center, 
      Toronto, Ontario, Canada.
FAU - Pal, Sumanta K
AU  - Pal SK
AUID- ORCID: 0000-0002-1712-0848
AD  - Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, 
      California.
FAU - Hakimi, A Ari
AU  - Hakimi AA
AD  - Memorial Sloan Kettering Cancer Center, New York, New York.
FAU - Kutikov, Alexander
AU  - Kutikov A
AD  - Department of Surgery, Division of Urology, Fox Chase Cancer Center, 
      Philadelphia, Pennsylvania.
FAU - Iliopoulos, Othon
AU  - Iliopoulos O
AD  - Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
FAU - Linehan, W Marston
AU  - Linehan WM
AD  - Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, 
      Bethesda, Maryland.
FAU - Jonasch, Eric
AU  - Jonasch E
AD  - The University of Texas MD Anderson Cancer Center, Houston, Texas.
FAU - Srinivasan, Ramaprasad
AU  - Srinivasan R
AD  - Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, 
      Bethesda, Maryland.
FAU - Shuch, Brian
AU  - Shuch B
AUID- ORCID: 0000-0003-2065-3570
AD  - Department of Urology, University of California Los Angeles, Los Angeles, 
      California.
LA  - eng
GR  - P30 CA072720/CA/NCI NIH HHS/United States
GR  - UL1 TR001863/TR/NCATS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20210803
PL  - United States
TA  - Cancer
JT  - Cancer
JID - 0374236
SB  - IM
MH  - *Carcinoma, Renal Cell/diagnosis/genetics
MH  - Consensus
MH  - Genetic Testing
MH  - Humans
MH  - *Kidney Neoplasms/diagnosis/genetics
MH  - Risk Assessment
PMC - PMC8711633
MID - NIHMS1706662
OTO - NOTNLM
OT  - *clinical consensus
OT  - *genetic risk assessment
OT  - *genetic testing
OT  - *germline mutations
OT  - *hereditary kidney cancer
OT  - *recommendations
OT  - *renal cell carcinoma
COIS- COI: There are no conflicts of interest to report
EDAT- 2021/08/04 06:00
MHDA- 2022/03/11 06:00
CRDT- 2021/08/03 17:30
PHST- 2021/04/15 00:00 [revised]
PHST- 2020/12/14 00:00 [received]
PHST- 2021/04/19 00:00 [accepted]
PHST- 2021/08/04 06:00 [pubmed]
PHST- 2022/03/11 06:00 [medline]
PHST- 2021/08/03 17:30 [entrez]
AID - 10.1002/cncr.33679 [doi]
PST - ppublish
SO  - Cancer. 2021 Nov 1;127(21):3957-3966. doi: 10.1002/cncr.33679. Epub 2021 Aug 3.

PMID- 36126402
OWN - NLM
STAT- MEDLINE
DCOM- 20221024
LR  - 20231102
IS  - 1361-8423 (Electronic)
IS  - 1361-8415 (Print)
IS  - 1361-8415 (Linking)
VI  - 82
DP  - 2022 Nov
TI  - Cross-modal attention for multi-modal image registration.
PG  - 102612
LID - S1361-8415(22)00240-7 [pii]
LID - 10.1016/j.media.2022.102612 [doi]
AB  - In the past few years, convolutional neural networks (CNNs) have been proven 
      powerful in extracting image features crucial for medical image registration. 
      However, challenging applications and recent advances in computer vision suggest 
      that CNNs are limited in their ability to understand the spatial correspondence 
      between features, which is at the core of image registration. The issue is 
      further exaggerated when it comes to multi-modal image registration, where the 
      appearances of input images can differ significantly. This paper presents a novel 
      cross-modal attention mechanism for correlating features extracted from the 
      multi-modal input images and mapping such correlation to image registration 
      transformation. To efficiently train the developed network, a contrastive 
      learning-based pre-training method is also proposed to aid the network in 
      extracting high-level features across the input modalities for the following 
      cross-modal attention learning. We validated the proposed method on transrectal 
      ultrasound (TRUS) to magnetic resonance (MR) registration, a clinically important 
      procedure that benefits prostate cancer biopsy. Our experimental results 
      demonstrate that for MR-TRUS registration, a deep neural network embedded with 
      the cross-modal attention block outperforms other advanced CNN-based networks 
      with ten times its size. We also incorporated visualization techniques to improve 
      the interpretability of our network, which helps bring insights into the deep 
      learning based image registration methods. The source code of our work is 
      available at https://github.com/DIAL-RPI/Attention-Reg.
CI  - Copyright © 2022 Elsevier B.V. All rights reserved.
FAU - Song, Xinrui
AU  - Song X
AD  - Department of Biomedical Engineering and Center for Biotechnology and 
      Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
FAU - Chao, Hanqing
AU  - Chao H
AD  - Department of Biomedical Engineering and Center for Biotechnology and 
      Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
FAU - Xu, Xuanang
AU  - Xu X
AD  - Department of Biomedical Engineering and Center for Biotechnology and 
      Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
FAU - Guo, Hengtao
AU  - Guo H
AD  - Department of Biomedical Engineering and Center for Biotechnology and 
      Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
FAU - Xu, Sheng
AU  - Xu S
AD  - Center for Interventional Oncology, Radiology & Imaging Sciences, National 
      Institutes of Health, Bethesda, MD 20892, USA.
FAU - Turkbey, Baris
AU  - Turkbey B
AD  - Molecular Imaging Program, National Cancer Institute, National Institutes of 
      Health, Bethesda, MD 20892, USA.
FAU - Wood, Bradford J
AU  - Wood BJ
AD  - Center for Interventional Oncology, Radiology & Imaging Sciences, National 
      Institutes of Health, Bethesda, MD 20892, USA.
FAU - Sanford, Thomas
AU  - Sanford T
AD  - Department of Urology, The State University of New York Upstate Medical 
      University, Syracuse, NY 13210, USA.
FAU - Wang, Ge
AU  - Wang G
AD  - Department of Biomedical Engineering and Center for Biotechnology and 
      Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
FAU - Yan, Pingkun
AU  - Yan P
AD  - Department of Biomedical Engineering and Center for Biotechnology and 
      Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA. 
      Electronic address: yanp2@rpi.edu.
LA  - eng
GR  - R01 EB027898/EB/NIBIB NIH HHS/United States
GR  - R21 EB028001/EB/NIBIB NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20220910
PL  - Netherlands
TA  - Med Image Anal
JT  - Medical image analysis
JID - 9713490
SB  - IM
MH  - Humans
MH  - Male
MH  - *Prostate/diagnostic imaging
MH  - Neural Networks, Computer
MH  - Magnetic Resonance Imaging/methods
MH  - *Prostatic Neoplasms/pathology
MH  - Ultrasonography/methods
PMC - PMC9588729
MID - NIHMS1835597
OTO - NOTNLM
OT  - Cross-modal attention
OT  - Deep learning
OT  - Multi-modal registration
OT  - Prostate caner imaging
COIS- Declaration of Competing Interest The authors declare that they have no known 
      competing financial interests or personal relationships that could have appeared 
      to influence the work reported in this paper.
EDAT- 2022/09/21 06:00
MHDA- 2022/10/25 06:00
CRDT- 2022/09/20 18:17
PHST- 2022/02/22 00:00 [received]
PHST- 2022/07/07 00:00 [revised]
PHST- 2022/08/30 00:00 [accepted]
PHST- 2022/09/21 06:00 [pubmed]
PHST- 2022/10/25 06:00 [medline]
PHST- 2022/09/20 18:17 [entrez]
AID - S1361-8415(22)00240-7 [pii]
AID - 10.1016/j.media.2022.102612 [doi]
PST - ppublish
SO  - Med Image Anal. 2022 Nov;82:102612. doi: 10.1016/j.media.2022.102612. Epub 2022 
      Sep 10.

PMID- 35394862
OWN - NLM
STAT- MEDLINE
DCOM- 20220415
LR  - 20231207
IS  - 1091-6490 (Electronic)
IS  - 0027-8424 (Print)
IS  - 0027-8424 (Linking)
VI  - 119
IP  - 15
DP  - 2022 Apr 12
TI  - Evaluation of individual and ensemble probabilistic forecasts of COVID-19 
      mortality in the United States.
PG  - e2113561119
LID - 10.1073/pnas.2113561119 [doi]
LID - e2113561119
AB  - Short-term probabilistic forecasts of the trajectory of the COVID-19 pandemic in 
      the United States have served as a visible and important communication channel 
      between the scientific modeling community and both the general public and 
      decision-makers. Forecasting models provide specific, quantitative, and evaluable 
      predictions that inform short-term decisions such as healthcare staffing needs, 
      school closures, and allocation of medical supplies. Starting in April 2020, the 
      US COVID-19 Forecast Hub (https://covid19forecasthub.org/) collected, 
      disseminated, and synthesized tens of millions of specific predictions from more 
      than 90 different academic, industry, and independent research groups. A 
      multimodel ensemble forecast that combined predictions from dozens of groups 
      every week provided the most consistently accurate probabilistic forecasts of 
      incident deaths due to COVID-19 at the state and national level from April 2020 
      through October 2021. The performance of 27 individual models that submitted 
      complete forecasts of COVID-19 deaths consistently throughout this year showed 
      high variability in forecast skill across time, geospatial units, and forecast 
      horizons. Two-thirds of the models evaluated showed better accuracy than a naïve 
      baseline model. Forecast accuracy degraded as models made predictions further 
      into the future, with probabilistic error at a 20-wk horizon three to five times 
      larger than when predicting at a 1-wk horizon. This project underscores the role 
      that collaboration and active coordination between governmental public-health 
      agencies, academic modeling teams, and industry partners can play in developing 
      modern modeling capabilities to support local, state, and federal response to 
      outbreaks.
FAU - Cramer, Estee Y
AU  - Cramer EY
AUID- ORCID: 0000-0003-1373-3177
AD  - Department of Biostatistics and Epidemiology, University of Massachusetts, 
      Amherst, MA 01003.
FAU - Ray, Evan L
AU  - Ray EL
AUID- ORCID: 0000-0003-4035-0243
AD  - Department of Biostatistics and Epidemiology, University of Massachusetts, 
      Amherst, MA 01003.
FAU - Lopez, Velma K
AU  - Lopez VK
AUID- ORCID: 0000-0003-2926-4010
AD  - COVID-19 Response, Centers for Disease Control and Prevention; Atlanta, GA 30333.
FAU - Bracher, Johannes
AU  - Bracher J
AUID- ORCID: 0000-0002-3777-1410
AD  - Chair of Econometrics and Statistics, Karlsruhe Institute of Technology, 76185 
      Karlsruhe, Germany.
AD  - Computational Statistics Group, Heidelberg Institute for Theoretical Studies, 
      69118 Heidelberg, Germany.
FAU - Brennen, Andrea
AU  - Brennen A
AD  - IQT Labs, In-Q-Tel, Waltham, MA 02451.
FAU - Castro Rivadeneira, Alvaro J
AU  - Castro Rivadeneira AJ
AD  - Department of Biostatistics and Epidemiology, University of Massachusetts, 
      Amherst, MA 01003.
FAU - Gerding, Aaron
AU  - Gerding A
AD  - Department of Biostatistics and Epidemiology, University of Massachusetts, 
      Amherst, MA 01003.
FAU - Gneiting, Tilmann
AU  - Gneiting T
AUID- ORCID: 0000-0001-9397-3271
AD  - Computational Statistics Group, Heidelberg Institute for Theoretical Studies, 
      69118 Heidelberg, Germany.
AD  - Institute of Stochastics, Karlsruhe Institute of Technology, 69118 Karlsruhe, 
      Germany.
FAU - House, Katie H
AU  - House KH
AD  - Department of Biostatistics and Epidemiology, University of Massachusetts, 
      Amherst, MA 01003.
FAU - Huang, Yuxin
AU  - Huang Y
AD  - Department of Biostatistics and Epidemiology, University of Massachusetts, 
      Amherst, MA 01003.
FAU - Jayawardena, Dasuni
AU  - Jayawardena D
AD  - Department of Biostatistics and Epidemiology, University of Massachusetts, 
      Amherst, MA 01003.
FAU - Kanji, Abdul H
AU  - Kanji AH
AD  - Department of Biostatistics and Epidemiology, University of Massachusetts, 
      Amherst, MA 01003.
FAU - Khandelwal, Ayush
AU  - Khandelwal A
AD  - Department of Biostatistics and Epidemiology, University of Massachusetts, 
      Amherst, MA 01003.
FAU - Le, Khoa
AU  - Le K
AD  - Department of Biostatistics and Epidemiology, University of Massachusetts, 
      Amherst, MA 01003.
FAU - Mühlemann, Anja
AU  - Mühlemann A
AD  - Institute of Mathematical Statistics and Actuarial Science, University of Bern, 
      CH-3012 Bern, Switzerland.
FAU - Niemi, Jarad
AU  - Niemi J
AUID- ORCID: 0000-0002-5079-158X
AD  - Department of Statistics, Iowa State University, Ames, IA 50011.
FAU - Shah, Apurv
AU  - Shah A
AD  - Department of Biostatistics and Epidemiology, University of Massachusetts, 
      Amherst, MA 01003.
FAU - Stark, Ariane
AU  - Stark A
AD  - Department of Biostatistics and Epidemiology, University of Massachusetts, 
      Amherst, MA 01003.
FAU - Wang, Yijin
AU  - Wang Y
AD  - Department of Biostatistics and Epidemiology, University of Massachusetts, 
      Amherst, MA 01003.
FAU - Wattanachit, Nutcha
AU  - Wattanachit N
AD  - Department of Biostatistics and Epidemiology, University of Massachusetts, 
      Amherst, MA 01003.
FAU - Zorn, Martha W
AU  - Zorn MW
AD  - Department of Biostatistics and Epidemiology, University of Massachusetts, 
      Amherst, MA 01003.
FAU - Gu, Youyang
AU  - Gu Y
AD  - Unaffiliated, New York, NY 10016.
FAU - Jain, Sansiddh
AU  - Jain S
AD  - Wadhwani Institute of Artificial Intelligence, Andheri East, Mumbai, 400093, 
      India.
FAU - Bannur, Nayana
AU  - Bannur N
AD  - Wadhwani Institute of Artificial Intelligence, Andheri East, Mumbai, 400093, 
      India.
FAU - Deva, Ayush
AU  - Deva A
AD  - Wadhwani Institute of Artificial Intelligence, Andheri East, Mumbai, 400093, 
      India.
FAU - Kulkarni, Mihir
AU  - Kulkarni M
AD  - Wadhwani Institute of Artificial Intelligence, Andheri East, Mumbai, 400093, 
      India.
FAU - Merugu, Srujana
AU  - Merugu S
AD  - Wadhwani Institute of Artificial Intelligence, Andheri East, Mumbai, 400093, 
      India.
FAU - Raval, Alpan
AU  - Raval A
AD  - Wadhwani Institute of Artificial Intelligence, Andheri East, Mumbai, 400093, 
      India.
FAU - Shingi, Siddhant
AU  - Shingi S
AD  - Wadhwani Institute of Artificial Intelligence, Andheri East, Mumbai, 400093, 
      India.
FAU - Tiwari, Avtansh
AU  - Tiwari A
AD  - Wadhwani Institute of Artificial Intelligence, Andheri East, Mumbai, 400093, 
      India.
FAU - White, Jerome
AU  - White J
AUID- ORCID: 0000-0003-4148-8834
AD  - Wadhwani Institute of Artificial Intelligence, Andheri East, Mumbai, 400093, 
      India.
FAU - Abernethy, Neil F
AU  - Abernethy NF
AD  - University of Washington, Seattle, WA 98109.
FAU - Woody, Spencer
AU  - Woody S
AUID- ORCID: 0000-0002-2882-3450
AD  - Department of Integrative Biology, University of Texas at Austin, Austin, TX 
      78712.
FAU - Dahan, Maytal
AU  - Dahan M
AD  - Texas Advanced Computing Center, Austin, TX 78758.
FAU - Fox, Spencer
AU  - Fox S
AUID- ORCID: 0000-0003-1969-3778
AD  - Department of Integrative Biology, University of Texas at Austin, Austin, TX 
      78712.
FAU - Gaither, Kelly
AU  - Gaither K
AUID- ORCID: 0000-0002-4272-175X
AD  - Texas Advanced Computing Center, Austin, TX 78758.
FAU - Lachmann, Michael
AU  - Lachmann M
AD  - Santa Fe Institute, Santa Fe, NM 87501.
FAU - Meyers, Lauren Ancel
AU  - Meyers LA
AUID- ORCID: 0000-0002-5828-8874
AD  - Department of Integrative Biology, University of Texas at Austin, Austin, TX 
      78712.
FAU - Scott, James G
AU  - Scott JG
AD  - Department of Information, Risk, and Operations Management, University of Texas 
      at Austin, Austin, TX 78712.
FAU - Tec, Mauricio
AU  - Tec M
AUID- ORCID: 0000-0002-1853-5842
AD  - Department of Statistics and Data Sciences, University of Texas at Austin, 
      Austin, TX 78712.
FAU - Srivastava, Ajitesh
AU  - Srivastava A
AD  - Ming Hsieh Department of Computer and Electrical Engineering, University of 
      Southern California, Los Angeles, CA 90089.
FAU - George, Glover E
AU  - George GE
AUID- ORCID: 0000-0003-4779-8702
AD  - US Army Engineer Research and Development Center, Vicksburg, MS 39180.
FAU - Cegan, Jeffrey C
AU  - Cegan JC
AUID- ORCID: 0000-0002-3065-3403
AD  - US Army Engineer Research and Development Center, Concord, MA 01742.
FAU - Dettwiller, Ian D
AU  - Dettwiller ID
AD  - US Army Engineer Research and Development Center, Vicksburg, MS 39180.
FAU - England, William P
AU  - England WP
AD  - US Army Engineer Research and Development Center, Vicksburg, MS 39180.
FAU - Farthing, Matthew W
AU  - Farthing MW
AD  - US Army Engineer Research and Development Center, Vicksburg, MS 39180.
FAU - Hunter, Robert H
AU  - Hunter RH
AUID- ORCID: 0000-0002-2382-7938
AD  - US Army Engineer Research and Development Center, Vicksburg, MS 39180.
FAU - Lafferty, Brandon
AU  - Lafferty B
AUID- ORCID: 0000-0002-2618-3787
AD  - US Army Engineer Research and Development Center, Vicksburg, MS 39180.
FAU - Linkov, Igor
AU  - Linkov I
AD  - US Army Engineer Research and Development Center, Concord, MA 01742.
FAU - Mayo, Michael L
AU  - Mayo ML
AUID- ORCID: 0000-0001-9014-1859
AD  - US Army Engineer Research and Development Center, Vicksburg, MS 39180.
FAU - Parno, Matthew D
AU  - Parno MD
AD  - US Army Engineer Research and Development Center, Hanover, NH 03755.
FAU - Rowland, Michael A
AU  - Rowland MA
AUID- ORCID: 0000-0002-6759-8225
AD  - US Army Engineer Research and Development Center, Vicksburg, MS 39180.
FAU - Trump, Benjamin D
AU  - Trump BD
AD  - US Army Engineer Research and Development Center, Concord, MA 01742.
FAU - Zhang-James, Yanli
AU  - Zhang-James Y
AD  - Department of Psychiatry and Behavioral Sciences, State University of New York 
      Upstate Medical University, Syracuse, NY 13210.
FAU - Chen, Samuel
AU  - Chen S
AUID- ORCID: 0000-0002-1070-9801
AD  - School of Medicine, State University of New York Upstate Medical University, 
      Syracuse, NY 13210.
FAU - Faraone, Stephen V
AU  - Faraone SV
AD  - Department of Psychiatry and Behavioral Sciences, State University of New York 
      Upstate Medical University, Syracuse, NY 13210.
FAU - Hess, Jonathan
AU  - Hess J
AD  - Department of Psychiatry and Behavioral Sciences, State University of New York 
      Upstate Medical University, Syracuse, NY 13210.
FAU - Morley, Christopher P
AU  - Morley CP
AD  - Department of Public Health & Preventive Medicine, State University of New York 
      Upstate Medical University, Syracuse, NY 13210.
FAU - Salekin, Asif
AU  - Salekin A
AUID- ORCID: 0000-0002-0807-8967
AD  - Department of Electrical Engineering and Computer Science, Syracuse University, 
      Syracuse, NY 13207.
FAU - Wang, Dongliang
AU  - Wang D
AD  - Department of Public Health & Preventive Medicine, State University of New York 
      Upstate Medical University, Syracuse, NY 13210.
FAU - Corsetti, Sabrina M
AU  - Corsetti SM
AUID- ORCID: 0000-0003-2216-2492
AD  - Department of Physics, University of Michigan, Ann Arbor, MI, 48109.
FAU - Baer, Thomas M
AU  - Baer TM
AD  - Department of Physics, Trinity University, San Antonio, TX 78212.
FAU - Eisenberg, Marisa C
AU  - Eisenberg MC
AD  - Department of Complex Systems, University of Michigan, Ann Arbor, MI 48109.
AD  - Department of Mathematics, University of Michigan, Ann Arbor, MI 48109.
AD  - School of Public Health, Department of Epidemiology, University of Michigan, Ann 
      Arbor, MI 48109.
FAU - Falb, Karl
AU  - Falb K
AUID- ORCID: 0000-0002-3465-3988
AD  - Department of Physics, University of Michigan, Ann Arbor, MI, 48109.
FAU - Huang, Yitao
AU  - Huang Y
AUID- ORCID: 0000-0001-7846-2174
AD  - Department of Physics, University of Michigan, Ann Arbor, MI, 48109.
FAU - Martin, Emily T
AU  - Martin ET
AD  - School of Public Health, Department of Epidemiology, University of Michigan, Ann 
      Arbor, MI 48109.
FAU - McCauley, Ella
AU  - McCauley E
AD  - Department of Physics, University of Michigan, Ann Arbor, MI, 48109.
FAU - Myers, Robert L
AU  - Myers RL
AD  - Department of Physics, University of Michigan, Ann Arbor, MI, 48109.
FAU - Schwarz, Tom
AU  - Schwarz T
AD  - Department of Physics, University of Michigan, Ann Arbor, MI, 48109.
FAU - Sheldon, Daniel
AU  - Sheldon D
AUID- ORCID: 0000-0002-4257-2432
AD  - College of Information and Computer Sciences, University of Massachusetts, 
      Amherst, MA 01003.
FAU - Gibson, Graham Casey
AU  - Gibson GC
AD  - School of Public Health and Health Sciences, University of Massachusetts, 
      Amherst, MA 01003.
FAU - Yu, Rose
AU  - Yu R
AD  - Department of Computer Science and Engineering, University of California, San 
      Diego, CA 92093.
AD  - Khoury College of Computer Sciences, Northeastern University, Boston, MA 02115.
FAU - Gao, Liyao
AU  - Gao L
AD  - Department of Statistics, University of Washington, Seattle, WA 98185.
FAU - Ma, Yian
AU  - Ma Y
AD  - Halıcıoğlu Data Science Institute, University of California, San Diego, CA 92093.
FAU - Wu, Dongxia
AU  - Wu D
AD  - Department of Computer Science and Engineering, University of California, San 
      Diego, CA 92093.
FAU - Yan, Xifeng
AU  - Yan X
AD  - Department of Computer Science, University of California, Santa Barbara, CA 
      93106.
FAU - Jin, Xiaoyong
AU  - Jin X
AD  - Department of Computer Science, University of California, Santa Barbara, CA 
      93106.
FAU - Wang, Yu-Xiang
AU  - Wang YX
AD  - Department of Computer Science, University of California, Santa Barbara, CA 
      93106.
FAU - Chen, YangQuan
AU  - Chen Y
AD  - Mechatronics, Embedded Systems and Automation Lab, Department of Mechanical 
      Engineering, University of California, Merced, CA 95301.
FAU - Guo, Lihong
AU  - Guo L
AUID- ORCID: 0000-0003-4804-4005
AD  - Jilin University, Changchun City, Jilin Province, 130012, People's Republic of 
      China.
FAU - Zhao, Yanting
AU  - Zhao Y
AD  - University of Science and Technology of China, Heifei, Anhui, 230027, People's 
      Republic of China.
FAU - Gu, Quanquan
AU  - Gu Q
AUID- ORCID: 0000-0001-9830-793X
AD  - Department of Computer Science, University of California, Los Angeles, CA 90095.
FAU - Chen, Jinghui
AU  - Chen J
AD  - Department of Computer Science, University of California, Los Angeles, CA 90095.
FAU - Wang, Lingxiao
AU  - Wang L
AD  - Department of Computer Science, University of California, Los Angeles, CA 90095.
FAU - Xu, Pan
AU  - Xu P
AUID- ORCID: 0000-0002-2559-8622
AD  - Department of Computer Science, University of California, Los Angeles, CA 90095.
FAU - Zhang, Weitong
AU  - Zhang W
AD  - Department of Computer Science, University of California, Los Angeles, CA 90095.
FAU - Zou, Difan
AU  - Zou D
AD  - Department of Computer Science, University of California, Los Angeles, CA 90095.
FAU - Biegel, Hannah
AU  - Biegel H
AD  - Department of Mathematics, University of Arizona, Tucson, AZ 85721.
FAU - Lega, Joceline
AU  - Lega J
AUID- ORCID: 0000-0003-2064-229X
AD  - Department of Mathematics, University of Arizona, Tucson, AZ 85721.
FAU - McConnell, Steve
AU  - McConnell S
AUID- ORCID: 0000-0002-0294-3737
AD  - Construx, Bellevue, WA 98004.
FAU - Nagraj, V P
AU  - Nagraj VP
AD  - Quality Assurance and Data Science, Signature Science, LLC, Charlottesville, VA 
      22911.
FAU - Guertin, Stephanie L
AU  - Guertin SL
AD  - Quality Assurance and Data Science, Signature Science, LLC, Charlottesville, VA 
      22911.
FAU - Hulme-Lowe, Christopher
AU  - Hulme-Lowe C
AD  - Quality Assurance and Data Science, Signature Science, LLC, Austin, TX 78759.
FAU - Turner, Stephen D
AU  - Turner SD
AUID- ORCID: 0000-0001-9140-9028
AD  - Quality Assurance and Data Science, Signature Science, LLC, Charlottesville, VA 
      22911.
FAU - Shi, Yunfeng
AU  - Shi Y
AUID- ORCID: 0000-0003-1700-6049
AD  - Department of Materials Science and Engineering, Rensselaer Polytechnic 
      Institute, Troy, NY 12309.
FAU - Ban, Xuegang
AU  - Ban X
AD  - Department of Civil and Environmental Engineering, University of Washington, 
      Seattle, WA 98195.
FAU - Walraven, Robert
AU  - Walraven R
AUID- ORCID: 0000-0002-5755-4325
AD  - Unaffiliated, Davis, CA 95616.
FAU - Hong, Qi-Jun
AU  - Hong QJ
AD  - School for Engineering of Matter, Transport and Energy, Arizona State University, 
      Tempe, AZ 85287.
AD  - School of Engineering, Brown University, Providence, RI 02912.
FAU - Kong, Stanley
AU  - Kong S
AD  - Manhasset Secondary School, Manhasset, NY 11030.
FAU - van de Walle, Axel
AU  - van de Walle A
AUID- ORCID: 0000-0002-3415-1494
AD  - School of Engineering, Brown University, Providence, RI 02912.
FAU - Turtle, James A
AU  - Turtle JA
AUID- ORCID: 0000-0003-0735-7769
AD  - Infectious Disease Group, Predictive Science, Inc, San Diego, CA 92121.
FAU - Ben-Nun, Michal
AU  - Ben-Nun M
AUID- ORCID: 0000-0002-9164-0008
AD  - Infectious Disease Group, Predictive Science, Inc, San Diego, CA 92121.
FAU - Riley, Steven
AU  - Riley S
AUID- ORCID: 0000-0001-7904-4804
AD  - Medical Research Council Centre for Global Infectious Disease Analysis, 
      Department of Infectious Disease Epidemiology, School of Public Health, Imperial 
      College, W2 1PG London, United Kingdom.
FAU - Riley, Pete
AU  - Riley P
AD  - Infectious Disease Group, Predictive Science, Inc, San Diego, CA 92121.
FAU - Koyluoglu, Ugur
AU  - Koyluoglu U
AUID- ORCID: 0000-0002-6286-351X
AD  - Financial Services, Oliver Wyman, New York, NY 10036.
FAU - DesRoches, David
AU  - DesRoches D
AD  - Oliver Wyman Digital, Oliver Wyman, Boston, MA 02110.
FAU - Forli, Pedro
AU  - Forli P
AD  - Oliver Wyman Digital, Oliver Wyman, Sao Paolo, Brazil 04711-904.
FAU - Hamory, Bruce
AU  - Hamory B
AD  - Health & Life Sciences, Oliver Wyman, Boston, MA 02110.
FAU - Kyriakides, Christina
AU  - Kyriakides C
AD  - Oliver Wyman Digital, Oliver Wyman, New York, NY 10036.
FAU - Leis, Helen
AU  - Leis H
AD  - Health & Life Sciences, Oliver Wyman, New York, NY 10036.
FAU - Milliken, John
AU  - Milliken J
AD  - Financial Services, Oliver Wyman, New York, NY 10036.
FAU - Moloney, Michael
AU  - Moloney M
AD  - Financial Services, Oliver Wyman, New York, NY 10036.
FAU - Morgan, James
AU  - Morgan J
AD  - Financial Services, Oliver Wyman, New York, NY 10036.
FAU - Nirgudkar, Ninad
AU  - Nirgudkar N
AD  - Core Consultant Group, Oliver Wyman, New York, NY 10036.
FAU - Ozcan, Gokce
AU  - Ozcan G
AD  - Financial Services, Oliver Wyman, New York, NY 10036.
FAU - Piwonka, Noah
AU  - Piwonka N
AD  - Health & Life Sciences, Oliver Wyman, New York, NY 10036.
FAU - Ravi, Matt
AU  - Ravi M
AD  - Core Consultant Group, Oliver Wyman, New York, NY 10036.
FAU - Schrader, Chris
AU  - Schrader C
AD  - Health & Life Sciences, Oliver Wyman, New York, NY 10036.
FAU - Shakhnovich, Elizabeth
AU  - Shakhnovich E
AD  - Health & Life Sciences, Oliver Wyman, New York, NY 10036.
FAU - Siegel, Daniel
AU  - Siegel D
AD  - Financial Services, Oliver Wyman, New York, NY 10036.
FAU - Spatz, Ryan
AU  - Spatz R
AD  - Core Consultant Group, Oliver Wyman, New York, NY 10036.
FAU - Stiefeling, Chris
AU  - Stiefeling C
AD  - Financial Services, Oliver Wyman Digital, Toronto, ON, Canada M5J 0A1.
FAU - Wilkinson, Barrie
AU  - Wilkinson B
AD  - Financial Services, Oliver Wyman, London, UK W1U 8EW.
FAU - Wong, Alexander
AU  - Wong A
AD  - Oliver Wyman Digital, Oliver Wyman, New York, NY 10036.
FAU - Cavany, Sean
AU  - Cavany S
AUID- ORCID: 0000-0002-2559-797X
AD  - Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 
      46556.
FAU - España, Guido
AU  - España G
AUID- ORCID: 0000-0002-9915-8056
AD  - Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 
      46556.
FAU - Moore, Sean
AU  - Moore S
AUID- ORCID: 0000-0001-9062-6100
AD  - Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 
      46556.
FAU - Oidtman, Rachel
AU  - Oidtman R
AUID- ORCID: 0000-0003-1773-9533
AD  - Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 
      46556.
AD  - Department of Ecology and Evolution, University of Chicago, Chicago, IL 60637.
FAU - Perkins, Alex
AU  - Perkins A
AUID- ORCID: 0000-0002-7518-4014
AD  - Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 
      46556.
FAU - Kraus, David
AU  - Kraus D
AUID- ORCID: 0000-0003-4376-3932
AD  - Department of Mathematics and Statistics, Masaryk University, 61137 Brno, Czech 
      Republic.
FAU - Kraus, Andrea
AU  - Kraus A
AD  - Department of Mathematics and Statistics, Masaryk University, 61137 Brno, Czech 
      Republic.
FAU - Gao, Zhifeng
AU  - Gao Z
AD  - Microsoft, Redmond, WA 98029.
FAU - Bian, Jiang
AU  - Bian J
AD  - Microsoft, Redmond, WA 98029.
FAU - Cao, Wei
AU  - Cao W
AUID- ORCID: 0000-0001-5640-0917
AD  - Microsoft, Redmond, WA 98029.
FAU - Lavista Ferres, Juan
AU  - Lavista Ferres J
AUID- ORCID: 0000-0002-9654-3178
AD  - Microsoft, Redmond, WA 98029.
FAU - Li, Chaozhuo
AU  - Li C
AD  - Microsoft, Redmond, WA 98029.
FAU - Liu, Tie-Yan
AU  - Liu TY
AD  - Microsoft, Redmond, WA 98029.
FAU - Xie, Xing
AU  - Xie X
AD  - Microsoft, Redmond, WA 98029.
FAU - Zhang, Shun
AU  - Zhang S
AD  - Microsoft, Redmond, WA 98029.
FAU - Zheng, Shun
AU  - Zheng S
AD  - Microsoft, Redmond, WA 98029.
FAU - Vespignani, Alessandro
AU  - Vespignani A
AUID- ORCID: 0000-0003-3419-4205
AD  - Institute for Scientific Interchange Foundation, Turin, 10133, Italy.
AD  - Laboratory for the Modeling of Biological and Socio-technical Systems, 
      Northeastern University, Boston, MA 02115.
FAU - Chinazzi, Matteo
AU  - Chinazzi M
AD  - Laboratory for the Modeling of Biological and Socio-technical Systems, 
      Northeastern University, Boston, MA 02115.
FAU - Davis, Jessica T
AU  - Davis JT
AD  - Laboratory for the Modeling of Biological and Socio-technical Systems, 
      Northeastern University, Boston, MA 02115.
FAU - Mu, Kunpeng
AU  - Mu K
AD  - Laboratory for the Modeling of Biological and Socio-technical Systems, 
      Northeastern University, Boston, MA 02115.
FAU - Pastore Y Piontti, Ana
AU  - Pastore Y Piontti A
AD  - Laboratory for the Modeling of Biological and Socio-technical Systems, 
      Northeastern University, Boston, MA 02115.
FAU - Xiong, Xinyue
AU  - Xiong X
AD  - Laboratory for the Modeling of Biological and Socio-technical Systems, 
      Northeastern University, Boston, MA 02115.
FAU - Zheng, Andrew
AU  - Zheng A
AD  - Operations Research Center, Massachusetts Institute of Technology; Cambridge, MA 
      02139.
FAU - Baek, Jackie
AU  - Baek J
AD  - Operations Research Center, Massachusetts Institute of Technology; Cambridge, MA 
      02139.
FAU - Farias, Vivek
AU  - Farias V
AD  - Sloan School of Management, Massachusetts Institute of Technology, Cambridge, MA 
      02142.
FAU - Georgescu, Andreea
AU  - Georgescu A
AD  - Operations Research Center, Massachusetts Institute of Technology; Cambridge, MA 
      02139.
FAU - Levi, Retsef
AU  - Levi R
AD  - Sloan School of Management, Massachusetts Institute of Technology, Cambridge, MA 
      02142.
FAU - Sinha, Deeksha
AU  - Sinha D
AUID- ORCID: 0000-0002-9788-728X
AD  - Operations Research Center, Massachusetts Institute of Technology; Cambridge, MA 
      02139.
FAU - Wilde, Joshua
AU  - Wilde J
AD  - Operations Research Center, Massachusetts Institute of Technology; Cambridge, MA 
      02139.
FAU - Perakis, Georgia
AU  - Perakis G
AUID- ORCID: 0000-0002-0888-9030
AD  - Massachusetts Institute of Technology, Cambridge, MA 02142.
FAU - Bennouna, Mohammed Amine
AU  - Bennouna MA
AUID- ORCID: 0000-0002-9123-8588
AD  - Massachusetts Institute of Technology, Cambridge, MA 02142.
FAU - Nze-Ndong, David
AU  - Nze-Ndong D
AD  - Massachusetts Institute of Technology, Cambridge, MA 02142.
FAU - Singhvi, Divya
AU  - Singhvi D
AD  - Technology, Operations and Statistics (TOPS) group, Stern School of Business, New 
      York University, New York, NY 10012.
FAU - Spantidakis, Ioannis
AU  - Spantidakis I
AUID- ORCID: 0000-0002-5149-6320
AD  - Massachusetts Institute of Technology, Cambridge, MA 02142.
FAU - Thayaparan, Leann
AU  - Thayaparan L
AD  - Massachusetts Institute of Technology, Cambridge, MA 02142.
FAU - Tsiourvas, Asterios
AU  - Tsiourvas A
AUID- ORCID: 0000-0002-2979-6300
AD  - Massachusetts Institute of Technology, Cambridge, MA 02142.
FAU - Sarker, Arnab
AU  - Sarker A
AUID- ORCID: 0000-0003-1680-9421
AD  - Institute for Data, Systems, and Society, Massachusetts Institute of Technology, 
      Cambridge, MA 02139.
FAU - Jadbabaie, Ali
AU  - Jadbabaie A
AUID- ORCID: 0000-0003-1122-3069
AD  - Institute for Data, Systems, and Society, Massachusetts Institute of Technology, 
      Cambridge, MA 02139.
FAU - Shah, Devavrat
AU  - Shah D
AUID- ORCID: 0000-0003-0737-3259
AD  - Institute for Data, Systems, and Society, Massachusetts Institute of Technology, 
      Cambridge, MA 02139.
FAU - Della Penna, Nicolas
AU  - Della Penna N
AD  - Laboratory for Computational Physiology, Massachusetts Institute of Technology, 
      Cambridge, MA 02139.
FAU - Celi, Leo A
AU  - Celi LA
AUID- ORCID: 0000-0001-6712-6626
AD  - Laboratory for Computational Physiology, Massachusetts Institute of Technology, 
      Cambridge, MA 02139.
FAU - Sundar, Saketh
AU  - Sundar S
AD  - River Hill High School, Clarksville, MD 21029.
FAU - Wolfinger, Russ
AU  - Wolfinger R
AD  - JMP Life Sciences, SAS Institute Inc, Cary, NC 27513.
FAU - Osthus, Dave
AU  - Osthus D
AUID- ORCID: 0000-0002-4681-091X
AD  - Statistical Sciences Group, Los Alamos National Laboratory, Los Alamos, NM 87545.
FAU - Castro, Lauren
AU  - Castro L
AD  - Information Systems and Modeling Group, Los Alamos National Laboratory, Los 
      Alamos, NM 87545.
FAU - Fairchild, Geoffrey
AU  - Fairchild G
AUID- ORCID: 0000-0001-5500-8120
AD  - Information Systems and Modeling Group, Los Alamos National Laboratory, Los 
      Alamos, NM 87545.
FAU - Michaud, Isaac
AU  - Michaud I
AD  - Statistical Sciences Group, Los Alamos National Laboratory, Los Alamos, NM 87545.
FAU - Karlen, Dean
AU  - Karlen D
AD  - Department of Physics and Astronomy, University of Victoria, Victoria, BC, V8W 
      2Y2, Canada.
AD  - Physical Sciences Division, TRIUMF, Vancouver, BC, V8W 2Y2, Canada.
FAU - Kinsey, Matt
AU  - Kinsey M
AD  - Johns Hopkins University Applied Physics Laboratory, Laurel, MD 20723.
FAU - Mullany, Luke C
AU  - Mullany LC
AUID- ORCID: 0000-0003-4668-9803
AD  - Johns Hopkins University Applied Physics Laboratory, Laurel, MD 20723.
FAU - Rainwater-Lovett, Kaitlin
AU  - Rainwater-Lovett K
AUID- ORCID: 0000-0002-8707-7339
AD  - Johns Hopkins University Applied Physics Laboratory, Laurel, MD 20723.
FAU - Shin, Lauren
AU  - Shin L
AD  - Johns Hopkins University Applied Physics Laboratory, Laurel, MD 20723.
FAU - Tallaksen, Katharine
AU  - Tallaksen K
AD  - Johns Hopkins University Applied Physics Laboratory, Laurel, MD 20723.
FAU - Wilson, Shelby
AU  - Wilson S
AD  - Johns Hopkins University Applied Physics Laboratory, Laurel, MD 20723.
FAU - Lee, Elizabeth C
AU  - Lee EC
AUID- ORCID: 0000-0002-4156-9637
AD  - Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, MD 21215.
FAU - Dent, Juan
AU  - Dent J
AUID- ORCID: 0000-0003-3154-0731
AD  - Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, MD 21215.
FAU - Grantz, Kyra H
AU  - Grantz KH
AD  - Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, MD 21215.
FAU - Hill, Alison L
AU  - Hill AL
AUID- ORCID: 0000-0002-6583-3623
AD  - Institute for Computational Medicine, Johns Hopkins Bloomberg School of Public 
      Health, Baltimore, MD 21218.
FAU - Kaminsky, Joshua
AU  - Kaminsky J
AD  - Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, MD 21215.
FAU - Kaminsky, Kathryn
AU  - Kaminsky K
AD  - Unaffiliated, Baltimore, MD 21205.
FAU - Keegan, Lindsay T
AU  - Keegan LT
AUID- ORCID: 0000-0002-8526-3007
AD  - Division of Epidemiology, Department of Internal Medicine, University of Utah, 
      Salt Lake City, UT 84108.
FAU - Lauer, Stephen A
AU  - Lauer SA
AD  - Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, MD 21215.
FAU - Lemaitre, Joseph C
AU  - Lemaitre JC
AUID- ORCID: 0000-0002-2677-6574
AD  - Laboratory of Ecohydrology, School of Architecture, Civil and Environmental 
      Engineering, École Polytechnique Fédérale de Lausanne, 1015 Lausanne, 
      Switzerland.
FAU - Lessler, Justin
AU  - Lessler J
AD  - Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, MD 21215.
FAU - Meredith, Hannah R
AU  - Meredith HR
AD  - Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, MD 21215.
FAU - Perez-Saez, Javier
AU  - Perez-Saez J
AD  - Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, MD 21215.
FAU - Shah, Sam
AU  - Shah S
AD  - Unaffiliated, San Francisco, CA 94122.
FAU - Smith, Claire P
AU  - Smith CP
AD  - Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, MD 21215.
FAU - Truelove, Shaun A
AU  - Truelove SA
AUID- ORCID: 0000-0003-0538-0607
AD  - Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, MD 21215.
AD  - International Vaccine Access Center, Johns Hopkins University, Baltimore, MD 
      21231.
AD  - Department of International Health, Johns Hopkins Bloomberg School of Public 
      Health, Baltimore, MD 21231.
FAU - Wills, Josh
AU  - Wills J
AUID- ORCID: 0000-0001-7285-9349
AD  - Unaffiliated, San Francisco, CA 94122.
FAU - Marshall, Maximilian
AU  - Marshall M
AD  - Department of Civil and Systems Engineering, Johns Hopkins University, Baltimore, 
      MD 21218.
FAU - Gardner, Lauren
AU  - Gardner L
AD  - Department of Civil and Systems Engineering, Johns Hopkins University, Baltimore, 
      MD 21218.
FAU - Nixon, Kristen
AU  - Nixon K
AD  - Department of Civil and Systems Engineering, Johns Hopkins University, Baltimore, 
      MD 21218.
FAU - Burant, John C
AU  - Burant JC
AD  - Unaffiliated, Amsterdam, The Netherlands.
FAU - Wang, Lily
AU  - Wang L
AD  - Department of Statistics, Iowa State University, Ames, IA 50011.
FAU - Gao, Lei
AU  - Gao L
AUID- ORCID: 0000-0002-4707-0933
AD  - Department of Finance, Iowa State University, Ames, IA 50011.
FAU - Gu, Zhiling
AU  - Gu Z
AUID- ORCID: 0000-0002-8052-7608
AD  - Department of Statistics, Iowa State University, Ames, IA 50011.
FAU - Kim, Myungjin
AU  - Kim M
AD  - Department of Statistics, Iowa State University, Ames, IA 50011.
FAU - Li, Xinyi
AU  - Li X
AD  - School of Mathematical and Statistical Sciences, Clemson University, Clemson, SC 
      29634.
FAU - Wang, Guannan
AU  - Wang G
AD  - Department of Mathematics, College of William & Mary, Williamsburg, VA 23187.
FAU - Wang, Yueying
AU  - Wang Y
AD  - Department of Statistics, Iowa State University, Ames, IA 50011.
FAU - Yu, Shan
AU  - Yu S
AUID- ORCID: 0000-0002-0271-5726
AD  - Department of Statistics, University of Virginia, Charlottesville, VA 22904.
FAU - Reiner, Robert C
AU  - Reiner RC
AD  - Institute for Health Metrics and Evaluation, University of Washington, Seattle, 
      WA 98195.
FAU - Barber, Ryan
AU  - Barber R
AD  - Institute for Health Metrics and Evaluation, University of Washington, Seattle, 
      WA 98195.
FAU - Gakidou, Emmanuela
AU  - Gakidou E
AD  - Institute for Health Metrics and Evaluation, University of Washington, Seattle, 
      WA 98195.
FAU - Hay, Simon I
AU  - Hay SI
AUID- ORCID: 0000-0002-0611-7272
AD  - Institute for Health Metrics and Evaluation, University of Washington, Seattle, 
      WA 98195.
FAU - Lim, Steve
AU  - Lim S
AD  - Institute for Health Metrics and Evaluation, University of Washington, Seattle, 
      WA 98195.
FAU - Murray, Chris
AU  - Murray C
AUID- ORCID: 0000-0002-4930-9450
AD  - Institute for Health Metrics and Evaluation, University of Washington, Seattle, 
      WA 98195.
FAU - Pigott, David
AU  - Pigott D
AD  - Institute for Health Metrics and Evaluation, University of Washington, Seattle, 
      WA 98195.
FAU - Gurung, Heidi L
AU  - Gurung HL
AD  - Emerging Technologies, IEM, Inc., Bel Air, MD 21015.
FAU - Baccam, Prasith
AU  - Baccam P
AD  - Emerging Technologies, IEM, Inc., Bel Air, MD 21015.
FAU - Stage, Steven A
AU  - Stage SA
AUID- ORCID: 0000-0001-5361-6464
AD  - Emerging Technologies, IEM, Inc., Baton Rouge, LA 70809.
FAU - Suchoski, Bradley T
AU  - Suchoski BT
AD  - Emerging Technologies, IEM, Inc., Bel Air, MD 21015.
FAU - Prakash, B Aditya
AU  - Prakash BA
AUID- ORCID: 0000-0002-3252-455X
AD  - College of Computing, Georgia Institute of Technology, Atlanta, GA 30308.
FAU - Adhikari, Bijaya
AU  - Adhikari B
AD  - Department of Computer Science, University of Iowa, Iowa City, IA 52242.
FAU - Cui, Jiaming
AU  - Cui J
AD  - College of Computing, Georgia Institute of Technology, Atlanta, GA 30308.
FAU - Rodríguez, Alexander
AU  - Rodríguez A
AUID- ORCID: 0000-0002-4313-9913
AD  - College of Computing, Georgia Institute of Technology, Atlanta, GA 30308.
FAU - Tabassum, Anika
AU  - Tabassum A
AD  - Department of Computer Science, Virginia Tech, Falls Church, VA 22043.
FAU - Xie, Jiajia
AU  - Xie J
AUID- ORCID: 0000-0001-6530-2489
AD  - College of Computing, Georgia Institute of Technology, Atlanta, GA 30308.
FAU - Keskinocak, Pinar
AU  - Keskinocak P
AUID- ORCID: 0000-0003-2686-546X
AD  - H. Milton Stewart School of Industrial and Systems Engineering, Georgia Institute 
      of Technology, Atlanta, GA, 30332.
FAU - Asplund, John
AU  - Asplund J
AD  - Advanced Data Analytics, Metron, Inc., Reston, VA 20190.
FAU - Baxter, Arden
AU  - Baxter A
AUID- ORCID: 0000-0002-6345-2229
AD  - H. Milton Stewart School of Industrial and Systems Engineering, Georgia Institute 
      of Technology, Atlanta, GA, 30332.
FAU - Oruc, Buse Eylul
AU  - Oruc BE
AUID- ORCID: 0000-0003-2431-3864
AD  - H. Milton Stewart School of Industrial and Systems Engineering, Georgia Institute 
      of Technology, Atlanta, GA, 30332.
FAU - Serban, Nicoleta
AU  - Serban N
AD  - H. Milton Stewart School of Industrial and Systems Engineering, Georgia Institute 
      of Technology, Atlanta, GA, 30332.
FAU - Arik, Sercan O
AU  - Arik SO
AD  - Google Cloud, Sunnyvale, CA 94089.
FAU - Dusenberry, Mike
AU  - Dusenberry M
AD  - Google Cloud, Sunnyvale, CA 94089.
FAU - Epshteyn, Arkady
AU  - Epshteyn A
AD  - Google Cloud, Sunnyvale, CA 94089.
FAU - Kanal, Elli
AU  - Kanal E
AD  - Google Cloud, Sunnyvale, CA 94089.
FAU - Le, Long T
AU  - Le LT
AD  - Google Cloud, Sunnyvale, CA 94089.
FAU - Li, Chun-Liang
AU  - Li CL
AD  - Google Cloud, Sunnyvale, CA 94089.
FAU - Pfister, Tomas
AU  - Pfister T
AD  - Google Cloud, Sunnyvale, CA 94089.
FAU - Sava, Dario
AU  - Sava D
AD  - Google Cloud, Sunnyvale, CA 94089.
FAU - Sinha, Rajarishi
AU  - Sinha R
AUID- ORCID: 0000-0001-9157-674X
AD  - Google Cloud, Sunnyvale, CA 94089.
FAU - Tsai, Thomas
AU  - Tsai T
AD  - Department of Health Policy and Management, Harvard University, Cambridge, MA 
      02138.
FAU - Yoder, Nate
AU  - Yoder N
AUID- ORCID: 0000-0003-4153-4722
AD  - Google Cloud, Sunnyvale, CA 94089.
FAU - Yoon, Jinsung
AU  - Yoon J
AD  - Google Cloud, Sunnyvale, CA 94089.
FAU - Zhang, Leyou
AU  - Zhang L
AUID- ORCID: 0000-0002-2454-0082
AD  - Google Cloud, Sunnyvale, CA 94089.
FAU - Abbott, Sam
AU  - Abbott S
AD  - Centre for Mathematical Modelling of Infectious Diseases, London School of 
      Hygiene & Tropical Medicine, WC1E 7HT London, United Kingdom.
FAU - Bosse, Nikos I
AU  - Bosse NI
AD  - Centre for Mathematical Modelling of Infectious Diseases, London School of 
      Hygiene & Tropical Medicine, WC1E 7HT London, United Kingdom.
FAU - Funk, Sebastian
AU  - Funk S
AUID- ORCID: 0000-0002-2842-3406
AD  - Centre for Mathematical Modelling of Infectious Diseases, London School of 
      Hygiene & Tropical Medicine, WC1E 7HT London, United Kingdom.
FAU - Hellewell, Joel
AU  - Hellewell J
AD  - Centre for Mathematical Modelling of Infectious Diseases, London School of 
      Hygiene & Tropical Medicine, WC1E 7HT London, United Kingdom.
FAU - Meakin, Sophie R
AU  - Meakin SR
AUID- ORCID: 0000-0002-6385-2652
AD  - Centre for Mathematical Modelling of Infectious Diseases, London School of 
      Hygiene & Tropical Medicine, WC1E 7HT London, United Kingdom.
FAU - Sherratt, Katharine
AU  - Sherratt K
AUID- ORCID: 0000-0003-2049-3423
AD  - Centre for Mathematical Modelling of Infectious Diseases, London School of 
      Hygiene & Tropical Medicine, WC1E 7HT London, United Kingdom.
FAU - Zhou, Mingyuan
AU  - Zhou M
AD  - McCombs School of Business, The University of Texas at Austin, Austin, TX 78712.
FAU - Kalantari, Rahi
AU  - Kalantari R
AD  - Department of Electrical and Computer Engineering, The University of Texas at 
      Austin, Austin, TX 78712.
FAU - Yamana, Teresa K
AU  - Yamana TK
AUID- ORCID: 0000-0001-8349-3151
AD  - Department of Environmental Health Sciences, Columbia University, New York, NY 
      10032.
FAU - Pei, Sen
AU  - Pei S
AUID- ORCID: 0000-0002-7072-2995
AD  - Department of Environmental Health Sciences, Columbia University, New York, NY 
      10032.
FAU - Shaman, Jeffrey
AU  - Shaman J
AUID- ORCID: 0000-0002-7216-7809
AD  - Department of Environmental Health Sciences, Columbia University, New York, NY 
      10032.
FAU - Li, Michael L
AU  - Li ML
AUID- ORCID: 0000-0002-2456-4834
AD  - Operations Research Center, Massachusetts Institute of Technology; Cambridge, MA 
      02139.
FAU - Bertsimas, Dimitris
AU  - Bertsimas D
AUID- ORCID: 0000-0002-1985-1003
AD  - Sloan School of Management, Massachusetts Institute of Technology, Cambridge, MA 
      02142.
FAU - Skali Lami, Omar
AU  - Skali Lami O
AUID- ORCID: 0000-0002-8208-3035
AD  - Operations Research Center, Massachusetts Institute of Technology; Cambridge, MA 
      02139.
FAU - Soni, Saksham
AU  - Soni S
AUID- ORCID: 0000-0002-8898-5726
AD  - Operations Research Center, Massachusetts Institute of Technology; Cambridge, MA 
      02139.
FAU - Tazi Bouardi, Hamza
AU  - Tazi Bouardi H
AUID- ORCID: 0000-0002-7871-325X
AD  - Operations Research Center, Massachusetts Institute of Technology; Cambridge, MA 
      02139.
FAU - Ayer, Turgay
AU  - Ayer T
AD  - H. Milton Stewart School of Industrial and Systems Engineering, Georgia Institute 
      of Technology, Atlanta, GA, 30332.
AD  - Winship Cancer Institute, Emory University Medical School, Atlanta, GA 30322.
FAU - Adee, Madeline
AU  - Adee M
AD  - Radiology-Institute for Technology Assessment, Massachusetts General Hospital, 
      Boston, MA 02114.
FAU - Chhatwal, Jagpreet
AU  - Chhatwal J
AD  - Radiology-Institute for Technology Assessment, Massachusetts General Hospital, 
      Boston, MA 02114.
FAU - Dalgic, Ozden O
AU  - Dalgic OO
AD  - Health Economic Modeling, Value Analytics Labs, 34776 İstanbul, Turkey.
FAU - Ladd, Mary A
AU  - Ladd MA
AD  - Radiology-Institute for Technology Assessment, Massachusetts General Hospital, 
      Boston, MA 02114.
FAU - Linas, Benjamin P
AU  - Linas BP
AD  - Department of Medicine, Section of Infectious Diseases, Boston University School 
      of Medicine, Boston, MA 02118.
FAU - Mueller, Peter
AU  - Mueller P
AD  - Radiology-Institute for Technology Assessment, Massachusetts General Hospital, 
      Boston, MA 02114.
FAU - Xiao, Jade
AU  - Xiao J
AD  - H. Milton Stewart School of Industrial and Systems Engineering, Georgia Institute 
      of Technology, Atlanta, GA, 30332.
FAU - Wang, Yuanjia
AU  - Wang Y
AUID- ORCID: 0000-0002-1510-3315
AD  - Department of Biostatistics, Columbia University, New York, NY 10032.
AD  - Department of Psychiatry, Columbia University, New York, NY 10032.
FAU - Wang, Qinxia
AU  - Wang Q
AD  - Department of Biostatistics, Columbia University, New York, NY 10032.
FAU - Xie, Shanghong
AU  - Xie S
AD  - Department of Biostatistics, Columbia University, New York, NY 10032.
FAU - Zeng, Donglin
AU  - Zeng D
AD  - Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel 
      Hill, NC 27599.
FAU - Green, Alden
AU  - Green A
AD  - Department of Statistics, Carnegie Mellon University, Pittsburgh, PA 15213.
FAU - Bien, Jacob
AU  - Bien J
AD  - Marshall School of Business, Department of Data Sciences and Operations (DSO), 
      University of Southern California, Los Angeles, CA 90089.
FAU - Brooks, Logan
AU  - Brooks L
AD  - Department of Statistics, Carnegie Mellon University, Pittsburgh, PA 15213.
FAU - Hu, Addison J
AU  - Hu AJ
AD  - Department of Statistics, Carnegie Mellon University, Pittsburgh, PA 15213.
FAU - Jahja, Maria
AU  - Jahja M
AD  - Department of Statistics, Carnegie Mellon University, Pittsburgh, PA 15213.
FAU - McDonald, Daniel
AU  - McDonald D
AUID- ORCID: 0000-0002-0443-4282
AD  - Department of Statistics, University of British Columbia, Vancouver, BC, V6T 1Z4, 
      Canada.
FAU - Narasimhan, Balasubramanian
AU  - Narasimhan B
AD  - Department of Biomedical Data Sciences, Stanford University, Stanford, CA 94305.
AD  - Department of Statistics, Stanford University, Stanford, CA 94305.
FAU - Politsch, Collin
AU  - Politsch C
AUID- ORCID: 0000-0003-3727-9167
AD  - Machine Learning Department, Carnegie Mellon University, Pittsburgh, PA 15213.
FAU - Rajanala, Samyak
AU  - Rajanala S
AUID- ORCID: 0000-0002-5791-3789
AD  - Department of Statistics, Stanford University, Stanford, CA 94305.
FAU - Rumack, Aaron
AU  - Rumack A
AUID- ORCID: 0000-0002-9181-1794
AD  - Machine Learning Department, Carnegie Mellon University, Pittsburgh, PA 15213.
FAU - Simon, Noah
AU  - Simon N
AD  - Department of Biostatistics, University of Washington, Seattle, WA 98195.
FAU - Tibshirani, Ryan J
AU  - Tibshirani RJ
AUID- ORCID: 0000-0002-2158-8304
AD  - Department of Statistics, Carnegie Mellon University, Pittsburgh, PA 15213.
FAU - Tibshirani, Rob
AU  - Tibshirani R
AD  - Department of Statistics, Stanford University, Stanford, CA 94305.
FAU - Ventura, Valerie
AU  - Ventura V
AD  - Department of Statistics, Carnegie Mellon University, Pittsburgh, PA 15213.
FAU - Wasserman, Larry
AU  - Wasserman L
AD  - Department of Statistics, Carnegie Mellon University, Pittsburgh, PA 15213.
FAU - O'Dea, Eamon B
AU  - O'Dea EB
AD  - Odum School of Ecology, University of Georgia, Athens, GA 30602.
FAU - Drake, John M
AU  - Drake JM
AUID- ORCID: 0000-0003-4646-1235
AD  - Odum School of Ecology, University of Georgia, Athens, GA 30602.
FAU - Pagano, Robert
AU  - Pagano R
AD  - Unaffiliated, Tucson, AZ 85704.
FAU - Tran, Quoc T
AU  - Tran QT
AD  - Catalog Data Science, Walmart Inc., Sunnyvale, CA 94085.
FAU - Ho, Lam Si Tung
AU  - Ho LST
AUID- ORCID: 0000-0002-0453-8444
AD  - Department of Mathematics and Statistics, Dalhousie University, Halifax, NS, B3H 
      4R2, Canada.
FAU - Huynh, Huong
AU  - Huynh H
AD  - Virtual Power System Inc, Milpitas, CA 95035.
FAU - Walker, Jo W
AU  - Walker JW
AD  - COVID-19 Response, Centers for Disease Control and Prevention; Atlanta, GA 30333.
FAU - Slayton, Rachel B
AU  - Slayton RB
AUID- ORCID: 0000-0003-4699-8040
AD  - COVID-19 Response, Centers for Disease Control and Prevention; Atlanta, GA 30333.
FAU - Johansson, Michael A
AU  - Johansson MA
AUID- ORCID: 0000-0002-5090-7722
AD  - COVID-19 Response, Centers for Disease Control and Prevention; Atlanta, GA 30333.
FAU - Biggerstaff, Matthew
AU  - Biggerstaff M
AUID- ORCID: 0000-0001-5108-8311
AD  - COVID-19 Response, Centers for Disease Control and Prevention; Atlanta, GA 30333.
FAU - Reich, Nicholas G
AU  - Reich NG
AUID- ORCID: 0000-0003-3503-9899
AD  - Department of Biostatistics and Epidemiology, University of Massachusetts, 
      Amherst, MA 01003.
LA  - eng
GR  - U01CK000538/ACL/ACL HHS/United States
GR  - MC_PC_19012/MRC_/Medical Research Council/United Kingdom
GR  - R01 EB017205/EB/NIBIB NIH HHS/United States
GR  - U01IP001137/ACL/ACL HHS/United States
GR  - NU38OT000297/CC/CDC HHS/United States
GR  - WT_/Wellcome Trust/United Kingdom
GR  - U01IP001122/ACL/ACL HHS/United States
GR  - R01 HL149683/HL/NHLBI NIH HHS/United States
GR  - R35 GM119582/GM/NIGMS NIH HHS/United States
GR  - U01 CK000531/CK/NCEZID CDC HHS/United States
GR  - 210758/Z/18/Z/WT_/Wellcome Trust/United Kingdom
GR  - R01 NS073671/NS/NINDS NIH HHS/United States
GR  - R01 GM124104/GM/NIGMS NIH HHS/United States
GR  - 200861/Z/16/Z/WT_/Wellcome Trust/United Kingdom
GR  - U01 IP001137/IP/NCIRD CDC HHS/United States
GR  - MR/J008761/1/MRC_/Medical Research Council/United Kingdom
GR  - U01 IP001122/IP/NCIRD CDC HHS/United States
GR  - U01CK000531/ACL/ACL HHS/United States
GR  - P2C HD050924/HD/NICHD NIH HHS/United States
GR  - MR/R015600/1/MRC_/Medical Research Council/United Kingdom
PT  - Journal Article
DEP - 20220408
PL  - United States
TA  - Proc Natl Acad Sci U S A
JT  - Proceedings of the National Academy of Sciences of the United States of America
JID - 7505876
SB  - IM
EIN - Proc Natl Acad Sci U S A. 2023 Apr 11;120(15):e2304076120. PMID: 37014868
MH  - *COVID-19/mortality
MH  - Data Accuracy
MH  - Forecasting
MH  - Humans
MH  - Pandemics
MH  - Probability
MH  - Public Health/trends
MH  - United States/epidemiology
PMC - PMC9169655
OTO - NOTNLM
OT  - COVID-19
OT  - ensemble forecast
OT  - forecasting
OT  - model evaluation
COIS- Competing interest statement: A.V., M.C., and A.P.P. report grants from Metabiota 
      Inc. outside the submitted work.
EDAT- 2022/04/09 06:00
MHDA- 2022/04/16 06:00
CRDT- 2022/04/08 17:09
PHST- 2022/04/08 17:09 [entrez]
PHST- 2022/04/09 06:00 [pubmed]
PHST- 2022/04/16 06:00 [medline]
AID - 202113561 [pii]
AID - 10.1073/pnas.2113561119 [doi]
PST - ppublish
SO  - Proc Natl Acad Sci U S A. 2022 Apr 12;119(15):e2113561119. doi: 
      10.1073/pnas.2113561119. Epub 2022 Apr 8.

PMID- 35703413
OWN - NLM
STAT- MEDLINE
DCOM- 20221025
LR  - 20221212
IS  - 1546-3141 (Electronic)
IS  - 0361-803X (Linking)
VI  - 219
IP  - 5
DP  - 2022 Nov
TI  - Impact of Artificial Intelligence Assistance on Chest CT Interpretation Times: A 
      Prospective Randomized Study.
PG  - 743-751
LID - 10.2214/AJR.22.27598 [doi]
AB  - BACKGROUND. Deep learning-based convolutional neural networks have enabled major 
      advances in development of artificial intelligence (AI) software applications. 
      Modern AI applications offer comprehensive multiorgan evaluation. OBJECTIVE. The 
      purpose of this article was to evaluate the impact of an automated AI platform 
      integrated into clinical workflow for chest CT interpretation on radiologists' 
      interpretation times when evaluated in a real-world clinical setting. METHODS. In 
      this prospective single-center study, a commercial AI software solution was 
      integrated into clinical workflow for chest CT interpretation. The software 
      provided automated analysis of cardiac, pulmonary, and musculoskeletal findings, 
      including labeling, segmenting, and measuring normal structures as well as 
      detecting, labeling, and measuring abnormalities. AI-annotated images and 
      autogenerated summary results were stored in the PACS and available to 
      interpreting radiologists. A total of 390 patients (204 women, 186 men; mean age, 
      62.8 ± 13.3 [SD] years) who underwent out-patient chest CT between January 19, 
      2021, and January 28, 2021, were included. Scans were randomized using 1:1 
      allocation between AI-assisted and non-AI-assisted arms and were clinically 
      interpreted by one of three cardiothoracic radiologists (65 scans per arm per 
      radiologist; total of 195 scans per arm) who recorded interpretation times using 
      a stopwatch. Findings were categorized according to review of report impressions. 
      Interpretation times were compared between arms. RESULTS. Mean interpretation 
      times were significantly shorter in the AI-assisted than in the non-AI-assisted 
      arm for all three readers (289 ± 89 vs 344 ± 129 seconds, p < .001; 449 ± 110 vs 
      649 ± 82 seconds, p < .001; 281 ± 114 vs 348 ± 93 seconds, p = .01) and for 
      readers combined (328 ± 122 vs 421 ± 175 seconds, p < .001). For readers 
      combined, the mean difference was 93 seconds (95% CI, 63-123 seconds), 
      corresponding with a 22.1% reduction in the AI-assisted arm. Mean interpretation 
      time was also shorter in the AI-assisted arm compared with the non-AI-assisted 
      arm for contrast-enhanced scans (83 seconds), noncontrast scans (104 seconds), 
      negative scans (84 seconds), positive scans without significant new findings (117 
      seconds), and positive scans with significant new findings (92 seconds). 
      CONCLUSION. Cardiothoracic radiologists exhibited a 22.1% reduction in chest CT 
      interpretations times when they had access to results from an automated AI 
      support platform during real-world clinical practice. CLINICAL IMPACT. 
      Integration of the AI support platform into clinical workflow improved 
      radiologist efficiency.
FAU - Yacoub, Basel
AU  - Yacoub B
AD  - Department of Radiology and Radiological Science, Division of Cardiovascular 
      Imaging, Medical University of South Carolina, 25 Courtenay Dr, Charleston, SC 
      29425.
AD  - Department of Radiology, Texas Tech University Health Sciences Center El Paso, El 
      Paso, TX.
FAU - Varga-Szemes, Akos
AU  - Varga-Szemes A
AD  - Department of Radiology and Radiological Science, Division of Cardiovascular 
      Imaging, Medical University of South Carolina, 25 Courtenay Dr, Charleston, SC 
      29425.
FAU - Schoepf, U Joseph
AU  - Schoepf UJ
AD  - Department of Radiology and Radiological Science, Division of Cardiovascular 
      Imaging, Medical University of South Carolina, 25 Courtenay Dr, Charleston, SC 
      29425.
FAU - Kabakus, Ismail M
AU  - Kabakus IM
AD  - Department of Radiology and Radiological Science, Division of Cardiovascular 
      Imaging, Medical University of South Carolina, 25 Courtenay Dr, Charleston, SC 
      29425.
FAU - Baruah, Dhiraj
AU  - Baruah D
AD  - Department of Radiology and Radiological Science, Division of Cardiovascular 
      Imaging, Medical University of South Carolina, 25 Courtenay Dr, Charleston, SC 
      29425.
FAU - Burt, Jeremy R
AU  - Burt JR
AD  - Department of Radiology and Radiological Science, Division of Cardiovascular 
      Imaging, Medical University of South Carolina, 25 Courtenay Dr, Charleston, SC 
      29425.
FAU - Aquino, Gilberto J
AU  - Aquino GJ
AD  - Department of Radiology and Radiological Science, Division of Cardiovascular 
      Imaging, Medical University of South Carolina, 25 Courtenay Dr, Charleston, SC 
      29425.
AD  - Department of Radiology, SUNY Upstate Medical University, Syracuse, NY.
FAU - Sullivan, Allison K
AU  - Sullivan AK
AD  - Department of Radiology and Radiological Science, Division of Cardiovascular 
      Imaging, Medical University of South Carolina, 25 Courtenay Dr, Charleston, SC 
      29425.
FAU - Doherty, Jim O'
AU  - Doherty JO
AD  - Siemens Healthcare USA, Malvern, PA.
FAU - Hoelzer, Philipp
AU  - Hoelzer P
AD  - Siemens Healthineers, Princeton, NJ.
FAU - Sperl, Jonathan
AU  - Sperl J
AD  - Siemens Healthineers, Erlangen, Germany.
FAU - Emrich, Tilman
AU  - Emrich T
AD  - Department of Radiology and Radiological Science, Division of Cardiovascular 
      Imaging, Medical University of South Carolina, 25 Courtenay Dr, Charleston, SC 
      29425.
AD  - Department of Diagnostic and Interventional Radiology, University Medical Center 
      Mainz, Mainz, Germany.
AD  - German Center for Cardiovascular Research (DZHK), Partner-Site Rhine-Main, Mainz, 
      Germany.
LA  - eng
PT  - Journal Article
PT  - Randomized Controlled Trial
DEP - 20220615
PL  - United States
TA  - AJR Am J Roentgenol
JT  - AJR. American journal of roentgenology
JID - 7708173
SB  - IM
CIN - AJR Am J Roentgenol. 2022 Jun 29;:. PMID: 35766533
MH  - Male
MH  - Humans
MH  - Female
MH  - Middle Aged
MH  - Aged
MH  - *Artificial Intelligence
MH  - Prospective Studies
MH  - *Tomography, X-Ray Computed/methods
MH  - Radiologists
MH  - Neural Networks, Computer
MH  - Retrospective Studies
OTO - NOTNLM
OT  - CT
OT  - artificial intelligence
OT  - time efficiency
EDAT- 2022/06/16 06:00
MHDA- 2022/10/26 06:00
CRDT- 2022/06/15 08:16
PHST- 2022/06/16 06:00 [pubmed]
PHST- 2022/10/26 06:00 [medline]
PHST- 2022/06/15 08:16 [entrez]
AID - 10.2214/AJR.22.27598 [doi]
PST - ppublish
SO  - AJR Am J Roentgenol. 2022 Nov;219(5):743-751. doi: 10.2214/AJR.22.27598. Epub 
      2022 Jun 15.

PMID- 33153497
OWN - NLM
STAT- MEDLINE
DCOM- 20211110
LR  - 20211110
IS  - 2051-5960 (Electronic)
IS  - 2051-5960 (Linking)
VI  - 8
IP  - 1
DP  - 2020 Nov 5
TI  - Characterizing temporal genomic heterogeneity in pediatric low-grade gliomas.
PG  - 182
LID - 10.1186/s40478-020-01054-w [doi]
LID - 182
AB  - Recent discoveries have provided valuable insight into the genomic landscape of 
      pediatric low-grade gliomas (LGGs) at diagnosis, facilitating molecularly 
      targeted treatment. However, little is known about their temporal and 
      therapy-related genomic heterogeneity. An adequate understanding of the evolution 
      of pediatric LGGs' genomic profiles over time is critically important in guiding 
      decisions about targeted therapeutics and diagnostic biopsy at recurrence. 
      Fluorescence in situ hybridization, mutation-specific immunohistochemistry, 
      and/or targeted sequencing were performed on paired tumor samples from primary 
      diagnostic and subsequent surgeries. Ninety-four tumor samples from 45 patients 
      (41 with two specimens, four with three specimens) from three institutions 
      underwent testing. Conservation of BRAF fusion, BRAF(V600E) mutation, and FGFR1 
      rearrangement status was observed in 100%, 98%, and 96% of paired specimens, 
      respectively. No loss or gain of IDH1 mutations or NTRK2, MYB, or MYBL1 
      rearrangements were detected over time. Histologic diagnosis remained the same in 
      all tumors, with no acquired H3K27M mutations or malignant transformation. 
      Changes in CDKN2A deletion status at recurrence occurred in 11 patients (42%), 
      with acquisition of hemizygous CDKN2A deletion in seven and loss in four. Shorter 
      time to progression and shorter time to subsequent surgery were observed among 
      patients with acquired CDKN2A deletions compared to patients without acquisition 
      of this alteration [median time to progression: 5.5 versus 16.0 months 
      (p = 0.048); median time to next surgery: 17.0 months versus 29.0 months 
      (p = 0.031)]. Most targetable genetic aberrations in pediatric LGGs, including 
      BRAF alterations, are conserved at recurrence and following chemotherapy or 
      irradiation. However, changes in CDKN2A deletion status over time were 
      demonstrated. Acquisition of CDKN2A deletion may define a higher risk subgroup of 
      pediatric LGGs with a poorer prognosis. Given the potential for targeted 
      therapies for tumors harboring CDKN2A deletions, biopsy at recurrence may be 
      indicated in certain patients, especially those with rapid progression.
FAU - Lazow, Margot A
AU  - Lazow MA
AD  - Brain Tumor Center, Cancer and Blood Diseases Institute, Cincinnati Children's 
      Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229, USA.
FAU - Hoffman, Lindsey
AU  - Hoffman L
AD  - Department of Oncology, Phoenix Children's Hospital, Phoenix, AZ, USA.
FAU - Schafer, Austin
AU  - Schafer A
AD  - Brain Tumor Center, Cancer and Blood Diseases Institute, Cincinnati Children's 
      Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229, USA.
FAU - Osorio, Diana S
AU  - Osorio DS
AD  - Department of Oncology, Nationwide Children's Hospital, The Ohio State 
      University, Columbus, OH, USA.
FAU - Boué, Daniel R
AU  - Boué DR
AD  - Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, 
      The Ohio State University, Columbus, OH, USA.
FAU - Rush, Sarah
AU  - Rush S
AD  - Department of Oncology, Akron Children's Hospital, Akron, OH, USA.
FAU - Wright, Erin
AU  - Wright E
AD  - Department of Oncology, Akron Children's Hospital, Akron, OH, USA.
FAU - Lane, Adam
AU  - Lane A
AD  - Brain Tumor Center, Cancer and Blood Diseases Institute, Cincinnati Children's 
      Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229, USA.
AD  - Department of Pediatrics, University of Cincinnati College of Medicine, 
      Cincinnati, OH, USA.
FAU - DeWire-Schottmiller, Mariko D
AU  - DeWire-Schottmiller MD
AD  - Brain Tumor Center, Cancer and Blood Diseases Institute, Cincinnati Children's 
      Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229, USA.
AD  - Department of Pediatrics, University of Cincinnati College of Medicine, 
      Cincinnati, OH, USA.
FAU - Smolarek, Teresa
AU  - Smolarek T
AD  - Department of Pediatrics, University of Cincinnati College of Medicine, 
      Cincinnati, OH, USA.
AD  - Department of Genetics, Cincinnati Children's Hospital Medical Center, 
      Cincinnati, OH, USA.
FAU - Sipple, Jared
AU  - Sipple J
AD  - Department of Genetics, Cincinnati Children's Hospital Medical Center, 
      Cincinnati, OH, USA.
FAU - Taggert, Heather
AU  - Taggert H
AD  - Department of Genetics, Cincinnati Children's Hospital Medical Center, 
      Cincinnati, OH, USA.
FAU - Reuss, Jaime
AU  - Reuss J
AD  - Brain Tumor Center, Cancer and Blood Diseases Institute, Cincinnati Children's 
      Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229, USA.
FAU - Salloum, Ralph
AU  - Salloum R
AD  - Brain Tumor Center, Cancer and Blood Diseases Institute, Cincinnati Children's 
      Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229, USA.
AD  - Department of Pediatrics, University of Cincinnati College of Medicine, 
      Cincinnati, OH, USA.
FAU - Hummel, Trent R
AU  - Hummel TR
AD  - Brain Tumor Center, Cancer and Blood Diseases Institute, Cincinnati Children's 
      Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229, USA.
AD  - Department of Pediatrics, University of Cincinnati College of Medicine, 
      Cincinnati, OH, USA.
FAU - de Blank, Peter
AU  - de Blank P
AD  - Brain Tumor Center, Cancer and Blood Diseases Institute, Cincinnati Children's 
      Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229, USA.
AD  - Department of Pediatrics, University of Cincinnati College of Medicine, 
      Cincinnati, OH, USA.
FAU - Pillay-Smiley, Natasha
AU  - Pillay-Smiley N
AD  - Brain Tumor Center, Cancer and Blood Diseases Institute, Cincinnati Children's 
      Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229, USA.
AD  - Department of Pediatrics, University of Cincinnati College of Medicine, 
      Cincinnati, OH, USA.
FAU - Sutton, Mary E
AU  - Sutton ME
AD  - Brain Tumor Center, Cancer and Blood Diseases Institute, Cincinnati Children's 
      Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229, USA.
AD  - Department of Pediatrics, University of Cincinnati College of Medicine, 
      Cincinnati, OH, USA.
FAU - Asher, Anthony
AU  - Asher A
AD  - Brain Tumor Center, Cancer and Blood Diseases Institute, Cincinnati Children's 
      Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229, USA.
FAU - Stevenson, Charles B
AU  - Stevenson CB
AD  - Brain Tumor Center, Cancer and Blood Diseases Institute, Cincinnati Children's 
      Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229, USA.
AD  - Department of Pediatrics, University of Cincinnati College of Medicine, 
      Cincinnati, OH, USA.
FAU - Drissi, Rachid
AU  - Drissi R
AD  - Brain Tumor Center, Cancer and Blood Diseases Institute, Cincinnati Children's 
      Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229, USA.
AD  - Department of Pediatrics, University of Cincinnati College of Medicine, 
      Cincinnati, OH, USA.
FAU - Finlay, Jonathan L
AU  - Finlay JL
AD  - Department of Oncology, Nationwide Children's Hospital, The Ohio State 
      University, Columbus, OH, USA.
FAU - Fouladi, Maryam
AU  - Fouladi M
AD  - Brain Tumor Center, Cancer and Blood Diseases Institute, Cincinnati Children's 
      Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229, USA. 
      maryam.fouladi@nationwidechildrens.org.
AD  - Department of Pediatrics, University of Cincinnati College of Medicine, 
      Cincinnati, OH, USA. maryam.fouladi@nationwidechildrens.org.
AD  - Pediatric Neuro-Oncology, Nationwide Children's Hospital, 700 Children's Dr., 
      Columbus, OH, 43205, USA. maryam.fouladi@nationwidechildrens.org.
FAU - Fuller, Christine
AU  - Fuller C
AUID- ORCID: 0000-0001-7919-7675
AD  - Brain Tumor Center, Cancer and Blood Diseases Institute, Cincinnati Children's 
      Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229, USA. 
      fullerch@upstate.edu.
AD  - Department of Pediatrics, University of Cincinnati College of Medicine, 
      Cincinnati, OH, USA. fullerch@upstate.edu.
AD  - Department of Pathology, Upstate Medical University, 750 E Adams St., Syracuse, 
      NY, 13210, USA. fullerch@upstate.edu.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20201105
PL  - England
TA  - Acta Neuropathol Commun
JT  - Acta neuropathologica communications
JID - 101610673
RN  - 0 (CDKN2A protein, human)
RN  - 0 (Cyclin-Dependent Kinase Inhibitor p16)
RN  - 0 (MYB protein, human)
RN  - 0 (MYBL1 protein, human)
RN  - 0 (Membrane Glycoproteins)
RN  - 0 (Proto-Oncogene Proteins)
RN  - 0 (Proto-Oncogene Proteins c-myb)
RN  - 0 (Trans-Activators)
RN  - EC 1.1.1.41 (Isocitrate Dehydrogenase)
RN  - EC 1.1.1.42. (IDH1 protein, human)
RN  - EC 2.7.10.1 (FGFR1 protein, human)
RN  - EC 2.7.10.1 (Receptor, Fibroblast Growth Factor, Type 1)
RN  - EC 2.7.10.1 (Receptor, trkB)
RN  - EC 2.7.10.1 (tropomyosin-related kinase-B, human)
RN  - EC 2.7.11.1 (BRAF protein, human)
RN  - EC 2.7.11.1 (Proto-Oncogene Proteins B-raf)
SB  - IM
MH  - Adolescent
MH  - Brain Neoplasms/*genetics/pathology/therapy
MH  - Child
MH  - Child, Preschool
MH  - Cyclin-Dependent Kinase Inhibitor p16/genetics
MH  - Disease Progression
MH  - Female
MH  - Gene Deletion
MH  - Genome
MH  - Genomics
MH  - Glioma/*genetics/pathology/therapy
MH  - Humans
MH  - Infant
MH  - Isocitrate Dehydrogenase/genetics
MH  - Male
MH  - Membrane Glycoproteins/genetics
MH  - Neoplasm Grading
MH  - Neoplasm Recurrence, Local/*genetics/therapy
MH  - Proto-Oncogene Proteins/genetics
MH  - Proto-Oncogene Proteins B-raf/genetics
MH  - Proto-Oncogene Proteins c-myb/genetics
MH  - Receptor, Fibroblast Growth Factor, Type 1/genetics
MH  - Receptor, trkB/genetics
MH  - Trans-Activators/genetics
PMC - PMC7643477
OTO - NOTNLM
OT  - BRAF
OT  - CDKN2A
OT  - Genomics
OT  - Paired
OT  - Pediatric low-grade gliomas
OT  - Recurrence
OT  - Tumor evolution
EDAT- 2020/11/07 06:00
MHDA- 2021/11/11 06:00
CRDT- 2020/11/06 05:36
PHST- 2020/08/25 00:00 [received]
PHST- 2020/10/10 00:00 [accepted]
PHST- 2020/11/06 05:36 [entrez]
PHST- 2020/11/07 06:00 [pubmed]
PHST- 2021/11/11 06:00 [medline]
AID - 10.1186/s40478-020-01054-w [pii]
AID - 1054 [pii]
AID - 10.1186/s40478-020-01054-w [doi]
PST - epublish
SO  - Acta Neuropathol Commun. 2020 Nov 5;8(1):182. doi: 10.1186/s40478-020-01054-w.

PMID- 36645099
OWN - NLM
STAT- MEDLINE
DCOM- 20230315
LR  - 20230320
IS  - 1097-0347 (Electronic)
IS  - 1043-3074 (Linking)
VI  - 45
IP  - 4
DP  - 2023 Apr
TI  - Genomic profiling and precision medicine in complex ameloblastoma.
PG  - 816-826
LID - 10.1002/hed.27294 [doi]
AB  - BACKGROUND: Ameloblastoma may present a significant treatment challenge in the 
      locally advanced, recurrent and metastatic setting. Comprehensive genomic 
      profiling (CGP) can identify targetable genomic alterations to aid in treatment. 
      METHODS: Ameloblastoma samples were sequenced using hybrid-capture based 
      sequencing. A systematic literature review was performed to examine outcomes in 
      studies employing targeted treatment in ameloblastoma. RESULTS: We reviewed 14 
      cases of Ameloblastoma using CGP. There were six patients with activating BRAF 
      mutations, five with PIK3CA, five with SMO, four with FGFR2, one with EGFR, and 
      one with ROS1. All cases were MSI stable and the median TMB was 2.5 mutations/Mb. 
      A separate literature review of clinical outcomes in ameloblastoma showed a 
      predominance of at least partial response to targeted treatment (7/12 cases). 
      CONCLUSION: CGP is helpful in identifying specific driver mutations in patients 
      with complex ameloblastoma. Targeted treatment has been employed with success in 
      achieving treatment response.
CI  - © 2023 Wiley Periodicals LLC.
FAU - Gates, James C
AU  - Gates JC
AUID- ORCID: 0000-0002-7491-8995
AD  - Department of Oral and Maxillofacial Surgery, Hospital of the University of 
      Pennsylvania, Penn Medicine, Philadelphia, Pennsylvania, USA.
FAU - Clark, Allison P
AU  - Clark AP
AD  - Foundation Medicine, Inc., Cambridge, Massachusetts, USA.
FAU - Cherkas, Elliot
AU  - Cherkas E
AD  - Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, 
      Pennsylvania, USA.
FAU - Shreenivas, Aditya V
AU  - Shreenivas AV
AD  - Department of Medical Oncology, Medical College of Wisconsin, Milwaukee, 
      Wisconsin, USA.
FAU - Kraus, Dennis
AU  - Kraus D
AD  - Director of Oncology, Centura Health, Centennial, Colorado, USA.
FAU - Danzinger, Natalie
AU  - Danzinger N
AD  - Foundation Medicine, Inc., Cambridge, Massachusetts, USA.
FAU - Huang, Richard S P
AU  - Huang RSP
AD  - Foundation Medicine, Inc., Cambridge, Massachusetts, USA.
FAU - Johnson, Jennifer
AU  - Johnson J
AD  - Department of Medical Oncology, Thomas Jefferson University, Philadelphia, 
      Pennsylvania, USA.
FAU - Ross, Jeffrey S
AU  - Ross JS
AD  - Foundation Medicine, Inc., Cambridge, Massachusetts, USA.
AD  - Department of Pathology, Upstate Medical University, Syracuse, New York, USA.
AD  - Department of Urology, Upstate Medical University, Syracuse, New York, USA.
LA  - eng
PT  - Journal Article
PT  - Systematic Review
DEP - 20230116
PL  - United States
TA  - Head Neck
JT  - Head & neck
JID - 8902541
RN  - EC 2.7.10.1 (Protein-Tyrosine Kinases)
RN  - 0 (Proto-Oncogene Proteins)
SB  - IM
MH  - Humans
MH  - *Precision Medicine
MH  - *Ameloblastoma/genetics/therapy
MH  - Protein-Tyrosine Kinases
MH  - Proto-Oncogene Proteins
MH  - Mutation
MH  - Genomics
OTO - NOTNLM
OT  - ameloblastoma
OT  - genomic profiling
OT  - molecular markers
OT  - next generation sequencing
OT  - odontogenic cysts and tumors
OT  - precision medicine
OT  - targeted treatment
EDAT- 2023/01/17 06:00
MHDA- 2023/03/16 06:00
CRDT- 2023/01/16 06:32
PHST- 2022/12/01 00:00 [revised]
PHST- 2022/09/14 00:00 [received]
PHST- 2022/12/27 00:00 [accepted]
PHST- 2023/01/17 06:00 [pubmed]
PHST- 2023/03/16 06:00 [medline]
PHST- 2023/01/16 06:32 [entrez]
AID - 10.1002/hed.27294 [doi]
PST - ppublish
SO  - Head Neck. 2023 Apr;45(4):816-826. doi: 10.1002/hed.27294. Epub 2023 Jan 16.

PMID- 37431438
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230718
IS  - 2692-9384 (Electronic)
IS  - 2692-9384 (Linking)
VI  - 1
IP  - 3
DP  - 2021 Oct
TI  - Ensemble classification of autism spectrum disorder using structural magnetic 
      resonance imaging features.
PG  - e12042
LID - 10.1002/jcv2.12042 [doi]
LID - e12042
AB  - BACKGROUND: Autism spectrum disorder (ASD) is characterized by a spectrum of 
      social and communication impairments and rigid and stereotyped behaviors that 
      have a neurodevelopmental origin. Although many imaging studies have reported 
      structural and functional alterations in multiple brain regions, clinically 
      useful diagnostic imaging biomarkers for ASD remain unavailable. METHODS: In this 
      study, we applied machine learning (ML) models to regional volumetric and 
      cortical thickness data from the largest structural magnetic resonance imaging 
      (sMRI) dataset available from the Enhancing Neuro Imaging Genetics Through 
      Meta-Analysis (ENIGMA) consortium (1833 subjects with ASD and 1838 without ASD; 
      age range: 1.5-64; average age: 15.6; male/female ratio: 4.2:1). RESULTS: The 
      highest classification accuracy on a hold-out test set was achieved using a 
      stacked Extra Tree Classifier. The area under the receiver operating 
      characteristic (ROC) curve (AUC) was 0.62 (95% confidence interval [CI]: 0.57, 
      0.68) and the area under the precision-recall curve was 0.58. Learning curve 
      analysis showed the good fit of the model and suggests that more training 
      examples will not likely benefit model performance. CONCLUSIONS: Our results 
      suggest that sMRI volumetric and cortical thickness data alone may not provide 
      clinically sufficient useful diagnostic biomarkers for ASD. Developing clinically 
      useful imaging classifiers for ASD will benefit from combining other data 
      modalities or feature types, such as functional MRI data and raw images that can 
      leverage other machine learning (ML) techniques such as convolutional neural 
      networks.
CI  - © 2021 The Authors. JCPP Advances published by John Wiley & Sons Ltd on behalf of 
      Association for Child and Adolescent Mental Health.
FAU - Zhang-James, Yanli
AU  - Zhang-James Y
AUID- ORCID: 0000-0002-2104-0963
AD  - Department of Psychiatry and Behavioral Sciences SUNY Upstate Medical University 
      Syracuse New York USA.
FAU - Buitelaar, Jan K
AU  - Buitelaar JK
AD  - Radboudumc, Radboud University Medical Center Nijmegen The Netherlands.
AD  - Donders Institute for Brain, Cognition, and Behaviour Radboud University Medical 
      Center Nijmegen The Netherlands.
AD  - Department of Cognitive Neuroscience Radboud University Medical Center Nijmegen 
      The Netherlands.
CN  - ENIGMA‐ASD Working Group
FAU - van Rooij, Daan
AU  - van Rooij D
AD  - Donders Centre for Cognitive Neuroimaging Radboud University Medical Center 
      Nijmegen The Netherlands.
FAU - Faraone, Stephen V
AU  - Faraone SV
AUID- ORCID: 0000-0002-9217-3982
AD  - Department of Psychiatry and Behavioral Sciences SUNY Upstate Medical University 
      Syracuse New York USA.
AD  - Department of Neuroscience and Physiology SUNY Upstate Medical University 
      Syracuse New York USA.
LA  - eng
PT  - Journal Article
DEP - 20211106
PL  - United States
TA  - JCPP Adv
JT  - JCPP advances
JID - 9918250414706676
PMC - PMC10242907
OTO - NOTNLM
OT  - MRI
OT  - autism spectrum disorder
OT  - biomarkers
OT  - classification
OT  - machine learning
COIS- S.V.F. received income, potential income, travel expenses continuing education 
      support, and/or research support from Takeda, OnDosis, Tris, Otsuka, Arbor, 
      Ironshore, Rhodes, Akili Interactive Labs, Enzymotec, Sunovion, Supernus, and 
      Genomind. With his institution, he has US patent US20130217707 A1 for the use of 
      sodium‐hydrogen exchange inhibitors in the treatment of ADHD. He also receives 
      royalties from books published by Guilford Press: Straight Talk about Your 
      Child's Mental Health, Oxford University Press: Schizophrenia: The Facts and 
      Elsevier: ADHD: Non‐Pharmacologic Interventions. He is Program Director of 
      www.ADHDinAdults.com. He is a member of the Editorial Advisory Board for JCPP 
      Advances. Y.Z‐J. is also a member of the Editorial Advisory Board for JCPP 
      Advances. J.K.B. has been in the past 3 years a consultant to/member of advisory 
      board of/and/or speaker for Takeda/Shire, Roche, Medice, Angelini, Janssen, and 
      Servier. He is not an employee of any of these companies, and not a stock 
      shareholder of any of these companies. He has no other financial or material 
      support, including expert testimony, patents, and royalties. The remaining 
      authors have declared that they have no competing or potential conflicts of 
      interest to declare. [Corrections made on 22 June 2022, after first online 
      publication: This Conflict of Interests statement has been updated in this 
      version.]Dr. Arango has been a consultant to or has received honoraria or grants 
      from Acadia, Angelini, Gedeon Richter, Janssen Cilag, Lundbeck, Minerva, Otsuka, 
      Roche, Sage, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovion 
      and Takeda. Dr. Anagnostou has served as a consultant or advisory board member 
      for Roche and Takeda. Dr. Freitag has served as a consultant for Desitin 
      regarding issues on ASD. Dr. Rubia has received funding from Takeda 
      pharmaceuticals for another project. Dr. Gallagher received funding from the 
      Meath Foundation and the National Children's Research Centre in Ireland. Dr. 
      Parellada has served as a consultant, advisory board member or received honoraria 
      from Sevier and Exeltis. She has received travel support from Janssen Cilag and 
      Lundbeck. Dr. Murphy has served on advisory boards for Roche and Servier. Dr. 
      Franke has received educational speaking fees from Medice. The other authors 
      report no financial relationships with commercial interests.
EDAT- 2021/11/06 00:00
MHDA- 2021/11/06 00:01
CRDT- 2023/07/11 03:37
PHST- 2021/04/20 00:00 [received]
PHST- 2021/09/14 00:00 [accepted]
PHST- 2021/11/06 00:01 [medline]
PHST- 2021/11/06 00:00 [pubmed]
PHST- 2023/07/11 03:37 [entrez]
AID - JCV212042 [pii]
AID - 10.1002/jcv2.12042 [doi]
PST - epublish
SO  - JCPP Adv. 2021 Nov 6;1(3):e12042. doi: 10.1002/jcv2.12042. eCollection 2021 Oct.

PMID- 34056577
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230201
IS  - 2624-8212 (Electronic)
IS  - 2624-8212 (Linking)
VI  - 4
DP  - 2021
TI  - Interpretability Versus Accuracy: A Comparison of Machine Learning Models Built 
      Using Different Algorithms, Performance Measures, and Features to Predict E. coli 
      Levels in Agricultural Water.
PG  - 628441
LID - 10.3389/frai.2021.628441 [doi]
LID - 628441
AB  - Since E. coli is considered a fecal indicator in surface water, government water 
      quality standards and industry guidance often rely on E. coli monitoring to 
      identify when there is an increased risk of pathogen contamination of water used 
      for produce production (e.g., for irrigation). However, studies have indicated 
      that E. coli testing can present an economic burden to growers and that time lags 
      between sampling and obtaining results may reduce the utility of these data. 
      Models that predict E. coli levels in agricultural water may provide a mechanism 
      for overcoming these obstacles. Thus, this proof-of-concept study uses previously 
      published datasets to train, test, and compare E. coli predictive models using 
      multiple algorithms and performance measures. Since the collection of different 
      feature data carries specific costs for growers, predictive performance was 
      compared for models built using different feature types [geospatial, water 
      quality, stream traits, and/or weather features]. Model performance was assessed 
      against baseline regression models. Model performance varied considerably with 
      root-mean-squared errors and Kendall's Tau ranging between 0.37 and 1.03, and 
      0.07 and 0.55, respectively. Overall, models that included turbidity, rain, and 
      temperature outperformed all other models regardless of the algorithm used. 
      Turbidity and weather factors were also found to drive model accuracy even when 
      other feature types were included in the model. These findings confirm previous 
      conclusions that machine learning models may be useful for predicting when, 
      where, and at what level E. coli (and associated hazards) are likely to be 
      present in preharvest agricultural water sources. This study also identifies 
      specific algorithm-predictor combinations that should be the foci of future 
      efforts to develop deployable models (i.e., models that can be used to guide 
      on-farm decision-making and risk mitigation). When deploying E. coli predictive 
      models in the field, it is important to note that past research indicates an 
      inconsistent relationship between E. coli levels and foodborne pathogen presence. 
      Thus, models that predict E. coli levels in agricultural water may be useful for 
      assessing fecal contamination status and ensuring compliance with regulations but 
      should not be used to assess the risk that specific pathogens of concern (e.g., 
      Salmonella, Listeria) are present.
CI  - Copyright © 2021 Weller, Love and Wiedmann.
FAU - Weller, Daniel L
AU  - Weller DL
AD  - Department of Biostatistics and Computational Biology, University of Rochester, 
      Rochester, NY, United States.
AD  - Department of Food Science, Cornell University, Ithaca, NY, United States.
AD  - Current Affiliation, Department of Environmental and Forest Biology, SUNY College 
      of Environmental Science and Forestry, Syracuse, NY, United States.
FAU - Love, Tanzy M T
AU  - Love TMT
AD  - Department of Biostatistics and Computational Biology, University of Rochester, 
      Rochester, NY, United States.
FAU - Wiedmann, Martin
AU  - Wiedmann M
AD  - Department of Food Science, Cornell University, Ithaca, NY, United States.
LA  - eng
GR  - T32 ES007271/ES/NIEHS NIH HHS/United States
PT  - Journal Article
DEP - 20210514
PL  - Switzerland
TA  - Front Artif Intell
JT  - Frontiers in artificial intelligence
JID - 101770551
PMC - PMC8160515
OTO - NOTNLM
OT  - E. coli
OT  - food safety
OT  - machine learning
OT  - predictive model
OT  - water quality
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2021/06/01 06:00
MHDA- 2021/06/01 06:01
CRDT- 2021/05/31 06:25
PHST- 2020/11/11 00:00 [received]
PHST- 2021/02/12 00:00 [accepted]
PHST- 2021/05/31 06:25 [entrez]
PHST- 2021/06/01 06:00 [pubmed]
PHST- 2021/06/01 06:01 [medline]
AID - 628441 [pii]
AID - 10.3389/frai.2021.628441 [doi]
PST - epublish
SO  - Front Artif Intell. 2021 May 14;4:628441. doi: 10.3389/frai.2021.628441. 
      eCollection 2021.

PMID- 37443264
OWN - NLM
STAT- MEDLINE
DCOM- 20231201
LR  - 20231216
IS  - 1759-4820 (Electronic)
IS  - 1759-4812 (Linking)
VI  - 20
IP  - 12
DP  - 2023 Dec
TI  - Effects of the environment on the evolution of the vertebrate urinary tract.
PG  - 719-738
LID - 10.1038/s41585-023-00794-3 [doi]
AB  - Evolution of the vertebrate urinary system occurs in response to numerous 
      selective pressures, which have been incompletely characterized. Developing 
      research into urinary evolution led to the occurrence of clinical applications 
      and insights in paediatric urology, reproductive medicine, urolithiasis and other 
      domains. Each nephron segment and urinary organ has functions that can be 
      contextualized within an evolutionary framework. For example, the structure and 
      function of the glomerulus and proximal tubule are highly conserved, enabling 
      blood cells and proteins to be retained, and facilitating the elimination of 
      oceanic Ca(+) and Mg(+). Urea emerged as an osmotic mediator during evolution, as 
      cells of large organisms required increased precision in the internal regulation 
      of salinity and solutes. As the first vertebrates moved from water to land, 
      acid-base regulation was shifted from gills to skin and kidneys in amphibians. In 
      reptiles and birds, solute regulation no longer occurred through the skin but 
      through nasal salt glands and post-renally, within the cloaca and the rectum. In 
      placental mammals, nasal salt glands are absent and the rectum and urinary tracts 
      became separate, which limited post-renal urine concentration and led to the 
      necessity of a kidney capable of high urine concentration. Considering the 
      evolutionary and environmental selective pressures that have contributed to renal 
      evolution can help to gain an increased understanding of renal physiology.
CI  - © 2023. Springer Nature Limited.
FAU - Wiener, Scott V
AU  - Wiener SV
AD  - Department of Urology, SUNY Upstate Medical University, Syracuse, NY, USA. 
      wienersc@upstate.edu.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20230713
PL  - England
TA  - Nat Rev Urol
JT  - Nature reviews. Urology
JID - 101500082
SB  - IM
MH  - Female
MH  - Humans
MH  - Pregnancy
MH  - Animals
MH  - Child
MH  - *Placenta
MH  - *Vertebrates/physiology
MH  - Kidney/physiology
MH  - Reptiles/physiology
MH  - Birds
MH  - Mammals
EDAT- 2023/07/14 13:07
MHDA- 2023/12/01 06:43
CRDT- 2023/07/13 23:51
PHST- 2023/06/12 00:00 [accepted]
PHST- 2023/12/01 06:43 [medline]
PHST- 2023/07/14 13:07 [pubmed]
PHST- 2023/07/13 23:51 [entrez]
AID - 10.1038/s41585-023-00794-3 [pii]
AID - 10.1038/s41585-023-00794-3 [doi]
PST - ppublish
SO  - Nat Rev Urol. 2023 Dec;20(12):719-738. doi: 10.1038/s41585-023-00794-3. Epub 2023 
      Jul 13.

PMID- 31104177
OWN - NLM
STAT- MEDLINE
DCOM- 20190722
LR  - 20200225
IS  - 1875-8312 (Electronic)
IS  - 1569-5794 (Linking)
VI  - 35
IP  - 7
DP  - 2019 Jul
TI  - Ventricular geometry-regularized QRSd predicts cardiac resynchronization therapy 
      response: machine learning from crosstalk between electrocardiography and 
      echocardiography.
PG  - 1221-1229
LID - 10.1007/s10554-019-01545-5 [doi]
AB  - Up to one-third of patients selected by current guidelines do not respond to 
      cardiac resynchronization therapy (CRT), the aim of this study was to find out 
      novel analytical approaches to improve pre-implantation CRT response prediction. 
      Among 31 pre-implantation features of clinical, laboratory, electrocardiography 
      (ECG), and echocardiography variables in a consecutive cohort of patients 
      receiving a first-time CRT device (CRT-pacemaker or CRT-defibrillator), we 
      developed a machine learning (ML) model with three classification algorithms 
      (support vector machines (SVM), K nearest neighbors, and random subspaces) with 
      the best features combination to predict CRT response. Three categorical 
      variables, left bundle branch block (LBBB), nonischemic cardiomyopathy, and 
      female gender, were independently associated with CRT responses. Among continuous 
      variables, including septal wall thickness, posterior wall thickness, and 
      relative wall thickness (RWT), could regularize ECG QRS duration (QRSd) and 
      significantly enhance the correlation between QRSd and CRT response. The 3 ML 
      algorithms in a total of 38 features combinations constantly recognized that the 
      features combined with QRSd/RWT outperformed the combinations without it. For 
      each of three algorithms, the triplet feature combination of QRSd/RWT, LBBB, and 
      nonischemic cardiomyopathy repeatedly increased the classification rate more than 
      8%. The best performance for CRT response prediction occurred with SVM model, 
      which proposed actual QRSd/RWT values that favored CRT responses in patients both 
      with and without LBBB. Lower QRSd/RWT values were required for CRT responses in 
      patients with ischemic cardiomyopathy compared to those with non-ischemic 
      cardiomyopathy. ML from ventricular remodeling characteristics-regularized QRSd 
      improves CRT response prediction.
FAU - Lei, Juan
AU  - Lei J
AD  - Division of Cardiology, Department of Medicine, State University of New York, 
      Upstate Medical University, Syracuse, NY, 13202, USA.
AD  - Department of Cardiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, 
      Guangzhou, 510120, Guangdong, China.
FAU - Wang, Yi Grace
AU  - Wang YG
AD  - Department of Mathematics, California State University Dominguez Hills, Carson, 
      CA, USA.
FAU - Bhatta, Luna
AU  - Bhatta L
AD  - Division of Cardiology, Department of Medicine, State University of New York, 
      Upstate Medical University, Syracuse, NY, 13202, USA.
FAU - Ahmed, Jamal
AU  - Ahmed J
AD  - Division of Cardiology, Department of Medicine, State University of New York, 
      Upstate Medical University, Syracuse, NY, 13202, USA.
FAU - Fan, Dali
AU  - Fan D
AD  - Division of Cardiology, Department of Medicine, University of California, Davis, 
      CA, USA.
FAU - Wang, Jingfeng
AU  - Wang J
AD  - Department of Cardiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, 
      Guangzhou, 510120, Guangdong, China. drwjf@hotmail.com.
FAU - Liu, Kan
AU  - Liu K
AUID- ORCID: 0000-0001-5236-9166
AD  - Division of Cardiology, Department of Medicine, State University of New York, 
      Upstate Medical University, Syracuse, NY, 13202, USA. Kan-Liu@uiowa.edu.
AD  - Division of Cardiology, Department of Medicine, University of Iowa, Iowa City, 
      IA, 52242, USA. Kan-Liu@uiowa.edu.
LA  - eng
PT  - Journal Article
DEP - 20190518
PL  - United States
TA  - Int J Cardiovasc Imaging
JT  - The international journal of cardiovascular imaging
JID - 100969716
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - *Cardiac Resynchronization Therapy
MH  - Clinical Decision-Making
MH  - Echocardiography/*methods
MH  - Electrocardiography/*methods
MH  - Female
MH  - Heart Failure/*diagnostic imaging/physiopathology/*therapy
MH  - Humans
MH  - Image Interpretation, Computer-Assisted/*methods
MH  - Male
MH  - Middle Aged
MH  - Patient Selection
MH  - Predictive Value of Tests
MH  - *Signal Processing, Computer-Assisted
MH  - *Support Vector Machine
MH  - Treatment Outcome
MH  - Ventricular Function, Left
MH  - Ventricular Remodeling
OTO - NOTNLM
OT  - Cardiac resynchronization therapy
OT  - Classification
OT  - Machine learning
OT  - QRS duration
OT  - Ventricular geometric characteristics
EDAT- 2019/05/20 06:00
MHDA- 2019/07/23 06:00
CRDT- 2019/05/20 06:00
PHST- 2018/12/03 00:00 [received]
PHST- 2019/01/23 00:00 [accepted]
PHST- 2019/05/20 06:00 [pubmed]
PHST- 2019/07/23 06:00 [medline]
PHST- 2019/05/20 06:00 [entrez]
AID - 10.1007/s10554-019-01545-5 [pii]
AID - 10.1007/s10554-019-01545-5 [doi]
PST - ppublish
SO  - Int J Cardiovasc Imaging. 2019 Jul;35(7):1221-1229. doi: 
      10.1007/s10554-019-01545-5. Epub 2019 May 18.

PMID- 32918774
OWN - NLM
STAT- MEDLINE
DCOM- 20210618
LR  - 20220531
IS  - 1549-490X (Electronic)
IS  - 1083-7159 (Print)
IS  - 1083-7159 (Linking)
VI  - 26
IP  - 1
DP  - 2021 Jan
TI  - Targetable BRAF and RAF1 Alterations in Advanced Pediatric Cancers.
PG  - e153-e163
LID - 10.1002/ONCO.13519 [doi]
AB  - RAF family protein kinases signal through the MAPK pathway to orchestrate 
      cellular proliferation, survival, and transformation. Identifying BRAF 
      alterations in pediatric cancers is critically important as therapeutic agents 
      targeting BRAF or MEK may be incorporated into the clinical management of these 
      patients. In this study, we performed comprehensive genomic profiling on 3,633 
      pediatric cancer samples and identified a cohort of 221 (6.1%) cases with known 
      or novel alterations in BRAF or RAF1 detected in extracranial solid tumors, brain 
      tumors, or hematological malignancies. Eighty percent (176/221) of these tumors 
      had a known-activating short variant (98, 55.7%), fusion (72, 40.9%), or 
      insertion/deletion (6, 3.4%). Among BRAF altered cancers, the most common tumor 
      types were brain tumors (74.4%), solid tumors (10.8%), hematological malignancies 
      (9.1%), sarcomas (3.4%), and extracranial embryonal tumors (2.3%). RAF1 fusions 
      containing intact RAF1 kinase domain (encoded by exons 10-17) were identified in 
      seven tumors, including two novel fusions TMF1-RAF1 and SOX6-RAF1. Additionally, 
      we highlight a subset of patients with brain tumor with positive clinical 
      response to BRAF inhibitors, demonstrating the rationale for incorporating 
      precision medicine into pediatric oncology. IMPLICATIONS FOR PRACTICE: Precision 
      medicine has not yet gained a strong foothold in pediatric cancers. This study 
      describes the landscape of BRAF and RAF1 genomic alterations across a diverse 
      spectrum of pediatric cancers, primarily brain tumors, but also encompassing 
      melanoma, sarcoma, several types of hematologic malignancy, and others. Given the 
      availability of multiple U.S. Food and Drug Administration-approved BRAF 
      inhibitors, identification of these alterations may assist with treatment 
      decision making, as described here in three cases of pediatric cancer.
CI  - © AlphaMed Press 2020.
FAU - Rankin, Andrew
AU  - Rankin A
AD  - Foundation Medicine Inc., Cambridge, Massachusetts, USA.
FAU - Johnson, Adrienne
AU  - Johnson A
AD  - Foundation Medicine Inc., Cambridge, Massachusetts, USA.
FAU - Roos, Alison
AU  - Roos A
AD  - Foundation Medicine Inc., Cambridge, Massachusetts, USA.
FAU - Kannan, Geoffrey
AU  - Kannan G
AD  - Center for Cancer and Blood Disorders, Pediatric Specialists of Virginia, Falls 
      Church, Virginia, USA.
FAU - Knipstein, Jeffrey
AU  - Knipstein J
AD  - Pediatric Hematology/Oncology/BMT, Medical College of Wisconsin, Milwaukee, 
      Wisconsin, USA.
FAU - Britt, Nicholas
AU  - Britt N
AD  - Foundation Medicine Inc., Morrisville, North, Carolina, USA.
FAU - Rosenzweig, Mark
AU  - Rosenzweig M
AD  - Foundation Medicine Inc., Cambridge, Massachusetts, USA.
FAU - Haberberger, James
AU  - Haberberger J
AD  - Foundation Medicine Inc., Morrisville, North, Carolina, USA.
FAU - Pavlick, Dean
AU  - Pavlick D
AD  - Foundation Medicine Inc., Cambridge, Massachusetts, USA.
FAU - Severson, Eric
AU  - Severson E
AD  - Foundation Medicine Inc., Morrisville, North, Carolina, USA.
FAU - Vergilio, Jo-Anne
AU  - Vergilio JA
AD  - Foundation Medicine Inc., Cambridge, Massachusetts, USA.
FAU - Squillace, Rachel
AU  - Squillace R
AD  - Foundation Medicine Inc., Cambridge, Massachusetts, USA.
FAU - Erlich, Rachel
AU  - Erlich R
AD  - Foundation Medicine Inc., Cambridge, Massachusetts, USA.
FAU - Sathyan, Pratheesh
AU  - Sathyan P
AD  - Foundation Medicine Inc., Cambridge, Massachusetts, USA.
FAU - Cramer, Stuart
AU  - Cramer S
AD  - University of South Carolina School of Medicine, Columbia, South Carolina, USA.
FAU - Kram, David
AU  - Kram D
AD  - Wake Forest Pediatric Oncology, Winston-Salem, North Carolina, USA.
FAU - Ross, Jeffrey
AU  - Ross J
AD  - Foundation Medicine Inc., Cambridge, Massachusetts, USA.
AD  - SUNY Upstate Medical University, Syracuse, New York, USA.
FAU - Miller, Vince
AU  - Miller V
AD  - Foundation Medicine Inc., Cambridge, Massachusetts, USA.
FAU - Reddy, Prasanth
AU  - Reddy P
AD  - Foundation Medicine Inc., Cambridge, Massachusetts, USA.
FAU - Alexander, Brian
AU  - Alexander B
AD  - Foundation Medicine Inc., Cambridge, Massachusetts, USA.
FAU - Ali, Siraj M
AU  - Ali SM
AD  - Foundation Medicine Inc., Cambridge, Massachusetts, USA.
FAU - Ramkissoon, Shakti
AU  - Ramkissoon S
AD  - Foundation Medicine Inc., Morrisville, North, Carolina, USA.
AD  - Wake Forest Comprehensive Cancer Center and Department of Pathology, Wake Forest 
      School of Medicine, Winston-Salem, North Carolina, USA.
LA  - eng
PT  - Journal Article
DEP - 20200925
PL  - England
TA  - Oncologist
JT  - The oncologist
JID - 9607837
RN  - 0 (MAS1 protein, human)
RN  - 0 (Proto-Oncogene Mas)
RN  - EC 2.7.11.1 (BRAF protein, human)
RN  - EC 2.7.11.1 (Proto-Oncogene Proteins B-raf)
RN  - EC 2.7.11.1 (Proto-Oncogene Proteins c-raf)
RN  - EC 2.7.11.1 (Raf1 protein, human)
SB  - IM
MH  - *Brain Neoplasms/drug therapy/genetics
MH  - Child
MH  - Humans
MH  - *Melanoma
MH  - Mutation
MH  - Proto-Oncogene Mas
MH  - *Proto-Oncogene Proteins B-raf/genetics
MH  - Proto-Oncogene Proteins c-raf/*genetics
MH  - *Sarcoma
MH  - *Soft Tissue Neoplasms
PMC - PMC7794197
OTO - NOTNLM
OT  - Biomarkers
OT  - Brain neoplasms
OT  - Leukemia
OT  - Pediatrics
OT  - Precision medicine
OT  - Proteins B-raf
OT  - Proto-oncogene
OT  - Tumor
COIS- Disclosures of potential conflicts of interest may be found at the end of this 
      article.
EDAT- 2020/09/13 06:00
MHDA- 2021/06/22 06:00
CRDT- 2020/09/12 12:07
PHST- 2019/11/17 00:00 [received]
PHST- 2020/07/28 00:00 [accepted]
PHST- 2020/09/13 06:00 [pubmed]
PHST- 2021/06/22 06:00 [medline]
PHST- 2020/09/12 12:07 [entrez]
AID - ONCO13519 [pii]
AID - 10.1002/ONCO.13519 [doi]
PST - ppublish
SO  - Oncologist. 2021 Jan;26(1):e153-e163. doi: 10.1002/ONCO.13519. Epub 2020 Sep 25.

PMID- 36076265
OWN - NLM
STAT- MEDLINE
DCOM- 20220913
LR  - 20231114
IS  - 1479-5868 (Electronic)
IS  - 1479-5868 (Linking)
VI  - 19
IP  - 1
DP  - 2022 Sep 8
TI  - A catalog of validity indices for step counting wearable technologies during 
      treadmill walking: the CADENCE-adults study.
PG  - 117
LID - 10.1186/s12966-022-01350-9 [doi]
LID - 117
AB  - BACKGROUND: Standardized validation indices (i.e., accuracy, bias, and precision) 
      provide a comprehensive comparison of step counting wearable technologies. 
      PURPOSE: To expand a previously published child/youth catalog of validity indices 
      to include adults (21-40, 41-60 and 61-85 years of age) assessed across a range 
      of treadmill speeds (slow [0.8-3.2 km/h], normal [4.0-6.4 km/h], fast 
      [7.2-8.0 km/h]) and device wear locations (ankle, thigh, waist, and wrist). 
      METHODS: Two hundred fifty-eight adults (52.5 ± 18.7 years, 49.6% female) 
      participated in this laboratory-based study and performed a series of 5-min 
      treadmill bouts while wearing multiple devices; 21 devices in total were 
      evaluated over the course of this multi-year cross-sectional study (2015-2019). 
      The criterion measure was directly observed steps. Computed validity indices 
      included accuracy (mean absolute percentage error, MAPE), bias (mean percentage 
      error, MPE), and precision (correlation coefficient, r; standard deviation, SD; 
      coefficient of variation, CoV). RESULTS: Over the range of normal speeds, 15 
      devices (Actical, waist-worn ActiGraph GT9X, activPAL, Apple Watch Series 1, 
      Fitbit Ionic, Fitbit One, Fitbit Zip, Garmin vivoactive 3, Garmin vivofit 3, 
      waist-worn GENEActiv, NL-1000, PiezoRx, Samsung Gear Fit2, Samsung Gear Fit2 Pro, 
      and StepWatch) performed at < 5% MAPE. The wrist-worn ActiGraph GT9X displayed 
      the worst accuracy across normal speeds (MAPE = 52%). On average, accuracy was 
      compromised across slow walking speeds for all wearable technologies (MAPE = 40%) 
      while all performed best across normal speeds (MAPE = 7%). When analyzing the 
      data by wear locations, the ankle and thigh demonstrated the best accuracy (both 
      MAPE = 1%), followed by the waist (3%) and the wrist (15%) across normal speeds. 
      There were significant effects of speed, wear location, and age group on accuracy 
      and bias (both p < 0.001) and precision (p ≤ 0.045). CONCLUSIONS: Standardized 
      validation indices cataloged by speed, wear location, and age group across the 
      adult lifespan facilitate selecting, evaluating, or comparing performance of step 
      counting wearable technologies. Speed, wear location, and age displayed a 
      significant effect on accuracy, bias, and precision. Overall, reduced performance 
      was associated with very slow walking speeds (0.8 to 3.2 km/h). Ankle- and 
      thigh-located devices logged the highest accuracy, while those located at the 
      wrist reported the worst accuracy. TRIAL REGISTRATION: Clinicaltrials.gov 
      NCT02650258. Registered 24 December 2015.
CI  - © 2022. The Author(s).
FAU - Mora-Gonzalez, Jose
AU  - Mora-Gonzalez J
AD  - PROFITH "PROmoting FITness and Health Through Physical Activity" Research Group, 
      Department of Physical Education and Sports, Faculty of Sport Sciences, Sport and 
      Health University Research Institute (iMUDS), University of Granada, Granada, 
      Spain.
AD  - College of Health and Human Services, University of North Carolina at Charlotte, 
      9201 University City Blvd, Charlotte, NC, 28223, USA.
FAU - Gould, Zachary R
AU  - Gould ZR
AD  - Department of Kinesiology, University of Massachusetts Amherst, Amherst, MA, USA.
FAU - Moore, Christopher C
AU  - Moore CC
AD  - Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel 
      Hill, NC, USA.
FAU - Aguiar, Elroy J
AU  - Aguiar EJ
AD  - Department of Kinesiology, The University of Alabama, Tuscaloosa, AL, USA.
FAU - Ducharme, Scott W
AU  - Ducharme SW
AD  - Department of Kinesiology, California State University, Long Beach, Long Beach, 
      CA, USA.
FAU - Schuna, John M Jr
AU  - Schuna JM Jr
AD  - School of Biological and Population Health Sciences, Oregon State University, 
      Corvallis, OR, USA.
FAU - Barreira, Tiago V
AU  - Barreira TV
AD  - Exercise Science Department, Syracuse University, Syracuse, NY, USA.
FAU - Staudenmayer, John
AU  - Staudenmayer J
AD  - Department of Mathematics and Statistics, University of Massachusetts Amherst, 
      Amherst, MA, USA.
FAU - McAvoy, Cayla R
AU  - McAvoy CR
AD  - College of Health and Human Services, University of North Carolina at Charlotte, 
      9201 University City Blvd, Charlotte, NC, 28223, USA.
FAU - Boikova, Mariya
AU  - Boikova M
AD  - College of Health and Human Services, University of North Carolina at Charlotte, 
      9201 University City Blvd, Charlotte, NC, 28223, USA.
FAU - Miller, Taavy A
AU  - Miller TA
AD  - College of Health and Human Services, University of North Carolina at Charlotte, 
      9201 University City Blvd, Charlotte, NC, 28223, USA.
AD  - Hanger Institute for Clinical Research and Education, Austin, TX, USA.
FAU - Tudor-Locke, Catrine
AU  - Tudor-Locke C
AUID- ORCID: 0000-0003-4342-5909
AD  - College of Health and Human Services, University of North Carolina at Charlotte, 
      9201 University City Blvd, Charlotte, NC, 28223, USA. Tudor-Locke@uncc.edu.
LA  - eng
SI  - ClinicalTrials.gov/NCT02650258
GR  - R01 AG049024/AG/NIA NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20220908
PL  - England
TA  - Int J Behav Nutr Phys Act
JT  - The international journal of behavioral nutrition and physical activity
JID - 101217089
SB  - IM
MH  - Adult
MH  - Child
MH  - Cross-Sectional Studies
MH  - Exercise Test
MH  - Female
MH  - Fitness Trackers
MH  - Humans
MH  - Male
MH  - Reproducibility of Results
MH  - *Walking
MH  - *Wearable Electronic Devices
PMC - PMC9461139
OTO - NOTNLM
OT  - Accelerometer
OT  - Accuracy
OT  - Bias
OT  - Measurement
OT  - Pedometer
OT  - Physical activity
COIS- The authors declare they have no conflicts of interest. The results of the 
      present study do not constitute endorsement by the American College of Sports 
      Medicine. The results of the study are presented clearly, honestly, and without 
      fabrication, falsification, or inappropriate data manipulation.
EDAT- 2022/09/09 06:00
MHDA- 2022/09/14 06:00
CRDT- 2022/09/08 23:41
PHST- 2022/02/22 00:00 [received]
PHST- 2022/08/17 00:00 [accepted]
PHST- 2022/09/08 23:41 [entrez]
PHST- 2022/09/09 06:00 [pubmed]
PHST- 2022/09/14 06:00 [medline]
AID - 10.1186/s12966-022-01350-9 [pii]
AID - 1350 [pii]
AID - 10.1186/s12966-022-01350-9 [doi]
PST - epublish
SO  - Int J Behav Nutr Phys Act. 2022 Sep 8;19(1):117. doi: 10.1186/s12966-022-01350-9.

PMID- 36323913
OWN - NLM
STAT- MEDLINE
DCOM- 20221104
LR  - 20230104
IS  - 2045-2322 (Electronic)
IS  - 2045-2322 (Linking)
VI  - 12
IP  - 1
DP  - 2022 Nov 2
TI  - Parallel functional annotation of cancer-associated missense mutations in histone 
      methyltransferases.
PG  - 18487
LID - 10.1038/s41598-022-23229-2 [doi]
LID - 18487
AB  - Using exome sequencing for biomarker discovery and precision medicine requires 
      connecting nucleotide-level variation with functional changes in encoded 
      proteins. However, for functionally annotating the thousands of cancer-associated 
      missense mutations, or variants of uncertain significance (VUS), purifying 
      variant proteins for biochemical and functional analysis is cost-prohibitive and 
      inefficient. We describe parallel functional annotation (PFA) of large numbers of 
      VUS using small cultures and crude extracts in 96-well plates. Using members of a 
      histone methyltransferase family, we demonstrate high-throughput structural and 
      functional annotation of cancer-associated mutations. By combining functional 
      annotation of paralogs, we discovered two phylogenetic and clustering parameters 
      that improve the accuracy of sequence-based functional predictions to over 90%. 
      Our results demonstrate the value of PFA for defining oncogenic/tumor suppressor 
      functions of histone methyltransferases as well as enhancing the accuracy of 
      sequence-based algorithms in predicting the effects of cancer-associated 
      mutations.
CI  - © 2022. The Author(s).
FAU - Canning, Ashley J
AU  - Canning AJ
AD  - Department of Biochemistry and Molecular Biology, State University of New York 
      (SUNY) Upstate Medical University, 4261 Weiskotten Hall, Syracuse, NY, 13210, 
      USA.
FAU - Viggiano, Susan
AU  - Viggiano S
AD  - Department of Biochemistry and Molecular Biology, State University of New York 
      (SUNY) Upstate Medical University, 4261 Weiskotten Hall, Syracuse, NY, 13210, 
      USA.
FAU - Fernandez-Zapico, Martin E
AU  - Fernandez-Zapico ME
AD  - Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo 
      Clinic, Rochester, MN, USA.
FAU - Cosgrove, Michael S
AU  - Cosgrove MS
AD  - Department of Biochemistry and Molecular Biology, State University of New York 
      (SUNY) Upstate Medical University, 4261 Weiskotten Hall, Syracuse, NY, 13210, 
      USA. cosgrovm@upstate.edu.
LA  - eng
GR  - R01 CA140522/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20221102
PL  - England
TA  - Sci Rep
JT  - Scientific reports
JID - 101563288
RN  - EC 2.1.1.- (Histone Methyltransferases)
SB  - IM
MH  - Humans
MH  - *Mutation, Missense
MH  - Phylogeny
MH  - Histone Methyltransferases/genetics
MH  - *Neoplasms/genetics
MH  - Algorithms
PMC - PMC9630446
COIS- The authors declare no competing interests.
EDAT- 2022/11/04 06:00
MHDA- 2022/11/05 06:00
CRDT- 2022/11/03 00:37
PHST- 2022/06/10 00:00 [received]
PHST- 2022/10/27 00:00 [accepted]
PHST- 2022/11/03 00:37 [entrez]
PHST- 2022/11/04 06:00 [pubmed]
PHST- 2022/11/05 06:00 [medline]
AID - 10.1038/s41598-022-23229-2 [pii]
AID - 23229 [pii]
AID - 10.1038/s41598-022-23229-2 [doi]
PST - epublish
SO  - Sci Rep. 2022 Nov 2;12(1):18487. doi: 10.1038/s41598-022-23229-2.

PMID- 34703393
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20211028
IS  - 1450-1147 (Print)
IS  - 1607-3312 (Electronic)
IS  - 1450-1147 (Linking)
VI  - 20
IP  - 3
DP  - 2021 Jul-Sep
TI  - Clinical predictors of I-131 therapy failure in differentiated thyroid cancer by 
      machine learning: A single-center experience.
PG  - 253-259
LID - 10.4103/wjnm.WJNM_104_20 [doi]
AB  - Well-differentiated thyroid carcinoma is predominantly a slow-growing malignancy, 
      amendable to treatment, and has an excellent prognosis following thyroidectomy 
      and radioiodine (RAI) therapy. However, patients who fail the initial RAI 
      treatment attempt may require repeated RAI or other treatments and with this, 
      comes an associated impact on patient quality of life. Therefore, the 
      anticipation of patients in whom there is a higher risk of RAI failure may help 
      in patient risk stratification and subsequent management. We conducted a 
      retrospective review to determine the factors associated with initial RAI therapy 
      failure in well-differentiated thyroid cancer patients. Using scikit-learn from 
      Python, we implemented a machine-learning algorithm to determine the clinical 
      patient factors associated with a higher likelihood of treatment resistance. We 
      found that clinical factors such as tumor focality (P = 0.026) and lymph node 
      invasion at surgical resection (P = 0.0135) were significantly associated with 
      initial treatment failure following RAI. Elevated serum thyroglobulin (Tg) and Tg 
      antibody levels following surgery but before RAI were also associated with 
      treatment resistance (P < 0.0001 and P = 0.011 respectively). Less expected 
      factors such as decreased time from surgery to RAI were also associated with 
      treatment failure, however not to a statistically significant degree (P > 0.064). 
      Clinical outcomes following RAI can be stratified by identifying factors that are 
      associated with initial treatment failure. These findings can help restratify 
      patients for RAI treatment and change patient management in certain cases. Such 
      stratification will ultimately help to optimize successful treatment outcomes and 
      improve patient quality of life.
CI  - Copyright: © 2021 World Journal of Nuclear Medicine.
FAU - Lubin, David J
AU  - Lubin DJ
AD  - Department of Radiology, Nuclear Medicine, University Hospital, SUNY Upstate, 
      Syracuse, NY, USA.
AD  - Department of Nuclear Medicine, University Hospital, SUNY Upstate, Syracuse,, 
      University Hospital, SUNY Upstate, Syracuse, NY, USA.
FAU - Tsetse, Caleb
AU  - Tsetse C
AD  - Department of Radiology, Nuclear Medicine, University Hospital, SUNY Upstate, 
      Syracuse, NY, USA.
FAU - Khorasani, Mohammad S
AU  - Khorasani MS
AD  - Department of Surgery, University Hospital, College of Medicine, Upstate Medical 
      University, SUNY Upstate, Syracuse, NY, USA.
FAU - Allahyari, Massoud
AU  - Allahyari M
AD  - Department of Radiology, Nuclear Medicine, University Hospital, SUNY Upstate, 
      Syracuse, NY, USA.
FAU - McGrath, Mary
AU  - McGrath M
AD  - Department of Radiology, Nuclear Medicine, University Hospital, SUNY Upstate, 
      Syracuse, NY, USA.
AD  - Department of Nuclear Medicine, University Hospital, SUNY Upstate, Syracuse,, 
      University Hospital, SUNY Upstate, Syracuse, NY, USA.
LA  - eng
PT  - Journal Article
DEP - 20210315
PL  - Germany
TA  - World J Nucl Med
JT  - World journal of nuclear medicine
JID - 101286955
PMC - PMC8488882
OTO - NOTNLM
OT  - Machine learning
OT  - radioiodine ablation
OT  - restratification
OT  - thyroglobulin
OT  - thyroid cancer
COIS- There are no conflicts of interest.
EDAT- 2021/10/28 06:00
MHDA- 2021/10/28 06:01
CRDT- 2021/10/27 07:06
PHST- 2020/07/28 00:00 [received]
PHST- 2020/10/09 00:00 [revised]
PHST- 2020/10/18 00:00 [accepted]
PHST- 2021/10/27 07:06 [entrez]
PHST- 2021/10/28 06:00 [pubmed]
PHST- 2021/10/28 06:01 [medline]
AID - WJNM-20-253 [pii]
AID - 10.4103/wjnm.WJNM_104_20 [doi]
PST - epublish
SO  - World J Nucl Med. 2021 Mar 15;20(3):253-259. doi: 10.4103/wjnm.WJNM_104_20. 
      eCollection 2021 Jul-Sep.

PMID- 33970367
OWN - NLM
STAT- MEDLINE
DCOM- 20220221
LR  - 20220224
IS  - 1573-3432 (Electronic)
IS  - 0162-3257 (Print)
IS  - 0162-3257 (Linking)
VI  - 52
IP  - 3
DP  - 2022 Mar
TI  - Cross-Disorder Analysis of De Novo Mutations in Neuropsychiatric Disorders.
PG  - 1299-1313
LID - 10.1007/s10803-021-05031-7 [doi]
AB  - The clinical similarity among different neuropsychiatric disorders (NPDs) 
      suggested a shared genetic basis. We catalogued 23,109 coding de novo mutations 
      (DNMs) from 6511 patients with autism spectrum disorder (ASD), 4,293 undiagnosed 
      developmental disorder (UDD), 933 epileptic encephalopathy (EE), 1022 
      intellectual disability (ID), 1094 schizophrenia (SCZ), and 3391 controls. We 
      evaluated that putative functional DNMs contribute to 38.11%, 34.40%, 33.31%, 
      10.98% and 6.91% of patients with ID, EE, UDD, ASD and SCZ, respectively. 
      Consistent with phenotype similarity and heterogeneity in different NPDs, they 
      show different degree of genetic association. Cross-disorder analysis of DNMs 
      prioritized 321 candidate genes (FDR < 0.05) and showed that genes shared in more 
      disorders were more likely to exhibited specific expression pattern, functional 
      pathway, genetic convergence, and genetic intolerance.
CI  - © 2021. The Author(s).
FAU - Li, Kuokuo
AU  - Li K
AD  - National Clinical Research Center for Geriatric Disorders, Department of 
      Geriatrics, Xiangya Hospital, Central South University, Xiangya Road, Kaifu 
      District, Changsha, 410013, Hunan, China.
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, Central South University, Xiangya Road, Kaifu District, Changsha, 
      410013, Hunan, China.
AD  - Department of Obstetrics and Gynecology, The First Affiliated Hospital of Anhui 
      Medical University, No 218 Jixi Road, Hefei, 230022, Anhui, China.
AD  - NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract (Anhui 
      Medical University), No 81 Meishan Road, Hefei, 230032, Anhui, China.
FAU - Fang, Zhenghuan
AU  - Fang Z
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, Central South University, Xiangya Road, Kaifu District, Changsha, 
      410013, Hunan, China.
FAU - Zhao, Guihu
AU  - Zhao G
AD  - National Clinical Research Center for Geriatric Disorders, Department of 
      Geriatrics, Xiangya Hospital, Central South University, Xiangya Road, Kaifu 
      District, Changsha, 410013, Hunan, China.
FAU - Li, Bin
AU  - Li B
AD  - National Clinical Research Center for Geriatric Disorders, Department of 
      Geriatrics, Xiangya Hospital, Central South University, Xiangya Road, Kaifu 
      District, Changsha, 410013, Hunan, China.
FAU - Chen, Chao
AU  - Chen C
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, Central South University, Xiangya Road, Kaifu District, Changsha, 
      410013, Hunan, China.
FAU - Xia, Lu
AU  - Xia L
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, Central South University, Xiangya Road, Kaifu District, Changsha, 
      410013, Hunan, China.
FAU - Wang, Lin
AU  - Wang L
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, Central South University, Xiangya Road, Kaifu District, Changsha, 
      410013, Hunan, China.
FAU - Luo, Tengfei
AU  - Luo T
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, Central South University, Xiangya Road, Kaifu District, Changsha, 
      410013, Hunan, China.
FAU - Wang, Xiaomeng
AU  - Wang X
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, Central South University, Xiangya Road, Kaifu District, Changsha, 
      410013, Hunan, China.
FAU - Wang, Zheng
AU  - Wang Z
AD  - National Clinical Research Center for Geriatric Disorders, Department of 
      Geriatrics, Xiangya Hospital, Central South University, Xiangya Road, Kaifu 
      District, Changsha, 410013, Hunan, China.
FAU - Zhang, Yi
AU  - Zhang Y
AD  - National Clinical Research Center for Geriatric Disorders, Department of 
      Geriatrics, Xiangya Hospital, Central South University, Xiangya Road, Kaifu 
      District, Changsha, 410013, Hunan, China.
FAU - Jiang, Yi
AU  - Jiang Y
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, Central South University, Xiangya Road, Kaifu District, Changsha, 
      410013, Hunan, China.
FAU - Pan, Qian
AU  - Pan Q
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, Central South University, Xiangya Road, Kaifu District, Changsha, 
      410013, Hunan, China.
FAU - Hu, Zhengmao
AU  - Hu Z
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, Central South University, Xiangya Road, Kaifu District, Changsha, 
      410013, Hunan, China.
AD  - Institute of Molecular Precision Medicine, Xiangya Hospital, Central South 
      University, Xiangya Road, Kaifu District, Changsha, 410013, Hunan, China.
FAU - Guo, Hui
AU  - Guo H
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, Central South University, Xiangya Road, Kaifu District, Changsha, 
      410013, Hunan, China.
AD  - Institute of Molecular Precision Medicine, Xiangya Hospital, Central South 
      University, Xiangya Road, Kaifu District, Changsha, 410013, Hunan, China.
FAU - Tang, Beisha
AU  - Tang B
AD  - National Clinical Research Center for Geriatric Disorders, Department of 
      Geriatrics, Xiangya Hospital, Central South University, Xiangya Road, Kaifu 
      District, Changsha, 410013, Hunan, China.
AD  - Institute of Molecular Precision Medicine, Xiangya Hospital, Central South 
      University, Xiangya Road, Kaifu District, Changsha, 410013, Hunan, China.
FAU - Liu, Chunyu
AU  - Liu C
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, Central South University, Xiangya Road, Kaifu District, Changsha, 
      410013, Hunan, China.
AD  - Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, USA.
FAU - Sun, Zhongsheng
AU  - Sun Z
AD  - Beijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, China. 
      sunzs@biols.ac.cn.
AD  - Institute of Genomic Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, 
      China. sunzs@biols.ac.cn.
FAU - Xia, Kun
AU  - Xia K
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, Central South University, Xiangya Road, Kaifu District, Changsha, 
      410013, Hunan, China. xiakun@sklmg.edu.cn.
AD  - School of Basic Medical Science, Central South University, Changsha, Hunan, 
      China. xiakun@sklmg.edu.cn.
AD  - CAS Center for Excellence in Brain Science and Intelligence Technology (CEBSIT), 
      Shanghai, China. xiakun@sklmg.edu.cn.
FAU - Li, Jinchen
AU  - Li J
AUID- ORCID: 0000-0003-3335-9303
AD  - National Clinical Research Center for Geriatric Disorders, Department of 
      Geriatrics, Xiangya Hospital, Central South University, Xiangya Road, Kaifu 
      District, Changsha, 410013, Hunan, China. lijinchen@csu.edu.cn.
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, Central South University, Xiangya Road, Kaifu District, Changsha, 
      410013, Hunan, China. lijinchen@csu.edu.cn.
AD  - Institute of Molecular Precision Medicine, Xiangya Hospital, Central South 
      University, Xiangya Road, Kaifu District, Changsha, 410013, Hunan, China. 
      lijinchen@csu.edu.cn.
LA  - eng
GR  - 81730036/The National Natural Science Foundation of China/
GR  - 81525007/The National Natural Science Foundation of China/
GR  - 31601027/The National Natural Science Foundation of China/
GR  - 81801133/The National Natural Science Foundation of China/
GR  - 2016JC2055/the Key R&D Program of Hunan Province/
GR  - 2016RS2001/Science and Technology Innovation Leader of Hunan Province/
GR  - 2018QNRC001/Young Elite Scientist Sponsorship Program by CAST/
GR  - 2020JJ3059/The Natural Science Foundation of Hunan Province for Outstanding Young 
      Scholars/
PT  - Journal Article
DEP - 20210510
PL  - United States
TA  - J Autism Dev Disord
JT  - Journal of autism and developmental disorders
JID - 7904301
SB  - IM
MH  - *Autism Spectrum Disorder/genetics
MH  - Genetic Predisposition to Disease
MH  - Humans
MH  - *Intellectual Disability/genetics
MH  - Mutation
MH  - Phenotype
MH  - *Schizophrenia
PMC - PMC8854168
OTO - NOTNLM
OT  - Candidate gene
OT  - De novo mutation
OT  - Expression pattern
OT  - Functional network
OT  - Neuropsychiatric disorder
EDAT- 2021/05/11 06:00
MHDA- 2022/02/22 06:00
CRDT- 2021/05/10 12:32
PHST- 2021/04/14 00:00 [accepted]
PHST- 2021/05/11 06:00 [pubmed]
PHST- 2022/02/22 06:00 [medline]
PHST- 2021/05/10 12:32 [entrez]
AID - 10.1007/s10803-021-05031-7 [pii]
AID - 5031 [pii]
AID - 10.1007/s10803-021-05031-7 [doi]
PST - ppublish
SO  - J Autism Dev Disord. 2022 Mar;52(3):1299-1313. doi: 10.1007/s10803-021-05031-7. 
      Epub 2021 May 10.

PMID- 35126215
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20221231
IS  - 1664-0640 (Print)
IS  - 1664-0640 (Electronic)
IS  - 1664-0640 (Linking)
VI  - 12
DP  - 2021
TI  - Saliva RNA Biomarkers of Gastrointestinal Dysfunction in Children With Autism and 
      Neurodevelopmental Disorders: Potential Implications for Precision Medicine.
PG  - 824933
LID - 10.3389/fpsyt.2021.824933 [doi]
LID - 824933
AB  - Gastrointestinal (GI) disorders are common in children with neurodevelopmental 
      disorders such as autism spectrum disorder (ASD). A limited understanding of the 
      biologic factors that predispose this population to GI disorders has prevented 
      development of individualized therapies to address this important medical issue. 
      The goal of the current study was to determine if elements of the salivary 
      micro-transcriptome could provide insight into the biologic perturbations unique 
      to children with ASD-related GI disturbance. This cohort study included 898 
      children (ages 18-73 months) with ASD, non-ASD developmental delay (DD), or 
      typical development (TD). The saliva micro-transcriptome of each child was 
      assessed with RNA-seq. Outputs were aligned to microbial and human databases. A 
      Kruskal Wallis analysis of variance (ANOVA) was used to compare levels of 1821 
      micro-transcriptome features across neurodevelopmental status (ASD, DD, or TD) 
      and GI presence or absence. An ANOVA was also used to compare micro-transcriptome 
      levels among GI sub-groups (constipation, reflux, food intolerance, other GI 
      condition, no GI condition), and to identify RNAs that differed among children 
      taking three common GI medications (probiotics, reflux medication, or laxatives). 
      Relationships between features identified in ANOVA testing were examined for 
      associations with scores on the Autism Diagnostic Observation Schedule, 2nd 
      Edition (ADOS-2) and the Vineland Adaptive Behavior Scales. GI disturbance rates 
      were higher among children with ASD than peers with TD but were similar to those 
      with DD. Five piwi-interacting RNAs and three microbial RNAs displayed an 
      interaction between developmental status and GI disturbance. Fifty-seven salivary 
      RNAs differed between GI sub-groups-with microRNA differences between food 
      intolerance and reflux groups being most common. Twelve microRNAs displayed an 
      effect of GI disturbance and showed association with GI medication uses and 
      measures of behavior. These 12 microRNAs displayed enrichment for 13 physiologic 
      pathways, including metabolism/digestion long-term depression, and neurobiology 
      of addiction. This study identifies salivary micro-transcriptome features with 
      differential expression among children with ASD-related GI disturbance. A subset 
      of the RNAs displays relationships with treatment modality and are associated 
      with autistic behaviors. The pathobiologic targets of the micro-transcriptome 
      markers may serve as targets for individualized therapeutic interventions aimed 
      at easing pain and behavioral difficulties seen in ASD-related GI disturbance.
CI  - Copyright © 2022 Beversdorf, Sohl, Levitskiy, Tennant, Goin-Kochel, Shaffer, 
      Confair, Middleton and Hicks.
FAU - Beversdorf, David Q
AU  - Beversdorf DQ
AD  - University of Missouri, Columbia, MO, United States.
FAU - Sohl, Kristin
AU  - Sohl K
AD  - University of Missouri, Columbia, MO, United States.
FAU - Levitskiy, David
AU  - Levitskiy D
AD  - Quadrant Biosciences Inc., Syracuse, NY, United States.
FAU - Tennant, Priscilla
AU  - Tennant P
AD  - Quadrant Biosciences Inc., Syracuse, NY, United States.
FAU - Goin-Kochel, Robin P
AU  - Goin-Kochel RP
AD  - Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States.
AD  - Meyer Center for Developmental Pediatrics and Autism, Texas Children's Hospital, 
      Houston, TX, United States.
FAU - Shaffer, Rebecca C
AU  - Shaffer RC
AD  - Cincinnati Children's Hospital, University of Cincinnati College of Medicine, 
      Cincinnati, OH, United States.
FAU - Confair, Alexandra
AU  - Confair A
AD  - Department of Pediatrics, Penn State College of Medicine, Hershey, PA, United 
      States.
FAU - Middleton, Frank A
AU  - Middleton FA
AD  - Department of Neuroscience and Physiology, The State University of New York, 
      Upstate Medical University, Syracuse, NY, United States.
FAU - Hicks, Steven D
AU  - Hicks SD
AD  - Department of Pediatrics, Penn State College of Medicine, Hershey, PA, United 
      States.
LA  - eng
GR  - R42 MH111347/MH/NIMH NIH HHS/United States
PT  - Journal Article
DEP - 20220120
PL  - Switzerland
TA  - Front Psychiatry
JT  - Frontiers in psychiatry
JID - 101545006
PMC - PMC8811462
OTO - NOTNLM
OT  - RNA
OT  - autism (ASD)
OT  - biomarkers
OT  - gastrointestinal
OT  - microRNA
OT  - saliva
COIS- DL and PT are paid employees of Quadrant Biosciences (QB). DB, KS, FM, and SH 
      serve on the Scientific Advisory Board of QB. QB has licensed IP regarding the 
      use of salivary transcripts for diagnosis of autism from the Penn State College 
      of Medicine and SUNY Upstate Medical University, on which FM and SH are named as 
      co-inventors. The remaining authors declare that the research was conducted in 
      the absence of any commercial or financial relationships that could be construed 
      as a potential conflict of interest.
EDAT- 2022/02/08 06:00
MHDA- 2022/02/08 06:01
CRDT- 2022/02/07 05:29
PHST- 2021/11/29 00:00 [received]
PHST- 2021/12/24 00:00 [accepted]
PHST- 2022/02/07 05:29 [entrez]
PHST- 2022/02/08 06:00 [pubmed]
PHST- 2022/02/08 06:01 [medline]
AID - 10.3389/fpsyt.2021.824933 [doi]
PST - epublish
SO  - Front Psychiatry. 2022 Jan 20;12:824933. doi: 10.3389/fpsyt.2021.824933. 
      eCollection 2021.

PMID- 34013251
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231020
DP  - 2021 Apr 26
TI  - A seq2seq model to forecast the COVID-19 cases, deaths and reproductive R numbers 
      in US counties.
LID - rs.3.rs-456641 [pii]
LID - 10.21203/rs.3.rs-456641/v1 [doi]
AB  - The global pandemic of coronavirus disease 2019 (COVID-19) has killed almost two 
      million people worldwide and over 400 thousand in the United States (US). As the 
      pandemic evolves, informed policy-making and strategic resource allocation relies 
      on accurate forecasts. To predict the spread of the virus within US counties, we 
      curated an array of county-level demographic and COVID-19-relevant health risk 
      factors. In combination with the county-level case and death numbers curated by 
      John Hopkins university, we developed a forecasting model using deep learning 
      (DL). We implemented an autoencoder-based Seq2Seq model with gated recurrent 
      units (GRUs) in the deep recurrent layers. We trained the model to predict future 
      incident cases, deaths and the reproductive number, R For most counties, it makes 
      accurate predictions of new incident cases, deaths and R values, up to 30 days in 
      the future. Our framework can also be used to predict other targets that are 
      useful indices for policymaking, for example hospitalization or the occupancy of 
      intensive care units. Our DL framework is publicly available on GitHub and can be 
      adapted for other indices of the COVID-19 spread. We hope that our forecasts and 
      model can help local governments in the continued fight against COVID-19.
FAU - Zhang-James, Yanli
AU  - Zhang-James Y
AUID- ORCID: 0000-0002-2104-0963
AD  - SUNY Upstate Medical University: State University of New York Upstate Medical 
      University.
FAU - Hess, Jonathan
AU  - Hess J
AD  - SUNY Upstate Medical University: State University of New York Upstate Medical 
      University.
FAU - Salkin, Asif
AU  - Salkin A
AD  - Syracuse University.
FAU - Wang, Dongliang
AU  - Wang D
AD  - SUNY Upstate Medical University: State University of New York Upstate Medical 
      University.
FAU - Chen, Samuel
AU  - Chen S
AD  - SUNY Upstate Medical University: State University of New York Upstate Medical 
      University.
FAU - Winkelstein, Peter
AU  - Winkelstein P
AD  - University at Buffalo.
FAU - Morley, Christopher P
AU  - Morley CP
AD  - SUNY Upstate Medical University: State University of New York Upstate Medical 
      University.
FAU - Faraone, Stephen V
AU  - Faraone SV
AD  - SUNY Upstate Medical University: State University of New York Upstate Medical 
      University.
LA  - eng
GR  - R01 MH101519/MH/NIMH NIH HHS/United States
GR  - U01 MH109536/MH/NIMH NIH HHS/United States
PT  - Preprint
DEP - 20210426
PL  - United States
TA  - Res Sq
JT  - Research square
JID - 101768035
PMC - PMC8132245
OTO - NOTNLM
OT  - Covid-19
OT  - Deep Learning
OT  - Gated Recurrent Unit
OT  - Machine Learning
OT  - Pandemic Forecasting
OT  - epidemic transmission
COIS- Other authors have no competing interest.
EDAT- 2021/05/21 06:00
MHDA- 2021/05/21 06:01
CRDT- 2021/05/20 06:49
PHST- 2021/05/21 06:00 [pubmed]
PHST- 2021/05/21 06:01 [medline]
PHST- 2021/05/20 06:49 [entrez]
AID - rs.3.rs-456641 [pii]
AID - 10.21203/rs.3.rs-456641/v1 [doi]
PST - epublish
SO  - Res Sq. 2021 Apr 26:rs.3.rs-456641. doi: 10.21203/rs.3.rs-456641/v1. Preprint.

PMID- 33907761
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231019
DP  - 2021 Apr 20
TI  - A seq2seq model to forecast the COVID-19 cases, deaths and reproductive R numbers 
      in US counties.
LID - 2021.04.14.21255507 [pii]
LID - 10.1101/2021.04.14.21255507 [doi]
AB  - The global pandemic of coronavirus disease 2019 (COVID-19) has killed almost two 
      million people worldwide and over 400 thousand in the United States (US). As the 
      pandemic evolves, informed policy-making and strategic resource allocation relies 
      on accurate forecasts. To predict the spread of the virus within US counties, we 
      curated an array of county-level demographic and COVID-19-relevant health risk 
      factors. In combination with the county-level case and death numbers curated by 
      John Hopkins university, we developed a forecasting model using deep learning 
      (DL). We implemented an autoencoder-based Seq2Seq model with gated recurrent 
      units (GRUs) in the deep recurrent layers. We trained the model to predict future 
      incident cases, deaths and the reproductive number, R. For most counties, it 
      makes accurate predictions of new incident cases, deaths and R values, up to 30 
      days in the future. Our framework can also be used to predict other targets that 
      are useful indices for policymaking, for example hospitalization or the occupancy 
      of intensive care units. Our DL framework is publicly available on GitHub and can 
      be adapted for other indices of the COVID-19 spread. We hope that our forecasts 
      and model can help local governments in the continued fight against COVID-19.
FAU - Zhang-James, Yanli
AU  - Zhang-James Y
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Syracuse, New York.
FAU - Hess, Jonathan
AU  - Hess J
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Syracuse, New York.
FAU - Salekin, Asif
AU  - Salekin A
AD  - Department of Electrical Engineering and Computer Science, Syracuse University, 
      Syracuse, New York.
FAU - Wang, Dongliang
AU  - Wang D
AD  - Department of Public Health & Preventive Medicine, SUNY Upstate Medical 
      University, Syracuse, New York.
FAU - Chen, Samuel
AU  - Chen S
AD  - School of Medicine, SUNY Upstate Medical University, Syracuse, New York.
FAU - Winkelstein, Peter
AU  - Winkelstein P
AD  - Institute for Healthcare Informatics, SUNY University at Buffalo, Buffalo, New 
      York, USA.
FAU - Morley, Christopher P
AU  - Morley CP
AD  - Department of Public Health & Preventive Medicine, SUNY Upstate Medical 
      University, Syracuse, New York.
AD  - Department of Family Medicine, SUNY Upstate Medical University, Syracuse, New 
      York.
FAU - Faraone, Stephen V
AU  - Faraone SV
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Syracuse, New York.
AD  - Department of Neuroscience and Physiology, SUNY Upstate Medical University, 
      Syracuse, New York.
LA  - eng
PT  - Preprint
DEP - 20210420
PL  - United States
TA  - medRxiv
JT  - medRxiv : the preprint server for health sciences
JID - 101767986
PMC - PMC8077584
OTO - NOTNLM
OT  - Covid-19
OT  - Deep Learning
OT  - Gated Recurrent Unit
OT  - Machine Learning
OT  - Pandemic Forecasting
OT  - epidemic transmission
EDAT- 2021/04/29 06:00
MHDA- 2021/04/29 06:01
CRDT- 2021/04/28 06:23
PHST- 2021/04/29 06:00 [pubmed]
PHST- 2021/04/29 06:01 [medline]
PHST- 2021/04/28 06:23 [entrez]
AID - 2021.04.14.21255507 [pii]
AID - 10.1101/2021.04.14.21255507 [doi]
PST - epublish
SO  - medRxiv. 2021 Apr 20:2021.04.14.21255507. doi: 10.1101/2021.04.14.21255507. 
      Preprint.

PMID- 36351892
OWN - NLM
STAT- MEDLINE
DCOM- 20221111
LR  - 20221116
IS  - 2158-3188 (Electronic)
IS  - 2158-3188 (Linking)
VI  - 12
IP  - 1
DP  - 2022 Nov 9
TI  - Comparative serum proteomic analysis of a selected protein panel in individuals 
      with schizophrenia and bipolar disorder and the impact of genetic risk burden on 
      serum proteomic profiles.
PG  - 471
LID - 10.1038/s41398-022-02228-x [doi]
LID - 471
AB  - The diagnostic criteria for schizophrenia (SCZ) and bipolar disorder (BD) are 
      based on clinical assessments of symptoms. In this pilot study, we applied 
      high-throughput antibody-based protein profiling to serum samples of healthy 
      controls and individuals with SCZ and BD with the aim of identifying 
      differentially expressed proteins in these disorders. Moreover, we explored the 
      influence of polygenic burden for SCZ and BD on the serum levels of these 
      proteins. Serum samples from 113 individuals with SCZ and 125 with BD from the 
      PsyCourse Study and from 44 healthy controls were analyzed by using a set of 155 
      antibodies in an antibody-based assay targeting a selected panel of 95 proteins. 
      For the cases, genotyping and imputation were conducted for DNA samples and SCZ 
      and BD polygenic risk scores (PRS) were calculated. Univariate linear and 
      logistic models were used for association analyses. The comparison between SCZ 
      and BD revealed two serum proteins that were significantly elevated in BD after 
      multiple testing adjustment: "complement C9" and "Interleukin 1 Receptor 
      Accessory Protein". Moreover, the first principal component of variance in the 
      proteomics dataset differed significantly between SCZ and BD. After multiple 
      testing correction, SCZ-PRS, BD-PRS, and SCZ-vs-BD-PRS were not significantly 
      associated with the levels of the individual proteins or the values of the 
      proteome principal components indicating no detectable genetic effects. Overall, 
      our findings contribute to the evidence suggesting that the analysis of 
      circulating proteins could lead to the identification of distinctive biomarkers 
      for SCZ and BD. Our investigation warrants replication in large-scale studies to 
      confirm these findings.
CI  - © 2022. The Author(s).
FAU - Oraki Kohshour, Mojtaba
AU  - Oraki Kohshour M
AUID- ORCID: 0000-0002-1357-2636
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, Germany.
AD  - Department of Immunology, Faculty of Medicine, Ahvaz Jundishapur University of 
      Medical Sciences, Ahvaz, Iran.
FAU - Kannaiyan, Nirmal R
AU  - Kannaiyan NR
AUID- ORCID: 0000-0002-7408-6842
AD  - Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, 
      Munich, Germany.
FAU - Falk, August Jernbom
AU  - Falk AJ
AUID- ORCID: 0000-0002-7773-1851
AD  - Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, 
      Stockholm, Sweden.
FAU - Papiol, Sergi
AU  - Papiol S
AUID- ORCID: 0000-0001-9366-8728
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, Germany.
AD  - Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, 
      Munich, Germany.
FAU - Heilbronner, Urs
AU  - Heilbronner U
AUID- ORCID: 0000-0001-7135-762X
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, Germany.
FAU - Budde, Monika
AU  - Budde M
AUID- ORCID: 0000-0001-7301-9157
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, Germany.
FAU - Kalman, Janos L
AU  - Kalman JL
AUID- ORCID: 0000-0003-0930-4214
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, Germany.
AD  - Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, 
      Munich, Germany.
AD  - International Max Planck Research School for Translational Psychiatry (IMPRS-TP), 
      Max Planck Institute of Psychiatry, Munich, Germany.
FAU - Schulte, Eva C
AU  - Schulte EC
AUID- ORCID: 0000-0003-3105-5672
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, Germany.
AD  - Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, 
      Munich, Germany.
FAU - Rietschel, Marcella
AU  - Rietschel M
AUID- ORCID: 0000-0002-5236-6149
AD  - Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental 
      Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
FAU - Witt, Stephanie
AU  - Witt S
AUID- ORCID: 0000-0002-1571-1468
AD  - Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental 
      Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
FAU - Forstner, Andreas J
AU  - Forstner AJ
AUID- ORCID: 0000-0002-1876-6368
AD  - Institute of Human Genetics, University of Bonn, School of Medicine &amp; 
      University Hospital Bonn, Bonn, Germany.
FAU - Heilmann-Heimbach, Stefanie
AU  - Heilmann-Heimbach S
AUID- ORCID: 0000-0003-1057-465X
AD  - Institute of Human Genetics, University of Bonn, School of Medicine &amp; 
      University Hospital Bonn, Bonn, Germany.
FAU - Nöthen, Markus M
AU  - Nöthen MM
AD  - Institute of Human Genetics, University of Bonn, School of Medicine &amp; 
      University Hospital Bonn, Bonn, Germany.
FAU - Spitzer, Carsten
AU  - Spitzer C
AD  - Department of Psychosomatic Medicine and Psychotherapy, University Medical Center 
      Rostock, Rostock, Germany.
FAU - Malchow, Berend
AU  - Malchow B
AD  - Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, 
      Göttingen, Germany.
FAU - Müller, Thorsten
AU  - Müller T
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, Germany.
FAU - Wiltfang, Jens
AU  - Wiltfang J
AUID- ORCID: 0000-0003-1492-5330
AD  - Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, 
      Göttingen, Germany.
AD  - German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.
AD  - iBiMED, Medical Sciences Department, University of Aveiro, Aveiro, Portugal.
FAU - Falkai, Peter
AU  - Falkai P
AD  - Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, 
      Munich, Germany.
FAU - Schmitt, Andrea
AU  - Schmitt A
AD  - Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, 
      Munich, Germany.
AD  - Laboratory of Neuroscience (LIM27), Institute of Psychiatry, University of Sao 
      Paulo, São Paulo, SP, Brazil.
FAU - Rossner, Moritz J
AU  - Rossner MJ
AUID- ORCID: 0000-0002-0667-3420
AD  - Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, 
      Munich, Germany.
FAU - Nilsson, Peter
AU  - Nilsson P
AUID- ORCID: 0000-0002-4657-8532
AD  - Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, 
      Stockholm, Sweden.
FAU - Schulze, Thomas G
AU  - Schulze TG
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, Germany. Thomas.Schulze@med.uni-muenchen.de.
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Syracuse, NY, USA. Thomas.Schulze@med.uni-muenchen.de.
AD  - Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School 
      of Medicine, Baltimore, MD, USA. Thomas.Schulze@med.uni-muenchen.de.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20221109
PL  - United States
TA  - Transl Psychiatry
JT  - Translational psychiatry
JID - 101562664
SB  - IM
MH  - Humans
MH  - *Bipolar Disorder/genetics/metabolism
MH  - *Schizophrenia/metabolism
MH  - Proteomics
MH  - Pilot Projects
MH  - Risk Factors
MH  - Genetic Predisposition to Disease
PMC - PMC9646817
COIS- The authors declare no competing interests.
EDAT- 2022/11/10 06:00
MHDA- 2022/11/15 06:00
CRDT- 2022/11/09 23:13
PHST- 2022/03/24 00:00 [received]
PHST- 2022/10/20 00:00 [accepted]
PHST- 2022/10/15 00:00 [revised]
PHST- 2022/11/09 23:13 [entrez]
PHST- 2022/11/10 06:00 [pubmed]
PHST- 2022/11/15 06:00 [medline]
AID - 10.1038/s41398-022-02228-x [pii]
AID - 2228 [pii]
AID - 10.1038/s41398-022-02228-x [doi]
PST - epublish
SO  - Transl Psychiatry. 2022 Nov 9;12(1):471. doi: 10.1038/s41398-022-02228-x.

PMID- 35698242
OWN - NLM
STAT- MEDLINE
DCOM- 20220615
LR  - 20220716
IS  - 1756-994X (Electronic)
IS  - 1756-994X (Linking)
VI  - 14
IP  - 1
DP  - 2022 Jun 13
TI  - Gain and loss of TASK3 channel function and its regulation by novel variation 
      cause KCNK9 imprinting syndrome.
PG  - 62
LID - 10.1186/s13073-022-01064-4 [doi]
LID - 62
AB  - BACKGROUND: Genomics enables individualized diagnosis and treatment, but large 
      challenges remain to functionally interpret rare variants. To date, only one 
      causative variant has been described for KCNK9 imprinting syndrome (KIS). The 
      genotypic and phenotypic spectrum of KIS has yet to be described and the precise 
      mechanism of disease fully understood. METHODS: This study discovers mechanisms 
      underlying KCNK9 imprinting syndrome (KIS) by describing 15 novel KCNK9 
      alterations from 47 KIS-affected individuals. We use clinical genetics and 
      computer-assisted facial phenotyping to describe the phenotypic spectrum of KIS. 
      We then interrogate the functional effects of the variants in the encoded TASK3 
      channel using sequence-based analysis, 3D molecular mechanic and dynamic protein 
      modeling, and in vitro electrophysiological and functional methodologies. 
      RESULTS: We describe the broader genetic and phenotypic variability for KIS in a 
      cohort of individuals identifying an additional mutational hotspot at p.Arg131 
      and demonstrating the common features of this neurodevelopmental disorder to 
      include motor and speech delay, intellectual disability, early feeding 
      difficulties, muscular hypotonia, behavioral abnormalities, and dysmorphic 
      features. The computational protein modeling and in vitro electrophysiological 
      studies discover variability of the impact of KCNK9 variants on TASK3 channel 
      function identifying variants causing gain and others causing loss of 
      conductance. The most consistent functional impact of KCNK9 genetic variants, 
      however, was altered channel regulation. CONCLUSIONS: This study extends our 
      understanding of KIS mechanisms demonstrating its complex etiology including gain 
      and loss of channel function and consistent loss of channel regulation. These 
      data are rapidly applicable to diagnostic strategies, as KIS is not identifiable 
      from clinical features alone and thus should be molecularly diagnosed. 
      Furthermore, our data suggests unique therapeutic strategies may be needed to 
      address the specific functional consequences of KCNK9 variation on channel 
      function and regulation.
CI  - © 2022. The Author(s).
FAU - Cousin, Margot A
AU  - Cousin MA
AUID- ORCID: 0000-0002-6119-9346
AD  - Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
AD  - Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.
FAU - Veale, Emma L
AU  - Veale EL
AUID- ORCID: 0000-0002-6778-9929
AD  - Medway School of Pharmacy, University of Kent and University of Greenwich, 
      Central Avenue, Anson Building, Central Avenue, Chatham Maritime, ME4 4, Kent, 
      TB, ME4 4 TB, UK.
FAU - Dsouza, Nikita R
AU  - Dsouza NR
AD  - Bioinformatics Research and Development Laboratory, Linda T. and John A. Mellowes 
      Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, 
      Milwaukee, WI, USA.
FAU - Tripathi, Swarnendu
AU  - Tripathi S
AD  - Bioinformatics Research and Development Laboratory, Linda T. and John A. Mellowes 
      Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, 
      Milwaukee, WI, USA.
FAU - Holden, Robyn G
AU  - Holden RG
AD  - Medway School of Pharmacy, University of Kent and University of Greenwich, 
      Central Avenue, Anson Building, Central Avenue, Chatham Maritime, ME4 4, Kent, 
      TB, ME4 4 TB, UK.
FAU - Arelin, Maria
AU  - Arelin M
AD  - Department for Women and Child Health, Hospital for Children and Adolescents, 
      University Hospitals, University of Leipzig, Leipzig, Germany.
FAU - Beek, Geoffrey
AU  - Beek G
AD  - Children's Hospital of Minnesota, Minneapolis, MN, USA.
FAU - Bekheirnia, Mir Reza
AU  - Bekheirnia MR
AD  - Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, 
      TX, USA.
FAU - Beygo, Jasmin
AU  - Beygo J
AD  - Institute of Human Genetics, University Hospital Essen, University of 
      Duisburg-Essen, Essen, Germany.
FAU - Bhambhani, Vikas
AU  - Bhambhani V
AD  - Children's Hospital of Minnesota, Minneapolis, MN, USA.
FAU - Bialer, Martin
AU  - Bialer M
AD  - Division of Medical Genetics, Northwell Health, Manhasset, NY, USA.
FAU - Bigoni, Stefania
AU  - Bigoni S
AD  - Medical Genetics Unit, Department of Medical Sciences, Ferrara University, 
      Ferrara, Italy.
FAU - Boelman, Cyrus
AU  - Boelman C
AD  - Division of Neurology, BC Children's Hospital, Vancouver, British Columbia, 
      Canada.
FAU - Carmichael, Jenny
AU  - Carmichael J
AD  - Oxford Centre for Genomic Medicine, ACE Building, Nuffield Orthopaedic centre, 
      Oxford University Hospitals NHS Foundation Trust, Windmill road, Headington, 
      Oxford, OX3 7HE, UK.
FAU - Courtin, Thomas
AU  - Courtin T
AD  - Département of Genetics, APHP, Hôpital Pitié-Salpêtrière, Sorbonne Université, 
      Paris, France.
FAU - Cogne, Benjamin
AU  - Cogne B
AD  - CHU Nantes, Service de génétique médicale, Nantes, France.
FAU - Dabaj, Ivana
AU  - Dabaj I
AD  - CHU de Rouen, Service de Néonatologie, Réanimation pédiatrique, Neuropédiatrie et 
      éducation fonctionnelle de l'enfant, INSERM U 1245, ED497, 76000, Rouen, France.
AD  - APHP, Hôpital Raymond Poincaré, Hôpitaux Universitaires Paris Ile-de-France 
      Ouest, Pôle pédiatrique, Service de Pédiatrie, Centre de Reference Nord-Est-Ile 
      de France, 92380, Garches, France.
FAU - Doummar, Diane
AU  - Doummar D
AD  - APHP, Department of Neuropediatrics, National Reference Center for Neurogenetic 
      Disorders, Hôpital Armand-Trousseau, GHUEP, Paris, France.
FAU - Fazilleau, Laura
AU  - Fazilleau L
AD  - Service de Néonatologie, CHU de Caen, Caen, France.
FAU - Ferlini, Alessandra
AU  - Ferlini A
AUID- ORCID: 0000-0001-8385-9870
AD  - Medical Genetics Unit, Department of Medical Sciences, Ferrara University, 
      Ferrara, Italy.
FAU - Gavrilova, Ralitza H
AU  - Gavrilova RH
AD  - Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.
AD  - Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA.
FAU - Graham, John M Jr
AU  - Graham JM Jr
AD  - Department of Pediatrics, Harbor-UCLA Medical Center, Cedars-Sinai Medical 
      Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
FAU - Haack, Tobias B
AU  - Haack TB
AD  - Centre for Rare Diseases, University of Tübingen, Tübingen, Germany.
AD  - Institute of Medical Genetics and Applied Genomics, University of Tübingen, 
      Tübingen, Germany.
FAU - Juusola, Jane
AU  - Juusola J
AD  - GeneDx, 207 Perry Parkway, Gaithersburg, MD, USA.
FAU - Kant, Sarina G
AU  - Kant SG
AD  - Department of Clinical Genetics, Leiden University Medical Center, Leiden, The 
      Netherlands.
AD  - Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, 
      Rotterdam, The Netherlands.
FAU - Kayani, Saima
AU  - Kayani S
AD  - Departments of Pediatrics and Neurology, University of Texas Southwestern Medical 
      Center and Children's Health, Dallas, TX, USA.
FAU - Keren, Boris
AU  - Keren B
AD  - APHP, Département de Génétique et Centre de Référence Déficiences Intellectuelles 
      de Causes Rares, Hôpital de la Pitié-Salpêtrière, Assistance Publique - Hôpitaux 
      de Paris, 75651, Paris, France.
FAU - Ketteler, Petra
AU  - Ketteler P
AD  - Institute of Human Genetics, University Hospital Essen, University of 
      Duisburg-Essen, Essen, Germany.
AD  - Pediatrics III, Pediatric Oncology and Hematology, University Hospital Essen, 
      Essen, Germany.
FAU - Klöckner, Chiara
AU  - Klöckner C
AD  - Institute of Human Genetics, University of Leipzig Medical Center, 04103, 
      Leipzig, Germany.
FAU - Koopmann, Tamara T
AU  - Koopmann TT
AD  - Department of Clinical Genetics, Leiden University Medical Center, Leiden, The 
      Netherlands.
FAU - Kruisselbrink, Teresa M
AU  - Kruisselbrink TM
AD  - Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.
AD  - Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA.
FAU - Kuechler, Alma
AU  - Kuechler A
AD  - Institute of Human Genetics, University Hospital Essen, University of 
      Duisburg-Essen, Essen, Germany.
FAU - Lambert, Laëtitia
AU  - Lambert L
AD  - Service de Genetique Clinique, CHRU de Nancy, F-54000, Vandoeuvre-les-Nancy, 
      France.
AD  - Unite INSERM N-GERE UMR_S 1256, Université de Lorraine, Faculté de Médecine, 9 
      avenue de la Forêt de Haye, CS 50184, Vandoeuvre-les-Nancy, France.
FAU - Latypova, Xénia
AU  - Latypova X
AD  - CHU Nantes, Service de génétique médicale, Nantes, France.
FAU - Lebel, Robert Roger
AU  - Lebel RR
AD  - Section of Medical Genetics, SUNY Upstate University Hospital, Syracuse, NY, USA.
FAU - Leduc, Magalie S
AU  - Leduc MS
AD  - Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, 
      TX, USA.
FAU - Leonardi, Emanuela
AU  - Leonardi E
AD  - Molecular Genetics of Neurodevelopmental Disorders, Department of Woman and Child 
      Health, University of Padova, Padua, Italy.
AD  - Pediatric Research Institute, Città della Speranza, Padova, Italy.
FAU - Lewis, Andrea M
AU  - Lewis AM
AD  - Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, 
      TX, USA.
FAU - Liew, Wendy
AU  - Liew W
AD  - Department of Paediatric Medicine, KK Women's and Children's Hospital, Mount 
      Elizabeth Hospital, Singapore, Singapore.
FAU - Machol, Keren
AU  - Machol K
AD  - Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, 
      TX, USA.
AD  - Texas Children's Hospital, Houston, TX, USA.
FAU - Mardini, Samir
AU  - Mardini S
AD  - Division of Plastic and Reconstructive Surgery, Mayo Clinic, Rochester, MN, USA.
FAU - McWalter, Kirsty
AU  - McWalter K
AD  - GeneDx, 207 Perry Parkway, Gaithersburg, MD, USA.
FAU - Mignot, Cyril
AU  - Mignot C
AD  - APHP, Département de Génétique et Centre de Référence Déficiences Intellectuelles 
      de Causes Rares, Hôpital de la Pitié-Salpêtrière, Assistance Publique - Hôpitaux 
      de Paris, 75651, Paris, France.
FAU - McLaughlin, Julie
AU  - McLaughlin J
AD  - Division of Medical Genetics, Northwell Health, Manhasset, NY, USA.
FAU - Murgia, Alessandra
AU  - Murgia A
AD  - Molecular Genetics of Neurodevelopmental Disorders, Department of Woman and Child 
      Health, University of Padova, Padua, Italy.
AD  - Pediatric Research Institute, Città della Speranza, Padova, Italy.
FAU - Narayanan, Vinodh
AU  - Narayanan V
AD  - Center for Rare Childhood Disorders, Translational Genomics Research Institute, 
      Phoenix, AZ, USA.
FAU - Nava, Caroline
AU  - Nava C
AD  - APHP, Département de Génétique et Centre de Référence Déficiences Intellectuelles 
      de Causes Rares, Hôpital de la Pitié-Salpêtrière, Assistance Publique - Hôpitaux 
      de Paris, 75651, Paris, France.
FAU - Neuser, Sonja
AU  - Neuser S
AD  - Institute of Human Genetics, University of Leipzig Medical Center, 04103, 
      Leipzig, Germany.
FAU - Nizon, Mathilde
AU  - Nizon M
AD  - CHU Nantes, Service de génétique médicale, Nantes, France.
FAU - Ognibene, Davide
AU  - Ognibene D
AD  - Medical Genetics Unit, Department of Medical Sciences, Ferrara University, 
      Ferrara, Italy.
FAU - Park, Joohyun
AU  - Park J
AD  - Institute of Medical Genetics and Applied Genomics, University of Tübingen, 
      Tübingen, Germany.
FAU - Platzer, Konrad
AU  - Platzer K
AUID- ORCID: 0000-0001-6127-6308
AD  - Institute of Human Genetics, University of Leipzig Medical Center, 04103, 
      Leipzig, Germany.
FAU - Poirsier, Céline
AU  - Poirsier C
AD  - Department of Genetics, Reims University Hospital, Reims, France.
FAU - Radtke, Maximilian
AU  - Radtke M
AD  - Institute of Human Genetics, University of Leipzig Medical Center, 04103, 
      Leipzig, Germany.
FAU - Ramsey, Keri
AU  - Ramsey K
AD  - Center for Rare Childhood Disorders, Translational Genomics Research Institute, 
      Phoenix, AZ, USA.
FAU - Runke, Cassandra K
AU  - Runke CK
AD  - Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA.
FAU - Guillen Sacoto, Maria J
AU  - Guillen Sacoto MJ
AD  - GeneDx, 207 Perry Parkway, Gaithersburg, MD, USA.
FAU - Scaglia, Fernando
AU  - Scaglia F
AD  - Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, 
      TX, USA.
AD  - Texas Children's Hospital, Houston, TX, USA.
AD  - Joint BCM-CUHK Center of Medical Genetics, Shatin, Hong Kong SAR.
FAU - Shinawi, Marwan
AU  - Shinawi M
AD  - Department of Pediatrics, Division of Genetics and Genomic Medicine, Washington 
      University School of Medicine, St. Louis, MT, USA.
FAU - Spranger, Stephanie
AU  - Spranger S
AD  - Practice of Human Genetics, Bremen, Germany.
FAU - Tan, Ee Shien
AU  - Tan ES
AD  - Department of Paediatric Medicine, KK Women's and Children's Hospital, Mount 
      Elizabeth Hospital, Singapore, Singapore.
FAU - Taylor, John
AU  - Taylor J
AD  - Oxford Centre for Genomic Medicine, ACE Building, Nuffield Orthopaedic centre, 
      Oxford University Hospitals NHS Foundation Trust, Windmill road, Headington, 
      Oxford, OX3 7HE, UK.
FAU - Trentesaux, Anne-Sophie
AU  - Trentesaux AS
AD  - Service de Néonatologie, CHU de Caen, Caen, France.
FAU - Vairo, Filippo
AU  - Vairo F
AD  - Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.
AD  - Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA.
FAU - Willaert, Rebecca
AU  - Willaert R
AD  - GeneDx, 207 Perry Parkway, Gaithersburg, MD, USA.
FAU - Zadeh, Neda
AU  - Zadeh N
AD  - Genetics Center, Orange, CA, USA.
AD  - Division of Medical Genetics, CHOC Children's Hospital, Orange, CA, USA.
FAU - Urrutia, Raul
AU  - Urrutia R
AD  - Bioinformatics Research and Development Laboratory, Linda T. and John A. Mellowes 
      Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, 
      Milwaukee, WI, USA.
AD  - Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA.
FAU - Babovic-Vuksanovic, Dusica
AU  - Babovic-Vuksanovic D
AD  - Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.
AD  - Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA.
FAU - Zimmermann, Michael T
AU  - Zimmermann MT
AUID- ORCID: 0000-0001-7073-0525
AD  - Bioinformatics Research and Development Laboratory, Linda T. and John A. Mellowes 
      Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, 
      Milwaukee, WI, USA. mtzimmermann@mcw.edu.
AD  - Clinical and Translational Sciences Institute, Medical College of Wisconsin, 
      Human Research Center, Milwaukee, Wl, USA. mtzimmermann@mcw.edu.
AD  - Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, USA. 
      mtzimmermann@mcw.edu.
FAU - Mathie, Alistair
AU  - Mathie A
AUID- ORCID: 0000-0001-6094-2890
AD  - Medway School of Pharmacy, University of Kent and University of Greenwich, 
      Central Avenue, Anson Building, Central Avenue, Chatham Maritime, ME4 4, Kent, 
      TB, ME4 4 TB, UK. a.a.mathie@kent.ac.uk.
AD  - School of Engineering, Arts, Science and Technology, University of Suffolk, 
      Ipswich, UK. a.a.mathie@kent.ac.uk.
FAU - Klee, Eric W
AU  - Klee EW
AUID- ORCID: 0000-0003-2946-5795
AD  - Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA. 
      klee.eric@mayo.edu.
AD  - Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA. 
      klee.eric@mayo.edu.
AD  - Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA. 
      klee.eric@mayo.edu.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20220613
PL  - England
TA  - Genome Med
JT  - Genome medicine
JID - 101475844
RN  - 0 (KCNK9 protein, human)
RN  - 0 (Potassium Channels, Tandem Pore Domain)
SB  - IM
MH  - Genotype
MH  - Humans
MH  - *Intellectual Disability/genetics
MH  - Muscle Hypotonia
MH  - Mutation
MH  - Phenotype
MH  - *Potassium Channels, Tandem Pore Domain/genetics/metabolism
PMC - PMC9195326
OTO - NOTNLM
OT  - Computational protein modeling
OT  - Electrophysiology
OT  - KCNK9 imprinting syndrome
OT  - Neurodevelopmental disorder
OT  - TASK3 channel
COIS- JJ, KMc, MJGS, and RW are employees of GeneDx. AML and GB are current 
      shareholders and employees of Invitae. The remaining authors declare that they 
      have no competing interests.
EDAT- 2022/06/14 06:00
MHDA- 2022/06/16 06:00
CRDT- 2022/06/13 23:50
PHST- 2021/11/23 00:00 [received]
PHST- 2022/05/19 00:00 [accepted]
PHST- 2022/06/13 23:50 [entrez]
PHST- 2022/06/14 06:00 [pubmed]
PHST- 2022/06/16 06:00 [medline]
AID - 10.1186/s13073-022-01064-4 [pii]
AID - 1064 [pii]
AID - 10.1186/s13073-022-01064-4 [doi]
PST - epublish
SO  - Genome Med. 2022 Jun 13;14(1):62. doi: 10.1186/s13073-022-01064-4.

PMID- 37213280
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230523
IS  - 2234-943X (Print)
IS  - 2234-943X (Electronic)
IS  - 2234-943X (Linking)
VI  - 13
DP  - 2023
TI  - Liquid biopsies and minimal residual disease in myeloid malignancies.
PG  - 1164017
LID - 10.3389/fonc.2023.1164017 [doi]
LID - 1164017
AB  - Minimal residual disease (MRD) assessment through blood component sampling by 
      liquid biopsies (LBs) is increasingly being investigated in myeloid malignancies. 
      Blood components then undergo molecular analysis by flow cytometry or sequencing 
      techniques and can be used as a powerful tool for prognostic and predictive 
      purposes in myeloid malignancies. There is evidence and more is evolving about 
      the quantification and identification of cell-based and gene-based biomarkers in 
      myeloid malignancies to monitor treatment response. MRD based acute myeloid 
      leukemia protocol and clinical trials are currently incorporating LB testing and 
      preliminary results are encouraging for potential widespread use in clinic in the 
      near future. MRD monitoring using LBs are not standard in myelodysplastic 
      syndrome (MDS) but this is an area of active investigation. In the future, LBs 
      can replace more invasive techniques such as bone marrow biopsies. However, the 
      routine clinical application of these markers continues to be an issue due to 
      lack of standardization and limited number of studies investigating their 
      specificities. Integrating artificial intelligence (AI) could help simplify the 
      complex interpretation of molecular testing and reduce errors related to operator 
      dependency. Though the field is rapidly evolving, the applicability of MRD 
      testing using LB is mostly limited to research setting at this time due to the 
      need for validation, regulatory approval, payer coverage, and cost issues. This 
      review focuses on the types of biomarkers, most recent research exploring MRD and 
      LB in myeloid malignancies, ongoing clinical trials, and the future of LB in the 
      setting of AI.
CI  - Copyright © 2023 Allam, Nasr, Khalid, Shah, Khan Suheb, Mulla, Vikash, Bou 
      Zerdan, Anwer and Chaulagain.
FAU - Allam, Sabine
AU  - Allam S
AD  - Department of Medicine and Medical Sciences, University of Balamand, Dekwaneh, 
      Lebanon.
FAU - Nasr, Kristina
AU  - Nasr K
AD  - Department of Medicine and Medical Sciences, University of Balamand, Dekwaneh, 
      Lebanon.
FAU - Khalid, Farhan
AU  - Khalid F
AD  - Department of Internal Medicine, Monmouth Medical Center, Long Branch, NJ, United 
      States.
FAU - Shah, Zunairah
AU  - Shah Z
AD  - Department of Internal Medicine, Weiss Memorial Hospital, Chicago, IL, United 
      States.
FAU - Khan Suheb, Mahammed Ziauddin
AU  - Khan Suheb MZ
AD  - Department of Internal Medicine, St. Luke's hospital, Milwaukee, WI, United 
      States.
FAU - Mulla, Sana
AU  - Mulla S
AD  - Department of Internal Medicine, St Mary's Medical Center, Apple Valley, CA, 
      United States.
FAU - Vikash, Sindhu
AU  - Vikash S
AD  - Department of Medicine, Jacobi Medical center/AECOM Bronx, Bronx, NY, United 
      States.
FAU - Bou Zerdan, Maroun
AU  - Bou Zerdan M
AD  - Department of Internal Medicine, SUNY Upstate Medical University, New York, NY, 
      United States.
FAU - Anwer, Faiz
AU  - Anwer F
AD  - Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, 
      Cleveland, OH, United States.
FAU - Chaulagain, Chakra P
AU  - Chaulagain CP
AD  - Department of Hematology and Oncology, Maroone Cancer Center, Cleveland Clinic 
      Florida, Weston, FL, United States.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20230505
PL  - Switzerland
TA  - Front Oncol
JT  - Frontiers in oncology
JID - 101568867
PMC - PMC10196237
OTO - NOTNLM
OT  - acute myeloid leukemia
OT  - acute myeloid leukemia (AML)
OT  - artificial intelligence - AI
OT  - blood biomarkers
OT  - liquid biopsies
OT  - minimal residual disease (MRD)
OT  - myelodysplastic syndromes (MDS)
OT  - myeloid malignancies
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2023/05/22 13:04
MHDA- 2023/05/22 13:05
CRDT- 2023/05/22 11:57
PHST- 2023/02/11 00:00 [received]
PHST- 2023/04/25 00:00 [accepted]
PHST- 2023/05/22 13:05 [medline]
PHST- 2023/05/22 13:04 [pubmed]
PHST- 2023/05/22 11:57 [entrez]
AID - 10.3389/fonc.2023.1164017 [doi]
PST - epublish
SO  - Front Oncol. 2023 May 5;13:1164017. doi: 10.3389/fonc.2023.1164017. eCollection 
      2023.

PMID- 34798638
OWN - NLM
STAT- MEDLINE
DCOM- 20220429
LR  - 20220429
IS  - 1473-6586 (Electronic)
IS  - 0963-0643 (Linking)
VI  - 32
IP  - 1
DP  - 2022 Jan 1
TI  - Are robots the future? A case for robotic pyeloplasty as the gold standard 
      treatment in ureteropelvic junction obstruction.
PG  - 109-115
LID - 10.1097/MOU.0000000000000944 [doi]
AB  - PURPOSE OF REVIEW: Robotic pyeloplasty is still a relatively novel procedure. 
      Clinically, early studies have shown high success rates, decreased complication 
      rates, decreased length of hospital stay, and better cosmetic results. This goal 
      of this article is to argue for the use of robotic pyeloplasty as the gold 
      standard of ureteropelvic junction obstruction (UPJO) treatment. Results of 
      studies that have compared robotic pyeloplasty with other procedures currently 
      used are reviewed. RECENT FINDINGS: Our study, a comprehensive review of 
      published outcomes of robotic pyeloplasty and alternative therapies, consisted of 
      666 pediatric patients and 653 adult patients. Our review coincided with the 
      previously established studies that robotic pyeloplasty shows equivalent surgical 
      success rates as previous standard of care treatments. Open pyeloplasty has 
      fallen out of favor as standard of care due to the increased length of hospital 
      stay, increased adverse events, and the undesirable aesthetics. SUMMARY: The use 
      of robotic pyeloplasty has shown to have clinical outcomes that are consistent 
      with other intervention for UPJO, with a potential decrease in length of stay and 
      morbidity. More work has to be done to develop ways to decrease cost of the robot 
      to help establish it as the gold standard for UPJO treatment.
CI  - Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
FAU - Beal, Robert
AU  - Beal R
AD  - SUNY Downstate Health Sciences University, New York.
FAU - Sicilila, Sabrina
AU  - Sicilila S
AD  - Associated Medical Professionals, Syracuse, New York, USA.
FAU - Riestra, Paola
AU  - Riestra P
AD  - Associated Medical Professionals, Syracuse, New York, USA.
FAU - Albala, David M
AU  - Albala DM
AD  - SUNY Downstate Health Sciences University, New York.
AD  - Associated Medical Professionals, Syracuse, New York, USA.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Curr Opin Urol
JT  - Current opinion in urology
JID - 9200621
SB  - IM
MH  - Adult
MH  - Child
MH  - Female
MH  - Humans
MH  - Kidney Pelvis/surgery
MH  - *Laparoscopy/adverse effects/methods
MH  - Male
MH  - Retrospective Studies
MH  - *Robotic Surgical Procedures/adverse effects/methods
MH  - *Robotics
MH  - Treatment Outcome
MH  - *Ureteral Obstruction/surgery
MH  - Urologic Surgical Procedures/adverse effects/methods
EDAT- 2021/11/20 06:00
MHDA- 2022/04/30 06:00
CRDT- 2021/11/19 20:38
PHST- 2021/11/20 06:00 [pubmed]
PHST- 2022/04/30 06:00 [medline]
PHST- 2021/11/19 20:38 [entrez]
AID - 00042307-202201000-00016 [pii]
AID - 10.1097/MOU.0000000000000944 [doi]
PST - ppublish
SO  - Curr Opin Urol. 2022 Jan 1;32(1):109-115. doi: 10.1097/MOU.0000000000000944.

PMID- 28761808
OWN - NLM
STAT- MEDLINE
DCOM- 20180605
LR  - 20200306
IS  - 2213-1582 (Electronic)
IS  - 2213-1582 (Linking)
VI  - 15
DP  - 2017
TI  - Machine-learning classification of 22q11.2 deletion syndrome: A diffusion tensor 
      imaging study.
PG  - 832-842
LID - S2213-1582(17)30078-5 [pii]
LID - 10.1016/j.nicl.2017.04.029 [doi]
AB  - Chromosome 22q11.2 deletion syndrome (22q11.2DS) is a genetic neurodevelopmental 
      syndrome that has been studied intensively in order to understand relationships 
      between the genetic microdeletion, brain development, cognitive function, and the 
      emergence of psychiatric symptoms. White matter microstructural abnormalities 
      identified using diffusion tensor imaging methods have been reported to affect a 
      variety of neuroanatomical tracts in 22q11.2DS. In the present study, we sought 
      to combine two discovery-based approaches: (1) white matter query language was 
      used to parcellate the brain's white matter into tracts connecting pairs of 34, 
      bilateral cortical regions and (2) the diffusion imaging characteristics of the 
      resulting tracts were analyzed using a machine-learning method called support 
      vector machine in order to optimize the selection of a set of imaging features 
      that maximally discriminated 22q11.2DS and comparison subjects. With this unique 
      approach, we both confirmed previously-recognized 22q11.2DS-related abnormalities 
      in the inferior longitudinal fasciculus (ILF), and identified, for the first 
      time, 22q11.2DS-related anomalies in the middle longitudinal fascicle and the 
      extreme capsule, which may have been overlooked in previous, hypothesis-guided 
      studies. We further observed that, in participants with 22q11.2DS, ILF metrics 
      were significantly associated with positive prodromal symptoms of psychosis.
FAU - Tylee, Daniel S
AU  - Tylee DS
AD  - Department of Neuroscience and Physiology, SUNY Upstate Medical University, 
      Syracuse, NY, USA; Department of Psychiatry and Behavioral Sciences; SUNY Upstate 
      Medical University, Syracuse, NY, USA.
FAU - Kikinis, Zora
AU  - Kikinis Z
AD  - Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, 
      Boston, MA, USA. Electronic address: zora@bwh.harvard.edu.
FAU - Quinn, Thomas P
AU  - Quinn TP
AD  - Bioinformatics Core Research Group, Deakin University, Geelong, Victoria, 
      Australia.
FAU - Antshel, Kevin M
AU  - Antshel KM
AD  - Syracuse University, Syracuse, NY, USA. Electronic address: kmantshe@syr.edu.
FAU - Fremont, Wanda
AU  - Fremont W
AD  - Department of Psychiatry and Behavioral Sciences; SUNY Upstate Medical 
      University, Syracuse, NY, USA. Electronic address: fremontw@upstate.edu.
FAU - Tahir, Muhammad A
AU  - Tahir MA
AD  - Department of Psychiatry and Behavioral Sciences; SUNY Upstate Medical 
      University, Syracuse, NY, USA.
FAU - Zhu, Anni
AU  - Zhu A
AD  - Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, 
      Boston, MA, USA.
FAU - Gong, Xue
AU  - Gong X
AD  - Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, 
      Boston, MA, USA.
FAU - Glatt, Stephen J
AU  - Glatt SJ
AD  - Department of Neuroscience and Physiology, SUNY Upstate Medical University, 
      Syracuse, NY, USA; Department of Psychiatry and Behavioral Sciences; SUNY Upstate 
      Medical University, Syracuse, NY, USA. Electronic address: 
      stephen.glatt@psychgenelab.com.
FAU - Coman, Ioana L
AU  - Coman IL
AD  - Department of Psychiatry and Behavioral Sciences; SUNY Upstate Medical 
      University, Syracuse, NY, USA. Electronic address: comani@upstate.edu.
FAU - Shenton, Martha E
AU  - Shenton ME
AD  - Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, 
      Boston, MA, USA; Department of Radiology, Brigham and Women's Hospital, Harvard 
      Medical School, Boston, MA, USA; VA Boston Healthcare System, Harvard Medical 
      School, Brockton, MA, USA. Electronic address: shenton@bwh.harvard.edu.
FAU - Kates, Wendy R
AU  - Kates WR
AD  - Department of Psychiatry and Behavioral Sciences; SUNY Upstate Medical 
      University, Syracuse, NY, USA. Electronic address: katesw@upstate.edu.
FAU - Makris, Nikos
AU  - Makris N
AD  - Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, 
      Boston, MA, USA; Department of Psychiatry, Massachusetts General Hospital, 
      Harvard Medical School, Boston, MA, USA. Electronic address: 
      nikos@nmr.mgh.harvard.edu.
LA  - eng
GR  - R01 AG042512/AG/NIA NIH HHS/United States
GR  - R01 MH064824/MH/NIMH NIH HHS/United States
GR  - R21 AT008865/AT/NCCIH NIH HHS/United States
GR  - R21 MH106793/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20170511
PL  - Netherlands
TA  - Neuroimage Clin
JT  - NeuroImage. Clinical
JID - 101597070
SB  - IM
MH  - Adult
MH  - DiGeorge Syndrome/*diagnostic imaging/genetics
MH  - Diffusion Tensor Imaging/methods
MH  - Female
MH  - Humans
MH  - Machine Learning
MH  - Male
MH  - Nerve Fibers, Myelinated/*pathology
MH  - Nerve Net/pathology
MH  - Neuropsychological Tests
MH  - White Matter/pathology
MH  - Young Adult
PMC - PMC5522376
OTO - NOTNLM
OT  - (-fp), fronto-parietal aspect
OT  - (-to), temporo-occipital aspect
OT  - (-tp), temporo-parietal aspect
OT  - (22q11.2DS), 22q11.2 deletion syndrome
OT  - (AD), axial diffusivity
OT  - (DTI), diffusion tensor imaging
OT  - (DWI), diffusion weighted image
OT  - (EmC), extreme capsule
OT  - (FA), fractional anisotropy
OT  - (FOV), field of view
OT  - (GDS), Gordon Diagnostic Systems
OT  - (ILF), inferior longitudinal fasciculus
OT  - (MdLF), middle longitudinal fascicle
OT  - (RD), radial diffusivity
OT  - (ROI), region of interest
OT  - (SIPS), Structured Interview for Prodromal Syndromes
OT  - (SRS), Social Responsiveness Scale
OT  - (STG), superior temporal gyrus
OT  - (SVM), support vector machine
OT  - (UKF), Unscented Kalman Filter
OT  - (WAIS-III), Wechsler Adult Intelligence Scale – 3rd edition
OT  - (WMQL), white matter query language
OT  - (dTP), dorsal temporal pole
OT  - 22q11.2 deletion syndrome
OT  - Callosal asymmetry
OT  - Diffusion tensor imaging
OT  - Extreme capsule
OT  - Inferior longitudinal fasciculus
OT  - Machine-learning
OT  - Middle longitudinal fascicle
OT  - Support vector machine
OT  - Velocardiofacial syndrome
OT  - White matter query language
EDAT- 2017/08/02 06:00
MHDA- 2018/06/06 06:00
CRDT- 2017/08/02 06:00
PHST- 2017/02/26 00:00 [received]
PHST- 2017/03/27 00:00 [revised]
PHST- 2017/04/04 00:00 [accepted]
PHST- 2017/08/02 06:00 [entrez]
PHST- 2017/08/02 06:00 [pubmed]
PHST- 2018/06/06 06:00 [medline]
AID - S2213-1582(17)30078-5 [pii]
AID - 10.1016/j.nicl.2017.04.029 [doi]
PST - epublish
SO  - Neuroimage Clin. 2017 May 11;15:832-842. doi: 10.1016/j.nicl.2017.04.029. 
      eCollection 2017.

PMID- 32719123
OWN - NLM
STAT- MEDLINE
DCOM- 20200930
LR  - 20210129
IS  - 1091-6490 (Electronic)
IS  - 0027-8424 (Print)
IS  - 0027-8424 (Linking)
VI  - 117
IP  - 32
DP  - 2020 Aug 11
TI  - Machine learning uncovers the most robust self-report predictors of relationship 
      quality across 43 longitudinal couples studies.
PG  - 19061-19071
LID - 10.1073/pnas.1917036117 [doi]
AB  - Given the powerful implications of relationship quality for health and 
      well-being, a central mission of relationship science is explaining why some 
      romantic relationships thrive more than others. This large-scale project used 
      machine learning (i.e., Random Forests) to 1) quantify the extent to which 
      relationship quality is predictable and 2) identify which constructs reliably 
      predict relationship quality. Across 43 dyadic longitudinal datasets from 29 
      laboratories, the top relationship-specific predictors of relationship quality 
      were perceived-partner commitment, appreciation, sexual satisfaction, 
      perceived-partner satisfaction, and conflict. The top individual-difference 
      predictors were life satisfaction, negative affect, depression, attachment 
      avoidance, and attachment anxiety. Overall, relationship-specific variables 
      predicted up to 45% of variance at baseline, and up to 18% of variance at the end 
      of each study. Individual differences also performed well (21% and 12%, 
      respectively). Actor-reported variables (i.e., own relationship-specific and 
      individual-difference variables) predicted two to four times more variance than 
      partner-reported variables (i.e., the partner's ratings on those variables). 
      Importantly, individual differences and partner reports had no predictive effects 
      beyond actor-reported relationship-specific variables alone. These findings imply 
      that the sum of all individual differences and partner experiences exert their 
      influence on relationship quality via a person's own relationship-specific 
      experiences, and effects due to moderation by individual differences and 
      moderation by partner-reports may be quite small. Finally, relationship-quality 
      change (i.e., increases or decreases in relationship quality over the course of a 
      study) was largely unpredictable from any combination of self-report variables. 
      This collective effort should guide future models of relationships.
FAU - Joel, Samantha
AU  - Joel S
AUID- ORCID: 0000-0001-5919-7408
AD  - Department of Psychology, Western University, London, ON N6A 3K7, Canada; 
      samantha.joel@uwo.ca.
FAU - Eastwick, Paul W
AU  - Eastwick PW
AD  - Department of Psychology, University of California, Davis, CA 95616.
FAU - Allison, Colleen J
AU  - Allison CJ
AD  - Department of Psychology, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.
FAU - Arriaga, Ximena B
AU  - Arriaga XB
AUID- ORCID: 0000-0003-2673-4638
AD  - Department of Psychological Sciences, Purdue University, West Lafayette, IN 
      47907.
FAU - Baker, Zachary G
AU  - Baker ZG
AD  - Department of Psychology, University of Houston, Houston, TX 77204.
FAU - Bar-Kalifa, Eran
AU  - Bar-Kalifa E
AD  - Department of Psychology, Ben Gurion University of the Negev, Be'er Sheva 
      8410501, Israel.
FAU - Bergeron, Sophie
AU  - Bergeron S
AD  - Department of Psychology, Université de Montréal, Montréal, QC H3T 1J4, Canada.
FAU - Birnbaum, Gurit E
AU  - Birnbaum GE
AUID- ORCID: 0000-0002-2033-4839
AD  - School of Psychology, Interdisciplinary Center Herzliya, Herzliya 4610101, 
      Israel.
FAU - Brock, Rebecca L
AU  - Brock RL
AD  - Department of Psychology, University of Nebraska, Lincoln, NE 68588.
FAU - Brumbaugh, Claudia C
AU  - Brumbaugh CC
AD  - Department of Psychology, Queens College & Graduate Center, City University of 
      New York, Flushing, NY 11367.
FAU - Carmichael, Cheryl L
AU  - Carmichael CL
AUID- ORCID: 0000-0002-4474-3485
AD  - Department of Psychology, Brooklyn College & Graduate Center, City University of 
      New York, Brooklyn, NY 11210.
FAU - Chen, Serena
AU  - Chen S
AD  - Department of Psychology, University of California, Berkeley, CA 94720.
FAU - Clarke, Jennifer
AU  - Clarke J
AD  - Department of Psychology, University of Colorado, Colorado Springs, CO 80918.
FAU - Cobb, Rebecca J
AU  - Cobb RJ
AD  - Department of Human Development and Family Sciences, Texas Tech University, 
      Lubbock, TX 79409.
FAU - Coolsen, Michael K
AU  - Coolsen MK
AD  - Department of Management, Marketing, and Entrepreneurship, Shippensburg 
      University, Shippensburg, PA 17257.
FAU - Davis, Jody
AU  - Davis J
AD  - Department of Psychology, Virginia Commonwealth University, Richmond, VA 23284.
FAU - de Jong, David C
AU  - de Jong DC
AD  - Department of Psychology, Western Carolina University, Cullowhee, NC 28723.
FAU - Debrot, Anik
AU  - Debrot A
AD  - Institute of Psychology, University of Lausanne, 1015 Lausanne, Switzerland.
FAU - DeHaas, Eva C
AU  - DeHaas EC
AD  - Department of Psychology, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.
FAU - Derrick, Jaye L
AU  - Derrick JL
AUID- ORCID: 0000-0002-9525-0170
AD  - Department of Psychology, University of Houston, Houston, TX 77204.
FAU - Eller, Jami
AU  - Eller J
AD  - Department of Psychology, University of Minnesota, Minneapolis, MN 55455.
FAU - Estrada, Marie-Joelle
AU  - Estrada MJ
AD  - Department of Psychology, University of Rochester, Rochester, NY 14627.
FAU - Faure, Ruddy
AU  - Faure R
AD  - Department of Experimental and Applied Psychology, Vrije Universiteit Amsterdam, 
      1081 HV Amsterdam, The Netherlands.
FAU - Finkel, Eli J
AU  - Finkel EJ
AD  - Department of Psychology and the Kellogg School of Management, Northwestern 
      University, Evanston, IL 60208.
FAU - Fraley, R Chris
AU  - Fraley RC
AD  - Department of Psychology, University of Illinois at Urbana-Champaign, Champaign, 
      IL 61820.
FAU - Gable, Shelly L
AU  - Gable SL
AD  - Department of Psychological & Brain Sciences, University of California, Santa 
      Barbara, CA 93106.
FAU - Gadassi-Polack, Reuma
AU  - Gadassi-Polack R
AD  - Department of Psychology, Yale University, New Haven, CT 06520.
FAU - Girme, Yuthika U
AU  - Girme YU
AUID- ORCID: 0000-0002-0059-2144
AD  - Department of Psychology, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.
FAU - Gordon, Amie M
AU  - Gordon AM
AD  - Department of Psychology, University of Michigan, Ann Arbor, MI 48109.
FAU - Gosnell, Courtney L
AU  - Gosnell CL
AD  - Department of Psychology, Pace University, Pleasantville, NY 10570.
FAU - Hammond, Matthew D
AU  - Hammond MD
AD  - School of Psychology, Victoria University of Wellington, Wellington 6012, New 
      Zealand.
FAU - Hannon, Peggy A
AU  - Hannon PA
AD  - Department of Health Services, University of Washington, Seattle, WA 98195.
FAU - Harasymchuk, Cheryl
AU  - Harasymchuk C
AD  - Department of Psychology, Carleton University, Ottawa, ON K1S 5B6, Canada.
FAU - Hofmann, Wilhelm
AU  - Hofmann W
AD  - Department of Psychology, Ruhr University Bochum, 44801 Bochum, Germany.
FAU - Horn, Andrea B
AU  - Horn AB
AD  - Department of Psychology and the University Research Priority Program "Dynamics 
      of Healthy Aging," University of Zurich, 8006 Zurich, Switzerland.
FAU - Impett, Emily A
AU  - Impett EA
AUID- ORCID: 0000-0003-3348-7524
AD  - Department of Psychology, University of Toronto Mississauga, Mississauga, ON L5L 
      1C6, Canada.
FAU - Jamieson, Jeremy P
AU  - Jamieson JP
AD  - Department of Psychology, University of Rochester, Rochester, NY 14627.
FAU - Keltner, Dacher
AU  - Keltner D
AD  - Department of Psychology, Brooklyn College & Graduate Center, City University of 
      New York, Brooklyn, NY 11210.
FAU - Kim, James J
AU  - Kim JJ
AD  - Department of Psychology, University of Toronto, Toronto, ON M5S 1A1, Canada.
FAU - Kirchner, Jeffrey L
AU  - Kirchner JL
AD  - Department of Psychology, University of North Carolina at Chapel Hill, Chapel 
      Hill, NC 27599.
FAU - Kluwer, Esther S
AU  - Kluwer ES
AD  - Department of Psychology, Utrecht University, 3584 CS Utrecht, The Netherlands.
AD  - Department of Psychology, Radboud University, 6525 HR Nijmegen, The Netherlands.
FAU - Kumashiro, Madoka
AU  - Kumashiro M
AD  - Department of Psychology, Goldsmiths, University of London, London SE14 6NW, 
      United Kingdom.
FAU - Larson, Grace
AU  - Larson G
AD  - Social Cognition Center Cologne, University of Cologne, 50923 Cologne, Germany.
FAU - Lazarus, Gal
AU  - Lazarus G
AUID- ORCID: 0000-0002-4209-432X
AD  - Department of Psychology, Bar-Ilan University, Ramat Gan 5290002, Israel.
FAU - Logan, Jill M
AU  - Logan JM
AD  - Department of Psychology, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.
FAU - Luchies, Laura B
AU  - Luchies LB
AD  - Center for Social Research, Calvin University, Grand Rapids, MI 49546.
FAU - MacDonald, Geoff
AU  - MacDonald G
AD  - Department of Psychology, University of Toronto, Toronto, ON M5S 1A1, Canada.
FAU - Machia, Laura V
AU  - Machia LV
AD  - Department of Psychology, Syracuse University, Syracuse, NY 13244.
FAU - Maniaci, Michael R
AU  - Maniaci MR
AD  - Department of Psychology, Florida Atlantic University, Boca Raton, FL 33431.
FAU - Maxwell, Jessica A
AU  - Maxwell JA
AD  - School of Psychology, University of Auckland, Auckland 1010, New Zealand.
FAU - Mizrahi, Moran
AU  - Mizrahi M
AD  - Department of Behavioral Sciences and Psychology, Ariel University Center of 
      Samaria, Ariel 44837, Israel.
FAU - Muise, Amy
AU  - Muise A
AD  - Department of Psychology, York University, Toronto, ON M3J 1P3, Canada.
FAU - Niehuis, Sylvia
AU  - Niehuis S
AD  - Department of Human Development and Family Sciences, Texas Tech University, 
      Lubbock, TX 79409.
FAU - Ogolsky, Brian G
AU  - Ogolsky BG
AUID- ORCID: 0000-0001-5201-6299
AD  - Department of Human Development and Family Studies, University of Illinois at 
      Urbana-Champaign, Champaign, IL 61820.
FAU - Oldham, C Rebecca
AU  - Oldham CR
AD  - Department of Human Development and Family Sciences, Texas Tech University, 
      Lubbock, TX 79409.
FAU - Overall, Nickola C
AU  - Overall NC
AD  - School of Psychology, University of Auckland, Auckland 1010, New Zealand.
FAU - Perrez, Meinrad
AU  - Perrez M
AD  - Department of Psychology, University of Fribourg, 1700 Fribourg, Switzerland.
FAU - Peters, Brett J
AU  - Peters BJ
AD  - Department of Psychology, Ohio University, Athens, OH 45701.
FAU - Pietromonaco, Paula R
AU  - Pietromonaco PR
AUID- ORCID: 0000-0003-1569-0246
AD  - Department of Psychological and Brain Sciences, University of Massachusetts, 
      Amherst, Amherst, MA 01003.
FAU - Powers, Sally I
AU  - Powers SI
AD  - Department of Psychological and Brain Sciences, University of Massachusetts, 
      Amherst, Amherst, MA 01003.
FAU - Prok, Thery
AU  - Prok T
AD  - Department of Psychological & Brain Sciences, University of California, Santa 
      Barbara, CA 93106.
FAU - Pshedetzky-Shochat, Rony
AU  - Pshedetzky-Shochat R
AD  - Department of Psychology, Bar-Ilan University, Ramat Gan 5290002, Israel.
FAU - Rafaeli, Eshkol
AU  - Rafaeli E
AD  - Department of Psychology, Bar-Ilan University, Ramat Gan 5290002, Israel.
AD  - Department of Psychology, Barnard College, Columbia University, New York, NY 
      10027.
FAU - Ramsdell, Erin L
AU  - Ramsdell EL
AUID- ORCID: 0000-0001-9634-2926
AD  - Department of Psychology, University of Nebraska, Lincoln, NE 68588.
FAU - Reblin, Maija
AU  - Reblin M
AUID- ORCID: 0000-0003-3108-465X
AD  - Department of Health Outcomes & Behavior, H. Lee Moffitt Cancer Center and 
      Research Institute, Tampa, FL 33612.
FAU - Reicherts, Michael
AU  - Reicherts M
AD  - Department of Psychology, University of Fribourg, 1700 Fribourg, Switzerland.
FAU - Reifman, Alan
AU  - Reifman A
AUID- ORCID: 0000-0002-5182-2894
AD  - Department of Human Development and Family Sciences, Texas Tech University, 
      Lubbock, TX 79409.
FAU - Reis, Harry T
AU  - Reis HT
AD  - Department of Psychology, University of Rochester, Rochester, NY 14627.
FAU - Rhoades, Galena K
AU  - Rhoades GK
AD  - Department of Psychology, University of Denver, Denver, CO 80208.
FAU - Rholes, William S
AU  - Rholes WS
AD  - Department of Psychological and Brain Sciences, Texas A & M University, College 
      Station, TX 77843.
FAU - Righetti, Francesca
AU  - Righetti F
AD  - Department of Experimental and Applied Psychology, Vrije Universiteit Amsterdam, 
      1081 HV Amsterdam, The Netherlands.
FAU - Rodriguez, Lindsey M
AU  - Rodriguez LM
AD  - Department of Psychology, University of South Florida, St. Petersburg, FL 33701.
FAU - Rogge, Ron
AU  - Rogge R
AUID- ORCID: 0000-0002-1875-3938
AD  - Department of Psychology, University of Rochester, Rochester, NY 14627.
FAU - Rosen, Natalie O
AU  - Rosen NO
AUID- ORCID: 0000-0002-4525-0770
AD  - Department of Psychology and Neuroscience, Dalhousie University, Halifax, NS B3H 
      4R2, Canada.
FAU - Saxbe, Darby
AU  - Saxbe D
AUID- ORCID: 0000-0001-8951-4216
AD  - Department of Psychology, University of Southern California, Los Angeles, CA 
      90007.
FAU - Sened, Haran
AU  - Sened H
AUID- ORCID: 0000-0003-0467-1154
AD  - Department of Psychology, Bar-Ilan University, Ramat Gan 5290002, Israel.
FAU - Simpson, Jeffry A
AU  - Simpson JA
AD  - Department of Psychology, University of Minnesota, Minneapolis, MN 55455.
FAU - Slotter, Erica B
AU  - Slotter EB
AD  - Department of Psychological and Brain Sciences, Villanova University, Villanova, 
      PA 19085.
FAU - Stanley, Scott M
AU  - Stanley SM
AD  - Department of Psychology, University of Denver, Denver, CO 80208.
FAU - Stocker, Shevaun
AU  - Stocker S
AD  - Human Behavior, Justice, and Diversity Department, University of Wisconsin, 
      Superior, WI 54880.
FAU - Surra, Cathy
AU  - Surra C
AD  - Department of Human Development and Family Sciences, University of Texas at 
      Austin, Austin, TX 78712.
FAU - Ter Kuile, Hagar
AU  - Ter Kuile H
AD  - Department of Psychology, Utrecht University, 3584 CS Utrecht, The Netherlands.
FAU - Vaughn, Allison A
AU  - Vaughn AA
AUID- ORCID: 0000-0001-8454-9284
AD  - Department of Psychology, San Diego State University, San Diego, CA 92182.
FAU - Vicary, Amanda M
AU  - Vicary AM
AD  - Department of Psychology, Illinois Wesleyan University, Bloomington, IL 61701.
FAU - Visserman, Mariko L
AU  - Visserman ML
AUID- ORCID: 0000-0001-8747-3852
AD  - Department of Psychology, University of Toronto, Toronto, ON M5S 1A1, Canada.
AD  - Department of Psychology, York University, Toronto, ON M3J 1P3, Canada.
FAU - Wolf, Scott
AU  - Wolf S
AD  - Department of Psychology, University of North Carolina at Chapel Hill, Chapel 
      Hill, NC 27599.
LA  - eng
GR  - F31 AA026195/AA/NIAAA NIH HHS/United States
GR  - R01 HD047564/HD/NICHD NIH HHS/United States
GR  - CIHR/Canada
GR  - F31 AA020442/AA/NIAAA NIH HHS/United States
GR  - R01 CA133908/CA/NCI NIH HHS/United States
GR  - R01 MH049599/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20200727
PL  - United States
TA  - Proc Natl Acad Sci U S A
JT  - Proceedings of the National Academy of Sciences of the United States of America
JID - 7505876
SB  - IM
MH  - Family Characteristics
MH  - Female
MH  - Humans
MH  - *Interpersonal Relations
MH  - Longitudinal Studies
MH  - *Machine Learning
MH  - Male
MH  - Self Report
PMC - PMC7431040
OTO - NOTNLM
OT  - Random Forests
OT  - ensemble methods
OT  - machine learning
OT  - relationship quality
OT  - romantic relationships
COIS- The authors declare no competing interest.
EDAT- 2020/07/29 06:00
MHDA- 2020/10/02 06:00
CRDT- 2020/07/29 06:00
PHST- 2020/07/29 06:00 [pubmed]
PHST- 2020/10/02 06:00 [medline]
PHST- 2020/07/29 06:00 [entrez]
AID - 1917036117 [pii]
AID - 201917036 [pii]
AID - 10.1073/pnas.1917036117 [doi]
PST - ppublish
SO  - Proc Natl Acad Sci U S A. 2020 Aug 11;117(32):19061-19071. doi: 
      10.1073/pnas.1917036117. Epub 2020 Jul 27.

PMID- 32237241
OWN - NLM
STAT- MEDLINE
DCOM- 20210929
LR  - 20210929
IS  - 1469-7610 (Electronic)
IS  - 0021-9630 (Print)
IS  - 0021-9630 (Linking)
VI  - 61
IP  - 12
DP  - 2020 Dec
TI  - Machine-Learning prediction of comorbid substance use disorders in ADHD youth 
      using Swedish registry data.
PG  - 1370-1379
LID - 10.1111/jcpp.13226 [doi]
AB  - BACKGROUND: Children with attention-deficit/hyperactivity disorder (ADHD) have a 
      high risk for substance use disorders (SUDs). Early identification of at-risk 
      youth would help allocate scarce resources for prevention programs. METHODS: 
      Psychiatric and somatic diagnoses, family history of these disorders, measures of 
      socioeconomic distress, and information about birth complications were obtained 
      from the national registers in Sweden for 19,787 children with ADHD born between 
      1989 and 1993. We trained (a) a cross-sectional random forest (RF) model using 
      data available by age 17 to predict SUD diagnosis between ages 18 and 19; and (b) 
      a longitudinal recurrent neural network (RNN) model with the Long Short-Term 
      Memory (LSTM) architecture to predict new diagnoses at each age. RESULTS: The 
      area under the receiver operating characteristic curve (AUC) was 0.73(95%CI 
      0.70-0.76) for the random forest model (RF). Removing prior diagnosis from the 
      predictors, the RF model was still able to achieve significant AUCs when 
      predicting all SUD diagnoses (0.69, 95%CI 0.66-0.72) or new diagnoses (0.67, 
      95%CI: 0.64, 0.71) during age 18-19. For the model predicting new diagnoses, 
      model calibration was good with a low Brier score of 0.086. Longitudinal LSTM 
      model was able to predict later SUD risks at as early as 2 years age, 10 years 
      before the earliest diagnosis. The average AUC from longitudinal models 
      predicting new diagnoses 1, 2, 5 and 10 years in the future was 0.63. 
      CONCLUSIONS: Population registry data can be used to predict at-risk comorbid 
      SUDs in individuals with ADHD. Such predictions can be made many years prior to 
      age of the onset, and their SUD risks can be monitored using longitudinal models 
      over years during child development. Nevertheless, more work is needed to create 
      prediction models based on electronic health records or linked population 
      registers that are sufficiently accurate for use in the clinic.
CI  - © 2020 The Authors. Journal of Child Psychology and Psychiatry published by John 
      Wiley & Sons Ltd on behalf of Association for Child and Adolescent Mental Health.
FAU - Zhang-James, Yanli
AU  - Zhang-James Y
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Syracuse, NY, USA.
FAU - Chen, Qi
AU  - Chen Q
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
FAU - Kuja-Halkola, Ralf
AU  - Kuja-Halkola R
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
FAU - Lichtenstein, Paul
AU  - Lichtenstein P
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
FAU - Larsson, Henrik
AU  - Larsson H
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
AD  - School of Medical Sciences, Örebro University, Örebro, Sweden.
FAU - Faraone, Stephen V
AU  - Faraone SV
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Syracuse, NY, USA.
AD  - Department of Neuroscience and Physiology, SUNY Upstate Medical University, 
      Syracuse, NY, USA.
LA  - eng
PT  - Journal Article
DEP - 20200401
PL  - England
TA  - J Child Psychol Psychiatry
JT  - Journal of child psychology and psychiatry, and allied disciplines
JID - 0375361
SB  - IM
MH  - Adolescent
MH  - Attention Deficit Disorder with Hyperactivity/*epidemiology
MH  - Child
MH  - Child, Preschool
MH  - Comorbidity
MH  - Cross-Sectional Studies
MH  - Humans
MH  - *Machine Learning
MH  - *Registries
MH  - Risk Factors
MH  - Substance-Related Disorders/*epidemiology
MH  - Sweden/epidemiology
PMC - PMC7754321
OTO - NOTNLM
OT  - Machine learning
OT  - attention-deficit hyperactive disorder
OT  - comorbidity
OT  - risk factor
OT  - substance use disorder
EDAT- 2020/04/03 06:00
MHDA- 2021/09/30 06:00
CRDT- 2020/04/03 06:00
PHST- 2019/10/24 00:00 [received]
PHST- 2020/01/03 00:00 [revised]
PHST- 2020/01/28 00:00 [accepted]
PHST- 2020/04/03 06:00 [pubmed]
PHST- 2021/09/30 06:00 [medline]
PHST- 2020/04/03 06:00 [entrez]
AID - JCPP13226 [pii]
AID - 10.1111/jcpp.13226 [doi]
PST - ppublish
SO  - J Child Psychol Psychiatry. 2020 Dec;61(12):1370-1379. doi: 10.1111/jcpp.13226. 
      Epub 2020 Apr 1.

PMID- 34268067
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231027
IS  - 2214-6490 (Print)
IS  - 2214-6512 (Electronic)
VI  - 5
IP  - 3-4
DP  - 2021
TI  - Opportunities, barriers, and recommendations in down syndrome research.
PG  - 99-129
LID - 10.3233/trd-200090 [doi]
AB  - BACKGROUND: Recent advances in medical care have increased life expectancy and 
      improved the quality of life for people with Down syndrome (DS). These advances 
      are the result of both pre-clinical and clinical research but much about DS is 
      still poorly understood. In 2020, the NIH announced their plan to update their DS 
      research plan and requested input from the scientific and advocacy community. 
      OBJECTIVE: The National Down Syndrome Society (NDSS) and the LuMind IDSC 
      Foundation worked together with scientific and medical experts to develop 
      recommendations for the NIH research plan. METHODS: NDSS and LuMind IDSC 
      assembled over 50 experts across multiple disciplines and organized them in 
      eleven working groups focused on specific issues for people with DS. RESULTS: 
      This review article summarizes the research gaps and recommendations that have 
      the potential to improve the health and quality of life for people with DS within 
      the next decade. CONCLUSIONS: This review highlights many of the scientific gaps 
      that exist in DS research. Based on these gaps, a multidisciplinary group of DS 
      experts has made recommendations to advance DS research. This paper may also aid 
      policymakers and the DS community to build a comprehensive national DS research 
      strategy.
FAU - Hendrix, James A
AU  - Hendrix JA
AD  - LuMind IDSC Foundation, Burlington, MA, USA.
FAU - Amon, Angelika
AU  - Amon A
AD  - Deceased. Koch Institute for Integrative Cancer Research, Massachusetts Institute 
      of Technology, Cambridge, MA, USA; Department of Biology, Massachusetts Institute 
      of Technology, Cambridge, MA, USA; Howard Hughes Medical Institute, Chevy Chase, 
      MD, USA.
FAU - Abbeduto, Leonard
AU  - Abbeduto L
AD  - Department of Psychiatry and Behavioral Sciences, University of California, 
      Davis, CA, USA; MIND Institute, University of California, Davis, CA, USA.
FAU - Agiovlasitis, Stamatis
AU  - Agiovlasitis S
AD  - Department of Kinesiology, Mississippi State University, Mississippi State, MS, 
      USA.
FAU - Alsaied, Tarek
AU  - Alsaied T
AD  - Heart Institute Department of Pediatrics Cincinnati Children's Hospital Medical 
      Center University of Cincinnati, Cincinnati, OH, USA.
FAU - Anderson, Heather A
AU  - Anderson HA
AD  - The Ohio State University College of Optometry, Columbus, OH, USA.
FAU - Bain, Lisa J
AU  - Bain LJ
AD  - Independent Science Writer, Elverson, PA, USA.
FAU - Baumer, Nicole
AU  - Baumer N
AD  - Department of Neurology, Boston Children's Hospital, Harvard Medical School, 
      Boston, MA, USA; Down Syndrome Program, Developmental Medicine Center, Boston 
      Children's Hospital, Boston, MA, USA.
FAU - Bhattacharyya, Anita
AU  - Bhattacharyya A
AD  - Waisman Center, University of Wisconsin-Madison, Madison, WI, USA.
AD  - Department of Cell and Regenerative Biology, School of Medicine and Public 
      Health, University of Wisconsin-Madison, Madison, WI, USA.
FAU - Bogunovic, Dusan
AU  - Bogunovic D
AD  - Department of Microbiology, Icahn School of Medicine at Mt. Sinai, New York, NY, 
      USA; Department of Pediatrics, Icahn School of Medicine at Mt. Sinai, New York, 
      NY; Precision Immunology Institute, Icahn School of Medicine at Mt. Sinai, New 
      York, NY, USA; Mindich Child Health and Development Institute, Icahn School of 
      Medicine at Mt. Sinai, New York, NY, USA.
FAU - Botteron, Kelly N
AU  - Botteron KN
AD  - Department of Psychiatry, Washington University School of Medicine, St. Louis, 
      MO, USA; Mallinckrodt Institute of Radiology, Washington University School of 
      Medicine, St. Louis, MO, USA.
FAU - Capone, George
AU  - Capone G
AD  - Kennedy Krieger Institute, Baltimore, MD, USA.
FAU - Chandan, Priya
AU  - Chandan P
AD  - Department of Neurosurgery, Division of Physical Medicine and Rehabilitation, 
      University of Louisville School of Medicine, Louisville, KY, USA.
FAU - Chase, Isabelle
AU  - Chase I
AD  - Department of Pediatric Dentistry, Boston Children's Hospital, Boston, MA, USA.
FAU - Chicoine, Brian
AU  - Chicoine B
AD  - Advocate Medical Group Adult Down Syndrome Center, Park Ridge, IL, USA.
FAU - Cieuta-Walti, Cécile
AU  - Cieuta-Walti C
AD  - Department of Pediatrics, University of Sherbrooke, Quebec, Canada.
FAU - DeRuisseau, Lara R
AU  - DeRuisseau LR
AD  - Department of Biological Sciences, Le Moyne College, Syracuse, NY, USA.
FAU - Durand, Sophie
AU  - Durand S
AD  - Institut Jérôme Lejeune, CRB BioJeL, Paris, France.
FAU - Esbensen, Anna
AU  - Esbensen A
AD  - Department of Pediatrics, University of Cincinnati College of Medicine & Division 
      of Developmental and Behavioral Pediatrics, Cincinnati Children's Hospital 
      Medical Center, Cincinnati, OH, USA.
FAU - Fortea, Juan
AU  - Fortea J
AD  - Barcelona Down Medical Center, Fundació Catalana de Síndrome de Down, Barcelona, 
      Spain; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i 
      Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de 
      Barcelona, Barcelona, Spain; Center of Biomedical Investigation Network for 
      Neurodegenerative Diseases, Madrid, Spain.
FAU - Giménez, Sandra
AU  - Giménez S
AD  - Multidisciplinary Sleep Unit, Respiratory Department, Hospital de la Santa Creu i 
      Sant Pau, Barcelona, Spain.
FAU - Granholm, Ann-Charlotte
AU  - Granholm AC
AD  - Knoebel Institute for Healthy Aging, University of Denver, Denver, CO, USA.
AD  - Department of Neurobiology, Care Sciences and Society (NVS), Karolinska 
      Institutet, Stockholm, Sweden.
FAU - Hahn, Laura J
AU  - Hahn LJ
AD  - Department of Speech and Hearing Science, University of Illinois Urbana 
      Champaign, Champaign, IL, USA.
FAU - Head, Elizabeth
AU  - Head E
AD  - Department of Pathology and Laboratory Medicine, UC Irvine School of Medicine, 
      Orange, CA, USA.
FAU - Hillerstrom, Hampus
AU  - Hillerstrom H
AD  - LuMind IDSC Foundation, Burlington, MA, USA.
FAU - Jacola, Lisa M
AU  - Jacola LM
AD  - Department of Psychology, St Jude Children's Research Hospital, Memphis, TN, USA.
FAU - Janicki, Matthew P
AU  - Janicki MP
AD  - University of Illinois at Chicago, Chicago, IL, USA.
FAU - Jasien, Joan M
AU  - Jasien JM
AD  - Division of Pediatric Neurology, Duke University Health System, Durham, NC, USA.
FAU - Kamer, Angela R
AU  - Kamer AR
AD  - Department of Periodontology and Implant Dentistry, New York University, College 
      of Dentistry, New York, NY, USA.
FAU - Kent, Raymond D
AU  - Kent RD
AD  - Waisman Center, University of Wisconsin-Madison, Madison, WI, USA.
FAU - Khor, Bernard
AU  - Khor B
AD  - Benaroy Research Institute at Virginia Mason, Seattle, WA, USA.
FAU - Lawrence, Jeanne B
AU  - Lawrence JB
AD  - Department of Neurology, University of Massachusetts Medical School, Worcester, 
      MA, USA; Department of Pediatrics, University of Massachusetts Medical School, 
      Worcester, MA, USA.
FAU - Lemonnier, Catherine
AU  - Lemonnier C
AD  - Institut Jérôme Lejeune, CRB BioJeL, Paris, France.
FAU - Lewanda, Amy Feldman
AU  - Lewanda AF
AD  - Children s National Rare Disease Institute, Children's National Health System, 
      Washington, DC., USA.
FAU - Mobley, William
AU  - Mobley W
AD  - Department of Neurosciences, University of California, San Diego, CA, USA.
FAU - Moore, Paul E
AU  - Moore PE
AD  - Division of Allergy, Immunology, and Pulmonology, Vanderbilt University Medical 
      Center, Nashville, TN, USA; Department of Pediatrics, Vanderbilt University 
      Medical Center, Nashville, TN, USA.
FAU - Nelson, Linda Pollak
AU  - Nelson LP
AD  - Harvard School of Dental Medicine, Boston, MA, USA.
FAU - Oreskovic, Nicolas M
AU  - Oreskovic NM
AD  - Department of Pediatrics, Massachusetts General Hospital, Boston, MA, USA; 
      Department of Internal Medicine, Massachusetts General Hospital, Boston, Mass.
AD  - Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
FAU - Osorio, Ricardo S
AU  - Osorio RS
AD  - Center for Brain Health, Department of Psychiatry, NYU Langone Medical Center, 
      New York, NY, USA.
FAU - Patterson, David
AU  - Patterson D
AD  - Knoebel Institute for Healthy Aging, University of Denver, Denver, CO, USA.
AD  - Eleanor Roosevelt Institute, University of Denver, Denver, CO, USA; Department of 
      Biological Sciences, University of Denver, Denver, CO, USA; Molecular and 
      Cellular Biophysics Program, University of Denver, Denver, CO, USA.
FAU - Rasmussen, Sonja A
AU  - Rasmussen SA
AD  - Department of Pediatrics, University of Florida College of Medicine, Gainesville, 
      FL; Department of Epidemiology, University of Florida College of Public Health 
      and Health Professions and College of Medicine, Gainesville, FL.
FAU - Reeves, Roger H
AU  - Reeves RH
AD  - Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, 
      MD, USA; McKusick-Nathans Department of Genetic Medicine, Johns Hopkins 
      University School of Medicine, Baltimore, MD, USA.
FAU - Roizen, Nancy
AU  - Roizen N
AD  - Department of Pediatrics, UH/Rainbow Babies and Children's Hospital and 
      Department of Pediatrics, Case Western Reserve University, Cleveland, OH, USA.
FAU - Santoro, Stephanie
AU  - Santoro S
AD  - Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
AD  - Down Syndrome Program, Division of Medical Genetics and Metabolism, Department of 
      Pediatrics, Massachusetts General Hospital, Boston, MA, USA.
FAU - Sherman, Stephanie L
AU  - Sherman SL
AD  - Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, 
      USA.
FAU - Talib, Nasreen
AU  - Talib N
AD  - Division of General Pediatrics, Children's Mercy Kansas City, 2401 Gillham Road, 
      Kansas City, MO, USA.
FAU - Tapia, Ignacio E
AU  - Tapia IE
AD  - Sleep Center, Division of Pulmonary Medicine, Children's Hospital of 
      Philadelphia, Philadelphia, PA, USA.
FAU - Walsh, Kyle M
AU  - Walsh KM
AD  - Division of Neuro-epidemiology, Department of Neurosurgery, Duke University, 
      Durham, NC, USA.
FAU - Warren, Steven F
AU  - Warren SF
AD  - Institute for Life Span Studies, University of Kansas, Lawrence, KS, USA.
FAU - White, A Nicole
AU  - White AN
AD  - Research Foundation, Cincinnati Children's Hospital Medical Center, Cincinnati, 
      OH, USA.
FAU - Wong, Guang William
AU  - Wong GW
AD  - Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, 
      MD, USA; McKusick-Nathans Department of Genetic Medicine, Johns Hopkins 
      University School of Medicine, Baltimore, MD, USA.
AD  - Center for Metabolism and Obesity Research, The Johns Hopkins University School 
      of Medicine, Baltimore, Maryland, USA.
FAU - Yi, John S
AU  - Yi JS
AD  - Division of Surgical Sciences, Department of Surgery, Duke University Medical 
      Center, Durham, NC, USA.
LA  - eng
GR  - R01 HD091357/HD/NICHD NIH HHS/United States
GR  - P30 AG066512/AG/NIA NIH HHS/United States
GR  - R01 HD094788/HD/NICHD NIH HHS/United States
GR  - U54 HD090255/HD/NICHD NIH HHS/United States
GR  - R21 HD099573/HD/NICHD NIH HHS/United States
GR  - RF1 AG061566/AG/NIA NIH HHS/United States
GR  - R15 HD076379/HD/NICHD NIH HHS/United States
PT  - Journal Article
DEP - 20210415
PL  - Netherlands
TA  - Transl Sci Rare Dis
JT  - Translational science of rare diseases
JID - 101695348
PMC - PMC8279178
MID - NIHMS1693350
OTO - NOTNLM
OT  - Alzheimer’s disease
OT  - Down syndrome
OT  - autism spectrum disorder
OT  - autoimmune disease
OT  - cognitive development
OT  - congenital heart disease
OT  - intellectual disability
OT  - leukemia
OT  - muscle hypotonia
OT  - obesity
OT  - obstructive sleep apnea
OT  - periodontitis
EDAT- 2021/07/17 06:00
MHDA- 2021/07/17 06:01
CRDT- 2021/07/16 06:39
PHST- 2021/07/16 06:39 [entrez]
PHST- 2021/07/17 06:00 [pubmed]
PHST- 2021/07/17 06:01 [medline]
AID - 10.3233/trd-200090 [doi]
PST - ppublish
SO  - Transl Sci Rare Dis. 2021;5(3-4):99-129. doi: 10.3233/trd-200090. Epub 2021 Apr 
      15.

PMID- 35194707
OWN - NLM
STAT- MEDLINE
DCOM- 20230921
LR  - 20230921
IS  - 1875-8312 (Electronic)
IS  - 1569-5794 (Linking)
VI  - 38
IP  - 8
DP  - 2022 Aug
TI  - Predicting adverse cardiac events in sarcoidosis: deep learning from automated 
      characterization of regional myocardial remodeling.
PG  - 1825-1836
LID - 10.1007/s10554-022-02564-5 [doi]
AB  - Recognizing early cardiac sarcoidosis (CS) imaging phenotypes can help identify 
      opportunities for effective treatment before irreversible myocardial pathology 
      occurs. We aimed to characterize regional CS myocardial remodeling features 
      correlating with future adverse cardiac events by coupling automated image 
      processing and data analysis on cardiac magnetic resonance (CMR) imaging 
      datasets. A deep convolutional neural network (DCNN) was used to process a CMR 
      database of a 10-year cohort of 117 consecutive biopsy-proven sarcoidosis 
      patients. The maximum relevance - minimum redundancy method was used to select 
      the best subset of all the features-24 (from manual processing) and 232 (from 
      automated processing) left ventricular (LV) structural/functional features. Three 
      machine learning (ML) algorithms, logistic regression (LogR), support vector 
      machine (SVM) and multi-layer neural networks (MLP), were used to build 
      classifiers to categorize endpoints. Over a median follow-up of 41.8 
      (inter-quartile range 20.4-60.5) months, 35 sarcoidosis patients experienced a 
      total of 43 cardiac events. After manual processing, LV ejection fraction (LVEF), 
      late gadolinium enhancement, abnormal segmental wall motion, LV mass (LVM), LVMI 
      index (LVMI), septal wall thickness, lateral wall thickness, relative wall 
      thickness, and wall thickness of 9 (out of 17) individual LV segments were 
      significantly different between patients with and without endpoints. After 
      automated processing, LVEF, end-diastolic volume, end-systolic volume, LV mass 
      and wall thickness of 92 (out of 216) individual LV segments were significantly 
      different between patients with and without endpoints. To achieve the best 
      predictive performance, ML algorithms selected lateral wall thickness, abnormal 
      segmental wall motion, septal wall thickness, and increased wall thickness of 3 
      individual segments after manual image processing, and selected end-diastolic 
      volume and 7 individual segments after automated image processing. LogR, SVM and 
      MLP based on automated image processing consistently showed better predictive 
      accuracies than those based on manual image processing. Automated image 
      processing with a DCNN improves data resolution and regional CS myocardial 
      remodeling pattern recognition, suggesting that a framework coupling automated 
      image processing with data analysis can help clinical risk stratification.
CI  - © 2022. The Author(s), under exclusive licence to Springer Nature B.V.
FAU - Lu, Chenying
AU  - Lu C
AD  - Departments of Medicine and Radiology, State University of New York, Upstate 
      Medical University Hospital, Syracuse, USA.
AD  - Zhejiang Provincial Key Laboratory of Imaging Diagnosis and Minimally Invasive 
      Intervention Research, The Fifth Affiliated Hospital of Wenzhou Medical 
      University, Zhejiang, China.
FAU - Wang, Yi Grace
AU  - Wang YG
AD  - Department of Mathematics, California State University Dominguez Hills, Carson, 
      USA.
FAU - Zaman, Fahim
AU  - Zaman F
AD  - Department of Electrical and Electronic Engineering, University of Iowa, Iowa 
      City, USA.
FAU - Wu, Xiaodong
AU  - Wu X
AD  - Department of Electrical and Electronic Engineering, University of Iowa, Iowa 
      City, USA.
FAU - Adhaduk, Mehul
AU  - Adhaduk M
AD  - Division of Cardiology, Department of Medicine, University of Iowa, Iowa City, 
      USA.
FAU - Chang, Amanda
AU  - Chang A
AD  - Division of Cardiology, Department of Medicine, University of Iowa, Iowa City, 
      USA.
FAU - Ji, Jiansong
AU  - Ji J
AD  - Zhejiang Provincial Key Laboratory of Imaging Diagnosis and Minimally Invasive 
      Intervention Research, The Fifth Affiliated Hospital of Wenzhou Medical 
      University, Zhejiang, China.
FAU - Wei, Tiemin
AU  - Wei T
AD  - Zhejiang Provincial Key Laboratory of Imaging Diagnosis and Minimally Invasive 
      Intervention Research, The Fifth Affiliated Hospital of Wenzhou Medical 
      University, Zhejiang, China.
FAU - Suksaranjit, Promporn
AU  - Suksaranjit P
AD  - Division of Cardiology, Department of Medicine, University of Iowa, Iowa City, 
      USA.
FAU - Christodoulidis, Georgios
AU  - Christodoulidis G
AD  - Division of Cardiology, Department of Medicine, University of Iowa, Iowa City, 
      USA.
FAU - Scalzetti, Ernest
AU  - Scalzetti E
AD  - Departments of Medicine and Radiology, State University of New York, Upstate 
      Medical University Hospital, Syracuse, USA.
FAU - Han, Yuchi
AU  - Han Y
AD  - Cardiovascular Division, University of Pennsylvania, Philadelphia, USA.
FAU - Feiglin, David
AU  - Feiglin D
AD  - Departments of Medicine and Radiology, State University of New York, Upstate 
      Medical University Hospital, Syracuse, USA.
FAU - Liu, Kan
AU  - Liu K
AUID- ORCID: 0000-0001-5236-9166
AD  - Departments of Medicine and Radiology, State University of New York, Upstate 
      Medical University Hospital, Syracuse, USA. Kan-Liu@uiowa.edu.
AD  - Division of Cardiology and Heart Vascular Center, University of Iowa, Iowa City, 
      IA, 52242, USA. Kan-Liu@uiowa.edu.
LA  - eng
PT  - Journal Article
DEP - 20220222
PL  - United States
TA  - Int J Cardiovasc Imaging
JT  - The international journal of cardiovascular imaging
JID - 100969716
RN  - 0 (Contrast Media)
RN  - AU0V1LM3JT (Gadolinium)
SB  - IM
MH  - Humans
MH  - Contrast Media
MH  - Magnetic Resonance Imaging, Cine/methods
MH  - *Deep Learning
MH  - Predictive Value of Tests
MH  - Gadolinium
MH  - Ventricular Function, Left
MH  - Stroke Volume
MH  - *Sarcoidosis/diagnostic imaging
MH  - *Cardiovascular Diseases
OTO - NOTNLM
OT  - Adverse cardiac events
OT  - Automated image processing
OT  - Cardiac sarcoidosis
OT  - Deep learning
OT  - Regional myocardial remodeling
EDAT- 2022/02/24 06:00
MHDA- 2023/09/21 06:42
CRDT- 2022/02/23 05:35
PHST- 2021/08/10 00:00 [received]
PHST- 2022/02/11 00:00 [accepted]
PHST- 2023/09/21 06:42 [medline]
PHST- 2022/02/24 06:00 [pubmed]
PHST- 2022/02/23 05:35 [entrez]
AID - 10.1007/s10554-022-02564-5 [pii]
AID - 10.1007/s10554-022-02564-5 [doi]
PST - ppublish
SO  - Int J Cardiovasc Imaging. 2022 Aug;38(8):1825-1836. doi: 
      10.1007/s10554-022-02564-5. Epub 2022 Feb 22.

PMID- 34028616
OWN - NLM
STAT- MEDLINE
DCOM- 20211013
LR  - 20230221
IS  - 1432-1459 (Electronic)
IS  - 0340-5354 (Print)
IS  - 0340-5354 (Linking)
VI  - 268
IP  - 11
DP  - 2021 Nov
TI  - Saliva RNA biomarkers predict concussion duration and detect symptom recovery: a 
      comparison with balance and cognitive testing.
PG  - 4349-4361
LID - 10.1007/s00415-021-10566-x [doi]
AB  - OBJECTIVE: The goals of this study were to assess the ability of salivary 
      non-coding RNA (ncRNA) levels to predict post-concussion symptoms 
      lasting ≥ 21 days, and to examine the ability of ncRNAs to identify recovery 
      compared to cognition and balance. METHODS: RNA sequencing was performed on 505 
      saliva samples obtained longitudinally from 112 individuals (8-24-years-old) with 
      mild traumatic brain injury (mTBI). Initial samples were obtained ≤ 14 days 
      post-injury, and follow-up samples were obtained ≥ 21 days post-injury. 
      Computerized balance and cognitive test performance were assessed at initial and 
      follow-up time-points. Machine learning was used to define: (1) a model employing 
      initial ncRNA levels to predict persistent post-concussion symptoms 
      (PPCS) ≥ 21 days post-injury; and (2) a model employing follow-up ncRNA levels to 
      identify symptom recovery. Performance of the models was compared against a 
      validated clinical prediction rule, and balance/cognitive test performance, 
      respectively. RESULTS: An algorithm using age and 16 ncRNAs predicted PPCS with 
      greater accuracy than the validated clinical tool and demonstrated additive 
      combined utility (area under the curve (AUC) 0.86; 95% CI 0.84-0.88). Initial 
      balance and cognitive test performance did not differ between PPCS and non-PPCS 
      groups (p > 0.05). Follow-up balance and cognitive test performance identified 
      symptom recovery with similar accuracy to a model using 11 ncRNAs and age. A 
      combined model (ncRNAs, balance, cognition) most accurately identified recovery 
      (AUC 0.86; 95% CI 0.83-0.89). CONCLUSIONS: ncRNA biomarkers show promise for 
      tracking recovery from mTBI, and for predicting who will have prolonged symptoms. 
      They could provide accurate expectations for recovery, stratify need for 
      intervention, and guide safe return-to-activities.
CI  - © 2021. The Author(s).
FAU - Fedorchak, Gregory
AU  - Fedorchak G
AD  - Quadrant Biosciences, Syracuse, NY, 13210, USA.
FAU - Rangnekar, Aakanksha
AU  - Rangnekar A
AD  - Quadrant Biosciences, Syracuse, NY, 13210, USA.
FAU - Onks, Cayce
AU  - Onks C
AD  - Department of Family Medicine, Penn State College of Medicine, Hershey, PA, 
      17033, USA.
FAU - Loeffert, Andrea C
AU  - Loeffert AC
AD  - Department of Pediatrics, Penn State College of Medicine, Hershey, PA, 17033, 
      USA.
FAU - Loeffert, Jayson
AU  - Loeffert J
AD  - Department of Family Medicine, Penn State College of Medicine, Hershey, PA, 
      17033, USA.
FAU - Olympia, Robert P
AU  - Olympia RP
AD  - Department of Emergency Medicine, Penn State College of Medicine, Hershey, PA, 
      17033, USA.
FAU - DeVita, Samantha
AU  - DeVita S
AD  - Quadrant Biosciences, Syracuse, NY, 13210, USA.
FAU - Leddy, John
AU  - Leddy J
AD  - SUNY Buffalo Jacobs School of Medicine and Biomedical Sciences, UBMD Orthopaedics 
      and Sports Medicine, Buffalo, NY, 14214, USA.
FAU - Haider, Mohammad N
AU  - Haider MN
AD  - SUNY Buffalo Jacobs School of Medicine and Biomedical Sciences, UBMD Orthopaedics 
      and Sports Medicine, Buffalo, NY, 14214, USA.
FAU - Roberts, Aaron
AU  - Roberts A
AD  - Department of Adena Regional Medical Center, Adena Bone and Joint Center, 
      Chillicothe, OH, 45601, USA.
FAU - Rieger, Jessica
AU  - Rieger J
AD  - Quadrant Biosciences, Syracuse, NY, 13210, USA.
FAU - Uhlig, Thomas
AU  - Uhlig T
AD  - Quadrant Biosciences, Syracuse, NY, 13210, USA.
FAU - Monteith, Chuck
AU  - Monteith C
AD  - Colgate University, Hamilton, NY, 13346, USA.
FAU - Middleton, Frank
AU  - Middleton F
AD  - Department of Neuroscience and Physiology, SUNY Upstate Medical University, 
      Syracuse, NY, 13210, USA.
FAU - Zuckerman, Scott L
AU  - Zuckerman SL
AD  - Vanderbilt Sports Concussion Center, Vanderbilt University Medical Center, 
      Nashville, TN, 37212, USA.
FAU - Lee, Timothy
AU  - Lee T
AD  - Vanderbilt Sports Concussion Center, Vanderbilt University Medical Center, 
      Nashville, TN, 37212, USA.
FAU - Yeates, Keith Owen
AU  - Yeates KO
AD  - Department of Psychology, Alberta Children's Hospital Research Institute, 
      Hotchkiss Brain Institute, University of Calgary, Calgary, AB, T2N 1N4, Canada.
FAU - Mannix, Rebekah
AU  - Mannix R
AD  - Division of Emergency Medicine, Boston Children's Hospital, Harvard Medical 
      School, Boston, MA, USA.
FAU - Hicks, Steven
AU  - Hicks S
AUID- ORCID: 0000-0002-9579-6798
AD  - Department of Pediatrics, Penn State College of Medicine, Hershey, PA, 17033, 
      USA. shicks1@pennstatehealth.psu.edu.
LA  - eng
GR  - R01 NS115942/NS/NINDS NIH HHS/United States
PT  - Journal Article
DEP - 20210524
PL  - Germany
TA  - J Neurol
JT  - Journal of neurology
JID - 0423161
RN  - 0 (Biomarkers)
RN  - 63231-63-0 (RNA)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Biomarkers
MH  - *Brain Concussion/diagnosis
MH  - Child
MH  - Humans
MH  - Neuropsychological Tests
MH  - RNA
MH  - Saliva
MH  - Young Adult
PMC - PMC8505318
OTO - NOTNLM
OT  - mTBI
OT  - microRNA
OT  - prognosis
OT  - return to play
OT  - spit
OT  - traumatic brain injury
COIS- SDH serves as a consultant for Quadrant Biosciences. SDH and FAM are scientific 
      advisory board members for Quadrant Biosciences and are named as a co-inventors 
      on intellectual property related to saliva RNA biomarkers in concussion that are 
      patented by The Penn State College of Medicine and The SUNY Upstate Research 
      Foundation and licensed to Quadrant Biosciences. SDV, GF, AR, and JR are paid 
      employees of Quadrant Biosciences. RM has received funding from the NFL 
      foundation. The other authors have no conflicts of interest to declare.
EDAT- 2021/05/25 06:00
MHDA- 2021/10/14 06:00
CRDT- 2021/05/24 12:33
PHST- 2021/01/15 00:00 [received]
PHST- 2021/04/15 00:00 [accepted]
PHST- 2021/04/14 00:00 [revised]
PHST- 2021/05/25 06:00 [pubmed]
PHST- 2021/10/14 06:00 [medline]
PHST- 2021/05/24 12:33 [entrez]
AID - 10.1007/s00415-021-10566-x [pii]
AID - 10566 [pii]
AID - 10.1007/s00415-021-10566-x [doi]
PST - ppublish
SO  - J Neurol. 2021 Nov;268(11):4349-4361. doi: 10.1007/s00415-021-10566-x. Epub 2021 
      May 24.

PMID- 33714545
OWN - NLM
STAT- MEDLINE
DCOM- 20210927
LR  - 20240112
IS  - 1873-2402 (Electronic)
IS  - 0006-3223 (Print)
IS  - 0006-3223 (Linking)
VI  - 90
IP  - 5
DP  - 2021 Sep 1
TI  - Investigating Shared Genetic Basis Across Tourette Syndrome and Comorbid 
      Neurodevelopmental Disorders Along the Impulsivity-Compulsivity Spectrum.
PG  - 317-327
LID - S0006-3223(21)00038-X [pii]
LID - 10.1016/j.biopsych.2020.12.028 [doi]
AB  - BACKGROUND: Tourette syndrome (TS) is often found comorbid with other 
      neurodevelopmental disorders across the impulsivity-compulsivity spectrum, with 
      attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), 
      and obsessive-compulsive disorder (OCD) as most prevalent. This points to the 
      possibility of a common etiological thread along an impulsivity-compulsivity 
      continuum. METHODS: Investigating the shared genetic basis across TS, ADHD, ASD, 
      and OCD, we undertook an evaluation of cross-disorder genetic architecture and 
      systematic meta-analysis, integrating summary statistics from the latest 
      genome-wide association studies (93,294 individuals, 6,788,510 markers). RESULTS: 
      As previously identified, a common unifying factor connects TS, ADHD, and ASD, 
      while TS and OCD show the highest genetic correlation in pairwise testing among 
      these disorders. Thanks to a more homogeneous set of disorders and a targeted 
      approach that is guided by genetic correlations, we were able to identify 
      multiple novel hits and regions that seem to play a pleiotropic role for the 
      specific disorders analyzed here and could not be identified through previous 
      studies. In the TS-ADHD-ASD genome-wide association study single nucleotide 
      polymorphism-based and gene-based meta-analysis, we uncovered 13 genome-wide 
      significant regions that host single nucleotide polymorphisms with a high 
      posterior probability for association with all three studied disorders (m-value > 
      0.9), 11 of which were not identified in previous cross-disorder analysis. In 
      contrast, we also identified two additional pleiotropic regions in the TS-OCD 
      meta-analysis. Through conditional analysis, we highlighted genes and genetic 
      regions that play a specific role in a TS-ADHD-ASD genetic factor versus TS-OCD. 
      Cross-disorder tissue specificity analysis implicated the 
      hypothalamus-pituitary-adrenal gland axis in TS-ADHD-ASD. CONCLUSIONS: Our work 
      underlines the value of redefining the framework for research across traditional 
      diagnostic categories.
CI  - Published by Elsevier Inc.
FAU - Yang, Zhiyu
AU  - Yang Z
AD  - Department of Biological Sciences, Purdue University, West Lafayette, Indiana.
FAU - Wu, Hanrui
AU  - Wu H
AD  - Department of Biological Sciences, Purdue University, West Lafayette, Indiana.
FAU - Lee, Phil H
AU  - Lee PH
AD  - Psychiatric and Neurodevelopmental Genetics Unit, Department of Medicine, 
      Massachusetts General Hospital, Boston, Massachusetts; Center for Genomic 
      Medicine, Department of Medicine, Massachusetts General Hospital, Boston, 
      Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, 
      Massachusetts.
FAU - Tsetsos, Fotis
AU  - Tsetsos F
AD  - Department of Molecular Biology and Genetics, Democritus University of Thrace, 
      Alexandroupoli, Greece.
FAU - Davis, Lea K
AU  - Davis LK
AD  - Division of Genetic Medicine, Vanderbilt Genetics Institute, Vanderbilt 
      University Medical Center, Nashville, Tennessee.
FAU - Yu, Dongmei
AU  - Yu D
AD  - Psychiatric and Neurodevelopmental Genetics Unit, Department of Medicine, 
      Massachusetts General Hospital, Boston, Massachusetts; Center for Genomic 
      Medicine, Department of Medicine, Massachusetts General Hospital, Boston, 
      Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, 
      Massachusetts.
FAU - Lee, Sang Hong
AU  - Lee SH
AD  - Queensland Brain Institute, University of Queensland, Brisbane, Queensland; 
      Australian Centre for Precision Health, University of South Australia Cancer 
      Research Institute, University of South Australia, Adelaide, South Australia.
FAU - Dalsgaard, Søren
AU  - Dalsgaard S
AD  - Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, 
      Aarhus, Denmark; National Centre for Register-based Research, Aarhus University, 
      Aarhus, Denmark; Department of Child and Adolescent Psychiatry, Hospital of 
      Telemark, Kragerø, Norway.
FAU - Haavik, Jan
AU  - Haavik J
AD  - K.G. Jebsen Centre for Neuropsychiatric Disorders, Department of Biomedicine, 
      University of Bergen, Bergen, Norway; Division of Psychiatry, Haukeland 
      University Hospital, Bergen, Norway.
FAU - Barta, Csaba
AU  - Barta C
AD  - Institute of Medical Chemistry, Molecular Biology and Pathobiochemistry, 
      Semmelweis University, Budapest, Hungary.
FAU - Zayats, Tetyana
AU  - Zayats T
AD  - Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts 
      General Hospital, Boston, Massachusetts; K.G. Jebsen Centre for Neuropsychiatric 
      Disorders, Department of Biomedicine, University of Bergen, Bergen, Norway.
FAU - Eapen, Valsamma
AU  - Eapen V
AD  - Academic Unit of Child Psychiatry South West Sydney, School of Psychiatry, 
      University of New South Wales, Sydney, New South Wales, Australia.
FAU - Wray, Naomi R
AU  - Wray NR
AD  - Queensland Brain Institute, University of Queensland, Brisbane, Queensland; 
      Institute for Molecular Bioscience, University of Queensland, Brisbane, 
      Queensland.
FAU - Devlin, Bernie
AU  - Devlin B
AD  - Department of Psychiatry, University of Pittsburgh School of Medicine, 
      Pittsburgh, Pennsylvania.
FAU - Daly, Mark
AU  - Daly M
AD  - Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts 
      General Hospital, Boston, Massachusetts; Stanley Center for Psychiatric Research, 
      Broad Institute, Cambridge, Massachusetts.
FAU - Neale, Benjamin
AU  - Neale B
AD  - Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts 
      General Hospital, Boston, Massachusetts; Stanley Center for Psychiatric Research, 
      Broad Institute, Cambridge, Massachusetts; Medical and Population Genetics, Broad 
      Institute, Cambridge, Massachusetts.
FAU - Børglum, Anders D
AU  - Børglum AD
AD  - Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, 
      Aarhus, Denmark; Department of Biomedicine - Human Genetics, Aarhus University, 
      Aarhus, Denmark; Center for Integrative Sequencing (iSEQ), Aarhus University, 
      Aarhus, Denmark; Center for Genomics and Personalized Medicine, Aarhus, Denmark.
FAU - Crowley, James J
AU  - Crowley JJ
AD  - Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, 
      North Carolina; Department of Psychiatry, University of North Carolina at Chapel 
      Hill, Chapel Hill, North Carolina.
FAU - Scharf, Jeremiah
AU  - Scharf J
AD  - Psychiatric and Neurodevelopmental Genetics Unit, Department of Medicine, 
      Massachusetts General Hospital, Boston, Massachusetts; Center for Genomic 
      Medicine, Department of Medicine, Massachusetts General Hospital, Boston, 
      Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, 
      Massachusetts.
FAU - Mathews, Carol A
AU  - Mathews CA
AD  - Department of Psychiatry, University of Florida, Gainesville, Florida; Department 
      of Genetics Institute, University of Florida, Gainesville, Florida.
FAU - Faraone, Stephen V
AU  - Faraone SV
AD  - Departmentof Psychiatry, SUNY Upstate Medical University, Syracuse, New York; 
      Departmentof Neuroscience and Physiology, SUNY Upstate Medical University, 
      Syracuse, New York.
FAU - Franke, Barbara
AU  - Franke B
AD  - Department of Human Genetics, Radboud University Medical Center, Radboud 
      University, Nijmegen, The Netherlands; Department of Psychiatry, Radboud 
      University Medical Center, Radboud University, Nijmegen, The Netherlands; Donders 
      Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The 
      Netherlands.
FAU - Mattheisen, Manuel
AU  - Mattheisen M
AD  - Department of Biomedicine, Aarhus University, Aarhus, Denmark; Department of 
      Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University 
      Hospital Wuerzburg, Wuerzburg, Germany; Department of Clinical Neuroscience, 
      Centre for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden.
FAU - Smoller, Jordan W
AU  - Smoller JW
AD  - Psychiatric and Neurodevelopmental Genetics Unit, Department of Medicine, 
      Massachusetts General Hospital, Boston, Massachusetts; Center for Genomic 
      Medicine, Department of Medicine, Massachusetts General Hospital, Boston, 
      Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, 
      Massachusetts; Stanley Center for Psychiatric Research, Broad Institute, 
      Cambridge, Massachusetts.
FAU - Paschou, Peristera
AU  - Paschou P
AD  - Department of Biological Sciences, Purdue University, West Lafayette, Indiana. 
      Electronic address: ppaschou@purdue.edu.
LA  - eng
GR  - R01 NS102371/NS/NINDS NIH HHS/United States
GR  - R01 NS105746/NS/NINDS NIH HHS/United States
GR  - K02 NS085048/NS/NINDS NIH HHS/United States
GR  - U01 MH109536/MH/NIMH NIH HHS/United States
GR  - R01 MH101519/MH/NIMH NIH HHS/United States
GR  - R01 MH119243/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Meta-Analysis
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20210108
PL  - United States
TA  - Biol Psychiatry
JT  - Biological psychiatry
JID - 0213264
SB  - IM
MH  - *Attention Deficit Disorder with Hyperactivity/epidemiology/genetics
MH  - *Autism Spectrum Disorder/genetics
MH  - Comorbidity
MH  - Genome-Wide Association Study
MH  - Humans
MH  - Impulsive Behavior
MH  - *Obsessive-Compulsive Disorder/epidemiology/genetics
MH  - *Tourette Syndrome/epidemiology/genetics
PMC - PMC9152955
MID - NIHMS1661062
OTO - NOTNLM
OT  - ADHD
OT  - ASD
OT  - Cross-disorder genetic analysis
OT  - GWAS meta-analysis
OT  - OCD
OT  - Tourette syndrome
EDAT- 2021/03/15 06:00
MHDA- 2021/09/28 06:00
CRDT- 2021/03/14 20:33
PHST- 2020/03/09 00:00 [received]
PHST- 2020/12/21 00:00 [revised]
PHST- 2020/12/21 00:00 [accepted]
PHST- 2021/03/15 06:00 [pubmed]
PHST- 2021/09/28 06:00 [medline]
PHST- 2021/03/14 20:33 [entrez]
AID - S0006-3223(21)00038-X [pii]
AID - 10.1016/j.biopsych.2020.12.028 [doi]
PST - ppublish
SO  - Biol Psychiatry. 2021 Sep 1;90(5):317-327. doi: 10.1016/j.biopsych.2020.12.028. 
      Epub 2021 Jan 8.

PMID- 36010347
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220830
IS  - 2075-4418 (Print)
IS  - 2075-4418 (Electronic)
IS  - 2075-4418 (Linking)
VI  - 12
IP  - 8
DP  - 2022 Aug 18
TI  - A Computational Approach to Identification of Candidate Biomarkers in 
      High-Dimensional Molecular Data.
LID - 10.3390/diagnostics12081997 [doi]
LID - 1997
AB  - Complex high-dimensional datasets that are challenging to analyze are frequently 
      produced through '-omics' profiling. Typically, these datasets contain more 
      genomic features than samples, limiting the use of multivariable statistical and 
      machine learning-based approaches to analysis. Therefore, effective alternative 
      approaches are urgently needed to identify features-of-interest in '-omics' data. 
      In this study, we present the molecular feature selection tool, a novel, 
      ensemble-based, feature selection application for identifying candidate 
      biomarkers in '-omics' data. As proof-of-principle, we applied the molecular 
      feature selection tool to identify a small set of immune-related genes as 
      potential biomarkers of three prostate adenocarcinoma subtypes. Furthermore, we 
      tested the selected genes in a model to classify the three subtypes and compared 
      the results to models built using all genes and all differentially expressed 
      genes. Genes identified with the molecular feature selection tool performed 
      better than the other models in this study in all comparison metrics: accuracy, 
      precision, recall, and F1-score using a significantly smaller set of genes. In 
      addition, we developed a simple graphical user interface for the molecular 
      feature selection tool, which is available for free download. This user-friendly 
      interface is a valuable tool for the identification of potential biomarkers in 
      gene expression datasets and is an asset for biomarker discovery studies.
FAU - Gerolami, Justin
AU  - Gerolami J
AD  - School of Computing, Queen's University, Kingston, ON K7L 3N6, Canada.
FAU - Wong, Justin Jong Mun
AU  - Wong JJM
AUID- ORCID: 0000-0001-9931-6539
AD  - Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON 
      K7L 3N6, Canada.
FAU - Zhang, Ricky
AU  - Zhang R
AD  - School of Computing, Queen's University, Kingston, ON K7L 3N6, Canada.
FAU - Chen, Tong
AU  - Chen T
AD  - School of Computing, Queen's University, Kingston, ON K7L 3N6, Canada.
FAU - Imtiaz, Tashifa
AU  - Imtiaz T
AD  - Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON 
      K7L 3N6, Canada.
FAU - Smith, Miranda
AU  - Smith M
AD  - School of Computing, Queen's University, Kingston, ON K7L 3N6, Canada.
FAU - Jamaspishvili, Tamara
AU  - Jamaspishvili T
AD  - Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON 
      K7L 3N6, Canada.
AD  - Department of Pathology & Laboratory Medicine, SUNY Upstate Medical University, 
      Syracuse, NY 13210, USA.
FAU - Koti, Madhuri
AU  - Koti M
AD  - Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON 
      K7L 3N6, Canada.
FAU - Glasgow, Janice Irene
AU  - Glasgow JI
AD  - School of Computing, Queen's University, Kingston, ON K7L 3N6, Canada.
FAU - Mousavi, Parvin
AU  - Mousavi P
AD  - School of Computing, Queen's University, Kingston, ON K7L 3N6, Canada.
FAU - Renwick, Neil
AU  - Renwick N
AUID- ORCID: 0000-0001-6695-8236
AD  - Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON 
      K7L 3N6, Canada.
FAU - Tyryshkin, Kathrin
AU  - Tyryshkin K
AUID- ORCID: 0000-0002-7726-6654
AD  - School of Computing, Queen's University, Kingston, ON K7L 3N6, Canada.
AD  - Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON 
      K7L 3N6, Canada.
LA  - eng
GR  - 468240/Natural Sciences and Engineering Research Council/
GR  - SEAMO AHSC Innovation Fund/
PT  - Journal Article
DEP - 20220818
PL  - Switzerland
TA  - Diagnostics (Basel)
JT  - Diagnostics (Basel, Switzerland)
JID - 101658402
PMC - PMC9407361
OTO - NOTNLM
OT  - RNA-Seq
OT  - big data analysis
OT  - biomarker
OT  - feature selection
OT  - prostate adenocarcinoma
COIS- The authors declare no conflict of interest.
EDAT- 2022/08/27 06:00
MHDA- 2022/08/27 06:01
CRDT- 2022/08/26 01:10
PHST- 2022/07/05 00:00 [received]
PHST- 2022/08/16 00:00 [revised]
PHST- 2022/08/17 00:00 [accepted]
PHST- 2022/08/26 01:10 [entrez]
PHST- 2022/08/27 06:00 [pubmed]
PHST- 2022/08/27 06:01 [medline]
AID - diagnostics12081997 [pii]
AID - diagnostics-12-01997 [pii]
AID - 10.3390/diagnostics12081997 [doi]
PST - epublish
SO  - Diagnostics (Basel). 2022 Aug 18;12(8):1997. doi: 10.3390/diagnostics12081997.

PMID- 34170972
OWN - NLM
STAT- MEDLINE
DCOM- 20211116
LR  - 20220119
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 16
IP  - 6
DP  - 2021
TI  - Harnessing clinical annotations to improve deep learning performance in prostate 
      segmentation.
PG  - e0253829
LID - 10.1371/journal.pone.0253829 [doi]
LID - e0253829
AB  - PURPOSE: Developing large-scale datasets with research-quality annotations is 
      challenging due to the high cost of refining clinically generated markup into 
      high precision annotations. We evaluated the direct use of a large dataset with 
      only clinically generated annotations in development of high-performance 
      segmentation models for small research-quality challenge datasets. MATERIALS AND 
      METHODS: We used a large retrospective dataset from our institution comprised of 
      1,620 clinically generated segmentations, and two challenge datasets (PROMISE12: 
      50 patients, ProstateX-2: 99 patients). We trained a 3D U-Net convolutional 
      neural network (CNN) segmentation model using our entire dataset, and used that 
      model as a template to train models on the challenge datasets. We also trained 
      versions of the template model using ablated proportions of our dataset, and 
      evaluated the relative benefit of those templates for the final models. Finally, 
      we trained a version of the template model using an out-of-domain brain cancer 
      dataset, and evaluated the relevant benefit of that template for the final 
      models. We used five-fold cross-validation (CV) for all training and evaluation 
      across our entire dataset. RESULTS: Our model achieves state-of-the-art 
      performance on our large dataset (mean overall Dice 0.916, average Hausdorff 
      distance 0.135 across CV folds). Using this model as a pre-trained template for 
      refining on two external datasets significantly enhanced performance (30% and 49% 
      enhancement in Dice scores respectively). Mean overall Dice and mean average 
      Hausdorff distance were 0.912 and 0.15 for the ProstateX-2 dataset, and 0.852 and 
      0.581 for the PROMISE12 dataset. Using even small quantities of data to train the 
      template enhanced performance, with significant improvements using 5% or more of 
      the data. CONCLUSION: We trained a state-of-the-art model using unrefined 
      clinical prostate annotations and found that its use as a template model 
      significantly improved performance in other prostate segmentation tasks, even 
      when trained with only 5% of the original dataset.
FAU - Sarma, Karthik V
AU  - Sarma KV
AUID- ORCID: 0000-0002-7442-9526
AD  - University of California, Los Angeles, Los Angeles, CA, United States of America.
FAU - Raman, Alex G
AU  - Raman AG
AD  - University of California, Los Angeles, Los Angeles, CA, United States of America.
AD  - Western University of Health Sciences, Pomona, CA, United States of America.
FAU - Dhinagar, Nikhil J
AU  - Dhinagar NJ
AD  - University of California, Los Angeles, Los Angeles, CA, United States of America.
AD  - Keck School of Medicine, University of Southern California, Los Angeles, CA, 
      United States of America.
FAU - Priester, Alan M
AU  - Priester AM
AD  - University of California, Los Angeles, Los Angeles, CA, United States of America.
FAU - Harmon, Stephanie
AU  - Harmon S
AD  - National Cancer Institute, National Institutes of Health, Bethesda, MD, United 
      States of America.
AD  - Clinical Research Directorate, Frederick National Laboratory for Cancer Research, 
      Frederick, MD, United States of America.
FAU - Sanford, Thomas
AU  - Sanford T
AD  - National Cancer Institute, National Institutes of Health, Bethesda, MD, United 
      States of America.
AD  - SUNY Upstate Medical Center, Syracuse, NY, United States of America.
FAU - Mehralivand, Sherif
AU  - Mehralivand S
AD  - National Cancer Institute, National Institutes of Health, Bethesda, MD, United 
      States of America.
FAU - Turkbey, Baris
AU  - Turkbey B
AD  - National Cancer Institute, National Institutes of Health, Bethesda, MD, United 
      States of America.
FAU - Marks, Leonard S
AU  - Marks LS
AD  - University of California, Los Angeles, Los Angeles, CA, United States of America.
FAU - Raman, Steven S
AU  - Raman SS
AD  - University of California, Los Angeles, Los Angeles, CA, United States of America.
FAU - Speier, William
AU  - Speier W
AD  - University of California, Los Angeles, Los Angeles, CA, United States of America.
FAU - Arnold, Corey W
AU  - Arnold CW
AD  - University of California, Los Angeles, Los Angeles, CA, United States of America.
LA  - eng
GR  - R01 CA195505/CA/NCI NIH HHS/United States
GR  - R21 CA220352/CA/NCI NIH HHS/United States
GR  - T32 GM008042/GM/NIGMS NIH HHS/United States
GR  - R01 CA158627/CA/NCI NIH HHS/United States
GR  - T32 EB016640/EB/NIBIB NIH HHS/United States
GR  - F30 CA210329/CA/NCI NIH HHS/United States
GR  - HHSN261200800001C/RC/CCR NIH HHS/United States
GR  - HHSN261200800001E/CA/NCI NIH HHS/United States
GR  - P50 CA092131/CA/NCI NIH HHS/United States
GR  - P30 CA016042/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, N.I.H., Intramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20210625
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
SB  - IM
MH  - *Data Curation
MH  - *Databases, Factual
MH  - *Deep Learning
MH  - Humans
MH  - Male
MH  - Prostate/*diagnostic imaging
MH  - Retrospective Studies
MH  - *Tomography, X-Ray Computed
PMC - PMC8232529
COIS- LSM and AMP report a financial interest in Avenda Health outside the submitted 
      work. BT reports IP-related royalties from Philips outside the submitted work. 
      The NIH has cooperative research and development agreements with NVIDIA, Philips, 
      Siemens, Xact Robotics, Celsion Corp, and Boston Scientific outside the submitted 
      work. The NIH has research partnerships with Angiodynamics, ArciTrax, and Exact 
      Imaging outside the submitted work. CWA has received research equipment from 
      NVIDIA Corporation, outside the submitted work. No commercial funding or 
      equipment was used in the execution of this study. No other authors have 
      competing interests to disclose.
EDAT- 2021/06/26 06:00
MHDA- 2021/11/17 06:00
CRDT- 2021/06/25 17:20
PHST- 2021/02/24 00:00 [received]
PHST- 2021/06/13 00:00 [accepted]
PHST- 2021/06/25 17:20 [entrez]
PHST- 2021/06/26 06:00 [pubmed]
PHST- 2021/11/17 06:00 [medline]
AID - PONE-D-21-06200 [pii]
AID - 10.1371/journal.pone.0253829 [doi]
PST - epublish
SO  - PLoS One. 2021 Jun 25;16(6):e0253829. doi: 10.1371/journal.pone.0253829. 
      eCollection 2021.

PMID- 33156863
OWN - NLM
STAT- MEDLINE
DCOM- 20210125
LR  - 20231112
IS  - 1549-1676 (Electronic)
IS  - 1549-1277 (Print)
IS  - 1549-1277 (Linking)
VI  - 17
IP  - 11
DP  - 2020 Nov
TI  - Predicting suicide attempt or suicide death following a visit to psychiatric 
      specialty care: A machine learning study using Swedish national registry data.
PG  - e1003416
LID - 10.1371/journal.pmed.1003416 [doi]
LID - e1003416
AB  - BACKGROUND: Suicide is a major public health concern globally. Accurately 
      predicting suicidal behavior remains challenging. This study aimed to use machine 
      learning approaches to examine the potential of the Swedish national registry 
      data for prediction of suicidal behavior. METHODS AND FINDINGS: The study sample 
      consisted of 541,300 inpatient and outpatient visits by 126,205 Sweden-born 
      patients (54% female and 46% male) aged 18 to 39 (mean age at the visit: 27.3) 
      years to psychiatric specialty care in Sweden between January 1, 2011 and 
      December 31, 2012. The most common psychiatric diagnoses at the visit were 
      anxiety disorders (20.0%), major depressive disorder (16.9%), and substance use 
      disorders (13.6%). A total of 425 candidate predictors covering demographic 
      characteristics, socioeconomic status (SES), electronic medical records, 
      criminality, as well as family history of disease and crime were extracted from 
      the Swedish registry data. The sample was randomly split into an 80% training set 
      containing 433,024 visits and a 20% test set containing 108,276 visits. Models 
      were trained separately for suicide attempt/death within 90 and 30 days following 
      a visit using multiple machine learning algorithms. Model discrimination and 
      calibration were both evaluated. Among all eligible visits, 3.5% (18,682) were 
      followed by a suicide attempt/death within 90 days and 1.7% (9,099) within 30 
      days. The final models were based on ensemble learning that combined predictions 
      from elastic net penalized logistic regression, random forest, gradient boosting, 
      and a neural network. The area under the receiver operating characteristic (ROC) 
      curves (AUCs) on the test set were 0.88 (95% confidence interval [CI] = 
      0.87-0.89) and 0.89 (95% CI = 0.88-0.90) for the outcome within 90 days and 30 
      days, respectively, both being significantly better than chance (i.e., AUC = 
      0.50) (p < 0.01). Sensitivity, specificity, and predictive values were reported 
      at different risk thresholds. A limitation of our study is that our models have 
      not yet been externally validated, and thus, the generalizability of the models 
      to other populations remains unknown. CONCLUSIONS: By combining the ensemble 
      method of multiple machine learning algorithms and high-quality data solely from 
      the Swedish registers, we developed prognostic models to predict short-term 
      suicide attempt/death with good discrimination and calibration. Whether novel 
      predictors can improve predictive performance requires further investigation.
FAU - Chen, Qi
AU  - Chen Q
AUID- ORCID: 0000-0002-4602-4388
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
FAU - Zhang-James, Yanli
AU  - Zhang-James Y
AUID- ORCID: 0000-0002-2104-0963
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Syracuse, New York, United States of America.
FAU - Barnett, Eric J
AU  - Barnett EJ
AD  - Department of Neuroscience and Physiology, SUNY Upstate Medical University, 
      Syracuse, New York, United States of America.
AD  - College of Medicine, MD Program, SUNY Upstate Medical University, Syracuse, New 
      York, United States of America.
FAU - Lichtenstein, Paul
AU  - Lichtenstein P
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
FAU - Jokinen, Jussi
AU  - Jokinen J
AD  - Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
AD  - Department of Clinical Sciences/Psychiatry, Umeå University, Umeå, Sweden.
FAU - D'Onofrio, Brian M
AU  - D'Onofrio BM
AUID- ORCID: 0000-0002-5248-7434
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
AD  - Department of Psychological and Brain Sciences, Indiana University, Bloomington, 
      Indiana, United States of America.
FAU - Faraone, Stephen V
AU  - Faraone SV
AUID- ORCID: 0000-0002-9217-3982
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Syracuse, New York, United States of America.
AD  - Department of Neuroscience and Physiology, SUNY Upstate Medical University, 
      Syracuse, New York, United States of America.
FAU - Larsson, Henrik
AU  - Larsson H
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
AD  - School of Medical Sciences, Örebro University, Örebro, Sweden.
FAU - Fazel, Seena
AU  - Fazel S
AUID- ORCID: 0000-0002-5383-5365
AD  - Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, 
      United Kingdom.
LA  - eng
GR  - 202836/Z/16/Z/WT_/Wellcome Trust/United Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20201106
PL  - United States
TA  - PLoS Med
JT  - PLoS medicine
JID - 101231360
SB  - IM
MH  - Adult
MH  - Depressive Disorder, Major/diagnosis/*psychology
MH  - Female
MH  - Humans
MH  - *Machine Learning
MH  - Male
MH  - *Predictive Value of Tests
MH  - Registries
MH  - Risk Assessment/statistics & numerical data
MH  - Risk Factors
MH  - Suicidal Ideation
MH  - Suicide, Attempted/*psychology
MH  - Sweden
MH  - Young Adult
PMC - PMC7647056
COIS- I have read the journal's policy and the authors of this manuscript have the 
      following competing interests: JJ participated in an Advisory Board for Janssen. 
      In the past year, SVF received income, potential income, travel expenses 
      continuing education support and/or research support from Vallon, Tris, Otsuka, 
      Arbor, Ironshore, Shire, Akili Interactive Labs, VAYA, Ironshore, Sunovion, 
      Supernus and Genomind. With his institution, he has US patent US20130217707 A1 
      for the use of sodium-hydrogen exchange inhibitors in the treatment of ADHD. HL 
      has served as a speaker for Evolan Pharma and Shire/Takeda and has received 
      research grants from Shire/Takeda; all outside the submitted work.
EDAT- 2020/11/07 06:00
MHDA- 2021/01/26 06:00
CRDT- 2020/11/06 17:35
PHST- 2020/01/10 00:00 [received]
PHST- 2020/10/08 00:00 [accepted]
PHST- 2020/11/06 17:35 [entrez]
PHST- 2020/11/07 06:00 [pubmed]
PHST- 2021/01/26 06:00 [medline]
AID - PMEDICINE-D-20-00084 [pii]
AID - 10.1371/journal.pmed.1003416 [doi]
PST - epublish
SO  - PLoS Med. 2020 Nov 6;17(11):e1003416. doi: 10.1371/journal.pmed.1003416. 
      eCollection 2020 Nov.

PMID- 38000670
OWN - NLM
STAT- Publisher
LR  - 20231215
IS  - 1878-8769 (Electronic)
IS  - 1878-8750 (Linking)
DP  - 2023 Nov 23
TI  - Development and Internal Validation of Machine Learning Models to Predict 
      Mortality and Disability After Mechanical Thrombectomy for Acute Anterior 
      Circulation Large Vessel Occlusion.
LID - S1878-8750(23)01622-4 [pii]
LID - 10.1016/j.wneu.2023.11.060 [doi]
AB  - OBJECTIVE: Mechanical thrombectomy (MT) improves outcomes in patients with LVO 
      but many still experience mortality or severe disability. We sought to develop 
      machine learning (ML) models that predict 90-day outcomes after MT for LVO. 
      METHODS: Consecutive patients who underwent MT for LVO between 2015-2021 at a 
      Comprehensive Stroke Center were reviewed. Outcomes included 90-day favorable 
      functional status (mRS 0-2), severe disability (mRS 4-6), and mortality. ML 
      models were trained for each outcome using prethrombectomy data (pre) and with 
      thrombectomy data (post). RESULTS: Three hundred and fifty seven patients met the 
      inclusion criteria. After model screening and hyperparameter tuning the top 
      performing ML model for each outcome and timepoint was random forest (RF). Using 
      only prethrombectomy features, the AUCs for the RF(pre) models were 0.73 (95% CI 
      0.62-0.85) for favorable functional status, 0.77 (95% CI 0.65-0.86) for severe 
      disability, and 0.78 (95% CI 0.64-0.88) for mortality. All of these were better 
      than a standard statistical model except for favorable functional status. Each RF 
      model outperformed Pre, SPAN-100, THRIVE, and HIAT scores (P < 0.0001 for all). 
      The most predictive features were premorbid mRS, age, and NIHSS. Incorporating MT 
      data, the AUCs for the RF(post) models were 0.80 (95% CI 0.67-0.90) for favorable 
      functional status, 0.82 (95% CI 0.69-0.91) for severe disability, and 0.71 (95% 
      CI 0.55-0.84) for mortality. CONCLUSIONS: RF models accurately predicted 90-day 
      outcomes after MT and performed better than standard statistical and clinical 
      prediction models.
CI  - Copyright © 2023 Elsevier Inc. All rights reserved.
FAU - Hoffman, Haydn
AU  - Hoffman H
AD  - Department of Neurosurgery, State University of New York Upstate Medical 
      University, Syracuse, New York, USA. Electronic address: 
      hhoffman@semmes-murphey.com.
FAU - Wood, Jacob
AU  - Wood J
AD  - Department of Neurosurgery, State University of New York Upstate Medical 
      University, Syracuse, New York, USA.
FAU - Cote, John R
AU  - Cote JR
AD  - Department of Neurosurgery, State University of New York Upstate Medical 
      University, Syracuse, New York, USA.
FAU - Jalal, Muhammad S
AU  - Jalal MS
AD  - Department of Neurosurgery, State University of New York Upstate Medical 
      University, Syracuse, New York, USA.
FAU - Otite, Fadar O
AU  - Otite FO
AD  - Department of Neurology, State University of New York Upstate Medical University, 
      Syracuse, New York, USA.
FAU - Masoud, Hesham E
AU  - Masoud HE
AD  - Department of Neurology, State University of New York Upstate Medical University, 
      Syracuse, New York, USA.
FAU - Gould, Grahame C
AU  - Gould GC
AD  - Department of Neurosurgery, State University of New York Upstate Medical 
      University, Syracuse, New York, USA.
LA  - eng
PT  - Journal Article
DEP - 20231123
PL  - United States
TA  - World Neurosurg
JT  - World neurosurgery
JID - 101528275
SB  - IM
OTO - NOTNLM
OT  - Large vessel occlusion
OT  - Machine learning
OT  - Mechanical thrombectomy
OT  - Outcome prediction
EDAT- 2023/11/25 07:42
MHDA- 2023/11/25 07:42
CRDT- 2023/11/24 19:29
PHST- 2023/08/12 00:00 [received]
PHST- 2023/11/14 00:00 [revised]
PHST- 2023/11/15 00:00 [accepted]
PHST- 2023/11/25 07:42 [pubmed]
PHST- 2023/11/25 07:42 [medline]
PHST- 2023/11/24 19:29 [entrez]
AID - S1878-8750(23)01622-4 [pii]
AID - 10.1016/j.wneu.2023.11.060 [doi]
PST - aheadofprint
SO  - World Neurosurg. 2023 Nov 23:S1878-8750(23)01622-4. doi: 
      10.1016/j.wneu.2023.11.060.

PMID- 37228488
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230528
IS  - 2234-943X (Print)
IS  - 2234-943X (Electronic)
IS  - 2234-943X (Linking)
VI  - 13
DP  - 2023
TI  - Liquid biopsies and minimal residual disease in lymphoid malignancies.
PG  - 1173701
LID - 10.3389/fonc.2023.1173701 [doi]
LID - 1173701
AB  - Minimal residual disease (MRD) assessment using peripheral blood instead of bone 
      marrow aspirate/biopsy specimen or the biopsy of the cancerous infiltrated by 
      lymphoid malignancies is an emerging technique with enormous interest of research 
      and technological innovation at the current time. In some lymphoid malignancies 
      (particularly ALL), Studies have shown that MRD monitoring of the peripheral 
      blood may be an adequate alternative to frequent BM aspirations. However, 
      additional studies investigating the biology of liquid biopsies in ALL and its 
      potential as an MRD marker in larger patient cohorts in treatment protocols are 
      warranted. Despite the promising data, there are still limitations in liquid 
      biopsies in lymphoid malignancies, such as standardization of the sample 
      collection and processing, determination of timing and duration for liquid biopsy 
      analysis, and definition of the biological characteristics and specificity of the 
      techniques evaluated such as flow cytometry, molecular techniques, and next 
      generation sequencies. The use of liquid biopsy for detection of minimal residual 
      disease in T-cell lymphoma is still experimental but it has made significant 
      progress in multiple myeloma for example. Recent attempt to use artificial 
      intelligence may help simplify the algorithm for testing and may help avoid 
      inter-observer variation and operator dependency in these highly technically 
      demanding testing process.
CI  - Copyright © 2023 Bou Zerdan, Kassab, Saba, Haroun, Bou Zerdan, Allam, Nasr, 
      Macaron, Mammadli, Abou Moussa and Chaulagain.
FAU - Bou Zerdan, Maroun
AU  - Bou Zerdan M
AD  - Department of Internal Medicine, State University of New York (SUNY) Upstate 
      Medical University, Syracuse, NY, United States.
FAU - Kassab, Joseph
AU  - Kassab J
AD  - Cleveland Clinic, Research Institute, Cleveland, OH, United States.
FAU - Saba, Ludovic
AU  - Saba L
AD  - Department of Hematology-Oncology, Myeloma and Amyloidosis Program, Maroone 
      Cancer Center, Cleveland Clinic Florida, Weston, FL, United States.
FAU - Haroun, Elio
AU  - Haroun E
AD  - Department of Medicine, State University of New York (SUNY) Upstate Medical 
      University, New York, NY, United States.
FAU - Bou Zerdan, Morgan
AU  - Bou Zerdan M
AD  - Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
FAU - Allam, Sabine
AU  - Allam S
AD  - Department of Medicine and Medical Sciences, University of Balamand, Balamand, 
      Lebanon.
FAU - Nasr, Lewis
AU  - Nasr L
AD  - University of Texas MD Anderson Cancer Center, Texas, TX, United States.
FAU - Macaron, Walid
AU  - Macaron W
AD  - University of Texas MD Anderson Cancer Center, Texas, TX, United States.
FAU - Mammadli, Mahinbanu
AU  - Mammadli M
AD  - Department of Internal Medicine, State University of New York (SUNY) Upstate 
      Medical University, Syracuse, NY, United States.
FAU - Abou Moussa, Sarah
AU  - Abou Moussa S
AD  - Faculty of Medicine, Université Paris-Saclay, Paris, France.
FAU - Chaulagain, Chakra P
AU  - Chaulagain CP
AD  - Department of Hematology-Oncology, Myeloma and Amyloidosis Program, Maroone 
      Cancer Center, Cleveland Clinic Florida, Weston, FL, United States.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20230509
PL  - Switzerland
TA  - Front Oncol
JT  - Frontiers in oncology
JID - 101568867
PMC - PMC10203459
OTO - NOTNLM
OT  - liquid biopsy
OT  - lymphoid malignancies
OT  - minimal residual disease
OT  - multiple myeloma
OT  - oncology
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2023/05/25 19:12
MHDA- 2023/05/25 19:13
CRDT- 2023/05/25 14:09
PHST- 2023/02/25 00:00 [received]
PHST- 2023/04/21 00:00 [accepted]
PHST- 2023/05/25 19:13 [medline]
PHST- 2023/05/25 19:12 [pubmed]
PHST- 2023/05/25 14:09 [entrez]
AID - 10.3389/fonc.2023.1173701 [doi]
PST - epublish
SO  - Front Oncol. 2023 May 9;13:1173701. doi: 10.3389/fonc.2023.1173701. eCollection 
      2023.

PMID- 37562456
OWN - NLM
STAT- MEDLINE
DCOM- 20230821
LR  - 20230907
IS  - 1098-9021 (Electronic)
IS  - 0271-8235 (Linking)
VI  - 43
IP  - 3
DP  - 2023 Jun
TI  - Robotic Interventional Neuroradiology: Progress, Challenges, and Future 
      Prospects.
PG  - 432-438
LID - 10.1055/s-0043-1771298 [doi]
AB  - Advances in robotic technology have improved standard techniques in numerous 
      surgical and endovascular specialties, offering more precision, control, and 
      better patient outcomes. Robotic-assisted interventional neuroradiology is an 
      emerging field at the intersection of interventional neuroradiology and 
      biomedical robotics. Endovascular robotics can automate maneuvers to reduce 
      procedure times and increase its safety, reduce occupational hazards associated 
      with ionizing radiations, and expand networks of care to reduce gaps in 
      geographic access to neurointerventions. To date, many robotic 
      neurointerventional procedures have been successfully performed, including 
      cerebral angiography, intracranial aneurysm embolization, carotid stenting, and 
      epistaxis embolization. This review aims to provide a survey of the state of the 
      art in robotic-assisted interventional neuroradiology, consider their technical 
      and adoption limitations, and explore future developments critical for the 
      widespread adoption of robotic-assisted neurointerventions.
CI  - Thieme. All rights reserved.
FAU - Ning, Shen
AU  - Ning S
AD  - Department of Radiology, Boston Medical Center, Boston, Massachusetts.
AD  - Department of Radiology, Boston University Chobanian and Avedisian School of 
      Medicine, Boston, Massachusetts.
FAU - Chautems, Christophe
AU  - Chautems C
AD  - Nanoflex Robotics, AG, Zurich, Switzerland.
FAU - Kim, Yoonho
AU  - Kim Y
AD  - Department of Mechanical Engineering, Massachusetts Institute of Technology, 
      Cambridge, Massachusetts.
FAU - Rice, Hal
AU  - Rice H
AD  - Neurointerventional Section, Gold Coast University Hospital, Queensland, 
      Australia.
FAU - Hanning, Uta
AU  - Hanning U
AD  - Klinik und Poliklinik für Interventionelle Neuroradiologie, Universitätsklinikum 
      Hamburg-Eppendorf, Hamburg, Germany.
FAU - Al Kasab, Sami
AU  - Al Kasab S
AD  - Department of Neurology, Medical University of South Carolina, Charleston, South 
      Carolina.
FAU - Meyer, Lukas
AU  - Meyer L
AD  - Klinik und Poliklinik für Interventionelle Neuroradiologie, Universitätsklinikum 
      Hamburg-Eppendorf, Hamburg, Germany.
FAU - Psychogios, Marios
AU  - Psychogios M
AD  - Department of Radiology, Basel University Hospital, University of Basel, 
      Switzerland.
FAU - Zaidat, Osama O
AU  - Zaidat OO
AD  - Department of Neurology, Mercy Vincent Hospital, Toledo, Ohio.
FAU - Hassan, Ameer E
AU  - Hassan AE
AD  - Department of Neurology, Valley Baptist Medical Center, University of Texas Rio 
      Grande Valley, Harlingen, Texas.
FAU - Masoud, Hesham E
AU  - Masoud HE
AD  - Division of Cerebrovascular, Department of Neurology, Upstate University 
      Hospital, Syracuse, New York.
FAU - Mujanovic, Adnan
AU  - Mujanovic A
AD  - Institute of Diagnostic and Interventional Neuroradiology, Institute of 
      Diagnostic, Interventional and Pediatric Radiology and Department of Neurology, 
      Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
FAU - Kaesmacher, Johannes
AU  - Kaesmacher J
AD  - Institute of Diagnostic and Interventional Neuroradiology, Institute of 
      Diagnostic, Interventional and Pediatric Radiology and Department of Neurology, 
      Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
FAU - Dhillon, Permesh S
AU  - Dhillon PS
AD  - Interventional Neuroradiology, University of Nottingham, Nottingham, United 
      Kingdom.
FAU - Ma, Alice
AU  - Ma A
AD  - Department of Neurosurgery, Royal North Shore Hospital, St Leonards, New South 
      Wales, Australia.
FAU - Kaliaev, Artem
AU  - Kaliaev A
AD  - Department of Radiology, Boston Medical Center, Boston, Massachusetts.
FAU - Nguyen, Thanh N
AU  - Nguyen TN
AD  - Department of Radiology, Boston Medical Center, Boston, Massachusetts.
AD  - Department of Neurology, Boston Medical Center, Boston, Massachusetts.
FAU - Abdalkader, Mohamad
AU  - Abdalkader M
AD  - Department of Radiology, Boston Medical Center, Boston, Massachusetts.
LA  - eng
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Review
DEP - 20230810
PL  - United States
TA  - Semin Neurol
JT  - Seminars in neurology
JID - 8111343
SB  - IM
MH  - Humans
MH  - *Robotics
MH  - *Intracranial Aneurysm/diagnostic imaging/surgery
MH  - *Endovascular Procedures/methods
COIS- S.N. is a founder of INIA Biosciences: none related to this topic; grant support 
      from National Institute of Neurological Disorders and Stroke. T.N.N.: research 
      support from Medtronic, Society of Vascular and Interventional Neurology. C.C. is 
      a founder of Nanoflex Robotics AG. S.A.K: grant support from Stryker 
      Neurovascular. No relevant disclosures for the remainder of the authors.
EDAT- 2023/08/11 00:42
MHDA- 2023/08/21 06:42
CRDT- 2023/08/10 19:13
PHST- 2023/08/21 06:42 [medline]
PHST- 2023/08/11 00:42 [pubmed]
PHST- 2023/08/10 19:13 [entrez]
AID - 10.1055/s-0043-1771298 [doi]
PST - ppublish
SO  - Semin Neurol. 2023 Jun;43(3):432-438. doi: 10.1055/s-0043-1771298. Epub 2023 Aug 
      10.

PMID- 27022133
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20181113
IS  - 1535-3699 (Electronic)
IS  - 1535-3702 (Print)
IS  - 1535-3699 (Linking)
VI  - 241
IP  - 7
DP  - 2016 Apr
TI  - Minireview: Multiomic candidate biomarkers for clinical manifestations of sickle 
      cell severity: Early steps to precision medicine.
PG  - 772-81
LID - 10.1177/1535370216640150 [doi]
AB  - In this review, we provide a description of those candidate biomarkers which have 
      been demonstrated by multiple-omics approaches to vary in correlation with 
      specific clinical manifestations of sickle cell severity. We believe that future 
      clinical analyses of severity phenotype will require a multiomic analysis, or an 
      omics stack approach, which includes integrated interactomics. It will also 
      require the analysis of big data sets. These candidate biomarkers, whether they 
      are individual or panels of functionally linked markers, will require future 
      validation in large prospective and retrospective clinical studies. Once 
      validated, the hope is that informative biomarkers will be used for the 
      identification of individuals most likely to experience severe complications, and 
      thereby be applied for the design of patient-specific therapeutic approaches and 
      response to treatment. This would be the beginning of precision medicine for 
      sickle cell disease.
CI  - © 2016 by the Society for Experimental Biology and Medicine.
FAU - Goodman, Steven R
AU  - Goodman SR
AD  - Department of Pediatrics and Department of Physiology, The University of 
      Tennessee Health Science Center, Memphis, TN 38163, USA sgoodma5@uthsc.edu.
FAU - Pace, Betty S
AU  - Pace BS
AD  - Department of Pediatrics, Augusta University, Augusta, GA 30912, USA.
FAU - Hansen, Kirk C
AU  - Hansen KC
AD  - Biochemistry and Molecular Genetics, University of Colorado Denver, Aurora, CO 
      80202, USA.
FAU - D'alessandro, Angelo
AU  - D'alessandro A
AD  - Biochemistry and Molecular Genetics, University of Colorado Denver, Aurora, CO 
      80202, USA.
FAU - Xia, Yang
AU  - Xia Y
AD  - Biochemistry and Molecular Biology Department, University of Texas at Houston, TX 
      77030, USA.
FAU - Daescu, Ovidiu
AU  - Daescu O
AD  - University of Texas at Dallas, Richardson, TX 75080, USA.
FAU - Glatt, Stephen J
AU  - Glatt SJ
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Syracuse, NY 13210, USA.
LA  - eng
GR  - P01 HL114457/HL/NHLBI NIH HHS/United States
GR  - R01 HL113574/HL/NHLBI NIH HHS/United States
PT  - Journal Article
PT  - Review
DEP - 20160327
PL  - England
TA  - Exp Biol Med (Maywood)
JT  - Experimental biology and medicine (Maywood, N.J.)
JID - 100973463
RN  - 0 (Biomarkers)
RN  - 0 (Genetic Markers)
RN  - 0 (MicroRNAs)
RN  - 9034-63-3 (Fetal Hemoglobin)
SB  - IM
MH  - Anemia, Sickle Cell/*diagnosis/genetics
MH  - Biomarkers/blood
MH  - Fetal Hemoglobin/analysis
MH  - Gene Expression Profiling
MH  - Genetic Markers
MH  - Humans
MH  - Metabolomics
MH  - MicroRNAs/genetics
MH  - Precision Medicine/*methods
MH  - Proteomics
MH  - Severity of Illness Index
PMC - PMC4950385
OTO - NOTNLM
OT  - Genomics
OT  - interactomics
OT  - metabolomics
OT  - precision medicine
OT  - proteomics
OT  - sickle cell disease
EDAT- 2016/03/30 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/03/30 06:00
PHST- 2016/03/30 06:00 [entrez]
PHST- 2016/03/30 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - 1535370216640150 [pii]
AID - 10.1177_1535370216640150 [pii]
AID - 10.1177/1535370216640150 [doi]
PST - ppublish
SO  - Exp Biol Med (Maywood). 2016 Apr;241(7):772-81. doi: 10.1177/1535370216640150. 
      Epub 2016 Mar 27.

PMID- 30473705
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20201001
IS  - 1664-8021 (Print)
IS  - 1664-8021 (Electronic)
IS  - 1664-8021 (Linking)
VI  - 9
DP  - 2018
TI  - Validation of a Salivary RNA Test for Childhood Autism Spectrum Disorder.
PG  - 534
LID - 10.3389/fgene.2018.00534 [doi]
LID - 534
AB  - Background: The diagnosis of autism spectrum disorder (ASD) relies on behavioral 
      assessment. Efforts to define biomarkers of ASD have not resulted in an 
      objective, reliable test. Studies of RNA levels in ASD have demonstrated 
      potential utility, but have been limited by a focus on single RNA types, small 
      sample sizes, and lack of developmental delay controls. We hypothesized that a 
      saliva-based poly-"omic" RNA panel could objectively distinguish children with 
      ASD from their neurotypical peers and children with non-ASD developmental delay. 
      Methods: This multi-center cross-sectional study included 456 children, ages 
      19-83 months. Children were either neurotypical (n = 134) or had a diagnosis of 
      ASD (n = 238), or non-ASD developmental delay (n = 84). Comprehensive human and 
      microbial RNA abundance was measured in the saliva of all participants using 
      unbiased next generation sequencing. Prior to analysis, the sample was randomly 
      divided into a training set (82% of subjects) and an independent validation test 
      set (18% of subjects). The training set was used to develop an RNA-based 
      algorithm that distinguished ASD and non-ASD children. The validation set was not 
      used in model development (feature selection or training) but served only to 
      validate empirical accuracy. Results: In the training set (n = 372; mean age 51 
      months; 75% male; 51% ASD), a set of 32 RNA features (controlled for demographic 
      and medical characteristics), identified ASD status with a cross-validated area 
      under the curve (AUC) of 0.87 (95% CI: 0.86-0.88). In the completely separate 
      validation test set (n = 84; mean age 50 months; 85% male; 60% ASD), the 
      algorithm maintained an AUC of 0.88 (82% sensitivity and 88% specificity). 
      Notably, the RNA features were implicated in physiologic processes related to ASD 
      (axon guidance, neurotrophic signaling). Conclusion: Salivary poly-omic RNA 
      measurement represents a novel, non-invasive approach that can accurately 
      identify children with ASD. This technology could improve the specificity of 
      referrals for ASD evaluation or provide objective support for ASD diagnoses.
FAU - Hicks, Steven D
AU  - Hicks SD
AD  - Department of Pediatrics, Penn State College of Medicine, Hershey, PA, United 
      States.
FAU - Rajan, Alexander T
AU  - Rajan AT
AD  - Quadrant Biosciences, Inc., Syracuse, NY, United States.
FAU - Wagner, Kayla E
AU  - Wagner KE
AD  - Quadrant Biosciences, Inc., Syracuse, NY, United States.
AD  - Departments of Neuroscience and Physiology, State University of New York Upstate 
      Medical University, Syracuse, NY, United States.
AD  - Departments of Psychiatry, Biochemistry and Molecular Biology, State University 
      of New York Upstate Medical University, Syracuse, NY, United States.
AD  - Department of Pediatrics, State University of New York Upstate Medical 
      University, Syracuse, NY, United States.
FAU - Barns, Sarah
AU  - Barns S
AD  - Quadrant Biosciences, Inc., Syracuse, NY, United States.
AD  - Departments of Neuroscience and Physiology, State University of New York Upstate 
      Medical University, Syracuse, NY, United States.
AD  - Departments of Psychiatry, Biochemistry and Molecular Biology, State University 
      of New York Upstate Medical University, Syracuse, NY, United States.
AD  - Department of Pediatrics, State University of New York Upstate Medical 
      University, Syracuse, NY, United States.
FAU - Carpenter, Randall L
AU  - Carpenter RL
AD  - Quadrant Biosciences, Inc., Syracuse, NY, United States.
FAU - Middleton, Frank A
AU  - Middleton FA
AD  - Departments of Neuroscience and Physiology, State University of New York Upstate 
      Medical University, Syracuse, NY, United States.
AD  - Departments of Psychiatry, Biochemistry and Molecular Biology, State University 
      of New York Upstate Medical University, Syracuse, NY, United States.
AD  - Department of Pediatrics, State University of New York Upstate Medical 
      University, Syracuse, NY, United States.
LA  - eng
GR  - KL2 TR002015/TR/NCATS NIH HHS/United States
GR  - R41 MH111347/MH/NIMH NIH HHS/United States
GR  - R42 MH111347/MH/NIMH NIH HHS/United States
GR  - UL1 TR002014/TR/NCATS NIH HHS/United States
PT  - Journal Article
DEP - 20181109
PL  - Switzerland
TA  - Front Genet
JT  - Frontiers in genetics
JID - 101560621
PMC - PMC6237842
OTO - NOTNLM
OT  - RNA
OT  - autism
OT  - diagnosis
OT  - epigenetics
OT  - machine learning
OT  - microRNA
OT  - screening
OT  - transcriptome
EDAT- 2018/11/27 06:00
MHDA- 2018/11/27 06:01
CRDT- 2018/11/27 06:00
PHST- 2018/08/22 00:00 [received]
PHST- 2018/10/22 00:00 [accepted]
PHST- 2018/11/27 06:00 [entrez]
PHST- 2018/11/27 06:00 [pubmed]
PHST- 2018/11/27 06:01 [medline]
AID - 10.3389/fgene.2018.00534 [doi]
PST - epublish
SO  - Front Genet. 2018 Nov 9;9:534. doi: 10.3389/fgene.2018.00534. eCollection 2018.

PMID- 35590853
OWN - NLM
STAT- MEDLINE
DCOM- 20220523
LR  - 20220716
IS  - 1424-8220 (Electronic)
IS  - 1424-8220 (Linking)
VI  - 22
IP  - 9
DP  - 2022 Apr 20
TI  - Identifying Individuals Who Currently Report Feelings of Anxiety Using Walking 
      Gait and Quiet Balance: An Exploratory Study Using Machine Learning.
LID - 10.3390/s22093163 [doi]
LID - 3163
AB  - Literature suggests that anxiety affects gait and balance among young adults. 
      However, previous studies using machine learning (ML) have only used gait to 
      identify individuals who report feeling anxious. Therefore, the purpose of this 
      study was to identify individuals who report feeling anxious at that time using a 
      combination of gait and quiet balance ML. Using a cross-sectional design, 
      participants (n = 88) completed the Profile of Mood Survey-Short Form (POMS-SF) 
      to measure current feelings of anxiety and were then asked to complete a modified 
      Clinical Test for Sensory Interaction in Balance (mCTSIB) and a two-minute walk 
      around a 6 m track while wearing nine APDM mobility sensors. Results from our 
      study finds that Random Forest classifiers had the highest median accuracy rate 
      (75%) and the five top features for identifying anxious individuals were all gait 
      parameters (turn angles, variance in neck, lumbar rotation, lumbar movement in 
      the sagittal plane, and arm movement). Post-hoc analyses suggest that individuals 
      who reported feeling anxious also walked using gait patterns most similar to 
      older individuals who are fearful of falling. Additionally, we find that 
      individuals who are anxious also had less postural stability when they had visual 
      input; however, these individuals had less movement during postural sway when 
      visual input was removed.
FAU - Stark, Maggie
AU  - Stark M
AD  - Department of Medicine, Lake Erie Osteopathic College of Medicine, Elmira, NY 
      14901, USA.
FAU - Huang, Haikun
AU  - Huang H
AD  - Department of Computer Science, George Mason University, Fairfax, VA 22030, USA.
FAU - Yu, Lap-Fai
AU  - Yu LF
AD  - Department of Computer Science, George Mason University, Fairfax, VA 22030, USA.
FAU - Martin, Rebecca
AU  - Martin R
AD  - Department of Physical Therapy, Hanover College, Hanover, IN 47243, USA.
FAU - McCarthy, Ryan
AU  - McCarthy R
AD  - Department of Biology, Clarkson University, Potsdam, NY 13699, USA.
AD  - Department of Psychology, Clarkson University, Potsdam, NY 13699, USA.
FAU - Locke, Emily
AU  - Locke E
AUID- ORCID: 0000-0001-5452-9928
AD  - Department of Chemistry and Biomolecular Science, Clarkson University, Potsdam, 
      NY 13699, USA.
FAU - Yager, Chelsea
AU  - Yager C
AD  - Department of Neurology, St. Joseph's Hospital Health Center, Syracuse, NY 13203, 
      USA.
FAU - Torad, Ahmed Ali
AU  - Torad AA
AUID- ORCID: 0000-0003-4170-6694
AD  - Department of Physical Therapy, Clarkson University, Potsdam, NY 13699, USA.
AD  - Faculty of Physical Therapy, Kafrelsheik University, Kafr El Sheik 33516, Egypt.
FAU - Kadry, Ahmed Mahmoud
AU  - Kadry AM
AUID- ORCID: 0000-0002-5009-4514
AD  - Department of Physical Therapy, Clarkson University, Potsdam, NY 13699, USA.
AD  - Faculty of Physical Therapy, Kafrelsheik University, Kafr El Sheik 33516, Egypt.
FAU - Elwan, Mostafa Ali
AU  - Elwan MA
AD  - Department of Physical Therapy, Clarkson University, Potsdam, NY 13699, USA.
AD  - Faculty of Physical Therapy, Beni-Suef University, Beni-Suef 62521, Egypt.
FAU - Smith, Matthew Lee
AU  - Smith ML
AUID- ORCID: 0000-0002-8232-9285
AD  - Department of Environmental and Occupational Health, School of Public Health, 
      Texas A&M University, College Station, TX 77843, USA.
FAU - Bradley, Dylan
AU  - Bradley D
AUID- ORCID: 0000-0003-1042-3624
AD  - Canino School of Engineering Technology, State University of New York, Canton, NY 
      13617, USA.
FAU - Boolani, Ali
AU  - Boolani A
AUID- ORCID: 0000-0002-2261-4498
AD  - Department of Biology, Clarkson University, Potsdam, NY 13699, USA.
AD  - Department of Physical Therapy, Clarkson University, Potsdam, NY 13699, USA.
LA  - eng
PT  - Journal Article
DEP - 20220420
PL  - Switzerland
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
JID - 101204366
SB  - IM
MH  - *Anxiety
MH  - Cross-Sectional Studies
MH  - Fear
MH  - *Gait
MH  - Humans
MH  - Machine Learning
MH  - *Postural Balance
MH  - Walking
MH  - Young Adult
PMC - PMC9105708
OTO - NOTNLM
OT  - APDM monitors
OT  - anxiety
OT  - balance
OT  - gait
OT  - mCTSIB
OT  - machine learning
OT  - sensors
COIS- The authors declare no conflict of interest.
EDAT- 2022/05/21 06:00
MHDA- 2022/05/24 06:00
CRDT- 2022/05/20 01:09
PHST- 2022/01/12 00:00 [received]
PHST- 2022/04/06 00:00 [revised]
PHST- 2022/04/18 00:00 [accepted]
PHST- 2022/05/20 01:09 [entrez]
PHST- 2022/05/21 06:00 [pubmed]
PHST- 2022/05/24 06:00 [medline]
AID - s22093163 [pii]
AID - sensors-22-03163 [pii]
AID - 10.3390/s22093163 [doi]
PST - epublish
SO  - Sensors (Basel). 2022 Apr 20;22(9):3163. doi: 10.3390/s22093163.

PMID- 37684322
OWN - NLM
STAT- Publisher
LR  - 20230908
IS  - 1476-5578 (Electronic)
IS  - 1359-4184 (Linking)
DP  - 2023 Sep 8
TI  - Incidence, prevalence, and global burden of ADHD from 1990 to 2019 across 204 
      countries: data, with critical re-analysis, from the Global Burden of Disease 
      study.
LID - 10.1038/s41380-023-02228-3 [doi]
AB  - Data on incidence, prevalence and burden of ADHD are crucial for clinicians, 
      patients, and stakeholders. We present the incidence, prevalence, and burden of 
      ADHD globally and across countries from 1990 to 2019 from the Global Burden of 
      Disease (GBD) study. We also: (1) calculated the ADHD prevalence based on data 
      actually collected as opposed to the prevalence estimated by the GBD with data 
      imputation for countries without prevalence data; (2) discussed the GBD estimated 
      ADHD burden in the light of recent meta-analytic evidence on ADHD-related 
      mortality. In 2019, GBD estimated global age-standardized incidence and 
      prevalence of ADHD across the lifespan at 0.061% (95%UI = 0.040-0.087) and 1.13% 
      (95%UI = 0.831-1.494), respectively. ADHD accounted for 0.8% of the global mental 
      disorder DALYs, with mortality set at zero by the GBD. From 1990 to 2019 there 
      was a decrease of -8.75% in the global age-standardized prevalence and of -4.77% 
      in the global age-standardized incidence. The largest increase in incidence, 
      prevalence, and burden from 1990 to 2019 was observed in the USA; the largest 
      decrease occurred in Finland. Incidence, prevalence, and DALYs remained 
      approximately 2.5 times higher in males than females from 1990 to 2019. Incidence 
      peaked at age 5-9 years, and prevalence and DALYs at age 10-14 years. Our 
      re-analysis of data prior to 2013 showed a prevalence in children/adolescents 
      two-fold higher (5.41%, 95% CI: 4.67-6.15%) compared to the corresponding GBD 
      estimated prevalence (2.68%, 1.83-3.72%), with no significant differences between 
      low- and middle- and high-income countries. We also found meta-analytic evidence 
      of significantly increased ADHD-related mortality due to unnatural causes. While 
      it provides the most detailed evidence on temporal trends, as well as on 
      geographic and sex variations in incidence, prevalence, and burden of ADHD, the 
      GBD may have underestimated the ADHD prevalence and burden. Given the influence 
      of the GBD on research and policies, methodological issues should be addressed in 
      its future editions.
CI  - © 2023. The Author(s), under exclusive licence to Springer Nature Limited.
FAU - Cortese, Samuele
AU  - Cortese S
AD  - Centre for Innovation in Mental Health, School of Psychology, Faculty of 
      Environmental and Life Sciences, University of Southampton, Southampton, UK. 
      samuele.cortese@soton.ac.uk.
AD  - Clinical and Experimental Sciences (CNS and Psychiatry), Faculty of Medicine, 
      University of Southampton, Southampton, UK. samuele.cortese@soton.ac.uk.
AD  - Solent NHS Trust, Southampton, UK. samuele.cortese@soton.ac.uk.
AD  - Hassenfeld Children's Hospital at NYU Langone, New York University Child Study 
      Center, New York City, NY, USA. samuele.cortese@soton.ac.uk.
AD  - Division of Psychiatry and Applied Psychology, School of Medicine, University of 
      Nottingham, Nottingham, UK. samuele.cortese@soton.ac.uk.
FAU - Song, Minjin
AU  - Song M
AD  - Yonsei University College of Medicine, Seoul, South Korea.
FAU - Farhat, Luis C
AU  - Farhat LC
AUID- ORCID: 0000-0002-3147-8344
AD  - Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
FAU - Yon, Dong Keon
AU  - Yon DK
AUID- ORCID: 0000-0003-1628-9948
AD  - Center for Digital Health, Medical Science Research Institute, Kyung Hee 
      University Medical Center, Kyung Hee University College of Medicine, Seoul, South 
      Korea.
FAU - Lee, Seung Won
AU  - Lee SW
AUID- ORCID: 0000-0001-5632-5208
AD  - Department of Precision Medicine, Sungkyunkwan University School of Medicine, 
      Suwon, South Korea.
FAU - Kim, Min Seo
AU  - Kim MS
AD  - Department of digital health, Samsung Advanced Institute for Health Sciences & 
      Technology (SAIHST), Sungkyunkwan University, Samsung Medical Center, Seoul, 
      Republic of Korea.
FAU - Park, Seoyeon
AU  - Park S
AD  - Yonsei University College of Medicine, Seoul, South Korea.
FAU - Oh, Jae Won
AU  - Oh JW
AUID- ORCID: 0000-0002-5379-9907
AD  - Department of Psychiatry, Yongin Severance Hospital, Yonsei University College of 
      Medicine, Seoul, Republic of Korea.
FAU - Lee, San
AU  - Lee S
AD  - Department of Psychiatry, Yongin Severance Hospital, Yonsei University College of 
      Medicine, Seoul, Republic of Korea.
AD  - Department of Psychiatry and Institute of Behavioral Science in Medicine, Yonsei 
      University College of Medicine, Seoul, Republic of Korea.
FAU - Cheon, Keun-Ah
AU  - Cheon KA
AUID- ORCID: 0000-0001-7113-9286
AD  - Division of Child and Adolescent Psychiatry, Department of Psychiatry, Severance 
      Hospital, Institute of Behavioral Science in Medicine, Yonsei University College 
      of Medicine, Seoul, Korea.
FAU - Smith, Lee
AU  - Smith L
AD  - Centre for Health, Performance, and Wellbeing, Anglia Ruskin University, 
      Cambridge, UK.
FAU - Gosling, Corentin J
AU  - Gosling CJ
AD  - Centre for Innovation in Mental Health, School of Psychology, Faculty of 
      Environmental and Life Sciences, University of Southampton, Southampton, UK.
AD  - DysCo Lab, Department of Psychology, Université Paris Nanterre, Nanterre, France.
AD  - Laboratoire de Psychopathologie et Processus de Santé, Université de Paris, 
      Boulogne-Billancourt, France.
FAU - Polanczyk, Guilherme V
AU  - Polanczyk GV
AUID- ORCID: 0000-0003-2311-3289
AD  - Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
FAU - Larsson, Henrik
AU  - Larsson H
AUID- ORCID: 0000-0002-6851-3297
AD  - School of Medical Sciences, Örebro University, Faculty of Medicine and Health, 
      Örebro, Sweden.
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
FAU - Rohde, Luis A
AU  - Rohde LA
AUID- ORCID: 0000-0002-4552-4188
AD  - ADHD Outpatient Program & Developmental Psychiatry Program, Hospital de Clinica 
      de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
AD  - UNIEDUK, National Institute of Developmental Psychiatry, São Paulo, Brazil.
FAU - Faraone, Stephen V
AU  - Faraone SV
AD  - Department of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical 
      University, Syracuse, NY, USA.
FAU - Koyanagi, Ai
AU  - Koyanagi A
AD  - Research and Development Unit, Parc Sanitari Sant Joan de Déu, CIBERSAM, ISCIII, 
      Barcelona, Spain.
AD  - ICREA, Pg. Lluis Companys, Barcelona, Spain.
FAU - Dragioti, Elena
AU  - Dragioti E
AUID- ORCID: 0000-0001-9019-4125
AD  - Pain and Rehabilitation Centre, and Department of Medical and Health Sciences, 
      Linköping University, Linköping, Sweden.
AD  - Research Laboratory Psychology of Patients, Families and Health Professionals, 
      Department of Nursing, School of Health Sciences, University of Ioannina, 
      Ioannina, Greece.
FAU - Radua, Joaquim
AU  - Radua J
AD  - Institut d'Investigacions Biomediques August Pi i Sunyer, CIBERSAM, Instituto de 
      Salud Carlos III, University of Barcelona, Barcelona, Spain.
FAU - Carvalho, Andre F
AU  - Carvalho AF
AUID- ORCID: 0000-0002-2500-5671
AD  - IMPACT (Innovation in Mental and Physical Health and Clinical Treatment) 
      Strategic Research Centre, School of Medicine, Barwon Health, Deakin University, 
      Geelong, Australia.
FAU - Il Shin, Jae
AU  - Il Shin J
AUID- ORCID: 0000-0003-2326-1820
AD  - Department of Pediatrics, Yonsei University College of Medicine, Seoul, Republic 
      of Korea. shinji@yuhs.ac.
AD  - Severance Underwood Meta-research Center, Institute of Convergence Science, 
      Yonsei University, Seoul, Republic of Korea. shinji@yuhs.ac.
FAU - Solmi, Marco
AU  - Solmi M
AUID- ORCID: 0000-0003-4877-7233
AD  - Centre for Innovation in Mental Health, School of Psychology, Faculty of 
      Environmental and Life Sciences, University of Southampton, Southampton, UK.
AD  - Department of Psychiatry, University of Ottawa, Ottawa, ON, Canada.
AD  - Department of Mental Health, The Ottawa Hospital, Ottawa, ON, Canada.
AD  - School of Epidemiology and Public Health, Faculty of Medicine, University of 
      Ottawa, Ottawa, ON, Canada.
AD  - Ottawa Hospital Research Institute (OHRI), Clinical Epidemiology Program, 
      University of Ottawa, Ottawa, ON, Canada.
AD  - Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, 
      Berlin, Germany.
LA  - eng
PT  - Journal Article
DEP - 20230908
PL  - England
TA  - Mol Psychiatry
JT  - Molecular psychiatry
JID - 9607835
SB  - IM
EDAT- 2023/09/09 10:41
MHDA- 2023/09/09 10:41
CRDT- 2023/09/08 23:24
PHST- 2023/04/02 00:00 [received]
PHST- 2023/08/09 00:00 [accepted]
PHST- 2023/08/02 00:00 [revised]
PHST- 2023/09/09 10:41 [medline]
PHST- 2023/09/09 10:41 [pubmed]
PHST- 2023/09/08 23:24 [entrez]
AID - 10.1038/s41380-023-02228-3 [pii]
AID - 10.1038/s41380-023-02228-3 [doi]
PST - aheadofprint
SO  - Mol Psychiatry. 2023 Sep 8. doi: 10.1038/s41380-023-02228-3.

PMID- 32229555
OWN - NLM
STAT- MEDLINE
DCOM- 20200731
LR  - 20231103
IS  - 1091-6490 (Electronic)
IS  - 0027-8424 (Print)
IS  - 0027-8424 (Linking)
VI  - 117
IP  - 15
DP  - 2020 Apr 14
TI  - Measuring the predictability of life outcomes with a scientific mass 
      collaboration.
PG  - 8398-8403
LID - 10.1073/pnas.1915006117 [doi]
AB  - How predictable are life trajectories? We investigated this question with a 
      scientific mass collaboration using the common task method; 160 teams built 
      predictive models for six life outcomes using data from the Fragile Families and 
      Child Wellbeing Study, a high-quality birth cohort study. Despite using a rich 
      dataset and applying machine-learning methods optimized for prediction, the best 
      predictions were not very accurate and were only slightly better than those from 
      a simple benchmark model. Within each outcome, prediction error was strongly 
      associated with the family being predicted and weakly associated with the 
      technique used to generate the prediction. Overall, these results suggest 
      practical limits to the predictability of life outcomes in some settings and 
      illustrate the value of mass collaborations in the social sciences.
CI  - Copyright © 2020 the Author(s). Published by PNAS.
FAU - Salganik, Matthew J
AU  - Salganik MJ
AD  - Department of Sociology, Princeton University, Princeton, NJ 08544; 
      mjs3@princeton.edu mclanaha@princeton.edu.
FAU - Lundberg, Ian
AU  - Lundberg I
AUID- ORCID: 0000-0002-1909-2270
AD  - Department of Sociology, Princeton University, Princeton, NJ 08544.
FAU - Kindel, Alexander T
AU  - Kindel AT
AD  - Department of Sociology, Princeton University, Princeton, NJ 08544.
FAU - Ahearn, Caitlin E
AU  - Ahearn CE
AD  - Department of Sociology, University of California, Los Angeles, CA 90095.
FAU - Al-Ghoneim, Khaled
AU  - Al-Ghoneim K
AD  - Hawaz, Riyadh 12363, Saudi Arabia.
FAU - Almaatouq, Abdullah
AU  - Almaatouq A
AUID- ORCID: 0000-0002-8467-9123
AD  - Sloan School of Management, Massachusetts Institute of Technology, Cambridge, MA 
      02142.
AD  - Media Lab, Massachusetts Institute of Technology, Cambridge, MA 02139.
FAU - Altschul, Drew M
AU  - Altschul DM
AUID- ORCID: 0000-0001-7053-4209
AD  - Mental Health Data Science Scotland, Department of Psychology, The University of 
      Edinburgh, Edinburgh EH8 9JZ, United Kingdom.
FAU - Brand, Jennie E
AU  - Brand JE
AD  - Department of Sociology, University of California, Los Angeles, CA 90095.
AD  - Department of Statistics, University of California, Los Angeles, CA 90095.
FAU - Carnegie, Nicole Bohme
AU  - Carnegie NB
AUID- ORCID: 0000-0001-7664-6682
AD  - Department of Mathematical Sciences, Montana State University, Bozeman, MT 59717.
FAU - Compton, Ryan James
AU  - Compton RJ
AD  - Human Computer Interaction Lab, University of California, Santa Cruz, CA 95064.
FAU - Datta, Debanjan
AU  - Datta D
AD  - Discovery Analytics Center, Virginia Polytechnic Institute and State University, 
      Arlington, VA 22203.
FAU - Davidson, Thomas
AU  - Davidson T
AD  - Department of Sociology, Cornell University, Ithaca, NY 14853.
FAU - Filippova, Anna
AU  - Filippova A
AD  - GitHub, San Francisco, CA 94107.
FAU - Gilroy, Connor
AU  - Gilroy C
AD  - Department of Sociology, University of Washington, Seattle, WA 98105.
FAU - Goode, Brian J
AU  - Goode BJ
AD  - Social and Decision Analytics Laboratory, Fralin Life Sciences Institute, 
      Virginia Polytechnic Institute and State University, Arlington, VA 22203.
FAU - Jahani, Eaman
AU  - Jahani E
AD  - Institute for Data, Systems and Society, Massachusetts Institute of Technology, 
      Cambridge, MA 02139.
FAU - Kashyap, Ridhi
AU  - Kashyap R
AUID- ORCID: 0000-0003-0615-2868
AD  - Department of Sociology, University of Oxford, Oxford OX1 1JD, United Kingdom.
AD  - Nuffield College, University of Oxford, Oxford OX1 1NF, United Kingdom.
AD  - School of Anthropology and Museum Ethnography, University of Oxford, Oxford OX2 
      6PE, United Kingdom.
FAU - Kirchner, Antje
AU  - Kirchner A
AD  - Program for Research in Survey Methodology, Survey Research Division, RTI 
      International, Research Triangle Park, NC 27709.
FAU - McKay, Stephen
AU  - McKay S
AUID- ORCID: 0000-0002-5080-8417
AD  - School of Social and Political Sciences, University of Lincoln, Brayford Pool, 
      Lincoln LN6 7TS, United Kingdom.
FAU - Morgan, Allison C
AU  - Morgan AC
AUID- ORCID: 0000-0003-2926-2162
AD  - Department of Computer Science, University of Colorado, Boulder, CO 80309.
FAU - Pentland, Alex
AU  - Pentland A
AD  - Media Lab, Massachusetts Institute of Technology, Cambridge, MA 02139.
FAU - Polimis, Kivan
AU  - Polimis K
AD  - Center for the Study of Demography and Ecology, University of Washington, 
      Seattle, WA 98105.
FAU - Raes, Louis
AU  - Raes L
AUID- ORCID: 0000-0003-2640-7493
AD  - Department of Economics, Tilburg School of Economics and Management, Tilburg 
      University, 5037 AB Tilburg, The Netherlands.
FAU - Rigobon, Daniel E
AU  - Rigobon DE
AD  - Department of Operations Research and Financial Engineering, Princeton 
      University, Princeton, NJ 08544.
FAU - Roberts, Claudia V
AU  - Roberts CV
AD  - Department of Computer Science, Princeton University, Princeton, NJ 08544.
FAU - Stanescu, Diana M
AU  - Stanescu DM
AD  - Department of Politics, Princeton University,Princeton, NJ, 08544.
FAU - Suhara, Yoshihiko
AU  - Suhara Y
AD  - Media Lab, Massachusetts Institute of Technology, Cambridge, MA 02139.
FAU - Usmani, Adaner
AU  - Usmani A
AD  - Department of Sociology, Harvard University, Cambridge, MA 02138.
FAU - Wang, Erik H
AU  - Wang EH
AD  - Department of Politics, Princeton University,Princeton, NJ, 08544.
FAU - Adem, Muna
AU  - Adem M
AD  - Department of Sociology, Indiana University, Bloomington, IN 47405.
FAU - Alhajri, Abdulla
AU  - Alhajri A
AD  - Department of Nuclear Science and Engineering, Massachusetts Institute of 
      Technology, Cambridge, MA 02139.
FAU - AlShebli, Bedoor
AU  - AlShebli B
AD  - Computational Social Science Lab, Social Science Division, New York University 
      Abu Dhabi, 129188 Abu Dhabi, United Arab Emirates.
FAU - Amin, Redwane
AU  - Amin R
AD  - Bendheim Center for Finance, Princeton University, Princeton, NJ 08544.
FAU - Amos, Ryan B
AU  - Amos RB
AD  - Department of Computer Science, Princeton University, Princeton, NJ 08544.
FAU - Argyle, Lisa P
AU  - Argyle LP
AUID- ORCID: 0000-0003-3109-2537
AD  - Department of Political Science, Brigham Young University, Provo, UT 84602.
FAU - Baer-Bositis, Livia
AU  - Baer-Bositis L
AD  - Department of Sociology, Stanford University, Stanford, CA 94305.
FAU - Büchi, Moritz
AU  - Büchi M
AUID- ORCID: 0000-0002-9202-889X
AD  - Department of Communication and Media Research, University of Zurich, Zurich, 
      Switzerland, ZH-8050.
FAU - Chung, Bo-Ryehn
AU  - Chung BR
AD  - Center for Statistics & Machine Learning, Princeton University, Princeton, NJ 
      08544.
FAU - Eggert, William
AU  - Eggert W
AD  - Department of Mechanical and Aerospace Engineering, Princeton University, 
      Princeton, NJ 08544.
FAU - Faletto, Gregory
AU  - Faletto G
AD  - Statistics Group, Department of Data Sciences and Operations, Marshall School of 
      Business, University of Southern California, Los Angeles, CA 90089.
FAU - Fan, Zhilin
AU  - Fan Z
AD  - Department of Statistics, Columbia University, New York, NY 10027.
FAU - Freese, Jeremy
AU  - Freese J
AD  - Department of Sociology, Stanford University, Stanford, CA 94305.
FAU - Gadgil, Tejomay
AU  - Gadgil T
AD  - Center for Data Science, New York University, New York, NY 10011.
FAU - Gagné, Josh
AU  - Gagné J
AD  - Department of Sociology, Stanford University, Stanford, CA 94305.
FAU - Gao, Yue
AU  - Gao Y
AD  - Department of Industrial Engineering and Operations Research, Columbia 
      University, New York, NY 10027.
FAU - Halpern-Manners, Andrew
AU  - Halpern-Manners A
AD  - Department of Sociology, Indiana University, Bloomington, IN 47405.
FAU - Hashim, Sonia P
AU  - Hashim SP
AD  - Department of Computer Science, Princeton University, Princeton, NJ 08544.
FAU - Hausen, Sonia
AU  - Hausen S
AD  - Department of Sociology, Stanford University, Stanford, CA 94305.
FAU - He, Guanhua
AU  - He G
AD  - Department of Molecular Biology, Princeton University, Princeton, NJ 08544.
FAU - Higuera, Kimberly
AU  - Higuera K
AD  - Department of Sociology, Stanford University, Stanford, CA 94305.
FAU - Hogan, Bernie
AU  - Hogan B
AD  - Oxford Internet Institute, University of Oxford, Oxford OX1 3JS, United Kingdom.
FAU - Horwitz, Ilana M
AU  - Horwitz IM
AD  - Graduate School of Education, Stanford University, Stanford, CA, 94305.
FAU - Hummel, Lisa M
AU  - Hummel LM
AD  - Department of Sociology, Stanford University, Stanford, CA 94305.
FAU - Jain, Naman
AU  - Jain N
AD  - Department of Operations Research and Financial Engineering, Princeton 
      University, Princeton, NJ 08544.
FAU - Jin, Kun
AU  - Jin K
AUID- ORCID: 0000-0002-0118-1021
AD  - Department of Computer Science, Ohio State University, Columbus, OH 43210.
FAU - Jurgens, David
AU  - Jurgens D
AD  - School of Information, University of Michigan, Ann Arbor, MI 48104.
FAU - Kaminski, Patrick
AU  - Kaminski P
AD  - Department of Sociology, Indiana University, Bloomington, IN 47405.
AD  - Center for Complex Networks and Systems Research, Indiana University, 
      Bloomington, IN 47405.
FAU - Karapetyan, Areg
AU  - Karapetyan A
AD  - Department of Computer Science, Masdar Institute, Khalifa University, 127788 Abu 
      Dhabi, United Arab Emirates.
AD  - Research Institute for Mathematical Sciences, Kyoto University, Kyoto 606-8502, 
      Japan.
FAU - Kim, E H
AU  - Kim EH
AD  - Department of Sociology, Stanford University, Stanford, CA 94305.
FAU - Leizman, Ben
AU  - Leizman B
AD  - Department of Computer Science, Princeton University, Princeton, NJ 08544.
FAU - Liu, Naijia
AU  - Liu N
AD  - Department of Politics, Princeton University,Princeton, NJ, 08544.
FAU - Möser, Malte
AU  - Möser M
AD  - Department of Computer Science, Princeton University, Princeton, NJ 08544.
FAU - Mack, Andrew E
AU  - Mack AE
AD  - Department of Politics, Princeton University,Princeton, NJ, 08544.
FAU - Mahajan, Mayank
AU  - Mahajan M
AD  - Department of Computer Science, Princeton University, Princeton, NJ 08544.
FAU - Mandell, Noah
AU  - Mandell N
AD  - Department of Astrophysical Sciences, Princeton University, Princeton, NJ 08544.
FAU - Marahrens, Helge
AU  - Marahrens H
AD  - Department of Sociology, Indiana University, Bloomington, IN 47405.
FAU - Mercado-Garcia, Diana
AU  - Mercado-Garcia D
AD  - Graduate School of Education, Stanford University, Stanford, CA, 94305.
FAU - Mocz, Viola
AU  - Mocz V
AD  - Department of Neuroscience, Princeton University, Princeton, NJ 08544.
FAU - Mueller-Gastell, Katariina
AU  - Mueller-Gastell K
AD  - Department of Sociology, Stanford University, Stanford, CA 94305.
FAU - Musse, Ahmed
AU  - Musse A
AD  - Department of Electrical Engineering, Princeton University, Princeton, NJ, 08544.
FAU - Niu, Qiankun
AU  - Niu Q
AD  - Bendheim Center for Finance, Princeton University, Princeton, NJ 08544.
FAU - Nowak, William
AU  - Nowak W
AD  - Dataiku, New York, NY 10010.
FAU - Omidvar, Hamidreza
AU  - Omidvar H
AD  - Department of Civil and Environmental Engineering, Princeton University, 
      Princeton, NJ 08544.
FAU - Or, Andrew
AU  - Or A
AD  - Department of Computer Science, Princeton University, Princeton, NJ 08544.
FAU - Ouyang, Karen
AU  - Ouyang K
AD  - Department of Computer Science, Princeton University, Princeton, NJ 08544.
FAU - Pinto, Katy M
AU  - Pinto KM
AD  - Department of Sociology, California State University, Dominguez Hills, Carson, CA 
      90747.
FAU - Porter, Ethan
AU  - Porter E
AD  - School of Media and Public Affairs, George Washington University, Washington, DC 
      20052.
FAU - Porter, Kristin E
AU  - Porter KE
AD  - Center for Data Insights, MDRC, Oakland, CA 94612.
FAU - Qian, Crystal
AU  - Qian C
AD  - Department of Computer Science, Princeton University, Princeton, NJ 08544.
FAU - Rauf, Tamkinat
AU  - Rauf T
AD  - Department of Sociology, Stanford University, Stanford, CA 94305.
FAU - Sargsyan, Anahit
AU  - Sargsyan A
AD  - Social Science Division, New York University Abu Dhabi, 129188 Abu Dhabi, United 
      Arab Emirates.
FAU - Schaffner, Thomas
AU  - Schaffner T
AD  - Department of Computer Science, Princeton University, Princeton, NJ 08544.
FAU - Schnabel, Landon
AU  - Schnabel L
AD  - Department of Sociology, Stanford University, Stanford, CA 94305.
FAU - Schonfeld, Bryan
AU  - Schonfeld B
AD  - Department of Politics, Princeton University,Princeton, NJ, 08544.
FAU - Sender, Ben
AU  - Sender B
AD  - Department of Economics, Princeton University, Princeton, NJ 08544.
FAU - Tang, Jonathan D
AU  - Tang JD
AD  - Department of Computer Science, Princeton University, Princeton, NJ 08544.
FAU - Tsurkov, Emma
AU  - Tsurkov E
AD  - Department of Sociology, Stanford University, Stanford, CA 94305.
FAU - van Loon, Austin
AU  - van Loon A
AD  - Department of Sociology, Stanford University, Stanford, CA 94305.
FAU - Varol, Onur
AU  - Varol O
AUID- ORCID: 0000-0002-3994-6106
AD  - Center for Complex Network Research, Northeastern University Networks Science 
      Institute, Boston, MA 02115.
AD  - Luddy School of Informatics, Computing, & Engineering, Indiana University, 
      Bloomington, IN 47408.
FAU - Wang, Xiafei
AU  - Wang X
AD  - School of Social Work, David B. Falk College of Sport and Human Dynamics, 
      Syracuse University, NY 13244.
FAU - Wang, Zhi
AU  - Wang Z
AD  - Luddy School of Informatics, Computing, & Engineering, Indiana University, 
      Bloomington, IN 47408.
AD  - School of Public Health, Indiana University, Bloomington, IN 47408.
FAU - Wang, Julia
AU  - Wang J
AD  - Department of Computer Science, Princeton University, Princeton, NJ 08544.
FAU - Wang, Flora
AU  - Wang F
AD  - Department of Economics, Princeton University, Princeton, NJ 08544.
FAU - Weissman, Samantha
AU  - Weissman S
AD  - Department of Computer Science, Princeton University, Princeton, NJ 08544.
FAU - Whitaker, Kirstie
AU  - Whitaker K
AD  - The Alan Turing Institute, London NW1 2DB, United Kingdom.
AD  - Department of Psychiatry, University of Cambridge, Cambridge CB2 0SZ, United 
      Kingdom.
FAU - Wolters, Maria K
AU  - Wolters MK
AD  - School of Informatics, University of Edinburgh, Edinburgh EH8 9AB, United 
      Kingdom.
FAU - Woon, Wei Lee
AU  - Woon WL
AD  - Department of Marketplaces & Yield Data Science, Expedia Group, Seattle, WA 
      98119.
FAU - Wu, James
AU  - Wu J
AD  - Department of the Applied Statistics, Social Science, and Humanities, New York 
      University, New York, NY 10003.
FAU - Wu, Catherine
AU  - Wu C
AD  - Department of Computer Science, Princeton University, Princeton, NJ 08544.
FAU - Yang, Kengran
AU  - Yang K
AD  - Department of Civil and Environmental Engineering, Princeton University, 
      Princeton, NJ 08544.
FAU - Yin, Jingwen
AU  - Yin J
AD  - Department of Statistics, Columbia University, New York, NY 10027.
FAU - Zhao, Bingyu
AU  - Zhao B
AD  - Department of Engineering, University of Cambridge, Cambridge CB2 1PZ, United 
      Kingdom.
FAU - Zhu, Chenyun
AU  - Zhu C
AD  - Department of Statistics, Columbia University, New York, NY 10027.
FAU - Brooks-Gunn, Jeanne
AU  - Brooks-Gunn J
AD  - Department of Human Development, Teachers College, Columbia University, New York, 
      NY 10027.
AD  - Department of Pediatrics, Vagelos College of Physicians and Surgeons, Columbia 
      University, New York, NY 10032.
FAU - Engelhardt, Barbara E
AU  - Engelhardt BE
AD  - Department of Computer Science, Princeton University, Princeton, NJ 08544.
AD  - Center for Statistics & Machine Learning, Princeton University, Princeton, NJ 
      08544.
FAU - Hardt, Moritz
AU  - Hardt M
AD  - Department of Electrical Engineering and Computer Sciences, University of 
      California, Berkeley, CA 94720.
FAU - Knox, Dean
AU  - Knox D
AD  - Department of Politics, Princeton University,Princeton, NJ, 08544.
FAU - Levy, Karen
AU  - Levy K
AD  - Department of Information Science, Cornell University, Ithaca, NY 14853.
FAU - Narayanan, Arvind
AU  - Narayanan A
AD  - Department of Computer Science, Princeton University, Princeton, NJ 08544.
FAU - Stewart, Brandon M
AU  - Stewart BM
AD  - Department of Sociology, Princeton University, Princeton, NJ 08544.
FAU - Watts, Duncan J
AU  - Watts DJ
AUID- ORCID: 0000-0001-5005-4961
AD  - Department of Computer and Information Science, University of Pennsylvania, 
      Philadelphia, PA 19104.
AD  - Annenberg School of Communication, University of Pennsylvania, Philadelphia, PA 
      19104.
AD  - Operations, Information and Decisions Department, University of Pennsylvania, 
      Philadelphia, PA 19104.
FAU - McLanahan, Sara
AU  - McLanahan S
AD  - Department of Sociology, Princeton University, Princeton, NJ 08544; 
      mjs3@princeton.edu mclanaha@princeton.edu.
LA  - eng
GR  - R01 HD039135/HD/NICHD NIH HHS/United States
GR  - P2C HD042828/HD/NICHD NIH HHS/United States
GR  - R24 HD047879/HD/NICHD NIH HHS/United States
GR  - T32 HD007545/HD/NICHD NIH HHS/United States
GR  - P2C HD047879/HD/NICHD NIH HHS/United States
GR  - R01 HD036916/HD/NICHD NIH HHS/United States
GR  - R01 HL133218/HL/NHLBI NIH HHS/United States
GR  - MC_PC_17209/MRC_/Medical Research Council/United Kingdom
GR  - P2C HD041022/HD/NICHD NIH HHS/United States
GR  - R01 HD040421/HD/NICHD NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20200330
PL  - United States
TA  - Proc Natl Acad Sci U S A
JT  - Proceedings of the National Academy of Sciences of the United States of America
JID - 7505876
SB  - IM
CIN - Proc Natl Acad Sci U S A. 2020 Apr 14;117(15):8234-8235. PMID: 32238558
EIN - Proc Natl Acad Sci U S A. 2021 Dec 14;118(50):. PMID: 34857664
MH  - Adolescent
MH  - Child
MH  - Child, Preschool
MH  - Cohort Studies
MH  - Family
MH  - Female
MH  - Humans
MH  - Infant
MH  - Life
MH  - Machine Learning
MH  - Male
MH  - Predictive Value of Tests
MH  - Social Sciences/methods/*standards/statistics & numerical data
PMC - PMC7165437
OTO - NOTNLM
OT  - life course
OT  - machine learning
OT  - mass collaboration
OT  - prediction
COIS- Competing interest statement: B.E.E. is on the scientific advisory boards of 
      Celsius Therapeutics and Freenome, is currently employed by Genomics plc and 
      Freenome, and is on a year leave-of-absence from Princeton University.
EDAT- 2020/04/02 06:00
MHDA- 2020/08/01 06:00
CRDT- 2020/04/02 06:00
PHST- 2020/04/02 06:00 [pubmed]
PHST- 2020/08/01 06:00 [medline]
PHST- 2020/04/02 06:00 [entrez]
AID - 1915006117 [pii]
AID - 201915006 [pii]
AID - 10.1073/pnas.1915006117 [doi]
PST - ppublish
SO  - Proc Natl Acad Sci U S A. 2020 Apr 14;117(15):8398-8403. doi: 
      10.1073/pnas.1915006117. Epub 2020 Mar 30.

PMID- 33587137
OWN - NLM
STAT- MEDLINE
DCOM- 20210412
LR  - 20210412
IS  - 2574-3805 (Electronic)
IS  - 2574-3805 (Linking)
VI  - 4
IP  - 2
DP  - 2021 Feb 1
TI  - Validation of a Machine Learning Brain Electrical Activity-Based Index to Aid in 
      Diagnosing Concussion Among Athletes.
PG  - e2037349
LID - 10.1001/jamanetworkopen.2020.37349 [doi]
LID - e2037349
AB  - IMPORTANCE: An objective, reliable indicator of the presence and severity of 
      concussive brain injury and of the readiness for the return to activity has the 
      potential to reduce concussion-related disability. OBJECTIVE: To validate the 
      classification accuracy of a previously derived, machine learning, multimodal, 
      brain electrical activity-based Concussion Index in an independent cohort of 
      athletes with concussion. DESIGN, SETTING, AND PARTICIPANTS: This prospective 
      diagnostic cohort study was conducted at 10 clinical sites (ie, US universities 
      and high schools) between February 4, 2017, and March 20, 2019. A cohort 
      comprising a consecutive sample of 207 athletes aged 13 to 25 years with 
      concussion and 373 matched athlete controls without concussion were assessed with 
      electroencephalography, cognitive testing, and symptom inventories within 72 
      hours of injury, at return to play, and 45 days after return to play. Variables 
      from the multimodal assessment were used to generate a Concussion Index at each 
      time point. Athletes with concussion had experienced a witnessed head impact, 
      were removed from play for 5 days or more, and had an initial Glasgow Coma Scale 
      score of 13 to 15. Participants were excluded for known neurologic disease or 
      history within the last year of traumatic brain injury. Athlete controls were 
      matched to athletes with concussion for age, sex, and type of sport played. MAIN 
      OUTCOMES AND MEASURES: Classification accuracy of the Concussion Index at time of 
      injury using a prespecified cutoff of 70 or less (total range, 0-100, where ≤70 
      indicates it is likely the individual has a concussion and >70 indicates it is 
      likely the individual does not have a concussion). RESULTS: Of 580 eligible 
      participants with analyzable data, 207 had concussion (124 male participants 
      [59.9%]; mean [SD] age, 19.4 [2.5] years), and 373 were athlete controls (187 
      male participants [50.1%]; mean [SD] age, 19.6 [2.2] years). The Concussion Index 
      had a sensitivity of 86.0% (95% CI, 80.5%-90.4%), specificity of 70.8% (95% CI, 
      65.9%-75.4%), negative predictive value of 90.1% (95% CI, 86.1%-93.3%), positive 
      predictive value of 62.0% (95% CI, 56.1%-67.7%), and area under receiver operator 
      characteristic curve of 0.89. At day 0, the mean (SD) Concussion Index among 
      athletes with concussion was significantly lower than among athletes without 
      concussion (75.0 [14.0] vs 32.7 [27.2]; P < .001). Among athletes with 
      concussion, there was a significant increase in the Concussion Index between day 
      0 and return to play, with a mean (SD) paired difference between these time 
      points of -41.2 (27.0) (P < .001). CONCLUSIONS AND RELEVANCE: These results 
      suggest that the multimodal brain activity-based Concussion Index has high 
      classification accuracy for identification of the likelihood of concussion at 
      time of injury and may be associated with the return to control values at the 
      time of recovery. The Concussion Index has the potential to aid in the clinical 
      diagnosis of concussion and in the assessment of athletes' readiness to return to 
      play.
FAU - Bazarian, Jeffrey J
AU  - Bazarian JJ
AD  - Department of Emergency Medicine, University of Rochester School of Medicine, 
      Rochester, New York.
FAU - Elbin, Robert J
AU  - Elbin RJ
AD  - Office for Sports Concussion Research, University of Arkansas, Fayetteville.
FAU - Casa, Douglas J
AU  - Casa DJ
AD  - Korey Stringer Institute, University of Connecticut, Storrs.
FAU - Hotz, Gillian A
AU  - Hotz GA
AD  - UHealth Concussion Program, University of Miami, Miami, Florida.
FAU - Neville, Christopher
AU  - Neville C
AD  - Department of Physical Therapy Education, SUNY Upstate Medical University, 
      Syracuse, New York.
FAU - Lopez, Rebecca M
AU  - Lopez RM
AD  - Morsani College of Medicine, Orthopedics and Sports Medicine, University of South 
      Florida, Tampa.
FAU - Schnyer, David M
AU  - Schnyer DM
AD  - Department of Psychology, University of Texas at Austin, Austin.
FAU - Yeargin, Susan
AU  - Yeargin S
AD  - Arnold School of Public Health, University of South Carolina, Columbia.
FAU - Covassin, Tracey
AU  - Covassin T
AD  - Department of Kinesiology, Michigan State University, East Lansing.
LA  - eng
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Validation Study
DEP - 20210201
PL  - United States
TA  - JAMA Netw Open
JT  - JAMA network open
JID - 101729235
SB  - IM
MH  - Adolescent
MH  - *Athletes
MH  - Athletic Injuries/*diagnosis/physiopathology
MH  - Brain/*physiopathology
MH  - Brain Concussion/*diagnosis/physiopathology
MH  - Case-Control Studies
MH  - *Electroencephalography
MH  - Female
MH  - Glasgow Coma Scale
MH  - Humans
MH  - *Machine Learning
MH  - Male
MH  - Mental Status and Dementia Tests
MH  - Prospective Studies
MH  - Reproducibility of Results
MH  - Return to Sport
MH  - Schools
MH  - Universities
MH  - Young Adult
PMC - PMC7885039
COIS- Conflict of Interest Disclosures: All authors were principal investigators at one 
      of the clinical data acquisition sites participating in the research, whose 
      institutions received contracts to support participant recruitment, consenting, 
      and data acquisition and have no competing financial interests to disclaim. Drs 
      Bazarian, Casa, Lopez, Schnyer, Yeargin, and Covassin reported receiving grants 
      from BrainScope Co Inc during the conduct of the study. Dr Bazarian reported 
      receiving personal fees from Abbott and Q30 Innovations outside the submitted 
      work. Dr Elbin reported receiving grants and consulting fees from BrainScope Co 
      Inc during the conduct of the study. Dr Neville reported being an equity owner of 
      Quadrant Biosciences Inc outside the submitted work. No other disclosures were 
      reported.
EDAT- 2021/02/16 06:00
MHDA- 2021/04/13 06:00
CRDT- 2021/02/15 12:11
PHST- 2021/02/15 12:11 [entrez]
PHST- 2021/02/16 06:00 [pubmed]
PHST- 2021/04/13 06:00 [medline]
AID - 2776443 [pii]
AID - zoi201117 [pii]
AID - 10.1001/jamanetworkopen.2020.37349 [doi]
PST - epublish
SO  - JAMA Netw Open. 2021 Feb 1;4(2):e2037349. doi: 
      10.1001/jamanetworkopen.2020.37349.

PMID- 35124239
OWN - NLM
STAT- MEDLINE
DCOM- 20220405
LR  - 20220620
IS  - 1943-7811 (Electronic)
IS  - 1525-1578 (Print)
IS  - 1525-1578 (Linking)
VI  - 24
IP  - 4
DP  - 2022 Apr
TI  - Development and Validation of Two RT-qPCR Diagnostic Assays for Detecting Severe 
      Acute Respiratory Syndrome Coronavirus 2 Genomic Targets across Two Specimen 
      Types.
PG  - 294-308
LID - S1525-1578(22)00018-6 [pii]
LID - 10.1016/j.jmoldx.2021.12.010 [doi]
AB  - Following the outbreak and subsequent pandemic of coronavirus disease 2019 
      (COVID-19), clinical diagnostic laboratories worldwide sought accurate and 
      reliable testing methodologies. However, many laboratories were and still are 
      hindered by a number of factors, including an unprecedented demand for testing, 
      reagent and laboratory supply shortages and availability of qualified staff. To 
      respond to these concerns, two separate laboratory-developed tests were validated 
      for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
      using two different specimen types. In addition, these assays target different 
      genomic regions of SARS-CoV-2, allowing for viral detection and mitigating 
      genetic variation. Lower limit of detection and clinical evaluation studies 
      showed detection of SARS-CoV-2 at 500 cp/mL with nasopharyngeal and saliva 
      samples. These multiplexed RT-qPCR assays, although based on modified CDC, New 
      York State Department of Health, and World Health Organization Emergency Use 
      Authorization tests, allow for higher throughput and rapid turnaround time, 
      benefiting patients, clinicians, and communities as a whole. These cost-effective 
      tests also use readily obtainable reagents, circumventing commercial assay supply 
      chain issues. The laboratory-developed tests described here have improved patient 
      care and are highly adaptable should the need arise at other clinical diagnostic 
      laboratories. Furthermore, the foundation and design of these assays may be 
      modified in the future for detection of COVID-19 variants or other RNA-based 
      viral detection tests.
CI  - Copyright © 2022 Association for Molecular Pathology and American Society for 
      Investigative Pathology. Published by Elsevier Inc. All rights reserved.
FAU - Miller, Eric W
AU  - Miller EW
AD  - Department of Pathology, SUNY Upstate Medical University, Syracuse, New York.
FAU - Lamberson, Celeste M
AU  - Lamberson CM
AD  - Department of Pathology, SUNY Upstate Medical University, Syracuse, New York.
FAU - Akabari, Ratilal R
AU  - Akabari RR
AD  - Department of Pathology, SUNY Upstate Medical University, Syracuse, New York.
FAU - Riddell, Scott W
AU  - Riddell SW
AD  - Department of Pathology, SUNY Upstate Medical University, Syracuse, New York.
FAU - Middleton, Frank A
AU  - Middleton FA
AD  - Department of Neuroscience and Physiology, SUNY Upstate Medical University, 
      Syracuse, New York.
FAU - Nasr, Michel R
AU  - Nasr MR
AD  - Department of Pathology, SUNY Upstate Medical University, Syracuse, New York.
FAU - Smith, Scott C
AU  - Smith SC
AD  - Department of Pathology, SUNY Upstate Medical University, Syracuse, New York.
FAU - Sperber, Steven M
AU  - Sperber SM
AD  - Department of Pathology, SUNY Upstate Medical University, Syracuse, New York. 
      Electronic address: sperbers@upstate.edu.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20220204
PL  - United States
TA  - J Mol Diagn
JT  - The Journal of molecular diagnostics : JMD
JID - 100893612
RN  - 0 (RNA, Viral)
RN  - SARS-CoV-2 variants
SB  - IM
MH  - *COVID-19/diagnosis
MH  - Genomics
MH  - Humans
MH  - RNA, Viral/analysis/genetics
MH  - *SARS-CoV-2/genetics
MH  - Sensitivity and Specificity
PMC - PMC8813189
EDAT- 2022/02/07 06:00
MHDA- 2022/04/06 06:00
CRDT- 2022/02/06 20:31
PHST- 2021/06/09 00:00 [received]
PHST- 2021/11/11 00:00 [revised]
PHST- 2021/12/16 00:00 [accepted]
PHST- 2022/02/07 06:00 [pubmed]
PHST- 2022/04/06 06:00 [medline]
PHST- 2022/02/06 20:31 [entrez]
AID - S1525-1578(22)00018-6 [pii]
AID - 10.1016/j.jmoldx.2021.12.010 [doi]
PST - ppublish
SO  - J Mol Diagn. 2022 Apr;24(4):294-308. doi: 10.1016/j.jmoldx.2021.12.010. Epub 2022 
      Feb 4.

PMID- 31951839
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20200225
LR  - 20200225
IS  - 1879-1026 (Electronic)
IS  - 0048-9697 (Linking)
VI  - 713
DP  - 2020 Apr 15
TI  - Estimation of spatially continuous daytime particulate matter concentrations 
      under all sky conditions through the synergistic use of satellite-based AOD and 
      numerical models.
PG  - 136516
LID - S0048-9697(20)30025-5 [pii]
LID - 10.1016/j.scitotenv.2020.136516 [doi]
AB  - Satellite-derived aerosol optical depth (AOD) products are one of main predictors 
      to estimate ground-level particulate matter (PM(10) and PM(2.5)) concentrations. 
      Since AOD products, however, are only provided under high-quality conditions, 
      missing values usually exist in areas such as clouds, cloud shadows, and bright 
      surfaces. In this study, spatially continuous AOD and subsequent PM(10) and 
      PM(2.5) concentrations were estimated over East Asia using satellite- and 
      model-based data and auxiliary data in a Random Forest (RF) approach. Data 
      collected from the Geostationary Ocean Color Imager (GOCI; 8 times per day) in 
      2016 were used to develop AOD and PM models. Three schemes (i.e. G1, A1, and A2) 
      were proposed for AOD modeling according to target AOD data (GOCI AOD and AERONET 
      AOD) and the existence of satellite-derived AOD. The A2 scheme showed the best 
      performance (validation R(2) of 0.74 and prediction R(2) of 0.73 when GOCI AOD 
      did not exist) and the resultant AOD was used to estimate spatially continuous PM 
      concentrations. The PM models with location information produced successful 
      estimation results with R(2) of 0.88 and 0.90, and rRMSE of 26.9 and 27.2% for 
      PM(10) and PM(2.5), respectively. The spatial distribution maps of PM well 
      captured the seasonal and spatial characteristics of PM reported in the 
      literature, which implies the proposed approaches can be adopted for an 
      operational estimation of spatially continuous AOD and PMs under all sky 
      conditions.
CI  - Copyright © 2020 Elsevier B.V. All rights reserved.
FAU - Park, Seohui
AU  - Park S
AD  - School of Urban & Environmental Engineering, Ulsan National Institute of Science 
      and Technology, Ulsan, Republic of Korea.
FAU - Lee, Junghee
AU  - Lee J
AD  - School of Urban & Environmental Engineering, Ulsan National Institute of Science 
      and Technology, Ulsan, Republic of Korea.
FAU - Im, Jungho
AU  - Im J
AD  - School of Urban & Environmental Engineering, Ulsan National Institute of Science 
      and Technology, Ulsan, Republic of Korea. Electronic address: ersgis@unist.ac.kr.
FAU - Song, Chang-Keun
AU  - Song CK
AD  - School of Urban & Environmental Engineering, Ulsan National Institute of Science 
      and Technology, Ulsan, Republic of Korea.
FAU - Choi, Myungje
AU  - Choi M
AD  - Jet Propulsion Laboratory, NASA, Pasadena, CA 91109, USA.
FAU - Kim, Jhoon
AU  - Kim J
AD  - Department of Atmospheric Sciences, Yonsei University, Seoul 03722, Republic of 
      Korea.
FAU - Lee, Seungun
AU  - Lee S
AD  - School of Earth and Environmental Sciences, Seoul National University, Seoul 
      08826, Republic of Korea.
FAU - Park, Rokjin
AU  - Park R
AD  - School of Earth and Environmental Sciences, Seoul National University, Seoul 
      08826, Republic of Korea.
FAU - Kim, Sang-Min
AU  - Kim SM
AD  - Environmental Satellite Centre, Climate and Air Quality Research Department, 
      National Institute of Environmental Research, Incheon 22689, Republic of Korea.
FAU - Yoon, Jongmin
AU  - Yoon J
AD  - Environmental Satellite Centre, Climate and Air Quality Research Department, 
      National Institute of Environmental Research, Incheon 22689, Republic of Korea.
FAU - Lee, Dong-Won
AU  - Lee DW
AD  - Environmental Satellite Centre, Climate and Air Quality Research Department, 
      National Institute of Environmental Research, Incheon 22689, Republic of Korea.
FAU - Quackenbush, Lindi J
AU  - Quackenbush LJ
AD  - Department of Environmental Resources Engineering, State University of New York, 
      College of Environmental Science and Forestry, Syracuse, NY 13210, USA.
LA  - eng
PT  - Journal Article
DEP - 20200108
PL  - Netherlands
TA  - Sci Total Environ
JT  - The Science of the total environment
JID - 0330500
SB  - IM
OTO - NOTNLM
OT  - AOD
OT  - Machine learning
OT  - Particulate matter
OT  - Random Forest
OT  - Satellite
COIS- Declaration of competing interest The authors declare that they have no known 
      competing financial interests or personal relationships that could have appeared 
      to influence the work reported in this paper.
EDAT- 2020/01/18 06:00
MHDA- 2020/01/18 06:01
CRDT- 2020/01/18 06:00
PHST- 2019/09/23 00:00 [received]
PHST- 2019/12/31 00:00 [revised]
PHST- 2020/01/03 00:00 [accepted]
PHST- 2020/01/18 06:00 [pubmed]
PHST- 2020/01/18 06:01 [medline]
PHST- 2020/01/18 06:00 [entrez]
AID - S0048-9697(20)30025-5 [pii]
AID - 10.1016/j.scitotenv.2020.136516 [doi]
PST - ppublish
SO  - Sci Total Environ. 2020 Apr 15;713:136516. doi: 10.1016/j.scitotenv.2020.136516. 
      Epub 2020 Jan 8.

PMID- 37534867
OWN - NLM
STAT- MEDLINE
DCOM- 20231002
LR  - 20231013
IS  - 1552-4876 (Electronic)
IS  - 1552-4868 (Print)
IS  - 1552-4868 (Linking)
VI  - 193
IP  - 3
DP  - 2023 Sep
TI  - Development of webcam-collected and artificial-intelligence-derived social and 
      cognitive performance measures for neurodevelopmental genetic syndromes.
PG  - e32058
LID - 10.1002/ajmg.c.32058 [doi]
AB  - This study focused on the development and initial psychometric evaluation of a 
      set of online, webcam-collected, and artificial intelligence-derived patient 
      performance measures for neurodevelopmental genetic syndromes (NDGS). Initial 
      testing and qualitative input was used to develop four stimulus paradigms 
      capturing social and cognitive processes, including social attention, receptive 
      vocabulary, processing speed, and single-word reading. The paradigms were 
      administered to a sample of 375 participants, including 163 with NDGS, 56 with 
      idiopathic neurodevelopmental disability (NDD), and 156 neurotypical controls. 
      Twelve measures were created from the four stimulus paradigms. Valid completion 
      rates varied from 87 to 100% across measures, with lower but adequate completion 
      rates in participants with intellectual disability. Adequate to excellent 
      internal consistency reliability (α = 0.67 to 0.95) was observed across measures. 
      Test-retest reproducibility at 1-month follow-up and stability at 4-month 
      follow-up was fair to good (r = 0.40-0.73) for 8 of the 12 measures. All 
      gaze-based measures showed evidence of convergent and discriminant validity with 
      parent-report measures of other cognitive and behavioral constructs. Comparisons 
      across NDGS groups revealed distinct patterns of social and cognitive 
      functioning, including people with PTEN mutations showing a less impaired overall 
      pattern and people with SYNGAP1 mutations showing more attentional, processing 
      speed, and social processing difficulties relative to people with NFIX mutations. 
      Webcam-collected performance measures appear to be a reliable and potentially 
      useful method for objective characterization and monitoring of social and 
      cognitive processes in NDGS and idiopathic NDD. Additional validation work, 
      including more detailed convergent and discriminant validity analyses and 
      examination of sensitivity to change, is needed to replicate and extend these 
      observations.
CI  - © 2023 The Authors. American Journal of Medical Genetics Part C: Seminars in 
      Medical Genetics published by Wiley Periodicals LLC.
FAU - Frazier, Thomas W
AU  - Frazier TW
AUID- ORCID: 0000-0002-6951-2667
AD  - Department of Psychology, John Carroll University, University Heights, Ohio, USA.
AD  - Departments of Pediatrics and Psychiatry, SUNY Upstate Medical University, 
      Syracuse, New York, USA.
FAU - Busch, Robyn M
AU  - Busch RM
AD  - Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, 
      Ohio, USA.
AD  - Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, 
      Cleveland, Ohio, USA.
FAU - Klaas, Patricia
AU  - Klaas P
AD  - Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, 
      Ohio, USA.
FAU - Lachlan, Katherine
AU  - Lachlan K
AD  - Human Genetics and Genomic Medicine, Faculty of Medicine, University of 
      Southampton and Wessex Clinical Genetics Service, University Hospital Southampton 
      NHS Foundation Trust, Southampton, UK.
FAU - Jeste, Shafali
AU  - Jeste S
AD  - Division of Neurology, Children's Hospital of Los Angeles, Los Angeles, 
      California, USA.
FAU - Kolevzon, Alexander
AU  - Kolevzon A
AD  - Departments of Psychiatry and Pediatrics, Seaver Autism Center for Research and 
      Treatment, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
FAU - Loth, Eva
AU  - Loth E
AD  - Department of Forensic and Neurodevelopmental Science, Institute of Psychiatry, 
      Psychology and Neuroscience, Kings College London, London, UK.
FAU - Harris, Jacqueline
AU  - Harris J
AD  - Department of Neurology, Kennedy Krieger Institute and Johns Hopkins University 
      School of Medicine, Baltimore, Maryland, USA.
FAU - Speer, Leslie
AU  - Speer L
AD  - Frazier Behavioral Health, Cleveland, Ohio, USA.
FAU - Pepper, Tom
AU  - Pepper T
AD  - PTEN Research Foundation, Cheltenham, UK.
FAU - Anthony, Kristin
AU  - Anthony K
AD  - PTEN Hamartoma Tumor Syndrome Foundation, Huntsville, Alabama, USA.
FAU - Graglia, J Michael
AU  - Graglia JM
AD  - SYNGAP Research Fund, Palo Alto, California, USA.
FAU - Delagrammatikas, Christal G
AU  - Delagrammatikas CG
AD  - Malan Syndrome Foundation, Old Bridge, New Jersey, USA.
FAU - Bedrosian-Sermone, Sandra
AU  - Bedrosian-Sermone S
AD  - ADNP Kids Foundation, Brush Prairie, Washington, USA.
FAU - Smith-Hicks, Constance
AU  - Smith-Hicks C
AUID- ORCID: 0000-0001-8241-9574
AD  - Department of Neurology, Kennedy Krieger Institute and Johns Hopkins University 
      School of Medicine, Baltimore, Maryland, USA.
FAU - Huba, Katie
AU  - Huba K
AD  - Department of Psychology, John Carroll University, University Heights, Ohio, USA.
FAU - Longyear, Robert
AU  - Longyear R
AD  - Autism Analytica, Syracuse, New York, USA.
FAU - Green-Snyder, LeeAnne
AU  - Green-Snyder L
AD  - Simons Foundation, New York, New York, USA.
FAU - Shic, Frederick
AU  - Shic F
AUID- ORCID: 0000-0002-9040-1259
AD  - Department of Pediatrics, University of Washington and Seattle Children's 
      Research Institute, Seattle, Washington, USA.
FAU - Sahin, Mustafa
AU  - Sahin M
AD  - Rosamund Stone Zander Translational Neuroscience Center, Department of Neurology, 
      Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, 
      USA.
FAU - Eng, Charis
AU  - Eng C
AD  - Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, 
      Cleveland, Ohio, USA.
FAU - Hardan, Antonio Y
AU  - Hardan AY
AD  - Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, 
      California, USA.
FAU - Uljarević, Mirko
AU  - Uljarević M
AD  - Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, 
      California, USA.
AD  - Melbourne School of Psychological Sciences, Faculty of Medicine, Dentistry, and 
      Health Sciences, The University of Melbourne, Melbourne, Victoria, Australia.
LA  - eng
GR  - R15 MH129815/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20230803
PL  - United States
TA  - Am J Med Genet C Semin Med Genet
JT  - American journal of medical genetics. Part C, Seminars in medical genetics
JID - 101235745
SB  - IM
MH  - Humans
MH  - Reproducibility of Results
MH  - *Artificial Intelligence
MH  - *Intellectual Disability
MH  - Intelligence
MH  - Psychometrics
PMC - PMC10543620
MID - NIHMS1923134
OTO - NOTNLM
OT  - eye tracking
OT  - facial expressions
OT  - genetic syndromes
OT  - neurodevelopment
OT  - webcam
COIS- Dr. Frazier has received funding or research support from, acted as a consultant 
      to, received travel support from, and/or received a speaker’s honorarium from the 
      PTEN Research Foundation, SYNGAP Research Fund, Malan Syndrome Foundation, ADNP 
      Kids Research Foundation, Quadrant Biosciences, Autism Speaks, Impel NeuroPharma, 
      F. Hoffmann-La Roche AG Pharmaceuticals, the Cole Family Research Fund, Simons 
      Foundation, Ingalls Foundation, Forest Laboratories, Ecoeos, IntegraGen, Kugona 
      LLC, Shire Development, Bristol-Myers Squibb, National Institutes of Health, and 
      the Brain and Behavior Research Foundation, is employed by and has equity options 
      in Quadrant Biosciences/Autism Analytica, has equity options in MaraBio and 
      Springtide, and has an investor stake in Autism EYES LLC and iSCAN-R. Dr. 
      Kolevzon has received funding or research support from, or acted as a consultant 
      to ADNP Kids Research Foundation, David Lynch Foundation, Klingestein Third 
      Generation Foundation, Ovid Therapeutics, Ritrova Therapeutics, Acadia, Alkermes, 
      Jaguar Therapeutics, GW Pharmaceuticals, Neuren Pharmaceuticals, Scioto 
      Biosciences, and Biogen. Dr. Sahin reports grant support from Novartis, Biogen, 
      Astellas, Aeovian, Bridgebio, and Aucta. He has served on Scientific Advisory 
      Boards for Novartis, Roche, Regenxbio, SpringWorks Therapeutics, Jaguar 
      Therapeutics and Alkermes. Dr. Hardan is a consultant to Beaming Health and IAMA 
      therapeutics. He also has equity options in Quadrant Biosciences/Autism 
      Analytica, and has an investor stake in iSCAN-R. Dr. Shic has acted as a 
      consultant to F. Hoffmann-La Roche AG Pharmaceuticals and Jansen Pharameuticals. 
      The remaining authors have no competing interests to disclose.
EDAT- 2023/08/03 13:08
MHDA- 2023/10/02 06:42
PMCR- 2024/09/01
CRDT- 2023/08/03 08:42
PHST- 2023/06/22 00:00 [received]
PHST- 2023/07/19 00:00 [accepted]
PHST- 2024/09/01 00:00 [pmc-release]
PHST- 2023/10/02 06:42 [medline]
PHST- 2023/08/03 13:08 [pubmed]
PHST- 2023/08/03 08:42 [entrez]
AID - 10.1002/ajmg.c.32058 [doi]
PST - ppublish
SO  - Am J Med Genet C Semin Med Genet. 2023 Sep;193(3):e32058. doi: 
      10.1002/ajmg.c.32058. Epub 2023 Aug 3.

PMID- 31326218
OWN - NLM
STAT- MEDLINE
DCOM- 20201217
LR  - 20201217
IS  - 1873-7560 (Electronic)
IS  - 0302-2838 (Print)
IS  - 0302-2838 (Linking)
VI  - 76
IP  - 6
DP  - 2019 Dec
TI  - Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights.
PG  - 754-764
LID - S0302-2838(19)30500-7 [pii]
LID - 10.1016/j.eururo.2019.06.015 [doi]
AB  - CONTEXT: Hereditary cases account for about 5% of all cases of renal cell 
      carcinoma (RCC). With advances in next-generation sequencing, several new 
      hereditary syndromes have been described in the last few years. OBJECTIVE: To 
      review and summarise the recent preclinical and clinical literature in hereditary 
      renal cancer. EVIDENCE ACQUISITION: A systematic review of the literature was 
      performed in November 2018 using PubMed and OMIM databases, with an emphasis on 
      kidney cancer, genetics and genomics, clinical criteria, and management. EVIDENCE 
      SYNTHESIS: Several autosomal dominant hereditary RCC syndromes have been 
      described, including those related to germline pathogenic variants in VHL, MET, 
      FH, TSC1/TSC2, FLCN, SDHA/B/C/D, BAP1, CDC73, and MITF. Clinical spectrum of SDH, 
      BAP1, and MITF is still being defined, although these appear to be associated 
      with a lower incidence of RCC. FH and likely BAP1 RCC are associated with more 
      aggressive disease. Preclinical and clinical studies show that using systemic 
      therapy that exploits specific genetic pathways is a promising strategy. 
      CONCLUSIONS: There are several well-described hereditary RCC syndromes, as well 
      as recently identified ones, for which the full clinical spectrum is yet to be 
      defined. In the new era of precision medicine, identification of these syndromes 
      may play an important role in management and systemic treatment selection. 
      PATIENT SUMMARY: This review covers updates in the diagnosis and management of 
      familial kidney cancer syndromes. We describe updates in testing and management 
      of the most common syndromes such as von Hippel-Lindau, and hereditary 
      leiomyomatosis and renal cell carcinoma. We also provide insights into recently 
      described familial kidney cancer syndromes.
CI  - Copyright © 2019 European Association of Urology. All rights reserved.
FAU - Carlo, Maria I
AU  - Carlo MI
AD  - Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: 
      carlom@mskcc.org.
FAU - Hakimi, A Ari
AU  - Hakimi AA
AD  - Memorial Sloan Kettering Cancer Center, New York, NY, USA.
FAU - Stewart, Grant D
AU  - Stewart GD
AD  - Department of Surgery, University of Cambridge, Cambridge Biomedical Campus, 
      Cambridge, UK.
FAU - Bratslavsky, Gennady
AU  - Bratslavsky G
AD  - Upstate Medical University, Syracuse, New York, NY, USA.
FAU - Brugarolas, James
AU  - Brugarolas J
AD  - UT Southwestern Medical Center, Dallas, TX, USA.
FAU - Chen, Ying-Bei
AU  - Chen YB
AD  - Memorial Sloan Kettering Cancer Center, New York, NY, USA.
FAU - Linehan, W Marston
AU  - Linehan WM
AD  - National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
FAU - Maher, Eamonn R
AU  - Maher ER
AD  - Department of Surgery, University of Cambridge, Cambridge Biomedical Campus, 
      Cambridge, UK; Department of Medical Genetics, University of Cambridge and NIHR 
      Cambridge Biomedical Research Centre, and Cancer Research UK Cambridge Cenre, 
      Cambridge, UK.
FAU - Merino, Maria J
AU  - Merino MJ
AD  - National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
FAU - Offit, Kenneth
AU  - Offit K
AD  - Memorial Sloan Kettering Cancer Center, New York, NY, USA.
FAU - Reuter, Victor E
AU  - Reuter VE
AD  - Memorial Sloan Kettering Cancer Center, New York, NY, USA.
FAU - Shuch, Brian
AU  - Shuch B
AD  - David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
FAU - Coleman, Jonathan A
AU  - Coleman JA
AD  - Memorial Sloan Kettering Cancer Center, New York, NY, USA.
LA  - eng
GR  - P30 CA008748/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Systematic Review
DEP - 20190718
PL  - Switzerland
TA  - Eur Urol
JT  - European urology
JID - 7512719
RN  - Familial renal cell carcinoma
RN  - Hereditary leiomyomatosis and renal cell cancer
SB  - IM
CIN - Eur Urol. 2019 Dec;76(6):765-766. PMID: 31337516
MH  - Carcinoma, Renal Cell/diagnosis/*genetics/therapy
MH  - Humans
MH  - Leiomyomatosis/diagnosis/genetics/therapy
MH  - Neoplastic Syndromes, Hereditary/diagnosis/genetics/therapy
MH  - Skin Neoplasms/diagnosis/genetics/therapy
MH  - Syndrome
MH  - Tuberous Sclerosis/diagnosis/genetics/therapy
MH  - Uterine Neoplasms/diagnosis/genetics/therapy
MH  - von Hippel-Lindau Disease/diagnosis/genetics/therapy
PMC - PMC7673107
MID - NIHMS1535005
OTO - NOTNLM
OT  - Birt-Hogg-Dubé syndrome
OT  - Genetic counselling
OT  - Hereditary cancer
OT  - Hereditary leiomyomatosis renal cell carcinoma
OT  - Hereditary papillary renal cell carcinoma
OT  - Kidney cancer
OT  - Renal cell carcinoma
OT  - Tuberous sclerosis complex
OT  - von Hippel-Lindau disease
EDAT- 2019/07/22 06:00
MHDA- 2020/12/18 06:00
CRDT- 2019/07/22 06:00
PHST- 2019/04/05 00:00 [received]
PHST- 2019/06/12 00:00 [accepted]
PHST- 2019/07/22 06:00 [pubmed]
PHST- 2020/12/18 06:00 [medline]
PHST- 2019/07/22 06:00 [entrez]
AID - S0302-2838(19)30500-7 [pii]
AID - 10.1016/j.eururo.2019.06.015 [doi]
PST - ppublish
SO  - Eur Urol. 2019 Dec;76(6):754-764. doi: 10.1016/j.eururo.2019.06.015. Epub 2019 
      Jul 18.

PMID- 34271922
OWN - NLM
STAT- MEDLINE
DCOM- 20210727
LR  - 20230126
IS  - 1479-5868 (Electronic)
IS  - 1479-5868 (Linking)
VI  - 18
IP  - 1
DP  - 2021 Jul 16
TI  - A catalog of validity indices for step counting wearable technologies during 
      treadmill walking: the CADENCE-Kids study.
PG  - 97
LID - 10.1186/s12966-021-01167-y [doi]
LID - 97
AB  - BACKGROUND: Wearable technologies play an important role in measuring physical 
      activity (PA) and promoting health. Standardized validation indices (i.e., 
      accuracy, bias, and precision) compare performance of step counting wearable 
      technologies in young people. PURPOSE: To produce a catalog of validity indices 
      for step counting wearable technologies assessed during different treadmill 
      speeds (slow [0.8-3.2 km/h], normal [4.0-6.4 km/h], fast [7.2-8.0 km/h]), wear 
      locations (waist, wrist/arm, thigh, and ankle), and age groups (children, 
      6-12 years; adolescents, 13-17 years; young adults, 18-20 years). METHODS: One 
      hundred seventeen individuals (13.1 ± 4.2 years, 50.4% female) participated in 
      this cross-sectional study and completed 5-min treadmill bouts (0.8 km/h to 
      8.0 km/h) while wearing eight devices (Waist: Actical, ActiGraph GT3X+, NL-1000, 
      SW-200; Wrist: ActiGraph GT3X+; Arm: SenseWear; Thigh: activPAL; Ankle: 
      StepWatch). Directly observed steps served as the criterion measure. Accuracy 
      (mean absolute percentage error, MAPE), bias (mean percentage error, MPE), and 
      precision (correlation coefficient, r; standard deviation, SD; coefficient of 
      variation, CoV) were computed. RESULTS: Five of the eight tested wearable 
      technologies (i.e., Actical, waist-worn ActiGraph GT3X+, activPAL, StepWatch, and 
      SW-200) performed at < 5% MAPE over the range of normal speeds. More generally, 
      waist (MAPE = 4%), thigh (4%) and ankle (5%) locations displayed higher accuracy 
      than the wrist location (23%) at normal speeds. On average, all wearable 
      technologies displayed the lowest accuracy across slow speeds 
      (MAPE = 50.1 ± 35.5%), and the highest accuracy across normal speeds 
      (MAPE = 15.9 ± 21.7%). Speed and wear location had a significant effect on 
      accuracy and bias (P < 0.001), but not on precision (P > 0.05). Age did not have 
      any effect (P > 0.05). CONCLUSIONS: Standardized validation indices focused on 
      accuracy, bias, and precision were cataloged by speed, wear location, and age 
      group to serve as important reference points when selecting and/or evaluating 
      device performance in young people moving forward. Reduced performance can be 
      expected at very slow walking speeds (0.8 to 3.2 km/h) for all devices. 
      Ankle-worn and thigh-worn devices demonstrated the highest accuracy. Speed and 
      wear location had a significant effect on accuracy and bias, but not precision. 
      TRIAL REGISTRATION: Clinicaltrials.gov NCT01989104 . Registered November 14, 
      2013.
CI  - © 2021. The Author(s).
FAU - Gould, Zachary R
AU  - Gould ZR
AD  - Department of Kinesiology, University of Massachusetts Amherst, Amherst, MA, USA.
FAU - Mora-Gonzalez, Jose
AU  - Mora-Gonzalez J
AD  - College of Health and Human Services, University of North Carolina at Charlotte, 
      9201 University City Blvd., Charlotte, NC, 28223, USA.
FAU - Aguiar, Elroy J
AU  - Aguiar EJ
AD  - Department of Kinesiology, The University of Alabama, Tuscaloosa, AL, USA.
FAU - Schuna, John M Jr
AU  - Schuna JM Jr
AD  - School of Biological and Population Health Sciences, Oregon State University, 
      Corvallis, OR, USA.
FAU - Barreira, Tiago V
AU  - Barreira TV
AD  - Exercise Science Department, Syracuse University, Syracuse, NY, USA.
FAU - Moore, Christopher C
AU  - Moore CC
AD  - Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel 
      Hill, NC, USA.
FAU - Staudenmayer, John
AU  - Staudenmayer J
AD  - Department of Mathematics and Statistics, University of Massachusetts Amherst, 
      Amherst, MA, USA.
FAU - Tudor-Locke, Catrine
AU  - Tudor-Locke C
AUID- ORCID: 0000-0003-4342-5909
AD  - College of Health and Human Services, University of North Carolina at Charlotte, 
      9201 University City Blvd., Charlotte, NC, 28223, USA. Tudor-Locke@uncc.edu.
LA  - eng
SI  - ClinicalTrials.gov/NCT01989104
GR  - NICHD 1R21HD073807/NH/NIH HHS/United States
GR  - R21 HD073807/HD/NICHD NIH HHS/United States
GR  - T32 HL007055/HL/NHLBI NIH HHS/United States
GR  - U54 GM104940/GM/NIGMS NIH HHS/United States
GR  - 1 U54 GM104940/GM/NIGMS NIH HHS/United States
PT  - Clinical Trial
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20210716
PL  - England
TA  - Int J Behav Nutr Phys Act
JT  - The international journal of behavioral nutrition and physical activity
JID - 101217089
SB  - IM
MH  - Actigraphy/*standards
MH  - Adolescent
MH  - Adult
MH  - *Catalogs as Topic
MH  - Child
MH  - Cross-Sectional Studies
MH  - Female
MH  - Humans
MH  - Male
MH  - Reproducibility of Results
MH  - *Walking
MH  - Wearable Electronic Devices/*standards/*statistics & numerical data
MH  - Young Adult
PMC - PMC8283935
OTO - NOTNLM
OT  - Accelerometer
OT  - Accuracy
OT  - Bias
OT  - Measurement
OT  - Pedometer
OT  - Physical activity
COIS- The authors declare they have no conflicts of interest. The results of the 
      present study do not constitute endorsement by the American College of Sports 
      Medicine. The results of the study are presented clearly, honestly, and without 
      fabrication, falsification, or inappropriate data manipulation.
EDAT- 2021/07/18 06:00
MHDA- 2021/07/28 06:00
CRDT- 2021/07/17 05:29
PHST- 2021/02/23 00:00 [received]
PHST- 2021/06/30 00:00 [accepted]
PHST- 2021/07/17 05:29 [entrez]
PHST- 2021/07/18 06:00 [pubmed]
PHST- 2021/07/28 06:00 [medline]
AID - 10.1186/s12966-021-01167-y [pii]
AID - 1167 [pii]
AID - 10.1186/s12966-021-01167-y [doi]
PST - epublish
SO  - Int J Behav Nutr Phys Act. 2021 Jul 16;18(1):97. doi: 10.1186/s12966-021-01167-y.

PMID- 28951311
OWN - NLM
STAT- MEDLINE
DCOM- 20171027
LR  - 20181202
IS  - 1879-0038 (Electronic)
IS  - 0378-1119 (Linking)
VI  - 638
DP  - 2018 Jan 5
TI  - PD-1 pathway and its clinical application: A 20year journey after discovery of 
      the complete human PD-1 gene.
PG  - 20-25
LID - S0378-1119(17)30782-5 [pii]
LID - 10.1016/j.gene.2017.09.050 [doi]
AB  - Anti-PD-1 therapy is a novel immune-checkpoint inhibition therapy with tremendous 
      potential in treating refractory/relapsed cancers. The 20year journey of human 
      PD-1 research went through 3 phases: 1) discovering PD-1 gene structure and 
      genomic organization, 2) understanding the mechanism of PD-1 mediated 
      immune-checkpoint regulatory effects in coordination with its ligands (PD-L1 and 
      L2), 3) and translating our knowledge of PD-1 gene into a robust clinical 
      anticancer approach by targeting the PD-1 immune-checkpoint pathway. The success 
      of human PD-1 gene study reflects the advancement and trends of modern biomedical 
      research from the laboratory to the bedside. However, our journey of 
      understanding the PD-1 gene is not yet complete. Clinical investigation data show 
      a high variety of response rates among different types of cancers to PD-1 
      immune-checkpoint inhibition therapy, with a range of 18% to 87%. There is no 
      reliable biomarker to predict an individual patient's response to PD-1 inhibitory 
      immunotherapy. Patients can present with primary, adaptive, or even acquired 
      resistance to PD-1 immune-checkpoint inhibition therapy. Furthermore, the 
      emerging data demonstrates that certain patients experience hyperprogressive 
      disease status after receiving PD-1 immune-checkpoint inhibition therapy. In 
      conclusion, PD-1 immune-checkpoint inhibition therapy has opened up a new venue 
      of advanced cancer immunotherapy. Meanwhile, further efforts are still warranted 
      in both basic scientific mechanism studies and clinical investigation using the 
      principles of personalized and precision medicine.
CI  - Copyright © 2017 Elsevier B.V. All rights reserved.
FAU - Berger, Kristin Nicole
AU  - Berger KN
AD  - Penn State Hershey Cancer Institute, Department of Medicine, Penn State 
      University College of Medicine, Hershey, PA, United States; Department of 
      Medicine, University of Pittsburgh School of Medicine, PA, United States.
FAU - Pu, Jeffrey Jiayu
AU  - Pu JJ
AD  - Penn State Hershey Cancer Institute, Department of Medicine, Penn State 
      University College of Medicine, Hershey, PA, United States; Department of 
      Pathology, Penn State University College of Medicine, Hershey, PA, United States; 
      Upstate Cancer Center, Departments of Medicine and Pathology, SUNY Upstate 
      Medical University, Syracuse, NY, United States. Electronic address: 
      jpu2@jhmi.edu.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20170923
PL  - Netherlands
TA  - Gene
JT  - Gene
JID - 7706761
RN  - 0 (Antibodies, Monoclonal)
RN  - 0 (PDCD1 protein, human)
RN  - 0 (Programmed Cell Death 1 Receptor)
RN  - 31YO63LBSN (Nivolumab)
SB  - IM
MH  - Animals
MH  - Antibodies, Monoclonal/therapeutic use
MH  - Humans
MH  - *Immunotherapy
MH  - Neoplasms/therapy
MH  - Nivolumab
MH  - Programmed Cell Death 1 Receptor/*genetics
MH  - T-Lymphocytes/metabolism
OTO - NOTNLM
OT  - Human Programmed Cell Death 1 (hPD-1) gene
OT  - Hyperprogressive disease status
OT  - Immune-checkpoint inhibition
OT  - Immunotherapy
EDAT- 2017/09/28 06:00
MHDA- 2017/10/28 06:00
CRDT- 2017/09/28 06:00
PHST- 2017/07/27 00:00 [received]
PHST- 2017/09/10 00:00 [revised]
PHST- 2017/09/22 00:00 [accepted]
PHST- 2017/09/28 06:00 [pubmed]
PHST- 2017/10/28 06:00 [medline]
PHST- 2017/09/28 06:00 [entrez]
AID - S0378-1119(17)30782-5 [pii]
AID - 10.1016/j.gene.2017.09.050 [doi]
PST - ppublish
SO  - Gene. 2018 Jan 5;638:20-25. doi: 10.1016/j.gene.2017.09.050. Epub 2017 Sep 23.

PMID- 35192687
OWN - NLM
STAT- MEDLINE
DCOM- 20220627
LR  - 20221105
IS  - 2473-9537 (Electronic)
IS  - 2473-9529 (Print)
IS  - 2473-9529 (Linking)
VI  - 6
IP  - 12
DP  - 2022 Jun 28
TI  - Laboratory assays of VWF activity and use of desmopressin trials in the diagnosis 
      of VWD: a systematic review and meta-analysis.
PG  - 3735-3745
LID - 10.1182/bloodadvances.2021005431 [doi]
AB  - von Willebrand Disease (VWD) is associated with significant morbidity because of 
      excessive bleeding. Early diagnosis and treatment are important to prevent and 
      treat these symptoms. We systematically reviewed the accuracy of any von 
      Willebrand factor (VWF) activity assay in the diagnosis and classification of 
      patients for VWD. We searched Cochrane Central, MEDLINE, and EMBASE for eligible 
      studies. The risk of bias was assessed using the Quality Assessment of Diagnostic 
      Accuracy Studies (QUADAS)-2 and the certainty of evidence using the GRADE 
      framework. We pooled estimates of sensitivity and specificity. The review 
      included 77 studies that evaluated the use of newer tests of VWF platelet binding 
      activity (VWF:GPIbR, VWF:GPIbM) and VWF:RCo for the diagnosis of VWD (13 
      studies), VWF propeptide to VWF:Ag ratio, and desmopressin trial for the 
      diagnosis of type 1C VWD (5 studies), VWF multimer analysis and VWF:CB/VWF:Ag 
      ratio for the classification of type 2 VWD (11 studies), genetic testing and 
      ristocetin-induced platelet aggregation to diagnose type 2B VWD (14 studies), 
      genetic testing and FVIII:VWF binding to diagnose type 2N VWD (17 studies). Based 
      on available diagnostic test accuracy, there appear to be comparable test 
      accuracy results between newer tests of platelet binding activity of VWF function 
      and VWF:RCo. The findings of these reviews support VWF multimer analysis or 
      VWF:CB/VWF:Ag to diagnose type 2 VWD. The desmopressin trial test with 1- and 
      4-hour postinfusion blood work is the test of choice to confirm increased VWF 
      clearance in patients with suspected VWD type 1C. Additionally, genetic testing 
      is most useful in diagnosing type 2B VWD and has a role in the diagnostic 
      algorithm of suspected type 2N VWD.
CI  - © 2022 by The American Society of Hematology. Licensed under Creative Commons 
      Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), 
      permitting only noncommercial, nonderivative use with attribution. All other 
      rights reserved.
FAU - Kalot, Mohamad A
AU  - Kalot MA
AUID- ORCID: 0000-0002-6581-4561
AD  - Department of Internal Medicine, State University of New York at Buffalo, 
      Buffalo, NY.
FAU - Husainat, Nedaa
AU  - Husainat N
AD  - Department of Internal Medicine, St. Mary's Hospital, St. Louis, MO.
FAU - Abughanimeh, Omar
AU  - Abughanimeh O
AUID- ORCID: 0000-0002-4189-5678
AD  - Division of Oncology and Hematology, University of Nebraska Medical Center-Fred & 
      Pamela Buffett Cancer Center, Omaha, NE.
FAU - Diab, Osama
AU  - Diab O
AD  - Department of Hematology.
FAU - El Alayli, Abdallah
AU  - El Alayli A
AD  - Department of Nephrology and Hypertension, Outcomes and Implementation Research 
      Unit, and.
FAU - Tayiem, Sammy
AU  - Tayiem S
AD  - Department of Internal Medicine, University of Kansas Medical Center, Kansas 
      City, KS.
FAU - Madoukh, Bader
AU  - Madoukh B
AD  - Department of Internal Medicine, State University of New York-Upstate Medical 
      University, Syracuse, NY.
FAU - Dimassi, Ahmad
AU  - Dimassi A
AUID- ORCID: 0000-0002-7671-9965
AD  - Department of Internal Medicine, Lebanese American University, Achrafiye, Beirut, 
      Lebanon.
FAU - Qureini, Aref
AU  - Qureini A
AD  - Department of Internal Medicine, University of Kansas Medical Center, Kansas 
      City, KS.
FAU - Ameer, Barbara
AU  - Ameer B
AUID- ORCID: 0000-0002-8740-9989
AD  - Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ.
FAU - Eikenboom, Jeroen
AU  - Eikenboom J
AD  - Division of Thrombosis and Hemostasis, Department of Internal Medicine, Leiden 
      University Medical Center, Leiden, The Netherlands.
FAU - Giraud, Nicolas
AU  - Giraud N
AD  - Association française des hémophiles (AFH), Paris, France.
FAU - Haberichter, Sandra
AU  - Haberichter S
AD  - Versiti-Blood Center of Wisconsin, Milwaukee, WI.
FAU - Jacobs-Pratt, Vicky
AU  - Jacobs-Pratt V
AD  - Infinity Way, Auburn, ME.
FAU - Konkle, Barbara A
AU  - Konkle BA
AUID- ORCID: 0000-0002-3959-8797
AD  - Division of Hematology, University of Washington, Seattle, WA.
FAU - McRae, Simon
AU  - McRae S
AD  - Royal Adelaide Hospital, Adelaide, Australia.
FAU - Montgomery, Robert
AU  - Montgomery R
AD  - Infinity Way, Auburn, ME.
AD  - Division of Hematology/Oncology, Department of Pediatrics, Medical College of 
      Wisconsin, Wauwatosa, WI.
FAU - O'Donnell, James S
AU  - O'Donnell JS
AUID- ORCID: 0000-0003-0309-3313
AD  - Royal College of Surgeons in Ireland, Irish Centre for Vascular Biology, Dublin 
      2, Ireland.
FAU - Brignardello-Petersen, Romina
AU  - Brignardello-Petersen R
AUID- ORCID: 0000-0002-6010-9900
AD  - Department of Health Research Methods, Evidence, and Impact, McMaster University, 
      Hamilton, ON, Canada.
FAU - Flood, Veronica
AU  - Flood V
AD  - Division of Hematology/Oncology, Department of Pediatrics, Medical College of 
      Wisconsin, Wauwatosa, WI.
FAU - Connell, Nathan T
AU  - Connell NT
AUID- ORCID: 0000-0003-4100-7826
AD  - Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and.
FAU - James, Paula
AU  - James P
AUID- ORCID: 0000-0003-4649-9014
AD  - Department of Medicine, Queen's University, Kingston ON, Canada.
FAU - Mustafa, Reem A
AU  - Mustafa RA
AUID- ORCID: 0000-0002-2091-0875
AD  - Department of Nephrology and Hypertension, Outcomes and Implementation Research 
      Unit, and.
LA  - eng
PT  - Journal Article
PT  - Meta-Analysis
PT  - Research Support, Non-U.S. Gov't
PT  - Systematic Review
PL  - United States
TA  - Blood Adv
JT  - Blood advances
JID - 101698425
RN  - 0 (von Willebrand Factor)
RN  - ENR1LLB0FP (Deamino Arginine Vasopressin)
SB  - IM
MH  - Blood Coagulation Tests
MH  - Deamino Arginine Vasopressin/therapeutic use
MH  - Humans
MH  - *von Willebrand Disease, Type 2
MH  - *von Willebrand Diseases/diagnosis/drug therapy
MH  - von Willebrand Factor/metabolism
PMC - PMC9631556
EDAT- 2022/02/23 06:00
MHDA- 2022/06/28 06:00
CRDT- 2022/02/22 17:12
PHST- 2021/10/13 00:00 [received]
PHST- 2022/02/02 00:00 [accepted]
PHST- 2022/02/23 06:00 [pubmed]
PHST- 2022/06/28 06:00 [medline]
PHST- 2022/02/22 17:12 [entrez]
AID - 484104 [pii]
AID - 2022/ADV2021005431C [pii]
AID - 10.1182/bloodadvances.2021005431 [doi]
PST - ppublish
SO  - Blood Adv. 2022 Jun 28;6(12):3735-3745. doi: 10.1182/bloodadvances.2021005431.

PMID- 32884130
OWN - NLM
STAT- MEDLINE
DCOM- 20211022
LR  - 20230210
IS  - 1530-0285 (Electronic)
IS  - 0893-3952 (Print)
IS  - 0893-3952 (Linking)
VI  - 34
IP  - 2
DP  - 2021 Feb
TI  - High throughput assessment of biomarkers in tissue microarrays using artificial 
      intelligence: PTEN loss as a proof-of-principle in multi-center prostate cancer 
      cohorts.
PG  - 478-489
LID - 10.1038/s41379-020-00674-w [doi]
AB  - Phosphatase and tensin homolog (PTEN) loss is associated with adverse outcomes in 
      prostate cancer and has clinical potential as a prognostic biomarker. The 
      objective of this work was to develop an artificial intelligence (AI) system for 
      automated detection and localization of PTEN loss on immunohistochemically (IHC) 
      stained sections. PTEN loss was assessed using IHC in two prostate tissue 
      microarrays (TMA) (internal cohort, n = 272 and external cohort, n = 129 
      patients). TMA cores were visually scored for PTEN loss by pathologists and, if 
      present, spatially annotated. Cores from each patient within the internal TMA 
      cohort were split into 90% cross-validation (N = 2048) and 10% hold-out testing 
      (N = 224) sets. ResNet-101 architecture was used to train core-based 
      classification using a multi-resolution ensemble approach (×5, ×10, and ×20). For 
      spatial annotations, single resolution pixel-based classification was trained 
      from patches extracted at ×20 resolution, interpolated to ×40 resolution, and 
      applied in a sliding-window fashion. A final AI-based prediction model was 
      created from combining multi-resolution and pixel-based models. Performance was 
      evaluated in 428 cores of external cohort. From both cohorts, a total of 2700 
      cores were studied, with a frequency of PTEN loss of 14.5% in internal (180/1239) 
      and external 13.5% (43/319) cancer cores. The final AI-based prediction of PTEN 
      status demonstrated 98.1% accuracy (95.0% sensitivity, 98.4% specificity; median 
      dice score = 0.811) in internal cohort cross-validation set and 99.1% accuracy 
      (100% sensitivity, 99.0% specificity; median dice score = 0.804) in internal 
      cohort test set. Overall core-based classification in the external cohort was 
      significantly improved in the external cohort (area under the curve = 0.964, 
      90.6% sensitivity, 95.7% specificity) when further trained (fine-tuned) using 15% 
      of cohort data (19/124 patients). These results demonstrate a robust and fully 
      automated method for detection and localization of PTEN loss in prostate cancer 
      tissue samples. AI-based algorithms have potential to streamline sample 
      assessment in research and clinical laboratories.
FAU - Harmon, Stephanie A
AU  - Harmon SA
AD  - Molecular Imaging Branch, National Cancer Institute, National Institutes of 
      Health, Bethesda, MD, USA.
AD  - Clinical Research Directorate, Frederick National Laboratory for Cancer Research, 
      Frederick, MD, USA.
FAU - Patel, Palak G
AU  - Patel PG
AD  - Division of Cancer Biology & Genetics, Cancer Research Institute, Queen's 
      University, Kingston, ON, Canada.
AD  - Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, 
      Canada.
AD  - Department of Cell Biology at The Arthur and Sonia Labatt Brain Tumour Research 
      Centre at the Hospital for Sick Children, Toronto, ON, Canada.
FAU - Sanford, Thomas H
AU  - Sanford TH
AD  - Molecular Imaging Branch, National Cancer Institute, National Institutes of 
      Health, Bethesda, MD, USA.
AD  - Department of Urology, Upstate Medical University, Syracuse, NY, USA.
FAU - Caven, Isabelle
AU  - Caven I
AD  - Division of Cancer Biology & Genetics, Cancer Research Institute, Queen's 
      University, Kingston, ON, Canada.
AD  - Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, 
      Canada.
FAU - Iseman, Rachael
AU  - Iseman R
AD  - Division of Cancer Biology & Genetics, Cancer Research Institute, Queen's 
      University, Kingston, ON, Canada.
AD  - Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, 
      Canada.
FAU - Vidotto, Thiago
AU  - Vidotto T
AD  - Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, 
      Ribeirão Preto, Brazil.
FAU - Picanço, Clarissa
AU  - Picanço C
AD  - Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, 
      Ribeirão Preto, Brazil.
FAU - Squire, Jeremy A
AU  - Squire JA
AD  - Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, 
      Canada.
AD  - Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, 
      Ribeirão Preto, Brazil.
FAU - Masoudi, Samira
AU  - Masoudi S
AD  - Molecular Imaging Branch, National Cancer Institute, National Institutes of 
      Health, Bethesda, MD, USA.
FAU - Mehralivand, Sherif
AU  - Mehralivand S
AD  - Molecular Imaging Branch, National Cancer Institute, National Institutes of 
      Health, Bethesda, MD, USA.
FAU - Choyke, Peter L
AU  - Choyke PL
AD  - Molecular Imaging Branch, National Cancer Institute, National Institutes of 
      Health, Bethesda, MD, USA.
FAU - Berman, David M
AU  - Berman DM
AUID- ORCID: 0000-0001-5985-3698
AD  - Division of Cancer Biology & Genetics, Cancer Research Institute, Queen's 
      University, Kingston, ON, Canada.
AD  - Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, 
      Canada.
FAU - Turkbey, Baris
AU  - Turkbey B
AD  - Molecular Imaging Branch, National Cancer Institute, National Institutes of 
      Health, Bethesda, MD, USA.
FAU - Jamaspishvili, Tamara
AU  - Jamaspishvili T
AUID- ORCID: 0000-0001-5836-7700
AD  - Division of Cancer Biology & Genetics, Cancer Research Institute, Queen's 
      University, Kingston, ON, Canada. tamara.jamaspishvili@queensu.ca.
AD  - Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, 
      Canada. tamara.jamaspishvili@queensu.ca.
LA  - eng
GR  - HHSN261200800001C/RC/CCR NIH HHS/United States
GR  - HHSN261200800001E/CA/NCI NIH HHS/United States
GR  - ZIH BC012032/ImNIH/Intramural NIH HHS/United States
GR  - T2014-01/Movember Foundation (Movember)/International
PT  - Journal Article
PT  - Multicenter Study
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20200903
PL  - United States
TA  - Mod Pathol
JT  - Modern pathology : an official journal of the United States and Canadian Academy 
      of Pathology, Inc
JID - 8806605
RN  - 0 (Biomarkers, Tumor)
RN  - EC 3.1.3.67 (PTEN Phosphohydrolase)
RN  - EC 3.1.3.67 (PTEN protein, human)
SB  - IM
MH  - Algorithms
MH  - Biomarkers, Tumor/*analysis
MH  - Cohort Studies
MH  - *Deep Learning
MH  - High-Throughput Nucleotide Sequencing/methods
MH  - Humans
MH  - Image Processing, Computer-Assisted/methods
MH  - Male
MH  - PTEN Phosphohydrolase/*analysis
MH  - *Prostatic Neoplasms
MH  - Tissue Array Analysis
PMC - PMC9152638
MID - NIHMS1801793
COIS- Conflict of interest The authors declare that they have no conflict of interest.
EDAT- 2020/09/05 06:00
MHDA- 2022/07/17 06:00
CRDT- 2020/09/05 06:00
PHST- 2019/12/30 00:00 [received]
PHST- 2020/08/21 00:00 [accepted]
PHST- 2020/08/21 00:00 [revised]
PHST- 2020/09/05 06:00 [pubmed]
PHST- 2022/07/17 06:00 [medline]
PHST- 2020/09/05 06:00 [entrez]
AID - S0893-3952(22)00688-3 [pii]
AID - 10.1038/s41379-020-00674-w [doi]
PST - ppublish
SO  - Mod Pathol. 2021 Feb;34(2):478-489. doi: 10.1038/s41379-020-00674-w. Epub 2020 
      Sep 3.

PMID- 33359203
OWN - NLM
STAT- MEDLINE
DCOM- 20211011
LR  - 20220302
IS  - 1879-0135 (Electronic)
IS  - 0020-7519 (Print)
IS  - 0020-7519 (Linking)
VI  - 51
IP  - 4
DP  - 2021 Mar
TI  - Spatio-temporal variation in environmental features predicts the distribution and 
      abundance of Ixodes scapularis.
PG  - 311-320
LID - S0020-7519(20)30331-3 [pii]
LID - 10.1016/j.ijpara.2020.10.002 [doi]
AB  - Many species have experienced dramatic changes in both geographic range and 
      population sizes in recent history. Increases in the geographic range or 
      population size of disease vectors have public health relevance as these 
      increases often precipitate the emergence of infectious diseases in human 
      populations. Accurately identifying environmental factors affecting the 
      biogeographic patterns of vector species is a long-standing analytical challenge, 
      stemming from a paucity of data capturing periods of rapid changes in vector 
      demographics. We systematically investigated the occurrence and abundance of 
      nymphal Ixodes scapularis ticks at 532 sampling locations throughout New York 
      State (NY), USA, between 2008 and 2018, a time frame that encompasses the 
      emergence of diseases vectored by these ticks. Analyses of these field-collected 
      data demonstrated a range expansion into northern and western NY during the last 
      decade. Nymphal abundances increased in newly colonised areas, while remaining 
      stable in areas with long-standing populations over the last decade. These trends 
      in the geographic range and abundance of nymphs correspond to both the geographic 
      expansion of human Lyme disease cases and increases in incidence rates. Analytic 
      models fitted to these data incorporating time, space, and environmental factors, 
      accurately identified drivers of the observed changes in nymphal occurrence and 
      abundance. These models accounted for the spatial and temporal variation in the 
      occurrence and abundance of nymphs and can accurately predict nymphal population 
      patterns in future years. Forecasting disease risk at fine spatial scales prior 
      to the transmission season can influence both public health mitigation strategies 
      and individual behaviours, potentially impacting tick-borne disease risk and 
      subsequently human disease incidence.
CI  - Copyright © 2020 Australian Society for Parasitology. Published by Elsevier Ltd. 
      All rights reserved.
FAU - Tran, Tam
AU  - Tran T
AD  - University of Pennsylvania, Biology Department, 433 S University Ave, 301 Leidy 
      Labs, Philadelphia, PA 19104, USA. Electronic address: tamt@sas.upenn.edu.
FAU - Prusinski, Melissa A
AU  - Prusinski MA
AD  - New York State Department of Health, Bureau of Communicable Disease Control, 
      Empire State Plaza, Corning Tower Building, Room 651, P.O. Box 509, Albany, NY 
      12201-0509, USA.
FAU - White, Jennifer L
AU  - White JL
AD  - New York State Department of Health, Bureau of Communicable Disease Control, 
      Empire State Plaza, Corning Tower Building, Room 651, P.O. Box 509, Albany, NY 
      12201-0509, USA.
FAU - Falco, Richard C
AU  - Falco RC
AD  - New York State Department of Health, Bureau of Communicable Disease Control, 
      Fordham University Louis Calder Center, 31 Whippoorwill Road, Armonk, NY 10504, 
      USA.
FAU - Vinci, Vanessa
AU  - Vinci V
AD  - New York State Department of Health, Bureau of Communicable Disease Control, 
      Fordham University Louis Calder Center, 31 Whippoorwill Road, Armonk, NY 10504, 
      USA.
FAU - Gall, Wayne K
AU  - Gall WK
AD  - New York State Department of Health, Bureau of Communicable Disease Control, 
      Buffalo State College, 1300 Elmwood Avenue, Buffalo, NY 14222, USA.
FAU - Tober, Keith
AU  - Tober K
AD  - New York State Department of Health, Bureau of Communicable Disease Control, 
      Buffalo State College, 1300 Elmwood Avenue, Buffalo, NY 14222, USA.
FAU - Oliver, JoAnne
AU  - Oliver J
AD  - Central New York Regional Office, Department of Health, State of New York, 217 
      South Salina Street, Syracuse, NY 13202, USA; Department of Environmental 
      Sciences, School of Agriculture and Natural Resources, College of Agriculture and 
      Technology, State University of New York, Morrisville, NY 13408, USA.
FAU - Sporn, Lee Ann
AU  - Sporn LA
AD  - Paul Smith's College, Natural Sciences Division, 7777 New York Route 30, Paul 
      Smiths, NY 12970, USA.
FAU - Meehan, Lisa
AU  - Meehan L
AD  - New York State Department of Health, Wadsworth Center, Division of Environmental 
      Health Sciences, Organic Analytical Chemistry Laboratory, P.O. Box 509, Albany, 
      NY 12201-0509, USA(1).
FAU - Banker, Elyse
AU  - Banker E
AD  - New York State Department of Health, Wadsworth Center, Division of Infectious 
      Disease, Griffin Laboratory, Arbovirus Laboratory, Building 2, 5668 State Farm 
      Road, Slingerlands, NY 12159, USA(2).
FAU - Backenson, P Bryon
AU  - Backenson PB
AD  - New York State Department of Health, Bureau of Communicable Disease Control, 
      Empire State Plaza, Corning Tower Building, Room 651, P.O. Box 509, Albany, NY 
      12201-0509, USA.
FAU - Jensen, Shane T
AU  - Jensen ST
AD  - University of Pennsylvania, Wharton Business School, 463 Jon M. Huntsman Hall, 
      3730 Walnut Street, Philadelphia, PA 19104, USA.
FAU - Brisson, Dustin
AU  - Brisson D
AD  - University of Pennsylvania, Biology Department, 433 S University Ave, 301 Leidy 
      Labs, Philadelphia, PA 19104, USA.
LA  - eng
GR  - R21 AI137433/AI/NIAID NIH HHS/United States
GR  - R01 AI142572/AI/NIAID NIH HHS/United States
GR  - F31 AI133871/AI/NIAID NIH HHS/United States
GR  - T32 AI055400/AI/NIAID NIH HHS/United States
GR  - R01 AI097137/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20201224
PL  - England
TA  - Int J Parasitol
JT  - International journal for parasitology
JID - 0314024
SB  - IM
MH  - Animals
MH  - Humans
MH  - *Ixodes
MH  - *Lyme Disease/epidemiology
MH  - Nymph
MH  - Population Density
MH  - *Tick-Borne Diseases
PMC - PMC7940570
MID - NIHMS1657448
OTO - NOTNLM
OT  - Distribution
OT  - Environmental change
OT  - Lyme disease
OT  - Predictive models
OT  - Ticks
EDAT- 2020/12/29 06:00
MHDA- 2021/10/12 06:00
CRDT- 2020/12/28 10:44
PHST- 2020/06/11 00:00 [received]
PHST- 2020/10/03 00:00 [revised]
PHST- 2020/10/04 00:00 [accepted]
PHST- 2020/12/29 06:00 [pubmed]
PHST- 2021/10/12 06:00 [medline]
PHST- 2020/12/28 10:44 [entrez]
AID - S0020-7519(20)30331-3 [pii]
AID - 10.1016/j.ijpara.2020.10.002 [doi]
PST - ppublish
SO  - Int J Parasitol. 2021 Mar;51(4):311-320. doi: 10.1016/j.ijpara.2020.10.002. Epub 
      2020 Dec 24.

PMID- 35349838
OWN - NLM
STAT- MEDLINE
DCOM- 20220421
LR  - 20230502
IS  - 1361-8423 (Electronic)
IS  - 1361-8415 (Print)
IS  - 1361-8415 (Linking)
VI  - 78
DP  - 2022 May
TI  - Polar transform network for prostate ultrasound segmentation with uncertainty 
      estimation.
PG  - 102418
LID - S1361-8415(22)00069-X [pii]
LID - 10.1016/j.media.2022.102418 [doi]
AB  - Automatic and accurate prostate ultrasound segmentation is a long-standing and 
      challenging problem due to the severe noise and ambiguous/missing prostate 
      boundaries. In this work, we propose a novel polar transform network (PTN) to 
      handle this problem from a fundamentally new perspective, where the prostate is 
      represented and segmented in the polar coordinate space rather than the original 
      image grid space. This new representation gives a prostate volume, especially the 
      most challenging apex and base sub-areas, much denser samples than the background 
      and thus facilitate the learning of discriminative features for accurate prostate 
      segmentation. Moreover, in the polar representation, the prostate surface can be 
      efficiently parameterized using a 2D surface radius map with respect to a 
      centroid coordinate, which allows the proposed PTN to obtain superior accuracy 
      compared with its counterparts using convolutional neural networks while having 
      significantly fewer (18%∼41%) trainable parameters. We also equip our PTN with a 
      novel strategy of centroid perturbed test-time augmentation (CPTTA), which is 
      designed to further improve the segmentation accuracy and quantitatively assess 
      the model uncertainty at the same time. The uncertainty estimation function 
      provides valuable feedback to clinicians when manual modifications or approvals 
      are required for the segmentation, substantially improving the clinical 
      significance of our work. We conduct a three-fold cross validation on a clinical 
      dataset consisting of 315 transrectal ultrasound (TRUS) images to comprehensively 
      evaluate the performance of the proposed method. The experimental results show 
      that our proposed PTN with CPTTA outperforms the state-of-the-art methods with 
      statistical significance on most of the metrics while exhibiting a much smaller 
      model size. Source code of the proposed PTN is released at 
      https://github.com/DIAL-RPI/PTN.
CI  - Copyright © 2022 Elsevier B.V. All rights reserved.
FAU - Xu, Xuanang
AU  - Xu X
AD  - Department of Biomedical Engineering and the Center for Biotechnology and 
      Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
FAU - Sanford, Thomas
AU  - Sanford T
AD  - Department of Urology, The State University of New York Upstate Medical 
      University, Syracuse, NY 13210, USA.
FAU - Turkbey, Baris
AU  - Turkbey B
AD  - Molecular Imaging Program, National Cancer Institute, National Institutes of 
      Health, Bethesda, MD 20892, USA.
FAU - Xu, Sheng
AU  - Xu S
AD  - Center for Interventional Oncology, Radiology & Imaging Sciences at National 
      Institutes of Health, Bethesda, MD 20892, USA.
FAU - Wood, Bradford J
AU  - Wood BJ
AD  - Center for Interventional Oncology, Radiology & Imaging Sciences at National 
      Institutes of Health, Bethesda, MD 20892, USA.
FAU - Yan, Pingkun
AU  - Yan P
AD  - Department of Biomedical Engineering and the Center for Biotechnology and 
      Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA. 
      Electronic address: yanp2@rpi.edu.
LA  - eng
GR  - R01 EB027898/EB/NIBIB NIH HHS/United States
GR  - R21 EB028001/EB/NIBIB NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20220317
PL  - Netherlands
TA  - Med Image Anal
JT  - Medical image analysis
JID - 9713490
SB  - IM
MH  - Humans
MH  - *Image Processing, Computer-Assisted/methods
MH  - Male
MH  - Neural Networks, Computer
MH  - *Prostate/diagnostic imaging
MH  - Ultrasonography
MH  - Uncertainty
PMC - PMC9082929
MID - NIHMS1795089
OTO - NOTNLM
OT  - Fully convolutional network
OT  - Polar transform
OT  - Prostate segmentation
OT  - Ultrasound image
OT  - Uncertainty estimation
COIS- Declaration of Competing Interest The authors declare that they have no known 
      competing financial interests or personal relationships that could have appeared 
      to influence the work reported in this paper.
EDAT- 2022/03/30 06:00
MHDA- 2022/04/22 06:00
CRDT- 2022/03/29 20:08
PHST- 2021/08/24 00:00 [received]
PHST- 2021/12/08 00:00 [revised]
PHST- 2022/03/07 00:00 [accepted]
PHST- 2022/03/30 06:00 [pubmed]
PHST- 2022/04/22 06:00 [medline]
PHST- 2022/03/29 20:08 [entrez]
AID - S1361-8415(22)00069-X [pii]
AID - 10.1016/j.media.2022.102418 [doi]
PST - ppublish
SO  - Med Image Anal. 2022 May;78:102418. doi: 10.1016/j.media.2022.102418. Epub 2022 
      Mar 17.

PMID- 34302054
OWN - NLM
STAT- MEDLINE
DCOM- 20220321
LR  - 20230210
IS  - 1530-0285 (Electronic)
IS  - 0893-3952 (Linking)
VI  - 34
IP  - 12
DP  - 2021 Dec
TI  - Clinicopathological and genomic characterization of BCORL1-driven high-grade 
      endometrial stromal sarcomas.
PG  - 2200-2210
LID - 10.1038/s41379-021-00873-z [doi]
AB  - BCORL1 is a transcriptional corepressor homologous to BCOR. We describe 12 
      BCORL1-altered uterine sarcomas with striking resemblance to BCOR-altered 
      endometrial stromal sarcoma (BCOR-ESS), including 5 with BCORL1 rearrangements 
      (JAZF1-BCORL1, EP300-BCORL1, or internal BCORL1 rearrangement), 5 with 
      inactivating BCORL1 mutations (T513fs*22, P600fs*1, R945*, R1196*, or R1265fs*4) 
      and 2 with homozygous BCORL1 deletion. The median patient age was 57.5 years 
      (range 33-79). An association with aggressive clinical behavior was identified. 
      Diagnoses assigned prior to genomic testing varied: 7 tumors were previously 
      diagnosed as ESS, 2 as high-grade uterine sarcomas, 2 as myxoid uterine 
      leiomyosarcomas, and 1 as a uterine spindle cell neoplasm consistent with 
      leiomyosarcoma. Tumors harbored frequent gelatinous, mucomyxoid-like appearance 
      by gross examination and unique histology with morphological overlap with 
      BCOR-ESS. Key microscopic features included (1) a spindle cell appearance, most 
      often with at least focal myxoid stroma, (2) variable amounts of hypocellular 
      fibromyxoid spindle areas with lower grade atypia and/or (3) variable amounts of 
      epithelioid areas with higher grade atypia. Specifically, spindle and epithelioid 
      components were present in 100 and 75% of sarcomas, respectively; myxoid stroma 
      was identified in 83%, collagen plaques or fibrosis in 50%, and high-grade 
      nuclear atypia was present in 42%. Like BCOR-ESS, 50% of BCORL1-altered sarcomas 
      exhibited CDK4 amplification or CDKN2A loss. In contrast, 33% harbored NF1 
      alterations, while 25% had other alterations in the NF2-mTOR pathway, expanding 
      potential therapeutic targets. In conclusion, inactivating BCORL1 genomic 
      alterations may define a distinct subset of high-grade endometrial stromal 
      sarcomas with biological overlap with BCOR-ESS, both of which may mimic myxoid 
      leiomyosarcomas.
CI  - © 2021. The Author(s), under exclusive licence to United States & Canadian 
      Academy of Pathology.
FAU - Lin, Douglas I
AU  - Lin DI
AUID- ORCID: 0000-0003-0105-9760
AD  - Foundation Medicine Inc., Cambridge, MA, USA. dlin@foundationmedicine.com.
FAU - Huang, Richard S P
AU  - Huang RSP
AD  - Foundation Medicine Inc., Morrisville, NC, USA.
FAU - Mata, Douglas A
AU  - Mata DA
AD  - Foundation Medicine Inc., Cambridge, MA, USA.
FAU - Decker, Brennan
AU  - Decker B
AD  - Foundation Medicine Inc., Cambridge, MA, USA.
FAU - Danziger, Natalie
AU  - Danziger N
AD  - Foundation Medicine Inc., Cambridge, MA, USA.
FAU - Lechpammer, Mirna
AU  - Lechpammer M
AD  - Foundation Medicine Inc., Cambridge, MA, USA.
FAU - Hiemenz, Matthew
AU  - Hiemenz M
AD  - Foundation Medicine Inc., Cambridge, MA, USA.
FAU - Ramkissoon, Shakti H
AU  - Ramkissoon SH
AD  - Foundation Medicine Inc., Morrisville, NC, USA.
AD  - Wake Forest Comprehensive Cancer Center and Department of Pathology, Wake Forest 
      School of Medicine, Winston-Salem, NC, USA.
FAU - Ross, Jeffrey S
AU  - Ross JS
AUID- ORCID: 0000-0001-8494-2596
AD  - Foundation Medicine Inc., Cambridge, MA, USA.
AD  - Upstate Medical University, Syracuse, NY, USA.
FAU - Elvin, Julia A
AU  - Elvin JA
AD  - Foundation Medicine Inc., Cambridge, MA, USA.
LA  - eng
PT  - Journal Article
DEP - 20210723
PL  - United States
TA  - Mod Pathol
JT  - Modern pathology : an official journal of the United States and Canadian Academy 
      of Pathology, Inc
JID - 8806605
RN  - 0 (BCORL1 protein, human)
RN  - 0 (Biomarkers, Tumor)
RN  - 0 (Repressor Proteins)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Biomarkers, Tumor/*genetics
MH  - Databases, Factual
MH  - Endometrial Neoplasms/*genetics/pathology
MH  - Female
MH  - Gene Amplification
MH  - Gene Rearrangement
MH  - Genetic Predisposition to Disease
MH  - Humans
MH  - Middle Aged
MH  - Molecular Diagnostic Techniques
MH  - Mutation
MH  - Neoplasm Grading
MH  - Phenotype
MH  - Predictive Value of Tests
MH  - Repressor Proteins/*genetics
MH  - Retrospective Studies
MH  - Sarcoma, Endometrial Stromal/*genetics/pathology
EDAT- 2021/07/25 06:00
MHDA- 2022/03/22 06:00
CRDT- 2021/07/24 06:15
PHST- 2021/01/17 00:00 [received]
PHST- 2021/07/08 00:00 [accepted]
PHST- 2021/07/02 00:00 [revised]
PHST- 2021/07/25 06:00 [pubmed]
PHST- 2022/03/22 06:00 [medline]
PHST- 2021/07/24 06:15 [entrez]
AID - S0893-3952(22)00381-7 [pii]
AID - 10.1038/s41379-021-00873-z [doi]
PST - ppublish
SO  - Mod Pathol. 2021 Dec;34(12):2200-2210. doi: 10.1038/s41379-021-00873-z. Epub 2021 
      Jul 23.

PMID- 32330067
OWN - NLM
STAT- MEDLINE
DCOM- 20210831
LR  - 20210831
IS  - 2473-4276 (Electronic)
IS  - 2473-4276 (Linking)
VI  - 4
DP  - 2020 Apr
TI  - Multiresolution Application of Artificial Intelligence in Digital Pathology for 
      Prediction of Positive Lymph Nodes From Primary Tumors in Bladder Cancer.
PG  - 367-382
LID - 10.1200/CCI.19.00155 [doi]
LID - CCI.19.00155
AB  - PURPOSE: To develop an artificial intelligence (AI)-based model for identifying 
      patients with lymph node (LN) metastasis based on digital evaluation of primary 
      tumors and train the model using cystectomy specimens available from The Cancer 
      Genome Atlas (TCGA) Project; patients from our institution were included for 
      validation of the leave-out test cohort. METHODS: In all, 307 patients were 
      identified for inclusion in the study (TCGA, n = 294; in-house, n = 13). Deep 
      learning models were trained from image patches at 2.5×, 5×, 10×, and 20× 
      magnifications, and spatially resolved prediction maps were combined with 
      microenvironment (lymphocyte infiltration) features to derive a final 
      patient-level AI score (probability of LN metastasis). Training and validation 
      included 219 patients (training, n = 146; validation, n = 73); 89 patients (TCGA, 
      n = 75; in-house, n = 13) were reserved as an independent testing set. 
      Multivariable logistic regression models for predicting LN status based on 
      clinicopathologic features alone and a combined model with AI score were fit to 
      training and validation sets. RESULTS: Several patients were determined to have 
      positive LN metastasis in TCGA (n = 105; 35.7%) and in-house (n = 3; 23.1%) 
      cohorts. A clinicopathologic model that considered using factors such as age, T 
      stage, and lymphovascular invasion demonstrated an area under the curve (AUC) of 
      0.755 (95% CI, 0.680 to 0.831) in the training and validation cohorts compared 
      with the cross validation of the AI score (likelihood of positive LNs), which 
      achieved an AUC of 0.866 (95% CI, 0.812 to 0.920; P = .021). Performance in the 
      test cohort was similar, with a clinicopathologic model AUC of 0.678 (95% CI, 
      0.554 to 0.802) and an AI score of 0.784 (95% CI, 0.702 to 0.896; P = .21). In 
      addition, the AI score remained significant after adjusting for clinicopathologic 
      variables (P = 1.08 × 10(-9)), and the combined model significantly outperformed 
      clinicopathologic features alone in the test cohort with an AUC of 0.807 (95% CI, 
      0.702 to 0.912; P = .047). CONCLUSION: Patients who are at higher risk of having 
      positive LNs during cystectomy can be identified on primary tumor samples using 
      novel AI-based methodologies applied to digital hematoxylin and eosin-stained 
      slides.
FAU - Harmon, Stephanie A
AU  - Harmon SA
AD  - Molecular Imaging Branch, National Cancer Institute, Bethesda, MD.
AD  - Clinical Research Directorate, Frederick National Laboratory for Cancer Research, 
      Frederick, MD.
FAU - Sanford, Thomas H
AU  - Sanford TH
AD  - Clinical Research Directorate, Frederick National Laboratory for Cancer Research, 
      Frederick, MD.
AD  - Department of Urology, Upstate Medical University, Syracuse, NY.
FAU - Brown, G Thomas
AU  - Brown GT
AD  - Clinical Research Directorate, Frederick National Laboratory for Cancer Research, 
      Frederick, MD.
AD  - National Library of Medicine, National Institutes of Health, Bethesda, MD.
FAU - Yang, Chris
AU  - Yang C
AD  - Molecular Imaging Branch, National Cancer Institute, Bethesda, MD.
FAU - Mehralivand, Sherif
AU  - Mehralivand S
AD  - Molecular Imaging Branch, National Cancer Institute, Bethesda, MD.
FAU - Jacob, Joseph M
AU  - Jacob JM
AD  - Department of Urology, Upstate Medical University, Syracuse, NY.
FAU - Valera, Vladimir A
AU  - Valera VA
AD  - Urologic Oncology Branch, National Cancer Institute, Bethesda, MD.
FAU - Shih, Joanna H
AU  - Shih JH
AD  - Division of Cancer Treatment and Diagnosis, Biometric Research Program, National 
      Cancer Institute, Bethesda, MD.
FAU - Agarwal, Piyush K
AU  - Agarwal PK
AD  - Urologic Oncology Branch, National Cancer Institute, Bethesda, MD.
FAU - Choyke, Peter L
AU  - Choyke PL
AD  - Molecular Imaging Branch, National Cancer Institute, Bethesda, MD.
FAU - Turkbey, Baris
AU  - Turkbey B
AD  - Molecular Imaging Branch, National Cancer Institute, Bethesda, MD.
LA  - eng
GR  - HHSN261200800001C/RC/CCR NIH HHS/United States
GR  - HHSN261200800001E/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PL  - United States
TA  - JCO Clin Cancer Inform
JT  - JCO clinical cancer informatics
JID - 101708809
SB  - IM
MH  - Artificial Intelligence
MH  - Humans
MH  - Lymph Nodes
MH  - Lymphatic Metastasis
MH  - Retrospective Studies
MH  - Tumor Microenvironment
MH  - *Urinary Bladder Neoplasms
PMC - PMC7259877
COIS- The following represents disclosure information provided by authors of this 
      manuscript. All relationships are considered compensated unless otherwise noted. 
      Relationships are self-held unless noted. I = Immediate Family Member, Inst = My 
      Institution. Relationships may not relate to the subject matter of this 
      manuscript. For more information about ASCO's conflict of interest policy, please 
      refer to www.asco.org/rwc or ascopubs.org/cci/author-center. Open Payments is a 
      public database containing information reported by companies about payments made 
      to US-licensed physicians (Open Payments). STEPHANIE A. HARMON: Patents, 
      Royalties, Other Intellectual Property: Patent: System and Method for Evaluation 
      of Disease Burden SHERIF MEHRALIVAND: Stock and Other Ownership Interests: AbbVie 
      PIYUSH K. AGARWAL: Employment: Pfizer (I) Travel, Accommodations, Expenses: 
      AstraZeneca/MedImmune PETER L. CHOYKE: Patents, Royalties, Other Intellectual 
      Property: Patent holder for magnetic resonance imaging-ultrasound fusion 
      technology licensed to InVivo which markets it as UroNav. However, as a 
      government employee I personally receive no financial benefit from this patent. 
      Other Relationship: Aspyrian Therapeutics, Philips Healthcare, GE Health Care 
      BARIS TURKBEY: Patents, Royalties, Other Intellectual Property: Royalties from US 
      government patents for magnetic resonance imaging/ultrasound fusion biopsy 
      computer-aided diagnosis software. Other Relationship: NVIDIA, Philips Healthcare 
      No other potential conflicts of interest were reported.
EDAT- 2020/04/25 06:00
MHDA- 2021/09/01 06:00
CRDT- 2020/04/25 06:00
PHST- 2020/04/25 06:00 [entrez]
PHST- 2020/04/25 06:00 [pubmed]
PHST- 2021/09/01 06:00 [medline]
AID - 1900155 [pii]
AID - 10.1200/CCI.19.00155 [doi]
PST - ppublish
SO  - JCO Clin Cancer Inform. 2020 Apr;4:367-382. doi: 10.1200/CCI.19.00155.

PMID- 33637877
OWN - NLM
STAT- MEDLINE
DCOM- 20220124
LR  - 20230210
IS  - 1530-0285 (Electronic)
IS  - 0893-3952 (Linking)
VI  - 34
IP  - 7
DP  - 2021 Jul
TI  - Clinicopathologic and genomic characterization of PD-L1-positive uterine cervical 
      carcinoma.
PG  - 1425-1433
LID - 10.1038/s41379-021-00780-3 [doi]
AB  - Positive program death-ligand 1 (PD-L1) immunohistochemistry (IHC) is an approved 
      companion diagnostic guiding the use of immune checkpoint inhibitors in uterine 
      cervical carcinoma (CXC). The clinical and genomic features of PD-L1-positive 
      (PD-L1(positive)) CXC have not been previously described. We reviewed the 
      clinicopathologic and molecular features of 647 CXC cases that were tested using 
      DAKO 22C3 PD-L1 IHC and comprehensive genomic profiling during the course of 
      clinical care. PD-L1(positive) cases were defined via a combined positive score 
      of ≥ 1. No differences were found in age, genetic ancestry, and HPV status of the 
      PD-L1(positive) (n = 548) and PD-L1(negative) disease subset. The PD-L1 
      positivity rate varied by histologic subtype of CXC with squamous cell carcinoma 
      (SCC) having a PD-L1 positivity rate of 91% (397/437) and usual-type 
      adenocarcinoma's PD-L1 positivity rate being 60% (35/58). In addition, the PD-L1 
      positivity rate varied depending on site of the specimen with 89.1% (261/293) 
      positivity rate observed in cervix specimens compared to 25% (2/8) in brain 
      metastases specimens. No significant difference in tumor mutational burden (TMB), 
      microsatellite instability, and CD274 (encoding PD-L1) amplification was observed 
      between PD-L1(positive) and PD-L1(negative) CXC subsets. By combining TMB with 
      PD-L1, an additional 17 patients are eligible for pembrolizumab when compared to 
      PD-L1 testing alone. TERT promoter alterations and APOBEC mutational signature 
      were enriched in the PD-L1(positive) CXC SCC (p = 0.011, and p = 0.004, 
      respectively). Our study reveals important prevalence data on PD-L1 positivity in 
      CXC non-SCC and suggests that further studies in these histologic subtypes are 
      warranted. In addition, we also provide a key framework to guide both specimen 
      selection and future investigations of predictors of immunotherapy response in 
      cervical cancer patients. Lastly, TERT promoter alterations and APOBEC mutational 
      signature may be a biologically unique subset of PD-L1(positive) CXC SCC.
FAU - Huang, Richard S P
AU  - Huang RSP
AD  - Foundation Medicine, Inc., Morrisville, NC, USA. rhuang@foundationmedicine.com.
FAU - Haberberger, James
AU  - Haberberger J
AD  - Foundation Medicine, Inc., Morrisville, NC, USA.
FAU - Murugesan, Karthikeyan
AU  - Murugesan K
AD  - Foundation Medicine, Inc., Cambridge, MA, USA.
FAU - Danziger, Natalie
AU  - Danziger N
AD  - Foundation Medicine, Inc., Cambridge, MA, USA.
FAU - Hiemenz, Matthew
AU  - Hiemenz M
AD  - Foundation Medicine, Inc., Cambridge, MA, USA.
FAU - Severson, Eric
AU  - Severson E
AD  - Foundation Medicine, Inc., Morrisville, NC, USA.
FAU - Duncan, Daniel L
AU  - Duncan DL
AD  - Foundation Medicine, Inc., Morrisville, NC, USA.
FAU - Ramkissoon, Shakti H
AU  - Ramkissoon SH
AD  - Foundation Medicine, Inc., Morrisville, NC, USA.
AD  - Wake Forest Comprehensive Cancer Center, and Department of Pathology, Wake Forest 
      School of Medicine, Winston-Salem, NC, USA.
FAU - Ross, Jeffrey S
AU  - Ross JS
AUID- ORCID: 0000-0001-8494-2596
AD  - Foundation Medicine, Inc., Morrisville, NC, USA.
AD  - Department of Pathology, State University of New York (SUNY) Upstate Medical 
      University, Syracuse, NY, USA.
FAU - Elvin, Julia A
AU  - Elvin JA
AD  - Foundation Medicine, Inc., Cambridge, MA, USA.
FAU - Lin, Douglas I
AU  - Lin DI
AUID- ORCID: 0000-0003-0105-9760
AD  - Foundation Medicine, Inc., Cambridge, MA, USA.
LA  - eng
PT  - Journal Article
DEP - 20210226
PL  - United States
TA  - Mod Pathol
JT  - Modern pathology : an official journal of the United States and Canadian Academy 
      of Pathology, Inc
JID - 8806605
RN  - 0 (B7-H1 Antigen)
RN  - 0 (CD274 protein, human)
SB  - IM
MH  - Adult
MH  - Aged
MH  - *B7-H1 Antigen
MH  - *Carcinoma
MH  - Female
MH  - Humans
MH  - Middle Aged
MH  - Retrospective Studies
MH  - Uterine Cervical Neoplasms
EDAT- 2021/02/28 06:00
MHDA- 2022/01/27 06:00
CRDT- 2021/02/27 05:38
PHST- 2020/11/13 00:00 [received]
PHST- 2021/02/02 00:00 [accepted]
PHST- 2021/02/01 00:00 [revised]
PHST- 2021/02/28 06:00 [pubmed]
PHST- 2022/01/27 06:00 [medline]
PHST- 2021/02/27 05:38 [entrez]
AID - S0893-3952(22)00591-9 [pii]
AID - 10.1038/s41379-021-00780-3 [doi]
PST - ppublish
SO  - Mod Pathol. 2021 Jul;34(7):1425-1433. doi: 10.1038/s41379-021-00780-3. Epub 2021 
      Feb 26.

PMID- 37457264
OWN - NLM
STAT- MEDLINE
DCOM- 20230725
LR  - 20231129
IS  - 2296-2565 (Electronic)
IS  - 2296-2565 (Linking)
VI  - 11
DP  - 2023
TI  - LetsTalkShots: personalized vaccine risk communication.
PG  - 1195751
LID - 10.3389/fpubh.2023.1195751 [doi]
LID - 1195751
AB  - INTRODUCTION: Vaccine hesitancy is a global health threat undermining control of 
      many vaccine-preventable diseases. Patient-level education has largely been 
      ineffective in reducing vaccine concerns and increasing vaccine uptake. We built 
      and evaluated a personalized vaccine risk communication website called 
      LetsTalkShots in English, Spanish and French (Canadian) for vaccines across the 
      lifespan. LetsTalkShots tailors lived experiences, credible sources and 
      informational animations to disseminate the right message from the right 
      messenger to the right person, applying a broad range of behavioral theories. 
      METHODS: We used mixed-methods research to test our animation and some aspects of 
      credible sources and personal narratives. We conducted 67 discussion groups (n = 
      325 persons), stratified by race/ethnicity (African American, Hispanic, and White 
      people) and population (e.g., parents, pregnant women, adolescents, younger 
      adults, and older adults). Using a large Ipsos survey among English-speaking 
      respondents (n = 2,272), we tested animations aligned with vaccine concerns and 
      specific to population (e.g., parents of children, parents of adolescents, 
      younger adults, older adults). RESULTS: Discussion groups provided robust 
      feedback specific to each animation as well as areas for improvements across 
      animations. Most respondents indicated that the information presented was 
      interesting (85.5%), clear (96.0%), helpful (87.0%), and trustworthy (82.2%). 
      DISCUSSION: Tailored vaccine risk communication can assist decision makers as 
      they consider vaccination for themselves, their families, and their communities. 
      LetsTalkShots presents a model for personalized communication in other areas of 
      medicine and public health.
CI  - Copyright © 2023 Salmon, Dudley, Brewer, Shaw, Schuh, Proveaux, Jamison, Forr, 
      Goryn, Breiman, Orenstein, Kao, Josiah Willcock, Cantu, Decea, Mowson, Tsubata, 
      Bucci, Lawler, Watkins, Moore, Fugett, Fugal, Tovar, Gay, Cary, Vann, Smith, Kan, 
      Mankel, Beekun, Smith, Adams, Harvey and Orton.
FAU - Salmon, Daniel A
AU  - Salmon DA
AD  - Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public 
      Health, Baltimore, MD, United States.
AD  - Department of International Health, Johns Hopkins University Bloomberg School of 
      Public Health, Baltimore, MD, United States.
AD  - Department of Health, Behavior, and Society, Johns Hopkins University Bloomberg 
      School of Public Health, Baltimore, MD, United States.
FAU - Dudley, Matthew Z
AU  - Dudley MZ
AD  - Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public 
      Health, Baltimore, MD, United States.
AD  - Department of International Health, Johns Hopkins University Bloomberg School of 
      Public Health, Baltimore, MD, United States.
FAU - Brewer, Janesse
AU  - Brewer J
AD  - Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public 
      Health, Baltimore, MD, United States.
AD  - Department of International Health, Johns Hopkins University Bloomberg School of 
      Public Health, Baltimore, MD, United States.
FAU - Shaw, Jana
AU  - Shaw J
AD  - Department of Public Health and Preventive Medicine, State University of New 
      York, Upstate Medical University, Syracuse, NY, United States.
AD  - Department of Pediatrics, State University of New York, Upstate Medical 
      University, Syracuse, NY, United States.
FAU - Schuh, Holly B
AU  - Schuh HB
AD  - Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, MD, United States.
FAU - Proveaux, Tina M
AU  - Proveaux TM
AD  - Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public 
      Health, Baltimore, MD, United States.
AD  - Department of International Health, Johns Hopkins University Bloomberg School of 
      Public Health, Baltimore, MD, United States.
FAU - Jamison, Amelia M
AU  - Jamison AM
AD  - Department of Health, Behavior, and Society, Johns Hopkins University Bloomberg 
      School of Public Health, Baltimore, MD, United States.
FAU - Forr, Amanda
AU  - Forr A
AD  - Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public 
      Health, Baltimore, MD, United States.
FAU - Goryn, Michelle
AU  - Goryn M
AD  - Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public 
      Health, Baltimore, MD, United States.
FAU - Breiman, Robert F
AU  - Breiman RF
AD  - Department of Global Health, Rollins School of Public Health, Emory University, 
      Atlanta, GA, United States.
FAU - Orenstein, Walter A
AU  - Orenstein WA
AD  - Division of Infectious Diseases, Department of Medicine, Emory University School 
      of Medicine, Atlanta, GA, United States.
FAU - Kao, Lee-Sien
AU  - Kao LS
AD  - ieas42.org, New York, NY, United States.
FAU - Josiah Willcock, Robina
AU  - Josiah Willcock R
AD  - Department of Community Health and Preventive Medicine, Morehouse School of 
      Medicine, Atlanta, GA, United States.
FAU - Cantu, Michelle
AU  - Cantu M
AD  - Department of Immunization, National Association of County and City Health 
      Officials, Washington, DC, United States.
FAU - Decea, Tori
AU  - Decea T
AD  - Department of Immunization, National Association of County and City Health 
      Officials, Washington, DC, United States.
FAU - Mowson, Robin
AU  - Mowson R
AD  - Department of Immunization, National Association of County and City Health 
      Officials, Washington, DC, United States.
FAU - Tsubata, Kate
AU  - Tsubata K
AD  - Bonnemaison, Baltimore, MD, United States.
FAU - Bucci, Lucie Marisa
AU  - Bucci LM
AD  - Bucci-Hepworth Health Services Inc., Pincourt, QC, Canada.
FAU - Lawler, Jaqueline
AU  - Lawler J
AD  - Orange County Department of Health, Goshen, NY, United States.
FAU - Watkins, James D
AU  - Watkins JD
AD  - Williams County Combined Health District, Montpelier, OH, United States.
FAU - Moore, Jamie W
AU  - Moore JW
AD  - Guilford County Division of Public Health, Greensboro, NC, United States.
FAU - Fugett, James H
AU  - Fugett JH
AD  - Guilford County Division of Public Health, Greensboro, NC, United States.
FAU - Fugal, Adriele
AU  - Fugal A
AD  - Monongalia County Health Department, Morgantown, WV, United States.
FAU - Tovar, Yazmine
AU  - Tovar Y
AD  - Monongalia County Health Department, Morgantown, WV, United States.
FAU - Gay, Marie
AU  - Gay M
AD  - Orange County Department of Health, Goshen, NY, United States.
FAU - Cary, Aleen M
AU  - Cary AM
AD  - Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public 
      Health, Baltimore, MD, United States.
FAU - Vann, Iulia
AU  - Vann I
AD  - Utah County Health Department, Provo, UT, United States.
FAU - Smith, Lee B
AU  - Smith LB
AD  - Guilford County Division of Public Health, Greensboro, NC, United States.
FAU - Kan, Lilly
AU  - Kan L
AD  - Department of Immunization, National Association of County and City Health 
      Officials, Washington, DC, United States.
FAU - Mankel, Magda
AU  - Mankel M
AD  - Border Studies Program, Earlham College, Tucson, AZ, United States.
FAU - Beekun, Sumayya
AU  - Beekun S
AD  - Department of International Health, Johns Hopkins University Bloomberg School of 
      Public Health, Baltimore, MD, United States.
AD  - Center for Indigenous Health, Johns Hopkins University Bloomberg School of Public 
      Health, Baltimore, MD, United States.
FAU - Smith, Victoria
AU  - Smith V
AD  - Williams County Combined Health District, Montpelier, OH, United States.
FAU - Adams, Stephanie D
AU  - Adams SD
AD  - Center for Global Health Innovation, Atlanta, GA, United States.
FAU - Harvey, Steven A
AU  - Harvey SA
AD  - Department of International Health, Johns Hopkins University Bloomberg School of 
      Public Health, Baltimore, MD, United States.
FAU - Orton, Peter Z
AU  - Orton PZ
AD  - Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public 
      Health, Baltimore, MD, United States.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, P.H.S.
DEP - 20230630
PL  - Switzerland
TA  - Front Public Health
JT  - Frontiers in public health
JID - 101616579
RN  - 0 (Vaccines)
SB  - IM
EIN - Front Public Health. 2023 Oct 30;11:1311055. PMID: 38026293
MH  - Adolescent
MH  - Aged
MH  - Child
MH  - Female
MH  - Humans
MH  - Pregnancy
MH  - Black or African American
MH  - Canada
MH  - *Communication
MH  - *Vaccination
MH  - *Vaccines
MH  - Precision Medicine
MH  - Vaccination Hesitancy
MH  - Risk
MH  - Public Health
MH  - Health Promotion
MH  - Health Education/methods
MH  - Hispanic or Latino
MH  - White
MH  - Young Adult
MH  - Parents
PMC - PMC10348877
OTO - NOTNLM
OT  - COVID-19
OT  - communication
OT  - tailored application
OT  - vaccine hesitancy
OT  - vaccines
COIS- DS has received research support from Merck and serves on advisory boards for 
      Merck, Janssen Moderna, and Sanofi. MD has received research support from Merck. 
      KT was employed by Bonnemaison. LB was employed by Bucci-Hepworth Health Services 
      Inc. The remaining authors declare that the research was conducted in the absence 
      of any commercial or financial relationships that could be construed as a 
      potential conflict of interest.
EDAT- 2023/07/17 06:42
MHDA- 2023/07/18 13:10
CRDT- 2023/07/17 04:35
PHST- 2023/03/30 00:00 [received]
PHST- 2023/06/12 00:00 [accepted]
PHST- 2023/07/18 13:10 [medline]
PHST- 2023/07/17 06:42 [pubmed]
PHST- 2023/07/17 04:35 [entrez]
AID - 10.3389/fpubh.2023.1195751 [doi]
PST - epublish
SO  - Front Public Health. 2023 Jun 30;11:1195751. doi: 10.3389/fpubh.2023.1195751. 
      eCollection 2023.

PMID- 32059026
OWN - NLM
STAT- MEDLINE
DCOM- 20200424
LR  - 20231103
IS  - 1935-2735 (Electronic)
IS  - 1935-2727 (Print)
IS  - 1935-2727 (Linking)
VI  - 14
IP  - 2
DP  - 2020 Feb
TI  - Severity Index for Suspected Arbovirus (SISA): Machine learning for accurate 
      prediction of hospitalization in subjects suspected of arboviral infection.
PG  - e0007969
LID - 10.1371/journal.pntd.0007969 [doi]
LID - e0007969
AB  - BACKGROUND: Dengue, chikungunya, and Zika are arboviruses of major global health 
      concern. Decisions regarding the clinical management of suspected arboviral 
      infection are challenging in resource-limited settings, particularly when 
      deciding on patient hospitalization. The objective of this study was to determine 
      if hospitalization of individuals with suspected arboviral infections could be 
      predicted using subject intake data. METHODOLOGY/PRINCIPAL FINDINGS: Two 
      prediction models were developed using data from a surveillance study in Machala, 
      a city in southern coastal Ecuador with a high burden of arboviral infections. 
      Data were obtained from subjects who presented at sentinel medical centers with 
      suspected arboviral infection (November 2013 to September 2017). The first 
      prediction model-called the Severity Index for Suspected Arbovirus (SISA)-used 
      only demographic and symptom data. The second prediction model-called the 
      Severity Index for Suspected Arbovirus with Laboratory (SISAL)-incorporated 
      laboratory data. These models were selected by comparing the prediction ability 
      of seven machine learning algorithms; the area under the receiver operating 
      characteristic curve from the prediction of a test dataset was used to select the 
      final algorithm for each model. After eliminating those with missing data, the 
      SISA dataset had 534 subjects, and the SISAL dataset had 98 subjects. For SISA, 
      the best prediction algorithm was the generalized boosting model, with an AUC of 
      0.91. For SISAL, the best prediction algorithm was the elastic net with an AUC of 
      0.94. A sensitivity analysis revealed that SISA and SISAL are not directly 
      comparable to one another. CONCLUSIONS/SIGNIFICANCE: Both SISA and SISAL were 
      able to predict arbovirus hospitalization with a high degree of accuracy in our 
      dataset. These algorithms will need to be tested and validated on new data from 
      future patients. Machine learning is a powerful prediction tool and provides an 
      excellent option for new management tools and clinical assessment of arboviral 
      infection.
FAU - Sippy, Rachel
AU  - Sippy R
AUID- ORCID: 0000-0003-3617-2093
AD  - Institute for Global Health and Translational Science, SUNY Upstate Medical 
      University, Syracuse, New York, United States of America.
AD  - Quantitative Disease Ecology and Conservation Lab, Department of Geography, 
      University of Florida, Gainesville, Florida, United States of America.
AD  - Emerging Pathogens Institute, University of Florida, Gainesville, Florida, United 
      States of America.
FAU - Farrell, Daniel F
AU  - Farrell DF
AD  - College of Medicine, MD Program, SUNY Upstate Medical University, Syracuse, New 
      York, United States of America.
FAU - Lichtenstein, Daniel A
AU  - Lichtenstein DA
AD  - College of Medicine, MD Program, SUNY Upstate Medical University, Syracuse, New 
      York, United States of America.
FAU - Nightingale, Ryan
AU  - Nightingale R
AD  - College of Medicine, MD Program, SUNY Upstate Medical University, Syracuse, New 
      York, United States of America.
FAU - Harris, Megan A
AU  - Harris MA
AD  - College of Medicine, MD Program, SUNY Upstate Medical University, Syracuse, New 
      York, United States of America.
FAU - Toth, Joseph
AU  - Toth J
AD  - College of Medicine, MD Program, SUNY Upstate Medical University, Syracuse, New 
      York, United States of America.
FAU - Hantztidiamantis, Paris
AU  - Hantztidiamantis P
AUID- ORCID: 0000-0002-7872-8355
AD  - College of Medicine, MD Program, SUNY Upstate Medical University, Syracuse, New 
      York, United States of America.
FAU - Usher, Nicholas
AU  - Usher N
AUID- ORCID: 0000-0001-8779-519X
AD  - Office of Undergraduate Biology, Cornell University, Ithaca, New York, United 
      States of America.
FAU - Cueva Aponte, Cinthya
AU  - Cueva Aponte C
AD  - Institute for Global Health and Translational Science, SUNY Upstate Medical 
      University, Syracuse, New York, United States of America.
FAU - Barzallo Aguilar, Julio
AU  - Barzallo Aguilar J
AD  - Teófilo Dávila Hospital, Ministry of Health, Machala, El Oro Province, Ecuador.
FAU - Puthumana, Anthony
AU  - Puthumana A
AD  - College of Medicine, MD Program, SUNY Upstate Medical University, Syracuse, New 
      York, United States of America.
FAU - Lupone, Christina D
AU  - Lupone CD
AUID- ORCID: 0000-0001-9241-5788
AD  - Institute for Global Health and Translational Science, SUNY Upstate Medical 
      University, Syracuse, New York, United States of America.
FAU - Endy, Timothy
AU  - Endy T
AD  - Institute for Global Health and Translational Science, SUNY Upstate Medical 
      University, Syracuse, New York, United States of America.
AD  - Department of Medicine, SUNY Upstate Medical University, Syracuse, New York, 
      United States of America.
FAU - Ryan, Sadie J
AU  - Ryan SJ
AUID- ORCID: 0000-0002-4308-6321
AD  - Quantitative Disease Ecology and Conservation Lab, Department of Geography, 
      University of Florida, Gainesville, Florida, United States of America.
AD  - Emerging Pathogens Institute, University of Florida, Gainesville, Florida, United 
      States of America.
FAU - Stewart Ibarra, Anna M
AU  - Stewart Ibarra AM
AD  - Institute for Global Health and Translational Science, SUNY Upstate Medical 
      University, Syracuse, New York, United States of America.
AD  - Department of Medicine, SUNY Upstate Medical University, Syracuse, New York, 
      United States of America.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20200214
PL  - United States
TA  - PLoS Negl Trop Dis
JT  - PLoS neglected tropical diseases
JID - 101291488
SB  - IM
MH  - Adolescent
MH  - Arbovirus Infections/epidemiology/pathology/*therapy/virology
MH  - Arboviruses/genetics/*physiology
MH  - Child
MH  - Child, Preschool
MH  - Ecuador/epidemiology
MH  - Female
MH  - Hospitalization/statistics & numerical data
MH  - Humans
MH  - Infant
MH  - Machine Learning
MH  - Male
MH  - Prospective Studies
MH  - Retrospective Studies
MH  - Severity of Illness Index
PMC - PMC7046343
COIS- The authors have declared that no competing interests exist.
EDAT- 2020/02/15 06:00
MHDA- 2020/04/25 06:00
CRDT- 2020/02/15 06:00
PHST- 2019/06/11 00:00 [received]
PHST- 2019/12/03 00:00 [accepted]
PHST- 2020/02/27 00:00 [revised]
PHST- 2020/02/15 06:00 [pubmed]
PHST- 2020/04/25 06:00 [medline]
PHST- 2020/02/15 06:00 [entrez]
AID - PNTD-D-19-00886 [pii]
AID - 10.1371/journal.pntd.0007969 [doi]
PST - epublish
SO  - PLoS Negl Trop Dis. 2020 Feb 14;14(2):e0007969. doi: 
      10.1371/journal.pntd.0007969. eCollection 2020 Feb.

PMID- 26573769
OWN - NLM
STAT- MEDLINE
DCOM- 20170926
LR  - 20220129
IS  - 1476-5578 (Electronic)
IS  - 1359-4184 (Print)
IS  - 1359-4184 (Linking)
VI  - 21
IP  - 9
DP  - 2016 Sep
TI  - Psychiatric gene discoveries shape evidence on ADHD's biology.
PG  - 1202-7
LID - 10.1038/mp.2015.163 [doi]
AB  - A strong motivation for undertaking psychiatric gene discovery studies is to 
      provide novel insights into unknown biology. Although attention-deficit 
      hyperactivity disorder (ADHD) is highly heritable, and large, rare copy number 
      variants (CNVs) contribute to risk, little is known about its pathogenesis and it 
      remains commonly misunderstood. We assembled and pooled five ADHD and control CNV 
      data sets from the United Kingdom, Ireland, United States of America, Northern 
      Europe and Canada. Our aim was to test for enrichment of neurodevelopmental gene 
      sets, implicated by recent exome-sequencing studies of (a) schizophrenia and (b) 
      autism as a means of testing the hypothesis that common pathogenic mechanisms 
      underlie ADHD and these other neurodevelopmental disorders. We also undertook 
      hypothesis-free testing of all biological pathways. We observed significant 
      enrichment of individual genes previously found to harbour schizophrenia de novo 
      non-synonymous single-nucleotide variants (SNVs; P=5.4 × 10(-4)) and targets of 
      the Fragile X mental retardation protein (P=0.0018). No enrichment was observed 
      for activity-regulated cytoskeleton-associated protein (P=0.23) or 
      N-methyl-D-aspartate receptor (P=0.74) post-synaptic signalling gene sets 
      previously implicated in schizophrenia. Enrichment of ADHD CNV hits for genes 
      impacted by autism de novo SNVs (P=0.019 for non-synonymous SNV genes) did not 
      survive Bonferroni correction. Hypothesis-free testing yielded several highly 
      significantly enriched biological pathways, including ion channel pathways. 
      Enrichment findings were robust to multiple testing corrections and to 
      sensitivity analyses that excluded the most significant sample. The findings 
      reveal that CNVs in ADHD converge on biologically meaningful gene clusters, 
      including ones now established as conferring risk of other neurodevelopmental 
      disorders.
FAU - Thapar, A
AU  - Thapar A
AD  - Institute of Psychological Medicine and Clinical Neurosciences and MRC Centre for 
      Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, 
      Cardiff, UK.
FAU - Martin, J
AU  - Martin J
AD  - Institute of Psychological Medicine and Clinical Neurosciences and MRC Centre for 
      Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, 
      Cardiff, UK.
FAU - Mick, E
AU  - Mick E
AD  - Department of Quantitative Health Sciences, Department of Psychiatry, University 
      of Massachusetts Medical School, Worcester, MA, USA.
AD  - Department of Psychiatry, University of Massachusetts Medical School, Worcester, 
      MA, USA.
FAU - Arias Vásquez, A
AU  - Arias Vásquez A
AD  - Radboud University Medical Center, Donders Institute for Brain, Cognition and 
      Behaviour, Departments of Psychiatry and Human Genetics, Nijmegen, The 
      Netherlands.
AD  - Radboud University Medical Center, Donders Institute for Brain, Cognition and 
      Behaviour, Department of Cognitive Neuroscience, Nijmegen, The Netherlands.
FAU - Langley, K
AU  - Langley K
AD  - Institute of Psychological Medicine and Clinical Neurosciences and MRC Centre for 
      Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, 
      Cardiff, UK.
AD  - School of Psychology, Cardiff University, Cardiff, UK.
FAU - Scherer, S W
AU  - Scherer SW
AD  - Centre for Applied Genomics, Hospital for Sick Children, Toronto, Ontario, 
      Canada.
FAU - Schachar, R
AU  - Schachar R
AD  - Department of Psychiatry, Neurosciences and Mental Health, Hospital for Sick 
      Children, University of Toronto, Toronto, Ontario, Canada.
FAU - Crosbie, J
AU  - Crosbie J
AD  - Department of Psychiatry, Neurosciences and Mental Health, Hospital for Sick 
      Children, University of Toronto, Toronto, Ontario, Canada.
FAU - Williams, N
AU  - Williams N
AD  - Institute of Psychological Medicine and Clinical Neurosciences and MRC Centre for 
      Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, 
      Cardiff, UK.
FAU - Franke, B
AU  - Franke B
AD  - Radboud University Medical Center, Donders Institute for Brain, Cognition and 
      Behaviour, Departments of Psychiatry and Human Genetics, Nijmegen, The 
      Netherlands.
FAU - Elia, J
AU  - Elia J
AD  - Department of Pediatrics and Psychiatry, Sidney Kimmel College of Medicine, 
      Thomas Jefferson University, Philadelphia, PA, USA.
AD  - Nemours Neuroscience Center, Wilmington, DE, USA.
AD  - Department of Psychiatry, University of Pennsylvania, Pennsylvania, PA, USA.
FAU - Glessner, J
AU  - Glessner J
AD  - Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA, 
      USA.
FAU - Hakonarson, H
AU  - Hakonarson H
AD  - Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, 
      PA, USA.
FAU - Owen, M J
AU  - Owen MJ
AD  - Institute of Psychological Medicine and Clinical Neurosciences and MRC Centre for 
      Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, 
      Cardiff, UK.
FAU - Faraone, S V
AU  - Faraone SV
AD  - Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate 
      Medical University, Syracuse, NY, USA.
AD  - K.G. Jebsen Centre for Research on Neuropsychiatric Disorders, University of 
      Bergen, Bergen, Norway.
FAU - O'Donovan, M C
AU  - O'Donovan MC
AD  - Institute of Psychological Medicine and Clinical Neurosciences and MRC Centre for 
      Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, 
      Cardiff, UK.
FAU - Holmans, P
AU  - Holmans P
AD  - Institute of Psychological Medicine and Clinical Neurosciences and MRC Centre for 
      Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, 
      Cardiff, UK.
LA  - eng
GR  - G1000632/MRC_/Medical Research Council/United Kingdom
GR  - R01 MH062873/MH/NIMH NIH HHS/United States
GR  - U54 HD086984/HD/NICHD NIH HHS/United States
GR  - R13 MH059126/MH/NIMH NIH HHS/United States
GR  - WT_/Wellcome Trust/United Kingdom
GR  - 079711/WT_/Wellcome Trust/United Kingdom
GR  - MR/L010305/1/MRC_/Medical Research Council/United Kingdom
GR  - R01 MH081803/MH/NIMH NIH HHS/United States
GR  - UL1 TR000161/TR/NCATS NIH HHS/United States
GR  - UL1 TR001453/TR/NCATS NIH HHS/United States
GR  - P30 HD004147/HD/NICHD NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20151117
PL  - England
TA  - Mol Psychiatry
JT  - Molecular psychiatry
JID - 9607835
SB  - IM
MH  - Adolescent
MH  - Attention Deficit Disorder with Hyperactivity/*genetics
MH  - Autistic Disorder/genetics
MH  - Biological Psychiatry/*methods
MH  - Canada
MH  - Child
MH  - Child, Preschool
MH  - DNA Copy Number Variations/genetics
MH  - Databases, Nucleic Acid
MH  - Europe
MH  - Female
MH  - Genetic Association Studies/methods
MH  - Genetic Predisposition to Disease/genetics
MH  - Genome-Wide Association Study
MH  - Humans
MH  - Ireland
MH  - Male
MH  - Neurodevelopmental Disorders/genetics
MH  - Polymorphism, Single Nucleotide/genetics
MH  - Schizophrenia/genetics
MH  - United Kingdom
PMC - PMC4820035
MID - EMS65004
OID - NLM: EMS65004
COIS- Dr R Schachar has served as an advisor or consultant to Eli Lilly, Purdue Pharma 
      and Highland Therapeutics and is named on institutional patents for several genes 
      involved in ADHD and for a stop-task software programme. Dr SV Faraone has 
      received research support from, served as consultant or adviser to or 
      participated in CME programmes sponsored by Alcobra, Janssen, Eli Lilly, NIH, 
      Novartis, McNeil, Pfizer and Shire; he receives royalties from Guilford Press and 
      Oxford University Press. In the past year, Dr SV Faraone received income, 
      potential income, travel expenses and/or research support from Pfizer, Ironshore, 
      Shire, Akili Interactive Labs, CogCubed, Alcobra, VAYA Pharma, Neurovance, Impax 
      and NeuroLifeSciences. With his institution, he has US patent US20130217707 A1 
      for the use of sodium-hydrogen exchange inhibitors in the treatment of ADHD. The 
      remaining authors declare no conflict of interest.
EDAT- 2015/11/18 06:00
MHDA- 2017/09/28 06:00
CRDT- 2015/11/18 06:00
PHST- 2015/04/02 00:00 [received]
PHST- 2015/07/08 00:00 [revised]
PHST- 2015/09/08 00:00 [accepted]
PHST- 2015/11/18 06:00 [entrez]
PHST- 2015/11/18 06:00 [pubmed]
PHST- 2017/09/28 06:00 [medline]
AID - mp2015163 [pii]
AID - 10.1038/mp.2015.163 [doi]
PST - ppublish
SO  - Mol Psychiatry. 2016 Sep;21(9):1202-7. doi: 10.1038/mp.2015.163. Epub 2015 Nov 
      17.

PMID- 32971544
OWN - NLM
STAT- MEDLINE
DCOM- 20210616
LR  - 20210616
IS  - 2567-6911 (Electronic)
IS  - 0932-0814 (Linking)
VI  - 33
IP  - 6
DP  - 2020 Nov
TI  - Radiographic and Biomechanical Assessment of Three Implant Designs for Canine 
      Cementless Total Hip Replacement.
PG  - 417-427
LID - 10.1055/s-0040-1715476 [doi]
AB  - OBJECTIVE:  The aim of this study was to evaluate the relationship between 
      radiographic fit/fill measurements and biomechanical performance of three canine 
      cementless total hip implant designs using an in vitro biomechanical testing 
      protocol that replicates compression and torsion. STUDY DESIGN:  Eighteen 
      (six/group) canine cadaveric femurs were implanted with one of three cementless 
      total hip implant designs: (1) collarless, (2) collared or (3) lateral bolt 
      stems. Femoral length, canal flare index (CFI), canal fill, stem fit, stem level 
      and stem angle were measured as independent variables. Biomechanical performance 
      was tested using physiological, non-destructive gait loading (loading protocols) 
      and destructive testing (failure protocols). RESULTS:  During loading protocols, 
      compressive stiffness was influenced by stem level (p < 0.05) and torsional 
      stiffness was influenced by stem level and CFI for collarless stems (p < 0.05). 
      During failure protocols, peak load was influenced by mediolateral (ML) stem 
      angle (p < 0.05) and CFI (p < 0.01) for collarless stems and CFI for lateral bolt 
      stems (p < 0.05). Peak torque was influenced by ML stem angle, craniocaudal stem 
      angle and CFI for collarless stems (p < 0.05) and average ML fill for collared 
      stems (p < 0.05). CONCLUSION:  Biomechanical performance of collarless stems in 
      cementless hip arthroplasty is more impacted by radiographic fit/fill than 
      lateral bolt and collared stems. As a result, collarless stems may be more 
      dependent on preoperative fit and intraoperative precision.
CI  - Thieme. All rights reserved.
FAU - Worden, Natalie J
AU  - Worden NJ
AUID- ORCID: 0000-0001-9843-8112
AD  - Department of Clinical Sciences, College of Veterinary Medicine, Cornell 
      University, Ithaca, New York, United States.
FAU - Ash, Kristian J
AU  - Ash KJ
AD  - Department of Clinical Sciences, College of Veterinary Medicine, Cornell 
      University, Ithaca, New York, United States.
FAU - Ordway, Nathaniel R
AU  - Ordway NR
AUID- ORCID: 0000-0002-4553-3412
AD  - Department of Orthopedic Surgery, SUNY Upstate Medical University, Syracuse, New 
      York, United States.
FAU - Miller, Mark A
AU  - Miller MA
AD  - Department of Orthopedic Surgery, SUNY Upstate Medical University, Syracuse, New 
      York, United States.
FAU - Mann, Kenneth A
AU  - Mann KA
AD  - Department of Orthopedic Surgery, SUNY Upstate Medical University, Syracuse, New 
      York, United States.
FAU - VanDeventer, Gretchen M
AU  - VanDeventer GM
AD  - Department of Clinical Sciences, College of Veterinary Medicine, Cornell 
      University, Ithaca, New York, United States.
FAU - Valenzano, Dominick M
AU  - Valenzano DM
AD  - Department of Clinical Sciences, College of Veterinary Medicine, Cornell 
      University, Ithaca, New York, United States.
FAU - Hart, Robert
AU  - Hart R
AD  - Department of Orthopedic Surgery, Animal Medical Center, New York, New York, 
      United States.
FAU - Kayano, Mitsunori
AU  - Kayano M
AD  - Department of Veterinary Medicine, Research Center for Global Agromedicine, 
      Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Japan.
FAU - Hayashi, Kei
AU  - Hayashi K
AD  - Department of Clinical Sciences, College of Veterinary Medicine, Cornell 
      University, Ithaca, New York, United States.
LA  - eng
PT  - Journal Article
DEP - 20200924
PL  - Germany
TA  - Vet Comp Orthop Traumatol
JT  - Veterinary and comparative orthopaedics and traumatology : V.C.O.T
JID - 8906319
SB  - IM
MH  - Animals
MH  - Arthroplasty, Replacement, Hip/*veterinary
MH  - Biomechanical Phenomena
MH  - Dogs/*surgery
MH  - Prostheses and Implants/veterinary
MH  - Radiography/veterinary
COIS- None declared.
EDAT- 2020/09/25 06:00
MHDA- 2021/06/17 06:00
CRDT- 2020/09/24 20:20
PHST- 2020/09/25 06:00 [pubmed]
PHST- 2021/06/17 06:00 [medline]
PHST- 2020/09/24 20:20 [entrez]
AID - 10.1055/s-0040-1715476 [doi]
PST - ppublish
SO  - Vet Comp Orthop Traumatol. 2020 Nov;33(6):417-427. doi: 10.1055/s-0040-1715476. 
      Epub 2020 Sep 24.

PMID- 36650021
OWN - NLM
STAT- MEDLINE
DCOM- 20230119
LR  - 20230206
IS  - 2051-1426 (Electronic)
IS  - 2051-1426 (Linking)
VI  - 11
IP  - 1
DP  - 2023 Jan
TI  - Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune 
      checkpoint inhibitor: a real-world outcomes analysis.
LID - 10.1136/jitc-2022-005801 [doi]
LID - e005801
AB  - BACKGROUND: For patients with advanced non-small cell lung carcinoma (NSCLC), 
      immune checkpoint inhibitor (ICPI) and chemotherapy (chemo) ICPI represent two 
      distinct first-line standard-of-care regimens without clear and established 
      biomarkers to inform the optimal choice for individual patients. Here, we 
      examined the complementary roles of tumor mutational burden (TMB) and programmed 
      death ligand-1 (PD-L1) immunohistochemistry (IHC) to inform first-line therapy 
      using a large real-world (rw) data set. MATERIALS AND METHODS: The study included 
      patients with NSCLC from an rw de-identified clinico-genomic database. All 
      patients underwent genomic testing using Foundation Medicine's tissue 
      comprehensive genomic profiling assay and PD-L1 IHC assay scored for tumor cell 
      staining (TS). RESULTS: Of 2165 patients included in the analysis, 150 exhibited 
      durable benefit from first-line ICPI regimens (these patients were enriched for 
      PD-L1 TS ≥50, non-squamous histology, and TMB ≥20 mutations/megabase (muts/Mb)). 
      Comparing low TMB (<10 muts/Mb), high TMB (10-19 muts/Mb), and very high TMB (≥20 
      muts/Mb) receiving ICPI alone, we observed a stepwise increase in median rwPFS 
      (real world-progression free survival) (6.5, 7.5, 17.2 months) and rwOS (real 
      world-overall survival) (10.1, 11.8, 26.9 months) as TMB increased. In the low 
      PD-L1 (TS <50%) cohort, TMB <20 muts/Mb showed a more favorable rwPFS (HR: 0.56 
      (95% CI: 0.40 to 0.79)) and rwOS (HR 0.74 (95% CI: 0.58 to 0.96)) on chemoICPI 
      when compared with ICPI alone while the point estimate in rwPFS favored monoICPI 
      in the TMB ≥20 muts/Mb cohort, the CI is wide and does not reach statistical 
      significance (HR: 1.68 (95% CI: 0.52 to 5.48)). CONCLUSION: This study provides 
      evidence that higher TMB cut-offs, such as 20 muts/Mb, can identify patients with 
      prolonged benefit from ICPI. TMB ≥20 muts/Mb is a potential biomarker that may 
      identify patients in whom an ICPI without chemo could be considered, even in the 
      setting of lower PD-L1 levels. Prospective validation of these findings could 
      increase access to chemo-sparing regimens for the first-line treatment of 
      advanced NSCLC.
CI  - © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No 
      commercial re-use. See rights and permissions. Published by BMJ.
FAU - Huang, Richard S P
AU  - Huang RSP
AUID- ORCID: 0000-0001-8395-5168
AD  - Foundation Medicine Inc, Cambridge, Massachusetts, USA 
      rhuang@foundationmedicine.com.
FAU - Carbone, David P
AU  - Carbone DP
AD  - The Ohio State University and the Pelotonia Institute for Immune Oncology, 
      Columbus, Ohio, USA.
FAU - Li, Gerald
AU  - Li G
AUID- ORCID: 0000-0002-5617-6262
AD  - Foundation Medicine Inc, Cambridge, Massachusetts, USA.
FAU - Schrock, Alexa
AU  - Schrock A
AD  - Foundation Medicine Inc, Cambridge, Massachusetts, USA.
FAU - Graf, Ryon P
AU  - Graf RP
AUID- ORCID: 0000-0002-8065-4148
AD  - Foundation Medicine Inc, Cambridge, Massachusetts, USA.
FAU - Zhang, Liangliang
AU  - Zhang L
AD  - Foundation Medicine Inc, Cambridge, Massachusetts, USA.
FAU - Murugesan, Karthikeyan
AU  - Murugesan K
AUID- ORCID: 0000-0002-2275-1126
AD  - Foundation Medicine Inc, Cambridge, Massachusetts, USA.
FAU - Ross, Jeffrey S
AU  - Ross JS
AD  - Foundation Medicine Inc, Cambridge, Massachusetts, USA.
AD  - Upstate Medical University, Syracuse, New York, USA.
FAU - Tolba, Khaled
AU  - Tolba K
AD  - Foundation Medicine Inc, Cambridge, Massachusetts, USA.
FAU - Sands, Jacob
AU  - Sands J
AD  - Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
FAU - Oxnard, Geoffrey R
AU  - Oxnard GR
AD  - Foundation Medicine Inc, Cambridge, Massachusetts, USA.
FAU - Spigel, David
AU  - Spigel D
AD  - Sarah Cannon Research Institute and Tennessee Oncology, Nashville, Tennessee, 
      USA.
LA  - eng
PT  - Journal Article
PL  - England
TA  - J Immunother Cancer
JT  - Journal for immunotherapy of cancer
JID - 101620585
RN  - 0 (Immune Checkpoint Inhibitors)
RN  - 0 (B7-H1 Antigen)
RN  - 0 (Biomarkers, Tumor)
SB  - IM
MH  - Humans
MH  - *Carcinoma, Non-Small-Cell Lung/drug therapy/genetics/pathology
MH  - *Lung Neoplasms/drug therapy/genetics/pathology
MH  - Immune Checkpoint Inhibitors/pharmacology/therapeutic use
MH  - B7-H1 Antigen
MH  - Mutation
MH  - Biomarkers, Tumor/genetics
PMC - PMC9853253
OTO - NOTNLM
OT  - Immunotherapy
OT  - Lung Neoplasms
OT  - Tumor Biomarkers
COIS- Competing interests: RSPH, GL, AS, RG, LZ, KM, JSR, KT, and GRO are employees of 
      Foundation Medicine, a wholly owned subsidiary of Roche and these employees have 
      equity interest in Roche. DC is an employee/paid consultant for AbbVie, 
      Adaptimmune, Agenus, Amgen, Ariad, AstraZeneca, Biocept, Boehringer Ingelheim, 
      Bristol Myers Squibb, Celgene, EMD Serono, Foundation Medicine, Genentech/Roche, 
      Gritstone, Guardant Health, Inovio, Merck, MSD, Novartis, Palobiofarma, Pfizer, 
      prIME Oncology, and Takeda, and reports receiving commercial research grants from 
      Bristol Myers Squibb. JSR has consulting/advisory board AstraZeneca, Curadev, 
      Daiichi-Sankyo, Jazz Pharmaceuticals, Medtronic, Pharma Mar. DS reports receiving 
      research funding from AstraZeneca, Genentech/Roche, Novartis, Celgene, Bristol 
      Myers Squibb, Pfizer, Boehringer Ingelheim, AbbVie, Foundation Medicine, 
      GlaxoSmithKline, Eli Lilly, Merck, Nektar, Takeda, Amgen, University of Texas 
      Southwestern Medical Center–Simmons Cancer Center, G1 Therapeutics, Neon 
      Therapeutics, Celldex, Clovis Oncology, Daiichi Sankyo, EMD Serono, Astellas 
      Pharma, GRAIL, Transgene, Aeglea Therapeutics, Tesaro, Ipsen, Janssen, BIND 
      Therapeutics, Eisai, and ImClone Systems; and consulting, advisory, and/or 
      speakers’ bureau fees from AstraZeneca, Genentech/Roche, Novartis, Celgene, 
      Bristol Myers Squibb, Pfizer, Boehringer Ingelheim, AbbVie, Foundation Medicine, 
      GlaxoSmithKline, Eli Lilly, Merck, Moderna, Nektar, Takeda, Amgen, TRM Oncology, 
      Precision Oncology, Evelo Therapeutics, Illumina, Pharmamar, EMD Serono, Aptitude 
      Health, Dracen Pharmaceuticals, Iksuda Therapeutics, Molecular Templates, Seattle 
      Genetics, TRIPTYCH Health Partners, and Intellisphere.
EDAT- 2023/01/18 06:00
MHDA- 2023/01/20 06:00
CRDT- 2023/01/17 21:12
PHST- 2022/12/30 00:00 [accepted]
PHST- 2023/01/17 21:12 [entrez]
PHST- 2023/01/18 06:00 [pubmed]
PHST- 2023/01/20 06:00 [medline]
AID - jitc-2022-005801 [pii]
AID - 10.1136/jitc-2022-005801 [doi]
PST - ppublish
SO  - J Immunother Cancer. 2023 Jan;11(1):e005801. doi: 10.1136/jitc-2022-005801.

PMID- 34114629
OWN - NLM
STAT- MEDLINE
DCOM- 20220119
LR  - 20221104
IS  - 1523-5866 (Electronic)
IS  - 1522-8517 (Print)
IS  - 1522-8517 (Linking)
VI  - 24
IP  - 1
DP  - 2022 Jan 5
TI  - Characteristics of patients ≥10 years of age with diffuse intrinsic pontine 
      glioma: a report from the International DIPG/DMG Registry.
PG  - 141-152
LID - 10.1093/neuonc/noab140 [doi]
AB  - BACKGROUND: Diffuse intrinsic pontine gliomas (DIPG) generally occur in young 
      school-age children, although can occur in adolescents and young adults. The 
      purpose of this study was to describe clinical, radiological, pathologic, and 
      molecular characteristics in patients ≥10 years of age with DIPG enrolled in the 
      International DIPG Registry (IDIPGR). METHODS: Patients ≥10 years of age at 
      diagnosis enrolled in the IDIPGR with imaging confirmed DIPG diagnosis were 
      included. The primary outcome was overall survival (OS) categorized as long-term 
      survivors (LTS) (≥24 months) or short-term survivors (STS) (<24 months). RESULTS: 
      Among 1010 patients, 208 (21%) were ≥10 years of age at diagnosis; 152 were 
      eligible with a median age of 12 years (range 10-26.8). Median OS was 13 (2-82) 
      months. The 1-, 3-, and 5-year OS was 59.2%, 5.3%, and 3.3%, respectively. The 
      18/152 (11.8%) LTS were more likely to be older (P < .01) and present with longer 
      symptom duration (P < .01). Biopsy and/or autopsy were performed in 50 (33%) 
      patients; 77%, 61%, 33%, and 6% of patients tested had H3K27M (H3F3A or 
      HIST1H3B), TP53, ATRX, and ACVR1 mutations/genome alterations, respectively. Two 
      of 18 patients with IDH1 testing were IDH1-mutant and 1 was a LTS. The presence 
      or absence of H3 alterations did not affect survival. CONCLUSION: Patients ≥10 
      years old with DIPG have a median survival of 13 months. LTS present with longer 
      symptom duration and are likely to be older at presentation compared to STS. ATRX 
      mutation rates were higher in this population than the general DIPG population.
CI  - © The Author(s) 2021. Published by Oxford University Press on behalf of the 
      Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: 
      journals.permissions@oup.com.
FAU - Erker, Craig
AU  - Erker C
AUID- ORCID: 0000-0003-1394-7167
AD  - Department of Pediatrics, Dalhousie University and IWK Health Centre, Halifax, 
      Nova Scotia, Canada.
FAU - Lane, Adam
AU  - Lane A
AUID- ORCID: 0000-0002-5522-8112
AD  - Division of Bone Marrow Transplantation and Immune Deficiency, Cancer and Blood 
      Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, 
      Ohio, USA.
FAU - Chaney, Brooklyn
AU  - Chaney B
AD  - Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's 
      Hospital Medical Center, Cincinnati, Ohio, USA.
FAU - Leary, Sarah
AU  - Leary S
AUID- ORCID: 0000-0003-0225-6184
AD  - Division of Hematology/Oncology, Seattle Children's Hospital, University of 
      Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
FAU - Minturn, Jane E
AU  - Minturn JE
AUID- ORCID: 0000-0001-9069-8761
AD  - Division of Oncology, Children's Hospital of Philadelphia and Perelman School of 
      Medicine, Philadelphia, Pennsylvania, USA.
FAU - Bartels, Ute
AU  - Bartels U
AUID- ORCID: 0000-0003-2112-5251
AD  - Department of Pediatrics, Division of Oncology, University of Toronto and The 
      Hospital for Sick Children, Toronto, Ontario, Canada.
FAU - Packer, Roger J
AU  - Packer RJ
AUID- ORCID: 0000-0001-9413-7531
AD  - Department of Neurology, Center for Neuroscience and Behavioral Medicine, 
      Children's National Hospital, Washington, DC, USA.
FAU - Dorris, Kathleen
AU  - Dorris K
AUID- ORCID: 0000-0003-0753-2176
AD  - Department of Pediatrics, University of Colorado School of Medicine, Aurora, 
      Colorado, USA.
FAU - Gottardo, Nicholas G
AU  - Gottardo NG
AUID- ORCID: 0000-0002-1082-6776
AD  - Department of Paediatric and Adolescent Oncology/Haematology, Perth Children's 
      Hospital, Nedlands, Western Australia, Australia.
AD  - Brain Tumour Research Programme, Telethon Kids Institute, Nedlands, Western 
      Australia, Australia.
FAU - Warren, Katherine E
AU  - Warren KE
AUID- ORCID: 0000-0003-2173-4129
AD  - Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's 
      Hospital, Boston, Massachusetts, USA.
FAU - Broniscer, Alberto
AU  - Broniscer A
AUID- ORCID: 0000-0001-9646-0463
AD  - Department of Oncology, St. Jude Children's Research Hospital, Memphis, 
      Tennessee, USA.
AD  - Department of Pediatrics, University of Tennessee Health Science Center, Memphis, 
      Tennessee, USA.
FAU - Kieran, Mark W
AU  - Kieran MW
AUID- ORCID: 0000-0003-2184-7692
AD  - Department of Pediatrics, Dana-Farber/Boston Children's Cancer and Blood 
      Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
FAU - Zhu, Xiaoting
AU  - Zhu X
AD  - Brain Tumor Center, Division of Oncology, Cincinnati Children's Hospital Medical 
      Center, Cincinnati, Ohio, USA.
AD  - Department of Electrical Engineering and Computer Science, University of 
      Cincinnati College of Engineering and Applied Science, Cincinnati, Ohio, USA.
AD  - Department of Biomedical Informatics, Cincinnati Children's Hospital Medical 
      Center, Cincinnati, Ohio, USA.
FAU - White, Peter
AU  - White P
AUID- ORCID: 0000-0003-0313-033X
AD  - Department of Biomedical Informatics, Cincinnati Children's Hospital Medical 
      Center and University of Cincinnati, Cincinnati, Ohio, USA.
FAU - Dexheimer, Phillip J
AU  - Dexheimer PJ
AUID- ORCID: 0000-0003-3965-6894
AD  - Department of Biomedical Informatics, Cincinnati Children's Hospital Medical 
      Center and University of Cincinnati, Cincinnati, Ohio, USA.
FAU - Black, Katie
AU  - Black K
AUID- ORCID: 0000-0002-3269-7303
AD  - Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's 
      Hospital Medical Center, Cincinnati, Ohio, USA.
FAU - Asher, Anthony
AU  - Asher A
AD  - Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's 
      Hospital Medical Center, Cincinnati, Ohio, USA.
FAU - DeWire, Mariko
AU  - DeWire M
AUID- ORCID: 0000-0002-8084-2720
AD  - Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's 
      Hospital Medical Center, Cincinnati, Ohio, USA.
FAU - Hansford, Jordan R
AU  - Hansford JR
AUID- ORCID: 0000-0001-7733-383X
AD  - Children's Cancer Centre, Royal Children's Hospital Melbourne Cancer, Cell 
      Biology, Murdoch Children's Research Institute Department of Paediatrics, 
      University of Melbourne, Melbourne, Victoria, Australia.
FAU - Gururangan, Sridharan
AU  - Gururangan S
AUID- ORCID: 0000-0003-0311-7127
AD  - Preston A. Wells Center for Brain Tumor Therapy, UF Health Shands Hospital, 
      Gainesville, Florida, USA.
FAU - Nazarian, Javad
AU  - Nazarian J
AUID- ORCID: 0000-0002-1951-9828
AD  - Center for Genetic Medicine, Children's National Hospital, Washington, DC, USA.
AD  - Department of Oncology, University Children's Hospital, Zurich, Zurich, 
      Switzerland.
FAU - Ziegler, David S
AU  - Ziegler DS
AUID- ORCID: 0000-0001-7451-7916
AD  - Children's Cancer Institute Australia, Lowy Cancer Research Centre, UNSW and Kids 
      Cancer Centre, Sydney's Children Hospital, Randwick, Sydney, New South Wales, 
      Australia.
AD  - School of Women's and Children's Health, University of New South Wales, Sydney, 
      New South Wales, Australia.
FAU - Sandler, Eric
AU  - Sandler E
AUID- ORCID: 0000-0002-0083-9370
AD  - Department of Pediatrics, Wolfson Children's Hospital and Nemours Children's 
      Specialty Care, Jacksonville, Florida, USA.
FAU - Bartlett, Allison
AU  - Bartlett A
AD  - Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's 
      Hospital Medical Center, Cincinnati, Ohio, USA.
FAU - Goldman, Stewart
AU  - Goldman S
AD  - Division of Hematology/Oncology, Ann & Robert H. Lurie Children's Hospital of 
      Chicago, Chicago, Illinois, USA.
FAU - Shih, Chie-Schin
AU  - Shih CS
AD  - Riley Children's Hospital, Indiana University, Indianapolis, Indiana, USA.
FAU - Hassall, Tim
AU  - Hassall T
AD  - Lady Cilento Children's Hospital, Brisbane, Queensland, Australia.
FAU - Dholaria, Hetal
AU  - Dholaria H
AD  - Princess Margaret Hospital for Children and The University of Western Australia, 
      Perth, Western Australia, Australia.
FAU - Bandopadhayay, Pratiti
AU  - Bandopadhayay P
AD  - Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's 
      Hospital, Boston, Massachusetts, USA.
FAU - Samson, Yvan
AU  - Samson Y
AD  - Départment de Pédiatrie, CHU Sainte-Justine and Université de Montréal, Montreal, 
      Quebec, Canada.
FAU - Monje, Michelle
AU  - Monje M
AD  - Department of Neurology and Neurological Sciences, Stanford University and Lucile 
      Packard Children's Hospital at Stanford, Stanford, California, USA.
FAU - Fisher, Paul G
AU  - Fisher PG
AD  - Department of Neurology and Neurological Sciences, Stanford University and Lucile 
      Packard Children's Hospital at Stanford, Stanford, California, USA.
FAU - Dodgshun, Andrew
AU  - Dodgshun A
AD  - Children's Haematology and Oncology Centre, Christchurch Hospital, Christchurch, 
      New Zealand.
FAU - Parkin, Sarah
AU  - Parkin S
AD  - Children's Haematology and Oncology Centre, Christchurch Hospital, Christchurch, 
      New Zealand.
FAU - Chintagumpala, Murali
AU  - Chintagumpala M
AD  - Department of Pediatrics, Section of Hematology/Oncology, Texas Children's Cancer 
      Center, Houston, Texas, USA.
FAU - Tsui, Karen
AU  - Tsui K
AD  - Starship Children's Hospital, Auckland, New Zealand.
FAU - Gass, David
AU  - Gass D
AD  - Division Hematology and Oncology, Levine Children's Cancer & Blood Disorders, 
      Charlotte, North Carolina, USA.
FAU - Larouche, Valerie
AU  - Larouche V
AD  - Department of Pediatrics, Centre Mère-enfant Soleil du CHU de Québec-Université 
      Laval, Quebec City, Quebec, Canada.
FAU - Broxson, Emmett
AU  - Broxson E
AD  - Division of Hematology/Oncology, Wright State University and Dayton Children's 
      Hospital, Dayton, Ohio, USA.
FAU - Garcia Lombardi, Mercedes
AU  - Garcia Lombardi M
AD  - Department of Oncology, Hospital de Ninos Ricardo Gutierrez, Buenos Aires, 
      Argentina.
FAU - Wang, Stacie Shiqi
AU  - Wang SS
AD  - Children's Cancer Centre, Royal Children's Hospital Melbourne Cancer, Cell 
      Biology, Murdoch Children's Research Institute Department of Paediatrics, 
      University of Melbourne, Melbourne, Victoria, Australia.
FAU - Ma, Jie
AU  - Ma J
AD  - Department of Pediatric Neurosurgery, Xin Hua Hospital Affiliated to Shanghai 
      Jiao Tong University School of Medicine, Shanghai, China.
FAU - Hawkins, Cynthia
AU  - Hawkins C
AD  - Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick 
      Children and the Department of Laboratory Medicine and Pathobiology, University 
      of Toronto, Toronto, Ontario, Canada.
FAU - Hamideh, Dima
AU  - Hamideh D
AD  - Department of Pediatrics and Adolescent Medicine, American University of Beirut, 
      Beirut, Lebanon.
FAU - Wagner, Lars
AU  - Wagner L
AUID- ORCID: 0000-0003-4717-9960
AD  - Division of Pediatric Hematology/Oncology, Kentucky Children's Hospital, 
      University of Kentucky, Lexington, Kentucky, USA.
FAU - Koschmann, Carl
AU  - Koschmann C
AUID- ORCID: 0000-0002-0825-7615
AD  - Department of Pediatrics, C.S. Mott Children's Hospital and University of 
      Michigan School of Medicine, Ann Arbor, Michigan, USA.
FAU - Fuller, Christine
AU  - Fuller C
AUID- ORCID: 0000-0001-7919-7675
AD  - Department of Pathology, Upstate Medical University, Syracuse, New York, USA.
FAU - Drissi, Rachid
AU  - Drissi R
AUID- ORCID: 0000-0003-0564-0181
AD  - Center for Childhood Cancer & Blood Disorders, Nationwide Children's Hospital, 
      Columbus, Ohio, USA.
AD  - The Ohio State University College of Medicine, Columbus, Ohio, USA.
FAU - Jones, Blaise V
AU  - Jones BV
AUID- ORCID: 0000-0001-9003-4578
AD  - Division of Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, 
      Ohio, USA.
FAU - Leach, James
AU  - Leach J
AUID- ORCID: 0000-0002-8602-4737
AD  - Division of Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, 
      Ohio, USA.
FAU - Fouladi, Maryam
AU  - Fouladi M
AUID- ORCID: 0000-0002-5693-035X
AD  - The Ohio State University College of Medicine, Columbus, Ohio, USA.
AD  - Pediatric Neuro-Oncology Program, Nationwide Children's Hospital, Columbus, Ohio, 
      USA.
LA  - eng
GR  - R01 NS124607/NS/NINDS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - England
TA  - Neuro Oncol
JT  - Neuro-oncology
JID - 100887420
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - *Astrocytoma
MH  - *Brain Stem Neoplasms/genetics
MH  - Child
MH  - *Diffuse Intrinsic Pontine Glioma
MH  - *Glioma/genetics
MH  - Humans
MH  - Registries
MH  - Young Adult
PMC - PMC8730773
OTO - NOTNLM
OT  - DIPG
OT  - International DIPG Registry
OT  - outcomes
OT  - ≥10 years old
EDAT- 2021/06/12 06:00
MHDA- 2022/01/20 06:00
CRDT- 2021/06/11 08:46
PHST- 2021/06/12 06:00 [pubmed]
PHST- 2022/01/20 06:00 [medline]
PHST- 2021/06/11 08:46 [entrez]
AID - 6296498 [pii]
AID - noab140 [pii]
AID - 10.1093/neuonc/noab140 [doi]
PST - ppublish
SO  - Neuro Oncol. 2022 Jan 5;24(1):141-152. doi: 10.1093/neuonc/noab140.

PMID- 34607609
OWN - NLM
STAT- MEDLINE
DCOM- 20220221
LR  - 20230415
IS  - 1756-994X (Electronic)
IS  - 1756-994X (Linking)
VI  - 13
IP  - 1
DP  - 2021 Oct 4
TI  - Molecular profiling of advanced malignancies guides first-line N-of-1 treatments 
      in the I-PREDICT treatment-naïve study.
PG  - 155
LID - 10.1186/s13073-021-00969-w [doi]
LID - 155
AB  - BACKGROUND: Malignancies are molecularly complex and become more resistant with 
      each line of therapy. We hypothesized that offering matched, individualized 
      combination therapies to patients with treatment-naïve, advanced cancers would be 
      feasible and efficacious. Patients with newly diagnosed unresectable/metastatic, 
      poor-prognosis cancers were enrolled in a cross-institutional prospective study. 
      METHODS: A total of 145 patients were included in the study. Genomic profiling 
      (tissue and/or circulating tumor DNA) was performed in all patients, and PD-L1 
      immunohistochemistry, tumor mutational burden, and microsatellite status 
      assessment were performed in a subset of patients. We evaluated safety and 
      outcomes: disease-control rate (stable disease for ≥ 6 months or partial or 
      complete response), progression-free survival (PFS), and overall survival (OS). 
      RESULTS: Seventy-six of 145 patients (52%) were treated, most commonly for 
      non-colorectal gastrointestinal cancers, carcinomas of unknown primary, and 
      hepatobiliary malignancies (53% women; median age, 63 years). The median number 
      of deleterious genomic alterations per patient was 5 (range, 0-15). Fifty-four 
      treated patients (71%) received ≥ 1 molecularly matched therapy, demonstrating 
      the feasibility of administering molecularly matched therapy. The Matching Score, 
      which reflects the percentage of targeted alterations, correlated linearly with 
      progression-free survival (R(2) = 0.92; P = 0.01), and high (≥ 60%) Matching 
      Score was an independent predictor of improved disease control rate [OR 3.31 (95% 
      CI 1.01-10.83), P = 0.048], PFS [HR 0.55 (0.28-1.07), P = 0.08], and OS [HR 0.42 
      (0.21-0.85), P = 0.02]. Serious adverse event rates were similar in the unmatched 
      and matched groups. CONCLUSIONS: Personalized combination therapies targeting a 
      majority of a patient's molecular alterations have antitumor activity as 
      first-line treatment. These findings underscore the feasibility and importance of 
      using tailored N-of-1 combination therapies early in the course of lethal 
      malignancies. TRIAL REGISTRATION: I-PREDICT ( NCT02534675 ) was registered on 
      August 25, 2015.
CI  - © 2021. The Author(s).
FAU - Sicklick, Jason K
AU  - Sicklick JK
AUID- ORCID: 0000-0003-4403-0271
AD  - Department of Surgery, Division of Surgical Oncology, UC San Diego School of 
      Medicine, San Diego, CA, USA. jsicklick@health.ucsd.edu.
AD  - Center for Personalized Cancer Therapy, Moores Cancer Center, UC San Diego 
      Health, 3855 Health Sciences Drive, Mail Code 0658, La Jolla, CA, 92093-0658, 
      USA. jsicklick@health.ucsd.edu.
FAU - Kato, Shumei
AU  - Kato S
AD  - Center for Personalized Cancer Therapy, Moores Cancer Center, UC San Diego 
      Health, 3855 Health Sciences Drive, Mail Code 0658, La Jolla, CA, 92093-0658, 
      USA.
AD  - Department of Medicine, Division of Hematology Oncology, UC San Diego School of 
      Medicine, San Diego, CA, USA.
FAU - Okamura, Ryosuke
AU  - Okamura R
AD  - Center for Personalized Cancer Therapy, Moores Cancer Center, UC San Diego 
      Health, 3855 Health Sciences Drive, Mail Code 0658, La Jolla, CA, 92093-0658, 
      USA.
AD  - Department of Medicine, Division of Hematology Oncology, UC San Diego School of 
      Medicine, San Diego, CA, USA.
FAU - Patel, Hitendra
AU  - Patel H
AD  - Center for Personalized Cancer Therapy, Moores Cancer Center, UC San Diego 
      Health, 3855 Health Sciences Drive, Mail Code 0658, La Jolla, CA, 92093-0658, 
      USA.
AD  - Department of Medicine, Division of Hematology Oncology, UC San Diego School of 
      Medicine, San Diego, CA, USA.
FAU - Nikanjam, Mina
AU  - Nikanjam M
AD  - Center for Personalized Cancer Therapy, Moores Cancer Center, UC San Diego 
      Health, 3855 Health Sciences Drive, Mail Code 0658, La Jolla, CA, 92093-0658, 
      USA.
AD  - Department of Medicine, Division of Hematology Oncology, UC San Diego School of 
      Medicine, San Diego, CA, USA.
FAU - Fanta, Paul T
AU  - Fanta PT
AD  - Center for Personalized Cancer Therapy, Moores Cancer Center, UC San Diego 
      Health, 3855 Health Sciences Drive, Mail Code 0658, La Jolla, CA, 92093-0658, 
      USA.
AD  - Department of Medicine, Division of Hematology Oncology, UC San Diego School of 
      Medicine, San Diego, CA, USA.
FAU - Hahn, Michael E
AU  - Hahn ME
AD  - Department of Radiology, UC San Diego School of Medicine, San Diego, CA, USA.
FAU - De, Pradip
AU  - De P
AD  - Avera Cancer Institute, Sioux Falls, SD, USA.
FAU - Williams, Casey
AU  - Williams C
AD  - Avera Cancer Institute, Sioux Falls, SD, USA.
FAU - Guido, Jessica
AU  - Guido J
AD  - Center for Personalized Cancer Therapy, Moores Cancer Center, UC San Diego 
      Health, 3855 Health Sciences Drive, Mail Code 0658, La Jolla, CA, 92093-0658, 
      USA.
FAU - Solomon, Benjamin M
AU  - Solomon BM
AD  - Avera Cancer Institute, Sioux Falls, SD, USA.
FAU - McKay, Rana R
AU  - McKay RR
AD  - Center for Personalized Cancer Therapy, Moores Cancer Center, UC San Diego 
      Health, 3855 Health Sciences Drive, Mail Code 0658, La Jolla, CA, 92093-0658, 
      USA.
AD  - Department of Medicine, Division of Hematology Oncology, UC San Diego School of 
      Medicine, San Diego, CA, USA.
FAU - Krie, Amy
AU  - Krie A
AD  - Avera Cancer Institute, Sioux Falls, SD, USA.
FAU - Boles, Sarah G
AU  - Boles SG
AD  - Center for Personalized Cancer Therapy, Moores Cancer Center, UC San Diego 
      Health, 3855 Health Sciences Drive, Mail Code 0658, La Jolla, CA, 92093-0658, 
      USA.
AD  - Department of Medicine, Division of Hematology Oncology, UC San Diego School of 
      Medicine, San Diego, CA, USA.
FAU - Ross, Jeffrey S
AU  - Ross JS
AD  - Foundation Medicine, Inc., Cambridge, MA, USA.
AD  - Departments of Pathology and Urology, SUNY Upstate Medical University, Syracuse, 
      NY, USA.
FAU - Lee, J Jack
AU  - Lee JJ
AD  - Department of Biostatistics, University of Texas MD Anderson Cancer Center, 
      Houston, TX, USA.
FAU - Leyland-Jones, Brian
AU  - Leyland-Jones B
AD  - Avera Cancer Institute, Sioux Falls, SD, USA.
FAU - Lippman, Scott M
AU  - Lippman SM
AD  - Center for Personalized Cancer Therapy, Moores Cancer Center, UC San Diego 
      Health, 3855 Health Sciences Drive, Mail Code 0658, La Jolla, CA, 92093-0658, 
      USA.
AD  - Department of Medicine, Division of Hematology Oncology, UC San Diego School of 
      Medicine, San Diego, CA, USA.
FAU - Kurzrock, Razelle
AU  - Kurzrock R
AD  - Center for Personalized Cancer Therapy, Moores Cancer Center, UC San Diego 
      Health, 3855 Health Sciences Drive, Mail Code 0658, La Jolla, CA, 92093-0658, 
      USA. rkurzrock@health.ucsd.edu.
AD  - Department of Medicine, Division of Hematology Oncology, UC San Diego School of 
      Medicine, San Diego, CA, USA. rkurzrock@health.ucsd.edu.
LA  - eng
SI  - ClinicalTrials.gov/NCT02534675
GR  - R01 CA226803/CA/NCI NIH HHS/United States
GR  - R01 FD006334/FD/FDA HHS/United States
GR  - P30 CA023100/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20211004
PL  - England
TA  - Genome Med
JT  - Genome medicine
JID - 101475844
SB  - IM
MH  - Adult
MH  - Aged
MH  - Antineoplastic Combined Chemotherapy Protocols
MH  - Combined Modality Therapy
MH  - Female
MH  - Genomics
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Molecular Targeted Therapy
MH  - Neoplasms/*genetics/*therapy
MH  - Prospective Studies
MH  - Young Adult
PMC - PMC8491393
OTO - NOTNLM
OT  - Clinical trial
OT  - Genomics
OT  - Immunotherapy
OT  - Personalized
OT  - Precision
OT  - Targeted
COIS- J.K.S receives research funding from Amgen Pharmaceuticals and Foundation 
      Medicine, consultant fees from Deciphera, speaker’s fees from Deciphera, 
      Foundation Medicine, La-Hoffman Roche, Merck, MJH Life Sciences, QED 
      Therapeutics, and has stock in Personalis. SK serves as a consultant to 
      Foundation Medicine and receives speaker’s fee from Roche. RK has the following 
      disclosure information: Stock and Other Equity Interests (IDbyDNA, CureMatch, 
      Inc., and Soluventis); Consulting or Advisory role (Gaido, Loxo, X-Biotech, 
      Actuate Therapeutics, Roche, NeoMed, Soluventis, and Pfizer); Speaker’s fee 
      (Roche); Research Funding (Incyte, Genentech, Merck Serono, Pfizer, Sequenom, 
      Foundation Medicine, Guardant Health, Grifols, Konica Minolta, DeBiopharm, 
      Boerhringer Ingelheim, and OmniSeq [All institutional]); Board Member (CureMatch, 
      Inc and CureMetrix Inc). BS received travel funds from AstraZeneca. RRM receives 
      institutional research funding from Bayer and Pfizer, as well as consultant fees 
      from Bayer, Bristol Meyers Squib, Dendreon, Exelixis, Johnson & Johnson, 
      Novartis, Pfizer, Sanofi, Vividion, and Tempus. JSR is an employee and equity 
      holder in Foundation Medicine, Inc. The remaining authors declare that they have 
      no competing interests.
EDAT- 2021/10/06 06:00
MHDA- 2022/02/22 06:00
CRDT- 2021/10/05 05:36
PHST- 2021/01/22 00:00 [received]
PHST- 2021/09/15 00:00 [accepted]
PHST- 2021/10/05 05:36 [entrez]
PHST- 2021/10/06 06:00 [pubmed]
PHST- 2022/02/22 06:00 [medline]
AID - 10.1186/s13073-021-00969-w [pii]
AID - 969 [pii]
AID - 10.1186/s13073-021-00969-w [doi]
PST - epublish
SO  - Genome Med. 2021 Oct 4;13(1):155. doi: 10.1186/s13073-021-00969-w.

PMID- 27185838
OWN - NLM
STAT- MEDLINE
DCOM- 20170731
LR  - 20220310
IS  - 1527-7755 (Electronic)
IS  - 0732-183X (Print)
IS  - 0732-183X (Linking)
VI  - 34
IP  - 20
DP  - 2016 Jul 10
TI  - Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With 
      Cancer.
PG  - 2366-71
LID - 10.1200/JCO.2015.65.4327 [doi]
AB  - PURPOSE: Older adults are at increased risk for chemotherapy toxicity, and 
      standard oncology assessment measures cannot identify those at risk. A predictive 
      model for chemotherapy toxicity was developed (N = 500) that consisted of 
      geriatric assessment questions and other clinical variables. This study aims to 
      externally validate this model in an independent cohort (N = 250). PATIENTS AND 
      METHODS: Patients age ≥ 65 years with a solid tumor, fluent in English, and who 
      were scheduled to receive a new chemotherapy regimen were recruited from eight 
      institutions. Risk of chemotherapy toxicity was calculated (low, medium, or high 
      risk) on the basis of the prediction model before the start of chemotherapy. 
      Chemotherapy-related toxicity was captured (grade 3 [hospitalization indicated], 
      grade 4 [life threatening], and grade 5 [treatment-related death]). Validation of 
      the prediction model was performed by calculating the area under the 
      receiver-operating characteristic curve. RESULTS: The study sample (N = 250) had 
      a mean age of 73 years (range, 65 to 94 [standard deviation, 5.8]). More than one 
      half of patients (58%) experienced grade ≥ 3 toxicity. Risk of toxicity increased 
      with increasing risk score (36.7% low, 62.4% medium, 70.2% high risk; P < .001). 
      The area under the curve of the receiver-operating characteristic curve was 0.65 
      (95% CI, 0.58 to 0.71), which was not statistically different from the 
      development cohort (0.72; 95% CI, 0.68 to 0.77; P = .09). There was no 
      association between Karnofsky Performance Status and chemotherapy toxicity (P = 
      .25). CONCLUSION: This study externally validated a chemotherapy toxicity 
      predictive model for older adults with cancer. This predictive model should be 
      considered when discussing the risks and benefits of chemotherapy with older 
      adults.
CI  - © 2016 by American Society of Clinical Oncology.
FAU - Hurria, Arti
AU  - Hurria A
AD  - Arti Hurria, Tao Feng, David Smith, Can-Lan Sun, Vani Katheria, Caroline Doan, 
      Laura Zavala, Abrahm Levi, and Chie Akiba, City of Hope Comprehensive Cancer 
      Center and Beckman Research Institute, Duarte, CA; Supriya Mohile, University of 
      Rochester Medical Center, Rochester; Ajeet Gajra, Upstate Medical University and 
      Syracuse VA Medical Center, Syracuse; William P. Tew, Memorial Sloan Kettering 
      Cancer Center, New York, NY; Heidi Klepin, Wake Forest University School of 
      Medicine, Winston Salem; Hyman Muss, University of North Carolina at Chapel Hill, 
      Lineberger Comprehensive Cancer Center, Chapel Hill; Harvey Jay Cohen, Duke 
      University, Durham, NC; Andrew Chapman, Sidney Kimmel Cancer Center, Thomas 
      Jefferson University, Philadelphia, PA; and Nienke De Glas, Leiden University 
      Medical Centre, Leiden, the Netherlands. ahurria@coh.org.
FAU - Mohile, Supriya
AU  - Mohile S
AD  - Arti Hurria, Tao Feng, David Smith, Can-Lan Sun, Vani Katheria, Caroline Doan, 
      Laura Zavala, Abrahm Levi, and Chie Akiba, City of Hope Comprehensive Cancer 
      Center and Beckman Research Institute, Duarte, CA; Supriya Mohile, University of 
      Rochester Medical Center, Rochester; Ajeet Gajra, Upstate Medical University and 
      Syracuse VA Medical Center, Syracuse; William P. Tew, Memorial Sloan Kettering 
      Cancer Center, New York, NY; Heidi Klepin, Wake Forest University School of 
      Medicine, Winston Salem; Hyman Muss, University of North Carolina at Chapel Hill, 
      Lineberger Comprehensive Cancer Center, Chapel Hill; Harvey Jay Cohen, Duke 
      University, Durham, NC; Andrew Chapman, Sidney Kimmel Cancer Center, Thomas 
      Jefferson University, Philadelphia, PA; and Nienke De Glas, Leiden University 
      Medical Centre, Leiden, the Netherlands.
FAU - Gajra, Ajeet
AU  - Gajra A
AD  - Arti Hurria, Tao Feng, David Smith, Can-Lan Sun, Vani Katheria, Caroline Doan, 
      Laura Zavala, Abrahm Levi, and Chie Akiba, City of Hope Comprehensive Cancer 
      Center and Beckman Research Institute, Duarte, CA; Supriya Mohile, University of 
      Rochester Medical Center, Rochester; Ajeet Gajra, Upstate Medical University and 
      Syracuse VA Medical Center, Syracuse; William P. Tew, Memorial Sloan Kettering 
      Cancer Center, New York, NY; Heidi Klepin, Wake Forest University School of 
      Medicine, Winston Salem; Hyman Muss, University of North Carolina at Chapel Hill, 
      Lineberger Comprehensive Cancer Center, Chapel Hill; Harvey Jay Cohen, Duke 
      University, Durham, NC; Andrew Chapman, Sidney Kimmel Cancer Center, Thomas 
      Jefferson University, Philadelphia, PA; and Nienke De Glas, Leiden University 
      Medical Centre, Leiden, the Netherlands.
FAU - Klepin, Heidi
AU  - Klepin H
AD  - Arti Hurria, Tao Feng, David Smith, Can-Lan Sun, Vani Katheria, Caroline Doan, 
      Laura Zavala, Abrahm Levi, and Chie Akiba, City of Hope Comprehensive Cancer 
      Center and Beckman Research Institute, Duarte, CA; Supriya Mohile, University of 
      Rochester Medical Center, Rochester; Ajeet Gajra, Upstate Medical University and 
      Syracuse VA Medical Center, Syracuse; William P. Tew, Memorial Sloan Kettering 
      Cancer Center, New York, NY; Heidi Klepin, Wake Forest University School of 
      Medicine, Winston Salem; Hyman Muss, University of North Carolina at Chapel Hill, 
      Lineberger Comprehensive Cancer Center, Chapel Hill; Harvey Jay Cohen, Duke 
      University, Durham, NC; Andrew Chapman, Sidney Kimmel Cancer Center, Thomas 
      Jefferson University, Philadelphia, PA; and Nienke De Glas, Leiden University 
      Medical Centre, Leiden, the Netherlands.
FAU - Muss, Hyman
AU  - Muss H
AD  - Arti Hurria, Tao Feng, David Smith, Can-Lan Sun, Vani Katheria, Caroline Doan, 
      Laura Zavala, Abrahm Levi, and Chie Akiba, City of Hope Comprehensive Cancer 
      Center and Beckman Research Institute, Duarte, CA; Supriya Mohile, University of 
      Rochester Medical Center, Rochester; Ajeet Gajra, Upstate Medical University and 
      Syracuse VA Medical Center, Syracuse; William P. Tew, Memorial Sloan Kettering 
      Cancer Center, New York, NY; Heidi Klepin, Wake Forest University School of 
      Medicine, Winston Salem; Hyman Muss, University of North Carolina at Chapel Hill, 
      Lineberger Comprehensive Cancer Center, Chapel Hill; Harvey Jay Cohen, Duke 
      University, Durham, NC; Andrew Chapman, Sidney Kimmel Cancer Center, Thomas 
      Jefferson University, Philadelphia, PA; and Nienke De Glas, Leiden University 
      Medical Centre, Leiden, the Netherlands.
FAU - Chapman, Andrew
AU  - Chapman A
AD  - Arti Hurria, Tao Feng, David Smith, Can-Lan Sun, Vani Katheria, Caroline Doan, 
      Laura Zavala, Abrahm Levi, and Chie Akiba, City of Hope Comprehensive Cancer 
      Center and Beckman Research Institute, Duarte, CA; Supriya Mohile, University of 
      Rochester Medical Center, Rochester; Ajeet Gajra, Upstate Medical University and 
      Syracuse VA Medical Center, Syracuse; William P. Tew, Memorial Sloan Kettering 
      Cancer Center, New York, NY; Heidi Klepin, Wake Forest University School of 
      Medicine, Winston Salem; Hyman Muss, University of North Carolina at Chapel Hill, 
      Lineberger Comprehensive Cancer Center, Chapel Hill; Harvey Jay Cohen, Duke 
      University, Durham, NC; Andrew Chapman, Sidney Kimmel Cancer Center, Thomas 
      Jefferson University, Philadelphia, PA; and Nienke De Glas, Leiden University 
      Medical Centre, Leiden, the Netherlands.
FAU - Feng, Tao
AU  - Feng T
AD  - Arti Hurria, Tao Feng, David Smith, Can-Lan Sun, Vani Katheria, Caroline Doan, 
      Laura Zavala, Abrahm Levi, and Chie Akiba, City of Hope Comprehensive Cancer 
      Center and Beckman Research Institute, Duarte, CA; Supriya Mohile, University of 
      Rochester Medical Center, Rochester; Ajeet Gajra, Upstate Medical University and 
      Syracuse VA Medical Center, Syracuse; William P. Tew, Memorial Sloan Kettering 
      Cancer Center, New York, NY; Heidi Klepin, Wake Forest University School of 
      Medicine, Winston Salem; Hyman Muss, University of North Carolina at Chapel Hill, 
      Lineberger Comprehensive Cancer Center, Chapel Hill; Harvey Jay Cohen, Duke 
      University, Durham, NC; Andrew Chapman, Sidney Kimmel Cancer Center, Thomas 
      Jefferson University, Philadelphia, PA; and Nienke De Glas, Leiden University 
      Medical Centre, Leiden, the Netherlands.
FAU - Smith, David
AU  - Smith D
AD  - Arti Hurria, Tao Feng, David Smith, Can-Lan Sun, Vani Katheria, Caroline Doan, 
      Laura Zavala, Abrahm Levi, and Chie Akiba, City of Hope Comprehensive Cancer 
      Center and Beckman Research Institute, Duarte, CA; Supriya Mohile, University of 
      Rochester Medical Center, Rochester; Ajeet Gajra, Upstate Medical University and 
      Syracuse VA Medical Center, Syracuse; William P. Tew, Memorial Sloan Kettering 
      Cancer Center, New York, NY; Heidi Klepin, Wake Forest University School of 
      Medicine, Winston Salem; Hyman Muss, University of North Carolina at Chapel Hill, 
      Lineberger Comprehensive Cancer Center, Chapel Hill; Harvey Jay Cohen, Duke 
      University, Durham, NC; Andrew Chapman, Sidney Kimmel Cancer Center, Thomas 
      Jefferson University, Philadelphia, PA; and Nienke De Glas, Leiden University 
      Medical Centre, Leiden, the Netherlands.
FAU - Sun, Can-Lan
AU  - Sun CL
AD  - Arti Hurria, Tao Feng, David Smith, Can-Lan Sun, Vani Katheria, Caroline Doan, 
      Laura Zavala, Abrahm Levi, and Chie Akiba, City of Hope Comprehensive Cancer 
      Center and Beckman Research Institute, Duarte, CA; Supriya Mohile, University of 
      Rochester Medical Center, Rochester; Ajeet Gajra, Upstate Medical University and 
      Syracuse VA Medical Center, Syracuse; William P. Tew, Memorial Sloan Kettering 
      Cancer Center, New York, NY; Heidi Klepin, Wake Forest University School of 
      Medicine, Winston Salem; Hyman Muss, University of North Carolina at Chapel Hill, 
      Lineberger Comprehensive Cancer Center, Chapel Hill; Harvey Jay Cohen, Duke 
      University, Durham, NC; Andrew Chapman, Sidney Kimmel Cancer Center, Thomas 
      Jefferson University, Philadelphia, PA; and Nienke De Glas, Leiden University 
      Medical Centre, Leiden, the Netherlands.
FAU - De Glas, Nienke
AU  - De Glas N
AD  - Arti Hurria, Tao Feng, David Smith, Can-Lan Sun, Vani Katheria, Caroline Doan, 
      Laura Zavala, Abrahm Levi, and Chie Akiba, City of Hope Comprehensive Cancer 
      Center and Beckman Research Institute, Duarte, CA; Supriya Mohile, University of 
      Rochester Medical Center, Rochester; Ajeet Gajra, Upstate Medical University and 
      Syracuse VA Medical Center, Syracuse; William P. Tew, Memorial Sloan Kettering 
      Cancer Center, New York, NY; Heidi Klepin, Wake Forest University School of 
      Medicine, Winston Salem; Hyman Muss, University of North Carolina at Chapel Hill, 
      Lineberger Comprehensive Cancer Center, Chapel Hill; Harvey Jay Cohen, Duke 
      University, Durham, NC; Andrew Chapman, Sidney Kimmel Cancer Center, Thomas 
      Jefferson University, Philadelphia, PA; and Nienke De Glas, Leiden University 
      Medical Centre, Leiden, the Netherlands.
FAU - Cohen, Harvey Jay
AU  - Cohen HJ
AD  - Arti Hurria, Tao Feng, David Smith, Can-Lan Sun, Vani Katheria, Caroline Doan, 
      Laura Zavala, Abrahm Levi, and Chie Akiba, City of Hope Comprehensive Cancer 
      Center and Beckman Research Institute, Duarte, CA; Supriya Mohile, University of 
      Rochester Medical Center, Rochester; Ajeet Gajra, Upstate Medical University and 
      Syracuse VA Medical Center, Syracuse; William P. Tew, Memorial Sloan Kettering 
      Cancer Center, New York, NY; Heidi Klepin, Wake Forest University School of 
      Medicine, Winston Salem; Hyman Muss, University of North Carolina at Chapel Hill, 
      Lineberger Comprehensive Cancer Center, Chapel Hill; Harvey Jay Cohen, Duke 
      University, Durham, NC; Andrew Chapman, Sidney Kimmel Cancer Center, Thomas 
      Jefferson University, Philadelphia, PA; and Nienke De Glas, Leiden University 
      Medical Centre, Leiden, the Netherlands.
FAU - Katheria, Vani
AU  - Katheria V
AD  - Arti Hurria, Tao Feng, David Smith, Can-Lan Sun, Vani Katheria, Caroline Doan, 
      Laura Zavala, Abrahm Levi, and Chie Akiba, City of Hope Comprehensive Cancer 
      Center and Beckman Research Institute, Duarte, CA; Supriya Mohile, University of 
      Rochester Medical Center, Rochester; Ajeet Gajra, Upstate Medical University and 
      Syracuse VA Medical Center, Syracuse; William P. Tew, Memorial Sloan Kettering 
      Cancer Center, New York, NY; Heidi Klepin, Wake Forest University School of 
      Medicine, Winston Salem; Hyman Muss, University of North Carolina at Chapel Hill, 
      Lineberger Comprehensive Cancer Center, Chapel Hill; Harvey Jay Cohen, Duke 
      University, Durham, NC; Andrew Chapman, Sidney Kimmel Cancer Center, Thomas 
      Jefferson University, Philadelphia, PA; and Nienke De Glas, Leiden University 
      Medical Centre, Leiden, the Netherlands.
FAU - Doan, Caroline
AU  - Doan C
AD  - Arti Hurria, Tao Feng, David Smith, Can-Lan Sun, Vani Katheria, Caroline Doan, 
      Laura Zavala, Abrahm Levi, and Chie Akiba, City of Hope Comprehensive Cancer 
      Center and Beckman Research Institute, Duarte, CA; Supriya Mohile, University of 
      Rochester Medical Center, Rochester; Ajeet Gajra, Upstate Medical University and 
      Syracuse VA Medical Center, Syracuse; William P. Tew, Memorial Sloan Kettering 
      Cancer Center, New York, NY; Heidi Klepin, Wake Forest University School of 
      Medicine, Winston Salem; Hyman Muss, University of North Carolina at Chapel Hill, 
      Lineberger Comprehensive Cancer Center, Chapel Hill; Harvey Jay Cohen, Duke 
      University, Durham, NC; Andrew Chapman, Sidney Kimmel Cancer Center, Thomas 
      Jefferson University, Philadelphia, PA; and Nienke De Glas, Leiden University 
      Medical Centre, Leiden, the Netherlands.
FAU - Zavala, Laura
AU  - Zavala L
AD  - Arti Hurria, Tao Feng, David Smith, Can-Lan Sun, Vani Katheria, Caroline Doan, 
      Laura Zavala, Abrahm Levi, and Chie Akiba, City of Hope Comprehensive Cancer 
      Center and Beckman Research Institute, Duarte, CA; Supriya Mohile, University of 
      Rochester Medical Center, Rochester; Ajeet Gajra, Upstate Medical University and 
      Syracuse VA Medical Center, Syracuse; William P. Tew, Memorial Sloan Kettering 
      Cancer Center, New York, NY; Heidi Klepin, Wake Forest University School of 
      Medicine, Winston Salem; Hyman Muss, University of North Carolina at Chapel Hill, 
      Lineberger Comprehensive Cancer Center, Chapel Hill; Harvey Jay Cohen, Duke 
      University, Durham, NC; Andrew Chapman, Sidney Kimmel Cancer Center, Thomas 
      Jefferson University, Philadelphia, PA; and Nienke De Glas, Leiden University 
      Medical Centre, Leiden, the Netherlands.
FAU - Levi, Abrahm
AU  - Levi A
AD  - Arti Hurria, Tao Feng, David Smith, Can-Lan Sun, Vani Katheria, Caroline Doan, 
      Laura Zavala, Abrahm Levi, and Chie Akiba, City of Hope Comprehensive Cancer 
      Center and Beckman Research Institute, Duarte, CA; Supriya Mohile, University of 
      Rochester Medical Center, Rochester; Ajeet Gajra, Upstate Medical University and 
      Syracuse VA Medical Center, Syracuse; William P. Tew, Memorial Sloan Kettering 
      Cancer Center, New York, NY; Heidi Klepin, Wake Forest University School of 
      Medicine, Winston Salem; Hyman Muss, University of North Carolina at Chapel Hill, 
      Lineberger Comprehensive Cancer Center, Chapel Hill; Harvey Jay Cohen, Duke 
      University, Durham, NC; Andrew Chapman, Sidney Kimmel Cancer Center, Thomas 
      Jefferson University, Philadelphia, PA; and Nienke De Glas, Leiden University 
      Medical Centre, Leiden, the Netherlands.
FAU - Akiba, Chie
AU  - Akiba C
AD  - Arti Hurria, Tao Feng, David Smith, Can-Lan Sun, Vani Katheria, Caroline Doan, 
      Laura Zavala, Abrahm Levi, and Chie Akiba, City of Hope Comprehensive Cancer 
      Center and Beckman Research Institute, Duarte, CA; Supriya Mohile, University of 
      Rochester Medical Center, Rochester; Ajeet Gajra, Upstate Medical University and 
      Syracuse VA Medical Center, Syracuse; William P. Tew, Memorial Sloan Kettering 
      Cancer Center, New York, NY; Heidi Klepin, Wake Forest University School of 
      Medicine, Winston Salem; Hyman Muss, University of North Carolina at Chapel Hill, 
      Lineberger Comprehensive Cancer Center, Chapel Hill; Harvey Jay Cohen, Duke 
      University, Durham, NC; Andrew Chapman, Sidney Kimmel Cancer Center, Thomas 
      Jefferson University, Philadelphia, PA; and Nienke De Glas, Leiden University 
      Medical Centre, Leiden, the Netherlands.
FAU - Tew, William P
AU  - Tew WP
AD  - Arti Hurria, Tao Feng, David Smith, Can-Lan Sun, Vani Katheria, Caroline Doan, 
      Laura Zavala, Abrahm Levi, and Chie Akiba, City of Hope Comprehensive Cancer 
      Center and Beckman Research Institute, Duarte, CA; Supriya Mohile, University of 
      Rochester Medical Center, Rochester; Ajeet Gajra, Upstate Medical University and 
      Syracuse VA Medical Center, Syracuse; William P. Tew, Memorial Sloan Kettering 
      Cancer Center, New York, NY; Heidi Klepin, Wake Forest University School of 
      Medicine, Winston Salem; Hyman Muss, University of North Carolina at Chapel Hill, 
      Lineberger Comprehensive Cancer Center, Chapel Hill; Harvey Jay Cohen, Duke 
      University, Durham, NC; Andrew Chapman, Sidney Kimmel Cancer Center, Thomas 
      Jefferson University, Philadelphia, PA; and Nienke De Glas, Leiden University 
      Medical Centre, Leiden, the Netherlands.
LA  - eng
GR  - K23 AG026749/AG/NIA NIH HHS/United States
GR  - P30 CA008748/CA/NCI NIH HHS/United States
GR  - P30 CA033572/CA/NCI NIH HHS/United States
GR  - UG1 CA189961/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Validation Study
DEP - 20160516
PL  - United States
TA  - J Clin Oncol
JT  - Journal of clinical oncology : official journal of the American Society of 
      Clinical Oncology
JID - 8309333
RN  - 0 (Antineoplastic Agents)
SB  - IM
MH  - Aged
MH  - Antineoplastic Agents/*adverse effects
MH  - Female
MH  - *Geriatric Assessment
MH  - Humans
MH  - Male
MH  - Neoplasms/*drug therapy
PMC - PMC5321104
COIS- Authors’ disclosures of potential conflicts of interest are found in the article 
      online at www.jco.org. Author contributions are found at the end of this article.
EDAT- 2016/05/18 06:00
MHDA- 2017/08/02 06:00
CRDT- 2016/05/18 06:00
PHST- 2016/05/18 06:00 [entrez]
PHST- 2016/05/18 06:00 [pubmed]
PHST- 2017/08/02 06:00 [medline]
AID - JCO.2015.65.4327 [pii]
AID - 654327 [pii]
AID - 10.1200/JCO.2015.65.4327 [doi]
PST - ppublish
SO  - J Clin Oncol. 2016 Jul 10;34(20):2366-71. doi: 10.1200/JCO.2015.65.4327. Epub 
      2016 May 16.

PMID- 35855604
OWN - NLM
STAT- MEDLINE
DCOM- 20220721
LR  - 20231213
IS  - 1471-2954 (Electronic)
IS  - 0962-8452 (Print)
IS  - 0962-8452 (Linking)
VI  - 289
IP  - 1979
DP  - 2022 Jul 27
TI  - Long-distance vocalizations of spotted hyenas contain individual, but not group, 
      signatures.
PG  - 20220548
LID - 10.1098/rspb.2022.0548 [doi]
LID - 20220548
AB  - In animal societies, identity signals are common, mediate interactions within 
      groups, and allow individuals to discriminate group-mates from out-group 
      competitors. However, individual recognition becomes increasingly challenging as 
      group size increases and as signals must be transmitted over greater distances. 
      Group vocal signatures may evolve when successful in-group/out-group distinctions 
      are at the crux of fitness-relevant decisions, but group signatures alone are 
      insufficient when differentiated within-group relationships are important for 
      decision-making. Spotted hyenas are social carnivores that live in stable clans 
      of less than 125 individuals composed of multiple unrelated matrilines. Clan 
      members cooperate to defend resources and communal territories from neighbouring 
      clans and other mega carnivores; this collective defence is mediated by 
      long-range (up to 5 km range) recruitment vocalizations, called whoops. Here, we 
      use machine learning to determine that spotted hyena whoops contain individual 
      but not group signatures, and that fundamental frequency features which propagate 
      well are critical for individual discrimination. For effective clan-level 
      cooperation, hyenas face the cognitive challenge of remembering and recognizing 
      individual voices at long range. We show that serial redundancy in whoop bouts 
      increases individual classification accuracy and thus extended call bouts used by 
      hyenas probably evolved to overcome the challenges of communicating individual 
      identity at long distance.
FAU - Lehmann, Kenna D S
AU  - Lehmann KDS
AUID- ORCID: 0000-0003-2690-7332
AD  - School of Biological Sciences, University of Nebraska-Lincoln, 1101T Street, 
      Lincoln, NE 68588, USA.
FAU - Jensen, Frants H
AU  - Jensen FH
AUID- ORCID: 0000-0001-8776-3606
AD  - Department of Biology, Syracuse University, 107 College Place, Syracuse, NY 
      13244, USA.
AD  - Biology Department, Woods Hole Oceanographic Institution, Woods Hole, MA 02543, 
      USA.
FAU - Gersick, Andrew S
AU  - Gersick AS
AUID- ORCID: 0000-0001-7701-7132
AD  - Dept of Ecology and Evolutionary Biology, Princeton University, 106A Guyot Hall, 
      Princeton, NJ 08544, USA.
FAU - Strandburg-Peshkin, Ariana
AU  - Strandburg-Peshkin A
AUID- ORCID: 0000-0003-2985-6788
AD  - Biology Department, University of Konstanz, Universitätsstrasse 10, 78464 
      Konstanz, Germany.
AD  - Centre for the Advanced Study of Collective Behaviour, University of Konstanz, 
      Universitätsstrasse 10, 78464 Konstanz, Germany.
AD  - Department for the Ecology of Animal Societies, Max Planck Institute of Animal 
      Behaviour, Bücklestrasse 5a, 78467 Konstanz, Germany.
FAU - Holekamp, Kay E
AU  - Holekamp KE
AUID- ORCID: 0000-0001-5471-1076
AD  - Department of Integrative Biology, Michigan State University, 288 Farm Lane, East 
      Lansing, MI 48824 USA.
AD  - Ecology, Evolution, and Behavior Program, Michigan State University, 293 Farm 
      Lane, East Lansing, MI 48824, USA.
LA  - eng
SI  - Dryad/10.5061/dryad.djh9w0w2h
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20220720
PL  - England
TA  - Proc Biol Sci
JT  - Proceedings. Biological sciences
JID - 101245157
SB  - IM
MH  - Animals
MH  - *Carnivora
MH  - *Hyaenidae
MH  - Mental Recall
MH  - Recognition, Psychology
PMC - PMC9297016
OTO - NOTNLM
OT  - animal communication
OT  - group signatures
OT  - individual signatures
OT  - long-distance signals
COIS- We declare we have no competing interests.
EDAT- 2022/07/21 06:00
MHDA- 2022/07/22 06:00
CRDT- 2022/07/20 03:13
PHST- 2022/07/20 03:13 [entrez]
PHST- 2022/07/21 06:00 [pubmed]
PHST- 2022/07/22 06:00 [medline]
AID - rspb20220548 [pii]
AID - 10.1098/rspb.2022.0548 [doi]
PST - ppublish
SO  - Proc Biol Sci. 2022 Jul 27;289(1979):20220548. doi: 10.1098/rspb.2022.0548. Epub 
      2022 Jul 20.

PMID- 35465359
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20221021
IS  - 2589-0042 (Electronic)
IS  - 2589-0042 (Linking)
VI  - 25
IP  - 4
DP  - 2022 Apr 15
TI  - Discovery of a novel SHIP1 agonist that promotes degradation of lipid-laden 
      phagocytic cargo by microglia.
PG  - 104170
LID - 10.1016/j.isci.2022.104170 [doi]
LID - 104170
AB  - Here, we describe the use of artificial intelligence to identify novel agonists 
      of the SH2-containing 5' inositol phosphatase 1 (SHIP1). One of the compounds, 
      K306, represents the most potent agonist identified to date. We find that K306 
      exhibits selectivity for SHIP1 vs. the paralog enzyme SHIP2, and this activation 
      does not require the C2 domain of SHIP1 which other known SHIP1 agonists require. 
      Thus, K306 represents a new class of SHIP1 agonists with a novel mode of agonism. 
      Importantly, we find that K306 can suppress induction of inflammatory cytokines 
      and iNOS in macrophages or microglia, but not by their SHIP1-deficient 
      counterparts. K306 also reduces TNF-α production in vivo in an LPS-induced 
      endotoxemia assay. Finally, we show that K306 enhances phagolysosomal degradation 
      of synaptosomes and dead neurons by microglia revealing a novel function for 
      SHIP1 that might be exploited therapeutically in dementia.
CI  - © 2022 The Author(s).
FAU - Pedicone, Chiara
AU  - Pedicone C
AD  - Department of Microbiology and Immunology, SUNY Upstate Medical University, 
      Syracuse, NY 13210, USA.
FAU - Fernandes, Sandra
AU  - Fernandes S
AD  - Department of Microbiology and Immunology, SUNY Upstate Medical University, 
      Syracuse, NY 13210, USA.
FAU - Matera, Alessandro
AU  - Matera A
AD  - Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.
FAU - Meyer, Shea T
AU  - Meyer ST
AD  - Chemistry Department, Syracuse University, Syracuse, NY 13210, USA.
FAU - Loh, Stewart
AU  - Loh S
AD  - Department of Biochemistry & Molecular Biology, SUNY Upstate Medical University, 
      Syracuse, NY 13210, USA.
FAU - Ha, Jeung-Hoi
AU  - Ha JH
AD  - Department of Biochemistry & Molecular Biology, SUNY Upstate Medical University, 
      Syracuse, NY 13210, USA.
FAU - Bernard, Denzil
AU  - Bernard D
AD  - Atomwise, San Francisco, CA, USA.
FAU - Chisholm, John D
AU  - Chisholm JD
AD  - Chemistry Department, Syracuse University, Syracuse, NY 13210, USA.
FAU - Paolicelli, Rosa Chiara
AU  - Paolicelli RC
AD  - Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.
FAU - Kerr, William G
AU  - Kerr WG
AD  - Department of Microbiology and Immunology, SUNY Upstate Medical University, 
      Syracuse, NY 13210, USA.
AD  - Chemistry Department, Syracuse University, Syracuse, NY 13210, USA.
LA  - eng
GR  - RF1 AG059717/AG/NIA NIH HHS/United States
PT  - Journal Article
DEP - 20220326
PL  - United States
TA  - iScience
JT  - iScience
JID - 101724038
PMC - PMC9020084
OTO - NOTNLM
OT  - Artificial intelligence
OT  - Biochemical mechanism
OT  - Biochemistry
OT  - Cellular neuroscience
OT  - Health sciences
COIS- D.B. is an Atomwise employee. The other authors declare no competing interests.
EDAT- 2022/04/26 06:00
MHDA- 2022/04/26 06:01
CRDT- 2022/04/25 05:49
PHST- 2021/11/08 00:00 [received]
PHST- 2021/12/31 00:00 [revised]
PHST- 2022/03/24 00:00 [accepted]
PHST- 2022/04/25 05:49 [entrez]
PHST- 2022/04/26 06:00 [pubmed]
PHST- 2022/04/26 06:01 [medline]
AID - S2589-0042(22)00440-0 [pii]
AID - 104170 [pii]
AID - 10.1016/j.isci.2022.104170 [doi]
PST - epublish
SO  - iScience. 2022 Mar 26;25(4):104170. doi: 10.1016/j.isci.2022.104170. eCollection 
      2022 Apr 15.

PMID- 35820087
OWN - NLM
STAT- MEDLINE
DCOM- 20220714
LR  - 20230421
IS  - 2473-4284 (Electronic)
IS  - 2473-4284 (Linking)
VI  - 6
DP  - 2022 Jul
TI  - Genomic Biomarkers and Genome-Wide Loss-of-Heterozygosity Scores in Metastatic 
      Prostate Cancer Following Progression on Androgen-Targeting Therapies.
PG  - e2200195
LID - 10.1200/PO.22.00195 [doi]
LID - e2200195
AB  - PURPOSE: To study the impact of standard-of-care hormonal therapies on metastatic 
      prostate cancer (mPC) clinical genomic profiles in real-world practice, with a 
      focus on homologous recombination-repair (HRR) genes. PATIENTS AND METHODS: 
      Targeted next-generation sequencing of 1,302 patients with mPC was pursued using 
      the FoundationOne or FoundationOne CDx assays. Longitudinal clinical data for 
      correlative analysis were curated via technology-enabled abstraction of 
      electronic health records. Genomic biomarkers, including individual gene 
      aberrations and genome-wide loss-of-heterozygosity (gLOH) scores, were compared 
      according to biopsy location and time of sample acquisition (androgen deprivation 
      therapy [ADT]-naïve, ADT-progression and post-ADT, and novel hormonal therapies 
      [NHT]-progression), using chi-square and Wilcoxon rank-sum tests. Multivariable 
      analysis used linear regression. False-discovery rate of 0.05 was applied to 
      account for multiple comparisons. RESULTS: Eight hundred forty (65%), 132 (10%), 
      and 330 (25%) biopsies were ADT-naïve, ADT-progression, and NHT-progression, 
      respectively. Later-stage samples were enriched for AR, MYC, TP53, PTEN, and RB1 
      aberrations (all adjusted P values < .05), but prevalence of HRR-related BRCA2, 
      ATM, and CDK12 aberrations remained stable. Primary and metastatic ADT-naïve 
      biopsies presented similar prevalence of TP53 (36% v 31%) and BRCA2 (8% v 7%) 
      aberrations; 81% of ADT-naïve BRCA2-mutated samples presented BRCA2 biallelic 
      loss. Higher gLOH scores were independently associated with HRR genes (BRCA2, 
      PALB2, and FANCA), TP53, and RB1 aberrations, and with prior exposure to hormonal 
      therapies in multivariable analysis. CONCLUSION: Prevalence of HRR-gene 
      aberrations remains stable along mPC progression, supporting the use of 
      diagnostic biopsies to guide poly (ADP-ribose) polymerase inhibitor treatment in 
      metastatic castration-resistant prostate cancer. gLOH scores increase with 
      emerging resistance to hormonal therapies, independently of individual HRR gene 
      mutations.
FAU - Zurita, Amado J
AU  - Zurita AJ
AUID- ORCID: 0000-0002-3805-7307
AD  - The University of Texas MD Anderson Cancer Center, Houston, TX.
FAU - Graf, Ryon P
AU  - Graf RP
AUID- ORCID: 0000-0002-8065-4148
AD  - Foundation Medicine Inc, Cambridge, MA.
FAU - Villacampa, Guillermo
AU  - Villacampa G
AUID- ORCID: 0000-0003-4868-6585
AD  - Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital 
      Campus, Barcelona, Spain.
FAU - Raskina, Kira
AU  - Raskina K
AUID- ORCID: 0000-0003-0899-6175
AD  - Foundation Medicine Inc, Cambridge, MA.
FAU - Sokol, Ethan
AU  - Sokol E
AUID- ORCID: 0000-0002-2988-0537
AD  - Foundation Medicine Inc, Cambridge, MA.
FAU - Jin, Dexter
AU  - Jin D
AD  - Foundation Medicine Inc, Cambridge, MA.
FAU - Antonarakis, Emmanuel S
AU  - Antonarakis ES
AUID- ORCID: 0000-0003-0031-9655
AD  - University of Minnesota, Masonic Cancer Center, Minneapolis, MN.
FAU - Li, Gerald
AU  - Li G
AD  - Foundation Medicine Inc, Cambridge, MA.
FAU - Huang, Richard S P
AU  - Huang RSP
AUID- ORCID: 0000-0001-8395-5168
AD  - Foundation Medicine Inc, Cambridge, MA.
FAU - Casanova-Salas, Irene
AU  - Casanova-Salas I
AD  - Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital 
      Campus, Barcelona, Spain.
FAU - Vivancos, Ana
AU  - Vivancos A
AUID- ORCID: 0000-0003-2888-6512
AD  - Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital 
      Campus, Barcelona, Spain.
FAU - Carles, Joan
AU  - Carles J
AUID- ORCID: 0000-0002-9983-5934
AD  - Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital 
      Campus, Barcelona, Spain.
FAU - Ross, Jeffrey S
AU  - Ross JS
AUID- ORCID: 0000-0001-8494-2596
AD  - Foundation Medicine Inc, Cambridge, MA.
AD  - SUNY Upstate Medical University, Syracuse, NY.
FAU - Schrock, Alexa B
AU  - Schrock AB
AUID- ORCID: 0000-0003-0106-9096
AD  - Foundation Medicine Inc, Cambridge, MA.
FAU - Oxnard, Geoffrey R
AU  - Oxnard GR
AUID- ORCID: 0000-0003-1054-8240
AD  - Foundation Medicine Inc, Cambridge, MA.
FAU - Mateo, Joaquin
AU  - Mateo J
AUID- ORCID: 0000-0001-5336-2548
AD  - Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital 
      Campus, Barcelona, Spain.
LA  - eng
GR  - P30 CA016672/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - JCO Precis Oncol
JT  - JCO precision oncology
JID - 101705370
RN  - 0 (Androgen Antagonists)
RN  - 0 (Androgens)
RN  - 0 (Biomarkers, Tumor)
SB  - IM
MH  - *Androgen Antagonists/therapeutic use
MH  - Androgens/therapeutic use
MH  - Biomarkers, Tumor/genetics
MH  - Genomics
MH  - Humans
MH  - Male
MH  - *Prostatic Neoplasms, Castration-Resistant/drug therapy
PMC - PMC9307307
COIS- The following represents disclosure information provided by authors of this 
      manuscript. All relationships are considered compensated unless otherwise noted. 
      Relationships are self-held unless noted. I = Immediate Family Member, Inst = My 
      Institution. Relationships may not relate to the subject matter of this 
      manuscript. For more information about ASCO's conflict of interest policy, please 
      refer to www.asco.org/rwc or ascopubs.org/po/author-center. Open Payments is a 
      public database containing information reported by companies about payments made 
      to US-licensed physicians (Open Payments). Joaquin Mateo This author is a member 
      of the JCO Precision Oncology Editorial Board. Journal policy recused the author 
      from having any role in the peer review of this manuscript. Consulting or 
      Advisory Role: AstraZeneca, Roche, MSD, Amgen, Pfizer, Daiichi Sankyo Speakers' 
      Bureau: AstraZeneca, Astellas, Janssen, Pfizer, Guardant Health Research Funding: 
      AstraZeneca (Inst), Pfizer (Inst) Travel, Accommodations, Expenses: AstraZeneca 
      No other potential conflicts of interest were reported.
EDAT- 2022/07/13 06:00
MHDA- 2022/07/15 06:00
CRDT- 2022/07/12 16:03
PHST- 2022/07/12 16:03 [entrez]
PHST- 2022/07/13 06:00 [pubmed]
PHST- 2022/07/15 06:00 [medline]
AID - PO.22.00195 [pii]
AID - 10.1200/PO.22.00195 [doi]
PST - ppublish
SO  - JCO Precis Oncol. 2022 Jul;6:e2200195. doi: 10.1200/PO.22.00195.

PMID- 27862943
OWN - NLM
STAT- MEDLINE
DCOM- 20170921
LR  - 20200930
IS  - 1552-485X (Electronic)
IS  - 1552-4841 (Print)
IS  - 1552-4841 (Linking)
VI  - 174
IP  - 3
DP  - 2017 Apr
TI  - Blood transcriptomic comparison of individuals with and without autism spectrum 
      disorder: A combined-samples mega-analysis.
PG  - 181-201
LID - 10.1002/ajmg.b.32511 [doi]
AB  - Blood-based microarray studies comparing individuals affected with autism 
      spectrum disorder (ASD) and typically developing individuals help characterize 
      differences in circulating immune cell functions and offer potential biomarker 
      signal. We sought to combine the subject-level data from previously published 
      studies by mega-analysis to increase the statistical power. We identified studies 
      that compared ex vivo blood or lymphocytes from ASD-affected individuals and 
      unrelated comparison subjects using Affymetrix or Illumina array platforms. Raw 
      microarray data and clinical meta-data were obtained from seven studies, totaling 
      626 affected and 447 comparison subjects. Microarray data were processed using 
      uniform methods. Covariate-controlled mixed-effect linear models were used to 
      identify gene transcripts and co-expression network modules that were 
      significantly associated with diagnostic status. Permutation-based gene-set 
      analysis was used to identify functionally related sets of genes that were over- 
      and under-expressed among ASD samples. Our results were consistent with 
      diminished interferon-, EGF-, PDGF-, PI3K-AKT-mTOR-, and RAS-MAPK-signaling 
      cascades, and increased ribosomal translation and NK-cell related activity in 
      ASD. We explored evidence for sex-differences in the ASD-related transcriptomic 
      signature. We also demonstrated that machine-learning classifiers using blood 
      transcriptome data perform with moderate accuracy when data are combined across 
      studies. Comparing our results with those from blood-based studies of protein 
      biomarkers (e.g., cytokines and trophic factors), we propose that ASD may feature 
      decoupling between certain circulating signaling proteins (higher in ASD samples) 
      and the transcriptional cascades which they typically elicit within circulating 
      immune cells (lower in ASD samples). These findings provide insight into 
      ASD-related transcriptional differences in circulating immune cells. © 2016 Wiley 
      Periodicals, Inc.
CI  - © 2016 Wiley Periodicals, Inc.
FAU - Tylee, Daniel S
AU  - Tylee DS
AD  - Departments of Psychiatry and Behavioral Sciences and Neuroscience and 
      Physiology, Psychiatric Genetic Epidemiology and Neurobiology Laboratory 
      (PsychGENe Lab), SUNY Upstate Medical University, Syracuse, New York.
FAU - Hess, Jonathan L
AU  - Hess JL
AD  - Departments of Psychiatry and Behavioral Sciences and Neuroscience and 
      Physiology, Psychiatric Genetic Epidemiology and Neurobiology Laboratory 
      (PsychGENe Lab), SUNY Upstate Medical University, Syracuse, New York.
FAU - Quinn, Thomas P
AU  - Quinn TP
AD  - Departments of Psychiatry and Behavioral Sciences and Neuroscience and 
      Physiology, Psychiatric Genetic Epidemiology and Neurobiology Laboratory 
      (PsychGENe Lab), SUNY Upstate Medical University, Syracuse, New York.
FAU - Barve, Rahul
AU  - Barve R
AD  - Departments of Psychiatry and Behavioral Sciences and Neuroscience and 
      Physiology, Psychiatric Genetic Epidemiology and Neurobiology Laboratory 
      (PsychGENe Lab), SUNY Upstate Medical University, Syracuse, New York.
FAU - Huang, Hailiang
AU  - Huang H
AD  - Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, 
      Massachusetts.
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
FAU - Zhang-James, Yanli
AU  - Zhang-James Y
AD  - Departments of Psychiatry and Behavioral Sciences and Neuroscience and 
      Physiology, Psychiatric Genetic Epidemiology and Neurobiology Laboratory 
      (PsychGENe Lab), SUNY Upstate Medical University, Syracuse, New York.
FAU - Chang, Jeffrey
AU  - Chang J
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Downstate Medical Center, 
      Brooklyn, New York.
FAU - Stamova, Boryana S
AU  - Stamova BS
AD  - Department of Neurology, UC Davis School of Medicine, Sacramento, California.
FAU - Sharp, Frank R
AU  - Sharp FR
AD  - Department of Neurology, UC Davis School of Medicine, Sacramento, California.
FAU - Hertz-Picciotto, Irva
AU  - Hertz-Picciotto I
AD  - Department of Public Health Sciences and UC Davis MIND Institute, School of 
      Medicine, Davis, California.
FAU - Faraone, Stephen V
AU  - Faraone SV
AD  - Departments of Psychiatry and Behavioral Sciences and Neuroscience and 
      Physiology, Psychiatric Genetic Epidemiology and Neurobiology Laboratory 
      (PsychGENe Lab), SUNY Upstate Medical University, Syracuse, New York.
AD  - K.G. Jebsen Centre for Research on Neuropsychiatric Disorders, University of 
      Bergen, Bergen, Norway.
FAU - Kong, Sek Won
AU  - Kong SW
AD  - Department of Pediatrics, Computational Health Informatics Program, Boston 
      Children's Hospital, Harvard Medical School, Boston, Massachusetts.
FAU - Glatt, Stephen J
AU  - Glatt SJ
AD  - Departments of Psychiatry and Behavioral Sciences and Neuroscience and 
      Physiology, Psychiatric Genetic Epidemiology and Neurobiology Laboratory 
      (PsychGENe Lab), SUNY Upstate Medical University, Syracuse, New York.
LA  - eng
GR  - R01 MH101519/MH/NIMH NIH HHS/United States
GR  - R01 MH107205/MH/NIMH NIH HHS/United States
GR  - P30 CA093373/CA/NCI NIH HHS/United States
GR  - R01 ES015359/ES/NIEHS NIH HHS/United States
GR  - P30 ES023513/ES/NIEHS NIH HHS/United States
GR  - U54 HD079125/HD/NICHD NIH HHS/United States
GR  - P50 MH094267/MH/NIMH NIH HHS/United States
GR  - R01 MH085143/MH/NIMH NIH HHS/United States
GR  - P01 ES011269/ES/NIEHS NIH HHS/United States
PT  - Journal Article
PT  - Meta-Analysis
DEP - 20161111
PL  - United States
TA  - Am J Med Genet B Neuropsychiatr Genet
JT  - American journal of medical genetics. Part B, Neuropsychiatric genetics : the 
      official publication of the International Society of Psychiatric Genetics
JID - 101235742
RN  - 0 (Biomarkers)
SB  - IM
MH  - Autism Spectrum Disorder/blood/diagnosis/*genetics
MH  - Biomarkers/blood
MH  - Female
MH  - Humans
MH  - Male
MH  - Oligonucleotide Array Sequence Analysis
MH  - Signal Transduction
MH  - Transcriptome/*genetics
PMC - PMC5499528
MID - NIHMS869131
OTO - NOTNLM
OT  - gene expression
OT  - immune system
OT  - machine learning
OT  - microarray
EDAT- 2016/11/20 06:00
MHDA- 2017/09/22 06:00
CRDT- 2016/11/19 06:00
PHST- 2016/07/29 00:00 [received]
PHST- 2016/10/21 00:00 [accepted]
PHST- 2016/11/20 06:00 [pubmed]
PHST- 2017/09/22 06:00 [medline]
PHST- 2016/11/19 06:00 [entrez]
AID - 10.1002/ajmg.b.32511 [doi]
PST - ppublish
SO  - Am J Med Genet B Neuropsychiatr Genet. 2017 Apr;174(3):181-201. doi: 
      10.1002/ajmg.b.32511. Epub 2016 Nov 11.

PMID- 27163203
OWN - NLM
STAT- MEDLINE
DCOM- 20170111
LR  - 20190112
IS  - 2158-3188 (Electronic)
IS  - 2158-3188 (Linking)
VI  - 6
IP  - 5
DP  - 2016 May 10
TI  - Candidate gene networks and blood biomarkers of methamphetamine-associated 
      psychosis: an integrative RNA-sequencing report.
PG  - e802
LID - 10.1038/tp.2016.67 [doi]
AB  - The clinical presentation, course and treatment of methamphetamine 
      (METH)-associated psychosis (MAP) are similar to that observed in schizophrenia 
      (SCZ) and subsequently MAP has been hypothesized as a pharmacological and 
      environmental model of SCZ. However, several challenges currently exist in 
      diagnosing MAP accurately at the molecular and neurocognitive level before the 
      MAP model can contribute to the discovery of SCZ biomarkers. We directly assessed 
      subcortical brain structural volumes and clinical parameters of MAP within the 
      framework of an integrative genome-wide RNA-Seq blood transcriptome analysis of 
      subjects diagnosed with MAP (N=10), METH dependency without psychosis (MA; N=10) 
      and healthy controls (N=10). First, we identified discrete groups of co-expressed 
      genes (that is, modules) and tested them for functional annotation and phenotypic 
      relationships to brain structure volumes, life events and psychometric 
      measurements. We discovered one MAP-associated module involved in 
      ubiquitin-mediated proteolysis downregulation, enriched with 61 genes previously 
      found implicated in psychosis and SCZ across independent blood and post-mortem 
      brain studies using convergent functional genomic (CFG) evidence. This module 
      demonstrated significant relationships with brain structure volumes including the 
      anterior corpus callosum (CC) and the nucleus accumbens. Furthermore, a second 
      MAP and psychoticism-associated module involved in circadian clock upregulation 
      was also enriched with 39 CFG genes, further associated with the CC. 
      Subsequently, a machine-learning analysis of differentially expressed genes 
      identified single blood-based biomarkers able to differentiate controls from 
      methamphetamine dependents with 87% accuracy and MAP from MA subjects with 95% 
      accuracy. CFG evidence validated a significant proportion of these putative MAP 
      biomarkers in independent studies including CLN3, FBP1, TBC1D2 and ZNF821 (RNA 
      degradation), ELK3 and SINA3 (circadian clock) and PIGF and UHMK1 
      (ubiquitin-mediated proteolysis). Finally, focusing analysis on brain structure 
      volumes revealed significantly lower bilateral hippocampal volumes in MAP 
      subjects. Overall, these results suggest similar molecular and neurocognitive 
      mechanisms underlying the pathophysiology of psychosis and SCZ regardless of 
      substance abuse and provide preliminary evidence supporting the MAP paradigm as 
      an exemplar for SCZ biomarker discovery.
FAU - Breen, M S
AU  - Breen MS
AD  - Department of Clinical and Experimental Sciences, Faculty of Medicine, University 
      of Southampton, Southampton, UK.
FAU - Uhlmann, A
AU  - Uhlmann A
AD  - Department of Psychiatry and MRC Unit on Anxiety and Stress Disorders, Groote 
      Schuur Hospital (J-2), University of Cape Town, Cape Town, South Africa.
FAU - Nday, C M
AU  - Nday CM
AD  - Department of Molecular and Cellular Biology, University of Cape Town, Cape Town, 
      South Africa.
FAU - Glatt, S J
AU  - Glatt SJ
AD  - Psychiatric Genetic Epidemiology and Neurobiology Laboratory, Departments of 
      Psychiatry and Behavioral Sciences and Neuroscience and Physiology, Medical 
      Genetics Research Center, SUNY Upstate Medical University, Syracuse, NY, USA.
FAU - Mitt, M
AU  - Mitt M
AD  - The Estonian Genome Center, University of Tartu, Tartu, Estonia.
FAU - Metsalpu, A
AU  - Metsalpu A
AD  - The Estonian Genome Center, University of Tartu, Tartu, Estonia.
FAU - Stein, D J
AU  - Stein DJ
AD  - Department of Psychiatry and MRC Unit on Anxiety and Stress Disorders, Groote 
      Schuur Hospital (J-2), University of Cape Town, Cape Town, South Africa.
FAU - Illing, N
AU  - Illing N
AD  - Department of Molecular and Cellular Biology, University of Cape Town, Cape Town, 
      South Africa.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20160510
PL  - United States
TA  - Transl Psychiatry
JT  - Translational psychiatry
JID - 101562664
RN  - 0 (Biomarkers)
RN  - 44RAL3456C (Methamphetamine)
SB  - IM
MH  - Adult
MH  - Amphetamine-Related Disorders/*blood/complications/physiopathology
MH  - Biomarkers/blood
MH  - Brain/physiopathology
MH  - Female
MH  - Gene Regulatory Networks/*physiology
MH  - Humans
MH  - Magnetic Resonance Imaging
MH  - Male
MH  - Methamphetamine/*blood
MH  - Psychoses, Substance-Induced/*blood/etiology/physiopathology
MH  - Sequence Analysis, RNA/*statistics & numerical data
MH  - Young Adult
PMC - PMC5070070
EDAT- 2016/05/11 06:00
MHDA- 2017/01/12 06:00
CRDT- 2016/05/11 06:00
PHST- 2015/10/09 00:00 [received]
PHST- 2016/01/21 00:00 [revised]
PHST- 2016/01/24 00:00 [accepted]
PHST- 2016/05/11 06:00 [entrez]
PHST- 2016/05/11 06:00 [pubmed]
PHST- 2017/01/12 06:00 [medline]
AID - tp201667 [pii]
AID - 10.1038/tp.2016.67 [doi]
PST - epublish
SO  - Transl Psychiatry. 2016 May 10;6(5):e802. doi: 10.1038/tp.2016.67.

PMID- 34726276
OWN - NLM
STAT- MEDLINE
DCOM- 20220406
LR  - 20220406
IS  - 1556-4029 (Electronic)
IS  - 0022-1198 (Linking)
VI  - 67
IP  - 2
DP  - 2022 Mar
TI  - Late-onset of ornithine transcarbamylase deficiency: A rare medical examiner 
      case.
PG  - 813-819
LID - 10.1111/1556-4029.14934 [doi]
AB  - Ornithine Transcarbamylase (OTC) is an enzyme of the urea cycle, which converts 
      ammonia into urea in the liver cells. OTC plays a crucial role in the breakdown 
      and removal of nitrogen in the body. OTC deficiency is a rare X-linked recessive 
      disorder that classically presents in early life with signs of hyperammonemia and 
      progressive central nervous system involvement resulting in seizures, coma, and 
      death. Sentinel presentation in adulthood is quite rare. A 29-year-old man 
      developed altered mental status after receiving an epidural steroid injection 
      3 days earlier for back pain. He presented to the emergency department severely 
      agitated, and his workup revealed an elevated ammonia level of 125 µmol/L. He 
      refused admission and was discharged against medical advice. The following day, 
      his mentation deteriorated, he developed status epilepticus, and was transported 
      to another emergency department. He was admitted with worsening hyperammonemia 
      (levels rising to over 700 µmol/L). His clinical condition progressive 
      deteriorated, and he developed encephalopathy and diffuse cerebral edema. Liver 
      function testing indicated progressive liver damage, and amino acids were 
      detected in his blood and urine. Clinical and laboratory findings suggested 
      undiagnosed OTC enzyme deficiency. He died 2 days after admission. An autopsy 
      showed an 1890 g liver with diffuse yellow discoloration and softening. Histology 
      and electron microscopy revealed findings suggestive of urea cycle disorder, such 
      as microvesicular steatosis, apoptosis, and scattered mitosis, clusters of clear 
      hepatocytes at the PAS stain, and mitochondria abnormalities. Genetic analysis 
      revealed a hemizygous pathogenic variant of the OTC gene (c.622G>A). OTC 
      deficiency should be suspected in subjects with hyperammonemic encephalopathy. If 
      a genetic mutation is identified in the deceased, surviving family members should 
      be screened to prevent potential life-threatening complications.
CI  - © 2021 American Academy of Forensic Sciences.
FAU - Gitto, Lorenzo
AU  - Gitto L
AUID- ORCID: 0000-0002-1435-1819
AD  - Department of Pathology, SUNY Upstate Medical University, Syracuse, New York, 
      USA.
FAU - Fuller, Cristine E
AU  - Fuller CE
AD  - Department of Pathology, SUNY Upstate Medical University, Syracuse, New York, 
      USA.
FAU - Calleo, Vincent J
AU  - Calleo VJ
AD  - Upstate New York Poison Center, SUNY Upstate Medical University, Syracuse, New 
      York, USA.
FAU - Tawil, Michel
AU  - Tawil M
AD  - Department of Pathology, SUNY Upstate Medical University, Syracuse, New York, 
      USA.
FAU - Thach, Rasmey
AU  - Thach R
AD  - Department of Medicine, William Beaumont Army Medical Center, Fort Bliss, Texas, 
      USA.
FAU - Revercomb, Carolyn
AU  - Revercomb C
AD  - Onondaga County Medical Examiner's Office, Syracuse, New York, USA.
LA  - eng
PT  - Case Reports
DEP - 20211102
PL  - United States
TA  - J Forensic Sci
JT  - Journal of forensic sciences
JID - 0375370
SB  - IM
MH  - Adult
MH  - Coma
MH  - Coroners and Medical Examiners
MH  - Humans
MH  - *Hyperammonemia/complications/genetics
MH  - Male
MH  - *Ornithine Carbamoyltransferase Deficiency 
      Disease/complications/diagnosis/genetics
MH  - Seizures
OTO - NOTNLM
OT  - autopsy
OT  - forensic pathology
OT  - genetic testing
OT  - hyperammonemia
OT  - liver failure
OT  - ornithine transcarbamylase
OT  - urea cycle
EDAT- 2021/11/03 06:00
MHDA- 2022/04/07 06:00
CRDT- 2021/11/02 09:16
PHST- 2021/10/21 00:00 [revised]
PHST- 2021/08/27 00:00 [received]
PHST- 2021/10/22 00:00 [accepted]
PHST- 2021/11/03 06:00 [pubmed]
PHST- 2022/04/07 06:00 [medline]
PHST- 2021/11/02 09:16 [entrez]
AID - 10.1111/1556-4029.14934 [doi]
PST - ppublish
SO  - J Forensic Sci. 2022 Mar;67(2):813-819. doi: 10.1111/1556-4029.14934. Epub 2021 
      Nov 2.

PMID- 28383675
OWN - NLM
STAT- MEDLINE
DCOM- 20180319
LR  - 20200101
IS  - 1460-2199 (Electronic)
IS  - 1047-3211 (Print)
IS  - 1047-3211 (Linking)
VI  - 27
IP  - 6
DP  - 2017 Jun 1
TI  - Intrinsic Connectivity Network-Based Classification and Detection of Psychotic 
      Symptoms in Youth With 22q11.2 Deletions.
PG  - 3294-3306
LID - 10.1093/cercor/bhx076 [doi]
AB  - 22q11.2 Deletion syndrome (22q11DS) is a genetic disorder associated with 
      numerous phenotypic consequences and is one of the greatest known risk factors 
      for psychosis. We investigated intrinsic-connectivity-networks (ICNs) as 
      potential biomarkers for patient and psychosis-risk status in 2 independent 
      cohorts, UCLA (33 22q11DS-participants, 33 demographically matched controls), and 
      Syracuse (28 22q11DS, 28 controls). After assessing group connectivity 
      differences, ICNs from the UCLA cohort were used to train classifiers to 
      distinguish cases from controls, and to predict psychosis risk status within 
      22q11DS; classifiers were subsequently tested on the Syracuse cohort. In both 
      cohorts we observed significant hypoconnectivity in 22q11DS relative to controls 
      within anterior cingulate (ACC)/precuneus, executive, default mode (DMN), 
      posterior DMN, and salience networks. Of 12 ICN-derived classifiers tested in the 
      Syracuse replication-cohort, the ACC/precuneus, DMN, and posterior DMN 
      classifiers accurately distinguished between 22q11DS and controls. Within 22q11DS 
      subjects, connectivity alterations within 4 networks predicted psychosis risk 
      status for a given individual in both cohorts: the ACC/precuneus, DMN, left 
      executive, and salience networks. Widespread within-network-hypoconnectivity in 
      large-scale networks implicated in higher-order cognition may be a defining 
      characteristic of 22q11DS during adolescence and early adulthood; furthermore, 
      loss of coherence within these networks may be a valuable biomarker for 
      individual prediction of psychosis-risk in 22q11DS.
CI  - © The Author 2017. Published by Oxford University Press. All rights reserved. For 
      Permissions, please e-mail: journals.permissions@oup.com.
FAU - Schreiner, Matthew
AU  - Schreiner M
AD  - Department of Psychiatry & Biobehavioral Sciences, University of California, Los 
      Angeles, CA 90095, USA.
AD  - Interdepartmental Neuroscience Program, University of California, Los Angeles, CA 
      90095, USA.
FAU - Forsyth, Jennifer K
AU  - Forsyth JK
AD  - Department of Psychology, University of California, Los Angeles, CA 90095, USA.
FAU - Karlsgodt, Katherine H
AU  - Karlsgodt KH
AD  - Department of Psychology, University of California, Los Angeles, CA 90095, USA.
FAU - Anderson, Ariana E
AU  - Anderson AE
AD  - Department of Psychiatry & Biobehavioral Sciences, University of California, Los 
      Angeles, CA 90095, USA.
FAU - Hirsh, Nurit
AU  - Hirsh N
AD  - Department of Psychology, University of California, Los Angeles, CA 90095, USA.
FAU - Kushan, Leila
AU  - Kushan L
AD  - Department of Psychology, University of California, Los Angeles, CA 90095, USA.
FAU - Uddin, Lucina Q
AU  - Uddin LQ
AD  - Department of Psychology, University of Miami, Coral Gables, FL 33124, USA.
AD  - Neuroscience Program, University of Miami Miller School of Medicine, Miami, FL 
      33136, USA.
FAU - Mattiacio, Leah
AU  - Mattiacio L
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, New York, NY 13210, USA.
FAU - Coman, Ioana L
AU  - Coman IL
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, New York, NY 13210, USA.
FAU - Kates, Wendy R
AU  - Kates WR
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, New York, NY 13210, USA.
FAU - Bearden, Carrie E
AU  - Bearden CE
AD  - Department of Psychiatry & Biobehavioral Sciences, University of California, Los 
      Angeles, CA 90095, USA.
AD  - Department of Psychology, University of California, Los Angeles, CA 90095, USA.
LA  - eng
GR  - F31 MH099786/MH/NIMH NIH HHS/United States
GR  - U54 HD087101/HD/NICHD NIH HHS/United States
GR  - R03 MH106922/MH/NIMH NIH HHS/United States
GR  - R01 MH085953/MH/NIMH NIH HHS/United States
GR  - R01 MH064824/MH/NIMH NIH HHS/United States
GR  - K25 AG051782/AG/NIA NIH HHS/United States
GR  - T32 MH096682/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Multicenter Study
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Cereb Cortex
JT  - Cerebral cortex (New York, N.Y. : 1991)
JID - 9110718
RN  - S88TT14065 (Oxygen)
SB  - IM
MH  - Adolescent
MH  - Case-Control Studies
MH  - Child
MH  - Cohort Studies
MH  - Connectome
MH  - DiGeorge Syndrome/*complications
MH  - Female
MH  - Gyrus Cinguli/diagnostic imaging/*physiopathology
MH  - Humans
MH  - Magnetic Resonance Imaging
MH  - Male
MH  - Motion
MH  - Nerve Net/diagnostic imaging/*physiopathology
MH  - Neuropsychological Tests
MH  - Oxygen/blood
MH  - Parietal Lobe/diagnostic imaging/*physiopathology
MH  - Psychiatric Status Rating Scales
MH  - *Psychotic Disorders/classification/etiology/genetics/pathology
MH  - Young Adult
PMC - PMC6059149
OTO - NOTNLM
OT  - intrinsic connectivity networks
OT  - machine learning
OT  - psychosis
OT  - resting state functional MRI
OT  - velocardiofacial syndrome
EDAT- 2017/04/07 06:00
MHDA- 2018/03/20 06:00
CRDT- 2017/04/07 06:00
PHST- 2015/07/03 00:00 [received]
PHST- 2017/04/07 06:00 [pubmed]
PHST- 2018/03/20 06:00 [medline]
PHST- 2017/04/07 06:00 [entrez]
AID - 3102949 [pii]
AID - bhx076 [pii]
AID - 10.1093/cercor/bhx076 [doi]
PST - ppublish
SO  - Cereb Cortex. 2017 Jun 1;27(6):3294-3306. doi: 10.1093/cercor/bhx076.

PMID- 35838915
OWN - NLM
STAT- MEDLINE
DCOM- 20221020
LR  - 20221024
IS  - 2212-1358 (Electronic)
IS  - 2212-134X (Print)
IS  - 2212-134X (Linking)
VI  - 10
IP  - 6
DP  - 2022 Nov
TI  - Spinal deformity surgery is accompanied by serious complications: report from the 
      Morbidity and Mortality Database of the Scoliosis Research Society from 2013 to 
      2020.
PG  - 1307-1313
LID - 10.1007/s43390-022-00548-y [doi]
AB  - PURPOSE: The Morbidity and Mortality (M&M) report of the Scoliosis Research 
      Society (SRS) has been collected since 1965 and since 1968 submission of 
      complications has been required of all members. Since 2009, the SRS has collected 
      information on death, blindness, and neurological deficit, with acute infection 
      being added in 2012 and unintentional return to the operating room (OR) being 
      added in 2017. In this report, we use the most recent data submitted to the SRS 
      M&M database to determine the rate of neurological deficit, blindness, acute 
      infection, unintentional return to the OR, and death, while also comparing this 
      information to previous reports. METHODS: The SRS M&M database was queried for 
      all cases from 2013 to 2020. The rates of death, vision loss, neurological 
      deficit, acute infection, and unintentional return to the OR were then calculated 
      and analyzed. The rates were compared to previously published data if available. 
      Differences in complication rates between years were analyzed with Poisson 
      regression with significance set at α = 0.05. RESULTS: The total number of cases 
      submitted per year varied with a maximum of 49,615 in 2018 and a minimum of 
      40,464 in 2020. The overall reported complication rate from 2013 to 2020 was 
      2.86%. The overall mortality rate ranged from 0.09% in 2018 to 0.14% in 2015. The 
      number of patients with visual impairment ranged from 4 to 13 between 2013 and 
      2015 (no data on visual impairment were collected after 2015). The overall 
      infection rate varied from 0.95 in 2020 to 1.30% in 2015. When the infection rate 
      was analyzed based on spinal deformity group, the neuromuscular scoliosis group 
      consistently had the highest infection rate ranging from 3.24 to 3.94%. The 
      overall neurological deficit rate ranged from 0.74 to 0.94%, with the congenital 
      kyphosis and dysplastic spondylolisthesis groups having the highest rates. The 
      rates of unintentional return to the OR ranged from 1.60 to 1.79%. Multiple 
      groups showed a statistically significant decreasing trend for infection, return 
      to the operating room, neurologic deficit, and death. CONCLUSIONS: Neuromuscular 
      scoliosis had the highest infection rate among all spinal deformity groups. 
      Congenital kyphosis and dysplastic spondylolisthesis had the highest rate of 
      neurological deficit postoperatively. This is similar to previously published 
      data. Contrary to previous reports, neuromuscular scoliosis did not have the 
      highest annual death rate. Multiple groups showed a statistically significant 
      decreasing trend in complication rates during the reporting period, with only 
      mortality in degenerative spondylolisthesis significantly trending upwards. LEVEL 
      OF EVIDENCE: Level III.
CI  - © 2022. The Author(s).
FAU - Bivona, Louis J
AU  - Bivona LJ
AUID- ORCID: 0000-0001-6005-3532
AD  - Department of Orthopaedic Surgery, West Virginia University School of Medicine, 1 
      Medical Center Dr, Morgantown, WV, 26506, USA. louis.bivona@hsc.wvu.edu.
FAU - France, John
AU  - France J
AD  - Department of Orthopaedic Surgery, West Virginia University School of Medicine, 1 
      Medical Center Dr, Morgantown, WV, 26506, USA.
FAU - Daly-Seiler, Conor S
AU  - Daly-Seiler CS
AD  - Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI, USA.
FAU - Burton, Douglas C
AU  - Burton DC
AD  - Department of Orthopaedic Surgery, University of Kansas Medical Center, Kansas 
      City, KS, USA.
FAU - Dolan, Lori A
AU  - Dolan LA
AD  - Department of Orthopaedics and Rehabilitation, University of Iowa, Iowa City, IA, 
      USA.
FAU - Seale, J Justin
AU  - Seale JJ
AD  - Baptist Health, OrthoArkansas, Little Rock, AR, USA.
FAU - de Kleuver, Marinus
AU  - de Kleuver M
AD  - Department of Orthopaedic Surgery, Sint Maartenskliniek, Radboud University 
      Medical Center, Nijmegen, The Netherlands.
FAU - Ferrero, Emmanuelle
AU  - Ferrero E
AD  - Department of Pediatric Orthopaedics, Robert-Debre Hospital, Paris, France.
FAU - Gurd, David P
AU  - Gurd DP
AD  - Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, OH, USA.
FAU - Konya, Deniz
AU  - Konya D
AD  - Department of Neurosurgery, Bahcesehir University School of Medicine, Istanbul, 
      Turkey.
FAU - Lavelle, William F
AU  - Lavelle WF
AD  - Department of Orthopedic Surgery, SUNY Upstate Medical University, Syracuse, NY, 
      USA.
FAU - Sarwahi, Vishal
AU  - Sarwahi V
AD  - Department of Pediatric Orthopaedics, Northwell Health System, New Hyde Park, NY, 
      USA.
FAU - Suratwala, Sanjeev J
AU  - Suratwala SJ
AD  - New York Orthopaedic and Spine Center, Northwell Health System, New Hyde Park, 
      NY, USA.
FAU - Yilgor, Caglar
AU  - Yilgor C
AD  - Department of Orthopedics and Traumatology, Acibadem University School of 
      Medicine, Istanbul, Turkey.
FAU - Li, Ying
AU  - Li Y
AD  - Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI, USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20220715
PL  - England
TA  - Spine Deform
JT  - Spine deformity
JID - 101603979
SB  - IM
MH  - Humans
MH  - *Scoliosis/surgery
MH  - *Spondylolisthesis
MH  - Retrospective Studies
MH  - Postoperative Complications/epidemiology
MH  - *Kyphosis
MH  - Morbidity
MH  - *Neuromuscular Diseases
MH  - Societies, Medical
MH  - Vision Disorders
MH  - Blindness
PMC - PMC9284960
OTO - NOTNLM
OT  - Complications
OT  - Deformity
OT  - Scoliosis
COIS- Dr. Burton reports personal fees and other from DePuy Spine, non-financial 
      support from Scoliosis Research Society, non-financial support from International 
      Spine Study Group, personal fees from Bioventus, personal fees from Globus, 
      personal fees from Progenerative Medical, personal fees from Blue Ocean Spine, 
      outside the submitted work. Dr. Dolan reports grants from POSNA, other from Green 
      Sun Medical, outside the submitted work. Dr. de Kleuver reports grants from 
      Netherlands National Institute of Health Research (ZonMw), grants from SRS 
      research grant, other from Medtronic, outside the submitted work; and is the SRS 
      vice president, the work submitted is from the SRS database. Dr. Lavelle reports 
      personal fees and other from 4-Web, grants from Abryx, grants from AO Foundation, 
      grants from Cerapedics, grants and personal fees from DePuy Spine, grants from 
      Empirical Spine, other from Expanding Innovations, grants and other from 
      Innovasis, grants from Medtronic, other from Prosydian, grants from Spinal 
      Kinetics, Inc., grants from Vertebral Technologies, Inc., personal fees from 
      Vertiflex, outside the submitted work. Dr. Sarwahi reports personal fees from 
      Medical Device Business Services, INC., personal fees from Depuy Synthes, INC., 
      personal fees from Precision Spine, INC., personal fees from Nuvasive, INC., 
      outside the submitted work. Dr. Li reports grants from Scoliosis Research 
      Society, personal fees from Medtronic, non-financial support from Zimmer, outside 
      the submitted work. The rest of the authors have nothing to disclose.
EDAT- 2022/07/16 06:00
MHDA- 2022/10/21 06:00
CRDT- 2022/07/15 12:03
PHST- 2022/01/10 00:00 [received]
PHST- 2022/06/18 00:00 [accepted]
PHST- 2022/07/16 06:00 [pubmed]
PHST- 2022/10/21 06:00 [medline]
PHST- 2022/07/15 12:03 [entrez]
AID - 10.1007/s43390-022-00548-y [pii]
AID - 548 [pii]
AID - 10.1007/s43390-022-00548-y [doi]
PST - ppublish
SO  - Spine Deform. 2022 Nov;10(6):1307-1313. doi: 10.1007/s43390-022-00548-y. Epub 
      2022 Jul 15.

PMID- 37327053
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230714
IS  - 2561-326X (Electronic)
IS  - 2561-326X (Linking)
VI  - 7
DP  - 2023 Jun 16
TI  - Models of Gender Dysphoria Using Social Media Data for Use in 
      Technology-Delivered Interventions: Machine Learning and Natural Language 
      Processing Validation Study.
PG  - e47256
LID - 10.2196/47256 [doi]
LID - e47256
AB  - BACKGROUND: The optimal treatment for gender dysphoria is medical intervention, 
      but many transgender and nonbinary people face significant treatment barriers 
      when seeking help for gender dysphoria. When untreated, gender dysphoria is 
      associated with depression, anxiety, suicidality, and substance misuse. 
      Technology-delivered interventions for transgender and nonbinary people can be 
      used discretely, safely, and flexibly, thereby reducing treatment barriers and 
      increasing access to psychological interventions to manage distress that 
      accompanies gender dysphoria. Technology-delivered interventions are beginning to 
      incorporate machine learning (ML) and natural language processing (NLP) to 
      automate intervention components and tailor intervention content. A critical step 
      in using ML and NLP in technology-delivered interventions is demonstrating how 
      accurately these methods model clinical constructs. OBJECTIVE: This study aimed 
      to determine the preliminary effectiveness of modeling gender dysphoria with ML 
      and NLP, using transgender and nonbinary people's social media data. METHODS: 
      Overall, 6 ML models and 949 NLP-generated independent variables were used to 
      model gender dysphoria from the text data of 1573 Reddit (Reddit Inc) posts 
      created on transgender- and nonbinary-specific web-based forums. After developing 
      a codebook grounded in clinical science, a research team of clinicians and 
      students experienced in working with transgender and nonbinary clients used 
      qualitative content analysis to determine whether gender dysphoria was present in 
      each Reddit post (ie, the dependent variable). NLP (eg, n-grams, Linguistic 
      Inquiry and Word Count, word embedding, sentiment, and transfer learning) was 
      used to transform the linguistic content of each post into predictors for ML 
      algorithms. A k-fold cross-validation was performed. Hyperparameters were tuned 
      with random search. Feature selection was performed to demonstrate the relative 
      importance of each NLP-generated independent variable in predicting gender 
      dysphoria. Misclassified posts were analyzed to improve future modeling of gender 
      dysphoria. RESULTS: Results indicated that a supervised ML algorithm (ie, 
      optimized extreme gradient boosting [XGBoost]) modeled gender dysphoria with a 
      high degree of accuracy (0.84), precision (0.83), and speed (1.23 seconds). Of 
      the NLP-generated independent variables, Diagnostic and Statistical Manual of 
      Mental Disorders, Fifth Edition (DSM-5) clinical keywords (eg, dysphoria and 
      disorder) were most predictive of gender dysphoria. Misclassifications of gender 
      dysphoria were common in posts that expressed uncertainty, featured a stressful 
      experience unrelated to gender dysphoria, were incorrectly coded, expressed 
      insufficient linguistic markers of gender dysphoria, described past experiences 
      of gender dysphoria, showed evidence of identity exploration, expressed aspects 
      of human sexuality unrelated to gender dysphoria, described socially based gender 
      dysphoria, expressed strong affective or cognitive reactions unrelated to gender 
      dysphoria, or discussed body image. CONCLUSIONS: Findings suggest that ML- and 
      NLP-based models of gender dysphoria have significant potential to be integrated 
      into technology-delivered interventions. The results contribute to the growing 
      evidence on the importance of incorporating ML and NLP designs in clinical 
      science, especially when studying marginalized populations.
CI  - ©Cory J Cascalheira, Ryan E Flinn, Yuxuan Zhao, Dannie Klooster, Danica Laprade, 
      Shah Muhammad Hamdi, Jillian R Scheer, Alejandra Gonzalez, Emily M Lund, Ivan N 
      Gomez, Koustuv Saha, Munmun De Choudhury. Originally published in JMIR Formative 
      Research (https://formative.jmir.org), 16.06.2023.
FAU - Cascalheira, Cory J
AU  - Cascalheira CJ
AUID- ORCID: 0000-0001-5780-3101
AD  - Department of Counseling & Educational Psychology, New Mexico State University, 
      Las Cruces, NM, United States.
AD  - Department of Psychology, Syracuse University, Syracuse, NY, United States.
FAU - Flinn, Ryan E
AU  - Flinn RE
AUID- ORCID: 0000-0003-2802-8331
AD  - Augusta University, Augusta, GA, United States.
AD  - University of North Dakota, Grand Forks, ND, United States.
FAU - Zhao, Yuxuan
AU  - Zhao Y
AUID- ORCID: 0009-0004-3053-1678
AD  - Department of Counseling & Educational Psychology, New Mexico State University, 
      Las Cruces, NM, United States.
FAU - Klooster, Dannie
AU  - Klooster D
AUID- ORCID: 0000-0002-8024-2645
AD  - Oklahoma State University, Stillwater, OK, United States.
FAU - Laprade, Danica
AU  - Laprade D
AUID- ORCID: 0000-0003-0110-6301
AD  - Northern Arizona University, Flagstaff, AZ, United States.
FAU - Hamdi, Shah Muhammad
AU  - Hamdi SM
AUID- ORCID: 0000-0002-9303-7835
AD  - Department of Computer Science, Utah State University, Logan, UT, United States.
FAU - Scheer, Jillian R
AU  - Scheer JR
AUID- ORCID: 0000-0002-7311-5904
AD  - Department of Psychology, Syracuse University, Syracuse, NY, United States.
FAU - Gonzalez, Alejandra
AU  - Gonzalez A
AUID- ORCID: 0000-0002-2525-2832
AD  - Xavier University, Cincinnati, OH, United States.
FAU - Lund, Emily M
AU  - Lund EM
AUID- ORCID: 0000-0003-2031-1415
AD  - University of Alabama, Tuscaloosa, AL, United States.
AD  - Ewha Women's University, Seoul, Republic of Korea.
FAU - Gomez, Ivan N
AU  - Gomez IN
AUID- ORCID: 0009-0006-0439-1557
AD  - Department of Counseling & Educational Psychology, New Mexico State University, 
      Las Cruces, NM, United States.
FAU - Saha, Koustuv
AU  - Saha K
AUID- ORCID: 0000-0002-8872-2934
AD  - University of Illinois at Urbana-Champaign, Champaign, IL, United States.
FAU - De Choudhury, Munmun
AU  - De Choudhury M
AUID- ORCID: 0000-0002-8939-264X
AD  - Georgia Institute of Technology, Atlanta, GA, United States.
LA  - eng
GR  - K01 AA028239/AA/NIAAA NIH HHS/United States
GR  - R25 DA035692/DA/NIDA NIH HHS/United States
GR  - R25 DA037190/DA/NIDA NIH HHS/United States
GR  - R25 GM061222/GM/NIGMS NIH HHS/United States
PT  - Journal Article
DEP - 20230616
PL  - Canada
TA  - JMIR Form Res
JT  - JMIR formative research
JID - 101726394
PMC - PMC10337393
OTO - NOTNLM
OT  - digital health
OT  - gender diverse
OT  - gender dysphoria
OT  - mobile phone
OT  - social computing
OT  - social media
COIS- Conflicts of Interest: None declared.
EDAT- 2023/06/16 13:10
MHDA- 2023/06/16 13:11
CRDT- 2023/06/16 11:54
PHST- 2023/03/13 00:00 [received]
PHST- 2023/05/15 00:00 [accepted]
PHST- 2023/04/28 00:00 [revised]
PHST- 2023/06/16 13:11 [medline]
PHST- 2023/06/16 13:10 [pubmed]
PHST- 2023/06/16 11:54 [entrez]
AID - v7i1e47256 [pii]
AID - 10.2196/47256 [doi]
PST - epublish
SO  - JMIR Form Res. 2023 Jun 16;7:e47256. doi: 10.2196/47256.

PMID- 32815519
OWN - NLM
STAT- MEDLINE
DCOM- 20210201
LR  - 20210206
IS  - 1305-3612 (Electronic)
IS  - 1305-3825 (Print)
IS  - 1305-3825 (Linking)
VI  - 27
IP  - 1
DP  - 2021 Jan
TI  - Determination of disease severity in COVID-19 patients using deep learning in 
      chest X-ray images.
PG  - 20-27
LID - 10.5152/dir.2020.20205 [doi]
AB  - PURPOSE: Chest X-ray plays a key role in diagnosis and management of COVID-19 
      patients and imaging features associated with clinical elements may assist with 
      the development or validation of automated image analysis tools. We aimed to 
      identify associations between clinical and radiographic features as well as to 
      assess the feasibility of deep learning applied to chest X-rays in the setting of 
      an acute COVID-19 outbreak. METHODS: A retrospective study of X-rays, clinical, 
      and laboratory data was performed from 48 SARS-CoV-2 RT-PCR positive patients 
      (age 60±17 years, 15 women) between February 22 and March 6, 2020 from a tertiary 
      care hospital in Milan, Italy. Sixty-five chest X-rays were reviewed by two 
      radiologists for alveolar and interstitial opacities and classified by severity 
      on a scale from 0 to 3. Clinical factors (age, symptoms, comorbidities) were 
      investigated for association with opacity severity and also with placement of 
      central line or endotracheal tube. Deep learning models were then trained for two 
      tasks: lung segmentation and opacity detection. Imaging characteristics were 
      compared to clinical datapoints using the unpaired student's t-test or 
      Mann-Whitney U test. Cohen's kappa analysis was used to evaluate the concordance 
      of deep learning to conventional radiologist interpretation. RESULTS: Fifty-six 
      percent of patients presented with alveolar opacities, 73% had interstitial 
      opacities, and 23% had normal X-rays. The presence of alveolar or interstitial 
      opacities was statistically correlated with age (P = 0.008) and comorbidities (P 
      = 0.005). The extent of alveolar or interstitial opacities on baseline X-ray was 
      significantly associated with the presence of endotracheal tube (P = 0.0008 and P 
      = 0.049) or central line (P = 0.003 and P = 0.007). In comparison to human 
      interpretation, the deep learning model achieved a kappa concordance of 0.51 for 
      alveolar opacities and 0.71 for interstitial opacities. CONCLUSION: Chest X-ray 
      analysis in an acute COVID-19 outbreak showed that the severity of opacities was 
      associated with advanced age, comorbidities, as well as acuity of care. 
      Artificial intelligence tools based upon deep learning of COVID-19 chest X-rays 
      are feasible in the acute outbreak setting.
FAU - Blain, Maxime
AU  - Blain M
AD  - Center for Interventional Oncology, National Institutes of Health Clinical Center 
      and National Cancer Institute, Bethesda, Maryland, USA.
FAU - Kassin, Michael T
AU  - Kassin MT
AD  - Center for Interventional Oncology, National Institutes of Health Clinical Center 
      and National Cancer Institute, Bethesda, Maryland, USA.
FAU - Varble, Nicole
AU  - Varble N
AD  - Philips Research North America, Cambridge, Massachusetts, USA.
FAU - Wang, Xiaosong
AU  - Wang X
AD  - NVIDIA Corporation, Bethesda, Maryland, USA.
FAU - Xu, Ziyue
AU  - Xu Z
AD  - NVIDIA Corporation, Bethesda, Maryland, USA.
FAU - Xu, Daguang
AU  - Xu D
AD  - Center for Interventional Oncology, National Institutes of Health Clinical Center 
      and National Cancer Institute, Bethesda, Maryland, USA.
FAU - Carrafiello, Gianpaolo
AU  - Carrafiello G
AD  - Department of Radiology,Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, 
      University of Milan, Italy.
FAU - Vespro, Valentina
AU  - Vespro V
AD  - Department of Radiology,Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, 
      University of Milan, Italy.
FAU - Stellato, Elvira
AU  - Stellato E
AD  - Department of Radiology,Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, 
      University of Milan, Italy.
FAU - Ierardi, Anna Maria
AU  - Ierardi AM
AD  - Department of Radiology,Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, 
      University of Milan, Italy.
FAU - Meglio, Letizia Di
AU  - Meglio LD
AD  - Department of Radiology,Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, 
      University of Milan, Italy.
FAU - D Suh, Robert
AU  - D Suh R
AD  - Department of Radiology, University of California Los Angeles, Los Angeles, 
      California, USA.
FAU - A Walker, Stephanie
AU  - A Walker S
AD  - National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 
      USA.
FAU - Xu, Sheng
AU  - Xu S
AD  - Center for Interventional Oncology, National Institutes of Health Clinical Center 
      and National Cancer Institute, Bethesda, Maryland, USA.
FAU - H Sanford, Thomas
AU  - H Sanford T
AD  - Center for Interventional Oncology, National Institutes of Health Clinical Center 
      and National Cancer Institute, Bethesda, Maryland, USA;State University of New 
      York Upstate Medical University, Syracuse, Newyork, USA.
FAU - B Turkbey, Evrim
AU  - B Turkbey E
AD  - Molecular Imaging Program, National Institutes of Health, Bethesda, Maryland, 
      USA;Department of Radiology and Imaging Sciences, National Institutes of Health, 
      Bethesda, Mayland, USA.
FAU - Harmon, Stephanie
AU  - Harmon S
AD  - National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 
      USA;Clinical Research Directorate, Frederick National Laboratory for Cancer 
      Research, Frederick, Maryland, USA.
FAU - Turkbey, Baris
AU  - Turkbey B
AD  - Department of Radiology and Imaging Sciences, National Institutes of Health, 
      Bethesda, Mayland, USA.
FAU - J Wood, Bradford
AU  - J Wood B
AD  - Center for Interventional Oncology, National Institutes of Health Clinical Center 
      and National Cancer Institute, Bethesda, Maryland, USA;Department of Radiology, 
      University of California Los Angeles, Los Angeles, California, USA;Department of 
      Radiology and Imaging Sciences, National Institutes of Health, Bethesda, Mayland, 
      USA.
LA  - eng
GR  - 75N91019D00024/CA/NCI NIH HHS/United States
GR  - ZID BC011242/ImNIH/Intramural NIH HHS/United States
PT  - Journal Article
PL  - Turkey
TA  - Diagn Interv Radiol
JT  - Diagnostic and interventional radiology (Ankara, Turkey)
JID - 101241152
SB  - IM
MH  - Adult
MH  - Age Factors
MH  - Aged
MH  - COVID-19/*diagnosis/epidemiology/therapy/virology
MH  - Comorbidity
MH  - Deep Learning/*statistics & numerical data
MH  - Feasibility Studies
MH  - Female
MH  - Humans
MH  - Italy/epidemiology
MH  - Male
MH  - Middle Aged
MH  - Radiography, Thoracic/classification/*methods
MH  - Radiologists
MH  - Retrospective Studies
MH  - SARS-CoV-2/*genetics
MH  - Severity of Illness Index
MH  - Thorax/*diagnostic imaging/pathology
PMC - PMC7837735
COIS- Conflict of interest disclosure NV is an employee of Philips Research. DX, ZX, XW 
      are employees of NVIDIA. MB is a recipient of the 2019 Alain Rahmouni SFR-CERF 
      research grant provided by the French Society of Radiology together with the 
      French Academic College of Radiology. BW is Principal Investigator on the 
      following CRADAs (Cooperative Research & Development Agreements) between NIH and 
      related commercial partners: Philips Image Guided Therapy (CRADA), Philips 
      Research (CRADA), Philips (CRADA), Siemens (CRADA), NVIDIA (CRADA). Licensed 
      Patents / Royalties: Philips (NIH and BW receive royalties for licensed patents 
      from Philips).
EDAT- 2020/08/21 06:00
MHDA- 2021/02/02 06:00
CRDT- 2020/08/21 06:00
PHST- 2020/08/21 06:00 [pubmed]
PHST- 2021/02/02 06:00 [medline]
PHST- 2020/08/21 06:00 [entrez]
AID - dir-27-1-20 [pii]
AID - 10.5152/dir.2020.20205 [doi]
PST - ppublish
SO  - Diagn Interv Radiol. 2021 Jan;27(1):20-27. doi: 10.5152/dir.2020.20205.

PMID- 31038663
OWN - NLM
STAT- MEDLINE
DCOM- 20200623
LR  - 20230807
IS  - 1569-8041 (Electronic)
IS  - 0923-7534 (Linking)
VI  - 30
IP  - 7
DP  - 2019 Jul 1
TI  - Tumor mutational burden is predictive of response to immune checkpoint inhibitors 
      in MSI-high metastatic colorectal cancer.
PG  - 1096-1103
LID - S0923-7534(19)31240-2 [pii]
LID - 10.1093/annonc/mdz134 [doi]
AB  - BACKGROUND: Microsatellite instability (MSI) is a biomarker for response to 
      immune checkpoint inhibitors (ICPIs). PD-1 inhibitors in metastatic colorectal 
      carcinoma (mCRC) with MSI-high (MSI-H) have demonstrated a high disease control 
      rate and favorable progression-free survival (PFS); however, reported response 
      rates to pembrolizumab and nivolumab are variable and often <50%, suggesting that 
      additional predictive biomarkers are needed. METHODS: Clinicopathologic data were 
      collected from patients with MSI-H mCRC confirmed by hybrid capture-based 
      next-generation sequencing (NGS) treated with PD-1/L1 inhibitors at five 
      institutes. Tumor mutational burden (TMB) was determined on 0.8-1.1 Mb of 
      sequenced DNA and reported as mutations/Mb. Potential biomarkers of response and 
      time to progression were analyzed by univariate and multivariate analyses. Once 
      TMB was confirmed as a predictive biomarker, a larger dataset of 18 140 unique 
      CRC patients was analyzed to define the relevance of the identified TMB 
      cut-point. RESULTS: A total of 22 patients were treated with PD-1/L1 inhibitors 
      including 19 with pembrolizumab monotherapy. Among tested variables, TMB showed 
      the strongest association with objective response (OR; P < 0.001) and PFS, by 
      univariate (P < 0.001) and multivariate analysis (P < 0.01). Using log-rank 
      statistics, the optimal predictive cut-point for TMB was estimated between 37 and 
      41 mutations/Mb. All 13 TMBhigh cases responded, while 6/9 TMBlow cases had 
      progressive disease. The median PFS for TMBhigh has not been reached (median 
      follow-up >18 months) while the median PFS for TMBlow was 2 months. A TMB of 37.4 
      mutations/Mb in a large MSI-H mCRC population (821/18, 140 cases; 4.5%) evaluated 
      by NGS corresponded to the 35th percentile cut-point. CONCLUSIONS: TMB appears to 
      be an important independent biomarker within MSI-H mCRC to stratify patients for 
      likelihood of response to ICPIs. If validated in prospective studies, TMB may 
      play an important role in guiding the sequencing and/or combinations of ICPIs in 
      MSI-H mCRC.
CI  - © The Author(s) 2019. Published by Oxford University Press on behalf of the 
      European Society for Medical Oncology. All rights reserved. For permissions, 
      please email: journals.permissions@oup.com.
FAU - Schrock, A B
AU  - Schrock AB
AD  - Foundation Medicine, Inc., Cambridge.
FAU - Ouyang, C
AU  - Ouyang C
AD  - Center for Informatics, City of Hope National Medical Center, Duarte; Department 
      of Computational and Quantitative Medicine, Beckman Research Institute of the 
      City of Hope, Duarte.
FAU - Sandhu, J
AU  - Sandhu J
AD  - Department of Medical Oncology and Therapeutics Research, City of Hope 
      Comprehensive Cancer Center, Duarte.
FAU - Sokol, E
AU  - Sokol E
AD  - Foundation Medicine, Inc., Cambridge.
FAU - Jin, D
AU  - Jin D
AD  - Foundation Medicine, Inc., Cambridge.
FAU - Ross, J S
AU  - Ross JS
AD  - Foundation Medicine, Inc., Cambridge; Department of Pathology, SUNY Upstate 
      Medical University, Syracuse.
FAU - Miller, V A
AU  - Miller VA
AD  - Foundation Medicine, Inc., Cambridge.
FAU - Lim, D
AU  - Lim D
AD  - Department of Medical Oncology and Therapeutics Research, City of Hope 
      Comprehensive Cancer Center, Duarte.
FAU - Amanam, I
AU  - Amanam I
AD  - Department of Medical Oncology and Therapeutics Research, City of Hope 
      Comprehensive Cancer Center, Duarte.
FAU - Chao, J
AU  - Chao J
AD  - Department of Medical Oncology and Therapeutics Research, City of Hope 
      Comprehensive Cancer Center, Duarte.
FAU - Catenacci, D
AU  - Catenacci D
AD  - Section of Hematology/Oncology, Department of Medicine, University of Chicago 
      Medical Center and Biological Sciences, Chicago.
FAU - Cho, M
AU  - Cho M
AD  - Division of Hematology and Oncology, Department of Internal Medicine, UC Davis 
      Comprehensive Cancer Center, Sacramento.
FAU - Braiteh, F
AU  - Braiteh F
AD  - Department of Hematology/Oncology, Comprehensive Cancer Centers of Nevada, Las 
      Vegas.
FAU - Klempner, S J
AU  - Klempner SJ
AD  - The Angeles Clinic and Research Institute, Los Angeles, USA.
FAU - Ali, S M
AU  - Ali SM
AD  - Foundation Medicine, Inc., Cambridge.
FAU - Fakih, M
AU  - Fakih M
AD  - Department of Medical Oncology and Therapeutics Research, City of Hope 
      Comprehensive Cancer Center, Duarte. Electronic address: mfakih@coh.org.
LA  - eng
PT  - Journal Article
PL  - England
TA  - Ann Oncol
JT  - Annals of oncology : official journal of the European Society for Medical 
      Oncology
JID - 9007735
RN  - 0 (Antibodies, Monoclonal, Humanized)
RN  - 0 (B7-H1 Antigen)
RN  - 0 (Biomarkers, Tumor)
RN  - 0 (CD274 protein, human)
RN  - 0 (PDCD1 protein, human)
RN  - 0 (Programmed Cell Death 1 Receptor)
RN  - 31YO63LBSN (Nivolumab)
RN  - DPT0O3T46P (pembrolizumab)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Antibodies, Monoclonal, Humanized/administration & dosage
MH  - Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
MH  - B7-H1 Antigen/antagonists & inhibitors
MH  - Biomarkers, Tumor/genetics
MH  - Colorectal Neoplasms/*drug therapy/*genetics/immunology/pathology
MH  - Female
MH  - Follow-Up Studies
MH  - Genetic Testing
MH  - High-Throughput Nucleotide Sequencing
MH  - Humans
MH  - Liver Neoplasms/*drug therapy/genetics/*secondary
MH  - Lymphatic Metastasis
MH  - Male
MH  - Microsatellite Instability
MH  - Middle Aged
MH  - *Mutation
MH  - Nivolumab/administration & dosage
MH  - Peritoneal Neoplasms/drug therapy/genetics/*secondary
MH  - Prognosis
MH  - Programmed Cell Death 1 Receptor/antagonists & inhibitors
MH  - Retrospective Studies
MH  - Survival Rate
OTO - NOTNLM
OT  - checkpoint inhibitor
OT  - colorectal cancer (CRC)
OT  - immunotherapy
OT  - microsatellite instability (MSI)
OT  - tumor mutational burden (TMB)
EDAT- 2019/05/01 06:00
MHDA- 2020/06/24 06:00
CRDT- 2019/05/01 06:00
PHST- 2019/05/01 06:00 [pubmed]
PHST- 2020/06/24 06:00 [medline]
PHST- 2019/05/01 06:00 [entrez]
AID - S0923-7534(19)31240-2 [pii]
AID - 10.1093/annonc/mdz134 [doi]
PST - ppublish
SO  - Ann Oncol. 2019 Jul 1;30(7):1096-1103. doi: 10.1093/annonc/mdz134.

PMID- 31161010
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231011
IS  - 2045-7758 (Print)
IS  - 2045-7758 (Electronic)
IS  - 2045-7758 (Linking)
VI  - 9
IP  - 10
DP  - 2019 May
TI  - Machine learning of large-scale spatial distributions of wild turkeys with 
      high-dimensional environmental data.
PG  - 5938-5949
LID - 10.1002/ece3.5177 [doi]
AB  - Species distribution modeling often involves high-dimensional environmental data. 
      Large amounts of data and multicollinearity among covariates impose challenges to 
      statistical models in variable selection for reliable inferences of the effects 
      of environmental factors on the spatial distribution of species. Few studies have 
      evaluated and compared the performance of multiple machine learning (ML) models 
      in handling multicollinearity. Here, we assessed the effectiveness of removal of 
      correlated covariates and regularization to cope with multicollinearity in ML 
      models for habitat suitability. Three machine learning algorithms maximum entropy 
      (MaxEnt), random forests (RFs), and support vector machines (SVMs) were applied 
      to the original data (OD) of 27 landscape variables, reduced data (RD) with 14 
      highly correlated covariates being removed, and 15 principal components (PC) of 
      the OD accounting for 90% of the original variability. The performance of the 
      three ML models was measured with the area under the curve and continuous Boyce 
      index. We collected 663 nonduplicated presence locations of Eastern wild turkeys 
      (Meleagris gallopavo silvestris) across the state of Mississippi, United States. 
      Of the total locations, 453 locations separated by a distance of ≥2 km were used 
      to train the three ML algorithms on the OD, RD, and PC data, respectively. The 
      remaining 210 locations were used to validate the trained ML models to measure ML 
      performance. Three ML models had excellent performance on the RD and PC data. 
      MaxEnt and SVMs had good performance on the OD data, indicating the adequacy of 
      regularization of the default setting for multicollinearity. Weak learning of RFs 
      through bagging appeared to alleviate multicollinearity and resulted in excellent 
      performance on the OD data. Regularization of ML algorithms may help exploratory 
      studies of the effects of environmental factors on the spatial distribution and 
      habitat suitability of wildlife.
FAU - Farrell, Annie
AU  - Farrell A
AD  - Department of Wildlife, Fisheries and Aquaculture Mississippi State University 
      Mississippi State Mississippi.
FAU - Wang, Guiming
AU  - Wang G
AUID- ORCID: 0000-0001-5002-0120
AD  - Department of Wildlife, Fisheries and Aquaculture Mississippi State University 
      Mississippi State Mississippi.
FAU - Rush, Scott A
AU  - Rush SA
AD  - Department of Wildlife, Fisheries and Aquaculture Mississippi State University 
      Mississippi State Mississippi.
FAU - Martin, James A
AU  - Martin JA
AD  - Warnell School of Forestry and Natural Resources and Savannah River Ecology 
      Laboratory University of Georgia Athens Georgia.
FAU - Belant, Jerrold L
AU  - Belant JL
AD  - Camp Fire Program in Wildlife Conservation State University of New York College 
      of Environmental Science and Forestry Syracuse New York.
FAU - Butler, Adam B
AU  - Butler AB
AD  - The Mississippi Department of Wildlife, Fisheries, and Parks Jackson Mississippi.
FAU - Godwin, Dave
AU  - Godwin D
AD  - Mississippi Forestry Association Jackson Mississippi.
LA  - eng
PT  - Journal Article
DEP - 20190424
PL  - England
TA  - Ecol Evol
JT  - Ecology and evolution
JID - 101566408
PMC - PMC6540709
OTO - NOTNLM
OT  - habitat suitability
OT  - maximum entropy
OT  - multicollinearity
OT  - predictive ecological niche models
OT  - random forests
OT  - regularization
OT  - support vector machines
OT  - wildlife management
COIS- The authors have no conflict of interest related to this work.
EDAT- 2019/06/05 06:00
MHDA- 2019/06/05 06:01
CRDT- 2019/06/05 06:00
PHST- 2019/01/11 00:00 [received]
PHST- 2019/03/27 00:00 [revised]
PHST- 2019/03/28 00:00 [accepted]
PHST- 2019/06/05 06:00 [entrez]
PHST- 2019/06/05 06:00 [pubmed]
PHST- 2019/06/05 06:01 [medline]
AID - ECE35177 [pii]
AID - 10.1002/ece3.5177 [doi]
PST - epublish
SO  - Ecol Evol. 2019 Apr 24;9(10):5938-5949. doi: 10.1002/ece3.5177. eCollection 2019 
      May.

PMID- 37620341
OWN - NLM
STAT- MEDLINE
DCOM- 20230901
LR  - 20231119
IS  - 2041-1723 (Electronic)
IS  - 2041-1723 (Linking)
VI  - 14
IP  - 1
DP  - 2023 Aug 24
TI  - Human forebrain organoid-based multi-omics analyses of PCCB as a schizophrenia 
      associated gene linked to GABAergic pathways.
PG  - 5176
LID - 10.1038/s41467-023-40861-2 [doi]
LID - 5176
AB  - Identifying genes whose expression is associated with schizophrenia (SCZ) risk by 
      transcriptome-wide association studies (TWAS) facilitates downstream experimental 
      studies. Here, we integrated multiple published datasets of TWAS, gene 
      coexpression, and differential gene expression analysis to prioritize SCZ 
      candidate genes for functional study. Convergent evidence prioritized 
      Propionyl-CoA Carboxylase Subunit Beta (PCCB), a nuclear-encoded mitochondrial 
      gene, as an SCZ risk gene. However, the PCCB's contribution to SCZ risk has not 
      been investigated before. Using dual luciferase reporter assay, we identified 
      that SCZ-associated SNPs rs6791142 and rs35874192, two eQTL SNPs for PCCB, showed 
      differential allelic effects on transcriptional activities. PCCB knockdown in 
      human forebrain organoids (hFOs) followed by RNA sequencing analysis revealed 
      dysregulation of genes enriched with multiple neuronal functions including 
      gamma-aminobutyric acid (GABA)-ergic synapse. The metabolomic and mitochondrial 
      function analyses confirmed the decreased GABA levels resulted from inhibited 
      tricarboxylic acid cycle in PCCB knockdown hFOs. Multielectrode array recording 
      analysis showed that PCCB knockdown in hFOs resulted into SCZ-related phenotypes 
      including hyper-neuroactivities and decreased synchronization of neural network. 
      In summary, this study utilized hFOs-based multi-omics analyses and revealed that 
      PCCB downregulation may contribute to SCZ risk through regulating GABAergic 
      pathways, highlighting the mitochondrial function in SCZ.
CI  - © 2023. Springer Nature Limited.
FAU - Zhang, Wendiao
AU  - Zhang W
AUID- ORCID: 0000-0002-3510-8383
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, and Department of Psychiatry, The Second Xiangya Hospital, Central 
      South University, 410008, Changsha, Hunan, China.
AD  - The First Affiliated Hospital, Multi-Omics Research Center for Brain Disorders, 
      Hengyang Medical School, University of South China, 421000, Hengyang, Hunan, 
      China.
AD  - The First Affiliated Hospital, Clinical Research Center for Immune-Related 
      Encephalopathy of Hunan Province, Hengyang Medical School, University of South 
      China, 421000, Hengyang, Hunan, China.
AD  - The First Affiliated Hospital, Department of Neurology, Hengyang Medical School, 
      University of South China, 421000, Hengyang, Hunan, China.
FAU - Zhang, Ming
AU  - Zhang M
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, and Department of Psychiatry, The Second Xiangya Hospital, Central 
      South University, 410008, Changsha, Hunan, China.
FAU - Xu, Zhenhong
AU  - Xu Z
AD  - The First Affiliated Hospital, Multi-Omics Research Center for Brain Disorders, 
      Hengyang Medical School, University of South China, 421000, Hengyang, Hunan, 
      China.
AD  - The First Affiliated Hospital, Clinical Research Center for Immune-Related 
      Encephalopathy of Hunan Province, Hengyang Medical School, University of South 
      China, 421000, Hengyang, Hunan, China.
AD  - The First Affiliated Hospital, Department of Neurology, Hengyang Medical School, 
      University of South China, 421000, Hengyang, Hunan, China.
FAU - Yan, Hongye
AU  - Yan H
AD  - The First Affiliated Hospital, Multi-Omics Research Center for Brain Disorders, 
      Hengyang Medical School, University of South China, 421000, Hengyang, Hunan, 
      China.
AD  - The First Affiliated Hospital, Clinical Research Center for Immune-Related 
      Encephalopathy of Hunan Province, Hengyang Medical School, University of South 
      China, 421000, Hengyang, Hunan, China.
AD  - The First Affiliated Hospital, Department of Neurology, Hengyang Medical School, 
      University of South China, 421000, Hengyang, Hunan, China.
FAU - Wang, Huimin
AU  - Wang H
AD  - The First Affiliated Hospital, Multi-Omics Research Center for Brain Disorders, 
      Hengyang Medical School, University of South China, 421000, Hengyang, Hunan, 
      China.
AD  - The First Affiliated Hospital, Clinical Research Center for Immune-Related 
      Encephalopathy of Hunan Province, Hengyang Medical School, University of South 
      China, 421000, Hengyang, Hunan, China.
AD  - The First Affiliated Hospital, Department of Neurology, Hengyang Medical School, 
      University of South China, 421000, Hengyang, Hunan, China.
FAU - Jiang, Jiamei
AU  - Jiang J
AD  - The First Affiliated Hospital, Multi-Omics Research Center for Brain Disorders, 
      Hengyang Medical School, University of South China, 421000, Hengyang, Hunan, 
      China.
AD  - The First Affiliated Hospital, Clinical Research Center for Immune-Related 
      Encephalopathy of Hunan Province, Hengyang Medical School, University of South 
      China, 421000, Hengyang, Hunan, China.
AD  - The First Affiliated Hospital, Department of Neurology, Hengyang Medical School, 
      University of South China, 421000, Hengyang, Hunan, China.
FAU - Wan, Juan
AU  - Wan J
AD  - The First Affiliated Hospital, Multi-Omics Research Center for Brain Disorders, 
      Hengyang Medical School, University of South China, 421000, Hengyang, Hunan, 
      China.
AD  - The First Affiliated Hospital, Clinical Research Center for Immune-Related 
      Encephalopathy of Hunan Province, Hengyang Medical School, University of South 
      China, 421000, Hengyang, Hunan, China.
AD  - The First Affiliated Hospital, Department of Neurology, Hengyang Medical School, 
      University of South China, 421000, Hengyang, Hunan, China.
FAU - Tang, Beisha
AU  - Tang B
AUID- ORCID: 0000-0003-2120-1576
AD  - The First Affiliated Hospital, Multi-Omics Research Center for Brain Disorders, 
      Hengyang Medical School, University of South China, 421000, Hengyang, Hunan, 
      China.
AD  - The First Affiliated Hospital, Clinical Research Center for Immune-Related 
      Encephalopathy of Hunan Province, Hengyang Medical School, University of South 
      China, 421000, Hengyang, Hunan, China.
AD  - The First Affiliated Hospital, Department of Neurology, Hengyang Medical School, 
      University of South China, 421000, Hengyang, Hunan, China.
AD  - Department of Neurology, Xiangya Hospital, Central South University, 410008, 
      Changsha, Hunan, China.
AD  - National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, 
      Central South University, 410008, Changsha, Hunan, China.
FAU - Liu, Chunyu
AU  - Liu C
AUID- ORCID: 0000-0002-5986-4415
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, and Department of Psychiatry, The Second Xiangya Hospital, Central 
      South University, 410008, Changsha, Hunan, China. liuch@upstate.edu.
AD  - Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, 13210, 
      USA. liuch@upstate.edu.
FAU - Chen, Chao
AU  - Chen C
AUID- ORCID: 0000-0002-5114-2282
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, and Department of Psychiatry, The Second Xiangya Hospital, Central 
      South University, 410008, Changsha, Hunan, China. chenchao@sklmg.edu.cn.
AD  - National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, 
      Central South University, 410008, Changsha, Hunan, China. chenchao@sklmg.edu.cn.
AD  - Hunan Key Laboratory of Animal Models for Human Diseases, Central South 
      University, Changsha, Hunan, 410008, China. chenchao@sklmg.edu.cn.
AD  - Hunan Key Laboratory of Molecular Precision Medicine, Central South University, 
      Changsha, Hunan, 410008, China. chenchao@sklmg.edu.cn.
FAU - Meng, Qingtuan
AU  - Meng Q
AUID- ORCID: 0000-0002-6421-162X
AD  - The First Affiliated Hospital, Multi-Omics Research Center for Brain Disorders, 
      Hengyang Medical School, University of South China, 421000, Hengyang, Hunan, 
      China. mengqingtuan@glmc.edu.cn.
AD  - The First Affiliated Hospital, Clinical Research Center for Immune-Related 
      Encephalopathy of Hunan Province, Hengyang Medical School, University of South 
      China, 421000, Hengyang, Hunan, China. mengqingtuan@glmc.edu.cn.
AD  - The First Affiliated Hospital, Department of Neurology, Hengyang Medical School, 
      University of South China, 421000, Hengyang, Hunan, China. 
      mengqingtuan@glmc.edu.cn.
AD  - MOE Key Lab of Rare Pediatric Diseases & School of Life Sciences, University of 
      South China, 421001, Hengyang, Hunan, China. mengqingtuan@glmc.edu.cn.
LA  - eng
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20230824
PL  - England
TA  - Nat Commun
JT  - Nature communications
JID - 101528555
RN  - EC 6.4.- (PCCB protein, human)
RN  - EC 6.4.- (Carbon-Carbon Ligases)
SB  - IM
UOF - Res Sq. 2023 Mar 29;:. PMID: 37034773
MH  - Humans
MH  - Metabolomics
MH  - *Multiomics
MH  - Organoids
MH  - Prosencephalon
MH  - *Schizophrenia/genetics
MH  - *Carbon-Carbon Ligases/genetics
PMC - PMC10449845
COIS- The authors declare no competing interests.
EDAT- 2023/08/25 00:42
MHDA- 2023/08/28 07:16
CRDT- 2023/08/24 23:19
PHST- 2023/03/14 00:00 [received]
PHST- 2023/08/14 00:00 [accepted]
PHST- 2023/08/28 07:16 [medline]
PHST- 2023/08/25 00:42 [pubmed]
PHST- 2023/08/24 23:19 [entrez]
AID - 10.1038/s41467-023-40861-2 [pii]
AID - 40861 [pii]
AID - 10.1038/s41467-023-40861-2 [doi]
PST - epublish
SO  - Nat Commun. 2023 Aug 24;14(1):5176. doi: 10.1038/s41467-023-40861-2.

PMID- 32542017
OWN - NLM
STAT- MEDLINE
DCOM- 20200814
LR  - 20210316
IS  - 1935-2735 (Electronic)
IS  - 1935-2727 (Print)
IS  - 1935-2727 (Linking)
VI  - 14
IP  - 6
DP  - 2020 Jun
TI  - Development of a small animal model for deer tick virus pathogenesis mimicking 
      human clinical outcome.
PG  - e0008359
LID - 10.1371/journal.pntd.0008359 [doi]
LID - e0008359
AB  - Powassan virus (POWV) is a tick-borne flavivirus that encompasses two genetic 
      lineages, POWV (Lineage I) and deer tick virus (DTV, Lineage II). In recent 
      years, the incidence of reported POWV disease cases has increased, coupled with 
      an expanded geographic range of the DTV tick vector, Ixodes scapularis. POWV and 
      DTV are serologically indistinguishable, and it is not known whether clinical 
      manifestations, pathology, or disease outcome differ between the two viruses. 
      Six-week-old male and female BALB/c mice were footpad-inoculated with DTV doses 
      ranging from 101 to 105 FFU. Dose-independent mortality, morbidity, and organ 
      viral loads were observed for mice inoculated with sequentially increasing doses 
      of DTV. By study completion, all surviving mice had cleared their viremias but 
      detectable levels of negative-sense DTV RNA were present in the brain, indicating 
      viral persistence of infectious DTV in the central nervous system. For mice that 
      succumbed to disease, neuropathology revealed meningoencephalitis characterized 
      by microscopic lesions with widespread distribution of viral RNA in the brain. 
      These findings, coupled with the rapid onset of neurological signs of disease and 
      high viral titers in nervous tissue, highlight the neurotropism of DTV in this 
      mouse model. Additionally, disease outcome for DTV-infected mice was not affected 
      by sex, as males and females were equally susceptible to disease. This is the 
      first study to comprehensively characterize the clinical disease outcome in a 
      small animal model across a spectrum of POWV/DTV infection doses. Here, we 
      developed a small animal model for DTV pathogenesis that mimics the 
      manifestations of POWV disease in humans. Since it is currently not known whether 
      DTV and POWV differ in their capacity to cause human disease, the animal model 
      detailed in our study could be utilized in future comparative pathogenesis 
      studies, or as a platform for testing the efficacy of vaccines, and anti-virals.
FAU - Hermance, Meghan E
AU  - Hermance ME
AD  - SUNY Center for Environmental Health and Medicine, SUNY Upstate Medical 
      University, Syracuse, New York, United States of America.
AD  - Institute for Global Health and Translational Sciences, SUNY Upstate Medical 
      University, Syracuse, New York, United States of America.
AD  - Department of Microbiology and Immunology, SUNY Upstate Medical University, 
      Syracuse, New York, United States of America.
FAU - Hart, Charles E
AU  - Hart CE
AD  - SUNY Center for Environmental Health and Medicine, SUNY Upstate Medical 
      University, Syracuse, New York, United States of America.
AD  - Institute for Global Health and Translational Sciences, SUNY Upstate Medical 
      University, Syracuse, New York, United States of America.
AD  - Department of Microbiology and Immunology, SUNY Upstate Medical University, 
      Syracuse, New York, United States of America.
FAU - Esterly, Allen T
AU  - Esterly AT
AD  - SUNY Center for Environmental Health and Medicine, SUNY Upstate Medical 
      University, Syracuse, New York, United States of America.
AD  - Institute for Global Health and Translational Sciences, SUNY Upstate Medical 
      University, Syracuse, New York, United States of America.
AD  - Department of Microbiology and Immunology, SUNY Upstate Medical University, 
      Syracuse, New York, United States of America.
FAU - Reynolds, Erin S
AU  - Reynolds ES
AD  - SUNY Center for Environmental Health and Medicine, SUNY Upstate Medical 
      University, Syracuse, New York, United States of America.
AD  - Institute for Global Health and Translational Sciences, SUNY Upstate Medical 
      University, Syracuse, New York, United States of America.
AD  - Department of Microbiology and Immunology, SUNY Upstate Medical University, 
      Syracuse, New York, United States of America.
FAU - Bhaskar, Jahnavi R
AU  - Bhaskar JR
AD  - SUNY Center for Environmental Health and Medicine, SUNY Upstate Medical 
      University, Syracuse, New York, United States of America.
AD  - Institute for Global Health and Translational Sciences, SUNY Upstate Medical 
      University, Syracuse, New York, United States of America.
AD  - Department of Microbiology and Immunology, SUNY Upstate Medical University, 
      Syracuse, New York, United States of America.
FAU - Thangamani, Saravanan
AU  - Thangamani S
AUID- ORCID: 0000-0002-4269-5993
AD  - SUNY Center for Environmental Health and Medicine, SUNY Upstate Medical 
      University, Syracuse, New York, United States of America.
AD  - Institute for Global Health and Translational Sciences, SUNY Upstate Medical 
      University, Syracuse, New York, United States of America.
AD  - Department of Microbiology and Immunology, SUNY Upstate Medical University, 
      Syracuse, New York, United States of America.
LA  - eng
GR  - R01 AI127771/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20200615
PL  - United States
TA  - PLoS Negl Trop Dis
JT  - PLoS neglected tropical diseases
JID - 101291488
RN  - 0 (RNA, Viral)
SB  - IM
MH  - Animals
MH  - Brain/pathology
MH  - Chlorocebus aethiops
MH  - *Disease Models, Animal
MH  - Encephalitis Viruses, Tick-Borne/*physiology
MH  - Encephalitis, Tick-Borne/mortality/pathology/*virology
MH  - Female
MH  - Humans
MH  - Ixodes/*virology
MH  - Male
MH  - Mice
MH  - Mice, Inbred BALB C
MH  - Mice, Inbred C57BL
MH  - Morbidity
MH  - RNA, Viral
MH  - Vero Cells
MH  - Viral Load
PMC - PMC7316340
COIS- The authors have declared that no competing interests exist.
EDAT- 2020/06/17 06:00
MHDA- 2020/08/15 06:00
CRDT- 2020/06/17 06:00
PHST- 2019/11/08 00:00 [received]
PHST- 2020/05/04 00:00 [accepted]
PHST- 2020/06/25 00:00 [revised]
PHST- 2020/06/17 06:00 [pubmed]
PHST- 2020/08/15 06:00 [medline]
PHST- 2020/06/17 06:00 [entrez]
AID - PNTD-D-19-01896 [pii]
AID - 10.1371/journal.pntd.0008359 [doi]
PST - epublish
SO  - PLoS Negl Trop Dis. 2020 Jun 15;14(6):e0008359. doi: 
      10.1371/journal.pntd.0008359. eCollection 2020 Jun.

PMID- 29472825
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20200930
IS  - 1523-6161 (Print)
IS  - 2153-8182 (Electronic)
IS  - 1523-6161 (Linking)
VI  - 19
IP  - 4
DP  - 2017
TI  - A Head-to-Head Comparative Phase II Study of Standard Urine Culture and 
      Sensitivity Versus DNA Next-generation Sequencing Testing for Urinary Tract 
      Infections.
PG  - 213-220
LID - 10.3909/riu0780 [doi]
AB  - Many studies have discussed clinical practice guidelines for the treatment of 
      cystitis and pyelonephritis. Treatment of uncomplicated urinary tract infections 
      (UTIs) can be based on empiric antibiotic therapy. For complicated or recurrent 
      UTIs, therapy can be based on laboratory-controlled culture and sensitivity (C&S) 
      reports. The diagnosis of UTI by clinical criteria alone has an error rate of up 
      to 33%. In addition, positive laboratory culture results do not always indicate a 
      diagnosis of UTI. Comparison of urine in a conventional culture model versus DNA 
      next-generation sequencing (NGS) to accurately identify and provide information 
      on resistance factors (mobile genetic elements) is warranted. Our study was a 
      head-to-head comparative phase II study of standard urine C&S versus DNA NGS 
      testing for the diagnosis and treatment efficacy in patients with symptoms of 
      acute cystitis based on short-term outcomes.
FAU - McDonald, Michael
AU  - McDonald M
AD  - Department of Urology, Florida Hospital Celebration Health Celebration, FL.
AD  - Department of Surgery, University of Central Florida Orlando, FL.
FAU - Kameh, Darian
AU  - Kameh D
AD  - Department of Pathology, Florida Hospital Celebration Health Celebration, FL.
FAU - Johnson, Mark E
AU  - Johnson ME
AD  - Department of Statistics, University of Central Florida Orlando, FL.
FAU - Johansen, Truls E Bjerklund
AU  - Johansen TEB
AD  - Department of Urology, Oslo University Hospital and University of Oslo Norway.
FAU - Albala, David
AU  - Albala D
AD  - Department of Urology, Associate Medical Professionals Syracuse, NY.
FAU - Mouraviev, Vladimir
AU  - Mouraviev V
AD  - Central Florida Cancer Institute Davenport, FL.
AD  - Nova Southeastern University Fort Lauderdale, FL.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Rev Urol
JT  - Reviews in urology
JID - 100889067
PMC - PMC5811878
OTO - NOTNLM
OT  - Cystitis
OT  - DNA next-generation sequencing
OT  - Pyelonephritis
OT  - Urinary tract infection
EDAT- 2018/02/24 06:00
MHDA- 2018/02/24 06:01
CRDT- 2018/02/24 06:00
PHST- 2018/02/24 06:00 [entrez]
PHST- 2018/02/24 06:00 [pubmed]
PHST- 2018/02/24 06:01 [medline]
AID - 10.3909/riu0780 [doi]
PST - ppublish
SO  - Rev Urol. 2017;19(4):213-220. doi: 10.3909/riu0780.

PMID- 36723991
OWN - NLM
STAT- MEDLINE
DCOM- 20230502
LR  - 20231102
IS  - 2643-3249 (Electronic)
IS  - 2643-3230 (Print)
IS  - 2643-3230 (Linking)
VI  - 4
IP  - 3
DP  - 2023 May 1
TI  - Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome 
      Sequencing of Hodgkin and Reed Sternberg Cells.
PG  - 208-227
LID - 10.1158/2643-3230.BCD-22-0128 [doi]
AB  - The rarity of malignant Hodgkin and Reed Sternberg (HRS) cells in classic Hodgkin 
      lymphoma (cHL) limits the ability to study the genomics of cHL. To circumvent 
      this, our group has previously optimized fluorescence-activated cell sorting to 
      purify HRS cells. Using this approach, we now report the whole-genome sequencing 
      landscape of HRS cells and reconstruct the chronology and likely etiology of 
      pathogenic events leading to cHL. We identified alterations in driver genes not 
      previously described in cHL, APOBEC mutational activity, and the presence of 
      complex structural variants including chromothripsis. We found that high ploidy 
      in cHL is often acquired through multiple, independent chromosomal gains events 
      including whole-genome duplication. Evolutionary timing analyses revealed that 
      structural variants enriched for RAG motifs, driver mutations in B2M, BCL7A, 
      GNA13, and PTPN1, and the onset of AID-driven mutagenesis usually preceded large 
      chromosomal gains. This study provides a temporal reconstruction of cHL 
      pathogenesis. SIGNIFICANCE: Previous studies in cHL were limited to coding 
      sequences and therefore not able to comprehensively decipher the tumor 
      complexity. Here, leveraging cHL whole-genome characterization, we identify 
      driver events and reconstruct the tumor evolution, finding that structural 
      variants, driver mutations, and AID mutagenesis precede chromosomal gains. This 
      article is highlighted in the In This Issue feature, p. 171.
CI  - ©2023 American Association for Cancer Research.
FAU - Maura, Francesco
AU  - Maura F
AUID- ORCID: 0000-0002-5017-1620
AD  - Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.
FAU - Ziccheddu, Bachisio
AU  - Ziccheddu B
AUID- ORCID: 0000-0002-2746-0053
AD  - Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.
FAU - Xiang, Jenny Z
AU  - Xiang JZ
AUID- ORCID: 0000-0003-0484-2769
AD  - Weill Cornell Medical College, New York, New York.
AD  - Englander Institute for Precision Medicine, Institute for Computational 
      Biomedicine, and Meyer Cancer Center, Weill Cornell Medical College, New York, 
      New York.
FAU - Bhinder, Bhavneet
AU  - Bhinder B
AUID- ORCID: 0000-0001-6685-8761
AD  - Englander Institute for Precision Medicine, Institute for Computational 
      Biomedicine, and Meyer Cancer Center, Weill Cornell Medical College, New York, 
      New York.
FAU - Rosiene, Joel
AU  - Rosiene J
AUID- ORCID: 0000-0002-8610-370X
AD  - Weill Cornell Medical College, New York, New York.
FAU - Abascal, Federico
AU  - Abascal F
AUID- ORCID: 0000-0002-6201-1587
AD  - The Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, 
      Hinxton, United Kingdom.
FAU - Maclachlan, Kylee H
AU  - Maclachlan KH
AUID- ORCID: 0000-0001-7873-4854
AD  - Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 
      New York, New York.
FAU - Eng, Kenneth Wha
AU  - Eng KW
AUID- ORCID: 0000-0002-3404-3610
AD  - Englander Institute for Precision Medicine, Institute for Computational 
      Biomedicine, and Meyer Cancer Center, Weill Cornell Medical College, New York, 
      New York.
FAU - Uppal, Manik
AU  - Uppal M
AUID- ORCID: 0000-0003-3628-1716
AD  - Englander Institute for Precision Medicine, Institute for Computational 
      Biomedicine, and Meyer Cancer Center, Weill Cornell Medical College, New York, 
      New York.
FAU - He, Feng
AU  - He F
AUID- ORCID: 0000-0002-6872-7586
AD  - Weill Cornell Medical College, New York, New York.
FAU - Zhang, Wei
AU  - Zhang W
AUID- ORCID: 0000-0002-6129-0772
AD  - Weill Cornell Medical College, New York, New York.
FAU - Gao, Qi
AU  - Gao Q
AUID- ORCID: 0000-0003-1054-4418
AD  - Memorial Sloan Kettering Cancer Center, New York, New York.
FAU - Yellapantula, Venkata D
AU  - Yellapantula VD
AUID- ORCID: 0000-0003-1592-7741
AD  - Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 
      New York, New York.
AD  - Department of Pathology and Laboratory Medicine at Children's Hospital Los 
      Angeles, Los Angeles, California.
FAU - Trujillo-Alonso, Vicenta
AU  - Trujillo-Alonso V
AUID- ORCID: 0000-0001-7642-6954
AD  - Weill Cornell Medical College, New York, New York.
FAU - Park, Sunita I
AU  - Park SI
AUID- ORCID: 0000-0002-8606-0519
AD  - Department of Pathology, Children's Hospital of Atlanta, Atlanta, Georgia.
FAU - Oberley, Matthew J
AU  - Oberley MJ
AUID- ORCID: 0000-0001-6419-2513
AD  - Caris Life Sciences, Phoenix, Arizona.
FAU - Ruckdeschel, Elizabeth
AU  - Ruckdeschel E
AUID- ORCID: 0000-0002-0985-1309
AD  - Department of Pathology, Upstate Medical University, Syracuse, New York.
FAU - Lim, Megan S
AU  - Lim MS
AUID- ORCID: 0000-0002-0415-2867
AD  - Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, 
      Philadelphia.
FAU - Wertheim, Gerald B
AU  - Wertheim GB
AUID- ORCID: 0000-0002-1585-846X
AD  - Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, 
      Philadelphia.
FAU - Barth, Matthew J
AU  - Barth MJ
AUID- ORCID: 0000-0001-5263-9509
AD  - Department of Pediatrics, Roswell Park Comprehensive Cancer Center, Buffalo, New 
      York.
FAU - Horton, Terzah M
AU  - Horton TM
AUID- ORCID: 0000-0001-8293-4242
AD  - Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
FAU - Derkach, Andriy
AU  - Derkach A
AUID- ORCID: 0000-0003-2178-8493
AD  - Department of Epidemiology and Statistics, Memorial Sloan Kettering Cancer 
      Center, New York, New York.
FAU - Kovach, Alexandra E
AU  - Kovach AE
AUID- ORCID: 0000-0002-6742-6749
AD  - Children's Hospital of Los Angeles, Los Angeles, California.
FAU - Forlenza, Christopher J
AU  - Forlenza CJ
AUID- ORCID: 0000-0003-2246-1206
AD  - Memorial Sloan Kettering Cancer Center, New York, New York.
FAU - Zhang, Yanming
AU  - Zhang Y
AUID- ORCID: 0000-0001-6138-6080
AD  - Memorial Sloan Kettering Cancer Center, New York, New York.
FAU - Landgren, Ola
AU  - Landgren O
AUID- ORCID: 0000-0001-6485-4839
AD  - Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.
FAU - Moskowitz, Craig H
AU  - Moskowitz CH
AUID- ORCID: 0000-0002-9189-3152
AD  - Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.
FAU - Cesarman, Ethel
AU  - Cesarman E
AUID- ORCID: 0000-0003-3303-6299
AD  - Weill Cornell Medical College, New York, New York.
FAU - Imielinski, Marcin
AU  - Imielinski M
AUID- ORCID: 0000-0002-2211-4741
AD  - Weill Cornell Medical College, New York, New York.
AD  - Englander Institute for Precision Medicine, Institute for Computational 
      Biomedicine, and Meyer Cancer Center, Weill Cornell Medical College, New York, 
      New York.
AD  - Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 
      New York, New York.
FAU - Elemento, Olivier
AU  - Elemento O
AUID- ORCID: 0000-0002-8061-9617
AD  - Weill Cornell Medical College, New York, New York.
AD  - Englander Institute for Precision Medicine, Institute for Computational 
      Biomedicine, and Meyer Cancer Center, Weill Cornell Medical College, New York, 
      New York.
FAU - Roshal, Mikhail
AU  - Roshal M
AUID- ORCID: 0000-0002-9585-0790
AD  - Memorial Sloan Kettering Cancer Center, New York, New York.
FAU - Giulino-Roth, Lisa
AU  - Giulino-Roth L
AUID- ORCID: 0000-0002-6040-8644
AD  - Weill Cornell Medical College, New York, New York.
LA  - eng
GR  - K08 CA219473/CA/NCI NIH HHS/United States
GR  - P30 CA008748/CA/NCI NIH HHS/United States
GR  - P30 CA240139/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Blood Cancer Discov
JT  - Blood cancer discovery
JID - 101764786
SB  - IM
CIN - 2643-3230. doi: 10.1158/2643-3230.BCD-4-3-ITI
MH  - Humans
MH  - *Reed-Sternberg Cells/pathology
MH  - *Hodgkin Disease/genetics/pathology
MH  - Flow Cytometry
MH  - Evolution, Molecular
PMC - PMC10150291
EDAT- 2023/02/02 06:00
MHDA- 2023/05/02 06:42
CRDT- 2023/02/01 11:43
PHST- 2022/08/08 00:00 [received]
PHST- 2022/11/21 00:00 [revised]
PHST- 2023/01/26 00:00 [accepted]
PHST- 2023/05/02 06:42 [medline]
PHST- 2023/02/02 06:00 [pubmed]
PHST- 2023/02/01 11:43 [entrez]
AID - 716329 [pii]
AID - BCD-22-0128 [pii]
AID - 10.1158/2643-3230.BCD-22-0128 [doi]
PST - ppublish
SO  - Blood Cancer Discov. 2023 May 1;4(3):208-227. doi: 10.1158/2643-3230.BCD-22-0128.

PMID- 33087175
OWN - NLM
STAT- MEDLINE
DCOM- 20211110
LR  - 20211110
IS  - 2051-5960 (Electronic)
IS  - 2051-5960 (Linking)
VI  - 8
IP  - 1
DP  - 2020 Oct 21
TI  - Distinct genomic subclasses of high-grade/progressive meningiomas: 
      NF2-associated, NF2-exclusive, and NF2-agnostic.
PG  - 171
LID - 10.1186/s40478-020-01040-2 [doi]
LID - 171
AB  - BACKGROUND: Genomic studies of high-grade/progressive meningiomas have reported a 
      heterogeneous mutation spectrum, identifying few recurrently mutated genes. Most 
      studies have been underpowered to detect genomic subclasses of aggressive 
      meningiomas due to relatively small number of available samples. Here, we present 
      a genomic survey of one of the largest multi-institutional cohorts of 
      high-grade/progressive meningiomas to date. METHODS: 850 high-grade/progressive 
      meningiomas, including 441 WHO grade 2 and 176 WHO grade 3 meningiomas and 220 
      progressive WHO grade 1 meningiomas, were tested as part of a clinical testing 
      program by hybridization capture of 406 cancer-related genes to detect base 
      substitutions, indels, amplifications, deletions, and rearrangements. Information 
      from pathology reports, histopathology review, and patient clinical data was 
      assessed. RESULTS: Genomic analyses converged to identify at least three distinct 
      patterns of biologically-aggressive meningiomas. The first and most common 
      contained NF2-mutant tumors (n = 426, 50%), was associated with male sex 
      (64.4% %, p = 0.0001) and often harbored additional mutations in CDKN2A/B (24%), 
      and the chromatin regulators ARID1A (9%), and KDM6A (6%). A second group 
      (NF2-agnostic) featured TERT promoter (TERTp; n = 56) or TP53 mutations (n = 25) 
      and were either NF2-mutant or wild-type, and displayed no association with either 
      sex (p = 0.39). The remaining group generally lacked NF2 mutations, and accounted 
      for 40% of the cases-with three subgroups. One consistent primarily of grade 3 
      lesions harboring alterations in chromatin regulators BAP1 (n = 22) or PBRM1 
      (n = 16). A second subgroup contained AKT1 (n = 26), PIK3CA (n = 14) and SMO 
      (n = 7) mutant skull-based meningiomas, and a third mixed subgroup included 237 
      meningiomas with a heterogeneous spectrum of low frequency and non-recurrent 
      alterations. CONCLUSIONS: Our findings indicate that the patterns of genomic 
      alterations in high-grade/progressive meningiomas commonly group into three 
      different categories. The most common NF2-associated canonical group frequently 
      harbored CDKN2A/B alterations, which is potentially amenable to targeted 
      therapies. An NF2-agnostic group harbored frequent TERTp and TP53 mutations. The 
      final subclass, distinct from the canonical NF2 mutant associated pathway, was 
      partly characterized by BAP1/PBRM1 alterations (rhabdoid/papillary histology) or 
      skull-base disease. Overall, these data increase our understanding of the 
      pathobiology of high-grade/progressive meningiomas and can guide the design of 
      clinical trials. IRB APPROVAL STATUS: Reviewed and approved by Western IRB; 
      Protocol No. 20152817.
FAU - Williams, Erik A
AU  - Williams EA
AD  - Foundation Medicine Inc, 150 Second Street, Cambridge, MA, 02141, USA. 
      erwilliams@foundationmedicine.com.
AD  - Translational Neuro-Oncology Laboratory, Department of Neurosurgery, 
      Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 
      USA. erwilliams@foundationmedicine.com.
FAU - Santagata, Sandro
AU  - Santagata S
AD  - Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
FAU - Wakimoto, Hiroaki
AU  - Wakimoto H
AD  - Translational Neuro-Oncology Laboratory, Department of Neurosurgery, 
      Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 
      USA.
FAU - Shankar, Ganesh M
AU  - Shankar GM
AD  - Department of Neurosurgery, Massachusetts General Hospital Cancer Center, Harvard 
      Medical School, Boston, MA, USA.
FAU - Barker, Fred G 2nd
AU  - Barker FG 2nd
AD  - Department of Neurosurgery, Massachusetts General Hospital Cancer Center, Harvard 
      Medical School, Boston, MA, USA.
FAU - Sharaf, Radwa
AU  - Sharaf R
AD  - Foundation Medicine Inc, 150 Second Street, Cambridge, MA, 02141, USA.
FAU - Reddy, Abhinav
AU  - Reddy A
AD  - Foundation Medicine Inc, 150 Second Street, Cambridge, MA, 02141, USA.
FAU - Spear, Phoebe
AU  - Spear P
AD  - Foundation Medicine Inc, 150 Second Street, Cambridge, MA, 02141, USA.
FAU - Alexander, Brian M
AU  - Alexander BM
AD  - Foundation Medicine Inc, 150 Second Street, Cambridge, MA, 02141, USA.
FAU - Ross, Jeffrey S
AU  - Ross JS
AD  - Foundation Medicine Inc, 150 Second Street, Cambridge, MA, 02141, USA.
AD  - Department of Pathology, State University of New York Upstate Medical University, 
      Syracuse, NY, USA.
FAU - Brastianos, Priscilla K
AU  - Brastianos PK
AD  - Stephen E. and Catherine Pappas Center for Neuro-Oncology, Division of 
      Hematology/Oncology, Department of Neurology, Massachusetts General Hospital, 
      Harvard Medical School, Boston, MA, USA.
FAU - Cahill, Daniel P
AU  - Cahill DP
AD  - Translational Neuro-Oncology Laboratory, Department of Neurosurgery, 
      Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 
      USA.
AD  - Department of Neurosurgery, Massachusetts General Hospital Cancer Center, Harvard 
      Medical School, Boston, MA, USA.
FAU - Ramkissoon, Shakti H
AU  - Ramkissoon SH
AD  - Foundation Medicine Inc, 150 Second Street, Cambridge, MA, 02141, USA.
AD  - Department of Pathology, Wake Forest School of Medicine, Wake Forest 
      Comprehensive Cancer Center, Winston-Salem, NC, USA.
FAU - Juratli, Tareq A
AU  - Juratli TA
AUID- ORCID: 0000-0003-2236-6719
AD  - Translational Neuro-Oncology Laboratory, Department of Neurosurgery, 
      Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 
      USA. tareq.juratli@uniklinikum-dresden.de.
AD  - Department of Neurosurgery, University Hospital Carl Gustav Carus, Technische 
      Universität Dresden, Fetscherstr. 74, Dresden, Germany. 
      tareq.juratli@uniklinikum-dresden.de.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20201021
PL  - England
TA  - Acta Neuropathol Commun
JT  - Acta neuropathologica communications
JID - 101610673
RN  - 0 (ARID1A protein, human)
RN  - 0 (BAP1 protein, human)
RN  - 0 (CDKN2A protein, human)
RN  - 0 (Cyclin-Dependent Kinase Inhibitor p16)
RN  - 0 (DNA-Binding Proteins)
RN  - 0 (NF2 protein, human)
RN  - 0 (Neurofibromin 2)
RN  - 0 (PBRM1 protein, human)
RN  - 0 (SMO protein, human)
RN  - 0 (Smoothened Receptor)
RN  - 0 (TP53 protein, human)
RN  - 0 (Transcription Factors)
RN  - 0 (Tumor Suppressor Protein p53)
RN  - 0 (Tumor Suppressor Proteins)
RN  - EC 1.14.11.- (Histone Demethylases)
RN  - EC 1.14.11.- (KDM6A protein, human)
RN  - EC 2.7.1.137 (Class I Phosphatidylinositol 3-Kinases)
RN  - EC 2.7.1.137 (PIK3CA protein, human)
RN  - EC 2.7.11.1 (AKT1 protein, human)
RN  - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt)
RN  - EC 2.7.7.49 (TERT protein, human)
RN  - EC 2.7.7.49 (Telomerase)
RN  - EC 3.4.19.12 (Ubiquitin Thiolesterase)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Child
MH  - Child, Preschool
MH  - Class I Phosphatidylinositol 3-Kinases/genetics
MH  - Cyclin-Dependent Kinase Inhibitor p16/genetics
MH  - DNA-Binding Proteins/genetics
MH  - Disease Progression
MH  - Female
MH  - Genomics
MH  - Histone Demethylases/genetics
MH  - Humans
MH  - Infant
MH  - Infant, Newborn
MH  - Male
MH  - Meningeal Neoplasms/classification/*genetics/pathology
MH  - Meningioma/classification/*genetics/pathology
MH  - Middle Aged
MH  - Neoplasm Grading
MH  - Neurofibromin 2/genetics
MH  - Promoter Regions, Genetic/genetics
MH  - Proto-Oncogene Proteins c-akt/genetics
MH  - Sex Factors
MH  - Smoothened Receptor/genetics
MH  - Telomerase/genetics
MH  - Transcription Factors/genetics
MH  - Tumor Suppressor Protein p53/genetics
MH  - Tumor Suppressor Proteins/genetics
MH  - Ubiquitin Thiolesterase/genetics
MH  - Young Adult
PMC - PMC7580027
OTO - NOTNLM
OT  - 1p loss
OT  - CDKN2A
OT  - KDM6A
OT  - Meningioma
OT  - Metastatic
OT  - NF2
OT  - PBRM1
OT  - Progressive
OT  - TERT
COIS- EAW, RS, AR, JMV, BMA, JSR, and SHR are employees or consultants of Foundation 
      Medicine, Inc., a wholly owned subsidiary of Roche Holdings, Inc. and Roche 
      Finance Ltd, and these employees have equity interest in an affiliate of these 
      Roche entities. SS is a consultant for RareCyte. PKB reports honoraria for 
      consulting from Tesaro, Lilly, Angiochem, and Genentech-Roche; speaker’s 
      honoraria from Genentech-Roche and Merck; and research funding (to Massachusetts 
      General Hospital) from BMS, Pfizer, Lilly and Merck. DPC reports receiving 
      honoraria from Merck, Lilly and Boston Pharmaceuticals outside the submitted 
      work. TAJ received honoraria from CSL Behring and Roche Pharma AG unrelated to 
      the submitted work.
EDAT- 2020/10/23 06:00
MHDA- 2021/11/11 06:00
CRDT- 2020/10/22 05:26
PHST- 2020/09/22 00:00 [received]
PHST- 2020/09/23 00:00 [accepted]
PHST- 2020/10/22 05:26 [entrez]
PHST- 2020/10/23 06:00 [pubmed]
PHST- 2021/11/11 06:00 [medline]
AID - 10.1186/s40478-020-01040-2 [pii]
AID - 1040 [pii]
AID - 10.1186/s40478-020-01040-2 [doi]
PST - epublish
SO  - Acta Neuropathol Commun. 2020 Oct 21;8(1):171. doi: 10.1186/s40478-020-01040-2.

PMID- 27696669
OWN - NLM
STAT- MEDLINE
DCOM- 20170505
LR  - 20211204
IS  - 1526-968X (Electronic)
IS  - 1526-954X (Print)
IS  - 1526-954X (Linking)
VI  - 54
IP  - 11
DP  - 2016 Nov
TI  - Mutant analysis by rescue gene excision: New tools for mosaic studies in 
      Drosophila.
PG  - 589-592
LID - 10.1002/dvg.22984 [doi]
AB  - A host of classical and molecular genetic tools make Drosophila a tremendous 
      model for the dissection of gene activity. In particular, the FLP-FRT technique 
      for mitotic recombination has greatly enhanced gene loss-of-function analysis. 
      This technique efficiently induces formation of homozygous mutant clones in 
      tissues of heterozygous organisms. However, the dependence of the FLP-FRT method 
      on cell division, and other constraints, also impose limits on its effectiveness. 
      We describe here the generation and testing of tools for Mutant Analysis by 
      Rescue Gene Excision (MARGE), an approach whereby mutant cells are formed by loss 
      of a rescue transgene in a homozygous mutant organism. Rescue-transgene loss can 
      be induced in any tissue or cell-type and at any time during development or in 
      the adult using available heat-shock-induced or tissue-specific flippases, or 
      combinations of UAS-FLP with Gal4 and Gal80(ts) reagents. The simultaneous loss 
      of a constitutive fluorescence marker (GFP or RFP) identifies the mutant cells. 
      We demonstrate the efficacy of the MARGE technique by flip-out (clonal and 
      disc-wide) of a Ubi-GFP-carrying construct in imaginal discs, and by inducing a 
      known yki mutant phenotype in the Drosophila ovary.
CI  - © 2016 Wiley Periodicals, Inc.
FAU - Zhou, Qingxiang
AU  - Zhou Q
AD  - Departments of Ophthalmology, Center for Vision Research and SUNY Eye Institute 
      SUNY Upstate Medical University, Syracuse, New York, USA.
FAU - Neal, Scott J
AU  - Neal SJ
AD  - Departments of Ophthalmology, Center for Vision Research and SUNY Eye Institute 
      SUNY Upstate Medical University, Syracuse, New York, USA.
FAU - Pignoni, Francesca
AU  - Pignoni F
AD  - Departments of Ophthalmology, Center for Vision Research and SUNY Eye Institute 
      SUNY Upstate Medical University, Syracuse, New York, USA.
AD  - Departments of Biochemistry & Molecular Biology, Neuroscience & Physiology, SUNY 
      Upstate Medical University, Syracuse, New York, USA.
LA  - eng
GR  - R01 GM110498/GM/NIGMS NIH HHS/United States
GR  - R03 HD082609/HD/NICHD NIH HHS/United States
PT  - Journal Article
DEP - 20161021
PL  - United States
TA  - Genesis
JT  - Genesis (New York, N.Y. : 2000)
JID - 100931242
RN  - 0 (Drosophila Proteins)
RN  - 0 (Nuclear Proteins)
RN  - 0 (Trans-Activators)
RN  - 0 (YAP-Signaling Proteins)
RN  - 0 (Yki protein, Drosophila)
SB  - IM
MH  - Animals
MH  - DNA Mutational Analysis
MH  - Drosophila/*genetics
MH  - Drosophila Proteins/*genetics
MH  - Female
MH  - Homozygote
MH  - Imaginal Discs/growth & development/metabolism
MH  - *Mosaicism
MH  - Nuclear Proteins/*genetics
MH  - Ovary/growth & development/metabolism
MH  - Phenotype
MH  - *Recombination, Genetic
MH  - Trans-Activators/*genetics
MH  - YAP-Signaling Proteins
PMC - PMC5357640
MID - NIHMS823042
OTO - NOTNLM
OT  - CKO
OT  - Flip-out Rescue Cassette vectors
OT  - FoRC vectors
OT  - MARGE
OT  - clonal analysis
OT  - conditional knockout
OT  - follicle cells
OT  - yorkie
EDAT- 2016/10/22 06:00
MHDA- 2017/05/06 06:00
CRDT- 2016/10/04 06:00
PHST- 2016/08/06 00:00 [received]
PHST- 2016/09/24 00:00 [revised]
PHST- 2016/09/29 00:00 [accepted]
PHST- 2016/10/22 06:00 [pubmed]
PHST- 2017/05/06 06:00 [medline]
PHST- 2016/10/04 06:00 [entrez]
AID - 10.1002/dvg.22984 [doi]
PST - ppublish
SO  - Genesis. 2016 Nov;54(11):589-592. doi: 10.1002/dvg.22984. Epub 2016 Oct 21.

PMID- 36536075
OWN - NLM
STAT- MEDLINE
DCOM- 20230314
LR  - 20230416
IS  - 1476-5578 (Electronic)
IS  - 1359-4184 (Print)
IS  - 1359-4184 (Linking)
VI  - 28
IP  - 3
DP  - 2023 Mar
TI  - Predicting childhood and adolescent attention-deficit/hyperactivity disorder 
      onset: a nationwide deep learning approach.
PG  - 1232-1239
LID - 10.1038/s41380-022-01918-8 [doi]
AB  - Attention-deficit/hyperactivity disorder (ADHD) is a heterogeneous disorder with 
      a high degree of psychiatric and physical comorbidity, which complicates its 
      diagnosis in childhood and adolescence. We analyzed registry data from 238,696 
      persons born and living in Sweden between 1995 and 1999. Several machine learning 
      techniques were used to assess the ability of registry data to inform the 
      diagnosis of ADHD in childhood and adolescence: logistic regression, random 
      Forest, gradient boosting, XGBoost, penalized logistic regression, deep neural 
      network (DNN), and ensemble models. The best fitting model was the DNN, achieving 
      an area under the receiver operating characteristic curve of 0.75, 95% CI 
      (0.74-0.76) and balanced accuracy of 0.69. At the 0.45 probability threshold, 
      sensitivity was 71.66% and specificity was 65.0%. There was an overall agreement 
      in the feature importance among all models (τ > .5). The top 5 features 
      contributing to classification were having a parent with criminal convictions, 
      male sex, having a relative with ADHD, number of academic subjects failed, and 
      speech/learning disabilities. A DNN model predicting childhood and adolescent 
      ADHD trained exclusively on Swedish register data achieved good discrimination. 
      If replicated and validated in an external sample, and proven to be 
      cost-effective, this model could be used to alert clinicians to individuals who 
      ought to be screened for ADHD and to aid clinicians' decision-making with the 
      goal of decreasing misdiagnoses. Further research is needed to validate results 
      in different populations and to incorporate new predictors.
CI  - © 2022. The Author(s).
FAU - Garcia-Argibay, Miguel
AU  - Garcia-Argibay M
AUID- ORCID: 0000-0002-4811-2330
AD  - School of Medical Sciences, Faculty of Medicine and Health, Örebro University, 
      Örebro, Sweden. miguel.garcia-argibay@oru.se.
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden. miguel.garcia-argibay@oru.se.
FAU - Zhang-James, Yanli
AU  - Zhang-James Y
AD  - Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate 
      Medical University, Syracuse, NY, USA.
FAU - Cortese, Samuele
AU  - Cortese S
AD  - School of Psychology, University of Southampton, Southampton, UK.
AD  - Clinical and Experimental Sciences (CNS and Psychiatry), Faculty of Medicine, 
      University of Southampton, Southampton, UK.
AD  - Solent NHS Trust, Southampton, UK.
AD  - Hassenfeld Children's Hospital at NYU Langone, New York University Child Study 
      Center, New York City, New York, NY, USA.
AD  - Division of Psychiatry and Applied Psychology, School of Medicine, University of 
      Nottingham, Nottingham, UK.
FAU - Lichtenstein, Paul
AU  - Lichtenstein P
AUID- ORCID: 0000-0003-3037-5287
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
FAU - Larsson, Henrik
AU  - Larsson H
AUID- ORCID: 0000-0002-6851-3297
AD  - School of Medical Sciences, Faculty of Medicine and Health, Örebro University, 
      Örebro, Sweden.
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
FAU - Faraone, Stephen V
AU  - Faraone SV
AD  - Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate 
      Medical University, Syracuse, NY, USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20221219
PL  - England
TA  - Mol Psychiatry
JT  - Molecular psychiatry
JID - 9607835
SB  - IM
MH  - Humans
MH  - Male
MH  - Adolescent
MH  - *Attention Deficit Disorder with Hyperactivity/epidemiology
MH  - *Deep Learning
MH  - *Learning Disabilities
MH  - Comorbidity
MH  - Sweden
PMC - PMC10005952
COIS- HL reported receiving grants from Shire/Takeda Pharmaceuticals during the conduct 
      of the study; personal fees from and serving as a speaker for Shire/Takeda 
      Pharmaceuticals and Evolan Pharma AB outside the submitted work; and sponsorship 
      for a conference on attention-deficit/hyperactivity disorder from Shire 
      Pharmaceuticals outside the submitted work. In the past year, SVF received 
      income, potential income, travel expenses continuing education support and/or 
      research support from Aardvark, Rhodes, OnDosis, Tris, Otsuka, Arbor, Ironshore, 
      KemPharm/Corium, Akili, Supernus, Takeda, Atentiv, Noven, Axsome and Genomind. 
      With his institution, he has US patent US20130217707 A1 for the use of 
      sodium-hydrogen exchange inhibitors in the treatment of ADHD. He also receives 
      royalties from books published by Guilford Press: Straight Talk about Your 
      Child’s Mental Health, Oxford University Press: Schizophrenia: The Facts and 
      Elsevier: ADHD: Non-Pharmacologic Interventions. He is Program Director of 
      www.ADHDEvidence.org and www.ADHDinAdults.com. The other authors declare no 
      competing interests.
EDAT- 2022/12/20 06:00
MHDA- 2023/03/15 06:00
CRDT- 2022/12/19 23:32
PHST- 2022/08/02 00:00 [received]
PHST- 2022/12/09 00:00 [accepted]
PHST- 2022/12/05 00:00 [revised]
PHST- 2022/12/20 06:00 [pubmed]
PHST- 2023/03/15 06:00 [medline]
PHST- 2022/12/19 23:32 [entrez]
AID - 10.1038/s41380-022-01918-8 [pii]
AID - 1918 [pii]
AID - 10.1038/s41380-022-01918-8 [doi]
PST - ppublish
SO  - Mol Psychiatry. 2023 Mar;28(3):1232-1239. doi: 10.1038/s41380-022-01918-8. Epub 
      2022 Dec 19.

PMID- 38150257
OWN - NLM
STAT- MEDLINE
DCOM- 20231228
LR  - 20240106
IS  - 2574-3805 (Electronic)
IS  - 2574-3805 (Linking)
VI  - 6
IP  - 12
DP  - 2023 Dec 1
TI  - Genomic Profiles and Clinical Outcomes of Penile Squamous Cell Carcinoma With 
      Elevated Tumor Mutational Burden.
PG  - e2348002
LID - 10.1001/jamanetworkopen.2023.48002 [doi]
LID - e2348002
AB  - IMPORTANCE: Tumor mutational burden (TMB) is a putative biomarker of efficacy for 
      immune checkpoint inhibitor (ICI) therapies of solid tumors, but not specifically 
      for penile squamous cell carcinoma (PSCC). OBJECTIVE: To characterize biomarker 
      features and ICI therapy outcomes associated with high TMB in PSCC in the routine 
      clinical practice setting. DESIGN, SETTING, AND PARTICIPANTS: In this cohort 
      study, 397 PSCC cases were analyzed to identify genomic alterations in more than 
      300 cancer-associated genes and genomic signatures, including TMB, using a hybrid 
      capture-based comprehensive genomic profiling assay. Tumor mutational burden was 
      categorized as low (<10 mutations per megabase [mut/Mb]), high (10-19 mut/Mb), or 
      very high (≥20 mut/Mb). Germline status of genetic alterations was predicted 
      using a validated somatic-germline computational method. Clinical outcomes of 
      patients with metastatic PSCC receiving first-line ICI were abstracted using the 
      deidentified nationwide Clinico-Genomic Database (CGDB) from January 1, 2011, 
      through December 31, 2022. EXPOSURE: Comprehensive genomic profiling was 
      performed using FoundationOne and FoundationOne CDx assays from Foundation 
      Medicine Inc. MAIN OUTCOMES AND MEASURES: The spectrum of genetic alterations by 
      TMB level in PSCC, the percentage of germline genetic alterations, and the 
      outcome (overall survival with routine clinical treatment) by TMB of 
      chemotherapy-naive patients with PSCC who received ICI treatment up front were 
      assessed in this descriptive study. RESULTS: Among 397 patients (median [IQR] 
      age, 65 [54-73] years; 266 [67.0%] of European, 83 [20.9%] of admixed American, 
      and 34 [8.5%] of African or other genomic ancestry), the median (IQR) age (eg, 65 
      [53-73] years for low TMB vs 68 [61-78] years for TMB ≥10 mut/Mb) and genomic 
      ancestry distribution (eg, European 228 of 339 [67.3%] for low TMB vs 38 of 58 
      [65.5%] for TMB ≥10 mut/Mb) were similar between TMB subgroups. There were 339 
      PSCC cases (85.4%) with low TMB, 40 cases (10.1%) with high TMB, and 18 cases 
      (4.5%) with very high TMB. Comparisons of TMB of 10 mut/Mb or higher vs low TMB 
      showed an enrichment of genetic alterations in PIK3CA (48.3% vs 18.3%; P < .001) 
      and KMT2D (29.3% vs 7.7%; P < .001) and less frequent genetic alterations in 
      CDKN2A (25.9% vs 45.7%; P = .05). Most genetic alterations did not co-occur. 
      Human papillomavirus identification was more frequent as TMB increased: 28.3% for 
      low TMB, 50.0% for high, and 72.2% for very high. In total, 95 of 1377 genetic 
      alterations (6.9%) were germline. Of 10 patients identified from the CGDB 
      receiving frontline ICIs, median (IQR) follow-up was 9.9 months. Four patients 
      had overall survival with clinical treatment of more than 12 months, including 2 
      of 3 patients with TMB of 10 mut/Mb or higher. CONCLUSIONS AND RELEVANCE: In this 
      cohort study of advanced metastatic PSCC based on TMB levels, significant 
      differences were observed for biomarkers in nearly 15% of patients with a TMB of 
      10 mut/Mb or higher. Germline testing and ICI-based therapy should be integrated 
      into the management of selected PSCC cases.
FAU - Necchi, Andrea
AU  - Necchi A
AD  - Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy.
AD  - Vita-Salute San Raffaele University, Milan, Italy.
FAU - Spiess, Philippe E
AU  - Spiess PE
AD  - Department of GU Oncology, H. Lee Moffitt Cancer Center and Research Institute, 
      Tampa, Florida.
FAU - Costa de Padua, Tiago
AU  - Costa de Padua T
AD  - Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy.
FAU - Li, Roger
AU  - Li R
AD  - Department of GU Oncology, H. Lee Moffitt Cancer Center and Research Institute, 
      Tampa, Florida.
FAU - Grivas, Petros
AU  - Grivas P
AD  - Division of Oncology, Department of Medicine, University of Washington, Seattle.
AD  - Fred Hutchinson Cancer Center, Seattle, Washington.
FAU - Huang, Richard S P
AU  - Huang RSP
AD  - Foundation Medicine, Inc, Cambridge, Massachusetts.
FAU - Lin, Douglas I
AU  - Lin DI
AD  - Foundation Medicine, Inc, Cambridge, Massachusetts.
FAU - Danziger, Natalie
AU  - Danziger N
AD  - Foundation Medicine, Inc, Cambridge, Massachusetts.
FAU - Ross, Jeffrey S
AU  - Ross JS
AD  - Foundation Medicine, Inc, Cambridge, Massachusetts.
AD  - SUNY Upstate Medical University, Syracuse, New York.
FAU - Jacob, Joseph M
AU  - Jacob JM
AD  - SUNY Upstate Medical University, Syracuse, New York.
FAU - Sager, Rebecca A
AU  - Sager RA
AD  - SUNY Upstate Medical University, Syracuse, New York.
FAU - Basnet, Alina
AU  - Basnet A
AD  - SUNY Upstate Medical University, Syracuse, New York.
FAU - Li, Gerald
AU  - Li G
AD  - Foundation Medicine, Inc, Cambridge, Massachusetts.
FAU - Graf, Ryon P
AU  - Graf RP
AD  - Foundation Medicine, Inc, Cambridge, Massachusetts.
FAU - Pavlick, Dean C
AU  - Pavlick DC
AD  - Foundation Medicine, Inc, Cambridge, Massachusetts.
FAU - Bratslavsky, Gennady
AU  - Bratslavsky G
AD  - SUNY Upstate Medical University, Syracuse, New York.
LA  - eng
PT  - Journal Article
DEP - 20231201
PL  - United States
TA  - JAMA Netw Open
JT  - JAMA network open
JID - 101729235
RN  - 0 (Biomarkers)
SB  - IM
MH  - Humans
MH  - Male
MH  - Aged
MH  - Middle Aged
MH  - Cohort Studies
MH  - *Carcinoma, Squamous Cell/genetics
MH  - *Penile Neoplasms/genetics
MH  - Biological Assay
MH  - Biomarkers
PMC - PMC10753400
COIS- Conflict of Interest Disclosures: Dr Necchi reported receiving grants from 
      AstraZeneca, Merck, Ipsen Institution, and Gilead Institution; and receiving 
      personal fees from Astellas, AstraZeneca, Basilea Pharmaceutica, Bristol Meyers 
      Squibb, Bicycle Therapeutics, Catalym, Clovis Oncology, Foundation Medicine Inc, 
      GlaxoSmithKline, Incyte, Janssen, Merck, Rainer Therapeutics, and Roche outside 
      the submitted work; and having a spouse with employment and stock in Bayer. Dr 
      Spiess reported being the vice chair of the National Comprehensive Cancer Center 
      bladder and penile cancer panel, president of Global Society of Rare 
      Genitourinary Tumors, and a member of the American Society of Clinical 
      Oncology/European Association of Urology penile cancer panel. Dr R. Li reported 
      receiving grants from Predicine, Valar Labs, and Veracyte; receiving personal 
      fees from Arquer Diagnostics, Bristol Meyers Squibb, CG Oncology, FerGene, 
      Lucence, Merck, and UroGen Pharma; and receiving nonfinancial support from 
      Janssen outside the submitted work. Dr Grivas reported receiving research funding 
      from Bristol Myers Squibb, G1 Therapeutics, Gilead Sciences, Merck KGaA, Mirati 
      Therapeutics, MSD, Pfizer, and QED Therapeutics; receiving grants from Acrivon 
      Therapeutics, ALX Oncology, Bavarian Nordic, Debiopharm Group, and 
      GlaxoSmithKline; and receiving personal fees from 4D Pharma, Aadi Bioscience, 
      Asieris Pharmaceuticals, Astellas, AstraZeneca, BostonGene, Bristol Myers Squibb, 
      CG Oncology, Dyania Health, Exelixis, Fresenius Kabi, G1 Therapeutics, Gilead 
      Sciences, Guardant Health, ImmunityBio, Infinity Pharmaceuticals, Janssen, 
      Lucence, Merck KGaA, Mirati Therapeutics, MSD, Pfizer, PureTech, QED 
      Therapeutics, Regeneron, Roche, Seattle Genetics, Silverback Therapeutics, Strata 
      Oncology, and UroGen Pharma outside the submitted work. Dr Huang reported 
      receiving personal fees from Foundation Medicine Inc during the conduct of the 
      study and outside the submitted work. Drs Lin, Danziger, G. Li, and Pavlick 
      reported being employed by Foundation Medicine Inc and holding stock in F. 
      Hoffmann-La Roche Ltd during the conduct of the study. Drs Ross and Graf reported 
      being employed by Foundation Medicine Inc during the conduct of the study. No 
      other disclosures were reported.
EDAT- 2023/12/27 12:41
MHDA- 2023/12/28 06:42
CRDT- 2023/12/27 11:35
PHST- 2023/12/28 06:42 [medline]
PHST- 2023/12/27 12:41 [pubmed]
PHST- 2023/12/27 11:35 [entrez]
AID - 2813294 [pii]
AID - zoi231402 [pii]
AID - 10.1001/jamanetworkopen.2023.48002 [doi]
PST - epublish
SO  - JAMA Netw Open. 2023 Dec 1;6(12):e2348002. doi: 
      10.1001/jamanetworkopen.2023.48002.

PMID- 29496126
OWN - NLM
STAT- MEDLINE
DCOM- 20191104
LR  - 20231012
IS  - 1527-5418 (Electronic)
IS  - 0890-8567 (Print)
IS  - 0890-8567 (Linking)
VI  - 57
IP  - 3
DP  - 2018 Mar
TI  - Working Memory and Vigilance as Multivariate Endophenotypes Related to Common 
      Genetic Risk for Attention-Deficit/Hyperactivity Disorder.
PG  - 175-182
LID - S0890-8567(18)30002-9 [pii]
LID - 10.1016/j.jaac.2017.12.013 [doi]
AB  - OBJECTIVE: Understanding the role of endophenotypes is essential for process 
      models of psychopathology. This study examined which candidate cognitive 
      endophenotypes statistically mediate common variant genetic risk for 
      attention-deficit/hyperactivity disorder (ADHD). METHOD: A case-control design 
      using community-recruited volunteer children 7 to 11 years of age (n = 656, n = 
      435 ADHD), of whom 514 were of homogenous European ancestry for the primary 
      models (n = 337 ADHD, 177 non-ADHD). Children were assessed with a 
      multi-informant, best-estimate diagnostic procedure and laboratory measures of 
      working memory, response inhibition, executive functioning, arousal/attention, 
      temporal information processing, and processing speed. Latent variables were 
      created for the candidate cognitive measures and for parent- and teacher-rated 
      ADHD dimensions. Polygenic risk scores (PGS) were computed using a discovery 
      sample of 20,183 individuals with ADHD and 35,191 controls from the Psychiatric 
      Genetics Consortium. Cognitive measures that survived multiple testing correction 
      for association with the PGS were evaluated for mediation with ADHD using 
      structural equation models. RESULTS: Results were essentially identical in the 
      homogeneous European ancestry subgroup (n = 514) and in the full sample (N = 
      656). For the European population, the PGS was associated with ADHD diagnosis 
      (Nagelkerke R(2) = 0.045; β = 0.233, SE = 0.053, p = .000011) and multi-indicator 
      dimensional ADHD latent variables by parent report (β = 0.185, SE = 0.043) and 
      teacher report (β = 0.165, SE = 0.042). The PGS effect was statistically mediated 
      by working memory (indirect effect, β = 0.101, SE = 0.029, 95% CI = 0.05, 0.16, 
      p = .00049, 43% of genetic effect accounted for) and arousal/alertness (indirect 
      effect β = 0.115, 95% CI = 0.04, 0.20, SE = 0.041, p = .005, 49% of genetic 
      effect accounted for). CONCLUSION: This is the first clear demonstration from 
      molecular genetic data that working memory and arousal regulation are promising 
      cognitive endophenotypes for ADHD with regard to mediating genetic risk from 
      common genetic variants.
CI  - Copyright © 2018 American Academy of Child and Adolescent Psychiatry. Published 
      by Elsevier Inc. All rights reserved.
FAU - Nigg, Joel T
AU  - Nigg JT
AD  - Oregon Health and Science University, Portland. Electronic address: 
      niggj@ohsu.edu.
FAU - Gustafsson, Hanna C
AU  - Gustafsson HC
AD  - Oregon Health and Science University, Portland.
FAU - Karalunas, Sarah L
AU  - Karalunas SL
AD  - Oregon Health and Science University, Portland.
FAU - Ryabinin, Peter
AU  - Ryabinin P
AD  - Oregon Health and Science University, Portland.
FAU - McWeeney, Shannon K
AU  - McWeeney SK
AD  - Oregon Health and Science University, Portland.
FAU - Faraone, Stephen V
AU  - Faraone SV
AD  - State University of New York Upstate Medical University, Syracuse.
FAU - Mooney, Michael A
AU  - Mooney MA
AD  - Oregon Health and Science University, Portland.
FAU - Fair, Damien A
AU  - Fair DA
AD  - Oregon Health and Science University, Portland.
FAU - Wilmot, Beth
AU  - Wilmot B
AD  - Oregon Health and Science University, Portland.
LA  - eng
GR  - R01 MH099064/MH/NIMH NIH HHS/United States
GR  - R01 MH115357/MH/NIMH NIH HHS/United States
GR  - R37 MH059105/MH/NIMH NIH HHS/United States
GR  - U01 MH109536/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20180109
PL  - United States
TA  - J Am Acad Child Adolesc Psychiatry
JT  - Journal of the American Academy of Child and Adolescent Psychiatry
JID - 8704565
SB  - IM
CIN - J Am Acad Child Adolesc Psychiatry. 2018 Mar;57(3):146-148. PMID: 29496121
MH  - Arousal/*genetics
MH  - Attention Deficit Disorder with Hyperactivity/epidemiology/*genetics
MH  - Case-Control Studies
MH  - Child
MH  - *Endophenotypes
MH  - Executive Function/*physiology
MH  - Female
MH  - Humans
MH  - Male
MH  - Memory, Short-Term/*physiology
MH  - Multifactorial Inheritance/genetics
MH  - Neuropsychological Tests/statistics & numerical data
PMC - PMC6547382
MID - NIHMS1026836
OTO - NOTNLM
OT  - ADHD
OT  - endophenotype
OT  - executive function
OT  - polygenic score
OT  - working memory
COIS- Dr. Mooney reports no biomedical financial interests or potential conflicts of 
      interest. Dr. Fair reports no biomedical financial interests or potential 
      conflicts of interest. Dr. Wilmot reports no biomedical financial interests or 
      potential conflicts of interest Dr. Gustafsson reports no biomedical financial 
      interests or potential conflicts of interest. Dr. Karalunas reports no biomedical 
      financial interests or potential conflicts of interest. Dr. Ryabinin reports no 
      biomedical financial interests or potential conflicts of interest. Dr. McWeeney 
      reports no biomedical financial interests or potential conflicts of interest.
EDAT- 2018/03/03 06:00
MHDA- 2019/11/05 06:00
CRDT- 2018/03/03 06:00
PHST- 2017/06/02 00:00 [received]
PHST- 2017/12/19 00:00 [revised]
PHST- 2018/01/03 00:00 [accepted]
PHST- 2018/03/03 06:00 [entrez]
PHST- 2018/03/03 06:00 [pubmed]
PHST- 2019/11/05 06:00 [medline]
AID - S0890-8567(18)30002-9 [pii]
AID - 10.1016/j.jaac.2017.12.013 [doi]
PST - ppublish
SO  - J Am Acad Child Adolesc Psychiatry. 2018 Mar;57(3):175-182. doi: 
      10.1016/j.jaac.2017.12.013. Epub 2018 Jan 9.

PMID- 35879306
OWN - NLM
STAT- MEDLINE
DCOM- 20220727
LR  - 20230315
IS  - 2158-3188 (Electronic)
IS  - 2158-3188 (Linking)
VI  - 12
IP  - 1
DP  - 2022 Jul 25
TI  - Polygenic resilience scores capture protective genetic effects for Alzheimer's 
      disease.
PG  - 296
LID - 10.1038/s41398-022-02055-0 [doi]
LID - 296
AB  - Polygenic risk scores (PRSs) can boost risk prediction in late-onset Alzheimer's 
      disease (LOAD) beyond apolipoprotein E (APOE) but have not been leveraged to 
      identify genetic resilience factors. Here, we sought to identify 
      resilience-conferring common genetic variants in (1) unaffected individuals 
      having high PRSs for LOAD, and (2) unaffected APOE-ε4 carriers also having high 
      PRSs for LOAD. We used genome-wide association study (GWAS) to contrast 
      "resilient" unaffected individuals at the highest genetic risk for LOAD with LOAD 
      cases at comparable risk. From GWAS results, we constructed polygenic resilience 
      scores to aggregate the addictive contributions of risk-orthogonal common 
      variants that promote resilience to LOAD. Replication of resilience scores was 
      undertaken in eight independent studies. We successfully replicated two polygenic 
      resilience scores that reduce genetic risk penetrance for LOAD. We also showed 
      that polygenic resilience scores positively correlate with polygenic risk scores 
      in unaffected individuals, perhaps aiding in staving off disease. Our findings 
      align with the hypothesis that a combination of risk-independent common variants 
      mediates resilience to LOAD by moderating genetic disease risk.
CI  - © 2022. This is a U.S. Government work and not under copyright protection in the 
      US; foreign copyright protection may apply.
FAU - Hou, Jiahui
AU  - Hou J
AD  - Psychiatric Genetic Epidemiology & Neurobiology Laboratory (PsychGENe Lab), SUNY 
      Upstate Medical University, Syracuse, NY, USA.
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Syracuse, NY, USA.
AD  - Department of Neuroscience and Physiology, SUNY Upstate Medical University, 
      Syracuse, NY, USA.
FAU - Hess, Jonathan L
AU  - Hess JL
AUID- ORCID: 0000-0001-8406-632X
AD  - Psychiatric Genetic Epidemiology & Neurobiology Laboratory (PsychGENe Lab), SUNY 
      Upstate Medical University, Syracuse, NY, USA.
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Syracuse, NY, USA.
AD  - Department of Neuroscience and Physiology, SUNY Upstate Medical University, 
      Syracuse, NY, USA.
FAU - Armstrong, Nicola
AU  - Armstrong N
AD  - Mathematics and Statistics, Curtin University, Perth, WA, Australia.
FAU - Bis, Joshua C
AU  - Bis JC
AUID- ORCID: 0000-0002-3409-1110
AD  - Department of Medicine, Cardiovascular Health Research Unit, University of 
      Washington, Seattle, WA, USA.
FAU - Grenier-Boley, Benjamin
AU  - Grenier-Boley B
AD  - U1167-RID-AGE - Facteurs de risque et déterminants moléculaires des maladies 
      liées au vieillissement, Univ. Lille, Inserm, CHU Lille, Institut Pasteur Lille, 
      F-59000, Lille, France.
FAU - Karlsson, Ida K
AU  - Karlsson IK
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
AD  - Aging Research Network - Jönköping (ARN-J), School of Health and Welfare, 
      Jönköping University, Jönköping, Sweden.
FAU - Leonenko, Ganna
AU  - Leonenko G
AD  - Dementia Research Institute, School of Medicine, Cardiff University, Cardiff, UK.
FAU - Numbers, Katya
AU  - Numbers K
AD  - Centre for Healthy Brain Ageing (CHeBA), Discipline of Psychiatry and Mental 
      Health, Faculty of Medicine, University of New South Wales, Sydney, NSW, 
      Australia.
FAU - O'Brien, Eleanor K
AU  - O'Brien EK
AD  - Centre for Precision Health, Edith Cowan University, Joondalup, WA, Australia.
AD  - Collaborative Genomics and Translation Group, School of Medical and Health 
      Sciences, Edith Cowan University, Joondalup, WA, Australia.
FAU - Shadrin, Alexey
AU  - Shadrin A
AUID- ORCID: 0000-0002-7467-250X
AD  - NORMENT Centre, Division of Mental Health and Addiction, Oslo University Hospital 
      & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
FAU - Thalamuthu, Anbupalam
AU  - Thalamuthu A
AD  - Centre for Healthy Brain Ageing (CHeBA), Discipline of Psychiatry and Mental 
      Health, Faculty of Medicine, University of New South Wales, Sydney, NSW, 
      Australia.
FAU - Yang, Qiong
AU  - Yang Q
AUID- ORCID: 0000-0002-3658-1375
AD  - Department of Biostatistics, School of Public Health, Boston University, Boston, 
      MA, USA.
FAU - Andreassen, Ole A
AU  - Andreassen OA
AUID- ORCID: 0000-0002-4461-3568
AD  - NORMENT Centre, Division of Mental Health and Addiction, Oslo University Hospital 
      & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
FAU - Brodaty, Henry
AU  - Brodaty H
AUID- ORCID: 0000-0001-9487-6617
AD  - Centre for Healthy Brain Ageing (CHeBA), Discipline of Psychiatry and Mental 
      Health, Faculty of Medicine, University of New South Wales, Sydney, NSW, 
      Australia.
FAU - Gatz, Margaret
AU  - Gatz M
AUID- ORCID: 0000-0002-1071-9970
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
AD  - Center for Economic and Social Research, University of Southern California, Los 
      Angeles, CA, USA.
FAU - Kochan, Nicole A
AU  - Kochan NA
AD  - Centre for Healthy Brain Ageing (CHeBA), Discipline of Psychiatry and Mental 
      Health, Faculty of Medicine, University of New South Wales, Sydney, NSW, 
      Australia.
FAU - Lambert, Jean-Charles
AU  - Lambert JC
AUID- ORCID: 0000-0003-0829-7817
AD  - U1167-RID-AGE - Facteurs de risque et déterminants moléculaires des maladies 
      liées au vieillissement, Univ. Lille, Inserm, CHU Lille, Institut Pasteur Lille, 
      F-59000, Lille, France.
FAU - Laws, Simon M
AU  - Laws SM
AUID- ORCID: 0000-0002-4355-7082
AD  - Centre for Precision Health, Edith Cowan University, Joondalup, WA, Australia.
AD  - Collaborative Genomics and Translation Group, School of Medical and Health 
      Sciences, Edith Cowan University, Joondalup, WA, Australia.
FAU - Masters, Colin L
AU  - Masters CL
AD  - The Florey Institute, The University of Melbourne, Melbourne, VIC, Australia.
FAU - Mather, Karen A
AU  - Mather KA
AUID- ORCID: 0000-0003-4143-8941
AD  - Centre for Healthy Brain Ageing (CHeBA), Discipline of Psychiatry and Mental 
      Health, Faculty of Medicine, University of New South Wales, Sydney, NSW, 
      Australia.
AD  - Neuroscience Research Australia, Randwick, NSW, Australia.
FAU - Pedersen, Nancy L
AU  - Pedersen NL
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden.
FAU - Posthuma, Danielle
AU  - Posthuma D
AUID- ORCID: 0000-0001-7582-2365
AD  - Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive 
      Research, Amsterdam Neuroscience, Vrije Universiteit, Amsterdam, the Netherlands.
FAU - Sachdev, Perminder S
AU  - Sachdev PS
AUID- ORCID: 0000-0002-9595-3220
AD  - Centre for Healthy Brain Ageing (CHeBA), Discipline of Psychiatry and Mental 
      Health, Faculty of Medicine, University of New South Wales, Sydney, NSW, 
      Australia.
FAU - Williams, Julie
AU  - Williams J
AUID- ORCID: 0000-0002-4069-0259
AD  - Division of Psychological Medicine and Clinical Neurology and Medical Research 
      Council (MRC) Centre for Neuropsychiatric Genetics and Genomics, School of 
      Medicine, Cardiff University, Cardiff, UK.
CN  - Alzheimer’s Disease Neuroimaging Initiative
FAU - Fan, Chun Chieh
AU  - Fan CC
AUID- ORCID: 0000-0001-9437-2128
AD  - Department of Cognitive Science, University of California San Diego, La Jolla, 
      CA, USA.
FAU - Faraone, Stephen V
AU  - Faraone SV
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Syracuse, NY, USA.
AD  - Department of Neuroscience and Physiology, SUNY Upstate Medical University, 
      Syracuse, NY, USA.
FAU - Fennema-Notestine, Christine
AU  - Fennema-Notestine C
AD  - Departments of Psychiatry and Radiology, University of California San Diego, La 
      Jolla, CA, USA.
FAU - Lin, Shu-Ju
AU  - Lin SJ
AD  - Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.
FAU - Escott-Price, Valentina
AU  - Escott-Price V
AUID- ORCID: 0000-0003-1784-5483
AD  - Dementia Research Institute, School of Medicine, Cardiff University, Cardiff, UK.
AD  - Division of Psychological Medicine and Clinical Neurology and Medical Research 
      Council (MRC) Centre for Neuropsychiatric Genetics and Genomics, School of 
      Medicine, Cardiff University, Cardiff, UK.
FAU - Holmans, Peter
AU  - Holmans P
AUID- ORCID: 0000-0003-0870-9412
AD  - Division of Psychological Medicine and Clinical Neurology and Medical Research 
      Council (MRC) Centre for Neuropsychiatric Genetics and Genomics, School of 
      Medicine, Cardiff University, Cardiff, UK.
FAU - Seshadri, Sudha
AU  - Seshadri S
AD  - Department of Neurology, School of Medicine, Boston University, Boston, MA, USA.
FAU - Tsuang, Ming T
AU  - Tsuang MT
AUID- ORCID: 0000-0002-0076-5340
AD  - Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.
FAU - Kremen, William S
AU  - Kremen WS
AD  - Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.
FAU - Glatt, Stephen J
AU  - Glatt SJ
AUID- ORCID: 0000-0002-0360-7567
AD  - Psychiatric Genetic Epidemiology & Neurobiology Laboratory (PsychGENe Lab), SUNY 
      Upstate Medical University, Syracuse, NY, USA. stephen.glatt@psychgenelab.com.
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Syracuse, NY, USA. stephen.glatt@psychgenelab.com.
AD  - Department of Neuroscience and Physiology, SUNY Upstate Medical University, 
      Syracuse, NY, USA. stephen.glatt@psychgenelab.com.
AD  - Department of Public Health and Preventive Medicine, SUNY Upstate Medical 
      University, Syracuse, NY, USA. stephen.glatt@psychgenelab.com.
LA  - eng
GR  - MC_PC_17112/MRC_/Medical Research Council/United Kingdom
GR  - G0902227/MRC_/Medical Research Council/United Kingdom
GR  - R01AG054002/AG/NIA NIH HHS/United States
GR  - R01 AG064955/AG/NIA NIH HHS/United States
GR  - R01AG064955/AG/NIA NIH HHS/United States
GR  - MR/L010305/1/MRC_/Medical Research Council/United Kingdom
GR  - G0300429/MRC_/Medical Research Council/United Kingdom
GR  - R01 AG076838/AG/NIA NIH HHS/United States
GR  - MR/L023784/2/MRC_/Medical Research Council/United Kingdom
GR  - MR/L501517/1/MRC_/Medical Research Council/United Kingdom
GR  - MR/T04604X/1/MRC_/Medical Research Council/United Kingdom
GR  - R01 MH116037/MH/NIMH NIH HHS/United States
GR  - R01 HL105756/HL/NHLBI NIH HHS/United States
GR  - MR/K013041/1/MRC_/Medical Research Council/United Kingdom
GR  - U01 AR076092/AR/NIAMS NIH HHS/United States
GR  - R01 AG050595/AG/NIA NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20220725
PL  - United States
TA  - Transl Psychiatry
JT  - Translational psychiatry
JID - 101562664
RN  - 0 (Apolipoprotein E4)
RN  - 0 (Apolipoproteins E)
SB  - IM
MH  - *Alzheimer Disease/genetics
MH  - Apolipoprotein E4/genetics
MH  - Apolipoproteins E/genetics
MH  - Genetic Predisposition to Disease
MH  - Genome-Wide Association Study
MH  - Humans
MH  - Multifactorial Inheritance
MH  - Risk Factors
PMC - PMC9314356
COIS- OAA is a consultant to HealthLytix. SVF in the past year, received income, 
      potential income, travel expenses continuing education support and/or research 
      support from Aardvark, Akili, Genomind, Ironshore, KemPharm/Corium, Noven, 
      Ondosis, Otsuka, Rhodes, Supernus, Takeda, Tris, and Vallon. With his 
      institution, he has US patent US20130217707 A1 for the use of sodium-hydrogen 
      exchange inhibitors in the treatment of ADHD. In previous years, he received 
      support from: Alcobra, Arbor, Aveksham, CogCubed, Eli Lilly, Enzymotec, Impact, 
      Janssen, Lundbeck/Takeda, McNeil, NeuroLifeSciences, Neurovance, Novartis, 
      Pfizer, Shire, and Sunovion. He also receives royalties from books published by 
      Guilford Press: Straight Talk about Your Child’s Mental Health; Oxford University 
      Press: Schizophrenia: The Facts; and Elsevier: ADHD: Non-Pharmacologic 
      Interventions. He is also Program Director of www.adhdinadults.com. He is 
      supported by the European Union’s Horizon 2020 research and innovation programme 
      under grant agreement No 965381; NIMH grants U01AR076092-01A1, 1R21MH1264940, 
      R01MH116037; Oregon Health and Science University, Otsuka Pharmaceuticals, Noven 
      Pharmaceuticals Incorporated, and Supernus Pharmaceutical Company. The remaining 
      authors declare no competing interests.
EDAT- 2022/07/26 06:00
MHDA- 2022/07/28 06:00
CRDT- 2022/07/25 23:15
PHST- 2022/06/16 00:00 [received]
PHST- 2022/07/01 00:00 [accepted]
PHST- 2022/06/23 00:00 [revised]
PHST- 2022/07/25 23:15 [entrez]
PHST- 2022/07/26 06:00 [pubmed]
PHST- 2022/07/28 06:00 [medline]
AID - 10.1038/s41398-022-02055-0 [pii]
AID - 2055 [pii]
AID - 10.1038/s41398-022-02055-0 [doi]
PST - epublish
SO  - Transl Psychiatry. 2022 Jul 25;12(1):296. doi: 10.1038/s41398-022-02055-0.

PMID- 38027708
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231201
IS  - 2405-8440 (Print)
IS  - 2405-8440 (Electronic)
IS  - 2405-8440 (Linking)
VI  - 9
IP  - 11
DP  - 2023 Nov
TI  - Multidrug-resistant Escherichia coli isolated from patients and surrounding 
      hospital environments in Bangladesh: A molecular approach for the determination 
      of pathogenicity and resistance.
PG  - e22109
LID - 10.1016/j.heliyon.2023.e22109 [doi]
LID - e22109
AB  - Extended spectrum β-lactamase producing Escherichia coli (ESBL E. coli) is a 
      primary concern for hospital and community healthcare settings, often linked to 
      an increased incidence of nosocomial infections. This study investigated the 
      characteristics of ESBL E. coli isolated from hospital environments and clinical 
      samples. In total, 117 ESBL E. coli isolates were obtained. The isolates were 
      subjected to molecular analysis for the presence of resistance and virulence 
      genes, antibiotic susceptibility testing, quantitative adherence assay, ERIC-PCR 
      for phylogenetic analysis and whole genome sequencing of four highly drug 
      resistant isolates. Out of the 117 isolates, 68.4% were positive for bla(CTX-M), 
      39.3% for bla(TEM), 30.8% for bla(NDM-1), 13.7% for bla(OXA) and 1.7% for 
      bla(SHV) gene. Upon screening for diarrheagenic genes, no isolates were found to 
      harbour any of the tested genes. In the case of extraintestinal pathogenic E. 
      coli (ExPEC) virulence factors, 7.6%, 11%, 5.9%, 4.3% and 21.2% of isolates 
      harbored the focG, kpsMII, sfaS, afa and iutA genes, respectively. At a 
      temperature of 25°C, 14.5% of isolates exhibited strong biofilm formation with 
      21.4% and 28.2% exhibiting moderate and weak biofilm formation respectively, 
      whereas 35.9% were non-biofilm formers. On the other hand at 37°C, 2.6% of 
      isolates showed strong biofilm formation with 3.4% and 31.6% showing moderate and 
      weak biofilm formation respectively, whereas, 62.4% were non-biofilm formers. 
      Regarding antibiotic susceptibility testing, all isolates were found to be 
      multidrug-resistant (MDR), with 30 isolates being highly drug resistant. ERIC-PCR 
      resulted in 12 clusters, with cluster E-10 containing the maximum number of 
      isolates. Hierarchical clustering and correlation analysis revealed associations 
      between environmental and clinical isolates, indicating likely transmission and 
      dissemination from the hospital environment to the patients. The whole genome 
      sequencing of four highly drug resistant ExPEC isolates showed the presence of 
      various antimicrobial resistance genes, virulence factors and mobile genetic 
      elements, with isolates harbouring the plasmid incompatibility group IncF (FII, 
      FIB, FIA). The sequenced isolates were identified as human pathogens with a 93.3% 
      average score. This study suggests that ESBL producing E. coli are prevalent in 
      the healthcare settings of Bangladesh, acting as a potential reservoir for AMR 
      bacteria. This information may have a profound effect on treatment, and 
      improvements in public healthcare policies are a necessity to combat the 
      increased incidences of hospital-acquired infections in the country.
CI  - © 2023 The Authors.
FAU - Moniruzzaman, M
AU  - Moniruzzaman M
AD  - Laboratory of Environmental Health, Health Systems and Population Studies 
      Division, International Centre for Diarrhoeal Disease Research, Bangladesh 
      (icddr,b), Dhaka 1212, Bangladesh.
AD  - Department of Microbiology, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.
FAU - Hussain, Mohammed Tanveer
AU  - Hussain MT
AD  - Laboratory of Environmental Health, Health Systems and Population Studies 
      Division, International Centre for Diarrhoeal Disease Research, Bangladesh 
      (icddr,b), Dhaka 1212, Bangladesh.
AD  - Microbiology Program, Department of Mathematics and Natural Sciences, BRAC 
      University, Mohakhali-66, Dhaka, Bangladesh.
FAU - Ali, Sobur
AU  - Ali S
AD  - Laboratory of Environmental Health, Health Systems and Population Studies 
      Division, International Centre for Diarrhoeal Disease Research, Bangladesh 
      (icddr,b), Dhaka 1212, Bangladesh.
AD  - Burnett School of Biomedical Sciences, University of Central Florida, Orlando, 
      FL, USA.
FAU - Hossain, Monir
AU  - Hossain M
AD  - Laboratory of Environmental Health, Health Systems and Population Studies 
      Division, International Centre for Diarrhoeal Disease Research, Bangladesh 
      (icddr,b), Dhaka 1212, Bangladesh.
AD  - Department of Microbiology and Immunology, SUNY Upstate Medical University, 
      Syracuse, NY 13210, USA.
FAU - Hossain, Md Sakib
AU  - Hossain MS
AD  - Laboratory of Environmental Health, Health Systems and Population Studies 
      Division, International Centre for Diarrhoeal Disease Research, Bangladesh 
      (icddr,b), Dhaka 1212, Bangladesh.
FAU - Alam, Mohammad Atique Ul
AU  - Alam MAU
AD  - Laboratory of Environmental Health, Health Systems and Population Studies 
      Division, International Centre for Diarrhoeal Disease Research, Bangladesh 
      (icddr,b), Dhaka 1212, Bangladesh.
FAU - Galib, Faisal Chowdhury
AU  - Galib FC
AD  - Laboratory of Environmental Health, Health Systems and Population Studies 
      Division, International Centre for Diarrhoeal Disease Research, Bangladesh 
      (icddr,b), Dhaka 1212, Bangladesh.
FAU - Islam, Md Tamzid
AU  - Islam MT
AD  - Laboratory of Environmental Health, Health Systems and Population Studies 
      Division, International Centre for Diarrhoeal Disease Research, Bangladesh 
      (icddr,b), Dhaka 1212, Bangladesh.
AD  - Department of Biostatistics & Data Science, University of Kansas Medical Center, 
      Kansas City, USA.
FAU - Paul, Partha
AU  - Paul P
AD  - BCSIR Rajshahi Laboratories, Bangladesh Council of Scientific and Industrial 
      Research, Dhaka, Bangladesh.
FAU - Islam, Md Shafiqul
AU  - Islam MS
AD  - Laboratory of Environmental Health, Health Systems and Population Studies 
      Division, International Centre for Diarrhoeal Disease Research, Bangladesh 
      (icddr,b), Dhaka 1212, Bangladesh.
FAU - Siddiqee, Mahbubul H
AU  - Siddiqee MH
AD  - Microbiology Program, Department of Mathematics and Natural Sciences, BRAC 
      University, Mohakhali-66, Dhaka, Bangladesh.
FAU - Mondal, Dinesh
AU  - Mondal D
AD  - Laboratory of Environmental Health, Health Systems and Population Studies 
      Division, International Centre for Diarrhoeal Disease Research, Bangladesh 
      (icddr,b), Dhaka 1212, Bangladesh.
FAU - Parveen, Shahana
AU  - Parveen S
AD  - Emerging Infections, Infectious Diseases Division, International Centre for 
      Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka 1212, Bangladesh.
FAU - Mahmud, Zahid Hayat
AU  - Mahmud ZH
AD  - Laboratory of Environmental Health, Health Systems and Population Studies 
      Division, International Centre for Diarrhoeal Disease Research, Bangladesh 
      (icddr,b), Dhaka 1212, Bangladesh.
LA  - eng
PT  - Journal Article
DEP - 20231107
PL  - England
TA  - Heliyon
JT  - Heliyon
JID - 101672560
PMC - PMC10679508
OTO - NOTNLM
OT  - Antibiotic resistance
OT  - Biofilm
OT  - E. coli
OT  - ESBL
OT  - ExPEC
OT  - Hospital environments
OT  - Whole genome sequencing (WGS)
COIS- The authors declare that they have no known competing financial interests or 
      personal relationships that could have appeared to influence the work reported in 
      this paper.
EDAT- 2023/11/29 18:42
MHDA- 2023/11/29 18:43
CRDT- 2023/11/29 17:07
PHST- 2023/03/18 00:00 [received]
PHST- 2023/09/08 00:00 [revised]
PHST- 2023/11/04 00:00 [accepted]
PHST- 2023/11/29 18:43 [medline]
PHST- 2023/11/29 18:42 [pubmed]
PHST- 2023/11/29 17:07 [entrez]
AID - S2405-8440(23)09317-9 [pii]
AID - e22109 [pii]
AID - 10.1016/j.heliyon.2023.e22109 [doi]
PST - epublish
SO  - Heliyon. 2023 Nov 7;9(11):e22109. doi: 10.1016/j.heliyon.2023.e22109. eCollection 
      2023 Nov.

PMID- 36741580
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230207
IS  - 1664-0640 (Print)
IS  - 1664-0640 (Electronic)
IS  - 1664-0640 (Linking)
VI  - 13
DP  - 2022
TI  - Editorial: Precision medicine approaches for heterogeneous conditions such as 
      autism spectrum disorders (The need for a biomarker exploration phase in clinical 
      trials - Phase 2m).
PG  - 1079006
LID - 10.3389/fpsyt.2022.1079006 [doi]
LID - 1079006
FAU - Beversdorf, David Q
AU  - Beversdorf DQ
AD  - Departments of Radiology, Neurology, and Psychological Sciences, William and 
      Nancy Thompson Endowed Chair in Radiology, University of Missouri, Columbia, MO, 
      United States.
FAU - Anagnostou, Evdokia
AU  - Anagnostou E
AD  - Holland Bloorview Kids Rehabilitation Hospital, University of Toronto, Toronto, 
      ON, Canada.
FAU - Hardan, Antonio
AU  - Hardan A
AD  - Division of Child and Adolescent Psychiatry, Department of Psychiatry and 
      Behavioral Sciences, Stanford University, Stanford, CA, United States.
FAU - Wang, Paul
AU  - Wang P
AD  - Clinical Research Associates LLC, Simons Foundation, Department of Pediatrics, 
      Yale University School of Medicine, New Haven, CT, United States.
FAU - Erickson, Craig A
AU  - Erickson CA
AD  - Division of Child and Adolescent Psychiatry, Cincinnati Children's Hospital 
      Medical Center, Cincinnati, OH, United States.
AD  - Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati 
      College of Medicine, Cincinnati, OH, United States.
FAU - Frazier, Thomas W
AU  - Frazier TW
AD  - Department of Psychology, John Carroll University, University Heights, OH, United 
      States.
AD  - Department of Pediatrics, State University of New York Upstate Medical 
      University, Syracuse, NY, United States.
FAU - Veenstra-VanderWeele, Jeremy
AU  - Veenstra-VanderWeele J
AD  - Departments of Psychiatry and Pediatrics, New York State Psychiatric Institute, 
      Columbia University, New York, NY, United States.
AD  - NewYork-Presbyterian Center for Autism and the Developing Brain, New York, NY, 
      United States.
LA  - eng
PT  - Editorial
DEP - 20230119
PL  - Switzerland
TA  - Front Psychiatry
JT  - Frontiers in psychiatry
JID - 101545006
CON - Editorial on the Research Topic Precision medicine approaches for heterogeneous 
      conditions such as autism spectrum disorders (The need for a biomarker 
      exploration phase in clinical trials - Phase 2m)
PMC - PMC9893852
OTO - NOTNLM
OT  - autism (ASD)
OT  - biomarkers
OT  - genetics
OT  - heterogeneity
OT  - treatment
COIS- DB consultant for YAMO Pharma, Impel Pharma, Scioto Biosci, Quadrant Biosci, 
      Stalicla Biosci, and Human Health. EA received consultation fees from F. 
      Hoffmann-La Roche AG Pharmaceuticals, Impel neuropharma, Cell-El Therapeutics 
      Ltd., ONO Pharma USA, Inc.; research funding from Roche, Anavex and 
      Sanofi-Aventis, and SynapDx; in kind supports from AMO pharma and CRA; editorial 
      honoraria from Wiley; book royalties from Springer and APPI, and has served on 
      advisory boards at Roche and Quadrant Biosciences. AH consultant for IAMA 
      Therapeutics, Jazz Pharmaceuticals, and Beaming Health. Has equity options in 
      Quadrant Biosciences and has an investor stake in SCAN-R LLC. PW is an employee 
      of Clinical Research Associates, LLC. CE consultant to Scioto Bioscience, Forge, 
      and Stalicla. Nothing else to report. None of my consulting is related directly 
      to the content of this Frontiers manuscript. TF has received funding or research 
      support from, acted as a consultant to, received travel support from, and/or 
      received a speaker's honorarium from the PTEN Research Foundation, SYNGAP 
      Research Fund, Malan Syndrome Foundation, ADNP Kids Research Foundation, Quadrant 
      Biosciences, Autism Speaks, Impel NeuroPharma, F. Hoffmann-La Roche AG 
      Pharmaceuticals, the Cole Family Research Fund, Simons Foundation, Ingalls 
      Foundation, Forest Laboratories, Ecoeos, IntegraGen, Kugona LLC, Shire 
      Development, Bristol-Myers Squibb, Roche Pharma, MaraBio, National Institutes of 
      Health, and the Brain and Behavior Research Foundation, has equity options in 
      Quadrant Biosciences and MaraBio, and has an investor stake in Autism EYES LLC 
      and iSCAN-R. JV-V received research funding from NIH, Simons Foundation, Roche, 
      Janssen, Novartis, Seaside Therapeutics, Acadia, Yamo, MapLight, and SynapDx. 
      Advisory board or consulting with Simons Foundation, Autism Speaks, Brain 
      Behavior Research Foundation, Roche, and Novartis. Editorial stipend from Wiley.
EDAT- 2023/02/07 06:00
MHDA- 2023/02/07 06:01
CRDT- 2023/02/06 03:33
PHST- 2022/10/24 00:00 [received]
PHST- 2022/12/13 00:00 [accepted]
PHST- 2023/02/06 03:33 [entrez]
PHST- 2023/02/07 06:00 [pubmed]
PHST- 2023/02/07 06:01 [medline]
AID - 10.3389/fpsyt.2022.1079006 [doi]
PST - epublish
SO  - Front Psychiatry. 2023 Jan 19;13:1079006. doi: 10.3389/fpsyt.2022.1079006. 
      eCollection 2022.

PMID- 32826963
OWN - NLM
STAT- MEDLINE
DCOM- 20210315
LR  - 20210315
IS  - 1476-5578 (Electronic)
IS  - 1359-4184 (Linking)
VI  - 25
IP  - 11
DP  - 2020 Nov
TI  - Integrative analyses prioritize GNL3 as a risk gene for bipolar disorder.
PG  - 2672-2684
LID - 10.1038/s41380-020-00866-5 [doi]
AB  - Genome-wide association studies (GWASs) have identified numerous single 
      nucleotide polymorphisms (SNPs) associated with bipolar disorder (BD), but what 
      the causal variants are and how they contribute to BD is largely unknown. In this 
      study, we used FUMA, a GWAS annotation tool, to pinpoint potential causal 
      variants and genes from the latest BD GWAS findings, and performed integrative 
      analyses, including brain expression quantitative trait loci (eQTL), gene 
      coexpression network, differential gene expression, protein-protein interaction, 
      and brain intermediate phenotype association analysis to identify the functions 
      of a prioritized gene and its connection to BD. Convergent lines of evidence 
      prioritized protein-coding gene G Protein Nucleolar 3 (GNL3) as a BD risk gene, 
      with integrative analyses revealing GNL3's roles in cell proliferation, neuronal 
      functions, and brain phenotypes. We experimentally revealed that BD-related eQTL 
      SNPs rs10865973, rs12635140, and rs4687644 regulate GNL3 expression using dual 
      luciferase reporter assay and CRISPR interference experiment in human neural 
      progenitor cells. We further identified that GNL3 knockdown and overexpression 
      led to aberrant neuronal proliferation and differentiation, using two-dimensional 
      human neural cell cultures and three-dimensional forebrain organoid model. This 
      study gathers evidence that BD-related genetic variants regulate GNL3 expression 
      which subsequently affects neuronal proliferation and differentiation.
FAU - Meng, Qingtuan
AU  - Meng Q
AUID- ORCID: 0000-0002-6421-162X
AD  - Guangxi Clinical Research Center for Neurological Diseases, Affiliated Hospital 
      of Guilin Medical University, 541001, Guilin, Guangxi, China. 
      mengqingtuan@glmc.edu.cn.
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, Central South University, 410008, Changsha, Hunan, China. 
      mengqingtuan@glmc.edu.cn.
AD  - Guangxi Key Laboratory of Brain and Cognitive Neuroscience, Guilin Medical 
      University, 541001, Guilin, Guangxi, China. mengqingtuan@glmc.edu.cn.
FAU - Wang, Le
AU  - Wang L
AUID- ORCID: 0000-0002-6825-6614
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, Central South University, 410008, Changsha, Hunan, China.
AD  - Department of Neuroscience and Cell Biology, Child Health Institute of New 
      Jersey, , Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, 08901, 
      USA.
FAU - Dai, Rujia
AU  - Dai R
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, Central South University, 410008, Changsha, Hunan, China.
AD  - Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, 13210, 
      USA.
FAU - Wang, Jiawen
AU  - Wang J
AD  - Guangxi Clinical Research Center for Neurological Diseases, Affiliated Hospital 
      of Guilin Medical University, 541001, Guilin, Guangxi, China.
AD  - Guangxi Key Laboratory of Brain and Cognitive Neuroscience, Guilin Medical 
      University, 541001, Guilin, Guangxi, China.
FAU - Ren, Zongyao
AU  - Ren Z
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, Central South University, 410008, Changsha, Hunan, China.
FAU - Liu, Sihan
AU  - Liu S
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, Central South University, 410008, Changsha, Hunan, China.
FAU - Xia, Yan
AU  - Xia Y
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, Central South University, 410008, Changsha, Hunan, China.
AD  - Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, 13210, 
      USA.
FAU - Jiang, Yi
AU  - Jiang Y
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, Central South University, 410008, Changsha, Hunan, China.
AD  - Department of Molecular Physiology & Biophysics, Vanderbilt University, 
      Nashville, TN, 37212, USA.
FAU - Duan, Fangyuan
AU  - Duan F
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, Central South University, 410008, Changsha, Hunan, China.
FAU - Wang, Kangli
AU  - Wang K
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, Central South University, 410008, Changsha, Hunan, China.
FAU - Liu, Chunyu
AU  - Liu C
AUID- ORCID: 0000-0002-5986-4415
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, Central South University, 410008, Changsha, Hunan, China. 
      liuch@upstate.edu.
AD  - Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, 13210, 
      USA. liuch@upstate.edu.
AD  - School of Psychology, Shaanxi Normal University, 710000, Xi'an, Shaanxi, China. 
      liuch@upstate.edu.
FAU - Chen, Chao
AU  - Chen C
AUID- ORCID: 0000-0002-5114-2282
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, Central South University, 410008, Changsha, Hunan, China. 
      chenchao@sklmg.edu.cn.
AD  - National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, 
      Central South University, 410008, Changsha, Hunan, China. chenchao@sklmg.edu.cn.
AD  - Hunan Key Laboratory of Animal Models for Human Diseases, Central South 
      University, 410008, Changsha, Hunan, China. chenchao@sklmg.edu.cn.
AD  - Hunan Key Laboratory of Molecular Precision Medicine, Central South University, 
      410008, Changsha, Hunan, China. chenchao@sklmg.edu.cn.
LA  - eng
GR  - U01 MH103340/MH/NIMH NIH HHS/United States
GR  - R01 ES024988/ES/NIEHS NIH HHS/United States
GR  - U01 MH103392/MH/NIMH NIH HHS/United States
GR  - U01 MH103365/MH/NIMH NIH HHS/United States
GR  - U01 MH103346/MH/NIMH NIH HHS/United States
GR  - U01 MH103339/MH/NIMH NIH HHS/United States
GR  - R21 MH109956/MH/NIMH NIH HHS/United States
GR  - R21 MH105881/MH/NIMH NIH HHS/United States
GR  - R21 MH105853/MH/NIMH NIH HHS/United States
GR  - R21 MH103877/MH/NIMH NIH HHS/United States
GR  - R21 MH102791/MH/NIMH NIH HHS/United States
GR  - R01 MH111721/MH/NIMH NIH HHS/United States
GR  - R01 MH110928/MH/NIMH NIH HHS/United States
GR  - R01 MH110927/MH/NIMH NIH HHS/United States
GR  - R01 MH110926/MH/NIMH NIH HHS/United States
GR  - R01 MH110921/MH/NIMH NIH HHS/United States
GR  - R01 MH110920/MH/NIMH NIH HHS/United States
GR  - R01 MH110905/MH/NIMH NIH HHS/United States
GR  - R01 MH109715/MH/NIMH NIH HHS/United States
GR  - R01 MH109677/MH/NIMH NIH HHS/United States
GR  - R01 MH105898/MH/NIMH NIH HHS/United States
GR  - R01 MH094714/MH/NIMH NIH HHS/United States
GR  - P50 MH106934/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20200821
PL  - England
TA  - Mol Psychiatry
JT  - Molecular psychiatry
JID - 9607835
RN  - 0 (GNL3 protein, human)
RN  - 0 (Nuclear Proteins)
RN  - EC 3.6.1.- (GTP-Binding Proteins)
SB  - IM
MH  - Bipolar Disorder/*genetics
MH  - GTP-Binding Proteins/*genetics
MH  - Genetic Predisposition to Disease/*genetics
MH  - Genome-Wide Association Study
MH  - Humans
MH  - Nuclear Proteins/*genetics
MH  - Polymorphism, Single Nucleotide/genetics
MH  - Quantitative Trait Loci/genetics
EDAT- 2020/08/23 06:00
MHDA- 2021/03/16 06:00
CRDT- 2020/08/23 06:00
PHST- 2020/01/16 00:00 [received]
PHST- 2020/08/06 00:00 [accepted]
PHST- 2020/07/30 00:00 [revised]
PHST- 2020/08/23 06:00 [pubmed]
PHST- 2021/03/16 06:00 [medline]
PHST- 2020/08/23 06:00 [entrez]
AID - 10.1038/s41380-020-00866-5 [pii]
AID - 10.1038/s41380-020-00866-5 [doi]
PST - ppublish
SO  - Mol Psychiatry. 2020 Nov;25(11):2672-2684. doi: 10.1038/s41380-020-00866-5. Epub 
      2020 Aug 21.

PMID- 32418989
OWN - NLM
STAT- MEDLINE
DCOM- 20210427
LR  - 20220210
IS  - 1530-0366 (Electronic)
IS  - 1098-3600 (Linking)
VI  - 22
IP  - 8
DP  - 2020 Aug
TI  - Implementation of population-based newborn screening reveals low incidence of 
      spinal muscular atrophy.
PG  - 1296-1302
LID - 10.1038/s41436-020-0824-3 [doi]
AB  - PURPOSE: Spinal muscular atrophy (SMA) was added to the Recommended Uniform 
      Screening Panel (RUSP) in July 2018, following FDA approval of the first 
      effective SMA treatment, and demonstration of feasibility of high-throughput 
      newborn screening using a primary molecular assay. SMA newborn screening was 
      implemented in New York State (NYS) on 1 October 2018. METHODS: Screening was 
      conducted using DNA extracted from dried blood spots with a multiplex real-time 
      quantitative polymerase chain reaction (qPCR) assay targeting the recurrent SMN1 
      exon 7 gene deletion. RESULTS: During the first year, 225,093 infants were 
      tested. Eight screened positive, were referred for follow-up, and confirmed to be 
      homozygous for the deletion. Infants with two or three copies of the SMN2 gene, 
      predicting more severe, earlier-onset SMA, were treated with antisense 
      oligonucleotide and/or gene therapy. One infant with ≥4 copies SMN2 also received 
      gene therapy. CONCLUSION: Newborn screening permits presymptomatic SMA diagnosis, 
      when treatment initiation is most beneficial. At 1 in 28,137 (95% confidence 
      interval [CI]: 1 in 14,259 to 55,525), the NYS SMA incidence is 2.6- to 4.7-fold 
      lower than expected. The low SMA incidence is likely attributable to imprecise 
      and biased estimates, coupled with increased awareness, access to and uptake of 
      carrier screening, genetic counseling, cascade testing, prenatal diagnosis, and 
      advanced reproductive technologies.
FAU - Kay, Denise M
AU  - Kay DM
AUID- ORCID: 0000-0002-9928-2698
AD  - Newborn Screening Program, Division of Genetics, Wadsworth Center, New York State 
      Department of Health, Albany, NY, USA. denise.kay@health.ny.gov.
FAU - Stevens, Colleen F
AU  - Stevens CF
AD  - Newborn Screening Program, Division of Genetics, Wadsworth Center, New York State 
      Department of Health, Albany, NY, USA.
FAU - Parker, April
AU  - Parker A
AD  - Newborn Screening Program, Division of Genetics, Wadsworth Center, New York State 
      Department of Health, Albany, NY, USA.
FAU - Saavedra-Matiz, Carlos A
AU  - Saavedra-Matiz CA
AD  - Newborn Screening Program, Division of Genetics, Wadsworth Center, New York State 
      Department of Health, Albany, NY, USA.
FAU - Sack, Virginia
AU  - Sack V
AD  - Newborn Screening Program, Division of Genetics, Wadsworth Center, New York State 
      Department of Health, Albany, NY, USA.
FAU - Chung, Wendy K
AU  - Chung WK
AD  - Department of Pediatrics, Columbia University, New York, NY, USA.
AD  - Department of Medicine, Columbia University, New York, NY, USA.
FAU - Chiriboga, Claudia A
AU  - Chiriboga CA
AD  - Division of Child Neurology, Department of Neurology, Columbia University, New 
      York, NY, USA.
FAU - Engelstad, Kristin
AU  - Engelstad K
AD  - Division of Child Neurology, Department of Neurology, Columbia University, New 
      York, NY, USA.
FAU - Laureta, Emma
AU  - Laureta E
AD  - Cohen Children's Medical Center, New Hyde Park, NY, USA.
FAU - Farooq, Osman
AU  - Farooq O
AD  - Department of Neurology, Jacobs School of Medicine & Biomedical Sciences, 
      University of Buffalo, Buffalo, NY, USA.
FAU - Ciafaloni, Emma
AU  - Ciafaloni E
AD  - Department of Neurology, University of Rochester, Rochester, NY, USA.
FAU - Lee, Bo Hoon
AU  - Lee BH
AD  - Department of Neurology, University of Rochester, Rochester, NY, USA.
FAU - Malek, Sohail
AU  - Malek S
AD  - Albany Medical Center, Albany, NY, USA.
FAU - Treidler, Simona
AU  - Treidler S
AD  - Department of Neurology, Renaissance School of Medicine, Stony Brook University, 
      Stony Brook, NY, USA.
FAU - Anziska, Yaacov
AU  - Anziska Y
AD  - SUNY Downstate Medical Center, Brooklyn, NY, USA.
FAU - Delfiner, Leslie
AU  - Delfiner L
AD  - Montefiore Medical Center, Bronx, NY, USA.
FAU - Sakonju, Ai
AU  - Sakonju A
AD  - SUNY Upstate Medical Center, Syracuse, NY, USA.
FAU - Caggana, Michele
AU  - Caggana M
AD  - Newborn Screening Program, Division of Genetics, Wadsworth Center, New York State 
      Department of Health, Albany, NY, USA.
LA  - eng
GR  - 6 NU88EH001319-01-01/CC/CDC HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, P.H.S.
DEP - 20200518
PL  - United States
TA  - Genet Med
JT  - Genetics in medicine : official journal of the American College of Medical 
      Genetics
JID - 9815831
RN  - 0 (Survival of Motor Neuron 1 Protein)
SB  - IM
CIN - Genet Med. 2020 Nov;22(11):1913-1914. PMID: 32601389
MH  - Female
MH  - Homozygote
MH  - Humans
MH  - Incidence
MH  - Infant
MH  - Infant, Newborn
MH  - *Muscular Atrophy, Spinal/diagnosis/epidemiology/genetics
MH  - *Neonatal Screening
MH  - New York
MH  - Pregnancy
MH  - Survival of Motor Neuron 1 Protein/genetics
OTO - NOTNLM
OT  - Recommended Uniform Screening Panel (RUSP)
OT  - SMN1
OT  - carrier screening
OT  - newborn screening (NBS)
OT  - spinal muscular atrophy (SMA)
EDAT- 2020/05/19 06:00
MHDA- 2021/04/28 06:00
CRDT- 2020/05/19 06:00
PHST- 2020/03/25 00:00 [received]
PHST- 2020/04/26 00:00 [accepted]
PHST- 2020/05/19 06:00 [pubmed]
PHST- 2021/04/28 06:00 [medline]
PHST- 2020/05/19 06:00 [entrez]
AID - S1098-3600(21)00703-6 [pii]
AID - 10.1038/s41436-020-0824-3 [doi]
PST - ppublish
SO  - Genet Med. 2020 Aug;22(8):1296-1302. doi: 10.1038/s41436-020-0824-3. Epub 2020 
      May 18.

PMID- 33588020
OWN - NLM
STAT- MEDLINE
DCOM- 20220124
LR  - 20220124
IS  - 1872-7549 (Electronic)
IS  - 0166-4328 (Linking)
VI  - 405
DP  - 2021 May 7
TI  - Effects of handling on the behavioural phenotype of the neuregulin 1 type III 
      transgenic mouse model for schizophrenia.
PG  - 113166
LID - S0166-4328(21)00053-X [pii]
LID - 10.1016/j.bbr.2021.113166 [doi]
AB  - Handling of laboratory mice affects animal wellbeing and behavioural test 
      outcomes. However, present research has focused on handling effects in common 
      strains of laboratory mice despite the knowledge that environmental factors can 
      modify established phenotypes of genetic mouse models. Thus, we examined the 
      impact of handling on the face validity of a transgenic mouse model for the 
      schizophrenia risk gene neuregulin 1 (i.e. Nrg1 type III overexpression). Nrg1 
      III tg and wild type-like (WT) control mice of both sexes underwent tail or 
      tunnel handling before being assessed in the open field (OF), elevated plus maze 
      (EPM), social preference/novelty, prepulse inhibition, and fear conditioning 
      tests. Tunnel-handling reduced the startle response in all mice, increased OF 
      locomotion and exploration in males and reduced anxiety in males (OF) and females 
      (EPM) compared to tail-handling. Importantly, tunnel handling induced a more 
      pronounced startle response to increasing startle stimuli in Nrg1 III tg females 
      compared to respective controls, a phenomenon absent in tail-handled females. 
      Finally, Nrg1 III tg males displayed reduced OF exploration and centre locomotion 
      and Nrg1 III tg females displayed increased cue freezing over time compared to 
      controls. In conclusion, handling methods have a significant impact on a variety 
      of behavioural domains thus the impact of routine handling procedures need be 
      considered when testing behavioural phenotypes. Handling did not change the main 
      schizophrenia-relevant characteristics of Nrg1 III tg mice but affected the 
      acoustic startle-response in a genotype- and sex-specific manner. Future research 
      should evaluate the effect of handling on other genetic models.
CI  - Copyright © 2021 Elsevier B.V. All rights reserved.
FAU - Guerra, Stefan
AU  - Guerra S
AD  - School of Medicine, Western Sydney University, Campbelltown, Australia.
FAU - Chesworth, Rose
AU  - Chesworth R
AD  - School of Medicine, Western Sydney University, Campbelltown, Australia.
FAU - Weickert, Cynthia Shannon
AU  - Weickert CS
AD  - Schizophrenia Research Laboratory, Neuroscience Research Australia, Randwick, 
      Australia; Department of Neuroscience & Physiology, Upstate Medical University, 
      Syracuse, USA; School of Psychiatry, Faculty of Medicine, University of New South 
      Wales, Kensington, Australia.
FAU - Karl, Tim
AU  - Karl T
AD  - School of Medicine, Western Sydney University, Campbelltown, Australia; 
      Neuroscience Research Australia, Randwick, Australia. Electronic address: 
      t.karl@westernsydney.edu.au.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20210212
PL  - Netherlands
TA  - Behav Brain Res
JT  - Behavioural brain research
JID - 8004872
RN  - 0 (Neuregulin-1)
RN  - 0 (Nrg1 protein, mouse)
SB  - IM
MH  - Animals
MH  - Anxiety/etiology/genetics/physiopathology
MH  - Behavior, Animal/*physiology
MH  - Cognitive Dysfunction/etiology/genetics/physiopathology
MH  - *Disease Models, Animal
MH  - Female
MH  - *Gene-Environment Interaction
MH  - *Handling, Psychological
MH  - Male
MH  - Mice
MH  - Mice, Inbred C57BL
MH  - Mice, Transgenic
MH  - Neuregulin-1/*genetics
MH  - Phenotype
MH  - Reflex, Startle/physiology
MH  - *Schizophrenia/etiology/genetics/physiopathology
MH  - Sex Factors
OTO - NOTNLM
OT  - Behaviour
OT  - Gene-environment interaction
OT  - Handling method
OT  - Mouse model
OT  - Neuregulin 1 type III
OT  - Schizophrenia
EDAT- 2021/02/16 06:00
MHDA- 2022/01/27 06:00
CRDT- 2021/02/15 20:09
PHST- 2020/06/30 00:00 [received]
PHST- 2021/01/14 00:00 [revised]
PHST- 2021/02/02 00:00 [accepted]
PHST- 2021/02/16 06:00 [pubmed]
PHST- 2022/01/27 06:00 [medline]
PHST- 2021/02/15 20:09 [entrez]
AID - S0166-4328(21)00053-X [pii]
AID - 10.1016/j.bbr.2021.113166 [doi]
PST - ppublish
SO  - Behav Brain Res. 2021 May 7;405:113166. doi: 10.1016/j.bbr.2021.113166. Epub 2021 
      Feb 12.

PMID- 35749302
OWN - NLM
STAT- MEDLINE
DCOM- 20221107
LR  - 20230103
IS  - 1549-490X (Electronic)
IS  - 1083-7159 (Print)
IS  - 1083-7159 (Linking)
VI  - 27
IP  - 11
DP  - 2022 Nov 3
TI  - Comprehensive Genomic Profiling of 274 Thymic Epithelial Tumors Unveils Oncogenic 
      Pathways and Predictive Biomarkers.
PG  - 919-929
LID - 10.1093/oncolo/oyac115 [doi]
AB  - BACKGROUND: Thymic malignancies represent a heterogeneous group of rare thoracic 
      cancers, which are classified according to the World Health Organization 
      histopathologic classification, that distinguishes thymomas from thymic 
      carcinomas. Data regarding the biology of those tumors are limited in the 
      literature, and the vast majority have been obtained using surgical specimens 
      from early-stage disease. Meanwhile, treatment of advanced, refractory thymic 
      tumors currently relies on chemotherapy, with limited efficacy. Comprehensive 
      genomic profiling (CGP) of advanced, refractory tumors would open some 
      opportunities for innovative treatments. PATIENTS AND METHODS: A total of 90 and 
      174 consecutive patients with thymoma or thymic carcinoma, respectively, for whom 
      formalin-fixed, paraffin-embedded specimens from recurrent, refractory tumor were 
      sequenced, were included. Sequencing was performed using hybridization-captured, 
      adaptor ligation-based libraries to a mean coverage depth of >500× for up to 315 
      cancer-related genes plus 37 introns from 28 genes frequently rearranged in 
      cancer. RESULTS: Thymomas featured a low frequency of genomic alterations 
      (average of 1.8/tumor), and low levels of TMB. The genomic alterations identified 
      in more than 10% of cases were in the CDKN2A/B and TP53 genes. Amplification in 
      the NTRK1 gene was found in an unresectable, stage III, type B3 thymoma. Thymic 
      carcinomas featured a significantly higher frequency of alterations at 4.0/tumor 
      (P < .0001). Clinically relevant genomic alterations were observed in the CDKN2A, 
      KIT, and PTEN/PI3K/MTOR pathways. Elevated TMB in thymic carcinomas was uncommon 
      with only 6% of cases featuring ≥10 mutations/Mb. CONCLUSIONS: Our cohort is the 
      largest available so far, reporting on CGP of thymic epithelial tumors in the 
      setting of advanced disease. The identification of clinically relevant genomic 
      alterations in the KIT, PI3K, CDKN2A/B, or NTRK genes provides a strong rationale 
      for potential precision medicine approaches using targeted agents. A subset of 
      thymic carcinomas show high tumor mutation burden, what may be a predictor of 
      efficacy of immune checkpoint inhibitors.
CI  - © The Author(s) 2022. Published by Oxford University Press.
FAU - Girard, Nicolas
AU  - Girard N
AUID- ORCID: 0000-0001-9909-2299
AD  - Institut Curie, Institut du Thorax Curie Montsouris, Paris, France.
AD  - Faculté de Médecine Simonbe Veil, UVSQ, Paris Saclay Campus, Versailles, France.
FAU - Basse, Clémence
AU  - Basse C
AUID- ORCID: 0000-0002-0523-0310
AD  - Institut Curie, Institut du Thorax Curie Montsouris, Paris, France.
AD  - Faculté de Médecine Simonbe Veil, UVSQ, Paris Saclay Campus, Versailles, France.
FAU - Schrock, Alexa
AU  - Schrock A
AD  - Foundation Medicine, Cambridge, MA, USA.
FAU - Ramkissoon, Shakti
AU  - Ramkissoon S
AD  - Foundation Medicine, Cambridge, MA, USA.
FAU - Killian, Keith
AU  - Killian K
AD  - Foundation Medicine, Cambridge, MA, USA.
FAU - Ross, Jeffrey S
AU  - Ross JS
AD  - Foundation Medicine, Cambridge, MA, USA.
AD  - SUNY Upstate Medical University, Syracuse, NY, USA.
LA  - eng
PT  - Journal Article
PL  - England
TA  - Oncologist
JT  - The oncologist
JID - 9607837
RN  - EC 2.7.1.- (Phosphatidylinositol 3-Kinases)
RN  - 0 (Biomarkers)
RN  - 0 (Biomarkers, Tumor)
RN  - Thymic epithelial tumor
SB  - IM
MH  - Humans
MH  - *Thymoma/genetics
MH  - *Thymus Neoplasms/genetics
MH  - *Neoplasms, Glandular and Epithelial/genetics
MH  - Mutation
MH  - Genomics
MH  - Phosphatidylinositol 3-Kinases/genetics
MH  - Biomarkers
MH  - Biomarkers, Tumor/genetics
PMC - PMC9632319
OTO - NOTNLM
OT  - chemotherapy
OT  - immunotherapy
OT  - targeted therapy
OT  - thymic carcinoma
OT  - thymoma
EDAT- 2022/06/25 06:00
MHDA- 2022/11/08 06:00
CRDT- 2022/06/24 13:12
PHST- 2021/11/25 00:00 [received]
PHST- 2022/04/13 00:00 [accepted]
PHST- 2022/06/25 06:00 [pubmed]
PHST- 2022/11/08 06:00 [medline]
PHST- 2022/06/24 13:12 [entrez]
AID - 6617572 [pii]
AID - oyac115 [pii]
AID - 10.1093/oncolo/oyac115 [doi]
PST - ppublish
SO  - Oncologist. 2022 Nov 3;27(11):919-929. doi: 10.1093/oncolo/oyac115.

PMID- 36712315
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230202
IS  - 2590-0595 (Electronic)
IS  - 2590-0595 (Linking)
VI  - 5
IP  - 2
DP  - 2023 Feb
TI  - Renal Genetics Clinic: 3-Year Experience in the Cleveland Clinic.
PG  - 100585
LID - 10.1016/j.xkme.2022.100585 [doi]
LID - 100585
AB  - RATIONALE & OBJECTIVE: There has been an increasing demand for the expertise 
      provided by a renal genetics clinic. Such programs are limited in the United 
      States and typically operate in a genomics research setting. Here we report a 
      3-year, real-world, single-center renal genetics clinic experience. STUDY DESIGN: 
      Retrospective cohort. SETTING & PARTICIPANTS: Outpatient cases referred to the 
      renal genetics clinic of the Cleveland Clinic between January 2019 and March 2022 
      were reviewed. ANALYTICAL APPROACH: Clinical and laboratory characteristics were 
      analyzed. All genetic testing was performed in clinical labs. RESULTS: 309 new 
      patients referred from 15 specialties were evaluated, including 118 males and 191 
      females aged 35.1 ± 20.3 years. Glomerular diseases were the leading presentation 
      followed by cystic kidney diseases, electrolyte disorders, congenital anomalies 
      of kidneys and urinary tract, nephrolithiasis, and tubulointerstitial kidney 
      diseases. Dysmorphic features were noted in 27 (8.7%) patients. Genetic testing 
      was recommended in 292 (94.5%) patients including chromosomal microarray (8.9%), 
      single-gene tests (19.5%), multigene panels (77.3%), and exome sequencing 
      (17.5%). 80.5% of patients received insurance coverage for genetic testing. 45% 
      (115/256) of patients had positive results, 25% (64/256) had variants of unknown 
      significance, and 22.3% (57/256) had negative results. 43 distinct monogenic 
      disorders were diagnosed. Family history of kidney disease was present in 52.8% 
      of patients and associated with positive genetic findings (OR, 2.28; 95% CI, 
      1.40-3.74). 69% of patients with positive results received a new diagnosis and/or 
      a change in the diagnosis. Among these, 39.7% (31/78) of patients received a 
      significant change in disease management. LIMITATIONS: Retrospective and 
      single-center study. CONCLUSIONS: The renal genetics clinic plays important roles 
      in the diagnosis and management of patients with genetic kidney diseases. 
      Multigene panels are the most frequently used testing modality with a high 
      diagnostic yield. Family history of kidney disease is a strong indication for 
      renal genetics clinic referral.
CI  - © 2022 The Authors.
FAU - Tan, Xin Yee
AU  - Tan XY
AD  - Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio.
FAU - Borden, Chloe
AU  - Borden C
AD  - Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, 
      Cleveland, Ohio.
FAU - Roberts, Mary-Beth
AU  - Roberts MB
AD  - Center for Personalized Genetic Healthcare, Cleveland Clinic, Cleveland, Ohio.
FAU - Mazzola, Sarah
AU  - Mazzola S
AD  - Center for Personalized Genetic Healthcare, Cleveland Clinic, Cleveland, Ohio.
FAU - Tan, Queenie K-G
AU  - Tan QK
AD  - Center for Personalized Genetic Healthcare, Cleveland Clinic, Cleveland, Ohio.
FAU - Fatica, Richard
AU  - Fatica R
AD  - Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio.
FAU - Simon, James
AU  - Simon J
AD  - Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio.
FAU - Calle, Juan
AU  - Calle J
AD  - Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio.
FAU - Taliercio, Jonathan
AU  - Taliercio J
AD  - Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio.
FAU - Dell, Katherine
AU  - Dell K
AD  - Center for Pediatric Nephrology and Hypertension, Cleveland Clinic Children's, 
      Cleveland, Ohio.
FAU - Provenzano, Laura Ferreira
AU  - Provenzano LF
AD  - Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio.
FAU - Deitzer, Diana
AU  - Deitzer D
AD  - Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio.
FAU - Rincon-Choles, Hernan
AU  - Rincon-Choles H
AD  - Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio.
FAU - Mehdi, Ali
AU  - Mehdi A
AD  - Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio.
FAU - Lioudis, Michael
AU  - Lioudis M
AD  - Section of Nephrology, Upstate Medical University, Syracuse, New York.
FAU - Poggio, Emilio D
AU  - Poggio ED
AD  - Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio.
FAU - Nakhoul, Georges
AU  - Nakhoul G
AD  - Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio.
FAU - Nurko, Saul
AU  - Nurko S
AD  - Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio.
FAU - Ashour, Tarek
AU  - Ashour T
AD  - Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio.
FAU - Bou Matar, Raed N
AU  - Bou Matar RN
AD  - Center for Pediatric Nephrology and Hypertension, Cleveland Clinic Children's, 
      Cleveland, Ohio.
FAU - Kwon, Charles
AU  - Kwon C
AD  - Center for Pediatric Nephrology and Hypertension, Cleveland Clinic Children's, 
      Cleveland, Ohio.
FAU - Stephany, Brian
AU  - Stephany B
AD  - Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio.
FAU - Thomas, George
AU  - Thomas G
AD  - Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio.
FAU - Cheng, Yu-Wei
AU  - Cheng YW
AD  - Molecular Genetics, Cleveland Clinic, Cleveland, Ohio.
FAU - Leingang, Deanna
AU  - Leingang D
AD  - Center for Personalized Genetic Healthcare, Cleveland Clinic, Cleveland, Ohio.
FAU - Alsadah, Adnan
AU  - Alsadah A
AD  - Center for Personalized Genetic Healthcare, Cleveland Clinic, Cleveland, Ohio.
FAU - Maditz, Rhyan
AU  - Maditz R
AD  - Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio.
FAU - Robert, Heyka
AU  - Robert H
AD  - Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio.
FAU - Vachhrajani, Tushar
AU  - Vachhrajani T
AD  - Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio.
FAU - Sedor, John
AU  - Sedor J
AD  - Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio.
FAU - Gadegbeku, Crystal
AU  - Gadegbeku C
AD  - Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio.
FAU - Wang, Xiangling
AU  - Wang X
AD  - Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio.
AD  - Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, 
      Cleveland, Ohio.
AD  - Center for Personalized Genetic Healthcare, Cleveland Clinic, Cleveland, Ohio.
AD  - Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, 
      Cleveland, Ohio.
AD  - Department of Molecular Medicine, Lerner College of Medicine, Case Western 
      Reserve University, Cleveland, Ohio.
LA  - eng
PT  - Journal Article
DEP - 20221213
PL  - United States
TA  - Kidney Med
JT  - Kidney medicine
JID - 101756300
PMC - PMC9874141
OTO - NOTNLM
OT  - Genetic testing
OT  - kidney disease
OT  - renal genetics
EDAT- 2023/01/31 06:00
MHDA- 2023/01/31 06:01
CRDT- 2023/01/30 04:00
PHST- 2023/01/30 04:00 [entrez]
PHST- 2023/01/31 06:00 [pubmed]
PHST- 2023/01/31 06:01 [medline]
AID - S2590-0595(22)00218-7 [pii]
AID - 100585 [pii]
AID - 10.1016/j.xkme.2022.100585 [doi]
PST - epublish
SO  - Kidney Med. 2022 Dec 13;5(2):100585. doi: 10.1016/j.xkme.2022.100585. eCollection 
      2023 Feb.

PMID- 25907074
OWN - NLM
STAT- MEDLINE
DCOM- 20150911
LR  - 20220410
IS  - 1749-6632 (Electronic)
IS  - 0077-8923 (Print)
IS  - 0077-8923 (Linking)
VI  - 1346
IP  - 1
DP  - 2015 Jun
TI  - mTOR activation is a biomarker and a central pathway to autoimmune disorders, 
      cancer, obesity, and aging.
PG  - 33-44
LID - 10.1111/nyas.12756 [doi]
AB  - The mechanistic target of rapamycin (mTOR) is a ubiquitous serine/threonine 
      kinase, which plays pivotal roles in integrating growth signals on a cellular 
      level. To support proliferation and survival under stress, two interacting 
      complexes that harbor mTOR, mTORC1 and mTORC2, promote the transcription of genes 
      involved in carbohydrate metabolism and lipogenesis, enhance protein translation, 
      and inhibit autophagy. Although rapamycin was originally developed as an 
      inhibitor of T cell proliferation for preventing organ transplant rejection, its 
      molecular target, mTOR, has been subsequently identified as a central regulator 
      of metabolic cues that drive lineage specification in the immune system. Owing to 
      oxidative stress, the activation of mTORC1 has emerged as a central pathway for 
      the pathogenesis of systemic lupus erythematosus and other autoimmune diseases. 
      Paradoxically, mTORC1 has also been identified as a mediator of the Warburg 
      effect that allows cell survival under hypoxia. Rapamycin and new classes of mTOR 
      inhibitors are being developed to block not only transplant rejection and 
      autoimmunity but also to treat obesity and various forms of cancer. Through 
      preventing these diseases, personalized mTOR blockade holds promise to extend 
      life span.
CI  - © 2015 New York Academy of Sciences.
FAU - Perl, Andras
AU  - Perl A
AD  - Division of Rheumatology, Department of Medicine State University of New York, 
      Upstate Medical University, College of Medicine, Syracuse, New York.
AD  - Division of Rheumatology, Department of Microbiology and Immunology, State 
      University of New York, Upstate Medical University, College of Medicine, 
      Syracuse, New York.
LA  - eng
GR  - R01 DK078922/DK/NIDDK NIH HHS/United States
GR  - R01 AT004332/AT/NCCIH NIH HHS/United States
GR  - AI 048079 AND/AI/NIAID NIH HHS/United States
GR  - R01 DK049221/DK/NIDDK NIH HHS/United States
GR  - R56 AI048079/AI/NIAID NIH HHS/United States
GR  - R01 AI048079/AI/NIAID NIH HHS/United States
GR  - R01 AI072648/AI/NIAID NIH HHS/United States
GR  - AI 072648/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Review
DEP - 20150423
PL  - United States
TA  - Ann N Y Acad Sci
JT  - Annals of the New York Academy of Sciences
JID - 7506858
RN  - 0 (Biomarkers)
RN  - EC 2.7.1.1 (MTOR protein, human)
RN  - EC 2.7.11.1 (TOR Serine-Threonine Kinases)
RN  - W36ZG6FT64 (Sirolimus)
SB  - IM
MH  - Aging/drug effects/*metabolism
MH  - Animals
MH  - Autoimmune Diseases/drug therapy/*metabolism
MH  - Biomarkers/*metabolism
MH  - Humans
MH  - Neoplasms/drug therapy/*metabolism
MH  - Obesity/drug therapy/*metabolism
MH  - Precision Medicine/methods
MH  - Signal Transduction/drug effects
MH  - Sirolimus/analogs & derivatives/therapeutic use
MH  - TOR Serine-Threonine Kinases/antagonists & inhibitors/*metabolism
PMC - PMC4480196
MID - NIHMS672578
OTO - NOTNLM
OT  - T cell activation
OT  - autoimmunity
OT  - autophagy
OT  - biomarker
OT  - glutathione
OT  - glycolysis
OT  - hypoxia
OT  - inflammation
OT  - keloid disease
OT  - kynurenine
OT  - mTOR
OT  - metabolism
OT  - mitochondria
OT  - oxidative stress
OT  - pathogenesis
OT  - pentose phosphate pathway
OT  - rapamycin
OT  - sirolimus
OT  - systemic lupus erythematosus
OT  - treatment
EDAT- 2015/04/25 06:00
MHDA- 2015/09/12 06:00
CRDT- 2015/04/25 06:00
PHST- 2015/04/25 06:00 [entrez]
PHST- 2015/04/25 06:00 [pubmed]
PHST- 2015/09/12 06:00 [medline]
AID - 10.1111/nyas.12756 [doi]
PST - ppublish
SO  - Ann N Y Acad Sci. 2015 Jun;1346(1):33-44. doi: 10.1111/nyas.12756. Epub 2015 Apr 
      23.

PMID- 33354105
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20201223
IS  - 1043-3155 (Print)
IS  - 2166-6482 (Electronic)
IS  - 1043-3155 (Linking)
VI  - 34
DP  - 2020 Dec 18
TI  - Prediction of EEG Seizures in Critically Ill Children.
PG  - 23
LID - 10.15844/pedneurbriefs-34-23 [doi]
AB  - In a prospective observational study, investigators from the Children's Hospital 
      of Philadelphia devised a predictive model for capturing electrographic seizures 
      in critically ill pediatric patients.
CI  - Copyright: © 2020 The Author(s).
FAU - Ghonim, Hesham T
AU  - Ghonim HT
AD  - Upstate Medical University, Syracuse, NY.
FAU - Anilkumar, Arayamparambil C
AU  - Anilkumar AC
AD  - Upstate Medical University, Syracuse, NY.
LA  - eng
PT  - Comment
PT  - Journal Article
DEP - 20201218
PL  - United States
TA  - Pediatr Neurol Briefs
JT  - Pediatric neurology briefs
JID - 9889575
CON - Epilepsia. 2020 Mar;61(3):498-508. PMID: 32077099
PMC - PMC7747508
OTO - NOTNLM
OT  - Critical Care
OT  - EEG monitoring
OT  - Encephalopathy
OT  - Neurology
OT  - Pediatric
OT  - Seizures
COIS- The authors have declared that no competing interests exist.
EDAT- 2020/12/24 06:00
MHDA- 2020/12/24 06:01
CRDT- 2020/12/23 05:48
PHST- 2020/12/23 05:48 [entrez]
PHST- 2020/12/24 06:00 [pubmed]
PHST- 2020/12/24 06:01 [medline]
AID - PNB-34-23 [pii]
AID - 10.15844/pedneurbriefs-34-23 [doi]
PST - epublish
SO  - Pediatr Neurol Briefs. 2020 Dec 18;34:23. doi: 10.15844/pedneurbriefs-34-23.

PMID- 35351869
OWN - NLM
STAT- MEDLINE
DCOM- 20220404
LR  - 20220419
IS  - 2158-3188 (Electronic)
IS  - 2158-3188 (Linking)
VI  - 12
IP  - 1
DP  - 2022 Mar 29
TI  - Human forebrain organoids reveal connections between valproic acid exposure and 
      autism risk.
PG  - 130
LID - 10.1038/s41398-022-01898-x [doi]
LID - 130
AB  - Valproic acid (VPA) exposure as an environmental factor that confers risk of 
      autism spectrum disorder (ASD), its functional mechanisms in the human brain 
      remain unclear since relevant studies are currently restricted to two-dimensional 
      cell cultures and animal models. To identify mechanisms by which VPA contribute 
      to ASD risk in human, here we used human forebrain organoids (hFOs), in vitro 
      derived three-dimensional cell cultures that recapitulate key human brain 
      developmental features. We identified that VPA exposure in hFOs affected the 
      expression of genes enriched in neural development, synaptic transmission, 
      oxytocin signaling, calcium, and potassium signaling pathways, which have been 
      implicated in ASD. Genes (e.g., CAMK4, CLCN4, DPP10, GABRB3, KCNB1, PRKCB, SCN1A, 
      and SLC24A2) that affected by VPA were significantly overlapped with those 
      dysregulated in brains or organoids derived from ASD patients, and known ASD risk 
      genes, as well as genes in ASD risk-associated gene coexpression modules. 
      Single-cell RNA sequencing analysis showed that VPA exposure affected the 
      expression of genes in choroid plexus, excitatory neuron, immature neuron, and 
      medial ganglionic eminence cells annotated in hFOs. Microelectrode array further 
      identified that VPA exposure in hFOs disrupted synaptic transmission. Taken 
      together, this study connects VPA exposure to ASD pathogenesis using hFOs, which 
      is valuable for illuminating the etiology of ASD and screening for potential 
      therapeutic targets.
CI  - © 2022. The Author(s).
FAU - Meng, Qingtuan
AU  - Meng Q
AUID- ORCID: 0000-0002-6421-162X
AD  - The First Affiliated Hospital, Multi-Omics Research Center for Brain Disorders, 
      Hengyang Medical School, University of South China, 421001, Hengyang, Hunan, 
      China.
FAU - Zhang, Wendiao
AU  - Zhang W
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, and Department of Psychiatry, The Second Xiangya Hospital, Central 
      South University, 410008, Changsha, Hunan, China.
FAU - Wang, Xuan
AU  - Wang X
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, and Department of Psychiatry, The Second Xiangya Hospital, Central 
      South University, 410008, Changsha, Hunan, China.
FAU - Jiao, Chuan
AU  - Jiao C
AD  - Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, 13210, 
      USA.
FAU - Xu, Sheng
AU  - Xu S
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, and Department of Psychiatry, The Second Xiangya Hospital, Central 
      South University, 410008, Changsha, Hunan, China.
FAU - Liu, Chunyu
AU  - Liu C
AUID- ORCID: 0000-0002-5986-4415
AD  - Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, 13210, 
      USA.
FAU - Tang, Beisha
AU  - Tang B
AUID- ORCID: 0000-0003-2120-1576
AD  - The First Affiliated Hospital, Multi-Omics Research Center for Brain Disorders, 
      Hengyang Medical School, University of South China, 421001, Hengyang, Hunan, 
      China. bstang7398@163.com.
FAU - Chen, Chao
AU  - Chen C
AUID- ORCID: 0000-0002-5114-2282
AD  - Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of 
      Life Sciences, and Department of Psychiatry, The Second Xiangya Hospital, Central 
      South University, 410008, Changsha, Hunan, China. chenchao@sklmg.edu.cn.
AD  - Hunan Key Laboratory of Animal Models for Human Diseases, Central South 
      University, 410008, Changsha, Hunan, China. chenchao@sklmg.edu.cn.
AD  - Hunan Key Laboratory of Molecular Precision Medicine, Central South University, 
      410008, Changsha, Hunan, China. chenchao@sklmg.edu.cn.
LA  - eng
GR  - U01 MH116489/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20220329
PL  - United States
TA  - Transl Psychiatry
JT  - Translational psychiatry
JID - 101562664
RN  - 0 (CLCN4 protein, human)
RN  - 0 (Chloride Channels)
RN  - 614OI1Z5WI (Valproic Acid)
SB  - IM
MH  - Animals
MH  - *Autism Spectrum Disorder/chemically induced/genetics/metabolism
MH  - *Autistic Disorder/metabolism
MH  - Chloride Channels/metabolism
MH  - Disease Models, Animal
MH  - Humans
MH  - Organoids/metabolism
MH  - *Prenatal Exposure Delayed Effects/chemically induced
MH  - Prosencephalon/metabolism
MH  - Valproic Acid/adverse effects
PMC - PMC8964691
COIS- The authors declare no competing interests.
EDAT- 2022/03/31 06:00
MHDA- 2022/04/05 06:00
CRDT- 2022/03/30 05:41
PHST- 2021/12/29 00:00 [received]
PHST- 2022/03/11 00:00 [accepted]
PHST- 2022/03/04 00:00 [revised]
PHST- 2022/03/30 05:41 [entrez]
PHST- 2022/03/31 06:00 [pubmed]
PHST- 2022/04/05 06:00 [medline]
AID - 10.1038/s41398-022-01898-x [pii]
AID - 1898 [pii]
AID - 10.1038/s41398-022-01898-x [doi]
PST - epublish
SO  - Transl Psychiatry. 2022 Mar 29;12(1):130. doi: 10.1038/s41398-022-01898-x.

PMID- 32292887
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220414
IS  - 2573-959X (Electronic)
IS  - 2573-9581 (Print)
IS  - 2573-9581 (Linking)
VI  - 1
IP  - 2
DP  - 2019 Jun 1
TI  - Development of the AASPIRE Web Accessibility Guidelines for Autistic Web Users.
PG  - 146-157
LID - 10.1089/aut.2018.0020 [doi]
AB  - Websites figure predominantly in everyday life. However, many websites remain 
      inaccessible to autistic people, and existing efforts to improve accessibility 
      are in early stages, do not directly include autistic users in their development, 
      or have not been empirically evaluated. The Academic Autism Spectrum Partnership 
      in Research and Education (AASPIRE) used a community-based participatory research 
      approach to create a website to improve health care access for autistic adults. 
      We used the creation of that website as a "living laboratory" to develop the 
      AASPIRE Web Accessibility Guidelines for Autistic Web Users. Our guidelines are 
      grounded in accessibility theory, had autistic end-user involvement at all 
      stages, and were empirically evaluated through a usability study and evaluation 
      surveys. We incorporated what we learned into the design of the website, and 
      compiled the accessibility information into a set of guidelines. The guidelines 
      offer recommendations for increasing the physical, intellectual, and social 
      acceptability of websites for use by autistic adults. In the evaluation of the 
      website by 170 autistic end users, nearly all indicated it was easy to use (97%), 
      easy to understand (95%), important (97%), and useful (96%). Ninety-two percent 
      would recommend it to a friend, and 95% would recommend it to a health care 
      provider. There were no significant associations between usability or 
      understandability and education level, receipt of help using the site, browser 
      type (e.g., IE or Safari), or device type (e.g., PC or tablet). We recommend 
      using the guidelines to improve website accessibility for autistic Internet 
      users. LAY SUMMARY: AASPIRE Web Accessibility Guideline: This guideline is a 
      summary of the accessibility features we identified and implemented during the 
      course of our study. None of these items were difficult or expensive for us to 
      implement. They did not require special expertise beyond basic web programming 
      and technical communications skills. We recommend that anyone seeking to create 
      accessible websites for autistic users follow the Academic Autism Spectrum 
      Partnership in Research and Education (AASPIRE) Web Accessibility Guideline in 
      addition to broader web and communications standards and principles.Physical 
      accessibility:Provide at least one low-contrast neutral color palette option to 
      accommodate sensitive vision.Provide a selection of color palettes, including one 
      with a dark background and one with a light background, again to accommodate 
      color and contrast sensitivity.Provide a no-style option (i.e., no cascading 
      style sheets (CSS) to accommodate browser customization and users who prefer no 
      stylistic formatting.Provide simple consistent navigation and highly consistent 
      site behavior for increased ease of operation.Avoid textured backgrounds, moving 
      images, decorative elements that do not convey information, and other visual 
      and/or sonic "clutter"; these types of elements may make the site difficult or 
      impossible to comprehend.Provide smaller font sizes in addition to larger ones; 
      large font sizes may make the page appear cluttered and difficult to read.Use a 
      plain accessible sans-serif font (e.g., Arial) for ease of 
      readability.Intellectual accessibility:Use the simplest interface possible for 
      ease of understanding.Use simple concrete icons or images to communicate 
      redundant information with text, and accommodate multiple ways of understanding 
      information.Clearly label site elements with their purpose everywhere on the 
      site, even if it seems redundant, to make navigation and site functionality 
      easier to follow.Provide concrete examples where applicable to accommodate 
      difficulties in understanding abstractions or generalizations.Minimize scrolling 
      so the user does not need to rely on assumptions about content to guess what 
      might be on the page.Show all important features and site navigation (as opposed 
      to within combo box drop-down areas) so the user does not need to rely on 
      assumptions to guess whether the item exists and how to access it. For example, 
      completely visible list boxes or radio buttons can be used instead of combo 
      boxes.Make content as short as possible without sacrificing precision and 
      specificity, to reduce cognitive burden.Social accessibility:Be specific and 
      precise in language use; avoid colloquialisms, idioms, and ambiguity to 
      accommodate difficulties with language pragmatics.Explain the reason behind any 
      nonstandard instructions or unusual information; provide additional pragmatic 
      context to accommodate difficulties with language pragmatics.Provide alternatives 
      to definitive response items on surveys and forms, for example, "do not know," 
      "do not wish to say," or "not applicable," to reduce frustration for not being 
      able to produce an exact answer.Use FAQ formats to organize complex information 
      to enhance clarity as to why the information might be useful to the user and how 
      it connects to their life.Define terms that might have different meanings 
      depending on social context, or which might be jargon related to a specialized 
      field (e.g., "drug interactions" and "health care providers"), to accommodate 
      difficulties with language pragmatics.Be mindful of autistic culture and 
      community preferences, including the language used to describe autism and how 
      community-based symbols and history might influence content and perception of 
      site credibility.
CI  - Copyright 2019, Mary Ann Liebert, Inc., publishers.
FAU - Raymaker, Dora M
AU  - Raymaker DM
AD  - School of Social Work, Regional Research Institute, Portland State University, 
      Portland, Oregon.
AD  - Academic Autism Spectrum Partnership in Research and Education, Portland State 
      University, Portland, Oregon.
FAU - Kapp, Steven K
AU  - Kapp SK
AD  - Academic Autism Spectrum Partnership in Research and Education, Portland State 
      University, Portland, Oregon.
AD  - College of Social Sciences and International Studies, Sociology, Philosophy, and 
      Anthropology, University of Exeter, Exeter, United Kingdom.
FAU - McDonald, Katherine E
AU  - McDonald KE
AD  - Academic Autism Spectrum Partnership in Research and Education, Portland State 
      University, Portland, Oregon.
AD  - Public Health, Food Studies, and Nutrition, David B. Balk College of Sport and 
      Human Dynamics, Syracuse University, Syracuse, New York.
FAU - Weiner, Michael
AU  - Weiner M
AD  - Academic Autism Spectrum Partnership in Research and Education, Portland State 
      University, Portland, Oregon.
AD  - Regenstrief Institute, Inc., Indiana University Center for Health Services and 
      Outcomes Research, Center for Health Information and Communication, U.S. 
      Department of Veterans Affairs, Veterans Health Administration, Health Services 
      Research and Development Service CIN 13-416, Richard L. Roudebush VA Medical 
      Center, Indianapolis, Indiana.
FAU - Ashkenazy, Elesia
AU  - Ashkenazy E
AD  - Academic Autism Spectrum Partnership in Research and Education, Portland State 
      University, Portland, Oregon.
FAU - Nicolaidis, Christina
AU  - Nicolaidis C
AD  - School of Social Work, Regional Research Institute, Portland State University, 
      Portland, Oregon.
AD  - Academic Autism Spectrum Partnership in Research and Education, Portland State 
      University, Portland, Oregon.
AD  - Department of Medicine, Oregon Health and Science University, Portland, Oregon.
LA  - eng
GR  - KL2 TR002370/TR/NCATS NIH HHS/United States
GR  - R34 MH092503/MH/NIMH NIH HHS/United States
GR  - UL1 RR024140/RR/NCRR NIH HHS/United States
PT  - Journal Article
DEP - 20190413
PL  - United States
TA  - Autism Adulthood
JT  - Autism in adulthood : challenges and management
JID - 101741462
PMC - PMC6485264
MID - NIHMS1033503
OTO - NOTNLM
OT  - autism
OT  - community-based participatory research
OT  - web accessibility
OT  - web accessibility guidelines
COIS- No competing financial interests exist.
EDAT- 2020/04/16 06:00
MHDA- 2020/04/16 06:01
CRDT- 2020/04/16 06:00
PHST- 2020/04/16 06:00 [entrez]
PHST- 2020/04/16 06:00 [pubmed]
PHST- 2020/04/16 06:01 [medline]
AID - 10.1089/aut.2018.0020 [pii]
AID - 10.1089/aut.2018.0020 [doi]
PST - ppublish
SO  - Autism Adulthood. 2019 Jun 1;1(2):146-157. doi: 10.1089/aut.2018.0020. Epub 2019 
      Apr 13.

PMID- 32796848
OWN - NLM
STAT- MEDLINE
DCOM- 20200825
LR  - 20210814
IS  - 2041-1723 (Electronic)
IS  - 2041-1723 (Linking)
VI  - 11
IP  - 1
DP  - 2020 Aug 14
TI  - Artificial intelligence for the detection of COVID-19 pneumonia on chest CT using 
      multinational datasets.
PG  - 4080
LID - 10.1038/s41467-020-17971-2 [doi]
LID - 4080
AB  - Chest CT is emerging as a valuable diagnostic tool for clinical management of 
      COVID-19 associated lung disease. Artificial intelligence (AI) has the potential 
      to aid in rapid evaluation of CT scans for differentiation of COVID-19 findings 
      from other clinical entities. Here we show that a series of deep learning 
      algorithms, trained in a diverse multinational cohort of 1280 patients to 
      localize parietal pleura/lung parenchyma followed by classification of COVID-19 
      pneumonia, can achieve up to 90.8% accuracy, with 84% sensitivity and 93% 
      specificity, as evaluated in an independent test set (not included in training 
      and validation) of 1337 patients. Normal controls included chest CTs from 
      oncology, emergency, and pneumonia-related indications. The false positive rate 
      in 140 patients with laboratory confirmed other (non COVID-19) pneumonias was 
      10%. AI-based algorithms can readily identify CT scans with COVID-19 associated 
      pneumonia, as well as distinguish non-COVID related pneumonias with high 
      specificity in diverse patient populations.
FAU - Harmon, Stephanie A
AU  - Harmon SA
AUID- ORCID: 0000-0002-2507-2399
AD  - Molecular Imaging Branch, National Cancer Institute, National Institutes of 
      Health, Bethesda, MD, USA.
AD  - Clinical Research Directorate, Frederick National Laboratory for Cancer Research, 
      Frederick, MD, USA.
FAU - Sanford, Thomas H
AU  - Sanford TH
AD  - State University of New York-Upstate Medical Center, Syracuse, NY, USA.
FAU - Xu, Sheng
AU  - Xu S
AD  - Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical 
      Center and National Cancer Institute, Center for Cancer Research, National 
      Institutes of Health, Bethesda, MD, USA.
FAU - Turkbey, Evrim B
AU  - Turkbey EB
AD  - Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 
      Bethesda, MD, USA.
FAU - Roth, Holger
AU  - Roth H
AUID- ORCID: 0000-0002-3662-8743
AD  - NVIDIA Corporation, Bethesda, MD, USA.
FAU - Xu, Ziyue
AU  - Xu Z
AD  - NVIDIA Corporation, Bethesda, MD, USA.
FAU - Yang, Dong
AU  - Yang D
AD  - NVIDIA Corporation, Bethesda, MD, USA.
FAU - Myronenko, Andriy
AU  - Myronenko A
AD  - NVIDIA Corporation, Bethesda, MD, USA.
FAU - Anderson, Victoria
AU  - Anderson V
AD  - Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical 
      Center and National Cancer Institute, Center for Cancer Research, National 
      Institutes of Health, Bethesda, MD, USA.
FAU - Amalou, Amel
AU  - Amalou A
AD  - Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical 
      Center and National Cancer Institute, Center for Cancer Research, National 
      Institutes of Health, Bethesda, MD, USA.
FAU - Blain, Maxime
AU  - Blain M
AUID- ORCID: 0000-0002-5753-8210
AD  - Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical 
      Center and National Cancer Institute, Center for Cancer Research, National 
      Institutes of Health, Bethesda, MD, USA.
FAU - Kassin, Michael
AU  - Kassin M
AD  - Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical 
      Center and National Cancer Institute, Center for Cancer Research, National 
      Institutes of Health, Bethesda, MD, USA.
FAU - Long, Dilara
AU  - Long D
AUID- ORCID: 0000-0002-5564-4773
AD  - Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical 
      Center and National Cancer Institute, Center for Cancer Research, National 
      Institutes of Health, Bethesda, MD, USA.
FAU - Varble, Nicole
AU  - Varble N
AD  - Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical 
      Center and National Cancer Institute, Center for Cancer Research, National 
      Institutes of Health, Bethesda, MD, USA.
AD  - Philips Research North America, Cambridge, MA, USA.
FAU - Walker, Stephanie M
AU  - Walker SM
AUID- ORCID: 0000-0002-0624-8723
AD  - Molecular Imaging Branch, National Cancer Institute, National Institutes of 
      Health, Bethesda, MD, USA.
FAU - Bagci, Ulas
AU  - Bagci U
AD  - Center for Research in Computer Vision, University of Central Florida, Orlando, 
      FL, USA.
FAU - Ierardi, Anna Maria
AU  - Ierardi AM
AD  - Department of Radiology Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico 
      Milano, Milan, Italy.
FAU - Stellato, Elvira
AU  - Stellato E
AD  - Department of Radiology Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico 
      Milano, Milan, Italy.
FAU - Plensich, Guido Giovanni
AU  - Plensich GG
AD  - Department of Radiology Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico 
      Milano, Milan, Italy.
FAU - Franceschelli, Giuseppe
AU  - Franceschelli G
AD  - Diagnostic and Interventional Radiology Service, ASST Santi Paolo e Carlo, San 
      Paolo Hospital, Milan, Italy.
FAU - Girlando, Cristiano
AU  - Girlando C
AD  - Postgraduation School in Radiodiagnostics, Università Degli Studi di Milano, Via 
      Festa del Perdono 7, 20122, Milan, Italy.
FAU - Irmici, Giovanni
AU  - Irmici G
AD  - Postgraduation School in Radiodiagnostics, Università Degli Studi di Milano, Via 
      Festa del Perdono 7, 20122, Milan, Italy.
FAU - Labella, Dominic
AU  - Labella D
AD  - State University of New York-Upstate Medical Center, Syracuse, NY, USA.
FAU - Hammoud, Dima
AU  - Hammoud D
AD  - Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 
      Bethesda, MD, USA.
FAU - Malayeri, Ashkan
AU  - Malayeri A
AD  - Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 
      Bethesda, MD, USA.
FAU - Jones, Elizabeth
AU  - Jones E
AD  - Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 
      Bethesda, MD, USA.
FAU - Summers, Ronald M
AU  - Summers RM
AD  - Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 
      Bethesda, MD, USA.
FAU - Choyke, Peter L
AU  - Choyke PL
AD  - Molecular Imaging Branch, National Cancer Institute, National Institutes of 
      Health, Bethesda, MD, USA.
FAU - Xu, Daguang
AU  - Xu D
AD  - NVIDIA Corporation, Bethesda, MD, USA.
FAU - Flores, Mona
AU  - Flores M
AD  - NVIDIA Corporation, Bethesda, MD, USA.
FAU - Tamura, Kaku
AU  - Tamura K
AD  - Self-Defense Forces Central Hospital, Tokyo, Japan.
FAU - Obinata, Hirofumi
AU  - Obinata H
AD  - Self-Defense Forces Central Hospital, Tokyo, Japan.
FAU - Mori, Hitoshi
AU  - Mori H
AD  - Self-Defense Forces Central Hospital, Tokyo, Japan.
FAU - Patella, Francesca
AU  - Patella F
AUID- ORCID: 0000-0001-5142-0345
AD  - Diagnostic and Interventional Radiology Service, ASST Santi Paolo e Carlo, San 
      Paolo Hospital, Milan, Italy.
FAU - Cariati, Maurizio
AU  - Cariati M
AUID- ORCID: 0000-0002-2437-6702
AD  - Diagnostic and Interventional Radiology Service, ASST Santi Paolo e Carlo, San 
      Paolo Hospital, Milan, Italy.
FAU - Carrafiello, Gianpaolo
AU  - Carrafiello G
AD  - Department of Radiology Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico 
      Milano, Milan, Italy.
AD  - Department of Health Sciences, University of Milano, Milan, Italy.
FAU - An, Peng
AU  - An P
AD  - Department of Radiology, Xiangyang NO.1 People's Hospital Affiliated to Hubei 
      University of Medicine Xiangyang, Hubei, China.
FAU - Wood, Bradford J
AU  - Wood BJ
AUID- ORCID: 0000-0002-4297-0051
AD  - Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical 
      Center and National Cancer Institute, Center for Cancer Research, National 
      Institutes of Health, Bethesda, MD, USA. bwood@cc.nih.gov.
FAU - Turkbey, Baris
AU  - Turkbey B
AUID- ORCID: 0000-0003-0853-6494
AD  - Molecular Imaging Branch, National Cancer Institute, National Institutes of 
      Health, Bethesda, MD, USA. turkbeyi@mail.nih.gov.
LA  - eng
GR  - 75N91019D00024/CA/NCI NIH HHS/United States
GR  - 75N91019F00129/CA/NCI NIH HHS/United States
GR  - ZIA CL040015/ImNIH/Intramural NIH HHS/United States
GR  - ZID BC011242/ImNIH/Intramural NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Intramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20200814
PL  - England
TA  - Nat Commun
JT  - Nature communications
JID - 101528555
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Algorithms
MH  - *Artificial Intelligence
MH  - Betacoronavirus/isolation & purification
MH  - COVID-19
MH  - COVID-19 Testing
MH  - Child
MH  - Child, Preschool
MH  - Clinical Laboratory Techniques/*methods
MH  - Coronavirus Infections/diagnosis/*diagnostic imaging/virology
MH  - Deep Learning
MH  - Female
MH  - Humans
MH  - Imaging, Three-Dimensional/methods
MH  - Lung/diagnostic imaging
MH  - Male
MH  - Middle Aged
MH  - Pandemics
MH  - Pneumonia, Viral/*diagnostic imaging/virology
MH  - Radiographic Image Interpretation, Computer-Assisted/methods
MH  - SARS-CoV-2
MH  - Tomography, X-Ray Computed/*methods
MH  - Young Adult
PMC - PMC7429815
COIS- H.R., Z.X., D.Y., A.M., D.X., and M.F. are employed by NVIDIA Corporation. N.V. 
      is employed by Philips Research, North America.
EDAT- 2020/08/17 06:00
MHDA- 2020/08/26 06:00
CRDT- 2020/08/16 06:00
PHST- 2020/05/08 00:00 [received]
PHST- 2020/07/13 00:00 [accepted]
PHST- 2020/08/16 06:00 [entrez]
PHST- 2020/08/17 06:00 [pubmed]
PHST- 2020/08/26 06:00 [medline]
AID - 10.1038/s41467-020-17971-2 [pii]
AID - 17971 [pii]
AID - 10.1038/s41467-020-17971-2 [doi]
PST - epublish
SO  - Nat Commun. 2020 Aug 14;11(1):4080. doi: 10.1038/s41467-020-17971-2.

PMID- 33526765
OWN - NLM
STAT- MEDLINE
DCOM- 20210628
LR  - 20221129
IS  - 2158-3188 (Electronic)
IS  - 2158-3188 (Linking)
VI  - 11
IP  - 1
DP  - 2021 Feb 1
TI  - Evidence for similar structural brain anomalies in youth and adult 
      attention-deficit/hyperactivity disorder: a machine learning analysis.
PG  - 82
LID - 10.1038/s41398-021-01201-4 [doi]
LID - 82
AB  - Attention-deficit/hyperactivity disorder (ADHD) affects 5% of children 
      world-wide. Of these, two-thirds continue to have impairing symptoms of ADHD into 
      adulthood. Although a large literature implicates structural brain differences of 
      the disorder, it is not clear if adults with ADHD have similar neuroanatomical 
      differences as those seen in children with recent reports from the large 
      ENIGMA-ADHD consortium finding structural differences for children but not for 
      adults. This paper uses deep learning neural network classification models to 
      determine if there are neuroanatomical changes in the brains of children with 
      ADHD that are also observed for adult ADHD, and vice versa. We found that 
      structural MRI data can significantly separate ADHD from control participants for 
      both children and adults. Consistent with the prior reports from ENIGMA-ADHD, 
      prediction performance and effect sizes were better for the child than the adult 
      samples. The model trained on adult samples significantly predicted ADHD in the 
      child sample, suggesting that our model learned anatomical features that are 
      common to ADHD in childhood and adulthood. These results support the continuity 
      of ADHD's brain differences from childhood to adulthood. In addition, our work 
      demonstrates a novel use of neural network classification models to test 
      hypotheses about developmental continuity.
FAU - Zhang-James, Yanli
AU  - Zhang-James Y
AUID- ORCID: 0000-0002-2104-0963
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Syracuse, NY, USA.
FAU - Helminen, Emily C
AU  - Helminen EC
AD  - Department of Psychology, Syracuse University, Syracuse, NY, USA.
FAU - Liu, Jinru
AU  - Liu J
AD  - University of Illinois at Urbana-Champaign, Champaign, IL, USA.
CN  - ENIGMA-ADHD Working Group
FAU - Franke, Barbara
AU  - Franke B
AUID- ORCID: 0000-0003-4375-6572
AD  - Department of Human Genetics, Radboud University Medical Center, Nijmegen, The 
      Netherlands.
AD  - Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands.
AD  - Department of Psychiatry, Radboud University Medical Center, Nijmegen, The 
      Netherlands.
FAU - Hoogman, Martine
AU  - Hoogman M
AD  - Department of Human Genetics, Radboud University Medical Center, Nijmegen, The 
      Netherlands.
AD  - Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands.
FAU - Faraone, Stephen V
AU  - Faraone SV
AUID- ORCID: 0000-0002-9217-3982
AD  - Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Syracuse, NY, USA. sfaraone@childpsychresearch.org.
AD  - Department of Neuroscience and Physiology, SUNY Upstate Medical University, 
      Syracuse, NY, USA. sfaraone@childpsychresearch.org.
LA  - eng
GR  - 5R01MH101519/U.S. Department of Health &amp; Human Services | National Institutes 
      of Health (NIH)/
GR  - U54 EB020403/EB/NIBIB NIH HHS/United States
GR  - U01 MH109536/MH/NIMH NIH HHS/United States
GR  - R01 MH101519/MH/NIMH NIH HHS/United States
GR  - R01 MH115357/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20210201
PL  - United States
TA  - Transl Psychiatry
JT  - Translational psychiatry
JID - 101562664
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - *Attention Deficit Disorder with Hyperactivity/diagnostic imaging
MH  - Brain/diagnostic imaging
MH  - Child
MH  - Humans
MH  - Machine Learning
MH  - Magnetic Resonance Imaging
MH  - Young Adult
PMC - PMC7851168
COIS- Dr. Barbara Franke has received educational speaking fees from Shire and Medice. 
      Dr. Stephen V Faraone received income, potential income, travel expenses 
      continuing education support and/or research support from Takeda, OnDosis, Tris, 
      Otsuka, Arbor, Ironshore, Rhodes, Akili Interactive Labs, Enzymotec, Sunovion, 
      Supernus, and Genomind. With his institution, he has US patent US20130217707 A1 
      for the use of sodium-hydrogen exchange inhibitors in the treatment of ADHD. He 
      also receives royalties from books published by Guilford Press: Straight Talk 
      about Your Child’s Mental Health, Oxford University Press: Schizophrenia: The 
      Facts and Elsevier: ADHD: Non-Pharmacologic Interventions. He is Program Director 
      of www.adhdinadults.com. Dr. Asherson has served as a consultant and as a speaker 
      at sponsored events for Eli Lilly, Novartis, and Shire, and he has received 
      educational/research awards from Eli Lilly, GW Pharma, Novartis, QbTech, Shire, 
      and Vifor Pharma. Dr. Banaschewski has served in an advisory or consultancy role 
      for Actelion, Eli Lilly, Hexal Pharma, Lundbeck, Medice, Neurim Pharmaceuticals, 
      Novartis, Oberberg GmbH, and Shire; he has received conference support or 
      speaking fees from Eli Lilly, Medice, Novartis, and Shire; he has been involved 
      in clinical trials conducted by Shire and Viforpharma; and he has received 
      royalties from CIP Medien, Hogrefe, Kohlhammer, and Oxford University Press. Dr. 
      Bellgrove has received speaking fees and travel support from Shire. Dr. Biederman 
      has received research support from AACAP, Alcobra, the Feinstein Institute for 
      Medical Research, the Forest Research Institute, Genentech, Headspace, Ironshore, 
      Lundbeck AS, Magceutics, Merck, Neurocentria, NIDA, NIH, PamLab, Pfizer, Roche 
      TCRC, Shire, SPRITES, Sunovion, the U.S. Department of Defense, the U.S. Food and 
      Drug Administration, and Vaya Pharma/Enzymotec; he has served as a consultant or 
      on scientific advisory boards for Aevi Genomics, Akili, Alcobra, Arbor 
      Pharmaceuticals, Guidepoint, Ironshore, Jazz Pharma, Medgenics, Piper Jaffray, 
      and Shire; he has received honoraria from Alcobra, the American Professional 
      Society of ADHD and Related Disorders, and the MGH Psychiatry Academy for 
      tuition-funded CME courses; he has a financial interest in Avekshan, a company 
      that develops treatments for ADHD; he has a U.S. patent application pending 
      (Provisional Number #61/233,686) through MGH corporate licensing, on a method to 
      prevent stimulant abuse; and his program has received royalties from a 
      copyrighted rating scale used for ADHD diagnoses, paid to the Department of 
      Psychiatry at Massachusetts General Hospital by Ingenix, Prophase, Shire, Bracket 
      Global, Sunovion, and Theravance. Dr. Brandeis has served as an unpaid scientific 
      consultant for an EU-funded neurofeedback trial. Dr. Buitelaar has served as a 
      consultant, advisory board member, and/or speaker for Eli Lilly, Janssen-Cilag, 
      Medice, Roche, Shire, and Servier. Dr. Coghill has served in an advisory or 
      consultancy role for Eli Lilly, Medice, Novartis, Oxford Outcomes, Shire, and 
      Viforpharma; he has received conference support or speaking fees from Eli Lilly, 
      Janssen McNeil, Medice, Novartis, Shire, and Sunovion; and he has been involved 
      in clinical trials conducted by Eli Lilly and Shire. Dr. Dale is a founder of and 
      holds equity in CorTechs Labs, Inc., and has served on the scientific advisory 
      boards of CorTechs Labs and Human Longevity, Inc., and he receives funding 
      through research grants with GE Healthcare. Mr. Earl is co-inventor of the Oregon 
      Health and Science University Technology #2198 (co-owned with Washington 
      University in St. Louis), FIRMM: Real time monitoring and prediction of motion in 
      MRI scans, exclusively licensed to Nous, Inc., and any related research. Any 
      potential conflict of interest has been reviewed and managed by OHSU. Dr. Fair is 
      a founder of Nous Imaging, Inc.; any potential conflicts of interest are being 
      reviewed and managed by OHSU. Dr. Haavik has received speaking fees from 
      Biocodex, Eli Lilly, HB Pharma, Janssen-Cilag, Medice, Novartis, and Shire. Dr. 
      Hoekstra has received a research grant from and served on the advisory board for 
      Shire. Dr. Karkashadze has received payment for article authorship and speaking 
      fees from Sanofi and from Pikfarma. Dr. Konrad has received speaking fees from 
      Eli Lilly, Medice, and Shire. Dr. Kuntsi has received speaking honoraria and 
      advisory panel payments for participation at educational events sponsored by 
      Medice; all funds are received by King’s College London and used for studies of 
      ADHD. Dr. Lesch has served as a speaker for Eli Lilly and has received research 
      support from Medice and travel support from Shire. Dr. Mattos has served on 
      speakers’ bureau and/or as a consultant for Janssen-Cilag, Novartis, and Shire 
      and has received travel awards from those companies to participate in scientific 
      meetings; the ADHD outpatient program (Grupo de Estudos do Déficit de 
      Atenção/Institute of Psychiatry) chaired by Dr. Mattos also received research 
      support from Novartis and Shire. Dr. Mehta has received research funding from 
      Lundbeck, Shire, and Takeda and has served on advisory boards for Lundbeck and 
      Autifony. Dr. Ramos-Quiroga has served on the speakers bureaus and/or as a 
      consultant for Almirall, Braingaze, Eli Lilly, Janssen-Cilag, Lundbeck, Medice, 
      Novartis, Shire, Sincrolab, and Rubió; he has received travel awards for taking 
      part in psychiatric meetings from Eli Lilly, Janssen-Cilag, Medice, Rubió, and 
      Shire; and the Department of Psychiatry chaired by him has received unrestricted 
      educational and research support from Actelion, Eli Lilly, Ferrer, Janssen-Cilag, 
      Lundbeck, Oryzon, Psious, Roche, Rubió, and Shire. Dr. Reif has received 
      honoraria for serving as speaking or on advisory boards for Janssen, Medice, 
      Neuraxpharm, Servier, and Shire. Dr. Rubia has received speaking fees form Shire 
      and Medice and a grant from Eli Lilly. Dr. Thompson has received funding support 
      from Biogen. Dr. Van Erp has served as consultant for Roche Pharmaceuticals and 
      has a contract with Otsuka Pharmaceutical, Ltd. Dr. Walitza has received lecture 
      honoraria from Eli Lilly and Opopharma, support from the Hartmann Müller, Olga 
      Mayenfisch, and Gertrud Thalmann foundations, and royalties from Beltz, Hogrefe, 
      Kohlhammer, Springer, and Thieme. Dr. Yanli Zhang-James is supported by the 
      European Union’s Seventh Framework Programme for research, technological 
      development, and demonstration under grant agreement no. 602805 and the European 
      Union’s Horizon 2020 research and innovation programme under grant agreement no. 
      667302. Emily C Helminen, Jinru Liu, Dr. Martine Hoogman, and other contributing 
      members of the ENIGMA-ADHD Working Group declare no conflict of interest.
FIR - Busatto, Geraldo F
IR  - Busatto GF
FIR - Calvo, Anna
IR  - Calvo A
FIR - Cercignani, Mara
IR  - Cercignani M
FIR - Chaim-Avancini, Tiffany M
IR  - Chaim-Avancini TM
FIR - Gabel, Matt C
IR  - Gabel MC
FIR - Harrison, Neil A
IR  - Harrison NA
FIR - Lazaro, Luisa
IR  - Lazaro L
FIR - Lera-Miguel, Sara
IR  - Lera-Miguel S
FIR - Louza, Mario R
IR  - Louza MR
FIR - Nicolau, Rosa
IR  - Nicolau R
FIR - Rosa, Pedro G P
IR  - Rosa PGP
FIR - Schulte-Rutte, Martin
IR  - Schulte-Rutte M
FIR - Zanetti, Marcus V
IR  - Zanetti MV
FIR - Ambrosino, Sara
IR  - Ambrosino S
FIR - Asherson, Philip
IR  - Asherson P
FIR - Banaschewski, Tobias
IR  - Banaschewski T
FIR - Baranov, Alexandr
IR  - Baranov A
FIR - Baumeister, Sarah
IR  - Baumeister S
FIR - Baur-Streubel, Ramona
IR  - Baur-Streubel R
FIR - Bellgrove, Mark A
IR  - Bellgrove MA
FIR - Biederman, Joseph
IR  - Biederman J
FIR - Bralten, Janita
IR  - Bralten J
FIR - Bramati, Ivanei E
IR  - Bramati IE
FIR - Brandeis, Daniel
IR  - Brandeis D
FIR - Brem, Silvia
IR  - Brem S
FIR - Buitelaar, Jan K
IR  - Buitelaar JK
FIR - Castellanos, Francisco X
IR  - Castellanos FX
FIR - Chantiluke, Kaylita C
IR  - Chantiluke KC
FIR - Christakou, Anastasia
IR  - Christakou A
FIR - Coghill, David
IR  - Coghill D
FIR - Conzelmann, Annette
IR  - Conzelmann A
FIR - Cubillo, Ana I
IR  - Cubillo AI
FIR - Dale, Anders M
IR  - Dale AM
FIR - de Zeeuw, Patrick
IR  - de Zeeuw P
FIR - Doyle, Alysa E
IR  - Doyle AE
FIR - Durston, Sarah
IR  - Durston S
FIR - Earl, Eric A
IR  - Earl EA
FIR - Epstein, Jeffrey N
IR  - Epstein JN
FIR - Ethofer, Thomas
IR  - Ethofer T
FIR - Fair, Damien A
IR  - Fair DA
FIR - Fallgatter, Andreas J
IR  - Fallgatter AJ
FIR - Frodl, Thomas
IR  - Frodl T
FIR - Gogberashvili, Tinatin
IR  - Gogberashvili T
FIR - Haavik, Jan
IR  - Haavik J
FIR - Hartman, Catharina A
IR  - Hartman CA
FIR - Heslenfeld, Dirk J
IR  - Heslenfeld DJ
FIR - Hoekstra, Pieter J
IR  - Hoekstra PJ
FIR - Hohmann, Sarah
IR  - Hohmann S
FIR - Høvik, Marie F
IR  - Høvik MF
FIR - Jahanshad, Neda
IR  - Jahanshad N
FIR - Jernigan, Terry L
IR  - Jernigan TL
FIR - Kardatzki, Bernd
IR  - Kardatzki B
FIR - Karkashadze, Georgii
IR  - Karkashadze G
FIR - Kelly, Clare
IR  - Kelly C
FIR - Kohls, Gregor
IR  - Kohls G
FIR - Konrad, Kerstin
IR  - Konrad K
FIR - Kuntsi, Jonna
IR  - Kuntsi J
FIR - Lesch, Klaus-Peter
IR  - Lesch KP
FIR - Lundervold, Astri J
IR  - Lundervold AJ
FIR - Malpas, Charles B
IR  - Malpas CB
FIR - Mattos, Paulo
IR  - Mattos P
FIR - McCarthy, Hazel
IR  - McCarthy H
FIR - Mehta, Mitul A
IR  - Mehta MA
FIR - Namazova-Baranova, Leyla
IR  - Namazova-Baranova L
FIR - Nigg, Joel T
IR  - Nigg JT
FIR - Novotny, Stephanie E
IR  - Novotny SE
FIR - O'Gorman Tuura, Ruth L
IR  - O'Gorman Tuura RL
FIR - Weiss, Eileen Oberwelland
IR  - Weiss EO
FIR - Oosterlaan, Jaap
IR  - Oosterlaan J
FIR - Oranje, Bob
IR  - Oranje B
FIR - Paloyelis, Yannis
IR  - Paloyelis Y
FIR - Pauli, Paul
IR  - Pauli P
FIR - Plessen, Kerstin J
IR  - Plessen KJ
FIR - Ramos-Quiroga, J Antoni
IR  - Ramos-Quiroga JA
FIR - Reif, Andreas
IR  - Reif A
FIR - Reneman, Liesbeth
IR  - Reneman L
FIR - Rubia, Katya
IR  - Rubia K
FIR - Schrantee, Anouk
IR  - Schrantee A
FIR - Schwarz, Lena
IR  - Schwarz L
FIR - Schweren, Lizanne J S
IR  - Schweren LJS
FIR - Seitz, Jochen
IR  - Seitz J
FIR - Shaw, Philip
IR  - Shaw P
FIR - Silk, Tim J
IR  - Silk TJ
FIR - Skokauskas, Norbert
IR  - Skokauskas N
FIR - Vila, Juan Carlos Soliva
IR  - Vila JCS
FIR - Stevens, Michael C
IR  - Stevens MC
FIR - Sudre, Gustavo
IR  - Sudre G
FIR - Tamm, Leanne
IR  - Tamm L
FIR - Thompson, Paul M
IR  - Thompson PM
FIR - Tovar-Moll, Fernanda
IR  - Tovar-Moll F
FIR - van Erp, Theo G M
IR  - van Erp TGM
FIR - Vance, Alasdair
IR  - Vance A
FIR - Vilarroya, Oscar
IR  - Vilarroya O
FIR - Vives-Gilabert, Yolanda
IR  - Vives-Gilabert Y
FIR - von Polier, Georg G
IR  - von Polier GG
FIR - Walitza, Susanne
IR  - Walitza S
FIR - Yoncheva, Yuliya N
IR  - Yoncheva YN
FIR - Ziegler, Georg C
IR  - Ziegler GC
EDAT- 2021/02/03 06:00
MHDA- 2021/06/29 06:00
CRDT- 2021/02/02 06:04
PHST- 2020/11/30 00:00 [received]
PHST- 2021/01/05 00:00 [accepted]
PHST- 2020/12/07 00:00 [revised]
PHST- 2021/02/02 06:04 [entrez]
PHST- 2021/02/03 06:00 [pubmed]
PHST- 2021/06/29 06:00 [medline]
AID - 10.1038/s41398-021-01201-4 [pii]
AID - 1201 [pii]
AID - 10.1038/s41398-021-01201-4 [doi]
PST - epublish
SO  - Transl Psychiatry. 2021 Feb 1;11(1):82. doi: 10.1038/s41398-021-01201-4.

PMID- 31391148
OWN - NLM
STAT- MEDLINE
DCOM- 20210617
LR  - 20210617
IS  - 1573-2509 (Electronic)
IS  - 0920-9964 (Print)
IS  - 0920-9964 (Linking)
VI  - 217
DP  - 2020 Mar
TI  - Transcriptomic abnormalities in peripheral blood in bipolar disorder, and 
      discrimination of the major psychoses.
PG  - 124-135
LID - S0920-9964(19)30316-0 [pii]
LID - 10.1016/j.schres.2019.07.036 [doi]
AB  - We performed a transcriptome-wide meta-analysis and gene co-expression network 
      analysis to identify genes and gene networks dysregulated in the peripheral blood 
      of bipolar disorder (BD) cases relative to unaffected comparison subjects, and 
      determined the specificity of the transcriptomic signatures of BD and 
      schizophrenia (SZ). Nineteen genes and 4 gene modules were significantly 
      differentially expressed in BD cases. Thirteen gene modules were shown to be 
      differentially expressed in a combined case-group of BD and SZ subjects called 
      "major psychosis", including genes biologically linked to apoptosis, reactive 
      oxygen, chromatin remodeling, and immune signaling. No modules were 
      differentially expressed between BD and SZ cases. Machine-learning classifiers 
      trained to separate diagnostic classes based solely on gene expression profiles 
      could distinguish BD cases from unaffected comparison subjects with an area under 
      the curve (AUC) of 0.724, as well as BD cases from SZ cases with AUC = 0.677 in 
      withheld test samples. We introduced a novel and straightforward method called 
      "polytranscript risk scoring" that could distinguish BD cases from unaffected 
      subjects (AUC = 0.672) and SZ cases (AUC = 0.607) significantly better than 
      expected by chance. Taken together, our results highlighted gene expression 
      alterations common to BD and SZ that involve biological processes of 
      inflammation, oxidative stress, apoptosis, and chromatin regulation, and 
      highlight disorder-specific changes in gene expression that discriminate the 
      major psychoses.
CI  - Copyright © 2019 Elsevier B.V. All rights reserved.
FAU - Hess, Jonathan L
AU  - Hess JL
AD  - Psychiatric Genetic Epidemiology & Neurobiology Laboratory (PsychGENe Lab), 
      Departments of Psychiatry and Behavioral Sciences & Neuroscience and Physiology, 
      SUNY Upstate Medical University, Syracuse, NY, USA.
FAU - Tylee, Daniel S
AU  - Tylee DS
AD  - Psychiatric Genetic Epidemiology & Neurobiology Laboratory (PsychGENe Lab), 
      Departments of Psychiatry and Behavioral Sciences & Neuroscience and Physiology, 
      SUNY Upstate Medical University, Syracuse, NY, USA.
FAU - Barve, Rahul
AU  - Barve R
AD  - Psychiatric Genetic Epidemiology & Neurobiology Laboratory (PsychGENe Lab), 
      Departments of Psychiatry and Behavioral Sciences & Neuroscience and Physiology, 
      SUNY Upstate Medical University, Syracuse, NY, USA.
FAU - de Jong, Simone
AU  - de Jong S
AD  - MRC Social, Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, 
      Psychology & Neuroscience, King's College London, UK.
FAU - Ophoff, Roel A
AU  - Ophoff RA
AD  - Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and 
      Behavior, David Geffen School of Medicine at the University of California Los 
      Angeles, Los Angeles, CA, USA; Department of Psychiatry, Brain Center Rudolf 
      Magnus, University Medical Center Utrecht, Utrecht, the Netherlands.
FAU - Kumarasinghe, Nishantha
AU  - Kumarasinghe N
AD  - School of Medicine & Public Health, The University of Newcastle, Callaghan, 
      Newcastle, Australia.; Department of Anatomy, Faculty of Medical Sciences, 
      University of Sri Jayawardenepura, Nugegoda, Sri Lanka; Faculty of Medicine, Sir 
      John Kotelawala Defence University, Ratmalana, Sri Lanka.
FAU - Tooney, Paul
AU  - Tooney P
AD  - School of Biomedical Sciences & Pharmacy, Faculty of Health, The University of 
      Newcastle, New South Wales, Australia; Hunter Medical Research Institute, 
      Newcastle, Australia.
FAU - Schall, Ulrich
AU  - Schall U
AD  - School of Medicine & Public Health, The University of Newcastle, Callaghan, 
      Newcastle, Australia.; Priority Centre for Brain & Mental Health Research, The 
      University of Newcastle, Callaghan, Newcastle, Australia.
FAU - Gardiner, Erin
AU  - Gardiner E
AD  - School of Biomedical Sciences & Pharmacy, Faculty of Health, The University of 
      Newcastle, New South Wales, Australia; Priority Centre for Brain & Mental Health 
      Research, The University of Newcastle, Callaghan, Newcastle, Australia.
FAU - Beveridge, Natalie Jane
AU  - Beveridge NJ
AD  - School of Medicine & Public Health, The University of Newcastle, Callaghan, 
      Newcastle, Australia.; Hunter Medical Research Institute, Newcastle, Australia; 
      Priority Centre for Brain & Mental Health Research, The University of Newcastle, 
      Callaghan, Newcastle, Australia.
FAU - Scott, Rodney J
AU  - Scott RJ
AD  - School of Biomedical Sciences & Pharmacy, Faculty of Health, The University of 
      Newcastle, New South Wales, Australia; Hunter Medical Research Institute, 
      Newcastle, Australia.
FAU - Yasawardene, Surangi
AU  - Yasawardene S
AD  - Department of Anatomy, Faculty of Medical Sciences, University of Sri 
      Jayawardenepura, Nugegoda, Sri Lanka.
FAU - Perera, Antionette
AU  - Perera A
AD  - Department of Anatomy, Faculty of Medical Sciences, University of Sri 
      Jayawardenepura, Nugegoda, Sri Lanka.
FAU - Mendis, Jayan
AU  - Mendis J
AD  - Department of Anatomy, Faculty of Medical Sciences, University of Sri 
      Jayawardenepura, Nugegoda, Sri Lanka.
FAU - Carr, Vaughan
AU  - Carr V
AD  - School of Psychiatry, University of New South Wales, Kensington, New South Wales, 
      Australia.
FAU - Kelly, Brian
AU  - Kelly B
AD  - School of Medicine & Public Health, The University of Newcastle, Callaghan, 
      Newcastle, Australia.; Hunter Medical Research Institute, Newcastle, Australia; 
      Priority Centre for Brain & Mental Health Research, The University of Newcastle, 
      Callaghan, Newcastle, Australia.
FAU - Cairns, Murray
AU  - Cairns M
AD  - School of Biomedical Sciences & Pharmacy, Faculty of Health, The University of 
      Newcastle, New South Wales, Australia; Hunter Medical Research Institute, 
      Newcastle, Australia; Priority Centre for Brain & Mental Health Research, The 
      University of Newcastle, Callaghan, Newcastle, Australia.
CN  - Neurobehavioural Genetics Unit
FAU - Tsuang, Ming T
AU  - Tsuang MT
AD  - Center for Behavioral Genomics, Department of Psychiatry, Institute for Genomic 
      Medicine, University of California, San Diego, La Jolla, CA, USA; Harvard 
      Institute of Psychiatric Epidemiology and Genetics, Boston, USA.
FAU - Glatt, Stephen J
AU  - Glatt SJ
AD  - Psychiatric Genetic Epidemiology & Neurobiology Laboratory (PsychGENe Lab), 
      Departments of Psychiatry and Behavioral Sciences & Neuroscience and Physiology, 
      SUNY Upstate Medical University, Syracuse, NY, USA. Electronic address: 
      stephen.glatt@psychgenelab.com.
LA  - eng
GR  - R01 AG054002/AG/NIA NIH HHS/United States
GR  - R01 MH101519/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Meta-Analysis
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20190804
PL  - Netherlands
TA  - Schizophr Res
JT  - Schizophrenia research
JID - 8804207
SB  - IM
MH  - *Bipolar Disorder/genetics
MH  - Gene Expression Profiling
MH  - Humans
MH  - *Psychotic Disorders/genetics
MH  - *Schizophrenia/genetics
MH  - Transcriptome
PMC - PMC6997041
MID - NIHMS1536691
OTO - NOTNLM
OT  - Biomarker
OT  - Bipolar disorder
OT  - Peripheral blood
OT  - Schizophrenia
OT  - Transcriptome
COIS- Declaration of Competing Interest The authors have no conflicts of interest to 
      declare.
EDAT- 2019/08/09 06:00
MHDA- 2021/06/22 06:00
CRDT- 2019/08/09 06:00
PHST- 2019/02/08 00:00 [received]
PHST- 2019/07/20 00:00 [revised]
PHST- 2019/07/23 00:00 [accepted]
PHST- 2019/08/09 06:00 [pubmed]
PHST- 2021/06/22 06:00 [medline]
PHST- 2019/08/09 06:00 [entrez]
AID - S0920-9964(19)30316-0 [pii]
AID - 10.1016/j.schres.2019.07.036 [doi]
PST - ppublish
SO  - Schizophr Res. 2020 Mar;217:124-135. doi: 10.1016/j.schres.2019.07.036. Epub 2019 
      Aug 4.

PMID- 29238802
OWN - NLM
STAT- MEDLINE
DCOM- 20190909
LR  - 20190909
IS  - 2380-6591 (Electronic)
VI  - 3
IP  - 2
DP  - 2018 Feb 1
TI  - Dyspnea in a Young Man.
PG  - 177-178
LID - 10.1001/jamacardio.2017.4676 [doi]
FAU - Abdelghany, Mahmoud
AU  - Abdelghany M
AD  - Division of Cardiology, Department of Medicine, State University of New York, 
      Upstate Medical University, Syracuse.
FAU - Chaudhary, Arbind
AU  - Chaudhary A
AD  - Division of Cardiology, Department of Medicine, State University of New York, 
      Upstate Medical University, Syracuse.
FAU - Mookherjee, Sakti
AU  - Mookherjee S
AD  - Division of Cardiology, Department of Medicine, State University of New York, 
      Upstate Medical University, Syracuse.
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - United States
TA  - JAMA Cardiol
JT  - JAMA cardiology
JID - 101676033
SB  - IM
MH  - Adult
MH  - Dyspnea/*etiology
MH  - Electrocardiography
MH  - Genetic Testing
MH  - Humans
MH  - Male
MH  - Muscular Dystrophy, Duchenne/complications/*diagnosis/genetics
EDAT- 2017/12/15 06:00
MHDA- 2019/09/10 06:00
CRDT- 2017/12/15 06:00
PHST- 2017/12/15 06:00 [pubmed]
PHST- 2019/09/10 06:00 [medline]
PHST- 2017/12/15 06:00 [entrez]
AID - 2666118 [pii]
AID - 10.1001/jamacardio.2017.4676 [doi]
PST - ppublish
SO  - JAMA Cardiol. 2018 Feb 1;3(2):177-178. doi: 10.1001/jamacardio.2017.4676.

PMID- 34062403
OWN - NLM
STAT- MEDLINE
DCOM- 20210624
LR  - 20210624
IS  - 1879-2448 (Electronic)
IS  - 0043-1354 (Linking)
VI  - 200
DP  - 2021 Jul 15
TI  - Detecting anomalous methane in groundwater within hydrocarbon production areas 
      across the United States.
PG  - 117236
LID - S0043-1354(21)00434-6 [pii]
LID - 10.1016/j.watres.2021.117236 [doi]
AB  - Numerous geochemical approaches have been proposed to ascertain if methane 
      concentrations in groundwater, [CH(4)], are anomalous, i.e., migrated from 
      hydrocarbon production wells, rather than derived from natural sources. We 
      propose a machine-learning model to consider alkalinity, Ca, Mg, Na, Ba, Fe, Mn, 
      Cl, sulfate, TDS, specific conductance, pH, temperature, and turbidity 
      holistically together. The model, an ensemble of sub-models targeting one 
      parameter pair per sub-model, was trained with groundwater chemistry from 
      Pennsylvania (n=19,086) and a set of 16 analyses from putatively contaminated 
      groundwater. For cases where [CH(4)] ≥ 10 mg/L, salinity- and redox-related 
      parameters sometimes show that CH(4) may have moved into the aquifer recently and 
      separately from natural brine migration, i.e., anomalous CH(4). We applied the 
      model to validation and hold-out data for Pennsylvania (n=4,786) and groundwater 
      data from three other gas-producing states: New York (n=203), Texas (n=688), and 
      Colorado (n=10,258). The applications show that 1.4%, 1.3%, 0%, and 0.9% of 
      tested samples in these four states, respectively, have high [CH(4)] and are ≥50% 
      likely to have been impacted by gas migrated from exploited reservoirs. If our 
      approach is indeed successful in flagging anomalous CH(4), we conclude that: i) 
      the frequency of anomalous CH(4) (# flagged water samples / total samples tested) 
      in the Appalachian Basin is similar in areas where gas wells target 
      unconventional as compared to conventional reservoirs, and ii) the frequency of 
      anomalous CH(4) in Pennsylvania is higher than in Texas + Colorado. We cannot, 
      however, exclude the possibility that differences among regions might be affected 
      by differences in data volumes. Machine learning models will become increasingly 
      useful in informing decision-making for shale gas development.
CI  - Copyright © 2021 Elsevier Ltd. All rights reserved.
FAU - Wen, Tao
AU  - Wen T
AD  - Department of Earth and Environmental Sciences, Syracuse University, Syracuse, 
      New York 13244, United States. Electronic address: twen08@syr.edu.
FAU - Liu, Mengqi
AU  - Liu M
AD  - College of Information Sciences and Technology, Pennsylvania State University, 
      University Park, Pennsylvania 16802, United States.
FAU - Woda, Josh
AU  - Woda J
AD  - Department of Geosciences, Pennsylvania State University, University Park, 
      Pennsylvania 16802, United States.
FAU - Zheng, Guanjie
AU  - Zheng G
AD  - College of Information Sciences and Technology, Pennsylvania State University, 
      University Park, Pennsylvania 16802, United States.
FAU - Brantley, Susan L
AU  - Brantley SL
AD  - Department of Geosciences, Pennsylvania State University, University Park, 
      Pennsylvania 16802, United States; Earth and Environmental Systems Institute, 
      Pennsylvania State University, University Park, Pennsylvania 16802, United 
      States.
LA  - eng
PT  - Journal Article
DEP - 20210513
PL  - England
TA  - Water Res
JT  - Water research
JID - 0105072
RN  - 0 (Hydrocarbons)
RN  - 0 (Natural Gas)
RN  - 0 (Water Pollutants, Chemical)
RN  - OP0UW79H66 (Methane)
SB  - IM
MH  - Colorado
MH  - Environmental Monitoring
MH  - *Groundwater
MH  - Hydrocarbons
MH  - Methane/analysis
MH  - Natural Gas
MH  - New York
MH  - Oil and Gas Fields
MH  - Pennsylvania
MH  - Texas
MH  - *Water Pollutants, Chemical/analysis
OTO - NOTNLM
OT  - Shale gas
OT  - groundwater
OT  - machine learning
OT  - methane, redox, salinity
EDAT- 2021/06/02 06:00
MHDA- 2021/06/25 06:00
CRDT- 2021/06/01 20:21
PHST- 2021/01/23 00:00 [received]
PHST- 2021/04/14 00:00 [revised]
PHST- 2021/05/07 00:00 [accepted]
PHST- 2021/06/02 06:00 [pubmed]
PHST- 2021/06/25 06:00 [medline]
PHST- 2021/06/01 20:21 [entrez]
AID - S0043-1354(21)00434-6 [pii]
AID - 10.1016/j.watres.2021.117236 [doi]
PST - ppublish
SO  - Water Res. 2021 Jul 15;200:117236. doi: 10.1016/j.watres.2021.117236. Epub 2021 
      May 13.

PMID- 35475041
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220716
IS  - 2168-8184 (Print)
IS  - 2168-8184 (Electronic)
IS  - 2168-8184 (Linking)
VI  - 14
IP  - 3
DP  - 2022 Mar
TI  - A Rare Case of Juvenile Polyposis Syndrome Mimicking Ménétrier's Disease.
PG  - e23389
LID - 10.7759/cureus.23389 [doi]
LID - e23389
AB  - There is a wide differential diagnosis within polyposis syndromes. Our case 
      represents an interesting and diagnostically challenging diagnosis involving a 
      41-year-old male who presented with an incidental gastric mass on imaging and a 
      colonic mass seen on colonoscopy. Following multiple endoscopic evaluations, 
      histological analysis, and genetic testing, the patient was ultimately diagnosed 
      with juvenile polyposis syndrome (JPS)/hereditary hemorrhagic telangiectasia 
      (HHT) despite the initial suspicion for Ménétrier's disease. His disease course 
      was complicated by an acute upper extremity thrombus and diagnosis of colorectal 
      carcinoma. This case highlights the importance of a thorough evaluation when 
      polyposis syndromes are suspected. Prompt and accurate diagnosis can aid in the 
      treatment, surveillance, and prevention of colorectal carcinoma.
CI  - Copyright © 2022, Bernshteyn et al.
FAU - Bernshteyn, Michelle
AU  - Bernshteyn M
AD  - Internal Medicine, Upstate University Hospital, Syracuse, USA.
FAU - Bhutta, Abdul Q
AU  - Bhutta AQ
AD  - Gastroenterology, Upstate University Hospital, Syracuse, USA.
FAU - Bordas, Jozsef
AU  - Bordas J
AD  - Pathology, Upstate University Hospital, Syracuse, USA.
FAU - Mehta, Rohin
AU  - Mehta R
AD  - Pathology, Upstate University Hospital, Syracuse, USA.
FAU - Arif, Muhammad Osman
AU  - Arif MO
AD  - Gastroenterology, Upstate University Hospital, Syracuse, USA.
LA  - eng
PT  - Case Reports
DEP - 20220322
PL  - United States
TA  - Cureus
JT  - Cureus
JID - 101596737
PMC - PMC9022607
OTO - NOTNLM
OT  - colorectal cancer
OT  - gastroenterology and endoscopy
OT  - gastrointestinal polyposis
OT  - gi polyposis syndrome
OT  - juvenile polyposis syndrome
OT  - menetrier's disease
OT  - polyposis
OT  - protein-losing enteropathy
OT  - upper extremity deep venous thrombosis
OT  -  colonoscopy
COIS- The authors have declared that no competing interests exist.
EDAT- 2022/04/28 06:00
MHDA- 2022/04/28 06:01
CRDT- 2022/04/27 06:20
PHST- 2022/03/22 00:00 [accepted]
PHST- 2022/04/27 06:20 [entrez]
PHST- 2022/04/28 06:00 [pubmed]
PHST- 2022/04/28 06:01 [medline]
AID - 10.7759/cureus.23389 [doi]
PST - epublish
SO  - Cureus. 2022 Mar 22;14(3):e23389. doi: 10.7759/cureus.23389. eCollection 2022 
      Mar.

PMID- 27004716
OWN - NLM
STAT- MEDLINE
DCOM- 20170921
LR  - 20220129
IS  - 1552-485X (Electronic)
IS  - 1552-4841 (Print)
IS  - 1552-4841 (Linking)
VI  - 171
IP  - 6
DP  - 2016 Sep
TI  - Pathway analysis in attention deficit hyperactivity disorder: An ensemble 
      approach.
PG  - 815-26
LID - 10.1002/ajmg.b.32446 [doi]
AB  - Despite a wealth of evidence for the role of genetics in attention deficit 
      hyperactivity disorder (ADHD), specific and definitive genetic mechanisms have 
      not been identified. Pathway analyses, a subset of gene-set analyses, extend the 
      knowledge gained from genome-wide association studies (GWAS) by providing 
      functional context for genetic associations. However, there are numerous methods 
      for association testing of gene sets and no real consensus regarding the best 
      approach. The present study applied six pathway analysis methods to identify 
      pathways associated with ADHD in two GWAS datasets from the Psychiatric Genomics 
      Consortium. Methods that utilize genotypes to model pathway-level effects 
      identified more replicable pathway associations than methods using summary 
      statistics. In addition, pathways implicated by more than one method were 
      significantly more likely to replicate. A number of brain-relevant pathways, such 
      as RhoA signaling, glycosaminoglycan biosynthesis, fibroblast growth factor 
      receptor activity, and pathways containing potassium channel genes, were 
      nominally significant by multiple methods in both datasets. These results support 
      previous hypotheses about the role of regulation of neurotransmitter release, 
      neurite outgrowth and axon guidance in contributing to the ADHD phenotype and 
      suggest the value of cross-method convergence in evaluating pathway analysis 
      results. © 2016 Wiley Periodicals, Inc.
CI  - © 2016 Wiley Periodicals, Inc.
FAU - Mooney, Michael A
AU  - Mooney MA
AD  - Division of Bioinformatics & Computational Biology, Department of Medical 
      Informatics & Clinical Epidemiology, Oregon Health & Science University, 
      Portland, Oregon.
AD  - OHSU Knight Cancer Institute, Portland, Oregon.
FAU - McWeeney, Shannon K
AU  - McWeeney SK
AD  - Division of Bioinformatics & Computational Biology, Department of Medical 
      Informatics & Clinical Epidemiology, Oregon Health & Science University, 
      Portland, Oregon.
AD  - OHSU Knight Cancer Institute, Portland, Oregon.
AD  - Oregon Clinical and Translational Research Institute, Portland, Oregon.
FAU - Faraone, Stephen V
AU  - Faraone SV
AD  - Departments of Psychiatry and Neuroscience & Physiology, State University of New 
      York, Syracuse, New York.
AD  - K.G. Jebsen Centre for Neuropsychiatric Disorders, Department of Biomedicine, 
      University of Bergen, Bergen, Norway.
FAU - Hinney, Anke
AU  - Hinney A
AD  - Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, 
      University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
FAU - Hebebrand, Johannes
AU  - Hebebrand J
AD  - Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, 
      University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
CN  - IMAGE2 Consortium
CN  - German ADHD GWAS Group
FAU - Nigg, Joel T
AU  - Nigg JT
AD  - Division of Psychology, Department of Psychiatry, Oregon Health & Science 
      University, Portland, Oregon.
AD  - Department of Behavioral Neuroscience, Oregon Health & Science University, 
      Portland, Oregon.
FAU - Wilmot, Beth
AU  - Wilmot B
AD  - Division of Bioinformatics & Computational Biology, Department of Medical 
      Informatics & Clinical Epidemiology, Oregon Health & Science University, 
      Portland, Oregon.
AD  - OHSU Knight Cancer Institute, Portland, Oregon.
AD  - Oregon Clinical and Translational Research Institute, Portland, Oregon.
LA  - eng
GR  - R01 MH094469/MH/NIMH NIH HHS/United States
GR  - UL1 TR000128/TR/NCATS NIH HHS/United States
GR  - MR/L010305/1/MRC_/Medical Research Council/United Kingdom
GR  - R13 MH059126/MH/NIMH NIH HHS/United States
GR  - R01 MH099064/MH/NIMH NIH HHS/United States
GR  - U54 EB020403/EB/NIBIB NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20160322
PL  - United States
TA  - Am J Med Genet B Neuropsychiatr Genet
JT  - American journal of medical genetics. Part B, Neuropsychiatric genetics : the 
      official publication of the International Society of Psychiatric Genetics
JID - 101235742
SB  - IM
MH  - Attention Deficit Disorder with Hyperactivity/*genetics/metabolism
MH  - Databases, Nucleic Acid
MH  - Genetic Predisposition to Disease/genetics
MH  - Genome-Wide Association Study/methods
MH  - Genotype
MH  - Humans
MH  - Polymorphism, Single Nucleotide/genetics
PMC - PMC4983253
MID - NIHMS795071
OTO - NOTNLM
OT  - ADHD
OT  - GWAS
OT  - pathway analyses
COIS- Conflict of interest: Barbara Franke received a speaker fee from Merz. All other 
      authors declare no conflict of interest.
FIR - Faraone, Stephen V
IR  - Faraone SV
FIR - Romanos, Marcel
IR  - Romanos M
FIR - Warnke, Andreas
IR  - Warnke A
FIR - Reif, Andreas
IR  - Reif A
FIR - Walitza, Susanne
IR  - Walitza S
FIR - Roeyers, Herbert
IR  - Roeyers H
FIR - Franke, Barbara
IR  - Franke B
FIR - Buitelaar, Jan K
IR  - Buitelaar JK
FIR - Lesch, Klaus-Peter
IR  - Lesch KP
FIR - Kent, Lindsey
IR  - Kent L
FIR - Vasquez, Alejandro Arias
IR  - Vasquez AA
FIR - Thapar, Anita
IR  - Thapar A
FIR - Martin, Joanna
IR  - Martin J
FIR - O'Donovan, Michael C
IR  - O'Donovan MC
FIR - Owen, Michael J
IR  - Owen MJ
FIR - Williams, Nigel
IR  - Williams N
FIR - Holmans, Peter
IR  - Holmans P
FIR - Langley, Kate
IR  - Langley K
FIR - Freitag, Christine
IR  - Freitag C
FIR - Lambregts-Rommelse, Nanda
IR  - Lambregts-Rommelse N
FIR - Anney, Richard J L
IR  - Anney RJ
FIR - Mulligan, Aisling
IR  - Mulligan A
FIR - Rothenberger, Aribert
IR  - Rothenberger A
FIR - Steinhausen, Hans-Christoph
IR  - Steinhausen HC
FIR - Gill, Michael
IR  - Gill M
FIR - Asherson, Philip
IR  - Asherson P
FIR - Nguyen, T Trang
IR  - Nguyen TT
FIR - Biederman, Joseph
IR  - Biederman J
FIR - Doyle, Alysa E
IR  - Doyle AE
FIR - Romanos, Jasmin
IR  - Romanos J
FIR - Rivero, Olga
IR  - Rivero O
FIR - Palmason, Haukur
IR  - Palmason H
FIR - Meyer, Jobst
IR  - Meyer J
FIR - Renner, Tobias J
IR  - Renner TJ
FIR - Hinney, Anke
IR  - Hinney A
FIR - Albayrak, Özgür
IR  - Albayrak Ö
FIR - Volckmar, Anna-Lena
IR  - Volckmar AL
FIR - Hebebrand, Johannes
IR  - Hebebrand J
FIR - Dempfle, Astrid
IR  - Dempfle A
FIR - Cichon, Sven
IR  - Cichon S
FIR - Hoffmann, Per
IR  - Hoffmann P
FIR - Nöthen, Markus M
IR  - Nöthen MM
FIR - Schreiber, Stefan
IR  - Schreiber S
FIR - Möbus, Susanne
IR  - Möbus S
FIR - Wichmann, H-Erich
IR  - Wichmann HE
FIR - Herpertz-Dahlmann, Beate
IR  - Herpertz-Dahlmann B
FIR - Sinzig, Judith
IR  - Sinzig J
FIR - Lehmkuhl, Gerd
IR  - Lehmkuhl G
FIR - Renner, Tobias J
IR  - Renner TJ
FIR - Romanos, Marcel
IR  - Romanos M
FIR - Schimmelmann, Benno G
IR  - Schimmelmann BG
EDAT- 2016/03/24 06:00
MHDA- 2017/09/22 06:00
PMCR- 2017/03/01
CRDT- 2016/03/24 06:00
PHST- 2016/02/29 00:00 [received]
PHST- 2016/03/07 00:00 [accepted]
PHST- 2017/03/01 00:00 [pmc-release]
PHST- 2016/03/24 06:00 [entrez]
PHST- 2016/03/24 06:00 [pubmed]
PHST- 2017/09/22 06:00 [medline]
AID - 10.1002/ajmg.b.32446 [doi]
PST - ppublish
SO  - Am J Med Genet B Neuropsychiatr Genet. 2016 Sep;171(6):815-26. doi: 
      10.1002/ajmg.b.32446. Epub 2016 Mar 22.

PMID- 37595761
OWN - NLM
STAT- MEDLINE
DCOM- 20231216
LR  - 20231216
IS  - 1097-6825 (Electronic)
IS  - 0091-6749 (Linking)
VI  - 152
IP  - 6
DP  - 2023 Dec
TI  - Polygenic risk scores identify heterogeneity in asthma and chronic obstructive 
      pulmonary disease.
PG  - 1423-1432
LID - S0091-6749(23)00988-0 [pii]
LID - 10.1016/j.jaci.2023.08.002 [doi]
AB  - BACKGROUND: Asthma and chronic obstructive pulmonary disease (COPD) have distinct 
      and overlapping genetic and clinical features. OBJECTIVE: We sought to test the 
      hypothesis that polygenic risk scores (PRSs) for asthma (PRS(Asthma)) and 
      spirometry (FEV(1) and FEV(1)/forced vital capacity; PRS(spiro)) would 
      demonstrate differential associations with asthma, COPD, and asthma-COPD overlap 
      (ACO). METHODS: We developed and tested 2 asthma PRSs and applied the higher 
      performing PRS(Asthma) and a previously published PRS(spiro) to research (Genetic 
      Epidemiology of COPD study and Childhood Asthma Management Program, with 
      spirometry) and electronic health record-based (Mass General Brigham Biobank and 
      Genetic Epidemiology Research on Adult Health and Aging [GERA]) studies. We 
      assessed the association of PRSs with COPD and asthma using modified 
      random-effects and binary-effects meta-analyses, and ACO and asthma exacerbations 
      in specific cohorts. Models were adjusted for confounders and genetic ancestry. 
      RESULTS: In meta-analyses of 102,477 participants, the PRS(Asthma) (odds ratio 
      [OR] per SD, 1.16 [95% CI, 1.14-1.19]) and PRS(spiro) (OR per SD, 1.19 [95% CI, 
      1.17-1.22]) both predicted asthma, whereas the PRS(spiro) predicted COPD (OR per 
      SD, 1.25 [95% CI, 1.21-1.30]). However, results differed by cohort. The 
      PRS(spiro) was not associated with COPD in GERA and Mass General Brigham Biobank. 
      In the Genetic Epidemiology of COPD study, the PRS(Asthma) (OR per SD: Whites, 
      1.3; African Americans, 1.2) and PRS(spiro) (OR per SD: Whites, 2.2; African 
      Americans, 1.6) were both associated with ACO. In GERA, the PRS(Asthma) was 
      associated with asthma exacerbations (OR, 1.18) in Whites; the PRS(spiro) was 
      associated with asthma exacerbations in White, LatinX, and East Asian 
      participants. CONCLUSIONS: PRSs for asthma and spirometry are both associated 
      with ACO and asthma exacerbations. Genetic prediction performance differs in 
      research versus electronic health record-based cohorts.
CI  - Published by Elsevier Inc.
FAU - Moll, Matthew
AU  - Moll M
AD  - Department of Medicine, Channing Division of Network Medicine, Division of 
      Pulmonary and Critical Care Medicine, Harvard Medical School, Boston, Mass; 
      Harvard Medical School, Brigham and Women's Hospital, Boston, Mass.
FAU - Sordillo, Joanne E
AU  - Sordillo JE
AD  - Department of Population Medicine, PRecisiOn Medicine Translational Research 
      (PROMoTeR) Center, Harvard Medical School and Harvard Pilgrim Health Care, 
      Boston, Mass.
FAU - Ghosh, Auyon J
AU  - Ghosh AJ
AD  - Division of Pulmonary and Critical Care Medicine, Department of Medicine, SUNY 
      Upstate Medical Center, Syracuse, NY.
FAU - Hayden, Lystra P
AU  - Hayden LP
AD  - Department of Pediatrics, Division of Pulmonary Medicine, Boston Children's 
      Hospital, Harvard Medical School, Massachusetts General Hospital, Boston, Mass; 
      Department of Medicine, Channing Division of Network Medicine, Brigham and 
      Women's Hospital, Massachusetts General Hospital, Boston, Mass.
FAU - McDermott, Gregory
AU  - McDermott G
AD  - Harvard Medical School, Brigham and Women's Hospital, Boston, Mass; Department of 
      Medicine, Division of Rheumatology, Inflammation, and Immunity, Brigham and 
      Women's Hospital, Boston, Mass.
FAU - McGeachie, Michael J
AU  - McGeachie MJ
AD  - Harvard Medical School, Brigham and Women's Hospital, Boston, Mass; Department of 
      Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital, 
      Massachusetts General Hospital, Boston, Mass.
FAU - Dahlin, Amber
AU  - Dahlin A
AD  - Harvard Medical School, Brigham and Women's Hospital, Boston, Mass; Department of 
      Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital, 
      Massachusetts General Hospital, Boston, Mass.
FAU - Tiwari, Anshul
AU  - Tiwari A
AD  - Harvard Medical School, Brigham and Women's Hospital, Boston, Mass; Department of 
      Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital, 
      Massachusetts General Hospital, Boston, Mass.
FAU - Manmadkar, Monica G
AU  - Manmadkar MG
AD  - Harvard Medical School, Brigham and Women's Hospital, Boston, Mass; Department of 
      Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital, 
      Massachusetts General Hospital, Boston, Mass.
FAU - Abston, Eric D
AU  - Abston ED
AD  - Department of Thoracic Surgery, Massachusetts General Hospital, Boston, Mass.
FAU - Pavuluri, Chandan
AU  - Pavuluri C
AD  - Department of Medicine, Channing Division of Network Medicine, Division of 
      Pulmonary and Critical Care Medicine, Harvard Medical School, Boston, Mass; 
      Harvard Medical School, Brigham and Women's Hospital, Boston, Mass.
FAU - Saferali, Aabida
AU  - Saferali A
AD  - Harvard Medical School, Brigham and Women's Hospital, Boston, Mass; Department of 
      Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital, 
      Massachusetts General Hospital, Boston, Mass.
FAU - Begum, Sofina
AU  - Begum S
AD  - Harvard Medical School, Brigham and Women's Hospital, Boston, Mass; Department of 
      Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital, 
      Massachusetts General Hospital, Boston, Mass.
FAU - Ziniti, John P
AU  - Ziniti JP
AD  - Harvard Medical School, Brigham and Women's Hospital, Boston, Mass; Department of 
      Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital, 
      Massachusetts General Hospital, Boston, Mass.
FAU - Gulsvik, Amund
AU  - Gulsvik A
AD  - Department of Clinical Science, University of Bergen, Bergen, Norway.
FAU - Bakke, Per S
AU  - Bakke PS
AD  - Department of Clinical Science, University of Bergen, Bergen, Norway.
FAU - Aschard, Hugues
AU  - Aschard H
AD  - Department of Computational Biology, Institut Pasteur, Universit de Paris, Paris, 
      France.
FAU - Iribarren, Carlos
AU  - Iribarren C
AD  - Division of Research, Kaiser Permanente Northern California, Oakland, Calif.
FAU - Hersh, Craig P
AU  - Hersh CP
AD  - Department of Medicine, Channing Division of Network Medicine, Division of 
      Pulmonary and Critical Care Medicine, Harvard Medical School, Boston, Mass; 
      Harvard Medical School, Brigham and Women's Hospital, Boston, Mass.
FAU - Sparks, Jeffrey A
AU  - Sparks JA
AD  - Harvard Medical School, Brigham and Women's Hospital, Boston, Mass; Department of 
      Medicine, Division of Rheumatology, Inflammation, and Immunity, Brigham and 
      Women's Hospital, Boston, Mass.
FAU - Hobbs, Brian D
AU  - Hobbs BD
AD  - Department of Medicine, Channing Division of Network Medicine, Division of 
      Pulmonary and Critical Care Medicine, Harvard Medical School, Boston, Mass; 
      Harvard Medical School, Brigham and Women's Hospital, Boston, Mass.
FAU - Lasky-Su, Jessica A
AU  - Lasky-Su JA
AD  - Harvard Medical School, Brigham and Women's Hospital, Boston, Mass; Department of 
      Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital, 
      Massachusetts General Hospital, Boston, Mass.
FAU - Silverman, Edwin K
AU  - Silverman EK
AD  - Harvard Medical School, Brigham and Women's Hospital, Boston, Mass; Department of 
      Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital, 
      Massachusetts General Hospital, Boston, Mass.
FAU - Weiss, Scott T
AU  - Weiss ST
AD  - Harvard Medical School, Brigham and Women's Hospital, Boston, Mass; Department of 
      Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital, 
      Massachusetts General Hospital, Boston, Mass.
FAU - Wu, Ann Chen
AU  - Wu AC
AD  - Department of Population Medicine, PRecisiOn Medicine Translational Research 
      (PROMoTeR) Center, Harvard Medical School and Harvard Pilgrim Health Care, 
      Boston, Mass.
FAU - Cho, Michael H
AU  - Cho MH
AD  - Department of Medicine, Channing Division of Network Medicine, Division of 
      Pulmonary and Critical Care Medicine, Harvard Medical School, Boston, Mass; 
      Harvard Medical School, Brigham and Women's Hospital, Boston, Mass. Electronic 
      address: remol@channing.harvard.edu.
LA  - eng
GR  - K23 HL136851/HL/NHLBI NIH HHS/United States
GR  - P01 HL132825/HL/NHLBI NIH HHS/United States
GR  - R01 HL135142/HL/NHLBI NIH HHS/United States
PT  - Journal Article
DEP - 20230816
PL  - United States
TA  - J Allergy Clin Immunol
JT  - The Journal of allergy and clinical immunology
JID - 1275002
SB  - IM
MH  - Adult
MH  - Humans
MH  - Child
MH  - *Pulmonary Disease, Chronic Obstructive/epidemiology/genetics
MH  - *Asthma/epidemiology/genetics
MH  - Vital Capacity
MH  - Respiratory Function Tests
MH  - Forced Expiratory Volume
OTO - NOTNLM
OT  - Asthma
OT  - asthma-COPD overlap
OT  - chronic obstructive pulmonary disease
OT  - heterogeneity
OT  - polygenic risk scores
EDAT- 2023/08/19 11:41
MHDA- 2023/12/17 09:42
CRDT- 2023/08/18 19:24
PHST- 2023/01/11 00:00 [received]
PHST- 2023/07/27 00:00 [revised]
PHST- 2023/08/08 00:00 [accepted]
PHST- 2023/12/17 09:42 [medline]
PHST- 2023/08/19 11:41 [pubmed]
PHST- 2023/08/18 19:24 [entrez]
AID - S0091-6749(23)00988-0 [pii]
AID - 10.1016/j.jaci.2023.08.002 [doi]
PST - ppublish
SO  - J Allergy Clin Immunol. 2023 Dec;152(6):1423-1432. doi: 
      10.1016/j.jaci.2023.08.002. Epub 2023 Aug 16.

PMID- 26196440
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20220129
IS  - 2158-3188 (Electronic)
IS  - 2158-3188 (Linking)
VI  - 5
IP  - 7
DP  - 2015 Jul 21
TI  - Analysis of exome sequence in 604 trios for recessive genotypes in schizophrenia.
PG  - e607
LID - 10.1038/tp.2015.99 [doi]
AB  - Genetic associations involving both rare and common alleles have been reported 
      for schizophrenia but there have been no systematic scans for rare recessive 
      genotypes using fully phased trio data. Here, we use exome sequencing in 604 
      schizophrenia proband-parent trios to investigate the role of recessive 
      (homozygous or compound heterozygous) nonsynonymous genotypes in the disorder. 
      The burden of recessive genotypes was not significantly increased in probands at 
      either a genome-wide level or in any individual gene after adjustment for 
      multiple testing. At a system level, probands had an excess of nonsynonymous 
      compound heterozygous genotypes (minor allele frequency, MAF ⩽ 1%) in 
      voltage-gated sodium channels (VGSCs; eight in probands and none in parents, P = 
      1.5 × 10(-)(4)). Previous findings of multiple de novo loss-of-function mutations 
      in this gene family, particularly SCN2A, in autism and intellectual disability 
      provide biological and genetic plausibility for this finding. Pointing further to 
      the involvement of VGSCs in schizophrenia, we found that these genes were 
      enriched for nonsynonymous mutations (MAF ⩽ 0.1%) in cases genotyped using an 
      exome array, (5585 schizophrenia cases and 8103 controls), and that in the trios 
      data, synaptic proteins interacting with VGSCs were also enriched for both 
      compound heterozygosity (P = 0.018) and de novo mutations (P = 0.04). However, we 
      were unable to replicate the specific association with compound heterozygosity at 
      VGSCs in an independent sample of Taiwanese schizophrenia trios (N = 614). We 
      conclude that recessive genotypes do not appear to make a substantial 
      contribution to schizophrenia at a genome-wide level. Although multiple lines of 
      evidence, including several from this study, suggest that rare mutations in VGSCs 
      contribute to the disorder, in the absence of replication of the original 
      findings regarding compound heterozygosity, this conclusion requires evaluation 
      in a larger sample of trios.
FAU - Rees, E
AU  - Rees E
AD  - Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, 
      Institute of Psychological Medicine and Clinical Neurosciences, Cardiff 
      University, Cardiff, UK.
FAU - Kirov, G
AU  - Kirov G
AD  - Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, 
      Institute of Psychological Medicine and Clinical Neurosciences, Cardiff 
      University, Cardiff, UK.
FAU - Walters, J T
AU  - Walters JT
AD  - Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, 
      Institute of Psychological Medicine and Clinical Neurosciences, Cardiff 
      University, Cardiff, UK.
FAU - Richards, A L
AU  - Richards AL
AD  - Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, 
      Institute of Psychological Medicine and Clinical Neurosciences, Cardiff 
      University, Cardiff, UK.
FAU - Howrigan, D
AU  - Howrigan D
AD  - Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts 
      General Hospital and Harvard Medical School, Boston, MA, USA.
FAU - Kavanagh, D H
AU  - Kavanagh DH
AD  - Division of Psychiatric Genomics, Department of Psychiatry, Institute for 
      Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New 
      York, NY, USA.
FAU - Pocklington, A J
AU  - Pocklington AJ
AD  - Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, 
      Institute of Psychological Medicine and Clinical Neurosciences, Cardiff 
      University, Cardiff, UK.
FAU - Fromer, M
AU  - Fromer M
AD  - 1] Division of Psychiatric Genomics, Department of Psychiatry, Institute for 
      Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New 
      York, NY, USA [2] Stanley Center for Psychiatric Research, Broad Institute of MIT 
      and Harvard, Cambridge, MA, USA.
FAU - Ruderfer, D M
AU  - Ruderfer DM
AD  - Division of Psychiatric Genomics, Department of Psychiatry, Institute for 
      Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New 
      York, NY, USA.
FAU - Georgieva, L
AU  - Georgieva L
AD  - Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, 
      Institute of Psychological Medicine and Clinical Neurosciences, Cardiff 
      University, Cardiff, UK.
FAU - Carrera, N
AU  - Carrera N
AD  - Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, 
      Institute of Psychological Medicine and Clinical Neurosciences, Cardiff 
      University, Cardiff, UK.
FAU - Gormley, P
AU  - Gormley P
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
FAU - Palta, P
AU  - Palta P
AUID- ORCID: 0000000193207008
AD  - Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, 
      Finland.
FAU - Williams, H
AU  - Williams H
AD  - GOSgene,ICH Genetics and Genomic Medicine Program, Institute of Child Health, 
      Faculty of Population Health Sciences, University College London, London, UK.
FAU - Dwyer, S
AU  - Dwyer S
AD  - Molecular Genetics and Genomics, National Heart and Lung Institute, Imperial 
      College London, London, UK.
FAU - Johnson, J S
AU  - Johnson JS
AD  - Division of Psychiatric Genomics, Department of Psychiatry, Institute for 
      Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New 
      York, NY, USA.
FAU - Roussos, P
AU  - Roussos P
AD  - Division of Psychiatric Genomics, Department of Psychiatry, Institute for 
      Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New 
      York, NY, USA.
FAU - Barker, D D
AU  - Barker DD
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
FAU - Banks, E
AU  - Banks E
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
FAU - Milanova, V
AU  - Milanova V
AD  - Department of Psychiatry, Medical University, Sofia, Bulgaria.
FAU - Rose, S A
AU  - Rose SA
AD  - Division of Psychiatric Genomics, Department of Psychiatry, Institute for 
      Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New 
      York, NY, USA.
FAU - Chambert, K
AU  - Chambert K
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
FAU - Mahajan, M
AU  - Mahajan M
AD  - Division of Psychiatric Genomics, Department of Psychiatry, Institute for 
      Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New 
      York, NY, USA.
FAU - Scolnick, E M
AU  - Scolnick EM
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
FAU - Moran, J L
AU  - Moran JL
AD  - Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
FAU - Tsuang, M T
AU  - Tsuang MT
AD  - 1] Center for Behavioral Genomics and Institute for Genomic Medicine, University 
      of California, San Diego, La Jolla, CA, USA [2] Department of Psychiatry, 
      University of California, San Diego, La Jolla, CA, USA [3] Harvard Institute of 
      Psychiatric Epidemiology and Genetics, Boston, MA, USA.
FAU - Glatt, S J
AU  - Glatt SJ
AD  - Psychiatric Genetic Epidemiology and Neurobiology Laboratory (PsychGENe Lab); 
      Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, Syracuse, NY, USA.
FAU - Chen, W J
AU  - Chen WJ
AD  - Institute of Epidemiology and Preventive Medicine, College of Public Health, 
      National Taiwan University, Taipei, Taiwan.
FAU - Hwu, H-G
AU  - Hwu HG
AD  - 1] Institute of Epidemiology and Preventive Medicine, College of Public Health, 
      National Taiwan University, Taipei, Taiwan [2] Department of Psychiatry, National 
      Taiwan University Hospital, College of Medicine, National Taiwan University, 
      Taipei, Taiwan.
CN  - Taiwanese Trios Exome Sequencing Consortium
FAU - Neale, B M
AU  - Neale BM
AD  - 1] Analytic and Translational Genetics Unit, Department of Medicine, 
      Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA [2] 
      Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
FAU - Palotie, A
AU  - Palotie A
AD  - Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA.
FAU - Sklar, P
AU  - Sklar P
AD  - Division of Psychiatric Genomics, Department of Psychiatry, Institute for 
      Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New 
      York, NY, USA.
FAU - Purcell, S M
AU  - Purcell SM
AD  - 1] Division of Psychiatric Genomics, Department of Psychiatry, Institute for 
      Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New 
      York, NY, USA [2] Stanley Center for Psychiatric Research, Broad Institute of MIT 
      and Harvard, Cambridge, MA, USA.
FAU - McCarroll, S A
AU  - McCarroll SA
AD  - 1] Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
      Cambridge, MA, USA [2] Program in Medical and Population Genetics, Broad 
      Institute of MIT and Harvard, Cambridge, MA, USA [3] Department of Genetics, 
      Harvard Medical School, Boston, MA, USA.
FAU - Holmans, P
AU  - Holmans P
AD  - Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, 
      Institute of Psychological Medicine and Clinical Neurosciences, Cardiff 
      University, Cardiff, UK.
FAU - Owen, M J
AU  - Owen MJ
AD  - Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, 
      Neuroscience and Mental Health Research Institute, Institute of Psychological 
      Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
FAU - O'Donovan, M C
AU  - O'Donovan MC
AD  - Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, 
      Institute of Psychological Medicine and Clinical Neurosciences, Cardiff 
      University, Cardiff, UK.
LA  - eng
GR  - U54 HG003067/HG/NHGRI NIH HHS/United States
GR  - G0801418/Medical Research Council/United Kingdom
GR  - MR/L010305/1/MRC_/Medical Research Council/United Kingdom
GR  - R01 MH071681/MH/NIMH NIH HHS/United States
GR  - U54HG003067/HG/NHGRI NIH HHS/United States
GR  - WT098051/Wellcome Trust/United Kingdom
GR  - R01 MH099126/MH/NIMH NIH HHS/United States
GR  - G0800509/Medical Research Council/United Kingdom
GR  - R01HG005827/HG/NHGRI NIH HHS/United States
GR  - R01 HG005827/HG/NHGRI NIH HHS/United States
GR  - R01 MH085521/MH/NIMH NIH HHS/United States
GR  - R01MH085560/MH/NIMH NIH HHS/United States
GR  - R01MH071681/MH/NIMH NIH HHS/United States
GR  - WT089062/Wellcome Trust/United Kingdom
GR  - R01 MH085560/MH/NIMH NIH HHS/United States
GR  - R01MH099126/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20150721
PL  - United States
TA  - Transl Psychiatry
JT  - Translational psychiatry
JID - 101562664
RN  - 0 (Voltage-Gated Sodium Channels)
SB  - IM
MH  - Case-Control Studies
MH  - Exome/*genetics
MH  - Family
MH  - Female
MH  - Gene Frequency
MH  - Genes, Recessive/*genetics
MH  - Genetic Predisposition to Disease/genetics
MH  - Genotype
MH  - Heterozygote
MH  - Homozygote
MH  - Humans
MH  - Male
MH  - Schizophrenia/*genetics
MH  - Voltage-Gated Sodium Channels/genetics
PMC - PMC5068730
FIR - Faraone, Stephen V
IR  - Faraone SV
FIR - Roe, Cheri A
IR  - Roe CA
FIR - Chandler, Sharon D
IR  - Chandler SD
FIR - Liu, Chih-Min
IR  - Liu CM
FIR - Liu, Chen-Chung
IR  - Liu CC
FIR - Yeh, Ling-Ling
IR  - Yeh LL
FIR - Ouyang, Wen-Chen
IR  - Ouyang WC
FIR - Chan, Hung-Yu
IR  - Chan HY
FIR - Chen, Chun-Ying
IR  - Chen CY
EDAT- 2015/07/22 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/07/22 06:00
PHST- 2015/06/02 00:00 [received]
PHST- 2015/06/02 00:00 [accepted]
PHST- 2015/07/22 06:00 [entrez]
PHST- 2015/07/22 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - tp201599 [pii]
AID - 10.1038/tp.2015.99 [doi]
PST - epublish
SO  - Transl Psychiatry. 2015 Jul 21;5(7):e607. doi: 10.1038/tp.2015.99.

PMID- 27786406
OWN - NLM
STAT- MEDLINE
DCOM- 20170720
LR  - 20181113
IS  - 1545-5017 (Electronic)
IS  - 1545-5009 (Print)
IS  - 1545-5009 (Linking)
VI  - 64
IP  - 4
DP  - 2017 Apr
TI  - Childhood Hodgkin International Prognostic Score (CHIPS) Predicts event-free 
      survival in Hodgkin Lymphoma: A Report from the Children's Oncology Group.
LID - 10.1002/pbc.26278 [doi]
AB  - BACKGROUND: Early response to initial chemotherapy in Hodgkin lymphoma (HL) 
      measured by computed tomography (CT) and/or positron emission tomography (PET) 
      after two to three cycles of chemotherapy may inform therapeutic decisions. Risk 
      stratification at diagnosis could, however, allow earlier and potentially more 
      efficacious treatment modifications. PATIENTS AND METHODS: We developed a 
      predictive model for event-free survival (EFS) in pediatric/adolescent HL using 
      clinical data known at diagnosis from 1103 intermediate-risk HL patients treated 
      on Children's Oncology Group protocol AHOD0031 with doxorubicin, bleomycin, 
      vincristine, etoposide, prednisone, cyclophosphamide (ABVE-PC) chemotherapy and 
      radiation. Independent predictors of EFS were identified and used to develop and 
      validate a prognostic score (Childhood Hodgkin International Prognostic Score 
      [CHIPS]). A training cohort was randomly selected to include approximately half 
      of the overall cohort, with the remainder forming the validation cohort. RESULTS: 
      Stage 4 disease, large mediastinal mass, albumin (<3.5), and fever were 
      independent predictors of EFS that were each assigned one point in the CHIPS.  
      Four-year EFS was 93.1% for patients with CHIPS = 0, 88.5% for patients with 
      CHIPS = 1, 77.6% for patients with CHIPS = 2, and 69.2% for patients with CHIPS = 
      3. CONCLUSIONS: CHIPS was highly predictive of EFS, identifying a subset (with 
      CHIPS 2 or 3) that comprises 27% of intermediate-risk patients who have a 4-year 
      EFS of <80% and who may benefit from early therapeutic augmentation. 
       Furthermore, CHIPS identified higher risk patients who were not identified by 
      early PET or CT response. CHIPS is a robust and inexpensive approach to 
      predicting risk in patients with intermediate-risk HL that may improve ability to 
      tailor therapy to risk factors known at diagnosis.
CI  - © 2016 Wiley Periodicals, Inc.
FAU - Schwartz, Cindy L
AU  - Schwartz CL
AD  - Division of Pediatrics, UT MD Anderson Cancer Center, Houston, Texas.
FAU - Chen, Lu
AU  - Chen L
AD  - Children's Oncology Group, Monrovia, California.
FAU - McCarten, Kathleen
AU  - McCarten K
AD  - Department of Radiology R.I. Hospital, Warren Alpert Medical School, Providence, 
      Rhode Island.
FAU - Wolden, Suzanne
AU  - Wolden S
AD  - Department of Pediatrics, Memorial Sloan Kettering Cancer Center, NY, New York.
FAU - Constine, Louis S
AU  - Constine LS
AD  - Department of Radiation Oncology, University of Rochester, Rochester, New York.
FAU - Hutchison, Robert E
AU  - Hutchison RE
AD  - Department of Pathology, S.U.N.Y. Upstate Medical University, Syracuse, New York.
FAU - de Alarcon, Pedro A
AU  - de Alarcon PA
AD  - Department of Pediatrics, University of Illinois College of Medicine, Peoria, 
      Illinois.
FAU - Keller, Frank G
AU  - Keller FG
AD  - Department of Pediatrics, Emory University, Atlanta, Georgia.
FAU - Kelly, Kara M
AU  - Kelly KM
AD  - Department of Pediatrics, Roswell Park Cancer Institute, Buffalo, New York.
FAU - Trippet, Tanya A
AU  - Trippet TA
AD  - Department of Pediatrics, Memorial Sloan Kettering Cancer Center, NY, New York.
FAU - Voss, Stephan D
AU  - Voss SD
AD  - Department of Radiology, Boston Children's Hospital, Boston, Massachusetts.
FAU - Friedman, Debra L
AU  - Friedman DL
AD  - Vanderbilt University School of Medicine, Ingram Cancer Center, Nashville, 
      Tennessee.
LA  - eng
GR  - U10 CA098543/CA/NCI NIH HHS/United States
GR  - U10 CA180886/CA/NCI NIH HHS/United States
GR  - U10 CA180899/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20161027
PL  - United States
TA  - Pediatr Blood Cancer
JT  - Pediatric blood & cancer
JID - 101186624
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
MH  - Child
MH  - Child, Preschool
MH  - Female
MH  - Follow-Up Studies
MH  - Hodgkin Disease/drug therapy/*mortality/pathology
MH  - Humans
MH  - Infant
MH  - Infant, Newborn
MH  - Male
MH  - Neoplasm Staging
MH  - Prognosis
MH  - Remission Induction
MH  - Survival Rate
MH  - Young Adult
PMC - PMC5702912
MID - NIHMS920697
OTO - NOTNLM
OT  - Hodgkin lymphoma
OT  - adolescent
OT  - outcomes
OT  - pediatric
OT  - prognostic score
COIS- CONFLICT OF INTEREST The authors declare that there is no conflict of interest.
EDAT- 2016/10/28 06:00
MHDA- 2017/07/21 06:00
CRDT- 2016/10/28 06:00
PHST- 2016/05/30 00:00 [received]
PHST- 2016/08/29 00:00 [revised]
PHST- 2016/08/31 00:00 [accepted]
PHST- 2016/10/28 06:00 [pubmed]
PHST- 2017/07/21 06:00 [medline]
PHST- 2016/10/28 06:00 [entrez]
AID - 10.1002/pbc.26278 [doi]
PST - ppublish
SO  - Pediatr Blood Cancer. 2017 Apr;64(4):10.1002/pbc.26278. doi: 10.1002/pbc.26278. 
      Epub 2016 Oct 27.

PMID- 32968041
OWN - NLM
STAT- MEDLINE
DCOM- 20210618
LR  - 20231113
IS  - 2158-3188 (Electronic)
IS  - 2158-3188 (Linking)
VI  - 10
IP  - 1
DP  - 2020 Sep 23
TI  - Gene co-expression networks in peripheral blood capture dimensional measures of 
      emotional and behavioral problems from the Child Behavior Checklist (CBCL).
PG  - 328
LID - 10.1038/s41398-020-01007-w [doi]
LID - 328
AB  - The U.S. National Institute of Mental Health (NIMH) introduced the research 
      domain criteria (RDoC) initiative to promote the integration of information 
      across multiple units of analysis (i.e., brain circuits, physiology, behavior, 
      self-reports) to better understand the basic dimensions of behavior and cognitive 
      functioning underlying normal and abnormal mental conditions. Along those lines, 
      this study examined the association between peripheral blood gene expression 
      levels and emotional and behavioral problems in school-age children. Children 
      were chosen from two age- and sex-matched groups: those with or without parental 
      reports of any prior or current psychiatric diagnosis. RNA-sequencing was 
      performed on whole blood from 96 probands aged 6-12 years who were 
      medication-free at the time of assessment. Module eigengenes were derived using 
      weighted gene co-expression network analysis (WGCNA). Associations were tested 
      between module eigengene expression levels and eight syndrome scales from parent 
      ratings on the Child Behavior Checklist (CBCL). Nine out of the 36 modules were 
      significantly associated with at least one syndrome scale measured by the CBCL 
      (i.e., aggression, social problems, attention problems, and/or thought problems) 
      after accounting for covariates and correcting for multiple testing. Our study 
      demonstrates that variation in peripheral blood gene expression relates to 
      emotional and behavioral profiles in children. If replicated and validated, our 
      results may help in identifying problem or at-risk behavior in pediatric 
      populations, and in elucidating the biological pathways that modulate complex 
      human behavior.
FAU - Hess, Jonathan L
AU  - Hess JL
AD  - Department of Psychiatry & Behavioral Sciences, SUNY Upstate Medical University, 
      Syracuse, NY, USA.
FAU - Nguyen, Nicholas H
AU  - Nguyen NH
AD  - Department of Psychiatry & Behavioral Sciences, SUNY Upstate Medical University, 
      Syracuse, NY, USA.
FAU - Suben, Jesse
AU  - Suben J
AD  - Department of Psychiatry & Behavioral Sciences, SUNY Upstate Medical University, 
      Syracuse, NY, USA.
FAU - Meath, Ryan M
AU  - Meath RM
AD  - Department of Psychiatry & Behavioral Sciences, SUNY Upstate Medical University, 
      Syracuse, NY, USA.
FAU - Albert, Avery B
AU  - Albert AB
AD  - Department of Psychiatry & Behavioral Sciences, SUNY Upstate Medical University, 
      Syracuse, NY, USA.
AD  - Department of Psychology, Syracuse University, Syracuse, NY, USA.
FAU - Van Orman, Sarah
AU  - Van Orman S
AD  - Department of Psychiatry & Behavioral Sciences, SUNY Upstate Medical University, 
      Syracuse, NY, USA.
FAU - Anders, Kristin M
AU  - Anders KM
AD  - Department of Psychiatry & Behavioral Sciences, SUNY Upstate Medical University, 
      Syracuse, NY, USA.
FAU - Forken, Patricia J
AU  - Forken PJ
AUID- ORCID: 0000-0002-9931-9753
AD  - Department of Psychiatry & Behavioral Sciences, SUNY Upstate Medical University, 
      Syracuse, NY, USA.
FAU - Roe, Cheryl A
AU  - Roe CA
AD  - Department of Public Health and Preventive Medicine, SUNY Upstate Medical 
      University, Syracuse, NY, USA.
FAU - Schulze, Thomas G
AU  - Schulze TG
AD  - Institute of Psychiatric Phenomics and Genomics, Medical Center of the University 
      of Munich, Munich, Germany.
AD  - Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, 
      Göttingen, Germany.
AD  - Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University, 
      Baltimore, MD, USA.
AD  - Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental 
      Health, Mannheim, Germany.
FAU - Faraone, Stephen V
AU  - Faraone SV
AD  - Department of Psychiatry & Behavioral Sciences, SUNY Upstate Medical University, 
      Syracuse, NY, USA.
AD  - Department of Neuroscience & Physiology, SUNY Upstate Medical University, 
      Syracuse, NY, USA.
FAU - Glatt, Stephen J
AU  - Glatt SJ
AD  - Department of Psychiatry & Behavioral Sciences, SUNY Upstate Medical University, 
      Syracuse, NY, USA. stephen.glatt@psychgenelab.com.
AD  - Department of Neuroscience & Physiology, SUNY Upstate Medical University, 
      Syracuse, NY, USA. stephen.glatt@psychgenelab.com.
LA  - eng
GR  - RO1MH101519/U.S. Department of Health &amp; Human Services | NIH | National 
      Institute of Mental Health (NIMH)/International
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20200923
PL  - United States
TA  - Transl Psychiatry
JT  - Translational psychiatry
JID - 101562664
SB  - IM
MH  - Aggression
MH  - Checklist
MH  - Child
MH  - Child Behavior
MH  - *Child Behavior Disorders/genetics
MH  - Gene Expression
MH  - Humans
MH  - *Mental Disorders
MH  - *Problem Behavior
PMC - PMC7511314
COIS- J.L.H., N.H.N., J.S., R.M.M., A.B.A., S.V., K.A., P.F., C.A.R., and T.G.S. have 
      no conflicts of interest to disclose. In the past year, Dr. Faraone received 
      income, potential income, travel expenses continuing education support and/or 
      research support from Tris, Otsuka, Arbor, Ironshore, Shire, Akili, Enzymotec, 
      Sunovion, Supernus and Genomind. With his institution, he has US patent 
      US20130217707 A1 for the use of sodium-hydrogen exchange inhibitors in the 
      treatment of ADHD. In previous years, he received support from: Shire, Ironshore, 
      Neurovance, Alcobra, Rhodes, CogCubed, KemPharm, Enzymotec, Akili, 
      Neurolifesciences, Lundbeck/Takeda, Otsuka, McNeil, Janssen, Novartis, Pfizer, 
      and Eli Lilly. He also receives royalties from books published by Guilford Press: 
      Straight Talk about Your Child’s Mental Health, Oxford University Press: 
      Schizophrenia: The Facts and Elsevier: ADHD: Non-Pharmacologic Interventions. He 
      is principal investigator of www.adhdinadults.com. In the past year, S.J.G. 
      received royalties from a book published by Oxford University Press: 
      Schizophrenia: The Facts.
EDAT- 2020/09/25 06:00
MHDA- 2021/06/22 06:00
CRDT- 2020/09/24 05:28
PHST- 2019/12/30 00:00 [received]
PHST- 2020/09/03 00:00 [accepted]
PHST- 2020/05/29 00:00 [revised]
PHST- 2020/09/24 05:28 [entrez]
PHST- 2020/09/25 06:00 [pubmed]
PHST- 2021/06/22 06:00 [medline]
AID - 10.1038/s41398-020-01007-w [pii]
AID - 1007 [pii]
AID - 10.1038/s41398-020-01007-w [doi]
PST - epublish
SO  - Transl Psychiatry. 2020 Sep 23;10(1):328. doi: 10.1038/s41398-020-01007-w.

PMID- 33314633
OWN - NLM
STAT- MEDLINE
DCOM- 20210720
LR  - 20210720
IS  - 2045-7634 (Electronic)
IS  - 2045-7634 (Linking)
VI  - 10
IP  - 1
DP  - 2021 Jan
TI  - Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast 
      Cancer.
PG  - 53-61
LID - 10.1002/cam4.3550 [doi]
AB  - We examined a large dataset of female metastatic breast cancers (MBCs) profiled 
      with comprehensive genomic profiling (CGP) to identify the prevalence and 
      distribution of immunotherapy responsiveness-associated biomarkers. DNA was 
      extracted from 3831 consecutive MBCs: 1237 (ER(pos) /HER2(neg) ), 1953 ER(neg) 
      /HER2(amp) , and 641 triple-negative breast cancer (TNBC). CGP was performed 
      using the FoundationOne(®) or FoundationOne(®) CDx NGS assay. Tumor mutational 
      burden (TMB) and microsatellite instability (MSI) were determined in a subset of 
      cases. PD-L1 expression in immunocytes in a subset of cases was determined by 
      immunohistochemistry using the companion diagnostic VENTANA PD-L1 SP142 Assay. 
      The median age of the cohort was 54 years (range 20-89). Genomic alterations 
      (GAs)/tumor were similar (range: 5.9-7.3). Markers of potential immune checkpoint 
      inhibitor (ICPI) benefit included: CD274 (PD-L1) amplification (1%-3%), BRAF GA 
      (1%-4%), TMB of ≥10 mutations/Mb (8%-12%), MSI-high (0.1%-0.4%), PBRM1 GA (1%), 
      and positive PD-L1 staining of immunocytes ranging from 13% in ER(pos) /HER2(neg) 
      and 33% in ER(neg) /HER2(amp) to 47% in the TNBC group. Potential markers of ICPI 
      resistance included inactivating STK11 GA (1%-2%) and MDM2 amplification (3%-6%). 
      MTOR pathway targets were common with lowest frequency in TNBC. ERBB2 short 
      variant mutations were most frequent ER(pos) /HER2(neg) and absent in TNBC. 
      BRCA1/2 GA were least frequent in ER(neg) /HER2(amp) . The demonstrations of 
      clinical benefit of immunotherapy in MBC support the need for development and 
      utilization of biomarkers to guide the use of ICPIs for these patients. In 
      addition to guiding therapy selection, CGP shows potential to identify GA linked 
      to response and resistance to ICPI in MBC.
CI  - © 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
FAU - Sivapiragasam, Abirami
AU  - Sivapiragasam A
AD  - Upstate Medical University, Syracuse, New York, USA.
FAU - Ashok Kumar, Prashanth
AU  - Ashok Kumar P
AUID- ORCID: 0000-0001-6236-2822
AD  - Upstate Medical University, Syracuse, New York, USA.
FAU - Sokol, Ethan S
AU  - Sokol ES
AD  - Foundation Medicine, Cambridge, Massachusetts, USA.
AD  - Foundation Medicine, Morrisville, North Carolina, USA.
FAU - Albacker, Lee A
AU  - Albacker LA
AD  - Foundation Medicine, Cambridge, Massachusetts, USA.
AD  - Foundation Medicine, Morrisville, North Carolina, USA.
FAU - Killian, Jonathan K
AU  - Killian JK
AD  - Foundation Medicine, Cambridge, Massachusetts, USA.
AD  - Foundation Medicine, Morrisville, North Carolina, USA.
FAU - Ramkissoon, Shakti H
AU  - Ramkissoon SH
AD  - Foundation Medicine, Cambridge, Massachusetts, USA.
AD  - Foundation Medicine, Morrisville, North Carolina, USA.
AD  - Wake Forest Comprehensive Cancer Center and Department of Pathology, Wake Forest 
      School of Medicine, Winston-Salem, North Carolina, USA.
FAU - Huang, Richard S P
AU  - Huang RSP
AD  - Foundation Medicine, Cambridge, Massachusetts, USA.
AD  - Foundation Medicine, Morrisville, North Carolina, USA.
FAU - Severson, Eric A
AU  - Severson EA
AD  - Foundation Medicine, Cambridge, Massachusetts, USA.
AD  - Foundation Medicine, Morrisville, North Carolina, USA.
FAU - Brown, Charlotte A
AU  - Brown CA
AUID- ORCID: 0000-0002-7328-3967
AD  - Foundation Medicine, Cambridge, Massachusetts, USA.
AD  - Foundation Medicine, Morrisville, North Carolina, USA.
FAU - Danziger, Natalie
AU  - Danziger N
AD  - Foundation Medicine, Cambridge, Massachusetts, USA.
AD  - Foundation Medicine, Morrisville, North Carolina, USA.
FAU - McGregor, Kimberly
AU  - McGregor K
AD  - Foundation Medicine, Cambridge, Massachusetts, USA.
AD  - Foundation Medicine, Morrisville, North Carolina, USA.
FAU - Ross, Jeffrey S
AU  - Ross JS
AD  - Upstate Medical University, Syracuse, New York, USA.
AD  - Foundation Medicine, Cambridge, Massachusetts, USA.
AD  - Foundation Medicine, Morrisville, North Carolina, USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20201212
PL  - United States
TA  - Cancer Med
JT  - Cancer medicine
JID - 101595310
RN  - 0 (B7-H1 Antigen)
RN  - 0 (Biomarkers, Tumor)
RN  - 0 (CD274 protein, human)
RN  - 0 (Immune Checkpoint Inhibitors)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - B7-H1 Antigen/analysis/*antagonists & inhibitors
MH  - Biomarkers, Tumor/*genetics
MH  - Breast Neoplasms/*drug therapy/*genetics/immunology/pathology
MH  - Clinical Decision-Making
MH  - Databases, Nucleic Acid
MH  - Drug Resistance, Neoplasm/genetics
MH  - Female
MH  - *Gene Expression Profiling
MH  - Humans
MH  - Immune Checkpoint Inhibitors/adverse effects/*therapeutic use
MH  - Microsatellite Instability
MH  - Middle Aged
MH  - Mutation
MH  - Neoplasm Metastasis
MH  - Precision Medicine
MH  - Predictive Value of Tests
MH  - *Transcriptome
MH  - Young Adult
PMC - PMC7826457
OTO - NOTNLM
OT  - PD-L1
OT  - biomarkers
OT  - comprehensive genomic profiling
OT  - immunotherapy
OT  - metastatic breast cancer
OT  - microsatellite instability
OT  - tumor mutational burden
COIS- Abirami Sivapiragasam: No conflict to disclose. P. Ashok Kumar: No conflict to 
      disclose. Ethan S. Sokol: Employment by Foundation Medicine Inc. Stock in F. 
      Hoffman La Roche Ltd. Lee A. Albacker: Employment by Foundation Medicine Inc. 
      Stock in F. Hoffman La Roche Ltd, J. Keith Killian: Employment by Foundation 
      Medicine Inc. Stock in F. Hoffman La Roche Ltd. Shakti Ramkissoon: Employment by 
      Foundation Medicine Inc. Stock in F. Hoffman La Roche Ltd. Richard Huang: 
      Employment by Foundation Medicine Inc. Stock in F. Hoffman La Roche Ltd. Patents 
      with VENTANA (Roche). Eric A. Severson: Employment by Foundation Medicine Inc. 
      Stock in F. Hoffman La Roche Ltd. Natalie Danziger: Employment by Foundation 
      Medicine Inc. Charlotte A. Brown: Employment by Foundation Medicine Inc. Stock in 
      F. Hoffman La Roche Ltd. Kimberly McGregor: Employment by Foundation Medicine 
      Inc. Stock in F. Hoffman La Roche Ltd. Jeffrey S. Ross: Employment by Foundation 
      Medicine Inc. Stock in F. Hoffman La Roche Ltd.
EDAT- 2020/12/15 06:00
MHDA- 2021/07/21 06:00
CRDT- 2020/12/14 11:15
PHST- 2020/08/17 00:00 [received]
PHST- 2020/10/01 00:00 [revised]
PHST- 2020/10/02 00:00 [accepted]
PHST- 2020/12/15 06:00 [pubmed]
PHST- 2021/07/21 06:00 [medline]
PHST- 2020/12/14 11:15 [entrez]
AID - CAM43550 [pii]
AID - 10.1002/cam4.3550 [doi]
PST - ppublish
SO  - Cancer Med. 2021 Jan;10(1):53-61. doi: 10.1002/cam4.3550. Epub 2020 Dec 12.

PMID- 33972391
OWN - NLM
STAT- MEDLINE
DCOM- 20220105
LR  - 20220105
IS  - 2051-1426 (Electronic)
IS  - 2051-1426 (Linking)
VI  - 9
IP  - 5
DP  - 2021 May
TI  - Pan-cancer landscape of CD274 (PD-L1) copy number changes in 244 584 patient 
      samples and the correlation with PD-L1 protein expression.
LID - 10.1136/jitc-2021-002680 [doi]
LID - e002680
AB  - INTRODUCTION: Several studies have shown clinical outcomes data that support the 
      use of CD274 (PD-L1) copy-number (CN) gains and/or losses as a biomarker for 
      immune checkpoint inhibitor (ICPI). Here, we present the landscape of CD274 CN 
      changes across a large cohort of solid tumor cases and correlate these with PD-L1 
      protein expression by immunohistochemistry. METHODS: We analyzed all cases that 
      underwent comprehensive genomic profiling (CGP) testing at Foundation Medicine 
      between August 2014 and June 2020. CD274 CN changes were correlated with PD-L1 
      expression in tumor types where there were Food and Drug Administration approved 
      companion diagnostic (CDx) claims and the CDx assay was used to assess PD-L1 
      expression. RESULTS: In all, 244 584 samples representing 290 solid tumor types 
      were included in the study. Overall, 17.6% (42 983/244 584) had CD274 CN gains 
      (>specimen ploidy), 44.6% (108 970/244 584) were CD274 CN neutral, and 37.9% (92 
      631/244 584) had CD274 CN loss. Using different CN cut offs to define CD274 
      positivity resulted in different prevalence estimates: ploidy +1, 17.4% (42 
      636/244 584); ploidy +2, 6.2% (15 183/244 584); ploidy +3, 2.2% (5375/244 584); 
      ploidy +4, 1.1% (2712/244 584); and ploidy +8, 0.2% (434/244 584). The prevalence 
      of CN changes and CN positivity varied based on tumor type. CD274 CN gains were 
      significantly associated with PD-L1 positivity in NSCLC, urothelial carcinoma, 
      breast carcinoma, cervical carcinoma, esophagus squamous cell carcinoma (SCC) and 
      head and neck SCC (ORs 3.3, 3.0, 2.0, 4.5. 3.8, 8.4, 1.4, respectively; p<0.05) 
      and with microsatellite instability status in only clinically relevant tumor 
      types (gastric adenocarcinoma, colorectal adenocarcinoma, uterine endometrial 
      adenocarcinoma, esophageal adenocarcinoma and gastroesophageal junction 
      adenocarcinoma (OR: 5.2, 1.9, 3.2, 3.7 and 6.5, respectively; p<0.05)). 
      Conversely, CD274 CN changes were not significantly correlated with tumor 
      mutational burden in almost all the tumor types. CONCLUSION: CD274 CN changes and 
      PD-L1 expression were highly correlated in multiple tumor types. These prevalence 
      data on CD274 CN changes across a large cohort of different solid tumors can be 
      used to design future clinical studies to assess whether CD274 CN changes could 
      be a potential biomarker for ICPI.
CI  - © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No 
      commercial re-use. See rights and permissions. Published by BMJ.
FAU - Huang, Richard S P
AU  - Huang RSP
AUID- ORCID: 0000-0001-8395-5168
AD  - Foundation Medicine Inc, Cambridge, Massachusetts, USA 
      rhuang@foundationmedicine.com.
FAU - Murugesan, Karthikeyan
AU  - Murugesan K
AD  - Foundation Medicine Inc, Cambridge, Massachusetts, USA.
FAU - Montesion, Meagan
AU  - Montesion M
AD  - Foundation Medicine Inc, Cambridge, Massachusetts, USA.
FAU - Pavlick, Dean C
AU  - Pavlick DC
AD  - Foundation Medicine Inc, Cambridge, Massachusetts, USA.
FAU - Mata, Douglas A
AU  - Mata DA
AD  - Foundation Medicine Inc, Cambridge, Massachusetts, USA.
FAU - Hiemenz, Matthew C
AU  - Hiemenz MC
AD  - Foundation Medicine Inc, Cambridge, Massachusetts, USA.
FAU - Decker, Brennan
AU  - Decker B
AD  - Foundation Medicine Inc, Cambridge, Massachusetts, USA.
FAU - Frampton, Garrett
AU  - Frampton G
AD  - Foundation Medicine Inc, Cambridge, Massachusetts, USA.
FAU - Albacker, Lee A
AU  - Albacker LA
AD  - Foundation Medicine Inc, Cambridge, Massachusetts, USA.
FAU - Ross, Jeffrey S
AU  - Ross JS
AD  - Foundation Medicine Inc, Cambridge, Massachusetts, USA.
AD  - Department of Pathology, State University of New York (SUNY) Upstate Medical 
      University, Syracuse, New York, USA.
LA  - eng
PT  - Journal Article
PL  - England
TA  - J Immunother Cancer
JT  - Journal for immunotherapy of cancer
JID - 101620585
RN  - 0 (B7-H1 Antigen)
RN  - 0 (Biomarkers, Tumor)
RN  - 0 (CD274 protein, human)
RN  - 0 (Immune Checkpoint Inhibitors)
SB  - IM
MH  - B7-H1 Antigen/antagonists & inhibitors/*genetics
MH  - Biomarkers, Tumor/*genetics
MH  - Clinical Decision-Making
MH  - *DNA Copy Number Variations
MH  - Female
MH  - *Gene Dosage
MH  - Genetic Predisposition to Disease
MH  - Humans
MH  - Immune Checkpoint Inhibitors/therapeutic use
MH  - Immunohistochemistry
MH  - Male
MH  - Microsatellite Instability
MH  - Molecular Diagnostic Techniques
MH  - Mutation
MH  - Neoplasms/drug therapy/*genetics/*immunology/pathology
MH  - Phenotype
MH  - Predictive Value of Tests
PMC - PMC8112409
OTO - NOTNLM
OT  - biomarkers
OT  - immunotherapy
OT  - tumor
OT  - tumor biomarkers
COIS- Competing interests: All authors of the manuscript are employees of Foundation 
      Medicine, which is a wholly owned subsidiary of Roche and receives stock from 
      Roche.
EDAT- 2021/05/12 06:00
MHDA- 2022/01/06 06:00
CRDT- 2021/05/11 05:57
PHST- 2021/04/09 00:00 [accepted]
PHST- 2021/05/11 05:57 [entrez]
PHST- 2021/05/12 06:00 [pubmed]
PHST- 2022/01/06 06:00 [medline]
AID - jitc-2021-002680 [pii]
AID - 10.1136/jitc-2021-002680 [doi]
PST - ppublish
SO  - J Immunother Cancer. 2021 May;9(5):e002680. doi: 10.1136/jitc-2021-002680.

PMID- 33748971
OWN - NLM
STAT- MEDLINE
DCOM- 20211026
LR  - 20240123
IS  - 1469-7610 (Electronic)
IS  - 0021-9630 (Print)
IS  - 0021-9630 (Linking)
VI  - 62
IP  - 10
DP  - 2021 Oct
TI  - Analysis of structural brain asymmetries in attention-deficit/hyperactivity 
      disorder in 39 datasets.
PG  - 1202-1219
LID - 10.1111/jcpp.13396 [doi]
AB  - OBJECTIVE: Some studies have suggested alterations of structural brain asymmetry 
      in attention-deficit/hyperactivity disorder (ADHD), but findings have been 
      contradictory and based on small samples. Here, we performed the largest ever 
      analysis of brain left-right asymmetry in ADHD, using 39 datasets of the ENIGMA 
      consortium. METHODS: We analyzed asymmetry of subcortical and cerebral cortical 
      structures in up to 1,933 people with ADHD and 1,829 unaffected controls. 
      Asymmetry Indexes (AIs) were calculated per participant for each bilaterally 
      paired measure, and linear mixed effects modeling was applied separately in 
      children, adolescents, adults, and the total sample, to test exhaustively for 
      potential associations of ADHD with structural brain asymmetries. RESULTS: There 
      was no evidence for altered caudate nucleus asymmetry in ADHD, in contrast to 
      prior literature. In children, there was less rightward asymmetry of the total 
      hemispheric surface area compared to controls (t = 2.1, p = .04). Lower rightward 
      asymmetry of medial orbitofrontal cortex surface area in ADHD (t = 2.7, p = .01) 
      was similar to a recent finding for autism spectrum disorder. There were also 
      some differences in cortical thickness asymmetry across age groups. In adults 
      with ADHD, globus pallidus asymmetry was altered compared to those without ADHD. 
      However, all effects were small (Cohen's d from -0.18 to 0.18) and would not 
      survive study-wide correction for multiple testing. CONCLUSION: Prior studies of 
      altered structural brain asymmetry in ADHD were likely underpowered to detect the 
      small effects reported here. Altered structural asymmetry is unlikely to provide 
      a useful biomarker for ADHD, but may provide neurobiological insights into the 
      trait.
CI  - © 2021 The Authors. Journal of Child Psychology and Psychiatry published by John 
      Wiley & Sons Ltd on behalf of Association for Child and Adolescent Mental Health.
FAU - Postema, Merel C
AU  - Postema MC
AUID- ORCID: 0000-0002-1536-7062
AD  - Language and Genetics Department, Max Planck Institute for Psycholinguistics, 
      Nijmegen, The Netherlands.
FAU - Hoogman, Martine
AU  - Hoogman M
AD  - Department of Human Genetics, Radboud University Medical Center, Nijmegen, 
      Netherlands.
AD  - Donders Institute for Brain, Cognition and Behaviour, Radboud University, 
      Nijmegen, Netherlands.
FAU - Ambrosino, Sara
AU  - Ambrosino S
AD  - NICHE lab, Department of Psychiatry, University Medical Center Utrecht Brain 
      Center, Utrecht University, Utrecht, The Netherlands.
FAU - Asherson, Philip
AU  - Asherson P
AD  - Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, 
      Psychology and Neuroscience, King's College London, London, UK.
FAU - Banaschewski, Tobias
AU  - Banaschewski T
AD  - Department of Child and Adolescent Psychiatry and Psychotherapy, Central 
      Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, 
      Mannheim, Germany.
FAU - Bandeira, Cibele E
AU  - Bandeira CE
AD  - Adulthood ADHD Outpatient Program (ProDAH), Clinical Research Center, Hospital de 
      Clínicas de Porto Alegre, Porto Alegre, Brazil.
AD  - Department of Genetics, Institute of Biosciences, Universidade Federal do Rio 
      Grande do Sul, Porto Alegre, Brazil.
FAU - Baranov, Alexandr
AU  - Baranov A
AD  - Research Institute of Pediatrics and Child Health of Central Clinical Hospital of 
      the Russian Academy of Sciences of the Ministry of Science and Higher Education 
      of the Russian Federation, Moscow, Russia.
FAU - Bau, Claiton H D
AU  - Bau CHD
AD  - Adulthood ADHD Outpatient Program (ProDAH), Clinical Research Center, Hospital de 
      Clínicas de Porto Alegre, Porto Alegre, Brazil.
AD  - Department of Genetics, Institute of Biosciences, Universidade Federal do Rio 
      Grande do Sul, Porto Alegre, Brazil.
AD  - Developmental Psychiatry Program, Experimental Research Center, Hospital de 
      Clínicas de Porto Alegre, Porto Alegre, Brazil.
FAU - Baumeister, Sarah
AU  - Baumeister S
AD  - Department of Child and Adolescent Psychiatry and Psychotherapy, Central 
      Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, 
      Mannheim, Germany.
FAU - Baur-Streubel, Ramona
AU  - Baur-Streubel R
AD  - Department of Biological Psychology, Clinical Psychology and Psychotherapy, 
      University of Würzburg, Würzburg, Germany.
FAU - Bellgrove, Mark A
AU  - Bellgrove MA
AD  - Turner Institute for Brain and Mental Health and School of Psychological 
      Sciences, Monash University, Melbourne, Vic., Australia.
FAU - Biederman, Joseph
AU  - Biederman J
AD  - Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, 
      Boston, MA, USA.
AD  - Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, 
      Boston, MA, USA.
FAU - Bralten, Janita
AU  - Bralten J
AD  - Department of Human Genetics, Radboud University Medical Center, Nijmegen, 
      Netherlands.
AD  - Donders Institute for Brain, Cognition and Behaviour, Radboud University, 
      Nijmegen, Netherlands.
FAU - Brandeis, Daniel
AU  - Brandeis D
AD  - Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric 
      Hospital, University of Zurich, Zurich, Switzerland.
AD  - The Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zurich, 
      Switzerland.
FAU - Brem, Silvia
AU  - Brem S
AD  - The Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zurich, 
      Switzerland.
AD  - Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric 
      Hospital, University of Zurich, Zurich, Switzerland.
FAU - Buitelaar, Jan K
AU  - Buitelaar JK
AD  - Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and 
      Behaviour, Radboudumc, Nijmegen, The Netherlands.
AD  - Karakter Child and Adolescent Psychiatry University Center, Nijmegen, The 
      Netherlands.
FAU - Busatto, Geraldo F
AU  - Busatto GF
AD  - Laboratory of Psychiatric Neuroimaging (LIM-21, Department and Institute of 
      Psychiatry, Hospital das Clinicas HCFMUSP, Faculty of Medicine, University of São 
      Paulo, Sao Paulo, Sao Paulo, Brazil.
FAU - Castellanos, Francisco X
AU  - Castellanos FX
AD  - Department of Child and Adolescent Psychiatry, NYU Grossman School of Medicine, 
      New York, NY, USA.
AD  - Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, USA.
FAU - Cercignani, Mara
AU  - Cercignani M
AD  - Department of Neuroscience, Brighton and Sussex Medical School, Falmer, Brighton, 
      UK.
FAU - Chaim-Avancini, Tiffany M
AU  - Chaim-Avancini TM
AD  - Laboratory of Psychiatric Neuroimaging (LIM-21, Department and Institute of 
      Psychiatry, Hospital das Clinicas HCFMUSP, Faculty of Medicine, University of São 
      Paulo, Sao Paulo, Sao Paulo, Brazil.
FAU - Chantiluke, Kaylita C
AU  - Chantiluke KC
AD  - Department of Child and Adolescent Psychiatry, Institute of Psychiatry, 
      Psychology and Neuroscience, King's College London, London, UK.
FAU - Christakou, Anastasia
AU  - Christakou A
AD  - Department of Child and Adolescent Psychiatry, Institute of Psychiatry, 
      Psychology and Neuroscience, King's College London, London, UK.
AD  - School of Psychology and Clinical Language Sciences, Centre for Integrative 
      Neuroscience and Neurodynamics, University of Reading, Reading, UK.
FAU - Coghill, David
AU  - Coghill D
AD  - Departments of Paediatrics and Psychiatry, University of Melbourne, Melbourne, 
      Vic., Australia.
AD  - Murdoch Children's Research Institute, Melbourne, Vic., Australia.
FAU - Conzelmann, Annette
AU  - Conzelmann A
AD  - Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, 
      University Hospital of Tübingen, Tübingen, Germany.
AD  - Department of Psychology (Clinical Psychology II), PFH - Private University of 
      Applied Sciences, Göttingen, Germany.
FAU - Cubillo, Ana I
AU  - Cubillo AI
AD  - Department of Child and Adolescent Psychiatry, Institute of Psychiatry, 
      Psychology and Neuroscience, King's College London, London, UK.
FAU - Cupertino, Renata B
AU  - Cupertino RB
AD  - Adulthood ADHD Outpatient Program (ProDAH), Clinical Research Center, Hospital de 
      Clínicas de Porto Alegre, Porto Alegre, Brazil.
AD  - Department of Genetics, Institute of Biosciences, Universidade Federal do Rio 
      Grande do Sul, Porto Alegre, Brazil.
FAU - de Zeeuw, Patrick
AU  - de Zeeuw P
AD  - NICHE Lab, Department of Psychiatry, Brain Center Rudolf Magnus, University 
      Medical Center Utrecht, Utrecht, The Netherlands.
FAU - Doyle, Alysa E
AU  - Doyle AE
AD  - Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, 
      Boston, MA, USA.
AD  - Center for Genomic Medicine, Massachusetts General Hospital, Harvard Medical 
      School, Boston, MA, USA.
FAU - Durston, Sarah
AU  - Durston S
AD  - NICHE Lab, Department of Psychiatry, Brain Center Rudolf Magnus, University 
      Medical Center Utrecht, Utrecht, The Netherlands.
FAU - Earl, Eric A
AU  - Earl EA
AD  - Department of Behavioral Neuroscience, Oregon Health & Science University, 
      Portland, OR, USA.
FAU - Epstein, Jeffery N
AU  - Epstein JN
AD  - Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's 
      Hospital Medical Center, Cincinnati, OH, USA.
AD  - Department of Pediatrics, University of Cincinnati College of Medicine, 
      Cincinnati, OH, USA.
FAU - Ethofer, Thomas
AU  - Ethofer T
AD  - Clinic for Psychiatry/Psychotherapy Tübingen/Department for Biomedical Magnetic 
      Resonance, Tübingen, Germany.
FAU - Fair, Damien A
AU  - Fair DA
AD  - Department of Behavioral Neuroscience, Oregon Health & Science University, 
      Portland, OR, USA.
FAU - Fallgatter, Andreas J
AU  - Fallgatter AJ
AD  - Department of Psychiatry and Psychotherapy, University Hospital of Tuebingen, 
      Tuebingen, Germany.
AD  - LEAD Graduate School, University of Tuebingen, Tübingen, Germany.
FAU - Faraone, Stephen V
AU  - Faraone SV
AD  - Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate 
      Medical University, Syracuse, NY, USA.
FAU - Frodl, Thomas
AU  - Frodl T
AD  - Department of Psychiatry and Psychotherapy, Otto von Guericke University, 
      Magdeburg, Germany.
AD  - Department of Psychiatry, Trinity College Dublin, Dublin, Ireland.
FAU - Gabel, Matt C
AU  - Gabel MC
AD  - Department of Neuroscience, Brighton and Sussex Medical School, Falmer, Brighton, 
      UK.
FAU - Gogberashvili, Tinatin
AU  - Gogberashvili T
AD  - Laboratory of Neurology and Cognitive Health, National Medical Research Center 
      for Children's Health, Moscow, Russia.
FAU - Grevet, Eugenio H
AU  - Grevet EH
AD  - Adulthood ADHD Outpatient Program (ProDAH), Clinical Research Center, Hospital de 
      Clínicas de Porto Alegre, Porto Alegre, Brazil.
AD  - Department of Genetics, Institute of Biosciences, Universidade Federal do Rio 
      Grande do Sul, Porto Alegre, Brazil.
AD  - Developmental Psychiatry Program, Experimental Research Center, Hospital de 
      Clínicas de Porto Alegre, Porto Alegre, Brazil.
FAU - Haavik, Jan
AU  - Haavik J
AD  - Department of Biomedicine, K.G. Jebsen Centre for Neuropsychiatric Disorders, 
      University of Bergen, Bergen, Norway.
AD  - Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.
FAU - Harrison, Neil A
AU  - Harrison NA
AD  - Department of Neuroscience, Brighton and Sussex Medical School, Falmer, Brighton, 
      UK.
AD  - Sussex Partnership NHS Foundation Trust, Swandean, East Sussex, UK.
FAU - Hartman, Catharina A
AU  - Hartman CA
AD  - Department of Psychiatry, Interdisciplinary Center Psychopathology and Emotion 
      Regulation (ICPE), University Medical Center Groningen, University of Groningen, 
      Groningen, The Netherlands.
FAU - Heslenfeld, Dirk J
AU  - Heslenfeld DJ
AD  - Faculty of Behavioural and Movement Sciences, Vrije Universiteit Amsterdam, 
      Amsterdam, The Netherlands.
FAU - Hoekstra, Pieter J
AU  - Hoekstra PJ
AD  - Department of Child and Adolescent Psychiatry, University Medical Center 
      Groningen, University of Groningen, Groningen, The Netherlands.
FAU - Hohmann, Sarah
AU  - Hohmann S
AD  - Department of Child and Adolescent Psychiatry and Psychotherapy, Central 
      Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, 
      Mannheim, Germany.
FAU - Høvik, Marie F
AU  - Høvik MF
AD  - Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.
AD  - Department of Clinical Medicine, University of Bergen, Bergen, Norway.
FAU - Jernigan, Terry L
AU  - Jernigan TL
AD  - Center for Human Development, UC San Diego, La Jolla, CA, USA.
FAU - Kardatzki, Bernd
AU  - Kardatzki B
AD  - Department of Biomedical Magnetic Resonance, University of Tuebingen, Tuebingen, 
      Germany.
FAU - Karkashadze, Georgii
AU  - Karkashadze G
AD  - Research Institute of Pediatrics and Child Health of Central Clinical Hospital of 
      the Russian Academy of Sciences of the Ministry of Science and Higher Education 
      of the Russian Federation, Moscow, Russia.
FAU - Kelly, Clare
AU  - Kelly C
AD  - School of Psychology and Department of Psychiatry at the School of Medicine, 
      Trinity College Dublin, Ireland.
AD  - Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, 
      Ireland.
FAU - Kohls, Gregor
AU  - Kohls G
AD  - Child Neuropsychology Section, Department of Child and Adolescent Psychiatry, 
      Psychosomatics, and Psychotherapy, University Hospital RWTH, Aachen, Germany.
FAU - Konrad, Kerstin
AU  - Konrad K
AD  - Child Neuropsychology Section, Department of Child and Adolescent Psychiatry, 
      Psychosomatics, and Psychotherapy, University Hospital RWTH, Aachen, Germany.
AD  - JARA Institute Molecular Neuroscience and Neuroimaging (INM-11), Institute for 
      Neuroscience and Medicine, Research Center Jülich, Jülich, Germany.
FAU - Kuntsi, Jonna
AU  - Kuntsi J
AD  - Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, 
      Psychology and Neuroscience, King's College London, London, UK.
FAU - Lazaro, Luisa
AU  - Lazaro L
AD  - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Biomedical 
      Network Research Center on Mental Health (CIBERSAM), Barcelona, Spain.
AD  - Department of Medicine, University of Barcelona, Barcelona, Spain.
FAU - Lera-Miguel, Sara
AU  - Lera-Miguel S
AD  - Department of Child and Adolescent Psychiatry and Psychology, Institute of 
      Neurosciencies, Hospital Clinic, Barcelona, Spain.
FAU - Lesch, Klaus-Peter
AU  - Lesch KP
AD  - Division of Molecular Psychiatry, Center of Mental Health, University of 
      Würzburg, Würzburg, Germany.
AD  - Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, I.M. 
      Sechenov First Moscow State Medical University, Moscow, Russia.
AD  - Department of Psychiatry and Neuropsychology, School for Mental Health and 
      Neuroscience (MHeNS), Maastricht University, Maastricht, The Netherlands.
FAU - Louza, Mario R
AU  - Louza MR
AD  - Institute of Psychiatry, Faculty of Medicine, University of São Paulo, São Paulo, 
      Brazil.
FAU - Lundervold, Astri J
AU  - Lundervold AJ
AD  - Department of Biomedicine, K.G. Jebsen Centre for Neuropsychiatric Disorders, 
      University of Bergen, Bergen, Norway.
AD  - Department of Biological and Medical Psychology, University of Bergen, Bergen, 
      Norway.
FAU - Malpas, Charles B
AU  - Malpas CB
AD  - Developmental Imaging Group, Murdoch Children's Research Institute, Melbourne, 
      Vic., Australia.
AD  - Clinical Outcomes Research Unit (CORe), Department of Medicine, Royal Melbourne 
      Hospital, The University of Melbourne, Melbourne, Vic., Australia.
FAU - Mattos, Paulo
AU  - Mattos P
AD  - D'Or Institute for Research and Education, Rio de Janeiro, Brazil.
AD  - Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
FAU - McCarthy, Hazel
AU  - McCarthy H
AD  - Department of Psychiatry, Trinity College Dublin, Dublin, Ireland.
AD  - Centre of Advanced Medical Imaging, St James's Hospital, Dublin, Ireland.
FAU - Namazova-Baranova, Leyla
AU  - Namazova-Baranova L
AD  - Research Institute of Pediatrics and Child Health of Central Clinical Hospital of 
      the Russian Academy of Sciences of the Ministry of Science and Higher Education 
      of the Russian Federation, Moscow, Russia.
AD  - Russian National Research Medical University Ministry of Health of the Russian 
      Federation, Moscow, Russia.
FAU - Nicolau, Rosa
AU  - Nicolau R
AD  - Department of Child and Adolescent Psychiatry and Psychology, Institut of 
      Neurosciencies, Hospital Clinic, Barcelona, Spain.
FAU - Nigg, Joel T
AU  - Nigg JT
AD  - Department of Behavioral Neuroscience, Oregon Health & Science University, 
      Portland, OR, USA.
AD  - Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA.
FAU - Novotny, Stephanie E
AU  - Novotny SE
AD  - Olin Neuropsychiatry Research Center, Hartford Hospital, Hartford, CT, USA.
FAU - Oberwelland Weiss, Eileen
AU  - Oberwelland Weiss E
AD  - Translational Neuroscience, Child and Adolescent Psychiatry, University Hospital 
      RWTH Aachen, Aachen, Germany.
AD  - Cognitive Neuroscience (INM-3), Institute for Neuroscience and Medicine, Research 
      Center Jülich, Jülich, Germany.
FAU - O'Gorman Tuura, Ruth L
AU  - O'Gorman Tuura RL
AD  - Center for MR Research, University Children's Hospital, Zurich, Switzerland.
AD  - Zurich Center for Integrative Human Physiology (ZIHP), Zurich, Switzerland.
FAU - Oosterlaan, Jaap
AU  - Oosterlaan J
AD  - Clinical Neuropsychology Section, Vrije Universiteit Amsterdam, Amsterdam, The 
      Netherlands.
AD  - Emma Neuroscience Group, Department of Pediatrics, Amsterdam Reproduction & 
      Development, Emma Children's Hospital Amsterdam University Medical Centers, 
      University of Amsterdam, Amsterdam, The Netherlands.
FAU - Oranje, Bob
AU  - Oranje B
AD  - NICHE Lab, Department of Psychiatry, Brain Center Rudolf Magnus, University 
      Medical Center Utrecht, Utrecht, The Netherlands.
FAU - Paloyelis, Yannis
AU  - Paloyelis Y
AD  - Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, 
      King's College London, London, UK.
FAU - Pauli, Paul
AU  - Pauli P
AD  - Department of Psychology (Biological Psychology, Clinical Psychology and 
      Psychotherapy) and Center of Mental Health, University of Würzburg, Würzburg, 
      Germany.
FAU - Picon, Felipe A
AU  - Picon FA
AD  - Adulthood ADHD Outpatient Program (ProDAH), Clinical Research Center, Hospital de 
      Clínicas de Porto Alegre, Porto Alegre, Brazil.
FAU - Plessen, Kerstin J
AU  - Plessen KJ
AD  - Child and Adolescent Mental Health Centre, Capital Region Copenhagen, Copenhagen, 
      Denmark.
AD  - Division of Child and Adolescent Psychiatry, Department of Psychiatry, University 
      Hospital Lausanne, Lausanne, Switzerland.
FAU - Ramos-Quiroga, J Antoni
AU  - Ramos-Quiroga JA
AD  - Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, 
      Catalonia, Spain.
AD  - Group of Psychiatry, Mental Health and Addictions, Vall d'Hebron Research 
      Institute (VHIR), Barcelona, Catalonia, Spain.
AD  - Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, 
      Catalonia, Spain.
AD  - Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, 
      Barcelona, Catalonia, Spain.
FAU - Reif, Andreas
AU  - Reif A
AD  - Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University 
      Hospital Frankfurt, Frankfurt, Germany.
FAU - Reneman, Liesbeth
AU  - Reneman L
AD  - Academic Medical Center, Amsterdam University Medical Center, Amsterdam, The 
      Netherlands.
FAU - Rosa, Pedro G P
AU  - Rosa PGP
AD  - Laboratory of Psychiatric Neuroimaging (LIM-21, Department and Institute of 
      Psychiatry, Hospital das Clinicas HCFMUSP, Faculty of Medicine, University of São 
      Paulo, Sao Paulo, Sao Paulo, Brazil.
FAU - Rubia, Katya
AU  - Rubia K
AD  - Department of Child and Adolescent Psychiatry, Institute of Psychiatry, 
      Psychology and Neuroscience, King's College London, London, UK.
FAU - Schrantee, Anouk
AU  - Schrantee A
AD  - Department of Radiology and Nuclear Medicine, Amsterdam University Medical 
      Centers, Amsterdam, The Netherlands.
FAU - Schweren, Lizanne J S
AU  - Schweren LJS
AD  - Department of Psychiatry, Interdisciplinary Center Psychopathology and Emotion 
      Regulation (ICPE), University Medical Center Groningen, University of Groningen, 
      Groningen, The Netherlands.
FAU - Seitz, Jochen
AU  - Seitz J
AD  - Child and Adolescent Psychiatry, University Hospital RWTH Aachen, Aachen, 
      Germany.
FAU - Shaw, Philip
AU  - Shaw P
AD  - National Human Genome Research Institute and National Institute of Mental health, 
      Bethesda, MD, USA.
FAU - Silk, Tim J
AU  - Silk TJ
AD  - School of Psychology, Deakin University, Geelong, Vic., Australia.
AD  - Murdoch Children's Research Institute, Developmental Imaging, Melbourne, Vic., 
      Australia.
FAU - Skokauskas, Norbert
AU  - Skokauskas N
AD  - Centre for Child and Adolescent Mental Health, NTNU, Trondheim, Norway.
AD  - Institute of Mental Health, Norwegian University of Science and Technology, 
      Trondheim, Norway.
FAU - Soliva Vila, Juan C
AU  - Soliva Vila JC
AD  - Department of Psychiatry and Forensic Medicine, Universitat Autonoma de 
      Barcelona, Barcelona, Spain.
FAU - Stevens, Michael C
AU  - Stevens MC
AD  - Olin Neuropsychiatry Research Center, Hartford Hospital, Hartford, CT, USA.
AD  - Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
FAU - Sudre, Gustavo
AU  - Sudre G
AD  - National Human Genome Research Institute, Bethesda, MD, USA.
FAU - Tamm, Leanne
AU  - Tamm L
AD  - Department of Pediatrics, Cincinnati Children's Hospital Medical Center, 
      Cincinnati, OH, USA.
AD  - College of Medicine, University of Cincinnati, Cincinnati, OH, USA.
FAU - Tovar-Moll, Fernanda
AU  - Tovar-Moll F
AD  - D'Or Institute for Research and Education, Rio de Janeiro, Brazil.
AD  - Morphological Sciences Program, Federal University of Rio de Janeiro, Rio de 
      Janeiro, Brazil.
FAU - van Erp, Theo G M
AU  - van Erp TGM
AD  - Clinical Translational Neuroscience Laboratory, Department of Psychiatry and 
      Human Behavior, University of California Irvine, Irvine, CA, USA.
AD  - Center for the Neurobiology of Learning and Memory, University of California 
      Irvine, Irvine, CA, USA.
FAU - Vance, Alasdair
AU  - Vance A
AD  - Department of Paediatrics, University of Melbourne, Parkville, Vic., Australia.
FAU - Vilarroya, Oscar
AU  - Vilarroya O
AD  - Department of Psychiatry and Forensic Medicine, Universitat Autonoma de 
      Barcelona, Barcelona, Spain.
AD  - Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
FAU - Vives-Gilabert, Yolanda
AU  - Vives-Gilabert Y
AD  - Instituto ITACA, Universitat Politècnica de València, València, Spain.
FAU - von Polier, Georg G
AU  - von Polier GG
AD  - Child and Adolescent Psychiatry, University Hospital RWTH Aachen, Aachen, 
      Germany.
AD  - Brain and Behavior (INM-7), Institute for Neuroscience and Medicine, Research 
      Center Jülich, Jülich, Germany.
FAU - Walitza, Susanne
AU  - Walitza S
AD  - Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric 
      Hospital, University of Zurich, Zurich, Switzerland.
FAU - Yoncheva, Yuliya N
AU  - Yoncheva YN
AD  - Department of Child and Adolescent Psychiatry, NYU Child Study Center, Hassenfeld 
      Children's Hospital at NYU Langone, New York, NY, USA.
FAU - Zanetti, Marcus V
AU  - Zanetti MV
AD  - Department of Psychiatry, Faculty of Medicine, University of São Paulo, São 
      Paulo, Brazil.
AD  - Hospital Sírio-Libanês, São Paulo, Brazil.
FAU - Ziegler, Georg C
AU  - Ziegler GC
AD  - Division of Molecular Psychiatry, Center of Mental Health, University of 
      Würzburg, Würzburg, Germany.
FAU - Glahn, David C
AU  - Glahn DC
AD  - Olin Neuropsychiatry Research Center, Hartford Hospital, Hartford, CT, USA.
AD  - Department of Psychiatry, Boston Children's Hospital and Harvard Medical School, 
      Boston, MA, USA.
FAU - Jahanshad, Neda
AU  - Jahanshad N
AD  - Imaging Genetics Center, Stevens Neuroimaging and Informatics Institute, Keck 
      School of Medicine of USC, Los Angeles, CA, USA.
FAU - Medland, Sarah E
AU  - Medland SE
AD  - Psychiatric Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Qld, 
      Australia.
CN  - ENIGMA ADHD Working Group
FAU - Thompson, Paul M
AU  - Thompson PM
AD  - Imaging Genetics Center, Stevens Institute for Neuroimaging & Informatics, Keck 
      School of Medicine, University of Southern California, Los Angeles, CA, USA.
FAU - Fisher, Simon E
AU  - Fisher SE
AD  - Language and Genetics Department, Max Planck Institute for Psycholinguistics, 
      Nijmegen, The Netherlands.
AD  - Donders Institute for Brain, Cognition and Behaviour, Radboud University, 
      Nijmegen, Netherlands.
FAU - Franke, Barbara
AU  - Franke B
AUID- ORCID: 0000-0003-4375-6572
AD  - Department of Human Genetics, Radboud University Medical Center, Nijmegen, 
      Netherlands.
AD  - Donders Institute for Brain, Cognition and Behaviour, Radboud University, 
      Nijmegen, Netherlands.
AD  - Department of Psychiatry, Radboud University Medical Center, Nijmegen, The 
      Netherlands.
FAU - Francks, Clyde
AU  - Francks C
AUID- ORCID: 0000-0002-9098-890X
AD  - Language and Genetics Department, Max Planck Institute for Psycholinguistics, 
      Nijmegen, The Netherlands.
AD  - Donders Institute for Brain, Cognition and Behaviour, Radboud University, 
      Nijmegen, Netherlands.
LA  - eng
GR  - P50 HD105351/HD/NICHD NIH HHS/United States
GR  - UL1 TR002369/TR/NCATS NIH HHS/United States
GR  - U54 EB020403/EB/NIBIB NIH HHS/United States
GR  - U01 DA041148/DA/NIDA NIH HHS/United States
GR  - R01 MH115357/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20210322
PL  - England
TA  - J Child Psychol Psychiatry
JT  - Journal of child psychology and psychiatry, and allied disciplines
JID - 0375361
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - *Attention Deficit Disorder with Hyperactivity
MH  - *Autism Spectrum Disorder
MH  - Brain/diagnostic imaging
MH  - Caudate Nucleus
MH  - Child
MH  - Humans
MH  - Magnetic Resonance Imaging
PMC - PMC8455726
MID - NIHMS1675125
OTO - NOTNLM
OT  - Attention-deficit
OT  - brain asymmetry
OT  - brain laterality
OT  - hyperactivity disorder
OT  - large-scale data
OT  - structural MRI
COIS- Conflict of interest statement: See Acknowledgements for full disclosures.
EDAT- 2021/03/23 06:00
MHDA- 2021/10/27 06:00
CRDT- 2021/03/22 08:39
PHST- 2020/12/19 00:00 [accepted]
PHST- 2021/03/23 06:00 [pubmed]
PHST- 2021/10/27 06:00 [medline]
PHST- 2021/03/22 08:39 [entrez]
AID - 10.1111/jcpp.13396 [doi]
PST - ppublish
SO  - J Child Psychol Psychiatry. 2021 Oct;62(10):1202-1219. doi: 10.1111/jcpp.13396. 
      Epub 2021 Mar 22.

PMID- 26822784
OWN - NLM
STAT- MEDLINE
DCOM- 20161213
LR  - 20200930
IS  - 1552-4833 (Electronic)
IS  - 1552-4825 (Linking)
VI  - 170A
IP  - 4
DP  - 2016 Apr
TI  - CLTC as a clinically novel gene associated with multiple malformations and 
      developmental delay.
PG  - 958-66
LID - 10.1002/ajmg.a.37506 [doi]
AB  - Diagnostic exome sequencing has recently emerged as an invaluable tool in 
      determining the molecular etiology of cases involving dysmorphism and 
      developmental delay that are otherwise unexplained by more traditional methods of 
      genetic testing. Our patient was large for gestational age at 35 weeks, delivered 
      to a 27-year-old primigravid Caucasian whose pregnancy was complicated by 
      preeclampsia. Neonatal period was notable for hypoglycemia, apnea, bradycardia, 
      hyperbilirubinemia, grade I intraventricular hemorrhage, subdural hematoma, 
      laryngomalacia, hypotonia, and feeding difficulties. The patient had numerous 
      minor dysmorphic features. At three and a half years of age, she has global 
      developmental delays and nystagmus, and is being followed for a mediastinal 
      neuroblastoma that is currently in remission. Karyotype and oligo-microarray were 
      normal. Whole-exome, next generation sequencing (NGS) coupled to bioinformatic 
      filtering and expert medical review at Ambry Genetics revealed 14 mutations in 9 
      genes, and these genes underwent medical review. A heterozygous de novo 
      frameshift mutation, c.2737_2738dupGA p.D913Efs*59, in which two nucleotides are 
      duplicated in exon 17 of the CLTC gene, results in substitution of glutamic acid 
      for aspartic acid at position 913 of the protein, as well as a frame shift that 
      results in a premature termination codon situated 58 amino acids downstream. 
      Clathrin Heavy Chain 1 (CHC1) has been shown to play an important role in the 
      brain for vesicle recycling and neurotransmitter release at pre-synaptic nerve 
      terminals. There is also evidence implicating it in the proper development of the 
      placenta during the early stages of pregnancy. The CLTC alteration identified 
      herein is likely to provide an explanation for the patient's adverse phenotype. 
      Ongoing functional studies will further define the impact of this alteration on 
      CHC1 function and consequently, human disease.
CI  - © 2016 Wiley Periodicals, Inc.
FAU - DeMari, Joseph
AU  - DeMari J
AD  - Department of Pediatrics, Section of Medical Genetics, SUNY Upstate Medical 
      University, Syracuse, New York.
FAU - Mroske, Cameron
AU  - Mroske C
AD  - Ambry Genetics Corporation, Aliso Viejo, California.
FAU - Tang, Sha
AU  - Tang S
AD  - Ambry Genetics Corporation, Aliso Viejo, California.
FAU - Nimeh, Joseph
AU  - Nimeh J
AD  - Department of Pediatrics, Section of Medical Genetics, SUNY Upstate Medical 
      University, Syracuse, New York.
FAU - Miller, Ryan
AU  - Miller R
AD  - Department of Pediatrics, Section of Medical Genetics, SUNY Upstate Medical 
      University, Syracuse, New York.
FAU - Lebel, Robert R
AU  - Lebel RR
AD  - Department of Pediatrics, Section of Medical Genetics, SUNY Upstate Medical 
      University, Syracuse, New York.
LA  - eng
PT  - Journal Article
DEP - 20160129
PL  - United States
TA  - Am J Med Genet A
JT  - American journal of medical genetics. Part A
JID - 101235741
RN  - 0 (CLTC protein, human)
RN  - 114899-12-6 (Clathrin Heavy Chains)
SB  - IM
MH  - Abnormalities, Multiple/*diagnosis/*genetics
MH  - Child, Preschool
MH  - Chromosome Segregation
MH  - Clathrin Heavy Chains/*genetics
MH  - Computational Biology
MH  - Developmental Disabilities/*diagnosis/*genetics
MH  - Facies
MH  - Female
MH  - Gene Duplication
MH  - *Genetic Association Studies
MH  - High-Throughput Nucleotide Sequencing
MH  - Humans
MH  - Inheritance Patterns
MH  - Male
OTO - NOTNLM
OT  - CLTC
OT  - clathrin
OT  - developmental delay
OT  - whole exome sequencing
EDAT- 2016/01/30 06:00
MHDA- 2016/12/15 06:00
CRDT- 2016/01/30 06:00
PHST- 2015/06/12 00:00 [received]
PHST- 2015/11/20 00:00 [accepted]
PHST- 2016/01/30 06:00 [entrez]
PHST- 2016/01/30 06:00 [pubmed]
PHST- 2016/12/15 06:00 [medline]
AID - 10.1002/ajmg.a.37506 [doi]
PST - ppublish
SO  - Am J Med Genet A. 2016 Apr;170A(4):958-66. doi: 10.1002/ajmg.a.37506. Epub 2016 
      Jan 29.

PMID- 29357741
OWN - NLM
STAT- MEDLINE
DCOM- 20200515
LR  - 20200515
IS  - 1557-1246 (Electronic)
IS  - 1087-0547 (Linking)
VI  - 23
IP  - 6
DP  - 2019 Apr
TI  - Clinical Validation of Eye Vergence as an Objective Marker for Diagnosis of ADHD 
      in Children.
PG  - 599-614
LID - 10.1177/1087054717749931 [doi]
AB  - OBJECTIVE: ADHD youth show poor oculomotor control. Recent research shows that 
      attention-related eye vergence is weak in ADHD children. METHOD: To validate 
      vergence as a marker to classify ADHD, we assessed the modulation in the angle of 
      vergence of children ( n = 43) previously diagnosed with ADHD while performing an 
      attention task and compared the results with age-matched clinical controls ( n = 
      19) and healthy peers ( n = 30). RESULTS: We observed strong vergence responses 
      in healthy participants and weak vergence in the clinical controls. ADHD children 
      showed no significant vergence responses. Machine-learning models classified ADHD 
      patients ( n = 21) from healthy controls ( n = 21) with an accuracy of 96.3% 
      (false positive [FP]: 5.12%; false negative [FN]: 0%; area under the curve [AUC]: 
      0.99) and ADHD children ( n = 11) from clinical controls ( n = 14) with an 
      accuracy of 85.7% (FP: 4.5%; FN: 19.2%, AUC: 0.90). CONCLUSION: In combination 
      with an attention task, vergence responses can be used as an objective marker to 
      detect ADHD in children.
FAU - Varela Casal, Paloma
AU  - Varela Casal P
AD  - 1 Departament of Psychiatry, Hospital de Mataró, Barcelona, Spain.
AD  - 2 Department of Psychiatry and Forensic Medicine, Universitat Autònoma de 
      Barcelona, Spain.
FAU - Lorena Esposito, Flavia
AU  - Lorena Esposito F
AD  - 3 University of Barcelona, Spain.
AD  - 4 Braingaze SL, Mataró, Spain.
FAU - Morata Martínez, Imanol
AU  - Morata Martínez I
AD  - 4 Braingaze SL, Mataró, Spain.
AD  - 5 Universitat Politècnica de Catalunya, Barcelona, Spain.
FAU - Capdevila, Alba
AU  - Capdevila A
AD  - 1 Departament of Psychiatry, Hospital de Mataró, Barcelona, Spain.
FAU - Solé Puig, Maria
AU  - Solé Puig M
AD  - 3 University of Barcelona, Spain.
FAU - de la Osa, Núria
AU  - de la Osa N
AD  - 6 Departament de Psicologia Clínica i de la Salud, Universitat Autònoma de 
      Barcelona, Spain.
FAU - Ezpeleta, Lourdes
AU  - Ezpeleta L
AD  - 6 Departament de Psicologia Clínica i de la Salud, Universitat Autònoma de 
      Barcelona, Spain.
FAU - Perera I Lluna, Alexandre
AU  - Perera I Lluna A
AUID- ORCID: 0000-0001-6427-851X
AD  - 5 Universitat Politècnica de Catalunya, Barcelona, Spain.
FAU - Faraone, Stephen V
AU  - Faraone SV
AD  - 7 SUNY Upstate Medical University, Syracuse, USA.
FAU - Ramos-Quiroga, Josep Antoni
AU  - Ramos-Quiroga JA
AD  - 2 Department of Psychiatry and Forensic Medicine, Universitat Autònoma de 
      Barcelona, Spain.
AD  - 8 Hospital Universitari Vall d'Hebron, Barcelona, Spain.
AD  - 9 Biomedical Network Research Centre on Mental Health, Barcelona, Spain.
FAU - Supèr, Hans
AU  - Supèr H
AD  - 3 University of Barcelona, Spain.
AD  - 4 Braingaze SL, Mataró, Spain.
AD  - 10 Institut de Neurociències, Universitat de Barcelona, Spain ( www.ir3c.ub.edu 
      ).
AD  - 12 Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, 
      Spain.
FAU - Cañete, Jose
AU  - Cañete J
AD  - 1 Departament of Psychiatry, Hospital de Mataró, Barcelona, Spain.
LA  - eng
PT  - Journal Article
DEP - 20180122
PL  - United States
TA  - J Atten Disord
JT  - Journal of attention disorders
JID - 9615686
RN  - 0 (Biomarkers)
SB  - IM
MH  - Adolescent
MH  - Attention Deficit Disorder with Hyperactivity/*diagnosis
MH  - Biomarkers
MH  - Case-Control Studies
MH  - Child
MH  - *Convergence, Ocular
MH  - Humans
MH  - Reproducibility of Results
OTO - NOTNLM
OT  - ADHD
OT  - binocular
OT  - biomarker
OT  - children
OT  - diagnosis
OT  - eye vergence
EDAT- 2018/01/24 06:00
MHDA- 2020/05/16 06:00
CRDT- 2018/01/24 06:00
PHST- 2018/01/24 06:00 [pubmed]
PHST- 2020/05/16 06:00 [medline]
PHST- 2018/01/24 06:00 [entrez]
AID - 10.1177/1087054717749931 [doi]
PST - ppublish
SO  - J Atten Disord. 2019 Apr;23(6):599-614. doi: 10.1177/1087054717749931. Epub 2018 
      Jan 22.

PMID- 35567871
OWN - NLM
STAT- MEDLINE
DCOM- 20220621
LR  - 20220726
IS  - 1573-2509 (Electronic)
IS  - 0920-9964 (Linking)
VI  - 244
DP  - 2022 Jun
TI  - A novel longitudinal clustering approach to psychopathology across diagnostic 
      entities in the hospital-based PsyCourse study.
PG  - 29-38
LID - S0920-9964(22)00163-3 [pii]
LID - 10.1016/j.schres.2022.05.001 [doi]
AB  - Biological research and clinical management in psychiatry face two major 
      impediments: the high degree of overlap in psychopathology between diagnoses and 
      the inherent heterogeneity with regard to severity. Here, we aim to stratify 
      cases into homogeneous transdiagnostic subgroups using psychometric information 
      with the ultimate aim of identifying individuals with higher risk for severe 
      illness. 397 participants of the PsyCourse study with schizophrenia- or 
      bipolar-spectrum diagnoses were prospectively phenotyped over 18 months. Factor 
      analysis of mixed data of different rating scales and subsequent longitudinal 
      clustering were used to cluster disease trajectories. Five clusters of 
      longitudinal trajectories were identified in the psychopathologic dimensions. 
      Clusters differed significantly with regard to Global Assessment of Functioning, 
      disease course, and-in some cases-diagnosis while there were no significant 
      differences regarding sex, age at baseline or onset, duration of illness, or 
      polygenic burden for schizophrenia. Longitudinal clustering may aid in 
      identifying transdiagnostic homogeneous subgroups of individuals with severe 
      psychiatric disease.
CI  - Copyright © 2022. Published by Elsevier B.V.
FAU - Schulte, Eva C
AU  - Schulte EC
AD  - Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, 
      Nussbaumstr 7, Munich 80336, Germany; Institute of Psychiatric Phenomics and 
      Genomics (IPPG), University Hospital, LMU Munich, Nussbaumstr 7, Munich 80336, 
      Germany. Electronic address: eva.schulte@med.uni-muenchen.de.
FAU - Kondofersky, Ivan
AU  - Kondofersky I
AD  - Institute of Computational Biology, Helmholtz Center Munich, Ingolstädter 
      Landstr. 1, Oberschleissheim 85764, Germany; Department of Mathematics, 
      Technische Universität München, Boltzmannstr 3, Garching 85748, Germany.
FAU - Budde, Monika
AU  - Budde M
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Nussbaumstr 7, Munich 80336, Germany.
FAU - Papiol, Sergi
AU  - Papiol S
AD  - Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, 
      Nussbaumstr 7, Munich 80336, Germany; Institute of Psychiatric Phenomics and 
      Genomics (IPPG), University Hospital, LMU Munich, Nussbaumstr 7, Munich 80336, 
      Germany.
FAU - Senner, Fanny
AU  - Senner F
AD  - Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, 
      Nussbaumstr 7, Munich 80336, Germany; Institute of Psychiatric Phenomics and 
      Genomics (IPPG), University Hospital, LMU Munich, Nussbaumstr 7, Munich 80336, 
      Germany.
FAU - Schaupp, Sabrina K
AU  - Schaupp SK
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Nussbaumstr 7, Munich 80336, Germany.
FAU - Reich-Erkelenz, Daniela
AU  - Reich-Erkelenz D
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Nussbaumstr 7, Munich 80336, Germany.
FAU - Klöhn-Saghatolislam, Farahnaz
AU  - Klöhn-Saghatolislam F
AD  - Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, 
      Nussbaumstr 7, Munich 80336, Germany; Institute of Psychiatric Phenomics and 
      Genomics (IPPG), University Hospital, LMU Munich, Nussbaumstr 7, Munich 80336, 
      Germany.
FAU - Kalman, Janos L
AU  - Kalman JL
AD  - Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, 
      Nussbaumstr 7, Munich 80336, Germany; Institute of Psychiatric Phenomics and 
      Genomics (IPPG), University Hospital, LMU Munich, Nussbaumstr 7, Munich 80336, 
      Germany; International Max Planck Research School (IMPRS-TP), Max-Planck 
      Institute of Psychiatry, Munich 80804, Germany.
FAU - Gade, Katrin
AU  - Gade K
AD  - Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, 
      von-Siebold-Str 5, Goettingen, 37075, Germany.
FAU - Hake, Maria
AU  - Hake M
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Nussbaumstr 7, Munich 80336, Germany.
FAU - Comes, Ashley L
AU  - Comes AL
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Nussbaumstr 7, Munich 80336, Germany; International Max Planck Research 
      School (IMPRS-TP), Max-Planck Institute of Psychiatry, Munich 80804, Germany.
FAU - Anderson-Schmidt, Heike
AU  - Anderson-Schmidt H
AD  - Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, 
      von-Siebold-Str 5, Goettingen, 37075, Germany.
FAU - Adorjan, Kristina
AU  - Adorjan K
AD  - Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, 
      Nussbaumstr 7, Munich 80336, Germany; Institute of Psychiatric Phenomics and 
      Genomics (IPPG), University Hospital, LMU Munich, Nussbaumstr 7, Munich 80336, 
      Germany.
FAU - Juckel, Georg
AU  - Juckel G
AD  - Department of Psychiatry, Psychotherapy and Preventive Medicine, LWL University 
      Hospital, Ruhr University Bochum, Alexandrinenstr. 1-3, Bochum 44791, Germany.
FAU - Schmauß, Max
AU  - Schmauß M
AD  - Clinic for Psychiatry, Psychotherapy and Psychosomatics, Bezirkskrankenhaus 
      Augsburg, Augsburg University, Dr.-Mack-Str. 1, Augsburg 86156, Germany.
FAU - Zimmermann, Jörg
AU  - Zimmermann J
AD  - Karl-Jaspers Clinic, European Medical School Oldenburg-Groningen, 
      Hermann-Ehlers-Str. 7, Bad Zwischenahn 26160, Germany.
FAU - Reimer, Jens
AU  - Reimer J
AD  - Center for Psychosocial Medicine, Gesundheit Nord Klinikverbund Bremen, Züricher 
      Str 40, Bremen 28325, Germany; Department of Psychiatry and Psychotherapy, 
      University Hospital Hamburg-Eppendorf, Martinistr 52, Hamburg 20246, Germany.
FAU - Wiltfang, Jens
AU  - Wiltfang J
AD  - Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, 
      von-Siebold-Str 5, Goettingen, 37075, Germany; German Center for 
      Neurodegenerative Diseases (DZNE), von-Siebold-Str. 3a, Goettingen 37075, 
      Germany; Neurosciences and Signaling Group, Institute of Biomedicine (iBiMED), 
      Department of Medical Sciences, University of Aveiro, Agra do Crasto, 3810-193 
      Aveiro, Portugal.
FAU - Reininghaus, Eva Z
AU  - Reininghaus EZ
AD  - Department of Psychiatry and Psychotherapeutic Medicine, Research Unit for 
      Bipolar Affective Disorder, Medical University of Graz, Auenbruggerplatz 31, Graz 
      8036, Austria.
FAU - Anghelescu, Ion-George
AU  - Anghelescu IG
AD  - Clinic Pacelliallee, Pacelliallee 6, Berlin 14195, Germany.
FAU - Konrad, Carsten
AU  - Konrad C
AD  - Department of Psychiatry and Psychotherapy, Agaplesion Diakonieklinikum, 
      Elise-Averdieck-Str. 17, Rotenburg 27356, Germany.
FAU - Figge, Christian
AU  - Figge C
AD  - Karl-Jaspers Clinic, European Medical School Oldenburg-Groningen, 
      Hermann-Ehlers-Str. 7, Bad Zwischenahn 26160, Germany.
FAU - von Hagen, Martin
AU  - von Hagen M
AD  - Clinic for Psychiatry and Psychotherapy, Clinical Center Werra-Meißner, Elsa 
      Branströmstrasse 1, Eschwege 37269, Germany.
FAU - Jäger, Markus
AU  - Jäger M
AD  - Department of Psychiatry II, Ulm University, Bezirkskrankenhaus Günzburg, 
      Günzburg 89312, Germany.
FAU - Dietrich, Detlef E
AU  - Dietrich DE
AD  - AMEOS Clinical Center Hildesheim, Goslarsche Landstr 60, Hildesheim 31135, 
      Germany; Center for Systems Neuroscience Hannover, Bünteweg 2, Hannover 30559, 
      Germany; Burghof-Klinik Rinteln, Ritterstr. 9, Rinteln 31737, Germany.
FAU - Spitzer, Carsten
AU  - Spitzer C
AD  - Department of Psychosomatics and Psychotherapeutic Medicine, University Medical 
      Center Rostock, Gehlsheimer Str 20, Rostock 18147, Germany.
FAU - Witt, Stephanie H
AU  - Witt SH
AD  - Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental 
      Health, Medical Faculty Mannheim, University of Heidelberg, J5, Mannheim 68159, 
      Germany.
FAU - Forstner, Andreas J
AU  - Forstner AJ
AD  - Institute of Human Genetics, University of Bonn, School of Medicine & University 
      Hospital Bonn, Venusberg-Campus 1, Bonn 53127, Germany; Centre for Human 
      Genetics, University of Marburg, Baldingerstr, Marburg 35033, Germany.
FAU - Rietschel, Marcella
AU  - Rietschel M
AD  - Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental 
      Health, Medical Faculty Mannheim, University of Heidelberg, J5, Mannheim 68159, 
      Germany.
FAU - Nöthen, Markus M
AU  - Nöthen MM
AD  - Institute of Human Genetics, University of Bonn, School of Medicine & University 
      Hospital Bonn, Venusberg-Campus 1, Bonn 53127, Germany; Department of Genomics, 
      Life & Brain Center, University of Bonn, Venusberg-Campus 1, Bonn 53127, Germany.
FAU - Falkai, Peter
AU  - Falkai P
AD  - Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, 
      Nussbaumstr 7, Munich 80336, Germany.
FAU - Heilbronner, Urs
AU  - Heilbronner U
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Nussbaumstr 7, Munich 80336, Germany.
FAU - Mueller, Nikola S
AU  - Mueller NS
AD  - Institute of Computational Biology, Helmholtz Center Munich, Ingolstädter 
      Landstr. 1, Oberschleissheim 85764, Germany.
FAU - Schulze, Thomas G
AU  - Schulze TG
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Nussbaumstr 7, Munich 80336, Germany; Department of Psychiatry and 
      Psychotherapy, University Medical Center Goettingen, von-Siebold-Str 5, 
      Goettingen, 37075, Germany; Department of Genetic Epidemiology in Psychiatry, 
      Central Institute of Mental Health, Medical Faculty Mannheim, University of 
      Heidelberg, J5, Mannheim 68159, Germany; Department of Psychiatry and Behavioral 
      Sciences, Johns Hopkins University, 1800 Orleans St, Baltimore, MD 21287, USA; 
      Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical 
      University, |50 East Adams Street, Syracuse, NY 13210, USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20220511
PL  - Netherlands
TA  - Schizophr Res
JT  - Schizophrenia research
JID - 8804207
SB  - IM
MH  - *Bipolar Disorder/diagnosis/epidemiology/psychology
MH  - Cluster Analysis
MH  - Hospitals
MH  - Humans
MH  - *Mental Disorders/diagnosis/epidemiology
MH  - Psychopathology
OTO - NOTNLM
OT  - Bipolar disorder
OT  - Cluster analysis
OT  - Machine learning
OT  - Psychopathology
OT  - Schizophrenia
EDAT- 2022/05/15 06:00
MHDA- 2022/06/22 06:00
CRDT- 2022/05/14 18:17
PHST- 2020/11/16 00:00 [received]
PHST- 2022/01/23 00:00 [revised]
PHST- 2022/05/02 00:00 [accepted]
PHST- 2022/05/15 06:00 [pubmed]
PHST- 2022/06/22 06:00 [medline]
PHST- 2022/05/14 18:17 [entrez]
AID - S0920-9964(22)00163-3 [pii]
AID - 10.1016/j.schres.2022.05.001 [doi]
PST - ppublish
SO  - Schizophr Res. 2022 Jun;244:29-38. doi: 10.1016/j.schres.2022.05.001. Epub 2022 
      May 11.

PMID- 27239542
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20160530
LR  - 20200929
IS  - 2352-8729 (Print)
IS  - 2352-8729 (Electronic)
IS  - 2352-8729 (Linking)
VI  - 2
DP  - 2016
TI  - Novel verbal fluency scores and structural brain imaging for prediction of 
      cognitive outcome in mild cognitive impairment.
PG  - 113-22
LID - 10.1016/j.dadm.2016.02.001 [doi]
AB  - INTRODUCTION: The objective of this study was to assess the utility of novel 
      verbal fluency scores for predicting conversion from mild cognitive impairment 
      (MCI) to clinical Alzheimer's disease (AD). METHOD: Verbal fluency lists 
      (animals, vegetables, F, A, and S) from 107 MCI patients and 51 cognitively 
      normal controls were transcribed into electronic text files and automatically 
      scored with traditional raw scores and five types of novel scores computed using 
      methods from machine learning and natural language processing. Additional scores 
      were derived from structural MRI scans: region of interest measures of 
      hippocampal and ventricular volumes and gray matter scores derived from 
      performing ICA on measures of cortical thickness. Over 4 years of follow-up, 24 
      MCI patients converted to AD. Using conversion as the outcome variable, ensemble 
      classifiers were constructed by training classifiers on the individual groups of 
      scores and then entering predictions from the primary classifiers into 
      regularized logistic regression models. Receiver operating characteristic curves 
      were plotted, and the area under the curve (AUC) was measured for classifiers 
      trained with five groups of available variables. RESULTS: Classifiers trained 
      with novel scores outperformed those trained with raw scores (AUC 0.872 vs 0.735; 
      P < .05 by DeLong test). Addition of structural brain measurements did not 
      improve performance based on novel scores alone. CONCLUSION: The brevity and cost 
      profile of verbal fluency tasks recommends their use for clinical decision 
      making. The word lists generated are a rich source of information for predicting 
      outcomes in MCI. Further work is needed to assess the utility of verbal fluency 
      for early AD.
FAU - Clark, David Glenn
AU  - Clark DG
AD  - Department of Neurology, Medical University of South Carolina, Charleston, SC, 
      USA; Department of Neurology, Ralph H. Johnson VA Medical Center, Charleston, SC, 
      USA.
FAU - McLaughlin, Paula M
AU  - McLaughlin PM
AD  - Ontario Neurodegenerative Disease Research Initiative, Schulich School of 
      Medicine and Dentistry, Western University, London, Ontario, Canada.
FAU - Woo, Ellen
AU  - Woo E
AD  - Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, 
      CA, USA.
FAU - Hwang, Kristy
AU  - Hwang K
AD  - Oakland University William Beaumont School of Medicine, Rochester, MI, USA.
FAU - Hurtz, Sona
AU  - Hurtz S
AD  - Drexel University College of Medicine, Philadelphia, PA, USA.
FAU - Ramirez, Leslie
AU  - Ramirez L
AD  - Drexel University College of Medicine, Philadelphia, PA, USA.
FAU - Eastman, Jennifer
AU  - Eastman J
AD  - Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
FAU - Dukes, Reshil-Marie
AU  - Dukes RM
AD  - Department of Neurology, Medical University of South Carolina, Charleston, SC, 
      USA.
FAU - Kapur, Puneet
AU  - Kapur P
AD  - Department of Neurology, SUNY Upstate Medical University, Syracuse, NY, USA.
FAU - DeRamus, Thomas P
AU  - DeRamus TP
AD  - Department of Psychology, University of Alabama at Birmingham, Birmingham, AL, 
      USA.
FAU - Apostolova, Liana G
AU  - Apostolova LG
AD  - Department of Neurology, Indiana University, Indianapolis, IN, USA.
LA  - eng
GR  - K02 AG048240/AG/NIA NIH HHS/United States
GR  - P30 AG010123-03/AG/NIA NIH HHS/United States
GR  - P50 AG016570/AG/NIA NIH HHS/United States
GR  - R01 AG040770/AG/NIA NIH HHS/United States
PT  - Journal Article
DEP - 20160215
PL  - United States
TA  - Alzheimers Dement (Amst)
JT  - Alzheimer's & dementia (Amsterdam, Netherlands)
JID - 101654604
PMC - PMC4879664
OTO - NOTNLM
OT  - Alzheimer's disease
OT  - Cognitive neuropsychology
OT  - Dementia
OT  - MCI (mild cognitive impairment)
OT  - MRI (magnetic resonance imaging)
OT  - Machine learning
OT  - Natural language processing
EDAT- 2016/05/31 06:00
MHDA- 2016/05/31 06:01
CRDT- 2016/05/31 06:00
PHST- 2016/05/31 06:00 [entrez]
PHST- 2016/05/31 06:00 [pubmed]
PHST- 2016/05/31 06:01 [medline]
AID - S2352-8729(16)00005-1 [pii]
AID - 10.1016/j.dadm.2016.02.001 [doi]
PST - epublish
SO  - Alzheimers Dement (Amst). 2016 Feb 15;2:113-22. doi: 10.1016/j.dadm.2016.02.001. 
      eCollection 2016.

PMID- 37059267
OWN - NLM
STAT- MEDLINE
DCOM- 20230724
LR  - 20230724
IS  - 1530-0307 (Electronic)
IS  - 0023-6837 (Linking)
VI  - 103
IP  - 7
DP  - 2023 Jul
TI  - Quantitative Nuclear Grading: An Objective, Artificial Intelligence-Facilitated 
      Foundation for Grading Noninvasive Papillary Urothelial Carcinoma.
PG  - 100155
LID - S0023-6837(23)00098-3 [pii]
LID - 10.1016/j.labinv.2023.100155 [doi]
AB  - In nonmuscle invasive bladder cancer, grade drives important treatment and 
      management decisions. However, grading is complex and qualitative, and it has 
      considerable interobserver and intraobserver variability. Previous literature 
      showed that nuclear features quantitatively differ between bladder cancer grades, 
      but these studies were limited in size and scope. In this study, we aimed to 
      measure morphometric features relevant to grading criteria and build simplified 
      classification models that objectively distinguish between the grades of 
      noninvasive papillary urothelial carcinoma (NPUC). We analyzed 516 low-grade and 
      125 high-grade 1.0-mm diameter image samples from a cohort of 371 NPUC cases. All 
      images underwent World Health Organization/International Society of Urological 
      Pathology 2004 consensus pathologist grading at our institution that was 
      subsequently validated by expert genitourinary pathologists from 2 additional 
      institutions. Automated software segmented the tissue regions and measured the 
      nuclear features of size, shape, and mitotic rate for millions of nuclei. Then, 
      we analyzed differences between grades and constructed classification models, 
      which had accuracies up to 88% and areas under the curve as high as 0.94. 
      Variation in the nuclear area was the best univariate discriminator and was 
      prioritized, along with the mitotic index, in the top-performing classifiers. 
      Adding shape-related variables improved accuracy further. These findings indicate 
      that nuclear morphometry and automated mitotic figure counts can be used to 
      objectively differentiate between grades of NPUC. Future efforts will adapt the 
      workflow to whole slides and tune grading thresholds to best reflect time to 
      recurrence and progression. Defining these essential quantitative elements of 
      grading has the potential to revolutionize pathologic assessment and provide a 
      starting point from which to improve the prognostic utility of grade.
CI  - Copyright © 2023 United States & Canadian Academy of Pathology. Published by 
      Elsevier Inc. All rights reserved.
FAU - Slotman, Ava
AU  - Slotman A
AD  - Division of Cancer Biology and Genetics, Queen's University, Kingston, Ontario, 
      Canada; Department of Pathology and Molecular Medicine, Queen's University, 
      Kingston, Ontario, Canada.
FAU - Xu, Minqi
AU  - Xu M
AD  - Department of Pathology and Molecular Medicine, Queen's University, Kingston, 
      Ontario, Canada.
FAU - Lindale, Katherine
AU  - Lindale K
AD  - Division of Cancer Biology and Genetics, Queen's University, Kingston, Ontario, 
      Canada; Department of Pathology and Molecular Medicine, Queen's University, 
      Kingston, Ontario, Canada.
FAU - Hardy, Céline
AU  - Hardy C
AD  - Division of Cancer Biology and Genetics, Queen's University, Kingston, Ontario, 
      Canada; Department of Pathology and Molecular Medicine, Queen's University, 
      Kingston, Ontario, Canada; Now with College of Medicine, Upstate Medical 
      University, Syracuse, New York.
FAU - Winkowski, Dan
AU  - Winkowski D
AD  - Visiopharm Corporation, Westminster, Colorado.
FAU - Baird, Regan
AU  - Baird R
AD  - Visiopharm Corporation, Westminster, Colorado.
FAU - Chen, Lina
AU  - Chen L
AD  - Department of Pathology and Molecular Medicine, Queen's University, Kingston, 
      Ontario, Canada; Now with Laboratory Medicine and Molecular Diagnostics, 
      Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, 
      Canada.
FAU - Lal, Priti
AU  - Lal P
AD  - Department of Pathology and Laboratory Medicine, University of Pennsylvania 
      Perelman School of Medicine, Philadelphia, Pennsylvania.
FAU - van der Kwast, Theodorus
AU  - van der Kwast T
AD  - University Health Network, Princess Margaret Cancer Center, University of 
      Toronto, Toronto, Ontario, Canada.
FAU - Jackson, Chelsea L
AU  - Jackson CL
AD  - Division of Cancer Biology and Genetics, Queen's University, Kingston, Ontario, 
      Canada; Department of Pathology and Molecular Medicine, Queen's University, 
      Kingston, Ontario, Canada; Now with CancerCare Manitoba Research Institute, 
      Winnipeg, Manitoba, Canada; Now with Department of Pathology, Rady Faculty of 
      Health Science, University of Manitoba, Winnipeg, Manitoba, Canada.
FAU - Gooding, Robert J
AU  - Gooding RJ
AD  - Division of Cancer Biology and Genetics, Queen's University, Kingston, Ontario, 
      Canada; Department of Physics, Engineering Physics, and Astronomy, Queen's 
      University, Kingston, Ontario, Canada.
FAU - Berman, David M
AU  - Berman DM
AD  - Division of Cancer Biology and Genetics, Queen's University, Kingston, Ontario, 
      Canada; Department of Pathology and Molecular Medicine, Queen's University, 
      Kingston, Ontario, Canada. Electronic address: bermand@queensu.ca.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20230413
PL  - United States
TA  - Lab Invest
JT  - Laboratory investigation; a journal of technical methods and pathology
JID - 0376617
SB  - IM
MH  - Humans
MH  - *Urinary Bladder Neoplasms/diagnosis/pathology
MH  - *Carcinoma, Transitional Cell/pathology
MH  - Artificial Intelligence
MH  - *Carcinoma, Papillary/pathology
MH  - Prognosis
MH  - Neoplasm Grading
OTO - NOTNLM
OT  - artificial intelligence
OT  - digital pathology
OT  - grading
OT  - urothelial carcinoma
EDAT- 2023/04/15 06:00
MHDA- 2023/07/24 06:42
CRDT- 2023/04/14 19:26
PHST- 2023/01/16 00:00 [received]
PHST- 2023/03/20 00:00 [revised]
PHST- 2023/04/01 00:00 [accepted]
PHST- 2023/07/24 06:42 [medline]
PHST- 2023/04/15 06:00 [pubmed]
PHST- 2023/04/14 19:26 [entrez]
AID - S0023-6837(23)00098-3 [pii]
AID - 10.1016/j.labinv.2023.100155 [doi]
PST - ppublish
SO  - Lab Invest. 2023 Jul;103(7):100155. doi: 10.1016/j.labinv.2023.100155. Epub 2023 
      Apr 13.

PMID- 32929213
OWN - NLM
STAT- MEDLINE
DCOM- 20220126
LR  - 20220726
IS  - 1476-5578 (Electronic)
IS  - 1359-4184 (Print)
IS  - 1359-4184 (Linking)
VI  - 26
IP  - 7
DP  - 2021 Jul
TI  - Transcription factor POU3F2 regulates TRIM8 expression contributing to cellular 
      functions implicated in schizophrenia.
PG  - 3444-3460
LID - 10.1038/s41380-020-00877-2 [doi]
AB  - Schizophrenia (SCZ) is a neuropsychiatric disorder with aberrant expression of 
      multiple genes. However, identifying its exact causal genes remains a 
      considerable challenge. The brain-specific transcription factor POU3F2 (POU 
      domain, class 3, transcription factor 2) has been recognized as a risk factor for 
      SCZ, but our understanding of its target genes and pathogenic mechanisms are 
      still limited. Here we report that POU3F2 regulates 42 SCZ-related genes in 
      knockdown and RNA-sequencing experiments of human neural progenitor cells (NPCs). 
      Among those SCZ-related genes, TRIM8 (Tripartite motif containing 8) is located 
      in SCZ-associated genetic locus and is aberrantly expressed in patients with SCZ. 
      Luciferase reporter and electrophoretic mobility shift assays (EMSA) showed that 
      POU3F2 induces TRIM8 expression by binding to the SCZ-associated SNP (single 
      nucleotide polymorphism) rs5011218, which affects POU3F2-binding efficiency at 
      the promoter region of TRIM8. We investigated the cellular functions of POU3F2 
      and TRIM8 as they co-regulate several pathways related to neural development and 
      synaptic function. Knocking down either POU3F2 or TRIM8 promoted the 
      proliferation of NPCs, inhibited their neuronal differentiation, and impaired the 
      excitatory synaptic transmission of NPC-derived neurons. These results indicate 
      that POU3F2 regulates TRIM8 expression through the SCZ-associated SNP rs5011218, 
      and both genes may be involved in the etiology of SCZ by regulating neural 
      development and synaptic function.
CI  - © 2020. The Author(s), under exclusive licence to Springer Nature Limited.
FAU - Ding, Chaodong
AU  - Ding C
AD  - Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School 
      of Life Sciences, Central South University, Changsha, Hunan, China.
AD  - Department of Psychiatry, State University of New York Upstate Medical 
      University, Syracuse, NY, USA.
FAU - Zhang, Chunling
AU  - Zhang C
AD  - Department of Neuroscience and Physiology, State University of New York Upstate 
      Medical University, Syracuse, NY, USA.
FAU - Kopp, Richard
AU  - Kopp R
AD  - Department of Psychiatry, State University of New York Upstate Medical 
      University, Syracuse, NY, USA.
FAU - Kuney, Liz
AU  - Kuney L
AUID- ORCID: 0000-0001-9324-5434
AD  - Department of Psychiatry, State University of New York Upstate Medical 
      University, Syracuse, NY, USA.
FAU - Meng, Qingtuan
AU  - Meng Q
AUID- ORCID: 0000-0002-6421-162X
AD  - Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School 
      of Life Sciences, Central South University, Changsha, Hunan, China.
AD  - Guangxi Clinical Research Center for Neurological Diseases, Affiliated Hospital 
      of Guilin Medical University, Guilin, Guangxi, China.
AD  - Guangxi Key Laboratory of Brain and Cognitive Neuroscience, Guilin Medical 
      University, Guilin, Guangxi, China.
FAU - Wang, Le
AU  - Wang L
AUID- ORCID: 0000-0002-6825-6614
AD  - Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School 
      of Life Sciences, Central South University, Changsha, Hunan, China.
AD  - Child Health Institute of New Jersey, Department of Neuroscience and Cell 
      Biology, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
FAU - Xia, Yan
AU  - Xia Y
AUID- ORCID: 0000-0001-6432-9911
AD  - Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School 
      of Life Sciences, Central South University, Changsha, Hunan, China.
AD  - Department of Psychiatry, State University of New York Upstate Medical 
      University, Syracuse, NY, USA.
FAU - Jiang, Yi
AU  - Jiang Y
AD  - Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School 
      of Life Sciences, Central South University, Changsha, Hunan, China.
AD  - Department of Molecular Physiology and Biophysics, Vanderbilt University, 
      Nashville, TN, USA.
FAU - Dai, Rujia
AU  - Dai R
AD  - Department of Psychiatry, State University of New York Upstate Medical 
      University, Syracuse, NY, USA.
FAU - Min, Shishi
AU  - Min S
AD  - Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School 
      of Life Sciences, Central South University, Changsha, Hunan, China.
AD  - Department of Psychiatry, State University of New York Upstate Medical 
      University, Syracuse, NY, USA.
FAU - Yao, Wei-Dong
AU  - Yao WD
AUID- ORCID: 0000-0001-5124-1486
AD  - Department of Psychiatry, State University of New York Upstate Medical 
      University, Syracuse, NY, USA.
FAU - Wong, Ma-Li
AU  - Wong ML
AUID- ORCID: 0000-0003-1512-3073
AD  - Department of Psychiatry, State University of New York Upstate Medical 
      University, Syracuse, NY, USA.
FAU - Ruan, Hongyu
AU  - Ruan H
AD  - Department of Psychiatry, State University of New York Upstate Medical 
      University, Syracuse, NY, USA. RuanH@upstate.edu.
FAU - Liu, Chunyu
AU  - Liu C
AUID- ORCID: 0000-0002-5986-4415
AD  - Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School 
      of Life Sciences, Central South University, Changsha, Hunan, China. 
      liuch@upstate.edu.
AD  - Department of Psychiatry, State University of New York Upstate Medical 
      University, Syracuse, NY, USA. liuch@upstate.edu.
AD  - School of Psychology, Shaanxi Normal University, Xi'an, Shaanxi, China. 
      liuch@upstate.edu.
FAU - Chen, Chao
AU  - Chen C
AUID- ORCID: 0000-0002-5114-2282
AD  - Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School 
      of Life Sciences, Central South University, Changsha, Hunan, China. 
      chenchao@sklmg.edu.cn.
AD  - National Clinical Research Center for Geriatric Disorders, the Xiangya Hospital, 
      Central South University, Changsha, Hunan, China. chenchao@sklmg.edu.cn.
AD  - Hunan Key Laboratory of Animal Models for Human Diseases, Central South 
      University, Changsha, Hunan, China. chenchao@sklmg.edu.cn.
AD  - Hunan Key Laboratory of Molecular Precision Medicine, Central South University, 
      Changsha, Hunan, China. chenchao@sklmg.edu.cn.
LA  - eng
GR  - U01 MH116489/MH/NIMH NIH HHS/United States
GR  - U01 MH103340/MH/NIMH NIH HHS/United States
GR  - R01 MH110920/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20200914
PL  - England
TA  - Mol Psychiatry
JT  - Molecular psychiatry
JID - 9607835
RN  - 0 (Carrier Proteins)
RN  - 0 (Homeodomain Proteins)
RN  - 0 (Nerve Tissue Proteins)
RN  - 0 (POU Domain Factors)
RN  - 0 (TRIM8 protein, human)
RN  - 0 (transcription factor Brn-2)
SB  - IM
MH  - *Carrier Proteins/genetics/metabolism
MH  - Gene Expression Regulation
MH  - *Homeodomain Proteins/genetics/metabolism
MH  - Humans
MH  - *Nerve Tissue Proteins/genetics/metabolism
MH  - *Neural Stem Cells/metabolism
MH  - *POU Domain Factors/genetics/metabolism
MH  - *Schizophrenia/genetics
PMC - PMC7956165
MID - NIHMS1626128
COIS- Conflict of interest: The authors declare that they have no conflicts of 
      interest.
EDAT- 2020/09/16 06:00
MHDA- 2022/01/27 06:00
CRDT- 2020/09/15 05:45
PHST- 2019/09/29 00:00 [received]
PHST- 2020/09/03 00:00 [accepted]
PHST- 2020/09/02 00:00 [revised]
PHST- 2020/09/16 06:00 [pubmed]
PHST- 2022/01/27 06:00 [medline]
PHST- 2020/09/15 05:45 [entrez]
AID - 10.1038/s41380-020-00877-2 [pii]
AID - 10.1038/s41380-020-00877-2 [doi]
PST - ppublish
SO  - Mol Psychiatry. 2021 Jul;26(7):3444-3460. doi: 10.1038/s41380-020-00877-2. Epub 
      2020 Sep 14.

PMID- 34476330
OWN - NLM
STAT- MEDLINE
DCOM- 20220323
LR  - 20220323
IS  - 2473-4284 (Electronic)
IS  - 2473-4284 (Linking)
VI  - 5
DP  - 2021 Aug
TI  - Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics 
      Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma.
LID - PO.20.00397 [pii]
LID - 10.1200/PO.20.00397 [doi]
AB  - PURPOSE: Combined hepatocellular cholangiocarcinoma (cHCC-CCA) is a rare, 
      aggressive primary liver carcinoma, with morphologic features of both 
      hepatocellular carcinomas (HCC) and liver cholangiocarcinomas (CCA). METHODS: The 
      genomic profiles of 4,975 CCA, 1,470 HCC, and 73 cHCC-CCA cases arising from 
      comprehensive genomic profiling in the course of clinical care were reviewed for 
      genomic alterations (GA), tumor mutational burden, microsatellite instability 
      status, genomic loss of heterozygosity, chromosomal aneuploidy, genomic ancestry, 
      and hepatitis B virus status. RESULTS: In cHCC-CCA, GA were most common in TP53 
      (65.8%), TERT (49.3%), and PTEN (9.6%), and 24.6% cHCC-CCA harbored potentially 
      targetable GA. Other GA were predominantly associated with either HCC or CCA, 
      including, but not limited to, TERT, FGFR2, IDH1, and presence of hepatitis B 
      virus. On the basis of these features, a machine learning (ML) model was trained 
      to classify a cHCC-CCA case as CCA-like or HCC-like. Of cHCC-CCA cases, 16% 
      (12/73) were ML-classified as CCA-like and 58% (42/73) cHCC-CCA were 
      ML-classified as HCC-like. The ML model classified more than 70% of cHCC-CCA as 
      CCA-like or HCC-like on the basis of genomic profiles, without additional 
      clinico-pathologic input. CONCLUSION: These findings demonstrate the use of ML 
      for classification as based on a targeted exome panel used during routine 
      clinical care. Classification of cHCC-CCA by genomic features alone creates 
      insights into the biology of the disease and warrants further investigation for 
      relevance to clinical care.
CI  - © 2021 by American Society of Clinical Oncology.
FAU - Murugesan, Karthikeyan
AU  - Murugesan K
AD  - Foundation Medicine Inc, Cambridge, MA.
FAU - Sharaf, Radwa
AU  - Sharaf R
AD  - Foundation Medicine Inc, Cambridge, MA.
FAU - Montesion, Meagan
AU  - Montesion M
AD  - Foundation Medicine Inc, Cambridge, MA.
FAU - Moore, Jay A
AU  - Moore JA
AD  - Foundation Medicine Inc, Cambridge, MA.
FAU - Pao, James
AU  - Pao J
AD  - Foundation Medicine Inc, Cambridge, MA.
FAU - Pavlick, Dean C
AU  - Pavlick DC
AD  - Foundation Medicine Inc, Cambridge, MA.
FAU - Frampton, Garrett M
AU  - Frampton GM
AD  - Foundation Medicine Inc, Cambridge, MA.
FAU - Upadhyay, Vivek A
AU  - Upadhyay VA
AD  - Foundation Medicine Inc, Cambridge, MA.
AD  - Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA.
FAU - Alexander, Brian M
AU  - Alexander BM
AD  - Foundation Medicine Inc, Cambridge, MA.
FAU - Miller, Vincent A
AU  - Miller VA
AD  - Foundation Medicine Inc, Cambridge, MA.
FAU - Javle, Milind M
AU  - Javle MM
AD  - Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson 
      Cancer Center, Houston, TX.
FAU - Bekaii Saab, Tanios S
AU  - Bekaii Saab TS
AD  - Mayo Clinic Cancer Center, Phoenix, AZ.
FAU - Albacker, Lee A
AU  - Albacker LA
AD  - Foundation Medicine Inc, Cambridge, MA.
FAU - Ross, Jeffrey S
AU  - Ross JS
AD  - Foundation Medicine Inc, Cambridge, MA.
AD  - Department of Pathology, State University of New York Upstate Medical University, 
      Syracuse, NY.
FAU - Ali, Siraj M
AU  - Ali SM
AD  - Foundation Medicine Inc, Cambridge, MA.
LA  - eng
PT  - Journal Article
DEP - 20210819
PL  - United States
TA  - JCO Precis Oncol
JT  - JCO precision oncology
JID - 101705370
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Bile Duct Neoplasms/*genetics/pathology
MH  - Carcinoma, Hepatocellular/*genetics/pathology
MH  - Cholangiocarcinoma/*genetics/pathology
MH  - Female
MH  - Genomics
MH  - Humans
MH  - Liver/pathology
MH  - Liver Neoplasms/*genetics/pathology
MH  - Machine Learning
MH  - Male
MH  - Middle Aged
MH  - Young Adult
PMC - PMC8384404
COIS- Karthikeyan Murugesan Employment: Foundation Medicine Stock and Other Ownership 
      Interests: Roche Pharma AG Patents, Royalties, Other Intellectual Property: 
      Antibiotic resistance causation identification (US10629291B2) filed with 
      Koninklijke Philips NV, Analytic prediction of antibiotic susceptibility 
      (US20190279738A1) filed with Koninklijke Philips NV, Methods and devices for 
      characterizing and treating combined hepatocellular cholangiocarcinoma, with 
      Foundation Medicine Inc Travel, Accommodations, Expenses: Foundation Medicine 
      Radwa Sharaf Employment: Foundation Medicine Stock and Other Ownership Interests: 
      Roche Meagan Montesion Employment: Foundation Medicine Stock and Other Ownership 
      Interests: Roche Jay A. Moore Employment: Foundation Medicine Stock and Other 
      Ownership Interests: Roche James Pao Employment: Foundation Medicine Stock and 
      Other Ownership Interests: Roche Research Funding: Foundation Medicine Patents, 
      Royalties, Other Intellectual Property: Provisional patent submitted for 
      Foundation Medicine, dealing with machine learning for gene predictions Dean C. 
      Pavlick Employment: Foundation Medicine Stock and Other Ownership Interests: 
      Roche Garrett M. Frampton Employment: Foundation Medicine Stock and Other 
      Ownership Interests: Roche Vivek A. Upadhyay Employment: EQRx Stock and Other 
      Ownership Interests: EQRx Consulting or Advisory Role: Foundation Medicine Brian 
      M. Alexander Employment: Foundation Medicine Leadership: Foundation Medicine 
      Stock and Other Ownership Interests: Roche Research Funding: Lilly, Puma 
      Biotechnology, Celgene Open Payments Link: 
      https://openpaymentsdata.cms.gov/physician/854258/summary Vincent A. Miller 
      Employment: Foundation Medicine, EQRx Leadership: Revolution Medicines Stock and 
      Other Ownership Interests: Foundation Medicine, Mirati Therapeutics, Revolution 
      Medicines, EQRx Patents, Royalties, Other Intellectual Property: Receives 
      periodic royalties related to T790M patent awarded to Memorial Sloan Kettering 
      Cancer Center Milind M. Javle Consulting or Advisory Role: QED Therapeutics, 
      Oncosil, Incyte, Mundipharma EDO GmbH, AstraZeneca, Merck, EMD Serono Other 
      Relationship: Rafael Pharmaceuticals, Incyte, Pieris Pharmaceuticals, Merck, 
      Merck Serono, Novartis, Seattle Genetics, BeiGene, QED Therapeutics, Bayer Tanios 
      S. Bekaii Saab Consulting or Advisory Role: Amgen, Ipsen, Lilly, Bayer, 
      Roche/Genentech, AbbVie, Incyte, Immuneering, Seattle Genetics, Pfizer, 
      Boehringer Ingelheim, Janssen, Eisai, Daiichi Sankyo/UCB Japan, AstraZeneca, 
      Exact Sciences, Natera, Treos Bio, Celularity, SOBI, BeiGene, Foundation Medicine 
      Patents, Royalties, Other Intellectual Property: Patent WO/2018/183488, Patent 
      WO/2019/055687 Other Relationship: Exelixis, Merck, AstraZeneca, Lilly, 
      Pancreatic Cancer Action Network Lee A. Albacker Employment: Foundation Medicine 
      Stock and Other Ownership Interests: Roche Jeffrey S. Ross Employment: Foundation 
      Medicine Leadership: Foundation Medicine Stock and Other Ownership Interests: 
      Foundation Medicine Consulting or Advisory Role: Celsius Therapeutics, Tango 
      Therapeutics Research Funding: Foundation Medicine Siraj M. Ali Employment: EQRx 
      Consulting or Advisory Role: Elevation Oncology, In8bio, Pillar Biosciences, 
      Takeda, ArcherDx Stock and Other Ownership Interests: In8bio, Pillar Biosciences, 
      EQRx Patents: Foundation Medicine No other potential conflicts of interest were 
      reported. Karthikeyan Murugesan Employment: Foundation Medicine Stock and Other 
      Ownership Interests: Roche Pharma AG Patents, Royalties, Other Intellectual 
      Property: Antibiotic resistance causation identification (US10629291B2) filed 
      with Koninklijke Philips NV, Analytic prediction of antibiotic susceptibility 
      (US20190279738A1) filed with Koninklijke Philips NV, Methods and devices for 
      characterizing and treating combined hepatocellular cholangiocarcinoma, with 
      Foundation Medicine Inc Travel, Accommodations, Expenses: Foundation Medicine 
      Radwa Sharaf Employment: Foundation Medicine Stock and Other Ownership Interests: 
      Roche Meagan Montesion Employment: Foundation Medicine Stock and Other Ownership 
      Interests: Roche Jay A. Moore Employment: Foundation Medicine Stock and Other 
      Ownership Interests: Roche James Pao Employment: Foundation Medicine Stock and 
      Other Ownership Interests: Roche Research Funding: Foundation Medicine Patents, 
      Royalties, Other Intellectual Property: Provisional patent submitted for 
      Foundation Medicine, dealing with machine learning for gene predictions Dean C. 
      Pavlick Employment: Foundation Medicine Stock and Other Ownership Interests: 
      Roche Garrett M. Frampton Employment: Foundation Medicine Stock and Other 
      Ownership Interests: Roche Vivek A. Upadhyay Employment: EQRx Stock and Other 
      Ownership Interests: EQRx Consulting or Advisory Role: Foundation Medicine Brian 
      M. Alexander Employment: Foundation Medicine Leadership: Foundation Medicine 
      Stock and Other Ownership Interests: Roche Research Funding: Lilly, Puma 
      Biotechnology, Celgene Open Payments Link: 
      https://openpaymentsdata.cms.gov/physician/854258/summary Vincent A. Miller 
      Employment: Foundation Medicine, EQRx Leadership: Revolution Medicines Stock and 
      Other Ownership Interests: Foundation Medicine, Mirati Therapeutics, Revolution 
      Medicines, EQRx Patents, Royalties, Other Intellectual Property: Receives 
      periodic royalties related to T790M patent awarded to Memorial Sloan Kettering 
      Cancer Center Milind M. Javle Consulting or Advisory Role: QED Therapeutics, 
      Oncosil, Incyte, Mundipharma EDO GmbH, AstraZeneca, Merck, EMD Serono Other 
      Relationship: Rafael Pharmaceuticals, Incyte, Pieris Pharmaceuticals, Merck, 
      Merck Serono, Novartis, Seattle Genetics, BeiGene, QED Therapeutics, Bayer Tanios 
      S. Bekaii Saab Consulting or Advisory Role: Amgen, Ipsen, Lilly, Bayer, 
      Roche/Genentech, AbbVie, Incyte, Immuneering, Seattle Genetics, Pfizer, 
      Boehringer Ingelheim, Janssen, Eisai, Daiichi Sankyo/UCB Japan, AstraZeneca, 
      Exact Sciences, Natera, Treos Bio, Celularity, SOBI, BeiGene, Foundation Medicine 
      Patents, Royalties, Other Intellectual Property: Patent WO/2018/183488, Patent 
      WO/2019/055687 Other Relationship: Exelixis, Merck, AstraZeneca, Lilly, 
      Pancreatic Cancer Action Network Lee A. Albacker Employment: Foundation Medicine 
      Stock and Other Ownership Interests: Roche Jeffrey S. Ross Employment: Foundation 
      Medicine Leadership: Foundation Medicine Stock and Other Ownership Interests: 
      Foundation Medicine Consulting or Advisory Role: Celsius Therapeutics, Tango 
      Therapeutics Research Funding: Foundation Medicine Siraj M. Ali Employment: EQRx 
      Consulting or Advisory Role: Elevation Oncology, In8bio, Pillar Biosciences, 
      Takeda, ArcherDx Stock and Other Ownership Interests: In8bio, Pillar Biosciences, 
      EQRx Patents: Foundation Medicine No other potential conflicts of interest were 
      reported.
EDAT- 2021/09/04 06:00
MHDA- 2021/09/04 06:01
CRDT- 2021/09/03 06:54
PHST- 2020/10/05 00:00 [received]
PHST- 2021/03/05 00:00 [revised]
PHST- 2021/06/11 00:00 [accepted]
PHST- 2021/09/03 06:54 [entrez]
PHST- 2021/09/04 06:00 [pubmed]
PHST- 2021/09/04 06:01 [medline]
AID - PO.20.00397 [pii]
AID - 10.1200/PO.20.00397 [doi]
PST - epublish
SO  - JCO Precis Oncol. 2021 Aug 19;5:PO.20.00397. doi: 10.1200/PO.20.00397. 
      eCollection 2021 Aug.

PMID- 26538069
OWN - NLM
STAT- MEDLINE
DCOM- 20161018
LR  - 20221207
IS  - 1098-1004 (Electronic)
IS  - 1059-7794 (Linking)
VI  - 37
IP  - 2
DP  - 2016 Feb
TI  - Clinical Sensitivity of Cystic Fibrosis Mutation Panels in a Diverse Population.
PG  - 201-8
LID - 10.1002/humu.22927 [doi]
AB  - Infants are screened for cystic fibrosis (CF) in New York State (NYS) using an 
      IRT-DNA algorithm. The purpose of this study was to validate and assess clinical 
      validity of the US FDA-cleared Illumina MiSeqDx CF 139-Variant Assay (139-VA) in 
      the diverse NYS CF population. The study included 439 infants with CF identified 
      via newborn screening (NBS) from 2002 to 2012. All had been screened using the 
      Abbott Molecular CF Genotyping Assay or the Hologic InPlex CF Molecular Test. All 
      with CF and zero or one mutation were tested using the 139-VA. DNA extracted from 
      dried blood spots was reliably and accurately genotyped using the 139-VA. 
      Sixty-three additional mutations were identified. Clinical sensitivity of three 
      panels ranged from 76.2% (23 mutations recommended for screening by ACMG/ACOG) to 
      79.7% (current NYS 39-mutation InPlex panel), up to 86.0% for the 139-VA. For 
      all, sensitivity was highest in Whites and lowest in the Black population. 
      Although the sample size was small, there was a nearly 20% increase in 
      sensitivity for the Black CF population using the 139-VA (68.2%) over the 
      ACMG/ACOG and InPlex panels (both 50.0%). Overall, the 139-VA is more sensitive 
      than other commercially available panels, and could be considered for NBS, 
      clinical, or research laboratories conducting CF screening.
CI  - © 2015 WILEY PERIODICALS, INC.
FAU - Hughes, Erin E
AU  - Hughes EE
AD  - Division of Genetics, Wadsworth Center, New York State Department of Health, 
      Albany, New York.
FAU - Stevens, Colleen F
AU  - Stevens CF
AD  - Division of Genetics, Wadsworth Center, New York State Department of Health, 
      Albany, New York.
FAU - Saavedra-Matiz, Carlos A
AU  - Saavedra-Matiz CA
AD  - Division of Genetics, Wadsworth Center, New York State Department of Health, 
      Albany, New York.
FAU - Tavakoli, Norma P
AU  - Tavakoli NP
AD  - Division of Genetics, Wadsworth Center, New York State Department of Health, 
      Albany, New York.
AD  - Department of Biomedical Sciences, School of Public Health, State University of 
      New York, Albany, New York.
FAU - Krein, Lea M
AU  - Krein LM
AD  - Division of Genetics, Wadsworth Center, New York State Department of Health, 
      Albany, New York.
FAU - Parker, April
AU  - Parker A
AD  - Division of Genetics, Wadsworth Center, New York State Department of Health, 
      Albany, New York.
FAU - Zhang, Zhen
AU  - Zhang Z
AD  - Applied Genomics Technologies Core, Wadsworth Center, New York State Department 
      of Health, Albany, New York.
FAU - Maloney, Breanne
AU  - Maloney B
AD  - Division of Genetics, Wadsworth Center, New York State Department of Health, 
      Albany, New York.
FAU - Vogel, Beth
AU  - Vogel B
AD  - Division of Genetics, Wadsworth Center, New York State Department of Health, 
      Albany, New York.
FAU - DeCelie-Germana, Joan
AU  - DeCelie-Germana J
AD  - Cohen Children's Medical Center of New York, Great Neck, New York.
FAU - Kier, Catherine
AU  - Kier C
AD  - University Medical Center at Stony Brook, Stony Brook, New York.
FAU - Anbar, Ran D
AU  - Anbar RD
AD  - SUNY Upstate Medical University/Golisano Children's Hospital, Syracuse, New York.
FAU - Berdella, Maria N
AU  - Berdella MN
AD  - The Cystic Fibrosis Center, Mount Sinai Beth Israel, New York, New York.
FAU - Comber, Paul G
AU  - Comber PG
AD  - Albany Medical Center, Albany, New York.
FAU - Dozor, Allen J
AU  - Dozor AJ
AD  - Maria Fareri Children's Hospital at Westchester Medical Center and New York 
      Medical College, Valhalla, New York.
FAU - Goetz, Danielle M
AU  - Goetz DM
AD  - Women & Children's Hospital of Buffalo, Buffalo, New York.
FAU - Guida, Louis Jr
AU  - Guida L Jr
AD  - Good Samaritan Hospital, North Babylon, New York.
FAU - Kattan, Meyer
AU  - Kattan M
AD  - Columbia University Medical Center, New York, New York.
FAU - Ting, Andrew
AU  - Ting A
AD  - Mount Sinai School of Medicine, New York, New York.
FAU - Voter, Karen Z
AU  - Voter KZ
AD  - Strong Memorial Hospital, University of Rochester Medical Center, Rochester, New 
      York.
CN  - New York State Cystic Fibrosis Newborn Screening Consortium
FAU - van Roey, Patrick
AU  - van Roey P
AD  - Division of Genetics, Wadsworth Center, New York State Department of Health, 
      Albany, New York.
AD  - Applied Genomics Technologies Core, Wadsworth Center, New York State Department 
      of Health, Albany, New York.
FAU - Caggana, Michele
AU  - Caggana M
AD  - Division of Genetics, Wadsworth Center, New York State Department of Health, 
      Albany, New York.
FAU - Kay, Denise M
AU  - Kay DM
AD  - Division of Genetics, Wadsworth Center, New York State Department of Health, 
      Albany, New York.
LA  - eng
PT  - Journal Article
DEP - 20151202
PL  - United States
TA  - Hum Mutat
JT  - Human mutation
JID - 9215429
RN  - 0 (CFTR protein, human)
RN  - 126880-72-6 (Cystic Fibrosis Transmembrane Conductance Regulator)
SB  - IM
MH  - *Biological Assay
MH  - Black People
MH  - Cystic Fibrosis/*diagnosis/ethnology/*genetics/pathology
MH  - Cystic Fibrosis Transmembrane Conductance Regulator/*genetics
MH  - Dried Blood Spot Testing
MH  - Female
MH  - Genetic Testing
MH  - Genotyping Techniques
MH  - Hispanic or Latino
MH  - Humans
MH  - Infant
MH  - Infant, Newborn
MH  - Male
MH  - *Mutation
MH  - Neonatal Screening
MH  - Sensitivity and Specificity
MH  - White People
OTO - NOTNLM
OT  - CFTR
OT  - NGS
OT  - clinical sensitivity
OT  - cystic fibrosis
OT  - mutation panel
OT  - newborn screening
OT  - next-generation sequencing
EDAT- 2015/11/06 06:00
MHDA- 2016/10/19 06:00
CRDT- 2015/11/06 06:00
PHST- 2015/08/10 00:00 [received]
PHST- 2015/10/20 00:00 [accepted]
PHST- 2015/11/06 06:00 [entrez]
PHST- 2015/11/06 06:00 [pubmed]
PHST- 2016/10/19 06:00 [medline]
AID - 10.1002/humu.22927 [doi]
PST - ppublish
SO  - Hum Mutat. 2016 Feb;37(2):201-8. doi: 10.1002/humu.22927. Epub 2015 Dec 2.
